PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Buttari, B; Profumo, E; Domenici, G; Tagliani, A; Ippoliti, F; Bonini, S; Businaro, R; Elenkov, I; Rigano, R				Buttari, Brigitta; Profumo, Elisabetta; Domenici, Giacomo; Tagliani, Angela; Ippoliti, Flora; Bonini, Sergio; Businaro, Rita; Elenkov, Ilia; Rigano, Rachele			Neuropeptide Y induces potent migration of human immature dendritic cells and promotes a T(h)2 polarization	FASEB JOURNAL			English	Article						adhesion to endothelial cells; cytokines; DC maturation; MAPKs; neuromediators; transendothelial migration	IN-VIVO; STIMULATES PROLIFERATION; RHEUMATOID-ARTHRITIS; ENDOTHELIAL-CELLS; SYMPATHETIC-NERVE; PEPTIDE-YY; IMMUNE; STRESS; NPY; RECEPTOR	Neuropeptide Y (NPY), a major autonomic nervous system and stress mediator, is emerging as an important regulator of inflammation, implicated in autoimmunity, asthma, atherosclerosis, and cancer. Yet the role of NPY in regulating phenotype and functions of dendritic cells (DCs), the professional antigen-presenting cells, remains undefined. Here we investigated whether NPY could induce DCs to migrate, mature, and polarize naive T lymphocytes. We found that NPY induced a dose-dependent migration of human monocyte-derived immature DCs through the engagement of NPY Y1 receptor and the activation of ERK and p38 mitogen-activated protein kinases. NPY promoted DC adhesion to endothelial cells and trans-endothelial migration. It failed to induce phenotypic DC maturation, whereas it conferred a T helper 2 (T(h)2) polarizing profile to DCs through the up-regulation of interleukin (IL)-6 and IL-10 production. Thus, during an immune/inflammatory response NPY may exert proinflammatory effects through the recruitment of immature DCs, but it may exert antiinflammatory effects by promoting a T(h)2 polarization. Locally, at inflammatory sites, cell recruitment could be amplified in conditions of intense acute, chronic, or cold stress. Thus, altered or amplified signaling through the NPY-NPY-Y1 receptor-DC axis may have implications for the development of inflammatory conditions.	[Buttari, Brigitta; Profumo, Elisabetta; Domenici, Giacomo; Rigano, Rachele] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy; [Tagliani, Angela; Businaro, Rita] Univ Roma La Sapienza, Dept Med Surg Sci & Biotechnol, I-00185 Rome, Italy; [Ippoliti, Flora] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Bonini, Sergio; Elenkov, Ilia] Italian Natl Res Council, Inst Neurobiol & Mol Med, Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS); Sapienza University Rome; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR)	Rigano, R (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.	rachele.rigano@iss.it	Businaro, Rita/AAG-1866-2021; Buttari, Brigitta/I-3030-2014; Riganò, Rachele/B-4256-2015; Bonini, Sergio/T-6594-2019; Buttari, Brigitta/ABB-4858-2021; Profumo, Elisabetta/B-4255-2015; Domenici, Giacomo/AAG-6224-2019	Businaro, Rita/0000-0002-7890-8524; Buttari, Brigitta/0000-0002-0575-4106; Riganò, Rachele/0000-0003-3014-3523; Bonini, Sergio/0000-0003-0079-3031; Buttari, Brigitta/0000-0002-0575-4106; Profumo, Elisabetta/0000-0002-7261-8884; reverberi, massimo/0000-0003-3671-6783; Domenici, Giacomo/0000-0002-3947-5930	European Community	European Community(European Commission)	The authors thank Dr. Giuseppina Mandarino for the linguistic revision of the manuscript and Mr. Massimo Delle Femmine for the graphic support of the figures. This work was supported by a Marie Curie International Reintegration grant (I.J.E.) within the 6th European Community Framework Program.	Bedoui S, 2004, TRENDS IMMUNOL, V25, P508, DOI 10.1016/j.it.2004.08.005; Bedoui S, 2002, J NEUROIMMUNOL, V132, P25, DOI 10.1016/S0165-5728(02)00278-3; Bedoui S, 2003, J NEUROIMMUNOL, V134, P1, DOI 10.1016/S0165-5728(02)00424-1; Bedoui S, 2001, J NEUROIMMUNOL, V117, P125, DOI 10.1016/S0165-5728(01)00328-9; BESEDOVSKY H, 1986, SCIENCE, V233, P652, DOI 10.1126/science.3014662; Buljevic S, 2013, RHEUMATOL INT, V33, P2867, DOI 10.1007/s00296-013-2823-z; Buttari B, 2005, BLOOD, V106, P3880, DOI 10.1182/blood-2005-03-1201; Chandrasekar B, 2004, BIOCHEM BIOPH RES CO, V319, P304, DOI 10.1016/j.bbrc.2004.04.185; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; Cutolo M, 2006, NEUROIMMUNOMODULAT, V13, P277, DOI 10.1159/000104855; Dave ND, 2011, IMMUNOL ALLERGY CLIN, V31, P55, DOI 10.1016/j.iac.2010.09.009; Decressac M, 2009, NEUROBIOL DIS, V34, P441, DOI 10.1016/j.nbd.2009.02.017; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Dimitrijevic M, 2013, AMINO ACIDS, V45, P41, DOI 10.1007/s00726-011-1185-7; Dunzendorfer S, 2001, J IMMUNOL, V166, P2167, DOI 10.4049/jimmunol.166.4.2167; Elenkov IJ, 1999, TRENDS ENDOCRIN MET, V10, P359, DOI 10.1016/S1043-2760(99)00188-5; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; ENQUSELASSIE F, 1993, INT J EPIDEMIOL, V22, P632, DOI 10.1093/ije/22.4.632; ERICSSON A, 1987, IMMUNOL REV, V100, P261, DOI 10.1111/j.1600-065X.1987.tb00535.x; Feigin VL, 2000, EUR J NEUROL, V7, P171, DOI 10.1046/j.1468-1331.2000.00016.x; Fenteany G, 2004, CURR OPIN HEMATOL, V11, P15, DOI 10.1097/00062752-200401000-00004; Ferreira R, 2012, J NEUROCHEM, V120, P93, DOI 10.1111/j.1471-4159.2011.07541.x; Ghersi G, 2001, PEPTIDES, V22, P453, DOI 10.1016/S0196-9781(01)00340-0; Gregory JL, 2009, MICROCIRCULATION, V16, P735, DOI 10.3109/10739680903210421; Han RJ, 2012, FASEB J, V26, P3528, DOI 10.1096/fj.12-203943; Hart DNJ, 1997, BLOOD, V90, P3245, DOI 10.1182/blood.V90.9.3245; Haug SR, 2006, J DENT RES, V85, P488, DOI 10.1177/154405910608500602; Heilig M, 2004, J PSYCHIATR RES, V38, P113, DOI 10.1016/S0022-3956(03)00101-8; Kalra SP, 1999, ENDOCR REV, V20, P68, DOI 10.1210/er.20.1.68; Kawamura N, 1998, NEUROIMMUNOMODULAT, V5, P9, DOI 10.1159/000026321; Kuo LE, 2007, NAT MED, V13, P803, DOI 10.1038/nm1611; Lee M, 2005, J BIOL CHEM, V280, P125, DOI 10.1074/jbc.M408858200; Levite M, 1998, P NATL ACAD SCI USA, V95, P12544, DOI 10.1073/pnas.95.21.12544; Li LJ, 2011, J CARDIOVASC TRANSL, V4, P351, DOI 10.1007/s12265-011-9271-5; Li LJ, 2005, ARTERIOSCL THROM VAS, V25, P2075, DOI 10.1161/01.ATV.0000179601.19888.19; LUNDBERG JM, 1989, NEUROSCIENCE, V28, P475, DOI 10.1016/0306-4522(89)90193-0; Macia L, 2011, IMMUNOL CELL BIOL, V89, P882, DOI 10.1038/icb.2011.6; Maestroni GJM, 2006, ANN NY ACAD SCI, V1069, P195, DOI 10.1196/annals.1351.017; Maestroni GJM, 2000, J IMMUNOL, V165, P6743, DOI 10.4049/jimmunol.165.12.6743; Malmstrom R E, 1997, Acta Physiol Scand Suppl, V636, P1; Manni M, 2008, BRAIN BEHAV IMMUN, V22, P80, DOI 10.1016/j.bbi.2007.06.016; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Medeiros PJ, 2012, INT J CANCER, V131, P276, DOI 10.1002/ijc.26350; Medina S, 1998, MECH AGEING DEV, V102, P249, DOI 10.1016/S0047-6374(98)00014-1; MICHEL MC, 1990, AM J PHYSIOL, V259, pE131; Michel MC, 1998, PHARMACOL REV, V50, P143; Mitic K, 2011, PEPTIDES, V32, P1626, DOI 10.1016/j.peptides.2011.06.007; Mohr DC, 2006, BRAIN BEHAV IMMUN, V20, P27, DOI 10.1016/j.bbi.2005.03.011; Morris MJ, 1998, J NEUROCHEM, V71, P1519; Movafagh S, 2006, FASEB J, V20, P1924, DOI 10.1096/fj.05-4770fje; Nave H, 2004, J NEUROIMMUNOL, V155, P1, DOI 10.1016/j.jneuroim.2004.05.009; Naveilhan P, 2001, NATURE, V409, P513, DOI 10.1038/35054063; Pacak K, 1998, AM J PHYSIOL-REG I, V275, pR1247, DOI 10.1152/ajpregu.1998.275.4.R1247; Patberg WR, 2004, J RHEUMATOL, V31, P1327; Reiche EMV, 2004, LANCET ONCOL, V5, P617, DOI 10.1016/S1470-2045(04)01597-9; Rethnam S, 2010, INT ENDOD J, V43, P492, DOI 10.1111/j.1365-2591.2010.01704.x; Ruohonen Suvi T, 2012, Indian J Endocrinol Metab, V16, pS569, DOI 10.4103/2230-8210.105574; Scheiermann C, 2012, IMMUNITY, V37, P290, DOI 10.1016/j.immuni.2012.05.021; SCHWARZ H, 1994, J NEUROIMMUNOL, V51, P53, DOI 10.1016/0165-5728(94)90128-7; Singer K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057929; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Straub RH, 2000, J LEUKOCYTE BIOL, V67, P553, DOI 10.1002/jlb.67.4.553; SUNG CP, 1991, CIRC RES, V68, P314, DOI 10.1161/01.RES.68.1.314; TATEMOTO K, 1982, P NATL ACAD SCI-BIOL, V79, P5485, DOI 10.1073/pnas.79.18.5485; Thorsell A, 2000, P NATL ACAD SCI USA, V97, P12852, DOI 10.1073/pnas.220232997; Vezzani A, 1999, TRENDS NEUROSCI, V22, P25, DOI 10.1016/S0166-2236(98)01284-3; von Horsten S, 1998, BRAIN RES, V806, P282, DOI 10.1016/S0006-8993(98)00772-0; Weissmann G, 2010, FASEB J, V24, P4129, DOI 10.1096/fj.10-1101ufm; Wheway J, 2005, J EXP MED, V202, P1527, DOI 10.1084/jem.20051971; Wheway J, 2007, CURR TOP MED CHEM, V7, P1743, DOI 10.2174/156802607782341046; Wheway J, 2007, PEPTIDES, V28, P453, DOI 10.1016/j.peptides.2006.09.030; Zhang L, 2011, PHARMACOL THERAPEUT, V131, P91, DOI 10.1016/j.pharmthera.2011.03.011	72	40	44	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					3038	3049		10.1096/fj.13-243485	http://dx.doi.org/10.1096/fj.13-243485			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24699455				2022-12-25	WOS:000337949400026
J	Wang, TY; Bruggeman, KAF; Sheean, RK; Turner, BJ; Nisbet, DR; Parish, CL				Wang, Ting-Yi; Bruggeman, Kiara A. F.; Sheean, Rebecca K.; Turner, Bradley J.; Nisbet, David R.; Parish, Clare L.			Characterization of the Stability and Bio-functionality of Tethered Proteins on Bioengineered Scaffolds IMPLICATIONS FOR STEM CELL BIOLOGY AND TISSUE REPAIR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTROPHIC FACTOR; GROWTH-FACTOR; GDNF; SURVIVAL; NEURONS; DIFFERENTIATION; PROLIFERATION; PARKINSONS; STRIATUM; SURFACE	Various engineering applications have been utilized to deliver molecules and compounds in both innate and biological settings. In the context of biological applications, the timely delivery of molecules can be critical for cellular and organ function. As such, previous studies have demonstrated the superiority of long-term protein delivery, by way of protein tethering onto bio-engineered scaffolds, compared with conventional delivery of soluble protein in vitro and in vivo. Despite such benefits little knowledge exists regarding the stability, release kinetics, longevity, activation of intracellular pathway, and functionality of these proteins over time. By way of example, here we examined the stability, degradation and functionality of a protein, glial-derived neurotrophic factor (GDNF), which is known to influence neuronal survival, differentiation, and neurite morphogenesis. Enzyme-linked immunosorbent assays (ELISA) revealed that GDNF, covalently tethered onto polycaprolactone (PCL) electrospun nanofibrous scaffolds, remained present on the scaffold surface for 120 days, with no evidence of protein leaching or degradation. The tethered GDNF protein remained functional and capable of activating downstream signaling cascades, as revealed by its capacity to phosphorylate intracellular Erk in a neural cell line. Furthermore, immobilization of GDNF protein promoted cell survival and differentiation in culture at both 3 and 7 days, further validating prolonged functionality of the protein, well beyond the minutes to hours timeframe observed for soluble proteins under the same culture conditions. This study provides important evidence of the stability and functionality kinetics of tethered molecules.	[Parish, Clare L.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia; [Bruggeman, Kiara A. F.; Nisbet, David R.] Australian Natl Univ, Res Sch Engn, Canberra, ACT 0200, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; Australian National University	Nisbet, DR (corresponding author), Australian Natl Univ, Canberra, ACT, Australia.	david.nisbet@anu.edu.au; cparish@unimelb.edu.au		Turner, Bradley/0000-0001-6580-7655; Nisbet, David/0000-0002-1343-0769; Parish, Clare/0000-0001-8212-9884; Wang, Ting-Yi/0000-0001-7722-8087	Australian Microscopy and Microanalysis Research Facility (AMMRF)	Australian Microscopy and Microanalysis Research Facility (AMMRF)	We thank Francesca Maclean for electrospinning and Dr. Francesca Ercole for assistance with the determination of attached amines. Access to the facilities of the Centre for Advanced Microscopy (CAM) with funding through the Australian Microscopy and Microanalysis Research Facility (AMMRF) is gratefully acknowledged.	Alexi T, 2000, PROG NEUROBIOL, V60, P409, DOI 10.1016/S0301-0082(99)00032-5; Bjorklund A, 1997, NEUROBIOL DIS, V4, P186, DOI 10.1006/nbdi.1997.0151; Bjorklund A, 2010, PROG BRAIN RES, V184, P237, DOI 10.1016/S0079-6123(10)84013-0; Chen Y, 2005, EXP NEUROL, V196, P87, DOI 10.1016/j.expneurol.2005.07.010; Consales C, 2007, BRAIN RES, V1159, P28, DOI 10.1016/j.brainres.2007.04.071; Enomoto Hideki, 2005, Anatomical Science International, V80, P42; Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320; Haniu M, 1996, BIOCHEMISTRY-US, V35, P16799, DOI 10.1021/bi9605550; Horne MK, 2010, STEM CELLS DEV, V19, P843, DOI 10.1089/scd.2009.0158; Kapur TA, 2003, J BIOMAT SCI-POLYM E, V14, P383, DOI 10.1163/156856203321478883; Kauhausen J, 2013, J PHYSIOL-LONDON, V591, P77, DOI 10.1113/jphysiol.2012.243063; Lee CS, 2005, EXP NEUROL, V191, P65, DOI 10.1016/j.expneurol.2004.08.025; Leipzig ND, 2011, BIOMATERIALS, V32, P57, DOI 10.1016/j.biomaterials.2010.09.031; Leipzig ND, 2010, J BIOMED MATER RES A, V93A, P625, DOI 10.1002/jbm.a.32573; Nakajima K, 2001, BRAIN RES, V916, P76, DOI 10.1016/S0006-8993(01)02866-9; Nisbet DR, 2006, J COLLOID INTERF SCI, V299, P647, DOI 10.1016/j.jcis.2006.02.057; Nisbet DR, 2009, J BIOMATER APPL, V24, P7, DOI 10.1177/0885328208099086; Nisbet DR, 2009, COLLOID SURFACE B, V71, pCP1, DOI 10.1016/j.colsurfb.2009.01.022; Nisbet DR, 2009, BIOMATERIALS, V30, P4573, DOI 10.1016/j.biomaterials.2009.05.011; Ortiz-Ortiz MA, 2011, ENVIRON TOXICOL PHAR, V31, P129, DOI 10.1016/j.etap.2010.09.013; Redmond DE, 2009, J COMP NEUROL, V515, P31, DOI 10.1002/cne.22028; Rosenblad C, 1996, NEUROSCIENCE, V75, P979; Sandhu JK, 2009, NEUROBIOL DIS, V33, P405, DOI 10.1016/j.nbd.2008.11.016; SHARPLES.NE, 1966, BIOCHEMISTRY-US, V5, P2963, DOI 10.1021/bi00873a028; Tessmar JK, 2007, ADV DRUG DELIVER REV, V59, P274, DOI 10.1016/j.addr.2007.03.020; Wang TY, 2012, BIOMATERIALS, V33, P9188, DOI 10.1016/j.biomaterials.2012.09.013	26	25	25	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					15044	15051		10.1074/jbc.M113.537381	http://dx.doi.org/10.1074/jbc.M113.537381			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24700461	hybrid, Green Published			2022-12-25	WOS:000337248100056
J	Silacci, M; Baenziger-Tobler, N; Lembke, W; Zha, WJ; Batey, S; Bertschinger, J; Grabulovski, D				Silacci, Michela; Baenziger-Tobler, Nadja; Lembke, Wibke; Zha, Wenjuan; Batey, Sarah; Bertschinger, Julian; Grabulovski, Dragan			Linker Length Matters, Fynomer-Fc Fusion with an Optimized Linker Displaying Picomolar IL-17A Inhibition Potency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drug Discovery; Inflammation; Interleukin; Protein Engineering; SH3 Domains; Fynomer	ANTI-INTERLEUKIN-17 MONOCLONAL-ANTIBODY; BINDING-PROTEINS; INTERLEUKIN-17; FRAGMENTS; SELECTION; DOMAINS; ALPHA; CELLS	Background: IL-17A is a proinflammatory cytokine involved in various inflammatory diseases. Results: Potent IL-17A inhibitors were generated by fusing human Fyn SH3 domain derivatives (Fynomers) to the Fc part of an antibody. Conclusion: The linker length between the Fc part and the binding domain influences significantly the potency of Fc fusion proteins. Significance: Fynomers represent a promising class of therapeutic proteins. Fynomers are small binding proteins derived from the human Fyn SH3 domain. Using phage display technology, Fynomers were generated inhibiting the activity of the proinflammatory cytokine interleukin-17A (IL-17A). One specific Fynomer called 2C1 inhibited human IL-17A in vitro with an IC50 value of 2.2 nm. Interestingly, when 2C1 was genetically fused to the Fc part of a human antibody via four different amino acid linkers to yield bivalent IL-17A binding proteins (each linker differed in length), the 2C1-Fc fusion protein with the longest linker displayed the most potent inhibitory activity. It blocked homodimeric IL-17A with an IC50 value of 21 pm, which corresponds to a hundredfold improved IC50 value as compared to the value obtained with monovalent Fynomer 2C1. In contrast, the 2C1-Fc fusion with the shortest linker showed only an approximate to 8-fold improved IC50 value of 260 pm. Furthermore, in a mouse model of acute inflammation, we have shown that the most potent 2C1-Fc fusion protein is able to efficiently inhibit IL-17A in vivo. With their suitable biophysical properties, Fynomer-Fc fusion proteins represent new drug candidates for the treatment of IL-17A mediated inflammatory conditions such as psoriasis, psoriatic arthritis, or rheumatoid arthritis.	[Silacci, Michela; Baenziger-Tobler, Nadja; Lembke, Wibke; Zha, Wenjuan; Batey, Sarah; Bertschinger, Julian; Grabulovski, Dragan] Covagen AG, CH-8952 Schlieren, Switzerland		Grabulovski, D (corresponding author), Covagen AG, Wagistr 25, CH-8952 Schlieren, Switzerland.	dragan.grabulovski@covagen.com						Allan B., 2007, Patent Number, Patent No. [WO2007/070750, 2007070750]; ARGOS P, 1990, J MOL BIOL, V211, P943, DOI 10.1016/0022-2836(90)90085-Z; Arican O, 2005, MEDIAT INFLAMM, P273, DOI 10.1155/MI.2005.273; Banner DW, 2013, ACTA CRYSTALLOGR D, V69, P1124, DOI 10.1107/S0907444913006574; Beck A, 2011, MABS-AUSTIN, V3, P415, DOI 10.4161/mabs.3.5.17334; Bertschinger J, 2007, PROTEIN ENG DES SEL, V20, P57, DOI 10.1093/protein/gzl055; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Brucklacher-Waldert V, 2009, J IMMUNOL, V183, P5494, DOI 10.4049/jimmunol.0901000; Carnemolla B, 1996, INT J CANCER, V68, P397, DOI 10.1002/(SICI)1097-0215(19961104)68:3<397::AID-IJC20>3.3.CO;2-D; Carter PJ, 2011, EXP CELL RES, V317, P1261, DOI 10.1016/j.yexcr.2011.02.013; Coppieters K, 2006, ARTHRITIS RHEUM-US, V54, P1856, DOI 10.1002/art.21827; Czajkowsky DM, 2012, EMBO MOL MED, V4, P1015, DOI 10.1002/emmm.201201379; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Gebauer M, 2009, CURR OPIN CHEM BIOL, V13, P245, DOI 10.1016/j.cbpa.2009.04.627; Genovese MC, 2010, ARTHRITIS RHEUM-US, V62, P929, DOI 10.1002/art.27334; Grabulovski D, 2007, J BIOL CHEM, V282, P3196, DOI 10.1074/jbc.M609211200; Huang CC, 2009, CURR OPIN BIOTECH, V20, P692, DOI 10.1016/j.copbio.2009.10.010; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Kontermann RE, 2009, BIODRUGS, V23, P93, DOI 10.2165/00063030-200923020-00003; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Lubberts E, 2008, CYTOKINE, V41, P84, DOI 10.1016/j.cyto.2007.09.014; MOHLER KM, 1993, J IMMUNOL, V151, P1548; Mourlane F, 2012, J CLIN ONCOL, V30; Nalbandian A, 2009, CLIN EXP IMMUNOL, V157, P209, DOI 10.1111/j.1365-2249.2009.03944.x; Schlatter D, 2012, MABS-AUSTIN, V4, P497, DOI 10.4161/mabs.20452; Suzuki T, 2010, J IMMUNOL, V184, P1968, DOI 10.4049/jimmunol.0903296; Viti F, 2000, METHOD ENZYMOL, V326, P480; Walsh G, 2010, NAT BIOTECHNOL, V28, P917, DOI 10.1038/nbt0910-917; Wozniak-Knopp G, 2010, PROTEIN ENG DES SEL, V23, P289, DOI 10.1093/protein/gzq005; Ziolkowska N, 2000, J IMMUNOL, V164, P2832, DOI 10.4049/jimmunol.164.5.2832	31	37	41	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14392	14398		10.1074/jbc.M113.534578	http://dx.doi.org/10.1074/jbc.M113.534578			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24692552	Green Published, hybrid			2022-12-25	WOS:000335984600064
J	Wu, J; Bakerink, KJ; Evangelista, ME; Thomas, GH				Wu, Juan; Bakerink, Katelyn J.; Evangelista, Meagan E.; Thomas, Graham H.			Cytoplasmic Capes Are Nuclear Envelope Intrusions That Are Enriched in Endosomal Proteins and Depend upon beta(H)-Spectrin and Annexin B9	PLOS ONE			English	Article							ANKYRIN-G; MEMBRANE; SPECTRIN; BETA(HEAVY)-SPECTRIN; TRANSPORT; ACTIVATION; CRUMBS; CELLS; BINDS; STAR	It is increasingly recognized that non-erythroid spectrins have roles remote from the plasma membrane, notably in endomembrane trafficking. The large spectrin isoform, beta(H), partners with Annexin B9 to modulate endosomal processing of internalized proteins. This modulation is focused on the early endosome through multivesicular body steps of endocytic processing and loss of either protein appears to cause a traffic jam before removal of ubiquitin at the multivesicular body. We previously reported that beta(H)/Annexin B9 influenced EGF receptor signaling. While investigating this effect we noticed that mSptiz, the membrane bound precursor of the secreted EGF receptor ligand sSpitz, is located in striking intrusions of the nuclear membrane. Here we characterize these structures and identify them as `cytoplasmic capes', which were previously identified in old ultrastructural studies and probably coincide with recently recognized sites of non-nuclear-pore RNA export. We show that cytoplasmic capes contain multiple endosomal markers and that their existence is dependent upon bH and Annexin B9. Diminution of these structures does not lead to a change in mSpitz processing. These results extend the endosomal influence of bH and its partner Annexin B9 to this unusual compartment at the nuclear envelope.	[Wu, Juan; Bakerink, Katelyn J.; Evangelista, Meagan E.; Thomas, Graham H.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Wu, Juan; Bakerink, Katelyn J.; Evangelista, Meagan E.; Thomas, Graham H.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Wu, Juan] Harvard Univ, Sch Med, Sch Publ Hlth, Boston, MA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Harvard University; Harvard Medical School; Harvard T.H. Chan School of Public Health	Thomas, GH (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	gxt5@psu.edu			National Science Foundation [MCB-1122013]; Direct For Biological Sciences [1122013] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by grant # MCB-1122013 from the National Science Foundation (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DERKSEN J, 1974, CELL DIFFER DEV, V3, P157, DOI 10.1016/0045-6039(74)90027-X; Eden ER, 2009, BIOCHEM SOC T, V37, P173, DOI 10.1042/BST0370173; Friedman JR, 2013, MOL BIOL CELL, V24, P1030, DOI 10.1091/mbc.E12-10-0733; Gabay L, 1997, SCIENCE, V277, P1103, DOI 10.1126/science.277.5329.1103; GAY H, 1956, COLD SPRING HARB SYM, V21, P257, DOI 10.1101/SQB.1956.021.01.021; Holleran EA, 2001, J BIOL CHEM, V276, P36598, DOI 10.1074/jbc.M104838200; Kizhatil K, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703158200; Kizhatil K, 2007, J BIOL CHEM, V282, P2029, DOI 10.1074/jbc.M608921200; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Lee S-K, 2010, MECH DEV; Lorenzo DN, 2010, J CELL BIOL, V189, P143, DOI 10.1083/jcb.200905158; Malhas A, 2011, TRENDS CELL BIOL, V21, P362, DOI 10.1016/j.tcb.2011.03.008; Medina E, 2002, J CELL BIOL, V158, P941, DOI 10.1083/jcb.200203080; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Natalizio BJ, 2013, TRENDS CELL BIOL, V23, P365, DOI 10.1016/j.tcb.2013.03.006; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; Phillips MD, 2006, J CELL SCI, V119, P1361, DOI 10.1242/jcs.02839; Pilecka I, 2007, EUR J CELL BIOL, V86, P533, DOI 10.1016/j.ejcb.2007.04.004; Pyrzynska B, 2009, MOL ONCOL, V3, P321, DOI 10.1016/j.molonc.2009.06.001; Rose A, 2012, TRENDS CELL BIOL, V22, P509, DOI 10.1016/j.tcb.2012.07.003; Rousso T, 2010, DEVELOPMENT, V137, P3427, DOI 10.1242/dev.049858; Schlesinger A, 2004, DEV CELL, V7, P535, DOI 10.1016/j.devcel.2004.09.001; Speese SD, 2012, CELL, V149, P832, DOI 10.1016/j.cell.2012.03.032; Sridharan D, 2003, J CELL SCI, V116, P823, DOI 10.1242/jcs.00294; THOMAS GH, 1994, DEVELOPMENT, V120, P2039; THOMOPOULOS GN, 1983, CELL TISSUE RES, V228, P497; Tjota M, 2011, J CELL SCI, V124, P2914, DOI 10.1242/jcs.078667; Tsruya R, 2002, GENE DEV, V16, P222, DOI 10.1101/gad.214202; Tsruya R, 2007, EMBO J, V26, P1211, DOI 10.1038/sj.emboj.7601581; Urban S, 2002, EMBO J, V21, P4277, DOI 10.1093/emboj/cdf434; White IJ, 2006, EMBO J, V25, P1, DOI 10.1038/sj.emboj.7600759; Williams JA, 2004, J CELL SCI, V117, P771, DOI 10.1242/jcs.00922; Yogev S, 2008, EMBO J, V27, P1219, DOI 10.1038/emboj.2008.58; Yogev S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000505	34	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93680	10.1371/journal.pone.0093680	http://dx.doi.org/10.1371/journal.pone.0093680			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705398	Green Submitted, Green Published, gold			2022-12-25	WOS:000334107500055
J	Zhang, YQ; Zheng, L; Huang, J; Gao, F; Lin, XS; He, L; Li, D; Li, ZJ; Ding, Y; Chen, LH				Zhang, Yuqin; Zheng, Lin; Huang, Jing; Gao, Fei; Lin, Xiaoshan; He, Lian; Li, Dan; Li, Zhijun; Ding, Yi; Chen, Longhua			MiR-124 Radiosensitizes Human Colorectal Cancer Cells by Targeting PRRX1	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; STEM-CELL; EXPRESSION PROFILES; IONIZING-RADIATION; TUMOR-CELLS; RADIORESISTANCE; RESISTANCE; EMT; MICRORNAS; GROWTH	One of the challenges in the treatment of colorectal cancer patients is that these tumors show resistance to radiation. MicroRNAs ( miRNAs) are involved in essential biological activities, including chemoresistance and radioresistance. Several research studies have indicated that miRNA played an important role in sensitizing cellular response to ionizing radiation (IR). In this study, we found that miR-124 was significantly down-regulated both in CRC-derived cell lines and clinical CRC samples compared with adjacent non-tumor colorectal tissues, MiR-124 could sensitize human colorectal cancer cells to IR in vitro and in vivo. We identified PRRX1, a new EMT inducer and stemness regulator as a novel direct target of miR-124 by using target prediction algorithms and luciferase assay. PRRX1 knockdown could sensitize CRC cells to IR similar to the effects caused by miR-124. Overexpression of PRRX1 in stably overexpressed-miR-124 cell lines could rescue the effects of radiosensitivity enhancement brought by miR-124. Taking these observations into consideration, we illustrated that miR-124 could increase the radiosensitivity of CRC cells by blocking the expression of PRRX1, which indicated miR-124 could act as a great therapeutic target for CRC patients.	[Zhang, Yuqin; Lin, Xiaoshan; He, Lian; Li, Dan; Li, Zhijun; Ding, Yi; Chen, Longhua] Southern Med Univ, Nanfang Hosp, Dept Radiat Oncol, Guangzhou, Guangdong, Peoples R China; [Zheng, Lin] Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Huang, Jing] Guangdong Med Coll, Affiliated Hosp, Dept Canc Ctr, Zhanjiang, Guangdong, Peoples R China; [Gao, Fei] Jinan Univ, Affiliated Hosp 1, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Guangdong Medical University; Jinan University	Ding, Y (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Radiat Oncol, Guangzhou, Guangdong, Peoples R China.	dingyi197980@126.com; chenlhsmu@126.com	Ding, Yi/CAG-6304-2022	Ding, Yi/0000-0001-5035-9255	National Natural Scientific Foundation of China [81272507]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Scientific Foundation of China (Grant No. 81272507). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas B, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2333; Ansieau S, 2013, CANCER LETT, V338, P63, DOI 10.1016/j.canlet.2012.05.014; Beskow C, 2009, BRIT J CANCER, V101, P816, DOI 10.1038/sj.bjc.6605201; Blick T, 2010, J MAMMARY GLAND BIOL, V15, P235, DOI 10.1007/s10911-010-9175-z; Chaachouay H, 2011, RADIOTHER ONCOL, V99, P287, DOI 10.1016/j.radonc.2011.06.002; Deng XB, 2013, J NEURO-ONCOL, V114, P263, DOI 10.1007/s11060-013-1179-2; Dumont FJ, 2012, CURR CANCER DRUG TAR, V12, P899; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Francescone RA, 2011, J BIOL CHEM, V286, P15332, DOI 10.1074/jbc.M110.212514; Fukuda K, 2004, BRIT J CANCER, V91, P1543, DOI 10.1038/sj.bjc.6602187; Guo P, 2013, EXP CELL RES; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Hollier BG, 2009, J MAMMARY GLAND BIOL, V14, P29, DOI 10.1007/s10911-009-9110-3; Inoue A, 2002, CANCER CELL, V2, P279, DOI 10.1016/S1535-6108(02)00155-1; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Jung IL, 2010, INT J MOL MED, V25, P517, DOI 10.3892/ijmm_00000372; KASID U, 1987, SCIENCE, V237, P1039, DOI 10.1126/science.3616625; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kitahara O, 2002, NEOPLASIA, V4, P295, DOI 10.1038/sj.neo.7900251; Kong DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012445; Liang YJ, 2013, CARCINOGENESIS, V34, P713, DOI 10.1093/carcin/bgs383; Liu KJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/867537; Liu YF, 2013, STAT INTERFACE, V6, P1; Lv ZH, 2013, MOL MED REP, V8, P345, DOI 10.3892/mmr.2013.1561; Magnon C, 2007, J CLIN INVEST, V117, P1844, DOI 10.1172/JCI30269; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marie-Egyptienne DT, 2013, CANCER LETT, V341, P63, DOI 10.1016/j.canlet.2012.11.019; Metheetrairut C, 2013, CURR OPIN GENET DEV, V23, P12, DOI 10.1016/j.gde.2013.01.002; Moncharmont C, 2012, CANCER LETT, V322, P139, DOI 10.1016/j.canlet.2012.03.024; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Niemoeller OM, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-29; Oh JS, 2010, INT J RADIAT ONCOL, V76, P5, DOI 10.1016/j.ijrobp.2009.08.028; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Reichert M, 2013, GENE DEV, V27, P288, DOI 10.1101/gad.204453.112; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Shi LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078344; Shimozaki K, 2013, J NEUROSCI, V33, P4066, DOI 10.1523/JNEUROSCI.4586-12.2013; Silber J, 2013, NEURO-ONCOLOGY, V15, P83, DOI 10.1093/neuonc/nos281; Takahashi Y, 2013, BRIT J CANCER, V109, P307, DOI 10.1038/bjc.2013.339; Theys J, 2011, RADIOTHER ONCOL, V99, P392, DOI 10.1016/j.radonc.2011.05.044; Wang P, 2013, ONCOGENE; Wang P, 2013, GASTROENTEROLOGY, V145, P1133, DOI 10.1053/j.gastro.2013.07.048; Wei J, 2013, CANCER RES, V73, P3913, DOI 10.1158/0008-5472.CAN-12-4318; Weidhaas JB, 2007, CANCER RES, V67, P11111, DOI 10.1158/0008-5472.CAN-07-2858; Xia HP, 2012, J BIOL CHEM, V287, P9962, DOI 10.1074/jbc.M111.332627; Xu DP, 2011, CARCINOGENESIS, V32, P488, DOI 10.1093/carcin/bgr007; Xu XL, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-276; Yaromina A, 2007, RADIOTHER ONCOL, V83, P304, DOI 10.1016/j.radonc.2007.04.020; Zafar F, 2010, RADIAT RES, V173, P27, DOI 10.1667/RR1910.1; Zhang HW, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-84; Zhang JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070300; Zhuang WZ, 2011, INT J CANCER, V129, P2720, DOI 10.1002/ijc.25975	54	61	72	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93917	10.1371/journal.pone.0093917	http://dx.doi.org/10.1371/journal.pone.0093917			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705396	Green Published, gold, Green Submitted			2022-12-25	WOS:000334107500094
J	Brar, MS; Shi, M; Hui, RKH; Leung, FCC				Brar, Manreetpal Singh; Shi, Mang; Hui, Raymond Kin-Hi; Leung, Frederick Chi-Ching			Genomic Evolution of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Isolates Revealed by Deep Sequencing	PLOS ONE			English	Article							MYSTERY SWINE DISEASE; NORTH-AMERICAN; STRUCTURAL PROTEINS; MOSAIC STRUCTURE; RECOMBINATION; STRAINS; NSP2; DISSECTION; EMERGENCE; ABORTION	Most studies on PRRSV evolution have been limited to a particular region of the viral genome. A thorough genome-wide understanding of the impact of different mechanisms on shaping PRRSV genetic diversity is still lacking. To this end, deep sequencing was used to obtain genomic sequences of a diverse set of 16 isolates from a region of Hong Kong with a complex PRRSV epidemiological record. Genome assemblies and phylogenetic typing indicated the co-circulation of strains of both genotypes (type 1and type 2) with varying Nsp2 deletion patterns and distinct evolutionary lineages ("High Fever''-like and local endemic type). Recombination analyses revealed genomic breakpoints in structural and non-structural regions of genomes of both genotypes with evidence of many recombination events originating from common ancestors. Additionally, the high fold of coverage per nucleotide allowed the characterization of minor variants arising from the quasispecies of each strain. Overall, 0.56-2.83% of sites were found to be polymorphic with respect to cognate consensus genomes. The distribution of minor variants across each genome was not uniform indicating the influence of selective forces. Proportion of variants capable of causing an amino acid change in their respective codons ranged between 25-67% with many predicted to be non-deleterious. Low frequency deletion variants were also detected providing one possible mechanism for their sudden emergence as cited in previous reports.	[Brar, Manreetpal Singh; Hui, Raymond Kin-Hi; Leung, Frederick Chi-Ching] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Shi, Mang] Univ Sydney, Sch Biol Sci, Sydney Emerging Infect & Biosecur Inst, Darlington, Australia; [Shi, Mang] Univ Sydney, Sydney Med Sch, Darlington, Australia	University of Hong Kong; University of Sydney; University of Sydney	Leung, FCC (corresponding author), Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China.	fcleung@hkucc.hku.hk		Shi, Mang/0000-0002-6154-4437	Research Grant Council of the Hong Kong Government [GRF770612]; HKU Strategic Research Theme of Infection and Immunology; Nanjing Agricultural University Bioinformatics Center	Research Grant Council of the Hong Kong Government; HKU Strategic Research Theme of Infection and Immunology; Nanjing Agricultural University Bioinformatics Center	This work was supported by grants from the Research Grant Council of the Hong Kong Government [GRF770612], HKU Strategic Research Theme of Infection and Immunology and Nanjing Agricultural University Bioinformatics Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; Damrongwatanapokin S., 1996, Journal of the Thai Veterinary Medical Association, V47, P19; Dea S, 2000, ARCH VIROL, V145, P659, DOI 10.1007/s007050050662; Duan X, 1997, ARCH VIROL, V142, P2483, DOI 10.1007/s007050050256; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards S, 1992, AM ASS SWINE PRACTIT, V4, P32; Fang Y, 2004, VIRUS RES, V100, P229, DOI 10.1016/j.virusres.2003.12.026; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Guo B., 1996, CHINESE J PREVENTIVE, V2, P1; Halbur PG, 1997, SWINE HEALTH PROD, V5, P73; Han J, 2006, VIRUS RES, V122, P175, DOI 10.1016/j.virusres.2006.06.003; Hill H., 1990, PROC MYSTERY SWINE D, P29; Holmes EC, 1999, MOL BIOL EVOL, V16, P405, DOI 10.1093/oxfordjournals.molbev.a026121; Kim WI, 2008, VIRUS GENES, V37, P380, DOI 10.1007/s11262-008-0278-1; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kweon C. H., 1994, Korean Journal of Veterinary Research, V34, P77; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; MAGAR R, 1995, CAN J VET RES, V59, P232; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Murtaugh MP, 2002, J SWINE HEALTH PROD, V10, P15; MURTAUGH MP, 1995, ARCH VIROL, V140, P1451, DOI 10.1007/BF01322671; Nelsen CJ, 1999, J VIROL, V73, P270, DOI 10.1128/JVI.73.1.270-280.1999; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Nielsen HS, 2001, J GEN VIROL, V82, P1263, DOI 10.1099/0022-1317-82-6-1263; Nodelijk G., 2002, Veterinary Quarterly, V24, P96; Opriessnig T, 2002, J VIROL, V76, P11837, DOI 10.1128/JVI.76.23.11837-11844.2002; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Paton D. J., 1995, Reviews in Medical Microbiology, V6, P119; PLANA J, 1992, VET MICROBIOL, V33, P203, DOI 10.1016/0378-1135(92)90048-X; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Roongtham K, 2010, VIROLOGY J, V7; Shi M, 2010, VIRUS RES; Shi M, 2010, J VIROL, V84, P8700, DOI 10.1128/JVI.02551-09; SHIMIZU M, 1994, J VET MED SCI, V56, P389, DOI 10.1292/jvms.56.389; SMITH JM, 1992, J MOL EVOL, V34, P126; Storgaard T, 1999, ARCH VIROL, V144, P2389, DOI 10.1007/s007050050652; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Team R. D. C., 2008, R LANG ENV STAT COMP; Tian KG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000526; van Vugt JJFA, 2001, J GEN VIROL, V82, P2615, DOI 10.1099/0022-1317-82-11-2615; WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296; Yoshii M, 2008, ARCH VIROL, V153, P1323, DOI 10.1007/s00705-008-0098-6; Yuan SS, 1999, VIRUS RES, V61, P87, DOI 10.1016/S0168-1702(99)00029-5; Zhou L, 2009, J VIROL, V83, P5156, DOI 10.1128/JVI.02678-08; Zhou Z, 2011, VET MICROBIOL, V150, P257, DOI 10.1016/j.vetmic.2011.02.013	49	38	43	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e88807	10.1371/journal.pone.0088807	http://dx.doi.org/10.1371/journal.pone.0088807			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24698958	Green Submitted, gold, Green Published			2022-12-25	WOS:000334105000003
J	Chen, FY; Jiang, LR; Zheng, JS; Huang, RY; Wang, HC; Hong, ZL; Huang, YM				Chen, Fangyu; Jiang, Liangrong; Zheng, Jingsheng; Huang, Rongyu; Wang, Houcong; Hong, Zonglie; Huang, Yumin			Identification of Differentially Expressed Proteins and Phosphorylated Proteins in Rice Seedlings in Response to Strigolactone Treatment	PLOS ONE			English	Article							MITOCHONDRIAL PHOSPHATE; SIGNAL-TRANSDUCTION; KINASE-ACTIVITY; BUD OUTGROWTH; ABSCISIC-ACID; DWARF MUTANT; ARABIDOPSIS; GENES; GROWTH; ELECTROPHORESIS	Strigolactones (SLs) are recently identified plant hormones that inhibit shoot branching and control various aspects of plant growth, development and interaction with parasites. Previous studies have shown that plant D10 protein is a carotenoid cleavage dioxygenase that functions in SL biosynthesis. In this work, we used an allelic SL-deficient d10 mutant XJC of rice (Oryza sativa L. spp. indica) to investigate proteins that were responsive to SL treatment. When grown in darkness, d10 mutant seedlings exhibited elongated mesocotyl that could be rescued by exogenous application of SLs. Soluble protein extracts were prepared from d10 mutant seedlings grown in darkness in the presence of GR24, a synthetic SL analog. Soluble proteins were separated on two-dimensional gels and subjected to proteomic analysis. Proteins that were expressed differentially and phosphoproteins whose phosphorylation status changed in response to GR24 treatment were identified. Eight proteins were found to be induced or down-regulated by GR24, and a different set of 8 phosphoproteins were shown to change their phosphorylation intensities in the dark-grown d10 seedlings in response to GR24 treatment. Analysis of these proteins revealed that they are important enzymes of the carbohydrate and amino acid metabolic pathways and key components of the cellular energy generation machinery. These proteins may represent potential targets of the SL signaling pathway. This study provides new insight into the complex and negative regulatory mechanism by which SLs control shoot branching and plant development.	[Chen, Fangyu; Jiang, Liangrong; Zheng, Jingsheng; Huang, Rongyu; Wang, Houcong; Hong, Zonglie; Huang, Yumin] Xiamen Univ, Sch Life Sci, Xiamen, Peoples R China; [Huang, Rongyu; Hong, Zonglie] Univ Idaho, Dept Plant Soil & Entomol Sci, Moscow, ID 83843 USA; [Huang, Rongyu; Hong, Zonglie] Univ Idaho, Program Microbiol Mol Biol & Biochem, Moscow, ID 83843 USA	Xiamen University; Idaho; University of Idaho; Idaho; University of Idaho	Hong, ZL (corresponding author), Xiamen Univ, Sch Life Sci, Xiamen, Peoples R China.	zhong@uidaho.edu; hym@xmu.edu.cn	Hong, Zonglie/F-5679-2010	Hong, Zonglie/0000-0001-9057-4128; Jiang, Liangrong/0000-0001-7294-0518; Chen, Fangyu/0000-0003-1476-5306	Natural Science Foundation of China [31100866]; Fundamental Research Funds for the Central Universities [2010121088]; Fujian Province Science and Technology Project [2011N5013]; Natural Science Foundation of Fujian Province [2011J01249]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Fujian Province Science and Technology Project; Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province)	This work was supported by the Natural Science Foundation of China (31100866), Fundamental Research Funds for the Central Universities (2010121088), Fujian Province Science and Technology Project (2011N5013) and Natural Science Foundation of Fujian Province (2011J01249). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder A, 2012, SCIENCE, V335, P1348, DOI 10.1126/science.1218094; Arite T, 2007, PLANT J, V51, P1019, DOI 10.1111/j.1365-313X.2007.03210.x; Arite T, 2009, PLANT CELL PHYSIOL, V50, P1416, DOI 10.1093/pcp/pcp091; Beveridge CA, 1996, PLANT PHYSIOL, V110, P859, DOI 10.1104/pp.110.3.859; BEVERIDGE CA, 1994, PLANT PHYSIOL, V104, P953, DOI 10.1104/pp.104.3.953; Booker J, 2004, CURR BIOL, V14, P1232, DOI 10.1016/j.cub.2004.06.061; Bouwmeester HJ, 2003, CURR OPIN PLANT BIOL, V6, P358, DOI 10.1016/S1369-5266(03)00065-7; CAPOBIANCO L, 1991, BIOCHEMISTRY-US, V30, P4963, DOI 10.1021/bi00234a018; Cardoso C, 2011, PLANT SCI, V180, P414, DOI 10.1016/j.plantsci.2010.11.007; Chen FY, 2013, PLANT OMICS, V6, P36; Chitteti BR, 2007, J PROTEOME RES, V6, P1718, DOI 10.1021/pr060678z; Choi DS, 2003, PLANT CELL, V15, P1386, DOI 10.1105/tpc.011965; DAMERVAL C, 1986, ELECTROPHORESIS, V7, P52, DOI 10.1002/elps.1150070108; Delaux PM, 2012, NEW PHYTOL, V195, P857, DOI 10.1111/j.1469-8137.2012.04209.x; Deng ZP, 2007, MOL CELL PROTEOMICS, V6, P2058, DOI 10.1074/mcp.M700123-MCP200; Engelsberger WR, 2012, PLANT J, V69, P978, DOI 10.1111/j.1365-313X.2011.04848.x; Gao JJ, 2009, NUCLEIC ACIDS RES, V37, pD960, DOI 10.1093/nar/gkn733; Gao ZY, 2009, PLANT MOL BIOL, V71, P265, DOI 10.1007/s11103-009-9522-x; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Gomi K, 2003, CURR OPIN PLANT BIOL, V6, P489, DOI 10.1016/S1369-5266(03)00079-7; Grimsrud PA, 2010, PLANT PHYSIOL, V152, P19, DOI 10.1104/pp.109.149625; Hamiaux C, 2012, CURR BIOL, V22, P2032, DOI 10.1016/j.cub.2012.08.007; He HQ, 2008, BIOCHEM BIOPH RES CO, V371, P883, DOI 10.1016/j.bbrc.2008.05.001; Hoeberichts FA, 2008, J BIOL CHEM, V283, P5708, DOI 10.1074/jbc.M704991200; Hondorp ER, 2004, PLOS BIOL, V2, P1738, DOI 10.1371/journal.pbio.0020336; Hsu YT, 2005, PHYSIOL PLANTARUM, V124, P71, DOI 10.1111/j.1399-3054.2005.00490.x; Hu ZY, 2010, PLANT CELL PHYSIOL, V51, P1136, DOI 10.1093/pcp/pcq075; Ishikawa S, 2005, PLANT CELL PHYSIOL, V46, P79, DOI 10.1093/pcp/pci022; Jiang L, 2013, NATURE, V504, P401, DOI 10.1038/nature12870; JONES AM, 1991, PLANT PHYSIOL, V97, P352, DOI 10.1104/pp.97.1.352; Kagiyama M, 2013, GENES CELLS, V18, P147, DOI 10.1111/gtc.12025; Kaufmann H, 2001, PROTEOMICS, V1, P194, DOI 10.1002/1615-9861(200102)1:2<194::AID-PROT194>3.3.CO;2-B; Ke YQ, 2009, BIOCHEM BIOPH RES CO, V379, P133, DOI 10.1016/j.bbrc.2008.12.067; Khan MMK, 2005, PLANT MOL BIOL, V58, P27, DOI 10.1007/s11103-005-4013-1; Komatsu S, 1999, ELECTROPHORESIS, V20, P630, DOI 10.1002/(SICI)1522-2683(19990301)20:3&lt;630::AID-ELPS630&gt;3.0.CO;2-Z; KOMATSU S, 1993, PLANT SCI, V94, P127, DOI 10.1016/0168-9452(93)90014-Q; Lewis TS, 2000, MOL CELL, V6, P1343, DOI 10.1016/S1097-2765(00)00132-5; Lin H, 2009, PLANT CELL, V21, P1512, DOI 10.1105/tpc.109.065987; Liu WZ, 2009, PLANTA, V230, P649, DOI 10.1007/s00425-009-0975-6; Mashiguchi K, 2009, BIOSCI BIOTECH BIOCH, V73, P2460, DOI 10.1271/bbb.90443; Mayank P, 2012, PLANT J, V72, P89, DOI 10.1111/j.1365-313X.2012.05061.x; Mayzlish-Gati E, 2012, PLANT PHYSIOL, V160, P1329, DOI 10.1104/pp.112.202358; Melo-Braga MN, 2012, MOL CELL PROTEOMICS, V11, P945, DOI 10.1074/mcp.M112.020214; Moffatt BA, 2002, PLANT PHYSIOL, V128, P812, DOI 10.1104/pp.010880; Mori M, 2002, PLANT PHYSIOL, V130, P1152, DOI 10.1104/pp.007179; Morris SE, 2001, PLANT PHYSIOL, V126, P1205, DOI 10.1104/pp.126.3.1205; Nakagami H, 2010, PLANT PHYSIOL, V153, P1161, DOI 10.1104/pp.110.157347; Napoli C, 1996, PLANT PHYSIOL, V111, P27, DOI 10.1104/pp.111.1.27; Nelson DC, 2011, P NATL ACAD SCI USA, V108, P8897, DOI 10.1073/pnas.1100987108; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; PALMIERI F, 1993, J BIOENERG BIOMEMBR, V25, P493, DOI 10.1007/BF01108406; Qian WQ, 2007, PLANT J, V49, P399, DOI 10.1111/j.1365-313X.2006.02967.x; Rasmussen A, 2012, PLANT PHYSIOL, V158, P1976, DOI 10.1104/pp.111.187104; Rate DN, 2001, PLANT J, V27, P203, DOI 10.1046/j.0960-7412.2001.1075umedoc.x; Reiland S, 2009, PLANT PHYSIOL, V150, P889, DOI 10.1104/pp.109.138677; Rose CM, 2012, MOL CELL PROTEOMICS, V11, P724, DOI 10.1074/mcp.M112.019208; Roth JR, 1996, ANNU REV MICROBIOL, V50, P137, DOI 10.1146/annurev.micro.50.1.137; Ruyter-Spira C, 2013, TRENDS PLANT SCI, V18, P72, DOI 10.1016/j.tplants.2012.10.003; Sawers RJH, 2002, PLANT PHYSIOL, V130, P155, DOI 10.1104/pp.006411; Scaffidi A, 2013, PLANT J, V76, P1, DOI 10.1111/tpj.12265; Shinohara N, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001474; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Simons JL, 2007, PLANT PHYSIOL, V143, P697, DOI 10.1104/pp.106.087957; Snowden KC, 2005, PLANT CELL, V17, P746, DOI 10.1105/tpc.104.027714; Somers DE, 2009, TRENDS PLANT SCI, V14, P206, DOI 10.1016/j.tplants.2009.01.003; Song JT, 2004, PLANT CELL, V16, P353, DOI 10.1105/tpc.019372; Sorefan K, 2003, GENE DEV, V17, P1469, DOI 10.1101/gad.256603; STAPPEN R, 1994, J BIOL CHEM, V269, P11240; Stirnberg P, 2002, DEVELOPMENT, V129, P1131; Sugiyama N, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.32; Sun TP, 2011, CURR BIOL, V21, pR338, DOI 10.1016/j.cub.2011.02.036; Tang WQ, 2008, SCIENCE, V321, P557, DOI 10.1126/science.1156973; Tang WQ, 2008, MOL CELL PROTEOMICS, V7, P728, DOI 10.1074/mcp.M700358-MCP200; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Umehara M, 2010, PLANT CELL PHYSIOL, V51, P1118, DOI 10.1093/pcp/pcq084; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Wang YH, 2008, ANNU REV PLANT BIOL, V59, P253, DOI 10.1146/annurev.arplant.59.032607.092902; Warren MJ, 2002, NAT PROD REP, V19, P390, DOI 10.1039/B108967F; Waters MT, 2012, DEVELOPMENT, V139, P1285, DOI 10.1242/dev.074567; Waters MT, 2011, PLANT SIGNAL BEHAV, V6, P1418, DOI 10.4161/psb.6.9.17303; Yamaguchi S, 2010, PLANT CELL PHYSIOL, V51, P1091, DOI 10.1093/pcp/pcq088; Yan H, 2007, GENES GENET SYST, V82, P361, DOI 10.1266/ggs.82.361; Zegzouti H, 1997, PLANT MOL BIOL, V35, P847, DOI 10.1023/A:1005860302313; Zhao LH, 2013, CELL RES, V23, P436, DOI 10.1038/cr.2013.19; Zhou F, 2013, NATURE, V504, P406, DOI 10.1038/nature12878; Zou JH, 2005, PLANTA, V222, P604, DOI 10.1007/s00425-005-0007-0; Zou JH, 2006, PLANT J, V48, P687, DOI 10.1111/j.1365-313X.2006.02916.x	87	9	9	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93947	10.1371/journal.pone.0093947	http://dx.doi.org/10.1371/journal.pone.0093947			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699514	Green Published, Green Submitted, gold			2022-12-25	WOS:000334105000124
J	Chou, YE; Hsieh, MJ; Hsin, CH; Chiang, WL; Lai, YC; Lee, YH; Huang, SC; Yang, SF; Lin, CW				Chou, Ying-Erh; Hsieh, Ming-Ju; Hsin, Chung-Han; Chiang, Whei-Ling; Lai, Yi-Cheng; Lee, Yu-Hsien; Huang, Shu-Ching; Yang, Shun-Fa; Lin, Chiao-Wen			CD44 Gene Polymorphisms and Environmental Factors on Oral Cancer Susceptibility in Taiwan	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; STEM-LIKE CELLS; CHANGHUA COUNTY; HEAD; EXPRESSION; ADHESION; MIGRATION; VARIANTS; IDENTIFICATION; CONSUMPTION	Background: Oral squamous cell carcinoma (OSCC) is the fourth leading cause of male cancer death in Taiwan. Exposure to environmental carcinogens is the primary risk factor for developing OSCC. CD44, a well-known tumor marker, plays a crucial role in tumor cell differentiation, invasion, and metastasis. This study investigated CD44 single-nucleotide polymorphisms (SNPs) with environmental risk factors to determine OSCC susceptibility and clinicopathological characteristics. Methodology/Principal Findings: Real-time polymerase chain reaction (PCR) was used to analyze 6 SNPs of CD44 in 599 patients with oral cancer and 561 cancer-free controls. We determined that the CD44 rs187115 polymorphism carriers with the genotype AG, GG, or AG+GG were associated with oral cancer susceptibility. Among 731 smokers, CD44 polymorphisms carriers with the betel-nut chewing habit had a 10.30-37.63-fold greater risk of having oral cancer compared to CD44 wild-type (WT) carriers without the betel-nut chewing habit. Among 552 betel-nut chewers, CD44 polymorphisms carriers who smoked had a 4.23-16.11-fold greater risk of having oral cancer compared to those who carried the WT but did not smoke. Finally, we also observed that the stage III and IV oral cancer patients had higher frequencies of CD44 rs187115 polymorphisms with the variant genotype (AG+GG) compared with the wild-type (WT) carriers. Conclusion: Our results suggest that gene-environment interactions between the CD44 polymorphisms and betel quid chewing and tobacco smoking increase the susceptibility to oral cancer development. Patients with CD44 rs187115 variant genotypes (AG+GG) were correlated with a higher risk of oral cancer development, and these patients may possess greater chemoresistance to advanced-to late-stage oral cancer than WT carriers do. The CD44 rs187115 polymorphism has potential predictive significance in oral carcinogenesis and also may be applied as factors to predict the clinical stage in OSCC patients.	[Chou, Ying-Erh; Hsieh, Ming-Ju; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Hsieh, Ming-Ju] Changhua Christian Hosp, Canc Res Ctr, Changhua, Taiwan; [Hsin, Chung-Han] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Hsin, Chung-Han] Chung Shan Med Univ Hosp, Dept Otolaryngol, Taichung, Taiwan; [Chiang, Whei-Ling] Chung Shan Med Univ, Sch Med Lab & Biotechnol, Taichung, Taiwan; [Lai, Yi-Cheng; Lee, Yu-Hsien; Huang, Shu-Ching] Chung Shan Med Univ, Sch Dent, Taichung, Taiwan; [Lee, Yu-Hsien; Huang, Shu-Ching; Lin, Chiao-Wen] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Lin, Chiao-Wen] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan	Chung Shan Medical University; Changhua Christian Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University	Lin, CW (corresponding author), Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan.	cwlin@csmu.edu.tw	Yang, Shun-Fa/AAN-1519-2020; Lai, Yi-Cheng/GRS-1513-2022; Hsieh, Ming-Ju/GQB-3025-2022	Yang, Shun-Fa/0000-0002-0365-7927; Hsieh, Ming-Ju/0000-0001-9726-3234	National Science Council, Taiwan [NSC-100-2632-B-040-001-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was financially supported by grants from National Science Council, Taiwan (NSC-100-2632-B-040-001-MY3). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourguignon LYW, 2001, J BIOL CHEM, V276, P48679, DOI 10.1074/jbc.M106759200; Chen YW, 2010, MOL CANCER THER, V9, P2879, DOI 10.1158/1535-7163.MCT-10-0504; Chien MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060283; Costea DE, 2006, ORAL DIS, V12, P443, DOI 10.1111/j.1601-0825.2006.01264.x; de Jong MC, 2010, CLIN CANCER RES, V16, P5329, DOI 10.1158/1078-0432.CCR-10-0799; Facompre N, 2012, ADV PHARMACOL, V65, P235, DOI 10.1016/B978-0-12-397927-8.00008-7; Gerger A, 2011, CLIN CANCER RES, V17, P6934, DOI 10.1158/1078-0432.CCR-11-1180; Gonzalez-Moles MA, 2007, ONCOL REP, V18, P389; Goodison S, 1999, J CLIN PATHOL-MOL PA, V52, P189; Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975; Hill A, 2006, CANCER LETT, V237, P1, DOI 10.1016/j.canlet.2005.05.006; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; HOFMANN M, 1993, CANCER RES, V53, P1516; Huang SM, 2011, J CELL BIOCHEM, V112, P643, DOI 10.1002/jcb.22966; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jiang L, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3225; Joshua B, 2012, HEAD NECK-J SCI SPEC, V34, P42, DOI 10.1002/hed.21699; Judd NP, 2012, CANCER RES, V72, P365, DOI 10.1158/0008-5472.CAN-11-1831; KO YC, 1995, J ORAL PATHOL MED, V24, P450, DOI 10.1111/j.1600-0714.1995.tb01132.x; Kokko LL, 2011, ORAL ONCOL, V47, P510, DOI 10.1016/j.oraloncology.2011.03.026; Kuo MYP, 1998, J ORAL PATHOL MED, V27, P428; LU CT, 1993, COMMUNITY DENT ORAL, V21, P370, DOI 10.1111/j.1600-0528.1993.tb01101.x; Lu CT, 1996, J ORAL PATHOL MED, V25, P245, DOI 10.1111/j.1600-0714.1996.tb01379.x; Lu DY, 2012, NEURO-ONCOLOGY, V14, P1367, DOI 10.1093/neuonc/nos262; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Margaritescu C, 2011, ROM J MORPHOL EMBRYO, V52, P985; Marhaba R, 2004, J MOL HISTOL, V35, P211; Marhaba R, 2008, CURR MOL MED, V8, P784, DOI 10.2174/156652408786733667; Maula SM, 2003, CANCER RES, V63, P1920; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Okamoto A, 2009, ORAL ONCOL, V45, P633, DOI 10.1016/j.oraloncology.2008.10.003; Okamoto I, 2002, AM J PATHOL, V160, P441, DOI 10.1016/S0002-9440(10)64863-8; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Reisman DN, 2002, ONCOGENE, V21, P1196, DOI 10.1038/sj.onc.1205188; Rogers SN, 2009, ORAL ONCOL, V45, P201, DOI 10.1016/j.oraloncology.2008.05.008; Sauna ZE, 2007, CANCER RES, V67, P9609, DOI 10.1158/0008-5472.CAN-07-2377; Shastry BS, 2009, METHODS MOL BIOL, V578, P3, DOI 10.1007/978-1-60327-411-1_1; Situ DR, 2010, J CANCER RES CLIN, V136, P1213, DOI 10.1007/s00432-010-0771-5; Stoll C, 1999, ORAL ONCOL, V35, P484, DOI 10.1016/S1368-8375(99)00021-4; Strobeck MW, 2001, J BIOL CHEM, V276, P9273, DOI 10.1074/jbc.M009747200; Tsai CF, 2012, INT J MOL SCI, V13, P9877, DOI 10.3390/ijms13089877; Vazquez A, 2010, CANCER RES, V70, P172, DOI 10.1158/0008-5472.CAN-09-2218; Wang SJ, 2011, AM J PATHOL, V178, P956, DOI 10.1016/j.ajpath.2010.11.077; Weg-Remers S, 2001, EMBO J, V20, P4194, DOI 10.1093/emboj/20.15.4194; Winder T, 2011, INT J CANCER, V129, P1096, DOI 10.1002/ijc.25787; Yang YH, 2005, J ORAL PATHOL MED, V34, P596, DOI 10.1111/j.1600-0714.2005.00266.x; Yen TT, 2008, EUR ARCH OTO-RHINO-L, V265, P1403, DOI 10.1007/s00405-008-0659-z; Zhang ZC, 2012, ORAL ONCOL, V48, P1, DOI 10.1016/j.oraloncology.2011.10.004; Zhou JH, 2010, ANTICANCER RES, V30, P1263	50	30	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93692	10.1371/journal.pone.0093692	http://dx.doi.org/10.1371/journal.pone.0093692			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699672	Green Published, Green Submitted, gold			2022-12-25	WOS:000334105000090
J	McAllister, DA; Ahmed, FS; Austin, JHM; Henschke, CI; Keller, BM; Lemeshow, A; Reeves, AP; Mesia-Vela, S; Pearson, GDN; Shiau, MC; Schwartz, JE; Yankelevitz, DF; Barr, RG				McAllister, David A.; Ahmed, Firas S.; Austin, John H. M.; Henschke, Claudia I.; Keller, Brad M.; Lemeshow, Adina; Reeves, Anthony P.; Mesia-Vela, Sonia; Pearson, G. D. N.; Shiau, Maria C.; Schwartz, Joseph E.; Yankelevitz, David F.; Barr, R. Graham			Emphysema Predicts Hospitalisation and Incident Airflow Obstruction among Older Smokers: A Prospective Cohort Study	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; LUNG-CANCER; PULMONARY-EMPHYSEMA; COPD; CT; PREVALENCE; TRIAL; DIAGNOSIS; MORTALITY; DISEASE	Background: Emphysema on CT is common in older smokers. We hypothesised that emphysema on CT predicts acute episodes of care for chronic lower respiratory disease among older smokers. Materials and Methods: Participants in a lung cancer screening study age >= 60 years were recruited into a prospective cohort study in 2001-02. Two radiologists independently visually assessed the severity of emphysema as absent, mild, moderate or severe. Percent emphysema was defined as the proportion of voxels <= -910 Hounsfield Units. Participants completed a median of 5 visits over a median of 6 years of follow-up. The primary outcome was hospitalization, emergency room or urgent office visit for chronic lower respiratory disease. Spirometry was performed following ATS/ERS guidelines. Airflow obstruction was defined as FEV1/FVC ratio <0.70 and FEV <80% predicted. Results: Of 521 participants, 4% had moderate or severe emphysema, which was associated with acute episodes of care (rate ratio 1.89; 95% CI: 1.01- 3.52) adjusting for age, sex and race/ ethnicity, as was percent emphysema, with similar associations for hospitalisation. Emphysema on visual assessment also predicted incident airflow obstruction ( HR 5.14; 95% CI 2.19- 21.1). Conclusion: Visually assessed emphysema and percent emphysema on CT predicted acute episodes of care for chronic lower respiratory disease, with the former predicting incident airflow obstruction among older smokers.	[McAllister, David A.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [McAllister, David A.; Ahmed, Firas S.; Lemeshow, Adina; Mesia-Vela, Sonia; Schwartz, Joseph E.; Barr, R. Graham] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10027 USA; [Austin, John H. M.; Pearson, G. D. N.] Columbia Univ Coll Phys & Surg, Dept Radiol, New York, NY 10032 USA; [Henschke, Claudia I.; Yankelevitz, David F.] Mt Sinai Med Ctr, Dept Radiol, New York, NY 10029 USA; [Keller, Brad M.] Univ Penn, Dept Biomed Engn, Philadelphia, PA 19104 USA; [Reeves, Anthony P.] Cornell Univ, Coll Engn, Sch Elect & Comp Engn, Ithaca, NY USA; [Shiau, Maria C.] NYU, Langone Med Ctr, Dept Radiol, New York, NY USA; [Barr, R. Graham] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	University of Edinburgh; Columbia University; Columbia University; Icahn School of Medicine at Mount Sinai; University of Pennsylvania; Cornell University; New York University; NYU Langone Medical Center; Columbia University	Barr, RG (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10027 USA.	rgb9@columbia.edu	Shiau, Maria/GQH-8481-2022	Schwartz, Joseph/0000-0002-8944-3566; McAllister, David/0000-0003-3550-1764	National Institutes of Health [R01-HL075476, R01-HL077612, R01-HL093081, RR024156, ES09089]; City of New York Department of Health and Mental Hygiene; Starr Foundation; Empire Blue Cross and Blue Shield; New York Community Trust; New York State Office of Science, Technology, and Academic Research; Rogers Family Fund; Weill Medical College of Cornell University; Cornell University; AMDeC Foundation; Chest Heart and Stroke Scotland [ResFell07/A109] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024156] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077612, R01HL075476, R01HL093081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH013043] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); City of New York Department of Health and Mental Hygiene; Starr Foundation; Empire Blue Cross and Blue Shield; New York Community Trust; New York State Office of Science, Technology, and Academic Research; Rogers Family Fund; Weill Medical College of Cornell University(General Electric); Cornell University; AMDeC Foundation; Chest Heart and Stroke Scotland; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Collection of spirometric and percent emphysema measures, longitudinal components from the third visit onwards, and analysis and interpretation of the data were supported via grants R01-HL075476, R01-HL077612, R01-HL093081, RR024156, and ES09089 from the National Institutes of Health. The baseline and second visits were funded by the City of New York Department of Health and Mental Hygiene; the Starr Foundation; Empire Blue Cross and Blue Shield; the New York Community Trust; New York State Office of Science, Technology, and Academic Research; the Rogers Family Fund; Weill Medical College of Cornell University; Cornell University; and AMDeC Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 2008, STAT CONS COPD EX TR; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 2010, NATL VITAL STAT REPO; Barr RG, 2008, RESP CARE, V53, P433; BERGIN C, 1986, AM REV RESPIR DIS, V133, P541; Burge S, 2003, EUR RESPIR J, V21, p46S, DOI 10.1183/09031936.03.00078002; Camiciottoli G, 2009, EUR RADIOL, V19, P58, DOI 10.1007/s00330-008-1131-6; Cazzola M, 2008, EUR RESPIR J, V31, P416, DOI 10.1183/09031936.00099306; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; COXSON HO, 1995, J APPL PHYSIOL, V79, P1525, DOI 10.1152/jappl.1995.79.5.1525; de Torres JP, 2007, CHEST, V132, P1932, DOI 10.1378/chest.07-1490; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Gelb AF, 1996, CHEST, V109, P353, DOI 10.1378/chest.109.2.353; Gevenois PA, 1996, RADIOLOGY, V199, P825, DOI 10.1148/radiology.199.3.8638012; Gietema HA, 2011, ACAD RADIOL, V18, P661, DOI 10.1016/j.acra.2011.01.011; Hall WB, 2009, ARCH INTERN MED, V169, P1961, DOI 10.1001/archinternmed.2009.360; Han MLK, 2011, RADIOLOGY, V261, P274, DOI 10.1148/radiol.11110173; Haruna A, 2010, CHEST, V138, P635, DOI 10.1378/chest.09-2836; Henschke CI, 2006, RADIOLOGY, V239, P586, DOI 10.1148/radiol.2392050261; Hoesein FAAM, 2011, THORAX, V66, P782, DOI 10.1136/thx.2010.145995; HRUBAN RH, 1987, AM REV RESPIR DIS, V136, P935, DOI 10.1164/ajrccm/136.4.935; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Jithoo A, 2013, EUR RESPIR J, V41, P548, DOI 10.1183/09031936.00132011; Johannessen A, 2013, AM J RESP CRIT CARE, V187, P602, DOI 10.1164/rccm.201209-1722OC; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; MULLER NL, 1988, CHEST, V94, P782, DOI 10.1378/chest.94.4.782; Omori H, 2006, RESPIROLOGY, V11, P205, DOI 10.1111/j.1440-1843.2006.00827.x; Onuma Y, 2006, J AM COLL CARDIOL, V48, P402, DOI 10.1016/j.jacc.2006.04.071; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Vestbo J, 2011, NEW ENGL J MED, V365, P1184, DOI 10.1056/NEJMoa1105482; Wise Robert A, 2008, Proc Am Thorac Soc, V5, P385, DOI 10.1513/pats.200709-153ET; World Health Organisation, 2008, WHO BURD CHRON OBSTR; Zulueta JJ, 2011, CHEST	34	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93221	10.1371/journal.pone.0093221	http://dx.doi.org/10.1371/journal.pone.0093221			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699215	Green Published, Green Accepted, gold			2022-12-25	WOS:000334105000047
J	Razzolini, NL; Vila, B; Castanera, D; Falkingham, PL; Barco, JL; Canudo, JI; Manning, PL; Galobart, A				Razzolini, Novella L.; Vila, Bernat; Castanera, Diego; Falkingham, Peter L.; Luis Barco, Jose; Ignacio Canudo, Jose; Manning, Phillip L.; Galobart, Angel			Intra-Trackway Morphological Variations Due to Substrate Consistency: The El Frontal Dinosaur Tracksite (Lower Cretaceous, Spain)	PLOS ONE			English	Article							FOSSIL VERTEBRATE TRACKS; EASTERN CAMEROS BASIN; MAMMALIAN TRACKS; FOOTPRINTS; PRESERVATION; SYSTEM; IMPACT; LIDAR	An ichnological and sedimentological study of the El Frontal dinosaur tracksite (Early Cretaceous, Cameros basin, Soria, Spain) highlights the pronounced intra-trackway variation found in track morphologies of four theropod trackways. Photogrammetric 3D digital models revealed various and distinct intra-trackway morphotypes, which reflect changes in footprint parameters such as the pace length, the track length, depth, and height of displacement rims. Sedimentological analyses suggest that the original substrate was non-homogenous due to lateral changes in adjoining microfacies. Multidata analyses indicate that morphological differences in these deep and shallow tracks represent a part of a continuum of track morphologies and geometries produced by a gradient of substrate consistencies across the site. This implies that the large range of track morphologies at this site resulted from similar trackmakers crossing variable facies. The trackways at the El Frontal site present an exemplary case of how track morphology, and consequently potential ichnotaxa, can vary, even when produced by a single trackmaker.	[Razzolini, Novella L.; Vila, Bernat; Galobart, Angel] Inst Catala Paleontol Miquel Crusafont, Barcelona, Catalonia, Spain; [Vila, Bernat; Castanera, Diego; Ignacio Canudo, Jose] Univ Zaragoza, Fac Ciencias, Dept Paleontol, Grupo Aragosaurus IUCA, E-50009 Zaragoza, Spain; [Falkingham, Peter L.] Univ London Royal Vet Coll, Struct & Mot Lab, Dept Comparat Biomed Sci, London, England; [Falkingham, Peter L.] Brown Univ, Div Biol & Med, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Luis Barco, Jose] Paleoymas SL Pol Empresarium, Zaragoza, Spain; [Manning, Phillip L.] Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA; [Manning, Phillip L.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester, Lancs, England	Institut Catala de Paleontologia Miquel Crusafont (ICP); University of Zaragoza; University of London; University of London Royal Veterinary College; Brown University; University of Pennsylvania; University of Manchester	Razzolini, NL (corresponding author), Inst Catala Paleontol Miquel Crusafont, Carrer Escola Ind 23, Barcelona, Catalonia, Spain.	novella.razzolini@icp.cat	VILA, BERNAT/AAA-7367-2021; Falkingham, Peter/C-7656-2014; Manning, Phillip/F-9966-2011; CASTANERA, DIEGO/AAH-5598-2019; Galobart, Àngel À/H-5024-2011	VILA, BERNAT/0000-0002-5935-1732; Falkingham, Peter/0000-0003-1856-8377; Manning, Phillip/0000-0002-7161-6246; CASTANERA, DIEGO/0000-0003-3950-1630; Galobart, Àngel À/0000-0003-1508-4561; Canudo Sanagustin, Jose Ignacio/0000-0003-1732-9155	Ministerio de Economia y Competitividad of Spain [CGL2011-30069-C02-01, CGL2010-16447]; Institut Catala de Paleontologia "Miquel Crusafont"; Ministerio de Economia y Competitividad [BES- 2012-051847]; Subprograma Juan de la Cierva [MICINN-JDC-2011]; Ministry of Education [AP2008-01340]; Marie Curie International Outgoing Fellowship within the 7th European Framework Programme	Ministerio de Economia y Competitividad of Spain(Spanish Government); Institut Catala de Paleontologia "Miquel Crusafont"; Ministerio de Economia y Competitividad(Spanish Government); Subprograma Juan de la Cierva; Ministry of Education; Marie Curie International Outgoing Fellowship within the 7th European Framework Programme	This paper is a contribution to the projects CGL2011-30069-C02-01 and CGL2010-16447, subsidized by the Ministerio de Economia y Competitividad of Spain. LiDAR data adquisition was funded by the Institut Catala de Paleontologia "Miquel Crusafont". N. L. Razzolini acknowledges support from BES- 2012-051847 subsized by the Ministerio de Economia y Competitividad. B. Vila acknowledges support from Subprograma Juan de la Cierva (MICINN-JDC-2011). D. Castanera is the beneficiary of a grant from the Ministry of Education (AP2008-01340). P. L. Falkingham was supported by a Marie Curie International Outgoing Fellowship within the 7th European Framework Programme.	Aguirrezabala L.M., 1980, Munibe, V32, P257; Allen J.R.L.., 1982, DEV SEDIMENTOL, V30, P593; Allen JRL, 1997, PHILOS T ROY SOC B, V352, P481, DOI 10.1098/rstb.1997.0035; ALLEN JRL, 1989, J GEOL SOC LONDON, V146, P600, DOI 10.1144/gsjgs.146.4.0600; Baird D., 1957, Bulletin of the Museum of Comparative Zoology, V117, P449; Barco JL, 2005, CUADERNOS PALEONTOLO, V4, P60; Barco JL, 2004, 1 INT C ICHN, P18; Barco JL, 2005, 21 JORN SOC ESP PAL, P169; Barnes H.A, 2000, HDB ELEMENTARY RHEOL; Bates KT, 2010, INT ARCH PHOTOGRAMM, V38, P68; Bates KT, 2008, PALAEONTOLOGY, V51, P999, DOI 10.1111/j.1475-4983.2008.00789.x; Bates KT, 2008, J GEOL SOC LONDON, V165, P115, DOI 10.1144/0016-76492007-033; Bellian JA, 2005, J SEDIMENT RES, V75, P166, DOI 10.2110/jsr.2005.013; Breithaupt Brent H., 2001, P113; Gomez-Fernandez JC, 1994, J PALEOLIMNOL, V11, P91, DOI 10.1007/BF00683272; Casamiquela RM, 1987, GLOSSARY MANUAL TETR, P22; Castanera D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081830; Castanera D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054177; Craig R.F., 2004, CRAIGS SOIL MECH, VSeventh; CURRIE PJ, 1979, PALAEOGEOGR PALAEOCL, V28, P103, DOI 10.1016/0031-0182(79)90114-7; Ellis RG, 2013, PALAEONTOL ELECTRON, V16; Falkingham PL, 2014, J ZOOL, V292, P222, DOI 10.1111/jzo.12110; Falkingham PL, 2011, J R SOC INTERFACE, V8, P1142, DOI 10.1098/rsif.2010.0634; Falkingham PL, 2010, PALAIOS, V25, P356, DOI 10.2110/palo.2009.p09-164r; Falkingham PL, 2012, PALAEONTOL ELECTRON, V15; Falkingham PL, 2009, PALAEOGEOGR PALAEOCL, V271, P69, DOI 10.1016/j.palaeo.2008.09.011; FUENTES VIDARTE C., 1998, ESTUD GEOL-MADRID, V54, P147, DOI DOI 10.3989/EGEOL.98543-4213; Fuentes Vidarte C., 1996, ZUBIA, V14, P57; Gatesy SM, 2005, PALAEONTOL ELECTRON, V8; Gatesy SM, 1999, NATURE, V399, P141, DOI 10.1038/20167; Gatesy Stephen M., 2003, Ichnos, V10, P91, DOI 10.1080/10420940390255484; Hernandez Medrano N, 2008, AREVACON, V28, P18; Jackson SJ, 2010, ICHNOS, V17, P197, DOI 10.1080/10420940.2010.510026; Kuban G.J., 1989, P57; Lockley MG, 2009, GEOL Q, V53, P415; Lucas SG, 2001, LETHAIA, V34, P30, DOI 10.1080/002411601300068198; Manning Phillip L., 2008, P204; Manning PL, 2004, GEOL SOC SPEC PUBL, V228, P93, DOI 10.1144/GSL.SP.2004.228.01.06; Manning PL, 1999, THESIS U SHEFFIELD; MARTIN-CLOSAS C., 1998, REV SOC GEOLOGICA ES, V11, P253; Marty D, 2009, ICHNOS, V16, P127, DOI 10.1080/10420940802471027; Mas R., 2004, GEOLOG A ESPA A, P503; Milan J, 2006, PALAEOGEOGR PALAEOCL, V231, P253, DOI 10.1016/j.palaeo.2004.12.022; Milan J., 2003, THESIS U COPENHAGEN; Milan J, 2008, ICHNOS, V15, P19, DOI 10.1080/10420940600864712; Minter NJ, 2007, LETHAIA, V40, P365, DOI 10.1111/j.1502-3931.2007.00035.x; MORATALLA GARCIA J.J., 1993, THESIS U COMPLUTENSE; Moratalla JJ, 2010, PALAEOGEOGR PALAEOCL, V295, P116, DOI 10.1016/j.palaeo.2010.05.027; Morse SA, 2013, AM J PHYS ANTHROPOL, V151, P265, DOI 10.1002/ajpa.22276; PADIAN K, 1984, J PALEONTOL, V58, P178; Padian K, 1999, NATURE, V399, P103, DOI 10.1038/20069; Pascual-Arribas Carlos, 2011, Studia Geologica Salmanticensia, V47, P77; Pereda-Suberbiola X, 2009, ACT 4 JORN INT PAL D, P207; Quijada I, 2010, GEOGACETA, V49, P15; Quijada IE, 2013, J IBER GEOL, V39, P313, DOI 10.5209/rev_JIGE.2013.v39.n2.42503; Razzolini NL, 2012, 10 ANN M EUR ASS VER, V20, p[1, 207]; Salas R, 2001, MEM MUS NAT HIST NAT, V186, P145; Sanz J.L., 1997, HUELLAS DINOSAURIOS; Schanz T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077606; Schudack U, 2009, J IBER GEOL, V35, P141; Scott JJ, 2010, J SEDIMENT RES, V80, P639, DOI 10.2110/jsr.2010.057; SCRIVNER PJ, 1986, PALAEOGEOGR PALAEOCL, V57, P285, DOI 10.1016/0031-0182(86)90017-9; Wu C, 2013, LINEAR TIME INCREMEN	63	43	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93708	10.1371/journal.pone.0093708	http://dx.doi.org/10.1371/journal.pone.0093708			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699696	Green Published, gold			2022-12-25	WOS:000334105000093
J	Wu, PH; Lin, YT; Kuo, CN; Chang, WC; Chang, WP				Wu, Ping-Hsun; Lin, Yi-Ting; Kuo, Chun-Nan; Chang, Wei-Chiao; Chang, Wei-Pin			No Increased Risk of Herpes Zoster Found in Cirrhotic Patients: A Nationwide Population-Based Study in Taiwan	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; LIVER-TRANSPLANTATION; RHEUMATOID-ARTHRITIS; UNITED-KINGDOM; MATCHED-COHORT; LONG-TERM; INFECTION; VIRUS; CYTOMEGALOVIRUS; COMPLICATIONS	Background: The association between liver cirrhosis (LC) and herpes zoster has rarely been studied. We investigated the hypothesis that LC, known as an immunodeficiency disease, may increase the risk of herpes zoster using a national health insurance database in Taiwan. Materials and Methods: The study cohort included cirrhotic patients between 1998 and 2005 (n = 4667), and a ratio of 1:5 randomly sampled age- and gender-matched control patients (n = 23,335). All subjects were followed up for 5 years from the date of cohort entry to identify whether or not they had developed herpes zoster. Cox proportional-hazard regressions were performed to evaluate 5-year herpes zoster-free survival rates. Results: Of all patients, 523 patients developed herpes zoster during the 5-year follow-up period, among whom 82 were LC patients and 441 were in the comparison cohort. The adjusted hazard ratio (AHR) of herpes zoster in patients with LC was not higher (AHR: 0.77, 95% confidence interval: 0.59-1.01, p = 0.06) than that of the controls during the 5-year follow-up. No increased risk of herpes zoster was found in LC patients after stratification by age, gender, urbanization level, income, geographic region, and all comorbidities. Conclusions: This large nationwide population-based cohort study suggests that there is no increased risk for herpes zoster among people who have LC compared to a matching population.	[Wu, Ping-Hsun] Kaohsiung Med Univ Hosp, Div Nephrol, Dept Internal Med, Kaohsiung, Taiwan; [Lin, Yi-Ting] Kaohsiung Med Univ Hosp, Dept Family Med, Kaohsiung, Taiwan; [Wu, Ping-Hsun] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Kuo, Chun-Nan; Chang, Wei-Chiao] Taipei Med Univ, Dept Pharm, Wanfang Hosp, Taipei, Taiwan; [Kuo, Chun-Nan; Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan; [Chang, Wei-Pin] Yuanpei Univ, Dept Healthcare Management, Hsinchu, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University	Chang, WC (corresponding author), Taipei Med Univ, Dept Pharm, Wanfang Hosp, Taipei, Taiwan.	weichiao.chang@gmail.com; wpchang@mail.ypu.edu.tw	Wu, Ping-Hsun/S-8746-2017; LIN, YI-TING/S-8855-2017	Wu, Ping-Hsun/0000-0003-1021-8161; Chang, Wei-Chiao/0000-0002-8573-5924; LIN, YI-TING/0000-0002-5833-0040	Taipei Medical University [TMU101-AE1-B14]	Taipei Medical University	This study was supported by grant TMU101-AE1-B14 from the Taipei Medical University (associate professor Wei-Chiao Chang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliegro MB, 1996, CLIN INFECT DIS, V23, P990, DOI 10.1093/clinids/23.5.990; Bahr MJ, 2001, Z GASTROENTEROL, V39, P601, DOI 10.1055/s-2001-16696; Bajaj JS, 2012, HEPATOLOGY, V56, P2328, DOI 10.1002/hep.25947; Bonnel AR, 2011, CLIN GASTROENTEROL H, V9, P727, DOI 10.1016/j.cgh.2011.02.031; Brisson M, 2001, EPIDEMIOL INFECT, V127, P305, DOI 10.1017/S0950268801005921; Chen HH, 2011, CLINICS, V66, P1177, DOI 10.1590/S1807-59322011000700009; Chiu HF, 2013, J EPIDEMIOL, V23, P205, DOI 10.2188/jea.JE20120155; Christou L, 2007, AM J GASTROENTEROL, V102, P1510, DOI 10.1111/j.1572-0241.2007.01286.x; DONAHUE JG, 1995, ARCH INTERN MED, V155, P1605, DOI 10.1001/archinte.155.15.1605; FELIU E, 1977, EUR J CLIN INVEST, V7, P571, DOI 10.1111/j.1365-2362.1977.tb01653.x; Ghassemi S, 2007, BEST PRACT RES CL GA, V21, P77, DOI 10.1016/j.bpg.2006.07.004; Gilden DH, 2000, NEW ENGL J MED, V342, P635, DOI 10.1056/NEJM200003023420906; Gourishankar S, 2004, AM J TRANSPLANT, V4, P108, DOI 10.1046/j.1600-6143.2003.00287.x; Herrero JI, 2004, LIVER TRANSPLANT, V10, P1140, DOI 10.1002/lt.20219; Heymann AD, 2008, INFECTION, V36, P226, DOI 10.1007/s15010-007-6347-x; Ho JD, 2011, OPHTHALMOLOGY, V118, P1076, DOI 10.1016/j.ophtha.2010.10.008; HOPESIMPSON RE, 1965, P ROY SOC MED, V58, P9, DOI 10.1177/003591576505800106; Jih JS, 2009, ACTA DERM-VENEREOL, V89, P612, DOI 10.2340/00015555-0729; Kang JH, 2009, STROKE, V40, P3443, DOI 10.1161/STROKEAHA.109.562017; Kuo CC, 2012, AM J KIDNEY DIS, V59, P428, DOI 10.1053/j.ajkd.2011.10.049; Kusaba N, 1998, INTERNAL MED, V37, P11; Levin MJ, 2003, J INFECT DIS, V188, P1336, DOI 10.1086/379048; Levitsky J, 2005, LIVER TRANSPLANT, V11, P320, DOI 10.1002/lt.20356; Liesegang Thomas J, 2004, Curr Opin Ophthalmol, V15, P531, DOI 10.1097/01.icu.0000143686.68103.46; Lin HC, 2010, NEUROLOGY, V74, P792, DOI 10.1212/WNL.0b013e3181d31e5c; Lin YH, 2010, VACCINE, V28, P1217, DOI 10.1016/j.vaccine.2009.11.029; McDonald JR, 2009, CLIN INFECT DIS, V48, P1364, DOI 10.1086/598331; Morgan D, 2001, AIDS, V15, P223, DOI 10.1097/00002030-200101260-00012; NAGASAWA K, 1990, ANN RHEUM DIS, V49, P630, DOI 10.1136/ard.49.8.630; Schmader K, 1998, J INFECT DIS, V178, pS67, DOI 10.1086/514254; Smitten AL, 2007, ARTHRIT RHEUM-ARTHR, V57, P1431, DOI 10.1002/art.23112; TANAKA S, 1992, HEPATOLOGY, V16, P1409, DOI 10.1002/hep.1840160617; Thomas SL, 2004, LANCET INFECT DIS, V4, P26, DOI 10.1016/S1473-3099(03)00857-0; Varani S, 2000, J MED VIROL, V62, P25, DOI 10.1002/1096-9071(200009)62:1&lt;25::AID-JMV4&gt;3.0.CO;2-E; Wareham DW, 2007, BMJ-BRIT MED J, V334, P1211, DOI 10.1136/bmj.39206.571042.AE; Wolfe F, 2006, RHEUMATOLOGY, V45, P1370, DOI 10.1093/rheumatology/kel328; Wu MY, 2012, AM J KIDNEY DIS, V60, P548, DOI 10.1053/j.ajkd.2012.03.018; Wung Peter K, 2005, Am J Med, V118, P1416, DOI 10.1016/j.amjmed.2005.06.012; Yang YW, 2011, CAN MED ASSOC J, V183, pE275, DOI 10.1503/cmaj.101137; Yawn BP, 2007, MAYO CLIN PROC, V82, P1341, DOI 10.4065/82.11.1341	40	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93443	10.1371/journal.pone.0093443	http://dx.doi.org/10.1371/journal.pone.0093443			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699628	gold, Green Published, Green Submitted			2022-12-25	WOS:000334105000061
J	Brooke, ZM; Bielby, J; Nambiar, K; Carbone, C				Brooke, Zoe M.; Bielby, Jon; Nambiar, Kate; Carbone, Chris			Correlates of Research Effort in Carnivores: Body Size, Range Size and Diet Matter	PLOS ONE			English	Article							EXTINCTION RISK; CONSERVATION RESEARCH; TAXONOMIC CHAUVINISM; SETTING PRIORITIES; ZOO ANIMALS; GAP; IMPLEMENTATION; PRACTITIONERS; RELEVANT; PRIMATES	Given the budgetary restrictions on scientific research and the increasing need to better inform conservation actions, it is important to identify the patterns and causes of biases in research effort. We combine bibliometric information from a literature review of almost 16,500 peer-reviewed publications on a well-known group of 286 species, the Order Carnivora, with global datasets on species' life history and ecological traits to explore patterns in research effort. Our study explores how species' characteristics influenced the degree to which they were studied ( measured as the number of publications). We identified a wide variation in intensity of research effort at both Family and Species levels, with some of the least studied being those which may need protection in future. Our findings hint at the complex role of human perspectives in setting research agendas. We found that better-studied species tended to be large-bodied and have a large geographic range whilst omnivory had a negative relationship with research effort. IUCN threat status did not exhibit a strong relationship with research effort which suggests that the conservation needs of individual species are not major drivers of research interest. This work is the first to use a combination of bibliometric analysis and biological data to quantify and interpret gaps in research knowledge across an entire Order. Our results could be combined with other resources, such as Biodiversity Action Plans, to prioritise and co-ordinate future research effort, whilst our methods can be applied across many scientific disciplines to describe knowledge gaps.	[Brooke, Zoe M.; Bielby, Jon; Carbone, Chris] Zool Soc London, Inst Zool, London NW1 4RY, England; [Nambiar, Kate] Univ Sussex, Brighton & Sussex Med Sch, Brighton, E Sussex, England	Zoological Society of London; University of Brighton; University of Sussex	Carbone, C (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	chris.carbone@ioz.ac.uk		Bielby, Jon/0000-0003-4586-0429; Nambiar, Kate/0000-0001-8591-0203				Amori G, 2000, BIODIVERS CONSERV, V9, P785, DOI 10.1023/A:1008971823774; [Anonymous], 2005, EC HUM WELLB CURR ST; Arlettaz R, 2010, BIOSCIENCE, V60, P835, DOI 10.1525/bio.2010.60.10.10; Bajomi B, 2010, ORYX, V44, P358, DOI 10.1017/S0030605310000281; Balme GA, 2013, CONSERV LETT, V00, P1; Balmford A, 1996, CONSERV BIOL, V10, P719, DOI 10.1046/j.1523-1739.1996.10030719.x; BITGOOD S, 1988, ENVIRON BEHAV, V20, P474, DOI 10.1177/0013916588204006; Bonnet X, 2002, TRENDS ECOL EVOL, V17, P1, DOI 10.1016/S0169-5347(01)02381-3; Braunisch V, 2012, BIOL CONSERV, V153, P201, DOI 10.1016/j.biocon.2012.05.007; Brodie JF, 2009, BIODIVERS CONSERV, V18, P2927, DOI 10.1007/s10531-009-9617-3; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1441, DOI 10.1098/rspb.2008.0179; Clark JA, 2002, SCIENCE, V297, P191; Collen B, 2004, GLOBAL ECOL BIOGEOGR, V13, P459, DOI 10.1111/j.1466-822X.2004.00121.x; Collen B, 2011, PHILOS T R SOC B, V366, P2577, DOI 10.1098/rstb.2011.0015; Fazey I, 2005, BIOL CONSERV, V124, P63, DOI 10.1016/j.biocon.2005.01.013; Fisher R, 2011, CONSERV LETT, V4, P64, DOI 10.1111/j.1755-263X.2010.00146.x; Frynta D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063110; Garfield E, 2007, CHEM HER FDN PHIL US; Ghosal S, 2013, BIODIVERS CONSERV, V22, P2665, DOI 10.1007/s10531-013-0549-6; Griffiths RA, 2012, BIOL CONSERV, V153, P153, DOI 10.1016/j.biocon.2012.05.011; Hopkins ME, 2007, DIVERS DISTRIB, V13, P561, DOI 10.1111/j.1472-4642.2007.00364.x; Howe D, 2008, NATURE, V455, P47, DOI 10.1038/455047a; IUCN, 2011, IUCN 2011 IUCN RED L; Johnson PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012866; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Kaschner K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044075; Knight AT, 2008, CONSERV BIOL, V22, P610, DOI 10.1111/j.1523-1739.2008.00914.x; Kot CY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012990; Laurance WF, 2012, BIOL CONSERV, V153, P164, DOI 10.1016/j.biocon.2012.05.012; Lawler JJ, 2006, FRONT ECOL ENVIRON, V4, P473, DOI 10.1890/1540-9295(2006)4[473:CSAYRC]2.0.CO;2; Loe J, 2004, AMBIO, V33, P283, DOI 10.1639/0044-7447(2004)033[0283:LCAHSA]2.0.CO;2; Mabe M, 2001, SCIENTOMETRICS, V51, P147, DOI 10.1023/A:1010520913124; MASTER LL, 1991, CONSERV BIOL, V5, P559, DOI 10.1111/j.1523-1739.1991.tb00370.x; Moss A, 2010, ZOO BIOL, V29, P715, DOI 10.1002/zoo.20316; NEWEY WK, 1987, ECONOMETRICA, V55, P703, DOI 10.2307/1913610; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; Pawar S, 2003, BIOSCIENCE, V53, P861, DOI 10.1641/0006-3568(2003)053[0861:TCATMC]2.0.CO;2; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Safi K, 2010, GLOBAL ECOL BIOGEOGR, V19, P352, DOI 10.1111/j.1466-8238.2010.00523.x; Thomas DF, 2012, QUANTPSYC QUANTIATIV; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Trimble MJ, 2010, CONSERV BIOL, V24, P886, DOI 10.1111/j.1523-1739.2010.01453.x; Tyler EHM, 2012, GLOBAL ECOL BIOGEOGR, V21, P922, DOI 10.1111/j.1466-8238.2011.00726.x; United Nations, 2012, DEM YB 2011; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Ward PI, 1998, CONSERV BIOL, V12, P1408, DOI 10.1046/j.1523-1739.1998.97402.x; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; *WORLD BANK, 2011, POP GROWTH ANN; Zeileis A., 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i10, DOI 10.18637/JSS.V011.I10]; ZEILEIS A., 2006, J STAT SOFTW, V16, P1, DOI DOI 10.18637/JSS.V016.I09; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	57	75	76	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93195	10.1371/journal.pone.0093195	http://dx.doi.org/10.1371/journal.pone.0093195			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LC	24695422	Green Published, gold, Green Submitted			2022-12-25	WOS:000334103000047
J	Finch, TM; Zhao, N; Korkin, D; Frederick, KH; Eggert, LS				Finch, Tabitha M.; Zhao, Nan; Korkin, Dmitry; Frederick, Katy H.; Eggert, Lori S.			Evidence of Positive Selection in Mitochondrial Complexes I and V of the African Elephant	PLOS ONE			English	Article							ADAPTIVE EVOLUTION; DNA; REVEAL; PERFORMANCE; METABOLISM; INFERENCE; MUTATION; RESERVE; GENE; SIZE	As species evolve, they become adapted to their local environments. Detecting the genetic signature of selection and connecting that to the phenotype of the organism, however, is challenging. Here we report using an integrative approach that combines DNA sequencing with structural biology analyses to assess the effect of selection on residues in the mitochondrial DNA of the two species of African elephants. We detected evidence of positive selection acting on residues in complexes I and V, and we used homology protein structure modeling to assess the effect of the biochemical properties of the selected residues on the enzyme structure. Given the role these enzymes play in oxidative phosphorylation, we propose that the selected residues may contribute to the metabolic adaptation of forest and savanna elephants to their unique habitats.	[Finch, Tabitha M.; Frederick, Katy H.; Eggert, Lori S.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Zhao, Nan] Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA; [Korkin, Dmitry] Univ Missouri, Inst Informat, Columbia, MO USA; [Korkin, Dmitry] Univ Missouri, Dept Comp Sci, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; Mississippi State University; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Finch, TM (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	tabitha.finch@mail.missouri.edu; eggertl@missouri.edu	Zhao, Nan/K-4015-2015	Zhao, Nan/0000-0002-7897-2374	National Science Foundation [DBI-0845196, IOS-1126992]; University of Missouri's Life Sciences Fellowship; Div Of Biological Infrastructure [0845196] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); University of Missouri's Life Sciences Fellowship; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation (DBI-0845196, IOS-1126992 to DK). Funding for TMF was provided by the University of Missouri's Life Sciences Fellowship, and NZ is supported by the National Science Foundation (IOS-1126992 to DK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; AMOS W, 1992, MAR MAMMAL SCI, V8, P275, DOI 10.1111/j.1748-7692.1992.tb00409.x; Archie EA, 2006, P ROY SOC B-BIOL SCI, V273, P513, DOI 10.1098/rspb.2005.3361; Arsenieva D, 2010, J BIOL CHEM, V285, P36561, DOI 10.1074/jbc.M110.174383; Ballard JWO, 2007, EVOLUTION, V61, P1735, DOI 10.1111/j.1558-5646.2007.00133.x; Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brandt AL, 2012, MOL ECOL, V21, P1175, DOI 10.1111/j.1365-294X.2012.05461.x; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Codron J, 2011, OECOLOGIA, V165, P89, DOI 10.1007/s00442-010-1835-6; da Fonseca RR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-119; Dalziel AC, 2009, MOL ECOL, V18, P4997, DOI 10.1111/j.1365-294X.2009.04427.x; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Eggert LS, 2005, METHOD ENZYMOL, V395, P73, DOI 10.1016/S0076-6879(05)95006-4; Eggert LS, 2002, P ROY SOC B-BIOL SCI, V269, P1993, DOI 10.1098/rspb.2002.2070; Foote AD, 2010, BIOL LETT; Garvin MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024127; Goodman M, 2009, P NATL ACAD SCI USA, V106, P20824, DOI 10.1073/pnas.0911239106; Greenwood AD, 1999, MOL ECOL, V8, P133, DOI 10.1046/j.1365-294X.1999.00507.x; Grossman LI, 2001, MOL PHYLOGENET EVOL, V18, P26, DOI 10.1006/mpev.2000.0890; Grossman LI, 2004, TRENDS GENET, V20, P578, DOI 10.1016/j.tig.2004.09.002; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hubbard S.J, 1993, NACCESS, V2; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Johnson MB, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-244; Krause J, 2006, NATURE, V439, P724, DOI 10.1038/nature04432; Lister Adrian M, 2013, Nature, V500, P331, DOI 10.1038/nature12275; MCNAB BK, 1983, J ZOOL, V199, P1; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Morgan BJ, 2003, J ZOOL, V259, P337, DOI 10.1017/S0952836902003291; Murata Y, 2009, GENE, V441, P176, DOI 10.1016/j.gene.2009.01.014; Ning T, 2010, GENET MOL RES, V9, P144, DOI 10.4238/vol9-1gmr705; Owen- Smith RN., 1988, MEGAHERBIVORES; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piccoli C, 2008, LEUKEMIA, V22, P1938, DOI 10.1038/leu.2008.69; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Radermacher M, 2006, J STRUCT BIOL, V154, P269, DOI 10.1016/j.jsb.2006.02.011; Rand DM, 1998, GENETICA, V102-3, P393, DOI 10.1023/A:1017006118852; Rankinen T, 2006, MED SCI SPORT EXER, V38, P1863, DOI 10.1249/01.mss.0000233789.01164.4f; Roca AL, 2001, SCIENCE, V293, P1473, DOI 10.1126/science.1059936; Roca AL, 2005, CURR OPIN GENET DEV, V15, P652, DOI 10.1016/j.gde.2005.09.014; Rohland N, 2007, PLOS BIOL, V5, P1663, DOI 10.1371/journal.pbio.0050207; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Sali A, 1994, PROTEIN STRUCTURE DI, V64, pC86; Sanchez R, 2000, METH MOL B, V143, P97; Schuttler SG, 2012, SECRET LIVES AFRICAN; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Sikes S.K, 1971, NATURAL HIST AFRICAN; Smith NGC, 2002, NATURE, V415, P1022, DOI 10.1038/4151022a; Tao N, 2005, FINDMODEL TOOL SELEC; TAYLOR WR, 1986, J THEOR BIOL, V119, P205, DOI 10.1016/S0022-5193(86)80075-3; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; Weber J, 1997, BBA-BIOENERGETICS, V1319, P19, DOI 10.1016/S0005-2728(96)00121-1; WHITE LJT, 1993, AFR J ECOL, V31, P181, DOI 10.1111/j.1365-2028.1993.tb00532.x; WILLIAMS TM, 1990, J ZOOL, V222, P235, DOI 10.1111/j.1469-7998.1990.tb05674.x; Woolley S, 2003, BIOINFORMATICS, V19, P671, DOI 10.1093/bioinformatics/btg043; Xu Shuqing, 2007, Journal of Genetics and Genomics, V34, P720, DOI 10.1016/S1673-8527(07)60081-2; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264	69	30	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e92587	10.1371/journal.pone.0092587	http://dx.doi.org/10.1371/journal.pone.0092587			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695069	Green Published, gold, Green Submitted			2022-12-25	WOS:000334103000022
J	Guo, S; Lopez-Marquez, H; Fan, KC; Choy, E; Cote, G; Harmon, D; Nielsen, GP; Yang, C; Zhang, CQ; Mankin, H; Hornicek, FJ; Borger, DR; Duan, ZF				Guo, Shang; Lopez-Marquez, Hector; Fan, Kenneth C.; Choy, Edwin; Cote, Gregory; Harmon, David; Nielsen, G. Petur; Yang, Cao; Zhang, Changqing; Mankin, Henry; Hornicek, Francis J.; Borger, Darrell R.; Duan, Zhenfeng			Synergistic Effects of Targeted PI3K Signaling Inhibition and Chemotherapy in Liposarcoma	PLOS ONE			English	Article							DEDIFFERENTIATED LIPOSARCOMA; EXPRESSION; DIAGNOSIS; PATHWAY; MDM2; CDK4; ACTIVATION; MANAGEMENT	While liposarcoma is the second most common soft tissue malignant tumor, the molecular pathogenesis in this malignancy is poorly understood. Our goal was therefore to expand the understanding of molecular mechanisms that drive liposarcoma and identify therapeutically-susceptible genetic alterations. We studied a cohort of high-grade liposarcomas and benign lipomas across multiple disease sites, as well as two liposarcoma cell lines, using multiplexed mutational analysis. Nucleic acids extracted from diagnostic patient tissue were simultaneously interrogated for 150 common mutations across 15 essential cancer genes using a clinically-validated platform for cancer genotyping. Western blot analysis was implemented to detect activation of downstream pathways. Liposarcoma cell lines were used to determine the effects of PI3K targeted drug treatment with or without chemotherapy. We identified mutations in the PIK3CA gene in 4 of 18 human liposarcoma patients (22%). No PIK3CA mutations were identified in benign lipomas. Western blot analysis confirmed downstream activation of AKT in both PIK3CA mutant and non-mutant liposarcoma samples. PI-103, a dual PI3K/mTOR inhibitor, effectively inhibited the activation of the PI3K/AKT in liposarcoma cell lines and induced apoptosis. Importantly, combination with PI-103 treatment strongly synergized the growth-inhibitory effects of the chemotherapy drugs doxorubicin and cisplatin in liposarcoma cells. Taken together, these findings suggest that activation of the PI3K/AKT pathway is an important cancer mechanism in liposarcoma. Targeting the PI3K/AKT/pathway with small molecule inhibitors in combination with chemotherapy could be exploited as a novel strategy in the treatment of liposarcoma.	[Guo, Shang; Choy, Edwin; Cote, Gregory; Harmon, David; Mankin, Henry; Hornicek, Francis J.; Duan, Zhenfeng] Massachusetts Gen Hosp, Ctr Sarcoma & Connect Tissue Oncol, Boston, MA 02114 USA; [Guo, Shang; Zhang, Changqing] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Shanghai 200030, Peoples R China; [Lopez-Marquez, Hector; Fan, Kenneth C.; Borger, Darrell R.] Massachusetts Gen Hosp, Translat Res Lab, Boston, MA 02114 USA; [Nielsen, G. Petur] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Yang, Cao] Huazhong Univ Sci & Technol, Union Hosp, Dept Orthopaed, Wuhan 430074, Peoples R China	Harvard University; Massachusetts General Hospital; Shanghai Jiao Tong University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Huazhong University of Science & Technology	Duan, ZF (corresponding author), Massachusetts Gen Hosp, Ctr Sarcoma & Connect Tissue Oncol, Boston, MA 02114 USA.	zduan@mgh.harvard.edu		zhang, changqing/0000-0002-7408-4126; Cote, Gregory/0000-0003-0181-886X	Jeff Guyer Fund; Gattegno fund; Wechsler fund; Kenneth Stanton Fund; Sarcoma Foundation of America (SFA); National Cancer Institute (NCI)/National Institutes of Health (NIH) [CA 151452-01]; Academic Enrichment Fund of MGH Orthopaedics; NATIONAL CANCER INSTITUTE [U01CA151452] Funding Source: NIH RePORTER	Jeff Guyer Fund; Gattegno fund; Wechsler fund; Kenneth Stanton Fund; Sarcoma Foundation of America (SFA); National Cancer Institute (NCI)/National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Academic Enrichment Fund of MGH Orthopaedics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported, in part, by grants from the Jeff Guyer Fund. Support has also been provided by the Gattegno and Wechsler funds, the Kenneth Stanton Fund. ZD is supported, in part, through a grant from Sarcoma Foundation of America (SFA), a grant from National Cancer Institute (NCI)/National Institutes of Health (NIH), UO1, CA 151452-01, and a grant from an Academic Enrichment Fund of MGH Orthopaedics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agell L, 2011, MODERN PATHOL, V24, P443, DOI 10.1038/modpathol.2010.208; Bagci-Onder T, 2011, CANCER RES, V71, P154, DOI 10.1158/0008-5472.CAN-10-1601; Barretina J, 2010, NAT GENET, V42, P715, DOI 10.1038/ng.619; Conyers Rachel, 2011, Sarcoma, V2011, P483154, DOI 10.1155/2011/483154; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Crago AM, 2011, CURR OPIN ONCOL, V23, P373, DOI 10.1097/CCO.0b013e32834796e6; Dalal KM, 2008, J SURG ONCOL, V97, P298, DOI 10.1002/jso.20975; de Vreeze RSA, 2010, ANN SURG ONCOL, V17, P686, DOI 10.1245/s10434-009-0806-9; Demicco EG, 2012, MODERN PATHOL, V25, P212, DOI 10.1038/modpathol.2011.148; Dias-Santagata D, 2010, EMBO MOL MED, V2, P146, DOI 10.1002/emmm.201000070; Duan Z, 2007, MOL PHARMACOL, V72, P1137, DOI 10.1124/mol.107.038117; Duan ZF, 2012, CLIN CANCER RES, V18, P4580, DOI 10.1158/1078-0432.CCR-12-1157; Duan ZF, 2010, CANCER LETT, V293, P220, DOI 10.1016/j.canlet.2010.01.014; Ebi H, 2011, J CLIN INVEST, V121, P4311, DOI 10.1172/JCI57909; Fan JX, 2013, AM J HEALTH PROMOT, V28, P41, DOI 10.4278/ajhp.120606-QUAL-286; Gutierrez A, 2011, P NATL ACAD SCI USA, V108, P16386, DOI 10.1073/pnas.1106127108; Hoffman A, 2011, DRUG RESIST UPDATE, V14, P52, DOI 10.1016/j.drup.2010.11.001; Italiano A, 2008, INT J CANCER, V122, P2233, DOI 10.1002/ijc.23380; Mankin Henry J, 2005, Cancer Control, V12, P5; Nardi V, 2012, CLIN CANCER RES, V18, P1227, DOI 10.1158/1078-0432.CCR-11-2308; Opel D, 2011, CLIN CANCER RES, V17, P3233, DOI 10.1158/1078-0432.CCR-10-2530; Pedeutour F, 1999, GENE CHROMOSOME CANC, V24, P30, DOI 10.1002/(SICI)1098-2264(199901)24:1<30::AID-GCC5>3.0.CO;2-P; Raynaud FI, 2007, CANCER RES, V67, P5840, DOI 10.1158/0008-5472.CAN-06-4615; Sachdeva MP, 2009, AM J DERMATOPATH, V31, P423, DOI 10.1097/DAD.0b013e3181a129b7; Sakamoto A, 2001, AM J CLIN PATHOL, V115, P235; Schneider-Stock R, 1998, VIRCHOWS ARCH, V433, P315, DOI 10.1007/s004280050255; Schwab J, 2009, ANTICANCER RES, V29, P1867; Segura-Sanchez J, 2006, ANTICANCER RES, V26, P4937; Smith KB, 2013, AM J PATHOL, V182, P1400, DOI 10.1016/j.ajpath.2013.01.002; Smith WA, 2013, BMC EVOL BIOL, V13, P109, DOI DOI 10.1186/1471-2148-13-109; Tanas MR, 2009, ADV ANAT PATHOL, V16, P383, DOI 10.1097/PAP.0b013e3181bb6b86; Tos APD, 2000, J PATHOL, V190, P531; Warner EL, 2014, J CANCER EPIDEMIOL, V2014, DOI 10.1155/2014/531958; Westhoff MA, 2009, ONCOGENE, V28, P3586, DOI 10.1038/onc.2009.215; Willems L, 2012, CURR ONCOL REP, V14, P129, DOI 10.1007/s11912-012-0227-y	35	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93996	10.1371/journal.pone.0093996	http://dx.doi.org/10.1371/journal.pone.0093996			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695632	Green Published, gold, Green Submitted			2022-12-25	WOS:000334103000133
J	Pedrelli, M; Davoodpour, P; Degirolamo, C; Gomaraschi, M; Graham, M; Ossoli, A; Larsson, L; Calabresi, L; Gustafsson, JA; Steffensen, KR; Eriksson, M; Parini, P				Pedrelli, Matteo; Davoodpour, Padideh; Degirolamo, Chiara; Gomaraschi, Monica; Graham, Mark; Ossoli, Alice; Larsson, Lilian; Calabresi, Laura; Gustafsson, Jan-Ake; Steffensen, Knut R.; Eriksson, Mats; Parini, Paolo			Hepatic ACAT2 Knock Down Increases ABCA1 and Modifies HDL Metabolism in Mice	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; REVERSE CHOLESTEROL TRANSPORT; TISSUE-CULTURE CELLS; APOLIPOPROTEIN-E; DIETARY-CHOLESTEROL; ESTER METABOLISM; ACYL-COENZYME; LXR AGONIST; PLASMA; EFFLUX	Objectives: ACAT2 is the exclusive cholesterol esterifying enzyme in hepatocytes and enterocytes. Hepatic ABCA1 transfers unesterified cholesterol (UC) to apoAI, thus generating HDL. By changing the hepatic UC pool available for ABCA1, ACAT2 may affect HDL metabolism. The aim of this study was to reveal whether hepatic ACAT2 influences HDL metabolism. Design: WT and LXR alpha/beta double knockout (DOKO) mice were fed a western-type diet for 8 weeks. Animals were i.p. injected with an antisense oligonucleotide targeted to hepatic ACAT2 (ASO6), or with an ASO control. Injections started 4 weeks after, or concomitantly with, the beginning of the diet. Results: ASO6 reduced liver cholesteryl esters, while not inducing UC accumulation. ASO6 increased hepatic ABCA1 protein independently of the diet conditions. ASO6 affected HDL lipids (increased UC) only in DOKO, while it increased apoE-containing HDL in both genotypes. In WT mice ASO6 led to the appearance of large HDL enriched in apoAI and apoE. Conclusions: The use of ASO6 revealed a new pathway by which the liver may contribute to HDL metabolism in mice. ACAT2 seems to be a hepatic player affecting the cholesterol fluxes fated to VLDL or to HDL, the latter via up-regulation of ABCA1.	[Pedrelli, Matteo; Davoodpour, Padideh; Larsson, Lilian; Parini, Paolo] Karolinska Inst, Dept Lab Med, Div Clin Chem, Stockholm, Sweden; [Pedrelli, Matteo; Gustafsson, Jan-Ake; Steffensen, Knut R.; Eriksson, Mats; Parini, Paolo] Karolinska Inst, Dept Biosci & Nutr, Mol Nutr Unit, Stockholm, Sweden; [Degirolamo, Chiara] Wake Forest Univ, Sch Med, Dept Pathol, Div Lipid Sci, Winston Salem, NC 27109 USA; [Gomaraschi, Monica; Ossoli, Alice; Calabresi, Laura] Univ Milan, Dept Pharmacol Sci, Milan, Italy; [Graham, Mark] Isis Pharmaceut Inc, Dept Antisense Drug Discovery, Cardiovasc Grp, Carlsbad, CA USA; [Gustafsson, Jan-Ake] Univ Houston, Ctr Nucl Receptors & Cell Signaling, Houston, TX USA; [Eriksson, Mats] Karolinska Inst, Dept Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Wake Forest University; University of Milan; Isis Pharmaceuticals Inc; University of Houston System; University of Houston; Karolinska Institutet	Parini, P (corresponding author), Karolinska Inst, Dept Lab Med, Div Clin Chem, Stockholm, Sweden.	paolo.parini@ki.se	Gomaraschi, Monica/A-3601-2014; Ossoli, Alice/K-5917-2016	Gomaraschi, Monica/0000-0003-3082-2120; Ossoli, Alice/0000-0002-9902-252X; Steffensen, Knut/0000-0001-6093-2801; Pedrelli, Matteo/0000-0003-0771-0569; Eriksson, Mats/0000-0001-6481-5549; Calabresi, Laura/0000-0001-5042-9532	Swedish Heart-Lung Foundation; Swedish Research Council; Karolinska Institutet; Swedish Medical Association; Stockholm County Council; Novo Nordisk Research Foundation	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Swedish Medical Association; Stockholm County Council(Stockholm County Council); Novo Nordisk Research Foundation(Novo Nordisk Foundation)	The studies described in this paper were supported by the Swedish Heart-Lung Foundation, the Swedish Research Council, the Karolinska Institutet, the Swedish Medical Association, the Stockholm County Council, and Novo Nordisk Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2001, J CLIN INVEST, V107, P565, DOI 10.1172/JCI9794; Alger HM, 2010, J BIOL CHEM, V285, P14267, DOI 10.1074/jbc.M110.118422; Bell TA, 2007, ARTERIOSCL THROM VAS, V27, P1396, DOI 10.1161/ATVBAHA.107.142802; Bell TA, 2006, ARTERIOSCL THROM VAS, V26, P1814, DOI 10.1161/01.ATV.0000225289.30767.06; Brown JM, 2008, J BIOL CHEM, V283, P10522, DOI 10.1074/jbc.M707659200; Buhman KK, 2000, NAT MED, V6, P1341, DOI 10.1038/82153; Camont L, 2013, ARTERIOSCL THROM VAS, V33, P2715, DOI 10.1161/ATVBAHA.113.301468; Camont L, 2011, TRENDS MOL MED, V17, P594, DOI 10.1016/j.molmed.2011.05.013; CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X; CARR TP, 1992, ARTERIOSCLER THROMB, V12, P1274, DOI 10.1161/01.ATV.12.11.1274; Chen SN, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-111; de la Llera-Moya M, 1999, J LIPID RES, V40, P575; de la Llera-Moya M, 2010, ARTERIOSCL THROM VAS, V30, P796, DOI 10.1161/ATVBAHA.109.199158; Duong PT, 2006, J LIPID RES, V47, P832, DOI 10.1194/jlr.M500531-JLR200; Favari E, 2004, J BIOL CHEM, V279, P9930, DOI 10.1074/jbc.M312476200; Favari E, 2009, BIOCHEMISTRY-US, V48, P11067, DOI 10.1021/bi901564g; Fazio S, 2006, NEW ENGL J MED, V354, P1307, DOI 10.1056/NEJMe068012; Feingold KR, 2011, J LIPID RES, V52, P1, DOI 10.1194/jlr.E012138; Jiang ZY, 2009, BIOCHEM BIOPH RES CO, V379, P49, DOI 10.1016/j.bbrc.2008.11.131; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Krimbou L, 2004, J LIPID RES, V45, P839, DOI 10.1194/jlr.M300418-JLR200; Lada AT, 2004, J LIPID RES, V45, P378, DOI 10.1194/jlr.D300037-JLR200; Lee RG, 2005, J LIPID RES, V46, P1205, DOI 10.1194/jlr.M500018-JLR200; Lee RG, 2004, CIRC RES, V95, P998, DOI 10.1161/01.RES.0000147558.15554.67; LEVINE DM, 1993, P NATL ACAD SCI USA, V90, P12040, DOI 10.1073/pnas.90.24.12040; Linder MD, 2009, ARTERIOSCL THROM VAS, V29, P883, DOI 10.1161/ATVBAHA.108.179481; Lovgren-Sandblom A, 2007, J CHROMATOGR B, V856, P15, DOI 10.1016/j.jchromb.2007.05.019; Ma J, 1997, AM J CLIN NUTR, V65, P551, DOI 10.1093/ajcn/65.2.551; Miller CD, 2012, ACAD EMERG MED, V19, P673, DOI 10.1111/j.1553-2712.2012.01378.x; Oram JF, 2003, ARTERIOSCL THROM VAS, V23, P720, DOI 10.1161/01.ATV.0000054662.44688.9A; Parini P, 2006, EUR J CLIN INVEST, V36, P98, DOI 10.1111/j.1365-2362.2006.01597.x; Parini P, 2004, CIRCULATION, V110, P2017, DOI 10.1161/01.CIR.0000143163.76212.0B; Parini P, 2009, ATHEROSCLEROSIS, V207, P266, DOI 10.1016/j.atherosclerosis.2009.04.010; Pedrelli M, 2010, ARTERIOSCLER THROMB, V30, pE183; Pramfalk C, 2012, EUR J LIPID SCI TECH, V114, P624, DOI 10.1002/ejlt.201100294; Qiu Shenfeng, 2012, Frontiers in Genetics, V3, P124, DOI 10.3389/fgene.2012.00124; ROTHBLAT GH, 1976, LIPIDS, V11, P97, DOI 10.1007/BF02532658; ROTHBLAT GH, 1974, LIPIDS, V9, P526, DOI 10.1007/BF02532500; Rudel LL, 2005, ARTERIOSCL THROM VAS, V25, P1112, DOI 10.1161/01.ATV.0000166548.65753.1e; SHENG J, 1990, METABOLISM, V39, P155, DOI 10.1016/0026-0495(90)90069-O; Singaraja RR, 2009, CIRC RES, V105, P138, DOI 10.1161/CIRCRESAHA.108.193011; Slatis K, 2010, J LIPID RES, V51, P3289, DOI 10.1194/jlr.M009308; Tang WQ, 2008, ARTERIOSCL THROM VAS, V28, P448, DOI 10.1161/ATVBAHA.107.160465; Temel RE, 2005, J LIPID RES, V46, P2423, DOI 10.1194/jlr.M500232-JLR200; Temel RE, 2007, J CLIN INVEST, V117, P1968, DOI 10.1172/JCI30060; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Vaisman BL, 2001, J CLIN INVEST, V108, P303; Wang MD, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M700326200; Warensjo E, 2008, AM J CLIN NUTR, V88, P203, DOI 10.1093/ajcn/88.1.203; Willner EL, 2003, P NATL ACAD SCI USA, V100, P1262, DOI 10.1073/pnas.0336398100; Yancey PG, 2003, ARTERIOSCL THROM VAS, V23, P712, DOI 10.1161/01.ATV.0000057572.97137.DD; Yancey PG, 2000, J BIOL CHEM, V275, P36596, DOI 10.1074/jbc.M006924200; Zanotti I, 2008, J LIPID RES, V49, P954, DOI 10.1194/jlr.M700254-JLR200; Zanotti I, 2011, ARTERIOSCL THROM VAS, V31, P74, DOI 10.1161/ATVBAHA.110.213892; Zhang J, 2012, J LIPID RES, V53, P1144, DOI 10.1194/jlr.M024356	55	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93552	10.1371/journal.pone.0093552	http://dx.doi.org/10.1371/journal.pone.0093552			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695360	Green Published, gold, Green Submitted			2022-12-25	WOS:000334103000089
J	Saunders, DR; Bex, PJ; Rose, DJ; Woods, RL				Saunders, Daniel R.; Bex, Peter J.; Rose, Dylan J.; Woods, Russell L.			Measuring Information Acquisition from Sensory Input Using Automated Scoring of Natural-Language Descriptions	PLOS ONE			English	Article							IMAGE QUALITY; READING-COMPREHENSION; VIDEO QUALITY; ENHANCEMENT; TEXT	Information acquisition, the gathering and interpretation of sensory information, is a basic function of mobile organisms. We describe a new method for measuring this ability in humans, using free-recall responses to sensory stimuli which are scored objectively using a "wisdom of crowds'' approach. As an example, we demonstrate this metric using perception of video stimuli. Immediately after viewing a 30 s video clip, subjects responded to a prompt to give a short description of the clip in natural language. These responses were scored automatically by comparison to a dataset of responses to the same clip by normally-sighted viewers (the crowd). In this case, the normative dataset consisted of responses to 200 clips by 60 subjects who were stratified by age (range 22 to 85y) and viewed the clips in the lab, for 2,400 responses, and by 99 crowdsourced participants (age range 20 to 66y) who viewed clips in their Web browser, for 4,000 responses. We compared different algorithms for computing these similarities and found that a simple count of the words in common had the best performance. It correctly matched 75% of the lab-sourced and 95% of crowdsourced responses to their corresponding clips. We validated the measure by showing that when the amount of information in the clip was degraded using defocus lenses, the shared word score decreased across the five predetermined visual-acuity levels, demonstrating a dose- response effect (N = 15). This approach, of scoring open-ended immediate free recall of the stimulus, is applicable not only to video, but also to other situations where a measure of the information that is successfully acquired is desirable. Information acquired will be affected by stimulus quality, sensory ability, and cognitive processes, so our metric can be used to assess each of these components when the others are controlled.	[Saunders, Daniel R.; Bex, Peter J.; Rose, Dylan J.; Woods, Russell L.] Schepens Eye Res Inst, Boston, MA 02114 USA	Harvard University; Schepens Eye Research Institute	Saunders, DR (corresponding author), Schepens Eye Res Inst, Boston, MA 02114 USA.	daniel_saunders@meei.harvard.edu	Woods, Russell L/O-2600-2015	Woods, Russell L/0000-0002-7193-1211	National Eye Institute [R01EY019100]; NATIONAL EYE INSTITUTE [R01EY019100] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by grant number R01EY019100 from the National Eye Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderson J. C, 2000, ASSESSING READING; Allwood CM, 2005, PSYCHOL CRIME LAW, V11, P183, DOI 10.1080/10683160512331329943; [Anonymous], 1992, HDB NEUROPSYCHOLOGIC; BAILEY IL, 1976, AM J OPTOM PHYS OPT, V53, P740; Baroni M, 2010, COMPUT LINGUIST, V36, P673, DOI 10.1162/coli_a_00016; Baroni M, 2009, LANG RESOUR EVAL, V43, P209, DOI 10.1007/s10579-009-9081-4; BARTEN PGJ, 1990, J OPT SOC AM A, V7, P2024, DOI 10.1364/JOSAA.7.002024; Bernhardt E.B., 1983, UNTERRICHTSPRAXIS, V16, P27, DOI DOI 10.2307/3530598; Bernhardt E. B., 1991, READING DEV 2 LANGUA; DICKINSON CM, 1991, CLIN VISION SCI, V6, P301; Eskicioglu AM, 1995, IEEE T COMMUN, V43, P2959, DOI 10.1109/26.477498; Ferraresi A., 2008, P 4 WEB CORPUS WORKS, P47; Fine E, 1996, VIS 96 P INT C LOW V, P85; Foltz PW, 1999, BEHAV RES METH INS C, V31, P208, DOI 10.3758/BF03207712; Fullerton M, 2007, J OPT SOC AM A, V24, pB174, DOI 10.1364/JOSAA.24.00B174; HAMBERG R, 1995, J OPT SOC AM A, V12, P2573, DOI 10.1364/JOSAA.12.002573; Heinz P. J, 2004, READING FOREIGN LANG, V16, P97; Janssen DP, 2012, BEHAV RES METHODS, V44, P232, DOI 10.3758/s13428-011-0145-1; Jepsen ML, 2008, J ACOUST SOC AM, V124, P422, DOI 10.1121/1.2924135; Kies JK, 1997, COMPUT EDUC, V28, P79, DOI 10.1016/S0360-1315(97)00004-3; Kim J, 2004, OPT ENG, V43, P1318, DOI 10.1117/1.1723493; Kintsch W., 1974, REPRESENTATION MEANI; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; Lee C, 2006, OPT ENG, V45, DOI 10.1117/1.2160515; Lubin J., 1995, VISION MODELS TARGET, P245; Martin Allwood C, 2008, PSYCHOL CRIME LAW, V14, P529, DOI 10.1080/10683160801961231; MEYER BJF, 1980, READ RES QUART, V16, P72, DOI 10.2307/747349; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Papineni K, 2002, 40TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P311, DOI 10.3115/1073083.1073135; Peli E, 2005, OPHTHAL PHYSL OPT, V25, P543, DOI 10.1111/j.1475-1313.2005.00340.x; Peli E, 1996, J VISUAL IMPAIR BLIN, V90, P378; Peli E., 1999, OSA TECHNICAL DIGEST, P46; Peli E, 2009, INT J ARTIF INTELL T, V18, P415, DOI 10.1142/S0218213009000214; Pinson M, 2003, PROC SPIE, V5150, P573, DOI 10.1117/12.509908; PYRCZAK F, 1975, J READING, V18, P308; Satgunam P, 2010, SOC INF DISPL INT S, P94; Saunders DR, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2620; SEKULER R, 1977, AM J OPTOM PHYS OPT, V54, P573; STOCKHAM TG, 1972, PR INST ELECTR ELECT, V60, P828, DOI 10.1109/PROC.1972.8782; Surowiecki J., 2004, WISDOM CROWDS WHY MA, VXXI, P295; Turney PD, 2010, J ARTIF INTELL RES, V37, P141, DOI 10.1613/jair.2934; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Zeimpekis D., 2005, P WORKSH CLUST HIGH, P38	43	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93251	10.1371/journal.pone.0093251	http://dx.doi.org/10.1371/journal.pone.0093251			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LC	24695546	Green Published, gold, Green Submitted			2022-12-25	WOS:000334103000053
J	Wang, N; Zhang, HY; Zhang, BQ; Liu, W; Zhang, ZL; Qiao, M; Zhang, HM; Deng, F; Wu, NN; Chen, X; Wen, S; Zhang, JH; Liao, Z; Zhang, Q; Yan, ZJ; Yin, LJ; Ye, JX; Deng, YL; Luu, HH; Haydon, RC; Liang, HJ; He, TC				Wang, Ning; Zhang, Hongyu; Zhang, Bing-Qiang; Liu, Wei; Zhang, Zhonglin; Qiao, Min; Zhang, Hongmei; Deng, Fang; Wu, Ningning; Chen, Xian; Wen, Sheng; Zhang, Junhui; Liao, Zhan; Zhang, Qian; Yan, Zhengjian; Yin, Liangjun; Ye, Jixing; Deng, Youlin; Luu, Hue H.; Haydon, Rex C.; Liang, Houjie; He, Tong-Chuan			Adenovirus-Mediated Efficient Gene Transfer into Cultured Three-Dimensional Organoids	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; IN-VITRO; RECOMBINANT ADENOVIRUSES; SELF-RENEWAL; DIFFERENTIATION; SYSTEM; INTESTINE; THERAPY; CRYPT; LGR5	Three-dimensional organoids have been recently established from various tissue-specific progenitors (such as intestinal stem cells), induced pluripotent stem cells, or embryonic stem cells. These cultured self-sustaining stem cell-based organoids may become valuable systems to study the roles of tissue-specific stem cells in tissue genesis and disease development. It is thus conceivable that effective genetic manipulations in such organoids may allow us to reconstruct disease processes and/or develop novel therapeutics. Recombinant adenoviruses are one of the most commonly used viral vectors for in vitro and in vivo gene deliveries. In this study, we investigate if adenoviruses can be used to effectively deliver transgenes into the cultured "mini-gut'' organoids derived from intestinal stem cells. Using adenoviral vectors that express fluorescent proteins, we demonstrate that adenoviruses can effectively deliver transgenes into the cultured 3-D "mini-gut'' organoids. The transgene expression can last at least 10 days in the cultured organoids. As a proof-of-principle experiment, we demonstrate that adenovirus-mediated noggin expression effectively support the survival and self-renewal of mini-gut organoids, while adenovirus-mediated expression of BMP4 inhibits the self-sustainability and proliferation of the organoids. Thus, our results strongly suggest that adenovirus vectors can be explored as effective gene delivery vehicles to introduce genetic manipulations in 3-D organoids.	[Wang, Ning; Liang, Houjie] Third Mil Med Univ, Affiliated Southwest Hosp, Dept Oncol, Chongqing, Peoples R China; [Wang, Ning; Liang, Houjie] Third Mil Med Univ, Affiliated Southwest Hosp, Southwest Canc Ctr, Chongqing, Peoples R China; [Wang, Ning; Zhang, Hongyu; Zhang, Bing-Qiang; Liu, Wei; Zhang, Zhonglin; Qiao, Min; Zhang, Hongmei; Deng, Fang; Wu, Ningning; Chen, Xian; Wen, Sheng; Zhang, Junhui; Liao, Zhan; Zhang, Qian; Yan, Zhengjian; Yin, Liangjun; Ye, Jixing; Deng, Youlin; Luu, Hue H.; Haydon, Rex C.; He, Tong-Chuan] Univ Chicago, Med Ctr, Dept Surg, Mol Oncol Lab, Chicago, IL 60637 USA; [Zhang, Hongyu; Zhang, Bing-Qiang; Liu, Wei; Qiao, Min; Zhang, Hongmei; Wu, Ningning; Chen, Xian; Wen, Sheng; Zhang, Junhui; Zhang, Qian; Yan, Zhengjian; Yin, Liangjun; Deng, Youlin; He, Tong-Chuan] Chongqing Med Univ, Key Lab Clin Diagnost Med, Minist Educ, Chongqing, Peoples R China; [Zhang, Hongyu; Zhang, Bing-Qiang; Liu, Wei; Qiao, Min; Zhang, Hongmei; Wu, Ningning; Chen, Xian; Wen, Sheng; Zhang, Junhui; Zhang, Qian; Yan, Zhengjian; Yin, Liangjun; Deng, Youlin; He, Tong-Chuan] Chongqing Med Univ, Affiliated Hosp, Chongqing, Peoples R China; [Zhang, Zhonglin] Wuhan Univ, Affiliated Zhongnan Hosp, Dept Surg, Wuhan 430072, Peoples R China; [Liao, Zhan] Cent S Univ, Xiang Ya Hosp, Dept Orthopaed Surg, Changsha, Hunan, Peoples R China; [Ye, Jixing] Chongqing Univ, Sch Bioengn, Chongqing 630044, Peoples R China	Army Medical University; Army Medical University; University of Chicago; University of Chicago Medical Center; Chongqing Medical University; Chongqing Medical University; Wuhan University; Central South University; Chongqing University	Liang, HJ (corresponding author), Third Mil Med Univ, Affiliated Southwest Hosp, Dept Oncol, Chongqing, Peoples R China.	lianghoujie@sina.com; tche@uchicago.edu		Deng, Fang/0000-0002-7927-5394; Yin, Liang-jun/0000-0002-9244-4965	National Institutes of Health [AT004418, AR50142, AR054381]; Ministry of Science and Technology (MOST) of China [2011CB707906]; National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health [UL1 TR000430]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P01AT004418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR050142, K08AR054381] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology (MOST) of China(Ministry of Science and Technology, China); National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by research grants from the National Institutes of Health (AT004418, AR50142, and AR054381 to TCH, RCH and HHL) and the Ministry of Science and Technology (MOST) of China (#2011CB707906 to TCH). This project was also supported by a core facility subsidies grant from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health through Grant Number UL1 TR000430. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Breyer Benjamin, 2001, Current Gene Therapy, V1, P149, DOI 10.2174/1566523013348689; Cao L, 2011, DIFFERENTIATION, V81, P1, DOI 10.1016/j.diff.2010.09.182; Chen X, 2013, CELL PHYSIOL BIOCHEM, V32, P1083, DOI 10.1159/000354508; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gao YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082436; Gasiunas G, 2013, TRENDS MICROBIOL, V21, P562, DOI 10.1016/j.tim.2013.09.001; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; He BC, 2011, MOL PHARMACOL, V79, P211, DOI 10.1124/mol.110.068668; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324; Kay MA, 2011, NAT REV GENET, V12, P316, DOI 10.1038/nrg2971; Kong YH, 2013, CELL PHYSIOL BIOCHEM, V32, P1187, DOI 10.1159/000354518; Koo BK, 2012, NAT METHODS, V9, P81, DOI [10.1038/NMETH.1802, 10.1038/nmeth.1802]; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lou JR, 1999, J ORTHOPAED RES, V17, P43, DOI 10.1002/jor.1100170108; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Malina A, 2013, GENE DEV, V27, P2602, DOI 10.1101/gad.227132.113; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sato Toshiro, 2013, Methods Mol Biol, V945, P319, DOI 10.1007/978-1-62703-125-7_19; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; St George JA, 2003, GENE THER, V10, P1135, DOI 10.1038/sj.gt.3302071; Subramanian K, 2014, STEM CELLS DEV, V23, P124, DOI 10.1089/scd.2013.0097; Takasato M, 2014, NAT CELL BIOL, V16, P118, DOI 10.1038/ncb2894; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Tang N, 2009, J CELL MOL MED, V13, P2448, DOI 10.1111/j.1582-4934.2008.00569.x; Wang Y, 2013, J ORTHOP RES; Yu B, 2013, CELL STEM CELL, V13, P328, DOI 10.1016/j.stem.2013.06.017; Zhang WW, 2013, INT J MED SCI, V10, P1888, DOI 10.7150/ijms.6019	43	56	56	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93608	10.1371/journal.pone.0093608	http://dx.doi.org/10.1371/journal.pone.0093608			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695466	Green Published, gold, Green Submitted			2022-12-25	WOS:000334103000092
J	Davis, SL; Dudle, DA; Nawrocki, JR; Freestone, LM; Konieczny, P; Tobin, MB; Britton, MM				Davis, Sandra L.; Dudle, Dana A.; Nawrocki, Jenna R.; Freestone, Leah M.; Konieczny, Peter; Tobin, Michael B.; Britton, Michael M.			Sexual Dimorphism of Staminate- and Pistillate-Phase Flowers of Saponaria officinalis (Bouncing Bet) Affects Pollinator Behavior and Seed Set	PLOS ONE			English	Article							FLORAL COLOR-CHANGE; ANTHOCYANIN BIOSYNTHETIC GENES; BIASED NECTAR PRODUCTION; SELECTION; EVOLUTION; DICHOGAMY; FEMALE; INTERFERENCE; EXPRESSION; DISPLAY	The sequential separation of male and female function in flowers of dichogamous species allows for the evolution of differing morphologies that maximize fitness through seed siring and seed set. We examined staminate- and pistillate-phase flowers of protandrous Saponaria officinalis for dimorphism in floral traits and their effects on pollinator attraction and seed set. Pistillate-phase flowers have larger petals, greater mass, and are pinker in color, but due to a shape change, pistillate-phase flowers have smaller corolla diameters than staminate-phase flowers. There was no difference in nectar volume or sugar content one day after anthesis, and minimal evidence for UV nectar guide patterns in staminate- and pistillate-phase flowers. When presented with choice arrays, pollinators discriminated against pistillate-phase flowers based on their pink color. Finally, in an experimental garden, in 2012 there was a negative correlation between seed set of an open-pollinated, emasculated flower and pinkness (as measured by reflectance spectrometry) of a pistillate-phase flower on the same plant in plots covered with shade cloth. In 2013, clones of genotypes chosen from the 2012 plants that produced pinker flowers had lower seed set than those from genotypes with paler flowers. Lower seed set of pink genotypes was found in open-pollinated and hand-pollinated flowers, indicating the lower seed set might be due to other differences between pink and pale genotypes in addition to pollinator discrimination against pink flowers. In conclusion, staminate- and pistillate-phase flowers of S. officinalis are dimorphic in shape and color. Pollinators discriminate among flowers based on these differences, and individuals whose pistillate-phase flowers are most different in color from their staminate-phase flowers make fewer seeds. We suggest morphological studies of the two sex phases in dichogamous, hermaphroditic species can contribute to understanding the evolution of sexual dimorphism in plants without the confounding effects of genetic differences between separate male and female individuals.	[Davis, Sandra L.; Nawrocki, Jenna R.] Univ Indianapolis, Dept Biol, Indianapolis, IN 46227 USA; [Dudle, Dana A.; Freestone, Leah M.; Konieczny, Peter; Tobin, Michael B.; Britton, Michael M.] Depauw Univ, Dept Biol, Greencastle, IN 46135 USA	DePauw University	Davis, SL (corresponding author), Univ Indianapolis, Dept Biol, Indianapolis, IN 46227 USA.	sdavis@uindy.edu			Indiana Academy of Sciences; University of Indianapolis; DePauw University	Indiana Academy of Sciences; University of Indianapolis; DePauw University	This project was funded by a Senior Research Grant from the Indiana Academy of Sciences (http://www.indianaacademyofscience.org) to S. L. D. and D. A. D., a summer research grant to S. L. D. from the University of Indianapolis (www.uindy.edu), the DePauw University student/faculty summer research program and DePauw University Science Research Fellows program (www.depauw.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbruster WS, 2002, J EVOLUTION BIOL, V15, P468, DOI 10.1046/j.1420-9101.2002.00399.x; Ashman TL, 2000, OIKOS, V90, P347, DOI 10.1034/j.1600-0706.2000.900216.x; Ashman TL, 2000, ECOLOGY, V81, P2577, DOI 10.1890/0012-9658(2000)081[2577:PSAIIF]2.0.CO;2; Barrett SCH, 2013, J EXP BOT, V64, P67, DOI 10.1093/jxb/ers308; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; BERTIN RI, 1993, BOT REV, V59, P112, DOI 10.1007/BF02856676; BEST LS, 1982, EVOLUTION, V36, P70, DOI 10.1111/j.1558-5646.1982.tb05011.x; Brunet J, 1998, FUNCT ECOL, V12, P596, DOI 10.1046/j.1365-2435.1998.00231.x; Campbell DR, 2012, J EVOLUTION BIOL, V25, P352, DOI 10.1111/j.1420-9101.2011.02430.x; CAMPBELL DR, 1989, EVOLUTION, V43, P318, DOI 10.1111/j.1558-5646.1989.tb04230.x; Carlson JE, 2007, AM J BOT, V94, P674, DOI 10.3732/ajb.94.4.674; Carlson JE, 2006, BOT REV, V72, P179, DOI 10.1663/0006-8101(2006)72[179:TEOGNP]2.0.CO;2; Cynthia AD., 2011, PLOS ONE, V16, P1; Dai C, 2011, FUNCT ECOL, V25, P271, DOI 10.1111/j.1365-2435.2010.01795.x; DELPH LF, 1989, EVOLUTION, V43, P1252, DOI [10.1111/j.1558-5646.1989.tb02572.x, 10.2307/2409360]; Delph LF, 2006, INTEGR COMP BIOL, V46, P465, DOI 10.1093/icb/icj038; Delph LF, 2012, EVOLUTION, V66, P1154, DOI 10.1111/j.1558-5646.2011.01510.x; Delph LF, 2010, EVOLUTION, V64, P2873, DOI 10.1111/j.1558-5646.2010.01048.x; Eckhart V.M., 1999, GENDER SEXUAL DIMORP, P123, DOI [DOI 10.1007/978-3-662-03908-3_5, 10.1007/978-3-662-03908-3_5]; Faegri K., 1979, PRINCIPLES POLLINATI; Farzad M, 2003, PLANT SCI, V165, P1333, DOI 10.1016/j.plantsci.2003.08.001; Frey FM, 2007, AM J BOT, V94, P437, DOI 10.3732/ajb.94.3.437; Frey FM, 2011, PLANT SPEC BIOL, V26, P235, DOI 10.1111/j.1442-1984.2011.00325.x; Galloway LF, 2002, INT J PLANT SCI, V163, P133, DOI 10.1086/324556; GEBER MA, 1995, TRENDS ECOL EVOL, V10, P222, DOI 10.1016/S0169-5347(00)89068-0; Gould KS, 2010, J EXP BOT, V61, P2707, DOI 10.1093/jxb/erq106; Gould KS, 2000, J EXP BOT, V51, P1107, DOI 10.1093/jexbot/51.347.1107; Harder LD, 2009, NEW PHYTOL, V183, P530, DOI 10.1111/j.1469-8137.2009.02914.x; He QL, 2011, PLOS ONE, V6, P1; Huang SQ, 2006, NEW PHYTOL, V171, P417, DOI 10.1111/j.1469-8137.2006.01766.x; Ishii HS, 2012, J ECOL, V100, P1029, DOI 10.1111/j.1365-2745.2012.01976.x; Jabbari SG, 2013, PLANT SPEC BIOL, V28, P21, DOI 10.1111/j.1442-1984.2011.00352.x; JACKSON D, 1992, PLANT J, V2, P425, DOI 10.1111/j.1365-313X.1992.00425.x; JOHNSON SG, 1995, OECOLOGIA, V102, P174, DOI 10.1007/BF00333249; Kudo G, 2007, OECOLOGIA, V154, P119, DOI 10.1007/s00442-007-0820-1; Kulbaba MW, 2012, EVOLUTION, V66, P1344, DOI 10.1111/j.1558-5646.2011.01536.x; LLOYD DG, 1986, NEW ZEAL J BOT, V24, P135, DOI 10.1080/0028825X.1986.10409725; Lowry DB, 2012, AM J BOT, V99, P82, DOI 10.3732/ajb.1100285; Mallick SA, 2001, OIKOS, V95, P533, DOI 10.1034/j.1600-0706.2001.950318.x; Moore JC, 2011, CURR BIOL, V21, pR176, DOI 10.1016/j.cub.2010.12.035; PRIMACK R B, 1982, Arnoldia (Jamaica Plain), V42, P139; Sahli HF, 2011, EVOLUTION, V65, P1457, DOI 10.1111/j.1558-5646.2011.01229.x; Sargent RD, 2006, EVOLUTION, V60, P934, DOI 10.1111/j.0014-3820.2006.tb01172.x; Schlessman MA, 2002, INT J PLANT SCI, V163, P409, DOI 10.1086/339513; Streisfeld MA, 2009, NEW PHYTOL, V183, P751, DOI 10.1111/j.1469-8137.2009.02929.x; Varga S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062575; Weiss MR, 1997, ISR J PLANT SCI, V45, P185, DOI 10.1080/07929978.1997.10676683; WEISS MR, 1995, AM J BOT, V82, P167, DOI 10.2307/2445525; WILLSON MF, 1979, AM NAT, V113, P777, DOI 10.1086/283437; Willson MF., 1983, MATE CHOICE PLANTS; Wolff D, 2006, FLORA, V201, P353, DOI 10.1016/j.flora.2005.07.010; Yakimowski SB, 2011, ANN BOT-LONDON, V108, P765, DOI 10.1093/aob/mcr025	52	5	5	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93615	10.1371/journal.pone.0093615	http://dx.doi.org/10.1371/journal.pone.0093615			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690875	gold, Green Published, Green Submitted			2022-12-25	WOS:000334101100111
J	Vonk, WIM; Kakkar, V; Bartuzi, P; Jaarsma, D; Berger, R; Hofker, MH; Klomp, LWJ; Wijmenga, C; Kampinga, HH; van de Sluis, B				Vonk, Willianne I. M.; Kakkar, Vaishali; Bartuzi, Paulina; Jaarsma, Dick; Berger, Ruud; Hofker, Marten H.; Klomp, Leo W. J.; Wijmenga, Cisca; Kampinga, Harm H.; van de Sluis, Bart			The Copper Metabolism MURR1 Domain Protein 1 (COMMD1) Modulates the Aggregation of Misfolded Protein Species in a Client-Specific Manner	PLOS ONE			English	Article							MOTOR-NEURON DISEASE; SUPEROXIDE-DISMUTASE SOD1; CU,ZN-SUPEROXIDE DISMUTASE; MUTANT; DEGENERATION; INHIBITION; MUTATIONS; TOXICITY; PROMOTES; DEATH	The Copper Metabolism MURR1 domain protein 1 (COMMD1) is a protein involved in multiple cellular pathways, including copper homeostasis, NF-kappa B and hypoxia signalling. Acting as a scaffold protein, COMMD1 mediates the levels, stability and proteolysis of its substrates (e.g. the copper-transporters ATP7B and ATP7A, RELA and HIF-1 alpha). Recently, we established an interaction between the Cu/Zn superoxide dismutase 1 (SOD1) and COMMD1, resulting in a decreased maturation and activation of SOD1. Mutations in SOD1, associated with the progressive neurodegenerative disorder Amyotrophic Lateral Sclerosis (ALS), cause misfolding and aggregation of the mutant SOD1 (mSOD1) protein. Here, we identify COMMD1 as a novel regulator of misfolded protein aggregation as it enhances the formation of mSOD1 aggregates upon binding. Interestingly, COMMD1 co-localizes to the sites of mSOD1 inclusions and forms high molecular weight complexes in the presence of mSOD1. The effect of COMMD1 on protein aggregation is client-specific as, in contrast to mSOD1, COMMD1 decreases the abundance of mutant Parkin inclusions, associated with Parkinson's disease. Aggregation of a polyglutamine-expanded Huntingtin, causative of Huntington's disease, appears unaltered by COMMD1. Altogether, this study offers new research directions to expand our current knowledge on the mechanisms underlying aggregation disease pathologies.	[Vonk, Willianne I. M.; Berger, Ruud; Klomp, Leo W. J.] Univ Med Ctr Utrecht, Dept Metab & Endocrine Dis, Utrecht, Netherlands; [Vonk, Willianne I. M.; Berger, Ruud; Klomp, Leo W. J.] Univ Med Ctr Utrecht, Netherlands Metabol Ctr, Utrecht, Netherlands; [Vonk, Willianne I. M.; Wijmenga, Cisca] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Kakkar, Vaishali; Kampinga, Harm H.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Groningen, Netherlands; [Bartuzi, Paulina; Hofker, Marten H.; van de Sluis, Bart] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Jaarsma, Dick] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Groningen; University of Groningen; Erasmus University Rotterdam; Erasmus MC; University of Groningen	van de Sluis, B (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands.	a.j.a.van.de.sluis@umcg.nl	Wijmenga, Cisca/AAE-7719-2019; Wijmenga, Cisca/D-2173-2009	Wijmenga, Cisca/0000-0002-5635-1614; Vonk, Willianne/0000-0002-5906-3933; Kampinga, Harm/0000-0002-8966-8466; van de Sluis, Bart (A.J.A.)/0000-0003-3039-4365	Netherlands Organization for Scientific Research (NWO) [40-00812-98-03106]; Marie Curie International Outgoing Fellowship Programme [303096 FOLDEG]; IOP Genomics Programme (Kampinga lab, IGE) [IGE07004]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Marie Curie International Outgoing Fellowship Programme; IOP Genomics Programme (Kampinga lab, IGE)	This work was supported by the Netherlands Organization for Scientific Research (NWO, grant number 40-00812-98-03106), and partially supported by the Marie Curie International Outgoing Fellowship Programme (WV, FP7-PEOPLE-2011-IOF; contract number 303096 FOLDEG) and the IOP Genomics Programme (Kampinga lab, IGE grant number IGE07004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardley HC, 2003, MOL BIOL CELL, V14, P4541, DOI 10.1091/mbc.E03-02-0078; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Biasio W, 2004, J BIOL CHEM, V279, P5429, DOI 10.1074/jbc.M311155200; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Burkhead JL, 2009, J BIOL CHEM, V284, P696, DOI 10.1074/jbc.M804766200; Burstein E, 2005, J BIOL CHEM, V280, P22222, DOI 10.1074/jbc.M501928200; Cao XH, 2008, J BIOL CHEM, V283, P16169, DOI 10.1074/jbc.M801522200; Chen XP, 2012, NEUROCHEM RES, V37, P835, DOI 10.1007/s11064-011-0679-8; Cleveland DW, 1999, NEURON, V24, P515, DOI 10.1016/S0896-6273(00)81108-3; Cozzolino M, 2008, J BIOL CHEM, V283, P866, DOI 10.1074/jbc.M705657200; da Costa CA, 2012, NEURODEGENER DIS, V10, P49, DOI 10.1159/000332803; de Bie P, 2007, J MED GENET, V44, P673, DOI 10.1136/jmg.2007.052746; de Bie P, 2007, GASTROENTEROLOGY, V133, P1316, DOI 10.1053/j.gastro.2007.07.020; de Bie P, 2006, BIOCHEM J, V398, P63, DOI 10.1042/BJ20051664; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Drevillon L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018334; Finkbemer S, 2011, COLD SPRING HARBOR P, V3; Fukada K, 2001, EUR J NEUROSCI, V14, P2032, DOI 10.1046/j.0953-816x.2001.01828.x; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Gu WJ, 2003, NEUROBIOL DIS, V14, P357, DOI 10.1016/j.nbd.2003.08.011; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hough MA, 2004, P NATL ACAD SCI USA, V101, P5976, DOI 10.1073/pnas.0305143101; Jaarsma D, 2000, NEUROBIOL DIS, V7, P623, DOI 10.1006/nbdi.2000.0299; Jonsson PA, 2006, J NEUROPATH EXP NEUR, V65, P1126, DOI 10.1097/01.jnen.0000248545.36046.3c; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Karch CM, 2008, J BIOL CHEM, V283, P13528, DOI 10.1074/jbc.M800564200; Ke Y, 2010, AM J PHYSIOL-RENAL, V298, pF1445, DOI 10.1152/ajprenal.00257.2009; Khare SD, 2004, P NATL ACAD SCI USA, V101, P15094, DOI 10.1073/pnas.0406650101; Kitamura A, 2006, NAT CELL BIOL, V8, P1163, DOI 10.1038/ncb1478; Klomp AEM, 2003, J HEPATOL, V39, P703, DOI 10.1016/S0168-8278(03)00380-5; Kumar KR, 2011, SEMIN NEUROL, V31, P433, DOI 10.1055/s-0031-1299782; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Mao XC, 2011, J BIOL CHEM, V286, P32355, DOI 10.1074/jbc.M111.278408; Matsumoto G, 2006, J BIOL CHEM, V281, P4477, DOI 10.1074/jbc.M509201200; Miyayama T, 2010, BIOCHEM J, V429, P53, DOI 10.1042/BJ20100223; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Munch C, 2010, J MOL BIOL, V399, P512, DOI 10.1016/j.jmb.2010.04.019; Narindrasorasak S, 2007, BIOCHEMISTRY-US, V46, P3116, DOI 10.1021/bi0620656; Niwa J, 2007, J BIOL CHEM, V282, P28087, DOI 10.1074/jbc.M704465200; Prudencio M, 2012, J NEUROCHEM, V121, P475, DOI 10.1111/j.1471-4159.2012.07690.x; Prudencio M, 2009, J NEUROCHEM, V108, P1009, DOI 10.1111/j.1471-4159.2008.05839.x; Rakhit R, 2004, J BIOL CHEM, V279, P15499, DOI 10.1074/jbc.M313295200; Redler RL, 2012, COMPLEX MOL BIOL AMY, P1; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Seetharaman SV, 2009, EXP BIOL MED, V234, P1140, DOI 10.3181/0903-MR-104; Shipp EL, 2003, BIOCHEMISTRY-US, V42, P1890, DOI 10.1021/bi026704y; Sommerhalter M, 2007, J MOL BIOL, V365, P715, DOI 10.1016/j.jmb.2006.10.030; Subramaniam JR, 2002, NAT NEUROSCI, V5, P301, DOI 10.1038/nn823; Tiwari A, 2005, J BIOL CHEM, V280, P29771, DOI 10.1074/jbc.M504039200; Toichi K, 2013, J BIOL CHEM, V288, P4970, DOI 10.1074/jbc.M112.414235; Urushitani M, 2002, J NEUROCHEM, V83, P1030, DOI 10.1046/j.1471-4159.2002.01211.x; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; van de Sluis B, 2007, MOL CELL BIOL, V27, P4142, DOI 10.1128/MCB.01932-06; van de Sluis B, 2010, J CLIN INVEST, V120, P2119, DOI 10.1172/JCI40583; van de Sluis B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007332; van Ham TJ, 2009, EMBO MOL MED, V1, P360, DOI 10.1002/emmm.200900051; Vonk WIM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029183; Vonk WIM, 2012, CELL MOL LIFE SCI, V69, P149, DOI 10.1007/s00018-011-0743-1; Vonk WIM, 2010, J BIOL CHEM, V285, P28991, DOI 10.1074/jbc.M110.101477; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898	64	31	31	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92408	10.1371/journal.pone.0092408	http://dx.doi.org/10.1371/journal.pone.0092408			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691167	Green Published, Green Submitted, gold			2022-12-25	WOS:000334101100021
J	Havel, JJ; Li, Z; Cheng, D; Peng, J; Fu, H				Havel, J. J.; Li, Z.; Cheng, D.; Peng, J.; Fu, H.			Nuclear PRAS40 couples the Akt/mTORC1 signaling axis to the RPL11-HDM2-p53 nucleolar stress response pathway	ONCOGENE			English	Article							RICH AKT SUBSTRATE; RIBOSOMAL-PROTEIN L11; LUNG-CANCER CELLS; 40 KDA PRAS40; MAMMALIAN TARGET; CELLULAR SENESCENCE; RAPAMYCIN COMPLEX-1; TUMOR SUPPRESSION; GROWTH-FACTOR; MTOR	The ribosomal protein (RP)-HDM2-p53 pathway has been shown to have key roles in oncogene-induced apoptosis and senescence, but the mechanism regulating this pathway remains elusive. The proline-rich Akt substrate of 40 kDa (PRAS40) has recently been identified as a binding partner and inhibitor of the mechanistic (formerly referred to as mammalian) target of rapamycin complex 1 (mTORC1). Although other inhibitors of mTORC1 are known tumor suppressors, PRAS40 promotes cell survival and tumorigenesis. Here we demonstrate that Akt- and mTORC1-mediated phosphorylation of PRAS40 at T246 and S221, respectively, promotes nuclear-specific association of PRAS40 with ribosomal protein L11 (RPL11). Importantly, silencing of PRAS40 induces upregulation of p53 in a manner dependent on RPL11. This effect is rescued by wild-type PRAS40, but not by the RPL11-binding-null PRAS40T246A mutant. We found that PRAS40 negatively regulates the RPL11-HDM2-p53 nucleolar stress response pathway and suppresses induction of p53-mediated cellular senescence. This work identifies nuclear PRAS40 as a dual-input signaling checkpoint that links cell growth and proliferation to inhibition of cellular senescence. These findings may help to explain the protumorigenic effect of PRAS40 and identify the PRAS40-RPL11 complex as a promising target for p53-restorative anticancer drug discovery.	[Havel, J. J.; Li, Z.; Fu, H.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Havel, J. J.] Emory Univ, Grad Program Mol & Syst Pharmacol, Atlanta, GA 30322 USA; [Cheng, D.; Peng, J.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Fu, H (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, 1510 Clifton Rd NE,Room 5111, Atlanta, GA 30322 USA.	hfu@emory.edu	Peng, Junmin/N-2614-2018	Peng, Junmin/0000-0003-0472-7648; Havel, Jonathan/0000-0003-0951-510X	NIH predoctoral NRSA [F31NS067844, T32GM008602]; NIH [U01CA168449]; Georgia Cancer Coalition Award; Emory University Integrated Cellular Imaging Microscopy Core of the Emory Neuroscience NINDS Core Facilities Grant [P30NS055077]; NATIONAL CANCER INSTITUTE [U01CA168449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS067844, P30NS055077] Funding Source: NIH RePORTER	NIH predoctoral NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Cancer Coalition Award; Emory University Integrated Cellular Imaging Microscopy Core of the Emory Neuroscience NINDS Core Facilities Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported in part by NIH predoctoral NRSA F31NS067844 and training grant T32GM008602 (to JJH), NIH U01CA168449 and a Georgia Cancer Coalition Award (to HF) and the Emory University Integrated Cellular Imaging Microscopy Core of the Emory Neuroscience NINDS Core Facilities Grant P30NS055077. We thank Shannon Elf for assistance with plasmid generation, and Anita Corbett and Maureen Powers for helpful discussions.	Andersen J, 2010, DANCING TIMES, V100, P55; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Cassell A, 2012, NEOPLASIA, V14, P1005, DOI 10.1593/neo.121212; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; de Marval PLM, 2011, ONCOTARGET, V2, P234; Deisenroth C, 2010, ONCOGENE, V29, P4253, DOI 10.1038/onc.2010.189; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Fregoso OI, 2013, MOL CELL, V50, P56, DOI 10.1016/j.molcel.2013.02.001; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Harthill JE, 2002, BIOCHEM J, V368, P565, DOI 10.1042/BJ20020838; Havel LS, 2011, HUM MOL GENET, V20, P1424, DOI 10.1093/hmg/ddr023; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Huang L, 2012, CANCER RES, V72, P1260, DOI 10.1158/0008-5472.CAN-11-2254; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Kim W, 2013, PHARMACOL RES, V70, P90, DOI 10.1016/j.phrs.2013.01.005; Kim W, 2011, RADIAT RES, V176, P539, DOI 10.1667/RR2609.1; Kovacina KS, 2003, J BIOL CHEM, V278, P10189, DOI 10.1074/jbc.M210837200; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li H, 2006, NATURE, V442, P1058, DOI 10.1038/nature05020; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Macias E, 2010, CANCER CELL, V18, P231, DOI 10.1016/j.ccr.2010.08.007; Madhunapantula SV, 2007, CANCER RES, V67, P3626, DOI 10.1158/0008-5472.CAN-06-4234; Makowski L, 2008, BRIT J CANCER, V99, P683, DOI 10.1038/sj.bjc.6604515; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; Nascimento EBM, 2006, DIABETES, V55, P3221, DOI 10.2337/db05-1390; Nascimento Emmani B. M., 2009, Archives of Physiology and Biochemistry, V115, P163, DOI 10.1080/13813450902988580; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; Patton EE, 2005, CURR BIOL, V15, P249, DOI 10.1016/j.cub.2005.01.031; Pestov DG, 2001, MOL CELL BIOL, V21, P4246, DOI 10.1128/MCB.21.13.4246-4255.2001; Rosner M, 2008, HUM MOL GENET, V17, P2934, DOI 10.1093/hmg/ddn192; Saito A, 2006, STROKE, V37, P513, DOI 10.1161/01.STR.0000198826.56611.a2; Saito A, 2004, J NEUROSCI, V24, P1584, DOI 10.1523/JNEUROSCI.5209-03.2004; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, J BIOL CHEM, V280, P39505, DOI 10.1074/jbc.M506096200; Sasaki M, 2011, NAT MED, V17, P944, DOI 10.1038/nm.2392; Sato T, 2010, ONCOGENE, V29, P2746, DOI 10.1038/onc.2010.28; Schmitt CA, 2007, BBA-REV CANCER, V1775, P5, DOI 10.1016/j.bbcan.2006.08.005; Scott MS, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-317; Scott MS, 2010, NUCLEIC ACIDS RES, V38, P7388, DOI 10.1093/nar/gkq653; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Thedieck K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001217; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Vredeveld LCW, 2012, GENE DEV, V26, P1055, DOI 10.1101/gad.187252.112; Wang L, 2008, J BIOL CHEM, V283, P15619, DOI 10.1074/jbc.M800723200; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Wei YH, 2009, EMBO J, V28, P2220, DOI 10.1038/emboj.2009.179; Wiza C, 2013, CELL SIGNAL, V25, P1762, DOI 10.1016/j.cellsig.2013.05.022; Wiza C, 2012, AM J PHYSIOL-ENDOC M, V302, pE1453, DOI 10.1152/ajpendo.00660.2011; Xu P, 2009, J PROTEOME RES, V8, P3944, DOI 10.1021/pr900251d; Yap TA, 2011, MOL CANCER THER, V10, P360, DOI 10.1158/1535-7163.MCT-10-0760; Yu FS, 2008, J CEREBR BLOOD F MET, V28, P44, DOI 10.1038/sj.jcbfm.9600501; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhang XW, 2002, J BIOL CHEM, V277, P28127, DOI 10.1074/jbc.M202625200; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003	68	29	32	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 19	2015	34	12					1487	1498		10.1038/onc.2014.91	http://dx.doi.org/10.1038/onc.2014.91			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CD9KI	24704832	Green Accepted			2022-12-25	WOS:000351416800002
J	Xue, G; Yan, HL; Zhang, Y; Hao, LQ; Zhu, XT; Mei, Q; Sun, SH				Xue, G.; Yan, H-L; Zhang, Y.; Hao, L-Q; Zhu, X-T; Mei, Q.; Sun, S-H			c-Myc-mediated repression of miR-15-16 in hypoxia is induced by increased HIF-2 alpha and promotes tumor angiogenesis and metastasis by upregulating FGF2	ONCOGENE			English	Article							TRANSCRIPTION FACTOR; GENE-EXPRESSION; BREAST-CANCER; METABOLISM; CELLS; HIF-1; TUMORIGENESIS; BIOGENESIS; APOPTOSIS; PATHWAYS	Previous studies have established the link between aberrant microRNA (miRNA) expression and hypoxia in various neoplasms. However, how these hypoxia-related miRNAs modulate tumor progression is still unclear. Therefore, the patterns of miRNA in colorectal carcinoma cell lines in response to hypoxia or not were first screened and the hypoxia-induced repression of the miR-15-16 cluster was confirmed. Then, this repression was found to be associated with high tumor stage and poor prognosis in colorectal carcinoma and is shown to promote tumor angiogenesis and metastasis by the loss of restriction of its target gene, fibroblast growth factor-2 (FGF2). Moreover, the general and alterative promoters of the miR-15-16 host (deleted in lymphocytic leukemia 2, DLEU2) were mapped, and three c-Myc/Max binding sites in response to the hypoxia-induced repression of miR-15-16 were further identified. Finally, an enhanced stability of c-Myc/Max heterodimer promoted by increased hypoxia-inducible factor-2 alpha (HIF-2 alpha) was validated, and we also verified that the enhancement contributed to the hypoxia-induced repression of miR-15-16. In brief, the c-Myc-mediated transcriptional repression of miR-15-16 in hypoxia is induced by increased HIF-2 alpha and promoted tumor angiogenesis and hematogenous metastasis by the further loss of post-transcriptional inhibition of FGF2. Our study provides a better understanding of the coping mechanisms in response to tumor hypoxia and may be helpful in developing an effective prognostic marker or treatment target against solid tumors.	[Xue, G.; Yan, H-L; Zhang, Y.; Zhu, X-T; Mei, Q.; Sun, S-H] Second Mil Med Univ, Coll Basic Med Sci, Dept Med Genet, Shanghai 200433, Peoples R China; [Hao, L-Q] Second Mil Med Univ, Changhai Hosp, Dept Colorectal Surg, Shanghai 200433, Peoples R China	Naval Medical University; Naval Medical University	Sun, SH (corresponding author), Second Mil Med Univ, Coll Basic Med Sci, Dept Med Genet, Xiang Yin Rd 800, Shanghai 200433, Peoples R China.	shsun@vip.sina.com	May, Mere/HIK-1050-2022		National Natural Science Foundation of China [31100920, 30972877]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank the National Natural Science Foundation of China for the financial support (Nos. 31100920 and 30972877).	Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Banning A, 2008, CANCER RES, V68, P9746, DOI 10.1158/0008-5472.CAN-08-1321; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Buendia MA, 2012, GASTROENTEROLOGY, V142, P214, DOI 10.1053/j.gastro.2011.12.023; Cao YH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003149; Chan DA, 2007, CANCER METAST REV, V26, P333, DOI 10.1007/s10555-007-9063-1; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chaudary N, 2007, CLIN CANCER RES, V13, P1947, DOI 10.1158/1078-0432.CCR-06-2971; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; Finger EC, 2010, CANCER METAST REV, V29, P285, DOI 10.1007/s10555-010-9224-5; Fong S, 2003, P NATL ACAD SCI USA, V100, P13543, DOI 10.1073/pnas.2230238100; FROMOWITZ FB, 1987, HUM PATHOL, V18, P1268, DOI 10.1016/S0046-8177(87)80412-4; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Gupta GP, 2007, P NATL ACAD SCI USA, V104, P19506, DOI 10.1073/pnas.0709185104; Hackl C, 2013, GUT, V62, P259, DOI 10.1136/gutjnl-2011-301585; Horan AD, 2001, RADIAT RES, V156, P388, DOI 10.1667/0033-7587(2001)156[0388:TKMFRO]2.0.CO;2; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Ivan M, 2008, J CELL MOL MED, V12, P1426, DOI 10.1111/j.1582-4934.2008.00398.x; Kaluz S, 2009, BBA-REV CANCER, V1795, P162, DOI 10.1016/j.bbcan.2009.01.001; Katoh M, 2007, STEM CELL REV, V3, P30, DOI 10.1007/s12015-007-0006-6; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Khew-Goodall Y, 2010, NAT CELL BIOL, V12, P209, DOI 10.1038/ncb0310-209; Kulshreshtha R, 2008, CELL DEATH DIFFER, V15, P667, DOI 10.1038/sj.cdd.4402310; Le QT, 2004, CANCER METAST REV, V23, P293, DOI 10.1023/B:CANC.0000031768.89246.d7; Lerner M, 2009, EXP CELL RES, V315, P2941, DOI 10.1016/j.yexcr.2009.07.001; Marinescu VD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-79; Ruan K, 2009, J CELL BIOCHEM, V107, P1053, DOI 10.1002/jcb.22214; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Shoushtari AN, 2011, NAT REV CLIN ONCOL, V8, P333, DOI 10.1038/nrclinonc.2011.65; Stockmann C, 2008, NATURE, V456, P814, DOI 10.1038/nature07445; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Voss MJ, 2010, CURR MOL MED, V10, P381, DOI 10.2174/156652410791317020; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107; Yan HL, 2009, EMBO J, V28, P2719, DOI 10.1038/emboj.2009.214; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001	40	58	61	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 12	2015	34	11					1393	1406		10.1038/onc.2014.82	http://dx.doi.org/10.1038/onc.2014.82			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CD1AR	24704828				2022-12-25	WOS:000350806500006
J	Mahalingam, B; Van Agthoven, JF; Xiong, JP; Alonso, JL; Adair, BD; Rui, XL; Anand, S; Mehrbod, M; Mofrad, MRK; Burger, C; Goodman, SL; Arnaout, MA				Mahalingam, Bhuvaneshwari; Van Agthoven, Johannes F.; Xiong, Jian-Ping; Alonso, Jose Luis; Adair, Brian D.; Rui, Xianliang; Anand, Saurabh; Mehrbod, Mehrdad; Mofrad, Mohammad R. K.; Burger, Christa; Goodman, Simon L.; Arnaout, M. Amin			Atomic Basis for the Species-specific Inhibition of alpha V Integrins by Monoclonal Antibody 17E6 Is Revealed by the Crystal Structure of alpha V beta 3 Ectodomain-17E6 Fab Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer Therapy; Cell Adhesion; Cell Surface Receptor; Crystal Structure; Extracellular Matrix Proteins; Fibronectin; Integrins	LIGAND-BINDING; EXTRACELLULAR SEGMENT; MOLECULAR-DYNAMICS; METASTATIC GROWTH; RGD PEPTIDES; ACTIVATION; ALPHA(5)BETA(1); ALPHA-V-BETA-3; MELANOMA; SYSTEM	Background: 17E6, a primate-specific mouse mAb that inhibits V integrins, is in phase II trials for treating cancer. Results: We determined crystal structure of the V3-17E6 Fab complex, revealing the molecular basis of 17E6 specificity and function. Conclusion: 17E6 is an allosteric inhibitor of fibronectin-integrin interaction. Significance: The defined 17E6 epitope may help in developing novel therapeutics targeting related regions in other integrins. The function-blocking, non-RGD-containing, and primate-specific mouse monoclonal antibody 17E6 binds the V subfamily of integrins. 17E6 is currently in phase II clinical trials for treating cancer. To elucidate the structural basis of recognition and the molecular mechanism of inhibition, we crystallized V3 ectodomain in complex with the Fab fragment of 17E6. Protein crystals grew in presence of the activating cation Mn2+. The integrin in the complex and in solution assumed the genuflected conformation. 17E6 Fab bound exclusively to the Propeller domain of the V subunit. At the core of V-Fab interface were interactions involving Propeller residues Lys-203 and Gln-145, with the latter accounting for primate specificity. The Propeller residue Asp-150, which normally coordinates Arg of the ligand Arg-Gly-Asp motif, formed contacts with Arg-54 of the Fab that were expected to reduce soluble FN10 binding to cellular V3 complexed with 17E6. This was confirmed in direct binding studies, suggesting that 17E6 is an allosteric inhibitor of V integrins.	[Mahalingam, Bhuvaneshwari; Van Agthoven, Johannes F.; Xiong, Jian-Ping; Adair, Brian D.; Arnaout, M. Amin] Massachusetts Gen Hosp, Struct Biol Program, Charlestown, MA 02129 USA; [Alonso, Jose Luis; Rui, Xianliang; Anand, Saurabh; Arnaout, M. Amin] Massachusetts Gen Hosp, Leukocyte Biol & Inflammat Program, Dept Med, Charlestown, MA 02129 USA; [Alonso, Jose Luis; Rui, Xianliang; Anand, Saurabh; Arnaout, M. Amin] Massachusetts Gen Hosp, Dept Dev & Regenerat Biol, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Mehrbod, Mehrdad; Mofrad, Mohammad R. K.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Mehrbod, Mehrdad; Mofrad, Mohammad R. K.] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA; [Burger, Christa; Goodman, Simon L.] Merck KGaA, D-64271 Darmstadt, Germany; [Burger, Christa] Discovery Technol, Mol Pharmacol, D-64271 Darmstadt, Germany; [Goodman, Simon L.] Therapeut Innovat Platform, Oncol, D-64271 Darmstadt, Germany	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Merck KGaA	Arnaout, MA (corresponding author), Massachusetts Gen Hosp, 149 13th St, Charlestown, MA 02129 USA.	aarnaout1@mgh.harvard.edu	Alonso, José Luis/ABF-5483-2021	Goodman, Simon L./0000-0002-3480-1346	National Institutes of Health [DK088327, DK096334, DK007540]; National Science Foundation [CBET-0955291]; Directorate For Engineering [0955291] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088327, T32DK007540, R21DK096334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK088327, DK096334, and DK007540 (to M. A. A.). This work was also supported by National Science Foundation CAREER Award CBET-0955291 (to M.R.K.M.).	Adair BD, 2005, J CELL BIOL, V168, P1109, DOI 10.1083/jcb.200410068; Adair BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057951; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALBELDA SM, 1990, CANCER RES, V50, P6757; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Artoni A, 2004, P NATL ACAD SCI USA, V101, P13114, DOI 10.1073/pnas.0404201101; BARON M, 1992, BIOCHEMISTRY-US, V31, P2068, DOI 10.1021/bi00122a025; BOWDITCH RD, 1994, J BIOL CHEM, V269, P10856; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Castel S, 2001, LAB INVEST, V81, P1615, DOI 10.1038/labinvest.3780375; Castel S, 2000, EUR J CELL BIOL, V79, P502, DOI 10.1078/0171-9335-00067; Chen W, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001086; Copie V, 1998, J MOL BIOL, V277, P663; Dechantsreiter MA, 1999, J MED CHEM, V42, P3033, DOI 10.1021/jm970832g; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Goodman SL, 2012, TRENDS PHARMACOL SCI, V33, P405, DOI 10.1016/j.tips.2012.04.002; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gupta V, 2007, BLOOD, V109, P3513, DOI 10.1182/blood-2005-11-056689; Hato T, 1998, J CELL BIOL, V141, P1685, DOI 10.1083/jcb.141.7.1685; Honda S, 2004, THROMB HAEMOSTASIS, V92, P1092, DOI 10.1160/TH04-04-0257; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kraft S, 1999, J BIOL CHEM, V274, P1979, DOI 10.1074/jbc.274.4.1979; Krautler V, 2001, J COMPUT CHEM, V22, P501, DOI 10.1002/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V; Lorger M, 2009, P NATL ACAD SCI USA, V106, P10666, DOI 10.1073/pnas.0903035106; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MARSHALL JF, 1995, J CELL SCI, V108, P1227; Max R, 1997, INT J CANCER, V71, P320, DOI 10.1002/(SICI)1097-0215(19970502)71:3<320::AID-IJC2>3.3.CO;2-3; McCabe NP, 2007, ONCOGENE, V26, P6238, DOI 10.1038/sj.onc.1210429; Mehrbod M, 2013, BIOPHYS J, V105, P1304, DOI 10.1016/j.bpj.2013.07.055; Mehrbod M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002948; MITJANS F, 1995, J CELL SCI, V108, P2825; Mould AP, 2000, J BIOL CHEM, V275, P20324, DOI 10.1074/jbc.M000572200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rodius S, 2008, J BIOL CHEM, V283, P24212, DOI 10.1074/jbc.M709704200; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Weis SM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006478; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Ye F, 2008, J MOL BIOL, V378, P976, DOI 10.1016/j.jmb.2008.03.014	46	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13801	13809		10.1074/jbc.M113.546929	http://dx.doi.org/10.1074/jbc.M113.546929			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24692540	hybrid, Green Published			2022-12-25	WOS:000335984600014
J	Tillman, TS; Seyoum, E; Mowrey, DD; Xu, Y; Tang, P				Tillman, Tommy S.; Seyoum, Edom; Mowrey, David D.; Xu, Yan; Tang, Pei			ELIC- alpha 7 Nicotinic Acetylcholine Receptor ( alpha 7nAChR) Chimeras Reveal a Prominent Role of the ExtracellularTransmembrane Domain Interface in Allosteric Modulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Ion Channels; Neurotransmitter Receptors; Nicotinic Acetylcholine Receptors; Protein Chimeras; ELIC; 7nAChR; pLGICs; Pentameric Ligand-gated Ion Channels	GATED ION-CHANNEL; X-RAY-STRUCTURE; CONFORMATIONAL-CHANGES; TRANSMEMBRANE DOMAIN; LIGAND-BINDING; OPEN STATE; IN-VITRO; LOOP; ACTIVATION; DESENSITIZATION	Background: Allosteric modulators bound to the transmembrane domain (TMD) of the 7 nicotinic acetylcholine receptor (7nAChR) can potentiate channel function. Results: ELIC-7nAChR showed potentiation only when the extracellular-transmembrane domain (ECD-TMD) interface matched that of 7nAChR. Conclusion: PAM modulation through the TMD requires a more specific ECD-TMD interface than agonist activation. Significance: The study provides insight into the basis for positive allosteric modulation of 7nAChR. The native 7 nicotinic acetylcholine receptor (7nAChR) is a homopentameric ligand-gated ion channel mediating fast synaptic transmission and is of pharmaceutical interest for treatment of numerous disorders. The transmembrane domain (TMD) of 7nAChR has been identified as a target for positive allosteric modulators (PAMs), but it is unclear whether modulation occurs through changes entirely within the TMD or changes involving both the TMD and the extracellular domain (ECD)-TMD interface. In this study, we constructed multiple chimeras using the TMD of human 7nAChR and the ECD of a prokaryotic homolog, ELIC, which is not sensitive to these modulators, and for which a high resolution structure has been solved. Functional ELIC-7nAChR (EA) chimeras were obtained when their ECD-TMD interfaces were modified to resemble either the ELIC interface (EA(ELIC)) or 7nAChR interface (EA(7)). Both EA(7) and EA(ELIC) show similar activation response and desensitization characteristics, but only EA(7) retained the unique pharmacology of 7nAChR evoked by PAMs, including potentiation by ivermectin, PNU-120596, and TQS, as well as activation by 4BP-TQS. This study suggests that PAM modulation through the TMD has a more stringent requirement at the ECD-TMD interface than agonist activation.	[Tillman, Tommy S.; Seyoum, Edom; Mowrey, David D.; Xu, Yan; Tang, Pei] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15260 USA; [Xu, Yan; Tang, Pei] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Mowrey, David D.; Tang, Pei] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA; [Xu, Yan] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Tang, P (corresponding author), Univ Pittsburgh, 2049 Biomed Sci Tower 3,3501 Fifth Ave, Pittsburgh, PA 15260 USA.	tangp@upmc.edu		Tang, Pei/0000-0002-2869-2737	National Institutes of Health [R01GM66358, R01GM56257, R37GM049202]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066358, R37GM049202, R01GM056257, R01GM049202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM66358 and R01GM56257 (to P. T.) and R37GM049202 (to Y.X.).	AlSharari SD, 2013, BIOCHEM PHARMACOL, V86, P1201, DOI 10.1016/j.bcp.2013.06.018; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Auerbach A, 2010, J PHYSIOL-LONDON, V588, P573, DOI 10.1113/jphysiol.2009.182774; Barron SC, 2009, MOL PHARMACOL, V76, P253, DOI 10.1124/mol.109.056226; Bertrand D, 2008, MOL PHARMACOL, V74, P1407, DOI 10.1124/mol.107.042820; Bertrand D, 2007, BIOCHEM PHARMACOL, V74, P1155, DOI 10.1016/j.bcp.2007.07.011; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bondarenko V, 2014, BBA-BIOMEMBRANES, V1838, P1389, DOI 10.1016/j.bbamem.2013.12.018; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Bouzat C, 2008, J NEUROSCI, V28, P7808, DOI 10.1523/JNEUROSCI.0448-08.2008; Bouzat C, 2012, J PHYSIOL-PARIS, V106, P23, DOI 10.1016/j.jphysparis.2011.09.012; Chang YC, 2010, PHARMACEUTICALS, V3, P2592, DOI 10.3390/ph3082592; Collins T, 2011, NEUROPHARMACOLOGY, V61, P1306, DOI 10.1016/j.neuropharm.2011.07.035; Collins T, 2010, MOL PHARMACOL, V78, P198, DOI 10.1124/mol.110.064295; Cooper ST, 1999, J BIOL CHEM, V274, P27145, DOI 10.1074/jbc.274.38.27145; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; Dacosta CJB, 2013, STRUCTURE, V21, P1271, DOI 10.1016/j.str.2013.06.019; daCosta CJB, 2011, J NEUROSCI, V31, P13870, DOI 10.1523/JNEUROSCI.2652-11.2011; Dascal N., 2001, CURR PROTOC NEUROSCI; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; Duret G, 2011, P NATL ACAD SCI USA, V108, P12143, DOI 10.1073/pnas.1104494108; Egleton RD, 2008, TRENDS PHARMACOL SCI, V29, P151, DOI 10.1016/j.tips.2007.12.006; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Flood P, 1997, ANESTHESIOLOGY, V86, P859, DOI 10.1097/00000542-199704000-00016; Gill JK, 2011, P NATL ACAD SCI USA, V108, P5867, DOI 10.1073/pnas.1017975108; Gonzalez-Gutierrez G, 2013, P NATL ACAD SCI USA, V110, P18716, DOI 10.1073/pnas.1313156110; Gonzalez-Gutierrez G, 2012, P NATL ACAD SCI USA, V109, P6331, DOI 10.1073/pnas.1119268109; Gronlien JH, 2007, MOL PHARMACOL, V72, P715, DOI 10.1124/mol.107.035410; Gronlien JH, 2010, EUR J PHARMACOL, V647, P37, DOI 10.1016/j.ejphar.2010.08.027; Grutter T, 2005, P NATL ACAD SCI USA, V102, P18207, DOI 10.1073/pnas.0509024102; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Keramidas A, 2013, CELL MOL LIFE SCI, V70, P1241, DOI 10.1007/s00018-012-1133-z; Krause RM, 1998, MOL PHARMACOL, V53, P283, DOI 10.1124/mol.53.2.283; Mnatsakanyan N, 2013, J NEUROCHEM, V125, P843, DOI 10.1111/jnc.12260; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Pan JJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1703; Pandya AA, 2013, BIOCHEM PHARMACOL, V86, P1054, DOI 10.1016/j.bcp.2013.05.018; Poorthuis RB, 2013, BIOCHEM PHARMACOL, V86, P1089, DOI 10.1016/j.bcp.2013.07.003; Sattelle DB, 2009, BIOCHEM PHARMACOL, V78, P836, DOI 10.1016/j.bcp.2009.06.020; Sauguet L, 2014, P NATL ACAD SCI USA, V111, P966, DOI 10.1073/pnas.1314997111; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Smart TG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009662; Smucny J, 2013, BIOCHEM PHARMACOL, V86, P1163, DOI 10.1016/j.bcp.2013.06.011; Spurny R, 2013, J BIOL CHEM, V288, P8355, DOI 10.1074/jbc.M112.424507; Spurny R, 2012, P NATL ACAD SCI USA, V109, pE3028, DOI 10.1073/pnas.1208208109; Thompson AJ, 2012, NEUROPHARMACOLOGY, V63, P761, DOI 10.1016/j.neuropharm.2012.05.027; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang Q, 2011, J BIOL CHEM, V286, P38814, DOI 10.1074/jbc.M111.273631; Wessler I, 2008, BRIT J PHARMACOL, V154, P1558, DOI 10.1038/bjp.2008.185; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105; Zhang JL, 2011, J BIOL CHEM, V286, P25331, DOI 10.1074/jbc.M111.221754; Zimmermann I, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001101	60	19	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13851	13857		10.1074/jbc.M113.524611	http://dx.doi.org/10.1074/jbc.M113.524611			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24695730	hybrid, Green Published			2022-12-25	WOS:000335984600018
J	Astola, L; Stigter, H; van Dijk, ADJ; van Daelen, R; Molenaar, J				Astola, Laura; Stigter, Hans; van Dijk, Aalt D. J.; van Daelen, Raymond; Molenaar, Jaap			Inferring the Gene Network Underlying the Branching of Tomato Inflorescence	PLOS ONE			English	Article							REPRODUCTIVE STRUCTURE; REGULATORY NETWORKS; ABSCISSION ZONE; FLOWERING TIME; INFERENCE; FALSIFLORA; TRANSITION; JOINTLESS	The architecture of tomato inflorescence strongly affects flower production and subsequent crop yield. To understand the genetic activities involved, insight into the underlying network of genes that initiate and control the sympodial growth in the tomato is essential. In this paper, we show how the structure of this network can be derived from available data of the expressions of the involved genes. Our approach starts from employing biological expert knowledge to select the most probable gene candidates behind branching behavior. To find how these genes interact, we develop a stepwise procedure for computational inference of the network structure. Our data consists of expression levels from primary shoot meristems, measured at different developmental stages on three different genotypes of tomato. With the network inferred by our algorithm, we can explain the dynamics corresponding to all three genotypes simultaneously, despite their apparent dissimilarities. We also correctly predict the chronological order of expression peaks for the main hubs in the network. Based on the inferred network, using optimal experimental design criteria, we are able to suggest an informative set of experiments for further investigation of the mechanisms underlying branching behavior.	[Astola, Laura; Stigter, Hans; van Dijk, Aalt D. J.; Molenaar, Jaap] Univ Wageningen & Res Ctr, Wageningen, Netherlands; [Astola, Laura; van Dijk, Aalt D. J.; van Daelen, Raymond; Molenaar, Jaap] Netherlands Consortium Syst Biol, Amsterdam, Netherlands; [van Daelen, Raymond] Keygene NV, Wageningen, Netherlands	Wageningen University & Research; Keygene N.V.	Astola, L (corresponding author), Univ Wageningen & Res Ctr, Wageningen, Netherlands.	l.j.astola@gmail.com		Stigter, Johannes Daniel/0000-0001-5210-5929; van Dijk, Aalt-Jan/0000-0002-8872-5123	Netherlands Genomics Initiative of the Netherlands Consortium for Systems Biology [050-060-620]	Netherlands Genomics Initiative of the Netherlands Consortium for Systems Biology	This work was funded by the Netherlands Genomics Initiative (grant 050-060-620) of the Netherlands Consortium for Systems Biology (http://www.ncsb.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1969, ANN I STAT MATH, V21, P243, DOI 10.1007/BF02532251; Akutsu T, 2000, BIOINFORMATICS, V16, P727, DOI 10.1093/bioinformatics/16.8.727; Allen KD, 1996, PLANTA, V200, P254, DOI 10.1007/BF00208316; Astola L, 2013, TICSP SERIES, V63, P42; Bansal M, 2006, BIOINFORMATICS, V22, P815, DOI 10.1093/bioinformatics/btl003; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Busch B, 2009, THESIS U KOLN GERMAN; Busch BL, 2011, PLANT CELL, V23, P3595, DOI 10.1105/tpc.111.087981; D'haeseleer P, 1999, Pac Symp Biocomput, P41; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; Dielen V, 1998, PLANT GROWTH REGUL, V25, P149, DOI 10.1023/A:1006094318083; Efroni I, 2008, PLANT CELL, V20, P2293, DOI 10.1105/tpc.107.057521; Gupta R, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-52; Lee WP, 2009, BRIEF BIOINFORM, V10, P408, DOI 10.1093/bib/bbp028; Lippman Z, 2008, PLOS BIOL, V6, P6398; Ljung L., 1999, SYSTEM IDENTIFICATIO; Lozano R, 2009, INT J DEV BIOL, V53, P1635, DOI 10.1387/ijdb.072440rl; MacAlister CA, 2012, NAT GENET, V44, P1393, DOI 10.1038/ng.2465; Mao L, 2000, NATURE, V406, P910, DOI 10.1038/35022611; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Molinero-Rosales N, 1999, PLANT J, V20, P685, DOI 10.1046/j.1365-313X.1999.00641.x; Nakano T, 2012, PLANT PHYSIOL, V158, P439, DOI 10.1104/pp.111.183731; Park SJ, 2012, P NATL ACAD SCI USA, V109, P639, DOI 10.1073/pnas.1114963109; Quinet M, 2006, NEW PHYTOL, V170, P701, DOI 10.1111/j.1469-8137.2006.01717.x; Quinet M., 2007, INT J PLANT DEV BIOL, V1, P64, DOI DOI 10.1093/JXB/ERJ117; Samach A, 2007, PLANT BIOTECHNOL-NAR, V24, P71, DOI 10.5511/plantbiotechnology.24.71; Schmidt H, 2005, FEBS J, V272, P2141, DOI 10.1111/j.1742-4658.2005.04605.x; Schmitz G, 2002, P NATL ACAD SCI USA, V99, P1064, DOI 10.1073/pnas.022516199; Stigter Johannes D, 2012, BMC Res Notes, V5, P518, DOI 10.1186/1756-0500-5-518; Stumpf M, 2011, HANDBOOK OF STATISTICAL SYSTEMS BIOLOGY, pXVII; Szymkowiak EJ, 2006, PLANTA, V223, P646, DOI 10.1007/s00425-005-0115-x; Szymkowiak EJ, 1999, PLANT CELL, V11, P159, DOI 10.1105/tpc.11.2.159; Thouet J, 2008, PLANT PHYSIOL, V148, P61, DOI 10.1104/pp.108.124164; Toni T, 2009, INTERFACE, V6; Voit Eberhard O., 2005, In Silico Biology, V5, P83; Weber M, 2013, BMC SYSTEMS BIOL, V7, P39; Yu J, 2004, BIOINFORMATICS, V20, P3594, DOI 10.1093/bioinformatics/bth448	38	4	4	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e89689	10.1371/journal.pone.0089689	http://dx.doi.org/10.1371/journal.pone.0089689			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699171	gold, Green Published, Green Submitted			2022-12-25	WOS:000334105000006
J	Farzan, SF; Karagas, MR; Christensen, BC; Li, ZZ; Kuriger, JK; Nelson, HH				Farzan, Shohreh F.; Karagas, Margaret R.; Christensen, Brock C.; Li, Zhongze; Kuriger, Jacquelyn K.; Nelson, Heather H.		New Hampshire Skin Canc Study	RNASEL and MIR146A SNP-SNP Interaction as a Susceptibility Factor for Non-Melanoma Skin Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; PROSTATE-CANCER; BASAL-CELL; CHINESE POPULATION; ARTHRITIS SUSCEPTIBILITY; FUNCTIONAL POLYMORPHISM; HUMAN PAPILLOMAVIRUSES; ORGAN-TRANSPLANTATION; SIGNALING PROTEINS; COLORECTAL-CANCER	Immunity and inflammatory pathways are important in the genesis of non-melanoma skin cancers (NMSC). Functional genetic variation in immune modulators has the potential to affect disease etiology. We investigated associations between common variants in two key regulators, MIR146A and RNASEL, and their relation to NMSCs. Using a large population-based case-control study of basal cell (BCC) and squamous cell carcinoma (SCC), we investigated the impact of MIR146A SNP rs2910164 on cancer risk, and interaction with a SNP in one of its putative targets (RNASEL, rs486907). To examine associations between genotype and BCC and SCC, occurrence odds ratios (OR) and 95% confidence intervals (95%CI) were calculated using unconditional logistic regression, accounting for multiple confounding factors. We did not observe an overall change in the odds ratios for SCC or BCC among individuals carrying either of the RNASEL or MIR146A variants compared with those who were wild type at these loci. However, there was a sex-specific association between BCC and MIR146A in women (ORGC=0.73, [95%CI=0.52-1.03]; ORCC=0.29, [95% CI=0.14-0.61], p-trend < 0.001), and a reduction in risk, albeit not statistically significant, associated with RNASEL and SCC in men (ORAG=0.88, [95%CI=0.65-1.19]; ORAA=0.68, [95%CI=0.43-1.08], p-trend=0.10). Most striking was the strong interaction between the two genes. Among individuals carrying variant alleles of both rs2910164 and rs486907, we observed inverse relationships with SCC (ORSCC=0.56, [95%CI=0.38-0.81], p-interaction=0.012) and BCC (ORBCC=0.57, [95%CI=0.40-0.80], p-interaction=0.005). Our results suggest that genetic variation in immune and inflammatory regulators may influence susceptibility to NMSC, and novel SNP-SNP interaction for a microRNA and its target. These data suggest that RNASEL, an enzyme involved in RNA turnover, is controlled by miR-146a and may be important in NMSC etiology.	[Farzan, Shohreh F.; Karagas, Margaret R.; Christensen, Brock C.; Li, Zhongze] Geisel Sch Med Dartmouth, Dept Community & Family Med, Sect Biostat & Epidemiol, Lebanon, NH USA; [Farzan, Shohreh F.; Karagas, Margaret R.; Christensen, Brock C.; Li, Zhongze] Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Lebanon, NH USA; [Christensen, Brock C.] Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, Hanover, NH USA; [Kuriger, Jacquelyn K.; Nelson, Heather H.] Univ Minnesota, Mason Canc Ctr, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA	Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; University of Minnesota System; University of Minnesota Twin Cities	Nelson, HH (corresponding author), Univ Minnesota, Mason Canc Ctr, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA.	hhnelson@umn.edu		Nelson, Heather/0000-0003-1901-9513	NIH [R01 CA82354, R01 CA057494, R25 CA134286]; NCI [R21 CA175553]; NATIONAL CANCER INSTITUTE [R21CA175553, R25CA134286, R01CA057494, P30CA023108, R01CA082354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022772] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIH R01 CA82354, NIH R01 CA057494, NIH R25 CA134286, and NCI R21 CA175553. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JB, 2007, ONCOGENE, V26, P3081, DOI 10.1038/sj.onc.1210111; Andersson K, 2012, AM J EPIDEMIOL, V175, P685, DOI 10.1093/aje/kwr373; Bartsch DK, 2005, INT J CANCER, V117, P718, DOI 10.1002/ijc.21254; Bavinck JNB, 2010, CANCER RES, V70, P9777, DOI 10.1158/0008-5472.CAN-10-0352; Bisbal C, 2007, BIOCHIMIE, V89, P789, DOI 10.1016/j.biochi.2007.02.006; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Casey G, 2002, NAT GENET, V32, P582, DOI 10.1038/ng1021; Castelli JC, 1997, J EXP MED, V186, P967, DOI 10.1084/jem.186.6.967; Chatzikyriakidou A, 2010, SCAND J IMMUNOL, V71, P382, DOI 10.1111/j.1365-3083.2010.02381.x; Chatzikyriakidou A, 2010, JOINT BONE SPINE, V77, P411, DOI 10.1016/j.jbspin.2010.05.013; Chen AC, 2013, PATHOLOGY, V45, P331, DOI 10.1097/PAT.0b013e32835f515c; Cheng HS, 2013, EMBO MOL MED, V5, P1017, DOI 10.1002/emmm.201202318; Cybulski C, 2007, UROL INT, V79, P44, DOI 10.1159/000102913; Daugherty SE, 2007, PROSTATE, V67, P849, DOI 10.1002/pros.20537; Etzrodt M, 2012, CELL REPORTS, V1, P317, DOI 10.1016/j.celrep.2012.02.009; Euvrard S, 2003, NEW ENGL J MED, V348, P1681, DOI 10.1056/NEJMra022137; Ezelle Heather J, 2012, Front Biosci (Schol Ed), V4, P767; Farzan SF, 2013, INT J CANC; Fesinmeyer MD, 2011, PROSTATE; Gazouli M, 2013, DIG DIS SCI; HASSEL BA, 1993, EMBO J, V12, P3297, DOI 10.1002/j.1460-2075.1993.tb05999.x; Iannacone MR, 2012, CANCER EPIDEM BIOMAR, V21, P1303, DOI 10.1158/1055-9965.EPI-12-0032; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Jazdzewski K, 2009, P NATL ACAD SCI USA, V106, P1502, DOI 10.1073/pnas.0812591106; Karagas M, 2006, CANC EPIDEMIOLOGY PR; Karagas MR, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c2986; Karagas MR, 2006, J NATL CANCER I, V98, P389, DOI 10.1093/jnci/djj092; Karagas MR, 1996, J NATL CANCER I, V88, P1848, DOI 10.1093/jnci/88.24.1848; Karagas MR, 2001, BRIT J CANCER, V85, P683, DOI 10.1054/bjoc.2001.1931; Karagas MR, 1999, INT J CANCER, V81, P555, DOI 10.1002/(SICI)1097-0215(19990517)81:4<555::AID-IJC9>3.0.CO;2-R; Kataria, 2016, SAUDI J SPORTS MED, V16, P139; Kim RH, 2012, DERMATOL CLIN, V30, P125, DOI 10.1016/j.det.2011.08.008; KRICKER A, 1994, CANCER CAUSE CONTROL, V5, P367, DOI 10.1007/BF01804988; KRICKER A, 1991, INT J CANCER, V48, P650, DOI 10.1002/ijc.2910480504; Krueger S, 2007, CANCER LETT, V252, P55, DOI 10.1016/j.canlet.2006.12.006; Kruger S, 2005, LANCET ONCOL, V6, P566, DOI 10.1016/S1470-2045(05)70253-9; Lee TY, 2013, J INTERF CYTOK RES, V33, P34, DOI 10.1089/jir.2012.0062; Leonardi-Bee J, 2012, ARCH DERMATOL, V148, P939, DOI 10.1001/archdermatol.2012.1374; Li XL, 2007, J BIOL CHEM, V282, P7950, DOI 10.1074/jbc.M607939200; Lian H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031615; Lindelof B, 2000, BRIT J DERMATOL, V143, P513, DOI 10.1046/j.1365-2133.2000.03703.x; Ma L, 2013, ARCH TOXICOL, V87, P825, DOI 10.1007/s00204-012-1004-2; Madan V, 2010, LANCET, V375, P673, DOI 10.1016/S0140-6736(09)61196-X; Madsen BE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002492; MIETTINEN O, 1976, AM J EPIDEMIOL, V103, P226, DOI 10.1093/oxfordjournals.aje.a112220; Moloney FJ, 2006, BRIT J DERMATOL, V154, P790, DOI 10.1111/j.1365-2133.2006.07156.x; Nguyen LH, 2001, BIOCHEMISTRY-US, V40, P7174, DOI 10.1021/bi010141t; Orsos Z, 2013, ANTICANCER RES, V33, P341; Pentecost BT, 1998, J STEROID BIOCHEM, V64, P25, DOI 10.1016/S0960-0760(97)00140-4; Quinn SR, 2011, INT IMMUNOL, V23, P421, DOI 10.1093/intimm/dxr034; Rennert H, 2005, CANCER EPIDEM BIOMAR, V14, P949, DOI 10.1158/1055-9965.EPI-04-0637; So AYL, 2013, IMMUNOL REV, V253, P129, DOI 10.1111/imr.12043; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; Thornton MJ, 2002, EXP DERMATOL, V11, P487, DOI 10.1034/j.1600-0625.2002.110601.x; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; Urosevic M, 2004, AM J CLIN DERMATOL, V5, P453, DOI 10.2165/00128071-200405060-00010; Wang AX, 2012, GENET MOL RES, V11, P3051, DOI 10.4238/2012.August.31.2; Wei WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056638; Welsh MM, 2008, CARCINOGENESIS, V29, P1950, DOI 10.1093/carcin/bgn160; Welsh MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020019; Whitehead Institute for Biomedical Research, TARGETSCANHUMAN PRED; Wu D, 2013, ASIAN PAC J CANCER P, V14, P399, DOI 10.7314/APJCP.2013.14.1.399; Xiang Y, 2003, CANCER RES, V63, P6795; Xu B, 2010, PROSTATE, V70, P467, DOI 10.1002/pros.21080; Yin ZH, 2013, MOL BIOL REP, V40, P3003, DOI 10.1007/s11033-012-2372-7; Yue C, 2011, GYNECOL ONCOL, V122, P33, DOI 10.1016/j.ygyno.2011.03.032; Zhang LF, 2011, MOL BIOL REP, V38, P5099, DOI 10.1007/s11033-010-0657-2; Zhou FY, 2012, DNA CELL BIOL, V31, P1290, DOI 10.1089/dna.2011.1596	69	21	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93602	10.1371/journal.pone.0093602	http://dx.doi.org/10.1371/journal.pone.0093602			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699816	gold, Green Published, Green Submitted			2022-12-25	WOS:000334105000078
J	Pak, T; Yoo, S; Miranda-Angulo, AM; Wang, H; Blackshaw, S				Pak, Thomas; Yoo, Sooyeon; Miranda-Angulo, Ana M.; Wang, Hong; Blackshaw, Seth			Rax-CreER(T2) Knock-In Mice: A Tool for Selective and Conditional Gene Deletion in Progenitor Cells and Radial Glia of the Retina and Hypothalamus	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; HOMEOBOX GENE; MOUSE; EXPRESSION; TANYCYTES; RAX; DIFFERENTIATION; CHX10; PROLIFERATION; SPECIFICATION	To study gene function in neural progenitors and radial glia of the retina and hypothalamus, we developed a Rax-CreER(T2) mouse line in which a tamoxifen-inducible Cre recombinase is inserted into the endogenous Rax locus. By crossing Rax-CreER(T2) with the Cre-dependent Ai9 reporter line, we demonstrate that tamoxifen-induced Cre activity recapitulates the endogenous Rax mRNA expression pattern. During embryonic development, Cre recombinase activity in Rax-CreER(T2) is confined to retinal and hypothalamic progenitor cells, as well as progenitor cells of the posterior pituitary. At postnatal time points, selective Cre recombinase activity is seen in radial glial-like cell types in these organs - specifically Muller glia and tanycytes - as well as pituicytes. We anticipate that this line will prove useful for cell lineage analysis and investigation of gene function in the developing and mature retina, hypothalamus and pituitary.	[Pak, Thomas; Yoo, Sooyeon; Miranda-Angulo, Ana M.; Wang, Hong; Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Ctr High Throughput Biol, Baltimore, MD USA; [Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD USA; [Miranda-Angulo, Ana M.] Univ Antioquia, Sch Med, Inst Med Res, Medellin, Colombia	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Universidad de Antioquia	Blackshaw, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	sblack@jhmi.edu		Pak, Thomas/0000-0003-2716-1210; Miranda-Angulo, Ana L./0000-0003-4938-3033	NIH [R21NS067393]; Diabetes Research and Training Center Pilot and Feasibility Award; NATIONAL EYE INSTITUTE [R01EY020560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS067393, P30NS050274] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Research and Training Center Pilot and Feasibility Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	These studies were supported by NIH R21NS067393 and a Diabetes Research and Training Center Pilot and Feasibility Award. SB was a WM Keck Distinguished Young Scholar in Medical Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Bolborea M, 2013, TRENDS NEUROSCI, V36, P91, DOI 10.1016/j.tins.2012.12.008; Brauksiepe B, 2013, CELL TISSUE RES; Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; Chen J, 2009, GENESIS, V47, P122, DOI 10.1002/dvg.20465; Coppola A, 2007, CELL METAB, V5, P21, DOI 10.1016/j.cmet.2006.12.002; Engelhard C, 2013, ELIFE, V2, DOI 10.7554/eLife.01160; Furukawa T, 1997, P NATL ACAD SCI USA, V94, P3088, DOI 10.1073/pnas.94.7.3088; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Gordon PJ, 2013, J NEUROSCI, V33, P12197, DOI 10.1523/JNEUROSCI.1494-13.2013; Haan N, 2013, J NEUROSCI, V33, P6170, DOI 10.1523/JNEUROSCI.2437-12.2013; Hafler BP, 2012, P NATL ACAD SCI USA, V109, P7882, DOI 10.1073/pnas.1203138109; HUXLIN KR, 1992, J NEUROCYTOL, V21, P530, DOI 10.1007/BF01186955; Karl MO, 2010, TRENDS MOL MED, V16, P193, DOI 10.1016/j.molmed.2010.02.003; Klimova L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063029; Lee DA, 2012, INT J DEV NEUROSCI, V30, P615, DOI 10.1016/j.ijdevneu.2012.07.003; Lee DA, 2012, NAT NEUROSCI, V15, P700, DOI 10.1038/nn.3079; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liu F, 2013, DEVELOPMENT, V140, P1111, DOI 10.1242/dev.080226; Livne-Bar I, 2006, P NATL ACAD SCI USA, V103, P4988, DOI 10.1073/pnas.0600083103; Lu FQ, 2013, J NEUROSCI, V33, P259, DOI 10.1523/JNEUROSCI.0913-12.2013; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Marsili A, 2011, J ENDOCRINOL, V211, P73, DOI 10.1530/JOE-11-0248; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; Matsuoka RL, 2011, NEURON, V71, P460, DOI 10.1016/j.neuron.2011.06.009; Miranda-Angulo AL, 2013, J COMP NEUROL; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; Muranishi Y, 2012, DEV GROWTH DIFFER, V54, P341, DOI 10.1111/j.1440-169X.2012.01337.x; Nelson BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022817; Pearson CA, 2011, DEVELOPMENT, V138, P2613, DOI 10.1242/dev.062794; Peng CY, 2012, J NEUROSCI, V32, P17211, DOI 10.1523/JNEUROSCI.2484-12.2012; Plageman TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050426; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Reichenbach A, 2013, GLIA, V61, P651, DOI 10.1002/glia.22477; Robins SC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3049; Roesch K, 2008, J COMP NEUROL, V509, P225, DOI 10.1002/cne.21730; Rohde K, 2011, J NEUROCHEM, V118, P999, DOI 10.1111/j.1471-4159.2011.07385.x; Rowan S, 2004, DEV BIOL, V271, P388, DOI 10.1016/j.ydbio.2004.03.039; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Roy A, 2013, J NEUROSCI, V33, P6877, DOI 10.1523/JNEUROSCI.4216-12.2013; Sato S, 2007, GENESIS, V45, P502, DOI 10.1002/dvg.20318; Shaham O, 2012, PROG RETIN EYE RES, V31, P351, DOI 10.1016/j.preteyeres.2012.04.002; Shimogori T, 2010, NAT NEUROSCI, V13, P767, DOI 10.1038/nn.2545; Swindell EC, 2006, GENESIS, V44, P361, DOI 10.1002/dvg.20225; Trimarchi JM, 2009, DEV DYNAM, V238, P2327, DOI 10.1002/dvdy.21973; Wei XY, 2009, NEUROSCI LETT, V465, P27, DOI 10.1016/j.neulet.2009.06.059; Wichterle H, 2013, SCIENCE, V341, P726, DOI 10.1126/science.1235884; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215	50	43	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e90381	10.1371/journal.pone.0090381	http://dx.doi.org/10.1371/journal.pone.0090381			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699247	gold, Green Submitted, Green Published			2022-12-25	WOS:000334105000009
J	Tsodikov, OV; Green, KD; Garneau-Tsodikova, S				Tsodikov, Oleg V.; Green, Keith D.; Garneau-Tsodikova, Sylvie			A Random Sequential Mechanism of Aminoglycoside Acetylation by Mycobacterium tuberculosis Eis Protein	PLOS ONE			English	Article							GENTAMICIN ACETYLTRANSFERASE-I; KINETIC MECHANISM; BISUBSTRATE; ENZYME; RESISTANCE; INHIBITOR; OVEREXPRESSION; PROBES	An important cause of bacterial resistance to aminoglycoside antibiotics is the enzymatic acetylation of their amino groups by acetyltransferases, which abolishes their binding to and inhibition of the bacterial ribosome. Enhanced intracellular survival (Eis) protein from Mycobacterium tuberculosis (Mt) is one of such acetyltransferases, whose upregulation was recently established as a cause of resistance to aminoglycosides in clinical cases of drug-resistant tuberculosis. The mechanism of aminoglycoside acetylation by MtEis is not completely understood. A systematic analysis of steady-state kinetics of acetylation of kanamycin A and neomycin B by Eis as a function of concentrations of these aminoglycosides and the acetyl donor, acetyl coenzyme A, reveals that MtEis employs a random-sequential bisubstrate mechanism of acetylation and yields the values of the kinetic parameters of this mechanism. The implications of these mechanistic properties for the design of inhibitors of Eis and other aminoglycoside acetyltransferases are discussed.	[Tsodikov, Oleg V.; Green, Keith D.; Garneau-Tsodikova, Sylvie] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40506 USA	University of Kentucky	Tsodikov, OV (corresponding author), Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, BioPharm Complex, Lexington, KY 40506 USA.	oleg.tsodikov@uky.edu; sylviegtsodikova@uky.edu	Garneau-Tsodikova, Sylvie/ABH-5882-2020	Garneau-Tsodikova, Sylvie/0000-0002-7961-5555	National Institutes of Health (NIH) [AI090048]; University of Kentucky College of Pharmacy; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090048] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Kentucky College of Pharmacy; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a National Institutes of Health (NIH) Grant AI090048 (to S.G.-T.) and startup funds from the University of Kentucky College of Pharmacy (to O.V.T. and S.G.-T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell PJ, 2011, ANTIMICROB AGENTS CH, V55, P2032, DOI 10.1128/AAC.01550-10; Chen WJ, 2012, BIOCHEMISTRY-US, V51, P4959, DOI 10.1021/bi3004473; Chen WJ, 2011, P NATL ACAD SCI USA, V108, P9804, DOI 10.1073/pnas.1105379108; Draker KA, 2003, BIOCHEMISTRY-US, V42, P6565, DOI 10.1021/bi034148h; Gao F, 2005, ANGEW CHEM INT EDIT, V44, P6859, DOI 10.1002/anie.200501399; Gao F, 2008, BIOORG MED CHEM LETT, V18, P5518, DOI 10.1016/j.bmcl.2008.09.004; Gao F, 2009, CHEM-EUR J, V15, P2064, DOI 10.1002/chem.200802172; Hegde SS, 2001, J BIOL CHEM, V276, P45876, DOI 10.1074/jbc.M108810200; Houghton JL, 2013, CHEMBIOCHEM, V14, P2127, DOI 10.1002/cbic.201300359; Houghton JL, 2013, J ANTIMICROB CHEMOTH, V68, P800, DOI 10.1093/jac/dks497; Khalil EM, 1998, J AM CHEM SOC, V120, P6195, DOI 10.1021/ja981365a; Kim C, 2007, BIOCHEMISTRY-US, V46, P5270, DOI 10.1021/bi700111z; Kim C, 2006, BIOCHEMISTRY-US, V45, P8368, DOI 10.1021/bi060723g; Magalhaes MLB, 2005, BIOCHEMISTRY-US, V44, P16275, DOI 10.1021/bi051777d; Magnet S, 2001, BIOCHEMISTRY-US, V40, P3700, DOI 10.1021/bi002736e; MARTEL A, 1983, EUR J BIOCHEM, V133, P515, DOI 10.1111/j.1432-1033.1983.tb07494.x; Poux AN, 2002, P NATL ACAD SCI USA, V99, P14065, DOI 10.1073/pnas.222373899; Pricer RE, 2012, MOL BIOSYST, V8, P3305, DOI 10.1039/c2mb25341k; WILLIAMS JW, 1979, J ANTIBIOT, V32, P1147, DOI 10.7164/antibiotics.32.1147; WILLIAMS JW, 1978, J BIOL CHEM, V253, P5902; Yu M, 2006, BIOCHEMISTRY-US, V45, P14788, DOI 10.1021/bi061621t; Zaunbrecher MA, 2009, P NATL ACAD SCI USA, V106, P20004, DOI 10.1073/pnas.0907925106	22	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e92370	10.1371/journal.pone.0092370	http://dx.doi.org/10.1371/journal.pone.0092370			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699000	Green Published, gold			2022-12-25	WOS:000334105000023
J	Das, S; Banerjee, S; Majumder, S; Chowdhury, BP; Goswami, A; Halder, K; Chakraborty, U; Pal, NK; Majumdar, S				Das, Shibali; Banerjee, Sayantan; Majumder, Saikat; Chowdhury, Bidisha Paul; Goswami, Avranil; Halder, Kuntal; Chakraborty, Urmita; Pal, Nishith K.; Majumdar, Subrata			Immune Subversion by Mycobacterium tuberculosis through CCR5 Mediated Signaling: Involvement of IL-10	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; IFN-GAMMA; T-CELLS; DENDRITIC CELLS; HIV-INFECTION; II EXPRESSION; MACROPHAGES; INHIBITION; BETA; INTERLEUKIN-10	Tuberculosis is characterized by severe immunosuppression of the host macrophages, resulting in the loss of the host protective immune responses. During Mycobacterium tuberculosis infection, the pathogen modulates C-C Chemokine Receptor 5 (CCR5) to enhance IL-10 production, indicating the possible involvement of CCR5 in regulation of the host immune response. Here, we found that Mycobacterium infection significantly increased CCR5 expression in macrophages there by facilitating the activation of its downstream signaling. These events culminated in up-regulation of the immunosuppressive cytokine IL-10 production, which was further associated with the down-regulation of macrophage MHC-II expression along with the up-regulation of CCR5 expression via engagement of STAT-3 in a positive feedback loop. Treatment of macrophages with CCR5 specific siRNA abrogated the IL-10 production and restored MHCII expression. While, in vivo CCR5 silencing was also effective for the restoration of host immune responses against tuberculosis. This study demonstrated that CCR5 played a very critical role for the immune subversion mechanism employed by the pathogen.	[Das, Shibali; Banerjee, Sayantan; Majumder, Saikat; Chowdhury, Bidisha Paul; Halder, Kuntal; Majumdar, Subrata] Bose Inst, Div Mol Med, Kolkata, India; [Goswami, Avranil; Chakraborty, Urmita; Pal, Nishith K.] Inst Post Grad Med Educ & Res, Dept Microbiol, Kolkata, India; Malda Med Coll, Dept Microbiol, Malda, India	Department of Science & Technology (India); Bose Institute; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata	Majumdar, S (corresponding author), Bose Inst, Div Mol Med, Kolkata, India.	subrata@bic.boseinst.ernet	Majumder, Saikat/ABC-2194-2020; BANERJEE, SAYANTAN/AAD-8420-2019; Das, Shibali/AAA-2683-2021	Majumder, Saikat/0000-0002-6591-9515; Das, Shibali/0000-0003-1263-8178	Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi	Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	The Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi provided a fellowship to Shibali Das. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algood HMS, 2004, J IMMUNOL, V173, P3287; Aliberti J, 2000, NAT IMMUNOL, V1, P83, DOI 10.1038/76957; Beamer GL, 2008, J IMMUNOL, V181, P5545, DOI 10.4049/jimmunol.181.8.5545; Bhattacharya P, 2011, PLOS ONE, V6, P1; Bhattacharyya S, 2008, SCAND J IMMUNOL, V67, P345, DOI 10.1111/j.1365-3083.2008.02076.x; Chan LLY, 2010, J LEUKOCYTE BIOL, V88, P303, DOI 10.1189/jlb.1009659; Cho H, 2005, INFECT IMMUN, V73, P1367, DOI 10.1128/IAI.73.3.1367-1376.2005; FAHEY TJ, 1992, J IMMUNOL, V148, P2764; Ferwerda G, 2007, J LEUKOCYTE BIOL, V82, P1011, DOI 10.1189/jlb.0307147; Fremond CM, 2004, J CLIN INVEST, V114, P1790, DOI 10.1172/JCI200421027; Fulton SA, 2004, INFECT IMMUN, V72, P2101, DOI 10.1128/IAI.72.4.2101-2110.2004; Gallegos AM, 2008, J EXP MED, V205, P2359, DOI 10.1084/jem.20080353; Ghosh S, 2002, INFECT IMMUN, V70, P6828, DOI 10.1128/IAI.70.12.6828-6838.2002; Green AM, 2013, J IMMUNOL, V190, P270, DOI 10.4049/jimmunol.1200061; Harris J, 2010, CLIN EXP IMMUNOL, V161, P1, DOI 10.1111/j.1365-2249.2010.04146.x; Hondalus MK, 2000, INFECT IMMUN, V68, P2888, DOI 10.1128/IAI.68.5.2888-2898.2000; Houle M, 1999, INFLAMMATION, V23, P241; Huffnagle GB, 1999, J IMMUNOL, V163, P4642; Kuipers HF, 2008, BLOOD, V112, P1610, DOI 10.1182/blood-2008-01-135111; Lande R, 2003, J IMMUNOL, V170, P1174, DOI 10.4049/jimmunol.170.3.1174; Lee B, 1999, P NATL ACAD SCI USA, V96, P5215, DOI 10.1073/pnas.96.9.5215; Liu Y, 2010, CLIN VACCINE IMMUNOL, V17, P1377, DOI 10.1128/CVI.00242-10; Madan-Lala R, 2011, INFECT IMMUN, V79, P4828, DOI 10.1128/IAI.05574-11; MAJUMDAR S, 1993, BIOCHIM BIOPHYS ACTA, V1176, P276, DOI 10.1016/0167-4889(93)90056-U; Makuta Y, 2003, BIOL PHARM BULL, V26, P1076, DOI 10.1248/bpb.26.1076; Mayanja-Kizza H, 2001, J INFECT DIS, V183, P1801, DOI 10.1086/320724; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Moreira AP, 2008, J IMMUNOL, V180, P3049, DOI 10.4049/jimmunol.180.5.3049; O'Garra A, 2008, IMMUNOL REV, V223, P114, DOI 10.1111/j.1600-065X.2008.00635.x; Olleros ML, 2005, AM J PATHOL, V166, P1109, DOI 10.1016/S0002-9440(10)62331-0; Pai RK, 2003, J IMMUNOL, V171, P175, DOI 10.4049/jimmunol.171.1.175; Pai RK, 2002, J IMMUNOL, V169, P1326, DOI 10.4049/jimmunol.169.3.1326; Parveen N, 2013, J BIOL CHEM, V288, P24956, DOI 10.1074/jbc.M113.461004; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Redpath S, 1999, J IMMUNOL, V162, P6701; Roach DR, 2002, J IMMUNOL, V168, P4620, DOI 10.4049/jimmunol.168.9.4620; Rosati M, 2001, J IMMUNOL, V167, P1654, DOI 10.4049/jimmunol.167.3.1654; Schafer G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008448; Simmons G, 2000, IMMUNOL REV, V177, P112, DOI 10.1034/j.1600-065X.2000.17719.x; Tomkowicz B, 2006, BLOOD, V108, P1145, DOI 10.1182/blood-2005-12-012815; Wieland CW, 2007, MICROBES INFECT, V9, P134, DOI 10.1016/j.micinf.2006.10.018; Wilkin TJ, 2012, ANNU REV MED, V63, P81, DOI 10.1146/annurev-med-052010-145454; World Health Organization, 2009, GLOB TUB CONTR EP ST; Yang XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030198; Yurchenko E, 2006, J EXP MED, V203, P2451, DOI 10.1084/jem.20060956; Zimmerli S, 1996, AM J RESP CELL MOL, V15, P760, DOI 10.1165/ajrcmb.15.6.8969271	46	20	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e92477	10.1371/journal.pone.0092477	http://dx.doi.org/10.1371/journal.pone.0092477			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695099	Green Submitted, gold, Green Published			2022-12-25	WOS:000334103000019
J	Falkingham, PL; Bates, KT; Farlow, JO				Falkingham, Peter L.; Bates, Karl T.; Farlow, James O.			Historical Photogrammetry: Bird's Paluxy River Dinosaur Chase Sequence Digitally Reconstructed as It Was prior to Excavation 70 Years Ago	PLOS ONE			English	Article								It is inevitable that some important specimens will become lost or damaged over time, conservation is therefore of vital importance. The Paluxy River dinosaur tracksite is among the most famous in the world. In 1940, Roland T. Bird described and excavated a portion of the site containing associated theropod and sauropod trackways. This excavated trackway was split up and housed in different institutions, and during the process a portion was lost or destroyed. We applied photogrammetric techniques to photographs taken by Bird over 70 years ago, before the trackway was removed, to digitally reconstruct the site as it was prior to excavation. The 3D digital model offers the opportunity to corroborate maps drawn by R.T. Bird when the tracksite was first described. More broadly, this work demonstrates the exciting potential for digitally recreating palaeontological, geological, or archaeological specimens that have been lost to science, but for which photographic documentation exists.	[Falkingham, Peter L.] Royal Vet Coll, Dept Comparat Biomed Sci, Struct & Motion Lab, London, England; [Falkingham, Peter L.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Bates, Karl T.] Univ Liverpool, Inst Ageing & Chron Dis, Dept Musculoskeletal Biol 2, Liverpool L69 3BX, Merseyside, England; [Farlow, James O.] Indiana Purdue Univ, Dept Geosci, Indiana, PA USA	University of London; University of London Royal Veterinary College; Brown University; University of Liverpool	Falkingham, PL (corresponding author), Royal Vet Coll, Dept Comparat Biomed Sci, Struct & Motion Lab, London, England.	pfalkingham@rvc.ac.uk	Falkingham, Peter/C-7656-2014	Falkingham, Peter/0000-0003-1856-8377	Marie Curie International Outgoing Fellowship within the 7th European Framework Programme; National Geographic grant; Jurassic foundation grant; Palaeontological Association grant	Marie Curie International Outgoing Fellowship within the 7th European Framework Programme; National Geographic grant(National Geographic Society); Jurassic foundation grant; Palaeontological Association grant	This work was supported by a Marie Curie International Outgoing Fellowship within the 7th European Framework Programme awarded to PLF, and a National Geographic grant awarded to JOF. The Laser scans of the AMNH and TMM sections were collected during previous work funded by Jurassic foundation and Palaeontological Association grants awarded to KTB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, SIFTGPU GPU IMPLEMEN; [Anonymous], 2010, CLUSTERING VIEWS MUL; Bates Karl T., 2009, Geology Today, V25, P134; Bennett MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060755; Bird R.T., 1985, BONES BARNUM BROWN A; Bird Roland T., 1944, NAT HIST [NEW YORK], V53, P60; Changchang Wu, 2011, 2011 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P3057, DOI 10.1109/CVPR.2011.5995552; Falkingham PL, 2011, BIOL LETTERS, V7, P142, DOI 10.1098/rsbl.2010.0403; Falkingham PL, 2012, PALAEONTOL ELECTRON, V15; Farlow J.O., 1989, P371; Farlow J.O., 2012, P 5 INT S DIN PAL TH, P41; Furukawa Y, 2010, INTERNET SCALE MULTI; Furukawa Y, 2010, IEEE T PATTERN ANAL, V32, P1362, DOI 10.1109/TPAMI.2009.161; Kazhdan M, 2013, ACM T GRAPHIC, V32, DOI 10.1145/2487228.2487237; Shuler E. W., 1937, Field & Laboratory Dallas, V5, P33; Shuler E.W., 1935, FIELD LAB, V4, P9; Shuler EW, 1917, AM J SCI, V44, P294; Thomas DA, 1997, SCI AM, V277, P74, DOI 10.1038/scientificamerican1297-74; [No title captured]	20	40	43	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93247	10.1371/journal.pone.0093247	http://dx.doi.org/10.1371/journal.pone.0093247			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695537	gold, Green Published, Green Accepted			2022-12-25	WOS:000334103000052
J	Suquet, M; Labbe, C; Puyo, S; Mingant, C; Quittet, B; Boulais, M; Queau, I; Ratiskol, D; Diss, B; Haffray, P				Suquet, Marc; Labbe, Catherine; Puyo, Sophie; Mingant, Christian; Quittet, Benjamin; Boulais, Myrina; Queau, Isabelle; Ratiskol, Dominique; Diss, Blandine; Haffray, Pierrick			Survival, Growth and Reproduction of Cryopreserved Larvae from a Marine Invertebrate, the Pacific Oyster (Crassostrea gigas)	PLOS ONE			English	Article							OOCYTES; EMBRYOS; SPERM; SYSTEM; DAMAGE; FISH	This study is the first demonstration of successful post-thawing development to reproduction stage of diploid cryopreserved larvae in an aquatic invertebrate. Survival, growth and reproductive performances were studied in juvenile and adult Pacific oysters grown from cryopreserved embryos. Cryopreservation was performed at three early stages: trochophore (13 +/- 2 hours post fertilization: hpf), early D-larvae (24 +/- 2 hpf) and late D-larvae (43 +/- 2 hpf). From the beginning (88 days) at the end of the ongrowing phase (195 days), no mortality was recorded and mean body weights did not differ between the thawed oysters and the control. At the end of the growing-out phase (982 days), survival of the oysters cryopreserved at 13 +/- 2 hpf and at 43 +/- 2 hpf was significantly higher (P<0.001) than those of the control (non cryopreserved larvae). Only the batches cryopreserved at 24 +/- 2 hpf showed lower survival than the control. Reproductive integrity of the mature oysters, formely cryopreserved at 13 +/- 2 hpf and 24 +/- 2 hpf, was estimated by the sperm movement and the larval development of their offspring in 13 crosses gamete pools (five males and five females in each pool). In all but two crosses out of 13 tested (P<0.001), development rates of the offspring were not significantly different between frozen and unfrozen parents. In all, the growth and reproductive performances of oysters formerly cryopreserved at larval stages are close to those of controls. Furthermore, these performances did not differ between the three initial larval stages of cryopreservation. The utility of larvae cryopreservation is discussed and compared with the cryopreservation of gametes as a technique for selection programs and shellfish cryobanking.	[Suquet, Marc; Mingant, Christian; Boulais, Myrina; Queau, Isabelle; Ratiskol, Dominique] IFREMER, PFOM Dept, Stn Expt Argenton, UMR 6539, Argenton, France; [Labbe, Catherine] INRA, LPGP, UR 1037, Rennes, France; [Puyo, Sophie; Quittet, Benjamin; Haffray, Pierrick] SYSAAF, LPGP, Rennes, France; [Diss, Blandine] Satmar, Barfleur, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Institut de Recherche pour le Developpement (IRD); INRAE	Suquet, M (corresponding author), IFREMER, PFOM Dept, Stn Expt Argenton, UMR 6539, Argenton, France.	marc.suquet@ifremer.fr		Haffray, Pierrick/0000-0001-8604-4562; Boulais, Myrina/0000-0002-9309-9278	national project CRECHE [Ofimer 136/08/C]; CRYOAQUA (GIS IBISA); European Union [FEP 30906-2009]	national project CRECHE; CRYOAQUA (GIS IBISA); European Union(European Commission)	The present research was supported by the national project CRECHE (Ofimer 136/08/C) and CRYOAQUA (GIS IBISA) and by the European Union (FEP 30906-2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boudry P, 2008, SUMMER MORTALITY PAC, P153; Cabrita E, 2005, CRYOBIOLOGY, V50, P144, DOI 10.1016/j.cryobiol.2004.12.003; Cabrita E, 2010, J APPL ICHTHYOL, V26, P623, DOI 10.1111/j.1439-0426.2010.01556.x; Gwo JC, 2003, CRYOLETTERS, V24, P171; Hiemstra S. J., 2006, The role of biotechnology in exploring and protecting agricultural genetic resources, P45; Honkoop PJC, 2002, AQUACULTURE, V213, P171, DOI 10.1016/S0044-8486(02)00030-3; Leopold Roger A., 2010, P325, DOI 10.1017/CBO9780511675997.014; Paniagua-Chavez C. O., 2000, CRYOPRESERVATION AQU, P230; Paredes E, 2012, CRYOBIOLOGY, V65, P256, DOI 10.1016/j.cryobiol.2012.07.078; Piferrer F, 2009, AQUACULTURE, V293, P125, DOI 10.1016/j.aquaculture.2009.04.036; RENARD P, 1991, AQUACULTURE, V92, P43, DOI 10.1016/0044-8486(91)90007-T; Rico-Villa B, 2008, AQUACULTURE, V282, P54, DOI 10.1016/j.aquaculture.2008.06.016; Smith GD, 2004, REPROD BIOMED ONLINE, V9, P171, DOI 10.1016/S1472-6483(10)62126-8; Song YP, 2009, AQUACULTURE, V287, P311, DOI 10.1016/j.aquaculture.2008.10.018; Suquet M, 2012, THERIOGENOLOGY, V78, P462, DOI 10.1016/j.theriogenology.2012.02.014; Tervit HR, 2005, CRYOBIOLOGY, V51, P142, DOI 10.1016/j.cryobiol.2005.06.001; TOLEDO JD, 1990, AQUACULTURE, V91, P385, DOI 10.1016/0044-8486(90)90202-X; Usuki H, 2002, FISHERIES SCI, V68, P757, DOI 10.1046/j.1444-2906.2002.00490.x; Wang HR, 2011, AQUAC RES, V42, P1816, DOI 10.1111/j.1365-2109.2010.02782.x; Wang WB, 2000, INVERTEBR BIOL, V119, P309; Wilson-Leedy JG, 2007, THERIOGENOLOGY, V67, P661, DOI 10.1016/j.theriogenology.2006.10.003	21	24	25	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93486	10.1371/journal.pone.0093486	http://dx.doi.org/10.1371/journal.pone.0093486			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695576	Green Published, gold			2022-12-25	WOS:000334103000079
J	Zhang, CX; Cui, W; Zhang, M; Zhang, J; Wang, TY; Zhu, J; Jiao, GZ; Tan, JH				Zhang, Chuan-Xin; Cui, Wei; Zhang, Min; Zhang, Jie; Wang, Tian-Yang; Zhu, Jiang; Jiao, Guang-Zhong; Tan, Jing-He			Role of Na+/Ca2+ Exchanger (NCX) in Modulating Postovulatory Aging of Mouse and Rat Oocytes	PLOS ONE			English	Article							NA-CA EXCHANGE; MAMMALIAN EGG ACTIVATION; CELL NUCLEAR TRANSFER; IN-VITRO; OXIDATIVE STRESS; CHROMOSOME CONDENSATION; CALCIUM OSCILLATIONS; PARTHENOGENETIC ACTIVATION; INTRACELLULAR CALCIUM; BLASTOCYST STAGE	We studied the role of the Na+/Ca2+ exchanger (NCX) in modulating oocyte postovulatory aging by observing changes in NCX contents and activities in aging mouse and rat oocytes. Whereas the NCX activity was measured by observing oocyte activation following culture with NCX inhibitor or activator, the NCX contents were determined by immunohistochemical quantification. Although NCX was active in freshly-ovulated rat oocytes recovered 13 h post hCG injection and in aged oocytes recovered 19 h post hCG in both species, it was not active in freshly-ovulated mouse oocytes. However, NCX became active when the freshly-ovulated mouse oocytes were activated with ethanol before culture. Measurement of cytoplasmic Ca2+ revealed Ca2+ increases always before NCX activation. Whereas levels of the reactive oxygen species (ROS) and the activation susceptibility increased, the density of NCX member 1 (NCX1) decreased significantly with oocyte aging in both species. While culture with H2O2 decreased the density of NCX1 significantly, culture with NaCl supplementation sustained the NCX1 density in mouse oocytes. It was concluded that (a) the NCX activity was involved in the modulation of oocyte aging and spontaneous activation; (b) ROS and Na+ regulated the NCX activity in aging oocytes by altering its density as well as functioning; and (c) cytoplasmic Ca2+ elevation was essential for NCX activation in the oocyte.	[Zhang, Chuan-Xin; Cui, Wei; Zhang, Min; Zhang, Jie; Wang, Tian-Yang; Zhu, Jiang; Jiao, Guang-Zhong; Tan, Jing-He] Shandong Agr Univ, Coll Anim Sci & Vet Med, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Tan, JH (corresponding author), Shandong Agr Univ, Coll Anim Sci & Vet Med, Tai An, Shandong, Peoples R China.	tanjh@sdau.edu.cn	Cui, Wei/F-2192-2016	Cui, Wei/0000-0001-7281-3471	National Basic Research Program of China [2012CB944403, 2014CB138503]; China National Natural Science Foundation [31272444, 30972096]	National Basic Research Program of China(National Basic Research Program of China); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Basic Research Program of China (Nos. 2012CB944403 and 2014CB138503) and the China National Natural Science Foundation (Nos. 31272444 and 30972096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajduk A, 2008, REPROD BIOLOGY, V8, P3, DOI 10.1016/S1642-431X(12)60001-1; BAKER PF, 1969, J PHYSIOL-LONDON, V200, P431, DOI 10.1113/jphysiol.1969.sp008702; BOERJAN ML, 1990, MOL REPROD DEV, V25, P155, DOI 10.1002/mrd.1080250208; BOSMIKICH A, 1995, MOL REPROD DEV, V41, P84, DOI 10.1002/mrd.1080410113; Carroll J, 2000, J REPROD FERTIL, V118, P337, DOI 10.1530/reprod/118.2.337; Cervera RP, 2003, ZYGOTE, V11, P151, DOI 10.1017/S0967199403002181; CHATOT CL, 1989, J REPROD FERTIL, V86, P679, DOI 10.1530/jrf.0.0860679; Chebotareva T, 2011, MOL REPROD DEV, V78, P795, DOI 10.1002/mrd.21385; COLONNA R, 1989, GAMETE RES, V24, P171, DOI 10.1002/mrd.1120240205; CRESPO LM, 1990, NATURE, V345, P618, DOI 10.1038/345618a0; Cui W, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.108266; Cui W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032044; Despa S, 2007, AM J PHYSIOL-CELL PH, V293, pC321, DOI 10.1152/ajpcell.00597.2006; DIPOLO R, 1979, NATURE, V278, P271, DOI 10.1038/278271a0; DiPolo R, 1989, SODIUM CALCIUM EXCHA, P526; DiPolo R, 2011, AM J PHYSIOL-CELL PH, V301, pC687, DOI 10.1152/ajpcell.00521.2010; Egger M, 1999, J MEMBRANE BIOL, V168, P107, DOI 10.1007/s002329900502; EISNER DA, 1985, AM J PHYSIOL, V248, pC189, DOI 10.1152/ajpcell.1985.248.3.C189; Ermak G, 2002, MOL IMMUNOL, V38, P713, DOI 10.1016/S0161-5890(01)00108-0; Galan C, 2010, MOLECULES, V15, P7167, DOI 10.3390/molecules15107167; GEORGIOU P, 1988, J PHYSIOL-LONDON, V402, P121, DOI 10.1113/jphysiol.1988.sp017196; Grupen CG, 2002, J REPROD DEVELOP, V48, P313, DOI 10.1262/jrd.48.313; Hayes E, 2001, PHYSIOL GENOMICS, V5, P193, DOI 10.1152/physiolgenomics.2001.5.4.193; Hirabayashi M, 2003, CLONING STEM CELLS, V5, P35, DOI 10.1089/153623003321512148; Iannaccone P, 2001, ZYGOTE, V9, P135, DOI 10.1017/S0967199401001149; IGUSA Y, 1983, J PHYSIOL-LONDON, V340, P611, DOI 10.1113/jphysiol.1983.sp014783; Ito J, 2005, REPRODUCTION, V129, P171, DOI 10.1530/rep.1.00431; Iwamoto M, 2005, ZYGOTE, V13, P335, DOI 10.1017/S0967199405003370; Jellerette T, 2000, DEV BIOL, V223, P238, DOI 10.1006/dbio.2000.9675; JUETTEN J, 1983, GAMETE RES, V8, P219, DOI 10.1002/mrd.1120080303; KEEFER CL, 1982, J EXP ZOOL, V224, P371, DOI 10.1002/jez.1402240310; KLINE D, 1992, DEV BIOL, V149, P80, DOI 10.1016/0012-1606(92)90265-I; Lacham-Kaplan O, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-58; Liu N, 2009, REPRODUCTION, V138, P223, DOI 10.1530/REP-09-0122; LONGO FJ, 1980, GAMETE RES, V3, P379, DOI 10.1002/mrd.1120030409; Lord T, 2013, REPRODUCTION, V146, pR217, DOI 10.1530/REP-13-0111; Machaty Z, 2002, BIOL REPROD, V67, P1133, DOI 10.1095/biolreprod67.4.1133; Malcuit C, 2006, J CELL PHYSIOL, V206, P565, DOI 10.1002/jcp.20471; Miao YL, 2005, BIOL REPROD, V73, P1025, DOI 10.1095/biolreprod.105.043703; NASRESFAHANI MH, 1990, DEVELOPMENT, V109, P501; Oh SH, 1998, BIOL REPROD, V59, P884, DOI 10.1095/biolreprod59.4.884; Pepperell JR, 1999, BIOL REPROD, V60, P1137, DOI 10.1095/biolreprod60.5.1137; REUTER H, 1968, J PHYSIOL-LONDON, V195, P451, DOI 10.1113/jphysiol.1968.sp008467; Salido GM, 2009, CELL SIGNAL, V21, P457, DOI 10.1016/j.cellsig.2008.11.005; Shiraga M, 1998, BLOOD, V92, P3710, DOI 10.1182/blood.V92.10.3710.422k13_3710_3720; Squier TC, 2000, FRONT BIOSCI-LANDMRK, V5, pD504, DOI 10.2741/Squier; Sterthaus O, 2009, CLONING STEM CELLS, V11, P463, DOI 10.1089/clo.2009.0014; Swift F, 2008, CARDIOVASC RES, V78, P71, DOI 10.1093/cvr/cvn013; Swift F, 2010, CELL CALCIUM, V48, P54, DOI 10.1016/j.ceca.2010.06.006; Takahashi T, 2003, MOL REPROD DEV, V66, P143, DOI 10.1002/mrd.10341; Tarin JJ, 1998, HUM REPROD, V13, P381, DOI 10.1093/humrep/13.2.381; Tarin JJ, 1999, BIOL REPROD, V61, P1347, DOI 10.1095/biolreprod61.5.1347; Tarin JJ, 2002, BIOL REPROD, V66, P495, DOI 10.1095/biolreprod66.2.495; TESARIK J, 1993, HUM REPROD, V8, P1245, DOI 10.1093/oxfordjournals.humrep.a138235; Tomioka I, 2007, J REPROD DEVELOP, V53, P835, DOI 10.1262/jrd.18144; Vines CA, 2002, P NATL ACAD SCI USA, V99, P2026, DOI 10.1073/pnas.042700899; WEBB M, 1986, J EMBRYOL EXP MORPH, V95, P131; WHITTINGHAM DG, 1978, EXP CELL RES, V113, P311, DOI 10.1016/0014-4827(78)90371-3; WINSTON NJ, 1993, HUM REPROD, V8, P503, DOI 10.1093/oxfordjournals.humrep.a138084; Wu YG, 2007, CLONING STEM CELLS, V9, P417, DOI 10.1089/clo.2006.0023; YANAGIMACHI R, 1961, J EXP ZOOL, V148, P185, DOI 10.1002/jez.1401480303	61	10	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93446	10.1371/journal.pone.0093446	http://dx.doi.org/10.1371/journal.pone.0093446			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695407	Green Published, Green Submitted, gold			2022-12-25	WOS:000334103000073
J	Huang, CW; Hayman-Abello, B; Hayman-Abello, S; Derry, P; McLachlan, RS				Huang, Chin-Wei; Hayman-Abello, Brent; Hayman-Abello, Susan; Derry, Paul; McLachlan, Richard S.			Subjective Memory Evaluation before and after Temporal Lobe Epilepsy Surgery	PLOS ONE			English	Article							COMPLAINTS; MOOD; PERFORMANCE; ADULTS	Subjective memory (SM), a self-evaluation of memory, in contrast to objective memory (OM) measured by neuropsychological testing, is less well studied in patients with epilepsy. We assessed SM before and after temporal lobectomy. The Frequency of Forgetting 10 scale (FOF-10), developed to evaluate SM in dementia, was given before and one year after temporal lobectomy. Reliability and validity for use in epilepsy were first assessed. Measures of depression (CES-D) and neuroticism (PANAS) were done before and after surgery as well as complete neuropsychological assessment of OM. Correlation analysis between FOF-10 results and all the other variables was implemented. In 48 patients the FOF-10 was reliable and valid showing high internal consistency in all items (Cronbach's alpha >0.82) and high reproducibility (p<0.01). The FOF-10 also correlated with the memory assessment clinics self rating scale (MAC-S) (p<0.01). FOF-10 scores improved or were unchanged postoperatively in 28 patients (58%) and worsened in 20 (42%). The FOF-10 did not significantly correlate with memory scores from neuropsychological testing but did correlate with perceived word finding difficulty (p< 0.001) and postoperative depression (p<0.05). A reduction in number of antiepileptic drugs (AEDs) after surgery distinguished those with improved postoperative SM. No correlation was found between SM and neuroticism, side of surgery or number of seizures. The FOF-10 is a brief and reliable measure of subjective memory in patients with epilepsy. Perceived memory impairment reflects more emotional state, language problems and quantity of AEDs than actual defects in memory function. These results would potentially be useful in presurgical counselling and management of memory issues after temporal lobe surgery.	[Huang, Chin-Wei; Hayman-Abello, Brent; Hayman-Abello, Susan; Derry, Paul; McLachlan, Richard S.] Univ Western Ontario, Dept Clin Neurol Sci, London, ON, Canada; [Huang, Chin-Wei] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Neurol, Tainan 70101, Taiwan	Western University (University of Western Ontario); National Cheng Kung University; National Cheng Kung University Hospital	Huang, CW (corresponding author), Univ Western Ontario, Dept Clin Neurol Sci, London, ON, Canada.	huangcw@mail.ncku.edu.tw; rick.mclachlan@lhsc.on.ca			Physicians' Services Incorporated Foundation of Ontario, Canada [07-50]; National Science Council, Taiwan [NSC-102-2314-B-006-051-MY3]	Physicians' Services Incorporated Foundation of Ontario, Canada; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a grant from the Physicians' Services Incorporated Foundation of Ontario (07-50), Canada and a grant from National Science Council (NSC-102-2314-B-006-051-MY3), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldenkamp AP, 2003, EPILEPSIA, V44, P21, DOI 10.1046/j.1528-1157.44.s4.3.x; Andelman F, 2004, EPILEPSIA, V45, P826, DOI 10.1111/j.0013-9580.2004.51703.x; Au A, 2006, EPILEPSY BEHAV, V9, P68, DOI 10.1016/j.yebeh.2006.04.004; Baxendale S, 2005, EPILEPSY BEHAV, V6, P207, DOI 10.1016/j.yebeh.2004.12.009; Bell B, 2011, NAT REV NEUROL, V7, P154, DOI 10.1038/nrneurol.2011.3; Busch RM, 2012, NEUROLOGY, V78, P1064, DOI 10.1212/WNL.0b013e31824e8efb; Canizares S, 2000, EPILEPSIA, V41, P1303, DOI 10.1111/j.1528-1157.2000.tb04609.x; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; CROOK TH, 1990, PSYCHOL AGING, V5, P48, DOI 10.1037/0882-7974.5.1.48; Elixhauser A, 1999, EPILEPSY RES, V37, P13, DOI 10.1016/S0920-1211(99)00036-4; Erk S, 2011, ARCH GEN PSYCHIAT, V68, P845, DOI 10.1001/archgenpsychiatry.2011.80; Fargo JD, 2004, EPILEPSY BEHAV, V5, P143, DOI 10.1016/j.yebeh.2003.11.023; Gauffin H, 2011, EPILEPSY BEHAV, V22, P750, DOI 10.1016/j.yebeh.2011.09.007; Giovagnoli AR, 1997, EPILEPSY RES, V28, P119, DOI 10.1016/S0920-1211(97)00036-3; Helmstaedter C, 2000, EPILEPSY RES, V41, P235, DOI 10.1016/S0920-1211(00)00148-0; Hendriks MPH, 2002, EPILEPSY BEHAV, V3, P165, DOI 10.1006/ebeh.2002.0320; Lineweaver TT, 2004, EPILEPSIA, V45, P1604, DOI 10.1111/j.0013-9580.2004.54503.x; Martin R, 2006, EPILEPSY BEHAV, V8, P239, DOI 10.1016/j.yebeh.2005.10.004; McAuley JW, 2010, EPILEPSY BEHAV, V19, P580, DOI 10.1016/j.yebeh.2010.09.001; MCGLONE J, 1994, EPILEPSIA, V35, P529, DOI 10.1111/j.1528-1157.1994.tb02473.x; Nunnally J., 1978, PSYCHOMETRIC THEORY; Piazzini A, 2001, EUR J NEUROL, V8, P613, DOI 10.1046/j.1468-1331.2001.00287.x; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reid LM, 2006, DEMENT GERIATR COGN, V22, P471, DOI 10.1159/000096295; Salas-Puig J, 2009, EPILEPSY BEHAV, V14, P622, DOI 10.1016/j.yebeh.2009.01.015; Sawrie SM, 1999, NEUROLOGY, V53, P1511, DOI 10.1212/WNL.53.7.1511; Streiner D. L., 2003, HLTH MEASUREMENT SCA; Thompson PJ, 2000, J NEUROL NEUROSUR PS, V69, P636, DOI 10.1136/jnnp.69.5.636; Wagner K, 2013, J NEUROL NEUROSUR PS, V84, P630, DOI 10.1136/jnnp-2012-304052; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Weitzman RA, 1996, EDUC PSYCHOL MEAS, V56, P779, DOI 10.1177/0013164496056005005; Witt JA, 2012, SEIZURE-EUR J EPILEP, V21, P134, DOI 10.1016/j.seizure.2011.10.007; Yurko-Mauro K, 2010, ALZHEIMERS DEMENT, V6, P456, DOI 10.1016/j.jalz.2010.01.013; Zelinski EM, 2004, AGING MENT HEALTH, V8, P293, DOI 10.1080/13607860410001709665	34	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93382	10.1371/journal.pone.0093382	http://dx.doi.org/10.1371/journal.pone.0093382			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690769	Green Published, Green Submitted, gold			2022-12-25	WOS:000334101100071
J	Kumar, N; Gupta, S; Chandan, NK; Aklakur, M; Pal, AK; Jadhao, SB				Kumar, Neeraj; Gupta, Subodh; Chandan, Nitish Kumar; Aklakur, Md; Pal, Asim Kumar; Jadhao, Sanjay Balkrishna			Lipotropes Protect against Pathogen-Aggravated Stress and Mortality in Low Dose Pesticide-Exposed Fish	PLOS ONE			English	Article							FRESH-WATER CATFISH; IMMUNE-RESPONSE; NILE TILAPIA; SUBLETHAL CONCENTRATIONS; DNA METHYLATION; RAINBOW-TROUT; HETEROPNEUSTES-FOSSILIS; BIOCHEMICAL RESPONSES; OREOCHROMIS-NILOTICUS; DISEASE RESISTANCE	The decline of freshwater fish biodiversity corroborates the trends of unsustainable pesticide usage and increase of disease incidence in the last few decades. Little is known about the role of nonlethal exposure to pesticide, which is not uncommon, and concurrent infection of opportunistic pathogens in species decline. Moreover, preventative measures based on current knowledge of stress biology and an emerging role for epigenetic (especially methylation) dysregulation in toxicity in fish are lacking. We herein report the protective role of lipotropes/methyl donors (like choline, betaine and lecithin) in eliciting primary (endocrine), secondary (cellular and hemato-immunological and histoarchitectural changes) and tertiary (whole animal) stress responses including mortality (50%) in pesticide-exposed (nonlethal dose) and pathogen-challenged fish. The relative survival with betaine and lecithin was 10 and 20 percent higher. This proof of cause-and-effect relation and physiological basis under simulated controlled conditions indicate that sustained stress even due to nonlethal exposure to single pollutant enhances pathogenic infectivity in already nutritionally-stressed fish, which may be a driver for freshwater aquatic species decline in nature. Dietary lipotropes can be used as one of the tools in resurrecting the aquatic species decline.	[Kumar, Neeraj; Gupta, Subodh; Chandan, Nitish Kumar; Aklakur, Md; Pal, Asim Kumar; Jadhao, Sanjay Balkrishna] Cent Inst Fisheries Educ, Dept Fish Nutr Biochem & Physiol, Bombay, Maharashtra, India	Indian Council of Agricultural Research (ICAR); ICAR - Central Institute of Fisheries Education	Jadhao, SB (corresponding author), Cent Inst Fisheries Educ, Dept Fish Nutr Biochem & Physiol, Bombay, Maharashtra, India.	sbjadhao@hotmail.com		Gupta, Subodh/0000-0002-9420-480X	Central Institute of Fisheries Education (Indian Council of Agricultural Research);  [CIFE (M)-2007/T6-1]	Central Institute of Fisheries Education (Indian Council of Agricultural Research); 	SBJ acknowledges the support for institutional project [CIFE (M)-2007/T6-1]. NK and NKC received an institutional research fellowship from the Central Institute of Fisheries Education (Indian Council of Agricultural Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 1998, J CELL BIOL, V140, P525, DOI 10.1083/jcb.140.3.525; Akhtar MS, 2012, PESTIC BIOCHEM PHYS, V103, P23, DOI 10.1016/j.pestbp.2012.02.004; Akhtar MS, 2010, AQUAC RES, V41, P991, DOI 10.1111/j.1365-2109.2009.02383.x; Altinok I, 2007, TOXICOL PATHOL, V35, P405, DOI 10.1080/01926230701230353; Anuradha CD, 2001, FREE RADICAL BIO MED, V31, P367, DOI 10.1016/S0891-5849(01)00591-3; AOAC, 2000, OFFICIAL METHODS ANA, V17th; Arkoosh MR, 2001, J AQUAT ANIM HEALTH, V13, P257, DOI 10.1577/1548-8667(2001)013&lt;0257:ISOJCS&gt;2.0.CO;2; Barton B.A., 1991, Annual Review of Fish Diseases, V1, P3, DOI 10.1016/0959-8030(91)90019-G; Barton BA, 2002, INTEGR COMP BIOL, V42, P517, DOI 10.1093/icb/42.3.517; BENNETT RO, 1987, J FISH BIOL, V31, P375, DOI 10.1111/j.1095-8649.1987.tb05242.x; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Canlet C, 2013, J TOXICOL-US, V2013, DOI 10.1155/2013/545802; Carey C, 2005, INTEGR COMP BIOL, V45, P4, DOI 10.1093/icb/45.1.4; Tellez-Banuelos MC, 2009, FISH SHELLFISH IMMUN, V27, P105, DOI 10.1016/j.fsi.2008.11.002; Chao JCJ, 2002, J NUTR BIOCHEM, V13, P653, DOI 10.1016/S0955-2863(02)00209-7; Chaurio RA, 2009, MOLECULES, V14, P4892, DOI 10.3390/molecules14124892; Chen CH, 2012, ACTIVATION AND DETOXIFICATION ENZYMES: FUNCTIONS AND IMPLICATIONS, P1, DOI 10.1007/978-1-4614-1049-2; Chondar SL, 1999, BIOL FISH SHELLFISH; Clesceri L.S, 1998, STANDARD METHODS EST; DANIEL CS, 1986, TOXICOL LETT, V32, P113, DOI 10.1016/0378-4274(86)90056-1; Danion M, 2012, ECOTOX ENVIRON SAFE, V79, P28, DOI 10.1016/j.ecoenv.2012.01.018; Desbonnet L, 2012, BEHAV BRAIN RES, V228, P351, DOI 10.1016/j.bbr.2011.12.014; DUTTA HM, 1993, B ENVIRON CONTAM TOX, V51, P895, DOI 10.1007/BF00198287; Elliott E, 2010, NAT NEUROSCI, V13, P1351, DOI 10.1038/nn.2642; Ellis A., 1990, TECHINIQUES FISH IMM; Engstad R. E., 1992, Fish & Shellfish Immunology, V2, P287, DOI 10.1016/S1050-4648(06)80033-1; Ezemonye LIN, 2011, FOOD CHEM TOXICOL, V49, P1898, DOI 10.1016/j.fct.2010.10.025; Garg UK, 2004, TOXICOL PATHOL, V32, P364, DOI 10.1080/01926230490431745; Ghyczy M, 2001, BRIT J NUTR, V85, P409, DOI 10.1079/BJN2000274; Gilliom RJ, 2007, QUALITY OUR NATIONS, P4; Giron-Perez MI, 2008, B ENVIRON CONTAM TOX, V80, P266, DOI 10.1007/s00128-008-9358-0; GRABER CD, 1981, J INFECT DIS, V143, P101, DOI 10.1093/infdis/143.1.101; Gupta SC, 2010, LIFE SCI, V86, P377, DOI 10.1016/j.lfs.2009.12.015; Hayes TB, 2010, J EXP BIOL, V213, P921, DOI 10.1242/jeb.040865; Henics T, 1999, BIOL CELL, V91, P485, DOI 10.1016/S0248-4900(00)88205-2; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Da Cuna RH, 2011, ECOTOX ENVIRON SAFE, V74, P1065, DOI 10.1016/j.ecoenv.2011.02.002; IUCN, 2021, THE IUCN RED LIST TH, DOI [10.2305/IUCN.UK.2015-2.RLTS.T2446A22156678.en, DOI 10.2305/IUCN.UK.2015-2.RLTS.T2446A22156678.EN]; IUCN, 2019, IUCN RED LIST THREAT; Iwama GK, 1998, REV FISH BIOL FISHER, V8, P35, DOI 10.1023/A:1008812500650; Jia ZQ, 2007, J APPL TOXICOL, V27, P434, DOI 10.1002/jat.1218; Kennedy CJ, 2008, AQUAT TOXICOL, V90, P172, DOI 10.1016/j.aquatox.2008.08.016; Kidd MT, 1997, WORLD POULTRY SCI J, V53, P125, DOI 10.1079/WPS19970013; Klasing KC, 2002, J NUTR, V132, P2274, DOI 10.1093/jn/132.8.2274; Kreutz LC, 2011, 38 C BRAZ VET MED; Kreutz LC, 2010, FISH SHELLFISH IMMUN, V29, P694, DOI 10.1016/j.fsi.2010.06.003; Kumar Ajith, 2000, P341; Kumar N, 2011, PESTIC BIOCHEM PHYS, V99, P45, DOI 10.1016/j.pestbp.2010.10.003; Lemaire B, 2010, AQUAT BIOL, V8, P161, DOI 10.3354/ab00227; Lien RJ, 1998, POULTRY SCI, V77, P41, DOI 10.1093/ps/77.1.41; Mills LJ, 2001, AQUAT TOXICOL, V52, P157, DOI 10.1016/S0166-445X(00)00139-9; Misra CK, 2006, FISH SHELLFISH IMMUN, V20, P305, DOI 10.1016/j.fsi.2005.05.007; Misra S, 2006, FISH SHELLFISH IMMUN, V21, P346, DOI 10.1016/j.fsi.2005.12.010; Miwa S, 2000, DIS AQUAT ORGAN, V42, P227, DOI 10.3354/dao042227; MORALES MH, 1991, J EXP ZOOL, V260, P50, DOI 10.1002/jez.1402600107; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; Morrow G, 2004, J BIOL CHEM, V279, P43382, DOI 10.1074/jbc.C400357200; MURRAY CK, 1976, J FISH BIOL, V9, P329, DOI 10.1111/j.1095-8649.1976.tb04681.x; Mustafa Ahmed, 2011, Journal of Applied Aquaculture, V23, P136, DOI 10.1080/10454438.2011.581573; Muthappa NA, 2014, CELL STRESS CHAPERON, V19, P61, DOI 10.1007/s12192-013-0434-y; Muthappa NA, 2011, NATL ACAD SCI LETT, V34, P211; Nair J R, 1998, ASIAN FISH SCI, V10, P179; National Research Council, 1993, NUTR REQ FISH; Paulsen SM, 2003, FISH SHELLFISH IMMUN, V14, P39, DOI 10.1006/fsim.2002.0416; PELISSERO C, 1991, GEN COMP ENDOCR, V83, P447, DOI 10.1016/0016-6480(91)90151-U; PELISSERO C, 1992, AQUACULTURE, V107, P283, DOI 10.1016/0044-8486(92)90078-Y; PLUMB JA, 1990, DEV COMP IMMUNOL, V14, P355, DOI 10.1016/0145-305X(90)90026-B; Pushpanjali, 2005, PESTIC BIOCHEM PHYS, V82, P103, DOI 10.1016/j.pestbp.2004.09.004; RAO DMR, 1980, J TOXICOL ENV HEALTH, V6, P825, DOI 10.1080/15287398009529900; REAP EA, 1990, J LAB CLIN MED, V115, P481; Rehulka J, AQUACULT RES, V34, P617; Relyea RA, 2001, P NATL ACAD SCI USA, V98, P2491, DOI 10.1073/pnas.031076198; Ren XF, 2011, ENVIRON HEALTH PERSP, V119, P11, DOI 10.1289/ehp.1002114; Roberts R.J., 1989, P337; Roberts R.J., 1978, P55; ROGERS AE, 1991, J NUTR BIOCHEM, V2, P579, DOI 10.1016/0955-2863(91)90023-X; RUNGE CF, 2003, ENDING HUNGER OUR LI; Salvo LM, 2012, J ENVIRON SCI HEAL A, V47, P1652, DOI 10.1080/10934529.2012.687236; SANDERS BM, 1993, CRIT REV TOXICOL, V23, P49, DOI 10.3109/10408449309104074; Sang S, 1999, ENDOSULFAN REV ITS T; Sano IM, 1998, BIOCHIM BIOPHYS ACTA, V951, P157; Saravanan M, 2011, PESTIC BIOCHEM PHYS, V100, P206, DOI 10.1016/j.pestbp.2011.04.002; Sarma K, 2009, SCI TOTAL ENVIRON, V407, P3668, DOI 10.1016/j.scitotenv.2009.02.031; SCHOLFIELD CR, 1981, J AM OIL CHEM SOC, V58, P889, DOI 10.1007/BF02659652; Sharp G. J. E., 1993, Fish & Shellfish Immunology, V3, P119, DOI 10.1006/fsim.1993.1013; Shved N, 2011, FISH PHYSIOL BIOCHEM, V37, P781, DOI 10.1007/s10695-011-9477-0; Singh PB, 2004, ECOTOX ENVIRON SAFE, V58, P77, DOI 10.1016/j.ecoenv.2003.07.014; Stromqvist M, 2010, AQUAT TOXICOL, V98, P275, DOI 10.1016/j.aquatox.2010.02.023; Suarez-Alvarez B, 2012, TRENDS GENET, V28, P506, DOI 10.1016/j.tig.2012.06.005; Sweilum MA, 2006, AQUAC RES, V37, P1079, DOI 10.1111/j.1365-2109.2006.01531.x; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Toppari J, 1996, ENVIRON HEALTH PERSP, V104, P741, DOI 10.2307/3432709; Tyler CR, 1996, J COMP PHYSIOL B, V166, P418, DOI 10.1007/BF02337886; Unternaehrer E, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.77; Varayoud J, 2008, REPROD TOXICOL, V26, P138, DOI 10.1016/j.reprotox.2008.08.004; Vijayan MM, 1998, AQUAT TOXICOL, V40, P101, DOI 10.1016/S0166-445X(97)00057-X; Wiegertjes GF, 1996, DEV COMP IMMUNOL, V20, P365, DOI 10.1016/S0145-305X(96)00032-8; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Yardimci B, 2011, ANKARA UNIV VET FAK, V58, P47, DOI 10.1501/Vetfak_0000002448	99	42	43	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93499	10.1371/journal.pone.0093499	http://dx.doi.org/10.1371/journal.pone.0093499			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690771	Green Published, Green Submitted, gold			2022-12-25	WOS:000334101100091
J	Lalle, E; Bordi, L; Caglioti, C; Garbuglia, AR; Castilletti, C; Taibi, C; Cristofari, F; Capobianchi, MR				Lalle, Eleonora; Bordi, Licia; Caglioti, Claudia; Garbuglia, Anna Rosa; Castilletti, Concetta; Taibi, Chiara; Cristofari, Francesca; Capobianchi, Maria Rosaria			IFN-Alpha Receptor-1 Upregulation in PBMC from HCV Naive Patients Carrying CC Genotype. Possible Role of IFN-Lambda	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; SINGLE-NUCLEOTIDE POLYMORPHISMS; GENE-EXPRESSION; MESSENGER-RNA; RIBAVIRIN THERAPY; INTERFERON-ALPHA; INTERLEUKIN 28B; INNATE IMMUNITY; IL28B; ASSOCIATION	Background and Aims: IL-28B gene polymorphisms predict better therapeutic response and spontaneous clearance of HCV. Moreover, higher expression of IFN-lambda has been reported in patients with the rs12979860 CC favourable genotype. The study aim was to establish possible relationships between IL-28B rs12979860 genotypes and expression of IFN-alpha receptor-1 (IFNAR-1) in naive HCV patients, and to explore the possible role of IFN-lambda. Methods: IFNAR-1 mRNA levels were measured in PBMC from naive patients with chronic hepatitis C with different IL-28 genotypes. The ability of IFN-lambda to up-regulate the expression of IFNAR-1 was established in PBMC from healthy donors carrying different IL-28B genotypes. Results: Lower IFNAR-1 mRNA levels were observed in PBMC from HCV-infected naive patients as compared to healthy donors. In healthy donors, IFNAR-1 mRNA levels were independent from IL-28B genotype, while in HCV patients, an increasing gradient was observed in TT vs CT vs CC carriers. In the latter group, a direct correlation between IFNAR-1 and endogenous IL-28B expression was observed. Moreover, IFN-lambda up-regulated IFNAR-1 expression in normal PBMC in a time-and dose-dependent manner, with a more effective response in CC vs TT carriers. Conclusion: Endogenous levels of IFN-lambda may be responsible for partial restoration of IFNAR-1 expression in HCV patients with favourable IL-28 genotype. This, in turn, may confer to CC carriers a response advantage to either endogenous or exogenous IFN-alpha, representing the biological basis for the observed association between CC genotype and favourable outcome of either natural infection (clearance vs chronicization) or IFN therapy.	[Lalle, Eleonora; Bordi, Licia; Caglioti, Claudia; Garbuglia, Anna Rosa; Castilletti, Concetta; Capobianchi, Maria Rosaria] Natl Inst Infect Dis Lazzaro Spallanzani, Virol Lab, Rome, Italy; [Taibi, Chiara; Cristofari, Francesca] Natl Inst Infect Dis Lazzaro Spallanzani, Clin Dept, Rome, Italy	IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani	Capobianchi, MR (corresponding author), Natl Inst Infect Dis Lazzaro Spallanzani, Virol Lab, Rome, Italy.	maria.capobianchi@inmi.it	Castilletti, Concetta/B-6545-2016; GARBUGLIA, ANNA ROSA/AAC-6556-2022; Bordi, Licia/B-6827-2017; Castilletti, Concetta/AAA-8408-2019	Castilletti, Concetta/0000-0001-9819-236X; GARBUGLIA, ANNA ROSA/0000-0002-2687-8642; Bordi, Licia/0000-0003-3962-3646; Castilletti, Concetta/0000-0001-9819-236X; lalle, eleonora/0000-0002-7063-9905; Capobianchi, Maria Rosaria/0000-0003-3465-0071	Italian Ministry of Health, Ricerca Corrente and Ricerca Finalizzata	Italian Ministry of Health, Ricerca Corrente and Ricerca Finalizzata(Ministry of Health, Italy)	This study has been partly supported by grants from Italian Ministry of Health, Ricerca Corrente and Ricerca Finalizzata. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate I, 2003, J MED VIROL, V70, P581, DOI 10.1002/jmv.10433; Abe H, 2011, J HEPATOL, V54, P1094, DOI 10.1016/j.jhep.2010.09.019; Asahina Y, 2012, HEPATOLOGY, V55, P20, DOI 10.1002/hep.24623; Booy S, 2014, J CELL MOL MED, V20, P1; Butera D, 2005, BLOOD, V106, P1175, DOI 10.1182/blood-2005-01-0126; Capobianchi MR, 2006, CELL MOL BIOL, V52, P3, DOI 10.1170/T692; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; Donnelly RP, 2010, J INTERF CYTOK RES, V30, P555, DOI 10.1089/jir.2010.0078; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Fukuda R, 1997, J HEPATOL, V26, P455, DOI 10.1016/S0168-8278(97)80407-2; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gerotto M, 2004, ANTIVIR THER, V9, P763; Giannelli G, 2004, J INTERF CYTOK RES, V24, P659, DOI 10.1089/jir.2004.24.659; Hadigan C, 2011, JAMA-J AM MED ASSOC, V306, P294, DOI 10.1001/jama.2011.975; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Lalle E, 2008, J BIOL REG HOMEOS AG, V22, P153; Lange CM, 2011, J HEPATOL, V55, P692, DOI 10.1016/j.jhep.2011.03.006; Langhans B, 2011, J HEPATOL, V54, P859, DOI 10.1016/j.jhep.2010.08.020; Mangia A, 2010, GASTROENTEROLOGY, V139, P821, DOI 10.1053/j.gastro.2010.05.079; Mathai J, 1999, J INTERF CYTOK RES, V19, P1011, DOI 10.1089/107999099313226; McCarthy JJ, 2010, GASTROENTEROLOGY, V138, P2307, DOI 10.1053/j.gastro.2010.02.009; Mihm S, 2004, LAB INVEST, V84, P1148, DOI 10.1038/labinvest.3700135; Naggie S, 2012, HEPATOLOGY, V56, P444, DOI 10.1002/hep.25647; Riva E, 2012, J VIRAL HEPATITIS, V19, P650, DOI 10.1111/j.1365-2893.2012.01606.x; Strader DB, 2004, HEPATOLOGY, V39, P1147, DOI 10.1002/hep.20119; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Torres C, 2013, INTERFERON CYTO 0926; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; World Health Organization, 2010, 63 WORLD HLTH ASS VI	32	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93434	10.1371/journal.pone.0093434	http://dx.doi.org/10.1371/journal.pone.0093434			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691098	Green Published, Green Submitted, gold			2022-12-25	WOS:000334101100080
J	Buler, M; Aatsinki, SM; Izzi, V; Uusimaa, J; Hakkola, J				Buler, Marcin; Aatsinki, Sanna-Mari; Izzi, Valerio; Uusimaa, Johanna; Hakkola, Jukka			SIRT5 is under the control of PGC-1 alpha and AMPK and is involved in regulation of mitochondrial energy metabolism	FASEB JOURNAL			English	Article						metformin; ATP; ERR alpha; PPAR alpha	PROLIFERATOR-ACTIVATED RECEPTOR; FATTY-ACID OXIDATION; HEPATIC GLUCONEOGENESIS; TRANSCRIPTIONAL CONTROL; SKELETAL-MUSCLE; GENE-EXPRESSION; PROTEIN-KINASE; METFORMIN; ALPHA; DEACETYLASE	The sirtuins (SIRTs; SIRT1-7) are a family of NAD(+)-dependent enzymes that dynamically regulate cellular physiology. Apart from SIRT1, the functions and regulatory mechanisms of the SIRTs are poorly defined. We explored regulation of the SIRT family by 2 energy metabolism-controlling factors: peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1 alpha) and AMP-activated protein kinase (AMPK). Overexpression of PGC-1 alpha in mouse primary hepatocytes increased SIRT5 mRNA expression 4-fold and also the protein in a peroxisome proliferator-activated receptor alpha (PPAR alpha)-and estrogen-related receptor alpha (ERR alpha)-dependent manner. Furthermore, food withdrawal increased SIRT5 mRNA 1.3-fold in rat liver. Overexpression of AMPK in mouse hepatocytes increased expression of SIRT1, SIRT2, SIRT3, and SIRT6 <2-fold. In contrast, SIRT5 mRNA was down-regulated by 58%. The antidiabetes drug metformin (1 mM), an established AMPK activator, reduced the mouse SIRT5 protein level by 44% in cultured hepatocytes and by 31% in liver in vivo (300 mg/kg, 7 d). Metformin also induced hypersuccinylation of mitochondrial proteins. Moreover, SIRT5 overexpression increased ATP synthesis and oxygen consumption in HepG2 cells, but did not affect mitochondrial biogenesis. In summary, our results identified SIRT5 as a novel factor that controls mitochondrial function. Moreover, SIRT5 levels are regulated by PGC-1 alpha and AMPK, which have opposite effects on its expression.	[Buler, Marcin; Aatsinki, Sanna-Mari; Hakkola, Jukka] Univ Oulu, Oulu Univ Hosp, Dept Pharmacol & Toxicol, Inst Biomed, Oulu 90014, Finland; [Izzi, Valerio] Univ Oulu, Oulu Univ Hosp, Ctr Cell Matrix Res, Oulu 90014, Finland; [Izzi, Valerio] Univ Oulu, Oulu Univ Hosp, Bioctr Oulu, Dept Med Biochem & Mol Biol, Oulu 90014, Finland; [Buler, Marcin; Aatsinki, Sanna-Mari; Uusimaa, Johanna; Hakkola, Jukka] Univ Oulu, Oulu Univ Hosp, Med Res Ctr Oulu, Oulu 90014, Finland; [Uusimaa, Johanna] Univ Oulu, Oulu Univ Hosp, Clin Res Ctr, Inst Clin Med & Pediat, Oulu 90014, Finland	University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu	Hakkola, J (corresponding author), Univ Oulu, Dept Pharmacol & Toxicol, Inst Biomed, POB 5000 Aapistie 5B, Oulu 90014, Finland.	jukka.hakkola@oulu.fi	Izzi, Valerio/Q-5720-2019	Izzi, Valerio/0000-0002-9960-4917; Hakkola, Jukka/0000-0001-5048-4363	Finnish Diabetes Research Foundation; Diabetes Wellness Finland; Research Council for Health of the Academy of Finland [138566]	Finnish Diabetes Research Foundation; Diabetes Wellness Finland; Research Council for Health of the Academy of Finland	The authors thank R. Tauriainen for skillful technical assistance. The work was supported by grants from the Finnish Diabetes Research Foundation, Diabetes Wellness Finland, and the Research Council for Health of the Academy of Finland (to J.U.; decision no. 138566).	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Anisimov VN, 2005, EXP GERONTOL, V40, P685, DOI 10.1016/j.exger.2005.07.007; Benton CR, 2008, APPL PHYSIOL NUTR ME, V33, P843, DOI 10.1139/H08-074; Berglund ED, 2010, AM J PHYSIOL-ENDOC M, V299, pE607, DOI 10.1152/ajpendo.00263.2010; Buler M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049863; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Caton PW, 2010, J ENDOCRINOL, V205, P97, DOI 10.1677/JOE-09-0345; Chalkiadaki A, 2012, NAT REV ENDOCRINOL, V8, P287, DOI 10.1038/nrendo.2011.225; De Souza AT, 2006, NUCLEIC ACIDS RES, V34, P4486, DOI 10.1093/nar/gkl609; Silva FMD, 2010, MOL CELL BIOCHEM, V340, P283, DOI 10.1007/s11010-010-0429-2; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Feldman JL, 2012, J BIOL CHEM, V287, P42419, DOI 10.1074/jbc.R112.378877; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Funk JA, 2010, J PHARMACOL EXP THER, V333, P593, DOI 10.1124/jpet.109.161992; Gaillard S, 2006, MOL CELL, V24, P797, DOI 10.1016/j.molcel.2006.10.012; Geng YQ, 2011, J CELL BIOCHEM, V112, P3755, DOI 10.1002/jcb.23315; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Herzog B, 2006, J BIOL CHEM, V281, P99, DOI 10.1074/jbc.M509276200; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Ichida M, 2002, J BIOL CHEM, V277, P50991, DOI 10.1074/jbc.M210262200; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jeninga EH, 2010, ONCOGENE, V29, P4617, DOI 10.1038/onc.2010.206; Jiang WQ, 2008, CANCER RES, V68, P5492, DOI 10.1158/0008-5472.CAN-07-6721; Jiang WQ, 2011, MOL CELL, V43, P33, DOI 10.1016/j.molcel.2011.04.028; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; MATTHEWS JNS, 1990, BRIT MED J, V300, P680, DOI 10.1136/bmj.300.6725.680-a; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; Nakamura Y, 2012, FEBS LETT, V586, P4076, DOI 10.1016/j.febslet.2012.10.009; Narayan N, 2012, NATURE, V492, P199, DOI 10.1038/nature11700; Ogura M, 2010, BIOCHEM BIOPH RES CO, V393, P73, DOI 10.1016/j.bbrc.2010.01.081; Park J, 2013, MOL CELL, V50, P919, DOI 10.1016/j.molcel.2013.06.001; Peng C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012658; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Rakhshandehroo M, 2007, PPAR RES, V2007, DOI 10.1155/2007/26839; Ramakrishnan G, 2014, J BIOL CHEM, V289, P6054, DOI 10.1074/jbc.M113.537266; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Ulvila J, 2004, BIOCHEM J, V381, P887, DOI 10.1042/BJ20040387; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Weinert BT, 2013, CELL REP, V4, P842, DOI 10.1016/j.celrep.2013.07.024; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yu JJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02806; Zhang PX, 2005, FEBS LETT, V579, P1446, DOI 10.1016/j.febslet.2005.01.046	64	81	92	2	50	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					3225	3237		10.1096/fj.13-245241	http://dx.doi.org/10.1096/fj.13-245241			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24687991				2022-12-25	WOS:000337949400042
J	Hartman, ME; Liu, YG; Zhu, WZ; Chien, WM; Weldy, CS; Fishman, GI; Laflamme, MA; Chin, MT				Hartman, Matthew E.; Liu, Yonggang; Zhu, Wei-Zhong; Chien, Wei-Ming; Weldy, Chad S.; Fishman, Glenn I.; Laflamme, Michael A.; Chin, Michael T.			Myocardial deletion of transcription factor CHF1/Hey2 results in altered myocyte action potential and mild conduction system expansion but does not alter conduction system function or promote spontaneous arrhythmias	FASEB JOURNAL			English	Article						Brugada syndrome; Notch signaling; electrophysiology; heart rate variability	CELL-DERIVED CARDIOMYOCYTES; ATRIAL GENE-EXPRESSION; CARDIAC CONDUCTION; MESENCHYMAL TRANSITION; BRUGADA SYNDROME; MICE LACKING; FACTOR TBX5; STEM-CELLS; HEART; NOTCH	CHF1/Hey2 is a Notch-responsive basic helix-loop-helix transcription factor involved in cardiac development. Common variants in Hey2 are associated with Brugada syndrome. We hypothesized that absence of CHF1/Hey2 would result in abnormal cellular electrical activity, altered cardiac conduction system (CCS) development, and increased arrhythmogenesis. We isolated neonatal CHF/Hey2-knockout (KO) cardiac myocytes and measured action potentials and ion channel subunit gene expression. We also crossed myocardial-specific CHF1/Hey2-KO mice with cardiac conduction system LacZ reporter mice and stained for conduction system tissue. We also performed ambulatory ECG monitoring for arrhythmias and heart rate variability. Neonatal cardiomyocytes from CHF1/Hey2-KO mice demonstrate a 50% reduction in action potential dV/dT, a 50-75% reduction in SCN5A, KCNJ2, and CACNA1C ion channel subunit gene expression, and an increase in delayed afterdepolarizations from 0/min to 12/min. CHF1/Hey2 cKO CCS-lacZ mice have a similar to 3-fold increase in amount of CCS tissue. Ambulatory ECG monitoring showed no difference in cardiac conduction, arrhythmias, or heart rate variability. Wild-type cells or animals were used in all experiments. CHF1/Hey2 may contribute to Brugada syndrome by influencing the expression of SCN5A and formation of the cardiac conduction system, but its absence does not cause baseline conduction defects or arrhythmias in the adult mouse.	[Hartman, Matthew E.; Liu, Yonggang; Chien, Wei-Ming; Weldy, Chad S.; Chin, Michael T.] Univ Washington, Div Cardiol, Dept Med, Seattle, WA 98195 USA; [Zhu, Wei-Zhong; Laflamme, Michael A.; Chin, Michael T.] Univ Washington, Dept Pathol, Inst Stem Cells & Regenerat Med, Seattle, WA 98195 USA; [Fishman, Glenn I.] NYU, Sch Med, Dept Med, Leon H Charney Div Cardiol, New York, NY USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; New York University	Chin, MT (corresponding author), UW Med South Lake Union, Ctr Cardiovasc Biol, 850 Republican St,Brotman 353, Seattle, WA 98109 USA.	mtchin@u.washington.edu	Laflamme, Michael/AAV-6791-2021	Laflamme, Michael/0000-0001-5908-880X; Hartman, Matt/0000-0002-6238-1887; Fishman, Glenn/0000-0002-2366-8527; Weldy, Chad/0000-0003-4652-6422	John L. Locke Foundation; U.S. National Institutes of Health (NIH) [T32 HL07828]; NIH [T32 HL007312, PO1-HL094374, R01HL105983]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007828, T32HL007312, R01HL105983, P01HL094374] Funding Source: NIH RePORTER	John L. Locke Foundation; U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the John L. Locke Foundation to M. T. C. M. E. H. was supported by U.S. National Institutes of Health (NIH) training grant T32 HL07828. C. S. W. was supported by NIH training grant T32 HL007312. W.Z.Z. and M. A. L. were supported by NIH grant PO1-HL094374. G. I. F. was supported by NIH grant R01HL105983. M. A. L. is a cofounder of and has equity in BEAT Biotechnology.	Berul CI, 2001, CIRCULATION, V104, P2734, DOI 10.1161/hc4701.099582; Bezzina CR, 2013, NAT GENET, V45, P1044, DOI 10.1038/ng.2712; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Drici MD, 1998, CIRC RES, V83, P95, DOI 10.1161/01.RES.83.1.95; Fijnvandraat AC, 2003, CARDIOVASC RES, V58, P303, DOI 10.1016/S0008-6363(03)00246-3; Fischer A, 2007, CIRC RES, V100, P856, DOI 10.1161/01.RES.0000260913.95642.3b; GOURDIE RG, 1995, DEVELOPMENT, V121, P1423; Hartman ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093033; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; King IN, 2006, BIOCHEM BIOPH RES CO, V345, P446, DOI 10.1016/j.bbrc.2006.04.097; Koibuchi N, 2007, CIRC RES, V100, P850, DOI 10.1161/01.RES.0000261693.13269.bf; Kokubo H, 2004, CIRC RES, V95, P540, DOI 10.1161/01.RES.0000141136.85194.f0; Kokubo H, 2007, DEVELOPMENT, V134, P747, DOI 10.1242/dev.02777; Liu YG, 2012, AM J PHYSIOL-HEART C, V302, pH1860, DOI 10.1152/ajpheart.00702.2011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mizusawa Y, 2012, CIRC-ARRHYTHMIA ELEC, V5, P606, DOI 10.1161/CIRCEP.111.964577; Moskowitz IPG, 2004, DEVELOPMENT, V131, P4107, DOI 10.1242/dev.01265; Moskowitz IPG, 2007, CELL, V129, P1365, DOI 10.1016/j.cell.2007.04.036; Nakagawa O, 2000, P NATL ACAD SCI USA, V97, P13655, DOI 10.1073/pnas.250485597; Reamon-Buettner Stella Marie, 2006, Hum Mutat, V27, P118, DOI 10.1002/humu.9390; Rentschler S, 2002, P NATL ACAD SCI USA, V99, P10464, DOI 10.1073/pnas.162301699; Rentschler S, 2001, DEVELOPMENT, V128, P1785; Rentschler S, 2003, NOVART FDN SYMP, V250, P276; Rentschler S, 2003, NOVART FDN SYMP, V250, P205; Rentschler S, 2012, CIRCULATION, V126, P1058, DOI 10.1161/CIRCULATIONAHA.112.103390; Rentschler S, 2011, J CLIN INVEST, V121, P525, DOI 10.1172/JCI44470; Rentschler Stacey, 2003, Novartis Found Symp, V250, P194; Sakata Y, 2006, J MOL CELL CARDIOL, V40, P267, DOI 10.1016/j.yjmcc.2005.09.006; Sakata Y, 2002, P NATL ACAD SCI USA, V99, P16197, DOI 10.1073/pnas.252648999; Shiba Y, 2009, CURR PHARM DESIGN, V15, P2791, DOI 10.2174/138161209788923804; SPRINGHORN JP, 1989, BIOCHEM J, V258, P73, DOI 10.1042/bj2580073; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Watanabe T, 2010, MECH DEVELOP, V127, P418, DOI 10.1016/j.mod.2010.07.001; Xiang F, 2006, AM J PHYSIOL-HEART C, V290, pH1997, DOI 10.1152/ajpheart.01106.2005; Xin M, 2007, P NATL ACAD SCI USA, V104, P7975, DOI 10.1073/pnas.0702447104; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; Zhu WZ, 2010, CIRC RES, V107, P776, DOI 10.1161/CIRCRESAHA.110.223917; Zhu WZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005407	38	17	17	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					3007	3015		10.1096/fj.14-251728	http://dx.doi.org/10.1096/fj.14-251728			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24687990	Green Published			2022-12-25	WOS:000337949400023
J	Sassa, A; Caglayan, M; Dyrkheeva, NS; Beard, WA; Wilson, SH				Sassa, Akira; Caglayan, Melike; Dyrkheeva, Nadezhda S.; Beard, William A.; Wilson, Samuel H.			Base Excision Repair of Tandem Modifications in a Methylated CpG Dinucleotide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Base Excision Repair; DNA Damage; DNA Methylation; DNA Polymerase; Oxidative Stress; 8-Oxoguanine; DNA Demethylation; DNA Glycosylase	THYMINE-DNA GLYCOSYLASE; POLYMERASE-BETA; SUBSTRATE-SPECIFICITY; AP-ENDONUCLEASE; INITIAL STEPS; MAMMALIAN DNA; ACTIVE-SITE; LIGASE-I; MISMATCH; BINDING	Background: Base excision repair is an important pathway for cytosine demethylation at the CpG dinucleotide for epigenetic control. Results: A deaminated 5-methylcytosine (thymine) and an adjacent oxidized guanine (7,8-dihydro-8-oxoguanine) retard base excision repair of each lesion. Conclusion: Altered in-tandem CpG dinucleotide is a poor substrate for base excision repair. Significance: Oxidized guanine in a CpG dinucleotide interferes with active DNA demethylation. Cytosine methylation and demethylation in tracks of CpG dinucleotides is an epigenetic mechanism for control of gene expression. The initial step in the demethylation process can be deamination of 5-methylcytosine producing the TpG alteration and T:G mispair, and this step is followed by thymine DNA glycosylase (TDG) initiated base excision repair (BER). A further consideration is that guanine in the CpG dinucleotide may become oxidized to 7,8-dihydro-8-oxoguanine (8-oxoG), and this could affect the demethylation process involving TDG-initiated BER. However, little is known about the enzymology of BER of altered in-tandem CpG dinucleotides; e.g. Tp8-oxoG. Here, we investigated interactions between this altered dinucleotide and purified BER enzymes, the DNA glycosylases TDG and 8-oxoG DNA glycosylase 1 (OGG1), apurinic/apyrimidinic (AP) endonuclease 1, DNA polymerase , and DNA ligases. The overall TDG-initiated BER of the Tp8-oxoG dinucleotide is significantly reduced. Specifically, TDG and DNA ligase activities are reduced by a 3-flanking 8-oxoG. In contrast, the OGG1-initiated BER pathway is blocked due to the 5-flanking T:G mispair; this reduces OGG1, AP endonuclease 1, and DNA polymerase activities. Furthermore, in TDG-initiated BER, TDG remains bound to its product AP site blocking OGG1 access to the adjacent 8-oxoG. These results reveal BER enzyme specificities enabling suppression of OGG1-initiated BER and coordination of TDG-initiated BER at this tandem alteration in the CpG dinucleotide.	[Sassa, Akira; Caglayan, Melike; Dyrkheeva, Nadezhda S.; Beard, William A.; Wilson, Samuel H.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Dyrkheeva, Nadezhda S.] Russian Acad Sci, Siberian Branch, Inst Chem Biol & Fundamental Med, Novosibirsk 630090, Russia	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Wilson, SH (corresponding author), NIEHS, Struct Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Wilson, Samuel H/E-6644-2019	Wilson, Samuel H/0000-0002-1702-5293; Dyrkheeva, Nadezhda/0000-0002-8360-1041; Sassa, Akira/0000-0003-2454-0223; CAGLAYAN, MELIKE/0000-0003-1107-1042	National Institutes of Health [Z01-ES050158, Z01-ES050159]; Eli Lilly and Co.; United States Department of State, as part of the United States-Russia Collaboration in the Biomedical Sciences NIH Visiting Fellows Program; NATIONAL CANCER INSTITUTE [U19CA177547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES050158, ZIAES050158, Z01ES050159] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eli Lilly and Co.(Eli Lilly); United States Department of State, as part of the United States-Russia Collaboration in the Biomedical Sciences NIH Visiting Fellows Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants Z01-ES050158 and Z01-ES050159 (NIEHS).; Supported in part by Eli Lilly and Co. and the United States Department of State, as part of the United States-Russia Collaboration in the Biomedical Sciences NIH Visiting Fellows Program.	Abu M, 2003, J BIOL CHEM, V278, P8739, DOI 10.1074/jbc.M211084200; Agar NS, 2004, P NATL ACAD SCI USA, V101, P4954, DOI 10.1073/pnas.0401141101; ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Beard WA, 2004, J BIOL CHEM, V279, P31921, DOI 10.1074/jbc.M404016200; Beard WA, 1995, METHOD ENZYMOL, V262, P98; Bennett MT, 2006, J AM CHEM SOC, V128, P12510, DOI 10.1021/ja0634829; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; BIRD AP, 1995, TRENDS GENET, V11, P94, DOI 10.1016/S0168-9525(00)89009-5; Boland MJ, 2008, J MOL BIOL, V379, P492, DOI 10.1016/j.jmb.2008.02.049; BROWN TC, 1987, CELL, V50, P945, DOI 10.1016/0092-8674(87)90521-6; Chen X, 2006, METHOD ENZYMOL, V409, P39, DOI 10.1016/S0076-6879(05)09003-8; Clark SJ, 1997, GENE, V195, P67, DOI 10.1016/S0378-1119(97)00164-9; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Deterding LJ, 2000, J BIOL CHEM, V275, P10463, DOI 10.1074/jbc.275.14.10463; Fitzgerald ME, 2008, J BIOL CHEM, V283, P32680, DOI 10.1074/jbc.M805504200; Ghosh R, 1999, NUCLEIC ACIDS RES, V27, P3213, DOI 10.1093/nar/27.15.3213; Gonzalgo ML, 1997, MUTAT RES-REV MUTAT, V386, P107, DOI 10.1016/S1383-5742(96)00047-6; Hardeland U, 2000, J BIOL CHEM, V275, P33449, DOI 10.1074/jbc.M005095200; Harris JL, 2009, HUM MOL GENET, V18, P4102, DOI 10.1093/hmg/ddp359; Hashimoto K, 2004, NUCLEIC ACIDS RES, V32, P5928, DOI 10.1093/nar/gkh909; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Hill JW, 2001, NUCLEIC ACIDS RES, V29, P430, DOI 10.1093/nar/29.2.430; Jarem DA, 2011, DNA REPAIR, V10, P887, DOI 10.1016/j.dnarep.2011.06.003; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kass SU, 1997, CURR BIOL, V7, P157, DOI 10.1016/S0960-9822(97)70086-1; Kasymov RD, 2013, FEBS LETT, V587, P3129, DOI 10.1016/j.febslet.2013.08.008; Kim K, 1998, J BIOL CHEM, V273, P8842, DOI 10.1074/jbc.273.15.8842; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Lavin MF, 2008, DNA REPAIR, V7, P1061, DOI 10.1016/j.dnarep.2008.03.008; Lee DH, 2002, NUCLEIC ACIDS RES, V30, P3566, DOI 10.1093/nar/gkf478; Li YQ, 2007, NUCLEIC ACIDS RES, V35, P390, DOI 10.1093/nar/gkl1052; Liu X, 2002, J MOL BIOL, V321, P265, DOI 10.1016/S0022-2836(02)00623-X; Maher RL, 2007, J BIOL CHEM, V282, P30577, DOI 10.1074/jbc.M704341200; Maiti A, 2008, P NATL ACAD SCI USA, V105, P8890, DOI 10.1073/pnas.0711061105; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Maltseva DV, 2009, BIOCHEMISTRY-US, V48, P1361, DOI 10.1021/bi801947f; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Minowa O, 2000, P NATL ACAD SCI USA, V97, P4156, DOI 10.1073/pnas.050404497; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Morgan MT, 2007, J BIOL CHEM, V282, P27578, DOI 10.1074/jbc.M704253200; Nilsen H, 2001, CARCINOGENESIS, V22, P987, DOI 10.1093/carcin/22.7.987; O'Neill RJ, 2003, J BIOL CHEM, V278, P20526, DOI 10.1074/jbc.M210860200; Pfeifer GP, 2000, CURR TOP MICROBIOL, V249, P1; Porello SL, 1998, BIOCHEMISTRY-US, V37, P14756, DOI 10.1021/bi981594+; Prasad R, 1998, J BIOL CHEM, V273, P15263, DOI 10.1074/jbc.273.24.15263; Prasad R, 1996, J BIOL CHEM, V271, P16000, DOI 10.1074/jbc.271.27.16000; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; Rass U, 2007, J BIOL CHEM, V282, P9469, DOI 10.1074/jbc.M611489200; Rosenquist TA, 1997, P NATL ACAD SCI USA, V94, P7429, DOI 10.1073/pnas.94.14.7429; Sakumi K, 2003, CANCER RES, V63, P902; Sassa A, 2013, JOVE-J VIS EXP, DOI 10.3791/50695; Sassa A, 2012, J BIOL CHEM, V287, P36702, DOI 10.1074/jbc.M112.397786; Scharer OD, 1997, P NATL ACAD SCI USA, V94, P4878, DOI 10.1073/pnas.94.10.4878; Schermerhorn KM, 2013, BIOCHEMISTRY-US, V52, P7669, DOI 10.1021/bi401218r; SHEN JC, 1994, NUCLEIC ACIDS RES, V22, P972, DOI 10.1093/nar/22.6.972; Siegfried Z, 1997, CURR BIOL, V7, pR305, DOI 10.1016/S0960-9822(06)00144-8; SINGHAL RK, 1995, J BIOL CHEM, V270, P949, DOI 10.1074/jbc.270.2.949; Song CX, 2013, CELL, V153, P678, DOI 10.1016/j.cell.2013.04.001; Strauss PR, 1997, J BIOL CHEM, V272, P1302, DOI 10.1074/jbc.272.2.1302; Sunaga N, 2001, CARCINOGENESIS, V22, P1355, DOI 10.1093/carcin/22.9.1355; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; TURK PW, 1995, CARCINOGENESIS, V16, P1253, DOI 10.1093/carcin/16.5.1253; UESUGI S, 1977, J AM CHEM SOC, V99, P3250, DOI 10.1021/ja00452a008; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; VANYUSHIN BF, 1970, NATURE, V225, P948, DOI 10.1038/225948a0; Vasovcak P, 2012, DNA REPAIR, V11, P616, DOI 10.1016/j.dnarep.2012.04.004; Waters TR, 1998, J BIOL CHEM, V273, P20007, DOI 10.1074/jbc.273.32.20007; Waters TR, 1999, J BIOL CHEM, V274, P67, DOI 10.1074/jbc.274.1.67; WEITZMAN SA, 1994, P NATL ACAD SCI USA, V91, P1261, DOI 10.1073/pnas.91.4.1261; WIEBAUER K, 1990, P NATL ACAD SCI USA, V87, P5842, DOI 10.1073/pnas.87.15.5842; WILSON DM, 1995, J BIOL CHEM, V270, P16002, DOI 10.1074/jbc.270.27.16002; Yamane A, 2003, CARCINOGENESIS, V24, P1031, DOI 10.1093/carcin/bgg056; Zawia NH, 2009, FREE RADICAL BIO MED, V46, P1241, DOI 10.1016/j.freeradbiomed.2009.02.006; Zhang L, 2012, NAT CHEM BIOL, V8, P328, DOI [10.1038/NCHEMBIO.914, 10.1038/nchembio.914]; Zhao XB, 2007, BIOCHEMISTRY-US, V46, P3734, DOI 10.1021/bi062214k; Zharkov DO, 2000, J BIOL CHEM, V275, P28607, DOI 10.1074/jbc.M002441200	80	21	24	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13996	14008		10.1074/jbc.M114.557769	http://dx.doi.org/10.1074/jbc.M114.557769			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24695738	hybrid, Green Published			2022-12-25	WOS:000335984600030
J	Ogata-Kawata, H; Izumiya, M; Kurioka, D; Honma, Y; Yamada, Y; Furuta, K; Gunji, T; Ohta, H; Okamoto, H; Sonoda, H; Watanabe, M; Nakagama, H; Yokota, J; Kohno, T; Tsuchiya, N				Ogata-Kawata, Hiroko; Izumiya, Masashi; Kurioka, Daisuke; Honma, Yoshitaka; Yamada, Yasuhide; Furuta, Koh; Gunji, Toshiaki; Ohta, Hideki; Okamoto, Hiroyuki; Sonoda, Hikaru; Watanabe, Masatoshi; Nakagama, Hitoshi; Yokota, Jun; Kohno, Takashi; Tsuchiya, Naoto			Circulating Exosomal microRNAs as Biomarkers of Colon Cancer	PLOS ONE			English	Article							PROGNOSTIC BIOMARKER; COLORECTAL-CANCER; PLASMA; DYSREGULATION; SIGNATURES; MARKERS; MIR-221; MIRNAS; GROWTH	Purpose: Exosomal microRNAs (miRNAs) have been attracting major interest as potential diagnostic biomarkers of cancer. The aim of this study was to characterize the miRNA profiles of serum exosomes and to identify those that are altered in colorectal cancer (CRC). To evaluate their use as diagnostic biomarkers, the relationship between specific exosomal miRNA levels and pathological changes of patients, including disease stage and tumor resection, was examined. Experimental Design: Microarray analyses of miRNAs in exosome-enriched fractions of serum samples from 88 primary CRC patients and 11 healthy controls were performed. The expression levels of miRNAs in the culture medium of five colon cancer cell lines were also compared with those in the culture medium of a normal colon-derived cell line. The expression profiles of miRNAs that were differentially expressed between CRC and control sample sets were verified using 29 paired samples from post-tumor resection patients. The sensitivities of selected miRNAs as biomarkers of CRC were evaluated and compared with those of known tumor markers (CA19-9 and CEA) using a receiver operating characteristic analysis. The expression levels of selected miRNAs were also validated by quantitative real-time RT-PCR analyses of an independent set of 13 CRC patients. Results: The serum exosomal levels of seven miRNAs (let-7a, miR-1229, miR-1246, miR-150, miR-21, miR-223, and miR-23a) were significantly higher in primary CRC patients, even those with early stage disease, than in healthy controls, and were significantly down-regulated after surgical resection of tumors. These miRNAs were also secreted at significantly higher levels by colon cancer cell lines than by a normal colon-derived cell line. The high sensitivities of the seven selected exosomal miRNAs were confirmed by a receiver operating characteristic analysis. Conclusion: Exosomal miRNA signatures appear to mirror pathological changes of CRC patients and several miRNAs are promising biomarkers for non-invasive diagnosis of the disease.	[Ogata-Kawata, Hiroko; Kurioka, Daisuke; Yokota, Jun; Kohno, Takashi; Tsuchiya, Naoto] Natl Canc Ctr, Res Inst, Div Genome Biol, Tokyo 104, Japan; [Nakagama, Hitoshi] Natl Canc Ctr, Res Inst, Div Canc Dev Syst, Tokyo 104, Japan; [Izumiya, Masashi] Tokyo Univ Hosp, Dept Gastroenterol, Tokyo 113, Japan; [Kurioka, Daisuke; Watanabe, Masatoshi] Yokohama Natl Univ, Grad Sch Engn, Div Mat & Chem Engn, Med Engn Lab, Yokohama, Kanagawa, Japan; [Honma, Yoshitaka; Yamada, Yasuhide] Natl Canc Ctr, Gastrointestinal Oncol Div, Tokyo, Japan; [Furuta, Koh] Natl Canc Ctr, Div Clin Labs, Tokyo, Japan; [Gunji, Toshiaki] NTT Med Ctr Tokyo, Tokyo, Japan; [Ohta, Hideki; Okamoto, Hiroyuki; Sonoda, Hikaru] Shionogi & Co Ltd, Osaka, Japan; [Yokota, Jun] Inst Predict & Personalized Med Canc IMPPC, Barcelona, Spain	National Cancer Center - Japan; National Cancer Center - Japan; University of Tokyo; Yokohama National University; National Cancer Center - Japan; National Cancer Center - Japan; Kanto Medical Center NTT EC; Shionogi & Company Limited	Tsuchiya, N (corresponding author), Natl Canc Ctr, Res Inst, Div Genome Biol, Tokyo 104, Japan.	ntsuchiy@ncc.go.jp	Yamada, Yasuhide/AAH-9124-2020; Izumiya, Masashi/AAL-3763-2020	Watanabe, Masatoshi/0000-0002-9423-0901	Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO) [08-02]; Ministry of Health, Labor and Welfare [13802015]; Ministry of Education, Culture, Sports & Technology of Japan [13314780]; National Cancer Center Research and Development Fund [23-B-08]; National Cancer Center Research and Development Fund; Grants-in-Aid for Scientific Research [23300359] Funding Source: KAKEN	Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports & Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Cancer Center Research and Development Fund(National Cancer Center - Japan); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding provided by The Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO)(08-02), http://www.nibio.go.jp; Grant-in-Aids from the Ministry of Health, Labor and Welfare (13802015), http://www.mhlw.go.jp/; Grant-in-Aids from the Ministry of Education, Culture, Sports & Technology of Japan (13314780), http://www.jsps.go.jp/; National Cancer Center Research and Development Fund (23-B-08), http://www.ncc.go.jp. National Cancer Center Biobank is supported by National Cancer Center Research and Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An J, 2013, J CELL BIOCHEM, V114, P2160, DOI 10.1002/jcb.24565; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; BOYD D, 1988, CANCER RES, V48, P3112; Bretthauer M, 2010, BEST PRACT RES CL GA, V24, P417, DOI 10.1016/j.bpg.2010.06.005; CHEN TR, 1987, CANCER GENET CYTOGEN, V27, P125, DOI 10.1016/0165-4608(87)90267-6; Cheng HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017745; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Hu Guoku, 2012, Frontiers in Genetics, V3, P56, DOI 10.3389/fgene.2012.00056; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Izumiya M, 2010, CARCINOGENESIS, V31, P1354, DOI 10.1093/carcin/bgq112; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kawaguchi T, 2013, BRIT J CANCER, V108, P361, DOI 10.1038/bjc.2012.546; Koberle V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075184; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locker GY, 2006, J CLIN ONCOL, V24, P5313, DOI 10.1200/JCO.2006.08.2644; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luo XY, 2011, CANCER EPIDEM BIOMAR, V20, P1272, DOI 10.1158/1055-9965.EPI-11-0035; Madhavan D, 2012, CLIN CANCER RES, V18, P5972, DOI 10.1158/1078-0432.CCR-12-1407; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Ogawa Y, 2008, BIOL PHARM BULL, V31, P1059, DOI 10.1248/bpb.31.1059; Pu XX, 2010, J GASTROEN HEPATOL, V25, P1674, DOI 10.1111/j.1440-1746.2010.06417.x; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Scheffer AR, 2012, WORLD J UROL; Si HY, 2013, J CANCER RES CLIN, V139, P223, DOI 10.1007/s00432-012-1315-y; SIDDIQUI KM, 1984, IN VITRO CELL DEV B, V20, P859; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Swarup V, 2007, FEBS LETT, V581, P795, DOI 10.1016/j.febslet.2007.01.051; Takeshita N, 2013, BRIT J CANCER, V108, P644, DOI 10.1038/bjc.2013.8; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Toiyama Y, 2013, JNCI-J NATL CANCER I, V105, P849, DOI 10.1093/jnci/djt101; Tsuchiya N, 2011, CANCER RES, V71, P4628, DOI 10.1158/0008-5472.CAN-10-2475; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang XF, 2012, J CANCER RES CLIN, V138, P573, DOI 10.1007/s00432-011-1114-x	37	588	614	8	166	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e92921	10.1371/journal.pone.0092921	http://dx.doi.org/10.1371/journal.pone.0092921			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705249	Green Published, gold, Green Submitted			2022-12-25	WOS:000334107500022
J	Yang, K; Xu, JF; Zhang, JF; Li, W; He, J; Liang, S; Bergquist, R				Yang, Kun; Xu, Jun-Fang; Zhang, Jian-Feng; Li, Wei; He, Jian; Liang, Song; Bergquist, Robert			Establishing and Applying a Schistosomiasis Early Warning Index (SEWI) in the Lower Yangtze River Region of Jiangsu Province, China	PLOS ONE			English	Article							REPUBLIC-OF-CHINA; ONCOMELANIA-HUPENSIS; JAPONICA; TRANSMISSION; SURVEILLANCE; ELIMINATION; SYSTEM; HEALTH; DETERMINANTS; CHALLENGES	Background: China has made remarkable progress in schistosomiasis control over the past decades. Transmission control has replaced morbidity control as the country moves towards the goal of elimination and the current challenge is to find a sensitive measure capable of gauging transmission risk in low-prevalence areas. The study aims to develop a Schistosomiasis Early Warning Index (SEWI) and demonstrate its use in Jiangsu Province along the lower Yangtze River. Methodology/Principal Findings: The Delphi approach, a structured communication technique, was used to develop the SEWI. Two rounds of interviews with 30 public health experts specialized in schistosomiasis control were conducted using 40 indicators that reflected different aspects of schistosomiasis transmission and control. The necessity, feasibility, and sensitivity of each indicator were assessed and the weight value of each indicator determined based on these experts' judgment. The system included 3 first-order indicators, 7 second-order indicators, and 30 third-order indicators. The 3 first-order indicators were endemic status, control measures, social and environmental factors, with the weight values 0.366, 0.343 and 0.291, respectively. For the 7 second-order indicators, the highest weight value was for control measures for snails (0.175) and the lowest for transmission route (0.110). We estimated and mapped the SEWI for endemic areas at the county scale in Jiangsu Province finding that the majority of the endemic areas were characterized as medium transmission risk (SEWI risk values between 0.3 and 0.6), while areas where transmission interruption had been officially declared showed SEWI values <0.30. A few isolated areas (e. g. endemic islands in the Yangtze River) produced SEWI values >0.60. These estimates are largely in agreement with the endemicity levels based on recent epidemiological surveys. Conclusions/Significance: The SEWI should be useful for estimation of schistosomiasis transmission surveillance, particularly with reference to the elimination of the disease in China.	[Yang, Kun; Zhang, Jian-Feng; Li, Wei; He, Jian] Jiangsu Inst Parasit Dis, Key Lab Parasit Dis Control & Prevent, Minist Health, Jiangsu Prov Key Lab Parasite Mol Biol, Wuxi, Jiangsu, Peoples R China; [Xu, Jun-Fang] Hubei Univ Nationalities, Sch Med, Enshi, Hubei Province, Peoples R China; [Liang, Song] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL USA; [Liang, Song] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA	Hubei Minzu University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Yang, K (corresponding author), Jiangsu Inst Parasit Dis, Key Lab Parasit Dis Control & Prevent, Minist Health, Jiangsu Prov Key Lab Parasite Mol Biol, Wuxi, Jiangsu, Peoples R China.	jipdyk76@hotmail.com		yang, kun/0000-0001-8198-132X	National Natural Science Foundation of China [81101275, 81101280]; Natural Science Foundation of Jiangsu Province [BS2010153]; Project of Public Health Department of Jiangsu Province [RC2011094]; Chinese Important Scientific Research Project on Infectious Diseases [2012ZX10004-220]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Project of Public Health Department of Jiangsu Province; Chinese Important Scientific Research Project on Infectious Diseases	This work received financial support from the National Natural Science Foundation of China (No. 81101275; 81101280), Natural Science Foundation of Jiangsu Province (BS2010153), Project of Public Health Department of Jiangsu Province (No. RC2011094), and the Chinese Important Scientific Research Project on Infectious Diseases (No. 2012ZX10004-220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulkedid R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020476; Coates V, 2001, TECHNOL FORECAST SOC, V67, P1, DOI 10.1016/S0040-1625(00)00122-0; Collins C, 2012, INFECT DIS POVERTY, V1, DOI 10.1186/2049-9957-1-8; Drake JM, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000020; Gavaza P, 2012, RURAL REMOTE HEALTH, V12; Gray DJ, 2010, LANCET INFECT DIS, V10, P733, DOI 10.1016/S1473-3099(10)70099-2; Green K., 2007, FORESIGHT INT J APPL, V8, P17; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Hong QB, 2011, ACTA TROP, V120, pS151, DOI 10.1016/j.actatropica.2010.11.006; HUANG YX, 1992, ACTA TROP, V51, P175, DOI 10.1016/0001-706X(92)90037-X; Huang YX, 2005, ACTA TROP, V96, P223, DOI 10.1016/j.actatropica.2005.07.015; King CH, 2009, NEW ENGL J MED, V360, P106, DOI 10.1056/NEJMp0808041; Landeta J, 2006, TECHNOL FORECAST SOC, V73, P467, DOI 10.1016/j.techfore.2005.09.002; Liang S, 2006, B WORLD HEALTH ORGAN, V84, P139, DOI 10.2471/BLT.05.025031; Liang You-Sheng, 2012, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V24, P119; Luo TianPeng, 2009, Chinese Journal of Schistosomiasis Control, V21, P27; Morse SS, 2012, BIOSECUR BIOTERROR, V10, P6, DOI 10.1089/bsp.2011.0088; Ross AGP, 2001, CLIN MICROBIOL REV, V14, P270, DOI 10.1128/CMR.14.2.270-295.2001; Rudge JW, 2013, P NATL ACAD SCI USA, V110, P11457, DOI 10.1073/pnas.1221509110; Sinha IP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000393; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Sun LP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-243; Sun LP, 2008, CHIN J SCHISTO CONTR, V20, P13; Sun LP, 2012, CHIN J SCHISTO CONTR, P32; Uphoff EPMM, 2012, CANCER NURS, V35, P29, DOI 10.1097/NCC.0b013e318210e3a2; Utzinger J, 2005, ACTA TROP, V96, P69, DOI 10.1016/j.actatropica.2005.08.004; Wang L, 2008, LANCET; Wang LD, 2009, NEW ENGL J MED, V360, P121, DOI 10.1056/NEJMoa0800135; Wang TP, 2005, ACTA TROP, V96, P198, DOI 10.1016/j.actatropica.2005.07.017; Webster RG, 2004, LANCET, V363, P234, DOI 10.1016/S0140-6736(03)15329-9; Wu XH, 2007, GEOSPATIAL HEALTH, V2, P75, DOI 10.4081/gh.2007.256; Xu Jing, 2013, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V25, P5; Yang J, 2009, INT J INFECT DIS; Yang K, 2008, INT J PARASITOL, V38, P1007, DOI 10.1016/j.ijpara.2007.12.007; Yang K, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-138; Yang K, 2012, GEOSPATIAL HEALTH, V6, P195, DOI 10.4081/gh.2012.137; Yang K, 2009, AM J TROP MED HYG, V81, P416, DOI 10.4269/ajtmh.2009.81.416; Yi YA, 2005, ACTA TROP, V96, P191, DOI 10.1016/j.actatropica.2005.07.014; Yu Hao, 1996, Chinese Journal of Schistosomiasis Control, V8, P263; Yu LeiBin, 2006, Chinese Journal of Schistosomiasis Control, V18, P146; YUAN HC, 1993, CHINESE MED J-PEKING, V106, P563; Zhao GM, 2005, ACTA TROP, V96, P288, DOI 10.1016/j.actatropica.2005.07.023; Zheng Q, 2013, INFECT DIS POVERTY, V2, DOI 10.1186/2049-9957-2-15; Zhou XN, 2007, EMERG INFECT DIS, V13, P1470, DOI 10.3201/eid1310.061423; Zhou XN, 2013, INFECT DIS POVERTY, V2, DOI 10.1186/2049-9957-2-1; Zhou XN, 2010, ADV PARASIT, V72, P145, DOI 10.1016/S0065-308X(10)72006-6; Zhou XN, 2005, ACTA TROP, V96, P255, DOI 10.1016/j.actatropica.2005.07.026	47	7	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94012	10.1371/journal.pone.0094012	http://dx.doi.org/10.1371/journal.pone.0094012			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705352	Green Published, gold, Green Submitted			2022-12-25	WOS:000334107500111
J	Chavez-Alvarez, R; Chavoya, A; Mendez-Vazquez, A				Chavez-Alvarez, Rocio; Chavoya, Arturo; Mendez-Vazquez, Andres			Discovery of Possible Gene Relationships through the Application of Self-Organizing Maps to DNA Microarray Databases	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; REGULATORY NETWORKS; EXPRESSION; TRANSCRIPTION; IDENTIFICATION; MODELS; PHASE	DNA microarrays and cell cycle synchronization experiments have made possible the study of the mechanisms of cell cycle regulation of Saccharomyces cerevisiae by simultaneously monitoring the expression levels of thousands of genes at specific time points. On the other hand, pattern recognition techniques can contribute to the analysis of such massive measurements, providing a model of gene expression level evolution through the cell cycle process. In this paper, we propose the use of one of such techniques -an unsupervised artificial neural network called a Self-Organizing Map (SOM)-which has been successfully applied to processes involving very noisy signals, classifying and organizing them, and assisting in the discovery of behavior patterns without requiring prior knowledge about the process under analysis. As a test bed for the use of SOMs in finding possible relationships among genes and their possible contribution in some biological processes, we selected 282 S. cerevisiae genes that have been shown through biological experiments to have an activity during the cell cycle. The expression level of these genes was analyzed in five of the most cited time series DNA microarray databases used in the study of the cell cycle of this organism. With the use of SOM, it was possible to find clusters of genes with similar behavior in the five databases along two cell cycles. This result suggested that some of these genes might be biologically related or might have a regulatory relationship, as was corroborated by comparing some of the clusters obtained with SOMs against a previously reported regulatory network that was generated using biological knowledge, such as protein-protein interactions, gene expression levels, metabolism dynamics, promoter binding, and modification, regulation and transport of proteins. The methodology described in this paper could be applied to the study of gene relationships of other biological processes in different organisms.	[Chavez-Alvarez, Rocio; Chavoya, Arturo] Univ Guadalajara, Dept Informat Syst CUCEA, Zapopan, Jalisco, Mexico; [Mendez-Vazquez, Andres] CINVESTAV, Dept Elect Engn & Comp Sci, Zapopan, Jalisco, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Chavoya, A (corresponding author), Univ Guadalajara, Dept Informat Syst CUCEA, Zapopan, Jalisco, Mexico.	achavoya@cucea.udg.mx		Chavez, Rocio/0000-0003-2012-0248	CONACYT	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was funded by a CONACYT Scholarship for PhD Student Rocio Chavez-Alvarez. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Abbas O, 2008, INT ARAB J INF TECHN, V5, P320; Alberghina L, 2012, BIOTECHNOL ADV, V30, P52, DOI 10.1016/j.biotechadv.2011.07.010; Alberghina L, 2009, BIOTECHNOL ADV, V27, P960, DOI 10.1016/j.biotechadv.2009.05.021; Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794; Cho KH, 2007, IET SYST BIOL, V1, P149, DOI 10.1049/iet-syb:20060075; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; D'haeseleer P, 1999, Pac Symp Biocomput, P41; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gaisne M, 1999, CURR GENET, V36, P195, DOI 10.1007/s002940050490; Hamalainen TD, 2002, STUD FUZZ SOFT COMP, V78, P245; Hancioglu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030810; He F, 2009, J BIOTECHNOL, V144, P190, DOI 10.1016/j.jbiotec.2009.07.013; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Heyer LJ, 1999, GENOME RES, V9, P1106, DOI 10.1101/gr.9.11.1106; Huang JH, 2003, J BIOSCI BIOENG, V96, P421, DOI 10.1263/jbb.96.421; Khan SQ, 2013, 5 INT C COMP SCI INF, DOI [10.1109/CSIT.2013.6588785, DOI 10.1109/CSIT.2013.6588785]; Kim H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-37; Kimura S, 2005, BIOINFORMATICS, V21, P1154, DOI 10.1093/bioinformatics/bti071; Kohonen T, 1998, NEUROCOMPUTING, V21, P1, DOI 10.1016/S0925-2312(98)00030-7; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; KOHONEN T, 1990, P IEEE, V78, P1464, DOI 10.1109/5.58325; Pozlbauer G., 2004, P 5 WORKSH DAT AN WD, P67; Pramila T, 2002, GENE DEV, V16, P3034, DOI 10.1101/gad.1034302; Pramila T, 2006, GENE DEV, V20, P2266, DOI 10.1101/gad.1450606; Repsilber D, 2002, BIOSYSTEMS, V66, P31, DOI 10.1016/S0303-2647(02)00019-9; Singh R, 2012, APPLIED WELDING ENGINEERING: PROCESSES, CODES AND STANDARDS, P7; Sokhansanj BA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-108; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Vesanto J., 1999, P MATL DSP C, V99, P16; Zou M, 2005, BIOINFORMATICS, V21, P71, DOI 10.1093/bioinformatics/bth463	33	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93233	10.1371/journal.pone.0093233	http://dx.doi.org/10.1371/journal.pone.0093233			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699245	Green Published, gold, Green Submitted			2022-12-25	WOS:000334105000048
J	Jamison, J; Wang, JHC; Wells, A				Jamison, Joshua; Wang, James H-C.; Wells, Alan			PKC delta Regulates Force Signaling during VEGF/CXCL4 Induced Dissociation of Endothelial Tubes	PLOS ONE			English	Article							PROTEIN-KINASE-C; BARRIER FUNCTION; CELL-MOVEMENT; WOUND REPAIR; ACTIVATION; MIGRATION; MOTILITY; PERMEABILITY; MECHANISMS; MEMBRANE	Wound healing requires the vasculature to re-establish itself from the severed ends; endothelial cells within capillaries must detach from neighboring cells before they can migrate into the nascent wound bed to initiate angiogenesis. The dissociation of these endothelial capillaries is driven partially by platelets' release of growth factors and cytokines, particularly the chemokine CXCL4/platelet factor-4 ( PF4) that increases cell-cell de-adherence. As this retraction is partly mediated by increased transcellular contractility, the protein kinase c-delta/myosin light chain-2 ( PKCd/MLC-2) signaling axis becomes a candidate mechanism to drive endothelial dissociation. We hypothesize that PKC delta activation induces contractility through MLC-2 to promote dissociation of endothelial cords after exposure to platelet-released CXCL4 and VEGF. To investigate this mechanism of contractility, endothelial cells were allowed to form cords following CXCL4 addition to perpetuate cord dissociation. In this study, CXCL4- induced dissociation was reduced by a VEGFR inhibitor ( sunitinib malate) and/or PKCd inhibition. During combined CXCL4+ VEGF treatment, increased contractility mediated by MLC-2 that is dependent on PKCd regulation. As cellular force is transmitted to focal adhesions, zyxin, a focal adhesion protein that is mechano-responsive, was upregulated after PKCd inhibition. This study suggests that growth factor regulation of PKCd may be involved in CXCL4- mediated dissociation of endothelial cords.	[Jamison, Joshua; Wells, Alan] Univ Pittsburgh, Dept Pathol, McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA; [Wang, James H-C.] Univ Pittsburgh, Dept Orthoped Surg, McGowan Inst Regenerat Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wells, A (corresponding author), Univ Pittsburgh, Dept Pathol, McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA.	wellsa@upmc.edu		Wells, Alan/0000-0002-1637-8150	National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL094295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069668, R01GM063569] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This has been funded the by National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; ANDUJAR MB, 1992, J SUBMICR CYTOL PATH, V24, P145; Bodnar RJ, 2006, CIRC RES, V98, P617, DOI 10.1161/01.RES.0000209968.66606.10; CHEN P, 1994, J CELL BIOL, V127, P847, DOI 10.1083/jcb.127.3.847; CHEN P, 1994, J CELL BIOL, V124, P547, DOI 10.1083/jcb.124.4.547; Fordjour AK, 2009, BBA-GEN SUBJECTS, V1790, P1179, DOI 10.1016/j.bbagen.2009.07.012; Geraldes P, 2009, NAT MED, V15, P1298, DOI 10.1038/nm.2052; Grinnell KL, 2012, MICROVASC RES, V83, P12, DOI 10.1016/j.mvr.2011.04.005; Harrington EO, 2005, EXP CELL RES, V308, P407, DOI 10.1016/j.yexcr.2005.05.005; Insall RH, 2001, DEV CELL, V1, P743, DOI 10.1016/S1534-5807(01)00086-7; Iwabu A, 2004, J BIOL CHEM, V279, P14551, DOI 10.1074/jbc.M311981200; Jamison J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077434; JOYCE NC, 1992, INVEST OPHTH VIS SCI, V33, P1958; Kikkawa U, 2002, J BIOCHEM, V132, P831, DOI 10.1093/oxfordjournals.jbchem.a003294; Lee S, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194115; Li J, 2003, MICROSC RES TECHNIQ, V60, P107, DOI 10.1002/jemt.10249; Li Q, 1999, J BIOL CHEM, V274, P3764, DOI 10.1074/jbc.274.6.3764; Lum H, 1996, CAN J PHYSIOL PHARM, V74, P787, DOI 10.1139/cjpp-74-7-787; LUM H, 1994, AM J PHYSIOL, V267, pL223, DOI 10.1152/ajplung.1994.267.3.L223; LYNCH JJ, 1990, J CLIN INVEST, V85, P1991, DOI 10.1172/JCI114663; Murphy Diane D., 1994, Microcirculation (New York), V1, P121, DOI 10.3109/10739689409148267; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Seki T, 2005, GENES CELLS, V10, P225, DOI 10.1111/j.1365-2443.2005.00830.x; Shao HS, 2006, MOL CELL BIOL, V26, P5481, DOI 10.1128/MCB.02243-05; Shizukuda Y, 1999, CIRC RES, V85, P247, DOI 10.1161/01.RES.85.3.247; Shizukuda Y, 1999, CIRCULATION, V100, P1909, DOI 10.1161/01.CIR.100.18.1909; Stahelin RV, 2005, J BIOL CHEM, V280, P19784, DOI 10.1074/jbc.M411285200; STOKES CL, 1991, J CELL SCI, V99, P419; Tinsley JH, 2004, AM J PHYSIOL-CELL PH, V286, pC105, DOI 10.1152/ajpcell.00340.2003; Wells A, 1999, CELL MOTIL CYTOSKEL, V44, P227, DOI 10.1002/(SICI)1097-0169(199912)44:4<227::AID-CM1>3.0.CO;2-B; Woo CH, 2005, AM J PHYSIOL-LUNG C, V288, pL307, DOI 10.1152/ajplung.00105.2004; Yamamura S, 1996, J SURG RES, V63, P349, DOI 10.1006/jsre.1996.0274	32	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93968	10.1371/journal.pone.0093968	http://dx.doi.org/10.1371/journal.pone.0093968			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699667	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000334105000128
J	Tanomsing, N; Mayxay, M; Newton, PN; Nosten, F; Dolecek, C; Hien, TT; White, NJ; Day, NPJ; Dondorp, AM; Imwong, M				Tanomsing, Naowarat; Mayxay, Mayfong; Newton, Paul N.; Nosten, Francois; Dolecek, Christiane; Tran Tinh Hien; White, Nicholas J.; Day, Nicholas P. J.; Dondorp, Arjen M.; Imwong, Mallika			Genetic Variability of Plasmodium malariae dihydropteroate synthase (dhps) in Four Asian Countries	PLOS ONE			English	Article							DIHYDROFOLATE-REDUCTASE GENE; POINT MUTATIONS; DRUG PRESSURE; PYRIMETHAMINE; RESISTANCE; FALCIPARUM; VIVAX	The dihydropteroate synthase (dhps) genes of 44 P. malariae strains from four Asian countries were isolated. Only a limited number of polymorphisms were observed. Comparison with homologous mutations in other Plasmodium species showed that these polymorphisms are unlikely to be associated with sulfadoxine resistance.	[Tanomsing, Naowarat; Imwong, Mallika] Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok, Thailand; [Mayxay, Mayfong; Newton, Paul N.] Lao Oxford Mahosot Hosp Wellcome Trust Res Unit, Microbiol Lab, Mahosot Hosp, Viangchan, Laos; [Mayxay, Mayfong] Univ Hlth Sci, Fac Postgrad Studies, Viangchan, Laos; [Mayxay, Mayfong; Newton, Paul N.; Nosten, Francois; Dolecek, Christiane; Tran Tinh Hien; White, Nicholas J.; Day, Nicholas P. J.; Dondorp, Arjen M.] Univ Oxford, Churchill Hosp, Nuffield Dept Med, Ctr Trop Med, Oxford, England; [Nosten, Francois] Mahidol Oxford Trop Med Res Unit, Shoklo Malaria Res Unit, Bangkok, Thailand; [Dolecek, Christiane; Tran Tinh Hien] Univ Oxford, Hosp Trop Dis, Ho Chi Minh City, Clin Res Unit, Ho Chi Minh City, Vietnam; [Tran Tinh Hien] Univ Oxford, Hosp Trop Dis, Clin Res Unit, Ho Chi Minh City, Vietnam; [White, Nicholas J.; Day, Nicholas P. J.; Dondorp, Arjen M.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand	Mahidol University; University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University	Imwong, M (corresponding author), Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok, Thailand.	noi@tropmedres.ac	Nosten, Francois/AAC-5509-2019; White, Nick/AAC-6527-2019; Imwong, Mallika/ABE-6493-2020	Nosten, Francois/0000-0002-7951-0745; White, Nick/0000-0002-1897-1978; Newton, Paul/0000-0002-4608-6431	Thailand Research Fund (TRF) [MRG5480066]; Mahidol University; Wellcome Trust of Great Britain	Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); Mahidol University; Wellcome Trust of Great Britain(Wellcome Trust)	This study was supported by Thailand Research Fund (TRF) grant code MRG5480066, Mahidol University and was part of the Wellcome Trust Mahidol University-Oxford Tropical Medicine Research Programme supported by the Wellcome Trust of Great Britain. NT is the TRF research grantee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Imwong M, 2003, ANTIMICROB AGENTS CH, V47, P1514, DOI 10.1128/AAC.47.5.1514-1521.2003; Imwong M, 2001, ANTIMICROB AGENTS CH, V45, P3122, DOI 10.1128/AAC.45.11.3122-3127.2001; Khim N, 2012, ANTIMICROB AGENTS CH, V56, P863, DOI 10.1128/AAC.05284-11; Plowe CV, 1997, J INFECT DIS, V176, P1590, DOI 10.1086/514159; Tanomsing N, 2007, ANTIMICROB AGENTS CH, V51, P3523, DOI 10.1128/AAC.00234-07; ZOLG JW, 1989, MOL BIOCHEM PARASIT, V36, P253, DOI 10.1016/0166-6851(89)90173-4	6	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93942	10.1371/journal.pone.0093942	http://dx.doi.org/10.1371/journal.pone.0093942			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699454	Green Published, gold, Green Submitted			2022-12-25	WOS:000334105000123
J	Li, HX; Shang, HQ; Shu, DM; Zhang, HM; Ji, J; Sun, BL; Li, HM; Xie, QM				Li, Hongxin; Shang, Huiqing; Shu, Dingming; Zhang, Huanmin; Ji, Jun; Sun, Baoli; Li, Hongmei; Xie, Qingmei			gga-miR-375 Plays a Key Role in Tumorigenesis Post Subgroup J Avian Leukosis Virus Infection	PLOS ONE			English	Article							ORGAN SIZE CONTROL; HUMAN CYCLIN-E; CELL-DEATH; MYELOID LEUKOSIS; HPRS-103 STRAIN; HIPPO PATHWAY; HEPATOCELLULAR-CARCINOMA; TUMOR SUPPRESSION; BREAST-CANCER; LIVER-CANCER	Avian leukosis is a neoplastic disease caused in part by subgroup J avian leukosis virus J (ALV-J). Micro ribonucleic acids (miRNAs) play pivotal oncogenic and tumour-suppressor roles in tumour development and progression. However, little is known about the potential role of miRNAs in avian leukosis tumours. We have found a novel tumour-suppressor miRNA, gga-miR-375, associated with avian leukosis tumorigenesis by miRNA microarray in a previous report. We have also previously studied the biological function of gga-miR-375; Overexpression of gga-miR-375 significantly inhibited DF-1 cell proliferation, and significantly reduced the expression of yes-associated protein 1 (YAP1) by repressing the activity of a luciferase reporter carrying the 3'-untranslated region of YAP1. This indicates that gga-miR-375 is frequently downregulated in avian leukosis by inhibiting cell proliferation through YAP1 oncogene targeting. Overexpression of gga-miR-375 markedly promoted serum starvation induced apoptosis, and there may be the reason why the tumour cycle is so long in the infected chickens. In vivo assays, gga-miR-375 was significantly downregulated in chicken livers 20 days after infection with ALV-J, and YAP1 was significantly upregulated 20 days after ALV-J infection (P<0.05). We also found that expression of cyclin E, an important regulator of cell cycle progression, was significantly upregulated (P<0.05). Drosophila inhibitor of apoptosis protein 1 (DIAP1), which is related to caspase-dependent apoptosis, was also significantly upregulated after infection. Our data suggests that gga-miR-375 may function as a tumour suppressor thereby regulating cancer cell proliferation and it plays a key role in avian leukosis tumorigenesis.	[Li, Hongxin; Shang, Huiqing; Ji, Jun; Sun, Baoli; Li, Hongmei; Xie, Qingmei] South China Agr Univ, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China; [Li, Hongxin; Sun, Baoli; Li, Hongmei; Xie, Qingmei] Minist Agr, Key Lab Chicken Genet Breeding & Reprod, Guangzhou, Guangdong, Peoples R China; [Shu, Dingming] State Key Lab Livestock & Poultry Breeding, Guangzhou, Guangdong, Peoples R China; [Zhang, Huanmin] USDA ARS, Avian Dis & Oncol Lab, E Lansing, MI 48823 USA	South China Agricultural University; Ministry of Agriculture & Rural Affairs; United States Department of Agriculture (USDA)	Xie, QM (corresponding author), South China Agr Univ, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China.	qmx@scau.edu.cn	Zhang, Huanmin/M-9792-2019	Zhang, Huanmin/0000-0003-4896-2391	National Natural Science Foundation of China [31072152]; State Key Laboratory of Biocontrol [SKLBC2010K07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Biocontrol	This work was supported by grants from the National Natural Science Foundation of China (31072152) and the Open Project of the State Key Laboratory of Biocontrol (SKLBC2010K07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2010, MOL CELL BIOL, V30, P4197, DOI 10.1128/MCB.00316-10; BABA TW, 1985, P NATL ACAD SCI USA, V82, P213, DOI 10.1073/pnas.82.1.213; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bertini E, 2009, CELL CYCLE, V8, P49, DOI 10.4161/cc.8.1.7259; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chen CY, 2012, RES VET SCI; Cheng Zi-qiang, 2005, Weishengwu Xuebao, V45, P584; Cui ZZ, 2009, AVIAN PATHOL, V38, P443, DOI 10.1080/03079450903349188; Ding L, 2010, CELL RES, V20, P784, DOI 10.1038/cr.2010.79; DULIC V, 1992, SCIENCE, V257, P1958, DOI 10.1126/science.1329201; DULIC V, 1993, P NATL ACAD SCI USA, V90, P11034, DOI 10.1073/pnas.90.23.11034; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Fadly AM, 1999, AVIAN DIS, V43, P391, DOI 10.2307/1592636; Fassan Matteo, 2011, Front Biosci (Schol Ed), V3, P970; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gao YL, 2010, EMERG INFECT DIS, V16, P1637, DOI 10.3201/eid1610.100780; Gao YL, 2012, J CLIN MICROBIOL, V50, P953, DOI 10.1128/JCM.06179-11; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; KEYOMARSI K, 1994, CANCER RES, V54, P380; Keyomarsi K, 2002, NEW ENGL J MED, V347, P1566, DOI 10.1056/NEJMoa021153; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Lee JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051592; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li HM, 2012, VIRUS RES, V169, P268, DOI 10.1016/j.virusres.2012.07.003; Li Y, 2010, INT J CLIN EXP PATHO, V3, P254; Lian L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051003; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lisi S, 2000, GENETICS, V154, P669; Liu AM, 2010, BIOCHEM BIOPH RES CO, V394, P623, DOI 10.1016/j.bbrc.2010.03.036; Lotterman CD, 2008, CELL CYCLE, V7, P2493, DOI 10.4161/cc.7.16.6452; MAAS HJL, 1982, AVIAN PATHOL, V11, P309, DOI 10.1080/03079458208436103; Mays JK, 2006, AVIAN DIS, V50, P342, DOI 10.1637/7493-121505R.1; Nishikawa E, 2011, CANCER RES, V71, P6165, DOI 10.1158/0008-5472.CAN-11-1020; Nolo R, 2006, CURR BIOL, V16, P1895, DOI 10.1016/j.cub.2006.08.057; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Oka T, 2009, GENES CELLS, V14, P607, DOI 10.1111/j.1365-2443.2009.01292.x; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Payne LN, 2012, AVIAN PATHOL, V41, P11, DOI 10.1080/03079457.2011.646237; PAYNE LN, 1991, VET REC, V129, P447, DOI 10.1136/vr.129.20.447; PAYNE LN, 1993, AVIAN DIS, V37, P438, DOI 10.2307/1591671; PAYNE LN, 1992, J GEN VIROL, V73, P2995, DOI 10.1099/0022-1317-73-11-2995; PAYNE LN, 1992, LEUKEMIA, V6, P1167; Payne LN, 1998, POULTRY SCI, V77, P1204, DOI 10.1093/ps/77.8.1204; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; RUBIN H, 1962, VIROLOGY, V17, P143, DOI 10.1016/0042-6822(62)90091-0; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Stik G, 2013, J VIROL, V87, P80, DOI 10.1128/JVI.02449-12; Strano S, 2001, J BIOL CHEM, V276, P15164, DOI 10.1074/jbc.M010484200; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Tsukamoto Y, 2010, CANCER RES, V70, P2339, DOI 10.1158/0008-5472.CAN-09-2777; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang KN, 2009, BIOCHEM CELL BIOL, V87, P77, DOI 10.1139/O08-114; Wang Q, 2013, VET MICROBIOL, V162, P232, DOI 10.1016/j.vetmic.2012.10.023; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; Wang Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-512; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Xu S, 2011, J VIROL, V85, P276, DOI 10.1128/JVI.01392-10; Yang Y, 2010, CANCER GENET CYTOGEN, V200, P127, DOI 10.1016/j.cancergencyto.2010.03.014; Yao YX, 2008, J VIROL, V82, P4007, DOI 10.1128/JVI.02659-07; Yokokura T, 2004, J BIOL CHEM, V279, P52603, DOI 10.1074/jbc.M409691200; Yoo SJ, 2002, NAT CELL BIOL, V4, P416, DOI 10.1038/ncb793; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang X, 2011, ANN ONCOL, V22, P2257, DOI 10.1093/annonc/mdq758; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	76	31	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e90878	10.1371/journal.pone.0090878	http://dx.doi.org/10.1371/journal.pone.0090878			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24694742	gold, Green Submitted, Green Published			2022-12-25	WOS:000334103000010
J	Long, HC; O'Connor, BP; Zemans, RL; Zhou, XF; Yang, IV; Schwartz, DA				Long, Huaicong; O'Connor, Brian P.; Zemans, Rachel L.; Zhou, Xiaofang; Yang, Ivana V.; Schwartz, David A.			The Toll-Like Receptor 4 Polymorphism Asp299Gly but Not Thr399Ile Influences TLR4 Signaling and Function	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE BINDING-PROTEIN; RESPIRATORY SYNCYTIAL VIRUS; RESPONSES; LPS; TRANSDUCTION; MACROPHAGES; POPULATION; HYALURONAN; EXPRESSION; MUTATIONS	The common, co-segregating Toll-like receptor 4 (TLR4) non-synonymous single nucleotide polymorphisms (SNPs), Asp299Gly and Thr399Ile, are associated with hyporesponsiveness to inhaled lipopolysaccharide (LPS) and increased susceptibility to Gram negative pathogens in humans. The purpose of this study was to identify the relative contributions of the Asp299Gly and the Thr399Ile variants in inhibiting the function of TLR4. 293/hMD2-CD14 cell line was transfected with lentiviral constructs containing human wild type (WT) TLR4-EGFP or TLR4-EGFP with Asp299Gly, Thr399Ile or Asp299Gly/Thr399Ile complementary DNA (cDNA). Multiple stable cell lines were established for each construct: three for WT TLR4, Asp299Gly, and Thr399Ile, and only two for Asp299Gly/Thr399Ile mutants and EGFP control. We did not observe a significant effect of polymorphisms on cell surface and intracellular TLR4 expression nor were there any significant differences in TLR4 and EGFP protein levels assessed by Western blotting and confocal microscopy among the multiple cell lines of each of the constructs. All cell lines had a dose-dependent responsiveness to LPS stimulation. However, compared to the WT TLR4, cells expressing TLR4 with Asp299Gly but not Thr399Ile polymorphism produced significantly less (P<0.05) IL-8 following LPS stimulation. Similarly, cells expressing TLR4 Asp299Gly but not Thr399Ile allele had significantly lower percentage of phosphorylated and total NF-kappa B P65 following LPS stimulation. While we could not do statistics on the Asp299Gly/Thr399Ile group, we observed a reduced responsiveness to LPS compared to WT TLR4. Taken together, we observed that the TLR4 Asp299Gly variant, but not the Thr399Ile variant, is responsible for impaired responsiveness of TLR4 to LPS and corresponding activation of NF-kappa B.	[Long, Huaicong; O'Connor, Brian P.; Zemans, Rachel L.; Yang, Ivana V.; Schwartz, David A.] Ctr Genes Environm & Hlth Natl Jewish Hlth, Denver, CO USA; [Long, Huaicong; Zhou, Xiaofang] Sichuan Acad Med Sci, Dept Geriatr, Chengdu, Sichuan, Peoples R China; [Long, Huaicong; Zhou, Xiaofang] Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China; [O'Connor, Brian P.; Schwartz, David A.] Univ Colorado & Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO USA; [Zemans, Rachel L.; Yang, Ivana V.; Schwartz, David A.] Univ Colorado Denver, Dept Med, Aurora, CO USA	Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Schwartz, DA (corresponding author), Ctr Genes Environm & Hlth Natl Jewish Hlth, Denver, CO USA.	david.schwartz@ucdenver.edu	Yang, Ivana V/P-3059-2018	Yang, Ivana V/0000-0002-1018-489X	National Institutes of Health; China Scholarship Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL103772] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The research reported in this manuscript has been funded through the National Institutes of Health and China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Balistreri CR, 2011, MECH AGEING DEV, V132, P86, DOI 10.1016/j.mad.2010.12.005; Bhuvanendran S, 2011, MICROBES INFECT, V13, P844, DOI 10.1016/j.micinf.2011.04.007; Bottcher MF, 2004, J ALLERGY CLIN IMMUN, V114, P561, DOI 10.1016/j.jaci.2004.04.050; Bulut Y, 2002, J IMMUNOL, V168, P1435, DOI 10.4049/jimmunol.168.3.1435; Candore G, 2006, ANN NY ACAD SCI, V1067, P282, DOI 10.1196/annals.1354.037; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Ferwerda B, 2007, P NATL ACAD SCI USA, V104, P16645, DOI 10.1073/pnas.0704828104; Figueroa L, 2012, J IMMUNOL, V188, P4506, DOI 10.4049/jimmunol.1200202; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Guillot L, 2002, J IMMUNOL, V168, P5989, DOI 10.4049/jimmunol.168.12.5989; Guo JS, 2009, HEPATOLOGY, V49, P960, DOI 10.1002/hep.22697; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Kuhns DB, 2001, J IMMUNOL, V167, P2869, DOI 10.4049/jimmunol.167.5.2869; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Liadaki K, 2011, CLIN VACCINE IMMUNOL, V18, P217, DOI 10.1128/CVI.00460-10; Lorenz E, 2002, ARCH INTERN MED, V162, P1028, DOI 10.1001/archinte.162.9.1028; Lorenz E, 2001, BIOTECHNIQUES, V31, P22, DOI 10.2144/01311bm01; Lundberg A, 2008, CLIN VACCINE IMMUNOL, V15, P1878, DOI 10.1128/CVI.00241-08; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; Montes AH, 2006, CLIN EXP IMMUNOL, V143, P404, DOI 10.1111/j.1365-2249.2005.03002.x; Norata GD, 2005, J INTERN MED, V258, P21, DOI 10.1111/j.1365-2796.2005.01509.x; OHTO U, 2012, J BIOL CHEM; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; Prohinar P, 2010, J IMMUNOL, V184, P4362, DOI 10.4049/jimmunol.0903142; Rallabhandi P, 2008, J IMMUNOL, V180, P1139, DOI 10.4049/jimmunol.180.2.1139; Rallabhandi P, 2006, J IMMUNOL, V177, P322, DOI 10.4049/jimmunol.177.1.322; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Senthilselvan A, 2009, J ALLERGY CLIN IMMUN, V123, P1034, DOI 10.1016/j.jaci.2009.02.019; Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; TOBIAS PS, 1988, J BIOL CHEM, V263, P13479; TOBIAS PS, 1989, J BIOL CHEM, V264, P10867; Tsan MF, 2004, AM J PHYSIOL-CELL PH, V286, pC739, DOI 10.1152/ajpcell.00364.2003; Tulic MK, 2007, J IMMUNOL, V179, P132, DOI 10.4049/jimmunol.179.1.132; Vogel SN, 2003, BIOCHEM SOC T, V31, P664, DOI 10.1042/bst0310664; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311	40	30	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93550	10.1371/journal.pone.0093550	http://dx.doi.org/10.1371/journal.pone.0093550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695807	Green Submitted, gold, Green Published			2022-12-25	WOS:000334103000088
J	Nagele, T; Mair, A; Sun, XL; Fragner, L; Teige, M; Weckwerth, W				Naegele, Thomas; Mair, Andrea; Sun, Xiaoliang; Fragner, Lena; Teige, Markus; Weckwerth, Wolfram			Solving the Differential Biochemical Jacobian from Metabolomics Covariance Data	PLOS ONE			English	Article							SYSTEMS BIOLOGY; ARABIDOPSIS; RECONSTRUCTION; NETWORK; ACCLIMATION; INTEGRATION; METABOLISM; RESPONSES; STRESSES; PLATFORM	High-throughput molecular analysis has become an integral part in organismal systems biology. In contrast, due to a missing systematic linkage of the data with functional and predictive theoretical models of the underlying metabolic network the understanding of the resulting complex data sets is lacking far behind. Here, we present a biomathematical method addressing this problem by using metabolomics data for the inverse calculation of a biochemical Jacobian matrix, thereby linking computer-based genome-scale metabolic reconstruction and in vivo metabolic dynamics. The incongruity of metabolome coverage by typical metabolite profiling approaches and genome-scale metabolic reconstruction was solved by the design of superpathways to define a metabolic interaction matrix. A differential biochemical Jacobian was calculated using an approach which links this metabolic interaction matrix and the covariance of metabolomics data satisfying a Lyapunov equation. The predictions of the differential Jacobian from real metabolomic data were found to be correct by testing the corresponding enzymatic activities. Moreover it is demonstrated that the predictions of the biochemical Jacobian matrix allow for the design of parameter optimization strategies for ODE-based kinetic models of the system. The presented concept combines dynamic modelling strategies with large-scale steady state profiling approaches without the explicit knowledge of individual kinetic parameters. In summary, the presented strategy allows for the identification of regulatory key processes in the biochemical network directly from metabolomics data and is a fundamental achievement for the functional interpretation of metabolomics data.	[Naegele, Thomas; Mair, Andrea; Sun, Xiaoliang; Fragner, Lena; Teige, Markus; Weckwerth, Wolfram] Univ Vienna, Dept Ecogen & Syst Biol, Vienna, Austria	University of Vienna	Weckwerth, W (corresponding author), Univ Vienna, Dept Ecogen & Syst Biol, Vienna, Austria.	wolfram.weckwerth@univie.ac.at	Weckwerth, Wolfram/G-5811-2010; Mair, Andrea/Y-8490-2019; Teige, Markus/R-6443-2016	Mair, Andrea/0000-0002-2492-4318; Teige, Markus/0000-0001-7204-1379; Nagele, Thomas/0000-0002-5896-238X; Weckwerth, Wolfram/0000-0002-9719-6358	EU-Marie-Curie ITN MERIT [GA 2010-264474]; Austrian Science Fund (FWF) [P23435-B12]; FWF [P26342]; Austrian Science Fund (FWF) [P 25359, P 23435] Funding Source: researchfish	EU-Marie-Curie ITN MERIT; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The authors thank the EU-Marie-Curie ITN MERIT (GA 2010-264474) for financial support of TN and the Austrian Science Fund (FWF) for financial support to AM and MT (FWF project P23435-B12). Thomas Nagele was funded by the FWF project P26342 "In situ studies of natural Arabidopsis thaliana populations." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Dawud R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039896; Baena-Gonzalez E, 2008, TRENDS PLANT SCI, V13, P474, DOI 10.1016/j.tplants.2008.06.006; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Banga JR, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-47; Dal'Molin CGD, 2010, PLANT PHYSIOL, V152, P579, DOI 10.1104/pp.109.148817; Doerfler H, 2013, METABOLOMICS, V9, P564, DOI 10.1007/s11306-012-0470-0; dos Santos Sandra C., 2012, Frontiers in Genetics, V3, P63, DOI 10.3389/fgene.2012.00063; Espinoza C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014101; Hirai MY, 2004, P NATL ACAD SCI USA, V101, P10205, DOI 10.1073/pnas.0403218101; Honerkamp J., 1990, STOCHASTISCHE DYNAMI; Mintz-Oron S, 2012, P NATL ACAD SCI USA, V109, P339, DOI 10.1073/pnas.1100358109; Nagele T, 2012, METABOLITES, V2, P553, DOI 10.3390/metabo2030553; Nagele T, 2012, PLANT J, V72, P102, DOI 10.1111/j.1365-313X.2012.05064.x; Nagele T, 2011, FEBS J, V278, P506, DOI 10.1111/j.1742-4658.2010.07971.x; Nagele T, 2010, PLANT PHYSIOL, V153, P260, DOI 10.1104/pp.110.154443; Patil KR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-308; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Poolman MG, 2009, PLANT PHYSIOL, V151, P1570, DOI 10.1104/pp.109.141267; Press WH., 2002, NUMERICAL RECIPES C, V2; Reed JL, 2004, GENOME RES, V14, P1797, DOI 10.1101/gr.2546004; Riedelsheimer C, 2012, P NATL ACAD SCI USA, V109, P8872, DOI 10.1073/pnas.1120813109; Rohwer JM, 2001, BIOCHEM J, V358, P437, DOI 10.1042/0264-6021:3580437; Rohwer JM, 2012, J EXP BOT, V63, P2275, DOI 10.1093/jxb/ers080; Schaber J, 2009, IET SYST BIOL, V3, P1, DOI 10.1049/iet-syb:20070042; Schallau K, 2010, PLANT PHYSIOL, V152, P1763, DOI 10.1104/pp.109.149237; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; Steuer R, 2003, BIOINFORMATICS, V19, P1019, DOI 10.1093/bioinformatics/btg120; Steuer R, 2006, P NATL ACAD SCI USA, V103, P11868, DOI 10.1073/pnas.0600013103; Sun XL, 2012, METABOLOMICS, V8, pS81, DOI 10.1007/s11306-012-0399-3; Sweetlove LJ, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00038; vanKampen, 1992, STOCHASTIC PROCESSES; Weckwerth W, 2011, J PROTEOMICS, V75, P284, DOI 10.1016/j.jprot.2011.07.010; Weckwerth W, 2011, ANAL BIOANAL CHEM, V400, P1967, DOI 10.1007/s00216-011-4948-9; Wienkoop S, 2008, MOL CELL PROTEOMICS, V7, P1725, DOI 10.1074/mcp.M700273-MCP200; Yu HL, 2012, PLANTA, V236, P387, DOI 10.1007/s00425-012-1620-3	35	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e92299	10.1371/journal.pone.0092299	http://dx.doi.org/10.1371/journal.pone.0092299			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695071	Green Published, Green Submitted, gold			2022-12-25	WOS:000334103000018
J	Davis, BT; Wang, XJ; Rohret, JA; Struzynski, JT; Merricks, EP; Bellinger, DA; Rohret, FA; Nichols, TC; Rogers, CS				Davis, Bryan T.; Wang, Xiao-Jun; Rohret, Judy A.; Struzynski, Jason T.; Merricks, Elizabeth P.; Bellinger, Dwight A.; Rohret, Frank A.; Nichols, Timothy C.; Rogers, Christopher S.			Targeted Disruption of LDLR Causes Hypercholesterolemia and Atherosclerosis in Yucatan Miniature Pigs	PLOS ONE			English	Article							CYSTIC-FIBROSIS; FAMILIAL HYPERCHOLESTEROLEMIA; RECEPTOR; MICE; LESIONS; IDENTIFICATION; MODEL; CHOLESTEROL; KNOCKOUT; MUTATION	Recent progress in engineering the genomes of large animals has spurred increased interest in developing better animal models for diseases where current options are inadequate. Here, we report the creation of Yucatan miniature pigs with targeted disruptions of the low-density lipoprotein receptor (LDLR) gene in an effort to provide an improved large animal model of familial hypercholesterolemia and atherosclerosis. Yucatan miniature pigs are well established as translational research models because of similarities to humans in physiology, anatomy, genetics, and size. Using recombinant adeno-associated virus-mediated gene targeting and somatic cell nuclear transfer, male and female LDLR+/- pigs were generated. Subsequent breeding of heterozygotes produced LDLR-/- pigs. When fed a standard swine diet (low fat, no cholesterol), LDLR+/- pigs exhibited a moderate, but consistent increase in total and LDL cholesterol, while LDLR-/- pigs had considerably elevated levels. This severe hypercholesterolemia in homozygote animals resulted in atherosclerotic lesions in the coronary arteries and abdominal aorta that resemble human atherosclerosis. These phenotypes were more severe and developed over a shorter time when fed a diet containing natural sources of fat and cholesterol. LDLR-targeted Yucatan miniature pigs offer several advantages over existing large animal models including size, consistency, availability, and versatility. This new model of cardiovascular disease could be an important resource for developing and testing novel detection and treatment strategies for coronary and aortic atherosclerosis and its complications.	[Davis, Bryan T.; Wang, Xiao-Jun; Rohret, Judy A.; Struzynski, Jason T.; Rohret, Frank A.; Rogers, Christopher S.] Exemplar Genet, Coralville, IA 52241 USA; [Merricks, Elizabeth P.; Bellinger, Dwight A.; Nichols, Timothy C.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Merricks, Elizabeth P.; Bellinger, Dwight A.; Nichols, Timothy C.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Rogers, CS (corresponding author), Exemplar Genet, Coralville, IA 52241 USA.	chris.rogers@exemplargenetics.com			National Heart, Lung, and Blood Institute of the National Institutes of Health [HL102950]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R43HL102950, R44HL102950] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by a grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health (HL102950). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005369; Al-Mashhadi RH, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004853; Bentzon JF, 2010, CURR OPIN LIPIDOL, V21, P434, DOI 10.1097/MOL.0b013e32833ded6a; Benvenuti Luiz Alberto, 2005, Clinics, V60, P355, DOI 10.1590/S1807-59322005000500002; Daugherty A, 2002, AM J MED SCI, V323, P3, DOI 10.1097/00000441-200201000-00002; Dixon JL, 1999, ARTERIOSCL THROM VAS, V19, P2981, DOI 10.1161/01.ATV.19.12.2981; Gerrity RG, 2001, DIABETES, V50, P1654, DOI 10.2337/diabetes.50.7.1654; GERRITY RG, 1985, ARTERIOSCLEROSIS, V5, P55, DOI 10.1161/01.ATV.5.1.55; Grunwald KAA, 1999, J LIPID RES, V40, P475; Hasler-Rapacz J, 1998, AM J MED GENET, V76, P379, DOI 10.1002/(SICI)1096-8628(19980413)76:5<379::AID-AJMG3>3.0.CO;2-I; Hickey RD, 2011, HEPATOLOGY, V54, P1351, DOI 10.1002/hep.24490; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Johnson GJ, 1999, THROMB HAEMOSTASIS, V81, P835; Kobayashi T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/406473; Lai LX, 2003, CLONING STEM CELLS, V5, P233, DOI 10.1089/153623003772032754; Libby P, 2013, IMMUNITY, V38, P1092, DOI 10.1016/j.immuni.2013.06.009; Lichtman AH, 1999, ARTERIOSCL THROM VAS, V19, P1938, DOI 10.1161/01.ATV.19.8.1938; LITTLE WC, 1988, CIRCULATION, V78, P1157, DOI 10.1161/01.CIR.78.5.1157; Lusis MJ, 2004, ANNU REV GENOM HUM G, V5, P189, DOI [10.1146/annurev.genom.5.061903.175930, 10.1016/j.tig.2012.03.001]; Mohammadpour AH, 2013, CLIN PHARMACOKINET, V52, P615, DOI 10.1007/s40262-013-0071-8; Mohiaddin RH, 2004, J CARDIOV MAGN RESON, V6, P517, DOI 10.1081/JCMR-120030576; Nichols TC, 2013, BLOOD, V122, P3551, DOI 10.1182/blood-2013-09-527697; Onuma Y, 2010, CIRCULATION, V122, P2288, DOI 10.1161/CIRCULATIONAHA.109.921528; Ostedgaard LS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001868; Pezzulo AA, 2012, NATURE, V487, P109, DOI 10.1038/nature11130; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; POMP D, 1995, J ANIM SCI, V73, P1408; PRESCOTT MF, 1991, AM J PATHOL, V139, P139; PURCELLHUYNH DA, 1995, J CLIN INVEST, V95, P2246, DOI 10.1172/JCI117915; Rader DJ, 2003, J CLIN INVEST, V111, P1795, DOI 10.1172/JCI200318925; RAPACZ J, 1986, SCIENCE, V234, P1573, DOI 10.1126/science.3787263; Rogan MP, 2010, P NATL ACAD SCI USA, V107, P20571, DOI 10.1073/pnas.1015281107; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Rogers CS, 2008, J CLIN INVEST, V118, P1571, DOI 10.1172/JCI34773; Sanz J, 2013, J AM COLL CARDIOL, V62, P1131, DOI 10.1016/j.jacc.2013.06.045; Schwartz RS, 2008, CIRC-CARDIOVASC INTE, V1, P143, DOI 10.1161/CIRCINTERVENTIONS.108.789974; Stoltz DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000928; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890; Thim T, 2010, EUROINTERVENTION, V6, P261, DOI 10.4244/; THOMAS WA, 1985, ANN NY ACAD SCI, V454, P305, DOI 10.1111/j.1749-6632.1985.tb11870.x; Walker Shawn C., 2002, Cloning and Stem Cells, V4, P105, DOI 10.1089/153623002320253283; Wang J, 2002, MOL CELL, V10, P951, DOI 10.1016/S1097-2765(02)00635-4; Wen J, 2008, BIOCHEM SOC T, V36, P514, DOI 10.1042/BST0360514	45	66	70	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93457	10.1371/journal.pone.0093457	http://dx.doi.org/10.1371/journal.pone.0093457			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691380	Green Submitted, Green Published, gold			2022-12-25	WOS:000334101100084
J	Gustafsson, ALS; Skrede, I; Rowe, HC; Gussarova, G; Borgen, L; Rieseberg, LH; Brochmann, C; Parisod, C				Gustafsson, A. Lovisa S.; Skrede, Inger; Rowe, Heather C.; Gussarova, Galina; Borgen, Liv; Rieseberg, Loren H.; Brochmann, Christian; Parisod, Christian			Genetics of Cryptic Speciation within an Arctic Mustard, Draba nivalis	PLOS ONE			English	Article							TERMINAL-REPEAT RETROTRANSPOSON; TRANSMISSION RATIO DISTORTION; TRANSPOSABLE ELEMENTS; CHROMOSOMAL REARRANGEMENTS; SEGREGATION DISTORTION; REPRODUCTIVE ISOLATION; POSTZYGOTIC ISOLATION; ARABIDOPSIS-THALIANA; MINIATURE TRIM; LINKAGE MAPS	Crossing experiments indicate that hybrid sterility barriers frequently have developed within diploid, circumpolar plant species of the genus Draba. To gain insight into the rapid evolution of postzygotic reproductive isolation in this system, we augmented the linkage map of one of these species, D. nivalis, and searched for quantitative trait loci (QTLs) associated with reproductive isolation. The map adds 63 new dominant markers to a previously published dataset of 31co-dominant microsatellites. These markers include 52 amplified fragment length polymorphisms (AFLPs) and 11 sequence-specific amplified polymorphisms (SSAPs) based on retrotransposon sequence. 22 markers displaying transmission ratio distortion were further included in the map. We resolved eight linkage groups with a total map length of 894 cM. Significant genotype-trait associations, or quantitative trait loci (QTL), were detected for reproductive phenotypes including pollen fertility (4 QTLs), seed set (3 QTLs), flowering time (3 QTLs) and number of flowers (4 QTLs). Observed patterns of inheritance were consistent with the influence of both nuclear-nuclear interactions and chromosomal changes on these traits. All seed set QTLs and one pollen fertility QTL displayed underdominant effects suggestive of the involvement of chromosomal rearrangements in hybrid sterility. Interestingly, D. nivalis is predominantly self-fertilizing, which may facilitate the establishment of underdominant loci and contribute to reproductive isolation.	[Gustafsson, A. Lovisa S.; Gussarova, Galina; Borgen, Liv; Brochmann, Christian; Parisod, Christian] Univ Oslo, Natl Ctr Biosystemat, Nat Hist Museum, Oslo, Norway; [Skrede, Inger] Univ Oslo, Dept Biosci, MERG, Oslo, Norway; [Rowe, Heather C.; Rieseberg, Loren H.] Univ British Columbia, Dept Bot, Vancouver, BC V5Z 1M9, Canada; [Gussarova, Galina] St Petersburg State Univ, Fac Biol & Soil Sci, Dept Bot, St Petersburg 199034, Russia; [Parisod, Christian] Univ Neuchatel, Inst Biol, Lab Evolutionary Bot, CH-2000 Neuchatel, Switzerland	University of Oslo; University of Oslo; University of British Columbia; Saint Petersburg State University; University of Neuchatel	Gustafsson, ALS (corresponding author), Univ Oslo, Natl Ctr Biosystemat, Nat Hist Museum, Oslo, Norway.	lovisa.gustafsson@nhm.uio.no	Brochmann, Christian/A-4105-2009; Gussarova, Galina/E-4758-2015; Parisod, Christian/A-1140-2010; Gussarova, Galina/ABC-8696-2021; Rieseberg, Loren H/B-3591-2013	Gussarova, Galina/0000-0001-5388-7491; Parisod, Christian/0000-0001-8798-0897; Gussarova, Galina/0000-0001-5388-7491; Rieseberg, Loren H/0000-0002-2712-2417; Skrede, Inger/0000-0002-1113-7403	Natural History Museum, University of Oslo; Swiss National Science Foundation [PBLAA122735, PZ00P3-131950]	Natural History Museum, University of Oslo; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funding was obtained from the Natural History Museum, University of Oslo and the Swiss National Science Foundation (grants PBLAA122735 and PZ00P3-131950 to CP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; [Anonymous], 2003, ALPINE PLANT LIFE, DOI DOI 10.1007/978-3-642-18970-8; Bennetzen JL, 2005, CURR OPIN GENET DEV, V15, P621, DOI 10.1016/j.gde.2005.09.010; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Bonchev G, 2013, MOL ECOL RESOUR, V13, P765, DOI 10.1111/1755-0998.12133; BROCHMANN C, 1993, NORD J BOT, V13, P121, DOI 10.1111/j.1756-1051.1993.tb00023.x; Broman K. W., 2010, GENETIC MAP CONSTRUC; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Butlin RK, 2005, MOL ECOL, V14, P2621, DOI 10.1111/j.1365-294X.2005.02617.x; Butlin R, 2012, TRENDS ECOL EVOL, V27, P27, DOI 10.1016/j.tree.2011.09.002; Colome-Tatche M, 2012, P NATL ACAD SCI USA, V109, P16240, DOI 10.1073/pnas.1212955109; Corbett-Detig RB, 2013, NATURE, V504, P135, DOI 10.1038/nature12678; Coyne JA, 1998, PHILOS T ROY SOC B, V353, P287, DOI 10.1098/rstb.1998.0210; Coyne JA, 2004, SPECIATION, V37; Deragon JM, 2006, SYST BIOL, V55, P949, DOI 10.1080/10635150601047843; Dooner HK, 2008, PLANT CELL, V20, P249, DOI 10.1105/tpc.107.057596; Faria R, 2010, TRENDS ECOL EVOL, V25, P660, DOI 10.1016/j.tree.2010.07.008; Fishman L, 2001, GENETICS, V159, P1701; Fishman L, 2013, EVOLUTION, V67, P2547, DOI 10.1111/evo.12154; Gaut BS, 2008, SCIENCE, V320, P484, DOI 10.1126/science.1153586; Glemin S, 2013, EVOLUTION, V67, P225, DOI 10.1111/j.1558-5646.2012.01778.x; Grundt HH, 2006, P NATL ACAD SCI USA, V103, P972, DOI 10.1073/pnas.0510270103; HEDRICK PW, 1981, EVOLUTION, V35, P322, DOI [10.1111/j.1558-5646.1981.tb04890.x, 10.2307/2407841]; Hoffmann AA, 2008, ANNU REV ECOL EVOL S, V39, P21, DOI 10.1146/annurev.ecolsys.39.110707.173532; Iwata H, 2006, BREEDING SCI, V56, P371, DOI 10.1270/jsbbs.56.371; Kidwell MG, 2001, EVOLUTION, V55, P1, DOI 10.1111/j.0014-3820.2001.tb01268.x; Kirkpatrick M, 2006, GENETICS, V173, P419, DOI 10.1534/genetics.105.047985; Kwon SJ, 2007, MOL GENET GENOMICS, V278, P361, DOI 10.1007/s00438-007-0249-6; Lenoir A, 2005, CYTOGENET GENOME RES, V110, P441, DOI 10.1159/000084976; Lenoir A, 2001, MOL BIOL EVOL, V18, P2315, DOI 10.1093/oxfordjournals.molbev.a003778; Leppala J, 2008, HEREDITY, V100, P71, DOI 10.1038/sj.hdy.6801066; Leppala J, 2011, EVOLUTION, V65, P2959, DOI 10.1111/j.1558-5646.2011.01361.x; Levin D. A, 2002, OX ECOL EV; Levin DA, 2003, SYST BOT, V28, P5; Lexer C, 2008, PHILOS T R SOC B, V363, P3023, DOI 10.1098/rstb.2008.0078; Lowry DB, 2008, PHILOS T R SOC B, V363, P3009, DOI 10.1098/rstb.2008.0064; Lowry DB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000500; Melamed-Bessudo C, 2012, P NATL ACAD SCI USA, V109, pE981, DOI 10.1073/pnas.1120742109; Nei M, 2011, GENOME BIOL EVOL, V3, P812, DOI 10.1093/gbe/evr028; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Orr HA, 2005, P NATL ACAD SCI USA, V102, P6522, DOI 10.1073/pnas.0501893102; Orr HA, 2001, EVOLUTION, V55, P1085; Parisod C, 2008, NEW PHYTOL, V178, P436, DOI 10.1111/j.1469-8137.2007.02361.x; Presgraves DC, 2010, NAT REV GENET, V11, P175, DOI 10.1038/nrg2718; Rieseberg LH, 2006, NATURE, V440, P524, DOI 10.1038/nature04402; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Rieseberg LH, 2010, ANN BOT-LONDON, V106, P439, DOI 10.1093/aob/mcq126; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Skrede I, 2009, HEREDITY, V102, P293, DOI 10.1038/hdy.2008.120; Skrede I, 2008, EVOLUTION, V62, P1840, DOI 10.1111/j.1558-5646.2008.00418.x; STEBBINS G. L., 1971, Chromosomal evolution in higher plants.; Syed NH, 2006, NAT PROTOC, V1, P2746, DOI 10.1038/nprot.2006.407; Terol J, 2001, MOL BIOL EVOL, V18, P882, DOI 10.1093/oxfordjournals.molbev.a003870; Torjek O, 2006, THEOR APPL GENET, V113, P1551, DOI 10.1007/s00122-006-0402-3; Via S, 2009, P NATL ACAD SCI USA, V106, P9939, DOI 10.1073/pnas.0901397106; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; WALSH JB, 1982, AM NAT, V120, P510, DOI 10.1086/284008; Waugh R, 1997, MOL GEN GENET, V253, P687, DOI 10.1007/s004380050372; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wu CI, 2001, J EVOLUTION BIOL, V14, P851, DOI 10.1046/j.1420-9101.2001.00335.x; Yang TJ, 2007, THEOR APPL GENET, V114, P627, DOI 10.1007/s00122-006-0463-3; Yin TM, 2004, THEOR APPL GENET, V109, P451, DOI 10.1007/s00122-004-1653-5	64	16	17	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93834	10.1371/journal.pone.0093834	http://dx.doi.org/10.1371/journal.pone.0093834			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691072	Green Published, gold, Green Submitted			2022-12-25	WOS:000334101100138
J	Recchiuti, A; Codagnone, M; Pierdomenico, AM; Rossi, C; Mari, VC; Cianci, E; Simiele, F; Gatta, V; Romano, M				Recchiuti, Antonio; Codagnone, Marilina; Pierdomenico, Anna Maria; Rossi, Cosmo; Mari, Veronica Cecilia; Cianci, Eleonora; Simiele, Felice; Gatta, Valentina; Romano, Mario			Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages	FASEB JOURNAL			English	Article						docosahexaenoic acid; chromatin-remodeling enzymes; pharmacology	LIPOXIN A(4); PROMOTE RESOLUTION; HUMAN PHAGOCYTES; LIPID MEDIATORS; GENE-EXPRESSION; INFLAMMATION; RECEPTOR; POLARIZATION; EFFEROCYTOSIS; MECHANISMS	Resolvin D1 (RvD1; 7S, 8R, 17S-trihydroxy-4Z, 9E,11E,13Z,15E,19Z-docosahexaenoic acid) is an endogenous immunoresolvent that regulates acute inflammation and orchestrates resolution. Here, we investigated anti-inflammatory and proresolving actions of RvD1 after oral administration. RvD1 rapidly accumulated in the mouse plasma after oral delivery and dose-dependently (1-100 ng/mouse) reduced leukocyte infiltration in zymosan A-induced acute peritonitis. Using mathematical resolution indices, RvD1 reduced Psi(max) by similar to 50%, shortened the resolution interval by 3 h, and significantly reduced total leukocyte (by similar to 30-45%) and polymorphonuclear neutrophil (by similar to 40-55%) accumulation when administered at the peak of peritonitis. RvD1 also improved course and outcome of severe peritonitis, shifting it toward resolution. In peritoneal macrophages (M Phi s) from the resolution phase of peritonitis, RvD1 down-regulated (by 2- to 3-fold) select genes that control gene transcription, namely coactivator-associated arginine methyltransferase 1 (CARM1), and downstream genes, such as colony-stimulating factor 3, intercellular adhesion molecule 1, and monocyte inflammatory protein 2, which promote neutrophil infiltration and reduce M Phi phagocytosis. Congruently, CARM1 knockdown in human and murine M Phi s induced a proresolving phenotype, recapitulating in vivo actions of RvD1. These results establish novel properties of RvD1 and demonstrate that RvD1 modifies the transcription control machinery in M Phi s, as part of its mechanisms of action during the resolution of acute inflammation.	[Recchiuti, Antonio; Codagnone, Marilina; Simiele, Felice; Romano, Mario] Univ G DAnnunzio, Dept Expt & Clin Sci, I-66013 Chieti, Italy; [Pierdomenico, Anna Maria; Cianci, Eleonora] Univ G DAnnunzio, Dept Med & Aging Sci, I-66013 Chieti, Italy; [Gatta, Valentina] Univ G DAnnunzio, Dept Psychol Humanities & Terr Sci, I-66013 Chieti, Italy; [Recchiuti, Antonio; Codagnone, Marilina; Pierdomenico, Anna Maria; Rossi, Cosmo; Mari, Veronica Cecilia; Cianci, Eleonora; Simiele, Felice; Gatta, Valentina; Romano, Mario] Univ G dAnnunzio, Ctr Excellence Aging, Chieti, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Recchiuti, A (corresponding author), Univ G DAnnunzio, Dept Expt & Clin Sci, Via Colle Ara, I-66013 Chieti, Italy.	a.recchiuti@unich.it	Romano, Mario/I-7986-2012; Recchiuti, Antonio/K-7670-2016; Gatta, Valentina/G-5765-2014	Romano, Mario/0000-0001-8512-1458; Recchiuti, Antonio/0000-0002-1409-5261; Pierdomenico, Anna Maria/0000-0002-1788-6106; GATTA, Valentina/0000-0002-9999-5823	European Union [294187 FP7-PEOPLE-CIG-2011]; Regione Abruzzo under the Piano Speciale Multiasse Reti per l'Alta Formazione-POFSE	European Union(European Commission); Regione Abruzzo under the Piano Speciale Multiasse Reti per l'Alta Formazione-POFSE	This work was supported by the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement 294187 FP7-PEOPLE-CIG-2011 (to A. R.) and by the Regione Abruzzo under the Piano Speciale Multiasse Reti per l'Alta Formazione-POFSE 2007-2013 (to A. R.). The authors thank Sara Patruno for SPE of plasma samples, Marco D'Aurora for gene array cluster analysis, and Dr. Giuseppina Bologna for FCM analysis of transfected M Phi s. The authors also acknowledge BioLegend (San Diego, CA, USA) and Cayman Chemical (Ann Arbor, MI, USA) for providing reagents for the initial setup and optimization of polychromatic FCM and RvD1 detection protocol. The authors declare no conflicts of interest. Author contributions: A. R. designed experiments and conceived overall research; A. R., M. C., A. P., C. R., V. C. M., E. C., F. S., and M. R. performed research and analyzed results; A. R. and M. R. wrote the manuscript.	Bannenberg G, 2004, BRIT J PHARMACOL, V143, P43, DOI 10.1038/sj.bjp.0705912; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Barnig C, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004812; Buchanan PJ, 2013, AM J PHYSIOL-LUNG C, V305, pL193, DOI 10.1152/ajplung.00058.2013; Buxton I. L., 2011, GOODMAN GILMAN S THE; Bystrom J, 2008, BLOOD, V112, P4117, DOI 10.1182/blood-2007-12-129767; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chen XF, 2012, P NATL ACAD SCI USA, V109, pE2865, DOI 10.1073/pnas.1121131109; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Claria J, 2013, AM J PHYSIOL-CELL PH, V304, pC1141, DOI 10.1152/ajpcell.00351.2012; Claria J, 2012, J IMMUNOL, V189, P2597, DOI 10.4049/jimmunol.1201272; Covic M, 2005, EMBO J, V24, P85, DOI 10.1038/sj.emboj.7600500; Dalli J, 2013, FASEB J, V27, P2573, DOI 10.1096/fj.13-227728; Dalli J, 2013, J IMMUNOL, V190, P6478, DOI 10.4049/jimmunol.1203000; Dalli J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01940; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; Gavins FNE, 2012, FASEB J, V26, P4977, DOI 10.1096/fj.12-205971; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Goffin E, 2005, LANCET, V366, P289, DOI 10.1016/S0140-6736(05)66976-0; Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638; Green E. L., 1966, BIOLOGY OF THE LABOR; Guilford WJ, 2004, J MED CHEM, V47, P2157, DOI 10.1021/jm030569l; Hecht I, 2009, J PHARMACOL EXP THER, V328, P426, DOI 10.1124/jpet.108.145821; Hellmann J, 2011, FASEB J, V25, P2399, DOI 10.1096/fj.10-178657; Kamaly N, 2013, P NATL ACAD SCI USA, V110, P6506, DOI 10.1073/pnas.1303377110; Krishnamoorthy S, 2012, AM J PATHOL, V180, P2018, DOI 10.1016/j.ajpath.2012.01.028; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Lawrence T, 2007, INT J EXP PATHOL, V88, P85, DOI 10.1111/j.1365-2613.2006.00507.x; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lee HN, 2013, BIOCHEM PHARMACOL, V86, P759, DOI 10.1016/j.bcp.2013.07.002; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Liao ZL, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-110; Maderna P, 2009, BRIT J PHARMACOL, V158, P947, DOI 10.1111/j.1476-5381.2009.00386.x; Majno G., 2004, CELLS TISSUES AND DI; Mattoscio D, 2010, FASEB J, V24, P3970, DOI 10.1096/fj.10-159921; Montero-Melendez T, 2013, CELL DEATH DIFFER, V20, P567, DOI 10.1038/cdd.2012.154; Navarro-Xavier RA, 2010, J IMMUNOL, V184, P1516, DOI 10.4049/jimmunol.0902866; Norling LV, 2012, ARTERIOSCL THROM VAS, V32, P1970, DOI 10.1161/ATVBAHA.112.249508; Norling LV, 2011, J IMMUNOL, V186, P5543, DOI 10.4049/jimmunol.1003865; Ohira T, 2010, J BIOL CHEM, V285, P3451, DOI 10.1074/jbc.M109.044131; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Planaguma A, 2008, AM J RESP CRIT CARE, V178, P574, DOI 10.1164/rccm.200801-061OC; Pruss H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055859; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Recchiuti A, 2011, FASEB J, V25, P544, DOI 10.1096/fj.10-169599; Rius B, 2014, FASEB J, V28, P836, DOI 10.1096/fj.13-235614; Rogerio AP, 2012, J IMMUNOL, V189, P1983, DOI 10.4049/jimmunol.1101665; Romano M, 2002, LAB INVEST, V82, P1253, DOI 10.1097/01.LAB.0000028823.53486.4A; Schif-Zuck S, 2011, EUR J IMMUNOL, V41, P366, DOI 10.1002/eji.201040801; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Shakespear MR, 2013, J BIOL CHEM, V288, P25362, DOI 10.1074/jbc.M113.496281; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Simiele F, 2012, FASEB J, V26, P1323, DOI 10.1096/fj.11-198069; Stables MJ, 2011, BLOOD, V118, pE192, DOI 10.1182/blood-2011-04-345330; Sun YP, 2007, J BIOL CHEM, V282, P9323, DOI 10.1074/jbc.M609212200; Sun YP, 2009, PROSTAG LEUKOTR ESS, V81, P357, DOI 10.1016/j.plefa.2009.09.004; Tang YN, 2013, DIABETES, V62, P618, DOI 10.2337/db12-0684; Tian HB, 2009, INVEST OPHTH VIS SCI, V50, P3613, DOI 10.1167/iovs.08-3146; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; Turner PV, 2011, J AM ASSOC LAB ANIM, V50, P600; WANG LF, 1990, TRANSPLANT P, V22, P2342; Weiss GA, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-89; Zhang MJ, 2012, ANNU REV NUTR, V32, P203, DOI 10.1146/annurev-nutr-071811-150726	64	36	36	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					3090	3102		10.1096/fj.13-248393	http://dx.doi.org/10.1096/fj.13-248393			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24692596				2022-12-25	WOS:000337949400030
J	Kanan, Y; Brobst, D; Han, ZC; Naash, MI; Al-Ubaidi, MR				Kanan, Yogita; Brobst, Daniel; Han, Zongchao; Naash, Muna I.; Al-Ubaidi, Muayyad R.			Fibulin 2, a Tyrosine O-Sulfated Protein, Is Up-regulated Following Retinal Detachment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Extracellular Matrix; Fibronectin; Post-translational Modification; Retinal Degeneration; Tyrosine Sulfation; Retinal Detachment; Retinal Pigment Epithelium	EPITHELIAL-MESENCHYMAL TRANSITION; MACULAR DEGENERATION; BASEMENT-MEMBRANE; CELL MIGRATION; PROLIFERATIVE VITREORETINOPATHY; TRANSGENIC MICE; PLASMID DNA; P-SELECTIN; CUTIS LAXA; T-ANTIGEN	Background: Fibulin 2 is an ECM protein of basement membranes and elastic tissues. Results: Fibulin 2 is up-regulated during retinal detachment. Conclusion: Up-regulation of fibulin 2 following detachment points to its role in the adhesion of the RPE to the Bruch membrane and prevention of RPE migration. Significance: This is the first study addressing the role of fibulin 2 in retinal detachment. Retinal detachment is the physical separation of the retina from the retinal pigment epithelium. It occurs during aging, trauma, or during a variety of retinal disorders such as age-related macular degeneration, diabetic retinopathy, retinopathy of prematurity, or as a complication following cataract surgery. This report investigates the role of fibulin 2, an extracellular component, in retinal detachment. A major mechanism for detachment resolution is enhancement of cellular adhesion between the retina and the retinal pigment epithelium and prevention of its cellular migration. This report shows that fibulin 2 is mainly present in the retinal pigment epithelium, Bruch membrane, choriocapillary, and to a lesser degree in the retina. In vitro studies revealed the presence of two isoforms for fibulin 2. The small isoform is located inside the cell, and the large isoform is present inside and outside the cells. Furthermore, fibulin 2 is post-translationally modified by tyrosine sulfation, and the sulfated isoform is present outside the cell, whereas the unsulfated pool is internally located. Interestingly, sulfated fibulin 2 significantly reduced the rate of cellular growth and migration. Finally, levels of fibulin 2 dramatically increased in the retinal pigment epithelium following retinal detachment, suggesting a direct role for fibulin 2 in the re-attachment of the retina to the retinal pigment epithelium. Understanding the role of fibulin 2 in enhancing retinal attachment is likely to help improve the current therapies or allow the development of new strategies for the treatment of this sight-threatening condition.	[Kanan, Yogita; Brobst, Daniel; Han, Zongchao; Naash, Muna I.; Al-Ubaidi, Muayyad R.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Kanan, Y (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, BMSB 781,940 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	ykanan@ouhsc.edu; muayyad-al-ubaidi@ouhsc.edu		Han, Zongchao/0000-0002-2019-395X	National Institutes of Health [R01EY10609, R01EY018137]; NEI [P30EY12190]; Oklahoma Center for the Advancement of Science and Technology; Foundation Fighting Blindness; NATIONAL EYE INSTITUTE [P30EY012190, R01EY018656, R01EY018137, R01EY010609] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Oklahoma Center for the Advancement of Science and Technology; Foundation Fighting Blindness(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01EY10609 (to M. I. N.) and R01EY018137 (to M. R. A.) and Grant P30EY12190 from NEI. This work was also supported by the Oklahoma Center for the Advancement of Science and Technology (to Y. K.) and the Foundation Fighting Blindness (to M. R. A.).	Alcendor DJ, 2011, AM J PATHOL, V179, P1443, DOI 10.1016/j.ajpath.2011.05.024; AlUbaidi MR, 1997, EXP EYE RES, V64, P573, DOI 10.1006/exer.1996.0240; ALUBAIDI MR, 1992, J CELL BIOL, V119, P1681, DOI 10.1083/jcb.119.6.1681; ANDERSON DH, 1981, INVEST OPHTH VIS SCI, V21, P10; Argraves WS, 2003, EMBO REP, V4, P1127, DOI 10.1038/sj.embor.7400033; Casaroli-Marano RP, 1999, INVEST OPHTH VIS SCI, V40, P2062; Chapman SL, 2010, ARTERIOSCL THROM VAS, V30, P68, DOI 10.1161/ATVBAHA.109.196725; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; de Vega S, 2009, CELL MOL LIFE SCI, V66, P1890, DOI 10.1007/s00018-009-8632-6; Debeer P, 2002, J MED GENET, V39, P98, DOI 10.1136/jmg.39.2.98; Dietrich-Ntoukas T, 2012, CORNEA, V31, P564, DOI 10.1097/ICO.0b013e3182254b78; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Dunwell TL, 2009, EPIGENETICS-US, V4, P185, DOI 10.4161/epi.4.3.8752; Farjo R, 2008, INVEST OPHTH VIS SCI, V49, P511, DOI 10.1167/iovs.07-1013; Fisher SA, 2007, HUM MUTAT, V28, P406, DOI 10.1002/humu.20464; FRIEDERICH E, 1988, J CELL BIOL, V107, P1655, DOI 10.1083/jcb.107.5.1655; Garcia S, 2008, J CELL BIOCHEM, V104, P377, DOI 10.1002/jcb.21633; Go SL, 2005, ARCH OPHTHALMOL-CHIC, V123, P1237, DOI 10.1001/archopht.123.9.1237; HACKETT SF, 1989, ARCH OPHTHALMOL-CHIC, V107, P391, DOI 10.1001/archopht.1989.01070010401033; Hill VK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-51; Hoffhines AJ, 2006, J BIOL CHEM, V281, P37877, DOI 10.1074/jbc.M609398200; Hoffhines AJ, 2009, J BIOL CHEM, V284, P3096, DOI 10.1074/jbc.M808434200; Hopf M, 1999, EUR J BIOCHEM, V259, P917, DOI 10.1046/j.1432-1327.1999.00127.x; Hucthagowder V, 2006, AM J HUM GENET, V78, P1075, DOI 10.1086/504304; Hunzelmann N, 2001, BRIT J DERMATOL, V145, P217, DOI 10.1046/j.1365-2133.2001.04337.x; HUTTNER WB, 1984, METHOD ENZYMOL, V107, P200; IMMEL J, 1986, INVEST OPHTH VIS SCI, V27, P1770; Ivert L, 2002, GRAEF ARCH CLIN EXP, V240, P232, DOI 10.1007/s00417-001-0392-4; Johnson EC, 2007, INVEST OPHTH VIS SCI, V48, P3161, DOI 10.1167/iovs.06-1282; Kanan Y, 2009, EXP EYE RES, V89, P559, DOI 10.1016/j.exer.2009.05.010; Kang HK, 2008, BMJ-BRIT MED J, V336, P1235, DOI 10.1136/bmj.39581.525532.47; Kim TH, 2010, MOL CELLS, V29, P413, DOI 10.1007/s10059-010-0049-4; Kusubata M, 1999, J INVEST DERMATOL, V113, P906, DOI 10.1046/j.1523-1747.1999.00802.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Law EWL, 2012, ONCOGENE, V31, P728, DOI 10.1038/onc.2011.272; LEE KP, 1990, ARCH TOXICOL, V64, P135, DOI 10.1007/BF01974399; LEYTE A, 1991, J BIOL CHEM, V266, P740; Lim JJ, 2013, BIOMATERIALS, V34, P5007, DOI 10.1016/j.biomaterials.2013.03.037; LINDAHL U, 1978, ANNU REV BIOCHEM, V47, P385, DOI 10.1146/annurev.bi.47.070178.002125; Lotery AJ, 2006, HUM MUTAT, V27, P568, DOI 10.1002/humu.20344; Loveland K, 1998, BIOL REPROD, V58, P1123, DOI 10.1095/biolreprod58.5.1123; Marmorstein LY, 2007, HUM MOL GENET, V16, P2423, DOI 10.1093/hmg/ddm199; Martin F, 2003, OPHTHALMIC RES, V35, P232, DOI 10.1159/000071175; Miosge N, 1996, HISTOCHEM J, V28, P109, DOI 10.1007/BF02331415; Monigatti F, 2002, BIOINFORMATICS, V18, P769, DOI 10.1093/bioinformatics/18.5.769; Moore KL, 2003, J BIOL CHEM, V278, P24243, DOI 10.1074/jbc.R300008200; Muthana SM, 2012, ACS CHEM BIOL, V7, P31, DOI 10.1021/cb2004466; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Nour M, 2003, INVEST OPHTH VIS SCI, V44, P4505, DOI 10.1167/iovs.03-0453; Olin AI, 2001, J BIOL CHEM, V276, P1253, DOI 10.1074/jbc.M006783200; PAN TC, 1993, J CELL BIOL, V123, P1269, DOI 10.1083/jcb.123.5.1269; Perkumas KM, 2012, EXP EYE RES, V96, P82, DOI 10.1016/j.exer.2011.12.017; PFAFF M, 1995, EXP CELL RES, V219, P87, DOI 10.1006/excr.1995.1208; Piscaglia F, 2009, CELL TISSUE RES, V337, P449, DOI 10.1007/s00441-009-0823-9; Polkinghorne PJ, 2004, CLIN EXP OPHTHALMOL, V32, P159, DOI 10.1111/j.1442-9071.2004.00003.x; Ramachandran V, 1999, P NATL ACAD SCI USA, V96, P13771, DOI 10.1073/pnas.96.24.13771; Rider CC, 2006, BIOCHEM SOC T, V34, P458, DOI 10.1042/BST0340458; Rodgers SD, 2001, BIOPHYS J, V81, P2001, DOI 10.1016/S0006-3495(01)75850-X; Saika Shizuya, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P69, DOI 10.2174/187153008783928343; Salmivirta K, 2002, EXP CELL RES, V279, P188, DOI 10.1006/excr.2002.5611; Sasaki T, 1996, J CELL SCI, V109, P2895; SASAKI T, 1995, J MOL BIOL, V254, P892, DOI 10.1006/jmbi.1995.0664; Senger DR, 2002, AM J PATHOL, V160, P195, DOI 10.1016/S0002-9440(10)64363-5; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Sherry DM, 2010, EUR J NEUROSCI, V32, P1461, DOI 10.1111/j.1460-9568.2010.07431.x; Sicot FX, 2008, MOL CELL BIOL, V28, P1061, DOI 10.1128/MCB.01876-07; Stone EM, 1999, NAT GENET, V22, P199, DOI 10.1038/9722; Stone EM, 2004, NEW ENGL J MED, V351, P346, DOI 10.1056/NEJMoa040833; Strom A, 2006, CARDIOVASC RES, V69, P755, DOI 10.1016/j.cardiores.2005.12.001; Tan E, 2004, INVEST OPHTH VIS SCI, V45, P764, DOI 10.1167/iovs.03-1114; Tsuda T, 2012, J MOL CELL CARDIOL, V52, P273, DOI 10.1016/j.yjmcc.2011.11.001; Utani A, 1997, J BIOL CHEM, V272, P2814, DOI 10.1074/jbc.272.5.2814; Westmuckett AD, 2008, GEN COMP ENDOCR, V156, P145, DOI 10.1016/j.ygcen.2007.12.006; Yanagisawa H, 2009, J CELL COMMUN SIGNAL, V3, P337, DOI 10.1007/s12079-009-0065-3; Yi CH, 2007, AM J PATHOL, V170, P1535, DOI 10.2353/ajpath.2007.060478; Zafiropoulos A, 2008, CONNECT TISSUE RES, V49, P153, DOI 10.1080/03008200802148702; Zeng R, 2012, INVEST OPHTH VIS SCI, V53, P1685, DOI 10.1167/iovs.11-8241; Zhu JZ, 2011, BIOCHEMISTRY-US, V50, P1524, DOI 10.1021/bi101240v	79	7	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13419	13433		10.1074/jbc.M114.562157	http://dx.doi.org/10.1074/jbc.M114.562157			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24692557	hybrid, Green Published			2022-12-25	WOS:000335522800040
J	Cheng, FY; Yang, YR; Wang, CJ; Wu, YR; Cheng, SJ; Wang, HC; Wang, RY				Cheng, Fang-Yu; Yang, Yea-Ru; Wang, Chung-Jen; Wu, Yih-Ru; Cheng, Shih-Jung; Wang, Han-Cheng; Wang, Ray-Yau			Factors Influencing Turning and Its Relationship with Falls in Individuals with Parkinson's Disease	PLOS ONE			English	Article							GAIT; WALKING; PEOPLE; PREDICTORS; MOVEMENT; MOBILITY	Background: Falls are a major problem for people with Parkinson's disease (PD). Many studies indicate that more than 50% of people with PD have difficulty in turning that may lead to falls during daily activities. The aims of this study were to identify the relationship between turning performance and falls, and to determine the factors that influence turning performance. Methods: This study examined 45 patients with idiopathic PD (Hoehn and Yahr stage 1-3) using a battery of tests, including 180 degrees turn time, balance, and muscle strength. The levels of disease severity and freezing of gait were also measured. The number of falls in the past 6 months was recorded. Results: Sixteen out of forty-five participants experienced falls in the past 6 months. A receiver operating characteristic curve showed that turn time was highly related to falls [more affected side: sensitivity = 0.81, specificity = 0.79, area under the curve (AUC) = 0.83; less affected side: sensitivity = 0.88, specificity = 0.76, AUC = 0.83]. The most important factor influencing turn time was balance ability (both sides: p = 0.000) according to the regression model. Correlations between turn time and dynamic balance were further established with reaction time, movement velocity, endpoint excursion, and maximal excursion of the LOS (limits of stability) test. Conclusion: The time needed to complete a 180 degrees turn during the SQT (step/quick turn) test is a good index to differentiate fallers from non-fallers in persons with PD. Turn time is most influenced by balance. Furthermore, balance control, especially in an anterior or sideways direction, is important for turning performance.	[Cheng, Fang-Yu; Yang, Yea-Ru; Wang, Ray-Yau] Natl Yang Ming Univ, Dept Phys Therapy & Assist Technol, Taipei 112, Taiwan; [Wang, Chung-Jen] Cheng Hsin Gen Hosp, Dept Neurol, Taipei, Taiwan; [Wu, Yih-Ru] Chang Guan Mem Hosp, Dept Neuromuscular Disorder, Linkou, Taiwan; [Cheng, Shih-Jung] Mackay Mem Hosp, Dept Neurol, Taipei, Taiwan; [Wang, Han-Cheng] Shin Kong Wu Ho Mem Hosp, Dept Neurol, Taipei, Taiwan	National Yang Ming Chiao Tung University; Cheng Hsin General Hospital; Chang Gung Memorial Hospital; Mackay Memorial Hospital; Shin Kong Wu Ho Su Memorial Hospital	Wang, RY (corresponding author), Natl Yang Ming Univ, Dept Phys Therapy & Assist Technol, Taipei 112, Taiwan.	rywang@ym.edu.tw			Cheng Hsin Rehabilitation Medical Center [101F195CY23]; National Science Council [NSC100-2314-B-010-022-MY2]	Cheng Hsin Rehabilitation Medical Center; National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the Cheng Hsin Rehabilitation Medical Center (Grant No. 101F195CY23) and National Science Council (NSC100-2314-B-010-022-MY2). In addition, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOHANNON RW, 1986, PHYS THER, V66, P206, DOI 10.1093/ptj/66.2.206; CUMMING RG, 1994, J AM GERIATR SOC, V42, P774, DOI 10.1111/j.1532-5415.1994.tb06540.x; Faria CDCM, 2009, BRAZ J PHYS THER, V13, P451, DOI 10.1590/S1413-35552009005000052; Giladi N, 2000, PARKINSONISM RELAT D, V6, P165, DOI 10.1016/S1353-8020(99)00062-0; Huxham F, 2008, MOVEMENT DISORD, V23, P817, DOI 10.1002/mds.21932; Jessop RT, 2006, NEUROREHAB NEURAL RE, V20, P459, DOI 10.1177/1545968306287107; JORDAN N, 1992, J NEUROL NEUROSUR PS, V55, P658, DOI 10.1136/jnnp.55.8.658; Kerr GK, 2010, NEUROLOGY, V75, P116, DOI 10.1212/WNL.0b013e3181e7b688; Laessoe U, 2008, GAIT POSTURE, V28, P62, DOI 10.1016/j.gaitpost.2007.10.001; Louie S, 2009, MOVEMENT DISORD, V24, P1991, DOI 10.1002/mds.22741; Mak MKY, 2008, EXP BRAIN RES, V190, P43, DOI 10.1007/s00221-008-1446-1; Mak MKY, 2009, J NEUROL, V256, P742, DOI 10.1007/s00415-009-5007-8; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; Mancini M, 2008, CLIN BIOMECH BRISTOL; MASSION J, 1992, PROG NEUROBIOL, V38, P35, DOI 10.1016/0301-0082(92)90034-C; Morris ME, 2001, CLIN BIOMECH, V16, P459, DOI 10.1016/S0268-0033(01)00035-3; NeuroCom International, 2001, BAL MAN SYST CLIN OP; Patla AE, 1999, EXP BRAIN RES, V129, P629, DOI 10.1007/s002210050932; Stack EL, 2006, PARKINSONISM RELAT D, V12, P87, DOI 10.1016/j.parkreldis.2005.08.008; Tan D, 2012, PARKINSONISM RELAT D, V18, P117, DOI 10.1016/j.parkreldis.2011.07.014; Thigpen MT, 2000, PHYS THER, V80, P1174, DOI 10.1093/ptj/80.12.1174; Thomas AA, 2010, J NEUROL, V257, P1124, DOI 10.1007/s00415-010-5475-x; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; Vaishali P., 2012, INT J BIOL MED RES, V3, P1392; Visser JE, 2007, CLIN NEUROPHYSIOL, V118, P1602, DOI 10.1016/j.clinph.2007.03.010; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	26	35	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93572	10.1371/journal.pone.0093572	http://dx.doi.org/10.1371/journal.pone.0093572			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699675	Green Published, gold, Green Submitted			2022-12-25	WOS:000334105000071
J	Sundararaj, S; Saxena, AK; Sharma, R; Vashisht, K; Sharma, S; Anvikar, A; Dixit, R; Rosenthal, PJ; Pandey, KC				Sundararaj, Srinivasan; Saxena, Ajay K.; Sharma, Ruby; Vashisht, Kapil; Sharma, Supriya; Anvikar, Anup; Dixit, Rajnikant; Rosenthal, Philip J.; Pandey, Kailash C.			Cross-Talk between Malarial Cysteine Proteases and Falstatin: The BC Loop as a Hot-Spot Target	PLOS ONE			English	Article							STRUCTURAL BASIS; FALCIPAIN-2; HEMOGLOBIN; INHIBITOR; CHAGASIN; BINDING; IDENTIFICATION; VIVAPAINS	Cysteine proteases play a crucial role in the development of the human malaria parasites Plasmodium falciparum and Plasmodium vivax. Our earlier studies demonstrated that these enzymes are equipped with specific domains for defined functions and further suggested the mechanism of activation of cysteine proteases. The activities of these proteases are regulated by a new class of endogenous inhibitors of cysteine proteases (ICPs). Structural studies of the ICPs of Trypanosoma cruzi (chagasin) and Plasmodium berghei (PbICP) indicated that three loops (termed BC, DE, and FG) are crucial for binding to target proteases. Falstatin, an ICP of P. falciparum, appears to play a crucial role in invasion of erythrocytes and hepatocytes. However, the mechanism of inhibition of cysteine proteases by falstatin has not been established. Our study suggests that falstatin is the first known ICP to function as a multimeric protein. Using site-directed mutagenesis, hemoglobin hydrolysis assays and peptide inhibition studies, we demonstrate that the BC loop, but not the DE or FG loops, inhibits cysteine proteases of P. falciparum and P. vivax via hydrogen bonds. These results suggest that the BC loop of falstatin acts as a hot-spot target for inhibiting malarial cysteine proteases. This finding suggests new strategies for the development of anti-malarial agents based on protease-inhibitor interactions.	[Sundararaj, Srinivasan; Vashisht, Kapil; Sharma, Supriya; Anvikar, Anup; Dixit, Rajnikant; Pandey, Kailash C.] Indian Council Med Res, Natl Inst Malaria Res, Host Parasite Interact Biol Grp, New Delhi, India; [Saxena, Ajay K.; Sharma, Ruby] Jawaharlal Nehru Univ, Sch Life Sci, Struct Biol Lab, New Delhi 110067, India; [Rosenthal, Philip J.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA USA	Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Jawaharlal Nehru University, New Delhi; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Pandey, KC (corresponding author), Indian Council Med Res, Natl Inst Malaria Res, Host Parasite Interact Biol Grp, New Delhi, India.	kailashcp@mrcindia.org	vashisht, kapil/ABB-3966-2020; Sundararaj, Srinivasan/AAF-6809-2019; Pandey, Kailash/H-5048-2011; Sharma, Supriya/M-3849-2017; Dixit, Rajnikant/D-2566-2009	Dixit, Rajnikant/0000-0002-3536-8329; SHARMA, RUBY/0000-0002-8441-0415; sundararaj, Srinivasan/0000-0002-9112-2454	Department of Biotechnology, Government of India [BT/HRD/35/02/2006]; Ramalingaswami Fellowship; NIMR	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Ramalingaswami Fellowship; NIMR	Work in the laboratory is supported by Department of Biotechnology, Government of India (BT/HRD/35/02/2006, dated 05.02.2010). KCP is a recipient of a Ramalingaswami Fellowship. The authors thank NIMR for extramural funds for setting a new laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Farias SL, 2005, MOL BIOCH; Hansen G, 2011, STRUCTURE, V19, P919, DOI 10.1016/j.str.2011.03.025; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jo H, 2012, J AM CHEM SOC, V134, P17704, DOI 10.1021/ja307599z; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kang JM, 2012, PARASITOLOGY, V139, P1029, DOI 10.1017/S0031182012000297; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kerr ID, 2009, J BIOL CHEM, V284, P25697, DOI 10.1074/jbc.M109.014340; Kerr LD, 2009, J MED CHEM, V52, P852, DOI 10.1021/jm8013663; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Liu S, 2004, PROTEINS, V56, P93, DOI 10.1002/prot.20019; Monteiro ACS, 2001, J CELL SCI, V114, P3933; Moon SU, 2011, EXP PARASITOL, V128, P127, DOI 10.1016/j.exppara.2011.02.015; Na BK, 2004, BIOCHEM J, V378, P529, DOI 10.1042/BJ20031487; Pandey KC, 2006, PLOS PATHOG, V2, P1031, DOI 10.1371/journal.ppat.0020117; Pandey KC, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/345195; Pandey Kailash C, 2011, J Parasit Dis, V35, P94; Pandey KC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005694; Pandey KC, 2005, P NATL ACAD SCI USA, V102, P9138, DOI 10.1073/pnas.0502368102; Rennenberg A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000825; Shahian T, 2009, NAT CHEM BIOL, V5, P640, DOI 10.1038/nchembio.192; Sijwali PS, 2002, J BIOL CHEM, V277, P14910, DOI 10.1074/jbc.M109680200; Smith BO, 2005, J BIOL CHEM, V510, P868; Subramanian S, 2007, J BIOL CHEM, V282, P24961, DOI 10.1074/jbc.M703316200; Sundararaj S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047227; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Men TT, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-272; Wang SX, 2007, STRUCTURE, V15, P535, DOI 10.1016/j.str.2007.03.012; Wang SX, 2006, P NATL ACAD SCI USA, V103, P11503, DOI 10.1073/pnas.0600489103; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI [10.1172/JCI21682, 10.1172/JCI200421682]; WHO, 2010, WORLD MALARIA REPORT 2010, P1	36	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93008	10.1371/journal.pone.0093008	http://dx.doi.org/10.1371/journal.pone.0093008			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699522	gold, Green Submitted, Green Published			2022-12-25	WOS:000334105000039
J	Liu, DG; Wang, LJ; Liu, CL; Song, XJ; He, SZ; Zhai, H; Liu, QC				Liu, Degao; Wang, Lianjun; Liu, Chenglong; Song, Xuejin; He, Shaozhen; Zhai, Hong; Liu, Qingchang			An Ipomoea batatas Iron-Sulfur Cluster Scaffold Protein Gene, IbNFU1, Is Involved in Salt Tolerance	PLOS ONE			English	Article							EMBRYOGENIC SUSPENSION-CULTURES; PROLINE ACCUMULATION; STRESS TOLERANCE; SWEET-POTATO; TRANSCRIPT EXPRESSION; PLANT-REGENERATION; FERREDOXIN; MECHANISMS; REDUCTASE; SALINITY	Iron-sulfur cluster biosynthesis involving the nitrogen fixation (Nif) proteins has been proposed as a general mechanism acting in various organisms. NifU-like protein may play an important role in protecting plants against abiotic and biotic stresses. An iron-sulfur cluster scaffold protein gene, IbNFU1, was isolated from a salt-tolerant sweetpotato (Ipomoea batatas (L.) Lam.) line LM79 in our previous study, but its role in sweetpotato stress tolerance was not investigated. In the present study, the IbNFU1 gene was introduced into a salt-sensitive sweetpotato cv. Lizixiang to characterize its function in salt tolerance. The IbNFU1-overexpressing sweetpotato plants exhibited significantly higher salt tolerance compared with the wild-type. Proline and reduced ascorbate content were significantly increased, whereas malonaldehyde (MDA) content was significantly decreased in the transgenic plants. The activities of superoxide dismutase (SOD) and photosynthesis were significantly enhanced in the transgenic plants. H2O2 was also found to be significantly less accumulated in the transgenic plants than in the wild-type. Overexpression of IbNFU1 up-regulated pyrroline-5-carboxylate synthase (P5CS) and pyrroline-5- carboxylate reductase (P5CR) genes under salt stress. The systemic up-regulation of reactive oxygen species (ROS) scavenging genes was found in the transgenic plants under salt stress. These findings suggest that IbNFU1gene is involved in sweetpotato salt tolerance and enhances salt tolerance of the transgenic sweetpotato plants by regulating osmotic balance, protecting membrane integrity and photosynthesis and activating ROS scavenging system.	[Liu, Degao; Wang, Lianjun; Liu, Chenglong; Song, Xuejin; He, Shaozhen; Zhai, Hong; Liu, Qingchang] China Agr Univ, Minist Educ, Lab Crop Heterosis & Utilizat, Beijing Key Lab Crop Genet Improvement, Beijing 100094, Peoples R China; [Wang, Lianjun] Hubei Acad Agr Sci, Inst Food Crops, Wuhan, Peoples R China	China Agricultural University; Hubei Academy of Agricultural Sciences	Liu, QC (corresponding author), China Agr Univ, Minist Educ, Lab Crop Heterosis & Utilizat, Beijing Key Lab Crop Genet Improvement, Beijing 100094, Peoples R China.	liuqc@cau.edu.cn	Liu, Degao/L-3682-2016	Liu, Degao/0000-0002-0090-9455	China Agriculture Research System [CARS-11]; National Natural Science Foundation of China [31371680]; Hubei Innovation Center of Agricultural Science and Technology [2007-620-001-03]	China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Innovation Center of Agricultural Science and Technology	This work was supported by China Agriculture Research System (CARS-11, Sweetpotato), the National Natural Science Foundation of China (31371680) and Hubei Innovation Center of Agricultural Science and Technology (2007-620-001-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agar JN, 2000, J BIOL INORG CHEM, V5, P167, DOI 10.1007/s007750050361; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Asano T, 2012, PLANT J, V69, P26, DOI 10.1111/j.1365-313X.2011.04766.x; Balasubramanian R, 2006, J BACTERIOL, V188, P3182, DOI 10.1128/JB.188.9.3182-3191.2006; Balk J, 2005, TRENDS PLANT SCI, V10, P324, DOI 10.1016/j.tplants.2005.05.002; Balk J, 2011, TRENDS PLANT SCI, V16, P218, DOI 10.1016/j.tplants.2010.12.006; Bao AK, 2009, PLANT SCI, V176, P232, DOI 10.1016/j.plantsci.2008.10.009; Chen HC, 2010, INTEGR SER INFORM SY, V21, P167, DOI 10.1007/978-1-4419-1278-7_12; de Ronde JA, 2000, PLANT GROWTH REGUL, V32, P13, DOI 10.1023/A:1006338911617; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; Deng XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069881; Dhir SK, 1998, PLANT CELL REP, V17, P665, DOI 10.1007/s002990050462; Dietz KJ, 2006, J EXP BOT, V57, P1697, DOI 10.1093/jxb/erj160; Eltayeb AE, 2006, PHYSIOL PLANTARUM, V127, P57, DOI 10.1111/j.1399-3054.2006.00624.x; Fan WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037344; Fernandez-Falcon M, 2006, SCI HORTIC-AMSTERDAM, V107, P373, DOI 10.1016/j.scienta.2005.08.009; Fricke W, 2004, J EXP BOT, V55, P1115, DOI 10.1093/jxb/erh117; Gallie DR, 2013, J EXP BOT, V64, P433, DOI 10.1093/jxb/ers330; Gao S, 2011, PLANT CELL TISS ORG, V107, P205, DOI 10.1007/s11240-011-9971-1; Giacomelli L, 2007, PLANT MOL BIOL, V65, P627, DOI 10.1007/s11103-007-9227-y; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Hare PD, 1997, PLANT GROWTH REGUL, V21, P79, DOI 10.1023/A:1005703923347; Hase Toshiharu, 2006, V24, P477; He SZ, 2009, PLANT CELL TISS ORG, V96, P69, DOI 10.1007/s11240-008-9461-2; Hoagland D.R., 1950, WATER CULTURE METHOD, V347, P1, DOI DOI 10.1007/S12374-010-9112-0; HU CAA, 1992, P NATL ACAD SCI USA, V89, P9354, DOI 10.1073/pnas.89.19.9354; JEFFERSON RA, 1987, EMBO J, V6, P3901; KISHOR PBK, 1995, PLANT PHYSIOL, V108, P1387, DOI 10.1104/pp.108.4.1387; Koca H, 2006, BIOL PLANTARUM, V50, P745, DOI 10.1007/s10535-006-0121-2; Kumar V, 2010, PLANT BIOTECHNOL REP, V4, P37, DOI 10.1007/s11816-009-0118-3; Kumeta H, 2007, J BIOMOL NMR, V38, P161, DOI 10.1007/s10858-007-9155-9; Leon S, 2003, BIOCHEM J, V371, P823, DOI 10.1042/BJ20021946; Lin YH, 2013, INT J MOL SCI, V14, P20913, DOI 10.3390/ijms141020913; Lintala M, 2009, PLANT J, V57, P1103, DOI 10.1111/j.1365-313X.2008.03753.x; Liu DG, 2014, PLANT CELL TISS ORG, V117, P1, DOI 10.1007/s11240-013-0415-y; Liu QC, 2001, IN VITRO CELL DEV-PL, V37, P564; Mano J, 2001, BBA-BIOENERGETICS, V1504, P275, DOI 10.1016/S0005-2728(00)00256-5; Mishra MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063064; MIYAKE C, 1994, PLANT CELL PHYSIOL, V35, P539, DOI 10.1093/oxfordjournals.pcp.a078628; Mohammadi M, 2008, GENOME, V51, P357, DOI 10.1139/G08-020; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; SAVOURE A, 1995, FEBS LETT, V372, P13, DOI 10.1016/0014-5793(95)00935-3; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schurmann P, 2008, ANTIOXID REDOX SIGN, V10, P1235, DOI 10.1089/ars.2007.1931; Shim KS, 2004, PLANT CELL REP, V22, P599, DOI 10.1007/s00299-003-0742-2; Sun YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059924; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; SZOKE A, 1992, PLANT PHYSIOL, V99, P1642, DOI 10.1104/pp.99.4.1642; Tognetti VB, 2006, PLANT CELL, V18, P2035, DOI 10.1105/tpc.106.042424; Touraine B, 2004, PLANT J, V40, P101, DOI 10.1111/j.1365-313X.2004.02189.x; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; VERBRUGGEN N, 1993, PLANT PHYSIOL, V103, P771, DOI 10.1104/pp.103.3.771; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Wang LJ, 2013, J INTEGR AGR, V12, P27, DOI 10.1016/S2095-3119(13)60202-6; Wang TZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058952; WATAD AEA, 1983, PLANT PHYSIOL, V73, P624, DOI 10.1104/pp.73.3.624; WYNJONES RG, 1978, AUST J PLANT PHYSIOL, V5, P817, DOI 10.1071/PP9780817; Xu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0069810, 10.1371/journal.pone.0079289]; Yabe T, 2004, PLANT CELL, V16, P993, DOI 10.1105/tpc.020511; Yale J, 2001, J BIOL CHEM, V276, P15996, DOI 10.1074/jbc.M008209200; Yang A, 2012, J EXP BOT, V63, P2541, DOI 10.1093/jxb/err431; Yu B, 2007, PLANT CELL TISS ORG, V90, P265, DOI 10.1007/s11240-007-9265-9; Yuvaniyama P, 2000, P NATL ACAD SCI USA, V97, P599, DOI 10.1073/pnas.97.2.599; Zang N, 2009, SCI HORTIC-AMSTERDAM, V122, P649, DOI 10.1016/j.scienta.2009.06.023; Zhang H, 2012, J PROTEOME RES, V11, P49, DOI 10.1021/pr200861w; Zhang H, 2012, PLANT CELL TISS ORG, V110, DOI 10.1007/s11240-012-0142-9; Zhao Q, 2013, J PROTEOMICS, V82, P230, DOI 10.1016/j.jprot.2013.01.024; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754; ZHENG LM, 1994, J BIOL CHEM, V269, P18723	73	18	22	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93935	10.1371/journal.pone.0093935	http://dx.doi.org/10.1371/journal.pone.0093935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695556	Green Submitted, Green Published, gold			2022-12-25	WOS:000334103000131
J	Cheriyan, VT; Wang, Y; Muthu, M; Jamal, S; Chen, D; Yang, HJ; Polin, LA; Tarca, AL; Pass, HI; Dou, QP; Sharma, S; Wali, A; Rishi, AK				Cheriyan, Vino T.; Wang, Ying; Muthu, Magesh; Jamal, Shazia; Chen, Di; Yang, Huanjie; Polin, Lisa A.; Tarca, Adi L.; Pass, Harvey I.; Dou, Q. Ping; Sharma, Sunita; Wali, Anil; Rishi, Arun K.			Disulfiram Suppresses Growth of the Malignant Pleural Mesothelioma Cells in Part by Inducing Apoptosis	PLOS ONE			English	Article							NF-KAPPA-B; BREAST-CANCER CELLS; FACTOR-BINDING PROTEIN-7; REGULATORY PROTEIN-1; IN-VITRO; PODOPLANIN; INHIBITION; CYCLE; TUMOR; CARCINOMA	Dithiocarbamate compound Disulfiram (DSF)that binds with copper and functions as an inhibitor of aldehyde dehydrogenase is a Food and Drug Administration approved agent for treatment of alcoholism. Copper complexed DSF (DSF-Cu) also possesses anti-tumor and chemosensitizing properties; however, its molecular mechanisms of action remain unclear. Here we investigated malignant pleural mesothelioma (MPM) suppressive effects of DSF-Cu and the molecular mechanisms involved. DSF-Cu inhibited growth of the murine as well as human MPM cells in part by increasing levels of ubiquitinated proteins. DSF-Cu exposure stimulated apoptosis in MPM cells that involved activation of stress-activated protein kinases (SAPKs) p38 and JNK1/2, caspase-3, and cleavage of poly-(ADP-ribose)-polymerase, as well as increased expression of sulfatase 1 and apoptosis transducing CARP-1/CCAR1 protein. Gene-array based analyses revealed that DSF-Cu suppressed cell growth and metastasis-promoting genes including matrix metallopeptidase 3 and 10. DSF inhibited MPM cell growth and survival by upregulating cell cycle inhibitor p27Kip1, IGFBP7, and inhibitors of NF-kB such as ABIN 1 and 2 and Inhibitory kB (IkB)alpha and beta proteins. DSF-Cu promoted cleavage of vimentin, as well as serine-phosphorylation and lysine-63 linked ubiquitination of podoplanin. Administration of 50 mg/kg DSF-Cu by daily i.p injections inhibited growth of murine MPM cell-derived tumors in vivo. Although podoplanin expression often correlates with metastatic disease and poor prognosis, phosphorylation of serines in cytoplasmic domain of podoplanin has recently been shown to interfere with cellular motility and migration signaling. Post-translational modification of podoplanin and cleavage of vimentin by DSF-Cu underscore a metastasis inhibitory property of this agent and together with our in vivo studies underscore its potential as an anti-MPM agent.	[Wang, Ying; Chen, Di; Polin, Lisa A.; Dou, Q. Ping; Sharma, Sunita; Wali, Anil; Rishi, Arun K.] Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA; [Cheriyan, Vino T.; Wang, Ying; Muthu, Magesh; Jamal, Shazia; Chen, Di; Polin, Lisa A.; Dou, Q. Ping; Sharma, Sunita; Rishi, Arun K.] Wayne State Univ, Dept Oncol, Detroit, MI USA; [Tarca, Adi L.] Wayne State Univ, Dept Comp Sci, Detroit, MI USA; [Muthu, Magesh; Wali, Anil; Rishi, Arun K.] John D Dingell VA Med Ctr, Detroit, MI USA; [Pass, Harvey I.] NYU, Ctr Canc, Div Cardiothorac Surg, New York, NY USA; [Yang, Huanjie] Harbin Inst Technol, Dept Life Sci & Engn, Harbin 150006, Peoples R China	Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; New York University; Harbin Institute of Technology	Dou, QP (corresponding author), Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA.	doup@karmanos.org; Rishia@Karmanos.org	muthu, magesh/N-6987-2017	muthu, magesh/0000-0003-3311-8120; Dou, Qingping/0000-0002-6465-1473; Pass, Harvey/0000-0003-3222-3471; jamal, shazia/0000-0003-4555-9513	Department of Veterans Affairs Merit Review grant [RO1 CA20009]; NCI/NIH Cancer Center Support Grant; NATIONAL CANCER INSTITUTE [R21CA184788] Funding Source: NIH RePORTER	Department of Veterans Affairs Merit Review grant(US Department of Veterans Affairs); NCI/NIH Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Department of Veterans Affairs Merit Review grant (AKR; AW), RO1 CA20009 (QPD), and the NCI/NIH Cancer Center Support Grant to Karmanos Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2013, J IMMUNOL, V190, P6239, DOI 10.4049/jimmunol.1300448; Ashour AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066733; Brahemi G, 2010, J MED CHEM, V53, P2757, DOI 10.1021/jm901757t; Cen DZ, 2004, J MED CHEM, V47, P6914, DOI 10.1021/jm049568z; Chen D, 2006, CANCER RES, V66, P10425, DOI 10.1158/0008-5472.CAN-06-2126; Chen D, 2013, MOL THER, V21, P758, DOI 10.1038/mt.2012.282; Cvek B, 2008, DRUG DISCOV TODAY, V13, P716, DOI 10.1016/j.drudis.2008.05.003; Furuta J, 2006, CANCER RES, V66, P6080, DOI 10.1158/0008-5472.CAN-06-0157; Gilles C, 1999, J CELL SCI, V112, P4615; Gilmore TD, 2006, ONCOGENE, V25, P6887, DOI 10.1038/sj.onc.1209982; Hoshino A, 2011, CANCER RES, V71, P4769, DOI 10.1158/0008-5472.CAN-10-3228; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; JOHANSSON B, 1992, ACTA PSYCHIAT SCAND, V86, P15, DOI 10.1111/j.1600-0447.1992.tb03310.x; Kamp DW, 2009, TRANSL RES, V153, P143, DOI 10.1016/j.trsl.2009.01.004; Kim JH, 2008, MOL CELL, V31, P510, DOI 10.1016/j.molcel.2008.08.001; Kimura N, 2005, PATHOL INT, V55, P83, DOI 10.1111/j.1440-1827.2005.01791.x; Komatsu S, 2000, BIOCHEM BIOPH RES CO, V267, P109, DOI 10.1006/bbrc.1999.1937; Krishnan H, 2013, J BIOL CHEM, V288, P12215, DOI 10.1074/jbc.C112.446823; Lai Jin-Ping, 2008, J Gastrointest Cancer, V39, P149, DOI 10.1007/s12029-009-9058-y; Liu CT, 2013, DIGEST DIS SCI, V58, P1256, DOI 10.1007/s10620-012-2429-4; Liu P, 2013, BRIT J CANCER, V109, P1876, DOI 10.1038/bjc.2013.534; Liu P, 2012, BRIT J CANCER, V107, P1488, DOI 10.1038/bjc.2012.442; Martin-Villar E, 2010, MOL BIOL CELL, V21, P4387, DOI 10.1091/mbc.E10-06-0489; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; Morrison BW, 2010, MELANOMA RES, V20, P11, DOI 10.1097/CMR.0b013e328334131d; Nakano H, 2006, CELL DEATH DIFFER, V13, P730, DOI 10.1038/sj.cdd.4401830; NOBEL CSI, 1995, J BIOL CHEM, V270, P26202, DOI 10.1074/jbc.270.44.26202; Odaka M, 2001, CANCER RES, V61, P6201; Oh YM, 1996, J BIOL CHEM, V271, P30322, DOI 10.1074/jbc.271.48.30322; Orrenius S, 1996, BIOCHEM SOC T, V24, P1032, DOI 10.1042/bst0241032; Osman I, 2006, CLIN CANCER RES, V12, P3374, DOI 10.1158/1078-0432.CCR-05-2081; PASS HI, 1995, ANN THORAC SURG, V59, P835, DOI 10.1016/0003-4975(95)00045-M; Pass HI, 2005, NEW ENGL J MED, V353, P1564, DOI 10.1056/NEJMoa051185; Pen A, 2008, ONCOGENE, V27, P6834, DOI 10.1038/onc.2008.287; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Peto J, 1999, BRIT J CANCER, V79, P666, DOI 10.1038/sj.bjc.6690105; Puliyappadamba VT, 2011, J BIOL CHEM, V286, P38000, DOI 10.1074/jbc.M111.222398; Rae C, 2013, J NUCL MED, V54, P953, DOI 10.2967/jnumed.112.113324; Rishi AK, 2006, J BIOL CHEM, V281, P13188, DOI 10.1074/jbc.M512279200; Rishi AK, 2003, J BIOL CHEM, V278, P33422, DOI 10.1074/jbc.M303173200; Robinson TJW, 2013, CELL CYCLE, V12, P3013, DOI 10.4161/cc.26063; Singh S, 2003, CANCER RES, V63, P2306; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Somers PK, 2000, FREE RADICAL BIO MED, V28, P1532, DOI 10.1016/S0891-5849(00)00257-4; Sprenger CC, 1999, CANCER RES, V59, P2370; Su S, 2009, SEMIN THORAC CARDIOV, V21, P125, DOI 10.1053/j.semtcvs.2009.07.006; Suzuki E, 2007, CANCER RES, V67, P2351, DOI 10.1158/0008-5472.CAN-06-2389; Tarca AL, 2007, PLOS COMPUT BIOL, V3, P953, DOI 10.1371/journal.pcbi.0030116; Tsao AS, 2009, J CLIN ONCOL, V27, P2081, DOI 10.1200/JCO.2008.19.8523; VALERIOTE F, 1989, CANCER RES, V49, P6658; Wang WG, 2003, INT J CANCER, V104, P504, DOI 10.1002/ijc.10972; Wang Y, 2011, MOL CELL BIOCHEM, V357, P83, DOI 10.1007/s11010-011-0878-2; Wang Y, 2010, CANCER CHEMOTH PHARM, V66, P455, DOI 10.1007/s00280-009-1181-8; Xiao GT, 2011, AM J CANCER RES, V1, P192; Yang HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041214; Ye F, 2007, J CANCER RES CLIN, V133, P305, DOI 10.1007/s00432-006-0171-z; Yip NC, 2011, BRIT J CANCER, V104, P1564, DOI 10.1038/bjc.2011.126; Zhang LY, 2007, MOL CANCER THER, V6, P1661, DOI 10.1158/1535-7163.MCT-06-0653	58	34	39	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93711	10.1371/journal.pone.0093711	http://dx.doi.org/10.1371/journal.pone.0093711			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690739	Green Submitted, gold, Green Published			2022-12-25	WOS:000334101100129
J	Moeton, M; Kanski, R; Stassen, OMJA; Sluijs, JA; Geerts, D; van Tijn, P; Wiche, G; van Strien, ME; Hol, EM				Moeton, Martina; Kanski, Regina; Stassen, Oscar M. J. A.; Sluijs, Jacqueline A.; Geerts, Dirk; van Tijn, Paula; Wiche, Gerhard; van Strien, Miriam E.; Hol, Elly M.			Silencing GFAP isoforms in astrocytoma cells disturbs laminin-dependent motility and cell adhesion	FASEB JOURNAL			English	Article						intermediate filaments; extracellular matrix; glia; glioma; cytoskeleton	FIBRILLARY ACIDIC PROTEIN; CENTRAL-NERVOUS-SYSTEM; HUMAN-BRAIN TUMORS; INTERMEDIATE-FILAMENTS; GLIOMA-CELLS; LENTIVIRAL VECTOR; COMPLEMENTARY-DNA; STEM-CELLS; EXPRESSION; MIGRATION	Glial fibrillary acidic protein (GFAP) is an intermediate filament protein expressed in astrocytes and neural stem cells. The GFAP gene is alternatively spliced, and expression of GFAP is highly regulated during development, on brain damage, and in neurodegenerative diseases. GFAP alpha is the canonical splice variant and is expressed in all GFAP-positive cells. In the human brain, the alternatively spliced transcript GFAP alpha marks specialized astrocyte populations, such as subpial astrocytes and the neurogenic astrocytes in the human subventricular zone. We here show that shifting the GFAP isoform ratio in favor of GFAP alpha in astrocytoma cells, by selectively silencing the canonical isoform GFAP alpha with short hairpin RNAs, induced a change in integrins, a decrease in plectin, and an increase in expression of the extracellular matrix component laminin. Together, this did not affect cell proliferation but resulted in a significantly decreased motility of astrocytoma cells. In contrast, a downregulation of all GFAP isoforms led to less cell spreading, increased integrin expression, and a >100-fold difference in the adhesion of astrocytoma cells to laminin. In summary, isoform-specific silencing of GFAP revealed distinct roles of a specialized GFAP network in regulating the interaction of astrocytoma cells with the extracellular matrix through laminin.	[Moeton, Martina; Kanski, Regina; Stassen, Oscar M. J. A.; Sluijs, Jacqueline A.; van Tijn, Paula; van Strien, Miriam E.; Hol, Elly M.] Netherlands Inst Neurosci, Amsterdam, Netherlands; [Sluijs, Jacqueline A.; Hol, Elly M.] Univ Med Ctr Utrecht, Dept Translat Neurosci, Brain Ctr Rudolf Magnus, NL-3508 AB Utrecht, Netherlands; [Geerts, Dirk] Erasmus Univ, Med Ctr, Dept Pediat Oncol & Hematol, Rotterdam, Netherlands; [van Tijn, Paula] Hubrecht Inst, Utrecht, Netherlands; [Wiche, Gerhard] Univ Vienna, Dept Biochem & Cell Biol, Max F Perutz Labs, Vienna, Austria; [Hol, Elly M.] Univ Amsterdam, Swammerdam Inst Life Sci, Ctr Neurosci, Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Amsterdam	Hol, EM (corresponding author), Univ Med Ctr Utrecht, Dept Translat Neurosci, Brain Ctr Rudolf Magnus, Str 4-205,POB 85060, NL-3508 AB Utrecht, Netherlands.	e.m.hol-2@umcutrecht.nl	Hol, Elly M/F-1891-2013; Hol, Elly/J-2025-2019; WICHE, Gerhard/AAA-3227-2021; van Tijn, Paula/E-4866-2012; Geerts, Dirk/K-8260-2015; Stassen, Oscar/I-9075-2014	Hol, Elly M/0000-0001-5604-2603; Hol, Elly/0000-0001-5604-2603; Geerts, Dirk/0000-0002-6386-8187; Stassen, Oscar/0000-0001-7485-0903; Wiche, Gerhard/0000-0001-9550-5463	Netherlands Organization for Scientific Research (NWO; VICI) [865.09.003]; FOM [09MMC06]; NANONET COST [BM1002]; Austrian Science Fund (FWF) [I 1207, P 23729] Funding Source: researchfish	Netherlands Organization for Scientific Research (NWO; VICI)(Netherlands Organization for Scientific Research (NWO)); FOM(FOM (The Netherlands)); NANONET COST(European Cooperation in Science and Technology (COST)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This project is funded by The Netherlands Organization for Scientific Research (NWO; VICI grant 865.09.003 to E. M. H.), FOM 09MMC06, and NANONET COST BM1002. The Netherlands Institute for Neuroscience and the Hubrecht Institute are institutes of the Royal Netherlands Academy of Arts and Sciences.	Andra K, 2003, J INVEST DERMATOL, V120, P189, DOI 10.1046/j.1523-1747.2003.12027.x; Aumailley M, 2000, J CELL SCI, V113, P259; Choi KC, 2009, NEUROSCI LETT, V463, P182, DOI 10.1016/j.neulet.2009.07.076; Chung BM, 2013, CURR OPIN CELL BIOL, V25, P600, DOI 10.1016/j.ceb.2013.06.008; Colognato H, 2005, TRENDS NEUROSCI, V28, P480, DOI 10.1016/j.tins.2005.07.004; DECK JHN, 1978, ACTA NEUROPATHOL, V42, P183, DOI 10.1007/BF00690355; Delamarre E, 2009, AM J PATHOL, V175, P844, DOI 10.2353/ajpath.2009.080920; Farin A, 2006, GLIA, V53, P799, DOI 10.1002/glia.20334; Franco SJ, 2011, DEV NEUROBIOL, V71, P889, DOI 10.1002/dneu.20946; Goldbrunner RH, 1999, ACTA NEUROCHIR, V141, P295, DOI 10.1007/s007010050301; Gregor M, 2014, FASEB J, V28, P715, DOI 10.1096/fj.13-231829; Heo DH, 2012, J NEURO-ONCOL, V108, P45, DOI 10.1007/s11060-012-0801-z; Ho CL, 1996, CANCER METAST REV, V15, P483, DOI 10.1007/BF00054014; Hol EM, 2003, MOL PSYCHIATR, V8, P786, DOI 10.1038/sj.mp.4001379; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; JACQUE CM, 1978, J NEUROL SCI, V35, P147, DOI 10.1016/0022-510X(78)90107-7; Kamphuis W, 2014, NEUROBIOL AGING, V35, P492, DOI 10.1016/j.neurobiolaging.2013.09.035; Kamphuis W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042823; Katada K, 2012, J PROTEOMICS, V75, P1803, DOI 10.1016/j.jprot.2011.12.018; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lepekhin EA, 2001, J NEUROCHEM, V79, P617, DOI 10.1046/j.1471-4159.2001.00595.x; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Menet V, 2001, J NEUROSCI, V21, P6147; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Middeldorp J, 2010, DEVELOPMENT, V137, P313, DOI 10.1242/dev.041632; Middeldorp J, 2009, FASEB J, V23, P2710, DOI 10.1096/fj.08-127696; Moyano JV, 2010, MOL BIOL CELL, V21, P3654, DOI 10.1091/mbc.E10-06-0523; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nielsen AL, 2004, J BIOL CHEM, V279, P41537, DOI 10.1074/jbc.M406601200; Nishio T, 2005, NEUROSCIENCE, V132, P87, DOI 10.1016/j.neuroscience.2004.12.028; Niu CS, 2011, ONCOL REP, V26, P593, DOI 10.3892/or.2011.1308; Ogier C, 2006, GLIA, V54, P272, DOI 10.1002/glia.20349; Palu E, 2002, J NEUROSCI RES, V69, P243, DOI 10.1002/jnr.10292; Perng MD, 2008, MOL BIOL CELL, V19, P4521, DOI 10.1091/mbc.E08-03-0284; Rebetz J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001936; Roelofs RF, 2005, GLIA, V52, P289, DOI 10.1002/glia.20243; Rooprai HK, 1999, INT J DEV NEUROSCI, V17, P613, DOI 10.1016/S0736-5748(99)00051-9; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Rousseau A, 2006, J NEUROPATH EXP NEUR, V65, P1149, DOI 10.1097/01.jnen.0000248543.90304.2b; Ruijter JM, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-2; RUTKA JT, 1993, CANCER RES, V53, P3624; RUTKA JT, 1994, CANCER RES, V54, P3267; Rutka JT, 1997, J NEUROSURG, V87, P420, DOI 10.3171/jns.1997.87.3.0420; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Skalli O, 2013, HUM PATHOL, V44, P2081, DOI 10.1016/j.humpath.2013.03.013; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Steinbock FA, 1999, BIOL CHEM, V380, P151, DOI 10.1515/BC.1999.023; TODA M, 1994, NEUROREPORT, V5, P1969, DOI 10.1097/00001756-199410000-00033; van den Berge SA, 2010, AGING CELL, V9, P313, DOI 10.1111/j.1474-9726.2010.00556.x; VELASCO ME, 1980, CANCER, V45, P484, DOI 10.1002/1097-0142(19800201)45:3<484::AID-CNCR2820450312>3.0.CO;2-9; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; WEINSTEIN DE, 1991, J CELL BIOL, V112, P1205, DOI 10.1083/jcb.112.6.1205; Wiche Gerhard, 2011, Bioarchitecture, V1, P14; YUNG WKA, 1985, J NEURO-ONCOL, V3, P35	55	30	30	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					2942	2954		10.1096/fj.13-245837	http://dx.doi.org/10.1096/fj.13-245837			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24696300				2022-12-25	WOS:000337949400018
J	Kim, J; Lee, H; Lee, JH; Kwon, DY; Genovesio, A; Fenistein, D; Ogier, A; Brondani, V; Grailhe, R				Kim, Jiho; Lee, Honggun; Lee, Joo Hyun; Kwon, Do-yoon; Genovesio, Auguste; Fenistein, Denis; Ogier, Arnaud; Brondani, Vincent; Grailhe, Regis			Dimerization, Oligomerization, and Aggregation of Human Amyotrophic Lateral Sclerosis Copper/Zinc Superoxide Dismutase 1 Protein Mutant Forms in Live Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC MICE; SOD1; MUTATION; COMMON; SUPEROXIDE-DISMUTASE-1; TOXICITY; GENE	More than 100 copper/zinc superoxide dismutase 1 (SOD1) genetic mutations have been characterized. These mutations lead to the death of motor neurons in ALS. In its native form, the SOD1 protein is expressed as a homodimer in the cytosol. In vitro studies have shown that SOD1 mutations impair the dimerization kinetics of the protein, and in vivo studies have shown that SOD1 forms aggregates in patients with familial forms of ALS. In this study, we analyzed WT SOD1 and 9 mutant (mt) forms of the protein by non-invasive fluorescence techniques. Using microscopic techniques such as fluorescence resonance energy transfer, fluorescence complementation, image-based quantification, and fluorescence correlation spectroscopy, we studied SOD1 dimerization, oligomerization, and aggregation. Our results indicate that SOD1 mutations lead to an impairment in SOD1 dimerization and, subsequently, affect protein aggregation. We also show that SOD1 WT and mt proteins can dimerize. However, aggregates are predominantly composed of SOD1 mt proteins.	[Kim, Jiho; Lee, Honggun; Lee, Joo Hyun; Kwon, Do-yoon; Genovesio, Auguste; Fenistein, Denis; Ogier, Arnaud; Brondani, Vincent; Grailhe, Regis] Inst Pasteur Korea, Songnam 463400, Gyeonggi Do, South Korea	Institut Pasteur Korea	Grailhe, R (corresponding author), Inst Pasteur Korea, Songnam 463400, Gyeonggi Do, South Korea.	regis.grailhe@ip-korea.org	GENOVESIO, Auguste/I-1656-2017; Brondani, Vincent/AAB-8394-2021	Genovesio, Auguste/0000-0003-1877-5595	Basic Science Research Program through the National Research Foundation of Korea Grant - Ministry of Education, Science, and Technology [2012R1A2004980]; National Research Foundation of Korea Grant - Korean government, the Gyeonggi-do [2007-00559]; Korea Institute of Science and Technology Information (KISTI)	Basic Science Research Program through the National Research Foundation of Korea Grant - Ministry of Education, Science, and Technology; National Research Foundation of Korea Grant - Korean government, the Gyeonggi-do; Korea Institute of Science and Technology Information (KISTI)(Korea Institute of Science & Technology Information (KISTI))	This work was supported by Basic Science Research Program through the National Research Foundation of Korea Grant 2012R1A2004980 funded by the Ministry of Education, Science, and Technology and by National Research Foundation of Korea Grant 2007-00559 funded by the Korean government, the Gyeonggi-do, and Korea Institute of Science and Technology Information (KISTI).	Abe K, 1996, J NEUROL SCI, V136, P108, DOI 10.1016/0022-510X(95)00314-R; ANDERSEN PM, 1995, NAT GENET, V10, P61, DOI 10.1038/ng0595-61; AOKI M, 1994, J NEUROL SCI, V126, P77, DOI 10.1016/0022-510X(94)90097-3; Banci L, 2009, P NATL ACAD SCI USA, V106, P6980, DOI 10.1073/pnas.0809845106; Bastiaens PIH, 1999, TRENDS CELL BIOL, V9, P48, DOI 10.1016/S0962-8924(98)01410-X; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; BOWLING AC, 1995, J NEUROCHEM, V64, P2366; Corson LB, 1998, P NATL ACAD SCI USA, V95, P6361, DOI 10.1073/pnas.95.11.6361; Dorval T, 2010, J BIOMOL SCREEN, V15, P847, DOI 10.1177/1087057110374993; Fenistein D, 2008, CYTOM PART A, V73A, P958, DOI 10.1002/cyto.a.20627; Hough MA, 2004, P NATL ACAD SCI USA, V101, P5976, DOI 10.1073/pnas.0305143101; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Khare SD, 2006, P NATL ACAD SCI USA, V103, P3147, DOI 10.1073/pnas.0511266103; Kim J, 2011, MOL BIOSYST, V7, P2991, DOI 10.1039/c1mb05279a; Lindberg MJ, 2005, P NATL ACAD SCI USA, V102, P9754, DOI 10.1073/pnas.0501957102; Lindberg MJ, 2002, P NATL ACAD SCI USA, V99, P16607, DOI 10.1073/pnas.262527099; Matsumoto G, 2005, J CELL BIOL, V171, P75, DOI 10.1083/jcb.200504050; Mishra A, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.08.016; Niwa J, 2002, J BIOL CHEM, V277, P36793, DOI 10.1074/jbc.M206559200; Niwa J, 2007, J BIOL CHEM, V282, P28087, DOI 10.1074/jbc.M704465200; Puttaparthi K, 2003, J NEUROCHEM, V87, P851, DOI 10.1046/j.1471-4159.2003.02028.x; ROSEN DR, 1994, HUM MOL GENET, V3, P981, DOI 10.1093/hmg/3.6.981; ROSEN DR, 1993, NATURE, V364, P362, DOI 10.1038/364362c0; Tu PH, 1996, P NATL ACAD SCI USA, V93, P3155, DOI 10.1073/pnas.93.7.3155	25	32	32	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					15094	15103		10.1074/jbc.M113.542613	http://dx.doi.org/10.1074/jbc.M113.542613			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24692554	hybrid, Green Published			2022-12-25	WOS:000337248100060
J	Jiang, XL; Fischer, D; Chen, XY; McKenna, SD; Liu, HL; Sriraman, V; Yu, HN; Goutopoulos, A; Arkinstall, S; He, XL				Jiang, Xuliang; Fischer, David; Chen, Xiaoyan; McKenna, Sean D.; Liu, Heli; Sriraman, Venkataraman; Yu, Henry N.; Goutopoulos, Andreas; Arkinstall, Steve; He, Xiaolin			Evidence for Follicle- stimulating Hormone Receptor as a Functional Trimer*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Arrestin; G Protein-coupled Receptors (GPCR); Glycoprotein Hormones; Receptor Structure-function; Reproduction; Cysteine-knot Growth Factor; Cysteine-knot Growth Factor	PROTEIN-COUPLED RECEPTOR; HUMAN CHORIONIC-GONADOTROPIN; BETA-ADRENERGIC-RECEPTOR; CRYSTAL-STRUCTURE; TSH RECEPTOR; COMPLEX; ACTIVATION; AGONIST; BINDING; RHODOPSIN	Background: A carbohydrate of follicle-stimulating hormone (FSH) has been proposed to sterically block other FSH molecules from binding to the putative receptor (FSHR) trimer. Results: FSH increases its receptor binding by 3-fold when the steric hindrance is removed. Conclusion: FSHR forms a functional trimer. Significance: This knowledge may improve designs of therapeutic drugs targeting FSHR. Follicle-stimulating hormone receptor (FSHR), a G-protein coupled receptor, is an important drug target in the development of novel therapeutics for reproductive indications. The FSHR extracellular domains were observed in the crystal structure as a trimer, which enabled us to propose a novel model for the receptor activation mechanism. The model predicts that FSHR binds Asn(52)-deglycosylated FSH at a 3-fold higher capacity than fully glycosylated FSH. It also predicts that, upon dissociation of the FSHR trimer into monomers, the binding of glycosylated FSH, but not deglycosylated FSH, would increase 3-fold, and that the dissociated monomers would in turn enhance FSHR binding and signaling activities by 3-fold. This study presents evidence confirming these predictions and provides crystallographic and mutagenesis data supporting the proposed model. The model also provides a mechanistic explanation to the agonist and antagonist activities of thyroid-stimulating hormone receptor autoantibodies. We conclude that FSHR exists as a functional trimer.	[Jiang, Xuliang; Fischer, David; McKenna, Sean D.; Sriraman, Venkataraman; Yu, Henry N.; Goutopoulos, Andreas; Arkinstall, Steve] EMD Serono Res & Dev Inst, Billerica, MA 01821 USA; [Chen, Xiaoyan; Liu, Heli; He, Xiaolin] Northwestern Univ, Feinberg Sch Med, Dept Biol Chem & Mol Pharmacol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Jiang, XL (corresponding author), 45A Middlesex Turnpike, Billerica, MA 01821 USA.	xuliang.jiang@emdserono.com			NCI NIH HHS [P30 CA060553] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderson RJ, 2005, PROTEINS, V60, P679, DOI 10.1002/prot.20530; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Blanc E., 2011, BUSTER VERSION 2 11; Bousfield GR, 2014, MOL CELL ENDOCRINOL, V382, P989, DOI 10.1016/j.mce.2013.11.008; Chazenbalk GD, 2002, J CLIN INVEST, V110, P209, DOI 10.1172/JCI200215745; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Cortes DM, 1997, BIOCHEMISTRY-US, V36, P10343, DOI 10.1021/bi971018y; DATTATREYAMURTY B, 1992, J MOL ENDOCRINOL, V9, P115, DOI 10.1677/jme.0.0090115; Dias JA, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.109397; Dias JA, 2011, MOL CELL ENDOCRINOL, V333, P143, DOI 10.1016/j.mce.2010.12.023; DIXON RAF, 1986, NATURE, V321, P75, DOI 10.1038/321075a0; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Fox KM, 2001, MOL ENDOCRINOL, V15, P378, DOI 10.1210/me.15.3.378; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Harvey R. A., 2012, LIPPINCOTTS ILLUSTRA; Hlavackova V, 2005, EMBO J, V24, P499, DOI 10.1038/sj.emboj.7600557; Janovick JA, 2009, MOL CELL ENDOCRINOL, V298, P84, DOI 10.1016/j.mce.2008.09.015; Jiang XL, 1995, STRUCTURE, V3, P1341, DOI 10.1016/S0969-2126(01)00272-6; Jiang XL, 2014, MOL CELL ENDOCRINOL, V382, P424, DOI 10.1016/j.mce.2013.08.021; Jiang XL, 2012, P NATL ACAD SCI USA, V109, P12491, DOI 10.1073/pnas.1206643109; Kim YJ, 2013, NATURE, V497, P142, DOI 10.1038/nature12133; KOSUGI S, 1991, J BIOL CHEM, V266, P19413; Landomiel F, 2014, MOL CELL ENDOCRINOL, V382, P452, DOI 10.1016/j.mce.2013.09.035; LAPTHORN AJ, 1994, NATURE, V369, P455, DOI 10.1038/369455a0; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Newton CL, 2011, P NATL ACAD SCI USA, V108, P7172, DOI 10.1073/pnas.1015723108; Nickolls SA, 2011, J BIOMOL SCREEN, V16, P706, DOI 10.1177/1087057111406548; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Sanders J, 2007, THYROID, V17, P395, DOI 10.1089/thy.2007.0034; Sanders P, 2011, J MOL ENDOCRINOL, V46, P81, DOI 10.1530/JME-10-0127; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; Simoni M, 1997, ENDOCR REV, V18, P739, DOI 10.1210/er.18.6.739; Tao YX, 2004, J BIOL CHEM, V279, P5904, DOI 10.1074/jbc.M311162200; Tegoni M, 1999, J MOL BIOL, V289, P1375, DOI 10.1006/jmbi.1999.2845; Thomas RM, 2007, ENDOCRINOLOGY, V148, P1987, DOI 10.1210/en.2006-1672; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; van Koppen CJ, 2013, BIOCHEM PHARMACOL, V85, P1162, DOI 10.1016/j.bcp.2013.02.001; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; WU H, 1994, STRUCTURE, V2, P545, DOI 10.1016/S0969-2126(00)00054-X; Yanofsky SD, 2006, J BIOL CHEM, V281, P13226, DOI 10.1074/jbc.M600601200; Zoenen M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1991	49	58	60	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14273	14282		10.1074/jbc.M114.549592	http://dx.doi.org/10.1074/jbc.M114.549592			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24692546	hybrid, Green Published			2022-12-25	WOS:000335984600052
J	Shah, S; King, EM; Chandrasekhar, A; Newton, R				Shah, Suharsh; King, Elizabeth M.; Chandrasekhar, Ambika; Newton, Robert			Roles for the Mitogen-activated Protein Kinase ( MAPK) Phosphatase, DUSP1, in Feedback Control of Inflammatory Gene Expression and Repression by Dexamethasone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Epithelial Cell; Gene Regulation; Glucocorticoid Receptor; Glucocorticoids; Inflammation; MAP Kinases (MAPKs); MAPK Phosphatase 1 (MKP-1); NR3C1; Anti-inflammatory; Corticosteroid	DUAL-SPECIFICITY PHOSPHATASE-1; INNATE IMMUNE-RESPONSES; SMOOTH-MUSCLE-CELLS; FACTOR-KAPPA-B; GLUCOCORTICOID-RECEPTOR; TRISTETRAPROLIN EXPRESSION; MOLECULAR-MECHANISMS; DOWN-REGULATION; MESSENGER-RNA; MKP-1	Background: Inflammatory gene expression is reduced by anti-inflammatory glucocorticoids. Results: With an inflammatory stimulus, glucocorticoids enhance expression of the phosphatase, DUSP1. This plays a transient role in the repression of some inflammatory genes. Conclusion: Glucocorticoids repress inflammatory gene expression via DUSP1-dependent and -independent mechanisms. Significance: Consideration of both DUSP1 and DUSP1-independent effectors is necessary to improve anti-inflammatory glucocorticoid action. Glucocorticoids act on the glucocorticoid receptor (NR3C1) to repress inflammatory gene expression. This is central to their anti-inflammatory effectiveness and rational improvements in therapeutic index depend on understanding the mechanism. Human pulmonary epithelial A549 cells were used to study the role of the mitogen-activated protein kinase (MAPK) phosphatase, dual-specificity phosphatase 1 (DUSP1), in the dexamethasone repression of 11 inflammatory genes induced, in a MAPK-dependent manner, by interleukin-1 (IL1B). Adenoviral over-expression of DUSP1 inactivated MAPK pathways and reduced expression of all 11 inflammatory genes. IL1B rapidly induced DUSP1 expression and RNA silencing revealed a transient role in feedback inhibition of MAPKs and inflammatory gene expression. With dexamethasone, which induced DUSP1 expression, plus IL1B (co-treatment), DUSP1 expression was further enhanced. At 1 h, this was responsible for the dexamethasone inhibition of IL1B-induced MAPK activation and CXCL1 and CXCL2 mRNA expression, with a similar trend for CSF2. Whereas, CCL20 mRNA was not repressed by dexamethasone at 1 h, repression of CCL2, CXCL3, IL6, and IL8 was unaffected, and PTGS2 repression was partially affected by DUSP1 knockdown. At later times, dexamethasone repression of MAPKs was unaffected by DUSP1 silencing. Likewise, 6 h post-IL1B, dexamethasone repression of all 11 mRNAs was essentially unaffected by DUSP1 knockdown. Qualitatively similar data were obtained for CSF2, CXCL1, IL6, and IL8 release. Thus, despite general roles in feedback inhibition, DUSP1 plays a transient, often partial, role in the dexamethasone-dependent repression of certain inflammatory genes. Therefore this also illustrates key roles for DUSP1-independent effectors in mediating glucocorticoid-dependent repression.	[Shah, Suharsh; King, Elizabeth M.; Chandrasekhar, Ambika; Newton, Robert] Univ Calgary, Airways Inflammat Res Grp, Snyder Inst Chron Dis, Calgary, AB T2N 4Z6, Canada	University of Calgary	Newton, R (corresponding author), Univ Calgary, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada.	rnewton@ucalgary.ca	Shah, Suharsh/N-1514-2015; Newton, Robert/C-6814-2012	Newton, Robert/0000-0002-4919-8498	Canadian Fund of Innovation (CFI); Alberta Science and Research Authority	Canadian Fund of Innovation (CFI); Alberta Science and Research Authority	Real-time PCR was performed by virtue of an equipment and infrastructure grant from the Canadian Fund of Innovation (CFI) and the Alberta Science and Research Authority.	Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Barnes PJ, 2006, EUR J PHARMACOL, V533, P2, DOI 10.1016/j.ejphar.2005.12.052; Beato M, 1996, STEROIDS, V61, P240, DOI 10.1016/0039-128X(96)00030-X; Brondello JM, 1997, J BIOL CHEM, V272, P1368, DOI 10.1074/jbc.272.2.1368; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Byon JCH, 2001, MOL CELL BIOCHEM, V218, P131, DOI 10.1023/A:1007204508882; Chang TS, 2003, J BIOL CHEM, V278, P48092, DOI 10.1074/jbc.M309421200; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Clark AR, 2008, J BIOL CHEM, V283, P25765, DOI 10.1074/jbc.R700053200; Clark AR, 2012, PHARMACOL THERAPEUT, V134, P54, DOI 10.1016/j.pharmthera.2011.12.004; Dauletbaev N, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.205724; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; Holden NS, 2004, EUR J BIOCHEM, V271, P785, DOI 10.1111/j.1432-1033.2004.03982.x; Hu JH, 2007, CELL SIGNAL, V19, P393, DOI 10.1016/j.cellsig.2006.07.010; Huotari N, 2012, APMIS, V120, P988, DOI 10.1111/j.1600-0463.2012.02927.x; Issa R, 2007, J IMMUNOL, V178, P7366, DOI 10.4049/jimmunol.178.11.7366; Ito K, 2000, MOL CELL BIOL, V20, P6891, DOI 10.1128/MCB.20.18.6891-6903.2000; Joanny E, 2012, BRIT J PHARMACOL, V165, P1124, DOI 10.1111/j.1476-5381.2011.01574.x; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; Kaur M, 2008, MOL PHARMACOL, V73, P203, DOI 10.1124/mol.107.040121; Kelly MM, 2012, BRIT J PHARMACOL, V165, P1737, DOI 10.1111/j.1476-5381.2011.01620.x; King EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053936; King EM, 2009, J BIOL CHEM, V284, P26803, DOI 10.1074/jbc.M109.028381; King EM, 2009, J PHARMACOL EXP THER, V330, P575, DOI 10.1124/jpet.109.151423; Korhonen R, 2014, BASIC CLIN PHARMACOL, V114, P24, DOI 10.1111/bcpt.12141; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Maier JV, 2007, MOL ENDOCRINOL, V21, P2663, DOI 10.1210/me.2007-0067; Newton R, 2000, THORAX, V55, P603, DOI 10.1136/thorax.55.7.603; Newton R, 2000, BRIT J PHARMACOL, V130, P1353, DOI 10.1038/sj.bjp.0703431; Newton R, 1998, J BIOL CHEM, V273, P32312, DOI 10.1074/jbc.273.48.32312; Newton R, 2007, MOL PHARMACOL, V72, P799, DOI 10.1124/mol.107.038794; Newton R, 2014, EUR J PHARMACOL, V724, P231, DOI 10.1016/j.ejphar.2013.05.035; Newton R, 2010, BIOCHEM J, V427, P113, DOI 10.1042/BJ20091038; Quante T, 2008, AM J RESP CELL MOL, V39, P208, DOI 10.1165/rcmb.2007-0014OC; Rider CF, 2011, J PHARMACOL EXP THER, V338, P860, DOI 10.1124/jpet.111.181016; Ristimaki A, 1996, BIOCHEM J, V318, P325, DOI 10.1042/bj3180325; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Stechschulte LA, 2011, CURR OPIN PHARMACOL, V11, P332, DOI 10.1016/j.coph.2011.04.012; Stellato Cristiana, 2004, Proc Am Thorac Soc, V1, P255, DOI 10.1513/pats.200402-015MS; Szczepankiewicz BG, 2006, J MED CHEM, V49, P3563, DOI 10.1021/jm060199b; Turpeinen T, 2010, J PHARMACOL EXP THER, V333, P310, DOI 10.1124/jpet.109.157438; Vollmer TR, 2012, J BIOL CHEM, V287, P35212, DOI 10.1074/jbc.M112.400671; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794; Zhao Q, 2005, J BIOL CHEM, V280, P8101, DOI 10.1074/jbc.M411760200	50	55	56	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13667	13679		10.1074/jbc.M113.540799	http://dx.doi.org/10.1074/jbc.M113.540799			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24692548	Green Published, hybrid			2022-12-25	WOS:000335522800060
J	Akkad, H; Corpeno, R; Larsson, L				Akkad, Hazem; Corpeno, Rebeca; Larsson, Lars			Masseter Muscle Myofibrillar Protein Synthesis and Degradation in an Experimental Critical Illness Myopathy Model	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; ACUTE QUADRIPLEGIC MYOPATHY; ALPHA-B-CRYSTALLIN; RESPIRATORY-DISTRESS-SYNDROME; HEAT-SHOCK PROTEINS; SKELETAL-MUSCLE; GENE-EXPRESSION; DISUSE ATROPHY; SOLEUS MUSCLE; NEUROMUSCULAR-TRANSMISSION	Critical illness myopathy (CIM) is a debilitating common consequence of modern intensive care, characterized by severe muscle wasting, weakness and a decreased myosin/actin (M/A) ratio. Limb/trunk muscles are primarily affected by this myopathy while cranial nerve innervated muscles are spared or less affected, but the mechanisms underlying these muscle-specific differences remain unknown. In this time-resolved study, the cranial nerve innervated masseter muscle was studied in a unique experimental rat intensive care unit (ICU) model, where animals were exposed to sedation, neuromuscular blockade (NMB), mechanical ventilation, and immobilization for durations varying between 6 h and 14d. Gel electrophoresis, immunoblotting, RT-PCR and morphological staining techniques were used to analyze M/A ratios, myofiber size, synthesis and degradation of myofibrillar proteins, and levels of heat shock proteins (HSPs). Results obtained in the masseter muscle were compared with previous observations in experimental and clinical studies of limb muscles. Significant muscle-specific differences were observed, i.e., in the masseter, the decline in M/A ratio and muscle fiber size was small and delayed. Furthermore, transcriptional regulation of myosin and actin synthesis was maintained, and Akt phosphorylation was only briefly reduced. In studied degradation pathways, only mRNA, but not protein levels of MuRF1, atrogin-1 and the autophagy marker LC3b were activated by the ICU condition. The matrix metalloproteinase MMP-2 was inhibited and protective HSPs were up-regulated early. These results confirm that the cranial nerve innervated masticatory muscles is less affected by the ICU-stress response than limb muscles, in accordance with clinical observation in ICU patients with CIM, supporting the model' credibility as a valid CIM model.	[Akkad, Hazem; Corpeno, Rebeca; Larsson, Lars] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Larsson, Lars] Penn State Univ, Dept Biobehav Hlth, University Pk, PA 16802 USA	Uppsala University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Larsson, L (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	lars.larsson@neurofys.uu.se	Larsson, Lars/AAY-1347-2021	Larsson, Lars/0000-0003-3722-035X	Swedish Research Council [8651]; STINT; European Commission (MyoAge) [EC Fp7 CT-223756, COST CM1001]	Swedish Research Council(Swedish Research CouncilEuropean Commission); STINT; European Commission (MyoAge)(European CommissionEuropean Commission Joint Research Centre)	This study was supported by grants from the Swedish Research Council (8651), STINT, and the European Commission (MyoAge, EC Fp7 CT-223756 and COST CM1001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aare S, 2013, PHYSIOL GENOMICS, V45, P312, DOI 10.1152/physiolgenomics.00123.2012; Aare S, 2012, PHYSIOL GENOMICS, V44, P865, DOI 10.1152/physiolgenomics.00031.2012; Aare S, 2011, PHYSIOL GENOMICS, V43, P1334, DOI 10.1152/physiolgenomics.00116.2011; Ahlbeck K, 2009, ACTA ANAESTH SCAND, V53, P717, DOI 10.1111/j.1399-6576.2009.01952.x; Ali MAM, 2010, CIRCULATION, V122, P2039, DOI 10.1161/CIRCULATIONAHA.109.930222; Arrigo AP, 2007, FEBS LETT, V581, P3665, DOI 10.1016/j.febslet.2007.04.033; Baehr LM, 2011, J PHYSIOL-LONDON, V589, P4759, DOI 10.1113/jphysiol.2011.212845; Banduseela VC, 2013, PHYSIOL GENOMICS, V45, P477, DOI 10.1152/physiolgenomics.00141.2012; Banduseela VC, 2009, PHYSIOL GENOMICS, V39, P141, DOI 10.1152/physiolgenomics.00026.2009; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Carmeli E., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P96; Carmeli E, 2004, MUSCLE NERVE, V29, P191, DOI 10.1002/mus.10529; Chen B, 2005, GENOMICS, V86, P627, DOI 10.1016/j.ygeno.2005.08.012; Choi YC, 2000, NEUROLOGY, V54, P65, DOI 10.1212/WNL.54.1.65; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Cros N, 2001, J CELL BIOCHEM, V83, P508, DOI 10.1002/jcb.1248; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; DALMAN FC, 1991, J BIOL CHEM, V266, P3482; Dupont E, 2011, AM J PHYSIOL-REG I, V300, pR408, DOI 10.1152/ajpregu.00793.2009; DWORKIN BR, 1990, BEHAV NEUROSCI, V104, P298, DOI 10.1037/0735-7044.104.2.298; Dworkin BR, 2000, AM J PHYSIOL-REG I, V279, pR1910, DOI 10.1152/ajpregu.2000.279.5.R1910; Ferrer-Martinez A, 2006, GENE, V384, P145, DOI 10.1016/j.gene.2006.07.042; Franch HA, 2005, CURR OPIN CLIN NUTR, V8, P271, DOI 10.1097/01.mco.0000165005.01331.45; Friedrich O, 2005, J NUTR, V135, p1813S, DOI 10.1093/jn/135.7.1813S; FURUNO K, 1990, J BIOL CHEM, V265, P8550; Giannelli G, 2005, HISTOL HISTOPATHOL, V20, P99, DOI 10.14670/HH-20.99; Glass DJ, 2010, CURR TOP MICROBIOL, V346, P267, DOI 10.1007/82_2010_78; Han B, 2007, APPL PHYSIOL NUTR ME, V32, P1115, DOI 10.1139/H07-102; Hermans G, 2009, COCHRANE DB SYST REV, V1; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; LARSSON L, 1979, J APPL PHYSIOL, V46, P451, DOI 10.1152/jappl.1979.46.3.451; Larsson L, 2000, CRIT CARE MED, V28, P34, DOI 10.1097/00003246-200001000-00006; Larsson L, 2008, ADV EXP MED BIOL, V642, P92; Latronico N, 2012, CURR OPIN RHEUMATOL, V24, P616, DOI 10.1097/BOR.0b013e3283588d2f; Latronico N, 2011, LANCET NEUROL, V10, P931, DOI 10.1016/S1474-4422(11)70178-8; Liu YF, 2001, FRONT BIOSCI-LANDMRK, V6, pD12, DOI 10.2741/Liu; Llano-Diez M, 2012, CRIT CARE, V16, DOI 10.1186/cc11841; Llano-Diez M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-602; Marimuthu K, 2011, J APPL PHYSIOL, V110, P555, DOI 10.1152/japplphysiol.00962.2010; MARTIN AF, 1981, J BIOL CHEM, V256, P964; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Matsumoto N, 2000, MUSCLE NERVE, V23, P1270, DOI 10.1002/1097-4598(200008)23:8<1270::AID-MUS18>3.0.CO;2-E; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; Nakao R, 2009, MOL CELL BIOL, V29, P4798, DOI 10.1128/MCB.01347-08; Nordquist J, 2007, MOL MED, V13, P461, DOI 10.2119/2006-00066.Nordquist; Norman H, 2006, PFLUG ARCH EUR J PHY, V453, P53, DOI 10.1007/s00424-006-0110-5; Norman H, 2009, J NEUROL SCI, V285, P28, DOI 10.1016/j.jns.2009.04.041; Ochala J, 2011, J PHYSIOL-LONDON, V589, P2007, DOI 10.1113/jphysiol.2010.202044; Parcellier A, 2005, ANTIOXID REDOX SIGN, V7, P404, DOI 10.1089/ars.2005.7.404; Renaud G, 2013, J PHYSIOL-LONDON, V591, P1385, DOI 10.1113/jphysiol.2012.248724; Rudis MI, 1996, CRIT CARE MED, V24, P1749, DOI 10.1097/00003246-199610000-00024; Sakurai T, 2005, FASEB J, V19, P1199, DOI 10.1096/fj.04-3060fje; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2010, AM J PHYSIOL-CELL PH, V298, pC1291, DOI 10.1152/ajpcell.00531.2009; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Seneff MG, 2000, CRIT CARE MED, V28, P342, DOI 10.1097/00003246-200002000-00009; Seo Y, 2006, J BIOCHEM, V139, P71, DOI 10.1093/jb/mvj007; Skittone LK, 2008, J ORTHOP RES, V26, P357, DOI 10.1002/jor.20513; Stephanou A, 1998, BIOCHEM J, V330, P189, DOI 10.1042/bj3300189; Stevenson EJ, 2003, J PHYSIOL-LONDON, V551, P33, DOI 10.1113/jphysiol.2003.044701; Wilcox ME, 2010, SEMIN RESP CRIT CARE, V31, P55, DOI 10.1055/s-0029-1246285; Yogev O, 2010, AUTOPHAGY, V6, P566, DOI 10.4161/auto.6.4.11950	66	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e92622	10.1371/journal.pone.0092622	http://dx.doi.org/10.1371/journal.pone.0092622			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705179	gold, Green Published, Green Submitted			2022-12-25	WOS:000334107500021
J	Collier, CJ; Villacorta-Rath, C; van Dijk, KJ; Takahashi, M; Waycott, M				Collier, Catherine J.; Villacorta-Rath, Cecilia; van Dijk, Kor-jent; Takahashi, Miwa; Waycott, Michelle			Seagrass Proliferation Precedes Mortality during Hypo-Salinity Events: A Stress-Induced Morphometric Response	PLOS ONE			English	Article							ANTARCTICA LABILL SONDER; POSIDONIA-OCEANICA; HALOPHILA-JOHNSONII; CYMODOCEA-NODOSA; MORPHOGENIC RESPONSES; MARINE ANGIOSPERMS; WESTERN-AUSTRALIA; SHARK BAY; GROWTH; SURVIVAL	Halophytes, such as seagrasses, predominantly form habitats in coastal and estuarine areas. These habitats can be seasonally exposed to hypo-salinity events during watershed runoff exposing them to dramatic salinity shifts and osmotic shock. The manifestation of this osmotic shock on seagrass morphology and phenology was tested in three Indo-Pacific seagrass species, Halophila ovalis, Halodule uninervis and Zostera muelleri, to hypo-salinity ranging from 3 to 36 PSU at 3 PSU increments for 10 weeks. All three species had broad salinity tolerance but demonstrated a moderate hypo-salinity stress response - analogous to a stress induced morphometric response (SIMR). Shoot proliferation occurred at salinities <30 PSU, with the largest increases, up to 400% increase in shoot density, occurring at the sub-lethal salinities <15 PSU, with the specific salinity associated with peak shoot density being variable among species. Resources were not diverted away from leaf growth or shoot development to support the new shoot production. However, at sub-lethal salinities where shoots proliferated, flowering was severely reduced for H. ovalis, the only species to flower during this experiment, demonstrating a diversion of resources away from sexual reproduction to support the investment in new shoots. This SIMR response preceded mortality, which occurred at 3 PSU for H. ovalis and 6 PSU for H. uninervis, while complete mortality was not reached for Z. muelleri. This is the first study to identify a SIMR in seagrasses, being detectable due to the fine resolution of salinity treatments tested. The detection of SIMR demonstrates the need for caution in interpreting in-situ changes in shoot density as shoot proliferation could be interpreted as a healthy or positive plant response to environmental conditions, when in fact it could signal pre-mortality stress.	[Collier, Catherine J.; Villacorta-Rath, Cecilia; van Dijk, Kor-jent; Takahashi, Miwa] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [van Dijk, Kor-jent; Waycott, Michelle] Univ Adelaide, Australian Ctr Evolutionary Biol & Biodivers, Sch Earth & Environm Sci, Adelaide, SA, Australia	James Cook University; University of Adelaide	Collier, CJ (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	Catherine.collier@jcu.edu.au	Collier, Catherine/M-6308-2014; Villacorta-Rath, Cecilia/G-8819-2013; Takahashi, Miwa/Y-8655-2019; Waycott, Michelle/AAR-8809-2021	Collier, Catherine/0000-0001-9494-6582; Villacorta-Rath, Cecilia/0000-0002-1060-5447; Waycott, Michelle/0000-0002-0822-0564; Takahashi, Miwa/0000-0001-8952-051X	Australian Government's National Environmental Research Program (NEEP) Tropical Ecosystem Hub	Australian Government's National Environmental Research Program (NEEP) Tropical Ecosystem Hub(Australian Government)	This work was funded by the Australian Government's National Environmental Research Program (NEEP) Tropical Ecosystem Hub. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JB, 1994, J EXP MAR BIOL ECOL, V183, P53, DOI 10.1016/0022-0981(94)90156-2; Campbell SJ, 2004, ESTUAR COAST SHELF S, V60, P477, DOI 10.1016/j.ecss.2004.02.007; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Coles R, 2001, GLOBAL SEAGRASS RESEARCH METHODS, P1, DOI 10.1016/B978-044450891-1/50001-3; Collier CJ, 2012, MAR POLLUT BULL, V65, P342, DOI 10.1016/j.marpolbul.2011.06.017; Fernandez-Torquemada Y, 2005, J EXP MAR BIOL ECOL, V320, P57, DOI 10.1016/j.jembe.2004.12.019; Fernandez-Torquemada Y, 2011, HYDROBIOLOGIA, V669, P21, DOI 10.1007/s10750-011-0644-1; Furnas M., 2003, CATCHMENT CORALS TER; Gacia E, 2007, ESTUAR COAST SHELF S, V72, P579, DOI 10.1016/j.ecss.2006.11.021; Griffin NE, 2012, MAR BIOL, V159, P1439, DOI 10.1007/s00227-012-1923-8; HILLMAN K, 1995, AQUAT BOT, V51, P1, DOI 10.1016/0304-3770(95)00466-D; Howarth JF, 2013, BOT MAR, V56, P261, DOI 10.1515/bot-2012-0226; Janssen T, 2004, BOT J LINN SOC, V146, P385, DOI 10.1111/j.1095-8339.2004.00345.x; Jiang ZJ, 2013, J EXP MAR BIOL ECOL, V443, P114, DOI 10.1016/j.jembe.2013.02.034; Kahn AE, 2006, J EXP MAR BIOL ECOL, V335, P1, DOI 10.1016/j.jembe.2006.02.011; Kahn AE, 2008, J EXP MAR BIOL ECOL, V367, P230, DOI 10.1016/j.jembe.2008.10.006; KIRKMAN H, 1990, AQUAT BOT, V37, P367, DOI 10.1016/0304-3770(90)90022-D; Koch MS, 2007, AQUAT BOT, V86, P14, DOI 10.1016/j.aquabot.2006.08.003; Koch MS, 2007, AQUAT BOT, V87, P104, DOI 10.1016/j.aquabot.2007.03.004; Les DH, 1997, SYST BOT, V22, P443, DOI 10.2307/2419820; Lirman D, 2003, ESTUARIES, V26, P131, DOI 10.1007/BF02691700; Marin-Guirao L, 2013, AQUAT BOT, V109, P14, DOI 10.1016/j.aquabot.2013.03.006; Marin-Guirao L, 2013, MAR ENVIRON RES, V84, P60, DOI 10.1016/j.marenvres.2012.12.001; Marin-Guirao L, 2011, ESTUAR COAST SHELF S, V92, P286, DOI 10.1016/j.ecss.2011.01.003; McMahon K.M., 2005, RECOVERY SUBTROPICAL; Sandoval-Gil JM, 2012, MAR BIOL, V159, P1129, DOI 10.1007/s00227-012-1892-y; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Pages JF, 2010, J EXP MAR BIOL ECOL, V386, P34, DOI 10.1016/j.jembe.2010.02.017; Potters G, 2009, PLANT CELL ENVIRON, V32, P158, DOI 10.1111/j.1365-3040.2008.01908.x; Potters G, 2007, TRENDS PLANT SCI, V12, P98, DOI 10.1016/j.tplants.2007.01.004; PREEN AR, 1995, AQUAT BOT, V52, P3, DOI 10.1016/0304-3770(95)00491-H; Ralph PJ, 1998, J EXP MAR BIOL ECOL, V227, P203, DOI 10.1016/S0022-0981(97)00269-4; Ruiz JM, 2009, BOT MAR, V52, P459, DOI 10.1515/BOT.2009.051; Sandoval-Gil JM, 2012, ESTUAR COAST SHELF S, V115, P260, DOI 10.1016/j.ecss.2012.09.008; Strazisar T, 2013, J EXP MAR BIOL ECOL, V445, P129, DOI 10.1016/j.jembe.2013.02.045; Torquemada YF, 2005, MAR BIOL, V148, P251, DOI 10.1007/s00227-005-0075-5; Touchette BW, 2007, J EXP MAR BIOL ECOL, V350, P194, DOI 10.1016/j.jembe.2007.05.037; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; WALKER DI, 1985, AQUAT BOT, V23, P13, DOI 10.1016/0304-3770(85)90017-8; WALKER DI, 1990, AQUAT BOT, V36, P359, DOI 10.1016/0304-3770(90)90052-M; WALKER DI, 1988, AQUAT BOT, V30, P305, DOI 10.1016/0304-3770(88)90063-0; WAYCOTT M, 2004, GUIDE TROPICAL SEAGR; Zolla G, 2010, J EXP BOT, V61, P211, DOI 10.1093/jxb/erp290	43	35	35	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94014	10.1371/journal.pone.0094014	http://dx.doi.org/10.1371/journal.pone.0094014			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705377	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000334107500112
J	Orozco-Nunnelly, DA; Muhammad, DS; Lee, BS; Jayathilaka, L; Kaufman, LS; Warpeha, KM				Orozco-Nunnelly, Danielle A.; Muhammad, DurreShahwar; Lee, Bao-Shiang; Jayathilaka, Lasanthi; Kaufman, Lon S.; Warpeha, Katherine M.			Pirin1 (PRN1) Is a Multifunctional Protein that Regulates Quercetin, and Impacts Specific Light and UV Responses in the Seed-to-Seedling Transition of Arabidopsis thaliana	PLOS ONE			English	Article							HETEROTRIMERIC G-PROTEIN; ALPHA-SUBUNIT GPA1; AUXIN TRANSPORT; GUARD-CELLS; BLUE-LIGHT; IN-VIVO; ACID; MODULATION; EXPRESSION; RECEPTOR	Pirins are cupin-fold proteins, implicated in apoptosis and cellular stress in eukaryotic organisms. Pirin1 (PRN1) plays a role in seed germination and transcription of a light-and ABA-regulated gene under specific conditions in the model plant system Arabidopsis thaliana. Herein, we describe that PRN1 possesses previously unreported functions that can profoundly affect early growth, development, and stress responses. In vitro-translated PRN1 possesses quercetinase activity. When PRN1 was incubated with G-protein-alpha subunit (GPA1) in the inactive conformation (GDP-bound), quercetinase activity was observed. Quercetinase activity was not observed when PRN1 was incubated with GPA1 in the active form (GTP-bound). Dark-grown prn1 mutant seedlings produced more quercetin after UV (317 nm) induction, compared to levels observed in wild type (WT) seedlings. prn1 mutant seedlings survived a dose of high-energy UV (254 nm) radiation that killed WT seedlings. prn1 mutant seedlings grown for 3 days in continuous white light display disoriented hypocotyl growth compared to WT, but hypocotyls of dark-grown prn1 seedlings appeared like WT. prn1 mutant seedlings transformed with GFP constructs containing the native PRN1 promoter and full ORF (PRN1::PRN1-GFP) were restored to WT responses, in that they did not survive UV (254 nm), and there was no significant hypocotyl disorientation in response to white light. prn1 mutants transformed with PRN1::PRN1-GFP were observed by confocal microscopy, where expression in the cotyledon epidermis was largely localized to the nucleus, adjacent to the nucleus, and diffuse and punctate expression occurred within some cells. WT seedlings transformed with the 35S::PRN1-GFP construct exhibited widespread expression in the epidermis of the cotyledon, also with localization in the nucleus. PRN1 may play a critical role in cellular quercetin levels and influence light- or hormonal-directed early development.	[Orozco-Nunnelly, Danielle A.; Muhammad, DurreShahwar; Lee, Bao-Shiang; Kaufman, Lon S.; Warpeha, Katherine M.] Univ Illinois, Dept Biol Sci, Dept Biol Sci, Mol Cell & Dev Grp, Chicago, IL 60612 USA; [Lee, Bao-Shiang; Jayathilaka, Lasanthi] Univ Illinois, Prot Res Lab, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Warpeha, KM (corresponding author), Univ Illinois, Dept Biol Sci, Dept Biol Sci, Mol Cell & Dev Grp, Chicago, IL 60612 USA.	kwarpeha@uic.edu		Warpeha, Katherine/0000-0001-6866-3028; Orozco-Nunnelly, Danielle/0000-0003-3381-0504	National Science Foundation [MCB-0848113]	National Science Foundation(National Science Foundation (NSF))	This work has been supported by National Science Foundation grant MCB-0848113 (NSF: http://www.nsf.gov/div/index.jsp?div=MCB) to Katherine M. Warpeha and Lon S. Kaufman. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 2005, J BIOL CHEM, V280, P28675, DOI 10.1074/jbc.M501034200; Adams MA, 2007, PROTEOMICS, V7, P2920, DOI 10.1002/pmic.200700099; Agati G, 2012, PLANT SCI, V196, P67, DOI 10.1016/j.plantsci.2012.07.014; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Alvarez S, 2011, J PROTEOME RES, V10, P3107, DOI 10.1021/pr2001786; Bandaranayake PCG, 2012, PLANT PHYSIOL, V158, P1046, DOI 10.1104/pp.111.186858; Bergman AC, 1999, CELL MOL LIFE SCI, V55, P467, DOI 10.1007/s000180050303; Boege F, 1996, J BIOL CHEM, V271, P2262, DOI 10.1074/jbc.271.4.2262; Brown DE, 2001, PLANT PHYSIOL, V126, P524, DOI 10.1104/pp.126.2.524; Brzoska K, 2011, REDOX REP, V16, P129, DOI 10.1179/1351000211Y.0000000002; Catala R, 2007, PLANT CELL, V19, P2952, DOI 10.1105/tpc.106.049981; Ciolino HP, 1999, BIOCHEM J, V340, P715, DOI 10.1042/0264-6021:3400715; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Dunwell JM, 2001, TRENDS BIOCHEM SCI, V26, P740, DOI 10.1016/S0968-0004(01)01981-8; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Gelbman BD, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-10; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Jensen PJ, 1998, PLANT PHYSIOL, V116, P455, DOI 10.1104/pp.116.2.455; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P17317, DOI 10.1073/pnas.0704751104; Joo JH, 2005, PLANT CELL, V17, P957, DOI 10.1105/tpc.104.029603; Kim JY, 2002, P NATL ACAD SCI USA, V99, P4103, DOI 10.1073/pnas.052484099; Klopffleisch K, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.66; Komatsu S, 2004, PLANT CELL ENVIRON, V27, P947, DOI 10.1111/j.1365-3040.2004.01202.x; Korkina LG, 2007, CELL MOL BIOL, V53, P15, DOI 10.1170/T772; KUBASEK WL, 1992, PLANT CELL, V4, P1229, DOI 10.1105/tpc.4.10.1229; Kuhn BM, 2011, PLANT PHYSIOL, V156, P585, DOI 10.1104/pp.111.175976; Lapik YR, 2003, PLANT CELL, V15, P1578, DOI 10.1105/tpc.011890; Lee JY, 2006, P NATL ACAD SCI USA, V103, P6055, DOI 10.1073/pnas.0510607103; Lewis DR, 2011, PLANT PHYSIOL, V156, P144, DOI 10.1104/pp.111.172502; Licciulli S, 2010, LEUKEMIA, V24, P429, DOI 10.1038/leu.2009.247; Licciulli S, 2011, AM J PATHOL, V178, P2397, DOI 10.1016/j.ajpath.2011.01.019; Liu X, 2011, PLANT PHYSIOL, V157, P891, DOI 10.1104/pp.111.181388; Murphy A, 2000, PLANTA, V211, P315, DOI 10.1007/s004250000300; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; Nilson SE, 2010, PLANT PHYSIOL, V152, P2067, DOI 10.1104/pp.109.148262; OKA T, 1971, BIOCHEM BIOPH RES CO, V43, P1, DOI 10.1016/S0006-291X(71)80076-1; Orzaez D, 2001, PLANT MOL BIOL, V46, P459, DOI 10.1023/A:1010618515051; Pandey S, 2006, PLANT PHYSIOL, V141, P243, DOI 10.1104/pp.106.079038; Pandey S, 2004, PLANT CELL, V16, P1616, DOI 10.1105/tpc.020321; Peer WA, 2001, PLANT PHYSIOL, V126, P536, DOI 10.1104/pp.126.2.536; Peer WA, 2011, MOL PLANT, V4, P487, DOI 10.1093/mp/ssr034; Pereira L, 2005, ENVIRON CHEM LETT, V3, P66, DOI 10.1007/s10311-005-0004-3; Perfus-Barbeoch L, 2004, CURR OPIN PLANT BIOL, V7, P719, DOI 10.1016/j.pbi.2004.09.013; Poppe C, 1996, PLANTA, V199, P511, DOI 10.1007/BF00195180; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; PRESTRIDGE DS, 1991, COMPUT APPL BIOSCI, V7, P203; Rashotte AM, 2003, PLANT PHYSIOL, V133, P761, DOI 10.1104/pp.103.022582; Routaboul JM, 2006, PLANTA, V224, P96, DOI 10.1007/s00425-005-0197-5; Rozema J, 2002, J PHOTOCH PHOTOBIO B, V66, P2, DOI 10.1016/S1011-1344(01)00269-X; Ruiz PA, 2007, J NUTR, V137, P1208, DOI 10.1093/jn/137.5.1208; Saslowsky DE, 2005, J BIOL CHEM, V280, P23735, DOI 10.1074/jbc.M413506200; Soo PC, 2007, J BACTERIOL, V189, P109, DOI 10.1128/JB.00710-06; Spencer JPE, 2003, J BIOL CHEM, V278, P34783, DOI 10.1074/jbc.M305063200; Temple BRS, 2007, ANNU REV PLANT BIOL, V58, P249, DOI 10.1146/annurev.arplant.58.032806.103827; Ullah H, 2001, SCIENCE, V292, P2066, DOI 10.1126/science.1059040; Usadel B, 2008, PLANT PHYSIOL, V146, P1834, DOI 10.1104/pp.107.115592; Warpeha KM, 2007, PLANT PHYSIOL, V143, P1590, DOI 10.1104/pp.106.089904; Warpeha KM, 2008, PLANT CELL ENVIRON, V31, P1756, DOI 10.1111/j.1365-3040.2008.01878.x; Warpeha KM, 2006, PLANT PHYSIOL, V140, P844, DOI 10.1104/pp.105.071282; WARPEHA KM, 2013, APPL ENV MICROBIOLOG; Weiss CA, 1997, FEBS LETT, V407, P361, DOI 10.1016/S0014-5793(97)00378-5; Wendler WMF, 1997, J BIOL CHEM, V272, P8482, DOI 10.1074/jbc.272.13.8482; Winkel-Shirley B, 2001, PLANT PHYSIOL, V127, P1399, DOI 10.1104/pp.127.4.1399; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Wiseman RL, 2010, MOL CELL, V38, P291, DOI 10.1016/j.molcel.2010.04.001; Xing NZ, 2001, CARCINOGENESIS, V22, P409, DOI 10.1093/carcin/22.3.409; Young JJ, 2006, P NATL ACAD SCI USA, V103, P7506, DOI 10.1073/pnas.0602225103; Zhang W, 2011, J EXP BOT, V62, P2371, DOI 10.1093/jxb/erq424; Zhao ZX, 2010, J PROTEOME RES, V9, P1637, DOI 10.1021/pr901011h	71	16	16	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93371	10.1371/journal.pone.0093371	http://dx.doi.org/10.1371/journal.pone.0093371			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705271	gold, Green Published, Green Submitted			2022-12-25	WOS:000334107500034
J	Sapre, N; Hong, MKH; Macintyre, G; Lewis, H; Kowalczyk, A; Costello, AJ; Corcoran, NM; Hovens, CM				Sapre, Nikhil; Hong, Matthew K. H.; Macintyre, Geoff; Lewis, Heather; Kowalczyk, Adam; Costello, Anthony J.; Corcoran, Niall M.; Hovens, Christopher M.			Curated MicroRNAs in Urine and Blood Fail to Validate as Predictive Biomarkers for High-Risk Prostate Cancer	PLOS ONE			English	Article							CIRCULATING MICRORNAS; ANTIGEN; EXPRESSION; GENE; DIAGNOSIS; IDENTIFICATION; PROGRESSION; SERUM; FLUID; PCR	Purpose: The purpose of this study was to determine if microRNA profiling of urine and plasma at radical prostatectomy can distinguish potentially lethal from indolent prostate cancer. Materials and Methods: A panel of microRNAs was profiled in the plasma of 70 patients and the urine of 33 patients collected prior to radical prostatectomy. Expression of microRNAs was correlated to the clinical endpoints at a follow-up time of 3.9 years to identify microRNAs that may predict clinical response after radical prostatectomy. A machine learning approach was applied to test the predictive ability of all microRNAs profiled in urine, plasma, and a combination of both, and global performance assessed using the area under the receiver operator characteristic curve (AUC). Validation of urinary expression of miRNAs was performed on a further independent cohort of 36 patients. Results: The best predictor in plasma using eight miRs yielded only moderate predictive performance (AUC = 0.62). The best predictor of high-risk disease was achieved using miR-16, miR-21 and miR-222 measured in urine (AUC = 0.75). This combination of three microRNAs in urine was a better predictor of high-risk disease than any individual microRNA. Using a different methodology we found that this set of miRNAs was unable to predict high-volume, high-grade disease. Conclusions: Our initial findings suggested that plasma and urinary profiling of microRNAs at radical prostatectomy may allow prognostication of prostate cancer behaviour. However we found that the microRNA expression signature failed to validate in an independent cohort of patients using a different platform for PCR. This highlights the need for independent validation patient cohorts and suggests that urinary microRNA signatures at radical prostatectomy may not be a robust way to predict the course of clinical disease after definitive treatment for prostate cancer.	[Sapre, Nikhil; Hong, Matthew K. H.; Costello, Anthony J.; Corcoran, Niall M.; Hovens, Christopher M.] Royal Melbourne Hosp, Dept Surg, Div Urol, Parkville, Vic 3050, Australia; [Sapre, Nikhil; Hong, Matthew K. H.; Costello, Anthony J.; Corcoran, Niall M.; Hovens, Christopher M.] Univ Melbourne, Parkville, Vic 3052, Australia; [Sapre, Nikhil; Hong, Matthew K. H.; Lewis, Heather; Costello, Anthony J.; Corcoran, Niall M.; Hovens, Christopher M.] Australian Prostate Canc Res Epworth, Richmond, Australia; [Macintyre, Geoff; Kowalczyk, Adam] Univ Melbourne, Dept Elect & Elect Engn, NICTA Victoria Res Lab, Parkville, Vic 3052, Australia; [Macintyre, Geoff] Univ Melbourne, Dept Comp & Informat Syst, Parkville, Vic 3052, Australia	Royal Melbourne Hospital; University of Melbourne; University of Melbourne; University of Melbourne	Sapre, N (corresponding author), Royal Melbourne Hosp, Dept Surg, Div Urol, Parkville, Vic 3050, Australia.	sapni973@gmail.com		Macintyre, Geoff/0000-0003-3906-467X; Hovens, Christopher/0000-0002-0610-1289	Cancer Council Victoria; Cybec Foundation; Royal Australasian College of Surgeons; Australian Government; NICTA; Australian Government as represented by the Department of Broadband,; Communications and the Digital Economy; Australian Research Council through the ICT Centre of Excellence program	Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Cybec Foundation; Royal Australasian College of Surgeons; Australian Government(Australian GovernmentCGIAR); NICTA(NICTA); Australian Government as represented by the Department of Broadband,(Australian Government); Communications and the Digital Economy; Australian Research Council through the ICT Centre of Excellence program(Australian Research Council)	NS is supported by postgraduate scholarships from the Cancer Council Victoria, Cybec Foundation and Royal Australasian College of Surgeons. This study was supported by funding from the Australian Government to the Australian Prostate Cancer Research Epworth. AK and GM are supported by NICTA. NICTA is funded by the Australian Government as represented by the Department of Broadband, Communications and the Digital Economy and the Australian Research Council through the ICT Centre of Excellence program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaoglu FY, 2011, TUMOR BIOL, V32, P583, DOI 10.1007/s13277-011-0154-9; Albertsen PC, 1998, JAMA-J AM MED ASSOC, V280, P975, DOI 10.1001/jama.280.11.975; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Antonarakis ES, 2010, BJU INT; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benes V, 2010, METHODS, V50, P244, DOI 10.1016/j.ymeth.2010.01.026; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Brase JC, 2011, INT J CANCER, V128, P608, DOI 10.1002/ijc.25376; Bryant RJ, 2012, BRIT J CANCER, V106, P768, DOI 10.1038/bjc.2011.595; Bussemakers MJG, 1999, CANCER RES, V59, P5975; Catalona WJ, 2011, J UROLOGY, V185, P1650, DOI 10.1016/j.juro.2010.12.032; CATALONA WJ, 1991, NEW ENGL J MED, V324, P1156, DOI 10.1056/NEJM199104253241702; Catto JWF, 2011, EUR UROL, V59, P671, DOI 10.1016/j.eururo.2011.01.044; Chen ZH, 2012, PROSTATE, V72, P1443, DOI 10.1002/pros.22495; Coppola V, 2010, ENDOCR-RELAT CANCER, V17, pF1, DOI 10.1677/ERC-09-0172; Daskivich TJ, 2006, J UROLOGY, V176, P1927, DOI 10.1016/j.juro.2006.07.002; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; EPSTEIN JI, 1994, JAMA-J AM MED ASSOC, V271, P368, DOI 10.1001/jama.271.5.368; Hessels D, 2003, EUR UROL, V44, P8, DOI 10.1016/S0302-2838(03)00201-X; JACOBSEN SJ, 1995, JAMA-J AM MED ASSOC, V274, P1445, DOI 10.1001/jama.274.18.1445; Jeronimo C, 2011, EUR UROL, V60, P753, DOI 10.1016/j.eururo.2011.06.035; Lu Q, 2009, PROSTATE, V69, P411, DOI 10.1002/pros.20902; Mahn R, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2011.01.020; Mees ST, 2011, J SURG RES, V169, P241, DOI 10.1016/j.jss.2009.10.005; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Molina-Pinelo S, 2012, DIS MARKERS, V32, P221, DOI [10.1155/2012/873749, 10.3233/DMA-2011-0882]; Moltzahn F, 2011, CANCER RES, V71, P550, DOI 10.1158/0008-5472.CAN-10-1229; Nilsson J, 2009, BRIT J CANCER, V100, P1603, DOI 10.1038/sj.bjc.6605058; OESTERLING JE, 1991, J UROLOGY, V145, P907, DOI 10.1016/S0022-5347(17)38491-4; Payne SR, 2009, PROSTATE, V69, P1257, DOI 10.1002/pros.20967; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; POTOSKY AL, 1995, JAMA-J AM MED ASSOC, V273, P548, DOI 10.1001/jama.273.7.548; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Roupret M, 2007, CLIN CANCER RES, V13, P1720, DOI 10.1158/1078-0432.CCR-06-2467; Sapre N, 2013, PROSTATE CANCER, V2013, DOI 10.1155/2013/539680; Shen J, 2012, PROSTATE, V72, P1469, DOI 10.1002/pros.22499; Sherwin JC, 2010, J UROLOGY, V183, P1808, DOI 10.1016/j.juro.2010.01.017; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; van Poppel H, 2012, BJU INT, V109, P360, DOI 10.1111/j.1464-410X.2011.10377.x; Velonas VM, 2013, INT J MOL SCI, V14, P11034, DOI 10.3390/ijms140611034; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405	42	42	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e91729	10.1371/journal.pone.0091729	http://dx.doi.org/10.1371/journal.pone.0091729			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705338	Green Published, gold			2022-12-25	WOS:000334107500007
J	Yamanishi, R; Yoshigai, E; Okuyama, T; Mori, M; Murase, H; Machida, T; Okumura, T; Nishizawa, M				Yamanishi, Ryota; Yoshigai, Emi; Okuyama, Tetsuya; Mori, Masatoshi; Murase, Hiromitsu; Machida, Toru; Okumura, Tadayoshi; Nishizawa, Mikio			The Anti-Inflammatory Effects of Flavanol-Rich Lychee Fruit Extract in Rat Hepatocytes	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; HEXOSE CORRELATED COMPOUND; MESSENGER-RNA; GENE-EXPRESSION; INDUCTION; POLYPHENOL; BINDING; INOS; DNA	Flavanol (flavan-3-ol)- rich lychee fruit extract (FRLFE) is a mixture of oligomerized polyphenols primarily derived from lychee fruit and is rich in flavanol monomers, dimers, and trimers. Supplementation with this functional food has been shown to suppress inflammation and tissue damage caused by high-intensity exercise training. However, it is unclear whether FRLFE has in vitro anti-inflammatory effects, such as suppressing the production of the proinflammatory cytokine tumor necrosis factor a (TNF-alpha) and the proinflammatory mediator nitric oxide (NO), which is synthesized by inducible nitric oxide synthase (iNOS). Here, we analyzed the effects of FRLFE and its constituents on the expression of inflammatory genes in interleukin 1 beta (IL- 1 beta)- treated rat hepatocytes. FRLFE decreased the mRNA and protein expression of the iNOS gene, leading to the suppression of IL- 1 beta- induced NO production. FRLFE also decreased the levels of the iNOS antisense transcript, which stabilizes iNOS mRNA. By contrast, unprocessed lychee fruit extract, which is rich in flavanol polymers, and flavanol monomers had little effect on NO production. When a construct harboring the iNOS promoter fused to the firefly luciferase gene was used, FRLFE decreased the luciferase activity in the presence of IL- 1 beta, suggesting that FRLFE suppresses the promoter activity of the iNOS gene at the transcriptional level. Electrophoretic mobility shift assays indicated that FRLFE reduced the nuclear transport of a key regulator, nuclear factor kappa B (NF-kappa B). Furthermore, FRLFE inhibited the phosphorylation of NF-kappa B inhibitor alpha(I kappa B-alpha). FRLFE also reduced the mRNA levels of NF-kappa B target genes encoding cytokines and chemokines, such as TNF-alpha. Therefore, FRLFE inhibited NF-kappa B activation and nuclear translocation to suppress the expression of these inflammatory genes. Our results suggest that flavanols may be responsible for the anti-inflammatory and hepatoprotective effects of FRLFE and may be used to treat inflammatory diseases.	[Yamanishi, Ryota; Yoshigai, Emi; Mori, Masatoshi; Murase, Hiromitsu; Machida, Toru; Nishizawa, Mikio] Ritsumeikan Univ, Coll Life Sci, Dept Biomed Sci, Kusatsu, Shiga, Japan; [Okuyama, Tetsuya] Ritsumeikan Univ, Grad Sch Sci & Engn, Kusatsu, Shiga, Japan; [Okumura, Tadayoshi] Ritsumeikan Univ, Res Org Sci & Technol, Kusatsu, Shiga, Japan; [Okumura, Tadayoshi] Kansai Med Univ, Dept Surg, Hirakata, Osaka, Japan	Ritsumeikan University; Ritsumeikan University; Ritsumeikan University; Kansai Medical University	Nishizawa, M (corresponding author), Ritsumeikan Univ, Coll Life Sci, Dept Biomed Sci, Kusatsu, Shiga, Japan.	nishizaw@sk.ritsumei.ac.jp	Nishizawa, Mikio/M-4544-2014	Nishizawa, Mikio/0000-0002-1117-2807	Amino Up Chemical Co., Ltd. (Sapporo, Japan); Amino Up Chemical Co., Ltd.; Ritsumeikan Global Innovation Research Organization (R-GIRO) of Ritsumeikan University	Amino Up Chemical Co., Ltd. (Sapporo, Japan); Amino Up Chemical Co., Ltd.; Ritsumeikan Global Innovation Research Organization (R-GIRO) of Ritsumeikan University	1) T. Okumura and M. Nishizawa received research grants from Amino Up Chemical Co., Ltd. (Sapporo, Japan). 2) E. Yoshigai, T. Okuyama, T. Okumura, and M. Nishizawa received travel grants from Amino Up Chemical Co., Ltd. 3) E. Yoshigai, T. Okumura, and M. Nishizawa received research funding from the Ritsumeikan Global Innovation Research Organization (R-GIRO) of Ritsumeikan University. 4) R. Yamanishi, M. Mori, H. Murase, and T. Machida performed this study as graduate students of the Graduate School of Science and Engineering, Ritsumeikan University and did not receive the above-mentioned research grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ANAL BIOCH, V126, P131; Aruoma OI, 2006, BIOFACTORS, V27, P245, DOI 10.1002/biof.5520270121; Brat P, 2006, J NUTR, V136, P2368, DOI 10.1093/jn/136.9.2368; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Colasanti M, 2000, TRENDS PHARMACOL SCI, V21, P249, DOI 10.1016/S0165-6147(00)01499-1; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Fujii H, 2007, FOOD CHEM TOXICOL, V45, P378, DOI 10.1016/j.fct.2006.08.026; Fujji H, 2006, BIOSCI BIOTECH BIOCH, V70, P2104, DOI 10.1271/bbb.60053; Gurib-Fakim Ameenah, 2006, Molecular Aspects of Medicine, V27, P1, DOI 10.1016/j.mam.2005.07.008; Hackman Robert M., 2008, Phytochemistry Reviews, V7, P195, DOI 10.1007/s11101-007-9070-4; Kalgaonkar S, 2010, PHYTOTHER RES, V24, P1223, DOI 10.1002/ptr.3137; KANEMAKI T, 1993, PROSTAGLANDINS, V45, P459, DOI 10.1016/0090-6980(93)90122-N; Kimura T, 2013, CELL MOL LIFE SCI, V70, P1451, DOI 10.1007/s00018-012-1216-x; Kitadate K, 2014, REGUL TOXICOL PHARM, V68, P140, DOI 10.1016/j.yrtph.2013.12.001; Kitade H, 1996, HEPATOLOGY, V23, P797, DOI 10.1002/hep.510230421; Kuzuhara T, 2006, J BIOL CHEM, V281, P17446, DOI 10.1074/jbc.M601196200; Lawrence T, 2010, INT J BIOCHEM CELL B, V42, P519, DOI 10.1016/j.biocel.2009.12.016; Lin YL, 1999, EUR J PHARMACOL, V367, P379, DOI 10.1016/S0014-2999(98)00953-4; Mackenzie GG, 2004, FASEB J, V18, P167, DOI 10.1096/fj.03-0402fje; Mahmoudi S, 2009, MOL CELL, V33, P462, DOI 10.1016/j.molcel.2009.01.028; Mao T, 2000, J NUTR, V130, p2093S, DOI 10.1093/jn/130.8.2093S; Matsui K, 2011, EUR SURG RES, V47, P274, DOI 10.1159/000333833; Matsui K, 2008, HEPATOLOGY, V47, P686, DOI 10.1002/hep.22036; Matsui K, 2007, JPEN-PARENTER ENTER, V31, P373, DOI 10.1177/0148607107031005373; Matsuura T, 2012, HEPATOL RES, V42, P76, DOI 10.1111/j.1872-034X.2011.00891.x; Miura T, 2010, BIOTECHNOLOGY IN FUNCTIONAL FOODS AND NUTRACEUTICALS, P91, DOI 10.1201/9781420087123-c6; Modarresi F, 2012, NAT BIOTECHNOL, V30, P453, DOI 10.1038/nbt.2158; Nafisi S, 2009, J PHOTOCH PHOTOBIO B, V94, P1, DOI 10.1016/j.jphotobiol.2008.08.001; Nakanishi H, 2004, J HEPATOL, V41, P730, DOI 10.1016/j.jhep.2004.07.007; Nishizawa M, 2000, GENES CELLS, V5, P111, DOI 10.1046/j.1365-2443.2000.00310.x; Nishizawa M, 2012, FRONT BIOSCI-LANDMRK, V17, P938, DOI 10.2741/3965; Nishizawa M, 2011, PHYTOTHER RES, V25, P1486, DOI 10.1002/ptr.3430; Nonaka G., 2004, International Patent Application, Patent No. [WO2004103988(A1), 2004103988, WO/2004/103988 A1]; Ogasawara J, 2009, PHYTOTHER RES, V23, P1626, DOI 10.1002/ptr.2846; Sakitani K, 1997, HEPATOLOGY, V25, P416; Serra A, 2013, EUR J NUTR, V52, P1029, DOI 10.1007/s00394-012-0409-2; Shimizu K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085520; Shoji T, 2006, J AGR FOOD CHEM, V54, P884, DOI 10.1021/jf052260b; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Suganuma M, 1998, CARCINOGENESIS, V19, P1771, DOI 10.1093/carcin/19.10.1771; Takimoto Y, 2013, NITRIC OXIDE-BIOL CH, V28, P47, DOI 10.1016/j.niox.2012.10.003; Tanaka T., 2007, JPN J FOOD CHEM, V14, P134; Uehata T, 2013, BBA-GENE REGUL MECH, V1829, P708, DOI 10.1016/j.bbagrm.2013.03.001; Ververidis Filippos, 2007, Biotechnology Journal, V2, P1214, DOI 10.1002/biot.200700084; Werner A, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-31; Yamada M, 2007, NITRIC OXIDE-BIOL CH, V17, P98, DOI 10.1016/j.niox.2007.06.003; Yamashita Y, 2013, BIOSCI BIOTECH BIOCH, V77, P888, DOI 10.1271/bbb.130095; Yoshigai E., 2012, HOAJ BIOL, V1, P10, DOI 10.7243/2050-0874-1-10.; Yoshigai E., 2012, HOAJ BIOL, V1, P10, DOI DOI 10.7243/2050-0874-1-10; Yoshigai E, 2014, HEPATOL RES, V44, P571, DOI 10.1111/hepr.12157; Yoshigai E, 2013, BIOCHEM BIOPH RES CO, V439, P54, DOI 10.1016/j.bbrc.2013.08.029; Yoshigai E, 2013, NITRIC OXIDE-BIOL CH, V30, P9, DOI 10.1016/j.niox.2013.01.001	52	32	33	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93818	10.1371/journal.pone.0093818	http://dx.doi.org/10.1371/journal.pone.0093818			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705335	Green Published, Green Submitted, gold			2022-12-25	WOS:000334107500071
J	Klein, EY; Serohijos, AWR; Choi, JM; Shakhnovich, EI; Pekosz, A				Klein, Eili Y.; Serohijos, Adrian W. R.; Choi, Jeong-Mo; Shakhnovich, Eugene I.; Pekosz, Andrew			Influenza A H1N1 Pandemic Strain Evolution - Divergence and the Potential for Antigenic Drift Variants	PLOS ONE			English	Article							VIRUS HEMAGGLUTININ; VACCINE EFFICACY; UNITED-STATES; HUMANS; SUBTYPE; DESIGN; MAFFT	The emergence of a novel A(H1N1) strain in 2009 was the first influenza pandemic of the genomic age, and unprecedented surveillance of the virus provides the opportunity to better understand the evolution of influenza. We examined changes in the nucleotide coding regions and the amino acid sequences of the hemagglutinin (HA), neuraminidase (NA), and nucleoprotein (NP) segments of the A(H1N1)pdm09 strain using publicly available data. We calculated the nucleotide and amino acid hamming distance from the vaccine strain A/California/07/2009 for each sequence. We also estimated P-epitope-a measure of antigenic diversity based on changes in the epitope regions-for each isolate. Finally, we compared our results to A(H3N2) strains collected over the same period. Our analysis found that the mean hamming distance for the HA protein of the A(H1N1)pdm09 strain increased from 3.6 (standard deviation [SD]: 1.3) in 2009 to 11.7 (SD: 1.0) in 2013, while the mean hamming distance in the coding region increased from 7.4 (SD: 2.2) in 2009 to 28.3 (SD: 2.1) in 2013. These trends are broadly similar to the rate of mutation in H3N2 over the same time period. However, in contrast to H3N2 strains, the rate of mutation accumulation has slowed in recent years. Our results are notable because, over the course of the study, mutation rates in H3N2 similar to that seen with A(H1N1)pdm09 led to the emergence of two antigenic drift variants. However, while there has been an H1N1 epidemic in North America this season, evidence to date indicates the vaccine is still effective, suggesting the epidemic is not due to the emergence of an antigenic drift variant. Our results suggest that more research is needed to understand how viral mutations are related to vaccine effectiveness so that future vaccine choices and development can be more predictive.	[Klein, Eili Y.] Johns Hopkins Sch Med, Dept Emergency Med, Ctr Adv Modeling Social Behav & Hlth Sci, Baltimore, MD 21205 USA; [Klein, Eili Y.] Ctr Dis Dynam Econ & Policy, Washington, DC USA; [Serohijos, Adrian W. R.; Choi, Jeong-Mo; Shakhnovich, Eugene I.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA USA; [Pekosz, Andrew] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Klein, EY (corresponding author), Johns Hopkins Sch Med, Dept Emergency Med, Ctr Adv Modeling Social Behav & Hlth Sci, Baltimore, MD 21205 USA.	eklein@jhu.edu		Serohijos, Adrian/0000-0001-8369-982X; Klein, Eili/0000-0002-1304-5289; Pekosz, Andrew/0000-0003-3248-1761; Choi, Jeong-Mo/0000-0003-2656-4851	Defense Advanced Research Projects Agency [HR0011-11-C-0093]; Models of Infectious Disease Agent Study (MIDAS) from the National Institutes of General Medical Sciences [U01GM070708]; National Institutes of Health [DP1OD003874]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070708] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003874] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Models of Infectious Disease Agent Study (MIDAS) from the National Institutes of General Medical Sciences; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by the Defense Advanced Research Projects Agency through grant HR0011-11-C-0093 and by the Models of Infectious Disease Agent Study (MIDAS), under Award Number U01GM070708 from the National Institutes of General Medical Sciences, as well as a National Institutes of Health Pioneer Award (DP1OD003874). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Office of Naval Research or the official policy or position of the Department of Defense or the U.S. government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Bush RM, 1999, MOL BIOL EVOL, V16, P1457, DOI 10.1093/oxfordjournals.molbev.a026057; Catania J, 2014, AM J RESP CRITICAL C; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Centers for Disease Control and Prevention, 2013, NOT CLIN EARL REP PH; Centers for Disease Control and Prevention, 2011, FIN EST 2009 10 SEAS; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de la Rosa-Zamboni D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050116; Deem MW, 2009, PROTEIN ENG DES SEL, V22, P543, DOI 10.1093/protein/gzp027; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Guarnaccia T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003354; Gupta V, 2006, VACCINE, V24, P3881, DOI 10.1016/j.vaccine.2006.01.010; Huang JW, 2012, VACCINE, V30, P6327, DOI 10.1016/j.vaccine.2012.07.079; Jegaskanda S, 2013, J INFECT DIS, V208, P1051, DOI 10.1093/infdis/jit294; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Khandaker I, 2013, VIRUS GENES, P1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Makkoch J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051275; Munoz ET, 2005, VACCINE, V23, P1144, DOI 10.1016/j.vaccine.2004.08.028; Ndifon W, 2009, P NATL ACAD SCI USA, V106, P8701, DOI 10.1073/pnas.0903427106; Park AW, 2009, SCIENCE, V326, P726, DOI 10.1126/science.1175980; Pascalis H, 2012, PLOS ONE, V7; Plotkin JB, 2002, P NATL ACAD SCI USA, V99, P6263, DOI 10.1073/pnas.082110799; R Core Team, 2018, R LANG ENV STAT COMP; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Shrestha SS, 2011, CLIN INFECT DIS, V52, pS75, DOI 10.1093/cid/ciq012; Skowronski DM, 2014, EUROSURVEILLANCE, V19, P4, DOI 10.2807/1560-7917.ES2014.19.5.20690; Smith CB, 2002, J INFECT DIS, V185, P980, DOI 10.1086/339416; Strengell M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025848; WHO, 2013, REC COMP INFL VIR VA; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; Wolf YI, 2010, PLOS CURRENTS, V2; Wu AP, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000882	34	29	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93632	10.1371/journal.pone.0093632	http://dx.doi.org/10.1371/journal.pone.0093632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699432	Green Published, Green Submitted, gold			2022-12-25	WOS:000334105000084
J	Mourao, M; Satin, L; Schnell, S				Mourao, Marcio; Satin, Leslie; Schnell, Santiago			Optimal Experimental Design to Estimate Statistically Significant Periods of Oscillations in Time Course Data	PLOS ONE			English	Article							CHI-SQUARE PERIODOGRAM; CIRCADIAN-RHYTHMS; SPECTRAL-ANALYSIS; SERIES; IDENTIFICATION; SEARCH	We investigated commonly used methods (Autocorrelation, Enright, and Discrete Fourier Transform) to estimate the periodicity of oscillatory data and determine which method most accurately estimated periods while being least vulnerable to the presence of noise. Both simulated and experimental data were used in the analysis performed. We determined the significance of calculated periods by applying these methods to several random permutations of the data and then calculating the probability of obtaining the period's peak in the corresponding periodograms. Our analysis suggests that the Enright method is the most accurate for estimating the period of oscillatory data. We further show that to accurately estimate the period of oscillatory data, it is necessary that at least five cycles of data are sampled, using at least four data points per cycle. These results suggest that the Enright method should be more widely applied in order to improve the analysis of oscillatory data.	[Mourao, Marcio; Schnell, Santiago] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Satin, Leslie] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Schnell, Santiago] Univ Michigan, Sch Med, Dept Computat Med & Bioinformat, Ann Arbor, MI USA; [Schnell, Santiago] Univ Michigan, Sch Med, Brehm Ctr Diabet Res, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Schnell, S (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	schnells@umich.edu	Schnell, Santiago/B-8682-2008	Schnell, Santiago/0000-0002-9477-3914	James S. McDonnell Foundation under the 21st Century Science Initiative, Studying Complex Systems Program [220020223]; National Institutes of Health [RO1 DK46409]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046409, P30DK020572] Funding Source: NIH RePORTER	James S. McDonnell Foundation under the 21st Century Science Initiative, Studying Complex Systems Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work has been funded by a grant of the James S. McDonnell Foundation under the 21st Century Science Initiative, Studying Complex Systems Program (Grant No. 220020223). Work in the Satin Lab was supported by research grant RO1 DK46409 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Jaoude W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017075; Bloomfield P., 2000, FOURIER ANAL TIME SE, P261; DOWSE HB, 1991, J THEOR BIOL, V148, P139, DOI 10.1016/S0022-5193(05)80468-0; DOWSE HB, 1989, J THEOR BIOL, V139, P487, DOI 10.1016/S0022-5193(89)80067-0; DUTILLEUL P, 1995, BIOL RHYTHM RES, V26, P173, DOI 10.1080/09291019509360334; ENRIGHT JT, 1965, J THEOR BIOL, V8, P426, DOI 10.1016/0022-5193(65)90021-4; Frescura FAM, 2008, MON NOT R ASTRON SOC, V388, P1693, DOI 10.1111/j.1365-2966.2008.13499.x; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Geva-Zatorsky N, 2010, P NATL ACAD SCI USA, V107, P13550, DOI 10.1073/pnas.1001107107; GIRLING AJ, 1995, BIOL RHYTHM RES, V26, P149, DOI 10.1080/09291019509360333; Gottman JM, 1981, COMPREHENSIVE INTRO; He L, 2010, NAT CELL BIOL, V12, P1133, DOI 10.1038/ncb2124; Herrgen L, 2010, CURR BIOL, V20, P1244, DOI 10.1016/j.cub.2010.06.034; KLEMFUSS H, 1993, J INTERDISCIPL CYCLE, V24, P1, DOI 10.1080/09291019309360191; KUSHLER RH, 1991, STAT MED, V10, P329, DOI 10.1002/sim.4780100305; Merrins MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034036; MINORS DS, 1989, BIOL RHYTHMS CLIN PR, P272; MORGAN E, 1995, BIOL RHYTHM RES, V26, P124, DOI 10.1080/09291019509360332; REFINETTI R, 1993, PHYSIOL BEHAV, V54, P869, DOI 10.1016/0031-9384(93)90294-P; REFINETTI R, 1992, BEHAV RES METH INS C, V24, P28, DOI 10.3758/BF03203466; REFINETTI R, 1991, INT J BIOMED COMPUT, V27, P125, DOI 10.1016/0020-7101(91)90091-R; Refinetti R, 2007, BIOL RHYTHM RES, V38, P275, DOI 10.1080/09291010600903692; Ristow M, 1999, DIABETES, V48, P1557, DOI 10.2337/diabetes.48.8.1557; SCARGLE JD, 1982, ASTROPHYS J, V263, P835, DOI 10.1086/160554; Schuster A, 1898, TERRESTRIAL MAGNETIS, V3, P179; Schwarzenberg-Czerny A, 1998, MON NOT R ASTRON SOC, V301, P831, DOI 10.1046/j.1365-8711.1998.02086.x; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; VANCAUTER E, 1988, AM J PHYSIOL, V254, pE786, DOI 10.1152/ajpendo.1988.254.6.E786; VELDHUIS JD, 1986, AM J PHYSIOL, V250, pE486, DOI 10.1152/ajpendo.1986.250.4.E486	29	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93826	10.1371/journal.pone.0093826	http://dx.doi.org/10.1371/journal.pone.0093826			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699692	Green Published, gold, Green Submitted			2022-12-25	WOS:000334105000113
J	Ng, CF; Possingham, HP; McAlpine, CA; de Villiers, DL; Preece, HJ; Rhodes, JR				Ng, Chooi Fei; Possingham, Hugh P.; McAlpine, Clive A.; de Villiers, Deidre L.; Preece, Harriet J.; Rhodes, Jonathan R.			Impediments to the Success of Management Actions for Species Recovery	PLOS ONE			English	Article							WILLINGNESS-TO-SELL; CONSERVATION OPPORTUNITY; MAXIMIZING RETURN; LAND MANAGERS; THREATS; COSTS; RESTORATION; INVESTMENT; ROADS	Finding cost-effective management strategies to recover species declining due to multiple threats is challenging, especially when there are limited resources. Recent studies offer insights into how costs and threats can influence the best choice of management actions. However, when implementing management actions in the real-world, a range of impediments to management success often exist that can be driven by social, technological and land-use factors. These impediments may limit the extent to which we can achieve recovery objectives and influence the optimal choice of management actions. Nonetheless, the implications of these impediments are not well understood, especially for recovery planning involving multiple actions. We used decision theory to assess the impact of these types of impediments for allocating resources among recovery actions to mitigate multiple threats. We applied this to a declining koala (Phascolarctos cinereus) population threatened by habitat loss, vehicle collisions, dog attacks and disease. We found that the unwillingness of dog owners to restrain their dogs at night (a social impediment), the effectiveness of wildlife crossings to reduce vehicle collisions (a technological impediment) and the unavailability of areas for restoration (a land-use impediment) significantly reduced the effectiveness of our actions. In the presence of these impediments, achieving successful recovery may be unlikely. Further, these impediments influenced the optimal choice of recovery actions, but the extent to which this was true depended on the target koala population growth rate. Given that species recovery is an important strategy for preserving biodiversity, it is critical that we consider how impediments to the success of recovery actions modify our choice of actions. In some cases, it may also be worth considering whether investing in reducing or removing impediments may be a cost-effective course of action.	[Ng, Chooi Fei; Possingham, Hugh P.] Univ Queensland, Sch Math & Phys, Brisbane, Qld, Australia; [Ng, Chooi Fei; Possingham, Hugh P.; Rhodes, Jonathan R.] Univ Queensland, Ctr Excellence Environm Decis, Australian Res Council, Brisbane, Qld, Australia; [Ng, Chooi Fei; Possingham, Hugh P.; McAlpine, Clive A.; Rhodes, Jonathan R.] Univ Queensland, Natl Environm Res Program, Environm Decis Hub, Brisbane, Qld, Australia; [Possingham, Hugh P.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Possingham, Hugh P.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot, Berks, England; [McAlpine, Clive A.; Rhodes, Jonathan R.] Univ Queensland, Sch Geog Planning & Environm Management, Brisbane, Qld, Australia; [de Villiers, Deidre L.; Preece, Harriet J.] Dept Environm & Heritage Protect, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland; University of Queensland; Imperial College London; University of Queensland	Ng, CF (corresponding author), Univ Queensland, Sch Math & Phys, Brisbane, Qld, Australia.	fei.ng@uqconnect.edu.au	Possingham, Hugh/B-1337-2008; POSSINGHAM, HUGH/R-8310-2019; Rhodes, Jonathan/C-4841-2008	Possingham, Hugh/0000-0001-7755-996X; POSSINGHAM, HUGH/0000-0001-7755-996X; McAlpine, Clive/0000-0003-0457-8144; Rhodes, Jonathan/0000-0001-6746-7412; Preece, Harriet/0000-0002-4404-8837	Queensland Department of Environment and Heritage Protection; Redland City Council; Queensland Department of Main Roads; Australian Research Council Centre of Excellence for Environmental Decisions; National Environmental Research Program Environmental Decisions Hub	Queensland Department of Environment and Heritage Protection; Redland City Council; Queensland Department of Main Roads; Australian Research Council Centre of Excellence for Environmental Decisions(Australian Research Council); National Environmental Research Program Environmental Decisions Hub	This research was conducted with the support of funding from Queensland Department of Environment and Heritage Protection (http://www.ehp.qld.gov.au/), Redland City Council (http://www.redland.qld.gov.au/Pages/home.aspx), the Queensland Department of Main Roads (http://www.tmr.qld.gov.au/), the Australian Research Council Centre of Excellence for Environmental Decisions (http://www.ceed.edu.au/) and the National Environmental Research Program Environmental Decisions Hub http://www.nerpdecisions.edu.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage DR, 2009, FRONT ECOL ENVIRON, V7, P95, DOI 10.1890/070089; Balmford A, 2006, CONSERV BIOL, V20, P692, DOI 10.1111/j.1523-1739.2006.00434.x; Baxter PWJ, 2006, CONSERV BIOL, V20, P893, DOI 10.1111/j.1523-1739.2006.00378.x; BenHaim Y, 2006, INFO GAP DECISION TH, DOI DOI 10.1016/B978-0-12-373552-2.X5000-0; Bode M, 2009, BIOL CONSERV, V142, P1333, DOI 10.1016/j.biocon.2009.01.029; Bottrill MC, 2008, TRENDS ECOL EVOL, V23, P649, DOI 10.1016/j.tree.2008.07.007; Burgman MA, 2007, BIOL CONSERV, V134, P73, DOI 10.1016/j.biocon.2006.08.005; Carey AJ, 2010, AM J REPROD IMMUNOL, V63, P161, DOI 10.1111/j.1600-0897.2009.00776.x; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Chomitz KM, 2005, ENVIRON DEV ECON, V10, P293, DOI 10.1017/S1355770X05002081; Clark M, 2006, STUDY ATTITUDES KOAL, P1; Crain CM, 2009, ANN NY ACAD SCI, V1162, P39, DOI 10.1111/j.1749-6632.2009.04496.x; Curran P, 2012, RESTOR ECOL, V20, P56, DOI 10.1111/j.1526-100X.2010.00746.x; Department of Environment and Resource Management (DERM), 2009, DECL KOAL COAST KOAL; DERM, 2006, NAT CONS KOAL CONS P, P140; Dique DS, 2003, WILDLIFE RES, V30, P419, DOI 10.1071/WR02029; Evans MEK, 2010, ECOL MONOGR, V80, P627, DOI 10.1890/09-1758.1; Evans MC, 2011, BIOSCIENCE, V61, P281, DOI 10.1525/bio.2011.61.4.8; Glista DJ, 2009, LANDSCAPE URBAN PLAN, V91, P1, DOI 10.1016/j.landurbplan.2008.11.001; Guerrero AM, 2010, CONSERV LETT, V3, P332, DOI 10.1111/j.1755-263X.2010.00116.x; Handasyde K.A., 1990, P203; *INT UN CONS NAT, 2012, IUCN RED LIST CAT CR; King SL, 1999, RESTOR ECOL, V7, P348, DOI 10.1046/j.1526-100X.1999.72029.x; Knight AT, 2007, CONSERV BIOL, V21, P1124, DOI 10.1111/j.1523-1739.2007.00690.x; Knight AT, 2011, DIVERS DISTRIB, V17, P1234, DOI 10.1111/j.1472-4642.2011.00789.x; Knight AT, 2011, BIOL CONSERV, V144, P2623, DOI 10.1016/j.biocon.2011.07.013; Knight AT, 2006, CONSERV BIOL, V20, P408, DOI 10.1111/j.1523-1739.2006.00305.x; Lawler JJ, 2002, ECOL APPL, V12, P663, DOI 10.2307/3060975; Lesbarreres D, 2012, TRENDS ECOL EVOL, V27, P374, DOI 10.1016/j.tree.2012.01.015; McCarthy MA, 2007, ENVIRON MANAGE, V39, P553, DOI 10.1007/s00267-006-0022-3; McCollister MF, 2010, J WILDLIFE MANAGE, V74, P1722, DOI 10.2193/2009-535; Melzer A, 2000, CONSERV BIOL, V14, P619, DOI 10.1046/j.1523-1739.2000.99383.x; Murdoch W, 2007, BIOL CONSERV, V139, P375, DOI 10.1016/j.biocon.2007.07.011; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Polasky S, 2008, P NATL ACAD SCI USA, V105, P6505, DOI 10.1073/pnas.0802815105; Possingham HP, 2001, CONSERVATION BIOLOGY: RESEARCH PRIORITIES FOR THE NEXT DECADE, P225; Prugh LR, 2010, CONSERV LETT, V3, P267, DOI 10.1111/j.1755-263X.2010.00111.x; Regan HM, 2005, ECOL APPL, V15, P1471, DOI 10.1890/03-5419; Rhodes JR, 2011, BIOL CONSERV, V144, P1081, DOI 10.1016/j.biocon.2010.12.027; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Runge MC, 2011, BIOL CONSERV, V144, P1214, DOI 10.1016/j.biocon.2010.12.020; Schneider RR, 2010, BIOL CONSERV, V143, P1603, DOI 10.1016/j.biocon.2010.04.002; Semeniuk M, 2011, NSW ROADS TRAFFIC AU, P1; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thompson J., 2006, THESIS U QUEENSLAND; Thomson JR, 2009, ECOL APPL, V19, P817, DOI 10.1890/08-0915.1; Tockner K, 2010, FRESHWATER BIOL, V55, P135, DOI 10.1111/j.1365-2427.2009.02371.x; Underwood EC, 2009, CONSERV LETT, V2, P130, DOI 10.1111/j.1755-263X.2008.00018.x; van der Ree R, 2008, REV MITIGATION MEASU; Venter O, 2006, BIOSCIENCE, V56, P903, DOI 10.1641/0006-3568(2006)56[903:TTESIC]2.0.CO;2; Vesk PA, 2008, BIOL CONSERV, V141, P174, DOI 10.1016/j.biocon.2007.09.010; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Wilson KA, 2007, PLOS BIOL, V5, P1850, DOI 10.1371/journal.pbio.0050223; Withey JC, 2012, ECOL LETT, V15, P1249, DOI 10.1111/j.1461-0248.2012.01847.x	54	11	11	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e92430	10.1371/journal.pone.0092430	http://dx.doi.org/10.1371/journal.pone.0092430			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699170	Green Published, gold, Green Submitted			2022-12-25	WOS:000334105000026
J	Palacios, L; Rosado, H; Micol, V; Rosato, AE; Bernal, P; Arroyo, R; Grounds, H; Anderson, JC; Stabler, RA; Taylor, PW				Palacios, Lucia; Rosado, Helena; Micol, Vicente; Rosato, Adriana E.; Bernal, Patricia; Arroyo, Raquel; Grounds, Helen; Anderson, James C.; Stabler, Richard A.; Taylor, Peter W.			Staphylococcal Phenotypes Induced by Naturally Occurring and Synthetic Membrane-Interactive Polyphenolic beta-Lactam Resistance Modifiers	PLOS ONE			English	Article							WALL STRESS STIMULON; CELL-WALL; TEA CATECHINS; GREEN TEA; ANTIBACTERIAL PROPERTIES; CYTOPLASMIC MEMBRANE; ANTIOXIDANT CAPACITY; EPICATECHIN GALLATE; TEICHOIC-ACID; AUREUS	Galloyl catechins, in particular (-)-epicatechin gallate (ECg), have the capacity to abrogate beta-lactam resistance in methicillin-resistant strains of Staphylococcus aureus (MRSA); they also prevent biofilm formation, reduce the secretion of a large proportion of the exoproteome and induce profound changes to cell morphology. Current evidence suggests that these reversible phenotypic traits result from their intercalation into the bacterial cytoplasmic membrane. We have endeavoured to potentiate the capacity of ECg to modify the MRSA phenotype by stepwise removal of hydroxyl groups from the B-ring pharmacophore and the A:C fused ring system of the naturally occurring molecule. ECg binds rapidly to the membrane, inducing up-regulation of genes responsible for protection against cell wall stress and maintenance of membrane integrity and function. Studies with artificial membranes modelled on the lipid composition of the staphylococcal bilayer indicated that ECg adopts a position deep within the lipid palisade, eliciting major alterations in the thermotropic behaviour of the bilayer. The non-galloylated homolog (-)-epicatechin enhanced ECg-mediated effects by facilitating entry of ECg molecules into the membrane. ECg analogs with unnatural B-ring hydroxylation patterns induced higher levels of gene expression and more profound changes to MRSA membrane fluidity than ECg but adopted a more superficial location within the bilayer. ECg possessed a high affinity for the positively charged staphylococcal membrane and induced changes to the biophysical properties of the bilayer that are likely to account for its capacity to disperse the cell wall biosynthetic machinery responsible for beta-lactam resistance. The ability to enhance these properties by chemical modification of ECg raises the possibility that more potent analogs could be developed for clinical evaluation.	[Palacios, Lucia; Rosado, Helena; Bernal, Patricia; Arroyo, Raquel; Taylor, Peter W.] UCL, Sch Pharm, London, England; [Micol, Vicente] Univ Miguel Hernandez, Alicante, Spain; [Rosato, Adriana E.] Methodist Hosp, Res Inst, Houston, TX 77030 USA; [Grounds, Helen; Anderson, James C.] UCL, Dept Chem, London, England; [Stabler, Richard A.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of London; University College London; University of London School of Pharmacy; Universidad Miguel Hernandez de Elche; The Methodist Hospital System; The Methodist Hospital - Houston; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Taylor, PW (corresponding author), UCL, Sch Pharm, London, England.	peter.taylor@ucl.ac.uk	Bernal, Patricia/K-6399-2014; Arroyo, Raquel/H-2952-2015; Arroyo, Raquel/AAZ-1323-2020; Micol, Vicente/K-6841-2014	Bernal, Patricia/0000-0002-6228-0496; Arroyo, Raquel/0000-0003-0612-3928; Arroyo, Raquel/0000-0003-0612-3928; Rosato, Adriana E./0000-0001-6115-6955; Micol, Vicente/0000-0001-8089-0696; Stabler, Richard/0000-0002-2402-6630	Medical Research Council [G060004, G0801757]; National Institute for Health Research University College London Hospitals Biomedical Research Centre; Spanish Ministry of Science and Innovation [AGL2011-29857-C03-03]; Generalitat Valenciana [PROMETEO/2012/007, ACOMP/2013/093]; CIBER from Fisiopatologia de la Obesidad y la Nutricion, CIBERobn, Instituto de Salud Carlos III [CB12/03/30038]; NIH [5R01AI080688-04]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080688] Funding Source: NIH RePORTER; Medical Research Council [G0600004] Funding Source: researchfish; MRC [G0600004, G0801757] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); CIBER from Fisiopatologia de la Obesidad y la Nutricion, CIBERobn, Instituto de Salud Carlos III; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by research grants G060004 and G0801757 from the Medical Research Council (http://www.mrc.ac.uk/index.htm) and was supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre. Work undertaken in VM's laboratory was supported by grants AGL2011-29857-C03-03 from the Spanish Ministry of Science and Innovation, PROMETEO/2012/007 and ACOMP/2013/093 from Generalitat Valenciana and CIBER CB12/03/30038 from Fisiopatologia de la Obesidad y la Nutricion, CIBERobn, Instituto de Salud Carlos III. Activities in AER's laboratory were supported by NIH grant 5R01AI080688-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Anderson DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008305; Anderson JC, 2011, BIOORG MED CHEM LETT, V21, P6996, DOI 10.1016/j.bmcl.2011.09.116; Anderson JC, 2005, TETRAHEDRON, V61, P7703, DOI 10.1016/j.tet.2005.05.086; Andra J, 2011, J BIOL CHEM, V286, P18692, DOI 10.1074/jbc.M111.226886; Bernal P, 2007, ENVIRON MICROBIOL, V9, P1135, DOI 10.1111/j.1462-2920.2006.01236.x; Bernal P, 2010, J BIOL CHEM, V285, P24055, DOI 10.1074/jbc.M110.114793; Bernal P, 2009, J ANTIMICROB CHEMOTH, V63, P1156, DOI 10.1093/jac/dkp094; Bertsche U, 2011, ANTIMICROB AGENTS CH, V55, P3922, DOI 10.1128/AAC.01226-10; Boyle-Vavra S, 2013, ANTIMICROB AGENTS CH, V57, P83, DOI 10.1128/AAC.01651-12; Caturla N, 2003, FREE RADICAL BIO MED, V34, P648, DOI 10.1016/S0891-5849(02)01366-7; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Cushnie TPT, 2011, INT J ANTIMICROB AG, V38, P99, DOI 10.1016/j.ijantimicag.2011.02.014; Datta R, 2008, CLIN INFECT DIS, V47, P176, DOI 10.1086/589241; DAVENPORT L, 1985, BIOCHEMISTRY-US, V24, P4097, DOI 10.1021/bi00336a044; Dengler V, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-16; Doyle M, 2009, J ANTIMICROB CHEMOTH, V64, P949, DOI 10.1093/jac/dkp325; Edgeworth JD, 2011, J ANTIMICROB CHEMOTH, V66, pII41, DOI 10.1093/jac/dkq325; EFTINK MR, 1976, J PHYS CHEM-US, V80, P486, DOI 10.1021/j100546a014; Ernst CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000660; Falord M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021323; Funes L, 2010, CHEM PHYS LIPIDS, V163, P190, DOI 10.1016/j.chemphyslip.2009.11.004; Geddes AM, 2007, INT J ANTIMICROB AG, V30, pS109, DOI 10.1016/j.ijantimicag.2007.07.015; Hubscher J, 2009, FEMS MICROBIOL LETT, V295, P251, DOI 10.1111/j.1574-6968.2009.01603.x; Ichihashi N, 2003, J BIOL CHEM, V278, P28778, DOI 10.1074/jbc.M212202200; Inoue R, 2001, MOL GENET GENOMICS, V266, P564, DOI 10.1007/s004380100564; Jousselin A, 2012, ANTIMICROB AGENTS CH, V56, P3629, DOI 10.1128/AAC.06264-11; Kaiser RD, 1998, BIOCHEMISTRY-US, V37, P8180, DOI 10.1021/bi980064a; Kajiya K, 2002, BIOSCI BIOTECH BIOCH, V66, P2330, DOI 10.1271/bbb.66.2330; Kajiya K, 2001, BIOSCI BIOTECH BIOCH, V65, P2638, DOI 10.1271/bbb.65.2638; Kajiya K, 2008, MAGN RESON CHEM, V46, P174, DOI 10.1002/mrc.2157; Laporta O, 2007, FOOD CHEM, V101, P1425, DOI 10.1016/j.foodchem.2006.03.051; Lazarevic V, 2011, FUTURE MICROBIOL, V6, P513, DOI [10.2217/FMB.11.38, 10.2217/fmb.11.38]; Lee BY, 2011, INFECT CONT HOSP EP, V32, P562, DOI 10.1086/660014; Lopez D, 2010, GENE DEV, V24, P1893, DOI 10.1101/gad.1945010; Martinez JL, 2007, NAT REV MICROBIOL, V5, P958, DOI 10.1038/nrmicro1796; McAleese F, 2006, J BACTERIOL, V188, P1120, DOI 10.1128/JB.188.3.1120-1133.2006; Mehta S, 2012, ANTIMICROB AGENTS CH, V56, P6192, DOI 10.1128/AAC.01525-12; Mehta S, 2012, ANTIMICROB AGENTS CH, V56, P92, DOI 10.1128/AAC.00432-10; Mishra NN, 2009, ANTIMICROB AGENTS CH, V53, P2312, DOI 10.1128/AAC.01682-08; Mukhopadhyay K, 2007, MICROBIOL-SGM, V153, P1187, DOI 10.1099/mic.0.2006/003111-0; Muthaiyan A, 2008, ANTIMICROB AGENTS CH, V52, P980, DOI 10.1128/AAC.01121-07; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Perez-Fons L, 2010, J AGR FOOD CHEM, V58, P161, DOI 10.1021/jf9026487; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; Peterson LR, 2007, JT COMM J QUAL PATIE, V33, P732, DOI 10.1016/S1553-7250(07)33088-2; Pinho MG, 2005, MOL MICROBIOL, V55, P799, DOI 10.1111/j.1365-2958.2004.04420.x; Pinho MG, 2003, MOL MICROBIOL, V50, P871, DOI 10.1046/j.1365-2958.2003.03719.x; Pinho MG, 2001, P NATL ACAD SCI USA, V98, P10886, DOI 10.1073/pnas.191260798; Rosado H, 2012, INT J ASTROBIOL, V11, P71, DOI 10.1017/S1473550411000346; Sass P, 2009, INT J MED MICROBIOL, V299, P313, DOI 10.1016/j.ijmm.2008.10.005; Shah S, 2008, LETT APPL MICROBIOL, V46, P181, DOI 10.1111/j.1472-765X.2007.02296.x; SHORT SA, 1971, J BACTERIOL, V108, P219, DOI 10.1128/JB.108.1.219-226.1971; Sirk TW, 2008, J AGR FOOD CHEM, V56, P7750, DOI 10.1021/jf8013298; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Stapleton MR, 2007, J BACTERIOL, V189, P7316, DOI 10.1128/JB.00734-07; Stapleton PD, 2007, MICROBIOL-SGM, V153, P2093, DOI 10.1099/mic.0.2007/007807-0; Stapleton PD, 2006, INT J FOOD MICROBIOL, V111, P276, DOI 10.1016/j.ijfoodmicro.2006.06.005; Stapleton PD, 2006, ANTIMICROB AGENTS CH, V50, P752, DOI 10.1128/AAC.50.2.752-755.2006; Stapleton PD, 2004, INT J ANTIMICROB AG, V23, P462, DOI 10.1016/j.ijantimicag.2003.09.027; Taylor Peter W, 2005, Food Sci Technol Bull, V2, P71, DOI 10.1616/1476-2137.14184; Taylor PW, 2013, INT J ANTIMICROB AG, V42, P195, DOI 10.1016/j.ijantimicag.2013.05.004; Taylor PW, 2009, PHARM RES SAF TEST, P43; Trevors JT, 2003, J BIOCHEM BIOPH METH, V57, P87, DOI 10.1016/S0165-022X(03)00076-9; TROTTER PJ, 1989, BIOCHIM BIOPHYS ACTA, V982, P131, DOI 10.1016/0005-2736(89)90183-1; Tsuchiya H, 2001, CHEM-BIOL INTERACT, V134, P41, DOI 10.1016/S0009-2797(00)00308-2; Turner RD, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1025; Utaida S, 2003, MICROBIOL-SGM, V149, P2719, DOI 10.1099/mic.0.26426-0; WARDLAW JR, 1987, FEBS LETT, V223, P20, DOI 10.1016/0014-5793(87)80502-1; Wilkinson Brian J., 2005, Current Medicinal Chemistry - Anti-Infective Agents, V4, P259, DOI 10.2174/1568012054368119; Witney AA, 2005, APPL ENVIRON MICROB, V71, P7504, DOI 10.1128/AEM.71.11.7504-7514.2005	71	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93830	10.1371/journal.pone.0093830	http://dx.doi.org/10.1371/journal.pone.0093830			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699700	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000334105000114
J	Stathopoulos, S; Bishop, JM; O'Ryan, C				Stathopoulos, Sofia; Bishop, Jacqueline M.; O'Ryan, Colleen			Genetic Signatures for Enhanced Olfaction in the African Mole-Rats	PLOS ONE			English	Article							FALSE DISCOVERY RATE; AMINO-ACID SITES; RECEPTOR GENES; MOLECULAR PHYLOGENY; EVOLUTIONARY DYNAMICS; COMPARATIVE GENOMICS; MAXIMUM-LIKELIHOOD; CLUSTAL-W; ODORANT; CRYPTOMYS	The Olfactory Receptor (OR) superfamily, the largest in the vertebrate genome, is responsible for vertebrate olfaction and is traditionally subdivided into 17 OR families. Recent studies characterising whole-OR subgenomes revealed a 'birth and death' model of evolution for a range of species, however little is known about fine-scale evolutionary dynamics within single-OR families. This study reports the first assessment of fine-scale OR evolution and variation in African mole-rats (Bathyergidae), a family of subterranean rodents endemic to sub-Saharan Africa. Because of the selective pressures of life underground, enhanced olfaction is proposed to be fundamental to the evolutionary success of the Bathyergidae, resulting in a highly diversified OR gene-repertoire. Using a PCR-sequencing approach, we analysed variation in the OR7 family across 14 extant bathyergid species, which revealed enhanced levels of functional polymorphisms concentrated across the receptors' ligand-binding region. We propose that mole-rats are able to recognise a broad range of odorants and that this diversity is reflected throughout their OR7 gene repertoire. Using both classic tests and tree-based methods to test for signals of selection, we investigate evolutionary forces across the mole-rat OR7 gene tree. Four well-supported clades emerged in the OR phylogeny, with varying signals of selection; from neutrality to positive and purifying selection. Bathyergid life-history traits and environmental niche-specialisation are explored as possible drivers of adaptive OR evolution, emerging as non-exclusive contributors to the positive selection observed at OR7 genes. Our results reveal unexpected complexity of evolutionary mechanisms acting within a single OR family, providing insightful perspectives into OR evolutionary dynamics.	[Stathopoulos, Sofia; O'Ryan, Colleen] Univ Cape Town, Dept Mol & Cell Biol, ZA-7925 Cape Town, Western Cape, South Africa; [Bishop, Jacqueline M.] Univ Cape Town, Dept Biol Sci, ZA-7925 Cape Town, Western Cape, South Africa	University of Cape Town; University of Cape Town	Stathopoulos, S (corresponding author), Univ Cape Town, Dept Mol & Cell Biol, ZA-7925 Cape Town, Western Cape, South Africa.	sofiastathopoulos@hotmail.com		O'Ryan, Colleen/0000-0003-3719-4657	University of Cape Town Research Committee; South African National Research Foundation	University of Cape Town Research Committee; South African National Research Foundation(National Research Foundation - South Africa)	This study was supported by the University of Cape Town Research Committee and the South African National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ache BW, 2005, NEURON, V48, P417, DOI 10.1016/j.neuron.2005.10.022; Adkins RM, 2001, MOL BIOL EVOL, V18, P777, DOI 10.1093/oxfordjournals.molbev.a003860; Alioto TS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-173; Bardeleben C, 2005, MOL PHYLOGENET EVOL, V37, P815, DOI 10.1016/j.ympev.2005.07.019; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett N.C., 2000, AFRICAN MOLE RATS EC; Bhatnagar KP, 2010, CURRENT NEUROBIOLOGY, V1, P1; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Blanga-Kanfi S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-71; Brennan PA, 2006, PHILOS T R SOC B, V361, P2061, DOI 10.1098/rstb.2006.1931; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; BURDA H, 1995, EXPERIENTIA, V51, P411, DOI 10.1007/BF01928906; Crish SD, 2003, BRAIN BEHAV EVOLUT, V62, P141, DOI 10.1159/000072723; Deuve JL, 2008, CHROMOSOMA, V117, P211, DOI 10.1007/s00412-007-0140-6; Deuve JL, 2008, CHROMOSOME RES, V16, P57, DOI 10.1007/s10577-007-1200-8; Deuve JL, 2006, CHROMOSOME RES, V14, P681, DOI 10.1007/s10577-006-1080-3; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; Doron-Faigenboim A, 2005, BIOINFORMATICS, V21, P2101, DOI 10.1093/bioinformatics/bti259; Dulac C, 2006, ANNU REV GENET, V40, P449, DOI 10.1146/annurev.genet.39.073003.093937; ELOFF G., 1958, S AFRICAN JOUR SCI, V54, P293; Emes RD, 2004, GENOME RES, V14, P591, DOI 10.1101/gr.1940604; Faulkes CG, 1990, THESIS U LONDON UK; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Freitag J, 1998, J COMP PHYSIOL A, V183, P635, DOI 10.1007/s003590050287; Freitag J, 1995, NEURON, V15, P1383, DOI 10.1016/0896-6273(95)90016-0; Gaillard I, 2002, EUR J NEUROSCI, V15, P409, DOI 10.1046/j.0953-816x.2001.01871.x; Gilad Y, 2004, PLOS BIOL, V2, P120, DOI 10.1371/journal.pbio.0020005; Gilad Y, 2003, AM J HUM GENET, V73, P489, DOI 10.1086/378132; Glusman G, 2000, MAMM GENOME, V11, P1016, DOI 10.1007/s003350010196; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Godfrey PA, 2004, P NATL ACAD SCI USA, V101, P2156, DOI 10.1073/pnas.0308051100; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hayden S, 2010, GENOME RES, V20, P1, DOI 10.1101/gr.099416.109; Heth G, 2004, FOLIA ZOOL, V53, P269; Heth G, 2002, BEHAV ECOL SOCIOBIOL, V52, P53, DOI 10.1007/s00265-002-0476-0; Heth G, 2002, J MAMMAL, V83, P569, DOI 10.1644/1545-1542(2002)083<0569:IOSWCA>2.0.CO;2; HOLMES WG, 1983, AM SCI, V71, P46; Ingram CM, 2004, MOL PHYLOGENET EVOL, V31, P997, DOI 10.1016/j.ympev.2003.11.004; Isogai Y, 2011, NATURE, V478, P241, DOI 10.1038/nature10437; Jacob S, 2001, PHYSIOL BEHAV, V74, P15, DOI 10.1016/S0031-9384(01)00537-6; Jacob S, 2001, NEUROREPORT, V12, P2391, DOI 10.1097/00001756-200108080-00021; Jarvis J.U.M., 1991, P384; Jarvis Jennifer U.M., 2002, Mammalian Species, V706, P1, DOI 10.1644/1545-1410(2002)706<0001:HG>2.0.CO;2; Judd TM, 1996, ANIM BEHAV, V52, P957, DOI 10.1006/anbe.1996.0244; Kambere MB, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-S3-S2; Katada S, 2005, J NEUROSCI, V25, P1806, DOI 10.1523/jneurosci.4723-04.2005; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Keller A, 2008, CURR OPIN NEUROBIOL, V18, P364, DOI 10.1016/j.conb.2008.09.020; KIMURA M, 1969, GENETICS, V61, P763; Kishida T, 2010, J EVOLUTION BIOL, V23, P302, DOI 10.1111/j.1420-9101.2009.01899.x; Kishida T, 2007, BIOLOGY LETT, V3, P428, DOI 10.1098/rsbl.2007.0191; Kishida T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002385; Klein J, 1998, ANNU REV ECOL SYST, V29, P1, DOI 10.1146/annurev.ecolsys.29.1.1; Kondo R, 2002, GENE, V282, P113, DOI 10.1016/S0378-1119(01)00843-5; Kott O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011810; Lacey EA, 2000, LIFE UNDERGROUND BIO; Lange S, 2005, FOLIA ZOOL, V54, P263; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LI WH, 1981, NATURE, V292, P237, DOI 10.1038/292237a0; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Malnic B, 2004, P NATL ACAD SCI USA, V101, P2584, DOI 10.1073/pnas.0307882100; Man O, 2004, PROTEIN SCI, V13, P240, DOI 10.1110/ps.03296404; Matsui A, 2010, MOL BIOL EVOL, V27, P1192, DOI 10.1093/molbev/msq003; Menashe I, 2007, PLOS BIOL, V5, P2462, DOI 10.1371/journal.pbio.0050284; MEYERHANS A, 1990, NUCLEIC ACIDS RES, V18, P1687, DOI 10.1093/nar/18.7.1687; NEDBAL MA, 1994, MOL PHYLOGENET EVOL, V3, P206, DOI 10.1006/mpev.1994.1023; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Nei M, 1997, P NATL ACAD SCI USA, V94, P7799, DOI 10.1073/pnas.94.15.7799; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Nemec P, 2008, BRAIN RES BULL, V75, P356, DOI 10.1016/j.brainresbull.2007.10.055; Nielsen R, 1998, GENETICS, V148, P929; Niimura Y, 2005, P NATL ACAD SCI USA, V102, P6039, DOI 10.1073/pnas.0501922102; Niimura Y, 2005, GENE, V346, P13, DOI 10.1016/j.gene.2004.09.025; Niimura Y, 2006, J HUM GENET, V51, P505, DOI 10.1007/s10038-006-0391-8; Niimura Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000708; Niimura Y, 2009, GENOME BIOL EVOL, V1, P34, DOI 10.1093/gbe/evp003; ORiain MJ, 1997, ANIM BEHAV, V53, P487, DOI 10.1006/anbe.1996.0299; Parsegian V. A., 2006, VANDERWAALS FORCES H; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ramm SA, 2008, MOL BIOL EVOL, V25, P207, DOI 10.1093/molbev/msm242; Reeve H., 1991, BIOL NAKED MOLE RAT, P337; Rouquier S, 2000, P NATL ACAD SCI USA, V97, P2870, DOI 10.1073/pnas.040580197; Rozas J, 2001, GENETICS, V158, P1147; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Sambrook J., 1989, MOL CLONING LAB MANU; Sanders KL, 2008, J EVOLUTION BIOL, V21, P682, DOI 10.1111/j.1420-9101.2008.01525.x; Smith TD, 2007, BRAIN RES, V1132, P78, DOI 10.1016/j.brainres.2006.11.021; Spinks AC, 1998, BEHAV ECOL, V69, P224; Steiger SS, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-117; Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Thewissen JGM, 2011, MAR MAMMAL SCI, V27, P282, DOI 10.1111/j.1748-7692.2010.00406.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Wyart C, 2007, J NEUROSCI, V27, P1261, DOI 10.1523/JNEUROSCI.4430-06.2007; Yang Z, 2009, PAML MANUAL VERSION; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zarzo M, 2007, BIOL REV, V82, P455, DOI 10.1111/j.1469-185X.2007.00019.x; Zhang XH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r86; Zhang XH, 2007, GENOMICS, V89, P441, DOI 10.1016/j.ygeno.2007.01.002; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zhao HY, 2009, J FRANKLIN I, V346, P945, DOI 10.1016/j.jfranklin.2009.05.007	114	11	11	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93336	10.1371/journal.pone.0093336	http://dx.doi.org/10.1371/journal.pone.0093336			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699281	Green Published, gold, Green Submitted			2022-12-25	WOS:000334105000054
J	Totaro, A; Astro, V; Tonoli, D; de Curtis, I				Totaro, Antonio; Astro, Veronica; Tonoli, Diletta; de Curtis, Ivan			Identification of Two Tyrosine Residues Required for the Intramolecular Mechanism Implicated in GIT1 Activation	PLOS ONE			English	Article							REGULATES PROTRUSIVE ACTIVITY; EPIDERMAL-GROWTH-FACTOR; PAXILLIN KINASE LINKER; SYNAPSE FORMATION; ANGIOTENSIN-II; LD4 MOTIF; BETA-PIX; PROTEINS; FAMILY; COMPLEX	GIT1 is an ArfGAP and scaffolding protein regulating cell adhesion and migration. The multidomain structure of GIT1 allows the interaction with several partners. Binding of GIT1 to some of its partners requires activation of the GIT1 polypeptide. Our previous studies indicated that binding of paxillin to GIT1 is enhanced by release of an intramolecular interaction between the amino-terminal and carboxy-terminal portions that keeps the protein in a binding-incompetent state. Here we have addressed the mechanism mediating this intramolecular inhibitory mechanism by testing the effects of the mutation of several formerly identified GIT1 phosphorylation sites on the binding to paxillin. We have identified two tyrosines at positions 246 and 293 of the human GIT1 polypeptide that are needed to keep the protein in the inactive conformation. Interestingly, mutation of these residues to phenylalanine did not affect binding to paxillin, while mutation to either alanine or glutamic acid enhanced binding to paxillin, without affecting the constitutive binding to the Rac/Cdc42 exchange factor beta PIX. The involvement of the two tyrosine residues in the intramolecular interaction was supported by reconstitution experiments showing that these residues are important for the binding between the amino-terminal fragment and carboxyterminal portions of GIT1. Either GIT1 or GIT1-N tyrosine phosphorylation by Src and pervanadate treatment to inhibit protein tyrosine phosphatases did not affect the intramolecular binding between the amino-and carboxy-terminal fragments, nor the binding of GIT1 to paxillin. Mutations increasing the binding of GIT1 to paxillin positively affected cell motility, measured both by transwell migration and wound healing assays. Altogether these results show that tyrosines 246 and 293 of GIT1 are required for the intramolecular inhibitory mechanism that prevents the binding of GIT1 to paxillin. The data also suggest that tyrosine phosphorylation may not be sufficient to release the intramolecular interaction that keeps GIT1 in the inactive conformation.	[Totaro, Antonio; Astro, Veronica; Tonoli, Diletta; de Curtis, Ivan] Ist Sci San Raffaele, Div Neurosci, Cell Adhes Unit, I-20132 Milan, Italy; [de Curtis, Ivan] Univ Vita Salute San Raffaele, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	de Curtis, I (corresponding author), Ist Sci San Raffaele, Div Neurosci, Cell Adhes Unit, I-20132 Milan, Italy.	decurtis.ivan@hsr.it		DE CURTIS, Ivanmatteo/0000-0002-7651-1515; Astro, Veronica/0000-0001-7852-7046	Telethon-Italy [GGP12126]; AIRC [10321]; FIRC	Telethon-Italy(Fondazione Telethon); AIRC(Fondazione AIRC per la ricerca sul cancro); FIRC(Fondazione AIRC per la ricerca sul cancro)	The following sources of funding to Ivan de Curtis have supported this work: Telethon-Italy, grant GGP12126 (http://www.telethon.it/). AIRC, grant 10321 (http://www.airc.it/). Moreover, a fellowship to Veronica Astro was supported by FIRC (http://www.fondazionefirc.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerongen GPV, 2004, CIRC RES, V94, P1041, DOI 10.1161/01.RES.0000125627.77235.0C; Bagrodia S, 1999, J BIOL CHEM, V274, P22393, DOI 10.1074/jbc.274.32.22393; Botrugno OA, 2006, EUR J CELL BIOL, V85, P35, DOI 10.1016/j.ejcb.2005.09.018; Brown MC, 2002, MOL BIOL CELL, V13, P1550, DOI 10.1091/mbc.02-02-0015; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Di Cesare A, 2000, NAT CELL BIOL, V2, P521, DOI 10.1038/35019561; ERPEL T, 1995, EMBO J, V14, P963, DOI 10.1002/j.1460-2075.1995.tb07077.x; Frank SR, 2008, SEMIN CELL DEV BIOL, V19, P234, DOI 10.1016/j.semcdb.2008.01.002; Fujikawa A, 2011, J BIOL CHEM, V286, P37137, DOI 10.1074/jbc.M111.270140; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Haendeler J, 2003, J BIOL CHEM, V278, P49936, DOI 10.1074/jbc.M307317200; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; Kim S, 2001, J BIOL CHEM, V276, P10581, DOI 10.1074/jbc.C000806200; Lamorte L, 2003, MOL BIOL CELL, V14, P2818, DOI 10.1091/mbc.E02-08-0497; Manabe R, 2002, J CELL SCI, V115, P1497; Matafora V, 2001, J CELL SCI, V114, P4509; Paris S, 2003, BIOCHEM J, V372, P391, DOI 10.1042/BJ20030047; Premont RT, 2000, J BIOL CHEM, V275, P22373, DOI 10.1074/jbc.275.29.22373; Premont RT, 2004, CELL SIGNAL, V16, P1001, DOI 10.1016/j.cellsig.2004.02.002; Sabe H, 2006, CURR OPIN CELL BIOL, V18, P558, DOI 10.1016/j.ceb.2006.08.002; Schmalzigaug R, 2007, CELL SIGNAL, V19, P1733, DOI 10.1016/j.cellsig.2007.03.010; Segura I, 2007, NAT NEUROSCI, V10, P301, DOI 10.1038/nn1858; Shih JL, 2005, MOL BIOL CELL, V16, P4595, DOI 10.1091/mbc.E05-02-0108; Shikata Y, 2003, J APPL PHYSIOL, V94, P1193, DOI 10.1152/japplphysiol.00690.2002; Totaro A, 2007, MOL BIOL CELL, V18, P5124, DOI 10.1091/mbc.E07-06-0550; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; Vitale N, 2000, J BIOL CHEM, V275, P13901, DOI 10.1074/jbc.275.18.13901; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Webb DJ, 2006, BIOCHEM BIOPH RES CO, V346, P1284, DOI 10.1016/j.bbrc.2006.06.036; Webb DJ, 2006, J CELL SCI, V119, P2847, DOI 10.1242/jcs03044; West KA, 2001, J CELL BIOL, V154, P161, DOI 10.1083/jcb.200101039; Yin GY, 2004, MOL CELL BIOL, V24, P875, DOI 10.1128/MCB.24.2.875-885.2004; Za L, 2006, J CELL SCI, V119, P2654, DOI 10.1242/jcs.02996; Zhang HY, 2003, J CELL BIOL, V161, P131, DOI 10.1083/jcb.200211002; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000	36	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93199	10.1371/journal.pone.0093199	http://dx.doi.org/10.1371/journal.pone.0093199			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699139	Green Published, Green Submitted, gold			2022-12-25	WOS:000334105000045
J	Yatkin, E; Polari, L; Laajala, TD; Smeds, A; Eckerman, C; Holmbom, B; Saarinen, NM; Aittokallio, T; Makela, SI				Yatkin, Emrah; Polari, Lauri; Laajala, Teemu D.; Smeds, Annika; Eckerman, Christer; Holmbom, Bjarne; Saarinen, Niina M.; Aittokallio, Tero; Makela, Sari I.			Novel Lignan and Stilbenoid Mixture Shows Anticarcinogenic Efficacy in Preclinical PC-3M-luc2 Prostate Cancer Model	PLOS ONE			English	Article							CELLS IN-VITRO; RESVERATROL; APOPTOSIS; GROWTH; TRAIL; CHEMOPREVENTION; MECHANISMS; PLANT; ADENOCARCINOMA; PROLIFERATION	Prostate cancer is the most common cancer of men in the Western world, and novel approaches for prostate cancer risk reduction are needed. Plant-derived phenolic compounds attenuate prostate cancer growth in preclinical models by several mechanisms, which is in line with epidemiological findings suggesting that consumption of plant-based diets is associated with low risk of prostate cancer. The objective of this study was to assess the effects of a novel lignan-stilbenoid mixture in PC-3M-luc2 human prostate cancer cells in vitro and in orthotopic xenografts. Lignan and stilbenoid -rich extract was obtained from Scots pine (Pinus sylvestris) knots. Pine knot extract as well as stilbenoids (methyl pinosylvin and pinosylvin), and lignans (matairesinol and nortrachelogenin) present in pine knot extract showed antiproliferative and proapoptotic efficacy at >= 40 mu M concentration in vitro. Furthermore, pine knot extract derived stilbenoids enhanced tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induced apoptosis already at >= 10 mu M concentrations. In orthotopic PC-3M-luc2 xenograft bearing immunocompromized mice, three-week peroral exposure to pine knot extract (52 mg of lignans and stilbenoids per kg of body weight) was well tolerated and showed anti-tumorigenic efficacy, demonstrated by multivariate analysis combining essential markers of tumor growth (i.e. tumor volume, vascularization, and cell proliferation). Methyl pinosylvin, pinosylvin, matairesinol, nortrachelogenin, as well as resveratrol, a metabolite of pinosylvin, were detected in serum at total concentration of 7-73 mu M, confirming the bioavailability of pine knot extract derived lignans and stilbenoids. In summary, our data indicates that pine knot extract is a novel and cost-effective source of resveratrol, methyl pinosylvin and other bioactive lignans and stilbenoids. Pine knot extract shows anticarcinogenic efficacy in preclinical prostate cancer model, and our in vitro data suggests that compounds derived from the extract may have potential as novel chemosensitizers to TRAIL. These findings promote further research on health-related applications of wood biochemicals.	[Yatkin, Emrah; Polari, Lauri; Saarinen, Niina M.; Makela, Sari I.] Univ Turku, Turku, Finland; [Yatkin, Emrah; Polari, Lauri; Saarinen, Niina M.; Makela, Sari I.] Univ Turku, Inst Biomed, TCDM, Turku, Finland; [Laajala, Teemu D.; Aittokallio, Tero] Univ Turku, Dept Math & Stat, Turku, Finland; [Smeds, Annika; Eckerman, Christer; Holmbom, Bjarne] Abo Akad Univ, Proc Chem Ctr, Lab Wood & Paper Chem, Turku, Finland; [Aittokallio, Tero] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland	University of Turku; University of Turku; University of Turku; Abo Akademi University; University of Helsinki	Makela, SI (corresponding author), Univ Turku, Turku, Finland.	sarmak@utu.fi	Aittokallio, Tero/B-6583-2009	Aittokallio, Tero/0000-0002-0886-9769; Laajala, Teemu Daniel/0000-0002-7016-7354; Saarinen, Niina/0000-0003-3531-378X; Makela, Sari/0000-0002-8698-4076; Polari, Lauri/0000-0002-0052-6489; Yatkin, Emrah/0000-0002-2597-6638	FIBIC Finnish Bioeconomy Cluster; BioRefine program of Finnish Funding Agency for Technology and Innovation; Academy of Finland	FIBIC Finnish Bioeconomy Cluster; BioRefine program of Finnish Funding Agency for Technology and Innovation; Academy of Finland(Academy of Finland)	This project was supported by the FIBIC Finnish Bioeconomy Cluster, the BioRefine program of Finnish Funding Agency for Technology and Innovation, and Academy of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlercreutz H, 2007, CRIT REV CL LAB SCI, V44, P483, DOI 10.1080/10408360701612942; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bylund A, 2005, EXP BIOL MED, V230, P217; Bylund A, 2000, PROSTATE, V42, P304, DOI 10.1002/(SICI)1097-0045(20000301)42:4<304::AID-PROS8>3.0.CO;2-Z; De Maesschalck R, 2000, CHEMOMETR INTELL LAB, V50, P1, DOI 10.1016/S0169-7439(99)00047-7; Deeb DD, 2005, J EXP THER ONCOL, V5, P81; Fulda S, 2004, CANCER RES, V64, P337, DOI 10.1158/0008-5472.CAN-03-1656; Ganapathy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015627; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Harper CE, 2007, CARCINOGENESIS, V28, P1946, DOI 10.1093/carcin/bgm144; Holmbom Bjarne, 2003, Phytochemistry Reviews, V2, P331, DOI 10.1023/B:PHYT.0000045493.95074.a8; Horvath Z, 2007, ANTICANCER RES, V27, P3459; Hutz JE, 2013, J BIOMOL SCREEN, V18, P367, DOI 10.1177/1087057112469257; Karna P, 2011, CARCINOGENESIS, V32, P1872, DOI 10.1093/carcin/bgr215; Kwon GT, 2012, J NUTR BIOCHEM, V23, P228, DOI 10.1016/j.jnutbio.2010.11.019; Laajala TD, 2012, CLIN CANCER RES, V18, P4385, DOI 10.1158/1078-0432.CCR-11-3215; Landstrom M, 1998, PROSTATE, V36, P151, DOI 10.1002/(SICI)1097-0045(19980801)36:3&lt;151::AID-PROS2&gt;3.0.CO;2-K; Li GL, 2012, SCI WORLD J, DOI 10.1100/2012/874053; Lieberman R, 2001, UROLOGY, V58, P835, DOI 10.1016/S0090-4295(01)01416-9; Lin X, 2001, ANTICANCER RES, V21, P3995; Lin X, 2002, UROLOGY, V60, P919, DOI 10.1016/S0090-4295(02)01863-0; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; McCann MJ, 2008, MOL NUTR FOOD RES, V52, P567, DOI 10.1002/mnfr.200700052; Park EJ, 2013, FOOD CHEM TOXICOL, V55, P424, DOI 10.1016/j.fct.2013.01.007; Peuhu E, 2010, ONCOGENE, V29, P898, DOI 10.1038/onc.2009.386; Peuhu E, 2013, BIOCHEM PHARMACOL, V86, P571, DOI 10.1016/j.bcp.2013.05.026; Roupe K, 2005, J PHARMACEUT BIOMED, V38, P148, DOI 10.1016/j.jpba.2004.12.015; Scalbert A, 2000, J NUTR, V130, p2073S, DOI 10.1093/jn/130.8.2073S; Scott E, 2012, MOL NUTR FOOD RES, V56, P7, DOI 10.1002/mnfr.201100400; Shankar S, 2007, MOL CELL BIOCHEM, V304, P273, DOI 10.1007/s11010-007-9510-x; Smeds AI, 2005, J CHROMATOGR B, V816, P87, DOI 10.1016/j.jchromb.2004.11.017; Smeds AI, 2004, J CHROMATOGR B, V813, P303, DOI 10.1016/j.jchromb.2004.10.033; Smeds AI, 2007, J AGR FOOD CHEM, V55, P1337, DOI 10.1021/jf0629134; Smeds AI, 2006, J PHARMACEUT BIOMED, V41, P898, DOI 10.1016/j.jpba.2005.12.036; Smeds AI, 2012, HOLZFORSCHUNG, V66, P283, DOI [10.1515/HF.2011.151, 10.1515/hf.2011.151]; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Szliszka E, 2011, INT J ONCOL, V39, P771, DOI 10.3892/ijo.2011.1116; Trottier G, 2010, NAT REV UROL, V7, P21, DOI 10.1038/nrurol.2009.234; Vang O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019881; Venkateswaran V, 2010, NAT REV UROL, V7, P442, DOI 10.1038/nrurol.2010.102; Wang TTY, 2008, CARCINOGENESIS, V29, P2001, DOI 10.1093/carcin/bgn131; Wang TTY, 2010, MOL NUTR FOOD RES, V54, P335, DOI 10.1002/mnfr.200900143; Wiezorek J, 2010, CLIN CANCER RES, V16, P1701, DOI 10.1158/1078-0432.CCR-09-1692; Willfor S, 2003, HOLZFORSCHUNG, V57, P359, DOI 10.1515/HF.2003.054; Xu Q, 2012, NUTR RES, V32, P648, DOI 10.1016/j.nutres.2012.07.002	45	22	25	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93764	10.1371/journal.pone.0093764	http://dx.doi.org/10.1371/journal.pone.0093764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699425	Green Published, gold, Green Submitted			2022-12-25	WOS:000334105000103
J	Berto, GE; Iobbi, C; Camera, P; Scarpa, E; Iampietro, C; Bianchi, F; Gai, M; Sgro, F; Cristofani, F; Gartner, A; Dotti, CG; Di Cunto, F				Berto, Gaia Elena; Iobbi, Cristina; Camera, Paola; Scarpa, Elena; Iampietro, Corinne; Bianchi, Federico; Gai, Marta; Sgro, Francesco; Cristofani, Flavio; Gaertner, Annette; Dotti, Carlos G.; Di Cunto, Ferdinando			The DCR Protein TTC3 Affects Differentiation and Golgi Compactness in Neurons through Specific Actin-Regulating Pathways	PLOS ONE			English	Article							SYNDROME CRITICAL REGION; CULTURED HIPPOCAMPAL-NEURONS; CITRON KINASE CONTROLS; DOWN-SYNDROME; LIM-KINASE; SYNAPTIC PLASTICITY; MOUSE MODEL; COFILIN PHOSPHORYLATION; CYTOSKELETAL DYNAMICS; AXON FORMATION	In neuronal cells, actin remodeling plays a well known role in neurite extension but is also deeply involved in the organization of intracellular structures, such as the Golgi apparatus. However, it is still not very clear which mechanisms may regulate actin dynamics at the different sites. In this report we show that high levels of the TTC3 protein, encoded by one of the genes of the Down Syndrome Critical Region (DCR), prevent neurite extension and disrupt Golgi compactness in differentiating primary neurons. These effects largely depend on the capability of TTC3 to promote actin polymerization through signaling pathways involving RhoA, ROCK, CIT-N and PIIa. However, the functional relationships between these molecules differ significantly if considering the TTC3 activity on neurite extension or on Golgi organization. Finally, our results reveal an unexpected stage-dependent requirement for F-actin in Golgi organization at different stages of neuronal differentiation.	[Berto, Gaia Elena; Camera, Paola; Scarpa, Elena; Iampietro, Corinne; Bianchi, Federico; Gai, Marta; Sgro, Francesco; Cristofani, Flavio; Di Cunto, Ferdinando] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Turin, Italy; [Gaertner, Annette; Dotti, Carlos G.] VIB, VIB Ctr Biol Dis, Louvain, Belgium; [Dotti, Carlos G.] CSIC UAM, Ctr Biol Mol Severo Ochoa, Madrid, Spain	University of Turin; Flanders Institute for Biotechnology (VIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Di Cunto, F (corresponding author), Univ Turin, Dept Mol Biotechnol & Hlth Sci, Turin, Italy.	gaia.berto@unito.it; ferdinando.dicunto@unito.it	Dotti, Carlos G/I-5533-2015; Di Cunto, Ferdinando/K-5575-2016; Gaertner, Annette/B-5393-2013	Dotti, Carlos G/0000-0003-4052-1719; Scarpa, Elena/0000-0002-0849-1276; di cunto, ferdinando/0000-0001-9367-6357; Bianchi, Federico Tommaso/0000-0002-8385-3310; Iampietro, Corinne/0000-0003-3153-9271	Jerome Lejeune foundation; Telethon Foundation	Jerome Lejeune foundation; Telethon Foundation(Fondazione Telethon)	This work was supported by the generous contribution of the Jerome Lejeune foundation to FDC. Moreover, the financial support of the Telethon Foundation, to the laboratory of FDC, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; BANKER G, 1988, NATURE, V336, P185, DOI 10.1038/336185a0; Bard F, 2003, J BIOL CHEM, V278, P46601, DOI 10.1074/jbc.M302221200; Bassi ZI, 2013, P NATL ACAD SCI USA, V110, P9782, DOI 10.1073/pnas.1301328110; Bassi ZI, 2011, J CELL BIOL, V195, P595, DOI 10.1083/jcb.201105136; BECKER L, 1991, PROG CLIN BIOL RES, V373, P133; BECKER LE, 1986, ANN NEUROL, V20, P520, DOI 10.1002/ana.410200413; Belichenko NP, 2009, J NEUROSCI, V29, P5938, DOI 10.1523/JNEUROSCI.1547-09.2009; Berto G, 2007, J CELL SCI, V120, P1859, DOI 10.1242/jcs.000703; Bisel B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080446; Bradke F, 2000, MICROSC RES TECHNIQ, V48, P3, DOI 10.1002/(SICI)1097-0029(20000101)48:1<3::AID-JEMT2>3.0.CO;2-O; Bradke F, 2000, CURR OPIN NEUROBIOL, V10, P574, DOI 10.1016/S0959-4388(00)00124-0; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Burkhardt JK, 1998, BBA-MOL CELL RES, V1404, P113, DOI 10.1016/S0167-4889(98)00052-4; Camera P, 2003, NAT CELL BIOL, V5, P1071, DOI 10.1038/ncb1064; Camera P, 2008, EMBO REP, V9, P384, DOI 10.1038/embor.2008.21; Da Silva JS, 2003, J CELL BIOL, V162, P1267, DOI 10.1083/jcb.200304021; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; Di Cunto F, 2000, NEURON, V28, P115, DOI 10.1016/S0896-6273(00)00090-8; Di Cunto F, 2003, BRAIN RES BULL, V60, P319, DOI 10.1016/S0361-9230(03)00058-3; Di Cunto F, 1998, J BIOL CHEM, V273, P29706, DOI 10.1074/jbc.273.45.29706; Dierssen M, 2006, THESCIENTIFICWORLDJO, V6, P1911, DOI 10.1100/tsw.2006.319; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Egea G, 2006, CURR OPIN CELL BIOL, V18, P168, DOI 10.1016/j.ceb.2006.02.007; Eki T, 1997, DNA SEQUENCE, V7, P153, DOI 10.3109/10425179709034031; Farg MA, 2013, HUM MOL GENET, V22, P717, DOI 10.1093/hmg/dds479; Flynn KC, 2012, NEURON, V76, P1091, DOI 10.1016/j.neuron.2012.09.038; Furuyashiki T, 1999, J NEUROSCI, V19, P109, DOI 10.1523/JNEUROSCI.19-01-00109.1999; Gai M, 2011, MOL BIOL CELL, V22, P3768, DOI 10.1091/mbc.E10-12-0952; Garvalov BK, 2007, J NEUROSCI, V27, P13117, DOI 10.1523/JNEUROSCI.3322-07.2007; Gonatas NK, 2006, J NEUROL SCI, V246, P21, DOI 10.1016/j.jns.2006.01.019; Holcomb PS, 2013, J PHYSIOL-LONDON, V591, P3145, DOI 10.1113/jphysiol.2012.248542; Hoogenraad CC, 2009, TRENDS CELL BIOL, V19, P669, DOI 10.1016/j.tcb.2009.08.006; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kleschevnikov AM, 2012, J NEUROSCI, V32, P9217, DOI 10.1523/JNEUROSCI.1673-12.2012; Lazaro-Dieguez F, 2006, CELL MOTIL CYTOSKEL, V63, P778, DOI 10.1002/cm.20161; Madaule P, 1995, FEBS LETT, V377, P243, DOI 10.1016/0014-5793(95)01351-2; Madaule P, 1998, NATURE, V394, P491, DOI 10.1038/28873; de Lagran MM, 2012, CEREB CORTEX, V22, P2867, DOI 10.1093/cercor/bhr362; Matas OB, 2004, TRAFFIC, V5, P838, DOI 10.1111/j.1600-0854.2004.00225.x; Neukirchen D, 2011, SEMIN CELL DEV BIOL, V22, P825, DOI 10.1016/j.semcdb.2011.08.007; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Rendon WO, 2013, HISTOCHEM CELL BIOL, V139, P671, DOI 10.1007/s00418-012-1059-4; Repetto D, 2014, J NEUROSCI, V34, P1542, DOI 10.1523/JNEUROSCI.2341-13.2014; Rosso S, 2004, MOL BIOL CELL, V15, P3433, DOI 10.1091/mbc.E03-05-0328; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Siarey RJ, 2005, NEUROPHARMACOLOGY, V49, P122, DOI 10.1016/j.neuropharm.2005.02.012; Stiess M, 2011, DEV NEUROBIOL, V71, P430, DOI 10.1002/dneu.20849; Suizu F, 2009, DEV CELL, V17, P800, DOI 10.1016/j.devcel.2009.09.007; Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519; Takata M, 2013, BR J PHARM; Tsukahara F, 1996, J BIOCHEM-TOKYO, V120, P820; Vilardell M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-229; Witke W, 2001, P NATL ACAD SCI USA, V98, P3832, DOI 10.1073/pnas.051515498; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Witte H, 2008, CURR OPIN NEUROBIOL, V18, P479, DOI 10.1016/j.conb.2008.09.019; Yadav S., 2011, COLD SPRING HARB PER, V3, P3; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yin DM, 2008, J NEUROSCI, V28, P8832, DOI 10.1523/JNEUROSCI.1291-08.2008	62	5	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93721	10.1371/journal.pone.0093721	http://dx.doi.org/10.1371/journal.pone.0093721			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695496	gold, Green Published			2022-12-25	WOS:000334103000110
J	Jiang, YD; Zhang, QH; Steinle, JJ				Jiang, Youde; Zhang, Qiuhua; Steinle, Jena J.			Intravitreal Injection of IGFBP-3 Restores Normal Insulin Signaling in Diabetic Rat Retina	PLOS ONE			English	Article							ENDOTHELIAL-CELL APOPTOSIS; NECROSIS-FACTOR-ALPHA; TNF-ALPHA; MULLER CELLS; RECEPTOR; SOCS-3; PHOSPHORYLATION; RESISTANCE; PATHWAYS; PROTEINS	Diabetes-induced changes in growth factor binding protein 3 (IGFBP-3) and tumor necrosis factor alpha (TNF alpha) have been linked to decreased insulin receptor signaling in diabetic retinopathy. Our previous studies in retinas of diabetic rats have shown that Compound 49b, a novel beta-adrenergic receptor agonist, prevented diabetic changes by increasing IGFBP-3 and decreasing TNF alpha, thus restoring insulin signaling and protection against diabetic retinopathy. The current study was designed to determine whether boosted expression of IGFBP-3 NB (a non-IGF-1 binding form of IGFBP-3) alone is sufficient to mimic the full actions of Compound 49b in protecting against diabetic retinopathy, as well as testing whether IGFBP-3 NB is linked to a restoration of normal insulin signal transduction. Two months after initiation of streptozotocin-induced diabetes, rats received a single intravitreal injection of IGFBP-3 NB plasmid in the right eye. Four days after injection, electroretinogram (ERG) analyses were performed prior to sacrifice. Whole retinal lysates from control, diabetic, diabetic + control plasmid, and diabetic+IGFBP-3 NB were analyzed for IGFBP-3, TNF alpha, suppressor of cytokine signaling 3 (SOCS3), and insulin receptor signaling partners using Western blotting or ELISA. Data show that a single intraocular injection of IGFBP-3 NB in diabetic animals significantly reduced TNF alpha levels, concomitant with reductions in IRS-1(Ser307), SOCS3, and proapoptotic markers, while restoring insulin receptor phosphorylation and increasing anti-apoptotic marker levels. These cellular changes were linked to restoration of retinal function. Our findings establish IGFBP-3 as a pivotal regulator of the insulin receptor/TNF alpha pathway and a potential therapeutic target for diabetic retinopathy.	[Jiang, Youde; Zhang, Qiuhua; Steinle, Jena J.] Univ Tennessee, Ctr Hlth Sci, Dept Ophthalmol, Memphis, TN 38163 USA; [Steinle, Jena J.] Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [Steinle, Jena J.] Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Steinle, JJ (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Ophthalmol, Memphis, TN 38163 USA.	jsteinl1@uthsc.edu	zhang, qiu/GXG-5600-2022	Steinle, Jena/0000-0002-7539-2892	NEI [R01-EY022045]; JDRF [2-2011-597]; Oxnard Foundation; HEI Research to Prevent Blindness Award; NEI Vision Core Grant [PHS 3P30 EY013080]; NATIONAL EYE INSTITUTE [R01EY022045, P30EY021721, P30EY013080] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); JDRF(Juvenile Diabetes Research Foundation); Oxnard Foundation; HEI Research to Prevent Blindness Award; NEI Vision Core Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NEI R01-EY022045 (JJS), JDRF (2-2011-597 to JJS), Oxnard Foundation (JJS), HEI Research to Prevent Blindness Award (PI: James C. Fleming), and NEI Vision Core Grant: PHS 3P30 EY013080 (PI: Dianna Johnson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Emanuelli B, 2000, J BIOL CHEM, V275, P15985, DOI 10.1074/jbc.275.21.15985; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Fasshauer M, 2004, J ENDOCRINOL, V181, P129, DOI 10.1677/joe.0.1810129; Ferry RJ, 1999, HORM RES, V51, P53; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Hotamisligil GS, 1999, J INTERN MED, V245, P621, DOI 10.1046/j.1365-2796.1999.00490.x; Jiang Y, 2013, PLOS ONE, V8; Jiang Y, 2013, MOL VIS, V19, P804; Jiang YD, 2012, CELL SIGNAL, V24, P1086, DOI 10.1016/j.cellsig.2012.01.003; Jiang YD, 2010, EXP EYE RES, V91, P171, DOI 10.1016/j.exer.2010.04.014; Krebs DL, 2000, J CELL SCI, V113, P2813; Panjala SR, 2011, MOL VIS, V17, P1822; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Steinle JJ, 2009, EXP EYE RES, V88, P1014, DOI 10.1016/j.exer.2008.12.015; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Walker RJ, 2011, INVEST OPHTHALMOL VI; Walker RJ, 2012, MOL VIS, V18, P271; Wiley LA, 2005, INVEST OPHTH VIS SCI, V46, P744, DOI 10.1167/iovs.04-1023; Zhang Q, 2013, INVEST OPHTHALMOL VI; Zhang QH, 2013, INVEST OPHTH VIS SCI, V54, P5376, DOI 10.1167/iovs.13-12497; Zhang QH, 2013, APOPTOSIS, V18, P361, DOI 10.1007/s10495-012-0793-3; Zhang QH, 2012, INVEST OPHTH VIS SCI, V53, P3004, DOI 10.1167/iovs.11-8779	23	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93788	10.1371/journal.pone.0093788	http://dx.doi.org/10.1371/journal.pone.0093788			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695399	Green Published, Green Submitted, gold			2022-12-25	WOS:000334103000123
J	Mercurio, AD; Hernandez, SM; Maerz, JC; Yabsley, MJ; Ellis, AE; Coleman, AL; Shelnutt, LM; Fischer, JR; Wilde, SB				Mercurio, Albert D.; Hernandez, Sonia M.; Maerz, John C.; Yabsley, Michael J.; Ellis, Angela E.; Coleman, Amanda L.; Shelnutt, Leslie M.; Fischer, John R.; Wilde, Susan B.			Experimental Feeding of Hydrilla verticillata Colonized by Stigonematales Cyanobacteria Induces Vacuolar Myelinopathy in Painted Turtles (Chrysemys picta)	PLOS ONE			English	Article							AMERICAN COOTS; RESERVOIRS; WATERBIRDS; MALLARDS	Vacuolar myelinopathy (VM) is a neurologic disease primarily found in birds that occurs when wildlife ingest submerged aquatic vegetation colonized by an uncharacterized toxin-producing cyanobacterium (hereafter "UCB'' for "uncharacterized cyanobacterium''). Turtles are among the closest extant relatives of birds and many species directly and/or indirectly consume aquatic vegetation. However, it is unknown whether turtles can develop VM. We conducted a feeding trial to determine whether painted turtles (Chrysemys picta) would develop VM after feeding on Hydrilla (Hydrilla verticillata), colonized by the UCB (Hydrilla is the most common "host'' of UCB). We hypothesized turtles fed Hydrilla colonized by the UCB would exhibit neurologic impairment and vacuolation of nervous tissues, whereas turtles fed Hydrilla free of the UCB would not. The ability of Hydrilla colonized by the UCB to cause VM (hereafter, "toxicity'') was verified by feeding it to domestic chickens (Gallus gallus domesticus) or necropsy of field collected American coots (Fulica americana) captured at the site of Hydrilla collections. We randomly assigned ten wild-caught turtles into toxic or non-toxic Hydrilla feeding groups and delivered the diets for up to 97 days. Between days 82 and 89, all turtles fed toxic Hydrilla displayed physical and/or neurologic impairment. Histologic examination of the brain and spinal cord revealed vacuolations in all treatment turtles. None of the control turtles exhibited neurologic impairment or had detectable brain or spinal cord vacuolations. This is the first evidence that freshwater turtles can become neurologically impaired and develop vacuolations after consuming toxic Hydrilla colonized with the UCB. The southeastern United States, where outbreaks of VM occur regularly and where vegetation colonized by the UCB is common, is also a global hotspot of freshwater turtle diversity. Our results suggest that further investigations into the effect of the putative UCB toxin on wild turtles in situ are warranted.	[Mercurio, Albert D.; Hernandez, Sonia M.; Maerz, John C.; Yabsley, Michael J.; Coleman, Amanda L.; Wilde, Susan B.] Univ Georgia, DB Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Mercurio, Albert D.; Hernandez, Sonia M.; Yabsley, Michael J.; Fischer, John R.] Univ Georgia, Coll Vet Med, Dept Populat Hlth, SCWDS, Athens, GA USA; [Ellis, Angela E.] Univ Georgia, Coll Vet Med, Athens Vet Diagnost Lab, Athens, GA USA; [Shelnutt, Leslie M.] Univ Georgia, Coll Vet Med, Athens, GA USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Mercurio, AD (corresponding author), Univ Georgia, DB Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA.	mercurad@uga.edu		Maerz, John/0000-0002-1592-5431; Wilde, Susan/0000-0002-5388-9582; Yabsley, Michael/0000-0003-2452-5015	University of Georgia Graduate School; D. B. Warnell school of Forestry and Natural Resources; National Institutes of Health (NIH R15) [1R15AI089565-01]; United States Army Corps of Engineers [W912HZ-12-2-0013]; United States Fish and Wildlife Service [F11AC00889]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI089565] Funding Source: NIH RePORTER	University of Georgia Graduate School; D. B. Warnell school of Forestry and Natural Resources; National Institutes of Health (NIH R15); United States Army Corps of Engineers(United States Department of DefenseUnited States Army); United States Fish and Wildlife Service(US Fish & Wildlife Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by The University of Georgia Graduate School, The D. B. Warnell school of Forestry and Natural Resources, The National Institutes of Health (NIH R15 # 1R15AI089565-01), The United States Army Corps of Engineers (W912HZ-12-2-0013), and The United States Fish and Wildlife Service (F11AC00889). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augspurger T, 2003, J WILDLIFE DIS, V39, P412, DOI 10.7589/0090-3558-39.2.412; Birrenkott AH, 2004, J WILDLIFE DIS, V40, P485, DOI 10.7589/0090-3558-40.3.485; Bjorndal Karen A., 1997, Chelonian Conservation and Biology, V2, P430; Buhlmann KA, 2009, CHELONIAN CONSERV BI, V8, P116, DOI 10.2744/CCB-0774.1; Chiari Y, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-65; Clippinger Tracy L, 2007, Vet Clin North Am Exot Anim Pract, V10, P803, DOI 10.1016/j.cvex.2007.04.006; Davis KM, 2007, BEHAV PROCESS, V75, P225, DOI 10.1016/j.beproc.2007.02.021; Ernst CH, 2009, TURTLES US CANADA; Fields JR, 2003, J HERPETOL, V37, P726, DOI 10.1670/193-02N; Fischer JR, 2006, J WILDLIFE DIS, V42, P501, DOI 10.7589/0090-3558-42.3.501; Fischer JR, 2003, J WILDLIFE DIS, V39, P400, DOI 10.7589/0090-3558-39.2.400; Haynie RS, 2013, J AQUAT ANIM HEALTH, V25, P252, DOI 10.1080/08997659.2013.833556; Johnson JH, 2004, SEMIN AVIAN EXOT PET, V13, P223, DOI 10.1053/j.saep.2004.04.008; Kozlowsky-Suzuki B, 2012, HARMFUL ALGAE, V18, P47, DOI 10.1016/j.hal.2012.04.002; Larsen RS, 2002, J AM VET MED ASSOC, V221, P80, DOI 10.2460/javma.2002.221.80; Lewis-Weis LA, 2004, J WILDLIFE DIS, V40, P476, DOI 10.7589/0090-3558-40.3.476; Lightfoot TL, 2006, CLIN AVIAN MED; Mader D.R, 2006, REPTILE MED SURG; Mariani Christopher L, 2007, Vet Clin North Am Exot Anim Pract, V10, P855, DOI 10.1016/j.cvex.2007.04.004; Quinn GP, 2003, EXPT DESIGN DATA ANA; Robertson SM, 2012, THESIS U GEORGIA; Rocke TE, 2005, J WILDLIFE DIS, V41, P163, DOI 10.7589/0090-3558-41.1.163; Rocke TE, 2002, J WILDLIFE DIS, V38, P678, DOI 10.7589/0090-3558-38.4.678; Thomas NJ, 1998, VET PATHOL, V35, P479, DOI 10.1177/030098589803500602; Wilde SB, 2005, ENVIRON TOXICOL, V20, P348, DOI 10.1002/tox.20111; Wiley FE, 2009, ENVIRON TOXICOL, V24, P362, DOI 10.1002/tox.20424; Williams BJ, 2009, J FRESHWATER ECOL, V24, P309, DOI 10.1080/02705060.2009.9664297; Williams SK, 2007, HARMFUL ALGAE, V6, P343, DOI 10.1016/j.hal.2006.07.005	28	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93295	10.1371/journal.pone.0093295	http://dx.doi.org/10.1371/journal.pone.0093295			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695109	Green Published, Green Submitted, gold			2022-12-25	WOS:000334103000056
J	Mollot, G; Duyck, PF; Lefeuvre, P; Lescourret, F; Martin, JF; Piry, S; Canard, E; Tixier, P				Mollot, Gregory; Duyck, Pierre-Francois; Lefeuvre, Pierre; Lescourret, Francoise; Martin, Jean-Francois; Piry, Sylvain; Canard, Elsa; Tixier, Philippe			Cover Cropping Alters the Diet of Arthropods in a Banana Plantation: A Metabarcoding Approach	PLOS ONE			English	Article							FOOD-WEB STRUCTURE; STABLE-ISOTOPES; SPECIES ABUNDANCE; TROPHIC POSITION; NATURAL ENEMIES; BODY-SIZE; DNA; PREDATORS; PREY; BIODIVERSITY	Plant diversification using cover crops may promote natural regulation of agricultural pests by supporting alternative prey that enable the increase of arthropod predator densities. However, the changes in the specific composition of predator diet induced by cover cropping are poorly understood. Here, we hypothesized that the cover crop can significantly alter the diet of predators in agroecosystems. The cover crop Brachiaria decumbens is increasingly used in banana plantations to control weeds and improve physical soil properties. In this paper, we used a DNA metabarcoding approach for the molecular analysis of the gut contents of predators (based on mini-COI) to identify 1) the DNA sequences of their prey, 2) the predators of Cosmopolites sordidus (a major pest of banana crops), and 3) the difference in the specific composition of predator diets between a bare soil plot (BSP) and a cover cropped plot (CCP) in a banana plantation. The earwig Euborellia caraibea, the carpenter ant Camponotus sexguttatus, and the fire ant Solenopsis geminata were found to contain C. sordidus DNA at frequencies ranging from 1 to 7%. While the frequencies of predators positive for C. sordidus DNA did not significantly differ between BSP and CCP, the frequency at which E. caraibea was positive for Diptera was 26% in BSP and 80% in CCP; the frequency at which C. sexguttatus was positive for Jalysus spinosus was 14% in BSP and 0% in CCP; and the frequency at which S. geminata was positive for Polytus mellerborgi was 21% in BSP and 3% in CCP. E. caraibea, C. sexguttatus and S. geminata were identified as possible biological agents for the regulation of C. sordidus. The detection of the diet changes of these predators when a cover crop is planted indicates the possible negative effects on pest regulation if predators switch to forage on alternative prey.	[Mollot, Gregory; Duyck, Pierre-Francois; Canard, Elsa; Tixier, Philippe] PRAM, CIRAD, UR Syst Culture Base Bananiers Plantains & Ananas, Le Lamentin, Martinique, France; [Mollot, Gregory; Lescourret, Francoise] INRA, UR Plantes & Syst Culture Hort 1115, Avignon, France; [Duyck, Pierre-Francois; Lefeuvre, Pierre] Univ Reunion, CIRAD, UMR PVBMT, St Pierre, Reunion, France; [Martin, Jean-Francois] Montpellier SupAgro, UMR CBGP, Montferrier Sur Lez, France; [Piry, Sylvain] INRA, CBGP, UMR1062, Montferrier Sur Lez, France; [Canard, Elsa] MIVEGEC, CNRS, IRD, UMR 2724, Montpellier, France; [Tixier, Philippe] CIRAD, CATIE, Dept Agr & Agroforesteria, Turrialba, Costa Rica	CIRAD; INRAE; CIRAD; University of La Reunion; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); INRAE; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CATIE - Centro Agronomico Tropical de Investigacion y Ensenanza; CIRAD	Duyck, PF (corresponding author), PRAM, CIRAD, UR Syst Culture Base Bananiers Plantains & Ananas, Le Lamentin, Martinique, France.	duyck@cirad.fr	Tixier, Philippe/C-2119-2008; Martin, Jean-Francois/AAD-3883-2019; Duyck, Pierre-François/C-2416-2008; Piry, Sylvain/Q-6206-2019; Martin, Jean-Francois/M-9426-2017	Tixier, Philippe/0000-0001-5147-9777; Martin, Jean-Francois/0000-0001-9176-4476; Duyck, Pierre-François/0000-0001-5484-1970; Piry, Sylvain/0000-0002-7717-7555; Martin, Jean-Francois/0000-0001-9176-4476; Lescourret, Francoise/0000-0002-6576-8067; Lefeuvre, Pierre/0000-0003-2645-8098	CIRAD; E.U. FEFER [30411]	CIRAD; E.U. FEFER	This research is a part of a PhD funded by the CIRAD and funded by the project "sustainable cropping systems design'' from E.U. FEFER (grant PRESAGE no 30411). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abera-Kalibata AM, 2008, BIOL CONTROL, V46, P147, DOI 10.1016/j.biocontrol.2008.04.017; Abera-Kalibata AM, 2006, BIOL CONTROL, V37, P16, DOI 10.1016/j.biocontrol.2005.11.009; Barberi P, 2010, WEED RES, V50, P388, DOI 10.1111/j.1365-3180.2010.00798.x; Berlow EL, 2004, J ANIM ECOL, V73, P585, DOI 10.1111/j.0021-8790.2004.00833.x; Blanchard JL, 2009, J ANIM ECOL, V78, P270, DOI 10.1111/j.1365-2656.2008.01466.x; BUGG RL, 1994, AGR ECOSYST ENVIRON, V50, P11, DOI 10.1016/0167-8809(94)90121-X; Cabana G, 1996, P NATL ACAD SCI USA, V93, P10844, DOI 10.1073/pnas.93.20.10844; Carreon-Martinez L, 2010, MOL ECOL, V19, P25, DOI 10.1111/j.1365-294X.2009.04412.x; Cohen JE, 2003, P NATL ACAD SCI USA, V100, P1781, DOI 10.1073/pnas.232715699; Dormann C. F., 2009, OPEN ECOL J, V2, P7, DOI DOI 10.2174/1874213000902010007; Dornhaus A, 2008, BEHAV ECOL SOCIOBIOL, V63, P43, DOI 10.1007/s00265-008-0634-0; Duyck PF, 2011, BASIC APPL ECOL, V12, P47, DOI 10.1016/j.baae.2010.11.009; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FRY B, 1988, LIMNOL OCEANOGR, V33, P1182, DOI 10.4319/lo.1988.33.5.1182; Gold Clifford S., 2002, Integrated Pest Management Reviews, V6, P79, DOI 10.1023/A:1023330900707; Harper GL, 2005, MOL ECOL, V14, P819, DOI [10.1111/j.1365-294X.2005.02442.x, 10.1111/j.1365-294x.2005.02442.x]; Harris DJ, 2003, TRENDS ECOL EVOL, V18, P317, DOI 10.1016/S0169-5347(03)00150-2; Harwood JD, 2007, BIOL CONTROL, V41, P397, DOI 10.1016/j.biocontrol.2007.02.008; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Jennings S, 2003, ECOL LETT, V6, P971, DOI 10.1046/j.1461-0248.2003.00529.x; Jonsson T, 2005, ADV ECOL RES, V36, P1, DOI 10.1016/S0065-2504(05)36001-6; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; KOPPENHOFER AM, 1993, J APPL ENTOMOL, V116, P352, DOI 10.1111/j.1439-0418.1993.tb01207.x; Leray M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058076; Letourneau DK, 2011, ECOL APPL, V21, P9, DOI 10.1890/09-2026.1; Meglecz E, 2011, BIOINFORMATICS, V27, P277, DOI 10.1093/bioinformatics/btq641; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Mollot G, 2012, AGR FOREST ENTOMOLOG; NICKERSON JC, 1977, FLA ENTOMOL, V60, P193, DOI 10.2307/3493905; Perfecto Ivette, 1998, P269, DOI 10.1016/B978-012078147-8/50061-X; PETERSON BJ, 1985, SCIENCE, V227, P1361, DOI 10.1126/science.227.4692.1361; Piry S, 2012, MOL ECOL RESOUR, V12, P1151, DOI 10.1111/j.1755-0998.2012.03171.x; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Ponsard S, 2000, ECOLOGY, V81, P852, DOI 10.1890/0012-9658(2000)081[0852:WCSINA]2.0.CO;2; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; R Core Team, 2021, R LANG ENV STAT COMP; RISCH S, 1981, J ECON ENTOMOL, V74, P88, DOI 10.1093/jee/74.1.88; Scherber C, 2010, NATURE, V468, P553, DOI 10.1038/nature09492; Simon S, 2010, AGRON SUSTAIN DEV, V30, P139, DOI 10.1051/agro/2009013; Symondson WOC, 2002, MOL ECOL, V11, P627, DOI 10.1046/j.1365-294X.2002.01471.x; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; TOPHAM M, 1975, P HAWAII ENTOMOL SOC, V22, P145; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Van Veen FJF, 2008, J ANIM ECOL, V77, P191, DOI 10.1111/j.1365-2656.2007.01325.x; VANDENBERG H, 1995, INT J PEST MANAGE, V41, P134, DOI 10.1080/09670879509371938; Vander Zanden MJ, 1999, ECOLOGY, V80, P1395; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Wise DH, 2006, ECOL APPL, V16, P865, DOI 10.1890/1051-0761(2006)016[0865:USITRS]2.0.CO;2; Yu DW, 2012, METHODS ECOL EVOL, V3, P613, DOI 10.1111/j.2041-210X.2012.00198.x	50	53	57	1	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93740	10.1371/journal.pone.0093740	http://dx.doi.org/10.1371/journal.pone.0093740			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695585	Green Published, gold, Green Submitted			2022-12-25	WOS:000334103000116
J	Pol, D; Nascimento, PM; Carvalho, AB; Riccomini, C; Pires-Domingues, RA; Zaher, H				Pol, Diego; Nascimento, Paulo M.; Carvalho, Alberto B.; Riccomini, Claudio; Pires-Domingues, Ricardo A.; Zaher, Hussam			A New Notosuchian from the Late Cretaceous of Brazil and the Phylogeny of Advanced Notosuchians	PLOS ONE			English	Article							CLARKI CROCODYLIFORMES NOTOSUCHIA; NEUQUEN BASIN ARGENTINA; BAURU BASIN; ADAMANTINA FORMATION; TERRESTRIS WOODWARD; CROCODYLOMORPHA; MESOEUCROCODYLIA; MORPHOLOGY; ANATOMY; REMAINS	A new notosuchian crocodyliform from the Late Cretaceous Bauru Group found in the southeastern State of Sao Paulo ( Brazil) is described here. The new taxon, Caipirasuchus stenognathus, is referred as a new species of the recently erected genus Caipirasuchus within the clade Sphagesauridae based on a phylogenetic analysis of basal mesoeucrocodylians. Caipirasuchus stenognathus is represented by an almost complete skull and lower jaw that has autapomorphic characters that distinguish it from other species of Sphagesauridae. These autapomorphies include: maxilla forming part of the orbital margin ( absence of lacrimal-jugal contact), nasal with smooth depressions on the posterior region close to the contact with the maxilla and lacrimal, postorbital with posterior palpebral facet that extends posteriorly underneath the ear-flap groove, and a distinct anterior process of the medial flange of the retroarticular process. Additionally, the new taxon lacks autapomorphic features described in other sphagesaurids. The phylogenetic analysis results in a monophyletic genus Caipirasuchus, that is the sister group of a clade fomed by Sphagesaurus huenei, Caryonosuchus pricei, and Armadillosuchus arrudai. Sphagesaurids also include a basal clade formed by Adamantinasuchus navae and Yacarerani boliviensis. Other notosuchian taxa, such as Mariliasuchus amarali, Labidiosuchus amicum, Notosuchus terrestris, and Morrinhosuchus luziae are successive sister taxa of Sphagesauridae, forming a clade of advanced notosuchians that are restricted to the Late Cretaceous of South America. These results contrast with most previous phylogenetic hypotheses of the group that depicted some members of Sphagesauridae as more closely related to baurusuchids, or found Asian ( e. g., Chimaerasuchus) or African (Malawisuchus, Pakasuchus) forms nested within advanced notosuchians that are, according to our analysis, endemic of the Late Cretaceous of South America.	[Pol, Diego] Consejo Nacl Invest Cient & Tecn, Museo Paleontol Egidio Feruglio, Trelew, Chubut, Argentina; [Nascimento, Paulo M.; Carvalho, Alberto B.; Pires-Domingues, Ricardo A.; Zaher, Hussam] Univ Sao Paulo, Museu Zool, Sao Paulo, Brazil; [Nascimento, Paulo M.] Univ Sao Paulo, Inst Biociencias, Programa Posgrad Zool, Sao Paulo, Brazil; [Riccomini, Claudio] Univ Sao Paulo, Inst Geociencias, Sao Paulo, Brazil	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Zaher, H (corresponding author), Univ Sao Paulo, Museu Zool, Sao Paulo, Brazil.	hussam.zaher@gmail.com	Zaher, Hussam/D-4000-2012; Pol, Diego/A-8007-2008; Zaher, Hussam/ABC-1701-2021; Fapesp, Biota/F-8655-2017; Riccomini, Claudio/G-1764-2010	Zaher, Hussam/0000-0002-6994-489X; Pol, Diego/0000-0002-9690-7517; Zaher, Hussam/0000-0002-6994-489X; Fapesp, Biota/0000-0002-9887-8449; Riccomini, Claudio/0000-0002-7249-5706	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [BIOTA/FAPESP 2011/50206-9]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq 565046/2010-1, 303545/2010-0, 401836/2010-0]; ANPCyT PICT [0736]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); ANPCyT PICT(ANPCyT)	This research was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (BIOTA/FAPESP 2011/50206-9) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq 565046/2010-1, 303545/2010-0, 401836/2010-0) to H. Zaher and A. B. Carvalho, and ANPCyT PICT 0736 to D. Pol. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera E, 1989, REV TECNICA YPFB, V10, P131; ANDRADE MB, 2008, HIST BIOL, V20, P101, DOI DOI 10.1080/08912960701642949; Batezelli A., 2003, GEOCIENCIAS, V22, P5; Bonaparte JF., 1991, REV MUSEO ARGENTINO, V4, P31; Bonaparte Jose F., 1996, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V30, P73; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Brochu CA, 1999, J VERTEBR PALEONTOL, V19, P9, DOI 10.1080/02724634.1999.10011201; Buckley GA, 1999, SPEC PAP PALAEONTOL, P149; Buckley GA, 2000, NATURE, V405, P941, DOI 10.1038/35016061; Buffetaut E., 1981, GEOL RUNDSCH, V70, P611, DOI DOI 10.1007/BF01822139; Busbey A.B. III, 1986, Journal of Vertebrate Paleontology, V6, P20; BUSBEY AB, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P173; Buscalioni AD, 2004, CRETACEOUS RES, V25, P267, DOI 10.1016/j.cretres.2003.12.004; Candeiro CRA, 2006, J S AM EARTH SCI, V22, P116, DOI 10.1016/j.jsames.2006.08.001; Carvalho I.S., 1999, GEOLOGIA COLOMBIANA, V24, P83, DOI DOI 10.15446/GC; Carvalho ID, 2004, GONDWANA RES, V7, P975, DOI 10.1016/S1342-937X(05)71079-0; Carvalho ID, 2005, GONDWANA RES, V8, P11, DOI 10.1016/S1342-937X(05)70259-8; Carvalho ID, 2007, ZOOTAXA, P35; Carvalho ID, 2011, ZOOTAXA, P19; Carvalho Ismar De Souza, 1994, Anais da Academia Brasileira de Ciencias, V66, P331; Carvalho ID, 2010, PALAEOGEOGR PALAEOCL, V297, P252, DOI 10.1016/j.palaeo.2010.08.003; Clark JM, 2011, ZOOL J LINN SOC-LOND, V163, pS152, DOI 10.1111/j.1096-3642.2011.00719.x; CLARK JM, 1994, IN THE SHADOW OF THE DINOSAURS, P84; CLARK JM, 1989, SCIENCE, V244, P1064, DOI 10.1126/science.244.4908.1064; CODDINGTON J, 1994, CLADISTICS, V10, P415; COLBERT EH, 1951, B AM MUS NAT HIST, V97, P143; de Andrade MB, 2011, ZOOL J LINN SOC-LOND, V163, pS66, DOI 10.1111/j.1096-3642.2011.00709.x; De Andrade Marco Brandalise, 2008, Arquivos do Museu Nacional Rio de Janeiro, V66, P7; De Andrade Marco Brandalise, 2008, Arquivos do Museu Nacional Rio de Janeiro, V66, P63; De Andrade Marco Brandalise, 2006, REVISTA BRASILEIRA DE PALEONTOLOGIA, V9, P323; Silva FDE, 2009, J S AM EARTH SCI, V28, P25, DOI 10.1016/j.jsames.2009.02.008; Dias-Brito Dimas, 2001, Revue de Paleobiologie, V20, P245; Dingus Lowell, 2000, American Museum Novitates, V3290, P1, DOI 10.1206/0003-0082(2000)290<0001:SAMFCF>2.0.CO;2; Endo H, 2002, ANAT HISTOL EMBRYOL, V31, P206, DOI 10.1046/j.1439-0264.2002.00396.x; Fernandes L.A., 2000, REV BRASILEIRA GEOCI, V30, P717, DOI DOI 10.25249/0375-7536.2000304717728; Fernandes L.A., 1996, AN ACAD BRAS CIENC, V68, P195; Fernandes LA, 2003, AN ACAD BRAS CIENC, V75, P173, DOI 10.1590/S0001-37652003000200006; Fiorelli Lucas, 2008, Arquivos do Museu Nacional Rio de Janeiro, V66, P83; Garrido Alberto C., 2010, Rev. Mus. Argent. Cienc. Nat., V12, P121; Gasparini, 1971, AMEGHINIANA, V8, P83; Gasparini Z., 1991, Journal of Vertebrate Paleontology, V11, P316; Gasparini Zulma, 1996, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V30, P159; Gasparini Zulma, 1993, Historical Biology, V7, P1; Gobbo-Rodrigues SR., 1999, ACTA GEOLOGICA LEOPO, V23, P3; Goloboff P.A., 2008, TNT TREE ANAL USING; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gomani EM, 1997, J VERTEBR PALEONTOL, V17, P280, DOI 10.1080/02724634.1997.10010975; Hecht MK., 1983, N JAHR GEOL PAL ONT, V11, P657; Holliday CM, 2007, J MORPHOL, V268, P457, DOI 10.1002/jmor.10524; Hugo C.A., 2001, HOJA GEOL GICA 3069, V308, P1; Iordansky N.N., 1973, P201; Iordansky NN, 2000, RUSSIAN J HERPETOLOG, V7, P41; Iori F. V., 2011, PALEONTOLOGIA CENARI, P585; Iori FV, 2011, J VERTEBR PALEONTOL, V31, P1255, DOI 10.1080/02724634.2011.602777; Iori FV, 2013, ZOOTAXA, V3686, P183; Iori FV., 2009, BRAZ J GEOL, V39, P717; Jouve S, 2009, J VERTEBR PALEONTOL, V29, P88, DOI 10.1080/02724634.2009.10010364; Kellner AWA, 2011, ZOOL J LINN SOC-LOND, V163, pS109, DOI 10.1111/j.1096-3642.2011.00711.x; Kellner AWA, 2011, ZOOL J LINN SOC-LOND, V163, pS57, DOI 10.1111/j.1096-3642.2011.00712.x; Kellner AWA, 2009, ZOOTAXA, P49, DOI 10.11646/zootaxa.2030.1.4; Kley NJ, 2010, J VERTEBR PALEONTOL, V30, P13, DOI 10.1080/02724634.2010.532674; Kuhn O, 1968, VORZEITLICHEN KRIKOD; Lamanna M, 2003, J VERTEBR PALEONTOL, V23, p70A; Larsson HCE, 2007, ZOOL J LINN SOC-LOND, V149, P533, DOI 10.1111/j.1096-3642.2007.00271.x; Larsson HCE, 2000, NEUES JAHRB GEOL P-A, V217, P131, DOI 10.1127/njgpa/217/2000/131; Leanza HA, 2004, CRETACEOUS RES, V25, P61, DOI 10.1016/j.cretres.2003.10.005; Lecuona A, 2008, CR PALEVOL, V7, P407, DOI 10.1016/j.crpv.2008.07.001; Legarreta L., 1989, CUENCAS SEDIMENTARIA, V6, P221; Lopez RM, 1975, INFORM ESTRATIGRAFIC; Marinho T.S, 2007, PALEONTOLOGIA CENARI, P481; Marinho TS, 2009, J S AM EARTH SCI, V27, P36, DOI 10.1016/j.jsames.2008.11.005; Leardi JM, 2009, CRETACEOUS RES, V30, P1376, DOI 10.1016/j.cretres.2009.08.002; Martinelli AG, 2003, AMEGHINIANA, V40, P559; Martinelli AG, 2012, CRETACEOUS RES, V37, P191, DOI 10.1016/j.cretres.2012.03.017; Montefeltro FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021916; Nascimento PM, 2011, ZOOL J LINN SOC-LOND, V163, pS116, DOI 10.1111/j.1096-3642.2011.00708.x; Nascimento Paulo Miranda, 2010, Pap. Avulsos Zool. (São Paulo), V50, P323, DOI 10.1590/S0031-10492010002100001; NASH D S, 1975, Annals of the South African Museum, V67, P227; Nobre PH, 2008, GONDWANA RES, V13, P139, DOI 10.1016/j.gr.2007.08.002; Nobre PH, 2006, GONDWANA RES, V10, P370, DOI 10.1016/j.gr.2006.05.008; NOBRE PH, 2007, ANUARIO I GEOCIENCIA, V30, P32; Novas FE, 2009, J VERTEBR PALEONTOL, V29, P1316, DOI 10.1671/039.029.0409; O'Connor PM, 2010, NATURE, V466, P748, DOI 10.1038/nature09061; Ortega F, 1996, GEOBIOS-LYON, V29, P353, DOI 10.1016/S0016-6995(96)80037-4; Ortega F, 2000, J VERTEBR PALEONTOL, V20, P57, DOI 10.1671/0272-4634(2000)020[0057:ANSOAC]2.0.CO;2; Osi A, 2013, HIST BIOL, V2013, P1; Paula E, 2003, GEOCIENCIAS, V22, P21, DOI DOI 10.4072/RBP.2004.3.07; Paula e Silva F., 2005, REV BRASILEIRA GEOCI, V35, P77, DOI DOI 10.25249/0375-7536.20053517788; Piacentini Pinheiro Andre Eduardo, 2008, Revista Brasileira de Paleontologia, V11, P37; Pires-Domingues Ricardo Angelim, 2007, P273; Pol D, 2005, AMEGHINIANA, V42, P21; Pol D, 2004, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2004)445<0001:ANCFCM>2.0.CO;2; Pol D, 2005, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2005)490[0001:NARFTE]2.0.CO;2; Pol D, 2003, J VERTEBR PALEONTOL, V23, P817, DOI 10.1671/A1015-7; Pol Diego, 2007, P116; Pol D, 2012, J VERTEBR PALEONTOL, V32, P328, DOI 10.1080/02724634.2012.646833; Pol D, 2011, ZOOL J LINN SOC-LOND, V163, pS7, DOI 10.1111/j.1096-3642.2011.00714.x; Pol D, 2009, CLADISTICS, V25, P515, DOI 10.1111/j.1096-0031.2009.00258.x; Pol D, 2009, J SYST PALAEONTOL, V7, P163, DOI 10.1017/S1477201908002605; Prasad Guntupalli V.R., 2002, Annales de Paleontologie, V88, P19, DOI 10.1016/S0753-3969(02)01036-4; Price L. I, 1959, Boletim Divisao de Geologia e Mineralogia Rio de Janeiro, V188, P1; Price L.I., 1945, NOTAS PRELIMINARES E, V25, P1; PRICE LLEWELLYN IVOR, 1950, AN ACAD BRASIL CIENC, V22, P77; Riccomini C., 1997, REV BRAS GEOCIENC, V27, P153; Riff D, 2011, ZOOL J LINN SOC-LOND, V163, pS37, DOI 10.1111/j.1096-3642.2011.00713.x; Rusconi C., 1933, Boletin del Instituto Geologia y Perforaciones Montevideo, V19, P1; Santucci R.M., 2001, BRAZ J GENET, V31, P307; Schumacher G. H., 1973, P101; Sereno PC, 2009, ZOOKEYS, P1, DOI 10.3897/zookeys.28.325; Sereno PC, 2003, J VERTEBR PALEONTOL, V23, P477, DOI 10.1671/0272-4634(2003)023[0477:ANNFTE]2.0.CO;2; Sereno PC, 2001, SCIENCE, V294, P1516, DOI 10.1126/science.1066521; Shu C.-K., 2005, VERTEBRAT PALASIATIC, V43, P312; SHUTE C. C. D., 1955, PROC ZOOL SOC LONDON, V124, P741; Soares P.C., 1980, REV BRASILEIRA GEOCI, V10, P177, DOI DOI 10.25249/0375-7536.1980177185; Soto M, 2011, ZOOL J LINN SOC-LOND, V163, pS173, DOI 10.1111/j.1096-3642.2011.00717.x; STROMER E, 2014, ABHANDLUNGEN KONIGLI, V27, P1; Turner AH, 2004, P ROY SOC B-BIOL SCI, V271, P2003, DOI 10.1098/rspb.2004.2840; Turner AH., 2006, HIST BIOL, V18, P255, DOI [10.1080/08912960500516112, DOI 10.1080/08912960500516112]; Turner AH, 2008, J VERTEBR PALEONTOL, V28, P382, DOI 10.1671/0272-4634(2008)28[382:MICMCA]2.0.CO;2; Turner AH, 2010, J VERTEBR PALEONTOL, V30, P177, DOI 10.1080/02724634.2010.532348; Vasc F. M., 2005, ANU INST GEOCIENC, V28, P49; Vasconcellos FM, 2006, PALEONTOLOGIA VERTEB, P229; Von Huene F., 1939, MINERACAO METALURGIA, V4, P190; Witmer LM, 1997, J VERTEBR PALEONTOL, V17, P1, DOI 10.1080/02724634.1997.10011027; Woodward A.S., 1896, ANALES MUSEO PLATA P, V4, P1; Wu XC, 1996, J VERTEBR PALEONTOL, V16, P688, DOI 10.1080/02724634.1996.10011358; WU XC, 1995, NATURE, V376, P678, DOI 10.1038/376678a0; WU XC, 1994, J VERTEBR PALEONTOL, V14, P210, DOI 10.1080/02724634.1994.10011553; Zaher H, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3512[1:ROTCMO]2.0.CO;2	129	102	107	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93105	10.1371/journal.pone.0093105	http://dx.doi.org/10.1371/journal.pone.0093105			66	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695105	Green Published, gold			2022-12-25	WOS:000334103000040
J	Wang, XW; Yuan, BB; Dong, WP; Yang, B; Yang, YC; Lin, X; Gong, G				Wang, Xiaowu; Yuan, Binbin; Dong, Wenpeng; Yang, Bo; Yang, Yongchao; Lin, Xi; Gong, Gu			Induction of Heat-Shock Protein 70 Expression by Geranylgeranylacetone Shows Cytoprotective Effects in Cardiomyocytes of Mice under Humid Heat Stress	PLOS ONE			English	Article							SHOCK-PROTEIN INDUCTION; CULTURED RAT HEPATOCYTES; NF-KAPPA-B; INDUCED APOPTOSIS; ISCHEMIA-REPERFUSION; HYDROGEN-PEROXIDE; INDUCED INJURY; LIVER-INJURY; HSP70; ACTIVATION	Background: Increasing evidence has revealed that humid heat stress (HHS) causes considerable damage to human health. The cardiovascular system has been suggested to be the primary target of heat stress, which results in serious cardiovascular diseases. However, there is still a lack of effective approaches for the prevention and treatment of cardiovascular diseases induced by HHS. Objective: Heat-shock proteins (Hsps), especially Hsp70, are reported to provide effective cytoprotection under various stress stimuli. In the present study, we evaluated the cytoprotective effect of geranylgeranylacetone (GGA), which was previously been reported to induce Hsp70 expression in cardiomyocytes under HHS. Methods and Principal Findings: Using a mouse model of HHS, we showed that the pretreatment of GGA enhanced Hsp70 expression under HHS, as examined by quantitative real-time polymerase chain reaction (qRT-PCR) and Western blot. We then examined the effect of GGA pretreatment on the cardiomyocyte apoptosis induced by HHS using terminal-deoxynucleoitidyl transferase mediated nick end labeling (TUNEL) staining, and found that GGA pretreatment inhibited mitochondria-mediated apoptosis. GGA pretreatment could reverse the effect of HHS on cell apoptosis by increasing expression of Bcl-2, decreasing cytochrome c in cytosol, and increasing cytochrome c in mitochondria. However, GGA pretreatment had no effect on the oxidative stress induced by HHS as determined by levels of superoxide dismutase (SOD), malondialdehyde (MDA), and glutathione (GSH). Conclusion: We have demonstrated that GGA pretreatment suppressed HHS-induced apoptosis of cardiomyocytes through the induction of Hsp70 overexpression.	[Wang, Xiaowu; Yuan, Binbin; Dong, Wenpeng; Yang, Bo; Yang, Yongchao; Lin, Xi] Guangzhou Gen Hosp Guangzhou Mil Command, Ctr Cardiovasc Surg, Guangzhou, Guangdong, Peoples R China; [Gong, Gu] Gen Hosp Chengdu Mil Command, Dept Anesthesiol, Chengdu, Peoples R China	Southern Theater Command General Hospital	Gong, G (corresponding author), Gen Hosp Chengdu Mil Command, Dept Anesthesiol, Chengdu, Peoples R China.	gugongcd@163.com		Wang, Xiaowu/0000-0003-1371-7791				Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; BOLLI R, 1995, J CLIN INVEST, V96, P1066, DOI 10.1172/JCI118093; BROWN CR, 1993, J CELL BIOL, V120, P1101, DOI 10.1083/jcb.120.5.1101; Buzzard KA, 1998, J BIOL CHEM, V273, P17147, DOI 10.1074/jbc.273.27.17147; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Carreira RS, 2011, CURR PHARM DESIGN, V17, P2017; Chen HQ, 2006, FEBS LETT, V580, P3145, DOI 10.1016/j.febslet.2006.04.066; Chien KR, 2000, NATURE, V407, P227, DOI 10.1038/35025196; Cvoro A, 2004, MOL CELL BIOCHEM, V265, P27, DOI 10.1023/B:MCBI.0000044312.59958.c8; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Fujimori S, 1997, DIGEST DIS SCI, V42, P1987, DOI 10.1023/A:1018892000606; Gabai VL, 1997, J BIOL CHEM, V272, P18033, DOI 10.1074/jbc.272.29.18033; Guzhova IV, 1997, CELL STRESS CHAPERON, V2, P132, DOI 10.1379/1466-1268(1997)002<0132:MSPHIW>2.3.CO;2; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hasegawa M, 2012, NAGOYA J MED SCI, V74, P123; Hirakawa T, 1996, GASTROENTEROLOGY, V111, P345, DOI 10.1053/gast.1996.v111.pm8690199; Hoshino T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076306; Ikeyama S, 2001, J HEPATOL, V35, P53, DOI 10.1016/S0168-8278(01)00053-8; Ishii H, 2005, LIFE SCI, V77, P858, DOI 10.1016/j.lfs.2004.11.038; IWAKI K, 1993, CIRCULATION, V87, P2023, DOI 10.1161/01.CIR.87.6.2023; Jaattela M, 1998, EMBO J, V17, P6124, DOI 10.1093/emboj/17.21.6124; Kamal Manal M, 2013, Pathophysiology, V20, P139, DOI 10.1016/j.pathophys.2013.03.003; Kayama M, 2011, AM J PATHOL, V178, P1080, DOI 10.1016/j.ajpath.2010.11.072; Kume M, 1996, J LAB CLIN MED, V128, P251, DOI 10.1016/S0022-2143(96)90026-8; Lau SS, 2000, AM J PHYSIOL-HEART C, V278, pH1439, DOI 10.1152/ajpheart.2000.278.5.H1439; Lennikov A, 2013, INT J MOL SCI, V14, P2175, DOI 10.3390/ijms14012175; Liu J, 2002, J BIOL CHEM, V277, P20927, DOI 10.1074/jbc.M110712200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo FC, 2013, MOL MED REP, V7, P694, DOI 10.3892/mmr.2012.1217; Luo FC, 2012, FREE RADICAL BIO MED, V52, P1218, DOI 10.1016/j.freeradbiomed.2012.01.004; Lv T, 2013, PHARMACOLOGY, V92, P131, DOI 10.1159/000353213; Mancuso DJ, 2003, J BIOL CHEM, V278, P22231, DOI 10.1074/jbc.C300033200; MELLO AC, 1984, BIOCHEM J, V218, P273, DOI 10.1042/bj2180273; MINOWADA G, 1995, J CLIN INVEST, V95, P3, DOI 10.1172/JCI117655; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; Mosser DD, 2000, MOL CELL BIOL, V20, P7146, DOI 10.1128/MCB.20.19.7146-7159.2000; Mosser DD, 1997, MOL CELL BIOL, V17, P5317, DOI 10.1128/MCB.17.9.5317; Ooie T, 2001, CIRCULATION, V104, P1837, DOI 10.1161/hc3901.095771; Pei YL, 2012, CELL STRESS CHAPERON, V17, P81, DOI 10.1007/s12192-011-0287-1; Polla BS, 1996, P NATL ACAD SCI USA, V93, P6458, DOI 10.1073/pnas.93.13.6458; Powers MV, 2010, CELL CYCLE, V9, P1542, DOI 10.4161/cc.9.8.11204; Prodius P A, 1997, Biull Eksp Biol Med, V123, P629; Qian LJ, 2004, CELL STRESS CHAPERON, V9, P281, DOI 10.1379/CSC-20R.1; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; SAAD S, 1995, SURGERY, V118, P510, DOI 10.1016/S0039-6060(05)80367-8; Salminen WF, 1997, TOXICOL APPL PHARM, V147, P247, DOI 10.1006/taap.1997.8290; Senf SM, 2008, FASEB J, V22, P3836, DOI 10.1096/fj.08-110163; Soti C, 2005, BRIT J PHARMACOL, V146, P769, DOI 10.1038/sj.bjp.0706396; Steenland K, 1996, AM J IND MED, V30, P495, DOI 10.1002/(SICI)1097-0274(199610)30:4<495::AID-AJIM16>3.3.CO;2-I; Takano M, 1998, CELL STRESS CHAPERON, V3, P109, DOI 10.1379/1466-1268(1998)003<0109:DCAMPM>2.3.CO;2; Tanito M, 2005, J NEUROSCI, V25, P2396, DOI 10.1523/JNEUROSCI.4866-04.2005; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Wu YJ, 2011, CELL TISSUE RES, V344, P355, DOI 10.1007/s00441-011-1151-4; Yamagami K, 1998, J SURG RES, V79, P47, DOI 10.1006/jsre.1998.5403; Yeh ETH, 1997, CIRCULATION, V95, P782; Yoda M, 2011, J ORTHOP SCI, V16, P791, DOI 10.1007/s00776-011-0138-z; Yun T, 2009, GUANGXI J TRADIT CHI, V32, P54; Zamzami N, 1997, J BIOENERG BIOMEMBR, V29, P185, DOI 10.1023/A:1022694131572; Zhao Y, 2007, CELL STRESS CHAPERON, V12, P83, DOI 10.1379/CSC-231R.1	61	29	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93536	10.1371/journal.pone.0093536	http://dx.doi.org/10.1371/journal.pone.0093536			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695789	Green Published, Green Submitted, gold			2022-12-25	WOS:000334103000085
J	Wang, Y; Wang, ZL; Feng, XP; Guo, CC; Chen, Q				Wang, Yidong; Wang, Zhong-Liang; Feng, Xiaoping; Guo, Changcheng; Chen, Qing			Long-Term Effect of Agricultural Reclamation on Soil Chemical Properties of a Coastal Saline Marsh in Bohai Rim, Northern China	PLOS ONE			English	Article							PINE PLANTATION; ORGANIC-MATTER; LITTER LAYER; RATIO; STRATIFICATION; DYNAMICS; WETLANDS; CARBON; N2O	Over the past six decades, coastal wetlands in China have experienced rapid and extensive agricultural reclamation. In the context of saline conditions, long-term effect of cultivation after reclamation on soil chemical properties has not been well understood. We studied this issue using a case of approximately 60-years cultivation of a coastal saline marsh in Bohai Rim, northern China. The results showed that long-term reclamation significantly decreased soil organic carbon (SOC) (-42.2%) and total nitrogen (TN) (-25.8%) at surface layer (0-30 cm) as well as their stratification ratios (SRs) (0-5 cm: 50-70 cm and 5-10 cm: 50-70 cm). However, there was no significant change in total phosphorus (TP) as well as its SRs under cultivation. Cultivation markedly reduced ratios of SOC to TN, SOC to TP and TN to TP at surface layer (0-30 cm) and their SRs (0-5 cm: 50-70 cm). After cultivation, electrical conductivity and salinity significantly decreased by 60.1% and 55.3% at 0-100 cm layer, respectively, suggesting a great desalinization. In contrast, soil pH at 20-70 cm horizons notably increased as an effect of reclamation. Cultivation also changed compositions of cations at 0-10 cm layer and anions at 5-100 cm layer, mainly decreasing the proportion of Na+, Cl- and SO42-. Furthermore, cultivation significantly reduced the sodium adsorption ratio and exchangeable sodium percentage in plow-layer (0-20 cm) but not residual sodium carbonate, suggesting a reduction in sodium harm.	[Wang, Yidong; Wang, Zhong-Liang; Feng, Xiaoping; Guo, Changcheng; Chen, Qing] Tianjin Normal Univ, Tianjin Key Lab Water Resources & Environm, Tianjin, Peoples R China; [Wang, Zhong-Liang] Chinese Acad Sci, Inst Geochem, State Key Lab Environm Geochem, Guiyang, Peoples R China; [Feng, Xiaoping] Tianjin Normal Univ, Coll Urban & Environm Sci, Tianjin, Peoples R China	Tianjin Normal University; Chinese Academy of Sciences; Guiyang Institute of Geochemistry, CAS; Tianjin Normal University	Wang, ZL (corresponding author), Tianjin Normal Univ, Tianjin Key Lab Water Resources & Environm, Tianjin, Peoples R China.	wangzhongliang@vip.skleg.cn	Wang, Yidong/I-4027-2014	Wang, Yidong/0000-0002-5399-2803; Chen, Qing/0000-0002-4589-0161	National Science & Technology Pillar Program [2012BAC07B02]; Program for New Century Excellent Talents in University [NCET-10-0954]; National Natural Science Foundation of China [31300381]; Opening Fund of Tianjin Key Laboratory of Water Resources and Environment [YF11700102]	National Science & Technology Pillar Program; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Opening Fund of Tianjin Key Laboratory of Water Resources and Environment	This research was supported by the National Science & Technology Pillar Program (2012BAC07B02), the Program for New Century Excellent Talents in University (NCET-10-0954), the National Natural Science Foundation of China (31300381), and the Opening Fund of Tianjin Key Laboratory of Water Resources and Environment (YF11700102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SQ, 2007, AMBIO, V36, P335, DOI 10.1579/0044-7447(2007)36[335:CNWPPC]2.0.CO;2; An SQ, 2013, AQUAT SCI, V75, P63, DOI 10.1007/s00027-012-0281-4; Bridgham SD, 1998, ECOLOGY, V79, P1545, DOI 10.1890/0012-9658(1998)079[1545:CNAPMI]2.0.CO;2; CASHIN GE, 1992, WETLANDS, V12, P63, DOI 10.1007/BF03160587; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Cui J, 2012, SOIL TILL RES, V123, P50, DOI 10.1016/j.still.2012.03.009; Du ZL, 2010, SOIL SCI SOC AM J, V74, P196, DOI 10.2136/sssaj2009.0048; Ellis S, 2003, CATENA, V52, P129, DOI 10.1016/S0341-8162(02)00179-0; Fernandez S, 2010, GEOMORPHOLOGY, V114, P497, DOI 10.1016/j.geomorph.2009.08.014; Franzluebbers AJ, 2002, SOIL TILL RES, V66, P95, DOI 10.1016/S0167-1987(02)00018-1; Han G, 2013, AGR ECOSYST ENV; Huang LB, 2012, ECOL INFORM, V10, P49, DOI 10.1016/j.ecoinf.2011.11.001; Huo Li-li, 2013, Huanjing Kexue, V34, P283; Iost S, 2007, GEODERMA, V142, P245, DOI 10.1016/j.geoderma.2007.08.001; Jin XB, 2012, BIOL FERT SOILS, V48, P363, DOI 10.1007/s00374-011-0631-8; Johnson D.W., 1980, ENVIRON INT, V3, P79; Liu H, 1999, SCI TECHNOL TIANJIN, V2, P43; Lou YL, 2012, CATENA, V95, P124, DOI 10.1016/j.catena.2012.02.009; Lou YL, 2011, CATENA, V87, P386, DOI 10.1016/j.catena.2011.07.006; Macreadie PI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069244; Munshower FF., 1994, PRACTICAL HDB DISTUR; OSTER JD, 1980, SOIL SCI SOC AM J, V44, P258, DOI 10.2136/sssaj1980.03615995004400020011x; Portnoy JW, 1999, ENVIRON MANAGE, V24, P111, DOI 10.1007/s002679900219; ROBBINS CW, 1984, IRRIGATION SCI, V5, P173, DOI 10.1007/BF00264606; Sahrawat KL, 2004, ADV AGRON, V81, P169, DOI 10.1016/S0065.2113(03)81004-0; Santin C, 2009, ORG GEOCHEM, V40, P931, DOI 10.1016/j.orggeochem.2009.06.005; Shen JB, 2011, PLANT PHYSIOL, V156, P997, DOI 10.1104/pp.111.175232; Shepard CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027374; Shi Y.C., 1983, WATER SALT MOVEMENT; Wan H, 1983, SOILS, V23, P319; Wang Li-li, 2009, China Environmental Science, V29, P656; Wang YD, 2014, ATMOS ENVIRON, V82, P106, DOI 10.1016/j.atmosenv.2013.10.028; Wang YD, 2013, SOIL BIOL BIOCHEM, V66, P45, DOI 10.1016/j.soilbio.2013.06.018; Wang YD, 2012, CAN J FOREST RES, V42, P657, DOI [10.1139/x2012-017, 10.1139/X2012-017]; Weston NB, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000071; Wong VNL, 2010, SOIL USE MANAGE, V26, P2, DOI 10.1111/j.1475-2743.2009.00251.x; [吴明 WU Ming], 2008, [土壤, Soils], V40, P760; Zhu M, 2011, THESIS CHINESE ACA A	38	21	24	7	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93727	10.1371/journal.pone.0093727	http://dx.doi.org/10.1371/journal.pone.0093727			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695526	Green Published, gold, Green Submitted			2022-12-25	WOS:000334103000111
J	Boissinot, S; Erdinger, M; Monsion, B; Ziegler-Graff, V; Brault, V				Boissinot, Sylvaine; Erdinger, Monique; Monsion, Baptiste; Ziegler-Graff, Veronique; Brault, Veronique			Both Structural and Non-Structural Forms of the Readthrough Protein of Cucurbit aphid-borne yellows virus Are Essential for Efficient Systemic Infection of Plants	PLOS ONE			English	Article							POTATO-LEAFROLL-VIRUS; MINOR CAPSID PROTEIN; COAT PROTEIN; MOVEMENT PROTEIN; DWARF VIRUS; NUCLEOTIDE-SEQUENCE; MUTATIONAL ANALYSIS; MYZUS-PERSICAE; 17-KDA PROTEIN; LUTEOVIRUS	Cucurbit aphid-borne yellows virus (CABYV) is a polerovirus (Luteoviridae family) with a capsid composed of the major coat protein and a minor component referred to as the readthrough protein (RT). Two forms of the RT were reported: a full-length protein of 74 kDa detected in infected plants and a truncated form of 55 kDa (RT*) incorporated into virions. Both forms were detected in CABYV-infected plants. To clarify the specific roles of each protein in the viral cycle, we generated by deletion a polerovirus mutant able to synthesize only the RT* which is incorporated into the particle. This mutant was unable to move systemically from inoculated leaves inferring that the C-terminal half of the RT is required for efficient long-distance transport of CABYV. Among a collection of CABYV mutants bearing point mutations in the central domain of the RT, we obtained a mutant impaired in the correct processing of the RT which does not produce the RT*. This mutant accumulated very poorly in upper non-inoculated leaves, suggesting that the RT* has a functional role in long-distance movement of CABYV. Taken together, these results infer that both RT proteins are required for an efficient CABYV movement.	[Boissinot, Sylvaine; Erdinger, Monique; Monsion, Baptiste; Brault, Veronique] INRA, Unite Mixte Rech Sante Vigne & Qual Vin 1131, Colmar, France; [Boissinot, Sylvaine; Erdinger, Monique; Monsion, Baptiste; Brault, Veronique] Univ Strasbourg, Strasbourg, France; [Monsion, Baptiste; Ziegler-Graff, Veronique] CNRS, Inst Biol Mol Plantes, Unite Propre Rech 2357, F-67084 Strasbourg, France	INRAE; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Brault, V (corresponding author), INRA, Unite Mixte Rech Sante Vigne & Qual Vin 1131, Colmar, France.	veronique.brault@colmar.inra.fr	Boissinot, Sylvaine/GMW-7580-2022; BRAULT, Veronique/AAV-1525-2021	Monsion, Baptiste/0000-0002-5174-4742	French government	French government	Funding of this project comes from the French government (public ressources). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bencharki B, 2010, MOL PLANT MICROBE IN, V23, P799, DOI 10.1094/MPMI-23-6-0799; BRAULT V, 1995, EMBO J, V14, P650, DOI 10.1002/j.1460-2075.1995.tb07043.x; Brault V, 2000, J VIROL, V74, P1140, DOI 10.1128/JVI.74.3.1140-1148.2000; Brault V, 2010, CR BIOL, V333, P524, DOI 10.1016/j.crvi.2010.04.001; Brault W, 2005, J VIROL, V79, P9685, DOI 10.1128/JVI.79.15.9685-9693.2005; Brown CM, 1996, J VIROL, V70, P5884, DOI 10.1128/JVI.70.9.5884-5892.1996; Bruyere A, 1997, VIROLOGY, V230, P323, DOI 10.1006/viro.1997.8476; Chavez JD, 2012, J PROTEOME RES, V11, P2968, DOI 10.1021/pr300041t; Chay CA, 1996, VIROLOGY, V219, P57, DOI 10.1006/viro.1996.0222; CHENG SL, 1994, VIROLOGY, V202, P1003, DOI 10.1006/viro.1994.1427; CLARK MF, 1977, J GEN VIROL, V34, P475, DOI 10.1099/0022-1317-34-3-475; de Zoeten GA, 2001, ADV VIRUS RES, V57, P323, DOI 10.1016/S0065-3527(01)57007-4; DEMLER SA, 1991, J GEN VIROL, V72, P1819, DOI 10.1099/0022-1317-72-8-1819; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; ESAU K, 1972, VIROLOGY, V48, P724, DOI 10.1016/0042-6822(72)90156-0; FILICHKIN SA, 1994, VIROLOGY, V205, P290, DOI 10.1006/viro.1994.1645; GARCIA JA, 1992, VIROLOGY, V188, P697, DOI 10.1016/0042-6822(92)90524-S; GUILLEY H, 1994, VIROLOGY, V202, P1012, DOI 10.1006/viro.1994.1429; Hamrita B, 2011, CLIN BIOCHEM, V44, P1097, DOI 10.1016/j.clinbiochem.2011.06.005; Hipper C, 2014, J GEN VIROL, V95, P496, DOI 10.1099/vir.0.058867-0; Hofius D, 2001, PLANT J, V28, P529, DOI 10.1046/j.1365-313X.2001.01179.x; JOLLY CA, 1994, VIROLOGY, V201, P182, DOI 10.1006/viro.1994.1283; LECOQ H, 1992, PLANT PATHOL, V41, P749, DOI 10.1111/j.1365-3059.1992.tb02559.x; Lee L, 2002, MOL PLANT MICROBE IN, V15, P1086, DOI 10.1094/MPMI.2002.15.10.1086; Mutterer JD, 1999, J GEN VIROL, V80, P2771, DOI 10.1099/0022-1317-80-10-2771; Nair S, 2010, VIROLOGY, V396, P106, DOI 10.1016/j.virol.2009.09.025; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Peter KA, 2009, J VIROL, V83, P5419, DOI 10.1128/JVI.02312-08; Peter KA, 2008, J GEN VIROL, V89, P2037, DOI 10.1099/vir.0.83625-0; PRUFER D, 1995, VIROLOGY, V214, P150, DOI 10.1006/viro.1995.9945; Reinbold C, 2001, J GEN VIROL, V82, P1995, DOI 10.1099/0022-1317-82-8-1995; REUTENAUER A, 1993, VIROLOGY, V195, P692, DOI 10.1006/viro.1993.1420; Revollon S, 2010, VIROLOGY, V402, P303, DOI 10.1016/j.virol.2010.03.037; Schmitz J, 1997, VIROLOGY, V235, P311, DOI 10.1006/viro.1997.8679; SHEPARDSON S, 1980, VIROLOGY, V105, P379, DOI 10.1016/0042-6822(80)90039-2; Sokolova M, 1997, FEBS LETT, V400, P201, DOI 10.1016/S0014-5793(96)01380-4; TACKE E, 1991, J GEN VIROL, V72, P2035, DOI 10.1099/0022-1317-72-8-2035; TACKE E, 1993, VIROLOGY, V197, P274, DOI 10.1006/viro.1993.1588; VandenHeuvel JFJM, 1997, J VIROL, V71, P7258, DOI 10.1128/JVI.71.10.7258-7265.1997; VANDENHEUVEL JFJM, 1991, PHYTOPATHOLOGY, V81, P150, DOI 10.1094/Phyto-81-150; WANG JY, 1995, VIROLOGY, V206, P954, DOI 10.1006/viro.1995.1018; Wilmarth PA, 2004, J PROTEOME RES, V3, P1017, DOI 10.1021/pr049911o; ZieglerGraff V, 1996, MOL PLANT MICROBE IN, V9, P501, DOI 10.1094/MPMI-9-0501	43	24	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93448	10.1371/journal.pone.0093448	http://dx.doi.org/10.1371/journal.pone.0093448			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691251	Green Published, gold, Green Submitted			2022-12-25	WOS:000334101100083
J	Gao, JJ; Wang, FL; Wang, WS; Su, ZG; Guo, CH; Cao, SY				Gao, Junjie; Wang, Fangli; Wang, Weisong; Su, Zhiguo; Guo, Canghui; Cao, Shuyi			Emodin Suppresses Hyperglycemia-Induced Proliferation and Fibronectin Expression in Mesangial Cells via Inhibiting cFLIP	PLOS ONE			English	Article							TRAIL-INDUCED APOPTOSIS; HIGH-GLUCOSE; DIABETIC-NEPHROPATHY; KIDNEY-DISEASE; PROTEIN-KINASE; PATHWAY; ACTIVATION; DEATH; DEGRADATION; INCREASES	As one of the most serious microvascular complications of diabetes and a major cause of end stage renal disease, diabetic nephropathy (DN) is calling for effective treatment strategies. Here, we provide evidence that hyperglycemia can induce proliferation and decreasing apoptosis of mesangial cells (MCs) and subsequent renal dysfunction by up-regulating cellular FLICE-inhibitory protein (cFLIP). Treatment with emodin significantly turns down the accelerated cell cycle and proliferation of MCs cultured in high glucose (HG) via inhibiting cFLIP. In vitro, knockdown of cFLIP can arrest cell cycle and accelerate cell death by activating caspase-8, caspase-3 and caspase-9, and down-regulate proliferating cell nuclear antigen (PCNA). Our results also suggest that emodin regulates cFLIP expression in transcriptional level. Importantly, emodin lessens proteinuria and fibronectin expression in early-stage of streptozotocin (STZ)-induced diabetic rats. These findings demonstrate that emodin represent a promising strategy to prevent renal dysfunction in early-stage of diabetes mellitus.	[Gao, Junjie; Wang, Fangli; Wang, Weisong; Su, Zhiguo; Guo, Canghui; Cao, Shuyi] Cangzhou Cent Hosp, Dept Nephrol, Cangzhou, Peoples R China		Gao, JJ (corresponding author), Cangzhou Cent Hosp, Dept Nephrol, Cangzhou, Peoples R China.	junjiegao_doc@126.com						Aouadi M, 2006, DIABETES, V55, P281, DOI 10.2337/diabetes.55.02.06.db05-0963; Bangert A, 2012, ONCOGENE, V31, P4677, DOI 10.1038/onc.2011.614; BOWLUS CL, 1991, J BIOL CHEM, V266, P1122; Castiglione RC, 2013, CELL PHYSIOL BIOCHEM, V32, P699, DOI 10.1159/000354473; COSIO FG, 1995, J AM SOC NEPHROL, V5, P1600; Ding YF, 2013, KIDNEY INT, V83, P845, DOI 10.1038/ki.2012.393; Gilbert RE, 1999, KIDNEY INT, V56, P1627, DOI 10.1046/j.1523-1755.1999.00721.x; Goltsev YV, 1997, J BIOL CHEM, V272, P19641, DOI 10.1074/jbc.272.32.19641; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Jelassi B, 2013, CARCINOGENESIS, V34, P1487, DOI 10.1093/carcin/bgt099; Kim S, 2008, J CELL BIOCHEM, V105, P971, DOI 10.1002/jcb.21905; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; Lan T, 2013, J CELL BIOCHEM, V114, P2562, DOI 10.1002/jcb.24601; Lan T, 2011, MOL ENDOCRINOL, V25, P2094, DOI 10.1210/me.2011-0095; Levin A, 2008, AM J KIDNEY DIS, V52, P661, DOI 10.1053/j.ajkd.2008.06.023; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li XJ, 2009, MOL CELL ENDOCRINOL, V307, P157, DOI 10.1016/j.mce.2009.03.006; Liu Y, 2009, EXP MOL MED, V41, P648, DOI 10.3858/emm.2009.41.9.071; Ljubimov AV, 2004, INVEST OPHTH VIS SCI, V45, P4583, DOI 10.1167/iovs.04-0686; Marques-Fernandez F, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.25; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; MCLENNAN SV, 1994, DIABETES, V43, P1041, DOI 10.2337/diabetes.43.8.1041; NAHMAN NS, 1992, KIDNEY INT, V41, P396, DOI 10.1038/ki.1992.55; Nam SY, 2003, CANCER SCI, V94, P1066, DOI 10.1111/j.1349-7006.2003.tb01402.x; Pennarun B, 2010, BBA-REV CANCER, V1805, P123, DOI 10.1016/j.bbcan.2009.11.004; Pesce CG, 1999, FEBS LETT, V457, P445, DOI 10.1016/S0014-5793(99)01091-1; Reddy MA, 2013, KIDNEY INT; Sanchez-Perez T, 2010, CELL DEATH DIFFER, V17, P883, DOI 10.1038/cdd.2009.176; Song P, 2013, J BIOL CHEM, V288, P5732, DOI 10.1074/jbc.M112.441477; Taniguchi K, 2013, DIABETES; Townsend RR, 2009, NEPHSAP, V8, P271; Vesely ED, 2009, AM J PHYSIOL-CELL PH, V297, pC759, DOI 10.1152/ajpcell.00213.2009; Woo SW, 2002, PHARMACOL TOXICOL, V90, P193, DOI 10.1034/j.1600-0773.2002.900404.x; Wu L, 2013, INFLAMMATION, V36, P1020, DOI 10.1007/s10753-013-9634-y; Yano N, 2009, BIOCHEM J, V423, P129, DOI 10.1042/BJ20082277; Zhang LY, 2012, INT J BIOCHEM CELL B, V44, P629, DOI 10.1016/j.biocel.2012.01.001; Zhang Z, 2009, FEBS LETT, V583, P2009, DOI 10.1016/j.febslet.2009.05.021	38	25	32	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93588	10.1371/journal.pone.0093588	http://dx.doi.org/10.1371/journal.pone.0093588			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691542	gold, Green Published, Green Submitted			2022-12-25	WOS:000334101100108
J	Pawelzyk, P; Mucke, N; Herrmann, H; Willenbacher, N				Pawelzyk, Paul; Muecke, Norbert; Herrmann, Harald; Willenbacher, Norbert			Attractive Interactions among Intermediate Filaments Determine Network Mechanics In Vitro	PLOS ONE			English	Article							COMPLEX FLUIDS; VISCOELASTIC PROPERTIES; BIOPOLYMER NETWORKS; ACTIN SOLUTIONS; TAIL DOMAIN; F-ACTIN; ELASTICITY; KERATINS; MODULUS; NANOMECHANICS	Mechanical and structural properties of K8/K18 and vimentin intermediate filament (IF) networks have been investigated using bulk mechanical rheometry and optical microrheology including diffusing wave spectroscopy and multiple particle tracking. A high elastic modulus G(0) at low protein concentration c, a weak concentration dependency of G(0) (G(0)similar to c(0.5 +/- 0.1)) and pronounced strain stiffening are found for these systems even without external crossbridgers. Strong attractive interactions among filaments are required to maintain these characteristic mechanical features, which have also been reported for various other IF networks. Filament assembly, the persistence length of the filaments and the network mesh size remain essentially unaffected when a nonionic surfactant is added, but strain stiffening is completely suppressed, G(0) drops by orders of magnitude and exhibits a scaling G(0)similar to c(1.9 +/- 0.2) in agreement with microrheological measurements and as expected for entangled networks of semi-flexible polymers. Tailless K8 Delta/K18 Delta T and various other tailless filament networks do not exhibit strain stiffening, but still show high G(0) values. Therefore, two binding sites are proposed to exist in IF networks. A weaker one mediated by hydrophobic amino acid clusters in the central rod prevents stretched filaments between adjacent cross-links from thermal equilibration and thus provides the high G(0) values. Another strong one facilitating strain stiffening is located in the tail domain with its high fraction of hydrophobic amino acid sequences. Strain stiffening is less pronounced for vimentin than for K8/K18 due to electrostatic repulsion forces partly compensating the strong attraction at filament contact points.	[Pawelzyk, Paul; Willenbacher, Norbert] Karlsruhe Inst Technol, Inst Mech Proc Engn & Mech, D-76021 Karlsruhe, Germany; [Muecke, Norbert] German Canc Res Ctr, Heidelberg, Germany; [Herrmann, Harald] German Canc Res Ctr, Div Mol Genet, Heidelberg, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Willenbacher, N (corresponding author), Karlsruhe Inst Technol, Inst Mech Proc Engn & Mech, D-76021 Karlsruhe, Germany.	norbert.willenbacher@kit.edu		Mucke, Norbert/0000-0002-0683-4386	German Research Foundation;  [HE 1853/8-1]	German Research Foundation(German Research Foundation (DFG)); 	Harald Herrmann received support from the German Research Foundation (http://www.dfg.de). The grant number is HE 1853/8-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apgar J, 2000, BIOPHYS J, V79, P1095, DOI 10.1016/S0006-3495(00)76363-6; Bar H, 2010, J MOL BIOL, V397, P1188, DOI 10.1016/j.jmb.2010.02.024; Bousquet O, 2001, J CELL BIOL, V155, P747, DOI 10.1083/jcb.200104063; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; Crassous JJ, 2005, J RHEOL, V49, P851, DOI 10.1122/1.1917843; DEGENNES PG, 1976, MACROMOLECULES, V9, P587, DOI 10.1021/ma60052a011; Gardel ML, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.158302; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Gittes F, 1998, PHYS REV E, V58, pR1241, DOI 10.1103/PhysRevE.58.R1241; HATZFELD M, 1990, J CELL SCI, V97, P317; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528; Herrmann H, 1998, CURR OPIN STRUC BIOL, V8, P177, DOI 10.1016/S0959-440X(98)80035-3; Herrmann H, 2002, J STRUCT BIOL, V137, P82, DOI 10.1006/jsbi.2002.4466; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; Hinner B, 1998, PHYS REV LETT, V81, P2614, DOI 10.1103/PhysRevLett.81.2614; JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155; Kasza KE, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.041928; Kayser J, 2012, SOFT MATTER, V8, P8873, DOI 10.1039/c2sm26032h; Kim AJ, 2005, J AM CHEM SOC, V127, P1592, DOI 10.1021/ja0450051; Koster S, 2010, SOFT MATTER, V6, P1910, DOI 10.1039/c000113a; Kroy K, 1996, PHYS REV LETT, V77, P306, DOI 10.1103/PhysRevLett.77.306; Kroy K, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/416; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Leitner A, 2012, BIOPHYS J, V103, P195, DOI 10.1016/j.bpj.2012.06.014; Lichtenstern T, 2012, J STRUCT BIOL, V177, P54, DOI 10.1016/j.jsb.2011.11.003; Lin YC, 2010, J MOL BIOL, V399, P637, DOI 10.1016/j.jmb.2010.04.054; Lin YC, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.058101; Ma LL, 2001, NAT CELL BIOL, V3, P503, DOI 10.1038/35074576; Ma LL, 1999, J BIOL CHEM, V274, P19145, DOI 10.1074/jbc.274.27.19145; MACKINTOSH FC, 1995, PHYS REV LETT, V75, P4425, DOI 10.1103/PhysRevLett.75.4425; Mason TG, 1997, PHYS REV LETT, V79, P3282, DOI 10.1103/PhysRevLett.79.3282; MASON TG, 1995, PHYS REV LETT, V74, P1250, DOI 10.1103/PhysRevLett.74.1250; Morse DC, 1998, MACROMOLECULES, V31, P7044, DOI 10.1021/ma980304u; Mucke N, 2004, J MOL BIOL, V335, P1241, DOI 10.1016/j.jmb.2003.11.038; OBUKHOV SP, 1994, MACROMOLECULES, V27, P3191, DOI 10.1021/ma00090a012; Oelschlaeger C, 2009, LANGMUIR, V25, P716, DOI 10.1021/la802323x; Pawelzyk P, 2013, SOFT MATTER, V9, P8871, DOI 10.1039/c3sm51999f; Schopferer M, 2009, J MOL BIOL, V388, P133, DOI 10.1016/j.jmb.2009.03.005; Semmrich C, 2007, P NATL ACAD SCI USA, V104, P20199, DOI 10.1073/pnas.0705513104; Steinmetz MO, 1998, J MOL BIOL, V276, P1, DOI 10.1006/jmbi.1997.1529; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Szeverenyi I, 2008, HUM MUTAT, V29, P351, DOI 10.1002/humu.20652; Tseng Y, 2001, BIOPHYS J, V81, P1643, DOI 10.1016/S0006-3495(01)75818-3; Willenbacher N, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.068302; Wolff L, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/5/053024; Yamada S, 2003, J STRUCT BIOL, V143, P45, DOI 10.1016/S1047-8477(03)00101-1	47	42	42	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93194	10.1371/journal.pone.0093194	http://dx.doi.org/10.1371/journal.pone.0093194			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690778	Green Submitted, Green Published, gold			2022-12-25	WOS:000334101100051
J	Zhu, GP; Peterson, AT				Zhu, Gengping; Peterson, A. Townsend			Potential Geographic Distribution of the Novel Avian-Origin Influenza A (H7N9) Virus	PLOS ONE			English	Article							RISK	Background: In late March 2013, a new avian-origin influenza virus emerged in eastern China. This H7N9 subtype virus has since infected 240 people and killed 60, and has awakened global concern as a potential pandemic threat. Ecological niche modeling has seen increasing applications as a useful tool in mapping geographic potential and risk of disease transmission. Methodology/Principals: We developed two datasets based on seasonal variation in Normalized Difference Vegetation Index (NDVI) from the MODIS sensor to characterize environmental dimensions of H7N9 virus. One-third of well-documented cases was used to test robustness of models calibrated based on the remaining two-thirds, and model significance was tested using partial ROC approaches. A final niche model was calibrated using all records available. Conclusions/Significance: Central-eastern China appears to represent an area of high risk for H7N9 spread, but suitable areas were distributed more spottily in the north and only along the coast in the south; highly suitable areas also were identified in western Taiwan. Areas identified as presenting high risk for H7N9 spread tend to present consistent NDVI values through the year, whereas unsuitable areas show greater seasonal variation.	[Zhu, Gengping] Tianjin Normal Univ, Coll Life Sci, Tianjin Key Lab Anim & Plant Resistance, Tianjin, Peoples R China; [Peterson, A. Townsend] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA	Tianjin Normal University; University of Kansas	Zhu, GP (corresponding author), Tianjin Normal Univ, Coll Life Sci, Tianjin Key Lab Anim & Plant Resistance, Tianjin, Peoples R China.	gengpingzhu@hotmail.com	Zhu, Gengping/CAF-4192-2022; Peterson, A. Townsend/I-5697-2013	Zhu, Gengping/0000-0001-6823-5840; Peterson, A. Townsend/0000-0003-0243-2379	Tianjin Normal University [5RL127]	Tianjin Normal University	No current funding sources were specifically designate for this study, however, partial support was from the talent introduction program award to GZ in Tianjin Normal University (5RL127). No additional funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butler D., 2013, NATURE, DOI [10.1038/nature.2013.12863, DOI 10.1038/NATURE.2013.12863]; Fang LQ, 2014, SCI REPORTS, V3, P2722; Gilbert M, 2008, P NATL ACAD SCI USA, V105, P4769, DOI 10.1073/pnas.0710581105; Giles J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000925; He JK, 2013, ARXIV13041985; JK He, 2013, PREDICTING GLOBAL TR; Li X W, 2007, CHINESE J NATURE, V29, P69; Martin V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001308; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2008, NATURWISSENSCHAFTEN, V95, P483, DOI 10.1007/s00114-008-0352-5; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Rangel TFLVB, 2006, GLOBAL ECOL BIOGEOGR, V15, P321, DOI 10.1111/j.1466-822x.2006.00237.x; Reed KD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002034; Shi BY, 2013, INFECT DIS POVERTY, V2, DOI 10.1186/2049-9957-2-8; Shi JZ, 2013, CHINESE SCI BULL, V58, P1857, DOI 10.1007/s11434-013-5873-4; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Uyeki TM, 2013, NEW ENGL J MED, V368, P1862, DOI 10.1056/NEJMp1304661; Wang CM, 2014, J INFECT DIS, V209, P34, DOI 10.1093/infdis/jit478; Williams RAJ, 2011, GEOSPATIAL HEALTH, V5, P247, DOI 10.4081/gh.2011.177; Wu SQ, 2013, LANCET, V381, P1539, DOI 10.1016/S0140-6736(13)60767-9; Xu R, 2013, SCIENCE, V342, P1230, DOI 10.1126/science.1243761	22	13	13	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93390	10.1371/journal.pone.0093390	http://dx.doi.org/10.1371/journal.pone.0093390			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690878	Green Published, gold, Green Submitted			2022-12-25	WOS:000334101100072
J	Karam, P; Powdrill, MH; Liu, HW; Vasquez, C; Mah, W; Bernatchez, J; Gotte, M; Cosa, G				Karam, Pierre; Powdrill, Megan H.; Liu, Hsiao-Wei; Vasquez, Colins; Mah, Wayne; Bernatchez, Jean; Goette, Matthias; Cosa, Gonzalo			Dynamics of Hepatitis C Virus ( HCV) RNA-dependent RNA Polymerase NS5B in Complex with RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antiviral Agents; Drug Resistance; Fluorescence Resonance Energy Transfer (FRET); Hepatitis c Virus; RNA Polymerase	DE-NOVO INITIATION; HIV REVERSE-TRANSCRIPTASE; SINGLE-STRANDED-DNA; FLUORESCENCE SPECTROSCOPY; CRYSTAL-STRUCTURE; MOLECULE; INHIBITORS; BINDING; IDENTIFICATION; SITE	Background: The dynamics associated with RNA binding by the hepatitis C virus (HCV) polymerase remain elusive. Results: Single molecule experiments reveal changing populations of binary RNA-enzyme complexes. Conclusion: Rapid enzyme conformational changes facilitate sliding/wrapping of the polymerase along its RNA substrate. Significance: This study provides novel insight into mechanisms associated with viral replication and its inhibition. The hepatitis C virus (HCV) non-structural protein 5B (NS5B) is an RNA-dependent RNA polymerase that is essentially required for viral replication. Although previous studies revealed important properties of static NS5B-RNA complexes, the nature and relevance of dynamic interactions have yet to be elucidated. Here, we devised a single molecule Forster Resonance Energy Transfer (SM-FRET) assay to monitor temporal changes upon binding of NS5B to surface immobilized RNA templates. The data show enzyme association-dissociation events that occur within the time resolution of our setup as well as FRET-fluctuations in association with stable binary complexes that extend over prolonged periods of time. Fluctuations are shown to be dependent on the length of the RNA substrate, and enzyme concentration. Mutations in close proximity to the template entrance (K98E, K100E), and in the center of the RNA binding channel (R394E), reduce both the population of RNA-bound enzyme and the fluctuations associated to the binary complex. Similar observations are reported with an allosteric nonnucleoside NS5B inhibitor. Our assay enables for the first time the visualization of association-dissociation events of HCV-NS5B with RNA, and also the direct monitoring of the interaction between HCV NS5B, its RNA template, and finger loop inhibitors. We observe both a remarkably low dissociation rate for wild type HCV NS5B, and a highly dynamic enzyme-RNA binary complex. These results provide a plausible mechanism for formation of a productive binary NS5B-RNA complex, here NS5B slides along the RNA template facilitating positioning of its 3 terminus at the enzyme active site.	[Karam, Pierre; Liu, Hsiao-Wei; Mah, Wayne; Goette, Matthias; Cosa, Gonzalo] McGill Univ, Dept Chem, Montreal, PQ H3A 2K6, Canada; [Cosa, Gonzalo] McGill Univ, Ctr Self Assembled Chem Struct CSACS CRMAA, Montreal, PQ H3A 2K6, Canada; [Powdrill, Megan H.; Vasquez, Colins; Bernatchez, Jean] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Goette, Matthias] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Goette, Matthias] McGill Univ, Div Expt Med, Dept Med, Montreal, PQ H3A 1A3, Canada	McGill University; McGill University; McGill University; McGill University; McGill University	Gotte, M (corresponding author), 3775 Univ St,Room D6, Montreal, PQ H3A 2B4, Canada.	matthias.gotte@mcgill.ca; gonzalo.cosa@mcgill.ca		Bernatchez, Jean/0000-0002-8309-1627; Cosa, Gonzalo/0000-0003-0064-1345	Fonds quebecois de la recherche sur la nature et les technologies (FQRNT) Team Grant; National Science and Engineering Research Council of Canada (NSERC); Nanoquebec; Canadian Institutes of Health Research (CIHR); McGill Chemical Biology Fellowship Program (CIHR); National CIHR Research Training Program in Hepatitis C (NCRTP); CIHR Drug Discovery and Training Program; Groupe de Recherche Axe sur la Structure des Proteines (GRASP)	Fonds quebecois de la recherche sur la nature et les technologies (FQRNT) Team Grant(FQRNT); National Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Nanoquebec; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); McGill Chemical Biology Fellowship Program (CIHR)(Canadian Institutes of Health Research (CIHR)); National CIHR Research Training Program in Hepatitis C (NCRTP)(Canadian Institutes of Health Research (CIHR)); CIHR Drug Discovery and Training Program(Canadian Institutes of Health Research (CIHR)); Groupe de Recherche Axe sur la Structure des Proteines (GRASP)	This work was supported by a Fonds quebecois de la recherche sur la nature et les technologies (FQRNT) Team Grant, the National Science and Engineering Research Council of Canada (NSERC), Nanoquebec, and The Canadian Institutes of Health Research (CIHR).; Recipient of the McGill Chemical Biology Fellowship Program (CIHR) for a postgraduate scholarship.; Recipient of a student stipend from the National CIHR Research Training Program in Hepatitis C (NCRTP).; Recipient of postdoctoral fellowships from the CIHR Drug Discovery and Training Program and from the Groupe de Recherche Axe sur la Structure des Proteines (GRASP).	Abbondanzieri EA, 2008, NATURE, V453, P184, DOI 10.1038/nature06941; Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3; Behrens SE, 1996, EMBO J, V15, P12, DOI 10.1002/j.1460-2075.1996.tb00329.x; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Deval J, 2007, ANTIMICROB AGENTS CH, V51, P2920, DOI 10.1128/AAC.00186-07; Deval J, 2007, J BIOL CHEM, V282, P16907, DOI 10.1074/jbc.M701973200; Di Marco S, 2005, J BIOL CHEM, V280, P29765, DOI 10.1074/jbc.M505423200; Ferrari E, 1999, J VIROL, V73, P1649, DOI 10.1128/JVI.73.2.1649-1654.1999; Ferrari E, 2008, J BIOL CHEM, V283, P33893, DOI 10.1074/jbc.M803094200; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Ha T, 2012, ANNU REV BIOPHYS, V41, P295, DOI 10.1146/annurev-biophys-042910-155351; Hwang H, 2011, P NATL ACAD SCI USA, V108, P7414, DOI 10.1073/pnas.1017672108; INCHAUSPE G, 1991, P NATL ACAD SCI USA, V88, P10292, DOI 10.1073/pnas.88.22.10292; Joo C, 2008, ANNU REV BIOCHEM, V77, P51, DOI 10.1146/annurev.biochem.77.070606.101543; Kao CC, 2001, VIROLOGY, V287, P251, DOI 10.1006/viro.2001.1039; Kao CC, 1999, VIROLOGY, V253, P1, DOI 10.1006/viro.1998.9517; Kim MJ, 2000, J VIROL, V74, P10312, DOI 10.1128/JVI.74.22.10312-10322.2000; Kim YC, 2005, J BIOL CHEM, V280, P38011, DOI 10.1074/jbc.M508145200; Kukolj G, 2005, J BIOL CHEM, V280, P39260, DOI 10.1074/jbc.M506407200; LaPlante SR, 2010, J AM CHEM SOC, V132, P15204, DOI 10.1021/ja101358s; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Liu SX, 2008, SCIENCE, V322, P1092, DOI 10.1126/science.1163108; Liu YY, 2006, BIOCHEMISTRY-US, V45, P11312, DOI 10.1021/bi060511j; Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997; Luo G, 2007, P NATL ACAD SCI USA, V104, P12610, DOI 10.1073/pnas.0700920104; Luo GX, 2000, J VIROL, V74, P851, DOI 10.1128/JVI.74.2.851-863.2000; Marko RA, 2013, J PHYS CHEM B, V117, P4560, DOI 10.1021/jp308674g; Moerner WE, 2003, REV SCI INSTRUM, V74, P3597, DOI 10.1063/1.1589587; Mosley RT, 2012, J VIROL, V86, P6503, DOI 10.1128/JVI.00386-12; Murphy MC, 2004, BIOPHYS J, V86, P2530, DOI 10.1016/S0006-3495(04)74308-8; O'Farrell D, 2003, J MOL BIOL, V326, P1025, DOI 10.1016/S0022-2836(02)01439-0; Ranjith-Kumar CT, 2006, RNA, V12, P303, DOI 10.1261/rna.2163106; Ranjith-Kumar CT, 2002, J VIROL, V76, P12526, DOI 10.1128/JVI.76.24.12526-12536.2002; Ranjith-Kumar CT, 2002, J VIROL, V76, P12513, DOI 10.1128/JVI.76.24.12513-12525.2002; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Sun XL, 2000, BIOCHEM BIOPH RES CO, V268, P798, DOI 10.1006/bbrc.2000.2120; Sy Theodore, 2006, Int J Med Sci, V3, P41; Tomei L, 2003, J VIROL, V77, P13225, DOI 10.1128/JVI.77.24.13225-13231.2003; Weiss S, 1999, SCIENCE, V283, P1676, DOI 10.1126/science.283.5408.1676; Yamashita T, 1998, J BIOL CHEM, V273, P15479, DOI 10.1074/jbc.273.25.15479; Zhong WD, 2000, J VIROL, V74, P2017, DOI 10.1128/JVI.74.4.2017-2022.2000; Zhong WD, 1998, J VIROL, V72, P9365, DOI 10.1128/JVI.72.11.9365-9369.1998	44	17	17	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14399	14411		10.1074/jbc.M113.529743	http://dx.doi.org/10.1074/jbc.M113.529743			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24692556	Green Published, hybrid			2022-12-25	WOS:000335984600065
J	Nagpal, K; Watanabe, KS; Tsao, BP; Tsokos, GC				Nagpal, Kamalpreet; Watanabe, Katsue Sunahori; Tsao, Betty P.; Tsokos, George C.			Transcription factor Ikaros Represses Protein Phosphatase 2A ( PP2A) Expression through an Intronic Binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin Modification; Gene Regulation; Protein Phosphatase; T Cell; Transcription Repressor	SYSTEMIC-LUPUS-ERYTHEMATOSUS; SERINE THREONINE PHOSPHATASES; T-CELLS; LYMPHOCYTE DEVELOPMENT; IL-2 PRODUCTION; FCR-GAMMA; DISEASE; GENE; METHYLATION; DETERMINES	Background: PP2A is a serine/threonine phosphatase playing a central role in the pathology of the autoimmune disease SLE. Results: Ikaros binds to an intronic site in PP2A and modulates its expression. Conclusion: Ikaros represses PP2A expression by recruiting histone deacetylase HDAC1. Significance: This study proposes a novel pathway for regulation of PP2A, a critical molecule in SLE pathogenesis. Protein phosphatase 2A (PP2A) is a highly conserved and ubiquitous serine/threonine phosphatase. We have shown previously that PP2A expression is increased in T cells of systemic lupus erythematosus patients and that this increased expression and activity of PP2A plays a central role in the molecular pathogenesis of systemic lupus erythematosus. Although the control of PP2A expression has been the focus of many studies, many aspects of its regulation still remain poorly understood. In this study, we describe a novel mechanism of PP2A regulation. We propose that the transcription factor Ikaros binds to a variant site in the first intron of PP2A and modulates its expression. Exogenous expression of Ikaros leads to reduced levels of PP2Ac message as well as protein. Conversely, siRNA-enabled silencing of Ikaros enhances the expression of PP2A, suggesting that Ikaros acts as a suppressor of PP2A expression. A ChIP analysis further proved that Ikaros is recruited to this site in T cells. We also attempted to delineate the mechanism of Ikaros-mediated PP2Ac gene suppression. We show that Ikaros-mediated suppression of PP2A expression is at least partially dependent on the recruitment of the histone deacetylase HDAC1 to this intronic site. We conclude that the transcription factor Ikaros can regulate the expression of PP2A by binding to a site in the first intron and modulating chromatin modifications at this site via recruitment of HDAC1.	[Nagpal, Kamalpreet; Watanabe, Katsue Sunahori; Tsokos, George C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Rheumatol, Boston, MA 02215 USA; [Tsao, Betty P.] Univ Calif Los Angeles, Div Rheumatol, Los Angeles, CA 90095 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of California System; University of California Los Angeles	Nagpal, K (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, 330 Brookline Ave,CLS 937, Boston, MA 02215 USA.	knagpal@bidmc.harvard.edu; gtsokos@bidmc.harvard.edu	tsokos, george C/O-3360-2013	tsokos, george C/0000-0001-9589-2360; Tsao, Betty/0000-0001-7938-5975	National Institutes of Health [R01 AI068787]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI068787 (to G.C.T.).	COHEN PTW, 1990, FEBS LETT, V268, P355, DOI 10.1016/0014-5793(90)81285-V; Georgopoulos K, 1997, ANNU REV IMMUNOL, V15, P155, DOI 10.1146/annurev.immunol.15.1.155; Grammatikos AP, 2012, TRENDS MOL MED, V18, P101, DOI 10.1016/j.molmed.2011.10.005; He CF, 2010, LUPUS, V19, P1181, DOI 10.1177/0961203310367918; Hoffmann C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083426; Hu WL, 2011, RHEUMATOL INT, V31, P819, DOI 10.1007/s00296-010-1576-1; Hu XL, 2001, J BIOL CHEM, V276, P4597, DOI 10.1074/jbc.M005477200; Juang YT, 2008, J IMMUNOL, V181, P3658, DOI 10.4049/jimmunol.181.5.3658; Katsiari CG, 2005, J CLIN INVEST, V115, P3193, DOI 10.1172/JCI24895; Krishnan S, 2003, J IMMUNOL, V170, P4189, DOI 10.4049/jimmunol.170.8.4189; Krishnan S, 2003, J IMMUNOL, V171, P3325, DOI 10.4049/jimmunol.171.7.3325; McEwen DG, 1998, J BIOL CHEM, V273, P5349, DOI 10.1074/jbc.273.9.5349; Moabbi AM, 2012, P NATL ACAD SCI USA, V109, P8505, DOI 10.1073/pnas.1112400109; Moulton VR, 2008, J BIOL CHEM, V283, P20037, DOI 10.1074/jbc.M710434200; Moulton VR, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3251; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; Popescu M, 2009, J BIOL CHEM, V284, P13869, DOI 10.1074/jbc.M900209200; Richardson B, 2003, CLIN IMMUNOL, V109, P72, DOI 10.1016/S1521-6616(03)00206-7; Sellars Maclean, 2011, World J Biol Chem, V2, P132, DOI 10.4331/wjbc.v2.i6.132; Solomou EE, 2001, J IMMUNOL, V166, P4216, DOI 10.4049/jimmunol.166.6.4216; Sun L, 1996, EMBO J, V15, P5358, DOI 10.1002/j.1460-2075.1996.tb00920.x; Sunahori K, 2009, J IMMUNOL, V182, P1500, DOI 10.4049/jimmunol.182.3.1500; Tan WF, 2011, ARTHRITIS RHEUM-US, V63, P2755, DOI 10.1002/art.30452; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359	24	18	18	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13751	13757		10.1074/jbc.M114.558197	http://dx.doi.org/10.1074/jbc.M114.558197			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24692537	Green Published, hybrid			2022-12-25	WOS:000335984600009
J	Hsu, CL; Voss, MW; Handy, TC; Davis, JC; Nagamatsu, LS; Chan, A; Bolandzadeh, N; Liu-Ambrose, T				Hsu, Chun Liang; Voss, Michelle W.; Handy, Todd C.; Davis, Jennifer C.; Nagamatsu, Lindsay S.; Chan, Alison; Bolandzadeh, Niousha; Liu-Ambrose, Teresa			Disruptions in Brain Networks of Older Fallers Are Associated with Subsequent Cognitive Decline: A 12-Month Prospective Exploratory Study	PLOS ONE			English	Article							WHITE-MATTER INTEGRITY; SELF-EFFICACY BELIEFS; RESTING-STATE; FUNCTIONAL CONNECTIVITY; ALZHEIMERS-DISEASE; DEFAULT NETWORK; MOTOR CONTROL; AGE-DIFFERENCES; GAIT; RISK	Cognitive impairment and impaired mobility are major public health concerns. There is growing recognition that impaired mobility is an early biomarker of cognitive impairment and dementia. The neural basis for this association is currently unclear. We propose disrupted functional connectivity as a potential mechanism. In this 12-month prospective exploratory study, we compared functional connectivity of four brain networks-the default mode network (DMN), fronto-executive network (FEN), fronto-parietal network (FPN), and the primary motor sensory network (SMN) - between community-dwelling older adults with >= two falls in the last 12 months and their non-falling counterparts (<= one fall in the last 12 months). Functional connectivity was examined both at rest and during a simple motor tapping task. Compared with non-fallers, fallers showed more connectivity between the DMN and FPN during right finger tapping (p=0.04), and significantly less functional connectivity between the SMN and FPN during rest (p <= 0.05). Less connectivity between the SMN and FPN during rest was significantly associated with greater decline in both cognitive function and mobility over the12-month period (r =-0.32 and 0.33 respectively; p <= 0.04). Thus, a recent history of multiple falls among older adults without a diagnosis of dementia may indicate sub-clinical changes in brain function and increased risk for subsequent decline.	[Hsu, Chun Liang; Nagamatsu, Lindsay S.; Chan, Alison; Bolandzadeh, Niousha; Liu-Ambrose, Teresa] Univ British Columbia, Aging Mobil & Cognit Neurosci Lab, Vancouver, BC V5Z 1M9, Canada; [Hsu, Chun Liang; Davis, Jennifer C.; Chan, Alison; Bolandzadeh, Niousha; Liu-Ambrose, Teresa] Univ British Columbia, Dept Phys Therapy, Vancouver, BC V5Z 1M9, Canada; [Hsu, Chun Liang; Davis, Jennifer C.; Nagamatsu, Lindsay S.; Chan, Alison; Bolandzadeh, Niousha; Liu-Ambrose, Teresa] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Hsu, Chun Liang; Nagamatsu, Lindsay S.; Chan, Alison; Bolandzadeh, Niousha; Liu-Ambrose, Teresa] Ctr Hip Hlth & Mobil, Vancouver, BC, Canada; [Voss, Michelle W.] Univ Iowa, Hlth Brain & Cognit Lab, Iowa City, IA USA; [Voss, Michelle W.] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA; [Handy, Todd C.; Davis, Jennifer C.] Univ British Columbia, Ctr Clin Epidemiol & Evaluat, Vancouver, BC V5Z 1M9, Canada; [Handy, Todd C.; Davis, Jennifer C.] VCHRI, Vancouver, BC, Canada; [Handy, Todd C.; Nagamatsu, Lindsay S.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of Iowa; University of Iowa; University of British Columbia; University of British Columbia	Liu-Ambrose, T (corresponding author), Univ British Columbia, Aging Mobil & Cognit Neurosci Lab, Vancouver, BC V5Z 1M9, Canada.	tlambrose@exchange.ubc.ca	Hsu, Chun Liang/AAN-4254-2021; Liu-Ambrose, Teresa/W-2332-2019	Hsu, Chun Liang/0000-0003-2090-1001; Liu-Ambrose, Teresa/0000-0002-8297-5308	Canadian Institutes of Health Research [MOB-93373]; Canadian Institutes of Health Research Emerging Team Grant: Mobility in Aging	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research Emerging Team Grant: Mobility in Aging(Canadian Institutes of Health Research (CIHR))	The Canadian Institutes of Health Research (MOB-93373) to TLA and a Canadian Institutes of Health Research Emerging Team Grant: Mobility in Aging to Karim Miran-Khan provided funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Aramaki Y, 2010, EXP BRAIN RES, V203, P407, DOI 10.1007/s00221-010-2244-0; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Atkinson HH, 2007, J GERONTOL A-BIOL, V62, P844, DOI 10.1093/gerona/62.8.844; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Berchicci M, 2012, NEUROIMAGE, V62, P1750, DOI 10.1016/j.neuroimage.2012.06.031; Brier MR, 2012, J NEUROSCI, V32, P8890, DOI 10.1523/JNEUROSCI.5698-11.2012; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buracchio T, 2010, ARCH NEUROL-CHICAGO, V67, P980, DOI 10.1001/archneurol.2010.159; COCKRELL JR, 1988, PSYCHOPHARMACOL BULL, V24, P689; Colcombe SJ, 2005, PSYCHOL AGING, V20, P363, DOI 10.1037/0882-7974.20.3.363; CUMMINGS SR, 1988, J AM GERIATR SOC, V36, P613, DOI 10.1111/j.1532-5415.1988.tb06155.x; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; DAVIS JC, 2012, AGE AGEING; Davis JC, 2012, AGE AGEING, V41, P495, DOI 10.1093/ageing/afs029; Davis SW, 2009, NEUROIMAGE, V46, P530, DOI 10.1016/j.neuroimage.2009.01.068; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; de Laat KF, 2011, BRAIN, V134, P73, DOI 10.1093/brain/awq343; Delbaere K, 2010, J AM GERIATR SOC, V58, P1679, DOI 10.1111/j.1532-5415.2010.03017.x; Delbaere K, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4165; Della Nave R, 2007, AM J NEURORADIOL, V28, P1313, DOI 10.3174/ajnr.A0555; Divani AA, 2011, STROKE, V42, P1821, DOI 10.1161/STROKEAHA.110.607630; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Esposito F, 2008, MAGN RESON IMAGING, V26, P905, DOI 10.1016/j.mri.2008.01.045; Fleisher AS, 2009, NEUROIMAGE, V47, P1678, DOI 10.1016/j.neuroimage.2009.06.021; Fogassi L, 2005, CURR OPIN NEUROBIOL, V15, P626, DOI 10.1016/j.conb.2005.10.015; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Geerligs L, 2012, HUM BRAIN MAPP; Grabowska A, 2012, ACTA NEUROBIOL EXP, V72, P439; GRAF P, 1995, J CLIN EXP NEUROPSYC, V17, P390, DOI 10.1080/01688639508405132; Greicius MD, 2004, J COGNITIVE NEUROSCI, V16, P1484, DOI 10.1162/0898929042568532; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Groll DL, 2005, J CLIN EPIDEMIOL, V58, P595, DOI 10.1016/j.jclinepi.2004.10.018; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Hauer K, 2006, AGE AGEING, V35, P5, DOI 10.1093/ageing/afi218; Inman CS, 2012, NEUROIMAGE, V59, P227, DOI 10.1016/j.neuroimage.2011.07.083; Inzitari M, 2007, NEUROEPIDEMIOLOGY, V29, P156, DOI 10.1159/000111577; KAFRI M, 2012, J NEUROIMAGING; Kahneman D., 1973, ATTENTION EFFORT; Kam JWY, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00329; Kantarci K, 2011, NEUROLOGY, V77, P26, DOI 10.1212/WNL.0b013e31822313dc; Kokmen E, 1996, NEUROLOGY, V46, P154, DOI 10.1212/WNL.46.1.154; KONISHI S, 1981, BIOMETRIKA, V68, P647, DOI 10.1093/biomet/68.3.647; Kuo HK, 2004, J GERONTOL A-BIOL, V59, P818; Liu-Ambrose T, 2006, J GERONTOL A-BIOL, V61, P832, DOI 10.1093/gerona/61.8.832; Liu-Ambrose T, 2009, J GERONTOL A-BIOL, V64, P975, DOI 10.1093/gerona/glp063; LORD SR, 1994, J AM GERIATR SOC, V42, P1110, DOI 10.1111/j.1532-5415.1994.tb06218.x; LORD SR, 1991, J AM GERIATR SOC, V39, P1194, DOI 10.1111/j.1532-5415.1991.tb03574.x; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Madden DJ, 2012, BBA-MOL BASIS DIS, V1822, P386, DOI 10.1016/j.bbadis.2011.08.003; Madden DJ, 2009, J COGNITIVE NEUROSCI, V21, P289, DOI 10.1162/jocn.2009.21047; Mennes M, 2013, CEREB CORTEX, V23, P223, DOI 10.1093/cercor/bhs010; Nagamatsu LS, 2013, PSYCHOL AGING, V28, P685, DOI 10.1037/a0034197; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; NEVITT MC, 1989, JAMA-J AM MED ASSOC, V261, P2663, DOI 10.1001/jama.261.18.2663; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; ONODA K, 2012, AGING EFFECTS FUNCTI, P119; Pammi VSC, 2012, NEUROIMAGE, V59, P1180, DOI 10.1016/j.neuroimage.2011.08.006; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Persson J, 2008, NEUROPSYCHOLOGIA, V46, P1679, DOI 10.1016/j.neuropsychologia.2008.01.026; Persson J, 2007, J COGNITIVE NEUROSCI, V19, P1021, DOI 10.1162/jocn.2007.19.6.1021; Persson J, 2006, CEREB CORTEX, V16, P907, DOI 10.1093/cercor/bhj036; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Qi ZG, 2010, NEUROIMAGE, V50, P48, DOI 10.1016/j.neuroimage.2009.12.025; Reuter-Lorenz PA, 2005, CURR OPIN NEUROBIOL, V15, P245, DOI 10.1016/j.conb.2005.03.016; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Rosano C, 2005, J AM GERIATR SOC, V53, P649, DOI 10.1111/j.1532-5415.2005.53214.x; Rosano C, 2008, J AM GERIATR SOC, V56, P1618, DOI 10.1111/j.1532-5415.2008.01856.x; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seeman T, 1996, PSYCHOL AGING, V11, P538, DOI 10.1037/0882-7974.11.3.538; Seeman TE, 1999, J GERONTOL B-PSYCHOL, V54, pP214, DOI 10.1093/geronb/54B.4.P214; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Spreen O., 1998, COMPENDIUM NEUROLOGI, V2nd ed.; Spreng RN, 2012, CEREB CORTEX, V22, P2610, DOI 10.1093/cercor/bhr339; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Stark S, 2011, ALZHEIMERS DEMENT, V7, pS176; Starr JM, 2003, J NEUROL NEUROSUR PS, V74, P94, DOI 10.1136/jnnp.74.1.94; Tomasi D, 2012, MOL PSYCHIATR, V17, P549, DOI 10.1038/mp.2011.81; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Van Impe A, 2012, NEUROBIOL AGING, V33, P1900, DOI 10.1016/j.neurobiolaging.2011.06.013; VANMARWIJK HWJ, 1995, BRIT J GEN PRACT, V45, P195; Verghese J, 2002, NEW ENGL J MED, V347, P1761, DOI 10.1056/NEJMoa020441; Verwey WB, 2001, ACTA PSYCHOL, V106, P69, DOI 10.1016/S0001-6918(00)00027-5; Verwey WB, 2010, ACTA PSYCHOL, V134, P206, DOI 10.1016/j.actpsy.2010.02.001; Vidoni ED, 2012, J NEUROL PHYS THER, V36, P8, DOI 10.1097/NPT.0b013e3182462ea6; Voss MW, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00032; Washburn RA, 1999, J CLIN EPIDEMIOL, V52, P643, DOI 10.1016/S0895-4356(99)00049-9; Wechsler D., 1997, WAIS 3 WECHSLER ADUL, V3rd, DOI 10.1111/j.1749-6632.1989.tb21005.x; Weerdesteyn V, 2008, J REHABIL RES DEV, V45, P1195, DOI 10.1682/JRRD.2007.09.0145; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25; Wu T, 2009, NEUROSCI LETT, V460, P6, DOI 10.1016/j.neulet.2009.05.046; Wymbs NF, 2012, NEURON, V74, P936, DOI 10.1016/j.neuron.2012.03.038; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	97	25	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93673	10.1371/journal.pone.0093673	http://dx.doi.org/10.1371/journal.pone.0093673			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699668	Green Published, gold			2022-12-25	WOS:000334105000089
J	Nah, GSS; Lim, ZW; Tay, BH; Osato, M; Venkatesh, B				Nah, Giselle Sek Suan; Lim, Zhi Wei; Tay, Boon-Hui; Osato, Motomi; Venkatesh, Byrappa			Runx Family Genes in a Cartilaginous Fish, the Elephant Shark (Callorhinchus milii)	PLOS ONE			English	Article							TRANSCRIPTION FACTOR PEBP2; DNA-BINDING ACTIVITY; BONE-FORMATION; FUGU GENOME; CBF-BETA; EXPRESSION; EVOLUTION; PROTEINS; LEUKEMIA; DOMAIN	The Runx family genes encode transcription factors that play key roles in hematopoiesis, skeletogenesis and neurogenesis and are often implicated in diseases. We describe here the cloning and characterization of Runx1, Runx2, Runx3 and Runxb genes in the elephant shark (Callorhinchus milii), a member of Chondrichthyes, the oldest living group of jawed vertebrates. Through the use of alternative promoters and/or alternative splicing, each of the elephant shark Runx genes expresses multiple isoforms similar to their orthologs in human and other bony vertebrates. The expression profiles of elephant shark Runx genes are similar to those of mammalian Runx genes. The syntenic blocks of genes at the elephant shark Runx gene loci are highly conserved in human, but represented by shorter conserved blocks in zebrafish indicating a higher degree of rearrangements in this teleost fish. Analysis of promoter regions revealed conservation of binding sites for transcription factors, including two tandem binding sites for Runx that are totally conserved in the distal promoter regions of elephant shark Runx1-3. Several conserved noncoding elements (CNEs), which are putative cis-regulatory elements, and miRNA binding sites were identified in the elephant shark and human Runx gene loci. Some of these CNEs and miRNA binding sites are absent in teleost fishes such as zebrafish and fugu. In summary, our analysis reveals that the genomic organization and expression profiles of Runx genes were already complex in the common ancestor of jawed vertebrates.	[Nah, Giselle Sek Suan; Lim, Zhi Wei; Tay, Boon-Hui; Osato, Motomi; Venkatesh, Byrappa] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore, Singapore; [Nah, Giselle Sek Suan] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Osato, Motomi] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Osato, Motomi] Agcy Sci Technol & Res, Inst Bioengn & Nanotechnol, Singapore, Singapore; [Venkatesh, Byrappa] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pediat, Singapore 117595, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Institute of Bioengineering & Nanotechnology (IBN); National University of Singapore	Osato, M (corresponding author), Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore, Singapore.	csimo@nus.edu.sg; mcbbv@imcb.a-star.edu.sg	Lim, Zhiwei/Q-7858-2016; Osato, Motomi/N-5056-2014	Lim, Zhiwei/0000-0003-4620-1986; Osato, Motomi/0000-0003-3982-9054; Venkatesh, Byrappa/0000-0003-3620-0277	Biomedical Research Council of A*STAR, Singapore	Biomedical Research Council of A*STAR, Singapore(Agency for Science Technology & Research (A*STAR))	Funding provided by Biomedical Research Council of A*STAR, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adya N, 2000, SEMIN CELL DEV BIOL, V11, P361, DOI 10.1006/scdb.2000.0189; Akamatsu Y, 1997, J BIOL CHEM, V272, P14497, DOI 10.1074/jbc.272.23.14497; Attanasio C, 2013, SCIENCE, V342, DOI 10.1126/science.1241006; Bee T, 2010, BLOOD, V115, P3042, DOI 10.1182/blood-2009-08-238626; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Boehm T, 2012, ANNU REV GENOM HUM G, V13, P127, DOI 10.1146/annurev-genom-090711-163747; Braun T, 2009, BLOOD CELL MOL DIS, V43, P43, DOI 10.1016/j.bcmd.2009.05.001; Brenner O, 2004, P NATL ACAD SCI USA, V101, P16016, DOI 10.1073/pnas.0407180101; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; Davies WIL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051276; Dooley H, 2006, DEV COMP IMMUNOL, V30, P43, DOI 10.1016/j.dci.2005.06.022; Drissi H, 2000, J CELL PHYSIOL, V184, P341, DOI 10.1002/1097-4652(200009)184:3<341::AID-JCP8>3.0.CO;2-Z; Drissi H, 2002, EXP CELL RES, V274, P323, DOI 10.1006/excr.2002.5474; Fainaru O, 2004, EMBO J, V23, P969, DOI 10.1038/sj.emboj.7600085; Fan HY, 2011, MOL ENDOCRINOL, V25, P253, DOI 10.1210/me.2010-0318; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Glusman G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-43; Goodman FR, 1997, P NATL ACAD SCI USA, V94, P7458, DOI 10.1073/pnas.94.14.7458; Hecht J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000025; Hovhannisyan H, 2013, J CELL PHYSIOL, V228, P313, DOI 10.1002/jcp.22109; Huang G, 2001, EMBO J, V20, P723, DOI 10.1093/emboj/20.4.723; Inoue K, 2002, NAT NEUROSCI, V5, P946, DOI 10.1038/nn925; Inoue KI, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-20; Jacob B, 2010, BLOOD, V115, P1610, DOI 10.1182/blood-2009-07-232249; Javed A, 2000, J CELL SCI, V113, P2221; Jeong JH, 2008, J CELL PHYSIOL, V217, P511, DOI 10.1002/jcp.21524; Jurka J, 1996, COMPUT CHEM, V20, P119, DOI 10.1016/S0097-8485(96)80013-1; Kagoshima H, 1996, J BIOL CHEM, V271, P33074, DOI 10.1074/jbc.271.51.33074; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kudo Y, 2011, J CELL BIOCHEM, V112, P387, DOI 10.1002/jcb.22967; Lee AP, 2011, MOL BIOL EVOL, V28, P1205, DOI 10.1093/molbev/msq304; Lee CWL, 2011, GYNECOL ONCOL, V122, P410, DOI 10.1016/j.ygyno.2011.04.044; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; Liu JC, 2011, J BIOL CHEM, V286, P30057, DOI 10.1074/jbc.M111.241505; Morrison NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042617; Ng CEL, 2007, GENE, V399, P162, DOI 10.1016/j.gene.2007.05.014; Ng CEL, 2010, STEM CELLS, V28, P1869, DOI 10.1002/stem.507; OGAWA E, 1993, VIROLOGY, V194, P314, DOI 10.1006/viro.1993.1262; Ohno SI, 2008, INT IMMUNOL, V20, P71, DOI 10.1093/intimm/dxm120; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Osato M, 2005, CRIT REV EUKAR GENE, V15, P217, DOI 10.1615/CritRevEukarGeneExpr.v15.i3.40; Osato M, 2004, ONCOGENE, V23, P4284, DOI 10.1038/sj.onc.1207779; Osorio KM, 2008, DEVELOPMENT, V135, P1059, DOI 10.1242/dev.012799; Otto F, 2002, HUM MUTAT, V19, P209, DOI 10.1002/humu.10043; Park ES, 2012, MOL CELL ENDOCRINOL, V362, P165, DOI 10.1016/j.mce.2012.06.005; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Qiao M, 2006, J BIOL CHEM, V281, P7118, DOI 10.1074/jbc.M508162200; Rossetti S, 2013, INT J MOL SCI, V14, P1566, DOI 10.3390/ijms14011566; Sears KE, 2007, EVOL DEV, V9, P555, DOI 10.1111/j.1525-142X.2007.00196.x; Soung DY, 2007, J BONE MINER RES, V22, P1260, DOI 10.1359/JBMR.070502; Speck NA, 2002, NAT REV CANCER, V2, P502, DOI 10.1038/nrc840; Spender LC, 2005, ONCOGENE, V24, P1873, DOI 10.1038/sj.onc.1208404; Sullivan JC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-228; Tahirov TH, 2001, CELL, V104, P755, DOI 10.1016/S0092-8674(01)00271-9; Tan YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047174; Tanaka T, 1996, MOL CELL BIOL, V16, P3967; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Terry A, 2004, GENE, V336, P115, DOI 10.1016/j.gene.2004.04.015; Thirunavukkarasu K, 1998, MOL CELL BIOL, V18, P4197, DOI 10.1128/MCB.18.7.4197; van der Meulen T, 2005, BBA-GENE STRUCT EXPR, V1729, P105, DOI 10.1016/j.bbaexp.2005.03.008; Venkatesh B, 2005, CURR BIOL, V15, pR82, DOI 10.1016/j.cub.2005.01.021; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101; Venkatesh B, 2006, SCIENCE, V314, P1892, DOI 10.1126/science.1130708; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Wang XX, 2005, GENE DEV, V19, P1715, DOI 10.1101/gad.1318305; Watanabe K, 2010, J IMMUNOL, V184, P2785, DOI 10.4049/jimmunol.0901823; Xu Y, 2013, FEBS LETT, V587, P3166, DOI 10.1016/j.febslet.2013.05.069; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Zhang YH, 2004, J BIOL CHEM, V279, P53116, DOI 10.1074/jbc.M405502200	72	4	5	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93816	10.1371/journal.pone.0093816	http://dx.doi.org/10.1371/journal.pone.0093816			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699678	Green Submitted, gold, Green Published			2022-12-25	WOS:000334105000111
J	Sandoval-Castro, E; Dodd, RS; Riosmena-Rodriguez, R; Enriquez-Paredes, LM; Tovilla-Hernandez, C; Lopez-Vivas, JM; Aguilar-May, B; Muniz-Salazar, R				Sandoval-Castro, Eduardo; Dodd, Richard S.; Riosmena-Rodriguez, Rafael; Manuel Enriquez-Paredes, Luis; Tovilla-Hernandez, Cristian; Lopez-Vivas, Juan Manuel; Aguilar-May, Bily; Muniz-Salazar, Raquel			Post-Glacial Expansion and Population Genetic Divergence of Mangrove Species Avicennia germinans (L.) Stearn and Rhizophora mangle L. along the Mexican Coast	PLOS ONE			English	Article							MIGRATION RATES; F-STATISTICS; DISPERSAL; DIVERSITY; INFERENCE; RECOLONIZATION; EXTINCTION; DISTANCES; SOFTWARE; ECOLOGY	Mangrove forests in the Gulf of California, Mexico represent the northernmost populations along the Pacific coast and thus they are likely to be source populations for colonization at higher latitudes as climate becomes more favorable. Today, these populations are relatively small and fragmented and prior research has indicated that they are poor in genetic diversity. Here we set out to investigate whether the low diversity in this region was a result of recent colonization, or fragmentation and genetic drift of once more extensive mangroves due to climatic changes in the recent past. By sampling the two major mangrove species, Rhizophora mangle and Avicennia germinans, along the Pacific and Atlantic coasts of Mexico, we set out to test whether concordant genetic signals could elucidate recent evolution of the ecosystem. Genetic diversity of both mangrove species showed a decreasing trend toward northern latitudes along the Pacific coast. The lowest levels of genetic diversity were found at the range limits around the Gulf of California and the outer Baja California peninsula. Lack of a strong spatial genetic structure in this area and recent northern gene flow in A. germinans suggest recent colonization by this species. On the other hand, lack of a signal of recent northern dispersal in R. mangle, despite the higher dispersal capability of this species, indicates a longer presence of populations, at least in the southern Gulf of California. We suggest that the longer history, together with higher genetic diversity of R. mangle at the range limits, likely provides a gene pool better able to colonize northwards under climate change than A. germinans.	[Sandoval-Castro, Eduardo; Muniz-Salazar, Raquel] Univ Autonoma Baja California, Escuela Ciencias Salud, Ensenada, Baja California, Mexico; [Sandoval-Castro, Eduardo; Manuel Enriquez-Paredes, Luis] Univ Autonoma Baja California, Fac Ciencias Marinas, Ensenada, Baja California, Mexico; [Dodd, Richard S.; Lopez-Vivas, Juan Manuel] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Riosmena-Rodriguez, Rafael] Univ Autonoma Baja California Sur, Dept Acad Biol Marina, La Paz, Baja California, Mexico; [Tovilla-Hernandez, Cristian] Colegio Frontera Sur, Tapachula, Chiapas, Mexico; [Aguilar-May, Bily] Inst Tecnol Super Villa La Venta, Huamanguillo, Tabasco, Mexico	Universidad Autonoma de Baja California; University of California System; University of California Berkeley; El Colegio de la Frontera Sur (ECOSUR)	Muniz-Salazar, R (corresponding author), Univ Autonoma Baja California, Escuela Ciencias Salud, Ensenada, Baja California, Mexico.	ramusal@uabc.edu.mx	Lopez-Vivas, Juan M/B-8015-2018; Sandoval-Castro, Eduardo/J-2164-2017; Sandoval-Castro, Eduardo/AAT-4171-2021; MUNIZ-SALAZAR, RAQUEL/F-5309-2019	Lopez-Vivas, Juan M/0000-0002-3417-1153; Sandoval-Castro, Eduardo/0000-0001-8875-0225; MUNIZ-SALAZAR, RAQUEL/0000-0001-5528-7772; Enriquez-Paredes, Luis Manuel/0000-0002-9835-1225; Tovilla, Cristian/0000-0003-0469-9771	International Community Foundation [20030900]; UABC [0843]; CONACYT-SEMARNAT-INE [107696]	International Community Foundation; UABC; CONACYT-SEMARNAT-INE	International Community Foundation Grant No.: 20030900; 14th Internal Call for Support to Investigation Projects of the UABC, Grant No. 0843; CONACYT-SEMARNAT-INE 2009, Grant No. 107696. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	Aburto-Oropeza O, 2008, P NATL ACAD SCI USA, V105, P10456, DOI 10.1073/pnas.0804601105; Acosta-Velazquez J, 2009, 33 INT S REM SENS EN, P1; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Bialozyt R, 2006, J EVOLUTION BIOL, V19, P12, DOI 10.1111/j.1420-9101.2005.00995.x; Castillo-Cardenas MF, 2005, BIOTROPICA, V37, P266, DOI 10.1111/j.1744-7429.2005.00036.x; Ceron-Souza I, 2006, MOL ECOL NOTES, V6, P692, DOI 10.1111/j.1471-8286.2006.01312.x; Ceron-Souza I, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-205; Dodd RS, 2002, MOL ECOL, V11, P1327, DOI 10.1046/j.1365-294X.2002.01525.x; Dodd RS, 2000, NEW PHYTOL, V145, P115, DOI 10.1046/j.1469-8137.2000.00551.x; Duke NC, 1998, GLOBAL ECOL BIOGEOGR, V7, P27, DOI 10.2307/2997695; Dutech C, 2003, EVOLUTION, V57, P2753, DOI 10.1111/j.0014-3820.2003.tb01517.x; Salas-Leiva DE, 2009, AQUAT BOT, V91, P187, DOI 10.1016/j.aquabot.2009.06.001; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Falush D, 2003, GENETICS, V164, P1567; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Graham A, 2006, ANN MO BOT GARD, V93, P325, DOI 10.3417/0026-6493(2006)93[325:PEAMDI]2.0.CO;2; Hardy OJ, 2003, GENETICS, V163, P1467; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, HEREDITY, V92, P1, DOI 10.1038/sj.hdy.6800365; Jacobs DK, 2004, ANNU REV EARTH PL SC, V32, P601, DOI 10.1146/annurev.earth.32.092203.122436; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Ledesma-Vazquez J., 1997, PLIOCENE CARBONATES, VVolume 318, P73; Lewis PO, 2001, GENETIC DATA ANAL GD; MCCAULEY DE, 1991, TRENDS ECOL EVOL, V6, P5, DOI 10.1016/0169-5347(91)90139-O; Michalakis Y, 1996, GENETICS, V142, P1061; Mila B, 2007, P R SOC B, V274, P2653, DOI 10.1098/rspb.2007.0852; Nettel A, 2005, MOL ECOL NOTES, V5, P103, DOI 10.1111/j.1471-8286.2004.00851.x; Nettel A, 2008, MOL ECOL, V17, P2680, DOI 10.1111/j.1365-294X.2008.03766.x; Nettel A, 2007, EVOLUTION, V61, P958, DOI 10.1111/j.1558-5646.2007.00070.x; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; ONG JE, 1993, CHEMOSPHERE, V27, P1097; Pacheco-Ruiz I, 2006, CIENCIA MAR, V28, P19; Perry CL, 2009, WETLANDS, V29, P396, DOI 10.1672/08-100.1; Peterman WE, 2013, BIOL CONSERV, V158, P351, DOI 10.1016/j.biocon.2012.07.028; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Pil MW, 2011, AM J BOT, V98, P1031, DOI 10.3732/ajb.1000392; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rosero-Galindo C, 2002, MOL ECOL NOTES, V2, P281, DOI 10.1046/j.1471-8286.2002.00232.x; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rull V., 1998, INTERCIENCIA, V23, P255; Sandoval-Castro E, 2012, AQUAT BOT, V99, P20, DOI 10.1016/j.aquabot.2012.01.002; SHERROD CL, 1985, CONTRIB MAR SCI, V28, P129; SLATKIN M, 1995, GENETICS, V139, P457; Sousa WP, 2007, ECOL MONOGR, V77, P53, DOI 10.1890/05-1935; Takayama K, 2013, AM J BOT, V100, P1191, DOI 10.3732/ajb.1200567; Thampanya U, 2006, ESTUAR COAST SHELF S, V68, P75, DOI 10.1016/j.ecss.2006.01.011; Tomlinson PB, 1994, BOT MANGROVES; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wilson GA, 2003, GENETICS, V163, P1177; WOODROFFE CD, 1991, J BIOGEOGR, V18, P479, DOI 10.2307/2845685; Yamano H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046474	60	40	40	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93358	10.1371/journal.pone.0093358	http://dx.doi.org/10.1371/journal.pone.0093358			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699389	Green Submitted, Green Published, gold			2022-12-25	WOS:000334105000056
J	Naghii, MR; Babaei, M; Hedayati, M				Naghii, Mohammad Reza; Babaei, Mnasour; Hedayati, Mehdi			Androgens Involvement in the Pathogenesis of Renal Stones Formation	PLOS ONE			English	Article							HORMONE-BINDING GLOBULIN; SEX-HORMONES; IDIOPATHIC NEPHROLITHIASIS; UROLITHIASIS; TESTOSTERONE; OXALATE; MEN; OLDER; RATS; AGE	Objective: The potential role for the gonadal steroids in the pathogenesis of urolithiasis, higher mean of plasma oxalate concentration and kidney calcium oxalate deposition influenced by androgens in men has been proposed. In this study, the serum levels of steroid hormones as a pathogenesis of this condition in male patients with active renal stone disease compared with controls was investigated. Methods: Forty patients diagnosed with renal stones and hospitalized for further clinical treatments or referred to our office after ultrasonographic evaluations participated in the study. Forty six healthy subjects served as controls. Steroid sex hormones in the plasma samples including testosterone, free testosterone, dihydrotestosterone, estradiol, and sex hormone binding globulin were analyzed. Results: A significant difference was observed between patients and the control subjects regarding serum testosterone, free testosterone, dihydrotestosterone, estradiol, and sex hormone binding globulin. Conclusions: Based on the results, a higher androgens level was diagnosed in renal stone patients, indicating a possibility of a substantial pathogenic role of testosterone, free testosterone, and dihydrotestosterone involvement in the pathogenesis of renal stones formation. Therefore, data presentation and further investigation on the relation between male steroids and urolithiasis is of importance and should be considered in evaluation of the etiology of the disease.	[Naghii, Mohammad Reza] Univ Med Sci, Baqiyatallah As, Hlth Sch, Sport Physiol Res Ctr, Tehran, Iran; [Naghii, Mohammad Reza] Univ Med Sci, Baqiyatallah As, Hlth Sch, Dept Nutr, Tehran, Iran; [Babaei, Mnasour] Univ Med Sci, Baqiyatallah As, Med Sci Res Management, Tehran, Iran; [Hedayati, Mehdi] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Cellular & Mol Endocrine Res Ctr, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Shahid Beheshti University Medical Sciences	Naghii, MR (corresponding author), Univ Med Sci, Baqiyatallah As, Hlth Sch, Sport Physiol Res Ctr, Tehran, Iran.	naghiimr@yahoo.com	babaei, mansuor/ABB-8590-2020; Hedayati, Mehdi/AAG-3006-2019	babaei, mansuor/0000-0001-7385-9885; Hedayati, Mehdi/0000-0001-5816-775X				Curhan GC, 2007, UROL CLIN N AM, V34, P287, DOI 10.1016/j.ucl.2007.04.003; Curhan GC, 1999, J ENDOUROL, V13, P629, DOI 10.1089/end.1999.13.629; Fan J, 1998, UROL RES, V26, P71, DOI 10.1007/s002400050026; Fan J, 1999, J AM SOC NEPHROL, V10, pS376; Finlayson B, 1974, Urol Clin North Am, V1, P181; Griffin DG, 2004, J CLIN PATHOL, V57, P793, DOI 10.1136/jcp.2003.014886; Hammond GL, 2012, CURR OPIN ENDOCRINOL, V19, P183, DOI 10.1097/MED.0b013e328353732f; Kato Y, 2005, UROL RES, V33, P476, DOI 10.1007/s00240-005-0511-5; Kaygusuz I, 2013, UROLITHIASIS, V41, P361, DOI 10.1007/s00240-013-0564-9; Li JY, 2010, J UROLOGY, V184, P2360, DOI 10.1016/j.juro.2010.08.009; Litman HJ, 2006, J CLIN ENDOCR METAB, V91, P4326, DOI 10.1210/jc.2006-0037; Liu PY, 2007, J CLIN ENDOCR METAB, V92, P3599, DOI 10.1210/jc.2007-0862; Naghii M R, 2010, Endocr Regul, V44, P143, DOI 10.4149/endo_2010_04_143; Naghii MR, 2013, UROLITHIASIS    1108; Nath SJ, 2013, UROTODAY INT J, V6; Shakhssalim N, 2011, UROL RES, V39, P1, DOI 10.1007/s00240-010-0276-3; Soundararajan P., 2006, Indian Journal of Experimental Biology, V44, P981; Travison TG, 2009, CURR OPIN ENDOCRINOL, V16, P211, DOI 10.1097/MED.0b013e32832b6348; Yagisawa T, 2001, J UROLOGY, V166, P1078, DOI 10.1016/S0022-5347(05)65925-3; Yeap BB, 2007, EUR J ENDOCRINOL, V156, P585, DOI 10.1530/EJE-06-0714; Yoshioka I, 2010, UROLOGY, V75, P907, DOI 10.1016/j.urology.2009.09.094; Zhao ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075513	22	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93790	10.1371/journal.pone.0093790	http://dx.doi.org/10.1371/journal.pone.0093790			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695421	Green Published, Green Submitted, gold			2022-12-25	WOS:000334103000124
J	Perjes, A; Skoumal, R; Tenhunen, O; Konyi, A; Simon, M; Horvath, IG; Kerkela, R; Ruskoaho, H; Szokodi, I				Perjes, Abel; Skoumal, Reka; Tenhunen, Olli; Konyi, Attila; Simon, Mihaly; Horvath, Ivan G.; Kerkela, Risto; Ruskoaho, Heikki; Szokodi, Istvan			Apelin Increases Cardiac Contractility via Protein Kinase C epsilon- and Extracellular Signal-Regulated Kinase-Dependent Mechanisms	PLOS ONE			English	Article							LIGHT-CHAIN PHOSPHORYLATION; ENDOGENOUS PEPTIDE LIGAND; ORPHAN RECEPTOR APJ; DIFFERENTIAL ACTIVATION; VENTRICULAR MYOCYTES; POSITIVE INOTROPY; TROPONIN-I; ENDOTHELIN-1; MYOCARDIUM; MODULATION	Background: Apelin, the endogenous ligand for the G protein-coupled apelin receptor, is an important regulator of the cardiovascular homoeostasis. We previously demonstrated that apelin is one of the most potent endogenous stimulators of cardiac contractility; however, its underlying signaling mechanisms remain largely elusive. In this study we characterized the contribution of protein kinase C (PKC), extracellular signal-regulated kinase 1/2 (ERK1/2) and myosin light chain kinase (MLCK) to the positive inotropic effect of apelin. Methods and Results: In isolated perfused rat hearts, apelin increased contractility in association with activation of prosurvival kinases PKC and ERK1/2. Apelin induced a transient increase in the translocation of PKC epsilon, but not PKC alpha, from the cytosol to the particulate fraction, and a sustained increase in the phosphorylation of ERK1/2 in the left ventricle. Suppression of ERK1/2 activation diminished the apelin-induced increase in contractility. Although pharmacological inhibition of PKC attenuated the inotropic response to apelin, it had no effect on ERK1/2 phosphorylation. Moreover, the apelin-induced positive inotropic effect was significantly decreased by inhibition of MLCK, a kinase that increases myofilament Ca2+ sensitivity. Conclusions: Apelin increases cardiac contractility through parallel and independent activation of PKCe and ERK1/2 signaling in the adult rat heart. Additionally MLCK activation represents a downstream mechanism in apelin signaling. Our data suggest that, in addition to their role in cytoprotection, modest activation of PKC epsilon and ERK1/2 signaling improve contractile function, therefore these pathways represent attractive possible targets in the treatment of heart failure.	[Perjes, Abel; Tenhunen, Olli; Kerkela, Risto; Ruskoaho, Heikki] Univ Oulu, Inst Biomed, Dept Pharmacol & Toxicol, Oulu, Finland; [Perjes, Abel; Skoumal, Reka; Konyi, Attila; Simon, Mihaly; Horvath, Ivan G.; Szokodi, Istvan] Univ Pecs, Sch Med, Inst Heart, Pecs, Hungary; [Perjes, Abel; Skoumal, Reka; Konyi, Attila; Simon, Mihaly; Horvath, Ivan G.; Szokodi, Istvan] Univ Pecs, Szentagothai Res Ctr, Pecs, Hungary; [Ruskoaho, Heikki] Univ Helsinki, Fac Pharm, Helsinki, Finland; [Kerkela, Risto] Med Res Ctr Oulu, Oulu, Finland	University of Oulu; University of Pecs; University of Pecs; University of Helsinki	Szokodi, I (corresponding author), Univ Oulu, Inst Biomed, Dept Pharmacol & Toxicol, Oulu, Finland.	istvan.szokodi@pte.hu	Szokodi, Istvan/X-3704-2019	Szokodi, Istvan/0000-0002-2162-6155	Academy of Finland Center of Excellence; Sigrid Juselius Foundation; Finnish Foundation for Cardiovascular Research; Biocenter Finland; Foundation for the Development of Interventional Cardiology (Hungary); Social Renewal Operational Programme of New Hungary Development Plan [TAMOP-4.2.4.A/2-11-1-2012-0001, TAMOP 4.2.2./B-10/1-2010-0029]; European Union; European Social Fund	Academy of Finland Center of Excellence(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Foundation for Cardiovascular Research; Biocenter Finland; Foundation for the Development of Interventional Cardiology (Hungary); Social Renewal Operational Programme of New Hungary Development Plan; European Union(European Commission); European Social Fund(European Social Fund (ESF))	This work was supported by the Academy of Finland Center of Excellence, the Sigrid Juselius Foundation, the Finnish Foundation for Cardiovascular Research, the Biocenter Finland (to A.P.), and the Foundation for the Development of Interventional Cardiology (Hungary). In addition, the study was supported by the Social Renewal Operational Programme of New Hungary Development Plan (TAMOP-4.2.4.A/2-11-1-2012-0001, Zoltan Magyary Postdoctoral Fellowship in the frames of the "National Excellence Program" to R.S.; and TAMOP 4.2.2./B-10/1-2010-0029 Supporting Scientific Training of Talented Youth at the University of Pecs to M.S., subsidized by the European Union and co-financed by the European Social Fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes GD, 2013, CIRC-HEART FAIL, V6, P482, DOI 10.1161/CIRCHEARTFAILURE.111.000077; Bellahcene M, 2006, J AM COLL CARDIOL, V48, P545, DOI 10.1016/j.jacc.2006.02.072; Berry MF, 2004, CIRCULATION, V110, pII187, DOI 10.1161/01.CIR.0000138382.57325.5c; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Chamberland C, 2010, J MOL CELL CARDIOL, V48, P694, DOI 10.1016/j.yjmcc.2009.12.011; Chan JY, 2008, CIRC RES, V102, P571, DOI 10.1161/CIRCRESAHA.107.161687; Chen MM, 2003, CIRCULATION, V108, P1432, DOI 10.1161/01.CIR.0000091235.94914.75; Cheng X, 2003, EUR J PHARMACOL, V470, P171, DOI 10.1016/S0014-2999(03)01821-1; Chun HJ, 2008, J CLIN INVEST, V118, P3343, DOI 10.1172/JCI34871; Churchill E, 2008, ANNU REV PHARMACOL, V48, P569, DOI 10.1146/annurev.pharmtox.48.121806.154902; CLERK A, 1994, J BIOL CHEM, V269, P32848; Colson BA, 2010, J PHYSIOL-LONDON, V588, P981, DOI 10.1113/jphysiol.2009.183897; D'Aniello C, 2009, CIRC RES, V105, P231, DOI 10.1161/CIRCRESAHA.109.201186; Dai TY, 2006, EUR J PHARMACOL, V553, P222, DOI 10.1016/j.ejphar.2006.09.034; Ding PG, 2010, J BIOL CHEM, V285, P40819, DOI 10.1074/jbc.M110.160499; Dorn GW, 1999, P NATL ACAD SCI USA, V96, P12798, DOI 10.1073/pnas.96.22.12798; Falcao-Pires I, 2009, AM J PHYSIOL-HEART C, V296, pH2007, DOI 10.1152/ajpheart.00089.2009; Farkasfalvi K, 2007, BIOCHEM BIOPH RES CO, V357, P889, DOI 10.1016/j.bbrc.2007.04.017; Foldes G, 2003, BIOCHEM BIOPH RES CO, V308, P480, DOI 10.1016/S0006-291X(03)01424-4; Grimm M, 2006, BRIT J PHARMACOL, V148, P991, DOI 10.1038/sj.bjp.0706803; Gu XH, 2010, CARDIOVASC RES, V88, P334, DOI 10.1093/cvr/cvq223; Hashimoto T, 2006, ARTERIOSCL THROM VAS, V26, P1267, DOI 10.1161/01.ATV.0000218841.39828.91; Heidkamp MC, 2001, CIRC RES, V89, P882, DOI 10.1161/hh2201.099434; Hidalgo C, 2006, ARCH BIOCHEM BIOPHYS, V456, P216, DOI 10.1016/j.abb.2006.06.026; Hunter J. Craig, 2005, Journal of Pharmacological and Toxicological Methods, V51, P129, DOI 10.1016/j.vascn.2004.10.003; Japp AG, 2010, CIRCULATION, V121, P1818, DOI 10.1161/CIRCULATIONAHA.109.911339; Kaikkonen L, 2014, J MOL CELL CARDIOL, V67, P86, DOI 10.1016/j.yjmcc.2013.12.005; Kamm KE, 2011, J BIOL CHEM, V286, P9941, DOI 10.1074/jbc.R110.198697; Kanaya N, 2003, ANESTHESIOLOGY, V98, P1363, DOI 10.1097/00000542-200306000-00010; Kang M, 2006, EXP BIOL MED, V231, P865; Kang MS, 2005, J MOL CELL CARDIOL, V38, P753, DOI 10.1016/j.yjmcc.2005.02.017; Kehat I, 2011, CIRC RES, V108, P176, DOI 10.1161/CIRCRESAHA.110.231514; KRAMER BK, 1991, CIRC RES, V68, P269, DOI 10.1161/01.RES.68.1.269; Kuba K, 2007, CIRC RES, V101, pE32, DOI 10.1161/CIRCRESAHA.107.158659; Liao P, 2002, CIRC RES, V90, P190, DOI 10.1161/hh0202.104220; Lips DJ, 2004, CIRCULATION, V109, P1938, DOI 10.1161/01.CIR.0000127126.73759.23; Maguire JJ, 2009, HYPERTENSION, V54, P598, DOI 10.1161/HYPERTENSIONAHA.109.134619; Malo ME, 2007, J BIOL CHEM, V282, P6292, DOI 10.1074/jbc.M611073200; Masri B, 2004, FASEB J, V18, P1909, DOI 10.1096/fj.04-1930fje; MOCHLYROSEN D, 1990, CELL REGUL, V1, P693, DOI 10.1091/mbc.1.9.693; O-Uchi J, 2008, CIRC RES, V102, P1378, DOI 10.1161/CIRCRESAHA.107.167734; ODOWD BF, 1993, GENE, V136, P355, DOI 10.1016/0378-1119(93)90495-O; Pi YQ, 2003, J PHYSIOL-LONDON, V552, P845, DOI 10.1113/jphysiol.2003.045260; Pitkin SL, 2010, PHARMACOL REV, V62, P331, DOI 10.1124/pr.110.002949; Rajashree R, 2005, AM J PHYSIOL-HEART C, V289, pH1736, DOI 10.1152/ajpheart.00318.2004; Riise J, 2008, CARDIOVASC RES, V80, P407, DOI 10.1093/cvr/cvn216; Robia SL, 2001, BIOPHYS J, V80, P2140, DOI 10.1016/S0006-3495(01)76187-5; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Russell FD, 2004, CARDIOVASC RES, V63, P673, DOI 10.1016/j.cardiores.2004.05.009; Scimia MC, 2012, NATURE, V488, P394, DOI 10.1038/nature11263; Simpkin JC, 2007, BASIC RES CARDIOL, V102, P518, DOI 10.1007/s00395-007-0671-2; Szokodi I, 2002, CIRC RES, V91, P434, DOI 10.1161/01.RES.0000033522.37861.69; Szokodi I, 2008, CIRCULATION, V118, P1651, DOI 10.1161/CIRCULATIONAHA.107.758623; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; VENEMA RC, 1993, BIOCHEM J, V294, P401, DOI 10.1042/bj2940401; Wang C, 2008, AM J PHYSIOL-HEART C, V294, pH2540, DOI 10.1152/ajpheart.00046.2008; Wang W, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000249; Wu GY, 2000, J BIOL CHEM, V275, P29927, DOI 10.1074/jbc.C000380200; Zheng M, 2000, J BIOL CHEM, V275, P40635, DOI 10.1074/jbc.M006325200	59	64	69	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93473	10.1371/journal.pone.0093473	http://dx.doi.org/10.1371/journal.pone.0093473			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695532	Green Submitted, gold, Green Published			2022-12-25	WOS:000334103000077
J	Scott, FM; Speck, SH				Scott, Francine M.; Speck, Samuel H.			A Tissue Culture Model of Murine Gammaherpesvirus Replication Reveals Roles for the Viral Cyclin in Both Virus Replication and Egress from Infected Cells	PLOS ONE			English	Article							68 V-CYCLIN; EPITHELIAL-CELL; HERPESVIRUS-INFECTION; CDK INHIBITORS; DEFICIENT MICE; PROTEIN; PATHOGENESIS; REACTIVATION; PROGRESSION; LYMPHOMA	Passage through the eukaryotic cell cycle is regulated by the activity of cyclins and their cyclin-dependent kinase partners. Rhadinoviruses, such as Kaposi's sarcoma-associated herpesvirus (KSHV) and murine gammaherpesvirus 68 (MHV68), encode a viral homologue of mammalian D-type cyclins. In MHV68, the interaction of the viral cyclin with its CDK partners is important for acute replication in the lungs following low dose inoculation. Attempts to further study this requirement in vitro have been limited by the lack of available tissue culture models that mimic the growth defect observed in vivo. It is hypothesized that analysis of virus replication in a cell line that displays properties of primary airway epithelium, such as the ability to polarize, might provide a suitable environment to characterize the role of the v-cyclin in virus replication. We report here MHV68 replication in the rat lung cell line RL-65, a non-transformed polarizable epithelial cell line. These analyses reveal a role for the v-cyclin in both virus replication, as well as virus egress from infected cells. As observed for acute replication in vivo, efficient replication in RL-65 cells requires CDK binding. However, we show that the KSHV v-cyclin (K-cyclin), which utilizes different CDK partners (CDK4 and CDK6) than the MHV68 v-cyclin (CDK2 and CDC2), can partially rescue the replication defect observed with a v-cyclin null mutant - both in vitro and in vivo. Finally, we show that MHV68 is shed from both the apical and basolateral surfaces of polarized RL-65 cells. In summary, the RL-65 cell line provides an attractive in vitro model that mimics critical aspects of MHV68 replication in the lungs.	[Scott, Francine M.; Speck, Samuel H.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Scott, Francine M.; Speck, Samuel H.] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA USA	Emory University; Emory University	Speck, SH (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	sspeck@emory.edu	Speck, Samuel/L-5893-2019		NIH	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton E, 2011, ANNU REV IMMUNOL, V29, P351, DOI 10.1146/annurev-immunol-072710-081639; Besson A, 2004, NAT REV CANCER, V4, P948, DOI 10.1038/nrc1501; Blagosklonny MV, 2006, J CELL PHYSIOL, V209, P592, DOI 10.1002/jcp.20750; Caldon CE, 2010, CELL CYCLE, V9, P1918, DOI 10.4161/cc.9.10.11474; Chang PC, 2008, J VIROL, V82, P278, DOI 10.1128/JVI.01552-07; Coleman HM, 2003, J VIROL, V77, P2410, DOI 10.1128/JVI.77.4.2410-2417.2003; Collins CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033230; Dal Conto AJ, 2000, J VIROL, V74, P11304, DOI 10.1128/JVI.74.23.11304-11310.2000; Ebrahimi B, 2001, AM J PATHOL, V158, P2117, DOI 10.1016/S0002-9440(10)64683-4; Flano E, 2000, J IMMUNOL, V165, P1074, DOI 10.4049/jimmunol.165.2.1074; GoddenKent D, 1997, J VIROL, V71, P4193, DOI 10.1128/JVI.71.6.4193-4198.1997; Hamirally S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000275; Johnson DC, 2002, J VIROL, V76, P1, DOI 10.1128/JVI.76.1.1-8.2002; Kazmierczak BI, 2001, ANNU REV MICROBIOL, V55, P407, DOI 10.1146/annurev.micro.55.1.407; Lee KS, 2009, J VIROL, V83, P11397, DOI 10.1128/JVI.00989-09; Li MT, 1997, J VIROL, V71, P1984, DOI 10.1128/JVI.71.3.1984-1991.1997; Mora AL, 2007, AM J RESP CRIT CARE, V175, P1139, DOI 10.1164/rccm.200610-1426OC; Nelson WJ, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000513; Platt GM, 2000, VIROLOGY, V272, P257, DOI 10.1006/viro.2000.0343; RAJCANI J, 1985, ACTA VIROL, V29, P51; ROBERTS PE, 1990, AM J PHYSIOL, V259, pL415, DOI 10.1152/ajplung.1990.259.6.L415; Ryeom SW, 2000, MOL BIOL CELL, V11, P1687, DOI 10.1091/mbc.11.5.1687; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SUNILCHANDRA NP, 1992, J GEN VIROL, V73, P2347, DOI 10.1099/0022-1317-73-9-2347; Swanton C, 2001, INT J EXP PATHOL, V82, P3, DOI 10.1046/j.1365-2613.2001.00165.x; Tarakanova VL, 2005, J VIROL, V79, P14668, DOI 10.1128/JVI.79.23.14668-14679.2005; Terry LA, 2000, J GEN VIROL, V81, P2635, DOI 10.1099/0022-1317-81-11-2635; Upton JW, 2006, J VIROL, V80, P11946, DOI 10.1128/JVI.01722-06; Upton JW, 2005, VIROLOGY, V341, P271, DOI 10.1016/j.virol.2005.07.014; van Dyk LF, 2000, J VIROL, V74, P7451, DOI 10.1128/JVI.74.16.7451-7461.2000; Van Dyk LF, 1999, J VIROL, V73, P5110, DOI 10.1128/JVI.73.6.5110-5122.1999; Verschuren EW, 2004, J GEN VIROL, V85, P1347, DOI 10.1099/vir.0.79812-0; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; Wang XQ, 2009, MOL BIOL CELL, V20, P791, DOI 10.1091/mbc.E08-07-0732; Xie ZG, 2006, CEREB CORTEX, V16, pI64, DOI 10.1093/cercor/bhj170	35	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93871	10.1371/journal.pone.0093871	http://dx.doi.org/10.1371/journal.pone.0093871			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695529	gold, Green Published, Green Submitted			2022-12-25	WOS:000334103000128
J	Arnold, BF; Priest, JW; Hamlin, KL; Moss, DM; Colford, JM; Lammie, PJ				Arnold, Benjamin F.; Priest, Jeffrey W.; Hamlin, Katy L.; Moss, Delynn M.; Colford, John M., Jr.; Lammie, Patrick J.			Serological Measures of Malaria Transmission in Haiti: Comparison of Longitudinal and Cross-Sectional Methods	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; WUCHERERIA-BANCROFTI; ANTIBODIES; INFECTION; AREA	Background: Efforts to monitor malaria transmission increasingly use cross-sectional surveys to estimate transmission intensity from seroprevalence data using malarial antibodies. To date, seroconversion rates estimated from cross-sectional surveys have not been compared to rates estimated in prospective cohorts. Our objective was to compare seroconversion rates estimated in a prospective cohort with those from a cross-sectional survey in a low-transmission population. Methods and Findings: The analysis included two studies from Haiti: a prospective cohort of 142 children ages <= 11 years followed for up to 9 years, and a concurrent cross-sectional survey of 383 individuals ages 0-90 years old. From all individuals, we analyzed 1,154 blood spot specimens for the malaria antibody MSP-1(19) using a multiplex bead antigen assay. We classified individuals as positive for malaria using a cutoff derived from the mean plus 3 standard deviations in antibody responses from a negative control set of unexposed individuals. We estimated prospective seroconversion rates from the longitudinal cohort based on 13 incident seroconversions among 646 person-years at risk. We also estimated seroconversion rates from the cross-sectional survey using a reversible catalytic model fit with maximum likelihood. We found the two approaches provided consistent results: the seroconversion rate for ages <= 11 years was 0.020 ( 0.010, 0.032) estimated prospectively versus 0.023 ( 0.001, 0.052) in the cross-sectional survey. Conclusions: The estimation of seroconversion rates using cross-sectional data is a widespread and generalizable problem for many infectious diseases that can be measured using antibody titers. The consistency between these two estimates lends credibility to model-based estimates of malaria seroconversion rates using cross-sectional surveys. This study also demonstrates the utility of including malaria antibody measures in multiplex assays alongside targets for vaccine coverage and other neglected tropical diseases, which together could comprise an integrated, large-scale serological surveillance platform.	[Arnold, Benjamin F.; Colford, John M., Jr.] Univ Calif Berkeley, Sch Publ Hlth, Dept Epidemiol, Berkeley, CA 94720 USA; [Priest, Jeffrey W.; Moss, Delynn M.] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA; [Hamlin, Katy L.; Lammie, Patrick J.] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Atlanta, GA USA	University of California System; University of California Berkeley; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Arnold, BF (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Dept Epidemiol, Berkeley, CA 94720 USA.	benarnold@berkeley.edu	Arnold, Benjamin/AAE-9656-2020	Arnold, Benjamin/0000-0001-6105-7295	National Institutes of Health; CDC; UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases [920528, 940441]; CDC/APHL Emerging Infectious Disease Fellowship	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases; CDC/APHL Emerging Infectious Disease Fellowship	The authors appreciate the financial support of the National Institutes of Health, CDC and the UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases (grants #920528 and #940441). Katy Hamlin was supported by a CDC/APHL Emerging Infectious Disease Fellowship. Besides the CDC, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Use of trade names is for identification only and does not imply endorsement by the Public Health Service of by the U. S. Department of Health and Human Services. The findings and conclusions in this report do not represent the official position of the Centers for Disease Control and Prevention.	Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000396; Badu K, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-50; BEKESSY A, 1976, B WORLD HEALTH ORGAN, V54, P685; Bousema T, 2010, EMERG INFECT DIS, V16, P392, DOI 10.3201/eid1603.090732; Bretscher MT, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-21; Charlwood JD, 1998, AM J TROP MED HYG, V59, P243, DOI 10.4269/ajtmh.1998.59.243; Cook J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-86; Cook J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025137; Cook J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-169; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Corran PH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-195; Drakeley C, 2009, ADV PARASIT, V69, P299, DOI 10.1016/S0065-308X(09)69005-9; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Freeman AR, 2001, AM J TROP MED HYG, V65, P865, DOI 10.4269/ajtmh.2001.65.865; Hamlin KL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001941; Hastie T, 2009, SPRINGER SERIES STAT, DOI [10.1007/978-0-387-84858-7, DOI 10.1007/978-0-387-84858-7]; Kitua AY, 1996, TROP MED INT HEALTH, V1, P475, DOI 10.1046/j.1365-3156.1996.d01-89.x; LAMMIE PJ, 1994, AM J TROP MED HYG, V51, P348, DOI 10.4269/ajtmh.1994.51.348; Lammie PJ, 1998, AM J TROP MED HYG, V59, P217, DOI 10.4269/ajtmh.1998.59.217; Moss DM, 2011, AM J TROP MED HYG, V85, P229, DOI 10.4269/ajtmh.2011.11-0029; Stewart L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006083	21	37	39	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93684	10.1371/journal.pone.0093684	http://dx.doi.org/10.1371/journal.pone.0093684			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691467	Green Submitted, gold, Green Published			2022-12-25	WOS:000334101100126
J	Feron, G; Ayed, C; Qannari, EM; Courcoux, P; Laboure, H; Guichard, E				Feron, Gilles; Ayed, Charfedinne; Qannari, El Mostafa; Courcoux, Philippe; Laboure, Helene; Guichard, Elisabeth			Understanding Aroma Release from Model Cheeses by a Statistical Multiblock Approach on Oral Processing	PLOS ONE			English	Article							PARTIAL LEAST-SQUARES; FOOD BOLUS PROPERTIES; FLAVOR RELEASE; IN-VIVO; HUMAN SALIVA; DIFFERENT TEXTURES; CHEWING ACTIVITY; MOUTH; BEHAVIOR; PLS	For human beings, the mouth is the first organ to perceive food and the different signalling events associated to food breakdown. These events are very complex and as such, their description necessitates combining different data sets. This study proposed an integrated approach to understand the relative contribution of main food oral processing events involved in aroma release during cheese consumption. In vivo aroma release was monitored on forty eight subjects who were asked to eat four different model cheeses varying in fat content and firmness and flavoured with ethyl propanoate and nonan-2-one. A multiblock partial least square regression was performed to explain aroma release from the different physiological data sets ( masticatory behaviour, bolus rheology, saliva composition and flux, mouth coating and bolus moistening). This statistical approach was relevant to point out that aroma release was mostly explained by masticatory behaviour whatever the cheese and the aroma, with a specific influence of mean amplitude on aroma release after swallowing. Aroma release from the firmer cheeses was explained mainly by bolus rheology. The persistence of hydrophobic compounds in the breath was mainly explained by bolus spreadability, in close relation with bolus moistening. Resting saliva poorly contributed to the analysis whereas the composition of stimulated saliva was negatively correlated with aroma release and mostly for soft cheeses, when significant.	[Feron, Gilles; Ayed, Charfedinne; Laboure, Helene; Guichard, Elisabeth] INRA, UMR1324, Ctr Sci Gout & Alimentat, F-21034 Dijon, France; [Feron, Gilles; Ayed, Charfedinne; Laboure, Helene; Guichard, Elisabeth] CNRS, UMR6265, Ctr Sci Gout & Alimentat, Dijon, France; [Feron, Gilles; Ayed, Charfedinne; Laboure, Helene; Guichard, Elisabeth] Univ Bourgogne, UMR, Ctr Sci Gout & Alimentat, Dijon, France; [Qannari, El Mostafa; Courcoux, Philippe] LUNAM Univ, ONIRIS, Ecole Natl Vet Agroalimentaire & Alimentat, USC Sensometr & Chemometr Lab, Nantes, France	INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Agro; AgroSup Dijon; Universite de Bourgogne; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique	Guichard, E (corresponding author), INRA, UMR1324, Ctr Sci Gout & Alimentat, F-21034 Dijon, France.	elisabeth.guichard@dijon.inra.fr	FERON, Gilles/AAW-8714-2020; Laboure, Helene/S-3006-2016; Ayed, Charfedinne/G-5348-2017	Laboure, Helene/0000-0002-8173-6145; Ayed, Charfedinne/0000-0002-1045-6314; Feron, Gilles/0000-0002-9522-9654	French National Research Agency [ANR-07-PNRA-014]; Regional Council for Burgundy; FEDER (European Union)	French National Research Agency(French National Research Agency (ANR)); Regional Council for Burgundy(Region Bourgogne-Franche-Comte); FEDER (European Union)(European Commission)	This work received financial support from the French National Research Agency (ANR-07-PNRA-014), the Regional Council for Burgundy and FEDER (European Union). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquilanti L, 2013, INT DAIRY J, V29, P42, DOI 10.1016/j.idairyj.2012.11.001; BENNICK A, 1982, MOL CELL BIOCHEM, V45, P83; Blissett A, 2006, J TEXTURE STUD, V37, P476, DOI 10.1111/j.1745-4603.2006.00064.x; Bougeard S, 2011, INFORMATICA-LITHUAN, V22, P11; Bras LP, 2005, CHEMOMETR INTELL LAB, V75, P91, DOI 10.1016/j.chemolab.2004.05.007; BUTTERY RG, 1973, J AGR FOOD CHEM, V21, P198, DOI 10.1021/jf60186a029; Cappellin L, 2012, CHEMOMETR INTELL LAB, V118, P301, DOI 10.1016/j.chemolab.2012.05.008; Carpenter G, 2012, ROLE SALIVA ORAL PRO, P45; Choi SW, 2005, J PROCESS CONTR, V15, P295, DOI 10.1016/j.jprocont.2004.06.010; de Roos KB, 2003, INT DAIRY J, V13, P593, DOI 10.1016/S0958-6946(03)00108-0; de Wijk RA, 2004, PHYSIOL BEHAV, V83, P81, DOI 10.1016/j.physbeh.2004.07.014; DEROOS KB, 1994, DEV FOOD SCI, V35, P15; Doyennette M, 2014, J THEOR BIOL, V340, P209, DOI 10.1016/j.jtbi.2013.09.005; Doyennette M, 2011, FOOD RES INT, V44, P3174, DOI 10.1016/j.foodres.2011.07.034; Doyennette M, 2011, FOOD CHEM, V128, P380, DOI 10.1016/j.foodchem.2011.03.039; Drago SR, 2011, FOOD HYDROCOLLOID, V25, P659, DOI 10.1016/j.foodhyd.2010.07.024; Dresselhuis DM, 2008, FOOD HYDROCOLLOID, V22, P1170, DOI 10.1016/j.foodhyd.2007.06.013; Emorine M, 2013, FOOD RES INT, V51, P641, DOI 10.1016/j.foodres.2013.01.006; Genovese A, 2009, FOOD CHEM, V114, P100, DOI 10.1016/j.foodchem.2008.09.022; GERLACH RW, 1979, ANAL CHIM ACTA-COMP, V3, P417, DOI 10.1016/S0003-2670(01)85039-X; Guinard JX, 1997, PHYSIOL BEHAV, V61, P591, DOI 10.1016/S0031-9384(96)00508-2; Haahr AM, 2004, PHYSIOL BEHAV, V82, P531, DOI 10.1016/j.physbeh.2004.04.061; Hansson A, 2003, J AGR FOOD CHEM, V51, P4732, DOI 10.1021/jf030050y; Harrison M, 1998, J AGR FOOD CHEM, V46, P2736, DOI 10.1021/jf980090f; Hassani S, 2012, CHEMOMETR INTELL LAB, V117, P42, DOI 10.1016/j.chemolab.2011.06.001; HUSSEIN MM, 1983, J FOOD SCI, V48, P1884, DOI 10.1111/j.1365-2621.1983.tb05113.x; Kohonen J, 2008, J CHEMOMETR, V22, P281, DOI 10.1002/cem.1120; Kohonen J, 2009, CHEMOMETR INTELL LAB, V97, P18, DOI 10.1016/j.chemolab.2008.06.015; Malone ME, 2003, FOOD HYDROCOLLOID, V17, P775, DOI 10.1016/S0268-005X(03)00098-5; Mevik B.-H., 2007, J STAT SOFTWARE, V18; Mioche L, 2003, ARCH ORAL BIOL, V48, P193, DOI 10.1016/S0003-9969(03)00002-5; Mioche L, 2002, FOOD QUAL PREFER, V13, P583, DOI 10.1016/S0950-3293(02)00056-3; Mishellany-Dutour A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041276; Mounayar R, 2013, CHEMOSENS PERCEPT, P1; Moyon T, 2012, METABOLOMICS, V8, P1090, DOI 10.1007/s11306-012-0415-7; NAES T, 1985, COMMUN STAT-SIMUL C, V14, P545, DOI 10.1080/03610918508812458; Neyraud E, 2012, ARCH ORAL BIOL, V57, P556, DOI 10.1016/j.archoralbio.2011.09.016; Normand V, 2004, CHEM SENSES, V29, P235, DOI 10.1093/chemse/bjh028; Odake S, 1998, NAHRUNG, V42, P385, DOI [10.1002/(SICI)1521-3803(199812)42:06<385::AID-FOOD385>3.0.CO;2-B, 10.1002/(SICI)1521-3803(199812)42:06&lt;385::AID-FOOD385&gt;3.0.CO;2-B]; Ono T, 2004, DYSPHAGIA, V19, P259, DOI 10.1007/s00455-004-0010-9; Piombino P, 2013, FOOD RES INT, V50, P409, DOI 10.1016/j.foodres.2012.10.033; Pionnier E, 2004, J AGR FOOD CHEM, V52, P557, DOI 10.1021/jf030544v; Poette J, 2014, FLAVOUR FRAG J, V29, P39, DOI 10.1002/ffj.3177; Prinz JF, 1997, P ROY SOC B-BIOL SCI, V264, P1715, DOI 10.1098/rspb.1997.0238; Reinikainen SP, 2007, ANAL CHIM ACTA, V595, P248, DOI 10.1016/j.aca.2007.02.019; Repoux M, 2012, ARCH ORAL BIOL, V57, P81, DOI 10.1016/j.archoralbio.2011.07.011; Repoux M, 2012, FLAVOUR FRAG J, V27, P414, DOI 10.1002/ffj.3110; Repoux M, 2012, FLAVOUR FRAG J, V27, P40, DOI 10.1002/ffj.2077; SCHENKELS LCPM, 1995, CRIT REV ORAL BIOL M, V6, P161, DOI 10.1177/10454411950060020501; Schipper RG, 2007, ARCH ORAL BIOL, V52, P1114, DOI 10.1016/j.archoralbio.2007.06.009; Silletti E, 2008, FOOD BIOPHYS, V3, P318, DOI 10.1007/s11483-008-9089-0; Silletti E, 2007, J COLLOID INTERF SCI, V313, P485, DOI 10.1016/j.jcis.2007.05.030; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Tarrega A, 2008, INT DAIRY J, V18, P849, DOI 10.1016/j.idairyj.2007.09.008; Tarrega A, 2011, INT DAIRY J, V21, P358, DOI 10.1016/j.idairyj.2010.12.010; Trelea IC, 2008, CHEM SENSES, V33, P181, DOI 10.1093/chemse/bjm077; van Ruth SM, 2000, FOOD CHEM, V71, P339, DOI 10.1016/S0308-8146(00)00186-2; VANDERREIJDEN WA, 1993, BIORHEOLOGY, V30, P141; VANRUTH SM, 1995, J SCI FOOD AGR, V67, P189, DOI 10.1002/jsfa.2740670208; Vingerhoeds MH, 2005, FOOD HYDROCOLLOID, V19, P915, DOI 10.1016/j.foodhyd.2004.12.005; Vingerhoeds MH, 2009, FOOD HYDROCOLLOID, V23, P773, DOI 10.1016/j.foodhyd.2008.04.014; Westerhuis JA, 1998, J CHEMOMETR, V12, P301, DOI 10.1002/(SICI)1099-128X(199809/10)12:5<301::AID-CEM515>3.0.CO;2-S; WOLD S, 1984, ANALUSIS, V12, P477; Wright KM, 2003, INT J FOOD SCI TECH, V38, P361, DOI 10.1046/j.1365-2621.2003.00682.x; Wright KM, 2003, INT J FOOD SCI TECH, V38, P343, DOI 10.1046/j.1365-2621.2003.00680.x; Yven C, 2012, J TEXTURE STUD, V43, P309, DOI 10.1111/j.1745-4603.2011.00340.x	66	51	51	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93113	10.1371/journal.pone.0093113	http://dx.doi.org/10.1371/journal.pone.0093113			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691625	Green Published, Green Submitted, gold			2022-12-25	WOS:000334101100047
J	Lim, JJ; Shim, MS; Lee, JE; Lee, DR				Lim, Jung Jin; Shim, Myung Sun; Lee, Jeoung Eun; Lee, Dong Ryul			Three-Step Method for Proliferation and Differentiation of Human Embryonic Stem Cell (hESC)-Derived Male Germ Cells	PLOS ONE			English	Article							LONG-TERM PROLIFERATION; IN-VITRO; RETINOIC ACID; MOUSE; CULTURE; GENERATION; DERIVATION; INDUCTION; PROTEINS; THERAPY	The low efficiency of differentiation into male germ cell (GC)-like cells and haploid germ cells from human embryonic stem cells (hESCs) reflects the culture method employed in the two-dimensional (2D)-microenvironment. In this study, we applied a three-step media and calcium alginate-based 3D-culture system for enhancing the differentiation of hESCs into male germ stem cell (GSC)-like cells and haploid germ cells. In the first step, embryoid bodies (EBs) were derived from hESCs cultured in EB medium for 3 days and re-cultured for 4 additional days in EB medium with BMP4 and RA to specify GSC-like cells. In the second step, the resultant cells were cultured in GC-proliferation medium for 7 days. The GSC-like cells were then propagated after selection using GFR-alpha 1 and were further cultured in GC-proliferation medium for 3 weeks. In the final step, a 3D-co-culture system using calcium alginate encapsulation and testicular somatic cells was applied to induce differentiation into haploid germ cells, and a culture containing approximately 3% male haploid germ cells was obtained after 2 weeks of culture. These results demonstrated that this culture system could be used to efficiently induce GSC-like cells in an EB population and to promote the differentiation of ESCs into haploid male germ cells.	[Lim, Jung Jin; Shim, Myung Sun; Lee, Jeoung Eun; Lee, Dong Ryul] CHA Univ, Coll Med, CHA Gangnam Med Ctr, Fertil Ctr, Seoul, South Korea; [Lee, Dong Ryul] CHA Univ, Coll Life Sci, Dept Biomed Sci, Seoul, South Korea	Pochon Cha University; Pochon Cha University	Lee, DR (corresponding author), CHA Univ, Coll Med, CHA Gangnam Med Ctr, Fertil Ctr, Seoul, South Korea.	drleedr@cha.ac.kr			Bio & Medical Technology Development Program of the National Research Foundation (NRF) [2012M3A9C6049723]; Ministry of Education, Science and Technology, South Korea	Bio & Medical Technology Development Program of the National Research Foundation (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology, South Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Bio & Medical Technology Development Program (2012M3A9C6049723; PI: D.R.L) of the National Research Foundation (NRF) funded by the Ministry of Education, Science and Technology, South Korea. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aflatoonian B, 2005, CURR OPIN BIOTECH, V16, P530, DOI 10.1016/j.copbio.2005.08.008; Boontheekul T, 2005, BIOMATERIALS, V26, P2455, DOI 10.1016/j.biomaterials.2004.06.044; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Brady-Kalnay SM, 1998, J CELL BIOL, V141, P287, DOI 10.1083/jcb.141.1.287; Castrillon DH, 2000, P NATL ACAD SCI USA, V97, P9585, DOI 10.1073/pnas.160274797; Chladek D, 2000, Ceska Gynekol, V65, P28; Clark AT, 2004, HUM MOL GENET, V13, P727, DOI 10.1093/hmg/ddh088; DEFELICI M, 1993, DEV BIOL, V157, P277, DOI 10.1006/dbio.1993.1132; Fujiwara T, 2001, P NATL ACAD SCI USA, V98, P13739, DOI 10.1073/pnas.241508898; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Hamra FK, 2004, DEV BIOL, V269, P393, DOI 10.1016/j.ydbio.2004.01.027; Huang ZQ, 1996, BIOTECHNIQUES, V20, P1012; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kawai K, 2010, ADV ENZYME REGUL, V50, P202, DOI 10.1016/j.advenzreg.2009.10.013; Kee K, 2006, STEM CELLS DEV, V15, P831, DOI 10.1089/scd.2006.15.831; Kerkis A, 2007, CLONING STEM CELLS, V9, P535, DOI 10.1089/clo.2007.0031; Kim S, 2007, STEM CELLS DEV, V16, P537, DOI 10.1089/scd.2006.0088; KOSHIMIZU U, 1995, DEV BIOL, V168, P683, DOI 10.1006/dbio.1995.1113; Kubota H, 2006, NAT CLIN PRACT ENDOC, V2, P99, DOI 10.1038/ncpendmet0098; Lee DR, 2006, HUM REPROD, V21, P471, DOI 10.1093/humrep/dei319; Lee DR, 2001, BIOL REPROD, V65, P873, DOI 10.1095/biolreprod65.3.873; Lee JE, 2010, CELL TRANSPLANT, V19, P1383, DOI 10.3727/096368910X513991; Li CY, 2007, DEVELOPMENT, V134, P167, DOI 10.1242/dev.02701; Lim JJ, 2010, CELL PROLIFERAT, V43, P405, DOI 10.1111/j.1365-2184.2010.00691.x; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Nagaraja GM, 2004, BIOCHEM BIOPH RES CO, V313, P654, DOI 10.1016/j.bbrc.2003.12.001; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Park SY, 2005, DEVELOPMENT, V132, P2415, DOI 10.1242/dev.01826; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Shang QX, 2001, J CRANIOFAC SURG, V12, P586, DOI 10.1097/00001665-200111000-00017; Starz-Gaiano M, 2001, MECH DEVELOP, V105, P5, DOI 10.1016/S0925-4773(01)00392-6; Thomas S, 2000, J Wound Care, V9, P56; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; von Schonfeldt V, 2004, CYTOGENET GENOME RES, V105, P235, DOI 10.1159/000078194; Wadham C, 2003, MOL BIOL CELL, V14, P2520, DOI 10.1091/mbc.E02-09-0577; Ying Y, 2000, MOL ENDOCRINOL, V14, P1053, DOI 10.1210/me.14.7.1053; Ying Y, 2001, P NATL ACAD SCI USA, V98, P7858, DOI 10.1073/pnas.151242798; ZANARIA E, 1994, NATURE, V372, P635, DOI 10.1038/372635a0; Zhou Q, 2008, BIOL REPROD, V78, P537, DOI 10.1095/biolreprod.107.064337	43	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e90454	10.1371/journal.pone.0090454	http://dx.doi.org/10.1371/journal.pone.0090454			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690677	Green Submitted, Green Published, gold			2022-12-25	WOS:000334101100010
J	Nestor, KA; Jones, JD; Butson, CR; Morishita, T; Jacobson, CE; Peace, DA; Chen, D; Foote, KD; Okun, MS				Nestor, Kelsey A.; Jones, Jacob D.; Butson, Christopher R.; Morishita, Takashi; Jacobson, Charles E.; Peace, David A.; Chen, Dennis; Foote, Kelly D.; Okun, Michael S.			Coordinate-Based Lead Location Does Not Predict Parkinson's Disease Deep Brain Stimulation Outcome	PLOS ONE			English	Article							HIGH-FREQUENCY STIMULATION; BILATERAL SUBTHALAMIC STIMULATION; GLOBUS-PALLIDUS; TECHNICAL APPROACH; MEDICAL THERAPY; IMAGE FUSION; NUCLEUS; ACCURACY; DBS; IMPLANTATION	Background: Effective target regions for deep brain stimulation (DBS) in Parkinson's disease (PD) have been well characterized. We sought to study whether the measured Cartesian coordinates of an implanted DBS lead are predictive of motor outcome(s). We tested the hypothesis that the position and trajectory of the DBS lead relative to the mid-commissural point (MCP) are significant predictors of clinical outcomes. We expected that due to neuroanatomical variation among individuals, a simple measure of the position of the DBS lead relative to MCP (commonly used in clinical practice) may not be a reliable predictor of clinical outcomes when utilized alone. Methods: 55 PD subjects implanted with subthalamic nucleus (STN) DBS and 41 subjects implanted with globus pallidus internus (GPi) DBS were included. Lead locations in AC-PC space (x, y, z coordinates of the active contact and sagittal and coronal entry angles) measured on high-resolution CT-MRI fused images, and motor outcomes (Unified Parkinson's Disease Rating Scale) were analyzed to confirm or refute a correlation between coordinate-based lead locations and DBS motor outcomes. Results: Coordinate-based lead locations were not a significant predictor of change in UPDRS III motor scores when comparing pre- versus post-operative values. The only potentially significant individual predictor of change in UPDRS motor scores was the antero-posterior coordinate of the GPi lead (more anterior lead locations resulted in a worse outcome), but this was only a statistical trend (p<.082). Conclusion: The results of the study showed that a simple measure of the position of the DBS lead relative to the MCP is not significantly correlated with PD motor outcomes, presumably because this method fails to account for individual neuroanatomical variability. However, there is broad agreement that motor outcomes depend strongly on lead location. The results suggest the need for more detailed identification of stimulation location relative to anatomical targets.	[Nestor, Kelsey A.; Jacobson, Charles E.; Chen, Dennis; Okun, Michael S.] Univ Florida, Ctr Movement Disorders & Neurorestorat, McKnight Brain Inst, Dept Neurol, Gainesville, FL 32610 USA; [Nestor, Kelsey A.; Morishita, Takashi; Peace, David A.; Chen, Dennis; Foote, Kelly D.; Okun, Michael S.] Univ Florida, Ctr Movement Disorders & Neurorestorat, McKnight Brain Inst, Dept Neurosurg, Gainesville, FL USA; [Jones, Jacob D.] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL USA; [Butson, Christopher R.] Med Coll Wisconsin, Dept Neurol, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Medical College of Wisconsin	Okun, MS (corresponding author), Univ Florida, Ctr Movement Disorders & Neurorestorat, McKnight Brain Inst, Dept Neurol, Gainesville, FL 32610 USA.	okun@neurology.ufl.edu	jones, jacob/AAC-1920-2021	jones, jacob/0000-0003-3544-7294; Foote, Kelly/0000-0002-2436-4138; Okun, Michael/0000-0002-6247-9358; Jacobson, Charles/0000-0002-7598-5217	National Institutes of Health (NIH); NPF; Michael J. Fox Foundation; Parkinson Alliance; Smallwood Foundation; Bachmann-Strauss Foundation; Tourette Syndrome Association; UF Foundation; PeerView; Prime; Vanderbilt University; Medtronic; ANS/St. Jude	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NPF; Michael J. Fox Foundation; Parkinson Alliance; Smallwood Foundation; Bachmann-Strauss Foundation; Tourette Syndrome Association; UF Foundation; PeerView; Prime; Vanderbilt University; Medtronic(Medtronic); ANS/St. Jude	Dr. Okun serves as a consultant for the National Parkinson Foundation, and has received research grants from National Institutes of Health (NIH), NPF, the Michael J. Fox Foundation, the Parkinson Alliance, Smallwood Foundation, the Bachmann-Strauss Foundation, the Tourette Syndrome Association, and the UF Foundation. Dr. Okun has previously received honoraria, but in the past months has received no support from industry. Dr. Okun has received royalties for publications with Demos, Manson, Amazon, and Cambridge (movement disorders books). Dr. Okun is an associate editor for New England Journal of Medicine Journal Watch Neurology. Dr. Okun has participated in CME activities on movement disorders in the last 36 months sponsored by PeerView, Prime, and by Vanderbilt University. The institution and not Dr. Okun receives grants from Medtronic and ANS/St. Jude, and the PI has no financial interest in these grants. Dr. Okun has participated as a site PI and/or co-I for several NIH, foundation, and industry sponsored trials over the years but has not received honoraria. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Benabid AL, 2000, NEUROLOGY, V55, pS40; Butson CR, 2011, NEUROIMAGE, V54, P2096, DOI 10.1016/j.neuroimage.2010.10.059; CAIRE F, 2013, ACTA NEUROCHIR WIEN; Chaudhuri KR, 2006, MOVEMENT DISORD, V21, P916, DOI 10.1002/mds.20844; Connolly PJ, 2012, J CLIN NEUROSCI, V19, P1029, DOI 10.1016/j.jocn.2011.12.002; Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281; Factor S., 2002, PARKINSONS DIS DIAGN; Garcia L, 2003, J NEUROSCI, V23, P8743; Gorgulho AA, 2009, J NEUROSURG, V110, P1317, DOI 10.3171/JNS.2008.10.JNS08835; Hamel W, 2003, J NEUROL NEUROSUR PS, V74, P1036, DOI 10.1136/jnnp.74.8.1036; Hamid NA, 2005, J NEUROL NEUROSUR PS, V76, P409, DOI 10.1136/jnnp.2003.032029; Herzog J, 2004, MOVEMENT DISORD, V19, P1050, DOI 10.1002/mds.20056; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Johnsen EL, 2010, EUR J NEUROL, V17, P746, DOI 10.1111/j.1468-1331.2010.02962.x; Kleiner-Fisman G, 2006, MOVEMENT DISORD, V21, pS290, DOI 10.1002/mds.20962; Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275; Lalys F, 2013, J NEUROSCI METH, V212, P297, DOI 10.1016/j.jneumeth.2012.11.002; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; LEHMAN RM, 2012, WORLD NEUROSURG; Lyons KE, 2005, J NEUROSURG, V103, P252, DOI 10.3171/jns.2005.103.2.0252; MCCLELLAND S, 2005, NEUROSURG FOCUS, pE12; Morishita T, 2011, NEUROLOGIST, V17, P263, DOI 10.1097/NRL.0b013e31822d1069; Morishita T, 2010, PARKINSONISM RELAT D, V16, P153, DOI 10.1016/j.parkreldis.2009.10.003; O'Gorman RL, 2009, STEREOT FUNCT NEUROS, V87, P205, DOI 10.1159/000225973; Obeso JA, 2001, NEW ENGL J MED, V345, P956, DOI 10.1056/nejmoa000827; Odekerken VJJ, 2013, LANCET NEUROL, V12, P37, DOI 10.1016/S1474-4422(12)70264-8; Okun MS, 2013, NEW ENGL J MED, V368, P483, DOI [10.1056/NEJMct1208070, 10.1056/NEJMc1214078]; Okun MS, 2010, EXPERT REV NEUROTHER, V10, P1847, DOI 10.1586/ERN.10.156; Okun MS, 2009, ANN NEUROL, V65, P586, DOI 10.1002/ana.21596; Paek SH, 2008, NEUROSURGERY, V63, P925, DOI 10.1227/01.NEU.0000334045.43940.FB; Pahwa R, 2003, J NEUROSURG, V99, P71, DOI 10.3171/jns.2003.99.1.0071; Parent B, 2011, J NEUROSURG, V114, P927, DOI 10.3171/2010.10.JNS10756; Pilitsis JG, 2008, J NEUROSURG, V109, P640, DOI 10.3171/JNS/2008/109/10/0640; Rodriguez-Oroz MC, 2005, BRAIN, V128, P2240, DOI 10.1093/brain/awh571; SCHLAIER JR, 2012, ACTA NEUROCHIR WIEN; Shahlaie K, 2011, NEUROSURGERY, V68, P114, DOI 10.1227/NEU.0b013e31820781bc; Starr PA, 2006, J NEUROSURG, V104, P488, DOI 10.3171/jns.2006.104.4.488; Starr PA, 2002, J NEUROSURG, V97, P370, DOI 10.3171/jns.2002.97.2.0370; Thani NB, 2011, NEUROSURGERY, V69, P207, DOI 10.1227/NEU.0b013e318218c7ae; Tsai ST, 2009, STEREOT FUNCT NEUROS, V87, P241, DOI 10.1159/000225977; Vergani F, 2007, SURG NEUROL, V67, P140, DOI 10.1016/j.surneu.2006.06.054; Volkmann J, 1998, ANN NEUROL, V44, P953, DOI 10.1002/ana.410440615; Walter U, 2011, ULTRASOUND MED BIOL, V37, P1382, DOI 10.1016/j.ultrasmedbio.2011.05.017; Weaver FM, 2009, JAMA-J AM MED ASSOC, V301, P63, DOI 10.1001/jama.2008.929; Wharen R, 2010, EUR J NEUROL, V17, P639, DOI 10.1111/j.1468-1331.2010.02968.x; Williams A, 2010, LANCET NEUROL, V9, P581, DOI 10.1016/S1474-4422(10)70093-4; York MK, 2009, J NEUROL SCI, V287, P159, DOI 10.1016/j.jns.2009.08.003	48	41	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93524	10.1371/journal.pone.0093524	http://dx.doi.org/10.1371/journal.pone.0093524			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691109	gold, Green Published, Green Submitted			2022-12-25	WOS:000334101100098
J	Sun, M; Yang, PZ; Du, LP; Yang, Y; Ye, J				Sun, Min; Yang, Peizeng; Du, Liping; Yang, Yan; Ye, Jian			The Role of Interleukin-1 Receptor-Associated Kinases in Vogt-Koyanagi-Harada Disease	PLOS ONE			English	Article							NF-KAPPA-B; T-CELLS; BACTERIAL-INFECTIONS; SIGNALING PATHWAYS; IRAK-4; ACTIVATION; IMMUNITY; FAMILY	Purpose: To explore whether IRAK1 and IRAK4 are involved in the pathogenesis of Vogt-Koyanagi-Harada (VKH) disease. Methods: Thirty-nine VKH patients and thirty-two healthy controls were included in this study. The mRNA levels of IRAK1 and IRAK4 from active VKH patients, inactive VKH patients, and normal controls in peripheral blood mononuclear cells (PBMCs) were detected using real-time quantitative PCR. CD4(+)T cells were purified from PBMCs obtained from active VKH patients and normal controls. The effect of IRAK1/4 inhibition on CD4(+)T cell proliferation following stimulation with IL-18 or IL-1 beta was measured using a modified MTT assay. CD4(+)T cell expression of IFN-gamma and IL-17 were detected by flow cytometry (FCM) and enzyme-linked immunosorbent assay (ELISA). The effect of IRAK1/4 inhibition on NF-kappa B, STAT1, and STAT3 activation was detected by FCM. Results: The mRNA levels of IRAK1 and IRAK4 were both significantly increased in active VKH patients compared to inactive VKH patients and healthy controls. No difference in the IRAK1 or IRAK4 mRNA level could be detected between inactive patients and healthy controls. After incubation with IRAK1/4 inhibitor, the proliferation of CD4(+)T cells was inhibited both in the active VKH patients and in the healthy controls. IRAK1/4 inhibition was also associated with a decreased expression of IFN-gamma and IL-17. Phosphorylation of NF-kappa B, STAT1, and STAT3 in CD4(+)T from healthy controls was significantly decreased after inhibition of IRAK1/4. Conclusions: High mRNA levels of IRAK1 and IRAK4 correlated with VKH disease activity. IRAK1 and IRAK4 play a role in the activation and proliferation of CD4(+)T cells and the higher expression observed in VKH may contribute to the pathogenesis of this blinding condition.	[Sun, Min; Ye, Jian] Third Mil Med Univ, Inst Surg Res, Dept Ophthalmol, Chongqing, Peoples R China; [Sun, Min; Ye, Jian] Third Mil Med Univ, Daping Hosp, Chongqing, Peoples R China; [Sun, Min; Yang, Peizeng; Du, Liping; Yang, Yan] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Eye Inst, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China	Army Medical University; Army Medical University; Chongqing Medical University	Yang, PZ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Chongqing Eye Inst, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China.	peizengycmu@126.com; yejian1979@163.com	Du, Liping/M-9495-2019		National Natural Science Foundation [81200679, 81070722]; Natural Science Foundation Project of ChongQing [CSTC2013jcyjA10015]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of ChongQing(Natural Science Foundation of Chongqing)	This study was supported by National Natural Science Foundation Project Grant 81200679, National Natural Science Foundation Project Grant 81070722 and Natural Science Foundation Project of ChongQing CSTC2013jcyjA10015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu El-Asrar AM, 2011, CLIN IMMUNOL, V139, P177, DOI 10.1016/j.clim.2011.01.014; Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Bykhovskaya I, 2005, AM J OPHTHALMOL, V140, P674, DOI 10.1016/j.ajo.2005.04.052; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Chi W, 2007, J ALLERGY CLIN IMMUN, V119, P1218, DOI 10.1016/j.jaci.2007.01.010; Egwuagu CE, 2009, CYTOKINE, V47, P149, DOI 10.1016/j.cyto.2009.07.003; Glimcher LH, 2004, NAT REV IMMUNOL, V4, P900, DOI 10.1038/nri1490; Gottipati S, 2008, CELL SIGNAL, V20, P269, DOI 10.1016/j.cellsig.2007.08.009; Greene CM, 2000, J IMMUNOL, V165, P4718, DOI 10.4049/jimmunol.165.8.4718; Haseeb A, 2013, RHEUMATOLOGY, V52, P998, DOI 10.1093/rheumatology/kes363; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hayden MS, 2011, CELL RES, V21, P223, DOI 10.1038/cr.2011.13; Jacob CO, 2009, P NATL ACAD SCI USA, V106, P6256, DOI 10.1073/pnas.0901181106; Ku CL, 2007, J EXP MED, V204, P2407, DOI 10.1084/jem.20070628; Li B, 2005, BRIT J OPHTHALMOL, V89, P1410, DOI 10.1136/bjo.2005.074062; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Noble A, 2003, IMMUNOLOGY, V109, P476, DOI 10.1046/j.1365-2567.2003.01687.x; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Rao NA, 2010, OPHTHALMOLOGY, V117, P591, DOI 10.1016/j.ophtha.2009.08.030; Read RW, 2001, AM J OPHTHALMOL, V131, P647, DOI 10.1016/S0002-9394(01)00925-4; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; Rosenbaum JT, 2011, INVEST OPHTH VIS SCI, V52, P6472, DOI 10.1167/iovs.11-7742; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Wang ZL, 2009, CURR TOP MED CHEM, V9, P724, DOI 10.2174/156802609789044407; Yamamoto Yumi, 2001, Current Molecular Medicine (Hilversum), V1, P287; Yang PZ, 2005, CURR EYE RES, V30, P943, DOI 10.1080/02713680500263606; Zhai Y, 2013, INFLAMM RES	29	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93214	10.1371/journal.pone.0093214	http://dx.doi.org/10.1371/journal.pone.0093214			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690905	Green Published, Green Submitted, gold			2022-12-25	WOS:000334101100053
J	Basit, A; Ahmad, N; Khan, AH; Javaid, A; Sulaiman, SAS; Afridi, AK; Adnan, AS; ul Haq, I; Shah, SS; Ahadi, A; Ahmad, I				Basit, Anila; Ahmad, Nafees; Khan, Amer Hayat; Javaid, Arshad; Sulaiman, Syed Azhar Syed; Afridi, Afsar Khan; Adnan, Azreen Syazril; ul Haq, Israr; Shah, Syed Saleem; Ahadi, Ahmed; Ahmad, Izaz			Predictors of Two Months Culture Conversion in Multidrug-Resistant Tuberculosis: Findings from a Retrospective Cohort Study	PLOS ONE			English	Article							POSITIVE PULMONARY TUBERCULOSIS; SPUTUM SMEAR; MYCOBACTERIUM-TUBERCULOSIS; TREATMENT OUTCOMES; TIME; TRANSMISSION; PAKISTAN	Background: Various studies have reported culture conversion at two months as a predictor of successful treatment outcome in multidrug-resistant tuberculosis (MDR-TB). Objectives: The present study was conducted with the aim to evaluate the rate and predictors of culture conversion at two months in MDR-TB patients. Methods: All confirmed pulmonary MDR-TB patients enrolled for treatment at Lady Reading Hospital Peshawar, Pakistan from 1 January to 31 December 2012 and met the inclusion criteria were reviewed retrospectively. Rate and predictors of culture conversion at two months were evaluated. Results: Eighty seven (53.4%) out of 163 patients achieved culture conversion at two months. In a multivariate analysis lung cavitation at baseline chest X-ray (P = 0.006, OR = 0.349), resistance to ofloxacin (P = 0.041, OR = 0.193) and streptomycin (P = 0.017, OR = 0.295) had statistically significant (P<0.05) negative association with culture conversion at two months. Conclusion: A reasonable proportion of patients achieved culture conversion at two months. Factors negatively associated with culture conversion at two months can be easily identified either before diagnosis or early in the course of MDR-TB treatment. This may help in better care of individual patients by identifying them early and treating them vigorously.	[Basit, Anila] Post Grad Med Inst, Peshawar, Pakistan; [Ahmad, Nafees; Khan, Amer Hayat; Sulaiman, Syed Azhar Syed] Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Clin Pharm, George Town, Malaysia; [Javaid, Arshad] Lady Reading Hosp, Dept Pulmonol, Peshawar, Pakistan; [Afridi, Afsar Khan] Lady Reading Hosp, Programmat Management Unit Drug Resistant TB, Peshawar, Pakistan; [Adnan, Azreen Syazril] Univ Sains Malaysia, Sch Med Sci, CKD Resource Ctr, Kota Baharu, Kelantan, Malaysia; [ul Haq, Israr] Saidu Med Coll, Dept Pediat, Saidu Sharif Swat, Pakistan; [Shah, Syed Saleem] Khyber Med Univ, Peshawar, Pakistan; [Ahadi, Ahmed] Univ Balochistan, Dept Pharm, Quetta, Pakistan; [Ahmad, Izaz] Quaid i Azam Univ, Dept Microbiol, Islamabad, Pakistan	Universiti Sains Malaysia; Universiti Sains Malaysia; Khyber Medical University; University of Balochistan; Quaid I Azam University	Ahmad, N (corresponding author), Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Clin Pharm, George Town, Malaysia.	nafeesuob@gmail.com	Khan, Amer Hayat/O-5310-2018	Khan, Amer Hayat/0000-0003-4802-6181; Syed Sulaiman, Syed Azhar/0000-0002-0775-859X; Basit, Anila/0000-0003-1166-1632				Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Brust JCM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073975; Chan ED, 2004, AM J RESP CRIT CARE, V169, P1103, DOI 10.1164/rccm.200308-1159OC; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; Dorman SE, 2009, AM J RESP CRIT CARE, V180, P273, DOI 10.1164/rccm.200901-0078OC; Guler M, 2007, INT J CLIN PRACT, V61, P231, DOI 10.1111/j.1742-1241.2006.01131.x; Hernandez-Garduno E, 2004, THORAX, V59, P286, DOI 10.1136/thx.2003.011759; Holtz TH, 2006, ANN INTERN MED, V144, P650, DOI 10.7326/0003-4819-144-9-200605020-00008; Hwang SS, 2009, EUR RESPIR J, V33, P581, DOI 10.1183/09031936.00099608; Jabeen K, 2011, EMERG INFECT DIS, V17, P564, DOI 10.3201/eid1703.100957; Joseph P, 2011, INDIAN J MED RES, V133, P529; Kim DH, 2010, AM J RESP CRIT CARE, V182, P113, DOI 10.1164/rccm.200911-1656OC; Kurbatova EV, 2012, INT J TUBERC LUNG D, V16, P1335, DOI 10.5588/ijtld.11.0811; Leimane V, 2005, LANCET, V365, P318, DOI 10.1016/S0140-6736(05)17786-1; Qazi F, 2011, INT J TUBERC LUNG D, V15, P1556, DOI 10.5588/ijtld.10.0679; Rieder HL, 1996, TUBERCLE LUNG DIS, V77, P124, DOI 10.1016/S0962-8479(96)90026-X; Rodriguez M, 2013, INT J TUBERC LUNG D, V17, P520, DOI 10.5588/ijtld.12.0481; Salaniponi FML, 1999, INT J TUBERC LUNG D, V3, P1047; Singla R, 2003, INT J TUBERC LUNG D, V7, P58; Singla R, 2009, INT J TUBERC LUNG D, V13, P976; Telzak EE, 1997, CLIN INFECT DIS, V25, P666, DOI 10.1086/513772; Wells WA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018964; Yew WW, 2000, CHEST, V117, P744, DOI 10.1378/chest.118.3.744	23	37	38	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93206	10.1371/journal.pone.0093206	http://dx.doi.org/10.1371/journal.pone.0093206			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705411	Green Published, Green Submitted, gold			2022-12-25	WOS:000334107500029
J	Cox, MC; Di Napoli, A; Scarpino, S; Salerno, G; Tatarelli, C; Talerico, C; Lombardi, M; Monarca, B; Amadori, S; Ruco, L				Cox, M. Christina; Di Napoli, Arianna; Scarpino, Stefania; Salerno, Gerardo; Tatarelli, Caterina; Talerico, Caterina; Lombardi, Mariangela; Monarca, Bruno; Amadori, Sergio; Ruco, Luigi			Clinicopathologic Characterization of Diffuse-Large-B-Cell Lymphoma with an Associated Serum Monoclonal IgM Component	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; RITUXIMAB PLUS CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN CLASS SWITCH; CHOP CHEMOTHERAPY; STRONG PREDICTOR; POOR-PROGNOSIS; EXPRESSION; MYC; BCL2; DOXORUBICIN	Recently, diffuse-large-B-cell lymphoma (DLBCL) associated with serum IgM monoclonal component (MC) has been shown to be a very poor prognostic subset although, detailed pathological and molecular data are still lacking. In the present study, the clinicopathological features and survival of IgM-secreting DLBCL were analyzed and compared to non-secreting cases in a series of 151 conventional DLBCL treated with R-CHOP. IgM MC was detected in 19 (12.5%) out of 151 patients at disease onset. In 17 of these cases secretion was likely due to the neoplastic clone, as suggested by the expression of heavy chain IgM protein in the cytoplasm of tumor cells. In IgM-secreting cases immunoblastic features (p <.0001), non-GCB-type (p = .002) stage III- IV(p = .003), >= 2 extra nodal sites (p <.0001), bone-marrow (p = .002), central-nervous- system (CNS) involvement at disease onset or relapse (p <.0001), IPI-score 3-5 (p = .009) and failure to achieve complete remission (p = .005), were significantly more frequent. FISH analyses for BCL2, BCL6 and MYC gene rearrangements detected only two cases harboring BCL2 gene translocation and in one case a concomitant BCL6 gene translocation was also observed. None of the IgM-secreting DLBCL was found to have L265P mutation of MYD88 gene. Thirty-six month event-free (11.8% vs 66.4% p <.0001), progression-free (23.5% vs 75.7%, p <.0001) and overall (47.1% vs 74.8%, p <.0001) survivals were significantly worse in the IgM-secreting group. In multivariate analysis IgM-secreting (p = .005, expB = 0.339, Cl = 0.160-0.716) and IPI-score 3-5 (p = .010, expB = 0.274, Cl = 0.102-0.737) were the only significant factors for progression-free-survival. Notably, four relapsed patients, who were treated with salvage immmunochemotherapy combined with bortezomib or lenalidomide, achieved lasting remission. Our data suggests that IgM-secreting cases are a distinct subset of DLBCL, originating from activated-B-cells with terminally differentiated features, prevalent extra nodal dissemination and at high risk of CNS involvement.	[Cox, M. Christina; Tatarelli, Caterina; Monarca, Bruno] Univ Roma La Sapienza, Dept Clin & Mol Med, Hematol Unit, St Andreas Hosp, I-00185 Rome, Italy; [Di Napoli, Arianna; Scarpino, Stefania; Talerico, Caterina; Lombardi, Mariangela; Ruco, Luigi] Univ Roma La Sapienza, Dept Clin & Mol Med, Pathol Unit, St Andreas Hosp, I-00185 Rome, Italy; [Salerno, Gerardo] Univ Roma La Sapienza, Dept Clin & Mol Med, Clin Pathol Unit, St Andreas Hosp, I-00185 Rome, Italy; [Amadori, Sergio] Univ Roma Tor Vergata, Dept Hematol, Rome, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; University of Rome Tor Vergata	Cox, MC (corresponding author), Univ Roma La Sapienza, Dept Clin & Mol Med, Hematol Unit, St Andreas Hosp, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	chrisscox@gmail.com	Cox, M Christina/AAB-3514-2022; Di Napoli, Arianna/AAB-3210-2022; cox, maria christina/K-7503-2016	Di Napoli, Arianna/0000-0002-3159-5380; cox, maria christina/0000-0002-8597-8459; Amadori, Sergio/0000-0002-2356-8681; Salerno, Gerardo/0000-0002-6597-1452	Fondi di ricerca di Ateneo	Fondi di ricerca di Ateneo	Fondi di ricerca di Ateneo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani RH, 2010, BRIT J HAEMATOL, V151, P143, DOI 10.1111/j.1365-2141.2010.08331.x; Ahn JS, 2013, AM J HEMATOL, V88, P774, DOI 10.1002/ajh.23507; Akyurek N, 2012, CANCER-AM CANCER SOC, V118, P4173, DOI 10.1002/cncr.27396; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Barrans S, 2010, J CLIN ONCOL, V28, P3360, DOI 10.1200/JCO.2009.26.3947; Barrans SL, 2003, CLIN CANCER RES, V9, P2133; Campo E, 2011, BLOOD, V117, P5019, DOI 10.1182/blood-2011-01-293050; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Choi JW, 2013, HUM PATHOL, V44, P1375, DOI 10.1016/j.humpath.2012.10.026; Copie-Bergman C, 2009, J CLIN ONCOL, V27, P5573, DOI 10.1200/JCO.2009.22.7058; COX DR, 1972, J R STAT SOC B, V34, P187; Cox MC, 2012, BLOOD, V120, DOI 10.1182/blood.V120.21.2659.2659; Cox MC, 2008, LEUKEMIA LYMPHOMA, V49, P1745, DOI 10.1080/10428190802226425; Eskazan Ahmet Emre, 2011, Case Rep Gastroenterol, V5, P262, DOI 10.1159/000328445; Fu K, 2008, J CLIN ONCOL, V26, P4587, DOI 10.1200/JCO.2007.15.9277; Green TM, 2012, J CLIN ONCOL, V30, P3460, DOI 10.1200/JCO.2011.41.4342; Hans CP, 2004, BLOOD; Hoeller S, 2010, HUM PATHOL, V41, P352, DOI 10.1016/j.humpath.2009.07.024; Horn H, 2013, BLOOD, V121, P2253, DOI 10.1182/blood-2012-06-435842; Jardin F, 2013, LEUKEMIA LYMPHOMA, V54, P1898, DOI 10.3109/10428194.2013.767456; Johnson NA, 2012, J CLIN ONCOL, V30, P3452, DOI 10.1200/JCO.2011.41.0985; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Koens L, 2010, AM J SURG PATHOL, V34, P1043, DOI 10.1097/PAS.0b013e3181e5060a; Kohyama S, 2001, SURG NEUROL, V56, P325, DOI 10.1016/S0090-3019(01)00573-0; Kraan W, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.28; Kramer MHH, 1998, BLOOD, V92, P3152, DOI 10.1182/blood.V92.9.3152.421a07_3152_3162; Lennert K, 1992, HISTOPATHOLOGY NONHO; Lenz G, 2007, J EXP MED, V204, P633, DOI 10.1084/jem.20062041; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Martelli M, 2013, CRIT REV ONCOL HEMAT, V87, P146, DOI 10.1016/j.critrevonc.2012.12.009; Marzano A, 2007, DIGEST LIVER DIS, V39, P397, DOI 10.1016/j.dld.2006.12.017; Maurer MJ, 2011, J CLIN ONCOL, V29, P1620, DOI 10.1200/JCO.2010.29.4413; Montes-Moreno S, 2010, HAEMATOL-HEMATOL J, V95, P1342, DOI 10.3324/haematol.2009.016113; Montesinos-Rongen M, 2005, AM J PATHOL, V166, P1773, DOI 10.1016/S0002-9440(10)62487-X; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Noguchi M, 2003, BRIT J HAEMATOL, V123, P600, DOI 10.1046/j.1365-2141.2003.04651.x; Ott G, 2010, BLOOD, V116, P4916, DOI 10.1182/blood-2010-03-276766; Pedersen MO, 2014, EUR J HAEMATOL, V92, P42, DOI 10.1111/ejh.12212; Pei L, 2005, AM J CLIN PATHOL, V123, P200, DOI 10.1309/2A0FL1HM5PN2510P; Pfreundschuh M, 2004, BLOOD, V104, P626, DOI 10.1182/blood-2003-06-2094; Randen U, 2014, HAEMATOLOGICA, V99, P497, DOI 10.3324/haematol.2013.091702; Ria R, 2009, EUR J CLIN INVEST, V39, P627, DOI 10.1111/j.1365-2362.2009.02147.x; Rigacci L, 2012, BLOOD, V120, DOI 10.1182/blood.V120.21.3694.3694; Ruminy P, 2011, LEUKEMIA, V25, P681, DOI 10.1038/leu.2010.302; Schroers R, 2010, EUR J HAEMATOL, V85, P236, DOI 10.1111/j.1600-0609.2010.01475.x; Sehn LH, 2005, J CLIN ONCOL, V23, P5027, DOI 10.1200/JCO.2005.09.137; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Swerdlow E., 2008, WHO CLASSIFICATION T; Ventura RA, 2006, J MOL DIAGN, V8, P141, DOI 10.2353/jmoldx.2006.050083; Visco C, 2012, LEUKEMIA, V26, P2103, DOI 10.1038/leu.2012.83; Vitolo U, 2009, HAEMATOL-HEMATOL J, V94, P1250, DOI 10.3324/haematol.2009.007005; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100; Xu L, 2013, BLOOD, V121, P2051, DOI 10.1182/blood-2012-09-454355; Zinzani PL PC, 2012, HEMATOLOGIC IN PRESS	54	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93903	10.1371/journal.pone.0093903	http://dx.doi.org/10.1371/journal.pone.0093903			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705344	Green Published, Green Submitted, gold			2022-12-25	WOS:000334107500091
J	Park, R; El-Guindy, A; Heston, L; Lin, SF; Yu, KP; Nagy, M; Borah, S; Delecluse, HJ; Steitz, J; Miller, G				Park, Richard; El-Guindy, Ayman; Heston, Lee; Lin, Su-Fang; Yu, Kuan-Ping; Nagy, Mate; Borah, Sumit; Delecluse, Henri-Jacques; Steitz, Joan; Miller, George			Nuclear Translocation and Regulation of Intranuclear Distribution of Cytoplasmic Poly(A)-Binding Protein Are Distinct Processes Mediated by Two Epstein Barr Virus Proteins	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; POLY(A) BINDING-PROTEIN; MESSENGER-RNA; GENE-EXPRESSION; ZEBRA PROTEIN; HOST SHUTOFF; IN-VIVO; REPLICATION COMPARTMENTS; BURKITTS-LYMPHOMA; DNA-REPLICATION	Many viruses target cytoplasmic polyA binding protein (PABPC) to effect widespread inhibition of host gene expression, a process termed viral host-shutoff (vhs). During lytic replication of Epstein Barr Virus (EBV) we observed that PABPC was efficiently translocated from the cytoplasm to the nucleus. Translocated PABPC was diffusely distributed but was excluded from viral replication compartments. Vhs during EBV infection is regulated by the viral alkaline nuclease, BGLF5. Transfection of BGLF5 alone into BGLF5-KO cells or uninfected 293 cells promoted translocation of PAPBC that was distributed in clumps in the nucleus. ZEBRA, a viral bZIP protein, performs essential functions in the lytic program of EBV, including activation or repression of downstream viral genes. ZEBRA is also an essential replication protein that binds to viral oriLyt and interacts with other viral replication proteins. We report that ZEBRA also functions as a regulator of vhs. ZEBRA translocated PABPC to the nucleus, controlled the intranuclear distribution of PABPC, and caused global shutoff of host gene expression. Transfection of ZEBRA alone into 293 cells caused nuclear translocation of PABPC in the majority of cells in which ZEBRA was expressed. Co-transfection of ZEBRA with BGLF5 into BGLF5-KO cells or uninfected 293 cells rescued the diffuse intranuclear pattern of PABPC seen during lytic replication. ZEBRA mutants defective for DNA-binding were capable of regulating the intranuclear distribution of PABPC, and caused PABPC to co-localize with ZEBRA. One ZEBRA mutant, Z(S186E), was deficient in translocation yet was capable of altering the intranuclear distribution of PABPC. Therefore ZEBRA-mediated nuclear translocation of PABPC and regulation of intranuclear PABPC distribution are distinct events. Using a click chemistry-based assay for new protein synthesis, we show that ZEBRA and BGLF5 each function as viral host shutoff factors.	[Park, Richard; Steitz, Joan; Miller, George] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; [El-Guindy, Ayman; Heston, Lee; Yu, Kuan-Ping; Miller, George] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Lin, Su-Fang] Natl Hlth Res Inst, Inst Canc Res, Zhunan Town, Taiwan; [Nagy, Mate] Yale Univ, Sch Med, Program Computat Biol & Bioinformat, New Haven, CT USA; [Borah, Sumit] Univ Colorado, Biofrontiers Inst, Howard Hughes Med Inst, Dept Biochem, Boulder, CO 80309 USA; [Delecluse, Henri-Jacques] German Canc Res Ctr, Dept Tumor Virol, Heidelberg, Germany; [Miller, George] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA	Yale University; Yale University; National Health Research Institutes - Taiwan; Yale University; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; Helmholtz Association; German Cancer Research Center (DKFZ); Yale University	Miller, G (corresponding author), Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA.	George.Miller@yale.edu	Lin, Su-Fang/B-2666-2010	BORAH, SUMIT/0000-0002-1842-7024; Lin, Su-Fang/0000-0001-8706-2439; Delecluse, Henri-Jacques/0000-0002-1744-6274	National Institutes of Health [CA16038, CA12055]; NATIONAL CANCER INSTITUTE [R37CA012055, R01CA012055, P01CA016038] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institutes of Health grants CA16038 and CA12055. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez E, 2006, BIOCHEM J, V396, P219, DOI 10.1042/BJ20060108; Aranda M, 1998, VIROLOGY, V243, P261, DOI 10.1006/viro.1998.9032; Bhende PM, 2005, J VIROL, V79, P7338, DOI 10.1128/JVI.79.12.7338-7348.2005; Bryant HE, 2001, J VIROL, V75, P4376, DOI 10.1128/JVI.75.9.4376-4385.2001; Covarrubias S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002339; Covarrubias S, 2009, J VIROL, V83, P9554, DOI 10.1128/JVI.01051-09; Daikoku T, 2005, J VIROL, V79, P3409, DOI 10.1128/JVI.79.6.3409-3418.2005; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; DETHE G, 1978, NATURE, V274, P756, DOI 10.1038/274756a0; Dobrikova E, 2010, J VIROL, V84, P270, DOI 10.1128/JVI.01740-09; Feederle R, 2000, EMBO J, V19, P3080, DOI 10.1093/emboj/19.12.3080; Feederle R, 2009, J VIROL, V83, P4952, DOI 10.1128/JVI.00170-09; Francis A, 1999, J VIROL, V73, P4543, DOI 10.1128/JVI.73.6.4543-4551.1999; Francis AL, 1997, J VIROL, V71, P3054, DOI 10.1128/JVI.71.4.3054-3061.1997; FU XD, 1990, NATURE, V343, P437, DOI 10.1038/343437a0; Gaglia MM, 2012, J VIROL; Glaunsinger B, 2004, MOL CELL, V13, P713, DOI 10.1016/S1097-2765(04)00091-7; Gruffat H, 2002, J VIROL, V76, P9635, DOI 10.1128/JVI.76.19.9635-9644.2002; Harb M, 2008, J VIROL, V82, P11283, DOI 10.1128/JVI.00872-08; Heston L, 2006, J VIROL, V80, P9115, DOI 10.1128/JVI.00909-06; Horst D, 2012, J VIROL, V86, P9175, DOI 10.1128/JVI.00309-12; Joachims M, 1999, J VIROL, V73, P718, DOI 10.1128/JVI.73.1.718-727.1999; Keryer-Bibens C, 2009, BIOCHEM BIOPH RES CO, V390, P302, DOI 10.1016/j.bbrc.2009.09.115; Kumar GR, 2010, MOL CELL BIOL, V30, P4996, DOI 10.1128/MCB.00600-10; Kuyumcu-Martinez NM, 2004, MOL CELL BIOL, V24, P1779, DOI 10.1128/MCB.24.4.1779-1790.2004; Kuyumcu-Martinez NM, 2002, J VIROL, V76, P2062, DOI 10.1128/JVI.76.5.2062-2074.2002; KWONG AD, 1987, P NATL ACAD SCI USA, V84, P1926, DOI 10.1073/pnas.84.7.1926; LIN SF, 1994, VIROLOGY, V199, P223, DOI 10.1006/viro.1994.1115; Mears WE, 1996, J VIROL, V70, P7445, DOI 10.1128/JVI.70.11.7445-7453.1996; OLD LJ, 1966, P NATL ACAD SCI USA, V56, P1699, DOI 10.1073/pnas.56.6.1699; OROSKAR AA, 1989, J VIROL, V63, P1897, DOI 10.1128/JVI.63.5.1897-1906.1989; Park R, 2008, VIROLOGY, V382, P145, DOI 10.1016/j.virol.2008.09.009; Park R, 2011, J BIOL CHEM, V286, P9748, DOI 10.1074/jbc.M110.198325; PEARSON GR, 1983, J VIROL, V47, P193, DOI 10.1128/JVI.47.1.193-201.1983; PHELAN A, 1993, P NATL ACAD SCI USA, V90, P9056, DOI 10.1073/pnas.90.19.9056; Piron M, 1999, J VIROL, V73, P5411, DOI 10.1128/JVI.73.7.5411-5421.1999; Piron M, 1998, EMBO J, V17, P5811, DOI 10.1093/emboj/17.19.5811; ROONEY C, 1988, P NATL ACAD SCI USA, V85, P9801, DOI 10.1073/pnas.85.24.9801; Rowe M, 2007, P NATL ACAD SCI USA, V104, P3366, DOI 10.1073/pnas.0611128104; Ruvolo V, 2001, J VIROL, V75, P6033, DOI 10.1128/JVI.75.13.6033-6041.2001; Salaun C, 2010, J VIROL, V84, P8539, DOI 10.1128/JVI.00668-10; Sandri-Goldin RM, 1998, GENE DEV, V12, P868, DOI 10.1101/gad.12.6.868; SANDRIGOLDIN RM, 1995, J VIROL, V69, P6063, DOI 10.1128/JVI.69.10.6063-6076.1995; SCHEPERS A, 1993, EMBO J, V12, P3921, DOI 10.1002/j.1460-2075.1993.tb06070.x; Sciabica KS, 2003, EMBO J, V22, P1608, DOI 10.1093/emboj/cdg166; Sokolowski M, 2003, J BIOL CHEM, V278, P33540, DOI 10.1074/jbc.M302063200; Sugimoto A, 2013, J VIROL, V87, P6693, DOI 10.1128/JVI.00219-13; VANDEREB AJ, 1977, GENE, V2, P115, DOI 10.1016/0378-1119(77)90012-9; Vende P, 2000, J VIROL, V74, P7064, DOI 10.1128/JVI.74.15.7064-7071.2000; Vitour D, 2004, J VIROL, V78, P3851, DOI 10.1128/JVI.78.8.3851-3862.2004; Walsh D, 2008, MOL CELL BIOL, V28, P2648, DOI 10.1128/MCB.01631-07; ZENG Y, 1985, INT J CANCER, V36, P545, DOI 10.1002/ijc.2910360505; Zhu H, 1998, P NATL ACAD SCI USA, V95, P14470, DOI 10.1073/pnas.95.24.14470	53	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e92593	10.1371/journal.pone.0092593	http://dx.doi.org/10.1371/journal.pone.0092593			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705134	Green Published, Green Submitted, gold			2022-12-25	WOS:000334107500020
J	Salazar-Echegarai, FJ; Tobar, HE; Nieto, PA; Riedel, CA; Bueno, SM				Salazar-Echegarai, Francisco J.; Tobar, Hugo E.; Nieto, Pamela A.; Riedel, Claudia A.; Bueno, Susan M.			Conjugal Transfer of the Pathogenicity Island ROD21 in Salmonella enterica serovar Enteritidis Depends on Environmental Conditions	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; ESCHERICHIA-COLI; COMPARATIVE GENOMICS; IN-VIVO; TYPHIMURIUM; TRANSFORMATION; RECOMBINATION; TEMPERATURE; PROTEINS; BARRIERS	Unstable pathogenicity islands are chromosomal elements that can be transferred from one bacterium to another. Salmonella enterica serovar Enteritidis (S. Enteritidis) is a pathogenic bacterium containing such unstable pathogenicity islands. One of them, denominated ROD21, is 26.5 kb in size and capable of excising from the chromosome in certain culture conditions, as well as during bacterial infection of phagocytic cells. In this study we have evaluated whether ROD21 can be effectively transferred from one bacterium to another. We generated a donor and several recipient strains of S. Enteritidis to carry out transfer assays in liquid LB medium. These assays showed that ROD21 is effectively transferred from donor to recipient strains of S. Enteritidis and S. Typhimurium. When Escherichia coli was used as the recipient strain, ROD21 transfer failed to be observed. Subsequently, we showed that a conjugative process was required for the transfer of the island and that changes in temperature and pH increased the transfer frequency between Salmonella strains. Our data indicate that ROD21 is an unstable pathogenicity island that can be transferred by conjugation in a species-specific manner between Salmonellae. Further, ROD21 transfer frequency increases in response to environmental changes, such as pH and temperature.	[Salazar-Echegarai, Francisco J.; Tobar, Hugo E.; Nieto, Pamela A.; Bueno, Susan M.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Mol Genet & Microbiol, Millennium Inst Immunol & Immunotherapy, Santiago, Chile; [Riedel, Claudia A.] Univ Andres Bello, Fac Ciencias Biol, Dept Ciencias Biol, Millennium Inst Immunol & Immunotherapy, Santiago, Chile; [Riedel, Claudia A.] Univ Andres Bello, Fac Med, Santiago, Chile; [Bueno, Susan M.] INSERM, UMR 1064, Nantes, France	Pontificia Universidad Catolica de Chile; Universidad Andres Bello; Universidad Andres Bello; Institut National de la Sante et de la Recherche Medicale (Inserm)	Bueno, SM (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Mol Genet & Microbiol, Millennium Inst Immunol & Immunotherapy, Alameda 340, Santiago, Chile.	sbueno@bio.puc.cl		Riedel, Claudia/0000-0001-6168-8601; Salazar-Echegarai, Francisco/0000-0001-6709-699X; Bueno, Susan M./0000-0002-7551-8088	Millennium Institute on Immunology and Immunotherapy [P09-016-F]; FONDECYT [11075060, 1110604, 1100971, 1110397, 1100926]	Millennium Institute on Immunology and Immunotherapy; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	The authors are supported by the following grants: FONDECYT N. 11075060, FONDECYT N. 1110604, FONDECYT N. 1100971, FONDECYT N. 1110397, FONDECYT N. 1100926 and Millennium Institute on Immunology and Immunotherapy (P09-016-F). PAN is a CONICYT fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betancor L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-237; Broudy TB, 2003, INFECT IMMUN, V71, P3782, DOI 10.1128/IAI.71.7.3782-3786.2003; Bustamante P, 2012, J MOL MICROB BIOTECH, V22, P399, DOI 10.1159/000346669; Coburn PS, 2007, MOL MICROBIOL, V63, P530, DOI 10.1111/j.1365-2958.2006.05520.x; Corvaglia AR, 2010, P NATL ACAD SCI USA, V107, P11954, DOI 10.1073/pnas.1000489107; Crossman LC, 2010, J BACTERIOL, V192, P5822, DOI 10.1128/JB.00710-10; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davison J, 1999, PLASMID, V42, P73, DOI 10.1006/plas.1999.1421; Doublet B, 2005, MOL MICROBIOL, V55, P1911, DOI 10.1111/j.1365-2958.2005.04520.x; Edwards RA, 2002, TRENDS MICROBIOL, V10, P94, DOI 10.1016/S0966-842X(01)02293-4; Forns N, 2005, J BACTERIOL, V187, P3950, DOI 10.1128/JB.187.12.3950-3959.2005; Garcia-Quintanilla M, 2011, PLASMID, V65, P169, DOI 10.1016/j.plasmid.2010.12.001; Garcillan-Barcia MP, 2009, FEMS MICROBIOL REV, V33, P657, DOI 10.1111/j.1574-6976.2009.00168.x; Giloh M, 2012, POULTRY SCI, V91, P175, DOI 10.3382/ps.2011-01497; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; LORENZ MG, 1994, MICROBIOL REV, V58, P563, DOI 10.1128/MMBR.58.3.563-602.1994; Maniatis T., 1982, MOL CLONING LAB MANU; Matic I, 2000, J BACTERIOL, V182, P5922, DOI 10.1128/JB.182.20.5922-5924.2000; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Newman RM, 2006, INFECT IMMUN, V74, P594, DOI 10.1128/IAI.74.1.594-601.2006; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Porwollik S, 2003, MICROBES INFECT, V5, P977, DOI 10.1016/S1286-4579(03)00186-2; Quiroz TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026031; Ramsay JP, 2009, MOL MICROBIOL, V73, P1141, DOI 10.1111/j.1365-2958.2009.06843.x; RAYSSIGUIER C, 1989, NATURE, V342, P396, DOI 10.1038/342396a0; RAYSSIGUIER C, 1991, BIOCHIMIE, V73, P371, DOI 10.1016/0300-9084(91)90103-8; Rotger R, 1999, Int Microbiol, V2, P177; Schubert S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000257; Sentchilo V, 2009, MOL MICROBIOL, V72, P1293, DOI 10.1111/j.1365-2958.2009.06726.x; Silva CA, 2012, INFECT IMMUN, V80, P839, DOI 10.1128/IAI.05497-11; Switt AIM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041247; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; TINGE SA, 1990, INFECT IMMUN, V58, P3084, DOI 10.1128/IAI.58.9.3084-3092.1990; Tobar HE, 2013, CURR GENE THER, V13, P240; Turner SA, 2004, ANTIMICROB AGENTS CH, V48, P1028, DOI 10.1128/AAC.48.3.1028-1031.2004; Williams HG, 1996, APPL ENVIRON MICROB, V62, P2994, DOI 10.1128/AEM.62.8.2994-2998.1996; Wozniak RAF, 2010, NAT REV MICROBIOL, V8, P552, DOI 10.1038/nrmicro2382; Yasmin A, 2010, J BACTERIOL, V192, P1122, DOI 10.1128/JB.01293-09	40	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e90626	10.1371/journal.pone.0090626	http://dx.doi.org/10.1371/journal.pone.0090626			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705125	gold, Green Published, Green Submitted			2022-12-25	WOS:000334107500001
J	Varendi, K; Airavaara, M; Anttila, J; Vose, S; Planken, A; Saarma, M; Mitchell, JR; Andressoo, JO				Varendi, Kart; Airavaara, Mikko; Anttila, Jenni; Vose, Sarah; Planken, Anu; Saarma, Mart; Mitchell, James R.; Andressoo, Jaan-Olle			Short-term Preoperative Dietary Restriction Is Neuroprotective in a Rat Focal Stroke Model	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; ISCHEMIA-REPERFUSION INJURY; TUMOR-NECROSIS-FACTOR; NEUROTROPHIC FACTOR; CARDIAC-SURGERY; TNF-ALPHA; CALORIE RESTRICTION; BRAIN ISCHEMIA; MICE; EXPRESSION	Stroke is a major complication of cardiovascular surgery, resulting in over 100,000 deaths and over a million postoperative encephalopathies annually in the US and Europe. While mitigating damage from stroke after it occurs has proven elusive, opportunities to reduce the incidence and/or severity of stroke prior to surgery in at-risk individuals remain largely unexplored. We tested the potential of short-term preoperative dietary restriction to provide neuroprotection in rat models of focal stroke. Rats were preconditioned with either three days of water-only fasting or six days of a protein free diet prior to induction of transient middle cerebral artery occlusion using two different methods, resulting in either a severe focal stroke to forebrain and midbrain, or a mild focal stroke localized to cortex only. Infarct volume, functional recovery and molecular markers of damage and protection were assessed up to two weeks after reperfusion. Preoperative fasting for 3 days reduced infarct volume after severe focal stroke. Neuroprotection was associated with modulation of innate immunity, including elevation of circulating neutrophil chemoattractant C-X-C motif ligand 1 prior to ischemia and suppression of striatal pro-inflammatory markers including tumor necrosis factor a, its receptor and downstream effector intercellular adhesion molecule-1 after reperfusion. Similarly, preoperative dietary protein restriction for 6 days reduced ischemic injury and improved functional recovery in a milder cortical infarction model. Our results suggest that short-term dietary restriction regimens may provide simple and translatable approaches to reduce perioperative stroke severity in high-risk elective vascular surgery.	[Varendi, Kart; Airavaara, Mikko; Anttila, Jenni; Planken, Anu; Saarma, Mart; Andressoo, Jaan-Olle] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Vose, Sarah; Mitchell, James R.] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA	University of Helsinki; Harvard University; Harvard T.H. Chan School of Public Health	Mitchell, JR (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	jmitchel@hsph.harvard.edu; Jaan-Olle.Andressoo@helsinki.fi	Andressoo, Jaan-Olle/AAA-1216-2021; Planken, Anu/N-6359-2019; Andressoo, Jaan-Olle/AFU-7846-2022	Planken, Anu/0000-0003-4553-1852; Andressoo, Jaan-Olle/0000-0002-0271-3157; Matlik, Kart/0000-0003-1777-5614; Anttila, Jenni E./0000-0001-6565-2323; Airavaara, Mikko/0000-0002-2026-1609	Sigrid Juselius Foundation; Academy of Finland [250275, 256398, 136591, 140983, 263700, 1126735]; Doctoral Program Brain Mind; National Institutes of Health [AG036712, DK090629]; Radiation Biology [T32CA009078]; NATIONAL CANCER INSTITUTE [T32CA009078] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES016645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG036712] Funding Source: NIH RePORTER	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Doctoral Program Brain Mind; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Radiation Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by the Sigrid Juselius Foundation; the Academy of Finland [grant number 250275, 256398 to MA; 136591, 140983 and 263700 to JOA; 1126735 to MS]; the Doctoral Program Brain & Mind to KV; JRM was supported by the National Institutes of Health [AG036712 and DK090629]; and SV by Radiation Biology T32CA009078.	Ahmet I, 2005, CIRCULATION, V112, P3115, DOI 10.1161/CIRCULATIONAHA.105.563817; Airavaara M, 2009, J COMP NEUROL, V515, P116, DOI 10.1002/cne.22039; Amantea D, 2009, FEBS J, V276, P13, DOI 10.1111/j.1742-4658.2008.06766.x; Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100; Arumugam TV, 2010, ANN NEUROL, V67, P41, DOI 10.1002/ana.21798; Barone FC, 1997, STROKE, V28, P1233, DOI 10.1161/01.STR.28.6.1233; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Bowen KK, 2006, NEUROCHEM INT, V49, P127, DOI 10.1016/j.neuint.2006.02.011; Bruggemans EF, 2013, NETH HEART J, V21, P70, DOI 10.1007/s12471-012-0347-x; Chandrasekar B, 2001, AM J PHYSIOL-HEART C, V280, pH2094, DOI 10.1152/ajpheart.2001.280.5.H2094; CHEN ST, 1986, STROKE, V17, P738, DOI 10.1161/01.STR.17.4.738; COMBS DJ, 1987, STROKE, V18, P503, DOI 10.1161/01.STR.18.2.503; Damm J, 2012, NEUROSCIENCE, V201, P166, DOI 10.1016/j.neuroscience.2011.11.013; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Duan WZ, 2001, J MOL NEUROSCI, V16, P1, DOI 10.1385/JMN:16:1:1; Duan WZ, 2001, J NEUROCHEM, V76, P619, DOI 10.1046/j.1471-4159.2001.00071.x; Ferrer I, 2001, ACTA NEUROPATHOL, V101, P229; Fond G, 2013, PSYCHIAT RES, V209, P253, DOI 10.1016/j.psychres.2012.12.018; Gandhi GY, 2005, MAYO CLIN PROC, V80, P862, DOI 10.4065/80.7.862; GO KG, 1988, METAB BRAIN DIS, V3, P257, DOI 10.1007/BF00999535; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Green AR, 2008, BRIT J PHARMACOL, V153, pS325, DOI 10.1038/sj.bjp.0707594; Gregersen R, 2000, J CEREBR BLOOD F MET, V20, P53, DOI 10.1097/00004647-200001000-00009; Hall MJ, 2010, NATL HLTH STAT REPOR, V26, p[1, 24]; Harvey BK, 2005, PHARMACOL THERAPEUT, V105, P113, DOI 10.1016/j.pharmthera.2004.09.003; Heilbronn LK, 2006, JAMA-J AM MED ASSOC, V295, P1539, DOI 10.1001/jama.295.13.1539; Kagansky N, 2001, ARCH NEUROL-CHICAGO, V58, P1209, DOI 10.1001/archneur.58.8.1209; Kellermann K, 2010, SEMIN CARDIOTHORAC V, V14, P95, DOI 10.1177/1089253210370902; KIRSCH JR, 1979, STROKE, V10, P288, DOI 10.1161/01.STR.10.3.288; Koizumi J., 1986, JPN J STROKE, V8, P1, DOI DOI 10.3995/JSTROKE.8.1; Kollmar R, 2007, STROKE, V38, P1585, DOI 10.1161/STROKEAHA.106.475897; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Lee J, 2000, J MOL NEUROSCI, V15, P99, DOI 10.1385/JMN:15:2:99; Lee ST, 2012, ANN NEUROL, V72, P269, DOI 10.1002/ana.23588; Lin T. N., 2009, P141, DOI 10.1007/978-1-60327-185-1_12; MARIE C, 1990, METAB BRAIN DIS, V5, P65, DOI 10.1007/BF01001047; Michalsen A, 2013, FORSCH KOMPLEMENTMED, V20, P444, DOI 10.1159/000357765; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; Mitchell JR, 2013, SURGERY, V153, P594, DOI 10.1016/j.surg.2012.09.007; Mitchell JR, 2010, AGING CELL, V9, P40, DOI 10.1111/j.1474-9726.2009.00532.x; Miura P, 2012, J NEUROCHEM, V120, P230, DOI 10.1111/j.1471-4159.2011.07583.x; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Newman MF, 2006, LANCET, V368, P694, DOI 10.1016/S0140-6736(06)69254-4; Pandya JD, 2011, BRAIN RES, V1384, P151, DOI 10.1016/j.brainres.2011.01.102; Peng Wei, 2012, Sci Transl Med, V4, p118ra11, DOI 10.1126/scitranslmed.3002629; PERDRIZET G A, 1989, Current Surgery, V46, P23; Poldermans D, 2009, EUR HEART J, V30, P2769, DOI 10.1093/eurheartj/ehp337; Reglodi D, 2000, EXP NEUROL, V163, P399, DOI 10.1006/exnr.2000.7367; REHNCRONA S, 1985, EXP NEUROL, V87, P458, DOI 10.1016/0014-4886(85)90176-1; Robertson LT, 2013, EXP GERONTOL, V48, P1043, DOI 10.1016/j.exger.2013.01.009; Rosenzweig HL, 2007, J CEREBR BLOOD F MET, V27, P1663, DOI 10.1038/sj.jcbfm.9600464; Schabitz WR, 1997, J CEREBR BLOOD F MET, V17, P500, DOI 10.1097/00004647-199705000-00003; Selim M, 2007, NEW ENGL J MED, V356, P706, DOI 10.1056/NEJMra062668; Sharp Frank R, 2004, NeuroRx, V1, P26, DOI 10.1602/neurorx.1.1.26; SIMONET WS, 1994, J CLIN INVEST, V94, P1310, DOI 10.1172/JCI117450; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Thored P, 2009, GLIA, V57, P835, DOI 10.1002/glia.20810; van Ginhoven TM, 2010, J SURG RES; Varon J, 2008, CHEST, V133, P1267, DOI 10.1378/chest.07-2190; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942; Yenari MA, 2010, NEUROTHERAPEUTICS, V7, P378, DOI 10.1016/j.nurt.2010.07.005; Yu ZF, 1999, J NEUROSCI RES, V57, P830, DOI 10.1002/(SICI)1097-4547(19990915)57:6&lt;830::AID-JNR8&gt;3.0.CO;2-2; Zeynalov E, 2009, NEUROBIOL DIS, V35, P264, DOI 10.1016/j.nbd.2009.05.010	63	24	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93911	10.1371/journal.pone.0093911	http://dx.doi.org/10.1371/journal.pone.0093911			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705386	Green Published, gold, Green Submitted			2022-12-25	WOS:000334107500093
J	Hannan, NJ; Bambang, K; Kaitu'u-Lino, TJ; Konje, JC; Tong, S				Hannan, Natalie J.; Bambang, Katerina; Kaitu'u-Lino, Tu'uhevaha J.; Konje, Justin C.; Tong, Stephen			A Bioplex Analysis of Cytokines and Chemokines in First Trimester Maternal Plasma to Screen for Predictors of Miscarriage	PLOS ONE			English	Article							MACROPHAGE INHIBITORY CYTOKINE-1; HUMAN ENDOMETRIUM; LEUKOCYTE RECRUITMENT; EMBRYO IMPLANTATION; EXPRESSION; PREGNANCY; RECEPTOR; WOMEN; SERUM; ROLES	Background: We have previously shown in two independent cohorts that circulating first trimester Macrophage Inhibitory Cytokine-1 (MIC-1) levels are lower in women in early pregnancy who are destined to miscarriage. While promising, the diagnostic performance of measuring MIC-1 alone was not sufficient for it to be a useful predictive test for miscarriage. Besides MIC-1, there are other cytokines, as well as chemokines, involved in facilitating early pregnancy. We reasoned that screening these factors in maternal plasma could uncover other predictive markers of miscarriage. Methods: This was a nested case control study, of 78 women from a prospective study of 462 attending the Early Pregnancy Assessment Unit in the first trimester (EPAU) with a threatened miscarriage; 34 of these subsequently miscarried (cases) and 44 went on to have a normal delivery (controls) Cytokines IL-1 beta, IL-6 and IL-10, and the chemokines, CXCL8, CCL2, CCL5, CCL7 and CX3CL1 were measured in plasma from our cohort. Results: The cytokines IL-1 beta, IL-6, IL-10 and the chemokine CXCL8 were not detectable in first trimester plasma. The chemokines CCL2, CCL5, CCL7 and CX3CL1 were detectable in all samples but levels did not vary across 5-12 weeks of gestation among controls. Plasma levels of these chemokines were no different in the miscarriage cohort compared to controls. Conclusion: The chemokines CCL2, CCL5, CCL7 and CX3CL1 were detectable in plasma during the first trimester while IL-1 beta, IL-6, IL-10 and CXCL8 were not. However, none of the cytokines and chemokines screened were different in maternal plasma in cases or controls. These therefore do not appear to have potential for application as predictive biomarkers of miscarriage.	[Hannan, Natalie J.; Kaitu'u-Lino, Tu'uhevaha J.; Tong, Stephen] Univ Melbourne, Dept Obstet & Gynaecol, Mercy Hosp Women, Translat Obstet Grp, Heidelberg, Vic, Australia; [Bambang, Katerina; Konje, Justin C.] Univ Leicester, Endocannabinoid Res Grp, Reprod Sci Sect, Dept Canc Studies & Mol Med, Leicester, Leics, England	University of Melbourne; University of Leicester	Hannan, NJ (corresponding author), Univ Melbourne, Dept Obstet & Gynaecol, Mercy Hosp Women, Translat Obstet Grp, Heidelberg, Vic, Australia.	nhannan@unimelb.edu.au	Proost, Paul/V-3052-2017	Proost, Paul/0000-0002-0133-5545; Hannan, Natalie/0000-0001-8446-2250; Kaitu'u-Lino, Tu'uhevaha/0000-0001-6233-9737; Tong, Stephen/0000-0002-2319-0586	Medical Research Council of the United Kingdom [G0801523]; National Health and Medical Research Council of Australia [628927, 1050765, 1062418]; MRC [G0801523] Funding Source: UKRI; Medical Research Council [G0801523] Funding Source: researchfish; National Institute for Health Research [PB-PG-0909-19305] Funding Source: researchfish	Medical Research Council of the United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The following funding bodies are acknowledged: The Medical Research Council of the United Kingdom for funding this work (#G0801523 to JCK) and The National Health and Medical Research Council of Australia who provided salary support (#628927 to NJH; #1050765 to ST; #1062418 to TJKL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arslan Emine, 2004, Archives of Gynecology and Obstetrics, V270, P227, DOI 10.1007/s00404-003-0547-0; Bates MD, 2002, HUM REPROD, V17, P2439, DOI 10.1093/humrep/17.9.2439; Calleja-Agius J, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/175041; Chaouat G, 2004, INT ARCH ALLERGY IMM, V134, P93, DOI 10.1159/000074300; Coomarasamy Arri, 2011, BMJ, V342, pd1914, DOI 10.1136/bmj.d1914; Dimitriadis E, 2006, J REPROD IMMUNOL, V69, P53, DOI 10.1016/j.jri.2005.07.004; Galazios G, 2011, J MATERN-FETAL NEO M, V24, P1283, DOI 10.3109/14767058.2011.575482; Hampton AL, 2001, J REPROD IMMUNOL, V49, P115, DOI 10.1016/S0165-0378(00)00082-6; Hanna J, 2003, BLOOD, V102, P1569, DOI 10.1182/blood-2003-02-0517; Hannan NJ, 2008, BIOL REPROD, V79, P58, DOI 10.1095/biolreprod.107.066480; Hannan NJ, 2007, CURR OPIN OBSTET GYN, V19, P266, DOI 10.1097/GCO.0b013e328133885f; Hannan NJ, 2011, EXPERT REV CLIN IMMU, V7, P789, DOI [10.1586/ECI.11.65, 10.1586/eci.11.65]; Hannan NJ, 2006, BIOL REPROD, V74, P896, DOI 10.1095/biolreprod.105.045518; Hannan NJ, 2004, J CLIN ENDOCR METAB, V89, P6119, DOI 10.1210/jc.2003-031379; Hefler LA, 2001, FERTIL STERIL, V76, P377, DOI 10.1016/S0015-0282(01)01914-8; Jasper MJ, 2007, J REPROD IMMUNOL, V73, P74, DOI 10.1016/j.jri.2006.06.003; Jauniaux E, 2006, HUM REPROD UPDATE, V12, P747, DOI 10.1093/humupd/dml016; Johns J, 2007, REPROD BIOMED ONLINE, V15, P413, DOI 10.1016/S1472-6483(10)60367-7; Jones RL, 2004, J CLIN ENDOCR METAB, V89, P6155, DOI 10.1210/jc.2004-0507; Kaitu'u-Lino TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072437; Kaitu'u-Lino TJ, 2012, J REPROD IMMUNOL, V95, P46, DOI 10.1016/j.jri.2012.06.003; KAUMA S, 1990, AM J OBSTET GYNECOL, V163, P1430, DOI 10.1016/0002-9378(90)90601-3; Koumantaki Y, 2001, EUR J OBSTET GYN R B, V98, P66, DOI 10.1016/S0301-2115(01)00289-5; Laird S, 2006, REPROD BIOMED ONLINE, V13, P13, DOI 10.1016/S1472-6483(10)62011-1; Lim KJH, 2000, FERTIL STERIL, V73, P136, DOI 10.1016/S0015-0282(99)00457-4; Marjono AB, 2003, PLACENTA, V24, P100, DOI 10.1053/plac.2002.0881; Muttukrishna S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018041; Red-Horse K, 2001, AM J PATHOL, V159, P2199, DOI 10.1016/S0002-9440(10)63071-4; Rumbold A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004073.pub3; Salamonsen LA, 2007, SEMIN REPROD MED, V25, P437, DOI 10.1055/s-2007-991041; Sato Y, 2003, DEVELOPMENT, V130, P5519, DOI 10.1242/dev.00729; Segerer SE, 2012, HUM REPROD, V27, P200, DOI 10.1093/humrep/der358; TABIBZADEH S, 1992, HUM REPROD, V7, P1214, DOI 10.1093/oxfordjournals.humrep.a137829; Tong S, 2004, LANCET, V363, P129, DOI 10.1016/S0140-6736(03)15265-8; Tong S, 2012, OBSTET GYNECOL, V119, P1000, DOI 10.1097/AOG.0b013e3182518fd3; von Wolff M, 2002, GYNECOL ENDOCRINOL, V16, P121, DOI 10.1080/713603031; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; Zenclussen AC, 2002, AM J REPROD IMMUNOL, V48, P245, DOI 10.1034/j.1600-0897.2002.01136.x; Zhang J, 2000, BIOL REPROD, V62, P404, DOI 10.1095/biolreprod62.2.404	39	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93320	10.1371/journal.pone.0093320	http://dx.doi.org/10.1371/journal.pone.0093320			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699265	Green Published, Green Submitted, gold			2022-12-25	WOS:000334105000051
J	Laitera, T; Sarajarvi, T; Haapasalo, A; Puli, L; Kauppinen, T; Makinen, P; Rauramaa, T; Tanila, H; Jaaskelainen, JE; Alafuzoff, I; Soininen, H; Leinonen, V; Hiltunen, M				Laitera, Tiina; Sarajarvi, Timo; Haapasalo, Annakaisa; Puli, Lakshman; Kauppinen, Tarja; Makinen, Petra; Rauramaa, Tuomas; Tanila, Heikki; Jaaskelainen, Juha E.; Alafuzoff, Irina; Soininen, Hilkka; Leinonen, Ville; Hiltunen, Mikko			Increased gamma-Secretase Activity in Idiopathic Normal Pressure Hydrocephalus Patients with beta-Amyloid Pathology	PLOS ONE			English	Article							CORTICAL BRAIN BIOPSY; ALZHEIMERS-DISEASE; EXPRESSION; PROTEIN; BACE1; ISCHEMIA; PATHWAY; APH-1; GENE; CSF	The potential similarity between the brain pathology of idiopathic normal pressure hydrocephalus (iNPH) and Alzheimer disease (AD) is intriguing and thus further studies focusing on the underlying molecular mechanisms may offer valuable information for differential diagnostics and the development of treatments for iNPH. Here, we investigated beta- and gamma-secretase activities in relation to amyloid-beta (A beta) pathology in the brain tissue samples collected from iNPH and AD patients. beta- and gamma-secretase activities were measured from the frontal cortical biopsies of 26 patients with suspected iNPH as well as post-mortem tissue samples from the inferior temporal cortex of 74 AD patients and eight subjects without neurofibrillary pathology. In iNPH samples with detectable A beta plaques, gamma-secretase activity was significantly increased (similar to 1.6-fold) when compared to iNPH samples without A beta plaques (p=0.009). In the AD samples, statistically significant differences in the gamma-secretase activity were not observed with respect to disease severity (mild, moderate and severe AD according to neurofibrillary pathology). Conversely, beta-secretase activity was unaltered in iNPH samples with or without A beta plaques, while it was significantly increased in relation to disease severity in the AD patients. These results show for the first time increased gamma-secretase but not b-secretase activity in the biopsy samples from the frontal cortex of iNPH patients with AD-like A beta pathology. Conversely, the opposite was observed in these secretase activities in AD patients with respect to neurofibrillary pathology. Despite the resemblances in the A beta pathology, iNPH and AD patients appear to have marked differences in the cellular mechanisms responsible for the production of A beta.	[Laitera, Tiina; Jaaskelainen, Juha E.; Leinonen, Ville] Univ Eastern Finland, Inst Clin Med Neurosurg, Kuopio, Finland; [Laitera, Tiina; Jaaskelainen, Juha E.; Leinonen, Ville] Kuopio Univ Hosp, Neurosurg NeuroCtr, SF-70210 Kuopio, Finland; [Sarajarvi, Timo; Haapasalo, Annakaisa; Kauppinen, Tarja; Makinen, Petra; Soininen, Hilkka; Hiltunen, Mikko] Univ Eastern Finland, Inst Clin Med Neurol, Kuopio, Finland; [Puli, Lakshman; Tanila, Heikki] Univ Eastern Finland, AI Virtanen Inst, Kuopio, Finland; [Rauramaa, Tuomas] Univ Eastern Finland, Inst Clin Med Pathol, Kuopio, Finland; [Rauramaa, Tuomas] Kuopio Univ Hosp, Dept Pathol, SF-70210 Kuopio, Finland; [Alafuzoff, Irina] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Soininen, Hilkka] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland	University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Uppsala University; Kuopio University Hospital; University of Eastern Finland	Hiltunen, M (corresponding author), Univ Eastern Finland, Inst Clin Med Neurol, Kuopio, Finland.	mikko.hiltunen@uef.fi	Sarajärvi, Timo/AAN-3855-2021	Sarajärvi, Timo/0000-0001-8710-1282; PULI, LAKSHMAN/0000-0001-9140-2360; Haapasalo, Annakaisa/0000-0003-0959-2957	Academy of Finland; Kuopio University Hospital [5772708]; Sigrid Juselius Foundation; University of Eastern Finland (UEF-Brain)	Academy of Finland(Academy of Finland); Kuopio University Hospital; Sigrid Juselius Foundation(Sigrid Juselius Foundation); University of Eastern Finland (UEF-Brain)	This study was funded by the Academy of Finland, EVO grant 5772708 of Kuopio University Hospital, Sigrid Juselius Foundation, and the Strategic Funding of the University of Eastern Finland (UEF-Brain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed RR, 2010, J NEUROCHEM, V112, P1045, DOI 10.1111/j.1471-4159.2009.06528.x; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; De Gasperi R, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-38; de la Torre JC, 2008, J ALZHEIMERS DIS, V14, P353; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; DELEON MJ, 1983, AM J NEURORADIOL, V4, P568; Farmery MR, 2003, J BIOL CHEM, V278, P24277, DOI 10.1074/jbc.M211992200; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Hakim S, 1965, J Neurol Sci, V2, P307, DOI 10.1016/0022-510X(65)90016-X; Imbimbo BP, 2011, CURR TOP MED CHEM, V11, P1555; Kakuda N, 2012, EMBO MOL MED, V4, P344, DOI 10.1002/emmm.201200214; Leinonen V, 2012, NEUROPATH APPL NEURO, V38, P72, DOI 10.1111/j.1365-2990.2011.01195.x; Leinonen V, 2010, ANN NEUROL, V68, P446, DOI 10.1002/ana.22100; Li L, 2009, NEUROBIOL AGING, V30, P1091, DOI 10.1016/j.neurobiolaging.2007.10.011; Liu F, 2013, EUR J NEUROSCI, V37, P1714, DOI 10.1111/ejn.12159; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Natunen T, 2013, J ALZHEIMERS DIS, V37, P217, DOI 10.3233/JAD-130104; Pluta R, 2007, CURR NEUROVASC RES, V4, P121, DOI 10.2174/156720207780637207; Relkin N, 2005, NEUROSURGERY, V57, P4, DOI 10.1227/01.NEU.0000168185.29659.C5; Seppala TT, 2012, NEUROLOGY, V78, P1568, DOI 10.1212/WNL.0b013e3182563bd0; Sun X, 2006, P NATL ACAD SCI USA, V103, P18727, DOI 10.1073/pnas.0606298103; Tabaton M, 2007, CELL MOL LIFE SCI, V64, P2211, DOI 10.1007/s00018-007-7219-3; Tanimukai H, 1998, MOL BRAIN RES, V54, P212, DOI 10.1016/S0169-328X(97)00337-9; Tanzi RE, 2004, NEURON, V43, P605, DOI 10.1016/j.neuron.2004.08.024; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Wen Y, 2004, BRAIN RES, V1009, P1, DOI 10.1016/j.brainres.2003.09.086; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Zhang X, 2007, J BIOL CHEM, V282, P10873, DOI 10.1074/jbc.M608856200	31	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93717	10.1371/journal.pone.0093717	http://dx.doi.org/10.1371/journal.pone.0093717			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699723	Green Published, Green Submitted, gold			2022-12-25	WOS:000334105000094
J	Nguitragool, W; Rayavara, K; Desai, SA				Nguitragool, Wang; Rayavara, Kempaiah; Desai, Sanjay A.			Proteolysis at a Specific Extracellular Residue Implicates Integral Membrane CLAG3 in Malaria Parasite Nutrient Channels	PLOS ONE			English	Article							SURFACE ANION CHANNEL; PLASMODIUM-FALCIPARUM; MULTIGENE FAMILY; RHOPTRY PROTEIN; PLASMA-MEMBRANE; ERYTHROCYTES; RESISTANCE; INVASION; PERMEABILITY; CHYMOTRYPSIN	The plasmodial surface anion channel mediates uptake of nutrients and other solutes into erythrocytes infected with malaria parasites. The clag3 genes of P. falciparum determine this channel's activity in human malaria, but how the encoded proteins contribute to transport is unknown. Here, we used proteases to examine the channel's composition and function. While proteases with distinct specificities all cleaved within an extracellular domain of CLAG3, they produced differing degrees of transport inhibition. Chymotrypsin-induced inhibition depended on parasite genotype, with channels induced by the HB3 parasite affected to a greater extent than those of the Dd2 clone. Inheritance of functional proteolysis in the HB3xDd2 genetic cross, DNA transfection, and gene silencing experiments all pointed to the clag3 genes, providing independent evidence for a role of these genes. Protease protection assays with a Dd2-specific inhibitor and site-directed mutagenesis revealed that a variant L1115F residue on a CLAG3 extracellular loop contributes to inhibitor binding and accounts for differences in functional proteolysis. These findings indicate that surface-exposed CLAG3 is the relevant pool of this protein for channel function. They also suggest structural models for how exposed CLAG3 domains contribute to pore formation and parasite nutrient uptake.	[Nguitragool, Wang; Rayavara, Kempaiah; Desai, Sanjay A.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Nguitragool, W (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA.	wang.ngu@mahidol.ac.th; sdesai@niaid.nih.gov		Nguitragool, Wang/0000-0002-5484-7130	National Institutes of Health, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000882] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexadre Jean Seme Fits, 2012, Tropical Medicine and Health, V40, P71, DOI 10.2149/tmh.2012-13; Alkhalil A, 2004, BLOOD, V104, P4279, DOI 10.1182/blood-2004-05-2047; Alkhalil A, 2007, CELL MICROBIOL, V9, P851, DOI 10.1111/j.1462-5822.2006.00834.x; Alkhalil A, 2009, MOL MICROBIOL, V72, P459, DOI 10.1111/j.1365-2958.2009.06661.x; ARMSTRONG CM, 1973, J GEN PHYSIOL, V62, P375, DOI 10.1085/jgp.62.4.375; Asahi H, 1996, PARASITOLOGY, V113, P19, DOI 10.1017/S0031182000066233; Baumeister S, 2006, MOL MICROBIOL, V60, P493, DOI 10.1111/j.1365-2958.2006.05112.x; Boddey JA, 2009, TRAFFIC, V10, P285, DOI 10.1111/j.1600-0854.2008.00864.x; Bouyer G, 2011, BLOOD, V118, P2305, DOI 10.1182/blood-2011-01-329300; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Bullen HE, 2012, CURR OPIN MICROBIOL, V15, P699, DOI 10.1016/j.mib.2012.09.008; Cohn JV, 2003, MOL BIOCHEM PARASIT, V132, P27, DOI 10.1016/j.molbiopara.2003.08.001; Cortes A, 2007, PLOS PATHOG, V3, P1023, DOI 10.1371/journal.ppat.0030107; Cortes A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002943; Counihan NA, 2013, TRENDS PARASITOL, V29, P228, DOI 10.1016/j.pt.2013.03.003; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Crowley VM, 2011, MOL MICROBIOL, V80, P391, DOI 10.1111/j.1365-2958.2011.07574.x; Desai SA, 2005, J BIOL CHEM, V280, P16861, DOI 10.1074/jbc.M414629200; Desai SA, 2005, NANOMED-NANOTECHNOL, V1, P58, DOI 10.1016/j.nano.2004.11.001; Desai SA, 2012, CELL MICROBIOL, V14, P1003, DOI 10.1111/j.1462-5822.2012.01790.x; El Bissati K, 2006, P NATL ACAD SCI USA, V103, P9286, DOI 10.1073/pnas.0602590103; FIEDLER F, 1987, EUR J BIOCHEM, V163, P303, DOI 10.1111/j.1432-1033.1987.tb10801.x; GINSBURG H, 1986, BIOCHIM BIOPHYS ACTA, V861, P194, DOI 10.1016/0005-2736(86)90418-9; Haerteis S, 2012, J GEN PHYSIOL, V140, P375, DOI 10.1085/jgp.201110763; HOMEWOOD CA, 1974, NATURE, V252, P718, DOI 10.1038/252718a0; Hviid L, 2010, HUM VACCINES, V6, P84, DOI 10.4161/hv.6.1.9602; Iriko H, 2008, MOL BIOCHEM PARASIT, V158, P11, DOI 10.1016/j.molbiopara.2007.11.004; Istvan ES, 2011, P NATL ACAD SCI USA, V108, P1627, DOI 10.1073/pnas.1011560108; Kaneko O, 2005, MOL BIOCHEM PARASIT, V143, P20, DOI 10.1016/j.molbiopara.2005.05.003; Kaneko O, 2001, MOL BIOCHEM PARASIT, V118, P223, DOI 10.1016/S0166-6851(01)00391-7; Kaneko O, 2007, PARASITOL INT, V56, P255, DOI 10.1016/j.parint.2007.05.003; Kang MS, 2005, MOL PHARMACOL, V68, P34, DOI 10.1124/mol.104.010553; Kerr LD, 2009, J MED CHEM, V52, P852, DOI 10.1021/jm8013663; King LS, 2000, MOL MED TODAY, V6, P60, DOI 10.1016/S1357-4310(99)01636-6; KUTNER S, 1985, J CELL PHYSIOL, V125, P521, DOI 10.1002/jcp.1041250323; KUTNER S, 1987, BIOCHEM PHARMACOL, V36, P123, DOI 10.1016/0006-2952(87)90389-3; Li J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-337; Lisk G, 2005, EUKARYOT CELL, V4, P2153, DOI 10.1128/EC.4.12.2153-2159.2005; Lisk G, 2008, ANTIMICROB AGENTS CH, V52, P2346, DOI 10.1128/AAC.00057-08; Liu J, 2005, J BIOL CHEM, V280, P1432, DOI 10.1074/jbc.M409740200; Lyko B, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-124; MCCONN J, 1971, J BIOL CHEM, V246, P2918; Mira-Martinez S, 2013, CELL MICROBIOL, V15, P1913, DOI 10.1111/cmi.12162; NARAHASH.Y, 1968, J BIOCHEM-TOKYO, V64, P427, DOI 10.1093/oxfordjournals.jbchem.a128914; Nguitragool W, 2011, CELL, V145, P665, DOI 10.1016/j.cell.2011.05.002; Ocampo M, 2005, PROTEIN SCI, V14, P504, DOI 10.1110/ps.04883905; Pillai AD, 2012, MOL PHARMACOL, V82, P1104, DOI 10.1124/mol.112.081224; Pillai AD, 2010, MOL PHARMACOL, V77, P724, DOI 10.1124/mol.109.062711; ROSENTHAL PJ, 1988, J CLIN INVEST, V82, P1560, DOI 10.1172/JCI113766; Saliba KJ, 1998, J BIOL CHEM, V273, P10190, DOI 10.1074/jbc.273.17.10190; Sharma P, 2013, J BIOL CHEM, V288, P19429, DOI 10.1074/jbc.M113.468371; Staines HM, 2007, INT J PARASITOL, V37, P475, DOI 10.1016/j.ijpara.2006.12.013; Trenholme KR, 2000, P NATL ACAD SCI USA, V97, P4029, DOI 10.1073/pnas.040561197; van Ooij C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000084; Vincensini L, 2008, MOL BIOCHEM PARASIT, V160, P81, DOI 10.1016/j.molbiopara.2008.04.002; Wagner MA, 2003, BIOPHYS J, V84, P116, DOI 10.1016/S0006-3495(03)74836-X	56	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93759	10.1371/journal.pone.0093759	http://dx.doi.org/10.1371/journal.pone.0093759			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699906	Green Published, Green Submitted, gold			2022-12-25	WOS:000334105000101
J	Weng, LM; Ziliak, D; LaCroix, B; Geeleher, P; Huang, RS				Weng, Liming; Ziliak, Dana; LaCroix, Bonnie; Geeleher, Paul; Huang, R. Stephanie			Integrative "Omic" Analysis for Tamoxifen Sensitivity through Cell Based Models	PLOS ONE			English	Article							BREAST-CANCER; TRANSCRIPTION; RECEPTOR; DISCOVERY; PATHWAY	It has long been observed that tamoxifen sensitivity varies among breast cancer patients. Further, ethnic differences of tamoxifen therapy between Caucasian and African American have also been reported. Since most studies have been focused on Caucasian people, we sought to comprehensively evaluate genetic variants related to tamoxifen therapy in African-derived samples. An integrative "omic" approach developed by our group was used to investigate relationships among endoxifen (an active metabolite of tamoxifen) sensitivity, SNP genotype, mRNA and microRNA expressions in 58 HapMap YRI lymphoblastoid cell lines. We identified 50 SNPs that associate with cellular sensitivity to endoxifen through their effects on 34 genes and 30 microRNA expression. Some of these findings are shared in both Caucasian and African samples, while others are unique in the African samples. Among gene/microRNA that were identified in both ethnic groups, the expression of TRAF1 is also correlated with tamoxifen sensitivity in a collection of 44 breast cancer cell lines. Further, knock-down TRAF1 and over-expression of hsa-let-7i confirmed the roles of hsa-let-7i and TRAF1 in increasing tamoxifen sensitivity in the ZR-75-1 breast cancer cell line. Our integrative omic analysis facilitated the discovery of pharmacogenomic biomarkers that potentially affect tamoxifen sensitivity.	[Weng, Liming; Ziliak, Dana; LaCroix, Bonnie; Geeleher, Paul; Huang, R. Stephanie] Univ Chicago, Dept Med, Sect Hematol & Oncol, Chicago, IL 60637 USA	University of Chicago	Huang, RS (corresponding author), Univ Chicago, Dept Med, Sect Hematol & Oncol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	rhuang@medicine.bsd.uchicago.edu	Weng, Liming/E-7791-2015; Geeleher, Paul/C-7040-2019	LaCroix, Bonnie/0000-0002-6833-5267; Huang, R. Stephanie/0000-0002-9862-0368	University of Chicago Cancer Center Support Grant [P30 CA14599]; National Institutes of Health/National Institute of General Medical Science [U01GM61393]; National Institute of General Medical Science [K08 (GM089941)]; National Cancer Institute [R21 (CA139278)]; University of Chicago Breast Cancer SPORE Career Development Award [CA125183]; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1RR024999]; NATIONAL CANCER INSTITUTE [P30CA014599, P50CA125183, R21CA139278] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM089941, U01GM061393] Funding Source: NIH RePORTER	University of Chicago Cancer Center Support Grant; National Institutes of Health/National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Chicago Breast Cancer SPORE Career Development Award; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study is supported by the University of Chicago Cancer Center Support Grant (#P30 CA14599) and the National Institutes of Health/National Institute of General Medical Science (Pharmacogenomics of Anticancer Agents grant U01GM61393). RSH also received support from the National Institute of General Medical Science K08 (GM089941), the National Cancer Institute R21 (CA139278), the University of Chicago Breast Cancer SPORE Career Development Award (CA125183), and the National Center for Advancing Translational Sciences of the National Institutes of Health (UL1RR024999). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nasiry S, 2007, HUM REPROD, V22, P1304, DOI 10.1093/humrep/dem011; Bernassola F, 2010, CELL DEATH DIFFER, V17, P1, DOI 10.1038/cdd.2009.189; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Cao J, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00026; Clarke R, 2001, PHARMACOL REV, V53, P25; Escarcega RO, 2007, CLIN ONCOL-UK, V19, P154, DOI 10.1016/j.clon.2006.11.013; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Gamazon Eric R., 2013, Frontiers in Genetics, V3, P202, DOI 10.3389/fgene.2012.00202; Gamazon ER, 2012, AM J HUM GENET, V90, P1046, DOI 10.1016/j.ajhg.2012.04.023; Gamazon ER, 2010, BIOINFORMATICS, V26, P259, DOI 10.1093/bioinformatics/btp644; Heiser LM, 2012, P NATL ACAD SCI USA, V109, P2724, DOI 10.1073/pnas.1018854108; Huang RS, 2007, AM J HUM GENET, V81, P427, DOI 10.1086/519850; Huang RS, 2011, CLIN CANCER RES, V17, P5490, DOI 10.1158/1078-0432.CCR-11-0724; Inoue A, 2004, J MOL ENDOCRINOL, V32, P649, DOI 10.1677/jme.0.0320649; Jemal A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1672; Lee JC, 2003, IMMUNOL REV, V193, P39, DOI 10.1034/j.1600-065X.2003.00043.x; Lin CY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r66; Moller S, 2008, ACTA ONCOL, V47, P506, DOI 10.1080/02841860802059259; Mueller MD, 2000, P NATL ACAD SCI USA, V97, P10972, DOI 10.1073/pnas.200377097; Newman LA, 2005, ONCOLOGIST, V10, P1, DOI 10.1634/theoncologist.10-1-1; Svaren J, 1996, MOL CELL BIOL, V16, P3545; Welsh M, 2009, PHARMACOL REV, V61, P413, DOI 10.1124/pr.109.001461; Weng L, 2013, ANN ONCOL, P1; Yang G, 2013, PHARMACOL THERAPEUT, V139, P392, DOI 10.1016/j.pharmthera.2013.05.005; Zapata JM, 2001, J BIOL CHEM, V276, P24242, DOI 10.1074/jbc.M100354200; Zhao YC, 2011, MOL MED, V17, P1233, DOI 10.2119/molmed.2010.00225; Ziliak D, 2011, TRANSL RES, V157, P265, DOI 10.1016/j.trsl.2011.01.005	27	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93420	10.1371/journal.pone.0093420	http://dx.doi.org/10.1371/journal.pone.0093420			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699530	Green Published, gold, Green Submitted			2022-12-25	WOS:000334105000060
J	Bello, NT; Yeh, CY; Verpeut, JL; Walters, AL				Bello, Nicholas T.; Yeh, Chung-Yang; Verpeut, Jessica L.; Walters, Amy L.			Binge-Like Eating Attenuates Nisoxetine Feeding Suppression, Stress Activation, and Brain Norepinephrine Activity	PLOS ONE			English	Article							LIMITED ACCESS; BULIMIA-NERVOSA; RECEPTOR EXPRESSION; INTERMITTENT ACCESS; GENDER DIFFERENCES; PREFRONTAL CORTEX; LOCUS-COERULEUS; REBOXETINE; ANTIDEPRESSANT; RESPONSES	Stress is often associated with binge eating. A critical component of the control of stress is the central norepinephrine system. We investigated how dietary-induced binge eating alters central norepinephrine and related behaviors. Young male Sprague Dawley rats received calorie deprivation (24 h) and /or intermittent sweetened fat (vegetable shortening with sucrose; 30 min) twice a week for 10 weeks. The groups were Restrict Binge (calorie deprivation/sweetened fat), Binge (sweetened fat), Restrict (calorie deprivation), and Naive (no calorie deprivation/no sweetened fat). Dietary-induced binge eating was demonstrated by Restrict Binge and Binge, which showed an escalation in 30-min intake over time. Feeding suppression following nisoxetine (3 mg/kg; IP), a selective norepinephrine reuptake inhibitor, was not evident in Restrict Binge (Restrict Binge: 107 +/- 13, Binge: 52 +/- 9, Restrict: 80 +/- 8, Naive: 59 +/- 13% of saline injection at 1 h). In subsequent experiments with Restrict Binge and Naive, Restrict Binge had reduced corticosterone (Restrict Binge: 266625; Naive: 494 +/- 36 ng/ml) and less feeding suppression (Restrict Binge: 81 +/- 12, Naive: 50 +/- 11% of non-restraint intake at 30 min) following restraint stress (1 h). Dietary-induced binge eating in Restrict Binge was not altered by a dorsal noradrenergic bundle lesion caused by N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP4), but frontal cortex norepinephrine was positively correlated with the average 30-min intake post- lesion (0.69; p<0.01). In a separate set of animals, single-unit in vivo electrophysiological recording of locus coeruleus-norepinephrine neural activity demonstrated reduced sensory-evoked response as a consequence of the Restrict Binge schedule (Restrict Binge: 8.1 +/- 0.67, Naive: 11.9 +/- 1.09 Hz). These results, which suggest that a consequence of dietary-induced binge eating is to attenuate the responsiveness of the brain norepinephrine system, will further our understanding of how highly palatable foods dampen the stress neuraxis.	[Bello, Nicholas T.; Yeh, Chung-Yang; Verpeut, Jessica L.; Walters, Amy L.] Rutgers State Univ, Dept Anim Sci, New Brunswick, NJ 08903 USA; [Bello, Nicholas T.; Verpeut, Jessica L.] Rutgers State Univ, Grad Program Endocrinol & Anim Biosci, New Brunswick, NJ 08903 USA; [Bello, Nicholas T.] Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Bello, NT (corresponding author), Rutgers State Univ, Dept Anim Sci, New Brunswick, NJ 08903 USA.	ntbello@aesop.rutgers.edu		Verpeut, Jessica/0000-0003-2941-7697; Yeh, Chung-Yang/0000-0002-0970-1300; Bello, Nicholas/0000-0001-5300-5604	USDA-NIFA [NJ06156]; Busch Biomedical Grant Program	USDA-NIFA(United States Department of Agriculture (USDA)); Busch Biomedical Grant Program	Support was provided by NJ06156 (USDA-NIFA) and the Busch Biomedical Grant Program (http://ored.rutgers.edu/internal-funding-programs/busch-biomedical-grant-program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT, Vxxvii; Aston-Jones G, 2000, PROG BRAIN RES, V126, P165; Babbs RK, 2012, APPETITE, V59, P478, DOI 10.1016/j.appet.2012.05.022; Bambico FR, 2010, NEUROBIOL DIS, V37, P641, DOI 10.1016/j.nbd.2009.11.020; Barry DT, 2002, INT J EAT DISORDER, V31, P63, DOI 10.1002/eat.1112; Bello NT, 2013, J OBES, V2013, DOI 10.1155/2013/457047; Bello NT, 2012, PHYSIOL BEHAV, V105, P720, DOI 10.1016/j.physbeh.2011.09.021; Bello NT, 2011, PHYSIOL BEHAV, V104, P98, DOI 10.1016/j.physbeh.2011.04.032; Bello NT, 2009, AM J PHYSIOL-REG I, V297, pR622, DOI 10.1152/ajpregu.00087.2009; Berner LA, 2008, OBESITY, V16, P1998, DOI 10.1038/oby.2008.328; Bingham B, 2011, NEUROPSYCHOPHARMACOL, V36, P896, DOI 10.1038/npp.2010.229; Boggiano M.M., 2006, CURR PROTOC NEUROSCI, V23A; Burton E, 2007, INT J EAT DISORDER, V40, P27, DOI 10.1002/eat.20292; Cheetham SC, 1996, NEUROPHARMACOLOGY, V35, P63, DOI 10.1016/0028-3908(95)00134-4; Cohen-Yavin I, 2009, CLIN NEUROPHARMACOL, V32, P179, DOI 10.1097/WNF.0b013e318183796d; Colantuoni C, 2002, OBES RES, V10, P478, DOI 10.1038/oby.2002.66; Corwin RL, 2011, PHYSIOL BEHAV, V104, P87, DOI 10.1016/j.physbeh.2011.04.041; Corwin RL, 1998, PHYSIOL BEHAV, V65, P545, DOI 10.1016/S0031-9384(98)00201-7; Corwin RL, 2004, APPETITE, V42, P139, DOI 10.1016/j.appet.2003.08.010; Cottone P, 2008, AM J PHYSIOL-REG I, V295, pR1066, DOI 10.1152/ajpregu.90309.2008; Cryan JF, 2002, EUR J PHARMACOL, V436, P197, DOI 10.1016/S0014-2999(01)01628-4; Cullinan WE, 2008, BRAIN STRUCT FUNCT, V213, P63, DOI 10.1007/s00429-008-0192-2; Dallman MF, 2010, TRENDS ENDOCRIN MET, V21, P159, DOI 10.1016/j.tem.2009.10.004; Davis JF, 2007, PHYSIOL BEHAV, V92, P924, DOI 10.1016/j.physbeh.2007.06.024; El-Giamal N, 2000, INT CLIN PSYCHOPHARM, V15, P351, DOI 10.1097/00004850-200015060-00006; ELMORE DK, 1991, PHYSIOL BEHAV, V49, P99, DOI 10.1016/0031-9384(91)90238-J; Fassino S, 2004, J PSYCHOPHARMACOL, V18, P423, DOI 10.1177/026988110401800314; Field AE, 2013, JAMA PEDIAT; FOOTE SL, 1983, PHYSIOL REV, V63, P844, DOI 10.1152/physrev.1983.63.3.844; Foster MT, 2009, ENDOCRINOLOGY, V150, P2325, DOI 10.1210/en.2008-1426; Gardner EL, 2011, ADV PSYCHOSOM MED, V30, P22, DOI 10.1159/000324065; GEORGE DT, 1990, PSYCHIAT RES, V33, P1, DOI 10.1016/0165-1781(90)90143-S; Gibson EL, 2006, PHYSIOL BEHAV, V89, P53, DOI 10.1016/j.physbeh.2006.01.024; Ginty AT, 2012, PSYCHONEUROENDOCRINO, V37, P715, DOI 10.1016/j.psyneuen.2011.09.004; GREENO CG, 1994, PSYCHOL BULL, V115, P444, DOI 10.1037/0033-2909.115.3.444; Greeno CG, 2000, J CONSULT CLIN PSYCH, V68, P95, DOI 10.1037/0022-006X.68.1.95; Itoi K, 2010, J NEUROENDOCRINOL, V22, P355, DOI 10.1111/j.1365-2826.2010.01988.x; JONSSON G, 1981, EUR J PHARMACOL, V72, P173, DOI 10.1016/0014-2999(81)90272-7; Karteris E, 2005, AM J PHYSIOL-ENDOC M, V288, pE1089, DOI 10.1152/ajpendo.00351.2004; KAYE WH, 1990, AM J PSYCHIAT, V147, P225; Kinzig KP, 2008, PHYSIOL BEHAV, V95, P108, DOI 10.1016/j.physbeh.2008.04.026; Koo-Loeb JH, 1998, PSYCHIAT RES, V80, P13, DOI 10.1016/S0165-1781(98)00057-2; la Fleur SE, 2005, ENDOCRINOLOGY, V146, P2193, DOI 10.1210/en.2004-1603; Lardeux S, 2013, PHYSIOL BEHAV, V114, P21, DOI 10.1016/j.physbeh.2013.03.005; Laugero KD, 2001, ENDOCRINOLOGY, V142, P2796, DOI 10.1210/en.142.7.2796; LEIBOWITZ SF, 1988, NEUROSCI BIOBEHAV R, V12, P101, DOI 10.1016/S0149-7634(88)80002-2; LEMBERGER L, 1976, BRIT J CLIN PHARMACO, V3, P215, DOI 10.1111/j.1365-2125.1976.tb00595.x; Levin BE, 1996, AM J PHYSIOL-REG I, V270, pR456, DOI 10.1152/ajpregu.1996.270.2.R456; Lewinsohn PM, 2002, INT J EAT DISORDER, V32, P426, DOI 10.1002/eat.10103; McElroy SL, 2007, J CLIN PSYCHIAT, V68, P390, DOI 10.4088/JCP.v68n0306; McGee HM, 2010, BRAIN RES, V1350, P103, DOI 10.1016/j.brainres.2010.01.033; Merali Z, 2003, BIOL PSYCHIAT, V54, P552, DOI 10.1016/S0006-3223(02)01827-9; Millan MJ, 2007, INT J NEUROPSYCHOPH, V10, P579, DOI 10.1017/S1461145706007309; Miner LH, 2003, J COMP NEUROL, V466, P478, DOI 10.1002/cne.10898; Moron JA, 2002, J NEUROSCI, V22, P389, DOI 10.1523/JNEUROSCI.22-02-00389.2002; Mussell MP, 1997, INT J EAT DISORDER, V21, P353, DOI 10.1002/(SICI)1098-108X(1997)21:4&lt;353::AID-EAT8&gt;3.0.CO;2-N; Ottersen O P, 1986, Adv Exp Med Biol, V203, P263; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pecoraro N, 2004, ENDOCRINOLOGY, V145, P3754, DOI 10.1210/en.2004-0305; Radley JJ, 2008, J NEUROSCI, V28, P5806, DOI 10.1523/JNEUROSCI.0552-08.2008; Radley JJ, 2009, J NEUROSCI, V29, P7330, DOI 10.1523/JNEUROSCI.5924-08.2009; Rinaman L, 2011, AM J PHYSIOL-REG I, V300, pR222, DOI 10.1152/ajpregu.00556.2010; Rosenberg N, 2012, PSYCHIAT RES; Rowley HL, 2000, N-S ARCH PHARMACOL, V361, P187, DOI 10.1007/s002109900170; Telch CF, 1996, INT J EAT DISORDER, V20, P271, DOI 10.1002/(SICI)1098-108X(199611)20:3&lt;271::AID-EAT6&gt;3.0.CO;2-L; Valentino RJ, 2008, EUR J PHARMACOL, V583, P194, DOI 10.1016/j.ejphar.2007.11.062; Vanderlinden J, 2004, Eat Weight Disord, V9, P300; Waters A, 2001, INT J EAT DISORDER, V29, P17, DOI 10.1002/1098-108X(200101)29:1<17::AID-EAT3>3.0.CO;2-R; Wojnicki FHE, 2008, PHYSIOL BEHAV, V95, P649, DOI 10.1016/j.physbeh.2008.09.017; WOLFMAN C, 1994, NEUROCHEM INT, V25, P395, DOI 10.1016/0197-0186(94)90147-3	71	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93610	10.1371/journal.pone.0093610	http://dx.doi.org/10.1371/journal.pone.0093610			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LC	24695494	Green Submitted, gold, Green Published			2022-12-25	WOS:000334103000093
J	Brakel, J; Werner, FJ; Tams, V; Reusch, TBH; Bockelmann, AC				Brakel, Janina; Werner, Franziska Julie; Tams, Verena; Reusch, Thorsten B. H.; Bockelmann, Anna-Christina			Current European Labyrinthula zosterae Are Not Virulent and Modulate Seagrass (Zostera marina) Defense Gene Expression	PLOS ONE			English	Article							EELGRASS WASTING DISEASE; CELL-DEATH; PHENOLIC-COMPOUNDS; TALL FESCUE; ENDOPHYTE; STRESS; INFECTION; IMMUNITY; POPULATIONS; RECURRENCE	Pro- and eukaryotic microbes associated with multi-cellular organisms are receiving increasing attention as a driving factor in ecosystems. Endophytes in plants can change host performance by altering nutrient uptake, secondary metabolite production or defense mechanisms. Recent studies detected widespread prevalence of Labyrinthula zosterae in European Zostera marina meadows, a protist that allegedly caused a massive amphi-Atlantic seagrass die-off event in the 1930's, while showing only limited virulence today. As a limiting factor for pathogenicity, we investigated genotypexgenotype interactions of host and pathogen from different regions (10-100 km-scale) through reciprocal infection. Although the endophyte rapidly infected Z. marina, we found little evidence that Z. marina was negatively impacted by L. zosterae. Instead Z. marina showed enhanced leaf growth and kept endophyte abundance low. Moreover, we found almost no interaction of protistxeelgrass-origin on different parameters of L. zosterae virulence/Z. marina performance, and also no increase in mortality after experimental infection. In a target gene approach, we identified a significant down-regulation in the expression of 6/11 genes from the defense cascade of Z. marina after real-time quantitative PCR, revealing strong immune modulation of the host's defense by a potential parasite for the first time in a marine plant. Nevertheless, one gene involved in phenol synthesis was strongly up-regulated, indicating that Z. marina plants were probably able to control the level of infection. There was no change in expression in a general stress indicator gene (HSP70). Mean L. zosterae abundances decreased below 10% after 16 days of experimental runtime. We conclude the under non-stress conditions L. zosterae infection in the study region is not associated with substantial virulence.	[Brakel, Janina; Werner, Franziska Julie; Bockelmann, Anna-Christina] Geomar Helmholtz Ctr Ocean Res Kiel, Expt Ecol Food webs, Kiel, Germany; [Tams, Verena; Reusch, Thorsten B. H.] Geomar Helmholtz Ctr Ocean Res Kiel, Evolutionary Ecol Marine Fishes, Kiel, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel	Bockelmann, AC (corresponding author), Geomar Helmholtz Ctr Ocean Res Kiel, Expt Ecol Food webs, Kiel, Germany.	abockelmann@geomar.de	Reusch, Thorsten B. H./B-9311-2019; Reusch, Thorsten B.H./G-4141-2011	Reusch, Thorsten B. H./0000-0002-8961-4337; Tams, Verena/0000-0002-9539-2603	State Agency for Agriculture, Environment and Rural Areas for Schleswig-Holstein(LLUR); excellence cluster "The Future Ocean"; Claussen-Simon-Foundation	State Agency for Agriculture, Environment and Rural Areas for Schleswig-Holstein(LLUR); excellence cluster "The Future Ocean"; Claussen-Simon-Foundation	The State Agency for Agriculture, Environment and Rural Areas for Schleswig-Holstein(LLUR) (http://www.schleswig-holstein.de/LLUR/EN/LLUR_node.html) and the excellence cluster "The Future Ocean" (http://www.futureocean.org/en/index.php) have funded the research project. The Claussen-Simon-Foundation provided funding for AC Bockelmann (http://www.claussen-simon-stiftung.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; ARACHEVALETA M, 1989, AGRON J, V81, P83, DOI 10.2134/agronj1989.00021962008100010015x; Arnold TM, 2002, J CHEM ECOL, V28, P1919, DOI 10.1023/A:1020737609151; Belesky DP, 1996, ANN BOT-LONDON, V78, P499, DOI 10.1006/anbo.1996.0147; Bergmann N, 2010, MOL ECOL, V19, P2870, DOI 10.1111/j.1365-294X.2010.04731.x; Bockelmann AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062169; Bockelmann AC, 2012, MAR ECOL PROG SER, V445, P109, DOI 10.3354/meps09398; BUCHSBAUM RN, 1990, AQUAT BOT, V37, P291, DOI 10.1016/0304-3770(90)90075-V; BUSH LP, 1993, AGR ECOSYST ENVIRON, V44, P81, DOI 10.1016/0167-8809(93)90040-V; CHRISTIANSEN C, 1981, SEDIMENT GEOL, V28, P163, DOI 10.1016/0037-0738(81)90063-4; Coll NS, 2011, CELL DEATH DIFFER, V18, P1247, DOI 10.1038/cdd.2011.37; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; da Cunha L, 2006, MICROBES INFECT, V8, P1372, DOI 10.1016/j.micinf.2005.12.018; Dangl JL, 2013, SCIENCE, V341, P746, DOI 10.1126/science.1236011; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; DEN HARTOG C., 1970, SEA GRASSES WORLD; DENHARTOG C, 1987, AQUAT BOT, V27, P3, DOI 10.1016/0304-3770(87)90082-9; Duarte CM, 1999, AQUAT BOT, V65, P159, DOI 10.1016/S0304-3770(99)00038-8; Duarte CM, 2005, BIOGEOSCIENCES, V2, P1, DOI 10.5194/bg-2-1-2005; Faeth SH, 2002, OIKOS, V98, P25, DOI 10.1034/j.1600-0706.2002.980103.x; Gachon CMM, 2010, TRENDS PLANT SCI, V15, P633, DOI 10.1016/j.tplants.2010.08.005; Garrett KA, 2006, ANNU REV PHYTOPATHOL, V44, P489, DOI 10.1146/annurev.phyto.44.070505.143420; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; HARRISON PG, 1982, MAR BIOL, V67, P225, DOI 10.1007/BF00401288; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hemminga M.A., 2000, SEAGRASS ECOLOGY, DOI [10.1017/CBO9780511525551, DOI 10.1017/CBO9780511525551]; Hofius D, 2007, SEMIN CANCER BIOL, V17, P166, DOI 10.1016/j.semcancer.2006.12.001; Jacobs S, 2013, ROOT BASED INNATE IM, P223; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Malinowski DP, 1998, PLANT SOIL, V205, P1, DOI 10.1023/A:1004331932018; Malinowski DP, 2000, CROP SCI, V40, P923, DOI 10.2135/cropsci2000.404923x; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; McKone KL, 2009, MAR ECOL PROG SER, V377, P123, DOI 10.3354/meps07860; MUEHLSTEIN LK, 1988, MAR BIOL, V99, P465, DOI 10.1007/BF00392553; MUEHLSTEIN LK, 1989, DIS AQUAT ORGAN, V7, P211, DOI 10.3354/dao007211; NICHOLSON RL, 1992, ANNU REV PHYTOPATHOL, V30, P369, DOI 10.1146/annurev.py.30.090192.002101; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Popay AJ, 2005, NEOTYPHODIUM IN COOL-SEASON GRASSES, P163, DOI 10.1002/9780470384916.ch7; Prestidge R., 1982, P 35 NZ WEED PEST CO, V35, P119; QUACKENBUSH RC, 1986, AQUAT BOT, V24, P83, DOI 10.1016/0304-3770(86)90119-1; Renn CE, 1936, BIOL BULL-US, V70, P148, DOI 10.2307/1537320; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Robb J, 2007, PLANTA, V226, P299, DOI 10.1007/s00425-007-0482-6; Romero J, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P227; Schlink K, 2010, FUNCT INTEGR GENOMIC, V10, P253, DOI 10.1007/s10142-009-0143-x; Shiraishi T, 1997, INT REV CYTOL, V172, P55, DOI 10.1016/S0074-7696(08)62358-X; SHORT FT, 1986, MAR ECOL PROG SER, V29, P89, DOI 10.3354/meps029089; SHORT FT, 1988, AQUAT BOT, V30, P295, DOI 10.1016/0304-3770(88)90062-9; SHORT FT, 1987, BIOL BULL, V173, P557, DOI 10.2307/1541701; SIEGEL MR, 1990, J CHEM ECOL, V16, P3301, DOI 10.1007/BF00982100; Smith D. M., 2005, INTRO R NOTES R PROG; Spoel SH, 2012, NAT REV IMMUNOL, V12, P89, DOI 10.1038/nri3141; Steele L, 2005, MAR ECOL PROG SER, V303, P123, DOI 10.3354/meps303123; Tanaka A, 2012, CURR OPIN PLANT BIOL, V15, P462, DOI 10.1016/j.pbi.2012.03.007; TODD JS, 1993, PHYTOCHEMISTRY, V34, P401, DOI 10.1016/0031-9422(93)80017-M; Tomas F, 2011, ECOLOGY, V92, P1807, DOI 10.1890/10-2095.1; Torres MA, 2005, NAT GENET, V37, P1130, DOI 10.1038/ng1639; Van der Veen TT, 1999, WILDFOWL WETLAND TRU, V50, P57; van Katwijk MM, 2010, BIOL CONSERV, V143, P248, DOI 10.1016/j.biocon.2009.08.014; VERGEER LHT, 1995, AQUAT BOT, V52, P35, DOI 10.1016/0304-3770(95)00480-N; Waller F, 2005, P NATL ACAD SCI USA, V102, P13386, DOI 10.1073/pnas.0504423102; WATERMAN PG, 1984, J CHEM ECOL, V10, P387, DOI 10.1007/BF00988087; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Winters G, 2011, MAR ECOL PROG SER, V435, P83, DOI 10.3354/meps09213; Wissler L, 2009, DR ZOMPO ONLINE DATA, DOI 010.1093/database/bap1009; Wohlenberg E, 1935, BEITRAGE HEIMATFORSC, V11, P1; Wooldridge SA, 2010, BIOESSAYS, V32, P615, DOI 10.1002/bies.200900182	70	27	27	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92448	10.1371/journal.pone.0092448	http://dx.doi.org/10.1371/journal.pone.0092448			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691450	Green Published, gold, Green Accepted			2022-12-25	WOS:000334101100025
J	Fancello, L; Monteil, S; Popgeorgiev, N; Rivet, R; Gouriet, F; Fournier, PE; Raoult, D; Desnues, C				Fancello, Laura; Monteil, Sonia; Popgeorgiev, Nikolay; Rivet, Romain; Gouriet, Frederique; Fournier, Pierre-Edouard; Raoult, Didier; Desnues, Christelle			Viral Communities Associated with Human Pericardial Fluids in Idiopathic Pericarditis	PLOS ONE			English	Article							TT VIRUS-INFECTION; SEQUENCE HETEROGENEITY; ETIOLOGIC DIAGNOSIS; MONOZYGOTIC TWINS; COMPLETE GENOME; DNA; HEPATITIS; GENES	Pericarditis is a common human disease defined by inflammation of the pericardium. Currently, 40% to 85% of pericarditis cases have no identified etiology. Most of these cases are thought to be caused by an infection of undetected, unsuspected or unknown viruses. In this work, we used a culture-and sequence-independent approach to investigate the viral DNA communities present in human pericardial fluids. Seven viral metagenomes were generated from the pericardial fluid of patients affected by pericarditis of unknown etiology and one metagenome was generated from the pericardial fluid of a sudden infant death case. As a positive control we generated one metagenome from the pericardial fluid of a patient affected by pericarditis caused by herpesvirus type 3. Furthermore, we used as negative controls a total of 6 pericardial fluids from 6 different individuals affected by pericarditis of non-infectious origin: 5 of them were sequenced as a unique pool and the remaining one was sequenced separately. The results showed a significant presence of torque teno viruses especially in one patient, while herpesviruses and papillomaviruses were present in the positive control. Co-infections by different genotypes of the same viral type (torque teno viruses) or different viruses (herpesviruses and papillomaviruses) were observed. Sequences related to bacteriophages infecting Staphylococcus, Enterobacteria, Streptococcus, Burkholderia and Pseudomonas were also detected in three patients. This study detected torque teno viruses and papillomaviruses, for the first time, in human pericardial fluids.	[Fancello, Laura; Monteil, Sonia; Popgeorgiev, Nikolay; Rivet, Romain; Gouriet, Frederique; Fournier, Pierre-Edouard; Raoult, Didier; Desnues, Christelle] Aix Marseille Univ, URMITE, CNRS, Unite Rech Maladies Infect & Trop Emergentes,UMR, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Desnues, C (corresponding author), Aix Marseille Univ, URMITE, CNRS, Unite Rech Maladies Infect & Trop Emergentes,UMR, Marseille, France.	christelle.desnues@univ-amu.fr	Fournier, Pierre-Edouard/AAC-6155-2021; Desnues, Christelle/B-1383-2010; Desnues, Christelle/ABG-2910-2021; Fancello, Laura/K-2218-2013; RAOULT, Didier/A-8434-2008	Fournier, Pierre-Edouard/0000-0001-8463-8885; Desnues, Christelle/0000-0002-2178-0355; Desnues, Christelle/0000-0002-2178-0355; RAOULT, Didier/0000-0002-0633-5974; Popgeorgiev, Nikolay/0000-0002-4835-5201; Fancello, Laura/0000-0003-4708-4080; RIVET, Romain/0000-0002-7290-6069	European Research Council [242729]	European Research Council(European Research Council (ERC)European Commission)	The research of LF and CD is financed through a starting grant number 242729 from the European Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1999, J CLIN MICROBIOL, V37, P2703, DOI 10.1128/JCM.37.8.2703-2705.1999; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Angly FE, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000593; Balding C, 2005, ENVIRON MICROBIOL, V7, P1558, DOI 10.1111/j.1462-2920.2005.00845.x; Ball JK, 1999, J GEN VIROL, V80, P1759, DOI 10.1099/0022-1317-80-7-1759; BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; Biagini P, 1999, J GEN VIROL, V80, P419, DOI 10.1099/0022-1317-80-2-419; Delius H, 1994, Curr Top Microbiol Immunol, V186, P13; Delius H, 1998, VIROLOGY, V240, P359, DOI 10.1006/viro.1997.8943; dHerelle f, 1922, BACTERIOPHAGE ITS RO; Dwivedi B, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-37; FAVRE M, 1989, J VIROL, V63, P4910, DOI 10.1128/JVI.63.11.4910-.1989; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Fournier PE, 2010, CLIN INFECT DIS, V51, P131, DOI 10.1086/653675; Gaidelyte A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001145; Greninger AL, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-82; Hallett RL, 2000, J GEN VIROL, V81, P2273, DOI 10.1099/0022-1317-81-9-2273; Holler F, 2001, BIOCHEM BIOPH RES CO, V289, P937, DOI 10.1006/bbrc.2001.6089; Hsieh SY, 1999, J CLIN MICROBIOL, V37, P1829, DOI 10.1128/JCM.37.6.1829-1831.1999; Imazio M, 2010, INT J CLIN PRACT, V64, P1384, DOI 10.1111/j.1742-1241.2009.02178.x; Irving WL, 1999, J INFECT DIS, V180, P27, DOI 10.1086/314825; Kao KL, 2010, PEDIATR CARDIOL, V31, P703, DOI 10.1007/s00246-009-9637-5; Khudyakov YE, 2000, J VIROL, V74, P2990, DOI 10.1128/JVI.74.7.2990-3000.2000; Knowlton KU, 2000, PRINCIPLES PRACTICE, P925; Levy PY, 2006, FUTURE MICROBIOL, V1, P229, DOI 10.2217/17460913.1.2.229; Levy PY, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2013.04.027; Levy PY, 2003, MEDICINE, V82, P385, DOI 10.1097/01.md.0000101574.54295.73; Li JJ, 2012, J VIROL, V86, P11936, DOI 10.1128/JVI.01988-12; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lysholm F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030875; McMullan LK, 2012, VIROLOGY, V422, P1, DOI 10.1016/j.virol.2011.08.024; Nakamura S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004219; Nishizawa T, 1997, BIOCHEM BIOPH RES CO, V241, P92, DOI 10.1006/bbrc.1997.7765; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Pantucek R, 2004, ARCH VIROL, V149, P1689, DOI 10.1007/s00705-004-0335-6; Peng YH, 2002, ARCH VIROL, V147, P21, DOI 10.1007/s705-002-8301-7; Pride DT, 2012, ISME J, V6, P915, DOI 10.1038/ismej.2011.169; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Roux S, 2011, BIOINFORMATICS, V27, P3074, DOI 10.1093/bioinformatics/btr519; Rozen S, 2000, Methods Mol Biol, V132, P365; SEDDON DJ, 1986, POSTGRAD MED J, V62, P1133, DOI 10.1136/pgmj.62.734.1133; Sullivan PF, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-2; Sun SL, 2011, NUCLEIC ACIDS RES, V39, pD546, DOI 10.1093/nar/gkq1102; Thurber RV, 2009, NAT PROTOC, V4, P470, DOI 10.1038/nprot.2009.10; Troughton RW, 2004, LANCET, V363, P717, DOI 10.1016/S0140-6736(04)15648-1; Willner D, 2011, P NATL ACAD SCI USA, V108, P4547, DOI 10.1073/pnas.1000089107; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Wommack KE, 1999, APPL ENVIRON MICROB, V65, P241; Zhong S, 2002, J MED VIROL, V66, P428, DOI 10.1002/jmv.2163	49	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93367	10.1371/journal.pone.0093367	http://dx.doi.org/10.1371/journal.pone.0093367			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690743	Green Submitted, gold, Green Published			2022-12-25	WOS:000334101100070
J	Kadye, WT; Booth, AJ				Kadye, Wilbert T.; Booth, Anthony J.			Alternative Responses to Predation in Two Headwater Stream Minnows Is Reflected in Their Contrasting Diel Activity Patterns	PLOS ONE			English	Article							DIURNAL ACTIVITY; HABITAT USE; ANTIPREDATOR BEHAVIOR; SHOALING BEHAVIOR; FISH PREDATION; SELFISH HERD; RISK; PLASTICITY; COMPETITION; AVOIDANCE	Animals exhibit diel periodicity in their activity in part to meet energy requirements whilst evading predation. A competing hypothesis suggests that partitioning of diel activities is less important because animals capitalise on opportunity. To test these hypotheses we examined the diel activity patterns for two cyprinid minnows, chubbyhead barb Barbus anoplus and the Eastern Cape redfin minnow Pseudobarbus afer that both occur within headwater streams in the Eastern Cape, South Africa. Chubbyhead barbs exhibited consistent nocturnal activity based on both field and laboratory observations. Due to the absence of fish predators within its habitat, its nocturnal behaviour suggests a response to the cost associated with diurnal activity, such as predation risk by diving and wading birds. In contrast, redfin minnows showed high diurnal activity and a shoaling behaviour in the wild, whereas, in the laboratory, they showed high refuge use during the diel cycle. Despite their preference for refuge in the laboratory, they were diurnally active, a behaviour that was consistent with observations in the wild. The diurnal activity of this species suggests a response to the cost associated with nocturnal activity. Such a cost could be inferred from the presence of the longfin eel, a native predator that was active at night, whereas the daytime shoaling behaviour suggests an anti-predator mechanism to diurnal visual predators. The implications of these findings relate to the impacts associated with the potential invasions by non-native piscivores that occur in the mainstem sections. Diurnal activity patterns for redfin minnows, that are IUCN-listed as endangered, may, in part, explain their susceptibility to high predation by visual non-native piscivores, such as bass and trout. In contrast, the nocturnal habits of chubbyhead barbs suggest a probable pre-adaptation to visual predation. The likelihood of invasion by nocturnally-active sharptooth catfish Clarias gariepinus, however, may compromise this prior advantage.	[Kadye, Wilbert T.; Booth, Anthony J.] Rhodes Univ, Dept Ichthyol & Fisheries Sci, ZA-6140 Grahamstown, South Africa	Rhodes University	Kadye, WT (corresponding author), Rhodes Univ, Dept Ichthyol & Fisheries Sci, ZA-6140 Grahamstown, South Africa.	kadyew@yahoo.com	Booth, Anthony/C-9932-2012	Booth, Anthony/0000-0002-5561-9260; Kadye, Wilbert/0000-0002-5273-8360	South Africa's National Research Foundation; Rufford Small Grants Foundation; Research Committee of Rhodes University	South Africa's National Research Foundation(National Research Foundation - South Africa); Rufford Small Grants Foundation; Research Committee of Rhodes University	Funding provided by South Africa's National Research Foundation, Rufford Small Grants Foundation, Research Committee of Rhodes University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Alanara A, 2001, J ANIM ECOL, V70, P980, DOI 10.1046/j.0021-8790.2001.00550.x; Ayala JR, 2007, BIOL INVASIONS, V9, P857, DOI 10.1007/s10530-006-9087-4; BAKER RL, 1995, FRESHWATER BIOL, V34, P101, DOI 10.1111/j.1365-2427.1995.tb00427.x; Barton K., 2011, MUMIN MULTIMODEL INF; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bool JD, 2011, MAR FRESHWATER RES, V62, P1230, DOI 10.1071/MF11140; Botham MS, 2008, ECOLOGY, V89, P3174, DOI 10.1890/07-0490.1; BOUSKILA A, 1995, ECOLOGY, V76, P165, DOI 10.2307/1940639; BOUSKILA A, 1992, AM NAT, V139, P161, DOI 10.1086/285318; Bovee K. D., 1986, 867 US FISH WILDL SE; Bradford MJ, 2001, CAN J FISH AQUAT SCI, V58, P365, DOI 10.1139/f00-253; Brook LA, 2012, J APPL ECOL, V49, P1278, DOI 10.1111/j.1365-2664.2012.02207.x; Bruton M.N., 1979, TRANSACTIONS OF THE ZOOLOGICAL SOCIETY OF LONDON, V35, P47; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CAMBRAY JA, 1985, ENVIRON BIOL FISH, V12, P131, DOI 10.1007/BF00002765; Cambray JA, 1995, J AFR ZOOL, V109, P350; Clavero M, 2005, J FISH BIOL, V67, P72, DOI 10.1111/j.0022-1112.2005.00934.x; Cohen R, 2006, PHYSIOL BEHAV, V87, P563, DOI 10.1016/j.physbeh.2005.12.010; Correa C, 2012, ECOL APPL, V22, P828, DOI 10.1890/11-1174.1; Crook DA, 2001, OECOLOGIA, V129, P525, DOI 10.1007/s004420100750; Dupuch A, 2009, J FISH BIOL, V74, P1371, DOI 10.1111/j.1095-8649.2009.02183.x; Ellender BR, 2011, AFR ZOOL, V46, P39, DOI 10.3377/004.046.0116; FLECKER AS, 1992, ECOLOGY, V73, P438, DOI 10.2307/1940751; FOSTER WA, 1981, NATURE, V293, P466, DOI 10.1038/293466a0; Fox RJ, 2011, FUNCT ECOL, V25, P1096, DOI 10.1111/j.1365-2435.2011.01874.x; Fraser DF, 2004, ECOLOGY, V85, P312, DOI 10.1890/03-3023; Fraser NHC, 1997, FUNCT ECOL, V11, P385, DOI 10.1046/j.1365-2435.1997.00098.x; Gutman R, 2005, ECOLOGY, V86, P164, DOI 10.1890/03-0369; Halle S, 2006, FOLIA PRIMATOL, V77, P15, DOI 10.1159/000089693; Harrington LA, 2009, ECOLOGY, V90, P1207, DOI 10.1890/08-0302.1; Havird JC, 2013, HYDROBIOLOGIA, V716, P189, DOI 10.1007/s10750-013-1568-8; Helfman G.S., 1993, BEHAV TELEOST FISHES, P479, DOI DOI 10.1007/978-94-011-1578-0; IUCN, 2013, IUCN RED LIST THREAT; Jones M, 2001, ECOLOGY, V82, P2164, DOI 10.1890/0012-9658(2001)082[2164:COTPSM]2.0.CO;2; Kadye WT, 2013, RIVER RES APPL, V29, P1131, DOI 10.1002/rra.2599; Kadye WT, 2012, J APPL ICHTHYOL, V28, P791, DOI 10.1111/j.1439-0426.2012.02027.x; Kramer Donald L., 1997, P37; Krause J, 2002, LIVING GROUPS; Kronfeld-Schor N, 2003, ANNU REV ECOL EVOL S, V34, P153, DOI 10.1146/annurev.ecolsys.34.011802.132435; Kronfeld-Schor N, 2001, AM NAT, V158, P451, DOI 10.1086/321991; LAMPERT W, 1989, FUNCT ECOL, V3, P21, DOI 10.2307/2389671; Levy O, 2007, CHRONOBIOL INT, V24, P599, DOI 10.1080/07420520701534640; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; Loppnow Grace L., 2013, Management of Biological Invasions, V4, P191; Lowe Steven R., 2008, African Journal of Aquatic Science, V33, P51, DOI 10.2989/AJAS.2007.33.1.6.390; Metcalfe NB, 1999, J ANIM ECOL, V68, P371, DOI 10.1046/j.1365-2656.1999.00289.x; Metcalfe NB, 2001, FUNCT ECOL, V15, P304, DOI 10.1046/j.1365-2435.2001.00527.x; Metcalfe NB, 1998, P ROY SOC B-BIOL SCI, V265, P1503, DOI 10.1098/rspb.1998.0464; Miller SA, 2014, ENVIRON BIOL FISH, V97, P357, DOI 10.1007/s10641-013-0157-z; Mueller R, 2010, COPEIA, P47, DOI 10.1643/CE-08-154; Orpwood JE, 2008, ANIM BEHAV, V76, P143, DOI 10.1016/j.anbehav.2008.01.016; Payne NL, 2012, P R SOC B, V280, P2012; POWER ME, 1984, ECOLOGY, V65, P523, DOI 10.2307/1941414; Queiroz H, 2005, BIOL LETTERS, V1, P155, DOI 10.1098/rsbl.2004.0267; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Railsback SF, 2005, ECOLOGY, V86, P947, DOI 10.1890/04-1178; Reebs SG, 2002, REV FISH BIOL FISHER, V12, P349, DOI 10.1023/A:1025371804611; REEBS SG, 1995, CAN J ZOOL, V73, P1221, DOI 10.1139/z95-146; Relyea RA, 2004, ECOLOGY, V85, P172, DOI 10.1890/03-0169; Roll U., 2002, ISR J ZOOL, V48, P177; Russell IA, 2011, AFR ZOOL, V46, P117, DOI 10.3377/004.046.0103; SCHLOSSER IJ, 1987, ECOLOGY, V68, P651, DOI 10.2307/1938470; Schoener T.W., 1986, P91; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Skelton P. H, 2001, COMPLETE GUTIDE FRES; Stuble KL, 2013, OECOLOGIA, V171, P981, DOI 10.1007/s00442-012-2459-9; TIKKANEN P, 1994, OECOLOGIA, V99, P252, DOI 10.1007/BF00627737; Tweddle D., 2009, STATUS DISTRIBUTION, P21; Wasserberg G, 2006, OIKOS, V112, P573, DOI 10.1111/j.0030-1299.2006.14302.x	72	15	15	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93666	10.1371/journal.pone.0093666	http://dx.doi.org/10.1371/journal.pone.0093666			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691382	gold, Green Published, Green Submitted			2022-12-25	WOS:000334101100123
J	Reinke, EN; Ekoue, DN; Bera, S; Mahmud, N; Diamond, AM				Reinke, Emily N.; Ekoue, Dede N.; Bera, Soumen; Mahmud, Nadim; Diamond, Alan M.			Translational Regulation of GPx-1 and GPx-4 by the mTOR Pathway	PLOS ONE			English	Article							HYDROPEROXIDE GLUTATHIONE-PEROXIDASE; CHRONIC MYELOGENOUS LEUKEMIA; MESSENGER-RNA; SELENOCYSTEINE INCORPORATION; CELL-LINE; SELENOPROTEIN SYNTHESIS; GENE-EXPRESSION; MEDIATED DECAY; RAT-TISSUES; PROTEIN	Glutathione peroxidase activity was previously determined to be elevated in lymphocytes obtained from patients treated with the Bcr-Abl kinase inhibitor imatinib mesylate. In order to expand upon this observation, the established chronic myelogenous leukemia cell lines KU812 and MEG-01 were treated with imatinib and the effect on several anti-oxidant proteins was determined. The levels of GPx-1 were significantly increased following treatment with imatinib. This increase was not due to altered steady-state mRNA levels, and appeared to be dependent on the expression of Bcr-Abl, as no increases were observed following imatinib treatment of cells that did not express the fusion protein. The nutrient-sensing signaling protein, mammalian target of rapamycin (mTOR), can be activated by Bcr-Abl and its activity regulates the translation of many different proteins. Treatment of those same cells used in the imatinib studies with rapamycin, an inhibitor of mTOR, resulted in elevated GPx-1 and GPx-4 protein levels independent of Bcr-Abl expression. These proteins all belong to the selenoprotein family of peptides that contain the UGA-encoded amino acid selenocysteine. Collectively, these data provide evidence of a novel means of regulating anti-oxidants of the selenoprotein family via the mTOR pathway.	[Reinke, Emily N.; Ekoue, Dede N.; Bera, Soumen; Diamond, Alan M.] Univ Illinois, Dept Pathol, Chicago, IL 60612 USA; [Mahmud, Nadim] Univ Illinois, Dept Med, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Diamond, AM (corresponding author), Univ Illinois, Dept Pathol, Chicago, IL 60612 USA.	adiamond@uic.edu	Bera, Soumen/ABG-1233-2021	Reinke, Emily/0000-0003-0995-7792	Public Health Service from the National Cancer Institute [CA129590, CA127943]; American Institute for Cancer Research [10A072]; NATIONAL CANCER INSTITUTE [R21CA129590, R01CA127943] Funding Source: NIH RePORTER	Public Health Service from the National Cancer Institute; American Institute for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Public Health Service Grants CA129590 and CA127943 to AMD from the National Cancer Institute (http://www.NIH.gov), and Post-Doctoral Fellowship # 10A072 to SB from the American Institute for Cancer Research (http://www.aicr.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai M, 1999, J BIOL CHEM, V274, P4924, DOI 10.1074/jbc.274.8.4924; Baliga MS, 2007, BIOL TRACE ELEM RES, V115, P227, DOI 10.1007/BF02685998; BERRY MJ, 1991, NATURE, V353, P273, DOI 10.1038/353273a0; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Budiman ME, 2009, MOL CELL, V35, P479, DOI 10.1016/j.molcel.2009.06.026; Caban K, 2006, CELL MOL LIFE SCI, V63, P73, DOI 10.1007/s00018-005-5402-y; Cao C, 2003, J BIOL CHEM, V278, P39609, DOI 10.1074/jbc.M305770200; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Diamond AM, 2012, MUTAGENESIS; Driscoll DM, 2003, ANNU REV NUTR, V23, P17, DOI 10.1146/annurev.nutr.23.011702.073318; Esworthy RS, 1997, ARCH BIOCHEM BIOPHYS, V340, P59, DOI 10.1006/abbi.1997.9901; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; FLOHE L, 1971, H-S Z PHYSIOL CHEM, V352, P1401, DOI 10.1515/bchm2.1971.352.2.1401; Fritz KS, 2012, J PROTEOME RES, V11, P1633, DOI 10.1021/pr2008384; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Hu YJ, 2003, CANCER RES, V63, P3347; Iglesias-Bartolome R, 2012, CELL STEM CELL, V11, P401, DOI 10.1016/j.stem.2012.06.007; Jameson RR, 2004, RNA, V10, P1142, DOI 10.1261/rna.7370104; Kharas NG, 2005, CANCER RES, V65, P2047, DOI 10.1158/0008-5472.CAN-04-3888; Kim JH, 2005, BLOOD, V105, P1717, DOI 10.1182/blood-2004-03-0849; Klejman A, 2002, ONCOGENE, V21, P5868, DOI 10.1038/sj.onc.1205724; Kollmus H, 1996, NUCLEIC ACIDS RES, V24, P1195, DOI 10.1093/nar/24.7.1195; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubos E, 2011, ANTIOXID REDOX SIGN, V15, P1957, DOI 10.1089/ars.2010.3586; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; Ly C, 2003, CANCER RES, V63, P5716; Martin GW, 2001, GENES CELLS, V6, P121, DOI 10.1046/j.1365-2443.2001.00402.x; Moriarty PM, 1998, MOL CELL BIOL, V18, P2932, DOI 10.1128/MCB.18.5.2932; Nasim MT, 2000, J BIOL CHEM, V275, P14846, DOI 10.1074/jbc.275.20.14846; OGURA M, 1985, BLOOD, V66, P1384; Patel S, 2013, CURR ONCOL REP, V15, P386, DOI 10.1007/s11912-013-0316-6; SAMUELS BL, 1991, CANCER RES, V51, P521; Shepard BD, 2010, ALCOHOL CLIN EXP RES, V34, P280, DOI 10.1111/j.1530-0277.2009.01091.x; Sinclair A, 2013, BRIT J PHARMACOL, V169, P1693, DOI 10.1111/bph.12183; Stoytcheva Z, 2006, MOL CELL BIOL, V26, P9177, DOI 10.1128/MCB.00856-06; Sun XL, 2001, MOL BIOL CELL, V12, P1009, DOI 10.1091/mbc.12.4.1009; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Terry EN, 2012, LEUKEMIA RES, V35, P831; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; UTSUNOMIYA H, 1991, J HISTOCHEM CYTOCHEM, V39, P1167, DOI 10.1177/39.9.1918936; Xing HY, 2012, LEUKEMIA RES, V36, P509, DOI 10.1016/j.leukres.2011.12.018; Yuan HF, 2010, J BIOL CHEM, V285, P5085, DOI 10.1074/jbc.M109.039206; Zhuo P, 2009, CANCER RES, V69, P8183, DOI 10.1158/0008-5472.CAN-09-1791	43	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93472	10.1371/journal.pone.0093472	http://dx.doi.org/10.1371/journal.pone.0093472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691473	Green Submitted, Green Published, gold			2022-12-25	WOS:000334101100087
J	Uri, K; Fagyas, M; Siket, IM; Kertesz, A; Csanadi, Z; Sandorfi, G; Clemens, M; Fedor, R; Papp, Z; Edes, I; Toth, A; Lizanecz, E				Uri, Katalin; Fagyas, Miklos; Siket, Ivetta Manyine; Kertesz, Attila; Csanadi, Zoltan; Sandorfi, Gabor; Clemens, Marcell; Fedor, Roland; Papp, Zoltan; Edes, Istvan; Toth, Attila; Lizanecz, Erzsebet			New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) IV: Circulating ACE2 as a Biomarker of Systolic Dysfunction in Human Hypertension and Heart Failure	PLOS ONE			English	Article							CONVERTING ENZYME; BLOOD-PRESSURE; ESC GUIDELINES; ANGIOTENSIN-CONVERTING-ENZYME-2; ASSOCIATION; RECEPTOR; OVEREXPRESSION; POLYMORPHISM; EXPRESSION; THERAPY	Background: Growing evidence exists for soluble Angiotensin Converting Enzyme-2 (sACE2) as a biomarker in definitive heart failure (HF), but there is little information about changes in sACE2 activity in hypertension with imminent heart failure and in reverse remodeling. Methods, Findings: Patients with systolic HF (NYHAII-IV, enrolled for cardiac resynchronisation therapy, CRT, n = 100) were compared to hypertensive patients (n = 239) and to a healthy cohort (n = 45) with preserved ejection fraction (EF>50%) in a single center prospective clinical study. The status of the heart failure patients were checked before and after CRT. Biochemical (ACE and sACE2 activity, ACE concentration) and echocardiographic parameters (EF, left ventricular end-diastolic (EDD) and end-systolic diameter (ESD) and dP/dt) were measured. sACE2 activity negatively correlated with EF and positively with ESD and EDD in all patient's populations, while it was independent in the healthy cohort. sACE2 activity was already increased in the hypertensive group, where signs for imminent heart failure (slightly decreased EF and barely increased NT-proBNP levels) were detected. sACE2 activities further increased in patients with definitive heart failure (EF<50%), while sACE2 activities decreased with the improvement of the heart failure after CRT (reverse remodeling). Serum angiotensin converting enzyme (ACE) concentrations were lower in the diseased populations, but did not show a strong correlation with the echocardiographic parameters. Conclusions: Soluble ACE2 activity appears to be biomarker in heart failure, and in hypertension, where heart failure may be imminent. Our data suggest that sACE2 is involved in the pathomechanism of hypertension and HF.	[Uri, Katalin; Fagyas, Miklos; Siket, Ivetta Manyine; Papp, Zoltan; Toth, Attila] Univ Debrecen, Med & Hlth Sci Ctr, Inst Cardiol, Div Clin Physiol, H-4012 Debrecen, Hungary; [Kertesz, Attila; Csanadi, Zoltan; Sandorfi, Gabor; Clemens, Marcell; Edes, Istvan; Lizanecz, Erzsebet] Univ Debrecen, Med & Hlth Sci Ctr, Inst Cardiol, H-4012 Debrecen, Hungary; [Fedor, Roland] Univ Debrecen, Med & Hlth Sci Ctr, Inst Surg, H-4012 Debrecen, Hungary; [Papp, Zoltan; Edes, Istvan; Toth, Attila] Univ Debrecen, Med & Hlth Sci Ctr, Res Ctr Mol Med, H-4012 Debrecen, Hungary	University of Debrecen; University of Debrecen; University of Debrecen; University of Debrecen	Lizanecz, E (corresponding author), Univ Debrecen, Med & Hlth Sci Ctr, Inst Cardiol, H-4012 Debrecen, Hungary.	lizanecz@yahoo.com	Fagyas, Miklós/AAQ-1013-2020; Tóth, Attila/F-4859-2010; Papp, Zoltán/HDO-3347-2022	Fagyas, Miklós/0000-0003-3262-884X; Tóth, Attila/0000-0001-6503-3653; 	 [TAMOP 4.2.2.A-11/1/KONV-2012-0045];  [TAMOP-4.2.2/B-10/1-2010-0024]	; 	The work was supported by TAMOP 4.2.2.A-11/1/KONV-2012-0045 and TAMOP-4.2.2/B-10/1-2010-0024 grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENETEAU B, 1986, CLIN CHEM, V32, P884; Bodiga S, 2011, CARDIOVASC RES, V91, P151, DOI 10.1093/cvr/cvr036; Burrell LM, 2005, EUR HEART J, V26, P369, DOI 10.1093/eurheartj/ehi114; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Der Sarkissian S, 2006, PROG BIOPHYS MOL BIO, V91, P163, DOI 10.1016/j.pbiomolbio.2005.05.011; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Dickstein K, 2010, EUR HEART J, V31, P2677, DOI 10.1093/eurheartj/ehq337; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Epelman S, 2008, J AM COLL CARDIOL, V52, P750, DOI 10.1016/j.jacc.2008.02.088; Epelman S, 2009, J CARD FAIL, V15, P565, DOI 10.1016/j.cardfail.2009.01.014; Fagyas M, 2014, PLOS ONE; FERRARIO CM, 1990, J CARDIOVASC PHARM, V15, pS1, DOI 10.1097/00005344-199000153-00001; Gallagher PE, 2008, AM J PHYSIOL-HEART C, V295, pH2373, DOI 10.1152/ajpheart.00426.2008; Goulter AB, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-19; Gurley SB, 2006, J CLIN INVEST, V116, P2218, DOI 10.1172/JCI16980; Kostenis E, 2005, CIRCULATION, V111, P1806, DOI 10.1161/01.CIR.0000160867.23556.7D; Lambert DW, 2005, J BIOL CHEM, V280, P30113, DOI 10.1074/jbc.M505111200; Lehmann HI, 2012, INT J CARDIOL, DOI 10.1016/j.ijcard.2012. 09. 083; Lu N, 2012, MOL BIOL REP, V39, P6581, DOI 10.1007/s11033-012-1487-1; Nicholls MG, 1998, J HUM HYPERTENS, V12, P295, DOI 10.1038/sj.jhh.1000638; Patel SK, 2012, AM J HYPERTENS, V25, P216, DOI 10.1038/ajh.2011.188; Patel SK, 2013, CLIN EXP PHARM PHYSL; Rentzsch B, 2008, HYPERTENSION, V52, P967, DOI 10.1161/HYPERTENSIONAHA.108.114322; RONCATESTONI S, 1983, CLIN CHEM, V29, P1093; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Tang WHW, 2007, CIRCULATION, V115, P161, DOI 10.1161/CIRCULATIONAHA.106.669879; van Kimmenade RRJ, 2012, CLIN CHEM, V58, P127, DOI 10.1373/clinchem.2011.165720; Vickers C, 2002, J BIOL CHEM, V277, P14838, DOI 10.1074/jbc.M200581200; Wang W, 2012, HEART FAIL REV, V17, P683, DOI 10.1007/s10741-011-9259-x; Wysocki J, 2010, HYPERTENSION, V55, P90, DOI 10.1161/HYPERTENSIONAHA.109.138420; Yamamoto K, 2006, HYPERTENSION, V47, P718, DOI 10.1161/01.HYP.0000205833.89478.5b; Yamazato M, 2007, HYPERTENSION, V49, P926, DOI 10.1161/01.HYP.0000259942.38108.20; Zhong J, 2006, J LAB CLIN MED, V147, P91, DOI 10.1016/j.lab.2005.10.001; Zhong JC, 2010, CIRCULATION, V122, P717, DOI 10.1161/CIRCULATIONAHA.110.955369	34	56	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e87845	10.1371/journal.pone.0087845	http://dx.doi.org/10.1371/journal.pone.0087845			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691269	gold, Green Published			2022-12-25	WOS:000334101100004
J	de la Cruz-Herrera, CF; Campagna, M; Lang, V; Gonzalez-Santamaria, JD; Marcos-Villar, L; Rodriguez, MS; Vidal, A; Collado, M; Rivas, C				de la Cruz-Herrera, C. F.; Campagna, M.; Lang, V.; del Carmen Gonzalez-Santamaria, J.; Marcos-Villar, L.; Rodriguez, M. S.; Vidal, A.; Collado, M.; Rivas, C.			SUMOylation regulates AKT1 activity	ONCOGENE			English	Article							PROTEIN-KINASE B; HEAT-SHOCK; ONCOGENIC TRANSFORMATION; QUANTITATIVE PROTEOMICS; SUMO-1 MODIFICATION; NIH3T3 CELLS; ACTIVATION; PATHWAY; PHOSPHORYLATION; PML	Serine threonine kinase AKT has a central role in the cell, controlling survival, proliferation, metabolism and angiogenesis. Deregulation of its activity underlies a wide range of pathological situations, including cancer. Here we show that AKT is post-translationally modified by the small ubiquitin-like modifier (SUMO) protein. Interestingly, neither SUMO conjugation nor activation of SUMOylated AKT is regulated by the classical AKT targeting to the cell membrane or by the phosphoinositide 3-kinase pathway. We demonstrate that SUMO induces the activation of AKT, whereas, conversely, down-modulation of the SUMO machinery diminishes AKT activation and cell proliferation. Furthermore, an AKT SUMOylation mutant shows reduced activation, and decreased anti-apoptotic and pro-tumoral activities in comparison with the wild-type protein. These results identify SUMO as a novel key regulator of AKT phosphorylation and activity.	[de la Cruz-Herrera, C. F.; Campagna, M.; del Carmen Gonzalez-Santamaria, J.; Marcos-Villar, L.; Rivas, C.] CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid 28049, Spain; [Lang, V.; Rodriguez, M. S.] Ubiquitylat & Canc Mol Biol Lab, Inbiomed, San Sebastian, Gipuzkoa, Spain; [Vidal, A.] Univ Santiago de Compostela, Inst Invest Sanitarias IDIS, Dept Fisiol, Santiago De Compostela, Spain; [Vidal, A.; Rivas, C.] Univ Santiago de Compostela, Inst Invest Sanitarias IDIS, Ctr Invest Med Mol CIMUS, Santiago De Compostela, Spain; [Collado, M.] Complexo Hosp Univ Santiago de Compostela CHUS, SERGAS, Inst Invest Sanit Santiago Compostela, Santiago De Compostela, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela	Rivas, C (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Darwin 3,Campus Univ Autonoma Madrid, Madrid 28049, Spain.	crivas@cnb.csic.es	Rivas, Carmen/L-3162-2017; Santamaria, Jose Gonzalez/AAN-1044-2020; Rivas, Carmen/AAB-6278-2019; RODRIGUEZ, Manuel S./D-5439-2018; Santamaría, José González/Q-2439-2015; Collado, Manuel/K-8140-2014; Vidal, Anxo/B-5010-2015	Rivas, Carmen/0000-0002-0518-7199; Rivas, Carmen/0000-0002-0518-7199; Santamaría, José González/0000-0003-1244-3477; Collado, Manuel/0000-0002-0330-0880; Vidal, Anxo/0000-0002-0866-4202; de la Cruz-Herrera, Carlos/0000-0002-7493-5154	Juan de la Cierva Programme; La Caixa fellowship;  [BFU-2011-27064]	Juan de la Cierva Programme; La Caixa fellowship(La Caixa Foundation); 	We thank Dr William R Sellers who deposited AKT plamids at Addgene. Funding at the laboratory of CR is provided by BFU-2011-27064. LM-V is supported by Juan de la Cierva Programme. CFC-H is supported by La Caixa fellowship. MC is an investigator of the Miguel Servet Program.	Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; Bang OS, 2000, BIOCHEM BIOPH RES CO, V278, P306, DOI 10.1006/bbrc.2000.3805; Bawa-Khalfe Tasneem, 2010, Genes Cancer, V1, P748; Bossis G, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-13; Brodbeck D, 1999, J BIOL CHEM, V274, P9133, DOI 10.1074/jbc.274.14.9133; Calleja Veronique, 2009, J Chem Biol, V2, P11, DOI 10.1007/s12154-009-0016-8; Campagna M, 2011, CELL DEATH DIFFER, V18, P72, DOI 10.1038/cdd.2010.77; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Gonzalez-Santamaria J, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.135; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Hong YL, 2001, J BIOL CHEM, V276, P40263, DOI 10.1074/jbc.M104714200; Hsieh AC, 2004, NUCLEIC ACIDS RES, V32, P893, DOI 10.1093/nar/gkh238; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Laine J, 2000, MOL CELL, V6, P395, DOI 10.1016/S1097-2765(00)00039-3; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Liu XS, 2004, ANTICANCER RES, V24, P2697; Mao Y, 2000, J BIOL CHEM, V275, P26066, DOI 10.1074/jbc.M001831200; Marcos-Villar L, 2009, J VIROL, V83, P8849, DOI 10.1128/JVI.00339-09; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Miller MJ, 2013, MOL CELL PROTEOMICS, V12, P449, DOI 10.1074/mcp.M112.025056; Nguyen H, 1999, MOL CELL BIOL, V19, P1190; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Sakoda H, 2003, J BIOL CHEM, V278, P25802, DOI 10.1074/jbc.M301127200; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Steinacher R, 2005, CURR BIOL, V15, P616, DOI 10.1016/j.cub.2005.02.054; Sun M, 2001, AM J PATHOL, V159, P431, DOI 10.1016/S0002-9440(10)61714-2; Tatham MH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001484; Testa JR, 2005, ONCOGENE, V24, P7391, DOI 10.1038/sj.onc.1209100; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; Warfel NA, 2011, J BIOL CHEM, V286, P39122, DOI 10.1074/jbc.M111.278747; Yoshihara T, 2013, ACTA PHYSIOL, V207, P416, DOI 10.1111/apha.12040	36	31	31	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 12	2015	34	11					1442	1450		10.1038/onc.2014.48	http://dx.doi.org/10.1038/onc.2014.48			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CD1AR	24704831	Green Published			2022-12-25	WOS:000350806500010
J	Nicolae, CM; Aho, ER; Vlahos, AHS; Choe, KN; De, S; Karras, GI; Moldovan, GL				Nicolae, Claudia M.; Aho, Erin R.; Vlahos, Alexander H. S.; Choe, Katherine N.; De, Subhajyoti; Karras, Georgios I.; Moldovan, George-Lucian			The ADP-ribosyltransferase PARP10/ARTD10 Interacts with Proliferating Cell Nuclear Antigen ( PCNA) and Is Required for DNA Damage Tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADP-ribosylation; DNA Damage; DNA Repair; DNA Replication; Genomic Instability; PCNA; Translesion Synthesis	REPLICATION FORK; S-PHASE; HOMOLOGOUS RECOMBINATION; MONOUBIQUITINATED PCNA; GENOME STABILITY; DVC1 C1ORF124; UBIQUITIN; PROTEIN; REPAIR; POLY(ADP-RIBOSE)	Background: PCNA mono-ubiquitination at stalled replication forks recruits translesion synthesis polymerases for fork restart. Results: The mono-ADP-ribosyltransferase PARP10 interacts with PCNA through a PIP-box. PARP10 knockdown results in DNA damage hypersensitivity and defective translesion synthesis. Conclusion: PARP10 participates in PCNA-dependent DNA damage tolerance. Significance: This is the first time that post-translational modification by mono-ADP-ribosylation is implicated in DNA repair. All cells rely on genomic stability mechanisms to protect against DNA alterations. PCNA is a master regulator of DNA replication and S-phase-coupled repair. PCNA post-translational modifications by ubiquitination and SUMOylation dictate how cells stabilize and re-start replication forks stalled at sites of damaged DNA. PCNA mono-ubiquitination recruits low fidelity DNA polymerases to promote error-prone replication across DNA lesions. Here, we identify the mono-ADP-ribosyltransferase PARP10/ARTD10 as a novel PCNA binding partner. PARP10 knockdown results in genomic instability and DNA damage hypersensitivity. Importantly, we show that PARP10 binding to PCNA is required for translesion DNA synthesis. Our work identifies a novel PCNA-linked mechanism for genome protection, centered on post-translational modification by mono-ADP-ribosylation.	[Nicolae, Claudia M.; Aho, Erin R.; Vlahos, Alexander H. S.; Choe, Katherine N.; Moldovan, George-Lucian] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [De, Subhajyoti] Univ Colorado, Dept Med, Sch Med, Aurora, CO 80045 USA; [De, Subhajyoti] Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO 80045 USA; [De, Subhajyoti] Univ Colorado, Ctr Canc, Mol Oncol Program, Aurora, CO 80045 USA; [Karras, Georgios I.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Massachusetts Institute of Technology (MIT); Whitehead Institute	Moldovan, GL (corresponding author), Penn State Univ, Coll Med, Dept Biochem & Mol Biol, 500 Univ Dr, Hershey, PA 17033 USA.	gmoldovan@hmc.psu.edu		George-Lucian, Moldovan/0000-0003-3825-149X; Nicolae, Claudia/0000-0003-4933-5496; Karras, Georgios/0000-0003-2933-1535	V Foundation Scholar Award; American Cancer Society (ACS IRG) [57-001-53]; Lung Cancer Colorado Fund; United Against Lung Cancer; Human Frontiers Science Program	V Foundation Scholar Award; American Cancer Society (ACS IRG)(American Cancer Society); Lung Cancer Colorado Fund; United Against Lung Cancer; Human Frontiers Science Program(Human Frontier Science Program)	This work was supported in part by the V Foundation Scholar Award (to G. L. M.); American Cancer Society (ACS IRG 57-001-53), Lung Cancer Colorado Fund, and United Against Lung Cancer (to S. D.); and the Human Frontiers Science Program (to G. I. K.).	Arakawa H, 2006, PLOS BIOL, V4, P1947, DOI 10.1371/journal.pbio.0040366; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Barkauskaite E, 2013, FEBS J, V280, P3491, DOI 10.1111/febs.12358; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Branzei D, 2011, FEBS LETT, V585, P2810, DOI 10.1016/j.febslet.2011.04.053; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Centore RC, 2012, MOL CELL, V46, P625, DOI 10.1016/j.molcel.2012.05.020; Chang DJ, 2009, NAT CHEM BIOL, V5, P82, DOI 10.1038/nchembio.139; Chiu RK, 2006, PLOS GENET, V2, P1070, DOI 10.1371/journal.pgen.0020116; Chou HYE, 2006, J BIOL CHEM, V281, P15201, DOI 10.1074/jbc.M506745200; Ciccia A, 2012, MOL CELL, V47, P396, DOI 10.1016/j.molcel.2012.05.024; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; Daigaku Y, 2010, NATURE, V465, P951, DOI 10.1038/nature09097; Davis EJ, 2012, NAT STRUCT MOL BIOL, V19, P1093, DOI 10.1038/nsmb.2394; Feijs KLH, 2013, FEBS J, V280, P3519, DOI 10.1111/febs.12315; Feijs KLH, 2013, NAT REV MOL CELL BIO, V14, P443, DOI 10.1038/nrm3601; Feijs KLH, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-5; Forst AH, 2013, STRUCTURE, V21, P462, DOI 10.1016/j.str.2012.12.019; Frouin I, 2003, J BIOL CHEM, V278, P39265, DOI 10.1074/jbc.C300098200; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Guo CX, 2006, MOL CELL BIOL, V26, P8892, DOI 10.1128/MCB.01118-06; Guo CX, 2009, CELL MOL LIFE SCI, V66, P2363, DOI 10.1007/s00018-009-0024-4; Herzog N, 2013, FEBS J, V280, P1330, DOI 10.1111/febs.12124; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Kalisch T, 2012, TRENDS BIOCHEM SCI, V37, P381, DOI 10.1016/j.tibs.2012.06.001; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Karras GI, 2010, CELL, V141, P255, DOI 10.1016/j.cell.2010.02.028; Kleine H, 2008, MOL CELL, V32, P57, DOI 10.1016/j.molcel.2008.08.009; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Lin JR, 2011, MOL CELL, V42, P237, DOI 10.1016/j.molcel.2011.02.026; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Mailand N, 2013, NAT REV MOL CELL BIO, V14, P269, DOI 10.1038/nrm3562; Messner S, 2011, TRENDS CELL BIOL, V21, P534, DOI 10.1016/j.tcb.2011.06.001; Miller KM, 2012, BIOCHEM SOC T, V40, P370, DOI 10.1042/BST20110747; Mirchandani KD, 2008, DNA REPAIR, V7, P902, DOI 10.1016/j.dnarep.2008.03.001; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Moldovan GL, 2012, MOL CELL, V45, P75, DOI 10.1016/j.molcel.2011.11.010; Moldovan GL, 2010, MOL CELL BIOL, V30, P1088, DOI 10.1128/MCB.01124-09; Mosbech A, 2012, NAT STRUCT MOL BIOL, V19, P1084, DOI 10.1038/nsmb.2395; Muller R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070430; O'Connor KW, 2013, CANCER RES, V73, P2529, DOI 10.1158/0008-5472.CAN-12-3313; Otto H, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-139; Papamichos-Chronakis M, 2013, NAT REV GENET, V14, P62, DOI 10.1038/nrg3345; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Verheugd P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2672; WANG G, 1995, MOL CELL BIOL, V15, P1759; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.3.CO;2-R; Yang KL, 2010, J BIOL CHEM, V285, P19085, DOI 10.1074/jbc.M109.100032; Yu M, 2005, ONCOGENE, V24, P1982, DOI 10.1038/sj.onc.1208410	57	63	68	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13627	13637		10.1074/jbc.M114.556340	http://dx.doi.org/10.1074/jbc.M114.556340			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24695737	Green Published, hybrid			2022-12-25	WOS:000335522800056
J	Lefevre, CE; Wilson, VAD; Morton, FB; Brosnan, SF; Paukner, A; Bates, TC				Lefevre, Carmen Emilia; Wilson, Vanessa A. D.; Morton, F. Blake; Brosnan, Sarah F.; Paukner, Annika; Bates, Timothy C.			Facial Width-To-Height Ratio Relates to Alpha Status and Assertive Personality in Capuchin Monkeys	PLOS ONE			English	Article							SEXUAL-DIMORPHISM; BODY-WEIGHT; COMPETITION; FACES; CUES; TESTOSTERONE; COOPERATION; AGGRESSION; STRATEGIES; COALITIONS	Social dominance hierarchies play a pivotal role in shaping the behaviour of many species, and sex differences within these hierarchies often exist. To date, however, few physical markers of dominance have been identified. Such markers would be valuable in terms of understanding the etiology of dominant behaviour and changes in social hierarchies over time. Animals may also use such traits to evaluate the potential dominance of others relative to themselves (i.e. a physical "cue"). Facial width-to-height ratio (fWHR), for example, has been suggested as a cue to dominance in humans, with links to both dominant behaviour and the perception of dominance in other individuals. Whether this association is present in nonhuman animals is currently not known. Therefore, here we examine within-species links between fWHR and dominant behaviour in 64 brown capuchin monkeys (Sapajus spp.) aged between 2 and 40 years. fWHR was positively associated with alpha status and with a dimensional rating of assertive personality in both males and females. Moreover, fWHR showed significant sexual dimorphism in adults but not juveniles, suggesting a developmental change may occur during puberty. In a sub-sample, sex differences were mediated by weight, suggesting fWHR dimorphism does not exceed what would be expected by differences in body weight. This is the first report of an association between face shape and behaviour in a nonhuman species. Results are discussed in terms of the role that face-behaviour associations might play within capuchin societies, and the possible selective forces that might have led to the evolution of fWHR-dominance associations in humans.	[Lefevre, Carmen Emilia] Univ Leeds, Sch Business, Ctr Decis Res, Leeds, W Yorkshire, England; [Wilson, Vanessa A. D.; Bates, Timothy C.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Wilson, Vanessa A. D.; Morton, F. Blake] Scottish Primate Res Grp, Edinburgh, Midlothian, Scotland; [Morton, F. Blake] Univ Stirling, Sch Nat Sci, Behav & Evolut Res Grp, Stirling FK9 4LA, Scotland; [Brosnan, Sarah F.] Georgia State Univ, Dept Psychol, Atlanta, GA 30303 USA; [Brosnan, Sarah F.] Georgia State Univ, Language Res Ctr, Atlanta, GA 30303 USA; [Paukner, Annika] NIH, Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Comparat Ethol Lab, Dept Hlth & Human Serv, Poolesville, MD USA	University of Leeds; University of Edinburgh; University of Stirling; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Lefevre, CE (corresponding author), Univ Leeds, Sch Business, Ctr Decis Res, Leeds, W Yorkshire, England.	carmenlefevre@me.com; tim.bates@ed.ac.uk	Paukner, Annika/ABA-3275-2020; Bates, Timothy C/C-9637-2010	Paukner, Annika/0000-0002-3421-1864; Bates, Timothy C/0000-0002-1153-9007; Wilson, Vanessa/0000-0001-7253-6013	Intramural NIH HHS [Z99 HD999999] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Alfaro JWL, 2012, AM J PRIMATOL, V74, P273, DOI 10.1002/ajp.22007; [Anonymous], 2012, ANIM BEHAV, V83, P301, DOI 10.1016/j.anbehav.2011.10.031; Archer J, 2004, REV GEN PSYCHOL, V8, P291, DOI 10.1037/1089-2680.8.4.291; Archer J, 2009, BEHAV BRAIN SCI, V32, P249, DOI 10.1017/S0140525X09990951; BERCU BB, 1983, J CLIN ENDOCR METAB, V56, P1214, DOI 10.1210/jcem-56-6-1214; Boinski S, 1996, ADAPTIVE RADIATIONS OF NEOTROPICAL PRIMATES, P251; Buikstra J, 1994, ARKANSAS AGR SURVEY, V44; Carre JM, 2010, PERCEPTION, V39, P356, DOI 10.1068/p6543; Carre JM, 2009, PSYCHOL SCI, V20, P1194, DOI 10.1111/j.1467-9280.2009.02423.x; Carre JM, 2008, P ROY SOC B-BIOL SCI, V275, P2651, DOI 10.1098/rspb.2008.0873; Clutton-Brock T.H., 1983, P457; Coetzee V, 2010, PERCEPTION, V39, P51, DOI 10.1068/p6560; Deaner RO, 2012, J RES PERS, V46, P235, DOI 10.1016/j.jrp.2012.01.005; DEWAAL FBM, 1984, ETHOL SOCIOBIOL, V5, P239, DOI 10.1016/0162-3095(84)90004-9; DiBitetti MS, 1997, ANIM BEHAV, V54, P199, DOI 10.1006/anbe.1996.0416; Fashing PJ, 2001, BEHAV ECOL SOCIOBIOL, V50, P219, DOI 10.1007/s002650100358; Fragaszy D. M., 2004, COMPLETE CAPUCHIN; Gammell MP, 2003, ANIM BEHAV, V66, P601, DOI 10.1006/anbe.2003.2226; Haselhuhn MP, 2012, P ROY SOC B-BIOL SCI, V279, P571, DOI 10.1098/rspb.2011.1193; IZAWA K, 1980, Primates, V21, P443, DOI 10.1007/BF02373834; JANSON C, 1985, BEHAV ECOL SOCIOBIOL, V18, P125, DOI 10.1007/BF00299041; Kapila Rishabh, 2011, J Dent Res Dent Clin Dent Prospects, V5, P51; Kramer RSS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042705; Lefevre CE, 2013, EVOL HUM BEHAV, V34, P273, DOI 10.1016/j.evolhumbehav.2013.03.005; Lefevre CE, 2012, EVOL HUM BEHAV, V33, P623, DOI 10.1016/j.evolhumbehav.2012.03.002; Leonardi R, 2010, AM J PRIMATOL, V72, P33, DOI 10.1002/ajp.20748; Lewis GJ, 2012, PERS INDIV DIFFER, V52, P855, DOI 10.1016/j.paid.2011.12.030; Macdonald C., 2011, International Zoo Yearbook, V45, P7, DOI 10.1111/j.1748-1090.2010.00120.x; Masterson TJ, 1997, AM J PHYS ANTHROPOL, V104, P487, DOI 10.1002/(SICI)1096-8644(199712)104:4<487::AID-AJPA5>3.3.CO;2-J; Mazur A, 1998, BEHAV BRAIN SCI, V21, P353, DOI 10.1017/S0140525X98001228; Michael PH, 1994, ANIM BEHAV, V48, P6; Morton FB, 2013, J COMP PSYCHOL, V127, P282, DOI 10.1037/a0031723; National Centre for the Replacement Refinement and Reduction of Animals in Research, 2006, NC3RS GUID PRIM ACC; Ozener B, 2012, EVOL HUM BEHAV, V33, P169, DOI 10.1016/j.evolhumbehav.2011.08.001; Plavcan JM, 2012, HUM NATURE-INT BIOS, V23, P45, DOI 10.1007/s12110-012-9130-3; Plavcan JM, 1997, AM J PHYS ANTHROPOL, V103, P37, DOI 10.1002/(SICI)1096-8644(199705)103:1<37::AID-AJPA4>3.0.CO;2-A; PLAVCAN JM, 1995, J HUM EVOL, V28, P245, DOI 10.1006/jhev.1995.1019; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; R Core Team, 2012, R LANG ENV STAT COMP; REY R, 1995, BIOL REPROD, V52, P997, DOI 10.1095/biolreprod52.5.997; Steiper ME, 2006, MOL PHYLOGENET EVOL, V41, P384, DOI 10.1016/j.ympev.2006.05.021; Stirrat M, 2012, PSYCHOL SCI, V23, P718, DOI 10.1177/0956797611435133; Stirrat M, 2010, PSYCHOL SCI, V21, P349, DOI 10.1177/0956797610362647; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; Weiss A, 2009, AM J PRIMATOL, V71, P283, DOI 10.1002/ajp.20649; Weston EM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000710; Weston EM, 2004, P ROY SOC B-BIOL SCI, V271, pS416, DOI 10.1098/rsbl.2004.0203; Wheeler BC, 2013, BEHAV ECOL, V24, P1369, DOI 10.1093/beheco/art076	48	41	41	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93369	10.1371/journal.pone.0093369	http://dx.doi.org/10.1371/journal.pone.0093369			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705247	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000334107500033
J	Oren, M; Brikner, I; Appelbaum, L; Levy, O				Oren, Matan; Brikner, Itzchak; Appelbaum, Lior; Levy, Oren			Fast Neurotransmission Related Genes Are Expressed in Non Nervous Endoderm in the Sea Anemone Nematostella vectensis	PLOS ONE			English	Article							ANTHO-RFAMIDE; EVOLUTIONARY ORIGIN; SYSTEM; IMMUNOREACTIVITY; NEUROPEPTIDE; JELLYFISH; NEURONS; HYDRA; GABA	Cnidarian nervous systems utilize chemical transmission to transfer signals through synapses and neurons. To date, ample evidence has been accumulated for the participation of neuropeptides, primarily RFamides, in neurotransmission. Yet, it is still not clear if this is the case for the classical fast neurotransmitters such as GABA, Glutamate, Acetylcholine and Monoamines. A large repertoire of cnidarian Fast Neurotransmitter related Genes (FNGs) has been recently identified in the genome of the sea anemone, Nematostella vectensis. In order to test whether FNGs are localized in cnidarian neurons, we characterized the expression patterns of eight Nematostella genes that are closely or distantly related to human central and peripheral nervous systems genes, in adult Nematostella and compared them to the RFamide localization. Our results show common expression patterns for all tested genes, in a single endodermal cell layer. These expressions did not correspond with the RFamide expressing nerve cell network. Following these results we suggest that the tested Nematostella genes may not be directly involved in vertebrate-like fast neurotransmission.	[Oren, Matan; Levy, Oren] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Appelbaum, Lior] Bar Ilan Univ, Leslie & Susan Gonda Multidisciplinary Brain Res, Ramat Gan, Israel; [Brikner, Itzchak] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Zool, IL-69978 Tel Aviv, Israel	Bar Ilan University; Bar Ilan University; Tel Aviv University	Oren, M (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.	matanok@gmail.com	oren, matan/AAX-8770-2021	oren, matan/0000-0002-6162-324X	United States -Israel Binational Science Foundation [2011187]; Ministry of Science, Israel [3-8874]	United States -Israel Binational Science Foundation(US-Israel Binational Science Foundation); Ministry of Science, Israel(Israel Science Foundation)	This work was supported by the United States -Israel Binational Science Foundation (award 2011187 to A. M. T. and O.L). The Ministry of Science, Israel (http://most.gov.il/Pages/HomePage.aspx) Grant no. 3-8874: The New Emerging Marine Model Organism Nematostella vectensis: Evolutionary, Genomic and Ecological studies with a potential for Industrial applications. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anctil M, 2009, COMP BIOCHEM PHYS D, V4, P268, DOI 10.1016/j.cbd.2009.07.001; Anderson PAV, 2004, BIOL BULL-US, V207, P141, DOI 10.2307/1543588; BATHAM EJ, 1960, Q J MICROSC SCI, V101, P487; Brown DA, 2010, J MOL NEUROSCI, V41, P340, DOI 10.1007/s12031-010-9377-2; Conaco C, 2012, P NATL ACAD SCI USA, V109, P10612, DOI 10.1073/pnas.1201890109; Darling JA, 2005, BIOESSAYS, V27, P211, DOI 10.1002/bies.20181; Delgado LM, 2010, J MORPHOL, V271, P845, DOI 10.1002/jmor.10838; Edmondson DE, 2004, CURR MED CHEM, V11, P1983, DOI 10.2174/0929867043364784; FRANK P, 1976, J NAT HIST, V10, P441, DOI 10.1080/00222937600770331; Fritzenwanker JH, 2002, DEV GENES EVOL, V212, P99, DOI 10.1007/s00427-002-0214-7; Galliot B, 2009, DEV BIOL, V332, P2, DOI 10.1016/j.ydbio.2009.05.563; Garm A, 2006, CELL TISSUE RES, V325, P333, DOI 10.1007/s00441-005-0134-8; Geigerseder C, 2003, NEUROENDOCRINOLOGY, V77, P314, DOI 10.1159/000070897; Girosi L, 2007, CELL TISSUE RES, V329, P187, DOI 10.1007/s00441-007-0408-4; GRIMMELIKHUIJZEN CJP, 1986, P NATL ACAD SCI USA, V83, P9817, DOI 10.1073/pnas.83.24.9817; Kass-Simon G, 2007, COMP BIOCHEM PHYS A, V146, P9, DOI 10.1016/j.cbpa.2006.09.008; Koizumi O, 2004, HYDROBIOLOGIA, V530, P41, DOI 10.1007/s10750-004-2636-x; Koizumi O, 2007, BRAIN BEHAV EVOLUT, V69, P151, DOI 10.1159/000095204; Liguz-Lecznar M, 2007, ACTA NEUROBIOL EXP, V67, P207; Mackie GO, 2004, NEUROSIGNALS, V13, P5, DOI 10.1159/000076155; Marlow HQ, 2009, DEV NEUROBIOL, V69, P235, DOI 10.1002/dneu.20698; MCFARLANE ID, 1987, J EXP BIOL, V133, P157; Nakanishi N, 2012, DEVELOPMENT, V139, P347, DOI 10.1242/dev.071902; PANTIN CFA, 1952, PROC R SOC SER B-BIO, V140, P147, DOI 10.1098/rspb.1952.0052; Pennisi E, 2013, SCIENCE, V339, P25; Pernet V, 2004, J COMP NEUROL, V472, P208, DOI 10.1002/cne.20108; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Richards GS, 2008, CURR BIOL, V18, P1156, DOI 10.1016/j.cub.2008.06.074; Roopin M, 2012, J PINEAL RES, V53, P259, DOI 10.1111/j.1600-079X.2012.00994.x; Ryan TJ, 2009, NAT REV NEUROSCI, V10, P701, DOI 10.1038/nrn2717; Sakarya O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000506; Satterlie RA, 2011, J EXP BIOL, V214, P1215, DOI 10.1242/jeb.043687; Stephenson TA, 1935, BRIT SEA ANEMONES, VII; Tripathi A, 2008, ANN NEUROSCI, V15; UMBRIACO D, 1990, J COMP NEUROL, V291, P167, DOI 10.1002/cne.902910202; Watanabe H, 2009, DEV GROWTH DIFFER, V51, P167, DOI 10.1111/j.1440-169X.2009.01103.x; Westfall JA, 1995, BIOL BULL, V189, P280, DOI 10.2307/1542145; WESTFALL JA, 1993, BIOL BULL, V185, P109, DOI 10.2307/1542134	38	8	8	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93832	10.1371/journal.pone.0093832	http://dx.doi.org/10.1371/journal.pone.0093832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705400	Green Published, Green Submitted, gold			2022-12-25	WOS:000334107500073
J	Singh, RK; Patel, KD; Lee, JH; Lee, EJ; Kim, JH; Kim, TH; Kim, HW				Singh, Rajendra K.; Patel, Kapil D.; Lee, Jae Ho; Lee, Eun-Jung; Kim, Joong-Hyun; Kim, Tae-Hyun; Kim, Hae-Won			Potential of Magnetic Nanofiber Scaffolds with Mechanical and Biological Properties Applicable for Bone Regeneration	PLOS ONE			English	Article							CELL-PROLIFERATION; HYPERTHERMIA; NANOPARTICLES; COMPOSITE	Magnetic nanofibrous scaffolds of poly(caprolactone) (PCL) incorporating magnetic nanoparticles (MNP) were produced, and their effects on physico-chemical, mechanical and biological properties were extensively addressed to find efficacy for bone regeneration purpose. MNPs 12 nm in diameter were citrated and evenly distributed in PCL solutions up to 20% and then were electrospun into nonwoven nanofibrous webs. Incorporation of MNPs greatly improved the hydrophilicity of the nanofibers. Tensile mechanical properties of the nanofibers (tensile strength, yield strength, elastic modulus and elongation) were significantly enhanced with the addition of MNPs up to 15%. In particular, the tensile strength increase was as high as similar to 25 MPa at 15% MNPs vs. similar to 10 MPa in pure PCL. PCL-MNP nanofibers exhibited magnetic behaviors, with a high saturation point and hysteresis loop area, which increased gradually with MNP content. The incorporation of MNPs substantially increased the degradation of the nanofibers, with a weight loss of similar to 20% in pure PCL, similar to 45% in 10% MNPs and similar to 60% in 20% MNPs. Apatite forming ability of the nanofibers tested in vitro in simulated body fluid confirmed the substantial improvement gained by the addition of MNPs. Osteoblastic cells favored the MNPs-incorporated nanofibers with significantly improved initial cell adhesion and subsequent penetration through the nanofibers, compared to pure PCL. Alkaline phosphatase activity and expression of genes associated with bone (collagen I, osteopontin and bone sialoprotein) were significantly up-regulated in cells cultured on PCL-MNP nanofibers than those on pure PCL. PCL-MNP nanofibers subcutaneously implanted in rats exhibited minimal adverse tissue reactions, while inducing substantial neoblood vessel formation, which however, greatly limited in pure PCL. In vivo study in radial segmental defects also signified the bone regeneration ability of the PCL-MNP nanofibrous scaffolds. The magnetic, bone-bioactive, mechanical, cellular and tissue attributes of MNP-incorporated PCL nanofibers make them promising candidate scaffolds for bone regeneration.	[Singh, Rajendra K.; Patel, Kapil D.; Lee, Jae Ho; Lee, Eun-Jung; Kim, Joong-Hyun; Kim, Tae-Hyun; Kim, Hae-Won] Dankook Univ, Inst Tissue Regenerat Engn ITREN, Cheonan, South Korea; [Singh, Rajendra K.; Patel, Kapil D.; Lee, Jae Ho; Lee, Eun-Jung; Kim, Joong-Hyun; Kim, Tae-Hyun; Kim, Hae-Won] Dankook Univ, Dept Nanobiomed Sci, Cheonan, South Korea; [Singh, Rajendra K.; Patel, Kapil D.; Lee, Jae Ho; Lee, Eun-Jung; Kim, Joong-Hyun; Kim, Tae-Hyun; Kim, Hae-Won] Dankook Univ, Plus NBM Global Res Ctr Regenerat Med BK21, Cheonan, South Korea; [Kim, Hae-Won] Dankook Univ, Coll Dent, Dept Biomat Sci, Cheonan, South Korea	Dankook University; Dankook University; Dankook University; Dankook University	Kim, HW (corresponding author), Dankook Univ, Inst Tissue Regenerat Engn ITREN, Cheonan, South Korea.	kimhw@dku.edu	Knowles, Jonathan Campbell/B-9019-2008; Singh, Rajendra K/O-9797-2016; Singh, Rajendra K/AAQ-1217-2020; Patel, Kapil/F-3874-2012	Knowles, Jonathan Campbell/0000-0003-3917-3446; Singh, Rajendra K/0000-0003-3127-3346; Singh, Rajendra K/0000-0003-3127-3346; Patel, Kapil/0000-0002-0393-9166	Priority Research Centers Program through the NSF [2009-0093829]; MEST, Republic of Korea	Priority Research Centers Program through the NSF; MEST, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Priority Research Centers Program (No. 2009-0093829) through the NSF, funded by the MEST, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bock N, 2010, ACTA BIOMATER, V6, P786, DOI 10.1016/j.actbio.2009.09.017; Campbell RB, 2007, NANOMEDICINE-UK, V2, P649, DOI 10.2217/17435889.2.5.649; Chung HJ, 2007, ADV DRUG DELIVER REV, V59, P249, DOI 10.1016/j.addr.2007.03.015; de la Presa P, 2012, J PHYS CHEM C, V116, P25602, DOI 10.1021/jp310771p; De Santis R, 2011, J APPL POLYM SCI, V122, P3599, DOI 10.1002/app.34771; Gu ZW, 2010, BIOMED MATER, V5; Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1; Hacliipanayis CG, 2008, SMALL, V4, P1925, DOI 10.1002/smll.200800261; Hammond C., 1997, BASICS CRYSTALLOGRAP; Holzwarth JM, 2011, BIOMATERIALS, V32, P9622, DOI 10.1016/j.biomaterials.2011.09.009; Hou RX, 2013, COLLOID SURFACE B, V103, P318, DOI 10.1016/j.colsurfb.2012.10.067; Hu H, 2013, RSC ADV, V3, P879, DOI 10.1039/c2ra22726f; Huang DM, 2009, BIOMATERIALS, V30, P3645, DOI 10.1016/j.biomaterials.2009.03.032; Hughes S, 2005, MED ENG PHYS, V27, P754, DOI 10.1016/j.medengphy.2005.04.006; Hwang NS, 2008, ADV DRUG DELIVER REV, V60, P199, DOI 10.1016/j.addr.2007.08.036; Cabaco MI, 2011, J PHYS CHEM B, V115, P3538, DOI 10.1021/jp111453a; Jang JH, 2009, ADV DRUG DELIVER REV, V61, P1065, DOI 10.1016/j.addr.2009.07.008; Kannarkat JT, 2010, J APPL PHYS, V107, DOI 10.1063/1.3357340; Kim HW, 2005, ADV FUNCT MATER, V15, P1988, DOI 10.1002/adfm.200500116; Kim HJ, 2012, TISSUE ENG REGEN MED, V9, P63, DOI 10.1007/s13770-012-0022-8; Kumar CSSR, 2011, ADV DRUG DELIVER REV, V63, P789, DOI 10.1016/j.addr.2011.03.008; Lai KL, 2012, RSC ADV, V2, P13007, DOI 10.1039/c2ra22376g; Lang S. B., 1996, NATURE, V212, P704; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Lee EJ, 2010, ACTA BIOMATER, V6, P3557, DOI 10.1016/j.actbio.2010.03.022; Lee JJ, 2009, J MATER SCI-MATER M, V20, P1927, DOI 10.1007/s10856-009-3743-z; Lim SH, 2009, ADV DRUG DELIVER REV, V61, P1084, DOI 10.1016/j.addr.2009.07.011; Lin TC, 2012, ACTA BIOMATER, V8, P2704, DOI 10.1016/j.actbio.2012.03.045; Lopez MB, 2011, J APPL PHYS, V109; Lv G, 2008, LANGMUIR, V24, P2151, DOI 10.1021/la702845s; Mavis B, 2009, ACTA BIOMATER, V5, P3098, DOI 10.1016/j.actbio.2009.04.037; Meenach SA, 2010, ACTA BIOMATER, V6, P1039, DOI 10.1016/j.actbio.2009.10.017; Meng J, 2010, NANOSCALE, V2, P2565, DOI 10.1039/c0nr00178c; Nomura S, 2000, MATRIX BIOL, V19, P91, DOI 10.1016/S0945-053X(00)00050-0; Oh SA, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/475260; Panseri S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038710; Patel KH, 2013, J TISSUE ENG, V4, DOI 10.1177/2041731413516782; Revi D, 2013, J TISSUE ENG, V4, DOI 10.1177/2041731413518060; Shin SH, 2012, J TISSUE ENG, V3, DOI 10.1177/2041731412443530; Singh A, 2010, J MATER CHEM, V20, P8832, DOI 10.1039/c0jm01613f; Singh RK, 2012, J BIOMED MATER RES A, V100A, P1734, DOI 10.1002/jbm.a.34140; Singh RK, 2012, MATER LETT, V75, P130, DOI 10.1016/j.matlet.2012.01.129; Tampieri A, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/1/015104; Tanahashi M, 1997, J BIOMED MATER RES, V34, P305; Wei Y, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/5/055008; Wu CT, 2011, ACTA BIOMATER, V7, P3563, DOI 10.1016/j.actbio.2011.06.028; Yu HS, 2009, J BIOMED MATER RES A, V88A, P747, DOI 10.1002/jbm.a.31709; Zeng XB, 2012, INT J NANOMED, V7, P3365, DOI 10.2147/IJN.S32264; Zhang F, 2008, J PHYS CHEM C, V112, P15151, DOI 10.1021/jp804452r	49	107	108	6	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e91584	10.1371/journal.pone.0091584	http://dx.doi.org/10.1371/journal.pone.0091584			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705279	Green Published, Green Submitted, gold			2022-12-25	WOS:000334107500005
J	Chiang, CY; Lee, JJ; Chien, ST; Enarson, DA; Chang, YC; Chen, YT; Hu, TY; Lin, CB; Suk, CW; Tao, JM; Bai, KJ				Chiang, Chen-Yuan; Lee, Jen-Jyh; Chien, Shun-Tien; Enarson, Donald A.; Chang, You-Cheng; Chen, Yi-Ting; Hu, Ting-Yu; Lin, Chih-Bin; Suk, Chi-Won; Tao, Jui-Ming; Bai, Kuan-Jen			Glycemic Control and Radiographic Manifestations of Tuberculosis in Diabetic Patients	PLOS ONE			English	Article							LOWER LUNG FIELD; PULMONARY TUBERCULOSIS; MELLITUS; AGE; IMAGES; IMPACT	Background: Radiographic manifestations of pulmonary tuberculosis (TB) in patients with diabetes mellitus (DM) have previously been reported, with inconsistent results. We conducted a study to investigate whether glycemic control has an impact on radiographic manifestations of pulmonary TB. Methods: Consecutive patients with culture-positive pulmonary TB who had DM in three tertiary care hospitals from 2005-2010 were selected for review and compared with a similar number without DM. Glycemic control was assessed by glycated haemoglobin A1C (HbA1C). A pre-treatment chest radiograph was read independently by two qualified pulmonologists blinded to patients' diabetic status. Films with any discordant reading were read by a third reader. Results: 1209 culture positive pulmonary TB patients (581 with DM and 628 without DM) were enrolled. Compared with those without DM, TB patients with DM were significantly more likely to have opacity over lower lung fields, extensive parenchymal lesions, any cavity, multiple cavities and large cavities (>= 3 cm). The relative risk of lower lung field opacities was 0.80 (95% CI 0.46-1.42) for those with DM with A1C<7%, 2.32 (95% CI 1.36 - 3.98) for A1C 7%-9%, and 1.62 (95% CI 1.12-2.36) for A1C>9%; and that of any cavity over no cavity was 0.87 (95% CI 0.46-1.62) for patients with DM with A1C<7%, 1.84 (95% CI 1.20-2.84) for A1C 7%-9%, and 3.71 (95% CI 2.64-5.22) for A1C>9%, relative to patients without DM. Conclusions: Glycemic control significantly influenced radiographic manifestations of pulmonary TB in patients with DM.	[Chiang, Chen-Yuan; Hu, Ting-Yu; Suk, Chi-Won; Bai, Kuan-Jen] Wan Fang Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan; [Chiang, Chen-Yuan] Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan; [Lee, Jen-Jyh; Chen, Yi-Ting; Lin, Chih-Bin] Tzu Chi Gen Hosp, Dept Internal Med, Hualien, Taiwan; [Lee, Jen-Jyh; Chen, Yi-Ting; Lin, Chih-Bin] Tzu Chi Univ, Hualien, Taiwan; [Chien, Shun-Tien; Chang, You-Cheng; Tao, Jui-Ming] Chest Hosp, Dept Hlth & Welf, Tainan, Taiwan; [Bai, Kuan-Jen] Taipei Med Univ, Coll Med, Sch Resp Therapy, Taipei, Taiwan	Taipei Municipal WanFang Hospital; Taipei Medical University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Taipei Medical University	Bai, KJ (corresponding author), Wan Fang Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan.	kjbai@wanfang.gov.tw	Hu, Ting-Yu/AAJ-3797-2021	Hu, Ting-Yu/0000-0002-8251-3808	Taiwan Centers for Disease Control [DOH101-DC-1103]	Taiwan Centers for Disease Control	This study was funded by a research grant DOH101-DC-1103 of Taiwan Centers for Disease Control. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRAWAL AK, 1988, LUNG INDIA, V6, P177; Aktogu S, 1996, EUR RESPIR J, V9, P2031, DOI 10.1183/09031936.96.09102031; Alisjahbana B, 2007, CLIN INFECT DIS, V45, P428, DOI 10.1086/519841; AlWabel AH, 1996, TROP DOCT, V26, P183, DOI 10.1177/004947559602600417; AlWabel AH, 1997, E AFR MED J, V74, P62; CHAN CHS, 1995, TUBERCLE LUNG DIS, V76, P290, DOI 10.1016/S0962-8479(05)80026-7; Chang JT, 2011, J FORMOS MED ASSOC, V110, P372, DOI 10.1016/S0929-6646(11)60055-7; CHANG SC, 1987, CHEST, V91, P230, DOI 10.1378/chest.91.2.230; Jimenez-Corona ME, 2013, THORAX, V68, P214, DOI 10.1136/thoraxjnl-2012-201756; HENDY M, 1983, BRIT J DIS CHEST, V77, P87, DOI 10.1016/0007-0971(83)90010-4; *INTL DIAB FED, IDF DIABETES ATLAS; Jain NK, 1985, LUNG INDIA, V3, P11; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Leung CC, 2008, AM J EPIDEMIOL, V167, P1486, DOI 10.1093/aje/kwn075; MARAIS RM, 1980, S AFR MED J, V57, P483; MORRIS JT, 1992, CHEST, V102, P539, DOI 10.1378/chest.102.2.539; Park SW, 2012, EUR J CLIN MICROBIOL, V31, P1305, DOI 10.1007/s10096-011-1443-3; Perez-Guzman C, 2000, AM J RESP CRIT CARE, V162, P1738, DOI 10.1164/ajrccm.162.5.2001040; Perez-Guzman C, 2001, INT J TUBERC LUNG D, V5, P455; Perez-Guzman Carlos, 1999, Chest, V116, P961, DOI 10.1378/chest.116.4.961; Podell BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046824; Shaikh MA, 2003, SAUDI MED J, V24, P278; Tsukaguchi Katsuhiko, 2002, Kekkaku, V77, P409; UMUT S, 1994, CHEST, V106, P326; Wang CS, 2009, EPIDEMIOL INFECT, V137, P203, DOI 10.1017/S0950268808000782; Wang JY, 2006, INT J TUBERC LUNG D, V10, P578; WEAVER RA, 1974, AM REV RESPIR DIS, V109, P162; Yamashiro S, 2005, CLIN EXP IMMUNOL, V139, P57, DOI 10.1111/j.1365-2249.2005.02677.x	28	40	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93397	10.1371/journal.pone.0093397	http://dx.doi.org/10.1371/journal.pone.0093397			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699457	Green Published, Green Submitted, gold			2022-12-25	WOS:000334105000058
J	Penton, CR; Gupta, VVSR; Tiedje, JM; Neate, SM; Ophel-Keller, K; Gillings, M; Harvey, P; Pham, A; Roget, DK				Penton, C. Ryan; Gupta, V. V. S. R.; Tiedje, James M.; Neate, Stephen M.; Ophel-Keller, Kathy; Gillings, Michael; Harvey, Paul; Pham, Amanda; Roget, David K.			Fungal Community Structure in Disease Suppressive Soils Assessed by 28S LSU Gene Sequencing	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; RHIZOSPHERE MICROBIOME; ENDOPHYTIC FUNGUS; ORGANIC-MATTER; PLANT; DIVERSITY; MANAGEMENT; WHEAT; GRADIENT; HEALTH	Natural biological suppression of soil-borne diseases is a function of the activity and composition of soil microbial communities. Soil microbe and phytopathogen interactions can occur prior to crop sowing and/or in the rhizosphere, subsequently influencing both plant growth and productivity. Research on suppressive microbial communities has concentrated on bacteria although fungi can also influence soil-borne disease. Fungi were analyzed in co-located soils 'suppressive' or 'non-suppressive' for disease caused by Rhizoctonia solani AG 8 at two sites in South Australia using 454 pyrosequencing targeting the fungal 28S LSU rRNA gene. DNA was extracted from a minimum of 125 g of soil per replicate to reduce the micro-scale community variability, and from soil samples taken at sowing and from the rhizosphere at 7 weeks to cover the peak Rhizoctonia infection period. A total of similar to 994,000 reads were classified into 917 genera covering 54% of the RDP Fungal Classifier database, a high diversity for an alkaline, low organic matter soil. Statistical analyses and community ordinations revealed significant differences in fungal community composition between suppressive and non-suppressive soil and between soil type/location. The majority of differences associated with suppressive soils were attributed to less than 40 genera including a number of endophytic species with plant pathogen suppression potentials and mycoparasites such as Xylaria spp. Non-suppressive soils were dominated by Alternaria, Gibberella and Penicillum. Pyrosequencing generated a detailed description of fungal community structure and identified candidate taxa that may influence pathogen-plant interactions in stable disease suppression.	[Penton, C. Ryan; Tiedje, James M.; Pham, Amanda] Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA; [Gupta, V. V. S. R.; Harvey, Paul; Roget, David K.] CSIRO Ecosyst Sci, Glen Osmond, SA, Australia; [Neate, Stephen M.] Leslie Res Ctr, Dept Agr Fisheries & Forestry, Towoomba, Qld, Australia; [Ophel-Keller, Kathy] SARDI, Glen Osmond, SA, Australia; [Gillings, Michael] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia	Michigan State University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Queensland Department of Agriculture & Fisheries; Macquarie University	Penton, CR (corresponding author), Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA.	dobber4uf@gmail.com	Gillings, Michael/AAF-5772-2020; Penton, C. Ryan/H-5274-2019; Neate, Stephen M/T-8753-2017; Harvey, Paul/C-7013-2008; vvsr, Gupta/C-1722-2009; Gillings, Michael R/C-6553-2008	Gillings, Michael/0000-0002-4043-4351; Penton, C. Ryan/0000-0001-9166-7852; Neate, Stephen M/0000-0003-0766-198X; vvsr, Gupta/0000-0001-9774-6471; Gillings, Michael R/0000-0002-4043-4351	Commonwealth Scientific and Industrial Research Organisation; Grains Research Development Corporation	Commonwealth Scientific and Industrial Research Organisation(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Grains Research Development Corporation(Grains R&D Corp)	Financial support was provided by the Commonwealth Scientific and Industrial Research Organisation and Grains Research Development Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; BAKER K F, 1974, P433; Barnett SJ, 2006, AUST J SOIL RES, V44, P331, DOI 10.1071/SR05113; Benitez MS, 2009, APPL ENVIRON MICROB, V75, P915, DOI 10.1128/AEM.01296-08; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Bonanomi G, 2010, SOIL BIOL BIOCHEM, V42, P136, DOI 10.1016/j.soilbio.2009.10.012; Bowen GD, 1999, ADV AGRON, V66, P1, DOI 10.1016/S0065-2113(08)60425-3; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; CAMBARDELLA CA, 1992, SOIL SCI SOC AM J, V56, P777, DOI 10.2136/sssaj1992.03615995005600030017x; Campbell CD, 2003, APPL ENVIRON MICROB, V69, P3593, DOI 10.1128/AEM.69.6.3593-3599.2003; Clarke K. R., 2001, CHANGES MARINE COMMU; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Conn VM, 2008, MOL PLANT MICROBE IN, V21, P208, DOI 10.1094/MPMI-21-2-0208; Cook A, 2008, P 14 ASA C; de Boer W, 2003, APPL ENVIRON MICROB, V69, P835, DOI 10.1128/AEM.69.2.835-844.2003; Duveiller E, 2007, EUPHYTICA, V157, P417, DOI 10.1007/s10681-007-9380-z; FAO, 2006, 103 UN FAO; Fernandez MR., 2011, PRAIRIE SOILS CROPS, V4, P151; Fukui R, 2003, MICROBES ENVIRON, V18, P1; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Garnica S, 2013, FEMS MICROBIOL ECOL, V83, P265, DOI 10.1111/j.1574-6941.2012.01473.x; Gottel NR, 2011, APPL ENVIRON MICROB, V77, P5934, DOI 10.1128/AEM.05255-11; Gupta V.V., 2011, RAINFED FARMING SYST, P149, DOI DOI 10.1007/978-1-4020-9132-2_6; Gupta VVSR, 1999, P 1 AUSTR SOILB DIS, P3; Hopple JS, 1999, MOL PHYLOGENET EVOL, V13, P1, DOI 10.1006/mpev.1999.0634; HORNBY D, 1983, ANNU REV PHYTOPATHOL, V21, P65, DOI 10.1146/annurev.py.21.090183.000433; Hyde KD, 2007, BIODIVERS CONSERV, V16, P7, DOI 10.1007/s10531-006-9119-5; Jang YW, 2007, J ANTIBIOT, V60, P696, DOI 10.1038/ja.2007.89; Janvier C, 2007, SOIL BIOL BIOCHEM, V39, P1, DOI 10.1016/j.soilbio.2006.07.001; Jeger MJ, 1996, POTATO RES, V39, P437, DOI 10.1007/BF02357949; Kim HY, 2007, LETT APPL MICROBIOL, V44, P332, DOI 10.1111/j.1472-765X.2006.02093.x; Kinkel LL, 2011, ANNU REV PHYTOPATHOL, V49, P47, DOI 10.1146/annurev-phyto-072910-095232; Klich MA, 1998, MYCOPATHOLOGIA, V142, P97, DOI 10.1023/A:1006989712282; Larran S, 2002, WORLD J MICROB BIOT, V18, P683, DOI 10.1023/A:1016857917950; Larran S, 2007, WORLD J MICROB BIOT, V23, P565, DOI 10.1007/s11274-006-9266-6; Liu KL, 2012, APPL ENVIRON MICROB, V78, P1523, DOI 10.1128/AEM.06826-11; Loss A, 2012, SOIL RES, V50, P685, DOI 10.1071/SR12196; Macia-Vicente JG, 2008, CAN J MICROBIOL, V54, P600, DOI [10.1139/W08-047, 10.1139/w08-047]; Mazzola M, 2004, ANNU REV PHYTOPATHOL, V42, P35, DOI 10.1146/annurev.phyto.42.040803.140408; McGuire KL, 2012, MICROB ECOL, V63, P804, DOI 10.1007/s00248-011-9973-x; McKay A, 2012, 7 AUSTR SOILB DIS S; McKay A, 2008, ROOT DIS RISK MAANGE; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; MOLLER WJ, 1978, PLANT DIS REP, V62, P254; Neate SM., 1994, SOIL BIOTA MANAGEMEN, P96; Nelson E. B., 2004, ENCY PLANT CROP SCI, P137; Northcote KH, 1975, DESCRIPTION AUSTR; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Ophel-Keller K, 2008, AUSTRALAS PLANT PATH, V37, P243, DOI 10.1071/AP08029; Orgiazzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034847; Pan JJ, 2008, NEW PHYTOL, V178, P147, DOI 10.1111/j.1469-8137.2007.02350.x; Park JH, 2005, J MICROBIOL BIOTECHN, V15, P112; PAULITZ TC, 1987, CAN J MICROBIOL, V33, P349, DOI 10.1139/m87-061; Paulitz TC, 2006, EUR J PLANT PATHOL, V115, P271, DOI 10.1007/s10658-006-9023-6; Penton CR, 2013, APPL ENVIRON MICROB, V79, P7063, DOI 10.1128/AEM.01702-13; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; Porter TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035749; Postma J, 2003, EUR J SOIL BIOL, V39, P157, DOI 10.1016/S1164-5563(03)00031-1; Reddy, 2010, P 6 AUSTR SOILB DIS; Roget D.K., 1999, P 1 AUSTRALASIAN SOI, P129; Roget DK, 1995, AUST J EXP AGR, V35, P1009, DOI 10.1071/EA9951009; Roget DK, 2009, 5 AUSTR SOILB DIS S, P85; ROPER MM, 1995, AUST J SOIL RES, V33, P321, DOI 10.1071/SR9950321; Rosenzweig N, 2012, PLANT DIS, V96, P718, DOI 10.1094/PDIS-07-11-0571; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; ROVIRA A, 1990, Australasian Plant Pathology, V19, P101, DOI 10.1071/APP9900101; Schadt CW, 2003, SCIENCE, V301, P1359, DOI 10.1126/science.1086940; Schnare MN, 1996, J MOL BIOL, V256, P701, DOI 10.1006/jmbi.1996.0119; Schroers HJ, 2001, STUD MYCOL, P1; Shannon CE., 1949, MATH THEORY COMMUNIC; Shiono Y, 2012, NAT PROD COMMUN, V7, P1065; Smalla K, 2007, J MICROBIOL METH, V69, P470, DOI 10.1016/j.mimet.2007.02.014; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Suryanarayanan TS, 2002, CAN J BOT, V80, P818, DOI [10.1139/B02-069, 10.1139/b02-069]; Vainio EJ, 2000, MYCOL RES, V104, P927, DOI 10.1017/S0953756200002471; van Elsas JD, 2008, TRENDS BIOTECHNOL, V26, P591, DOI 10.1016/j.tibtech.2008.07.004; Vilich V, 1998, Z PFLANZENK PFLANZEN, V105, P130; Vinale F, 2008, SOIL BIOL BIOCHEM, V40, P1, DOI 10.1016/j.soilbio.2007.07.002; WARWICK RM, 1990, J EXP MAR BIOL ECOL, V138, P119, DOI 10.1016/0022-0981(90)90180-K; Weber CF, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00078; Wellacher M, 1991, THESIS; Weller DM, 2007, PLANT BIOLOGY, V9, P4, DOI 10.1055/s-2006-924473; Weller DM, 2002, ANNU REV PHYTOPATHOL, V40, P309, DOI 10.1146/annurev.phyto.40.030402.110010; White T., 1990, PCR PROTOCOLS GUIDE, P315; Wiseman BM, 1996, SOIL BIOL BIOCHEM, V28, P727, DOI 10.1016/0038-0717(95)00178-6; Woo Sheridan L., 2007, P107, DOI 10.1007/978-1-4020-5799-1_6; Xu LH, 2012, FEMS MICROBIOL ECOL, V82, P736, DOI 10.1111/j.1574-6941.2012.01445.x; Xu LH, 2012, SOIL BIOL BIOCHEM, V46, P26, DOI 10.1016/j.soilbio.2011.11.010	90	84	87	2	135	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93893	10.1371/journal.pone.0093893	http://dx.doi.org/10.1371/journal.pone.0093893			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699870	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000334105000119
J	Pozeg, P; Rognini, G; Salomon, R; Blanke, O				Pozeg, Polona; Rognini, Giulio; Salomon, Roy; Blanke, Olaf			Crossing the Hands Increases Illusory Self-Touch	PLOS ONE			English	Article							RUBBER HAND; REFERENCE FRAMES; SOMATOSENSORY HOMUNCULUS; SPATIAL INFORMATION; SENSORY INFORMATION; BODY REPRESENTATION; TACTILE PERCEPTION; TEMPORAL-ORDER; VISUAL CAPTURE; ILLUSION	Manipulation of hand posture, such as crossing the hands, has been frequently used to study how the body and its immediately surrounding space are represented in the brain. Abundant data show that crossed arms posture impairs remapping of tactile stimuli from somatotopic to external space reference frame and deteriorates performance on several tactile processing tasks. Here we investigated how impaired tactile remapping affects the illusory self-touch, induced by the non-visual variant of the rubber hand illusion (RHI) paradigm. In this paradigm blindfolded participants (Experiment 1) had their hands either uncrossed or crossed over the body midline. The strength of illusory self-touch was measured with questionnaire ratings and proprioceptive drift. Our results showed that, during synchronous tactile stimulation, the strength of illusory self-touch increased when hands were crossed compared to the uncrossed posture. Follow-up experiments showed that the increase in illusion strength was not related to unfamiliar hand position (Experiment 2) and that it was equally strengthened regardless of where in the peripersonal space the hands were crossed (Experiment 3). However, while the boosting effect of crossing the hands was evident from subjective ratings, the proprioceptive drift was not modulated by crossed posture. Finally, in contrast to the illusion increase in the non-visual RHI, the crossed hand postures did not alter illusory ownership or proprioceptive drift in the classical, visuo-tactile version of RHI (Experiment 4). We argue that the increase in illusory self-touch is related to misalignment of somatotopic and external reference frames and consequently inadequate tactile-proprioceptive integration, leading to re-weighting of the tactile and proprioceptive signals. The present study not only shows that illusory self-touch can be induced by crossing the hands, but importantly, that this posture is associated with a stronger illusion.	[Pozeg, Polona; Rognini, Giulio; Salomon, Roy; Blanke, Olaf] Ecole Polytech Fed Lausanne, Sch Life Sci, Ctr Neuroprosthet, Lausanne, Switzerland; [Pozeg, Polona; Rognini, Giulio; Salomon, Roy] Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lab Cognit Neurosci, Lausanne, Switzerland; [Rognini, Giulio; Blanke, Olaf] Ecole Polytech Fed Lausanne, Sch Engn, Inst Microengn, Robot Syst Lab 1, Lausanne, Switzerland; [Blanke, Olaf] Univ Hosp Geneva, Dept Neurol, Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva	Blanke, O (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Ctr Neuroprosthet, Lausanne, Switzerland.	olaf.blanke@epfl.ch	Salomon, Roy/N-8249-2015	Salomon, Roy/0000-0002-6688-617X	Swiss National Science Foundation [CRSII1_125135/1]; Bertarelli Foundation; Swiss National Science Foundation (NCCR) [SYNAPSY 51AU40_125759]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Bertarelli Foundation; Swiss National Science Foundation (NCCR)(Swiss National Science Foundation (SNSF))	This work has been supported by the grants from Swiss National Science Foundation (CRSII1_125135/1) and the Bertarelli Foundation. RS was suported by the Swiss National Science Foundation (NCCR, SYNAPSY 51AU40_125759). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglioti S, 1999, J COGNITIVE NEUROSCI, V11, P67, DOI 10.1162/089892999563256; Aristotle, 2007, METAPHYSICS; Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Azanon E, 2008, CURR BIOL, V18, P1044, DOI 10.1016/j.cub.2008.06.045; BENEDETTI F, 1985, J EXP PSYCHOL HUMAN, V11, P517, DOI 10.1037/0096-1523.11.4.517; Berlucchi G, 1997, TRENDS NEUROSCI, V20, P560, DOI 10.1016/S0166-2236(97)01136-3; Blanke O, 2009, TRENDS COGN SCI, V13, P7, DOI 10.1016/j.tics.2008.10.003; Block HJ, 2011, J NEUROPHYSIOL, V106, P59, DOI 10.1152/jn.00641.2010; Bolognini N, 2007, CURR BIOL, V17, P1890, DOI 10.1016/j.cub.2007.09.057; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Bremner AJ, 2008, J EXP PSYCHOL GEN, V137, P149, DOI 10.1037/0096-3445.137.1.149; Cadieux ML, 2011, NEUROSCI LETT, V504, P191, DOI 10.1016/j.neulet.2011.09.010; Costantini M, 2007, CONSCIOUS COGN, V16, P229, DOI 10.1016/j.concog.2007.01.001; Damasio A. R., 1999, FEELING WHAT HAPPENS; Davies AMA, 2013, CONSCIOUS COGN, V22, P613, DOI 10.1016/j.concog.2013.03.006; Davies AMA, 2010, PERCEPTION, V39, P830, DOI 10.1068/p6610; de Haan AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045408; de Vignemont F, 2005, CURR BIOL, V15, P1286, DOI 10.1016/j.cub.2005.06.067; Dieguez S, 2009, CURR BIOL, V19, pR1108, DOI 10.1016/j.cub.2009.10.055; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Eimer M, 2003, PSYCHOPHYSIOLOGY, V40, P924, DOI 10.1111/1469-8986.00110; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Farne A, 2000, BRAIN, V123, P2350, DOI 10.1093/brain/123.11.2350; Gallagher S., 2005, BODY SHAPES MIND; Graziano MSA, 1998, CURR OPIN NEUROBIOL, V8, P195, DOI 10.1016/S0959-4388(98)80140-2; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Graziano MSA, 2000, SCIENCE, V290, P1782, DOI 10.1126/science.290.5497.1782; Gruasser O.-J., 1983, SPATIALLY ORIENTED B, P327, DOI 10.1007/978-1-4612-5488-1_18; Haans A, 2008, BODY IMAGE, V5, P389, DOI 10.1016/j.bodyim.2008.04.003; Haggard P, 2003, CURR BIOL, V13, pR170, DOI 10.1016/S0960-9822(03)00115-5; Hagura N, 2007, J NEUROSCI, V27, P7047, DOI 10.1523/JNEUROSCI.0970-07.2007; Holmes Nicholas P, 2004, Cogn Process, V5, P94, DOI 10.1007/s10339-004-0013-3; Holmes NP, 2006, BRAIN RES, V1077, P108, DOI 10.1016/j.brainres.2005.11.010; Jeannerod M, 2007, J PHYSIOL-PARIS, V101, P161, DOI 10.1016/j.jphysparis.2007.11.005; Kammers MPM, 2010, CURR BIOL, V20, P1819, DOI 10.1016/j.cub.2010.08.038; Kobor I, 2006, NEUROSCI LETT, V400, P163, DOI 10.1016/j.neulet.2006.02.037; Kurth R, 2000, NEUROREPORT, V11, P1487, DOI 10.1097/00001756-200005150-00025; Lloyd DM, 2007, BRAIN COGNITION, V64, P104, DOI 10.1016/j.bandc.2006.09.013; Longo MR, 2010, NEUROPSYCHOLOGIA, V48, P655, DOI 10.1016/j.neuropsychologia.2009.08.022; Lopez C, 2010, CONSCIOUS COGN, V19, P33, DOI 10.1016/j.concog.2009.12.003; Macaluso E, 2010, NEUROPSYCHOLOGIA, V48, P782, DOI 10.1016/j.neuropsychologia.2009.10.010; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; Matsumoto E, 2004, EXP BRAIN RES, V158, P9, DOI 10.1007/s00221-004-1872-7; Medina J, 2010, NEUROPSYCHOLOGIA, V48, P645, DOI 10.1016/j.neuropsychologia.2009.08.017; Merleau-Ponty Maurice, 2005, PHENOMENOLOGY PERCEP; Metzinger T, 2008, PROG BRAIN RES, V168, P215, DOI 10.1016/S0079-6123(07)68018-2; MOSCOVITCH M, 1994, J COGNITIVE NEUROSCI, V6, P151, DOI 10.1162/jocn.1994.6.2.151; Nakamura A, 1998, NEUROIMAGE, V7, P377, DOI 10.1006/nimg.1998.0332; NARICI L, 1991, NEUROSCI LETT, V121, P51, DOI 10.1016/0304-3940(91)90647-C; OLDFIELD SR, 1983, PERCEPTION, V12, P615, DOI 10.1068/p120615; Pavani F, 2000, PSYCHOL SCI, V11, P353, DOI 10.1111/1467-9280.00270; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Peru A, 2006, EXP BRAIN RES, V169, P145, DOI 10.1007/s00221-005-0132-9; Petkova VI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035912; Pouget A, 2002, NAT REV NEUROSCI, V3, P741, DOI 10.1038/nrn914; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; RIVERS WHR, 1894, MIND, V3, P583; Roder B, 2004, CURR BIOL, V14, P121, DOI 10.1016/j.cub.2003.12.054; Salomon R, 2013, EXP BRAIN RES, V228, P173, DOI 10.1007/s00221-013-3549-6; Schutz-Bosbach S, 2009, CONSCIOUS COGN, V18, P2, DOI 10.1016/j.concog.2008.08.003; Sekine T, 2009, NEUROREPORT, V20, P467, DOI 10.1097/WNR.0b013e3283277087; Serino A, 2010, NEUROSCI BIOBEHAV R, V34, P224, DOI 10.1016/j.neubiorev.2009.04.004; Shore DI, 2002, COGNITIVE BRAIN RES, V14, P153, DOI 10.1016/S0926-6410(02)00070-8; Sigmundsson H, 2007, SEX ROLES, V57, P181, DOI 10.1007/s11199-007-9228-y; Spence C, 2004, COGN AFFECT BEHAV NE, V4, P148, DOI 10.3758/CABN.4.2.148; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; van Beers RJ, 1998, EXP BRAIN RES, V122, P367, DOI 10.1007/s002210050525; van Stralen HE, 2011, PHILOS T R SOC B, V366, P3142, DOI 10.1098/rstb.2011.0163; VONHOFSTEN C, 1988, NEUROPSYCHOLOGIA, V26, P805, DOI 10.1016/0028-3932(88)90051-6; Wada M, 2004, NEUROPSYCHOLOGIA, V42, P1887, DOI 10.1016/j.neuropsychologia.2004.05.009; White RC, 2011, CONSCIOUS COGN, V20, P956, DOI 10.1016/j.concog.2011.03.021; White RC, 2010, CONSCIOUS COGN, V19, P505, DOI 10.1016/j.concog.2009.08.003; Yamamoto S, 2001, NAT NEUROSCI, V4, P759, DOI 10.1038/89559	74	15	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e94008	10.1371/journal.pone.0094008	http://dx.doi.org/10.1371/journal.pone.0094008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LR	24699795	Green Published, gold, Green Submitted			2022-12-25	WOS:000334105000135
J	Subramaniam, G; Campsteijn, C; Thompson, EM				Subramaniam, Gunasekaran; Campsteijn, Coen; Thompson, Eric M.			Lifespan Extension in a Semelparous Chordate Occurs via Developmental Growth Arrest Just Prior to Meiotic Entry	PLOS ONE			English	Article							GERMLINE STEM-CELLS; ELEGANS L1 ARREST; OIKOPLEURA-DIOICA; CAENORHABDITIS-ELEGANS; C-ELEGANS; STRESS RESPONSES; DROSOPHILA OVARY; TOR PATHWAY; P38 MAPK; RAPAMYCIN	It is proposed that the ageing process is linked to signaling from the germline such that the rate of ageing can be adjusted to the state of the reproductive system, allowing these two processes to co-evolve. Mechanistic insight into this link has been primarily derived from iteroparous reproductive models, the nematode C. elegans, and the arthropod Drosophila. Here, we examined to what extent these mechanisms are evolutionarily conserved in a semelparous chordate, Oikopleura dioica, where we identify a developmental growth arrest (GA) in response to crowded, diet-restricted conditions, which can extend its lifespan at least three-fold. Under nutritional stress, the iteroparative models sacrifice germ cells that have entered meiosis, while maintaining a reduced pool of active germline stem cells (GSCs). In contrast, O. dioica only entered GA prior to meiotic entry. Stress conditions encountered after this point led to maturation in a normal time frame but with reduced reproductive output. During GA, TOR signaling was inhibited, whereas MAPK, ERK1/2 and p38 pathways were activated, and under such conditions, activation of these pathways was shown to be critical for survival. Direct inhibition of TOR signaling alone was sufficient to prevent meiotic entry and germline differentiation. This inhibition activated the p38 pathway, but did not activate the ERK1/2 pathway. Thus, the link between reproductive status and lifespan extension in response to nutrient-limited conditions is interpreted in a significantly different manner in these iteroparative versus semelparous models. In the latter case, meiotic entry is a definitive signal that lifespan extension can no longer occur, whereas in the former, meiotic entry is not a unique chronological event, and can be largely erased during lifespan extension in response to nutrient stress, and reactivated from a pool of maintained GSCs when conditions improve.	[Subramaniam, Gunasekaran; Campsteijn, Coen; Thompson, Eric M.] Univ Bergen, Sars Int Ctr Marine Mol Biol, Bergen, Norway; [Thompson, Eric M.] Univ Bergen, Dept Biol, Bergen, Norway	University of Bergen; University of Bergen	Thompson, EM (corresponding author), Univ Bergen, Sars Int Ctr Marine Mol Biol, Bergen, Norway.	Eric.Thompson@sars.uib.no			Norwegian Research Council [183690/S10 NFR-FUGE, 133335/V40]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by grants 183690/S10 NFR-FUGE and 133335/V40 from the Norwegian Research Council (http://www.forskningsradet.no/en/Home_page/1177315753906) to EMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelo G, 2009, SCIENCE, V326, P954, DOI 10.1126/science.1178343; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Baugh LR, 2013, GENETICS, V194, P539, DOI 10.1534/genetics.113.150847; Baugh LR, 2006, CURR BIOL, V16, P780, DOI 10.1016/j.cub.2006.03.021; Blain SW, 2008, CELL CYCLE, V7, P892, DOI 10.4161/cc.7.7.5637; Bouquet JM, 2009, J PLANKTON RES, V31, P359, DOI 10.1093/plankt/fbn132; Britton JS, 1998, DEVELOPMENT, V125, P2149; Campsteijn C, 2012, MOL BIOL EVOL, V29, P487, DOI 10.1093/molbev/msr136; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Cloninger C, 2011, MOL CANCER THER, V10, P2244, DOI 10.1158/1535-7163.MCT-11-0478; Craig CR, 2004, EMBO REP, V5, P1058, DOI 10.1038/sj.embor.7400282; Cully M, 2010, MOL CELL BIOL, V30, P481, DOI 10.1128/MCB.00688-09; Delsuc F, 2008, GENESIS, V46, P592, DOI 10.1002/dvg.20450; Densham RM, 2008, CELL SIGNAL, V20, P1986, DOI 10.1016/j.cellsig.2008.07.005; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fox PM, 2011, DEVELOPMENT, V138, P2223, DOI 10.1242/dev.059535; FRIEDMAN DB, 1988, GENETICS, V118, P75; Fukuyama M, 2012, BIOL OPEN, V1, P929, DOI 10.1242/bio.2012836; Gaben AM, 2004, INT J CANCER, V108, P200, DOI 10.1002/ijc.11521; Ganot P, 2002, DEV BIOL, V252, P59, DOI 10.1006/dbio.2002.0834; Ganot P, 2007, DEV BIOL, V302, P577, DOI 10.1016/j.ydbio.2006.10.022; Ganot P, 2007, DEV BIOL, V302, P591, DOI 10.1016/j.ydbio.2006.10.021; Ganot P, 2006, BIOL CELL, V98, P389, DOI 10.1042/BC20060005; Ganot P, 2008, DEV BIOL, V324, P266, DOI 10.1016/j.ydbio.2008.09.016; HARPER JW, 1993, CELL, V75, P805; Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027; Honjoh S, 2009, NATURE, V457, P726, DOI 10.1038/nature07583; Hosp J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040172; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Ikeyama S, 2002, FASEB J, V16, pA1163, DOI 10.1096/fj.01-0409fje; Inoue H, 2001, EMBO J, V20, P5421, DOI 10.1093/emboj/20.19.5421; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kimble J, 1988, NEMATODE CAENORHABDI, P191; Koga M, 2000, EMBO J, V19, P5148, DOI 10.1093/emboj/19.19.5148; LaFever L, 2010, DEVELOPMENT, V137, P2117, DOI 10.1242/dev.050351; Leung-Pineda V, 2004, BIOCHEM J, V379, P79, DOI 10.1042/BJ20031383; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Liu GM, 2002, J BIOL CHEM, V277, P8810, DOI 10.1074/jbc.M110477200; Lobon CM, 2013, LIMNOL OCEANOGR, V58, P215, DOI 10.4319/lo.2013.58.1.0215; Long XM, 2002, CURR BIOL, V12, P1448, DOI 10.1016/S0960-9822(02)01091-6; Luo Y, 1996, MOL CELL BIOL, V16, P6744; Martinet W, 2012, ARTERIOSCL THROM VAS, V32, P1228, DOI 10.1161/ATVBAHA.112.245381; Mattock H, 2001, EXP CELL RES, V265, P234, DOI 10.1006/excr.2001.5160; Mifsud KR, 2011, BRAIN BEHAV IMMUN, V25, P1305, DOI 10.1016/j.bbi.2011.06.005; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Okuyama T, 2010, J BIOL CHEM, V285, P30274, DOI 10.1074/jbc.M110.146274; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Petersen J, 2007, NAT CELL BIOL, V9, P1263, DOI 10.1038/ncb1646; Robida-Stubbs S, 2012, CELL METAB, V15, P713, DOI 10.1016/j.cmet.2012.04.007; Sato R, 2001, J PLANKTON RES, V23, P415, DOI 10.1093/plankt/23.4.415; Schulmeister A, 2007, CHROMOSOME RES, V15, P189, DOI 10.1007/s10577-006-1112-z; Seidel HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028074; SHAN B, 1992, MOL CELL BIOL, V12, P5620, DOI 10.1128/MCB.12.12.5620; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Shibutani ST, 2008, DEV CELL, V15, P890, DOI 10.1016/j.devcel.2008.10.003; Spada F, 2005, J CELL BIOCHEM, V95, P885, DOI 10.1002/jcb.20416; Staver JM, 2002, BIOL BULL, V203, P58, DOI 10.2307/1543458; Sun P, 2010, DEVELOPMENT, V137, P2461, DOI 10.1242/dev.051466; Troedsson C, 2002, MAR ECOL PROG SER, V243, P83, DOI 10.3354/meps243083; Troedsson C, 2009, J PLANKTON RES, V31, P1453, DOI 10.1093/plankt/fbp085; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; van der Heide LP, 2011, J BIOL CHEM, V286, P5003, DOI 10.1074/jbc.M110.167379; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zheng N, 1999, GENE DEV, V13, P666, DOI 10.1101/gad.13.6.666; Zheng XF, 1997, P NATL ACAD SCI USA, V94, P3070, DOI 10.1073/pnas.94.7.3070; Zielke N, 2011, NATURE, V480, P123, DOI 10.1038/nature10579	76	6	6	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93787	10.1371/journal.pone.0093787	http://dx.doi.org/10.1371/journal.pone.0093787			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695788	Green Submitted, Green Published, gold			2022-12-25	WOS:000334103000122
J	Zhang, LJ; Dong, LJ; Liu, X; Jiang, YF; Zhang, LJ; Zhang, XM; Li, XR; Zhang, Y				Zhang, Lijuan; Dong, Lijie; Liu, Xun; Jiang, Yuanfeng; Zhang, Lingjun; Zhang, Xiaomin; Li, Xiaorong; Zhang, Yan			alpha-Melanocyte-Stimulating Hormone Protects Retinal Vascular Endothelial Cells from Oxidative Stress and Apoptosis in a Rat Model of Diabetes	PLOS ONE			English	Article							MELANOCORTIN SYSTEM; NEURAL APOPTOSIS; GLYCEMIC CONTROL; MAP KINASE; RETINOPATHY; EXPRESSION; INSULIN; TYPE-1; MECHANISMS; RECEPTORS	Aims: Oxidative stress and apoptosis are among the earliest lesions of diabetic retinopathy. This study sought to examine the anti-oxidative and anti-apoptotic effects of alpha-melanocyte-stimulating hormone (alpha-MSH) in early diabetic retinas and to explore the underlying mechanisms in retinal vascular endothelial cells. Methods: Sprague-Dawley rats were injected intravenously with streptozocin to induce diabetes. The diabetic rats were injected intravitreally with alpha-MSH or saline. At week 5 after diabetes, the retinas were analyzed for reactive oxygen species (ROS) and gene expression. One week later, the retinas were processed for terminal deoxynucleotidyl transferase dUTP nick-end labeling staining and transmission electron microscopy. Retinal vascular endothelial cells were stimulated by high glucose (HG) with or without alpha-MSH. The expression of Forkhead box O genes (Foxos) was examined through real-time PCR. The Foxo4 gene was overexpressed in endothelial cells by transient transfection prior to alpha-MSH or HG treatment, and oxidative stress and apoptosis were analyzed through CM-H2DCFDA and annexin-V assays, respectively. Results: In diabetic retinas, the levels of H2O2 and ROS and the total anti-oxidant capacity were normalized, the apoptotic cell number was reduced, and the ultrastructural injuries were ameliorated by alpha-MSH. Treatment with alpha-MSH also corrected the aberrant changes in eNOS, iNOS, ICAM-1, and TNF-alpha expression levels in diabetic retinas. Furthermore, alpha-MSH inhibited Foxo4 up-regulation in diabetic retinas and in endothelial cells exposed to HG, whereas Foxo4 overexpression abrogated the anti-oxidative and anti-apoptotic effects of alpha-MSH in HG-stimulated retinal vascular endothelial cells. Conclusions: alpha-MSH normalized oxidative stress, reduced apoptosis and ultrastructural injuries, and corrected gene expression levels in early diabetic retinas. The protective effects of alpha-MSH in retinal vascular endothelial cells may be mediated through the inhibition of Foxo4 up-regulation induced by HG. This study suggests an alpha-MSH-mediated potential intervention approach to early diabetic retinopathy and a novel regulatory mechanism involving Foxo4.	[Zhang, Lijuan; Dong, Lijie; Liu, Xun; Jiang, Yuanfeng; Zhang, Lingjun; Zhang, Xiaomin; Li, Xiaorong; Zhang, Yan] Tianjin Med Univ, Hosp Eye, Inst Eye, Tianjin, Peoples R China	Tianjin Medical University	Li, XR (corresponding author), Tianjin Med Univ, Hosp Eye, Inst Eye, Tianjin, Peoples R China.	xiaorli@163.com; yanzhang9927@163.com	Jiang, Yuanfeng/ABC-4039-2020	Zhang, Xiaomin/0000-0003-4898-4152	Ph.D. Programs Foundation of Ministry of Education of China [20121202120005, 20111202110008]; 45th Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry; start-up fund for introduction of talents to Tianjin Medical University Eye Hospital [TJEC20101110]; National Natural Science Foundation of China [31100991]	Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); 45th Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); start-up fund for introduction of talents to Tianjin Medical University Eye Hospital; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research work was supported by Ph.D. Programs Foundation of Ministry of Education of China (# 20121202120005 to Y.Z., URL: http://www.cutech.edu.cn/cn/zxgz/2012/12/1354173228992896.htm); The 45th Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry to Y.Z., URL: http://www.cscse.edu.cn/publish/portal0/tab182/; The start-up fund for introduction of talents to Tianjin Medical University Eye Hospital (# TJEC20101110 to Y.Z., URL: http://www.tmuec.com/tmuec/ykzx/ykindex.jsp); Ph.D. Programs Foundation of Ministry of Education of China (# 20111202110008 to X. L., URL: http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/2012/02/1326778644477072.htm); The National Natural Science Foundation of China (# 31100991 to L. D., URL: http://npd.nsfc.gov. cnfundingProjectSearchAction!search.action). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Aleksandrushkina NI, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1436, DOI 10.1134/S0006297912130032; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Asa FA, 2007, J MOL NEUROSCI, V33, P239, DOI 10.1007/s12031-007-0019-2; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Barber AJ, 2011, INVEST OPHTH VIS SCI, V52, P1156, DOI 10.1167/iovs.10-6293; BAUMGARTI HJ, 1991, DIABETES RES CLIN EX, V16, P145; Behl Y, 2009, DIABETES, V58, P917, DOI 10.2337/db08-0537; Bressler NM, 2011, NEW ENGL J MED, V365, P1520, DOI 10.1056/NEJMct0908432; Ceriello A, 2009, J CLIN ENDOCR METAB, V94, P2751, DOI 10.1210/jc.2009-0762; Chai BX, 2007, REGUL PEPTIDES, V139, P115, DOI 10.1016/j.regpep.2006.11.003; Chen Y, 2013, DIABETES, V62, P261, DOI 10.2337/db11-0413; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Chuang PY, 2007, KIDNEY INT, V72, P965, DOI 10.1038/sj.ki.5002456; Chuang PY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023566; da Silva AA, 2008, HYPERTENSION, V51, P884, DOI 10.1161/HYPERTENSIONAHA.107.100636; Dietrich Nadine, 2012, Methods Mol Biol, V933, P291, DOI 10.1007/978-1-62703-068-7_19; Edling AE, 2011, J NEUROIMMUNOL, V236, P1, DOI 10.1016/j.jneuroim.2011.04.015; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Fujita K, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/324256; HAMMES HP, 1995, MOL MED, V1, P527, DOI 10.1007/BF03401589; Hammes HP, 2002, DIABETES, V51, P3107, DOI 10.2337/diabetes.51.10.3107; Haynes WG, 1999, HYPERTENSION, V33, P542, DOI 10.1161/01.HYP.33.1.542; Hazra S, 2012, DIABETES, V61, P3270, DOI 10.2337/db11-1596; Henri P, 2012, J CELL PHYSIOL, V227, P2578, DOI 10.1002/jcp.22996; Hu BJ, 2014, INT J MOL SCI, V15, P1606, DOI 10.3390/ijms15011606; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Jarrett SG, 2012, MOL ASPECTS MED, V33, P399, DOI 10.1016/j.mam.2012.03.009; Jung DS, 2008, AM J PHYSIOL-RENAL, V295, pF595, DOI 10.1152/ajprenal.00624.2007; Kadekaro AL, 2012, MOL CANCER RES, V10, P778, DOI 10.1158/1541-7786.MCR-11-0436; Kay JG, 2013, ADV EXP MED BIOL, V991, P177, DOI 10.1007/978-94-007-6331-9_10; Kokot A, 2009, ENDOCRINOLOGY, V150, P3197, DOI 10.1210/en.2008-1315; Kowluru RA, 2003, DIABETES, V52, P818, DOI 10.2337/diabetes.52.3.818; Kowluru RA, 2007, EXP DIABETES RES, DOI 10.1155/2007/43603; Lee DJ, 2009, INT IMMUNOPHARMACOL, V9, P1079, DOI 10.1016/j.intimp.2009.05.001; Li QH, 2010, INVEST OPHTH VIS SCI, V51, P5240, DOI 10.1167/iovs.09-5147; [刘冕 Liu Mian], 2013, [中华实验眼科杂志, Chinese Journal of Experimental Ophthalmology], V31, P440; Mason JO, 2006, CURR OPIN OPHTHALMOL, V17, P281, DOI 10.1097/01.icu.0000193098.28798.18; Naveh N, 2003, GRAEF ARCH CLIN EXP, V241, P1044, DOI 10.1007/s00417-003-0781-y; Nohara K, 2011, ENDOCRINOLOGY, V152, P1661, DOI 10.1210/en.2010-1288; Ponugoti B, 2012, EXP DIABETES RES, DOI 10.1155/2012/939751; Rahmouni K, 2003, J NEUROSCI, V23, P5998, DOI 10.1523/JNEUROSCI.23-14-05998.2003; Robinson R, 2012, DIS MODEL MECH, V5, P444, DOI 10.1242/dmm.009597; Rodrigues AR, 2009, MOL CELL ENDOCRINOL, V303, P74, DOI 10.1016/j.mce.2009.01.014; RUDMAN D, 1983, AM J PHYSIOL, V245, pE47, DOI 10.1152/ajpendo.1983.245.1.E47; Schaible EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071056; Shiratori K, 2004, INVEST OPHTH VIS SCI, V45, P159, DOI 10.1167/iovs.03-0492; Spaccapelo L, 2011, EUR J PHARMACOL, V670, P479, DOI 10.1016/j.ejphar.2011.09.015; Stitt AW, 2013, CLIN SCI, V125, P1, DOI 10.1042/CS20120588; Stitt AW, 1997, AM J PATHOL, V150, P523; Taylor AW, 2010, ADV EXP MED BIOL, V681, P143, DOI 10.1007/978-1-4419-6354-3_12; Tsuchiya K, 2012, CELL METAB, V15, P372, DOI 10.1016/j.cmet.2012.01.018; Ugwu SO, 1997, BIOPHARM DRUG DISPOS, V18, P259, DOI 10.1002/(SICI)1099-081X(199704)18:3<259::AID-BDD20>3.0.CO;2-X; Urbich C, 2005, FASEB J, V19, P974, DOI 10.1096/fj.04-2727fje; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Voisey J, 2003, CURR DRUG TARGETS, V4, P586; Vongs A, 2004, REGUL PEPTIDES, V120, P113, DOI 10.1016/j.regpep.2004.02.018; Wardlaw SL, 2011, EUR J PHARMACOL, V660, P213, DOI 10.1016/j.ejphar.2010.10.107; WILSON JF, 1980, J ENDOCRINOL, V86, P61, DOI 10.1677/joe.0.0860061; Xu L, 2013, PEPTIDES, V48, P137, DOI 10.1016/j.peptides.2013.08.010; Yang YK, 2011, EUR J PHARMACOL, V660, P125, DOI 10.1016/j.ejphar.2010.12.020; Zhang B, 2009, INVEST OPHTH VIS SCI, V50, P3943, DOI 10.1167/iovs.08-2954; Zhang LW, 2012, DIABETES RES CLIN PR, V96, P286, DOI 10.1016/j.diabres.2011.12.006; Zhang Y, 2009, J NEUROCHEM, V110, P390, DOI 10.1111/j.1471-4159.2009.06144.x	64	44	49	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93433	10.1371/journal.pone.0093433	http://dx.doi.org/10.1371/journal.pone.0093433			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695675	Green Published, gold			2022-12-25	WOS:000334103000071
J	Corso, B; Greenberg, DA				Corso, Barbara; Greenberg, David A.			Using Linkage Analysis to Detect Gene-Gene Interaction by Stratifying Family Data on Known Disease, or Disease-Associated, Alleles	PLOS ONE			English	Article							SIMULATION; MODELS; POWER	Detecting gene-gene interaction in complex diseases is a major challenge for common disease genetics. Most interaction detection approaches use disease-marker associations and such methods have low power and unknown reliability in real data. We developed and tested a powerful linkage-analysis-based gene-gene interaction detection strategy based on conditioning the family data on a known disease-causing allele or disease-associated marker allele. We computer-generated multipoint linkage data for a disease caused by two epistatically interacting loci (A and B). We examined several two-locus epistatic inheritance models: dominant-dominant, dominant-recessive, recessive-dominant, recessive-recessive. At one of the loci (A), there was a known disease-related allele. We stratified the family data on the presence of this allele, eliminating family members who were without it. This elimination step has the effect of raising the "penetrance" at the second locus (B). We then calculated the lod score at the second locus (B) and compared the pre- and post-stratification lod scores at B. A positive difference indicated interaction. We also examined if it was possible to detect interaction with locus B based on a disease-marker association (instead of an identified disease allele) at locus A. We also tested whether the presence of genetic heterogeneity would generate false positive evidence of interaction. The power to detect interaction for a known disease allele was 60-90%. The probability of false positives, based on heterogeneity, was low. Decreasing linkage disequilibrium between the disease and marker at locus A decreased the likelihood of detecting interaction. The allele frequency of the associated marker made little difference to the power.	[Corso, Barbara] CNR, Inst Neurosci, Padua, Italy; [Greenberg, David A.] Nationwide Childrens Hosp, Battelle Ctr Math Med, Columbus, OH 43205 USA; [Greenberg, David A.] Ohio State Univ, Dept Pediat, Wexner Med Ctr, Columbus, OH 43210 USA	Consiglio Nazionale delle Ricerche (CNR); University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University	Greenberg, DA (corresponding author), Nationwide Childrens Hosp, Battelle Ctr Math Med, Columbus, OH 43205 USA.	david.greenberg@nationwidechildrens.org	Corso, Barbara/P-1796-2018	Corso, Barbara/0000-0002-0684-9078	Nationwide Children's Hospital, Columbus OH [T32-MH65213, NINDS NS27941, NIMH MH48858, NS61829, NS70323]; New York State Psychiatric Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048858, T32MH065213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027941, R01NS061829, R21NS070323] Funding Source: NIH RePORTER	Nationwide Children's Hospital, Columbus OH; New York State Psychiatric Institute; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grants T32-MH65213, NINDS NS27941, NIMH MH48858, NS61829, NS70323, Nationwide Children's Hospital, Columbus OH, and the New York State Psychiatric Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu PC, 1999, AM J HUM GENET, V65, P847, DOI 10.1086/302536; Cavalli-Sforza L.L., 1971, GENETICS HUMAN POPUL; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; GREENBERG DA, 1981, AM J HUM GENET, V33, P519; Greenberg DA, 2001, GENET EPIDEMIOL, V21, P299, DOI 10.1002/gepi.1036; Greenberg DA, 2011, HUM HERED, V72, P247, DOI 10.1159/000330633; Hodge SE, 1997, AM J HUM GENET, V60, P217; Kruglyak L, 1998, J COMPUT BIOL, V5, P1, DOI 10.1089/cmb.1998.5.1; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Rodriguez-Murillo L, 2010, J HEART LUNG TRANSPL, V29, P174, DOI 10.1016/j.healun.2009.08.022; Rodriguez-Murillo L, 2008, INT J ANDROL, V31, P546, DOI 10.1111/j.1365-2605.2008.00896.x	12	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93398	10.1371/journal.pone.0093398	http://dx.doi.org/10.1371/journal.pone.0093398			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690899	Green Submitted, Green Published, gold			2022-12-25	WOS:000334101100074
J	Farooq, SM; Boppana, NB; Asokan, D; Sekaran, SD; Shankar, EM; Li, CY; Gopal, K; Bakar, SA; Karthik, HS; Ebrahim, AS				Farooq, Shukkur M.; Boppana, Nithin B.; Asokan, Devarajan; Sekaran, Shamala D.; Shankar, Esaki M.; Li, Chunying; Gopal, Kaliappan; Bakar, Sazaly A.; Karthik, Harve S.; Ebrahim, Abdul S.			C- Phycocyanin Confers Protection against Oxalate-Mediated Oxidative Stress and Mitochondrial Dysfunctions in MDCK Cells	PLOS ONE			English	Article							RENAL EPITHELIAL-CELLS; LIPID-PEROXIDATION; ANTIOXIDANT; KINASE; INJURY; ACID; INFLAMMATION; GLUTATHIONE; ACTIVATION; INHIBITION	Oxalate toxicity is mediated through generation of reactive oxygen species ( ROS) via a process that is partly dependent on mitochondrial dysfunction. Here, we investigated whether C- phycocyanin ( CP) could protect against oxidative stress-mediated intracellular damage triggered by oxalate in MDCK cells. DCFDA, a fluorescence- based probe and hexanoyl- lysine adduct ( HEL), an oxidative stress marker were used to investigate the effect of CP on oxalate- induced ROS production and membrane lipid peroxidation ( LPO). The role of CP against oxalate- induced oxidative stress was studied by the evaluation of mitochondrial membrane potential by JC1 fluorescein staining, quantification of ATP synthesis and stress- induced MAP kinases ( JNK/ SAPK and ERK1/ 2). Our results revealed that oxalate- induced cells show markedly increased ROS levels and HEL protein expression that were significantly decreased following pre- treatment with CP. Further, JC1 staining showed that CP pre- treatment conferred significant protection from mitochondrial membrane permeability and increased ATP production in CP- treated cells than oxalate- alone- treated cells. In addition, CP treated cells significantly decreased the expression of phosphorylated JNK/ SAPK and ERK1/ 2 as compared to oxalate- alone- treated cells. We concluded that CP could be used as a potential free radical- scavenging therapeutic strategy against oxidative stress- associated diseases including urolithiasis.	[Farooq, Shukkur M.] Wayne State Univ, Eugene Applebaum Coll Pharm & Hlth Sci, Dept Pharm Practice, Detroit, MI 48202 USA; [Boppana, Nithin B.] Wayne State Univ, Eugene Applebaum Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Detroit, MI USA; [Asokan, Devarajan] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Sekaran, Shamala D.] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Shankar, Esaki M.; Bakar, Sazaly A.] Univ Malaya, Fac Med, TIDREC, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Li, Chunying] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI USA; [Gopal, Kaliappan] Univ Malaya, Fac Med, Natl Orthoped Ctr Excellence Res & Learning NOCER, Dept Orthoped, Kuala Lumpur, Malaysia; [Karthik, Harve S.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117595, Singapore; [Ebrahim, Abdul S.] Wayne State Univ, Dept Internal Med, Detroit, MI 48202 USA	Wayne State University; Wayne State University; University of California System; University of California Los Angeles; Universiti Malaya; Universiti Malaya; Wayne State University; Universiti Malaya; National University of Singapore; Wayne State University	Farooq, SM (corresponding author), Wayne State Univ, Eugene Applebaum Coll Pharm & Hlth Sci, Dept Pharm Practice, Detroit, MI 48202 USA.	mabdulsh@med.wayne.edu; shankarem@um.edu.my; eabdulsh@med.wayne.edu	Muthu, Shankar Esaki/B-3132-2019; Sekaran, Shamala Devi/B-8482-2008; Shankar, EM/G-6444-2011; Devi, Shamala Devi/B-9735-2010; abubakar, sazaly/B-3957-2010; Boppana, Nithin B/I-8118-2019; K, Gopal/D-6751-2012	Muthu, Shankar Esaki/0000-0002-7866-9818; Sekaran, Shamala Devi/0000-0002-0478-0425; Devi, Shamala Devi/0000-0002-0478-0425; abubakar, sazaly/0000-0002-9267-1420; 				Aronson PS, 2002, CELL BIOCHEM BIOPHYS, V36, P147, DOI 10.1385/CBB:36:2-3:147; Bagga HS, 2013, UROL CLIN N AM, V40, P1, DOI 10.1016/j.ucl.2012.09.006; Benedetti S, 2004, LIFE SCI, V75, P2353, DOI 10.1016/j.lfs.2004.06.004; Bhat VB, 2000, BIOCHEM BIOPH RES CO, V275, P20, DOI 10.1006/bbrc.2000.3270; Brzica H, 2013, ARH HIG RADA TOKSIKO, V64, P609, DOI 10.2478/10004-1254-64-2013-2428; Cao LC, 2004, KIDNEY INT, V66, P1890, DOI 10.1111/j.1523-1755.2004.00963.x; Chang CJ, 2011, AM J RESP CRIT CARE, V183, P15, DOI 10.1164/rccm.201001-0009OC; Cherdkiatikul T, 2014, J BIOMOL SCREEN, V19, P959, DOI 10.1177/1087057113520565; Davalos M, 2010, J ENDOUROL, V24, P339, DOI 10.1089/end.2009.0205; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Dimroth P, 2000, J EXP BIOL, V203, P51; Farooq SM, 2006, MOL CELL BIOCHEM, V284, P95, DOI 10.1007/s11010-005-9019-0; Farooq SM, 2004, CLIN CHIM ACTA, V348, P199, DOI 10.1016/j.cccn.2004.05.016; Farooq SM, 2004, CHEM-BIOL INTERACT, V149, P1, DOI 10.1016/j.cbi.2004.05.006; Fosslien E, 2001, ANN CLIN LAB SCI, V31, P25; Gantar M, 2012, J BIOTECHNOL, V159, P21, DOI 10.1016/j.jbiotec.2012.02.004; GARRIDO MC, 1992, J CLIN PATHOL, V45, P860, DOI 10.1136/jcp.45.10.860; Gonzalez R, 1999, PHARMACOL RES, V39, P55, DOI 10.1006/phrs.1998.0409; Guo Q, 2004, J BIOL CHEM, V279, P13272, DOI 10.1074/jbc.M310034200; Huang HS, 2003, UROLOGY, V62, P1123, DOI 10.1016/S0090-4295(03)00764-7; Ishihara K, 2009, J NEUROCHEM, V110, P1965, DOI 10.1111/j.1471-4159.2009.06294.x; Itoh Y, 2005, UROL RES, V33, P261, DOI 10.1007/s00240-005-0465-7; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Johri N, 2010, NEPHRON CLIN PRACT, V116, pC159, DOI 10.1159/000317196; Joshi S, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/462361; Kato Y, 1999, J BIOL CHEM, V274, P20406, DOI 10.1074/jbc.274.29.20406; Khand FD, 2002, FREE RADICAL BIO MED, V32, P1339, DOI 10.1016/S0891-5849(02)00846-8; KURIEN TB, 1989, INDIAN J EXP BIOL, V27, P450; Lee HC, 2007, EXP BIOL MED, V232, P592; Leung PO, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/916590; Li ZY, 2011, BIOCHEM BIOPH RES CO, V414, P5, DOI 10.1016/j.bbrc.2011.09.046; Lissi EA, 2000, FREE RADICAL BIO MED, V28, P1051, DOI 10.1016/S0891-5849(00)00193-3; Molinari BL, 2003, ANAL QUANT CYTOL, V25, P254; Mulay SR, 2013, J CLIN INVEST, V123, P236, DOI 10.1172/JCI63679; Musatov A, 2012, FREE RADICAL RES, V46, P1313, DOI 10.3109/10715762.2012.717273; Ou Y, 2010, CHEM-BIOL INTERACT, V185, P94, DOI 10.1016/j.cbi.2010.03.013; Park C, 2003, BIOCHEM PHARMACOL, V66, P1287, DOI 10.1016/S0006-2952(03)00478-7; Park J, 1997, J BIOL CHEM, V272, P16725, DOI 10.1074/jbc.272.27.16725; Poonkuzhali B., 1994, Indian Journal of Experimental Biology, V32, P20; Rashed T, 2004, AM J NEPHROL, V24, P557, DOI 10.1159/000082043; Reers M, 1995, METHOD ENZYMOL, V260, P406, DOI 10.1016/0076-6879(95)60154-6; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Rimbau V, 1999, NEUROSCI LETT, V276, P75, DOI 10.1016/S0304-3940(99)00792-2; Romay C, 2000, J PHARM PHARMACOL, V52, P367, DOI 10.1211/0022357001774093; Romay C, 2003, CURR PROTEIN PEPT SC, V4, P207, DOI 10.2174/1389203033487216; Runchel C, 2011, ANTIOXID REDOX SIGN, V15, P205, DOI 10.1089/ars.2010.3733; Sakhaee K, 2012, J CLIN ENDOCR METAB, V97, P1847, DOI 10.1210/jc.2011-3492; Saxena Anil K, 2003, Saudi J Kidney Dis Transpl, V14, P531; Scheid C, 1996, KIDNEY INT, V49, P413, DOI 10.1038/ki.1996.60; Selivanov VA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001115; Selvakumar D, 2013, J BIOL CHEM, V288, P7215, DOI 10.1074/jbc.M112.443226; Selvakumar D, 2012, BIOCHEM J, V443, P463, DOI 10.1042/BJ20111255; Shih CM, 2009, ANESTH ANALG, V108, P1303, DOI 10.1213/ane.0b013e318193e919; Shukkur EA, 2006, HUM MOL GENET, V15, P2752, DOI 10.1093/hmg/ddl211; Son Yong, 2011, J Signal Transduct, V2011, P792639, DOI 10.1155/2011/792639; Sun YX, 2011, ENVIRON TOXICOL PHAR, V32, P168, DOI 10.1016/j.etap.2011.04.008; Thaakur S, 2010, J NEURAL TRANSM, V117, P1083, DOI 10.1007/s00702-010-0440-5; Thamilselvan S, 2003, UROL RES, V31, P3, DOI 10.1007/s00240-002-0286-x; Thamilselvan S, 2000, J UROLOGY, V164, P224, DOI 10.1016/S0022-5347(05)67499-X; Thamilselvan V, 2014, BJU INT, V114, P140, DOI 10.1111/bju.12642; Thamilselvan V, 2012, UROL RES, V40, P415, DOI 10.1007/s00240-011-0405-7; Ukuku DO, 2001, J FOOD PROTECT, V64, P813, DOI 10.4315/0362-028X-64.6.813; Vijaya LB, 2005, FREE RADICAL BIO MED, V38, P1614, DOI 10.1016/j.freeadbiomed.2005.02.029; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yin TG, 1997, J BIOL CHEM, V272, P19943, DOI 10.1074/jbc.272.32.19943	66	35	37	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93056	10.1371/journal.pone.0093056	http://dx.doi.org/10.1371/journal.pone.0093056			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691130	gold, Green Submitted, Green Published			2022-12-25	WOS:000334101100040
J	Fujie, S; Sato, K; Miyamoto-Mikami, E; Hasegawa, N; Fujita, S; Sanada, K; Hamaoka, T; Iemitsu, M				Fujie, Shumpei; Sato, Koji; Miyamoto-Mikami, Eri; Hasegawa, Natsuki; Fujita, Satoshi; Sanada, Kiyoshi; Hamaoka, Takafumi; Iemitsu, Motoyuki			Reduction of Arterial Stiffness by Exercise Training Is Associated with Increasing Plasma Apelin Level in Middle-Aged and Older Adults	PLOS ONE			English	Article							NITRIC-OXIDE; HYPERTENSIVE PATIENTS; CARDIOVASCULAR RISK; PHYSICAL-ACTIVITY; BLOOD-PRESSURE; APJ; ATHEROSCLEROSIS; RECEPTOR; DISEASE; EXPRESSION	Aging-induced deterioration of arterial stiffness is decreased by regular exercise, and increased nitric oxide (NO) production participates in this effect. Apelin regulates endothelial NO synthase in endothelial cells, promoting NO production. However, the effect of aerobic exercise training on circulating apelin levels in healthy middle-aged and older adults remains unknown. Accordingly, this study aimed to clarify the effects of regular aerobic exercise on apelin concentrations in middle-aged and older adults. Thirty-four healthy middle-aged and older subjects (67.0 +/- 1.3 years) were randomly divided into two groups: exercise intervention and sedentary controls. Subjects in the training group completed 8-week of aerobic exercise training (60-70% peak oxygen uptake [VO2peak] for 45 min, 3 days/week). Before and after the intervention, we evaluated plasma apelin and nitrite/nitrate (NOx) concentrations, VO2peak, and arterial stiffness index. In the training group, VO2peak was significantly increased, and carotid beta-stiffness was significantly decreased, after the intervention (P<0.05). Moreover, plasma apelin and NOx levels were significantly increased in the training group after the intervention (P<0.05). Additionally, there was a correlation between the training effects of plasma apelin levels and carotid beta-stiffness (r = -0.508, P = 0.032) and plasma NOx levels (r = 0.494, P = 0.037). By contrast, none of these parameters changed significantly in the control group. These results suggest that the increased in plasma apelin levels may be associated with exercise training-induced alternation of arterial stiffness in middle-aged and older adults.	[Fujie, Shumpei; Sato, Koji; Miyamoto-Mikami, Eri; Hasegawa, Natsuki; Fujita, Satoshi; Sanada, Kiyoshi; Hamaoka, Takafumi; Iemitsu, Motoyuki] Ritsumeikan Univ, Fac Sport & Hlth Sci, Shiga, Japan	Ritsumeikan University	Iemitsu, M (corresponding author), Ritsumeikan Univ, Fac Sport & Hlth Sci, Shiga, Japan.	iemitsu@fc.ritsumei.ac.jp	MIYAMOTO-MIKAMI, ERI/AAT-3245-2020	Miyamoto-Mikami, Eri/0000-0002-4864-8581; Sanada, Kiyoshi/0000-0003-3703-4098	Ministry of Education, Culture, Sports, Science and Technology of Japan [23680071, 25560378]; Grants-in-Aid for Scientific Research [25560378] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (#23680071 and #25560378, M. Iemitsu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen Charlotte U, 2011, Pulm Circ, V1, P334, DOI 10.4103/2045-8932.87299; ARNETT DK, 1994, AM J EPIDEMIOL, V140, P669, DOI 10.1093/oxfordjournals.aje.a117315; Blacher J, 1999, HYPERTENSION, V33, P1111, DOI 10.1161/01.HYP.33.5.1111; Goetze JP, 2006, REGUL PEPTIDES, V133, P134, DOI 10.1016/j.regpep.2005.09.032; Hambrecht R, 2003, CIRCULATION, V107, P3152, DOI 10.1161/01.CIR.0000074229.93804.5C; HIRAI T, 1989, CIRCULATION, V80, P78, DOI 10.1161/01.CIR.80.1.78; Ishida J, 2004, J BIOL CHEM, V279, P26274, DOI 10.1074/jbc.M404149200; Jia Yue Xia, 2007, Peptides, V28, P2023, DOI 10.1016/j.peptides.2007.07.016; Kadoglou NPE, 2013, DIABETIC MED, V30, pE41, DOI 10.1111/dme.12055; Kadoglou NPE, 2012, EUR J INTERN MED, V23, P137, DOI 10.1016/j.ejim.2011.10.020; Kawano H, 2006, J HYPERTENS, V24, P1753, DOI 10.1097/01.hjh.0000242399.60838.14; Kleinz MJ, 2005, REGUL PEPTIDES, V126, P233, DOI 10.1016/j.regpep.2004.10.019; Kleinz MJ, 2005, PHARMACOL THERAPEUT, V107, P198, DOI 10.1016/j.pharmthera.2005.04.001; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; Lee DK, 2005, ENDOCRINOLOGY, V146, P231, DOI 10.1210/en.2004-0359; Maeda S, 2004, HYPERTENS RES, V27, P947, DOI 10.1291/hypres.27.947; MOHIADDIN RH, 1989, BRIT HEART J, V62, P90; Napoli C, 2001, NITRIC OXIDE-BIOL CH, V5, P88, DOI 10.1006/niox.2001.0337; Przewlocka-Kosmala M, 2011, J HYPERTENS, V29, P971, DOI 10.1097/HJH.0b013e328344da76; ROWE JW, 1987, AM J CARDIOL, V60, pG68, DOI 10.1016/0002-9149(87)90594-7; Tanabe T, 2003, ACTA PHYSIOL SCAND, V178, P3, DOI 10.1046/j.1365-201X.2003.01100.x; Tanaka H, 1998, ARTERIOSCL THROM VAS, V18, P127, DOI 10.1161/01.ATV.18.1.127; Tanaka H, 2000, CIRCULATION, V102, P1270, DOI 10.1161/01.CIR.102.11.1270; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Tatemoto K, 2001, REGUL PEPTIDES, V99, P87, DOI 10.1016/S0167-0115(01)00236-1; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; VAITKEVICIUS PV, 1993, CIRCULATION, V88, P1456, DOI 10.1161/01.CIR.88.4.1456; Zhang J, 2006, LIFE SCI, V79, P1153, DOI 10.1016/j.lfs.2006.03.040	28	47	48	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93545	10.1371/journal.pone.0093545	http://dx.doi.org/10.1371/journal.pone.0093545			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691252	Green Published, gold, Green Submitted			2022-12-25	WOS:000334101100101
J	Lowenstein, J				Lowenstein, Jerome			Agent Orange and Heart Disease: Is There a Connection?	FASEB JOURNAL			English	Article									NYU Med Ctr, New York, NY 10016 USA	New York University	Lowenstein, J (corresponding author), NYU Med Ctr, New York, NY 10016 USA.	Jerome.Lowenstein@nyumc.org		Lowenstein, Jerome/0000-0002-2090-2015				Blagg CR, 2010, CLIN J AM SOC NEPHRO, V5, P2146, DOI 10.2215/CJN.07640810; Brownson P. J., 1989, CANCER, V64, P2381; Department of Veterans Affairs, 2010, DIS ASS EXP CERT HER; DUBROW R, 1988, BRIT J IND MED, V45, P25; Gondouin B, 2013, KIDNEY INT, V84, P733, DOI 10.1038/ki.2013.133; GUYATT G, 1992, JAMA-J AM MED ASSOC, V268, P2420, DOI 10.1001/jama.1992.03490170092032; Lowenstein J., 1997, MIDNIGHT MEAL OTHER, P88; Lowenstein J, 2011, FASEB J, V25, P1781, DOI 10.1096/fj.11-0602ufm; National Research Council, 2009, VET AG OR UPD 2008; Schecter A, 2006, ENVIRON RES, V101, P419, DOI 10.1016/j.envres.2005.12.003; Schwartz M, 1988, BR J IND MED, V45, P234; Wu DL, 2011, ARTERIOSCL THROM VAS, V31, P1260, DOI 10.1161/ATVBAHA.110.220202	12	2	2	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2014	28	4					1531	1533		10.1096/fj.14-0402ufm	http://dx.doi.org/10.1096/fj.14-0402ufm			3	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3UC	24688078				2022-12-25	WOS:000335344300002
J	Naish, S; Dale, P; Mackenzie, JS; McBride, J; Mengersen, K; Tong, SL				Naish, Suchithra; Dale, Pat; Mackenzie, John S.; McBride, John; Mengersen, Kerrie; Tong, Shilu			Spatial and Temporal Patterns of Locally- Acquired Dengue Transmission in Northern Queensland, Australia, 1993-2012	PLOS ONE			English	Article							FOREST VIRUS-DISEASE; METEOROLOGICAL FACTORS; CLIMATE-CHANGE; OUTBREAK; VECTORS	Background: Dengue has been a major public health concern in Australia since it re- emerged in Queensland in 1992- 1993. We explored spatio- temporal characteristics of locally- acquired dengue cases in northern tropical Queensland, Australia during the period 1993- 2012. Methods: Locally- acquired notified cases of dengue were collected for northern tropical Queensland from 1993 to 2012. Descriptive spatial and temporal analyses were conducted using geographic information system tools and geostatistical techniques. Results: 2,398 locally- acquired dengue cases were recorded in northern tropical Queensland during the study period. The areas affected by the dengue cases exhibited spatial and temporal variation over the study period. Notified cases of dengue occurred more frequently in autumn. Mapping of dengue by statistical local areas ( census units) reveals the presence of substantial spatio- temporal variation over time and place. Statistically significant differences in dengue incidence rates among males and females ( with more cases in females) ( chi 2 = 15.17, d. f. = 1, p < 0.01). Differences were observed among age groups, but these were not statistically significant. There was a significant positive spatial autocorrelation of dengue incidence for the four sub- periods, with the Moran's I statistic ranging from 0.011 to 0.463 ( p < 0.01). Semi- variogram analysis and smoothed maps created from interpolation techniques indicate that the pattern of spatial autocorrelation was not homogeneous across the northern Queensland. Conclusions: Tropical areas are potential high- risk areas for mosquito- borne diseases such as dengue. This study demonstrated that the locally- acquired dengue cases have exhibited a spatial and temporal variation over the past twenty years in northern tropical Queensland, Australia. Therefore, this study provides an impetus for further investigation of clusters and risk factors in these high- risk areas.	[Naish, Suchithra; Tong, Shilu] Queensland Univ Technol, Sch Publ Hlth & Social Work, Brisbane, Qld 4001, Australia; [Naish, Suchithra; Tong, Shilu] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Dale, Pat] Griffith Univ, Griffith Sch Environm, Environm Futures Ctr, Australian Rivers Inst, Brisbane, Qld 4111, Australia; [Mackenzie, John S.] Curtin Univ, Australian Biosecur CRC, Perth, WA 6845, Australia; [Mackenzie, John S.] Curtin Univ, Fac Hlth Sci, Perth, WA 6845, Australia; [McBride, John] James Cook Univ, Sch Med & Dent, Cairns, Qld, Australia; [Mengersen, Kerrie] Queensland Univ Technol, Brisbane, Qld 4001, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); Griffith University; Curtin University; Curtin University; James Cook University; Queensland University of Technology (QUT)	Naish, S (corresponding author), Queensland Univ Technol, Sch Publ Hlth & Social Work, Kelvin Grove Campus, Brisbane, Qld 4001, Australia.	s.naish@qut.edu.au	Mengersen, Kerrie/AHC-4096-2022; /S-4986-2019; McBride, William John Hannan/B-9145-2008	/0000-0002-5918-2190; McBride, William John Hannan/0000-0001-8894-533X; Mengersen, Kerrie/0000-0001-8625-9168	ARC [DP 110 100 651]	ARC(Australian Research Council)	Authors would like to acknowledge ARC grant (#DP 110 100 651). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, GLOB STRAT DENG PREV; [Anonymous], 2011, MAPINFO PROF SOFTW V; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; Anselin L, 1999, INTERACTIVE TECHNIQU; Australian Bureau of Statistics (ABS), 2012, CENS POP HOUS BAS CO; Beebe NW, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000429; Collinge SK, 2010, NATURE, V1, P69; Earnest A, 2012, EPIDEMIOL INFECT, V140, P1244, DOI 10.1017/S095026881100183X; Er A., 2010, INT J HUMAN SOCIAL S, V5, P3410, DOI DOI 10.5281/ZENODO.1327911; Fotheringham AS, 2009, SAGE HDB SPATIAL ANA; Githeko AK, 2012, INDIAN J MED RES, V136, P7; Haining R., 2003, SPATIAL DATA ANAL TH; Hu WB, 2012, ENVIRON HEALTH PERSP, V120, P260, DOI 10.1289/ehp.1003270; Hu WB, 2010, OCCUP ENVIRON MED, V67, P307, DOI 10.1136/oem.2008.044966; Huang F, 2011, AM J TROP MED HYG, V85, P560, DOI 10.4269/ajtmh.2011.11-0156; Impoinvil DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022192; Indaratna Kaemthong, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P669; Isaaks E.H., 1989, APPL GEOSTATISTICS; Jansen CC, 2010, MICROBES INFECT, V12, P272, DOI 10.1016/j.micinf.2009.12.011; Keim DA, 2002, IEEE T VIS COMPUT GR, V8, P1, DOI 10.1109/2945.981847; Kitron U, 2000, PARASITOL TODAY, V16, P324, DOI 10.1016/S0169-4758(00)01708-7; Knope KGC, 2013, COMMUN DIS INTELL, V37, pE5; Lloyd C, 2005, ENVIRON PLANN A, V37, P81, DOI 10.1068/a36116; Lloyd C., 2010, SPATIAL DATA ANAL IN; Lloyd CD, 2009, ANN ASSOC AM GEOGR, V99, P27, DOI 10.1080/00045600802224638; Moore DA, 1999, EPIDEMIOL REV, V21, P143, DOI 10.1093/oxfordjournals.epirev.a017993; Naish S, 2011, TROP MED INT HEALTH, V16, P884, DOI 10.1111/j.1365-3156.2011.02775.x; Naish S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025688; Nakhapakorn K., 2006, Dengue Bulletin, V30, P177; National Notificable Disease surveillance system N, 2013, NUMB NOT DENG VIR IN; Queensland Health, 2013, DENG FEV; Queensland Health, 2013, MOSQ BORN DIS; Queensland Treasury and Trade, 2013, POP GROWTH HIGHL TRE; Quinn HE, 2005, J MED ENTOMOL, V42, P882, DOI 10.1603/0022-2585(2005)042[0882:AOBFVD]2.0.CO;2; Rezaeian M, 2008, MIDDLE E J FAMILY ME, V7, P42; Rochlin I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023280; Russell R. C., 1994, Bulletin of the Society for Vector Ecology, V19, P73; Russell RC, 1998, J VECTOR ECOL, V23, P1; Russell RC, 2009, MED J AUSTRALIA, V190, P265, DOI 10.5694/j.1326-5377.2009.tb02393.x; Schwartz E, 2008, EMERG INFECT DIS, V14, P1081, DOI 10.3201/eid1407.071412; Tstuzuki A, 2009, AM J TROP MED HYG, V81, P645, DOI 10.4269/ajtmh.2009.08-0175; WHO, 2013, DENG NEGL TROP DIS R; Williams CR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000922; Woodruff RE, 2006, EPIDEMIOLOGY, V17, P569, DOI 10.1097/01.ede.0000229467.92742.7b; [No title captured]	45	25	27	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92524	10.1371/journal.pone.0092524	http://dx.doi.org/10.1371/journal.pone.0092524			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691549	Green Published, gold, Green Accepted			2022-12-25	WOS:000334101100028
J	Pietrantonio, F; Maggi, C; Di Bartolomeo, M; Facciorusso, MG; Perrone, F; Testi, A; Iacovelli, R; Miceli, R; Bossi, I; Leone, G; Milione, M; Pelosi, G; de Braud, F				Pietrantonio, Filippo; Maggi, Claudia; Di Bartolomeo, Maria; Facciorusso, Maria Grazia; Perrone, Federica; Testi, Adele; Iacovelli, Roberto; Miceli, Rosalba; Bossi, Ilaria; Leone, Giorgia; Milione, Massimo; Pelosi, Giuseppe; de Braud, Filippo			Gain of ALK Gene Copy Number May Predict Lack of Benefit from Anti-EGFR Treatment in Patients with Advanced Colorectal Cancer and RAS-RAF-PI3KCA Wild-Type Status	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; ANAPLASTIC LYMPHOMA KINASE; PHASE-III TRIAL; 1ST-LINE TREATMENT; MONOCLONAL-ANTIBODIES; RAS MUTATIONS; SOLID TUMORS; CETUXIMAB; KRAS	Introduction: Although cetuximab and panitumumab show an increased efficacy for patients with KRAS-NRAS-BRAF and PI3KCA wild-type metastatic colorectal cancer, primary resistance occurs in a relevant subset of molecularly enriched populations. Patients and Methods: We evaluated the outcome of 68 patients with advanced colorectal cancer and RAS, BRAF and PI3KCA status according to ALK gene status (disomic vs. gain of ALK gene copy number - defined as mean of 3 to 5 fusion signals in >= 10% of cells). All consecutive patients received cetuximab and irinotecan or panitumumab alone for chemorefractory disease. Results: No ALK translocations or amplifications were detected. ALK gene copy number gain was found in 25 (37%) tumors. Response rate was significantly higher in patients with disomic ALK as compared to those with gain of gene copy number (70% vs. 32%; p = 0.0048). Similarly, progression-free survival was significantly different when comparing the two groups (6.7 vs. 5.3 months; p = 0.045). A trend was observed also for overall survival (18.5 vs. 15.6 months; p = 0.885). Conclusion: Gain of ALK gene copy number might represent a negative prognostic factor in mCRC and may have a role in resistance to anti-EGFR therapy.	[Pietrantonio, Filippo; Maggi, Claudia; Di Bartolomeo, Maria; Iacovelli, Roberto; Bossi, Ilaria; de Braud, Filippo] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy; [Facciorusso, Maria Grazia; Perrone, Federica; Testi, Adele; Leone, Giorgia; Milione, Massimo; Pelosi, Giuseppe] Fdn IRCCS Ist Nazl Tumori, Dept Pathol, Milan, Italy; [Miceli, Rosalba] Fdn IRCCS Ist Nazl Tumori, Unit Med Stat Biometry & Bioinformat, Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan	Pietrantonio, F (corresponding author), Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy.	filippo.pietrantonio@istitutotumori.mi.it	Miceli, Rosalba/C-1215-2017; de Braud, Filippo/B-9997-2017; maggi, claudia/J-6831-2018; Testi, Maria Adele/D-6994-2017; Di Bartolomeo, Maria/D-1655-2017; Pietrantonio, Filippo/C-2180-2017; Milione, Massimo/B-8644-2017; Iacovelli, Roberto/AAB-9850-2019; Perrone, Federica/S-6171-2016; Pelosi, Giuseppe/F-5073-2012	Miceli, Rosalba/0000-0003-0954-375X; de Braud, Filippo/0000-0003-0103-730X; maggi, claudia/0000-0001-8780-0606; Testi, Maria Adele/0000-0002-9462-0336; Di Bartolomeo, Maria/0000-0002-7954-6609; Pietrantonio, Filippo/0000-0002-8530-8420; Milione, Massimo/0000-0002-1202-139X; Iacovelli, Roberto/0000-0002-1750-2117; Perrone, Federica/0000-0003-4406-8245; Pelosi, Giuseppe/0000-0003-4725-4692	Italian law Law [183]	Italian law Law	This work was supported in part by funds obtained through Italian law Law 12 november 2011 n. 183 that allows taxpayers to allocate 0.5 percent share of their income tax contribution to a research institution of their choice. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisner DL, 2014, MOL CANCER RES, V12, P111, DOI 10.1158/1541-7786.MCR-13-0479-T; Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Bavi P, 2013, BRIT J CANCER, V109, P2735, DOI 10.1038/bjc.2013.641; Bokemeyer C, 2012, EUR J CANCER, V48, P1466, DOI 10.1016/j.ejca.2012.02.057; Cappuzzo F, 2005, J CLIN ONCOL, V23, P5007, DOI 10.1200/JCO.2005.09.111; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Chung KY, 2005, J CLIN ONCOL, V23, P1803, DOI 10.1200/JCO.2005.08.037; de Braud F, 2013, ANN ONCOL; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Di Bartolomeo M, 2013, TARGET ONCOL; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Douillard JY, 2013, NEW ENGL J MED, V369, P1023, DOI 10.1056/NEJMoa1305275; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Inno A, 2011, CLIN COLORECTAL CANC, V10, P325, DOI 10.1016/j.clcc.2011.03.028; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Lin E, 2009, MOL CANCER RES, V7, P1466, DOI 10.1158/1541-7786.MCR-08-0522; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Mao C, 2012, ANN ONCOL, V23, P1518, DOI 10.1093/annonc/mdr464; Molinari F, 2011, CLIN CANCER RES, V17, P4901, DOI 10.1158/1078-0432.CCR-10-3137; Mosse YP, 2013, LANCET ONCOL, V14, P472, DOI 10.1016/S1470-2045(13)70095-0; Pelosi G, 2012, LUNG CANCER, V77, P507, DOI 10.1016/j.lungcan.2012.05.093; Perrone F, 2009, ANN ONCOL, V20, P84, DOI 10.1093/annonc/mdn541; Pietrantonio F, 2013, CANC BIOL THER, V14; Salido M, 2011, J THORAC ONCOL, V6, P21, DOI 10.1097/JTO.0b013e3181fb7cd6; Sartore-Bianchi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007287; Scartozzi M, 2011, ONCOLOGIST, V16, P53, DOI 10.1634/theoncologist.2010-0119; Scartozzi M, 2010, INT J CANCER, V127, P1941, DOI 10.1002/ijc.25193; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Tanizaki J, 2012, CLIN CANCER RES, V18, P6219, DOI 10.1158/1078-0432.CCR-12-0392; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; van Essen HF, 2012, METHODS MOL BIOL, V838, P329, DOI 10.1007/978-1-61779-507-7_16; Von Hoff DD, 2010, J CLIN ONCOL, V28, P4877, DOI 10.1200/JCO.2009.26.5983	37	15	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92147	10.1371/journal.pone.0092147	http://dx.doi.org/10.1371/journal.pone.0092147			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691006	Green Published, Green Submitted, gold			2022-12-25	WOS:000334101100016
J	Song, JY; Nahm, MH; Cheong, HJ; Kim, WJ				Song, Joon Young; Nahm, Moon H.; Cheong, Hee Jin; Kim, Woo Joo			Impact of Preceding Flu-Like Illness on the Serotype Distribution of Pneumococcal Pneumonia	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; PANDEMIC INFLUENZA; INVASIVE DISEASE; BACTERIAL PNEUMONIA; CONJUGATE VACCINE; RECEPTOR; KOREA; COLONIZATION; SURVEILLANCE; POPULATION	Background: Even though the pathogenicity and invasiveness of pneumococcus largely depend on capsular types, the impact of serotypes on post-viral pneumococcal pneumonia is unknown. Methods and Findings: This study was performed to evaluate the impact of capsular serotypes on the development of pneumococcal pneumonia after preceding respiratory viral infections. Patients with a diagnosis of pneumococcal pneumonia were identified. Pneumonia patients were divided into two groups (post-viral pneumococcal pneumonia versus primary pneumococcal pneumonia), and then their pneumococcal serotypes were compared. Nine hundred and nineteen patients with pneumococcal pneumonia were identified during the study period, including 327 (35.6%) cases with post-viral pneumococcal pneumonia and 592 (64.4%) cases with primary pneumococcal pneumonia. Overall, serotypes 3 and 19A were the most prevalent, followed by serotypes 19F, 6A, and 11A/11E. Although relatively uncommon (33 cases, 3.6%), infrequently colonizing invasive serotypes (4, 5, 7F/7A, 8, 9V/9A, 12F, and 18C) were significantly associated with preceding respiratory viral infections (69.7%, P<0.01). Multivariate analysis revealed several statistically significant risk factors for post-viral pneumococcal pneumonia: immunodeficiency (OR 1.66; 95% CI, 1.10-2.53), chronic lung diseases (OR 1.43; 95% CI, 1.09-1.93) and ICI serotypes (OR 4.66; 95% CI, 2.07-10.47). Conclusions: Infrequently colonizing invasive serotypes would be more likely to cause pneumococcal pneumonia after preceding respiratory viral illness, particularly in patients with immunodeficiency or chronic lung diseases.	[Song, Joon Young; Nahm, Moon H.] Univ Alabama Birmingham, Sch Med, Dept Pathol, Birmingham, AL 35233 USA; [Nahm, Moon H.] Univ Alabama Birmingham, Sch Med, Dept Microbiol, Birmingham, AL 35294 USA; [Song, Joon Young; Cheong, Hee Jin; Kim, Woo Joo] Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul 136705, South Korea	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Korea University; Korea University Medicine (KU Medicine)	Song, JY (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Pathol, Birmingham, AL 35233 USA.	infection@korea.ac.kr	Kim, Woo Joo/D-2733-2015	Kim, Woo Joo/0000-0002-4546-3880; Song, Joon Young/0000-0002-0148-7194; Cheong, Hee Jin/0000-0002-2532-1463; Nahm, Moon/0000-0002-6922-1042	NIH [AI-30021]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported in part by funding from NIH (AI-30021) to MHN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; AVERY OSWALD T., 1931, JOUR EXP MED, V54, P73, DOI 10.1084/jem.54.1.73; Ballinger MN, 2010, J INTERF CYTOK RES, V30, P643, DOI 10.1089/jir.2010.0049; Bennett Nancy M., 2012, Morbidity and Mortality Weekly Report, V61, P816; Blaschke AJ, 2011, CLIN INFECT DIS, V52, pS331, DOI 10.1093/cid/cir048; Bodi M, 2005, CLIN INFECT DIS, V41, P1709, DOI 10.1086/498119; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cho EY, 2012, J KOREAN MED SCI, V27, P716, DOI 10.3346/jkms.2012.27.7.716; CUNDELL DR, 1995, NATURE, V377, P435, DOI 10.1038/377435a0; Diavatopoulos DA, 2010, FASEB J, V24, P1789, DOI 10.1096/fj.09-146779; Didierlaurent A, 2008, J EXP MED, V205, P323, DOI 10.1084/jem.20070891; Giannella M, 2011, CLIN MICROBIOL INFEC, V17, P1160, DOI 10.1111/j.1469-0691.2010.03399.x; Harboe ZB, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000081; Ihekweazu C, 2010, J INFECTION, V61, P21, DOI 10.1016/j.jinf.2010.03.032; Kabra SK, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004874.pub3; Kaetzel CS, 2005, IMMUNOL REV, V206, P83, DOI 10.1111/j.0105-2896.2005.00278.x; Kieninger DM, 2010, VACCINE, V28, P4192, DOI 10.1016/j.vaccine.2010.04.008; Kronenberg A, 2006, J CLIN MICROBIOL, V44, P2032, DOI 10.1128/JCM.00275-06; Lee JS, 2007, EPIDEMIOL INFECT, V135, P1117, DOI 10.1017/S0950268807007820; Lee N, 2009, J INFECT DIS, V200, P492, DOI 10.1086/600383; Magee AD, 2001, INFECT IMMUN, V69, P3755, DOI 10.1128/IAI.69.6.3755-3761.2001; McCullers JA, 2010, J INFECT DIS, V202, P1287, DOI 10.1086/656333; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Musher DM, 2012, CLIN INFECT DIS, V55, P265, DOI 10.1093/cid/cis364; Neill DR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002660; Nelson AL, 2007, INFECT IMMUN, V75, P83, DOI 10.1128/IAI.01475-06; Niederman MS, 2004, AM J MED, V117, P51, DOI 10.1016/j.amjmed.2004.07.008; NUGENT KM, 1983, INFECT IMMUN, V42, P1102, DOI 10.1128/IAI.42.3.1102-1108.1983; Park IH, 2012, MBIO, V3, DOI 10.1128/mBio.00035-12; Pinsky BA, 2010, EMERG INFECT DIS, V16, P1165, DOI 10.3201/eid1607.091248; Rakov AV, 2011, INFECT GENET EVOL, V11, P1929, DOI 10.1016/j.meegid.2011.08.016; Rothberg MB, 2008, AM J MED, V121, P258, DOI 10.1016/j.amjmed.2007.10.040; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Sanz JC, 2011, CLIN MICROBIOL INFEC, V17, P1094, DOI 10.1111/j.1469-0691.2011.03495.x; Scott JR, 2012, J INFECT DIS, V206, P73, DOI 10.1093/infdis/jis307; Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Shouval DS, 2006, PEDIATR INFECT DIS J, V25, P602, DOI 10.1097/01.inf.0000220231.79968.f6; Shrestha S, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0233; Singanayagam A, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-27; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Song JY, 2011, INFLUENZA OTHER RESP, V5, pR535, DOI 10.1111/j.1750-2659.2011.00269.x; Song JY, 2013, INFECT CHEMOTHER, V45, P351, DOI 10.3947/ic.2013.45.4.351; Song JY, 2013, J MED VIROL, V85, P910, DOI 10.1002/jmv.23548; Song JY, 2013, J KOREAN MED SCI, V28, P4, DOI 10.3346/jkms.2013.28.1.4; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Vainio A, 2009, APMIS, V117, P488, DOI 10.1111/j.1600-0463.2009.02463.x; Vanderkooi OG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028547; Walter ND, 2010, CLIN INFECT DIS, V50, P175, DOI 10.1086/649208; Werno AM, 2008, CLIN INFECT DIS, V46, P926, DOI 10.1086/528798; Yeh SH, 2010, PEDIATRICS, V126, pE493, DOI 10.1542/peds.2009-3027; Yildirim I, 2010, VACCINE, V29, P283, DOI 10.1016/j.vaccine.2010.10.032; Yu JG, 2011, CLIN VACCINE IMMUNOL, V18, P1900, DOI 10.1128/CVI.05312-11; Zhou H, 2012, EMERG INFECT DIS, V18, P294, DOI 10.3201/eid1802.102025	54	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93477	10.1371/journal.pone.0093477	http://dx.doi.org/10.1371/journal.pone.0093477			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691515	gold, Green Submitted, Green Published			2022-12-25	WOS:000334101100088
J	Thomson, CJ; Rajala, AK; Carlson, SR; Rupert, JL				Thomson, Cynthia J.; Rajala, Amelia K.; Carlson, Scott R.; Rupert, Jim L.			Variants in the Dopamine-4-Receptor Gene Promoter Are Not Associated with Sensation Seeking in Skiers	PLOS ONE			English	Article							DOPAMINE-D4 RECEPTOR GENE; TANDEM DUPLICATION POLYMORPHISM; DEFICIT HYPERACTIVITY DISORDER; PERSONALITY-TRAITS; NOVELTY SEEKING; DRD4 GENE; REGION; ADHD; SCHIZOPHRENIA; METAANALYSIS	Sensation seeking is a personality trait that has been associated with disinhibited behaviours including substance use and gambling, but also with high-risk sport practices including skydiving, paragliding, and downhill skiing. Twin studies have shown that sensation seeking is moderately heritable, and candidate genes encoding components involved in dopaminergic transmission have been investigated as contributing to this type of behaviour. To determine whether variants in the regulatory regions of the dopamine-4-receptor gene (DRD4) influenced sport-specific sensation seeking, we analyzed five polymorphisms (-1106T/C, -906T/C, -809G/A, -291C/T, 120-bp duplication) in the promoter region of the gene in a cohort of skiers and snowboarders (n = 599) that represented a broad range of sensation seeking behaviours. We grouped subjects by genotype at each of the five loci and compared impulsive sensation seeking and domain-specific (skiing) sensation seeking between groups. There were no significant associations between genotype(s) and general or domain-specific sensation seeking in the skiers and snowboarders, suggesting that while DRD4 has previously been implicated in sensation seeking, the promoter variants investigated in this study do not contribute to sensation seeking in this athlete population.	[Thomson, Cynthia J.; Rupert, Jim L.] Univ British Columbia, Sch Kinesiol, Vancouver, BC V5Z 1M9, Canada; [Rajala, Amelia K.] Univ British Columbia, Dept Sci, Vancouver, BC V5Z 1M9, Canada; [Carlson, Scott R.] Univ Minnesota, Dept Psychol, Duluth, MN 55812 USA	University of British Columbia; University of British Columbia; University of Minnesota System; University of Minnesota Duluth	Thomson, CJ (corresponding author), Univ British Columbia, Sch Kinesiol, Vancouver, BC V5Z 1M9, Canada.	cynthia.thomson@questu.ca	Carlson, Scott R/Q-2375-2019	Carlson, Scott R/0000-0002-5417-4343; THOMSON, CYNTHIA/0000-0002-7767-2820	Canadian Institute for Health Research; British Columbia Mental Health and Addictions Research; Deutscher Akademischer Austausch Dienst (DAAD; German Academic Exchange Service)	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); British Columbia Mental Health and Addictions Research; Deutscher Akademischer Austausch Dienst (DAAD; German Academic Exchange Service)(Deutscher Akademischer Austausch Dienst (DAAD))	Canadian Graduate Scholarship from Canadian Institute for Health Research to C.J. Thomson (CANADA), British Columbia Mental Health and Addictions Research to J.L. Rupert (CANADA), and Deutscher Akademischer Austausch Dienst (DAAD; German Academic Exchange Service) to N. Hase (GERMANY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi SM, 2003, BEHAV PROCESS, V64, P345, DOI 10.1016/S0376-6357(03)00150-5; Attia J, 2009, JAMA-J AM MED ASSOC, V301, P191, DOI 10.1001/jama.2008.946; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Cam FS, 2010, TURK KLIN TIP BILIM, V30, P1459, DOI 10.5336/medsci.2009-14839; Carlson SR, 2010, ADDICT BEHAV, V35, P242, DOI 10.1016/j.addbeh.2009.10.020; Cross CP, 2011, PSYCHOL BULL, V137, P97, DOI 10.1037/a0021591; D'Souza UM, 2004, BIOL PSYCHIAT, V56, P691, DOI 10.1016/j.biopsych.2004.08.008; Derringer J, 2010, PSYCHOL SCI, V21, P1282, DOI 10.1177/0956797610380699; Dick DM, 2010, HANDBOOK OF BEHAVIOR GENETICS, P433, DOI 10.1007/978-0-387-76727-7_29; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Golimbet VE, 2005, RUSS J GENET+, V41, P789, DOI 10.1007/s11177-005-0161-2; Freixanet MGI, 2012, AN PSICOL-SPAIN, V28, P223; Heck A, 2009, GENES BRAIN BEHAV, V8, P464, DOI 10.1111/j.1601-183X.2009.00494.x; Kereszturi E, 2007, AM J MED GENET B, V144B, P231, DOI 10.1002/ajmg.b.30444; Lai JH, 2010, BRAIN RES, V1359, P227, DOI 10.1016/j.brainres.2010.08.064; Lasky-Su J, 2007, BIOL PSYCHIAT, V62, P985, DOI 10.1016/j.biopsych.2007.03.006; Lauzon NM, 2010, BEHAV BRAIN RES, V208, P12, DOI 10.1016/j.bbr.2009.11.037; McCracken JT, 2000, MOL PSYCHIATR, V5, P531, DOI 10.1038/sj.mp.4000770; McGeary JE, 2007, PHARMACOL BIOCHEM BE, V86, P401, DOI 10.1016/j.pbb.2006.11.001; Mitsuyasu H, 2001, J HUM GENET, V46, P26, DOI 10.1007/s100380170120; Mitsuyasu H, 2007, J PSYCHIATR RES, V41, P763, DOI 10.1016/j.jpsychires.2006.05.014; Munafo MR, 2008, BIOL PSYCHIAT, V63, P197, DOI 10.1016/j.biopsych.2007.04.006; Nakajima M, 2007, J HUM GENET, V52, P86, DOI 10.1007/s10038-006-0084-3; Oades RD, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-48; Okuyama Y, 2000, MOL PSYCHIATR, V5, P64, DOI 10.1038/sj.mp.4000563; Paunonen SV, 2001, J PERS SOC PSYCHOL, V81, P524, DOI 10.1037/0022-3514.81.3.524; Rogers G, 2004, AM J MED GENET B, V126B, P95, DOI 10.1002/ajmg.b.20133; Saftlas AF, 2004, AM J EPIDEMIOL, V160, P77, DOI 10.1093/aje/kwh171; Salamone JD, 2007, PSYCHOPHARMACOLOGY, V191, P389, DOI 10.1007/s00213-006-0623-9; Sanchez-Mora C, 2011, AM J MED GENET B, V156B, P600, DOI 10.1002/ajmg.b.31202; Schinka JA, 2002, AM J MED GENET, V114, P643, DOI 10.1002/ajmg.10649; Seaman MI, 1999, AM J MED GENET, V88, P705, DOI 10.1002/(SICI)1096-8628(19991215)88:6<705::AID-AJMG22>3.0.CO;2-F; Stoel RD, 2006, BEHAV GENET, V36, P229, DOI 10.1007/s10519-005-9028-5; Thomson CJ, 2013, SCAND J MED SCI SPOR, V23, pe108, DOI 10.1111/sms.12031; Thomson CJ, 2012, INT J SPORT PSYCHOL, V43, P503, DOI 10.7352/IJSP2012.43.033; Verdejo-Garcia A, 2008, NEUROSCI BIOBEHAV R, V32, P777, DOI 10.1016/j.neubiorev.2007.11.003; ZUCKERMAN M, 1993, J PERS SOC PSYCHOL, V65, P757, DOI 10.1037/0022-3514.65.4.757; ZUCKERMAN M, 1978, J CONSULT CLIN PSYCH, V46, P139, DOI 10.1037/0022-006X.46.1.139; ZUCKERMAN M, 1983, PERS INDIV DIFFER, V4, P285, DOI 10.1016/0191-8869(83)90150-2	41	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93521	10.1371/journal.pone.0093521	http://dx.doi.org/10.1371/journal.pone.0093521			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691022	Green Published, gold, Green Submitted			2022-12-25	WOS:000334101100096
J	Gudi, R; Zou, CZ; Dhar, J; Gao, QS; Vasu, C				Gudi, Radhika; Zou, Chaozhong; Dhar, Jayeeta; Gao, Qingshen; Vasu, Chenthamarakshan			Centrobin-Centrosomal Protein 4.1-associated Protein (CPAP) Interaction Promotes CPAP Localization to the Centrioles during Centriole Duplication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Centriole; Centrosome; Cloning; Confocal Microscopy; Gene Expression; CEP152; CPAP; Centrobin	MAMMALIAN-CELL; CEP152; KINASE; PLK4; ULTRASTRUCTURE; BIOGENESIS; MECHANISMS; ASTERLESS; SUBSTRATE; SCAFFOLD	Background: The mechanism and players involved in centriole duplication process are not fully understood. Results: Centrobin and centrosomal protein 4.1-associated-protein (CPAP) interact. Depletion of centrobin results in the disappearance of CPAP from centrioles and inhibition of centriole elongation. Conclusion: Centrobin-CPAP interaction promotes centriolar CPAP localization for centriole duplication. Significance: Identifying the key molecular events is crucial for understanding the centriole duplication process. Centriole duplication is the process by which two new daughter centrioles are generated from the proximal end of preexisting mother centrioles. Accurate centriole duplication is important for many cellular and physiological events, including cell division and ciliogenesis. Centrosomal protein 4.1-associated protein (CPAP), centrosomal protein of 152 kDa (CEP152), and centrobin are known to be essential for centriole duplication. However, the precise mechanism by which they contribute to centriole duplication is not known. In this study, we show that centrobin interacts with CEP152 and CPAP, and the centrobin-CPAP interaction is critical for centriole duplication. Although depletion of centrobin from cells did not have an effect on the centriolar levels of CEP152, it caused the disappearance of CPAP from both the preexisting and newly formed centrioles. Moreover, exogenous expression of the CPAP-binding fragment of centrobin also caused the disappearance of CPAP from both the preexisting and newly synthesized centrioles, possibly in a dominant negative manner, thereby inhibiting centriole duplication and the PLK4 overexpression-mediated centrosome amplification. Interestingly, exogenous overexpression of CPAP in the centrobin-depleted cells did not restore CPAP localization to the centrioles. However, restoration of centrobin expression in the centrobin-depleted cells led to the reappearance of centriolar CPAP. Hence, we conclude that centrobin-CPAP interaction is critical for the recruitment of CPAP to procentrioles to promote the elongation of daughter centrioles and for the persistence of CPAP on preexisting mother centrioles. Our study indicates that regulation of CPAP levels on the centrioles by centrobin is critical for preserving the normal size, shape, and number of centrioles in the cell.	[Gudi, Radhika; Vasu, Chenthamarakshan] Med Univ S Carolina, Dept Surg, Charleston, SC 29425 USA; [Vasu, Chenthamarakshan] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Zou, Chaozhong; Dhar, Jayeeta; Gao, Qingshen] NorthShore Res Inst, Dept Med, Evanston, IL 60201 USA	Medical University of South Carolina; Medical University of South Carolina; NorthShore University Health System	Gudi, R (corresponding author), Med Univ S Carolina, HO602,86 Jonathan Lucas St, Charleston, SC 29425 USA.	gudi@musc.edu			Cell and Molecular Imaging Facility and the Regenerative Medicine/Cell Biology and Hollings Cancer Center Flow Cytometry Facility at the Medical University of South Carolina	Cell and Molecular Imaging Facility and the Regenerative Medicine/Cell Biology and Hollings Cancer Center Flow Cytometry Facility at the Medical University of South Carolina	We thank Dr. Kunsoo Rhee, Dr. Ingrid Hoffmann, Dr. Tang, Dr. Pierre Gonczy, and Dr. Puligilla for invaluable help in providing reagents. We also thank the Cell and Molecular Imaging Facility and the Regenerative Medicine/Cell Biology and Hollings Cancer Center Flow Cytometry Facility at the Medical University of South Carolina for support and cooperation.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Azimzadeh J, 2007, J CELL SCI, V120, P2139, DOI 10.1242/jcs.005231; Balestra FR, 2013, DEV CELL, V25, P555, DOI 10.1016/j.devcel.2013.05.016; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Blachon S, 2008, GENETICS, V180, P2081, DOI 10.1534/genetics.108.095141; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; Cizmecioglu O, 2010, J CELL BIOL, V191, P731, DOI 10.1083/jcb.201007107; Delattre M, 2004, J CELL SCI, V117, P1619, DOI 10.1242/jcs.01128; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Doxsey S, 2001, NAT REV MOL CELL BIO, V2, P688, DOI 10.1038/35089575; Dzhindzhev NS, 2010, NATURE, V467, P714, DOI 10.1038/nature09445; Gonczy P, 2012, NAT REV MOL CELL BIO, V13, P425, DOI 10.1038/nrm3373; Gudi R, 2011, J CELL BIOL, V193, P711, DOI 10.1083/jcb.201006135; Guernsey DL, 2010, AM J HUM GENET, V87, P40, DOI 10.1016/j.ajhg.2010.06.003; Gul A, 2006, J HUM GENET, V51, P760, DOI 10.1007/s10038-006-0017-1; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hatch EM, 2010, J CELL BIOL, V191, P721, DOI 10.1083/jcb.201006049; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; Hinchcliffe EH, 2001, CURR BIOL, V11, pR698, DOI 10.1016/S0960-9822(01)00412-2; Hsu WB, 2008, EXP CELL RES, V314, P2591, DOI 10.1016/j.yexcr.2008.05.012; Hung LY, 2004, MOL BIOL CELL, V15, P2697, DOI 10.1091/mbc.E04-02-0121; Issa L, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-59; Jeffery JM, 2010, ONCOGENE, V29, P2649, DOI 10.1038/onc.2010.37; Jeong Y, 2007, J CELL SCI, V120, P2106, DOI 10.1242/jcs.03458; Job D, 2003, CURR OPIN CELL BIOL, V15, P111, DOI 10.1016/S0955-0674(02)00003-0; Kalay E, 2011, NAT GENET, V43, P23, DOI 10.1038/ng.725; Kitagawa D, 2011, J CELL SCI, V124, P3884, DOI 10.1242/jcs.089888; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Kohlmaier G, 2009, CURR BIOL, V19, P1012, DOI 10.1016/j.cub.2009.05.018; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; LANGE BMH, 1995, J CELL BIOL, V130, P919, DOI 10.1083/jcb.130.4.919; Lee J, 2010, J BIOL CHEM, V285, P25476, DOI 10.1074/jbc.M109.099127; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Loncarek J, 2009, MOL CELLS, V27, P135, DOI 10.1007/s10059-009-0017-z; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; McIntyre RE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003022; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Paoletti A, 1996, J CELL SCI, V109, P3089; Pihan GA, 2001, CANCER RES, V61, P2212; Pihan GA, 1998, CANCER RES, V58, P3974; ROBBINS E, 1964, J CELL BIOL, V21, P429, DOI 10.1083/jcb.21.3.429; Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016; Strnad P, 2008, TRENDS CELL BIOL, V18, P389, DOI 10.1016/j.tcb.2008.06.004; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Tang CJC, 2009, NAT CELL BIOL, V11, P825, DOI 10.1038/ncb1889; Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011; VOROBJEV IA, 1980, CELL BIOL INT REP, V4, P1037, DOI 10.1016/0309-1651(80)90177-0; Zou CZ, 2005, J CELL BIOL, V171, P437, DOI 10.1083/jcb.200506185	51	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15166	15178		10.1074/jbc.M113.531152	http://dx.doi.org/10.1074/jbc.M113.531152			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24700465	Green Published, hybrid			2022-12-25	WOS:000337465400004
J	Gu, XR; Hu, ZB; Ebrahem, Q; Crabb, JS; Mahfouz, RZ; Radivoyevitch, T; Crabb, JW; Saunthararajah, Y				Gu, Xiaorong; Hu, Zhenbo; Ebrahem, Quteba; Crabb, John S.; Mahfouz, Reda Z.; Radivoyevitch, Tomas; Crabb, John W.; Saunthararajah, Yogen			Runx1 Regulation of Pu.1 Corepressor/Coactivator Exchange Identifies Specific Molecular Targets for Leukemia Differentiation Therapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; HISTONE DEACETYLASE; TRANSCRIPTIONAL CONTROL; DNA METHYLATION; CELLS; AML1; GENE; REPRESSION; BINDING; C/EBP	Gene activation requires cooperative assembly of multiprotein transcription factor-coregulator complexes. Disruption to cooperative assemblage could underlie repression of tumor suppressor genes in leukemia cells. Mechanisms of cooperation and its disruption were therefore examined for PU.1 and RUNX1, transcription factors that cooperate to activate hematopoietic differentiation genes. PU.1 is highly expressed in leukemia cells, whereas RUNX1 is frequently inactivated by mutation or translocation. Thus, coregulator interactions of Pu.1 were examined by immunoprecipitation coupled with tandem mass spectrometry/Western blot in wild-type and Runx1-deficient hematopoietic cells. In wild-type cells, the NuAT and Baf families of coactivators coimmunoprecipitated with Pu.1. Runx1 deficiency produced a striking switch to Pu.1 interaction with the Dnmt1, Sin3A, Nurd, CoRest, and B-Wich corepressor families. Corepressors of the Polycomb family, which are frequently inactivated by mutation or deletion in myeloid leukemia, did not interact with Pu.1. The most significant gene ontology association of Runx1-Pu.1 co-bound genes was with macrophages, therefore, functional consequences of altered corepressor/coactivator exchange were examined at Mcsfr, a key macrophage differentiation gene. In chromatin immunoprecipitation analyses, high level Pu.1 binding to the Mcsfr promoter was not decreased by Runx1 deficiency. However, the Pu.1-driven shift from histone repression to activation marks at this locus, and terminal macrophage differentiation, were substantially diminished. DNMT1 inhibition, but not Polycomb inhibition, in RUNX1-translocated leukemia cells induced terminal differentiation. Thus, RUNX1 and PU.1 cooperate to exchange corepressors for coactivators, and the specific corepressors recruited to PU.1 as a consequence of RUNX1 deficiency could be rational targets for leukemia differentiation therapy.	[Gu, Xiaorong; Hu, Zhenbo; Ebrahem, Quteba; Mahfouz, Reda Z.; Saunthararajah, Yogen] Cleveland Clin, Dept Translat Hematol & Oncol Res, Taussig Canc Inst, Cleveland, OH 44195 USA; [Crabb, John S.; Crabb, John W.] Cleveland Clin, Dept Ophthalm Res, Cole Eye Inst, Cleveland, OH 44195 USA; [Radivoyevitch, Tomas] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University	Saunthararajah, Y (corresponding author), 9500 Euclid Ave,R40, Cleveland, OH 44195 USA.	saunthy@ccf.org	Mahfouz, Reda Z/G-2307-2011	Mahfouz, Reda Z/0000-0003-4250-9422; Radivoyevitch, Tomas/0000-0002-9701-1851	National Institutes of Health [R01CA138858]; Department of Defense [PR081404]; Case Western Reserve University/Cleveland Clinic [CTSA UL1RR024989]; NATIONAL CANCER INSTITUTE [R01CA138858] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Case Western Reserve University/Cleveland Clinic; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA138858, Department of Defense Grant PR081404, and Case Western Reserve University/Cleveland Clinic Grant CTSA UL1RR024989 (to Y. S.).	Agrawal S, 2007, BLOOD, V109, P3895, DOI 10.1182/blood-2006-08-040147; Broske AM, 2009, NAT GENET, V41, P1207, DOI 10.1038/ng.463; Elagib KE, 2003, BLOOD, V101, P4333, DOI 10.1182/blood-2002-09-2708; Gentles AJ, 2010, JAMA-J AM MED ASSOC, V304, P2706, DOI 10.1001/jama.2010.1862; Goetz TL, 2000, MOL CELL BIOL, V20, P81, DOI 10.1128/MCB.20.1.81-90.2000; Goodliffe JM, 2005, GENE DEV, V19, P2941, DOI 10.1101/gad.1352305; Grand F, 1999, CANCER RES, V59, P3870; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Hu ZB, 2011, BLOOD, V117, P6498, DOI 10.1182/blood-2010-10-312512; Hu ZB, 2010, MOL CANCER THER, V9, P1536, DOI 10.1158/1535-7163.MCT-10-0191; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang H, 2009, MOL CELL BIOL, V29, P4103, DOI 10.1128/MCB.00090-09; Kim WY, 1999, EMBO J, V18, P1609, DOI 10.1093/emboj/18.6.1609; Kosugi H, 1999, LEUKEMIA, V13, P1316, DOI 10.1038/sj.leu.2401508; MIYOSHI H, 1991, P NATL ACAD SCI USA, V88, P10431, DOI 10.1073/pnas.88.23.10431; Negrotto S, 2012, LEUKEMIA, V26, P244, DOI 10.1038/leu.2011.207; Ng KP, 2011, LEUKEMIA, V25, P1739, DOI 10.1038/leu.2011.159; Niimi H, 2006, LEUKEMIA, V20, P635, DOI 10.1038/sj.leu.2404136; Nowak D, 2009, BLOOD, V113, P3655, DOI 10.1182/blood-2009-01-198911; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Petrovick HS, 1998, MOL CELL BIOL, V18, P3915, DOI 10.1128/MCB.18.7.3915; Ptasinska A, 2012, LEUKEMIA, V26, P1829, DOI 10.1038/leu.2012.49; Puig-Kroger A, 2003, BLOOD, V102, P3252, DOI 10.1182/blood-2003-02-0618; R Core Team, 2012, R LANG ENV STAT COMP; Ram O, 2011, CELL, V147, P1628, DOI 10.1016/j.cell.2011.09.057; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Rush Margaret, 2009, Epigenetics, V4, P404; Saunthararajah Y, 2013, HEMATOL-AM SOC HEMAT, P511, DOI 10.1182/asheducation-2013.1.511; Saunthararajah Y, 2012, BLOOD, V119, P1097, DOI 10.1182/blood-2011-12-391268; Saunthararajah Y, 2012, SEMIN ONCOL, V39, P97, DOI 10.1053/j.seminoncol.2011.11.011; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Stopka T, 2000, LEUKEMIA, V14, P1247, DOI 10.1038/sj.leu.2401807; Sun W, 2004, BLOOD, V104, P3565, DOI 10.1182/blood-2003-12-4349; Tagoh H, 2006, EMBO J, V25, P1070, DOI 10.1038/sj.emboj.7600997; Trowbridge JJ, 2012, GENE DEV, V26, P344, DOI 10.1101/gad.184341.111; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Walsh JC, 2002, IMMUNITY, V17, P665, DOI 10.1016/S1074-7613(02)00452-1; Waltzer L, 2003, EMBO J, V22, P6516, DOI 10.1093/emboj/cdg622; Wang JX, 1999, CANCER RES, V59, P2766; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Warrell RP, 1998, JNCI-J NATL CANCER I, V90, P1621, DOI 10.1093/jnci/90.21.1621; Weigelt K, 2009, BIOCHEM BIOPH RES CO, V380, P308, DOI 10.1016/j.bbrc.2009.01.067; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Xu G, 2006, LEUKEMIA, V20, P1002, DOI 10.1038/sj.leu.2404223; Yergeau DA, 1997, NAT GENET, V15, P303, DOI 10.1038/ng0397-303; Zhang DE, 1996, CURR TOP MICROBIOL, V211, P137; Zhang DE, 1996, MOL CELL BIOL, V16, P1231	47	27	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14881	14895		10.1074/jbc.M114.562447	http://dx.doi.org/10.1074/jbc.M114.562447			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24695740	hybrid, Green Published			2022-12-25	WOS:000337248100040
J	Goodman, CD; McFadden, GI				Goodman, Christopher D.; McFadden, Geoffrey I.			Ycf93 (Orf105), a Small Apicoplast-Encoded Membrane Protein in the Relict Plastid of the Malaria Parasite Plasmodium falciparum That Is Conserved in Apicomplexa	PLOS ONE			English	Article							GREEN ALGAL ORIGIN; PEPTIDE DEFORMYLASE; GENOME SEQUENCE; ERYTHROCYTE INVASION; BABESIA-BOVIS; LIFE-CYCLE; TARGET; IDENTIFICATION; LOCALIZATION; PLAYS	Malaria parasites retain a relict plastid (apicoplast) from a photosynthetic ancestor shared with dinoflagellate algae. The apicoplast is a useful drug target; blocking housekeeping pathways such as genome replication and translation in the organelle kills parasites and protects against malaria. The apicoplast of Plasmodium falciparum encodes 30 proteins and a suite of rRNAs and tRNAs that facilitate their expression. orf105 is a hypothetical apicoplast gene that would encode a small protein (PfOrf105) with a predicted C-terminal transmembrane domain. We produced antisera to a predicted peptide within PfOrf105. Western blot analysis confirmed expression of orf105 and immunofluorescence localised the gene product to the apicoplast. Pforf105 encodes a membrane protein that has an apparent mass of 17.5 kDa and undergoes substantial turnover during the 48-hour asexual life cycle of the parasite in blood stages. The effect of actinonin, an antimalarial with a putative impact on post-translational modification of apicoplast proteins like PfOrf105, was examined. Unlike other drugs perturbing apicoplast housekeeping that induce delayed death, actinonin kills parasites immediately and has an identical drug exposure phenotype to the isopentenyl diphosphate synthesis blocker fosmidomycin. Open reading frames of similar size to PfOrf105, which also have predicted C-terminal trans membrane domains, occur in syntenic positions in all sequenced apicoplast genomes from Phylum Apicomplexa. We therefore propose to name these genes ycf93 (hypothetical chloroplast reading frame 93) according to plastid gene nomenclature convention for conserved proteins of unknown function.	[Goodman, Christopher D.; McFadden, Geoffrey I.] Univ Melbourne, Sch Bot, Parkville, Vic 3052, Australia	University of Melbourne	McFadden, GI (corresponding author), Univ Melbourne, Sch Bot, Parkville, Vic 3052, Australia.	gim@unimelb.edu.au	McFadden, Geoffrey McFadden I/F-7667-2014	McFadden, Geoffrey McFadden I/0000-0002-5351-1627; Goodman, Christopher/0000-0002-8923-7594	Australian National Medical Health and Research Council; Federation Fellowship; Discovery Project	Australian National Medical Health and Research Council; Federation Fellowship; Discovery Project(Australian Research Council)	A Program Grant from the Australian National Medical Health and Research Council and a Federation Fellowship to GIM and a Discovery Project to GIM are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arisue N, 2012, MOL BIOL EVOL, V29, P2095, DOI 10.1093/molbev/mss082; Biswal U.C., 2013, ADV PHOTOSYNTHESIS R, V36, P453, DOI 10.1007/978-94-007-5724-0_20; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Boyle MJ, 2010, BLOOD, V115, P4559, DOI 10.1182/blood-2009-09-243725; Bracchi-Ricard V, 2001, ARCH BIOCHEM BIOPHYS, V396, P162, DOI 10.1006/abbi.2001.2631; Brayton KA, 2007, PLOS PATHOG, V3, P1401, DOI 10.1371/journal.ppat.0030148; Cai XM, 2003, GENE, V321, P39, DOI 10.1016/j.gene.2003.08.008; Clements JM, 2001, ANTIMICROB AGENTS CH, V45, P563, DOI 10.1128/AAC.45.2.563-570.2001; Dahl EL, 2008, TRENDS PARASITOL, V24, P279, DOI 10.1016/j.pt.2008.03.007; Dahl EL, 2007, ANTIMICROB AGENTS CH, V51, P3485, DOI 10.1128/AAC.00527-07; Dahl EL, 2006, ANTIMICROB AGENTS CH, V50, P3124, DOI 10.1128/AAC.00394-06; Drew DR, 2005, INFECT IMMUN, V73, P3912, DOI 10.1128/IAI.73.7.3912-3922.2005; El Bakkouri M, 2010, J MOL BIOL, V404, P456, DOI 10.1016/j.jmb.2010.09.051; Fichera ME, 1997, NATURE, V390, P407, DOI 10.1038/37132; Gardner MJ, 2005, SCIENCE, V309, P134, DOI 10.1126/science.1110439; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Giglione C, 2003, EMBO J, V22, P13, DOI 10.1093/emboj/cdg007; Giglione C, 2001, TRENDS PLANT SCI, V6, P566, DOI 10.1016/S1360-1385(01)02151-3; Giglione C, 2000, MOL MICROBIOL, V36, P1197, DOI 10.1046/j.1365-2958.2000.01908.x; Giglione Carmela, 2002, Expert Opin Ther Targets, V6, P691, DOI 10.1517/14728222.6.6.691; Goodman CD, 2007, MOL BIOCHEM PARASIT, V152, P181, DOI 10.1016/j.molbiopara.2007.01.005; HALLICK RB, 1994, PLANT MOL BIOL REP, V12, pS29, DOI DOI 10.1007/BF02671562; Imura T, 2014, PARASITOL RES, V113, P823, DOI 10.1007/s00436-013-3712-9; Janouskovec J, 2010, P NATL ACAD SCI USA, V107, P10949, DOI 10.1073/pnas.1003335107; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Kalanon M, 2009, EUKARYOT CELL, V8, P1146, DOI 10.1128/EC.00061-09; Kohler S, 1997, SCIENCE, V275, P1485, DOI 10.1126/science.275.5305.1485; Krishna S, 2012, TREATMENT PREVENTION, P141; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KUMAR N, 1991, MOL BIOCHEM PARASIT, V48, P47, DOI 10.1016/0166-6851(91)90163-Z; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau AOT, 2009, EXP PARASITOL, V123, P236, DOI 10.1016/j.exppara.2009.07.007; Lin WJ, 2009, PARASITOL RES, V105, P1715, DOI 10.1007/s00436-009-1612-9; Madison V, 2002, BIOPHYS CHEM, V101, P239, DOI 10.1016/S0301-4622(02)00179-5; McFadden GI, 1997, BIOESSAYS, V19, P1033, DOI 10.1002/bies.950191114; Molteni V, 2004, BIOORG MED CHEM LETT, V14, P1477, DOI 10.1016/j.bmcl.2004.01.014; Moore RB, 2008, NATURE, V451, P959, DOI 10.1038/nature06635; Mullin KA, 2006, P NATL ACAD SCI USA, V103, P9572, DOI 10.1073/pnas.0602293103; Nair SC, 2011, J EXP MED, V208, P1547, DOI 10.1084/jem.20110039; Obornik M, 2012, PROTIST, V163, P306, DOI 10.1016/j.protis.2011.09.001; Okamoto N, 2008, FUTURE MICROBIOL, V3, P391, DOI 10.2217/17460913.3.4.391; Ponpuak M, 2007, MOL MICROBIOL, V63, P314, DOI 10.1111/j.1365-2958.2006.05443.x; PREISER P, 1995, NUCLEIC ACIDS RES, V23, P4329, DOI 10.1093/nar/23.21.4329; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Rathore S, 2010, MOL MICROBIOL, V77, P873, DOI 10.1111/j.1365-2958.2010.07251.x; Sato S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061778; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Tan KR, 2011, AM J TROP MED HYG, V84, P517, DOI 10.4269/ajtmh.2011.10-0285; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; van Dooren GG, 2005, MOL MICROBIOL, V57, P405, DOI 10.1111/j.1365-2958.2005.04699.x; van Dooren GG, 2002, J BIOL CHEM, V277, P23612, DOI 10.1074/jbc.M201748200; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; WELLNER D, 1990, P NATL ACAD SCI USA, V87, P1947, DOI 10.1073/pnas.87.5.1947; Wiesner J, 2001, TRENDS PARASITOL, V17, P7, DOI 10.1016/S1471-4922(00)01735-9; Wilson RJM, 1996, J MOL BIOL, V261, P155, DOI 10.1006/jmbi.1996.0449; Yeh E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001138; Zhang YJ, 2009, BMC EVOL BIOL, V9, DOI [10.1186/1471-2148-9-290, 10.1186/1471-2148-9-137]	59	16	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e91178	10.1371/journal.pone.0091178	http://dx.doi.org/10.1371/journal.pone.0091178			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705170	Green Published, gold			2022-12-25	WOS:000334107500002
J	Ali, SE; Thoen, E; Evensen, O; Skaar, I				Ali, Shimaa E.; Thoen, Even; Evensen, Oystein; Skaar, Ida			Boric Acid Inhibits Germination and Colonization of Saprolegnia Spores In Vitro and In Vivo	PLOS ONE			English	Article							RAINBOW-TROUT; ATLANTIC SALMON; MALACHITE GREEN; BORON; MECHANISMS; GROWTH; EGGS; FISH; SPP.	Saprolegnia infections cause severe economic losses among freshwater fish and their eggs. The banning of malachite green increased the demand for finding effective alternative treatments to control the disease. In the present study, we investigated the ability of boric acid to control saprolegniosis in salmon eggs and yolk sac fry. Under in vitro conditions, boric acid was able to decrease Saprolegnia spore activity and mycelial growth in all tested concentrations above 0.2 g/L, while complete inhibition of germination and growth was observed at a concentration of 0.8 g/L. In in vivo experiments using Atlantic salmon eyed eggs, saprolegniosis was controlled by boric acid at concentrations ranging from 0.2-1.4 g/L during continuous exposure, and at 1.0-4.0 g/L during intermittent exposure. The same effect was observed on salmon yolk sac fry exposed continuously to 0.5 g/L boric acid during the natural outbreak of saprolegniosis. During the experiments no negative impact with regard to hatchability and viability was observed in either eggs or fry, which indicate safety of use at all tested concentrations. The high hatchability and survival rates recorded following the in vivo testing suggest that boric acid is a candidate for prophylaxis and control of saprolegniosis.	[Ali, Shimaa E.; Thoen, Even; Skaar, Ida] Norwegian Vet Inst, Oslo, Norway; [Thoen, Even; Evensen, Oystein] Norwegian Sch Vet Sci, Oslo, Norway	Norwegian Veterinary Institute; Norwegian University of Life Sciences	Skaar, I (corresponding author), Norwegian Vet Inst, Oslo, Norway.	ida.skaar@vetinst.no	Ali, Shimaa E/HHD-0713-2022; Evensen, Øystein/O-3011-2015	Evensen, Øystein/0000-0002-4856-3043; Ali, Shimaa E/0000-0002-0227-8124	European Commission through the EU Marie Curie ITN project SAPRO [238550]	European Commission through the EU Marie Curie ITN project SAPRO	The work has been funded by the European Commission through the EU Marie Curie ITN project SAPRO (238550) (http://www.abdn.ac.uk/oomycetes/SAPRO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SE, 2013, VET MICROBIOL, V163, P133, DOI 10.1016/j.vetmic.2012.12.012; Bailey TA, 1989, FISH WILDLIFE SERVIC, V99, P1; BEAKES GW, 1980, J GEN MICROBIOL, V119, P361; Branson E, 2002, VET REC, V151, P539, DOI 10.1136/vr.151.18.539; Bruno DW, 2011, FISH DISEASES AND DISORDERS, VOL 3: VIRAL, BACTERIAL AND FUNGAL INFECTIONS, 2ND EDITION, P669, DOI 10.1079/9781845935542.0669; Cao BH, 2012, POSTHARVEST BIOL TEC, V68, P16, DOI 10.1016/j.postharvbio.2012.01.008; De Seta F, 2009, J ANTIMICROB CHEMOTH, V63, P325, DOI 10.1093/jac/dkn486; Decision RE, 1993, 738R93017 EPA; DieguezUribeondo J, 1996, AQUACULTURE, V140, P247; Eckhert CD, 1998, J NUTR, V128, P2488, DOI 10.1093/jn/128.12.2488; Fregeneda-Grandes JM, 2007, J FISH BIOL, V71, P510, DOI 10.1111/j.1095-8649.2007.01510.x; Magaraggia M, 2006, J ENVIRON MONITOR, V8, P923, DOI 10.1039/b606975d; MARKING LL, 1994, PROG FISH CULT, V56, P225, DOI 10.1577/1548-8640(1994)056&lt;0225:AFSEOA&gt;2.3.CO;2; MEYER FP, 1983, T AM FISH SOC, V112, P818, DOI 10.1577/1548-8659(1983)112&lt;818:TAOEOM&gt;2.0.CO;2; NEISH GA, 1980, DIS FISHES, P159; Pottinger TG, 1999, DIS AQUAT ORGAN, V36, P129, DOI 10.3354/dao036129; Qin GZ, 2010, INT J FOOD MICROBIOL, V138, P145, DOI 10.1016/j.ijfoodmicro.2009.12.018; Quarles W., 2001, IPM Practitioner, V23, P1; Rowe RI, 1999, J EXP BIOL, V202, P1649; Shi XQ, 2011, PLANT DIS, V95, P63, DOI 10.1094/PDIS-06-10-0437; Srivastava R. C., 1987, FISH MYCOPATHOLOGY; Srivastava S, 2004, AQUAT TOXICOL, V66, P319, DOI 10.1016/j.aquatox.2003.09.008; Stueland S, 2005, J FISH DIS, V28, P445, DOI 10.1111/j.1365-2761.2005.00635.x; Thoen E, 2011, J FISH DIS, V34, P601, DOI 10.1111/j.1365-2761.2011.01273.x; WILLOUGHBY LG, 1994, FUNGI FISH DIS	25	26	27	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e91878	10.1371/journal.pone.0091878	http://dx.doi.org/10.1371/journal.pone.0091878			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699283	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000334105000017
J	Barden, P; Grimaldi, D				Barden, Phillip; Grimaldi, David			A Diverse Ant Fauna from the Mid-Cretaceous of Myanmar (Hymenoptera: Formicidae)	PLOS ONE			English	Article							AMBER HYMENOPTERA; GENUS	A new collection of 24 wingless ant specimens from mid-Cretaceous Burmese amber (Albian-Cenomanian, 99 Ma) comprises nine new species belonging to the genus Sphecomyrmodes Engel and Grimaldi. Described taxa vary considerably with regard to total size, head and body proportion, cuticular sculpturing, and petiole structure while all species are unified by a distinct shared character. The assemblage represents the largest known diversification of closely related Cretaceous ants with respect to species number. These stem-group ants exhibit some characteristics previously known only from their extant counterparts along with presumed plesiomorphic morphology. Consequently, their morphology may inform hypotheses relating to basal relationships and general patterns of ant evolution. These and other uncovered Cretaceous species indicate that stem-group ants are not simply wasp-like, transitional formicids, but rather a group of considerable adaptive diversity, exhibiting innovations analogous to what crown-group ants would echo 100 million years later.	[Barden, Phillip; Grimaldi, David] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Barden, Phillip] Amer Museum Nat Hist, Richard Gilder Grad Sch, New York, NY 10024 USA	American Museum of Natural History (AMNH); American Museum of Natural History (AMNH)	Barden, P (corresponding author), Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA.	pbarden@amnh.org	Barden, Phillip/GLS-1283-2022	Barden, Phillip/0000-0001-6277-320X	Richard Gilder Graduate School at the American Museum of Natural History; National Science Foundation Graduate Research Fellowship Program	Richard Gilder Graduate School at the American Museum of Natural History; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF))	Financial support was provided by the Richard Gilder Graduate School at the American Museum of Natural History and National Science Foundation Graduate Research Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barden P, 2013, ZOOTAXA, V3681, P405, DOI 10.11646/zootaxa.3681.4.5; Barden P, 2012, AM MUS NOVIT, P1; Bolton Barry, 2003, Memoirs of the American Entomological Institute (Gainesville), V71, P1; Cruickshank RD, 2003, J ASIAN EARTH SCI, V21, P441, DOI 10.1016/S1367-9120(02)00044-5; Dlussky G. M., 1996, PALEONTOL J, V1996, p[83, 449]; Engel MS, 2005, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2005)485[0001:PNAICA]2.0.CO;2; Grimaldi DA, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)361<0001:FCAFMB>2.0.CO;2; Grimaldi David, 1997, American Museum Novitates, V3208, P1; Grimaldi David A., 2010, P167; LaPolla JS, 2013, ANNU REV ENTOMOL, V58, P609, DOI 10.1146/annurev-ento-120710-100600; McKellar RC, 2013, CAN ENTOMOL, V145, P454, DOI 10.4039/tce.2013.23; Nascimbene Paul, 2000, P93; Nel A., 2004, Geologica Acta, V2, P23; Noetling F., 1893, RECORDS GEOLOGICAL S, V26, P31; Perrichot V, 2008, NATURWISSENSCHAFTEN, V95, P91, DOI 10.1007/s00114-007-0302-7; Rabeling C, 2008, P NATL ACAD SCI USA, V105, P14913, DOI 10.1073/pnas.0806187105; Ross Andrew, 2010, P208; Shi GH, 2012, CRETACEOUS RES, V37, P155, DOI 10.1016/j.cretres.2012.03.014; WARD PS, 1994, SYST ENTOMOL, V19, P159, DOI 10.1111/j.1365-3113.1994.tb00585.x; WILSON EDWARD O., 1967, PSYCHE J ENTOMOL, V74, P1, DOI 10.1155/1967/89604; Xu X.D, 2011, CHINESE ANCIENT AMBE; Yoshimura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033325	22	30	31	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93627	10.1371/journal.pone.0093627	http://dx.doi.org/10.1371/journal.pone.0093627			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699881	Green Submitted, Green Published, gold			2022-12-25	WOS:000334105000082
J	Dauvilliers, Y; Bayard, S; Lopez, R; Comte, F; Zanca, M; Peigneux, P				Dauvilliers, Yves; Bayard, Sophie; Lopez, Regis; Comte, Frederic; Zanca, Michel; Peigneux, Philippe			Widespread Hypermetabolism in Symptomatic and Asymptomatic Episodes in Kleine-Levin Syndrome	PLOS ONE			English	Article							HYPERSOMNIA; SPECT; PET	Background: No reliable biomarkers are identified in KLS. However, few functional neuroimaging studies suggested hypoactivity in thalamic and hypothalamic regions during symptomatic episodes. Here, we investigated relative changes in regional brain metabolism in Kleine-Levin syndrome (KLS) during symptomatic episodes and asymptomatic periods, as compared to healthy controls. Methods: Four drug-free male patients with typical KLS and 15 healthy controls were included. (18)-F-fluorodeoxy glucose positron emission tomography (PET) was obtained in baseline condition in all participants, and during symptomatic episodes in KLS patients. All participants were asked to remain fully awake during the whole PET procedure. Results: Between state-comparisons in KLS disclosed higher metabolism in paracentral, precentral, and postcentral areas, supplementary motor area, medial frontal gyrus, thalamus and putamen during symptomatic episodes, and decreased metabolism in occipital and temporal gyri. As compared to healthy control subjects, KLS patients in the asymptomatic phase consistently exhibited significant hypermetabolism in a wide cortical network including frontal and temporal cortices, posterior cingulate and precuneus, with no detected hypometabolism. In symptomatic KLS episodes, hypermetabolism was additionally found in orbital frontal and supplementary motor areas, insula and inferior parietal areas, and right caudate nucleus, and hypometabolism in the middle occipital gyrus and inferior parietal areas. Conclusion: Our results demonstrated significant hypermetabolism and few hypometabolism in specific but widespread brain regions in drug-free KLS patients at baseline and during symptomatic episodes, highlighting the behavioral state-dependent nature of changes in regional brain activity in KLS.	[Dauvilliers, Yves; Bayard, Sophie; Lopez, Regis] CHU Montpellier, Hop Gui de Chauliac, Serv Neurol, Montpellier, France; [Dauvilliers, Yves; Bayard, Sophie; Lopez, Regis] Ctr Reference Natl Malad Rare Narcolepsie & Hyper, Montpellier, France; [Dauvilliers, Yves; Bayard, Sophie; Lopez, Regis] Inserm U1061, Montpellier, France; [Comte, Frederic; Zanca, Michel] CHU Montpellier, Hop Gui de Chauliac, Nucl Med Serv, Montpellier, France; [Peigneux, Philippe] Univ Libre Bruxelles, Neuropsychol & Funct Neuroimaging Res Unit, UR2NF, Brussels, Belgium	Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite Libre de Bruxelles	Dauvilliers, Y (corresponding author), CHU Montpellier, Hop Gui de Chauliac, Serv Neurol, Montpellier, France.	ydauvilliers@yahoo.fr	Lopez, Regis/X-4694-2019	Bayard, Sophie/0000-0003-0767-4924; Peigneux, Philippe/0000-0003-4745-1434; Dauvilliers, yves/0000-0003-0683-6506; Lopez, Regis/0000-0001-8591-0553				Arias M, 2002, REV NEUROLOGIA, V35, P531, DOI 10.33588/rn.3506.2002264; Arnulf I, 2005, BRAIN, V128, P2763, DOI 10.1093/brain/awh620; Arnulf I, 2008, ANN NEUROL, V63, P482, DOI 10.1002/ana.21333; Arnulf I, 2012, LANCET NEUROL, V11, P918, DOI 10.1016/S1474-4422(12)70187-4; Billiard M, 2011, SLEEP MED REV, V15, P247, DOI 10.1016/j.smrv.2010.08.001; Dauvilliers Y, 2002, NEUROLOGY, V59, P1739, DOI 10.1212/01.WNL.0000036605.89977.D0; Dauvilliers Y, 2010, J NEUROL NEUROSUR PS, V81, P344, DOI 10.1136/jnnp.2009.175786; Drummond SPA, 2001, J SLEEP RES, V10, P85, DOI 10.1046/j.1365-2869.2001.00245.x; Haba-Rubio J, 2012, NEUROLOGY, V79, P1927, DOI 10.1212/WNL.0b013e318271f85a; Hong SB, 2006, SLEEP, V29, P1091, DOI 10.1093/sleep/29.8.1091; Huang YS, 2005, SLEEP, V28, P955, DOI 10.1093/sleep/28.8.955; Huang YS, 2012, SLEEP, V35, P123, DOI 10.5665/sleep.1600; Landtblom AM, 2002, ACTA NEUROL SCAND, V105, P318, DOI 10.1034/j.1600-0404.2002.1c162.x; Lo YC, 2012, SLEEP MED, V13, P771, DOI 10.1016/j.sleep.2012.01.009; The International Classification of Sleep Disorders, 2005, INT CLASS SLEEP DIS; Vigren P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056279	16	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93813	10.1371/journal.pone.0093813	http://dx.doi.org/10.1371/journal.pone.0093813			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699677	Green Published, gold, Green Submitted			2022-12-25	WOS:000334105000110
J	Li, QG; Cai, GX; Li, DW; Wang, YW; Zhuo, CH; Cai, SJ				Li, Qingguo; Cai, Guoxiang; Li, Dawei; Wang, Yuwei; Zhuo, Changhua; Cai, Sanjun			Better Long-Term Survival in Young Patients with Non-Metastatic Colorectal Cancer after Surgery, an Analysis of 69,835 Patients in SEER Database	PLOS ONE			English	Article							COLON-CANCER; OLDER PATIENTS; CARCINOMA; ADENOCARCINOMA; PROGNOSIS; ADULTS; RATES; AGE	Objective: To compare the long-term survival of colorectal cancer (CRC) in young patients with elderly ones. Methods: Using Surveillance, Epidemiology, and End Results (SEER) population-based data, we identified 69,835 patients with non-metastatic colorectal cancer diagnosed between January 1, 1988 and December 31, 2003 treated with surgery. Patients were divided into young (40 years and under) and elderly groups (over 40 years of age). Five-year cancer specific survival data were obtained. Kaplan-Meier methods were adopted and multivariable Cox regression models were built for the analysis of long-term survival outcomes and risk factors. Results: Young patients showed significantly higher pathological grading (p < 0.001), more cases of mucinous and signet-ring histological type (p < 0.001), later AJCC stage (p<0.001), more lymph nodes (>= 12 nodes) dissected (p < 0.001) and higher metastatic lymph node ratio (p < 0.001). The 5-year colorectal cancer specific survival rates were 78.6% in young group and 75.3% in elderly group, which had significant difference in both univariate and multivariate analysis (P < 0.001). Further analysis showed this significant difference only existed in stage II and III patients. Conclusions: Compared with elderly patients, young patients with colorectal cancer treated with surgery appear to have unique characteristics and a higher cancer specific survival rate although they presented with higher proportions of unfavorable biological behavior as well as advanced stage disease.	Fudan Univ, Shanghai Canc Ctr, Dept Colorectal Surg, Shanghai 200433, Peoples R China; [Li, Qingguo; Cai, Guoxiang; Li, Dawei; Wang, Yuwei; Zhuo, Changhua; Cai, Sanjun] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Cai, SJ (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Colorectal Surg, Shanghai 200433, Peoples R China.	caisanjun_sh@163.com	ZHUO, CHANGHUA/H-7592-2012	ZHUO, CHANGHUA/0000-0002-5900-9048	National Natural Science Foundation of China [81001055]; Shanghai Pujiang Program [13PJD008]; National High Technology Research and Development Program (863 Program) [2012AA02A506]; Shanghai Shenkang Program [SHDC12012120]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); National High Technology Research and Development Program (863 Program)(National High Technology Research and Development Program of China); Shanghai Shenkang Program	This study was supported by grants from the National Natural Science Foundation of China (No.81001055), Shanghai Pujiang Program (No.13PJD008), National High Technology Research and Development Program (863 Program, No.2012AA02A506) and Shanghai Shenkang Program (No. SHDC12012120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADKINS RB, 1987, AM SURGEON, V53, P141; ATKIN WS, 1993, LANCET, V341, P736, DOI 10.1016/0140-6736(93)90499-7; Ben-Ishay O, 2013, ISR MED ASSOC J, V15, P284; Benmoussa A, 2012, TURK J GASTROENTEROL, V23, P686, DOI 10.4318/tjg.2012.0474; Byeon JS, 2007, GASTROINTEST ENDOSC, V65, P1015, DOI 10.1016/j.gie.2006.12.065; Chan KK, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-82; Chang GJ, 2007, J NATL CANCER I, V99, P433, DOI 10.1093/jnci/djk092; Chew MH, 2009, INT J COLORECTAL DIS, V24, P1075, DOI 10.1007/s00384-009-0701-7; Cusack JC, 1996, J AM COLL SURGEONS, V183, P105; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Goodwin Rachel A, 2009, Clin Colon Rectal Surg, V22, P251, DOI 10.1055/s-0029-1242465; HEIMANN TM, 1989, DIS COLON RECTUM, V32, P473, DOI 10.1007/BF02554500; Kam M H, 2004, Colorectal Dis, V6, P191, DOI 10.1111/j.1463-1318.2004.00596.x; Karsten B, 2008, AM SURGEON, V74, P973; Le Voyer TE, 2003, J CLIN ONCOL, V21, P2912, DOI 10.1200/JCO.2003.05.062; Li M, 2011, J SURG RES, V167, P231, DOI 10.1016/j.jss.2010.10.040; MARBLE K, 1992, J SURG ONCOL, V51, P179, DOI 10.1002/jso.2930510311; Mitry E, 2001, DIS COLON RECTUM, V44, P380, DOI 10.1007/BF02234737; Nakamura T, 1999, SURG TODAY, V29, P226, DOI 10.1007/BF02483011; Neufeld D, 2009, TECH COLOPROCTOL, V13, P201, DOI 10.1007/s10151-009-0501-7; O'Connell JB, 2004, AM J SURG, V187, P343, DOI 10.1016/j.amjsurg.2003.12.020; O'Connell JB, 2003, AM SURGEON, V69, P866; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Schellerer VS, 2012, INT J COLORECTAL DIS, V27, P71, DOI 10.1007/s00384-011-1291-8; Serra-Rexach JA, 2012, ONCOLOGIST, V17, P1277, DOI 10.1634/theoncologist.2012-0060; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Siegel RL, 2009, CANCER EPIDEM BIOMAR, V18, P1695, DOI 10.1158/1055-9965.EPI-09-0186; Sung JJY, 2008, GUT, V57, P1166, DOI 10.1136/gut.2007.146316; TAYLOR MC, 1988, CAN J SURG, V31, P150; Varma J R, 1990, J Am Board Fam Pract, V3, P54; You YN, 2012, ARCH INTERN MED, V172, P287, DOI 10.1001/archinternmed.2011.602; Zhang JZ, 2013, J CANCER RES CLIN, V139, P1947, DOI 10.1007/s00432-013-1525-y	32	46	47	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93756	10.1371/journal.pone.0093756	http://dx.doi.org/10.1371/journal.pone.0093756			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699879	Green Submitted, gold, Green Published			2022-12-25	WOS:000334105000100
J	Mei, SY; Liu, YH; Bao, Y; Zhang, Y; Min, SP; Liu, YF; Huang, Y; Yuan, XD; Feng, Y; Shi, JD; Yang, RC				Mei, Shiyue; Liu, Yuanhang; Bao, Yue; Zhang, Yuan; Min, Siping; Liu, Yifei; Huang, Yun; Yuan, Xidi; Feng, Yue; Shi, Jiandang; Yang, Rongcun			Dendritic Cell-Associated miRNAs Are Modulated via Chromatin Remodeling in Response to Different Environments	PLOS ONE			English	Article							NF-KAPPA-B; HISTONE METHYLTRANSFERASE ACTIVITY; EMBRYONIC STEM-CELLS; RNA-POLYMERASE-II; MICRORNA GENES; LYSINE-27 METHYLATION; REPRESSOR COMPLEX; IMMUNE-RESPONSES; EXPRESSION; PHOSPHORYLATION	Introduction: Epigenetic modification plays a critical role in regulating gene expression. To understand how epigenetic modification alters miRNA expression in monocyte-derived dendritic cells (moDCs) in different environments, we analyzed the connections between H3K4me3 and H3K27me3 modification and the expression of miRNAs in LPS- and TGF-beta-conditioned moDCs. Results: In moDCs, H3K4me3 modification was strongly associated with the expression of activating miRNAs, whereas H3K27me3 was related to repressive miRNAs. The regulation of miRNA expression by H3K4me3 and H3K27me3 was further confirmed by silencing or inhibiting methyltransferases or methylation-associated factors in LPS- and TGF-beta-conditioned moDCs. siRNAs targeting H3K4me3-associated mixed lineage leukemia (MLL) and retinoblastoma binding protein 5 (RBBP5) reduced H3K4me3 enrichment and downregulated miRNA expression; conversely, silencing H3K27me3-associated enhancer of zeste homolog 2 (EZH2) and embryonic ectoderm development (EED) genes upregulated the DC-associated miRNAs. However, LPS-mediated miRNAs were often associated with H3K4me3 redistribution from the transcription start site (TSS) to the miRNA-coding region. Silencing LPS-associated NF-kappa B p65 and CBP/p300 not only inhibited H3K4m3 redistribution but also reduced miRNA expression. LPS-upregulated RBBP4 and RBBP7, which are involved in chromatin remodeling, also affected the redistribution of H3K4me3 and reduced the expression of miRNAs. Conclusion: In LPS- and TGF-beta-conditioned moDCs, miRNAs may be modulated not only by H3K4m3 and H3K27me3 modification but also by redistribution of H3K4me3 around the transcriptional start site of miRNAs. Thus, H3K4me3 and H3K27me3 epigenetic modification may play an important role in regulating DC differentiation and function in the presence of tumor or inflammatory environments.	[Mei, Shiyue; Liu, Yuanhang; Bao, Yue; Zhang, Yuan; Min, Siping; Liu, Yifei; Huang, Yun; Yuan, Xidi; Feng, Yue; Yang, Rongcun] Nankai Univ, Sch Med, Dept Immunol, Tianjin 300071, Peoples R China; [Yang, Rongcun] Minist Educ, Key Lab Bioact Mat, Tianjin, Peoples R China; [Shi, Jiandang] Nankai Univ, Coll Life Sci, Dept Biochem, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Yang, RC (corresponding author), Nankai Univ, Sch Med, Dept Immunol, Tianjin 300071, Peoples R China.	ryang@nankai.edu.cn		Liu, Yuanhang/0000-0002-0147-8394	NSFC [91029736]; Ministry of Science and Technology [2008AA02Z129]; National Theme Program of China (863 Program) [2011AA020116]; National Key Scientific Program [2011CB964902]	NSFC(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Theme Program of China (863 Program); National Key Scientific Program	This research was supported by NSFC grants 91029736, a Ministry of Science and Technology grant (863 program, 2008AA02Z129), the National Theme Program of China (863 Program, 2011AA020116) and the National Key Scientific Program (2011CB964902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; Araki Y, 2009, IMMUNITY, V30, P912, DOI 10.1016/j.immuni.2009.05.006; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Dufter C, 2001, TRANSPLANT P, V33, P190, DOI 10.1016/S0041-1345(00)01971-0; Elsharkawy AM, 2010, J HEPATOL, V53, P519, DOI 10.1016/j.jhep.2010.03.025; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Gao Y, 2011, NUCLEIC ACIDS RES, V39, P454, DOI 10.1093/nar/gkq782; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Huang Y, 2012, GENES IMMUN, V13, P311, DOI 10.1038/gene.2011.87; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Hussain A, 2011, CANCER BIOTHER RADIO, V26, P519, DOI 10.1089/cbr.2010.0925; Jamaluddin M, 2007, CELL SIGNAL, V19, P1419, DOI 10.1016/j.cellsig.2007.01.020; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Krutzik SR, 2005, NAT MED, V11, P653, DOI 10.1038/nm1246; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Liu YJ, 2001, NAT IMMUNOL, V2, P585, DOI 10.1038/89726; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Palucka K, 2010, IMMUNITY, V33, P464, DOI 10.1016/j.immuni.2010.10.007; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pulendran B, 2001, SCIENCE, V293, P253, DOI 10.1126/science.1062060; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Song W, 2011, LEUKEMIA, V25, P161, DOI 10.1038/leu.2010.244; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tserel L, 2011, J BIOL CHEM, V286, P26487, DOI 10.1074/jbc.M110.213561; Tserel L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-642; Turner ML, 2011, J IMMUNOL, V187, P3911, DOI 10.4049/jimmunol.1101137; Ura H, 2011, EMBO J, V30, P2190, DOI 10.1038/emboj.2011.126; Varga-Weisz P, 2005, PROG MOLEC, V38, P1; Wang JQ, 2012, NUCLEUS-AUSTIN, V3, P155, DOI 10.4161/nucl.19477; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yang RC, 1999, J IMMUNOL, V163, P1037; Zhan YF, 2012, PROTEIN CELL, V3, P497, DOI 10.1007/s13238-012-0042-0; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	48	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e90231	10.1371/journal.pone.0090231	http://dx.doi.org/10.1371/journal.pone.0090231			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699235	Green Submitted, gold, Green Published			2022-12-25	WOS:000334105000008
J	Damiens, D; Ayrinhac, A; Van Bortel, W; Versteirt, V; Dekoninck, W; Hance, T				Damiens, David; Ayrinhac, Audrey; Van Bortel, Wim; Versteirt, Veerle; Dekoninck, Wouter; Hance, Thierry			Invasive Process and Repeated Cross-Sectional Surveys of the Mosquito Aedes japonicus japonicus Establishment in Belgium	PLOS ONE			English	Article							HOST-FEEDING PATTERNS; OCHLEROTATUS-JAPONICUS; EXPERIMENTAL TRANSMISSION; INTRODUCED MOSQUITO; ENCEPHALITIS-VIRUS; DIPTERA-CULICIDAE; VECTOR COMPETENCE; FINLAYA; COQUILLETTIDIA; CLASSIFICATION	When accidentally introduced in a new location, a species does not necessarily readily become invasive, but it usually needs several years to adapt to its new environment. In 2009, a national mosquito survey (MODIRISK) reported the introduction and possible establishment of an invasive mosquito species, Aedes j. japonicus, in Belgium. First collected in 2002 in the village of Natoye from a second-hand tire company, then sampled in 2003 and 2004, the presence of adults and larvae was confirmed in 2007 and 2008. A repeated cross-sectional survey of Ae. j. japonicus was then conducted in 2009 in Natoye to study the phenology of the species on two different sites using three kinds of traps: Mosquito Magnet Liberty Plus traps, BG sentinel traps and CDC Gravid traps. An analysis of the blood meals was done on females to assess the epidemiological risks. Five species of mosquitos were caught using the different kind of traps: Culex pipiens, Cx torrentium, Anopheles claviger, Aedes geniculatus and Ae. j. japonicus, Cx pipiens being the most abundant. The CDC gravid traps gave the best results. Surprisingly Ae. j. japonicus was only found on one site although both sites seem similar and are only distant of 2.5 km. Its population peak was reached in July. Most of the engorged mosquitoes tested acquired blood meals from humans (60%). No avian blood meals were unambiguously identified. Larvae were also collected, mostly from tires but also from buckets and from one tree hole. Only one larva was found in a puddle at 100 m of the tire storage. A first local treatment of Ae. j. japonicus larvae population was done in May 2012 using Bacillus thuringiensis subsp. israelensis (Bti) and was followed by preventive actions and public information. A monitoring is also presently implemented.	[Damiens, David; Ayrinhac, Audrey; Hance, Thierry] Catholic Univ Louvain, Earth & Life Inst, Biodivers Res Ctr, B-1348 Louvain, Belgium; [Damiens, David] IAEA, Insect Pest Control Lab, A-1400 Vienna, Austria; [Van Bortel, Wim; Versteirt, Veerle] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Versteirt, Veerle] Avia GIS, Precis Pest Management Unit, Zoersel, Belgium; [Dekoninck, Wouter] Royal Belgian Inst Nat Sci, KBIN IRSNB, Brussels, Belgium	Universite Catholique Louvain; International Atomic Energy Agency; Institute of Tropical Medicine (ITM); Royal Belgian Institute of Natural Sciences	Hance, T (corresponding author), Catholic Univ Louvain, Earth & Life Inst, Biodivers Res Ctr, B-1348 Louvain, Belgium.	thierry.hance@uclouvain.be	Van Bortel, Wim/AFV-4687-2022; Van Bortel, Wim/AAU-5948-2021	Van Bortel, Wim/0000-0002-6644-518X; 	Belgium federal government (Belspo) [SD/BD/04A, SD/BD/04B]; FSR grant of the Universite catholique de Louvain, UCL	Belgium federal government (Belspo)(Belgian Federal Science Policy Office); FSR grant of the Universite catholique de Louvain, UCL	This work was funded by the Belgium federal government (Belspo; SD/BD/04A and SD/BD/04B) and by a FSR grant of the Universite catholique de Louvain, UCL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreadis TG, 2001, J MED ENTOMOL, V38, P774, DOI 10.1603/0022-2585-38.6.774; Andreadis TG, 2010, J MED ENTOMOL, V47, P43, DOI 10.1603/033.047.0106; [Anonymous], 2003, MOSQUITOES THEIR CON; Apperson CS, 2004, VECTOR-BORNE ZOONOT, V4, P71, DOI 10.1089/153036604773083013; Catford JA, 2009, DIVERS DISTRIB, V15, P22, DOI 10.1111/j.1472-4642.2008.00521.x; Kent RJ, 2005, AM J TROP MED HYG, V73, P336, DOI 10.4269/ajtmh.2005.73.336; LACASSE W, 1948, MOSQUITO FAUNA JAP 2; Maciel-de-Freitas R, 2006, MEM I OSWALDO CRUZ, V101, P321, DOI 10.1590/S0074-02762006000300017; Maniatis T., 1982, MOL CLONING LAB MANU; Marfin AA, 2001, CLIN INFECT DIS, V33, P1713, DOI 10.1086/322700; Molaei G, 2008, J MED ENTOMOL, V45, P1143, DOI 10.1603/0022-2585(2008)45[1143:HPOPMV]2.0.CO;2; Molaei G, 2009, J AM MOSQUITO CONTR, V25, P210, DOI 10.2987/09-0012.1; Morris JA, 2007, J AM MOSQUITO CONTR, V23, P243, DOI 10.2987/8756-971X(2007)23[243:FROAJJ]2.0.CO;2; Ngo KA, 2003, J MED ENTOMOL, V40, P215, DOI 10.1603/0022-2585-40.2.215; Oliver J, 2003, J AM MOSQUITO CONTR, V19, P121; Peyton EL, 1999, J AM MOSQUITO CONTR, V15, P238; Puth LM, 2005, ECOL LETT, V8, P715, DOI 10.1111/j.1461-0248.2005.00774.x; Reinert JF, 2000, J AM MOSQUITO CONTR, V16, P175; Reinert JF, 2006, ZOOL J LINN SOC-LOND, V148, P1, DOI 10.1111/j.1096-3642.2006.00254.x; Saenz VL, 2006, J AM MOSQUITO CONTR, V22, P754, DOI 10.2987/8756-971X(2006)22[754:OJJITS]2.0.CO;2; Sardelis MR, 2003, J AM MOSQUITO CONTR, V19, P159; Sardelis MR, 2002, J MED ENTOMOL, V39, P635, DOI 10.1603/0022-2585-39.4.635; Sardelis MR, 2002, J MED ENTOMOL, V39, P480, DOI 10.1603/0022-2585-39.3.480; Sardelis MR, 2001, J AM MOSQUITO CONTR, V17, P137; Sardelis MR, 2001, EMERG INFECT DIS, V7, P1018, DOI 10.3201/eid0706.010617; Schaffner F, 2013, CLIN MICROBIOL INFEC, V19, P685, DOI 10.1111/1469-0691.12189; Schaffner F, 2009, MED VET ENTOMOL, V23, P448, DOI 10.1111/j.1365-2915.2009.00825.x; Schaffner F, 2003, J AM MOSQUITO CONTR, V19, P1; Schaffner F., 2001, MOSQUITOES EUROPE ID; Schaffner Francis, 2003, European Mosquito Bulletin, V16, P7; Scott JJ, 2001, J AM MOSQUITO CONTR, V17, P142; Sorenson MD, 1999, MOL PHYLOGENET EVOL, V12, P105, DOI 10.1006/mpev.1998.0602; TANAKA K, 1979, Contributions of the American Entomological Institute, V16, P1; Theobald F.V., 1901, MONOGRAPH CULICIDAE, V1; Thielman A, 2006, J MED ENTOMOL, V43, P138, DOI 10.1603/0022-2585(2006)043[0138:EOOJDC]2.0.CO;2; Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2; Versteirt V, 2013, B ENTOMOL RES, V103, P193, DOI 10.1017/S0007485312000521; Versteirt V, 2009, J MED ENTOMOL, V46, P1464, DOI 10.1603/033.046.0632; Williges E, 2008, J AM MOSQUITO CONTR, V24, P591, DOI 10.2987/5714.1	39	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e89358	10.1371/journal.pone.0089358	http://dx.doi.org/10.1371/journal.pone.0089358			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24694576	Green Published, Green Submitted, gold			2022-12-25	WOS:000334103000005
J	Hakonen, E; Ustinov, J; Palgi, J; Miettinen, PJ; Otonkoski, T				Hakonen, Elina; Ustinov, Jarkko; Palgi, Jaan; Miettinen, Paivi J.; Otonkoski, Timo			EGFR Signaling Promotes beta-Cell Proliferation and Survivin Expression during Pregnancy	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; PANCREATIC-ISLETS; LACTOGENIC HORMONES; INSULIN-SECRETION; GENE-EXPRESSION; FACTOR RECEPTOR; MICE; LANGERHANS; MASS; APOPTOSIS	Placental lactogen (PL) induced serotonergic signaling is essential for gestational beta-cell mass expansion. We have previously shown that intact Epidermal growth factor -receptor (EGFR) function is a crucial component of this pathway. We now explored more specifically the link between EGFR and pregnancy-induced beta-cell mass compensation. Islets were isolated from wild-type and beta-cell-specific EGFR-dominant negative mice (E1-DN), stimulated with PL and analyzed for beta-cell proliferation and expression of genes involved in gestational beta-cell growth. beta-cell mass dynamics were analyzed both with traditional morphometrical methods and three dimensional optical projection tomography (OPT) of whole-mount insulin-stained pancreata. Insulin-positive volume analyzed with OPT increased 1.4-fold at gestational day 18.5 (GD18.5) when compared to non-pregnant mice. Number of islets peaked by GD13.5 (680 vs 1134 islets per pancreas, non-pregnant vs. GD13.5). PL stimulated beta cell proliferation in the wild-type islets, whereas the proliferative response was absent in the E1-DN mouse islets. Serotonin synthesizing enzymes were upregulated similarly in both the wild-type and E1-DN mice. However, while survivin (Birc5) mRNA was upregulated 5.5-fold during pregnancy in the wild-type islets, no change was seen in the E1-DN pregnant islets. PL induced survivin expression also in isolated islets and this was blocked by EGFR inhibitor gefitinib, mTOR inhibitor rapamycin and MEK inhibitor PD0325901. Our 3D-volumetric analysis of beta-cell mass expansion during murine pregnancy revealed that islet number increases during pregnancy. In addition, our results suggest that EGFR signaling is required for lactogen-induced survivin expression via MAPK and mTOR pathways.	[Hakonen, Elina; Ustinov, Jarkko; Palgi, Jaan; Miettinen, Paivi J.; Otonkoski, Timo] Univ Helsinki, Mol Neurol Biomedicum Stem Cell Ctr, Res Programs Unit, Helsinki, Finland; [Miettinen, Paivi J.; Otonkoski, Timo] Univ Helsinki, Childrens Hosp, Helsinki, Finland; [Miettinen, Paivi J.; Otonkoski, Timo] Univ Helsinki, Cent Hosp, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Hakonen, E (corresponding author), Univ Helsinki, Mol Neurol Biomedicum Stem Cell Ctr, Res Programs Unit, Helsinki, Finland.	elina.hakonen@helsinki.fi		Hakonen, Elina/0000-0002-9652-3724; Miettinen, Paivi/0000-0002-5184-9616	Diabetes Research Foundation; Helsinki University Central Hospital; Foundation for Pediatric Research; Sigrid Juselius Foundation; Helsinki Biomedical Graduate Program; Academy of Finland [257157]; Orion-Farmos Research Foundation; Biomedicum Helsinki Foundation	Diabetes Research Foundation; Helsinki University Central Hospital; Foundation for Pediatric Research; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Helsinki Biomedical Graduate Program; Academy of Finland(Academy of Finland); Orion-Farmos Research Foundation; Biomedicum Helsinki Foundation	These studies were funded by the Diabetes Research Foundation (www.diabetestutkimus.fi), the Helsinki University Central Hospital, the Foundation for Pediatric Research (www.lastentautientutkimussaatio.fi), the Sigrid Juselius Foundation (www.sigridjuselius.fi), the Helsinki Biomedical Graduate Program (www.hbgs.helsinki.fi), the Academy of Finland (Grant no 257157) (www.aka.fi), the Orion-Farmos Research Foundation and the Biomedicum Helsinki Foundation (www.biomedicum.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouna S, 2010, ORGANOGENESIS, V6, P125, DOI 10.4161/org.6.2.10374; Alanentalo T, 2007, NAT METHODS, V4, P31, DOI 10.1038/NMETH985; Alanentalo T, 2010, DIABETES, V59, P1756, DOI 10.2337/db09-1400; Amaral MEC, 2003, HORM METAB RES, V35, P282; Brelje TC, 2002, J HISTOCHEM CYTOCHEM, V50, P365, DOI 10.1177/002215540205000308; Butler AE, 2010, DIABETOLOGIA, V53, P2167, DOI 10.1007/s00125-010-1809-6; Cras-Meneur C, 2001, DIABETES, V50, P1571, DOI 10.2337/diabetes.50.7.1571; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Dohi T, 2006, EMBO REP, V7, P438, DOI 10.1038/sj.embor.7400640; Frank SJ, 2008, J MAMMARY GLAND BIOL, V13, P119, DOI 10.1007/s10911-008-9065-9; Hakonen E, 2011, DIABETOLOGIA, V54, P1735, DOI 10.1007/s00125-011-2153-1; Hakonen E, 2014, DIABETOLOGIA, V57, P970, DOI 10.1007/s00125-014-3175-2; Hanley SC, 2011, J ENDOCRINOLOGY; Holbro T, 2004, ANNU REV PHARMACOL, V44, P195, DOI 10.1146/annurev.pharmtox.44.101802.121440; Huang C, 2009, ENDOCRINOLOGY, V150, P1618, DOI 10.1210/en.2008-1003; Huang Y, 2006, ONCOGENE, V25, P7565, DOI 10.1038/sj.onc.1209740; Huotari MA, 2002, ENDOCRINOLOGY, V143, P4437, DOI 10.1210/en.2002-220382; Jiang Y, 2008, DIABETES, V57, P2718, DOI 10.2337/db08-0170; Kanwar JR, 2011, DRUG DISCOV TODAY, V16, P485, DOI 10.1016/j.drudis.2011.04.001; Karnik SK, 2007, SCIENCE, V318, P806, DOI 10.1126/science.1146812; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Means AL, 2003, GASTROENTEROLOGY, V124, P1020, DOI 10.1053/gast.2003.50150; Miettinen PJ, 2006, DIABETES, V55, P3299, DOI 10.2337/db06-0413; PARSONS JA, 1995, ENDOCRINOLOGY, V136, P2013, DOI 10.1210/en.136.5.2013; PARSONS JA, 1992, ENDOCRINOLOGY, V130, P1459, DOI 10.1210/en.130.3.1459; Peng XH, 2006, J BIOL CHEM, V281, P25903, DOI 10.1074/jbc.M603414200; Rescan C, 2005, LAB INVEST, V85, P65, DOI 10.1038/labinvest.3700204; Rieck S, 2010, TRENDS ENDOCRIN MET, V21, P151, DOI 10.1016/j.tem.2009.11.001; Rieck S, 2009, MOL ENDOCRINOL, V23, P1702, DOI 10.1210/me.2009-0144; Schraenen A, 2010, DIABETOLOGIA, V53, P2579, DOI 10.1007/s00125-010-1912-8; Schraenen A, 2010, DIABETOLOGIA, V53, P2589, DOI 10.1007/s00125-010-1913-7; Sorenson RL, 1997, HORM METAB RES, V29, P301, DOI 10.1055/s-2007-979040; Tamm I, 1998, CANCER RES, V58, P5315; VinterJensen L, 1997, GASTROENTEROLOGY, V113, P1367, DOI 10.1053/gast.1997.v113.pm9322532; Wang Q, 2005, EXP MOL PATHOL, V79, P100, DOI 10.1016/j.yexmp.2005.05.002; Wu X, 2009, DIABETOLOGIA, V52, P2130, DOI 10.1007/s00125-009-1469-6; Wu XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041976; Zarrouki B, 2014, DIABETES, V63, P982, DOI 10.2337/db13-0425; Zhang H, 2010, DIABETES, V59, P143, DOI 10.2337/db09-0050	40	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93651	10.1371/journal.pone.0093651	http://dx.doi.org/10.1371/journal.pone.0093651			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695557	Green Submitted, Green Published, gold			2022-12-25	WOS:000334103000098
J	Kojima, H; Watanabe, T; Iwata, T; Fukui, M				Kojima, Hisaya; Watanabe, Tomohiro; Iwata, Tomoya; Fukui, Manabu			Identification of Major Planktonic Sulfur Oxidizers in Stratified Freshwater Lake	PLOS ONE			English	Article							MOLECULAR ANALYSIS; DIVERSITY; REDUCTASE; MARKER; GENE; DETOXIFICATION; PROKARYOTES; PHYLOGENY; SEDIMENT; BACTERIA	Planktonic sulfur oxidizers are important constituents of ecosystems in stratified water bodies, and contribute to sulfide detoxification. In contrast to marine environments, taxonomic identities of major planktonic sulfur oxidizers in freshwater lakes still remain largely unknown. Bacterioplankton community structure was analyzed in a stratified freshwater lake, Lake Mizugaki in Japan. In the clone libraries of 16S rRNA gene, clones very closely related to a sulfur oxidizer isolated from this lake, Sulfuritalea hydrogenivorans, were detected in deep anoxic water, and occupied up to 12.5% in each library of different water depth. Assemblages of planktonic sulfur oxidizers were specifically analyzed by constructing clone libraries of genes involved in sulfur oxidation, aprA, dsrA, soxB and sqr. In the libraries, clones related to betaproteobacteria were detected with high frequencies, including the close relatives of Sulfuritalea hydrogenivorans.	[Kojima, Hisaya; Watanabe, Tomohiro; Fukui, Manabu] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 060, Japan; [Iwata, Tomoya] Univ Yamanashi, Dept Environm Sci, Kofu, Yamanashi, Japan	Hokkaido University; University of Yamanashi	Kojima, H (corresponding author), Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 060, Japan.	kojimah@pop.lowtem.hokudai.ac.jp	Watanabe, Tomohiro/U-2519-2019; Kojima, Hisaya/D-9100-2012; Fukui, Manabu/E-1323-2012	Iwata, Tomoya/0000-0003-4258-0050; Watanabe, Tomohiro/0000-0002-5397-2124	Institute for Fermentation, Osaka; JSPS KAKENHI [22370005, 16710016]	Institute for Fermentation, Osaka(Institute for Fermentation (IFO)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Institute for Fermentation, Osaka, to Kojima. This study was also supported by JSPS KAKENHI Grant Number 22370005 (to Fukui) and 16710016 (to Iwata). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Biderre-Petit C, 2011, MICROB ECOL, V61, P313, DOI 10.1007/s00248-010-9769-4; Danis PA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020833; Grote J, 2012, P NATL ACAD SCI USA, V109, P506, DOI 10.1073/pnas.1111262109; Juretschko S, 2002, SYST APPL MICROBIOL, V25, P84, DOI 10.1078/0723-2020-00093; Kojima H, 2012, SYST APPL MICROBIOL, V35, P233, DOI 10.1016/j.syapm.2012.03.005; Kojima H, 2011, INT J SYST EVOL MICR, V61, P1651, DOI 10.1099/ijs.0.024968-0; Kojima H, 2009, FRESHWATER BIOL, V54, P1501, DOI 10.1111/j.1365-2427.2009.02199.x; Lavik G, 2009, NATURE, V457, P581, DOI 10.1038/nature07588; Livingstone DM, 2003, CLIMATIC CHANGE, V57, P205, DOI 10.1023/A:1022119503144; Loy A, 2009, ENVIRON MICROBIOL, V11, P289, DOI 10.1111/j.1462-2920.2008.01760.x; Luo JF, 2011, APPL MICROBIOL BIOT, V90, P769, DOI 10.1007/s00253-010-3061-x; Matzinger A, 2007, LIMNOL OCEANOGR, V52, P338, DOI 10.4319/lo.2007.52.1.0338; Meyer B, 2007, APPL ENVIRON MICROB, V73, P7664, DOI 10.1128/AEM.01272-07; Meyer B, 2007, ENVIRON MICROBIOL, V9, P2957, DOI 10.1111/j.1462-2920.2007.01407.x; Meyer B, 2007, MICROBIOL-SGM, V153, P3478, DOI 10.1099/mic.0.2007/008250-0; Pham VH, 2008, MICROBIOL-SGM, V154, P3112, DOI 10.1099/mic.0.2008/018580-0; Rotaru AE, 2010, FEMS MICROBIOL ECOL, V71, P460, DOI 10.1111/j.1574-6941.2009.00814.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsutsumi M, 2011, FRESHWATER BIOL, V56, P342, DOI 10.1111/j.1365-2427.2010.02502.x; Walsh DA, 2009, SCIENCE, V326, P578, DOI 10.1126/science.1175309; Watanabe T, 2013, SYST APPL MICROBIOL, V36, P436, DOI 10.1016/j.syapm.2013.04.009; Yagi JM, 2010, ISME J, V4, P131, DOI 10.1038/ismej.2009.101	24	25	28	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93877	10.1371/journal.pone.0093877	http://dx.doi.org/10.1371/journal.pone.0093877			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695535	Green Submitted, gold, Green Published			2022-12-25	WOS:000334103000129
J	Rowan, MP; Bierbower, SM; Eskander, MA; Szteyn, K; Por, ED; Gomez, R; Veldhuis, N; Bunnett, NW; Jeske, NA				Rowan, Matthew P.; Bierbower, Sonya M.; Eskander, Michael A.; Szteyn, Kalina; Por, Elaine D.; Gomez, Ruben; Veldhuis, Nicholas; Bunnett, Nigel W.; Jeske, Nathaniel A.			Activation of Mu Opioid Receptors Sensitizes Transient Receptor Potential Vanilloid Type 1 (TRPV1) via beta-Arrestin-2-Mediated Cross-Talk	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; ROOT GANGLION NEURONS; INDUCED HYPERALGESIA; BETA-ARRESTINS; ANTINOCICEPTIVE TOLERANCE; SENSORY NEURONS; CAPSAICIN RECEPTOR; PAIN; DESENSITIZATION; MECHANISMS	The transient receptor potential family V1 channel (TRPV1) is activated by multiple stimuli, including capsaicin, acid, endovanilloids, and heat (>42C). Post-translational modifications to TRPV1 result in dynamic changes to the sensitivity of receptor activation. We have previously demonstrated that beta-arrestin2 actively participates in a scaffolding mechanism to inhibit TRPV1 phosphorylation, thereby reducing TRPV1 sensitivity. In this study, we evaluated the effect of beta-arrestin2 sequestration by G-protein coupled receptors (GPCRs) on thermal and chemical activation of TRPV1. Here we report that activation of mu opioid receptor by either morphine or DAMGO results in beta-arrestin2 recruitment to mu opioid receptor in sensory neurons, while activation by herkinorin does not. Furthermore, treatment of sensory neurons with morphine or DAMGO stimulates beta-arrestin2 dissociation from TRPV1 and increased sensitivity of the receptor. Conversely, herkinorin treatment has no effect on TRPV1 sensitivity. Additional behavioral studies indicate that GPCR-driven beta-arrestin2 sequestration plays an important peripheral role in the development of thermal sensitivity. Taken together, the reported data identify a novel cross-talk mechanism between GPCRs and TRPV1 that may contribute to multiple clinical conditions.	[Rowan, Matthew P.; Szteyn, Kalina; Gomez, Ruben; Jeske, Nathaniel A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Oral & Maxillofacial Surg, San Antonio, TX 78229 USA; [Eskander, Michael A.; Por, Elaine D.; Jeske, Nathaniel A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Bierbower, Sonya M.; Jeske, Nathaniel A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Veldhuis, Nicholas; Bunnett, Nigel W.] Monash Inst Pharmacol Sci, Dept Pharmacol, Parkville, Vic, Australia; [Veldhuis, Nicholas; Bunnett, Nigel W.] Monash Inst Pharmacol Sci, Dept Med, Parkville, Vic, Australia	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Jeske, NA (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Oral & Maxillofacial Surg, San Antonio, TX 78229 USA.	jeske@uthscsa.edu		Veldhuis, Nicholas/0000-0002-8902-9365; Por, Elaine/0000-0001-8025-5713; Bunnett, Nigel W./0000-0003-3367-0644	NIH [NINDS R01NS061884, RO1NS082746, NINDS F32NS079148]; NHMRC [63303, 103188, 1049682]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001120] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE014318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061884, R01NS082746, F31NS083358, F32NS079148] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants NINDS R01NS061884 and RO1NS082746 to NAJ, NINDS F32NS079148 to SMB and NHMRC grants 63303, 103188 and 1049682 to NWB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angst MS, 2006, ANESTHESIOLOGY, V104, P570, DOI 10.1097/00000542-200603000-00025; Axelrod D, 2003, METHOD ENZYMOL, V361, P1; Belanger S, 2002, NEUROSCIENCE, V115, P441, DOI 10.1016/S0306-4522(02)00452-9; Berg KA, 2007, J PHARMACOL EXP THER, V321, P839, DOI 10.1124/jpet.106.116681; Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Bohn LM, 2002, J NEUROSCI, V22, P10494; Butelman ER, 2008, J PHARMACOL EXP THER, V327, P154, DOI 10.1124/jpet.108.140079; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chia YT, 1999, CAN J ANAESTH, V46, P872, DOI 10.1007/BF03012978; Compton P, 2001, DRUG ALCOHOL DEPEN, V63, P139, DOI 10.1016/S0376-8716(00)00200-3; Cunha TM, 2010, P NATL ACAD SCI USA, V107, P4442, DOI 10.1073/pnas.0914733107; De Felice M, 2009, CEPHALALGIA, V29, P1277, DOI 10.1111/j.1468-2982.2009.01873.x; Debic HH, 2005, J NEUROSCI, V25, P7847, DOI 10.1523/JNEUROSCI.5045-04.2005; Diogenes A, 2006, J NEUROSCI, V26, P8126, DOI 10.1523/JNEUROSCI.0793-06.2006; Endres-Becker J, 2007, MOL PHARMACOL, V71, P12, DOI 10.1124/mol.106.026740; Ferrini F, 2013, NAT NEUROSCI, V16, P183, DOI 10.1038/nn.3295; Groer CE, 2007, MOL PHARMACOL, V71, P549, DOI 10.1124/mol.106.028258; Groer CE, 2011, J BIOL CHEM, V286, P31731, DOI 10.1074/jbc.M111.248310; Guignard B, 2000, ANESTHESIOLOGY, V93, P409, DOI 10.1097/00000542-200008000-00019; Harding WW, 2005, J MED CHEM, V48, P4765, DOI 10.1021/jm048963m; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Heinke B, 2011, J NEUROSCI, V31, P1313, DOI 10.1523/JNEUROSCI.4060-10.2011; Heinl C, 2011, J NEUROSCI, V31, P16748, DOI 10.1523/JNEUROSCI.3491-11.2011; Hernandez L, 2009, BRAIN RES, V1248, P31, DOI 10.1016/j.brainres.2008.10.065; Holzer P, 2008, BRIT J PHARMACOL, V155, P1145, DOI 10.1038/bjp.2008.351; Jeske NA, 2006, J NEUROCHEM, V97, P13, DOI 10.1111/j.1471-4159.2006.03706.x; Jeske NA, 2011, J NEUROSCI, V31, P8681, DOI 10.1523/JNEUROSCI.0020-11.2011; Johnson EE, 2005, NEUROSIGNALS, V14, P290, DOI 10.1159/000093044; Lamb K, 2012, DRUG ALCOHOL DEPEN, V121, P181, DOI 10.1016/j.drugalcdep.2011.10.026; Law PY, 2000, ANNU REV PHARMACOL, V40, P389, DOI 10.1146/annurev.pharmtox.40.1.389; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Li XQ, 2001, MOL BRAIN RES, V86, P56, DOI 10.1016/S0169-328X(00)00260-6; Low Y, 2012, SINGAP MED J, V53, P357; Mohapatra DP, 2005, J BIOL CHEM, V280, P13424, DOI 10.1074/jbc.M410917200; Patierno S, 2011, GASTROENTEROLOGY, V140, P618, DOI 10.1053/j.gastro.2010.11.005; Patil MJ, 2011, J NEUROSCI RES, V89, P945, DOI 10.1002/jnr.22597; Piovezan AP, 1998, EUR J PHARMACOL, V351, P15, DOI 10.1016/S0014-2999(98)00281-7; Por ED, 2012, J BIOL CHEM, V287, P37552, DOI 10.1074/jbc.M112.391847; Por ED, 2010, BIOCHEM J, V432, P549, DOI 10.1042/BJ20100936; Raehal KM, 2011, NEUROPHARMACOLOGY, V60, P58, DOI 10.1016/j.neuropharm.2010.08.003; Ramasubbu Chitra, 2011, J Pain Palliat Care Pharmacother, V25, P219, DOI 10.3109/15360288.2011.589490; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Rowan MP, 2009, EUR J PHARMACOL, V602, P283, DOI 10.1016/j.ejphar.2008.11.028; Shukla AK, 2010, J BIOL CHEM, V285, P30115, DOI 10.1074/jbc.M110.141549; Spahn V, 2013, PAIN, V154, P598, DOI 10.1016/j.pain.2012.12.026; STEIN C, 1989, J PHARMACOL EXP THER, V248, P1269; Tominaga M, 2005, PFLUG ARCH EUR J PHY, V451, P143, DOI 10.1007/s00424-005-1457-8; Tominaga M, 2004, NOVART FDN SYMP, V261, P47; Tominaga M, 2004, NOVART FDN SYMP, V261, P12; Tominaga Makoto, 2004, Novartis Found Symp, V261, P4; Vanderah TW, 2000, J NEUROSCI, V20, P7074, DOI 10.1523/JNEUROSCI.20-18-07074.2000; Vardanyan A, 2009, J PAIN, V10, P243, DOI 10.1016/j.jpain.2008.07.004; Vetter I, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-22; Vetter I, 2008, J BIOL CHEM, V283, P19540, DOI 10.1074/jbc.M707865200; Walwyn WM, 2006, NEUROSCIENCE, V142, P493, DOI 10.1016/j.neuroscience.2006.06.021; Wang HJ, 2011, PAIN, V152, P1649, DOI 10.1016/j.pain.2011.03.010; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Wu ZZ, 2004, J PHARMACOL EXP THER, V311, P939, DOI 10.1124/jpet.104.073429; Xu H, 2007, SYNAPSE, V61, P166, DOI 10.1002/syn.20356; Zeitelhofer M, 2007, NAT PROTOC, V2, P1692, DOI 10.1038/nprot.2007.226; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157	63	33	35	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93688	10.1371/journal.pone.0093688	http://dx.doi.org/10.1371/journal.pone.0093688			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695785	Green Published, gold			2022-12-25	WOS:000334103000104
J	Kissick, HT; Sanda, MG; Dunn, LK; Arredouani, MS				Kissick, Haydn T.; Sanda, Martin G.; Dunn, Laura K.; Arredouani, Mohamed S.			Immunization with a Peptide Containing MHC Class I and II Epitopes Derived from the Tumor Antigen SIM2 Induces an Effective CD4 and CD8 T-Cell Response	PLOS ONE			English	Article							CANCER; MELANOMA; VACCINE; EXPRESSION; INDUCTION; IMMUNITY; IMMUNOTHERAPY; INTERLEUKIN-2; LYMPHOCYTES; GENERATION	Here, we sought to determine whether peptide vaccines designed harbor both class I as well as class II restricted antigenic motifs could concurrently induce CD4 and CD8 T cell activation against autologous tumor antigens. Based on our prior genome-wide interrogation of human prostate cancer tissues to identify genes over-expressed in cancer and absent in the periphery, we targeted SIM2 as a prototype autologous tumor antigen for these studies. Using humanized transgenic mice we found that the 9aa HLA-A*0201 epitope, SIM2(237-245), was effective at inducing an antigen specific response against SIM2-expressing prostate cancer cell line, PC3. Immunization with a multi-epitope peptide harboring both MHC-I and MHC-II restricted epitopes induced an IFN-gamma response in CD8 T cells to the HLA-A*0201-restricted SIM2(237-245) epitope, and an IL-2 response by CD4 T cells to the SIM2(240-254) epitope. This peptide was also effective at inducing CD8(+) T-cells that responded specifically to SIM2-expressing tumor cells. Collectively, the data presented in this study suggest that a single peptide containing multiple SIM2 epitopes can be used to induce both a CD4 and CD8 T cell response, providing a peptide-based vaccine formulation for potential use in immunotherapy of various cancers.	[Kissick, Haydn T.; Dunn, Laura K.; Arredouani, Mohamed S.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg,Urol Div, Boston, MA 02215 USA; [Sanda, Martin G.] Emory Univ, Sch Med, Dept Urol, Atlanta, GA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Emory University	Arredouani, MS (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg,Urol Div, Boston, MA 02215 USA.	marredou@bidmc.harvard.edu	Kissick, Haydn/AAS-6292-2021; Sanda, Martin G/B-2023-2015	Kissick, Haydn/0000-0001-7624-5598; 	National Institutes of Health-National Cancer Institute Early Detection Research Network [UO1-CA113913]; National Cancer Institute Prostate Specialized Program of Research Excellence Career Development Award [2P50CA90381-06]; Prostate Cancer Foundation Young Investigator Award; Prostate Cancer Foundation A. Mazzone Challenge Award; US Department of Defense Prostate Cancer Research Program New Investigator Award [W81XWH-09-1-0448]; US Department of Defense Prostate Cancer Research Program Laboratory-Clinical Transition Award [W81XWH-09-1-0156]; US Department of Defense Prostate Cancer Research Program Laboratory-Postdoctoral Training Award [W81XWH-12-PCRP-PTA]; NATIONAL CANCER INSTITUTE [P50CA090381, U01CA113913] Funding Source: NIH RePORTER	National Institutes of Health-National Cancer Institute Early Detection Research Network; National Cancer Institute Prostate Specialized Program of Research Excellence Career Development Award; Prostate Cancer Foundation Young Investigator Award; Prostate Cancer Foundation A. Mazzone Challenge Award; US Department of Defense Prostate Cancer Research Program New Investigator Award(United States Department of Defense); US Department of Defense Prostate Cancer Research Program Laboratory-Clinical Transition Award(United States Department of Defense); US Department of Defense Prostate Cancer Research Program Laboratory-Postdoctoral Training Award(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding came from: A) National Institutes of Health-National Cancer Institute Early Detection Research Network grant UO1-CA113913 (M. G. Sanda), B) National Cancer Institute Prostate Specialized Program of Research Excellence Career Development Award 2P50CA90381-06 (M. S. Arredouani), C) Prostate Cancer Foundation Young Investigator Award (M. S. Arredouani), D) Prostate Cancer Foundation A. Mazzone Challenge Award (M. G. Sanda), E) US Department of Defense Prostate Cancer Research Program New Investigator Award W81XWH-09-1-0448 (M. S. Arredouani), F) US Department of Defense Prostate Cancer Research Program Laboratory-Clinical Transition Award W81XWH-09-1-0156 (M. S. Arredouani & M. G. Sanda, Co-PI), G) US Department of Defense Prostate Cancer Research Program Laboratory-Postdoctoral Training Award W81XWH-12-PCRP-PTA (H. T. Kissick). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER J, 1994, IMMUNITY, V1, P751, DOI 10.1016/S1074-7613(94)80017-0; Arredouani MS, 2009, CLIN CANCER RES, V15, P5794, DOI 10.1158/1078-0432.CCR-09-0911; Bhasin M, 2003, BIOINFORMATICS, V19, P665, DOI 10.1093/bioinformatics/btg055; Bijker MS, 2007, J IMMUNOL, V179, P5033, DOI 10.4049/jimmunol.179.8.5033; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; FEARON ER, 1990, CELL, V60, P397, DOI 10.1016/0092-8674(90)90591-2; Gluck S, 2012, BREAST CANCER RES TR, V132, P781, DOI 10.1007/s10549-011-1412-7; GOLUMBEK PT, 1991, SCIENCE, V254, P713, DOI 10.1126/science.1948050; Halvorsen OJ, 2007, CLIN CANCER RES, V13, P892, DOI 10.1158/1078-0432.CCR-06-1207; Hasle H, 2000, LANCET, V355, P165, DOI 10.1016/S0140-6736(99)05264-2; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Hung K, 1998, J EXP MED, V188, P2357, DOI 10.1084/jem.188.12.2357; KAHN M, 1991, J IMMUNOL, V146, P3235; KAST WM, 1989, CELL, V59, P603, DOI 10.1016/0092-8674(89)90006-8; Kayaga J, 1999, GENE THER, V6, P1475, DOI 10.1038/sj.gt.3300961; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Kissick HT, 2013, CANCER IMMUNOL IMMUN, V62, P1831, DOI 10.1007/s00262-013-1482-y; Krug LM, 2010, CANCER IMMUNOL IMMUN, V59, P1467, DOI 10.1007/s00262-010-0871-8; Kwak HI, 2007, CARCINOGENESIS, V28, P259, DOI 10.1093/carcin/bgl122; Lu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028837; Maeurer MJ, 1996, CLIN CANCER RES, V2, P641; Matsui S, 1999, J IMMUNOL, V163, P184; Melief CJM, 2008, NAT REV CANCER, V8, P351, DOI 10.1038/nrc2373; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Ossendorp F, 2000, IMMUNOL LETT, V74, P75, DOI 10.1016/S0165-2478(00)00252-2; Ossendorp F, 1998, J EXP MED, V187, P693, DOI 10.1084/jem.187.5.693; Pardoll DM, 1998, CURR OPIN IMMUNOL, V10, P588, DOI 10.1016/S0952-7915(98)80228-8; Pascolo S, 1997, J EXP MED, V185, P2043, DOI 10.1084/jem.185.12.2043; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Schwartzentruber DJ, 2011, NEW ENGL J MED, V364, P2119, DOI 10.1056/NEJMoa1012863; Skrzypczak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013091; Speetjens FM, 2009, CLIN CANCER RES, V15, P1086, DOI 10.1158/1078-0432.CCR-08-2227; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Wang P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-568; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; WEISS WR, 1993, J IMMUNOL, V151, P2690; Welters MJP, 2008, CLIN CANCER RES, V14, P178, DOI 10.1158/1078-0432.CCR-07-1880; Welters MJP, 2007, VACCINE, V25, P1379, DOI 10.1016/j.vaccine.2006.10.049; Yamada A, 2013, CANCER SCI, V104, P15, DOI 10.1111/cas.12050; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zwaveling S, 2002, J IMMUNOL, V169, P350, DOI 10.4049/jimmunol.169.1.350	44	9	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93231	10.1371/journal.pone.0093231	http://dx.doi.org/10.1371/journal.pone.0093231			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690990	Green Published, Green Submitted, gold			2022-12-25	WOS:000334101100055
J	Ding, LW; Sun, QY; Lin, DC; Chien, W; Hattori, N; Dong, XM; Gery, S; Garg, M; Doan, NB; Said, JW; Xiao, JF; Yang, H; Liu, LZ; Meng, X; Huang, RYJ; Tang, K; Koeffler, H				Ding, L-W; Sun, Q-Y; Lin, D-C; Chien, W.; Hattori, N.; Dong, X-M; Gery, S.; Garg, M.; Doan, N. B.; Said, J. W.; Xiao, J-F; Yang, H.; Liu, L-Z; Meng, X.; Huang, R. Y-J; Tang, K.; Koeffler, H. P.			LNK (SH2B3): paradoxical effects in ovarian cancer	ONCOGENE			English	Article							ADAPTER PROTEIN LNK; ACUTE LYMPHOBLASTIC-LEUKEMIA; MYELOPROLIFERATIVE NEOPLASMS; HEMATOPOIETIC STEM; PLECKSTRIN HOMOLOGY; ENDOTHELIAL-CELLS; PROGENITOR CELLS; ACTIVATION; EXPRESSION; MUTATIONS	LNK (SH2B3) is an adaptor protein studied extensively in normal and malignant hematopoietic cells. In these cells, it downregulates activated tyrosine kinases at the cell surface resulting in an antiproliferative effect. To date, no studies have examined activities of LNK in solid tumors. In this study, we found by in silico analysis and staining tissue arrays that the levels of LNK expression were elevated in high-grade ovarian cancer. To test the functional importance of this observation, LNK was either overexpressed or silenced in several ovarian cancer cell lines. Remarkably, overexpression of LNK rendered the cells resistant to death induced by either serum starvation or nutrient deprivation, and generated larger tumors using a murine xenograft model. In contrast, silencing of LNK decreased ovarian cancer cell growth in vitro and in vivo. Western blot studies indicated that overexpression of LNK upregulated and extended the transduction of the mitogenic signal, whereas silencing of LNK produced the opposite effects. Furthermore, forced expression of LNK reduced cell size, inhibited cell migration and markedly enhanced cell adhesion. Liquid chromatography-mass spectroscopy identified 14-3-3 as one of the LNK-binding partners. Our results suggest that in contrast to the findings in hematologic malignancies, the adaptor protein LNK acts as a positive signal transduction modulator in ovarian cancers.	[Ding, L-W; Sun, Q-Y; Lin, D-C; Chien, W.; Hattori, N.; Garg, M.; Xiao, J-F; Yang, H.; Liu, L-Z; Meng, X.; Huang, R. Y-J; Koeffler, H. P.] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Lin, D-C; Gery, S.; Koeffler, H. P.] Univ Calif Los Angeles, Sch Med, Cedar Sinai Med Ctr, Div Hematol Oncol, Los Angeles, CA USA; [Dong, X-M; Tang, K.] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Doan, N. B.; Said, J. W.] Santa Monica Univ Calif, Los Angeles Med Ctr, Los Angeles, CA USA; [Koeffler, H. P.] Natl Univ Singapore Hosp, Natl Univ Canc Inst, Singapore 117548, Singapore	National University of Singapore; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; National University of Singapore	Ding, LW (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, 13 North,MD6,14 Med Dr, Singapore 117599, Singapore.	csidlw@nus.edu.sg	Huang, Ruby Yun-Ju/AAE-8854-2019; Garg, Manoj/C-4076-2019; Ding, Ling-Wen/H-6916-2019; Tang, Kai/A-2194-2011; Sun, Qiao-Yang/ABA-6813-2020	Huang, Ruby Yun-Ju/0000-0001-6376-3185; Garg, Manoj/0000-0002-3492-2957; Ding, Ling-Wen/0000-0003-0022-1551; Sun, Qiao-Yang/0000-0002-9855-5586	National Research Foundation Singapore; Singapore Ministry of Education under the Research Centres of Excellence initiative; National Institutes of Health of the USA [R01CA026038-33]; Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research Investigator Award; NATIONAL CANCER INSTITUTE [R01CA026038] Funding Source: NIH RePORTER	National Research Foundation Singapore(National Research Foundation, Singapore); Singapore Ministry of Education under the Research Centres of Excellence initiative(Ministry of Education, Singapore); National Institutes of Health of the USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research Investigator Award(Ministry of Health-SingaporeNational Medical Research Council, Singapore); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research is supported by the National Research Foundation Singapore and the Singapore Ministry of Education under the Research Centres of Excellence initiative, and by the National Institutes of Health of the USA (R01CA026038-33) and the Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research Investigator Award to HPK.	Ahmed Z, 2003, BIOCHEM J, V371, P405, DOI 10.1042/BJ20021589; Almudi I, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-26; Baran-Marszak F, 2010, BLOOD, V116, P5961, DOI 10.1182/blood-2009-12-256768; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bersenev A, 2010, J CLIN INVEST, V120, P2058, DOI 10.1172/JCI42032; Buza-Vidas N, 2006, GENE DEV, V20, P2018, DOI 10.1101/gad.385606; Chatelais M, 2011, XENOTRANSPLANTATION, V18, P108, DOI 10.1111/j.1399-3089.2011.00629.x; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Devalliere J, 2012, FASEB J, V26, P2592, DOI 10.1096/fj.11-193383; Devalliere J, 2011, BIOCHEM PHARMACOL, V82, P1391, DOI 10.1016/j.bcp.2011.06.023; Fitau J, 2006, J BIOL CHEM, V281, P20148, DOI 10.1074/jbc.M510997200; Gery S, 2013, ONCOGENE, V32, P3111, DOI 10.1038/onc.2012.435; Gery S, 2007, BLOOD, V110, P3360, DOI 10.1182/blood-2007-05-089326; Gery S, 2009, J LEUKOCYTE BIOL, V85, P957, DOI 10.1189/jlb.0908575; Gery S, 2009, EXP HEMATOL, V37, P585, DOI 10.1016/j.exphem.2009.01.009; Gueller S, 2008, BIOCHEM J, V415, P241, DOI 10.1042/BJ20080102; Gueller S, 2011, EXP HEMATOL, V39, P591, DOI 10.1016/j.exphem.2011.02.001; Gueller S, 2010, J LEUKOCYTE BIOL, V88, P699, DOI 10.1189/jlb.0309185; Ha JS, 2011, AM J HEMATOL, V86, P866, DOI 10.1002/ajh.22107; Hurtado C, 2011, LEUKEMIA RES, V35, P1537, DOI 10.1016/j.leukres.2011.07.009; Jiang J, 2012, J CLIN INVEST, V122, P2079, DOI 10.1172/JCI59719; Lanning NJ, 2011, J CELL SCI, V124, P3095, DOI 10.1242/jcs.081547; Lasho TL, 2010, NEW ENGL J MED, V363, P1189, DOI 10.1056/NEJMc1006966; Lee JI, 2008, PHYSIOL GENOMICS, V33, P218, DOI 10.1152/physiolgenomics.00263.2007; Li YJ, 2000, J IMMUNOL, V164, P5199, DOI 10.4049/jimmunol.164.10.5199; Lin DC, 2012, BLOOD, V120, P3310, DOI 10.1182/blood-2011-10-388611; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maures TJ, 2009, MOL ENDOCRINOL, V23, P1077, DOI 10.1210/me.2009-0011; Nishi M, 2005, MOL CELL BIOL, V25, P2607, DOI 10.1128/MCB.25.7.2607-2621.2005; Oh ST, 2011, THER ADV HEMATOL, V2, P11, DOI 10.1177/2040620710393391; Oh ST, 2010, BLOOD, V116, P988, DOI 10.1182/blood-2010-02-270108; Pellinen T, 2008, DEV CELL, V15, P371, DOI 10.1016/j.devcel.2008.08.001; Perez-Garcia A, 2013, BLOOD, V122, P2425, DOI 10.1182/blood-2013-05-500850; Qian XZ, 2001, MOL CELL BIOL, V21, P1613, DOI 10.1128/MCB.21.5.1613-1620.2001; Roberts KG, 2012, CANCER CELL, V22, P153, DOI 10.1016/j.ccr.2012.06.005; Rudd C E, 2001, Sci STKE, V2001, ppe1; Seita J, 2007, P NATL ACAD SCI USA, V104, P2349, DOI 10.1073/pnas.0606238104; Simon C, 2008, BLOOD, V112, P1039, DOI 10.1182/blood-2008-05-154849; Takaki S, 2002, J EXP MED, V195, P151, DOI 10.1084/jem.20011170; Tan TZ, 2013, EMBO MOL MED, V5, P1051, DOI 10.1002/emmm.201201823; Tong W, 2005, BLOOD, V105, P4604, DOI 10.1182/blood-2004-10-4093; Tong W, 2004, J EXP MED, V200, P569, DOI 10.1084/jem.20040762; Velazquez L, 2002, J EXP MED, V195, P1599, DOI 10.1084/jem.20011883; Werz C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000596; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yoshida K, 2013, NAT GENET, V45, P1293, DOI 10.1038/ng.2759; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	47	16	18	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 12	2015	34	11					1463	1474		10.1038/onc.2014.34	http://dx.doi.org/10.1038/onc.2014.34			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CD1AR	24704825	Green Submitted, Green Accepted			2022-12-25	WOS:000350806500012
J	Hoffmann, AK; Naj, XN; Linder, S				Hoffmann, Ann-Kathrin; Naj, Xenia; Linder, Stefan			Daam1 is a regulator of filopodia formation and phagocytic uptake of Borrelia burgdorferi by primary human macrophages	FASEB JOURNAL			English	Article						formins; actin cytoskeleton; cell protrusion; coiling pseudopod	COILING PHAGOCYTOSIS; FORMIN DAAM1; MAMMALIAN FORMINS; HUMAN MONOCYTES; ARP2/3 COMPLEX; ACTIN DYNAMICS; LYME CARDITIS; HOST-DEFENSE; ACTIVATION; MECHANISM	Borrelia burgdorferi is the causative agent of Lyme disease, an infectious disease that primarily affects the skin, nervous system, and joints. Uptake of borreliae by immune cells is decisive for the course of the infection, and remodelling of the host actin cytoskeleton is crucial in this process. In this study, we showed that the actin-regulatory formin Daam1 is important in Borrelia phagocytosis by primary human macrophages. Uptake of borreliae proceeds preferentially through capture by filopodia and formation of coiling pseudopods that enwrap the spirochetes. Using immunofluorescence, we localized endogenous and overexpressed Daam1 to filopodia and to F-actin-rich uptake structures. Live-cell imaging further showed that Daam1 is enriched at coiling pseudopods that arise from the macrophage surface. This filopodia-independent step was corroborated by control experiments of phagocytic cup formation with latex beads. Moreover, siRNA-mediated knockdown of Daam1 led to a 65% reduction of borreliae-induced filopodia, and, as shown by the outside-inside staining technique, to a 50% decrease in phagocytic uptake of borreliae, as well as a 37% reduction in coiling pseudopod formation. Collectively, we showed that Daam1 plays a dual role in the phagocytic uptake of borreliae: first, as a regulator of filopodia, which are used for capturing spirochetes, and second, in the formation of the coiling pseudopod that enwraps the bacterial cell. These data identify Daam1 as a novel regulator of B. burgdorferi phagocytosis. At the same time, this is the first demonstration of a role for Daam1 in phagocytic processes in general.	[Hoffmann, Ann-Kathrin; Naj, Xenia; Linder, Stefan] Univ Med Ctr Eppendorf, Inst Med Microbiol Virol & Hyg, D-20246 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Linder, S (corresponding author), Univ Med Ctr Eppendorf, Inst Med Microbiol Virol & Hyg, Martinistr 52, D-20246 Hamburg, Germany.	s.linder@uke.de			Deutsche Forschungsgemeinschaft [GRK1459, SPP1464, LI 925/2-2]; Wilhelm Sander-Stiftung [2012.26.1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wilhelm Sander-Stiftung	The authors thank Frank Bentzien [Transfusion Medicine, Universitatsklinikum Eppendorf (UKE), Hamburg, Germany] for the buffy coats, Peter Kraiczy for the B. burgdorferi B31 WT strain, Klemens Rottner (University of Bonn, Bonn, Germany) for GFP-Daam1 and GFP-Daam1 Delta C50, Danijela Vignjevic (Institut Curie, Paris, France) for mCherry-fascin and the fascin antibody, Mirko Himmel for help and discussions, Bernd Zobiak and Virgilio Failla (UKE Microscopy Facility) for expert technical help, and Martin Aepfelbacher for constant support. Work in the S. L. laboratory is funded by Deutsche Forschungsgemeinschaft (GRK1459, SPP1464, and LI 925/2-2) and Wilhelm Sander-Stiftung (2012.26.1).	Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Aspenstrom P, 2006, EXP CELL RES, V312, P2180, DOI 10.1016/j.yexcr.2006.03.013; Berende A, 2010, EUR CYTOKINE NETW, V21, P7, DOI 10.1684/ecn.2009.0179; Biesiada Grazyna, 2010, Przegl Lek, V67, P181; Bornschlogl T, 2013, P NATL ACAD SCI USA, V110, P18928, DOI 10.1073/pnas.1316572110; Bornschlogl T, 2013, CYTOSKELETON, V70, P590, DOI 10.1002/cm.21130; Cervantes JL, 2011, P NATL ACAD SCI USA, V108, P3683, DOI 10.1073/pnas.1013776108; Charon NW, 2012, ANNU REV MICROBIOL, V66, P349, DOI 10.1146/annurev-micro-092611-150145; Cinco M, 1998, WIEN KLIN WOCHENSCHR, V110, P866; Cruz AR, 2008, INFECT IMMUN, V76, P56, DOI 10.1128/IAI.01039-07; Dames SA, 2011, BIOMOL NMR ASSIGN, V5, P47, DOI 10.1007/s12104-010-9264-3; Esue O, 2008, J MOL BIOL, V384, P324, DOI 10.1016/j.jmb.2008.09.043; Faix J, 2009, INT J BIOCHEM CELL B, V41, P1656, DOI 10.1016/j.biocel.2009.02.012; Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200; Harris ES, 2010, CYTOSKELETON, V67, P755, DOI 10.1002/cm.20485; Harris ES, 2004, CURR BIOL, V14, pR520, DOI 10.1016/j.cub.2004.06.043; Hawley KL, 2012, P NATL ACAD SCI USA, V109, P1228, DOI 10.1073/pnas.1112078109; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; HORWITZ MA, 1984, CELL, V36, P27, DOI 10.1016/0092-8674(84)90070-9; Hovius JWR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000447; Jaiswal R, 2013, CURR BIOL, V23, P1373, DOI 10.1016/j.cub.2013.06.013; Jaumouille V, 2011, CURR OPIN CELL BIOL, V23, P22, DOI 10.1016/j.ceb.2010.10.006; Ju R, 2010, P NATL ACAD SCI USA, V107, P6906, DOI 10.1073/pnas.1001075107; Kida YS, 2007, P NATL ACAD SCI USA, V104, P6708, DOI 10.1073/pnas.0608946104; KOERTEN HK, 1980, EXP CELL RES, V128, P470, DOI 10.1016/0014-4827(80)90084-1; Koval M, 1998, EXP CELL RES, V242, P265, DOI 10.1006/excr.1998.4110; Kress H, 2007, P NATL ACAD SCI USA, V104, P11633, DOI 10.1073/pnas.0702449104; Lee JY, 2011, J PHYS CHEM B, V115, P186, DOI 10.1021/jp108249g; Li DQ, 2011, DEVELOPMENT, V138, P303, DOI 10.1242/dev.055566; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Linder S, 2001, INFECT IMMUN, V69, P1739, DOI 10.1128/IAI.69.3.1739-1746.2001; Liu W, 2008, P NATL ACAD SCI USA, V105, P210, DOI 10.1073/pnas.0707277105; Margos G, 2011, INFECT GENET EVOL, V11, P1545, DOI 10.1016/j.meegid.2011.07.022; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Matusek T, 2008, J NEUROSCI, V28, P13310, DOI 10.1523/JNEUROSCI.2727-08.2008; Miller RK, 2011, J AM SOC NEPHROL, V22, P1654, DOI 10.1681/ASN.2010101086; Montgomery RR, 2007, INFECT IMMUN, V75, P613, DOI 10.1128/IAI.00685-06; Moriarty TJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000090; Naj X, 2013, INFECT IMMUN, V81, P1683, DOI 10.1128/IAI.01411-12; Olson CM, 2009, J IMMUNOL, V182, P3728, DOI 10.4049/jimmunol.0804111; Rittig MG, 1998, INFECT IMMUN, V66, P627, DOI 10.1128/IAI.66.2.627-635.1998; RITTIG MG, 1992, INFECT IMMUN, V60, P4205, DOI 10.1128/IAI.60.10.4205-4212.1992; Salazar JC, 2003, J IMMUNOL, V171, P2660, DOI 10.4049/jimmunol.171.5.2660; Salazar JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000444; Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014; Schoumacher M, 2010, J CELL BIOL, V189, P541, DOI 10.1083/jcb.200909113; Seth A, 2006, J CELL BIOL, V174, P701, DOI 10.1083/jcb.200605006; Shin OS, 2009, J IMMUNOL, V183, P491, DOI 10.4049/jimmunol.0900724; Suhonen J, 1998, INFECT IMMUN, V66, P3433, DOI 10.1128/IAI.66.7.3433-3435.1998; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Vonna L, 2007, EUR BIOPHYS J BIOPHY, V36, P145, DOI 10.1007/s00249-006-0118-y; Wang GQ, 2004, FEMS MICROBIOL LETT, V231, P219, DOI 10.1016/S0378-1097(03)00960-1; Wiedemann A, 2001, CELL MICROBIOL, V3, P693, DOI 10.1046/j.1462-5822.2001.00149.x; Wu J, 2011, INFECT IMMUN, V79, P1338, DOI 10.1128/IAI.01188-10; Zhu J, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.031914; Zhu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037823	58	26	26	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					3075	3089		10.1096/fj.13-247049	http://dx.doi.org/10.1096/fj.13-247049			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24696301				2022-12-25	WOS:000337949400029
J	Guerra, ML; Wauson, EM; McGlynn, K; Cobb, MH				Guerra, Marcy L.; Wauson, Eric M.; McGlynn, Kathleen; Cobb, Melanie H.			Muscarinic Control of MIN6 Pancreatic beta Cells Is Enhanced by Impaired Amino Acid Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium; Diabetes; ERK; G Protein-coupled Receptors (GPCR); mTOR Complex (mTORC)	OPERATED CA2+ ENTRY; ACETYLCHOLINE-RECEPTORS; REGULATED KINASES; INSULIN-RELEASE; TRPC6 CHANNELS; ACTIVATION; TRANSCRIPTION; GLUCOSE; PRESERVATION; HOMEOSTASIS	Background: Depletion of the GPCR T1R1/T1R3 increased calcium and ERK1/2 signaling by carbachol. Results: T1R3 depletion or reducing amino acids overnight increased M3 muscarinic receptor expression and altered calcium responses. Conclusion: M3 receptor expression in cells is up-regulated by reduced amino acid availability. Significance: The M3 muscarinic receptor is a potential therapeutic target in cells with impaired amino acid sensitivity. We have shown recently that the class C G protein-coupled receptor T1R1/T1R3 taste receptor complex is an early amino acid sensor in MIN6 pancreatic cells. Amino acids are unable to activate ERK1/2 in cells in which T1R3 has been depleted. The muscarinic receptor agonist carbachol activated ERK1/2 better in T1R3-depleted cells than in control cells. Ligands that activate certain G protein-coupled receptors in pancreatic cells potentiate glucose-stimulated insulin secretion. Among these is the M3 muscarinic acetylcholine receptor, the major muscarinic receptor in cells. We found that expression of M3 receptors increased in T1R3-depleted MIN6 cells and that calcium responses were altered. To determine whether these changes were related to impaired amino acid signaling, we compared responses in cells exposed to reduced amino acid concentrations. M3 receptor expression was increased, and some, but not all, changes in calcium signaling were mimicked. These findings suggest that M3 acetylcholine receptors are increased in cells as a mechanism to compensate for amino acid deficiency.	[Guerra, Marcy L.; Wauson, Eric M.; McGlynn, Kathleen; Cobb, Melanie H.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Cobb, MH (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	Melanie.Cobb@UTSouthwestern.edu		Cobb, Melanie/0000-0003-0833-5473	National Institutes of Health [DK55310]; Robert A. Welch Foundation [I1243]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055310] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK55310. This work was also supported by Robert A. Welch Foundation Grant I1243.; Supported by a mentor-based postdoctoral fellowship from the American Diabetes Association during the initial part of this study.	Ahren B, 2000, DIABETOLOGIA, V43, P393, DOI 10.1007/s001250051322; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Benes C, 1999, BIOCHEM J, V340, P219, DOI 10.1042/0264-6021:3400219; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BONNER TI, 1989, TRENDS PHARMACOL SCI, P11; Boulay G, 2002, CELL CALCIUM, V32, P201, DOI 10.1016/S0143416002001550; BOULTON TG, 1991, CELL REGUL, V2, P357, DOI 10.1091/mbc.2.5.357; Cayouette S, 2004, J BIOL CHEM, V279, P7241, DOI 10.1074/jbc.M312042200; Conklin BR, 2008, NAT METHODS, V5, P673, DOI 10.1038/nmeth.1232; de Azua IR, 2010, P NATL ACAD SCI USA, V107, P7999, DOI 10.1073/pnas.1003655107; de Koning EJP, 2008, TRENDS PHARMACOL SCI, V29, P218, DOI 10.1016/j.tips.2008.02.001; Duttaroy A, 2004, DIABETES, V53, P1714, DOI 10.2337/diabetes.53.7.1714; Estacion M, 2004, J BIOL CHEM, V279, P22047, DOI 10.1074/jbc.M402320200; Gautam D, 2006, CELL METAB, V3, P449, DOI 10.1016/j.cmet.2006.04.009; Gautam D, 2010, ENDOCRINOLOGY, V151, P5185, DOI 10.1210/en.2010-0519; Guettier JM, 2009, P NATL ACAD SCI USA, V106, P19197, DOI 10.1073/pnas.0906593106; Guo Y, 2006, DIABETES, V55, P3625, DOI 10.2337/db06-0379; GYLFE E, 1991, PFLUG ARCH EUR J PHY, V419, P639, DOI 10.1007/BF00370308; Hofmann T, 2000, J MOL MED, V78, P14, DOI 10.1007/s001090050378; Iismaa TP, 2000, DIABETES, V49, P392, DOI 10.2337/diabetes.49.3.392; Jain S, 2013, J CLIN INVEST, V123, P1750, DOI 10.1172/JCI66432; Khoo S, 2003, J BIOL CHEM, V278, P32969, DOI 10.1074/jbc.M301198200; Lawrence MC, 2005, J BIOL CHEM, V280, P26751, DOI 10.1074/jbc.M503158200; Lawrence MC, 2008, P NATL ACAD SCI USA, V105, P13315, DOI 10.1073/pnas.0806465105; Liu YJ, 1997, CELL CALCIUM, V22, P277, DOI 10.1016/S0143-4160(97)90066-X; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Missiaen L, 2001, CELL CALCIUM, V29, P111, DOI 10.1054/ceca.2000.0163; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sassmann A, 2010, J CLIN INVEST, V120, P2184, DOI 10.1172/JCI41541; Selway JL, 2012, ACTA DIABETOL, V49, P277, DOI 10.1007/s00592-011-0314-9; Wajchenberg BL, 2007, ENDOCR REV, V28, P187, DOI 10.1210/er.2006-0038; Wauson EM, 2012, MOL CELL, V47, P851, DOI 10.1016/j.molcel.2012.08.001; Wess J, 1996, CRIT REV NEUROBIOL, V10, P69, DOI 10.1615/CritRevNeurobiol.v10.i1.40; Zawalich WS, 2004, BIOCHEM BIOPH RES CO, V315, P872, DOI 10.1016/j.bbrc.2004.01.139; Zhang L, 2006, J BIOCHEM, V139, P459, DOI 10.1093/jb/mvj065	36	7	7	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14370	14379		10.1074/jbc.M114.565069	http://dx.doi.org/10.1074/jbc.M114.565069			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24695728	Green Published, hybrid			2022-12-25	WOS:000335984600062
J	Shibafuji, Y; Nakamura, A; Uchihashi, T; Sugimoto, N; Fukuda, S; Watanabe, H; Samejima, M; Ando, T; Noji, H; Koivula, A; Igarashi, K; Iino, R				Shibafuji, Yusuke; Nakamura, Akihiko; Uchihashi, Takayuki; Sugimoto, Naohisa; Fukuda, Shingo; Watanabe, Hiroki; Samejima, Masahiro; Ando, Toshio; Noji, Hiroyuki; Koivula, Anu; Igarashi, Kiyohiko; Iino, Ryota			Single-molecule Imaging Analysis of Elementary Reaction Steps of Trichoderma reesei Cellobiohydrolase I ( Cel7A) Hydrolyzing Crystalline Cellulose I (alpha) and III (I)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biofuel; Cellulase; Enzyme Kinetics; Molecular Motors; Single-molecule Biophysics; Cellobiohydrolase; Cellulose; High Speed Atomic Force Microscopy; Single-molecule Fluorescence Imaging	NEUTRON FIBER DIFFRACTION; SYNCHROTRON X-RAY; BIOMASS RECALCITRANCE; KRAFT PULP; PROCESSIVITY; SUBSTRATE; BINDING; SURFACE; MICROSCOPY; F-1-ATPASE	Background: The catalytic mechanism of Trichoderma reesei cellobiohydrolase I (TrCel7A) is still unclear. Results:TrCel7A exhibited similar reaction kinetics during crystalline cellulose I and IIII hydrolysis. Conclusion: Not differences in kinetic parameters but surface properties of the crystalline cellulose influence the susceptibilities of cellulose I and IIII to hydrolysis by TrCel7A. Significance: Single-molecule measurements further our understanding of TrCel7A mechanism. Trichoderma reesei cellobiohydrolase I (TrCel7A) is a molecular motor that directly hydrolyzes crystalline celluloses into water-soluble cellobioses. It has recently drawn attention as a tool that could be used to convert cellulosic materials into biofuel. However, detailed mechanisms of action, including elementary reaction steps such as binding, processive hydrolysis, and dissociation, have not been thoroughly explored because of the inherent challenges associated with monitoring reactions occurring at the solid/liquid interface. The crystalline cellulose I and IIII were previously reported as substrates with different crystalline forms and different susceptibilities to hydrolysis by TrCel7A. In this study, we observed that different susceptibilities of cellulose I and IIII are highly dependent on enzyme concentration, and at nanomolar enzyme concentration, TrCel7A shows similar rates of hydrolysis against cellulose I and IIII. Using single-molecule fluorescence microscopy and high speed atomic force microscopy, we also determined kinetic constants of the elementary reaction steps for TrCel7A against cellulose I and IIII. These measurements were performed at picomolar enzyme concentration in which density of TrCel7A on crystalline cellulose was very low. Under this condition, TrCel7A displayed similar binding and dissociation rate constants for cellulose I and IIII and similar fractions of productive binding on cellulose I and IIII. Furthermore, once productively bound, TrCel7A processively hydrolyzes and moves along cellulose I and IIII with similar translational rates. With structural models of cellulose I and IIII, we propose that different susceptibilities at high TrCel7A concentration arise from surface properties of substrate, including ratio of hydrophobic surface and number of available lanes.	[Shibafuji, Yusuke; Noji, Hiroyuki; Iino, Ryota] Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan; [Nakamura, Akihiko; Sugimoto, Naohisa; Samejima, Masahiro; Igarashi, Kiyohiko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Tokyo 1138657, Japan; [Uchihashi, Takayuki; Fukuda, Shingo; Watanabe, Hiroki; Ando, Toshio] Kanazawa Univ, Coll Sci & Engn, Dept Phys, Kanazawa, Ishikawa 9201192, Japan; [Uchihashi, Takayuki; Ando, Toshio] Kanazawa Univ, Coll Sci & Engn, BioAFM Frontier Res Ctr, Kanazawa, Ishikawa 9201192, Japan; [Koivula, Anu] VTT Tech Res Ctr Finland, FI-02044 Espoo, Finland	University of Tokyo; University of Tokyo; Kanazawa University; Kanazawa University; VTT Technical Research Center Finland	Iino, R (corresponding author), Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan.	iino@appchem.t.u-tokyo.ac.jp	Igarashi, Kiyohiko/E-6799-2016; Iino, Ryota/B-7746-2011; Uchihashi, Takayuki/D-5209-2011; ANDO, Toshio/E-7054-2015; Nakamura, Akihiko/U-1988-2019	Igarashi, Kiyohiko/0000-0001-5152-7177; Iino, Ryota/0000-0003-0110-5704; Uchihashi, Takayuki/0000-0002-0263-5312; ANDO, Toshio/0000-0001-8819-154X; Nakamura, Akihiko/0000-0003-0409-5759; Fukuda, Shingo/0000-0002-0723-2088; Koivula, Anu/0000-0002-7600-5700	Ministry of Education, Culture, Sports, Science, and Technology, Japan [24370062, 24114001, 24114008, 24380089, 23115008, 24241048]; Grants-in-Aid for Scientific Research [24114008] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research 24370062 (to R. I.), 24114001, 24114008, and 24380089 (to K. I.), and 23115008 and 24241048 (to T. U.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Ando T, 2013, ANNU REV BIOPHYS, V42, P393, DOI 10.1146/annurev-biophys-083012-130324; Beckham GT, 2011, J PHYS CHEM B, V115, P4118, DOI 10.1021/jp1106394; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Chundawat SPS, 2011, J AM CHEM SOC, V133, P11163, DOI 10.1021/ja2011115; Cruys-Bagger N, 2013, BIOCHEMISTRY-US, V52, P8938, DOI 10.1021/bi401210n; DIVNE C, 1993, J MOL BIOL, V234, P905, DOI 10.1006/jmbi.1993.1640; Fox JM, 2012, BIOCHEMISTRY-US, V51, P442, DOI 10.1021/bi2011543; Fukuda S, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4813280; Gao DH, 2013, P NATL ACAD SCI USA, V110, P10922, DOI 10.1073/pnas.1213426110; Greenleaf WJ, 2007, ANNU REV BIOPH BIOM, V36, P171, DOI 10.1146/annurev.biophys.36.101106.101451; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Igarashi K, 2007, FEBS J, V274, P1785, DOI 10.1111/j.1742-4658.2007.05727.x; Igarashi K, 2006, FEBS J, V273, P2869, DOI 10.1111/j.1742-4658.2006.05299.x; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Jalak J, 2012, J BIOL CHEM, V287, P28802, DOI 10.1074/jbc.M112.381624; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; KREMER SM, 1992, EUR J BIOCHEM, V205, P133, DOI 10.1111/j.1432-1033.1992.tb16760.x; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Minagawa Y, 2013, J BIOL CHEM, V288, P32700, DOI 10.1074/jbc.M113.506329; Nakamura A, 2014, J AM CHEM SOC, V136, P4584, DOI 10.1021/ja4119994; Nishiyama Y, 2003, J AM CHEM SOC, V125, P14300, DOI 10.1021/ja037055w; Nishizaka T, 2011, METHODS MOL BIOL, V778, P259, DOI 10.1007/978-1-61779-261-8_17; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Payne CM, 2013, J AM CHEM SOC, V135, P18831, DOI 10.1021/ja407287f; REINIKAINEN T, 1995, PROTEINS, V22, P392, DOI 10.1002/prot.340220409; SRISODSUK M, 1993, J BIOL CHEM, V268, P20756; Tenkanen M, 1997, J BIOTECHNOL, V57, P191, DOI 10.1016/S0168-1656(97)00099-0; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; Uchihashi T, 2011, SCIENCE, V333, P755, DOI 10.1126/science.1205510; Ueno H, 2010, BIOPHYS J, V98, P2014, DOI 10.1016/j.bpj.2010.01.011; Wada M, 2004, MACROMOLECULES, V37, P8548, DOI 10.1021/ma0485585; Wada M, 2006, MACROMOLECULES, V39, P2947, DOI 10.1021/ma060228s; Wada M, 2001, MACROMOLECULES, V34, P1237, DOI 10.1021/ma001406z; Wada M, 2001, J WOOD SCI, V47, P124, DOI 10.1007/BF00780560; Wilson DB, 2012, APPL MICROBIOL BIOT, V93, P497, DOI 10.1007/s00253-011-3701-9; Wilson DB, 2009, CURR OPIN BIOTECH, V20, P295, DOI 10.1016/j.copbio.2009.05.007; Yanagisawa M, 2005, CELLULOSE, V12, P151, DOI 10.1007/s10570-004-0866-8	40	38	40	1	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14056	14065		10.1074/jbc.M113.546085	http://dx.doi.org/10.1074/jbc.M113.546085			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24692563	Green Published, hybrid			2022-12-25	WOS:000335984600035
J	Wu, Z; Zhou, Q; Duan, HY; Wang, XR; Xiao, JH; Duan, HC; Li, NY; Li, CY; Wan, PX; Liu, Y; Song, YY; Zhou, CJ; Huang, ZQ; Wang, ZC				Wu, Zheng; Zhou, Qiang; Duan, Haoyun; Wang, Xiaoran; Xiao, Jianhui; Duan, Hucheng; Li, Naiyang; Li, Chaoyang; Wan, Pengxia; Liu, Ying; Song, Yiyue; Zhou, Chenjing; Huang, Zheqian; Wang, Zhichong			Reconstruction of Auto-Tissue-Engineered Lamellar Cornea by Dynamic Culture for Transplantation: A Rabbit Model	PLOS ONE			English	Article							LIMBAL EPITHELIAL-CELLS; OCULAR SURFACE; REGENERATIVE MEDICINE; STROMA; SCAFFOLD; MATRIX; COLLAGEN; SHEETS; GEL; DIFFERENTIATION	To construct an auto-tissue-engineered lamellar cornea (ATELC) for transplantation, based on acellular porcine corneal stroma and autologous corneal limbal explants, a dynamic culture process, which composed of a submersion culture, a perfusion culture and a dynamic air-liquid interface culture, was performed using appropriate parameters. The results showed that the ATELC-Dynamic possessed histological structure and DNA content that were similar to native lamellar cornea (NLC, p>0.05). Compared to NLC, the protein contents of zonula occludens-1, desmocollin-2 and integrin beta 4 in ATELC-Dynamic reached 93%, 89% and 73%, respectively. The basal cells of ATELC-Dynamic showed a better differentiation phenotype (K3(-), P63(+), ABCG2(+)) compared with that of ATELC in static air-lift culture (ATELC-Static, K3(+), P63(-), ABCG2(-)). Accordingly, the cell-cloning efficiency of ATELC-Dynamic (9.72 +/- 3.5%) was significantly higher than that of ATELC-Static (2.13 +/- 1.46%, p<0.05). The levels of trans-epithelial electrical resistance, light transmittance and areal modulus variation in ATELC-Dynamic all reached those of NLC (p>0.05). Rabbit lamellar keratoplasty showed that the barrier function of ATELC-Dynamic was intact, and there were no signs of epithelial shedding or neovascularization. Furthermore, the ATELC-Dynamic group had similar optical properties and wound healing processes compared with the NLC group. Thus, the sequential dynamic culture process that was designed according to corneal physiological characteristics could successfully reconstruct an auto-lamellar cornea with favorable morphological characteristics and satisfactory physiological function.	[Wu, Zheng; Zhou, Qiang; Duan, Haoyun; Wang, Xiaoran; Xiao, Jianhui; Duan, Hucheng; Li, Naiyang; Li, Chaoyang; Wan, Pengxia; Liu, Ying; Song, Yiyue; Zhou, Chenjing; Huang, Zheqian; Wang, Zhichong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Wang, ZC (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	wzc001@hotmail.com	Li, Chao/GSM-8117-2022; zhou, qiang/AAJ-7571-2020	Li, Chao/0000-0001-6110-6210; 	National High Technology Research and Development Program of China (863 Project) [2012AA020507]; National Natural Science Foundation of China [81270971, 31000445]; Guangdong Province & Ministry of Education Industry-University-Research Institute Collaboration Project of China [2011B090400353]; Fundamental Research Funds of State Key Laboratory of Ophthalmology [2012PI05, 2010Q02]	National High Technology Research and Development Program of China (863 Project)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province & Ministry of Education Industry-University-Research Institute Collaboration Project of China; Fundamental Research Funds of State Key Laboratory of Ophthalmology	This work was supported by grant No. 2012AA020507 (Z. Wang) from the National High Technology Research and Development Program of China (863 Project), grant No. 81270971 (Z. Wang) from the National Natural Science Foundation of China, grant No. 2011B090400353 (Z. Wang) from Guangdong Province & Ministry of Education Industry-University-Research Institute Collaboration Project of China, grant No. 31000445 (Z. Wu) from the National Natural Science Foundation of China, grant No. 2012PI05 (Z. Wang) and No. 2010Q02 (Z. Wu) from the Fundamental Research Funds of State Key Laboratory of Ophthalmology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cattan V, 2011, EUR UROL, V60, P1291, DOI 10.1016/j.eururo.2011.05.051; Chen B, 2010, TISSUE ENG PT A, V16, P2721, DOI 10.1089/ten.tea.2009.0711; Das S, 2007, CORNEA, V26, P526, DOI 10.1097/ICO.0b013e318038d2e8; Deng C, 2010, ACTA BIOMATER, V6, P187, DOI 10.1016/j.actbio.2009.07.027; Dua HS, 2010, CLIN EXP OPHTHALMOL, V38, P104, DOI 10.1111/j.1442-9071.2010.02229.x; Fagerholm P, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001022; Gonzalez-Andrades M, 2009, J TISSUE ENG REGEN M, V3, P442, DOI 10.1002/term.178; Griffith M, 1999, SCIENCE, V286, P2169, DOI 10.1126/science.286.5447.2169; Griffith M, 2009, EYE, V23, P1985, DOI 10.1038/eye.2008.409; Han ES, 2007, GRAEF ARCH CLIN EXP, V245, P745, DOI 10.1007/s00417-006-0453-9; Hashimoto Y, 2010, BIOMATERIALS, V31, P3941, DOI 10.1016/j.biomaterials.2010.01.122; Hayashi R, 2010, TISSUE ENG PART C-ME, V16, P553, DOI [10.1089/ten.tec.2009.0277, 10.1089/ten.TEC.2009.0277]; Huang MH, 2011, BIOMATERIALS, V32, P7812, DOI 10.1016/j.biomaterials.2011.07.012; Jayasuriya AC, 2003, BIOSENS BIOELECTRON, V18, P381, DOI 10.1016/S0956-5663(02)00144-6; Ke QC, 2011, J TISSUE ENG REGEN M, V5, P138, DOI 10.1002/term.298; Lin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049571; Liu JB, 2007, EXP EYE RES, V84, P599, DOI 10.1016/j.exer.2006.11.014; Liu JB, 2012, INVEST OPHTH VIS SCI, V53, P4130, DOI 10.1167/iovs.12-9876; Liu Y, 2010, TISSUE ENG PART C-ME, V16, P793, DOI [10.1089/ten.tec.2009.0380, 10.1089/ten.TEC.2009.0380]; Liu Z, 2012, BIOMATERIALS, V33, P7336, DOI 10.1016/j.biomaterials.2012.06.080; Macri L, 2007, ADV DRUG DELIVER REV, V59, P1366, DOI 10.1016/j.addr.2007.08.015; Meek KM, 2003, EYE, V17, P927, DOI 10.1038/sj.eye.6700574; Meek KM, 2003, BIOPHYS J, V85, P2205, DOI 10.1016/S0006-3495(03)74646-3; Mi SL, 2010, TISSUE ENG PT A, V16, P2091, DOI 10.1089/ten.TEA.2009.0748; Mi SL, 2010, J BIOMED MATER RES A, V95A, P447, DOI 10.1002/jbm.a.32861; MINAMI Y, 1993, INVEST OPHTH VIS SCI, V34, P2316; Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Pang KP, 2010, BIOMATERIALS, V31, P7257, DOI 10.1016/j.biomaterials.2010.05.066; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Shafiq MA, 2012, TISSUE ENG PART C-ME, V18, P340, DOI [10.1089/ten.tec.2011.0072, 10.1089/ten.TEC.2011.0072]; Sitalakshmi G, 2009, TISSUE ENG PT A, V15, P407, DOI 10.1089/ten.tea.2008.0041; Song JJ, 2011, TRENDS MOL MED, V17, P424, DOI 10.1016/j.molmed.2011.03.005; Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202; Tseng SCG, 1996, CURR EYE RES, V15, P973, DOI 10.3109/02713689609017643; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; Wu Z, 2009, BIOMATERIALS, V30, P3513, DOI 10.1016/j.biomaterials.2009.03.003; Xiao JH, 2011, BIOMATERIALS, V32, P6962, DOI 10.1016/j.biomaterials.2011.05.084; Zhang W, 2011, TISSUE ENG PART C-ME, V17, P569, DOI [10.1089/ten.TEC.2010.0529, 10.1089/ten.tec.2010.0529]; Zhu J, 2013, TISSUE ENG PT A, V19, P2412, DOI [10.1089/ten.tea.2013.0097, 10.1089/ten.TEA.2013.0097]	40	22	23	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93012	10.1371/journal.pone.0093012	http://dx.doi.org/10.1371/journal.pone.0093012			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705327	Green Published, Green Submitted, gold			2022-12-25	WOS:000334107500025
J	Ahn, JH; Yu, HK; Lee, HJ; Hong, SW; Kim, SJ; Kim, JS				Ahn, Jin-Hyung; Yu, Hyun-Kyung; Lee, Ho-Jeong; Hong, Soon Won; Kim, Sun Jin; Kim, Jang-Seong			Suppression of Colorectal Cancer Liver Metastasis by Apolipoprotein(a) Kringle V in a Nude Mouse Model through the Induction of Apoptosis in Tumor-Associated Endothelial Cells	PLOS ONE			English	Article							HUMAN PLASMINOGEN KRINGLE-5; HUMAN PROSTATE-CANCER; SURGICAL RESECTION; IN-VITRO; ANGIOGENESIS; THERAPY; GROWTH; CARCINOMA; MICE; ANGIOSTATIN	The formation of liver metastases in colorectal cancer patients is the primary cause of patient death. Current therapies directed at liver metastasis from colorectal cancer have had minimal impact on patient outcomes. Therefore, the development of alternative treatment strategies for liver metastasis is needed. In the present study, we demonstrated that recombinant human apolipoprotein(a) kringle V, also known as rhLK8, induced the apoptotic turnover of endothelial cells in vitro through the mitochondrial apoptosis pathway. The interaction of rhLK8 with glucose-regulated protein 78 (GRP78) may be involved in the induction of apoptosis because the inhibition of GRP78 by GRP78-specific antibodies or siRNA knockdown inhibited the rhLK8-mediated apoptosis of human umbilical vein endothelial cells in vitro. Next, to evaluate the effects of rhLK8 on angiogenesis and metastasis, an experimental model of liver metastasis was established by injecting a human colorectal cancer cell line, LS174T, into the spleens of BALB/c nude mice. The systemic administration of rhLK8 significantly suppressed liver metastasis from human colorectal cancer cells and improved host survival compared with controls. The combination of rhLK8 and 5-fluorouracil substantially increased these survival benefits compared with either therapy alone. Histological observation showed significant induction of apoptosis among tumor-associated endothelial cells in liver metastases from rhLK8-treated mice compared with control mice. Collectively, these results suggest that the combination of rhLK8 with conventional chemotherapy may be a promising approach for the treatment of patients with life-threatening colorectal cancer liver metastases.	[Ahn, Jin-Hyung; Yu, Hyun-Kyung; Lee, Ho-Jeong; Kim, Jang-Seong] Mogam Biotechnol Res Inst, Canc Biol Team, Yongin, South Korea; [Hong, Soon Won] Yonsei Univ, Gangnam Sevrance Hosp, Dept Pathol, Seoul 120749, South Korea; [Lee, Ho-Jeong; Kim, Sun Jin] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Kim, Jang-Seong] Korea Res Inst Biosci & Biotechnol, Res Ctr Integrat Cellul, Taejon, South Korea	Yonsei University; University of Texas System; UTMD Anderson Cancer Center; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kim, SJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA.	sunkim@mdanderson.org; jangskim@kribb.re.kr		Hong, SoonWon/0000-0002-0324-2414	Green Cross Corporation; Ministry for Health, Welfare and Family Affairs, Republic of Korea [A050905]; KRIBB Research Initiative Program; National Research Foundation of Korea; Ministry of Education, Science and Technology [2012R1A1A2007994]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Green Cross Corporation; Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); KRIBB Research Initiative Program; National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was financially supported by the Green Cross Corporation, a grant from the Korea Health 21 R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (A050905), a grant from the KRIBB Research Initiative Program, and by a Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2012R1A1A2007994). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao YH, 1997, J BIOL CHEM, V272, P22924, DOI 10.1074/jbc.272.36.22924; Cao Yihai, 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P667, DOI 10.2174/1568011023353705; Chambers AF, 2000, ADV CANCER RES, V79, P91, DOI 10.1016/S0065-230X(00)79003-8; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chavakis E, 2002, ARTERIOSCL THROM VAS, V22, P887, DOI 10.1161/01.ATV.0000017728.55907.A9; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Davidson DJ, 2005, CANCER RES, V65, P4663, DOI 10.1158/0008-5472.CAN-04-3426; Eberhard A, 2000, CANCER RES, V60, P1388; Fan JK, 2008, BIOCHEM BIOPH RES CO, V374, P198, DOI 10.1016/j.bbrc.2008.07.005; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; FIDLER IJ, 1982, SCIENCE, V217, P998, DOI 10.1126/science.7112116; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Gerber HP, 2005, CANCER RES, V65, P671; Gu XQ, 2011, APOPTOSIS, V16, P846, DOI 10.1007/s10495-011-0618-9; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; HOBSON B, 1984, BRIT J CANCER, V49, P405, DOI 10.1038/bjc.1984.66; Hofmeister V, 2008, CANCER IMMUNOL IMMUN, V57, P1, DOI 10.1007/s00262-007-0365-5; Huang GC, 2008, CANCER BIOTHER RADIO, V23, P661, DOI 10.1089/cbr.2008.0492; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Ji WDR, 1998, FASEB J, V12, P1731, DOI 10.1096/fasebj.12.15.1731; Jin GH, 2007, INT J CANCER, V121, P2539, DOI 10.1002/ijc.22708; Jung YD, 2000, CANCER METAST REV, V19, P147, DOI 10.1023/A:1026510130114; Kang KY, 2006, BIOSCI BIOTECH BIOCH, V70, P916, DOI 10.1271/bbb.70.916; Katsouras CS, 2001, J CARDIOVASC RISK, V8, P311, DOI 10.1097/00043798-200110000-00011; Kim JS, 2004, BIOCHEM BIOPH RES CO, V313, P534, DOI 10.1016/j.bbrc.2003.11.148; Kim JS, 2003, J BIOL CHEM, V278, P29000, DOI 10.1074/jbc.M301042200; Kim SJ, 2004, CANCER RES, V64, P4201, DOI 10.1158/0008-5472.CAN-03-3763; Lee HJ, 2012, NEOPLASIA, V14, P335, DOI 10.1593/neo.12380; Lee TH, 2006, J BIOTECHNOL, V126, P562, DOI 10.1016/j.jbiotec.2006.05.011; Li YH, 2008, CANCER BIOTHER RADIO, V23, P332, DOI 10.1089/cbr.2007.0437; Lorenz M, 2000, SEMIN ONCOL, V27, P112; Lucas R, 1998, BLOOD, V92, P4730; Ma J, 2008, MOL CANCER THER, V7, P3670, DOI 10.1158/1535-7163.MCT-08-0715; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; Midgley R, 1999, LANCET, V353, P391, DOI 10.1016/S0140-6736(98)07127-X; Mikhailov V, 2001, J BIOL CHEM, V276, P18361, DOI 10.1074/jbc.M100655200; Mow BMF, 2001, CURR OPIN ONCOL, V13, P453, DOI 10.1097/00001622-200111000-00007; Nguyen TMB, 2007, BLOOD, V109, P4793, DOI 10.1182/blood-2006-11-059352; OReilly MS, 1996, NAT MED, V2, P689, DOI 10.1038/nm0696-689; Perri SR, 2007, MOL CANCER THER, V6, P441, DOI 10.1158/1535-7163.MCT-06-0434; Perri SR, 2005, CANCER RES, V65, P8359, DOI 10.1158/0008-5472.CAN-05-0508; Pijpers AHJM, 2001, J AM SOC NEPHROL, V12, P767, DOI 10.1681/ASN.V124767; SCHEELE J, 1990, BRIT J SURG, V77, P1241, DOI 10.1002/bjs.1800771115; Schulter V, 2001, ARTERIOSCL THROM VAS, V21, P433, DOI 10.1161/01.ATV.21.3.433; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Takeda A, 2002, ANN SURG ONCOL, V9, P610, DOI 10.1245/aso.2002.9.7.610; Trieu VN, 1999, BIOCHEM BIOPH RES CO, V257, P714, DOI 10.1006/bbrc.1999.0519; Velde ET, 2005, BRIT J CANCER, V92, P729, DOI 10.1038/sj.bjc.6602385; Yang Y, 2006, CANCER BIOL THER, V5, P399	50	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93794	10.1371/journal.pone.0093794	http://dx.doi.org/10.1371/journal.pone.0093794			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699568	Green Published, Green Submitted, gold			2022-12-25	WOS:000334105000107
J	Cordova, C; Gutierrez, B; Martinez-Garcia, C; Martin, R; Gallego-Munoz, P; Hernandez, M; Nieto, ML				Cordova, Claudia; Gutierrez, Beatriz; Martinez-Garcia, Carmen; Martin, Ruben; Gallego-Munoz, Patricia; Hernandez, Marita; Nieto, Maria L.			Oleanolic Acid Controls Allergic and Inflammatory Responses in Experimental Allergic Conjunctivitis	PLOS ONE			English	Article							EPITHELIAL-CELLS; MURINE MODEL; MAST-CELLS; EXPRESSION; INTERLEUKIN-13; IL-13; HYPERSENSITIVITY; CHEMOATTRACTANT; DEGRANULATION; TRITERPENES	Pollen is the most common aeroallergen to cause seasonal conjunctivitis. The result of allergen exposure is a strong Th2-mediated response along with conjunctival mast cell degranulation and eosinophilic infiltration. Oleanolic acid (OA) is natural a triterpene that displays strong anti-inflammatory and immunomodulatory properties being an active anti-allergic molecule on hypersensitivity reaction models. However, its effect on inflammatory ocular disorders including conjunctivits, has not yet been addressed. Hence, using a Ragweed pollen (RWP)-specific allergic conjunctivitis (EAC) mouse model we study here whether OA could modify responses associated to allergic processes. We found that OA treatment restricted mast cell degranulation and infiltration of eosinophils in conjunctival tissue and decreased allergen-specific Igs levels in EAC mice. Th2-type cytokines, secreted phospholipase A(2) type-IIA (sPLA(2)-IIA), and chemokines levels were also significantly diminished in the conjunctiva and serum of OA-treated EAC mice. Moreover, OA treatment also suppressed RWP-specific T-cell proliferation. In vitro studies, on relevant cells of the allergic process, revealed that OA reduced the proliferative and migratory response, as well as the synthesis of proinflammatory mediators on EoL-1 eosinophils and RBL-2H3 mast cells exposed to allergic and/or crucial inflammatory stimuli such as RWP, sPLA(2)-IIA or eotaxin. Taken together, these findings demonstrate the beneficial activity of OA in ocular allergic processes and may provide a new intervention strategy and potential therapy for allergic diseases.	[Cordova, Claudia; Gutierrez, Beatriz; Hernandez, Marita; Nieto, Maria L.] Univ Valladolid, Consejo Super Invest Cient, Inst Biol & Genet Mol, Valladolid, Spain; [Martinez-Garcia, Carmen; Gallego-Munoz, Patricia] Univ Valladolid, Dept Biol Celular Histol & Farmacol, Valladolid, Spain; [Martin, Ruben] Hosp Clin Univ, Inst Ciencias Corazon, Valladolid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; Universidad de la Laguna	Nieto, ML (corresponding author), Univ Valladolid, Consejo Super Invest Cient, Inst Biol & Genet Mol, Valladolid, Spain.	mlnieto@ibgm.uva.es	Nieto, Maria L/G-7492-2015; Martinez, Carmen/G-7166-2017; hernández, marita/H-6122-2015; Muñoz, Patricia Gallego/AAB-6111-2019	Nieto, Maria L/0000-0001-6842-799X; Martinez, Carmen/0000-0002-9533-6169; hernández, marita/0000-0002-3999-5653; Muñoz, Patricia Gallego/0000-0002-1826-8123; Cordova Marcos, Claudia/0000-0002-2108-2629	Spanish MINECO [SAF2009-08407]; FPI Program from the Government of Castilla y Leon; FSE; Sara Borrell Program from the Spanish MINECO	Spanish MINECO(Spanish Government); FPI Program from the Government of Castilla y Leon; FSE(European Social Fund (ESF)); Sara Borrell Program from the Spanish MINECO	The study was supported by grants from the Spanish MINECO (reference SAF2009-08407). Patricia Gallego-Munoz and Claudia Cordova were funded by the FPI Program from the Government of Castilla y Leon (co-funded by FSE). Ruben Martin was supported by the Sara Borrell Program from the Spanish MINECO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho VV, 2002, GRAEF ARCH CLIN EXP, V240, P521, DOI 10.1007/s00417-002-0477-8; BARSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317, DOI 10.1002/eji.1830110410; Bielory L, 2003, CURR OPIN ALLERGY CL, V3, P395, DOI 10.1097/01.a11.0000092612.76804.18; Bundoc VG, 2007, EXP EYE RES, V85, P575, DOI 10.1016/j.exer.2007.07.005; Chen DM, 2009, EXP EYE RES, V88, P880, DOI 10.1016/j.exer.2008.11.035; Chung SH, 2012, MOL VIS, V18, P1966; Cipriani S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025637; Cota BB, 2013, RECENT PATENTS ENDOC, V7, P26, DOI 10.2174/1872214811307010026; Fukushima A, 2006, BIOCHEM BIOPH RES CO, V339, P1048, DOI 10.1016/j.bbrc.2005.11.114; Giner-Larza EM, 2001, EUR J PHARMACOL, V428, P137, DOI 10.1016/S0014-2999(01)01290-0; Gu NB, 2010, AM J PHYSIOL-LUNG C, V298, pL290, DOI 10.1152/ajplung.90612.2008; Hayat K, 2011, CURR EYE RES, V36, P591, DOI 10.3109/02713683.2011.573898; Hingorani M, 1998, J ALLERGY CLIN IMMUN, V102, P821, DOI 10.1016/S0091-6749(98)70023-5; Ingram JL, 2012, J ALLERGY CLIN IMMUN, V130, P829, DOI 10.1016/j.jaci.2012.06.034; Kim YH, 2012, ALLERGY, V67, P183, DOI 10.1111/j.1398-9995.2011.02735.x; Komai-Koma M, 2007, EUR J IMMUNOL, V37, P2779, DOI 10.1002/eji.200737547; Lee DKC, 2003, CLIN EXP ALLERGY, V33, P882, DOI 10.1046/j.1365-2222.2003.01705.x; Leonardi A, 2012, ALLERGY, V67, P1327, DOI 10.1111/all.12009; Li KJ, 2010, MOL VIS, V16, P2084; Lim EJ, 2011, J BIOL CHEM, V286, P13193, DOI 10.1074/jbc.M110.210724; Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2; Magone MT, 1998, CLIN IMMUNOL IMMUNOP, V87, P75, DOI 10.1006/clin.1997.4507; Mainardi T, 2009, J ALLERGY CLIN IMMUN, V123, P283, DOI 10.1016/j.jaci.2008.12.023; Mannon P, 2012, GUT, V61, P1765, DOI 10.1136/gutjnl-2012-303461; Martin R, 2012, BRIT J PHARMACOL, V166, P1708, DOI 10.1111/j.1476-5381.2012.01869.x; Martin R, 2010, BIOCHEM PHARMACOL, V79, P198, DOI 10.1016/j.bcp.2009.08.002; Matsuba-Kitamura S, 2010, INT IMMUNOL, V22, P479, DOI 10.1093/intimm/dxq035; Matsukura S, 2001, AM J RESP CELL MOL, V24, P755, DOI 10.1165/ajrcmb.24.6.4351; MAYUMI M, 1992, LEUKEMIA LYMPHOMA, V7, P243, DOI 10.3109/10428199209053629; Miyahara S, 2006, J ALLERGY CLIN IMMUN, V118, P1110, DOI 10.1016/j.jaci.2006.06.014; Mould AW, 1997, J CLIN INVEST, V99, P1064, DOI 10.1172/JCI119234; MURAKAMI M, 1993, J IMMUNOL, V151, P5675; Oh MH, 2011, J IMMUNOL, V186, P7232, DOI 10.4049/jimmunol.1100504; Pecaric-Petkovic T, 2009, BLOOD, V113, P1526, DOI 10.1182/blood-2008-05-157818; PRICE KR, 1987, CRC CR REV FOOD SCI, V26, P27, DOI 10.1080/10408398709527461; Rios JL, 2010, J ETHNOPHARMACOL, V128, P1, DOI 10.1016/j.jep.2009.12.045; Royer B, 2001, CLIN EXP ALLERGY, V31, P694, DOI 10.1046/j.1365-2222.2001.01069.x; SAITO H, 1985, BLOOD, V66, P1233; Sanchez MC, 2011, J INVEST ALLERG CLIN, V21, P1; Schempp CM, 2003, PHYTOMEDICINE, P1031; Somova LI, 2003, J ETHNOPHARMACOL, V84, P299, DOI 10.1016/S0378-8741(02)00332-X; Somova LO, 2003, PHYTOMEDICINE, V10, P115, DOI 10.1078/094471103321659807; Tominaga T, 2009, INVEST OPHTH VIS SCI, V50, P5181, DOI 10.1167/iovs.09-3637; Wei Y, 2011, INVEST OPHTH VIS SCI, V52, P4780, DOI 10.1167/iovs.10-6350; Zheng T, 2009, J INVEST DERMATOL, V129, P742, DOI 10.1038/jid.2008.295	45	32	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e91282	10.1371/journal.pone.0091282	http://dx.doi.org/10.1371/journal.pone.0091282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699261	Green Published, gold			2022-12-25	WOS:000334105000013
J	Haley, BJ; Choi, SY; Grim, CJ; Onifade, TJ; Cinar, HN; Tall, BD; Taviani, E; Hasan, NA; Abdullah, AH; Carter, L; Sahu, SN; Kothary, MH; Chen, A; Baker, R; Hutchinson, R; Blackmore, C; Cebula, TA; Huq, A; Colwell, RR				Haley, Bradd J.; Choi, Seon Young; Grim, Christopher J.; Onifade, Tiffiani J.; Cinar, Hediye N.; Tall, Ben D.; Taviani, Elisa; Hasan, Nur A.; Abdullah, AbdulShakur H.; Carter, Laurenda; Sahu, Surasri N.; Kothary, Mahendra H.; Chen, Arlene; Baker, Ron; Hutchinson, Richard; Blackmore, Carina; Cebula, Thomas A.; Huq, Anwar; Colwell, Rita R.			Genomic and Phenotypic Characterization of Vibrio cholerae Non-O1 Isolates from a US Gulf Coast Cholera Outbreak	PLOS ONE			English	Article							EL-TOR STRAINS; TOXIN-COREGULATED PILI; UNITED-STATES; CTX PROPHAGE; INFECTIONS; VIRULENCE; DIARRHEA; HEMAGGLUTININ/PROTEASE; VIBRIO-CHOLERAE-O1; EPIDEMIOLOGY	Between November 2010, and May 2011, eleven cases of cholera, unrelated to a concurrent outbreak on the island of Hispaniola, were recorded, and the causative agent, Vibrio cholerae serogroup O75, was traced to oysters harvested from Apalachicola Bay, Florida. From the 11 diagnosed cases, eight isolates of V. cholerae were isolated and their genomes were sequenced. Genomic analysis demonstrated the presence of a suite of mobile elements previously shown to be involved in the disease process of cholera (ctxAB, VPI-1 and -2, and a VSP-II like variant) and a phylogenomic analysis showed the isolates to be sister taxa to toxigenic V. cholerae V51 serogroup O141, a clinical strain isolated 23 years earlier. Toxigenic V. cholerae O75 has been repeatedly isolated from clinical cases in the southeastern United States and toxigenic V. cholerae O141 isolates have been isolated globally from clinical cases over several decades. Comparative genomics, phenotypic analyses, and a Caenorhabditis elegans model of infection for the isolates were conducted. This analysis coupled with isolation data of V. cholerae O75 and O141 suggests these strains may represent an underappreciated clade of cholera-causing strains responsible for significant disease burden globally.	[Haley, Bradd J.; Taviani, Elisa; Hasan, Nur A.; Chen, Arlene; Huq, Anwar; Colwell, Rita R.] Univ Maryland, Maryland Pathogen Res Inst, College Pk, MD 20742 USA; [Choi, Seon Young; Hasan, Nur A.; Abdullah, AbdulShakur H.; Cebula, Thomas A.; Colwell, Rita R.] CosmosID, College Pk, MD USA; [Grim, Christopher J.; Cinar, Hediye N.; Tall, Ben D.; Carter, Laurenda; Sahu, Surasri N.; Kothary, Mahendra H.] US FDA, CFSAN, DVA, Laurel, MD USA; [Onifade, Tiffiani J.; Hutchinson, Richard; Blackmore, Carina] Bur Environm Publ Hlth Med, Florida Dept Hlth, Tallahassee, FL USA; [Baker, Ron] Florida Dept Hlth Bur, Publ Hlth Labs, Jacksonville, FL USA; [Cebula, Thomas A.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Huq, Anwar] Univ Maryland, Sch Publ Hlth, Maryland Inst Appl Environm Hlth, College Pk, MD 20742 USA; [Colwell, Rita R.] Univ Maryland, Inst Adv Comp Studies, College Pk, MD 20742 USA; [Colwell, Rita R.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	University System of Maryland; University of Maryland College Park; US Food & Drug Administration (FDA); Florida Department of Health; Florida Department of Health; Johns Hopkins University; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Colwell, RR (corresponding author), Univ Maryland, Maryland Pathogen Res Inst, College Pk, MD 20742 USA.	rcolwell@umiacs.umd.edu	Taviani, Elisa/AAB-1000-2020; Haley, Bradd/AAB-9164-2020; hasan, nur a/AAX-3881-2021	Taviani, Elisa/0000-0002-1025-0439; Haley, Bradd/0000-0001-7996-1143; hasan, nur a/0000-0003-0175-8879; Tall, Ben/0000-0003-0399-3629; Colwell, Rita R./0000-0001-5432-1502	National Science Foundation [0813066]; National Institutes of Health [2RO1A1039129-11A2]; National Institutes of Health-Fogarty International Center [1RC1TW008587-01]; National Oceanic and Atmospheric Administration [SO660009]	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health-Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	This work was supported by a grant the National Science Foundation (www.nsf.gov), No. 0813066, National Institutes of Health (www.nih.gov) Grant 2RO1A1039129-11A2, National Institutes of Health-Fogarty International Center (http://www.fic.nih.gov) Challenge Grant 1RC1TW008587-01 and National Oceanic and Atmospheric Administration (www.noaa.gov) Grant No. SO660009. The funders provided salary and laboratory supplies only. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro-Moreno S, 2009, INFECT IMMUN, V77, P3807, DOI 10.1128/IAI.00279-09; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; BLAKE PA, 1980, NEW ENGL J MED, V302, P305, DOI 10.1056/NEJM198002073020601; Boucher Y, 2011, MBIO, V2, DOI 10.1128/mBio.00335-10; Chatterjee S, 2009, J CLIN MICROBIOL, V47, P1087, DOI 10.1128/JCM.02026-08; Choi SY, 2010, J MED MICROBIOL, V59, P302, DOI 10.1099/jmm.0.017053-0; Choi SY, 2011, ASM BIOD EM PATH RES; Chun J, 2009, P NATL ACAD SCI USA, V106, P15442, DOI 10.1073/pnas.0907787106; Cinar HN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011558; Crump JA, 2003, J INFECT DIS, V187, P866, DOI 10.1086/368330; Dalsgaard A, 2001, J CLIN MICROBIOL, V39, P4086, DOI 10.1128/JCM.39.11.4086-4092.2001; Dumontier S, 1998, FEMS MICROBIOL LETT, V164, P91, DOI 10.1016/S0378-1097(98)00201-8; Ghosh R, 2008, FEMS MICROBIOL LETT, V288, P196, DOI 10.1111/j.1574-6968.2008.01352.x; Haley BJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-154; HALL RH, 1990, INFECT IMMUN, V58, P3375, DOI 10.1128/IAI.58.10.3375-3379.1990; Halpern M, 2003, APPL ENVIRON MICROB, V69, P4200, DOI 10.1128/AEM.69.7.4200-4204.2003; Hasan NA, 2012, P NATL ACAD SCI USA, V109, pE2010, DOI 10.1073/pnas.1207359109; Hlady WG, 1996, J INFECT DIS, V173, P1176, DOI 10.1093/infdis/173.5.1176; Huq A, 2005, APPL ENVIRON MICROB, V71, P4645, DOI 10.1128/AEM.71.8.4645-4654.2005; Ko WC, 1998, CLIN INFECT DIS, V27, P774, DOI 10.1086/514947; Krukonis ES, 2003, CURR OPIN MICROBIOL, V6, P186, DOI 10.1016/S1369-5274(03)00032-8; Lang H, 1994, Infect Immun, V62, P4781; LIN FYC, 1986, J CLIN MICROBIOL, V23, P624, DOI 10.1128/JCM.23.3.624-626.1986; Lipp EK, 2002, CLIN MICROBIOL REV, V15, P757, DOI 10.1128/CMR.15.4.757-770.2002; Lukinmaa S, 2006, DIAGN MICR INFEC DIS, V54, P1, DOI 10.1016/j.diagmicrobio.2005.06.020; Manning SD, 2008, P NATL ACAD SCI USA, V105, P4868, DOI 10.1073/pnas.0710834105; Marin MA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002049; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; Michel-Briand Y, 2002, BIOCHIMIE, V84, P499, DOI 10.1016/S0300-9084(02)01422-0; Mohamed AA, 2012, EMERG INFECT DIS, V18, P925, DOI 10.3201/eid1806.111774; Morita M, 2013, MICROBIOL IMMUNOL, V57, P334, DOI 10.1111/1348-0421.12039; Murphy RA, 2008, J BACTERIOL, V190, P636, DOI 10.1128/JB.00562-07; Nair GB, 2006, J CLIN MICROBIOL, V44, P4211, DOI 10.1128/JCM.01304-06; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nusrin S, 2004, J CLIN MICROBIOL, V42, P5854, DOI 10.1128/JCM.42.12.5854-5856.2004; Octavia S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065342; Onifade TJM, 2011, EUROSURVEILLANCE, V16, P10; Reguera G, 2005, J BACTERIOL, V187, P3551, DOI 10.1128/JB.187.10.3551-3555.2005; Safa A, 2008, EMERG INFECT DIS, V14, P987, DOI 10.3201/eid1406.080129; SAFRIN S, 1988, REV INFECT DIS, V10, P1012; Shannon JD, 2006, J CLIN MICROBIOL, V44, P3459, DOI 10.1128/JCM.02343-05; Shapiro RL, 1998, J INFECT DIS, V178, P752, DOI 10.1086/515367; Shin OS, 2011, MBIO, V2, DOI 10.1128/mBio.00106-11; Shinoda S, 2011, INFECT DIS-SER, P245, DOI 10.1007/978-1-60327-265-0_14; Silva AJ, 2006, INFECT IMMUN, V74, P2072, DOI 10.1128/IAI.74.4.2072-2079.2006; Son MS, 2011, CURR PROTOC MICROBIO, V22; Sprando RL, 2009, FOOD CHEM TOXICOL, V47, P722, DOI 10.1016/j.fct.2009.01.007; Tacket CO, 1998, INFECT IMMUN, V66, P692, DOI 10.1128/IAI.66.2.692-695.1998; Tamplin ML, 2001, HUM ECOL RISK ASSESS, V7, P1437, DOI 10.1080/20018091095113; Taviani E, 2010, FEMS MICROBIOL LETT, V308, P130, DOI 10.1111/j.1574-6968.2010.02008.x; Tobin-D'Angelo M, 2008, CLIN INFECT DIS, V47, P1035, DOI 10.1086/591973; Udden SMN, 2008, P NATL ACAD SCI USA, V105, P11951, DOI 10.1073/pnas.0805560105; Vanden Broeck D, 2007, INT J BIOCHEM CELL B, V39, P1771, DOI 10.1016/j.biocel.2007.07.005; Vora GJ, 2005, P NATL ACAD SCI USA, V102, P19109, DOI 10.1073/pnas.0505033102; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Yamasaki S, 1999, GENE, V237, P321, DOI 10.1016/S0378-1119(99)00344-3	56	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e86264	10.1371/journal.pone.0086264	http://dx.doi.org/10.1371/journal.pone.0086264			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699521	gold, Green Submitted, Green Published			2022-12-25	WOS:000334105000001
J	Hu, XJ; Shang, MQ; Zhou, J; Ye, YX; Lu, XJ; Tao, CM; Ying, BW; Wang, LL				Hu, Xuejiao; Shang, Mengqiao; Zhou, Juan; Ye, Yuanxin; Lu, Xiaojun; Tao, Chuanmin; Ying, Binwu; Wang, Lanlan			Association of Genetic Variants in Wnt Signaling Pathway with Tuberculosis in Chinese Han Population	PLOS ONE			English	Article							BETA-CATENIN; CANCER; AXIN2; SUSCEPTIBILITY; MACROPHAGES; IMMUNITY; RISK; POLYMORPHISMS; ACTIVATION; SPECTRUM	Compelling studies have implicated that the Wnt signaling pathway plays an important role in the development and progression of tuberculosis, however, there is little literature addressing the role of polymorphisms in Wnt pathway on tuberculosis. We took a pathway based candidate gene approach to investigate the possible correlation between genetic variants in Wnt pathway and tuberculosis. Three single nucleotide polymorphisms (SNPs) in Wnt pathway (rs4135385 in CTNNB1 gene, rs7832767 in SFRP1 gene, and rs11079571 in AXIN2 gene) were genotyped in 422 Chinese Han tuberculosis patients and 402 frequency matched (age, gender, and ethnicity) controls using high-resolution melting analysis. The genotype and allelic frequencies of rs4135385 and rs7832767 were significantly different among patients and controls. The dominant model of rs4135385 was significantly associated with an increased risk of tuberculosis (AG/GG versus AA: OR = 1.49, 95% CI = 1.06-2.09, p = 0.019). The recessive model of rs7832767 posed a significant higher risk for tuberculosis (TT versus TC/CC, OR = 2.70, 95% CI = 1.41-5.18, p = 0.002). These SNPs were further evaluated whether they were correlated with the site of tuberculosis and the level of inflammatory markers. Rs7832767 was significantly associated with the level of CRP (p = 0.014), and the patients carrying T allele might present with elevated CRP values (OR = 1.90, 95% CI = 1.21-2.96, p = 0.005). Our study provided the first evidence that rs4135385 and rs7832767 were associated with tuberculosis risk, and genetic variants in Wnt signaling pathway might participate in genetic susceptibility to tuberculosis in Chinese Han population. Further epidemiological and functional studies in larger populations are warranted to verify our results.	[Hu, Xuejiao; Shang, Mengqiao; Zhou, Juan; Ye, Yuanxin; Lu, Xiaojun; Tao, Chuanmin; Ying, Binwu; Wang, Lanlan] Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu 610064, Sichuan Provinc, Peoples R China	Sichuan University	Ying, BW (corresponding author), Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu 610064, Sichuan Provinc, Peoples R China.	docbwy@126.com; huaxiwangll@gmail.com	Ying, Binwu/AAB-5934-2022	Ying, Binwu/0000-0001-8077-3908				Akiyama T, 2000, CYTOKINE GROWTH F R, V11, P273, DOI 10.1016/S1359-6101(00)00011-3; Alanazi MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059555; Ansari A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004778; Barandon L, 2011, ARTERIOSCL THROM VAS, V31, pE80, DOI 10.1161/ATVBAHA.111.232280; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Christman MA, 2008, AM J PHYSIOL-HEART C, V294, pH2864, DOI 10.1152/ajpheart.00982.2007; Davila S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000218; Dong X, 2001, CYTOGENET CELL GENET, V93, P26, DOI 10.1159/000056942; Feng WX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014652; Furuhashi Kazuki, 2012, Kekkaku, V87, P1; Gunes EG, 2009, MOL MED REP, V2, P1029, DOI 10.3892/mmr_00000210; Guo S, 2010, MED MICROBIOL IMMUN, V199, P129, DOI 10.1007/s00430-010-0146-1; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Ke BB, 2013, HEPATOLOGY, V57, P1203, DOI 10.1002/hep.26100; Kumar AS, 2012, MOL IMMUNOL, V49, P655, DOI 10.1016/j.molimm.2011.11.011; Lawn SD, 2013, INT J TUBERC LUNG D, V17, P636, DOI 10.5588/ijtld.12.0811; Lee JY, 2009, CARCINOGENESIS, V30, P1528, DOI 10.1093/carcin/bgp084; Liu WG, 2000, NAT GENET, V26, P146, DOI 10.1038/79859; Liu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084407; Lonnroth K, 2008, SEMIN RESP CRIT CARE, V29, P481, DOI 10.1055/s-0028-1085700; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; Neumann J, 2010, FASEB J, V24, P4599, DOI 10.1096/fj.10-160994; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Rogler A, 2013, INT J CLIN EXP PATHO, V6, P1984; Schaale K, 2013, J IMMUNOL, V191, P5182, DOI 10.4049/jimmunol.1201819; Schaale K, 2011, EUR J CELL BIOL, V90, P553, DOI 10.1016/j.ejcb.2010.11.004; Sims AM, 2008, J BONE MINER RES, V23, P499, DOI 10.1359/JBMR.071113; Song XB, 2013, MOL BIOL REP, V40, P6027, DOI 10.1007/s11033-013-2712-2; Taniguchi K, 2002, ONCOGENE, V21, P4863, DOI 10.1038/sj.onc.1205591; Torres-Garcia D, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-220; Wang M, 2010, ONCOGENE, V29, P1920, DOI 10.1038/onc.2009.484; Wang SZ, 2012, MUTAGENESIS, V27, P623, DOI 10.1093/mutage/ges027; Wang XS, 2008, CANCER EPIDEM BIOMAR, V17, P2101, DOI 10.1158/1055-9965.EPI-08-0134; Zhao L, 2014, CELL BIOCHEM BIOPHYS, V68, P529, DOI 10.1007/s12013-013-9733-2	35	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93841	10.1371/journal.pone.0093841	http://dx.doi.org/10.1371/journal.pone.0093841			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695522	Green Submitted, gold, Green Published			2022-12-25	WOS:000334103000127
J	Jun, LS; Showalter, AD; Ali, N; Dai, FH; Ma, WZ; Coskun, T; Ficorilli, JV; Wheeler, MB; Michael, MD; Sloop, KW				Jun, Lucy S.; Showalter, Aaron D.; Ali, Nosher; Dai, Feihan; Ma, Wenzhen; Coskun, Tamer; Ficorilli, James V.; Wheeler, Michael B.; Michael, M. Dodson; Sloop, Kyle W.			A Novel Humanized GLP-1 Receptor Model Enables Both Affinity Purification and Cre-LoxP Deletion of the Receptor	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; EXOCRINE PANCREAS DYSPLASIA; SURFACTANT SECRETION; TISSUE DISTRIBUTION; ENDOCRINE PANCREAS; INCRETIN THERAPY; MARKED EXPANSION; EXPRESSION; MOUSE; RAT	Class B G protein-coupled receptors (GPCRs) are important regulators of endocrine physiology, and peptide-based therapeutics targeting some of these receptors have proven effective at treating disorders such as hypercalcemia, osteoporosis, and type 2 diabetes mellitus (T2DM). As next generation efforts attempt to develop novel non-peptide, orally available molecules for these GPCRs, new animal models expressing human receptor orthologs may be required because small molecule ligands make fewer receptor contacts, and thus, the impact of amino acid differences across species may be substantially greater. The objective of this report was to generate and characterize a new mouse model of the human glucagon-like peptide-1 receptor (hGLP-1R), a class B GPCR for which established peptide therapeutics exist for the treatment of T2DM. hGLP-1R knock-in mice express the receptor from the murine Glp-1r locus. Glucose tolerance tests and gastric emptying studies show hGLP-1R mice and their wild-type littermates display similar physiological responses for glucose metabolism, insulin secretion, and gastric transit, and treatment with the GLP-1R agonist, exendin-4, elicits similar responses in both groups. Further, ex vivo assays show insulin secretion from humanized islets is glucose-dependent and enhanced by GLP-1R agonists. To enable additional utility, the targeting construct of the knock-in line was engineered to contain both flanking LoxP sites and a C-terminal FLAG epitope. Anti-FLAG affinity purification shows strong expression of hGLP-1R in islets, lung, and stomach. We crossed the hGLP-1R line with Rosa26Cre mice and generated global Glp-1r(-/-) animals. Immunohistochemistry of pancreas from humanized and knock-out mice identified a human GLP-1R-specific antibody that detects the GLP-1R in human pancreas as well as in the pancreas of hGLP-1r knock-in mice. This new hGLP-1R model will allow tissue-specific deletion of the GLP-1R, purification of potential GLP-1R partner proteins, and testing of novel therapeutic agents targeting the hGLP-1R.	[Jun, Lucy S.; Showalter, Aaron D.; Ali, Nosher; Ma, Wenzhen; Coskun, Tamer; Ficorilli, James V.; Michael, M. Dodson; Sloop, Kyle W.] Eli Lilly & Co, Lilly Res Labs, Endocrine Discovery, Indianapolis, IN 46285 USA; [Dai, Feihan; Wheeler, Michael B.] Univ Toronto, Dept Physiol, Toronto, ON, Canada	Eli Lilly; University of Toronto	Sloop, KW (corresponding author), Eli Lilly & Co, Lilly Res Labs, Endocrine Discovery, Indianapolis, IN 46285 USA.	sloop_kyle_w@lilly.com	Coskun, Tamer/AAR-8422-2021	Michael, Mervyn/0000-0002-0224-1065; Wheeler, Michael B./0000-0002-7480-7267	Eli Lilly and Company; Lilly Research Awards Program (LRAP)	Eli Lilly and Company(Eli Lilly); Lilly Research Awards Program (LRAP)	This work was supported by Eli Lilly and Company and the Lilly Research Awards Program (LRAP). The LRAP grant enabled immunohistochemistry analyses of the mouse and human pancreas tissues. The funders had no other role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Ban K, 2008, CIRCULATION, V117, P2340, DOI 10.1161/CIRCULATIONAHA.107.739938; Benito E, 1998, ENDOCRINOLOGY, V139, P2363, DOI 10.1210/en.139.5.2363; Bullock BP, 1996, ENDOCRINOLOGY, V137, P2968, DOI 10.1210/en.137.7.2968; Butler AE, 2013, DIABETES; Butler AE, 2013, DIABETES, V62, P2595, DOI 10.2337/db12-1686; CAMPOS RV, 1994, ENDOCRINOLOGY, V134, P2156, DOI 10.1210/en.134.5.2156; Chen QA, 2010, AM J PHYSIOL-ENDOC M, V299, pE62, DOI 10.1152/ajpendo.00067.2010; Chia CW, 2008, J CLIN ENDOCR METAB, V93, P3703, DOI 10.1210/jc.2007-2109; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Dunphy JL, 1998, MOL CELL ENDOCRINOL, V141, P179, DOI 10.1016/S0303-7207(98)00096-3; Estall JL, 2006, CURR PHARM DESIGN, V12, P1731, DOI 10.2174/138161206776873671; Gier B, 2012, J CLIN ENDOCR METAB, V97, P121, DOI 10.1210/jc.2011-2407; GOKE R, 1994, PEPTIDES, V15, P675, DOI 10.1016/0196-9781(94)90095-7; Halbirk M, 2010, AM J PHYSIOL-HEART C, V298, pH1096, DOI 10.1152/ajpheart.00930.2009; Hansotia T, 2005, REGUL PEPTIDES, V128, P125, DOI 10.1016/j.regpep.2004.07.019; Hansotia T, 2004, DIABETES, V53, P1326, DOI 10.2337/diabetes.53.5.1326; Heine RJ, 2013, DIABETES, V62, pE16, DOI 10.2337/db13-0690; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Imeryuz N, 1997, AM J PHYSIOL-GASTR L, V273, pG920, DOI 10.1152/ajpgi.1997.273.4.G920; Kim M, 2013, NAT MED, V19, P567, DOI 10.1038/nm.3128; Knudsen LB, 2010, ENDOCRINOLOGY, V151, P1473, DOI 10.1210/en.2009-1272; Korner M, 2007, J NUCL MED, V48, P736, DOI 10.2967/jnumed.106.038679; Kojima K, 2012, PROTEOMICS, V12, P3393, DOI 10.1002/pmic.201100663; Lamont BJ, 2012, J CLIN INVEST, V122, P388, DOI 10.1172/JCI42497; Lobbestael E, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-16; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Mendis B, 2012, BRIT J CLIN PHARMACO, V74, P437, DOI 10.1111/j.1365-2125.2012.04214.x; Monami M, 2009, EUR J ENDOCRINOL, V160, P909, DOI 10.1530/EJE-09-0101; NAUCK MA, 1993, DIABETOLOGIA, V36, P741, DOI 10.1007/BF00401145; Otto C, 2009, BIOL REPROD, V80, P34, DOI 10.1095/biolreprod.108.071175; Panjwani N, 2013, ENDOCRINOLOGY, V154, P127, DOI 10.1210/en.2012-1937; Persani L, 2007, NAT CLIN PRACT ENDOC, V3, P180, DOI 10.1038/ncpendmet0401; Pyke C, 2013, ENDOCRINOLOGY, V154, P4, DOI 10.1210/en.2012-2124; RICHTER G, 1993, AM J PHYSIOL, V265, pL374, DOI 10.1152/ajplung.1993.265.4.L374; Roman-Perez M, 2013, ENDOCRINOLOGY, V154, P1144, DOI 10.1210/en.2012-1786; Schlatter P, 2007, REGUL PEPTIDES, V141, P120, DOI 10.1016/j.regpep.2006.12.016; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Scrocchi LA, 1996, NAT MED, V2, P1254, DOI 10.1038/nm1196-1254; Sloop KW, 2004, J CLIN INVEST, V113, P1571, DOI 10.1172/JCI200420911; Sloop KW, 2010, DIABETES, V59, P3099, DOI 10.2337/db10-0689; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Suzuki H, 2013, GENESIS, V51, P50, DOI 10.1002/dvg.22347; THORENS B, 1992, P NATL ACAD SCI USA, V89, P8641, DOI 10.1073/pnas.89.18.8641; Tornehave D, 2008, J HISTOCHEM CYTOCHEM, V56, P841, DOI 10.1369/jhc.2008.951319; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; Tushuizen ME, 2006, LIVER INT, V26, P1015, DOI 10.1111/j.1478-3231.2006.01315.x; Vara E, 2001, AM J RESP CRIT CARE, V163, P840, DOI 10.1164/ajrccm.163.4.9912132; Whitaker GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032675; Wilson-Perez HE, 2013, DIABETES, V62, P2380, DOI 10.2337/db12-1498; Zvonok N, 2007, J PROTEOME RES, V6, P2068, DOI 10.1021/pr060671h	52	24	25	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93746	10.1371/journal.pone.0093746	http://dx.doi.org/10.1371/journal.pone.0093746			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695667	Green Submitted, Green Published, gold			2022-12-25	WOS:000334103000118
J	Carroll, EL; Jackson, JA; Paton, D; Smith, TD				Carroll, Emma L.; Jackson, Jennifer A.; Paton, David; Smith, Tim D.			Two Intense Decades of 19(th) Century Whaling Precipitated Rapid Decline of Right Whales around New Zealand and East Australia	PLOS ONE			English	Article							SOUTHERN RIGHT WHALES	Right whales (Eubalaenaspp.)werethe focus of worldwide whaling activities from the 16 (th) to the 20(th) century. During the first part of the 19 th century, the southern right whale (E. australis) was heavily exploited on whaling grounds around New Zealand (NZ) and east Australia (EA). Here we build upon previous estimates of the total catch of NZ and EA right whales by improving and combining estimates from four different fisheries. Two fisheries have previously been considered: shorebased whaling in bays and ship-based whaling offshore. These were both improved by comparison with primary sources and the American offshore whaling catch record was improved by using a sample of logbooks to produce a more accurate catch record in terms of location and species composition. Two fisheries had not been previously integrated into the NZ and EA catch series: ship-based whaling in bays and whaling in the 20 th century. To investigate the previously unaddressed problem of offshore whalers operating in bays, we identified a subset of vessels likely to be operating in bays and read available extant logbooks. This allowed us to estimate the total likely catch from bay-whaling by offshore whalers from the number of vessels seasons and whales killed per season: it ranged from 2,989 to 4,652 whales. The revised total estimate of 53,000 to 58,000 southern right whales killed is a considerable increase on the previous estimate of 26,000, partly because it applies fishery-specific estimates of struck and loss rates. Over 80% of kills were taken between 1830 and 1849, indicating a brief and intensive fishery that resulted in the commercial extinction of southern right whales in NZ and EA in just two decades. This conforms to the global trend of increasingly intense and destructive southern right whale fisheries over time.	[Carroll, Emma L.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Jackson, Jennifer A.] British Antarctic Survey, Cambridge CB3 0ET, Cambs, England; [Paton, David] Blue Planet Marine, Canberra, ACT, Australia; [Smith, Tim D.] World Whaling Hist, Redding, CA USA	University of Auckland; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Carroll, EL (corresponding author), Univ St Andrews, Scottish Oceans Inst, St Andrews, Fife, Scotland.	elc6@st-andrews.ac.uk	Carroll, Emma/U-9133-2019	Carroll, Emma/0000-0003-3193-7288	New Zealand Ministry of Fisheries [ZBD200505]; Atmospheric Research (NIWA); Oregon State University General Research Fund; Lenfest Ocean Program of the Pew Charitable Trust; Tertiary Education Commission; TS through the History of Marine Animal Populations (HMAP); Natural Environment Research Council [bas0100026] Funding Source: researchfish; NERC [bas0100026] Funding Source: UKRI	New Zealand Ministry of Fisheries; Atmospheric Research (NIWA); Oregon State University General Research Fund; Lenfest Ocean Program of the Pew Charitable Trust; Tertiary Education Commission; TS through the History of Marine Animal Populations (HMAP); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding for the review and report preparation was provided by the New Zealand Ministry of Fisheries through Project ZBD200505 to the National Institute of Water and Atmospheric Research (NIWA), Oregon State University General Research Fund to JJ and CS Baker and the Lenfest Ocean Program of the Pew Charitable Trust to SR Palumbi. EC was supported by a fellowship from the Tertiary Education Commission and TS through the History of Marine Animal Populations (HMAP) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GREAT BRITAIN PARLIA; Bannister J. L., 1986, REP INT WHAL COMM, P255; Bannister JL, 2011, INT WHAL COMM WORKSH; Brandao A, 2010, SC62BRG30; Carroll E, 2011, MAR ECOL PROG SER, V432, P257, DOI 10.3354/meps09145; Carroll EL, 2013, ECOL APPL, V23, P1677, DOI 10.1890/12-1657.1; Carroll EL, 2014, MAR MAMMAL SCI, V30, P206, DOI 10.1111/mms.12031; CLAPHAM PJ, 2002, ENCY MARINE MAMMALS, P1328; Dawbin W, 1985, HIST DOCUMENTS RELAT; Dawbin W., 1986, REPORT INT WHALING C, V10, P261; Dorsey, 2014, WHALES NATIONS ENV D; Du Pasquier T, 1986, REPORT INT WHALING C, V10, P268; Fujiwara M, 2001, NATURE, V414, P537, DOI 10.1038/35107054; GASKIN D. E., 1964, TUATARA, V12, P115; Great Britain Colonial Office, 1853, BLUE BOOK STAT 1841; Hjort J., 1933, HVALRADETS SKRIFTER, V7, P7; IWC, 2012, SC64REP5 IWC; IWC, 1986, REPORT INT WHALING C, V44, P146; IWC, 2001, J CETACEAN RES MANAG, V2, P1; Jackson JA, 2008, MOL ECOL, V17, P236, DOI 10.1111/j.1365-294X.2007.03497.x; Josephson E, 2008, OCEANS PAST MANAGEMN; Josephson E, 2008, FISH FISH, V9, P155, DOI 10.1111/j.1467-2979.2008.00275.x; Kato H, 2007, SC59SH10; Lund JN, 2010, PLOS ONE, VI; McNab R, 1909, DISCOVERY ISLANDS SU, VI; McNab R, 1908, HIST RECORDS NZ, V1; McNab R., 1913, OLD WHALING DAYS HIS; McNab R, 1907, MURIHIKU SO ISLANDS; Morton H., 1982, WHALES WAKE; Papworth SK, 2009, CONSERV LETT, V2, P93, DOI 10.1111/j.1755-263X.2009.00049.x; Patenaude NJ, 2007, J HERED, V98, P147, DOI 10.1093/jhered/esm005; Patenaude NJ, 2002, THESIS U AUCKLAND AU; Reeves R. R., 2010, US NMFS MAR FISH REV, V72, P26; Reeves R. R., 2007, WHALES WHALING OCEAN; Reeves RR, 2006, URBAN WHALE; Reilly SB, 2008, IUCN 2009 IUCN RED L; Richards R, 2002, J ROY SOC NEW ZEAL, V32, P355, DOI 10.1080/03014223.2002.9517699; Richards R, 2009, GREAT CIRCLE, V31, P59; Richards R., 1992, BAY ISLANDS SHIPPING; Seber G.A.F., 1973, ESTIMATION ANIMAL AB; Sherrin RAA, 1886, HDB FISHES NZ; Smith T. D., 1994, SCALING FISHERIES; Smith TD, 2010, MAR FISH REV, V72, P1; Smith TD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034905; Starbuck A., 1878, HIST AM WHALE FISH 4; Statistics New Zealand, 1900, STAT NZ 1854 1900; Tormosov DD, 1998, BIOL CONSERV, V86, P185, DOI 10.1016/S0006-3207(98)00008-1; Wade PR, 2011, BIOL LETTERS, V7, P83, DOI 10.1098/rsbl.2010.0477; Wakefield E.J., 1848, HDB NZ	49	16	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93789	10.1371/journal.pone.0093789	http://dx.doi.org/10.1371/journal.pone.0093789			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690918	gold, Green Published, Green Accepted			2022-12-25	WOS:000334101100134
J	Cochain, C; Chaudhari, SM; Koch, M; Wiendl, H; Eckstein, HH; Zernecke, A				Cochain, Clement; Chaudhari, Sweena M.; Koch, Miriam; Wiendl, Heinz; Eckstein, Hans-Henning; Zernecke, Alma			Programmed Cell Death-1 Deficiency Exacerbates T Cell Activation and Atherogenesis despite Expansion of Regulatory T Cells in Atherosclerosis-Prone Mice	PLOS ONE			English	Article							PATHWAY; PD-1; COSTIMULATION; PROGRESSION; RESPONSES	T cell activation represents a double-edged sword in atherogenesis, as it promotes both pro-inflammatory T cell activation and atheroprotective Foxp3(+) regulatory T cell (Treg) responses. Here, we investigated the role of the co-inhibitory receptor programmed cell death-1 (PD-1) in T cell activation and CD4(+) T cell polarization towards pro-atherogenic or atheroprotective responses in mice. Mice deficient for both low density lipoprotein receptor and PD-1 (Ldlr(-/-)Pd1(-/-)) displayed striking increases in systemic CD4(+) and CD8(+) T cell activation after 9 weeks of high fat diet feeding, associated with an expansion of both pro-atherogenic IFN gamma-secreting T helper 1 cells and atheroprotective Foxp3+ Tregs. Importantly, PD-1 deficiency did not affect Treg suppressive function in vitro. Notably, PD-1 deficiency exacerbated atherosclerotic lesion growth and entailed a massive infiltration of T cells in atherosclerotic lesions. In addition, aggravated hypercholesterolemia was observed in Ldlr(-/-) Pd1(-/-) mice. In conclusion, we here demonstrate that although disruption of PD-1 signaling enhances both pro-and anti-atherogenic T cell responses in Ldlr(-/-) mice, pro-inflammatory T cell activation prevails and enhances dyslipidemia, vascular inflammation and atherosclerosis.	[Cochain, Clement; Chaudhari, Sweena M.; Koch, Miriam; Zernecke, Alma] Univ Hosp Wurzburg, Inst Clin Biochem & Pathobiochem, Wurzburg, Germany; [Cochain, Clement; Chaudhari, Sweena M.; Eckstein, Hans-Henning; Zernecke, Alma] Tech Univ Munich, Klinikum Rechts Isar, Dept Vasc Surg, D-80290 Munich, Germany; [Wiendl, Heinz] Univ Munster, Dept Neurol, D-48149 Munster, Germany; [Eckstein, Hans-Henning] DZHK German Ctr Cardiovasc Res, Munich Heart Alliance, Munich, Germany	University of Wurzburg; Technical University of Munich; University of Munster; German Centre for Cardiovascular Research; Munich Heart Alliance	Zernecke, A (corresponding author), Univ Hosp Wurzburg, Inst Clin Biochem & Pathobiochem, Wurzburg, Germany.	alma.zernecke@uni-wuerzburg.de	Eckstein, Hans-Henning/AAF-9200-2022; Eckstein, Hans-Henning/AFK-1881-2022; Wiendl, Heinz/AAX-6041-2021	Wiendl, Heinz/0000-0003-4310-3432; Eckstein, Hans-Henning/0000-0002-0743-1642	Deutsche Forschungsgemeinschaft [SFB1009, SFB688, FOR809 ZE 827/1-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (SFB1009, project A3, to H. W., and SFB688 project A12 and A22, and FOR809 ZE 827/1-2 to A.Z.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. or preparation of the manuscript.	Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Benagiano M, 2003, P NATL ACAD SCI USA, V100, P6658, DOI 10.1073/pnas.1135726100; Bu DX, 2011, ARTERIOSCL THROM VAS, V31, P1100, DOI 10.1161/ATVBAHA.111.224709; Buono C, 2004, CIRCULATION, V109, P2009, DOI 10.1161/01.CIR.0000127121.16815.F1; Cardilo-Reis L, 2012, EMBO MOL MED, V4, P1072, DOI 10.1002/emmm.201201374; Franceschini D, 2009, J CLIN INVEST, V119, P551, DOI 10.1172/JCI36604; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Gotsman I, 2008, CIRC RES, V103, P1220, DOI 10.1161/CIRCRESAHA.108.182428; Gotsman I, 2007, J CLIN INVEST, V117, P2974, DOI 10.1172/JCI31344; Hirahara K, 2012, IMMUNITY, V36, P1017, DOI 10.1016/j.immuni.2012.03.024; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Klingenberg R, 2013, J CLIN INVEST, V123, P1323, DOI 10.1172/JCI63891; Kuipers H, 2006, EUR J IMMUNOL, V36, P2472, DOI 10.1002/eji.200635978; Kyaw T, 2013, CIRCULATION, V127, P1028, DOI 10.1161/CIRCULATIONAHA.112.001347; Ma KF, 2012, DIABETES-METAB RES, V28, P388, DOI 10.1002/dmrr.2291; Sage PT, 2013, NAT IMMUNOL, V14, P152, DOI 10.1038/ni.2496; Salama AD, 2003, J EXP MED, V198, P71, DOI 10.1084/jem.20022119; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Subramanian M, 2013, J CLIN INVEST, V123, P179, DOI 10.1172/JCI64617; Taleb S, 2010, CURR OPIN LIPIDOL, V21, P404, DOI 10.1097/MOL.0b013e32833dc7f9; Dinh TN, 2012, CIRCULATION, V126, P1256, DOI 10.1161/CIRCULATIONAHA.112.099044; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415	23	65	68	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93280	10.1371/journal.pone.0093280	http://dx.doi.org/10.1371/journal.pone.0093280			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691202	Green Submitted, Green Published, gold			2022-12-25	WOS:000334101100061
J	Chen, SR; Chen, H; Yuan, WX; Wess, J; Pan, HL				Chen, Shao-Rui; Chen, Hong; Yuan, Wei-Xiu; Wess, Juergen; Pan, Hui-Lin			Differential Regulation of Primary Afferent Input to Spinal Cord by Muscarinic Receptor Subtypes Delineated Using Knockout Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acetylcholinesterase; Cholinergic Receptor; Gene Knockout; Glutamate; Neurons; Pain; Synaptic Plasticity; Acetylcholine; Muscarinic; Spinal Cord	DORSAL-HORN NEURONS; METABOTROPIC GLUTAMATE RECEPTORS; SUBSTANTIA GELATINOSA NEURONS; ACETYLCHOLINE-RECEPTOR; CHOLINERGIC RECEPTORS; AUTORADIOGRAPHIC LOCALIZATION; CHOLINESTERASE INHIBITION; SYNAPTIC-TRANSMISSION; GABA(B) RECEPTORS; GLYCINERGIC INPUT	Background: Activation of muscarinic receptors reduces pain at the spinal level. Results: M-2 and M-4 subtypes mediate muscarinic inhibition of sensory nerve input. M-5 subtype stimulation directly increases sensory input or indirectly inhibits it through metabotropic glutamate receptors. Conclusion: M-2, M-4, and M-5 subtypes differentially regulate nociceptive input to the spinal cord. Significance: This study demonstrates how individual muscarinic receptor subtypes control pain transmission. Stimulation of muscarinic acetylcholine receptors (mAChRs) inhibits nociceptive transmission at the spinal level. However, it is unclear how each mAChR subtype regulates excitatory synaptic input from primary afferents. Here we examined excitatory postsynaptic currents (EPSCs) of dorsal horn neurons evoked by dorsal root stimulation in spinal cord slices from wild-type and mAChR subtype knock-out (KO) mice. In wild-type mice, mAChR activation with oxotremorine-M decreased the amplitude of monosynaptic EPSCs in approximate to 67% of neurons but increased it in approximate to 10% of neurons. The inhibitory effect of oxotremorine-M was attenuated by the M-2/M-4 antagonist himbacine in the majority of neurons, and the remaining inhibition was abolished by group II/III metabotropic glutamate receptor (mGluR) antagonists in wild-type mice. In M-2/M-4 double-KO mice, oxotremorine-M inhibited monosynaptic EPSCs in significantly fewer neurons (approximate to 26%) and increased EPSCs in significantly more neurons (33%) compared with wild-type mice. Blocking group II/III mGluRs eliminated the inhibitory effect of oxotremorine-M in M-2/M-4 double-KO mice. In M-2 single-KO and M-4 single-KO mice, himbacine still significantly reduced the inhibitory effect of oxotremorine-M. However, the inhibitory and potentiating effects of oxotremorine-M on EPSCs in M-3 single-KO and M-1/M-3 double-KO mice were similar to those in wild-type mice. In M-5 single-KO mice, oxotremorine-M failed to potentiate evoked EPSCs, and its inhibitory effect was abolished by himbacine. These findings indicate that activation of presynaptic M-2 and M-4 subtypes reduces glutamate release from primary afferents. Activation of the M-5 subtype either directly increases primary afferent input or inhibits it through indirectly stimulating group II/III mGluRs.	[Chen, Shao-Rui; Chen, Hong; Yuan, Wei-Xiu; Pan, Hui-Lin] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Ctr Neurosci & Pain Res, Houston, TX 77030 USA; [Wess, Juergen] NIDDK, Bioorgan Chem Lab, Natl Inst Hlth, Bethesda, MD 20892 USA	University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Pan, HL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Unit 110, 1515 Holcombe Blvd, Houston, TX 77030 USA.	huilinpan@mdanderson.org		Pan, Hui-Lin/0000-0001-8444-3770	National Institutes of Health [NS073935, NS045602]; N. G. and Helen T. Hawkins Endowment; Intramural Research Program of NIDDK, National Institutes of Health; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073935, R01NS045602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); N. G. and Helen T. Hawkins Endowment; Intramural Research Program of NIDDK, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS073935 and NS045602. This work was also supported by a grant from the N. G. and Helen T. Hawkins Endowment (to H.-L. P.).; Supported by the Intramural Research Program of NIDDK, National Institutes of Health.	Anwyl R, 1999, BRAIN RES REV, V29, P83, DOI 10.1016/S0165-0173(98)00050-2; Basile AS, 2002, P NATL ACAD SCI USA, V99, P11452, DOI 10.1073/pnas.162371899; Cai YQ, 2009, J NEUROCHEM, V111, P1000, DOI 10.1111/j.1471-4159.2009.06396.x; Cao XH, 2011, J NEUROCHEM, V119, P594, DOI 10.1111/j.1471-4159.2011.07456.x; Chen SR, 2010, J BIOL CHEM, V285, P40427, DOI 10.1074/jbc.M110.176966; Chen SR, 2005, J PHARMACOL EXP THER, V313, P765, DOI 10.1124/jpet.104.082537; Chen SR, 2004, NEUROSCIENCE, V125, P141, DOI 10.1016/j.neuroscience.2004.01.015; Chen SR, 2003, J PHARMACOL EXP THER, V307, P676, DOI 10.1124/jpet.103.055905; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Doller D, 1999, BIOORG MED CHEM LETT, V9, P901, DOI 10.1016/S0960-894X(99)00101-8; Duttaroy A, 2002, MOL PHARMACOL, V62, P1084, DOI 10.1124/mol.62.5.1084; Gautam D, 2004, MOL PHARMACOL, V66, P260, DOI 10.1124/mol.66.2.260; Gerber G, 2000, NEUROSCIENCE, V100, P393, DOI 10.1016/S0306-4522(00)00269-4; Gomeza J, 1999, P NATL ACAD SCI USA, V96, P1692, DOI 10.1073/pnas.96.4.1692; Gomeza J, 1999, P NATL ACAD SCI USA, V96, P10483, DOI 10.1073/pnas.96.18.10483; Hoglund AU, 1997, J PHARMACOL EXP THER, V281, P470; Hood DD, 1997, J PHARMACOL EXP THER, V282, P86; KUMAZAWA T, 1978, J COMP NEUROL, V177, P417, DOI 10.1002/cne.901770305; Li DP, 2002, J PHYSIOL-LONDON, V543, P807, DOI 10.1113/jphysiol.2002.020644; MCKINNEY M, 1993, PROG BRAIN RES, V98, P333; MILLER JH, 1992, J PHARMACOL EXP THER, V263, P663; Mitsuya M, 1999, BIOORGAN MED CHEM, V7, P2555, DOI 10.1016/S0968-0896(99)00177-7; NAGUIB M, 1994, ANESTHESIOLOGY, V80, P1338, DOI 10.1097/00000542-199406000-00022; Nakayama M, 2001, J CLIN ANESTH, V13, P86, DOI 10.1016/S0952-8180(01)00218-5; Pan HL, 2003, J NEUROSCI, V23, P2911; Pan HL, 2008, PHARMACOL THERAPEUT, V117, P141, DOI 10.1016/j.pharmthera.2007.09.003; Pan YZ, 2004, J NEUROPHYSIOL, V91, P2413, DOI 10.1152/jn.01242.2003; SCATTON B, 1984, NEUROSCI LETT, V49, P239, DOI 10.1016/0304-3940(84)90296-9; Stefani A, 1998, EXP BRAIN RES, V119, P237, DOI 10.1007/s002210050337; VILLIGER JW, 1985, BRAIN RES, V345, P196, DOI 10.1016/0006-8993(85)90854-6; Wang XL, 2006, J PHYSIOL-LONDON, V571, P403, DOI 10.1113/jphysiol.2005.102905; Wess J, 1996, CRIT REV NEUROBIOL, V10, P69, DOI 10.1615/CritRevNeurobiol.v10.i1.40; Yamada M, 2001, NATURE, V410, P207, DOI 10.1038/35065604; YAMAMURA HI, 1983, EUR J PHARMACOL, V91, P147, DOI 10.1016/0014-2999(83)90379-5; YOSHIMURA M, 1990, J PHYSIOL-LONDON, V430, P315, DOI 10.1113/jphysiol.1990.sp018293; Yung KKL, 1997, NEUROSCI LETT, V229, P81, DOI 10.1016/S0304-3940(97)00426-6; Zhang HM, 2009, NEUROSCIENCE, V158, P875, DOI 10.1016/j.neuroscience.2008.10.042; Zhang HM, 2006, MOL PHARMACOL, V69, P1048, DOI 10.1124/mol.105.018069; Zhang HM, 2005, J PHARMACOL EXP THER, V313, P697, DOI 10.1124/jpet.104.079939; Zhang HM, 2007, J PHARMACOL EXP THER, V323, P963, DOI 10.1124/jpet.107.127795; Zhang HM, 2007, J NEUROPHYSIOL, V97, P102, DOI 10.1152/jn.00586.2006; Zhou HY, 2007, J NEUROPHYSIOL, V97, P871, DOI 10.1152/jn.00964.2006; Zhou HY, 2010, J NEUROSCI, V30, P4460, DOI 10.1523/JNEUROSCI.5857-09.2010; ZHUO M, 1991, PAIN, V46, P211, DOI 10.1016/0304-3959(91)90078-C	44	18	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14321	14330		10.1074/jbc.M114.550384	http://dx.doi.org/10.1074/jbc.M114.550384			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24695732	hybrid, Green Published			2022-12-25	WOS:000335984600057
J	Foradori, MJ; Chen, Q; Fernandez, CA; Harper, J; Li, X; Tsang, PCW; Langer, R; Moses, MA				Foradori, Matthew J.; Chen, Qian; Fernandez, Cecilia A.; Harper, Jay; Li, Xin; Tsang, Paul C. W.; Langer, Robert; Moses, Marsha A.			Matrilin-1 Is an Inhibitor of Neovascularization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiogenesis; Cartilage; Endothelium; Mass Spectrometry (MS); Matrix Metalloproteinase (MMP)	CARTILAGE MATRIX PROTEIN; RENAL-CELL CARCINOMA; PHASE-III TRIAL; CHONDROMODULIN-I; SHARK CARTILAGE; ANGIOGENESIS INHIBITOR; NEOVASTAT AE-941; TUMOR-GROWTH; TISSUE INHIBITOR; ENDOCHONDRAL OSSIFICATION	Background: The relative avascularity of cartilage has made it a promising source of angiogenesis inhibitors. Results: MATN-1, identified by mass spectrometry, suppresses capillary endothelial cell proliferation and migration. Conclusion: MATN-1 is a novel inhibitor of neovascularization in vivo and in vitro. Significance: This is the first demonstration that MATN-1 is an inhibitor of both normal and pathological neovascularization. In the course of conducting a series of studies whose goal was to discover novel endogenous angiogenesis inhibitors, we have purified matrilin-1 (MATN-1) and have demonstrated, for the first time, that it inhibits neovascularization both in vitro and in vivo. Proteins were extracted from cartilage using a 2 m NaCl, 0.01 m HEPES buffer at 4 degrees C, followed by concentration of the extract. The concentrate was fractionated by size exclusion chromatography, and fractions were then screened for their ability to inhibit capillary endothelial cell (EC) proliferation in vitro. Fractions containing EC inhibitory activity were pooled and further purified by cation exchange chromatography. The resulting fractions from this step were then screened to isolate the antiangiogenic activity in vitro. This activity was identified by tandem mass spectrometry as being MATN-1. Human MATN-1 was cloned and expressed in Pichia pastoris and purified to homogeneity. Purified recombinant MATN-1, along with purified native protein, was shown to inhibit angiogenesis in vivo using the chick chorioallantoic membrane assay by the inhibition of capillary EC proliferation and migration. Finally, using a MATN-1-deficient mouse, we showed that angiogenesis during fracture healing was significantly higher in MATN-1(-/-) mice compared with the wild type mice as demonstrated by in vivo imaging and by elevated expression of angiogenesis markers including PECAM1, VEGFR, and VE-cadherin.	[Moses, Marsha A.] Boston Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA; [Moses, Marsha A.] Boston Childrens Hosp, Dept Surg, Boston, MA 02115 USA; [Foradori, Matthew J.; Fernandez, Cecilia A.; Harper, Jay; Moses, Marsha A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Chen, Qian; Li, Xin] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Dept Orthopaed, Providence, RI 02903 USA; [Tsang, Paul C. W.] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA; [Langer, Robert] MIT, Dept Biochem Engn, Cambridge, MA 02139 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; University System Of New Hampshire; University of New Hampshire; Massachusetts Institute of Technology (MIT)	Moses, MA (corresponding author), Boston Childrens Hosp, Vasc Biol Program, Karp Family Res Bldg,Rm 12-214,300 Longwood Ave, Boston, MA 02115 USA.	marsha.moses@childrens.harvard.edu	Chen, Qian/C-4354-2011	Chen, Qian/0000-0003-4406-5618; LI, XIN/0000-0003-0003-8554	National Institutes of Health [AT00650, AG017021, GM104937]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT000650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017021] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AT00650, AG017021, and GM104937.	Batist G, 2002, ANN ONCOL, V13, P1259, DOI 10.1093/annonc/mdf195; Beliveau R, 2002, CLIN CANCER RES, V8, P1242; Bornstein P, 2009, J CELL COMMUN SIGNAL, V3, P189, DOI 10.1007/s12079-009-0060-8; CHEN Q, 1995, DEV BIOL, V172, P293, DOI 10.1006/dbio.1995.0024; Chen Q, 1999, MOL BIOL CELL, V10, P2149, DOI 10.1091/mbc.10.7.2149; Davies CD, 2001, BRIT J CANCER, V85, P1968, DOI 10.1054/bjoc.2001.2180; Dupont E, 2002, CLIN EXP METASTAS, V19, P145, DOI 10.1023/A:1014546909573; Escudier B, 2007, J UROLOGY, V178, P1901, DOI 10.1016/j.juro.2007.07.035; Falardeau P, 2001, SEMIN ONCOL, V28, P620, DOI 10.1053/sonc.2001.28598; Fernandez CA, 2003, J BIOL CHEM, V278, P40989, DOI 10.1074/jbc.M306176200; Gingras D, 2001, ANTICANCER RES, V21, P145; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; Grant DS, 2002, ONCOGENE, V21, P4765, DOI 10.1038/sj.onc.1205595; Harper J, 2006, EXP SUPPL, V96, P223; HILTUNEN A, 1993, J ORTHOP RES, V11, P305, DOI 10.1002/jor.1100110219; Hiraki Y, 2005, CONNECT TISSUE RES, V46, P44, DOI 10.1080/03008200590935547; Hiraki Y, 1997, J BIOL CHEM, V272, P32419, DOI 10.1074/jbc.272.51.32419; Kamphaus GD, 2000, J BIOL CHEM, V275, P1209, DOI 10.1074/jbc.275.2.1209; Kang JA, 2003, BBA-GEN SUBJECTS, V1620, P59, DOI 10.1016/S0304-4165(02)00508-1; Kim DH, 2002, MAR BIOTECHNOL, V4, P63, DOI 10.1007/s1012601-0070-x; Kim JT, 2001, BBA-GENE STRUCT EXPR, V1517, P311, DOI 10.1016/S0167-4781(00)00255-4; Kusafuka K, 2002, ACTA HISTOCHEM, V104, P167, DOI 10.1078/0065-1281-00642; Langer R., 1991, BIOTECHNOLOGY, V9, P630; Latreille Jean, 2003, Clin Lung Cancer, V4, P231, DOI 10.3816/CLC.2003.n.003; LEE A, 1983, SCIENCE, V221, P1185, DOI 10.1126/science.6193581; Liang JH, 2000, ADV EXP MED BIOL, V476, P209; Lu C, 2010, JNCI-J NATL CANCER I, V102, P859, DOI 10.1093/jnci/djq179; Luo HY, 2007, ASIA PAC J CLIN NUTR, V16, P286; MacCoss MJ, 2002, ANAL CHEM, V74, P5593, DOI 10.1021/ac025826t; Maeshima Y, 2000, J BIOL CHEM, V275, P21340, DOI 10.1074/jbc.M001956200; Mann HH, 2004, J BIOL CHEM, V279, P25294, DOI 10.1074/jbc.M403778200; MOSES MA, 1992, J CELL BIOL, V119, P475, DOI 10.1083/jcb.119.2.475; Moses MA, 1999, P NATL ACAD SCI USA, V96, P2645, DOI 10.1073/pnas.96.6.2645; MOSES MA, 1990, SCIENCE, V248, P1408, DOI 10.1126/science.1694043; Neame PJ, 1999, CELL MOL LIFE SCI, V55, P1327, DOI 10.1007/s000180050373; Nyberg P, 2008, EXP CELL RES, V314, P3292, DOI 10.1016/j.yexcr.2008.08.011; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Oshima Y, 2004, J CELL SCI, V117, P2731, DOI 10.1242/jcs.01112; PAULSSON M, 1982, BIOCHEM J, V207, P207, DOI 10.1042/bj2070207; Petitclerc E, 2000, J BIOL CHEM, V275, P8051, DOI 10.1074/jbc.275.11.8051; Rabbani-Chadegani A, 2008, J PHARMACEUT BIOMED, V46, P563, DOI 10.1016/j.jpba.2007.10.029; Ren B, 2006, BBA-REV CANCER, V1765, P178, DOI 10.1016/j.bbcan.2005.11.002; Roy R, 2008, CLIN CANCER RES, V14, P6610, DOI 10.1158/1078-0432.CCR-08-1136; Sauder DN, 2002, J AM ACAD DERMATOL, V47, P535, DOI 10.1067/mjd.2002.124702; Shen XR, 2001, ACTA BIOCH BIOPH SIN, V33, P99; Sheu JR, 1998, ANTICANCER RES, V18, P4435; Shukunami C, 2005, BIOCHEM BIOPH RES CO, V333, P299, DOI 10.1016/j.bbrc.2005.05.133; Shukunami C, 2001, BIOCHEM BIOPH RES CO, V280, P1323, DOI 10.1006/bbrc.2001.4271; Shukunami C, 2007, CURR PHARM DESIGN, V13, P2101; Sottile J, 2004, BBA-REV CANCER, V1654, P13, DOI 10.1016/j.bbcan.2003.07.002; Sund M, 2010, PHARMACEUTICALS, V3, P3021, DOI 10.3390/ph3103021; Wen W, 1999, CANCER RES, V59, P6052; Wiberg C, 2003, J BIOL CHEM, V278, P37698, DOI 10.1074/jbc.M304638200; WINTERBOTTOM N, 1992, DEV DYNAM, V193, P266, DOI 10.1002/aja.1001930307; Zhang Y, 2000, J BIOL CHEM, V275, P32628, DOI 10.1074/jbc.M002594200; Zilberman Y, 2008, J ORTHOP RES, V26, P522, DOI 10.1002/jor.20518	56	14	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14301	14309		10.1074/jbc.M113.529982	http://dx.doi.org/10.1074/jbc.M113.529982			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24692560	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000335984600055
J	Chen, X; Foy, M; Kimmel, M; Gorlova, OY				Chen, Xing; Foy, Millennia; Kimmel, Marek; Gorlova, Olga Y.			Modeling the Natural History and Detection of Lung Cancer Based on Smoking Behavior	PLOS ONE			English	Article							TUMOR DOUBLING TIME; SIZE; METASTASIS; MORTALITY	In this study, we developed a method for modeling the progression and detection of lung cancer based on the smoking behavior at an individual level. The model allows obtaining the characteristics of lung cancer in a population at the time of diagnosis. Lung cancer data from Surveillance, Epidemiology and End Results ( SEER) database collected between 2004 and 2008 were used to fit the lung cancer progression and detection model. The fitted model combined with a smoking based carcinogenesis model was used to predict the distribution of age, gender, tumor size, disease stage and smoking status at diagnosis and the results were validated against independent data from the SEER database collected from 1988 to 1999. The model accurately predicted the gender distribution and median age of LC patients of diagnosis, and reasonably predicted the joint tumor size and disease stage distribution.	[Chen, Xing] Zhejiang Univ, Minist Educ China, Key Lab Biomed Engn, Dept Biomed Engn, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Xing; Gorlova, Olga Y.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Foy, Millennia] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Houston, TX 77030 USA; [Kimmel, Marek] Rice Univ, Dept Stat & Bioengn, Houston, TX USA; [Gorlova, Olga Y.] Dartmouth Coll, Geisel Sch Med, Dept Community & Family Med, Lebanon, NH 03756 USA	Ministry of Education, China; Zhejiang University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; Rice University; Dartmouth College	Chen, X (corresponding author), Zhejiang Univ, Minist Educ China, Key Lab Biomed Engn, Dept Biomed Engn, Hangzhou 310003, Zhejiang, Peoples R China.	cnxingchen@gmail.com			CISNET [5 U01 CA097431]; FAMRI Young Clinical Scientist Award; Prevent Cancer Foundation; National Institutes of Health (NIH) [R01 CA149462, R03CA1338885, R03128025, CA55769]; National Natural Science Foundation of China [81201166]; Research Fund for the Doctoral Program of Ministry of Education of China [20120101120165]; Zhejiang Key Science and Technology Innovation Team [2011R50018, CA016672]; NATIONAL CANCER INSTITUTE [T32CA096520, R01CA055769, R01CA149462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104416] Funding Source: NIH RePORTER	CISNET; FAMRI Young Clinical Scientist Award; Prevent Cancer Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Ministry of Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); Zhejiang Key Science and Technology Innovation Team; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by the following grants: CISNET 5 U01 CA097431 to M. K. and O.G., FAMRI Young Clinical Scientist Award and Prevent Cancer Foundation grants to O.G., National Institutes of Health (NIH) grants R01 CA149462 to OYG, R03CA1338885 and R03128025 to I. G., CA55769 to M. R. S., National Natural Science Foundation of China No. 81201166 to X. C., Research Fund for the Doctoral Program of Ministry of Education of China No. 20120101120165 to X. C., Zhejiang Key Science and Technology Innovation Team 2011R50018 to X. C., and CA016672 to MD Anderson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1973, SURV EP END RES SEER; ARAI T, 1994, JPN J CLIN ONCOL, V24, P199; Bacac M, 2008, ANNU REV PATHOL-MECH, V3, P221, DOI 10.1146/annurev.pathmechdis.3.121806.151523; Barton RR, 1996, MANAGE SCI, V42, P954, DOI 10.1287/mnsc.42.7.954; Bartoszynski R, 2001, MATH BIOSCI, V171, P113, DOI 10.1016/S0025-5564(01)00058-X; Boffetta P, 2011, CANCER CAUSE CONTROL, V22, P73, DOI 10.1007/s10552-010-9676-5; Campbell M, 2007, BRIT J GEN PRACT, V57, P410; Del Monte U, 2009, CELL CYCLE, V8, P505, DOI 10.4161/cc.8.3.7608; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; FLEHINGER BJ, 1987, BIOMETRICS, V43, P127, DOI 10.2307/2531955; Foy M, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-64; Foy M, 2011, CANCER-AM CANCER SOC, V117, P2703, DOI 10.1002/cncr.25847; Foy M, 2011, INT J CANCER, V129, P1907, DOI 10.1002/ijc.25834; Gasperino J, 2011, MED HYPOTHESES, V76, P328, DOI 10.1016/j.mehy.2010.10.030; Gorlova O, 2005, STAT MED, V24, P1117, DOI 10.1002/sim.1987; Hasegawa M, 2000, BRIT J RADIOL, V73, P1252, DOI 10.1259/bjr.73.876.11205667; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; KIMMEL M, 1991, BIOMETRICS, V47, P987, DOI 10.2307/2532654; KOSCIELNY S, 1984, BRIT J CANCER, V49, P709, DOI 10.1038/bjc.1984.112; Magdowski M, 2010, IEEE T ELECTROMAGN C, V52, P1060, DOI 10.1109/TEMC.2010.2052621; MOOLGAVKAR SH, 1979, MATH BIOSCI, V47, P55, DOI 10.1016/0025-5564(79)90005-1; Moolgavkar SH, 2012, JNCI-J NATL CANCER I, V104, P541, DOI 10.1093/jnci/djs136; OLSSON DM, 1975, TECHNOMETRICS, V17, P45, DOI 10.2307/1267998; Plevritis SK, 2007, STAT MED, V26, P581, DOI 10.1002/sim.2550; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; USUDA K, 1994, CANCER, V74, P2239, DOI 10.1002/1097-0142(19941015)74:8<2239::AID-CNCR2820740806>3.0.CO;2-P; Wang Xin, 2009, Zhonghua Zhongliu Zazhi, V31, P456, DOI 10.3760/cma.j.issn.0253-3766.2009.06.015; Xu JL, 1998, BIOMETRICS, V54, P859, DOI 10.2307/2533840	28	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93430	10.1371/journal.pone.0093430	http://dx.doi.org/10.1371/journal.pone.0093430			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705368	Green Published, gold			2022-12-25	WOS:000334107500037
J	Obradovic, AL; Hwang, SM; Scarpa, J; Hong, SJ; Todorovic, SM; Jevtovic-Todorovic, V				Obradovic, Aleksandar Lj.; Hwang, Sung Mi; Scarpa, Joseph; Hong, Sung Jun; Todorovic, Slobodan M.; Jevtovic-Todorovic, Vesna			CaV3.2 T-Type Calcium Channels in Peripheral Sensory Neurons Are Important for Mibefradil-Induced Reversal of Hyperalgesia and Allodynia in Rats with Painful Diabetic Neuropathy	PLOS ONE			English	Article							PHARMACOLOGICAL-PROPERTIES; RO 40-5967; INHIBITION; BLOCKADE	We recently showed that streptozotocin (STZ) injections in rats lead to the development of painful peripheral diabetic neuropathy (PDN) accompanied by enhancement of Ca(V)3.2 T-type calcium currents (T-currents) and hyperexcitability in dorsal root ganglion (DRG) neurons. Here we used the classical peripherally acting T-channel blocker mibefradil to examine the role of Ca(V)3.2 T-channels as pharmacological targets for treatment of painful PDN. When administered intraperitoneally (i.p.), at clinically relevant doses, mibefradil effectively alleviated heat, cold and mechanical hypersensitivities in STZ-treated diabetic rats in a dose-dependent manner. We also found that Ca(V)3.2 antisense (AS)-treated diabetic rats exhibit a significant decrease in painful PDN compared with mismatch antisense (MIS)-treated diabetic rats. Co-treatment with mibefradil (9 mg/kg i.p.) resulted in reversal of heat, cold and mechanical hypersensitivity in MIS-treated but not in AS-treated diabetic rats, suggesting that mibefradil and Ca(V)3.2 AS share the same cellular target. Using patch-clamp recordings from acutely dissociated DRG neurons, we demonstrated that mibefradil similarly blocked T-currents in diabetic and healthy rats in a voltage-dependent manner by stabilizing inactive states of T-channels. We conclude that antihyperalgesic and antiallodynic effects of mibefradil in PDN are at least partly mediated by inhibition of Ca(V)3.2 channels in peripheral nociceptors. Hence, peripherally acting voltage-dependent T-channel blockers could be very useful in the treatment of painful symptoms of PDN.	[Obradovic, Aleksandar Lj.; Hwang, Sung Mi; Scarpa, Joseph; Hong, Sung Jun; Todorovic, Slobodan M.; Jevtovic-Todorovic, Vesna] Univ Virginia Hlth Syst, Dept Anesthesiol, Charlottesville, VA 22903 USA; [Obradovic, Aleksandar Lj.] Univ Belgrade, Fac Pharm, Dept Physiol, Belgrade, Serbia; [Hwang, Sung Mi] Hallym Univ, Coll Med, Chuncheon Sacred Heart Hosp, Dept Anesthesiol & Pain Med, Chunchon, South Korea; [Hong, Sung Jun] Hallym Univ, Coll Med, Kangdong Sacred Heart Hosp, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Todorovic, Slobodan M.; Jevtovic-Todorovic, Vesna] Univ Virginia Hlth Syst, Dept Neurosci, Charlottesville, VA USA; [Todorovic, Slobodan M.; Jevtovic-Todorovic, Vesna] Univ Virginia Hlth Syst, Neurosci Grad Program, Charlottesville, VA USA	University of Virginia; University of Belgrade; Hallym University; Hallym University; University of Virginia; University of Virginia	Jevtovic-Todorovic, V (corresponding author), Univ Virginia Hlth Syst, Dept Anesthesiol, Charlottesville, VA 22903 USA.	vj3w@virginia.edu	Obradovic, Aleksandar/AAO-9200-2020	Obradovic, Aleksandar/0000-0003-0606-4913	National Institutes of Health [DA 029342]; American Diabetes Association Basic Research Grant [7-09-BS-190]; UVA Diabetes Launch Pad Grant; Hallym University; Harold Carron Endowment; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA029342] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Basic Research Grant(American Diabetes Association); UVA Diabetes Launch Pad Grant; Hallym University; Harold Carron Endowment; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by grants from National Institutes of Health DA 029342 to SMT and VJT, American Diabetes Association Basic Research Grant 7-09-BS-190 to SMT, UVA Diabetes Launch Pad Grant to VJT, funds from Hallym University to SJH and SMH, and the Harold Carron Endowment to VJT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbara G, 2009, J NEUROSCI, V29, P13106, DOI 10.1523/JNEUROSCI.2919-09.2009; Barriere DA, 2012, PAIN, V153, P553, DOI 10.1016/j.pain.2011.11.019; Bourinet E, 2005, EMBO J, V24, P315, DOI 10.1038/sj.emboj.7600515; Brederson JD, 2013, EUR J PHARMACOL, V716, P61, DOI 10.1016/j.ejphar.2013.03.003; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Choe W, 2011, MOL PHARMACOL, V80, P900, DOI 10.1124/mol.111.073205; CHOI Y, 1994, PAIN, V59, P369, DOI 10.1016/0304-3959(94)90023-X; Clozel JP, 1997, J HYPERTENS, V15, pS17, DOI 10.1097/00004872-199715055-00004; Dogrul A, 2003, PAIN, V105, P159, DOI 10.1016/S0304-3959(03)00177-5; Edwards JL, 2008, PHARMACOL THERAPEUT, V120, P1, DOI 10.1016/j.pharmthera.2008.05.005; Ertel SI, 1997, CARDIOVASC DRUG THER, V11, P723, DOI 10.1023/A:1007706022381; Flatters SJL, 2004, PAIN, V109, P150, DOI 10.1016/j.pain.2004.01.029; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hulse RP, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-41; Jagodic MM, 2007, J NEUROSCI, V27, P3305, DOI 10.1523/JNEUROSCI.4866-06.2007; Jimenez C, 2000, NEUROPHARMACOLOGY, V39, P1, DOI 10.1016/S0028-3908(99)00153-7; Karam H, 1999, HYPERTENSION, V34, P673, DOI 10.1161/01.HYP.34.4.673; Khomula EV, 2013, BBA-MOL BASIS DIS, V1832, P636, DOI 10.1016/j.bbadis.2013.01.017; Kraus RL, 2010, J PHARMACOL EXP THER, V335, P409, DOI 10.1124/jpet.110.171058; Latham JR, 2009, DIABETES, V58, P2656, DOI 10.2337/db08-1763; McDonough SI, 1998, MOL PHARMACOL, V54, P1080, DOI 10.1124/mol.54.6.1080; McNulty MM, 2004, MOL PHARMACOL, V66, P1652, DOI 10.1124/mol.66.6.1652; Messinger RB, 2009, PAIN, V145, P184, DOI 10.1016/j.pain.2009.06.012; Naik AK, 2008, NEUROSCIENCE, V154, P1539, DOI 10.1016/j.neuroscience.2008.04.061; Nelson MT, 2007, J NEUROSCI, V27, P8250, DOI 10.1523/JNEUROSCI.1800-07.2007; Nelson MT, 2005, J NEUROSCI, V25, P8766, DOI 10.1523/JNEUROSCI.2527-05.2005; Paquette F, 1999, CARDIOVASC DRUG THER, V13, P525, DOI 10.1023/A:1007879704878; Reid G, 2001, NATURE, V413, P480, DOI 10.1038/35097164; Sandmann S, 2001, J CARDIOVASC PHARM, V37, P64, DOI 10.1097/00005344-200101000-00008; Todorovic SM, 2011, BRIT J PHARMACOL, V163, P484, DOI 10.1111/j.1476-5381.2011.01256.x; Todorovic SM, 2002, BRAIN RES, V951, P336, DOI 10.1016/S0006-8993(02)03350-4; Todorovic SM, 1998, J NEUROPHYSIOL, V79, P240, DOI 10.1152/jn.1998.79.1.240; Uebele VN, 2009, J CLIN INVEST, V119, P1659, DOI 10.1172/JCI36954; Viana F, 2002, NAT NEUROSCI, V5, P254, DOI 10.1038/nn809; Viana F, 1997, CELL CALCIUM, V22, P299, DOI 10.1016/S0143-4160(97)90068-3; Wu ZZ, 2004, J PHARMACOL EXP THER, V311, P939, DOI 10.1124/jpet.104.073429	36	44	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e91467	10.1371/journal.pone.0091467	http://dx.doi.org/10.1371/journal.pone.0091467			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705276	Green Published, Green Submitted, gold			2022-12-25	WOS:000334107500004
J	Yadav, K; Kumar, C; Archana, G; Kumar, GN				Yadav, Kavita; Kumar, Chanchal; Archana, G.; Kumar, G. Naresh			Pseudomonas fluorescens ATCC 13525 Containing an Artificial Oxalate Operon and Vitreoscilla Hemoglobin Secretes Oxalic Acid and Solubilizes Rock Phosphate in Acidic Alfisols	PLOS ONE			English	Article							HETEROLOGOUS EXPRESSION; OXALOACETATE HYDROLASE; OXALOBACTER-FORMIGENES; TRICARBOXYLIC-ACID; ORGANIC-ACIDS; PLANT-GROWTH; TRANSPORTER; BACTERIA; CLONING; INVOLVEMENT	Oxalate secretion was achieved in Pseudomonas fluorescens ATCC 13525 by incorporation of genes encoding Aspergillus niger oxaloacetate acetyl hydrolase (oah), Fomitopsis plaustris oxalate transporter (FpOAR) and Vitreoscilla hemoglobin (vgb) in various combinations. Pf (pKCN2) transformant containing oah alone accumulated 19 mM oxalic acid intracellularly but secreted 1.2 mM. However, in the presence of an artificial oxalate operon containing oah and FpOAR genes in plasmid pKCN4, Pf (pKCN4) secreted 13.6 mM oxalate in the medium while 3.6 mM remained inside. This transformant solubilized 509 mM of phosphorus from rock phosphate in alfisol which is 4.5 fold higher than the Pf (pKCN2) transformant. Genomic integrants of P. fluorescens (Pf int1 and Pf int2) containing artificial oxalate operon (plac-FpOAR-oah) and artificial oxalate gene cluster (plac-FpOAR-oah, vgb, egfp) secreted 4.8 mM and 5.4 mM oxalic acid, released 329 mM and 351 mM P, respectively, in alfisol. The integrants showed enhanced root colonization, improved growth and increased P content of Vigna radiata plants. This study demonstrates oxalic acid secretion in P. fluorescens by incorporation of an artificial operon constituted of genes for oxalate synthesis and transport, which imparts mineral phosphate solubilizing ability to the organism leading to enhanced growth and P content of V. radiata in alfisol soil.	[Yadav, Kavita; Kumar, Chanchal; Kumar, G. Naresh] Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Biochem, Mol Microbial Biochem Lab, Vadodara, India; [Archana, G.] Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Microbiol, Vadodara, India; [Archana, G.] Maharaja Sayajirao Univ Baroda, Fac Sci, Ctr Biotechnol, Vadodara, India	Maharaja Sayajirao University Baroda; Maharaja Sayajirao University Baroda; Maharaja Sayajirao University Baroda	Kumar, GN (corresponding author), Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Biochem, Mol Microbial Biochem Lab, Vadodara, India.	gnaresh_k@yahoo.co.in	Kumar, Chanchal/I-8545-2016; Archana, G/AAA-8828-2019; Gattupalli, Naresh Kumar/AAF-5987-2020	Gattupalli, Nareshkumar/0000-0001-7317-7438; YADAV, KAVITA/0000-0002-2249-0675	Council for Scientific and Industrial Research, (CSIR) New Delhi, Government of India	Council for Scientific and Industrial Research, (CSIR) New Delhi, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	CK was provided with a fellowship from the Council for Scientific and Industrial Research, (CSIR) New Delhi, Government of India.	AE N, 1990, SCIENCE, V248, P477, DOI 10.1126/science.248.4954.477; Ae N, 1991, PHOSPHORUS RESPONSE; Agbenin JO, 2003, SOIL SCI SOC AM J, V67, P589, DOI 10.2136/sssaj2003.0589; Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; Yarzabal LA, 2010, SOIL BIOL, V21, P209, DOI 10.1007/978-3-642-05076-3_10; Appanna VD, 2003, CURR MICROBIOL, V47, P521, DOI 10.1007/s00284-003-4100-y; Archana G., 2012, MICROORGANISMS SUSTA, P35, DOI DOI 10.1007/978-94-007-2214-9_3; BOLAN NS, 1994, BIOL FERT SOILS, V18, P311, DOI 10.1007/BF00570634; Buch AD, 2010, APPL MICROBIOL BIOT, V88, P209, DOI 10.1007/s00253-010-2717-x; Chen C, 2010, J BIOL CHEM, V285, P26685, DOI 10.1074/jbc.M110.117804; Chien SH, 2011, NUTR CYCL AGROECOSYS, V89, P229, DOI 10.1007/s10705-010-9390-4; Choi KH, 2005, NAT METHODS, V2, P443, DOI 10.1038/NMETH765; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; COHEN SN, 1972, P NATL ACAD SCI USA, V69, P2110, DOI 10.1073/pnas.69.8.2110; El-Swaify S.A., 1985, ADV SOIL SCI, V1, P1, DOI [10.1007/978-1-4612-5046-3_1, DOI 10.1007/978-1-4612-5046-3_]; Fu DX, 1998, J BIOL CHEM, V273, P17962, DOI 10.1074/jbc.273.28.17962; Gadd GM, 1999, ADV MICROB PHYSIOL, V41, P47, DOI 10.1016/S0065-2911(08)60165-4; Gyaneshwar P, 1999, FEMS MICROBIOL LETT, V171, P223, DOI 10.1111/j.1574-6968.1999.tb13436.x; Gyaneshwar P, 1998, WORLD J MICROB BIOT, V14, P669, DOI 10.1023/A:1008852718733; Gyaneshwar P, 2002, PLANT SOIL, V245, P83, DOI 10.1023/A:1020663916259; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Han Y, 2007, J BIOL CHEM, V282, P9581, DOI 10.1074/jbc.M608961200; Hinsinger P, 2001, PLANT SOIL, V237, P173, DOI 10.1023/A:1013351617532; JONES DL, 1994, PLANT SOIL, V166, P247, DOI 10.1007/BF00008338; Khademi Z, 2010, PLANT SOIL, V334, P151, DOI 10.1007/s11104-009-0215-7; KHAN MS, 2006, AGRON SUSTAIN DEV, V26, P1, DOI DOI 10.1051/agro:2005055; KHOSLA C, 1988, MOL GEN GENET, V214, P158, DOI 10.1007/BF00340195; KHOSLA C, 1988, NATURE, V331, P633, DOI 10.1038/331633a0; KPOMBLEKOUA K, 1994, SOIL SCI, V158, P442, DOI 10.1097/00010694-199415860-00006; KUBICEK CP, 1988, APPL ENVIRON MICROB, V54, P633, DOI 10.1128/AEM.54.3.633-637.1988; KUCEY RMN, 1989, ADV AGRON, V42, P199; LENZ H, 1976, EUR J BIOCHEM, V65, P225, DOI 10.1111/j.1432-1033.1976.tb10409.x; Liu YH, 2012, J FOOD AGRIC ENVIRON, V10, P1001; Ma JF, 1998, PLANT PHYSIOL, V117, P753, DOI 10.1104/pp.117.3.753; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Patel KJ, 2010, J MICROBIOL BIOTECHN, V20, P1491, DOI 10.4014/jmb.1006.06016; Pedersen H, 2000, MOL GEN GENET, V263, P281, DOI 10.1007/s004380051169; PETERSON GL, 1979, ANAL BIOCHEM, V100, P201, DOI 10.1016/0003-2697(79)90222-7; Rajan SSS, 1996, ADV AGRON, V57, P77, DOI 10.1016/S0065-2113(08)60923-2; Ramirez M, 1999, MOL PLANT MICROBE IN, V12, P1008, DOI 10.1094/MPMI.1999.12.11.1008; Reyes I, 1999, FEMS MICROBIOL ECOL, V28, P291, DOI 10.1016/S0168-6496(98)00118-4; Rodriguez H, 1999, BIOTECHNOL ADV, V17, P319, DOI 10.1016/S0734-9750(99)00014-2; Sambrook J, 2001, MOL CLONING LAB MANU; Singh R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007344; Srivastava S, 2006, DEV PLANT SOIL SCI, P117; Stark BC, 2011, BIOTECHNOL LETT, V33, P1705, DOI 10.1007/s10529-011-0621-9; Valentini M, 2011, J BACTERIOL, V193, P4307, DOI 10.1128/JB.05074-11; Vassilev N, 1996, BIORESOURCE TECHNOL, V55, P237, DOI 10.1016/0960-8524(96)00008-9; VONUEXKULL HR, 1995, PLANT SOIL, V171, P1, DOI 10.1007/BF00009558; Watanabe T, 2010, APPL ENVIRON MICROB, V76, P7683, DOI 10.1128/AEM.00829-10; Ye LW, 2001, J BACTERIOL, V183, P2490, DOI 10.1128/JB.183.8.2490-2496.2001	51	11	12	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e92400	10.1371/journal.pone.0092400	http://dx.doi.org/10.1371/journal.pone.0092400			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705024	Green Published, gold, Green Submitted			2022-12-25	WOS:000334107500016
J	Brizuela, M; Huang, HM; Smith, C; Burgio, G; Foote, SJ; McMorran, BJ				Brizuela, Mariana; Huang, Hong Ming; Smith, Clare; Burgio, Gaetan; Foote, Simon J.; McMorran, Brendan J.			Treatment of Erythrocytes with the 2-Cys Peroxiredoxin Inhibitor, Conoidin A, Prevents the Growth of Plasmodium falciparum and Enhances Parasite Sensitivity to Chloroquine	PLOS ONE			English	Article							OXIDATIVE STRESS; MALARIA; RESISTANCE; ARTEMISININ; GLUTATHIONE; PEROXIDE; SURVIVAL; REQUIRES; DEFENSE; BERGHEI	The human erythrocyte contains an abundance of the thiol-dependant peroxidase Peroxiredoxin-2 (Prx2), which protects the cell from the pro-oxidant environment it encounters during its 120 days of life in the blood stream. In malarial infections, the Plasmodium parasite invades red cells and imports Prx2 during intraerythrocytic development, presumably to supplement in its own degradation of peroxides generated during cell metabolism, especially hemoglobin (Hb) digestion. Here we demonstrate that an irreversible Prx2 inhibitor, Conoidin A (2,3-bis(bromomethyl)-1,4-dioxide-quinoxaline; BBMQ), has potent cytocidal activity against cultured P. falciparum. Parasite growth was also inhibited in red cells that were treated with BBMQ and then washed prior to parasite infection. These cells remained susceptible to merozoite invasion, but failed to support normal intraerythrocytic development. In addition the potency of chloroquine (CQ), an antimalarial drug that prevents the detoxification of Hb-derived heme, was significantly enhanced in the presence of BBMQ. CQ IC50 values decreased an order of magnitude when parasites were either co-incubated with BBMQ, or introduced into BBMQ-pretreated cells; these effects were equivalent for both drug-resistant and drug-sensitive parasite lines. Together these results indicate that treatment of red cells with BBMQ renders them incapable of supporting parasite growth and increases parasite sensitivity to CQ. We also propose that molecules such as BBMQ that target host cell proteins may constitute a novel host-directed therapeutic approach for treating malaria.	[Brizuela, Mariana; Smith, Clare] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia; [Huang, Hong Ming; Burgio, Gaetan; Foote, Simon J.; McMorran, Brendan J.] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia	University of Tasmania; Macquarie University	McMorran, BJ (corresponding author), Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia.	Brendan.mcmorran@mq.edu.au	Burgio, Gaetan/B-6722-2015	Burgio, Gaetan/0000-0002-7434-926X; McMorran, Brendan/0000-0003-1845-8872; Foote, Simon/0000-0002-9142-2107; Smith, Clare M./0000-0003-2601-0955	Australian Research Council [DP120100061]; National Health and Medical Research Council of Australia [490037, 605524]; Australian Cancer Research Foundation; National Collaborative Research Infrastructure Strategy of Australia; Bill & Melinda Gates Foundation Grand Challenges Explorations; Howard Hughes Medical Institute	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Cancer Research Foundation; National Collaborative Research Infrastructure Strategy of Australia(Australian GovernmentDepartment of Industry, Innovation and Science); Bill & Melinda Gates Foundation Grand Challenges Explorations; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	The Australian Research Council (DP120100061; http://www.arc.gov.au); The National Health and Medical Research Council of Australia (490037 and 605524), http://www.nhmrc.gov.au. Australian Cancer Research Foundation, The National Collaborative Research Infrastructure Strategy of Australia, The Bill & Melinda Gates Foundation Grand Challenges Explorations and The Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker K, 2004, INT J PARASITOL, V34, P163, DOI 10.1016/j.ijpara.2003.09.011; Cimen MYB, 2008, CLIN CHIM ACTA, V390, P1, DOI 10.1016/j.cca.2007.12.025; DUBOIS VL, 1995, EXP PARASITOL, V81, P117, DOI 10.1006/expr.1995.1099; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Fitch CD, 2004, LIFE SCI, V74, P1957, DOI 10.1016/j.lfs.2003.10.003; Foote SJ, 2004, PHARMACOGENOMICS J, V4, P141, DOI 10.1038/sj.tpj.6500241; Foth BJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006411; Frosch AEP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-116; Han YH, 2012, BIOCHEM BIOPH RES CO, V426, P427, DOI 10.1016/j.bbrc.2012.08.113; Haraldsen JD, 2009, ORG BIOMOL CHEM, V7, P3040, DOI 10.1039/b901735f; Klonis N, 2011, P NATL ACAD SCI USA, V108, P11405, DOI 10.1073/pnas.1104063108; Koncarevic S, 2009, P NATL ACAD SCI USA, V106, P13323, DOI 10.1073/pnas.0905387106; Krnajski Z, 2002, J BIOL CHEM, V277, P25970, DOI 10.1074/jbc.M203539200; Lee TH, 2003, BLOOD, V101, P5033, DOI 10.1182/blood-2002-08-2548; Li QG, 2007, CYTOM PART A, V71A, P297, DOI 10.1002/cyto.a.20380; Low FM, 2007, BLOOD, V109, P2611, DOI 10.1182/blood-2006-09-048728; McMorran BJ, 2009, SCIENCE, V323, P797, DOI 10.1126/science.1166296; MOORE RB, 1991, J BIOL CHEM, V266, P18964; Muller S, 2004, MOL MICROBIOL, V53, P1291, DOI 10.1111/j.1365-2958.2004.04257.x; Nickel C, 2006, ANTIOXID REDOX SIGN, V8, P1227, DOI 10.1089/ars.2006.8.1227; Nogueira F, 2010, ACTA TROP, V114, P109, DOI 10.1016/j.actatropica.2010.01.013; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; Prudencio M, 2013, CURR PHARM DESIGN, V19, P290, DOI 10.2174/138161213804070276; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Richard D, 2011, J BIOL CHEM, V286, P11746, DOI 10.1074/jbc.M110.198499; Safeukui I, 2004, BIOCHEM PHARMACOL, V68, P1903, DOI 10.1016/j.bcp.2004.05.049; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tucker MS, 2012, ANTIMICROB AGENTS CH, V56, P302, DOI 10.1128/AAC.05540-11; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Wilson DW, 2013, ANTIMICROB AGENTS CH, V57, P1455, DOI 10.1128/AAC.01881-12; Witkowski B, 2010, ANTIMICROB AGENTS CH, V54, P1872, DOI 10.1128/AAC.01636-09	31	29	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e92411	10.1371/journal.pone.0092411	http://dx.doi.org/10.1371/journal.pone.0092411			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699133	gold, Green Published, Green Submitted			2022-12-25	WOS:000334105000025
J	Rod, NH; Kumari, M; Lange, T; Kivimaki, M; Shipley, M; Ferrie, J				Rod, Naja Hulvej; Kumari, Meena; Lange, Theis; Kivimaeki, Mika; Shipley, Martin; Ferrie, Jane			The Joint Effect of Sleep Duration and Disturbed Sleep on Cause-Specific Mortality: Results from the Whitehall II Cohort Study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; RISK; EPIDEMIOLOGY; ASSOCIATIONS; INSOMNIA; QUALITY	Background: Both sleep duration and sleep quality are related to future health, but their combined effects on mortality are unsettled. We aimed to examine the individual and joint effects of sleep duration and sleep disturbances on cause-specific mortality in a large prospective cohort study. Methods: We included 9,098 men and women free of pre-existing disease from the Whitehall II study, UK. Sleep measures were self-reported at baseline (1985-1988). Participants were followed until 2010 in a nationwide death register for total and cause-specific (cardiovascular disease, cancer and other) mortality. Results: There were 804 deaths over a mean 22 year follow-up period. In men, short sleep (<= 6 hrs/night) and disturbed sleep were not independently associated with CVD mortality, but there was an indication of higher risk among men who experienced both (HR = 1.57; 95% CI: 0.96-2.58). In women, short sleep and disturbed sleep were independently associated with CVD mortality, and women with both short and disturbed sleep experienced a much higher risk of CVD mortality (3.19; 1.52-6.72) compared to those who slept 7-8 hours with no sleep disturbances; equivalent to approximately 90 additional deaths per 100,000 person years. Sleep was not associated with death due to cancer or other causes. Conclusion: Both short sleep and disturbed sleep are independent risk factors for CVD mortality in women and future studies on sleep may benefit from assessing disturbed sleep in addition to sleep duration in order to capture health-relevant features of inadequate sleep.	[Rod, Naja Hulvej; Lange, Theis] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Rod, Naja Hulvej] Copenhagen Stress Res Ctr, Copenhagen, Denmark; [Kumari, Meena; Kivimaeki, Mika; Shipley, Martin; Ferrie, Jane] UCL, Dept Epidemiol & Publ Hlth, London, England; [Ferrie, Jane] Univ Bristol, Sch Social & Community Med, Bristol, England	University of Copenhagen; University of London; University College London; University of Bristol	Rod, NH (corresponding author), Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark.	nahuro@sund.ku.dk	Ferrie, Jane/AAZ-2009-2020; Kivimaki, Mika/B-3607-2012; Rod, Naja/B-9411-2015	Kivimaki, Mika/0000-0002-4699-5627; Rod, Naja/0000-0002-6400-5105; Lange, Theis/0000-0001-6807-8347	UK Dunhill Medical Trust; National Heart, Lung and Blood Institute [R01HL36310]; ESRC professorship, UK; Academy of Finland; EU New OSH ERA research programme; British Heart Foundation; ESRC [ES/H029745/1, ES/K005146/1, ES/J023299/1] Funding Source: UKRI; MRC [MR/K013351/1] Funding Source: UKRI; British Heart Foundation [RG/13/2/30098] Funding Source: researchfish; Economic and Social Research Council [ES/H029745/1, ES/J023299/1, ES/K005146/1] Funding Source: researchfish; Medical Research Council [MR/K013351/1] Funding Source: researchfish; The Dunhill Medical Trust [R247/0512] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013196] Funding Source: NIH RePORTER	UK Dunhill Medical Trust; National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ESRC professorship, UK(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Academy of Finland(Academy of Finland); EU New OSH ERA research programme; British Heart Foundation(British Heart Foundation); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Dunhill Medical Trust(Dunhill Medical Trust); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The UK Medical Research Council, British Heart Foundation, and the US National Institutes of Health (R01HL36310, R01AG013196) have supported collection of data in the Whitehall II Study. Meena Kumari is supported by the UK Dunhill Medical Trust and the National Heart, Lung and Blood Institute (R01HL36310); Mika Kivimaki by an ESRC professorship, UK, the Academy of Finland, and the EU New OSH ERA research programme; and Martin J. Shipley by the British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cappuccio FP, 2007, HYPERTENSION, V50, P693, DOI 10.1161/HYPERTENSIONAHA.107.095471; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Chandola T, 2010, SLEEP, V33, P739, DOI 10.1093/sleep/33.6.739; Chien KL, 2010, SLEEP, V33, P177, DOI 10.1093/sleep/33.2.177; Ferrie JE, 2007, SLEEP, V30, P1659, DOI 10.1093/sleep/30.12.1659; Ferrie JE, 2011, SLEEP EPIDEMIOLOGY A; Gallicchio L, 2009, J SLEEP RES, V18, P148, DOI 10.1111/j.1365-2869.2008.00732.x; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Greenland S, 2009, EPIDEMIOLOGY, V20, P14, DOI 10.1097/EDE.0b013e318193e7b5; Hoevenaar-Blom MP, 2011, SLEEP, V34, P1487, DOI 10.5665/sleep.1382; Krueger PM, 2009, AM J EPIDEMIOL, V169, P1052, DOI 10.1093/aje/kwp023; Kumari M, 2009, J CLIN ENDOCR METAB, V94, P4801, DOI 10.1210/jc.2009-0555; Lockley SW, 1999, J SLEEP RES, V8, P175, DOI 10.1046/j.1365-2869.1999.00155.x; Marmot M, 2005, INT J EPIDEMIOL, V34, P251, DOI 10.1093/ije/dyh372; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Martinussen T., 2006, STAT BIOL HEALTH; McEwen BS, 2006, METABOLISM, V55, pS20, DOI 10.1016/j.metabol.2006.07.008; Miller MA, 2009, SLEEP, V32, P857; Patel SR, 2004, SLEEP, V27, P440, DOI 10.1093/sleep/27.3.440; Punjabi Naresh M, 2008, Proc Am Thorac Soc, V5, P136, DOI 10.1513/pats.200709-155MG; Rod NH, 2012, EPIDEMIOLOGY, V23, P733, DOI 10.1097/EDE.0b013e31825fa218; Rod NH, 2011, AM J EPIDEMIOL, V173, P300, DOI 10.1093/aje/kwq371; Signal TL, 2005, AVIAT SPACE ENVIR MD, V76, P1058; Swerdlow DI, 2012, LANCET, V379, P1214, DOI 10.1016/S0140-6736(12)60110-X; Tasali E, 2009, PROG CARDIOVASC DIS, V51, P381, DOI 10.1016/j.pcad.2008.10.002; Vgontzas AN, 2010, SLEEP, V33, P1159, DOI 10.1093/sleep/33.9.1159; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Young T, 2000, SLEEP, V23, pS122	28	70	70	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e91965	10.1371/journal.pone.0091965	http://dx.doi.org/10.1371/journal.pone.0091965			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699341	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000334105000018
J	Fujita, M; Takada, YK; Izumiya, Y; Takada, Y				Fujita, Masaaki; Takada, Yoko K.; Izumiya, Yoshihiro; Takada, Yoshikazu			The Binding of Monomeric C-Reactive Protein (mCRP) to Integrins alpha v beta 3 and alpha 4 beta 1 Is Related to Its Pro-Inflammatory Action	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; ACTIVATED PLATELETS; ENDOTHELIAL-CELLS; LIGAND-BINDING; RISK; EXPRESSION; SUBUNIT; MARKERS	The prototypic acute phase reactant C-reactive protein (CRP) is not only a marker but also a potential contributor to inflammatory diseases. CRP exists as the circulating native, pentameric CRP (pCRP) and the monomeric isoform (mCRP), formed as a result of a dissociation process of pCRP. mCRP is highly pro-inflammatory, but pCRP is not. The mechanism of pro-inflammatory action of mCRP is unclear. We studied the role of integrins in pro-inflammatory action of mCRP. Docking simulation of interaction between mCRP and integrin alpha v beta 3 predicted that mCRP binds to alpha v beta 3 well. We found that mCRP actually bound to integrins alpha v beta 3 and alpha 4 beta 1 well. Antagonists to alpha v beta 3 or alpha 4 beta 1 effectively suppressed the interaction, suggesting that the interaction is specific. Using an integrin beta 1 mutant (beta 1-3-1) that has a small fragment from the ligand binding site of beta 3, we showed that mCRP bound to the classical RGD-binding site in alpha v beta 3. We studied the role of integrins in CRP signaling in monocytic U937 cells. Integrins alpha v beta 3 and alpha 4 beta 1 specifically mediated binding of mCRP to U937 cells. mCRP induced AKT phosphorylation, but not ERK1/2 phosphorylation, in U937 cells. Notably, mCRP induced robust chemotaxis in U937 cells, and antagonists to integrins alpha v beta 3 and alpha 4 beta 1 and an inhibitor to phosphatidylinositide 3-kinase, but not an MEK inhibitor, effectively suppressed mCRP-induced chemotaxis in U937 cells. These results suggest that the integrin and AKT/phosphatidylinositide 3-kinase pathways play a role in pro-inflammatory action of mCRP in U937 cells. In contrast, pCRP is predicted to have a limited access to alpha v beta 3 due to steric hindrance in the simulation. Consistent with the prediction, pCRP was much less effective in integrin binding, chemotaxis, or AKT phosphorylation. These findings suggest that the ability of CRP isoforms to bind to the integrins is related to their pro-inflammatory action.	[Takada, Yoshikazu] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA; Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis	Takada, Y (corresponding author), Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA.	ytakada@ucdavis.edu			NIH [CA13015]; TRDRP [18TX-0169]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TRDRP; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH CA13015 and TRDRP (tobacco-related disease research program; grant 18TX-0169) to YT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonov AS, 2004, AM J PATHOL, V165, P247, DOI 10.1016/S0002-9440(10)63293-2; AUMAILLEY M, 1991, FEBS LETT, V291, P50, DOI 10.1016/0014-5793(91)81101-D; Brennan MP, 2008, J THROMB HAEMOST, V6, P1239, DOI 10.1111/j.1538-7836.2008.02993.x; Chen LL, 1999, J BIOL CHEM, V274, P13167, DOI 10.1074/jbc.274.19.13167; Eisenhardt SU, 2009, TRENDS CARDIOVAS MED, V19, P232, DOI 10.1016/j.tcm.2010.02.002; Eisenhardt SU, 2009, CELL CYCLE, V8, P3885, DOI 10.4161/cc.8.23.10068; Eisenhardt SU, 2009, CIRC RES, V105, P128, DOI 10.1161/CIRCRESAHA.108.190611; Heuertz RM, 2005, INT J BIOCHEM CELL B, V37, P320, DOI 10.1016/j.biocel.2004.07.002; HOSHIGA M, 1995, CIRC RES, V77, P1129, DOI 10.1161/01.RES.77.6.1129; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; IRIE A, 1995, EMBO J, V14, P5550, DOI 10.1002/j.1460-2075.1995.tb00242.x; Ji SR, 2009, FASEB J, V23, P1806, DOI 10.1096/fj.08-116962; KAMATA T, 1995, BIOCHEM J, V305, P945, DOI 10.1042/bj3050945; Khreiss T, 2004, CIRCULATION, V109, P2016, DOI 10.1161/01.CIR.0000125527.41598.68; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Molins B, 2008, ARTERIOSCL THROM VAS, V28, P2239, DOI 10.1161/ATVBAHA.108.174359; Mori S, 2008, J BIOL CHEM, V283, P18066, DOI 10.1074/jbc.M801213200; POTEMPA LA, 1983, MOL IMMUNOL, V20, P1165, DOI 10.1016/0161-5890(83)90140-2; POTEMPA LA, 1987, MOL IMMUNOL, V24, P531, DOI 10.1016/0161-5890(87)90028-9; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Saegusa J, 2008, J BIOL CHEM, V283, P26107, DOI 10.1074/jbc.M804835200; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Slevin M, 2010, BRAIN PATHOL, V20, P151, DOI 10.1111/j.1750-3639.2008.00256.x; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Takagi J, 1997, J BIOL CHEM, V272, P19794, DOI 10.1074/jbc.272.32.19794; Tsimikas S, 2006, J AM COLL CARDIOL, V47, pC19, DOI 10.1016/j.jacc.2005.10.066; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yeh ETH, 2003, CIRCULATION, V107, P370, DOI 10.1161/01.CIR.0000053731.05365.5A; Zhao J, 2010, CELL MOL BIOL LETT, V15, P485, DOI 10.2478/s11658-010-0022-4	29	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93738	10.1371/journal.pone.0093738	http://dx.doi.org/10.1371/journal.pone.0093738			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695572	gold, Green Published, Green Submitted			2022-12-25	WOS:000334103000115
J	Gaimster, H; Cama, J; Hernaandez-Ainsa, S; Keyser, UF; Summers, DK				Gaimster, Hannah; Cama, Jehangir; Hernandez-Ainsa, Silvia; Keyser, Ulrich F.; Summers, David K.			The Indole Pulse: A New Perspective on Indole Signalling in Escherichia coli	PLOS ONE			English	Article							STATIONARY-PHASE; GENES; RESISTANCE; EXPRESSION	Indole has diverse signalling roles, including modulation of biofilm formation, virulence and stress responses. Changes are induced by indole concentrations of 0.5-1.0 mM, similar to those found in the supernatant of Escherichia coli stationary phase culture. Here we describe an alternative mode of indole signalling that promotes the survival of E. coli cells during long-term stationary phase. A mutant that has lost the ability to produce indole demonstrates reduced survival under these conditions. Significantly, the addition of 1 mM indole to the culture supernatant is insufficient to restore long-term survival to the mutant. We provide evidence that the pertinent signal in this case is not 1 mM indole in the culture supernatant but a transient pulse of intra-cellular indole at the transition from exponential growth to stationary phase. During this pulse the cell-associated indole reaches a maximum of approximately 60 mM. We argue that this is sufficient to inhibit growth and division by an ionophore-based mechanism and causes the cells to enter stationary phase before resources are exhausted. The unused resources are used to repair and maintain cells during the extended period of starvation.	[Gaimster, Hannah; Summers, David K.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Cama, Jehangir; Hernandez-Ainsa, Silvia; Keyser, Ulrich F.] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England	University of Cambridge; University of Cambridge	Gaimster, H (corresponding author), Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.	hdg24@cam.ac.uk	Cama, Jehangir/K-3405-2019; Keyser, Ulrich/E-7696-2012; Hernandez Ainsa, silvia/J-9171-2017	Cama, Jehangir/0000-0002-5982-1941; Keyser, Ulrich/0000-0003-3188-5414; Hernandez Ainsa, silvia/0000-0003-3109-4284; Gaimster, Hannah/0000-0002-8593-0746	BBSRC DTG studentship [PCAG-EJNF]; ERC starting grant [261101 Passmembrane]; Internal Graduate Studentship from Trinity College, Cambridge; Biotechnology and Biological Sciences Research Council [BB/F002912/1] Funding Source: researchfish; BBSRC [BB/F002912/1] Funding Source: UKRI	BBSRC DTG studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ERC starting grant(European Research Council (ERC)); Internal Graduate Studentship from Trinity College, Cambridge; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	HG was funded by a BBSRC DTG studentship, http://www.bbsrc.ac.uk/home/home.aspx, grant number PCAG-EJNF. JC, SHA and UFK acknowledge support from an ERC starting grant, http://erc.europa.eu/, grant number 261101 Passmembrane. JC is also supported by an Internal Graduate Studentship from Trinity College, Cambridge, http://www.trin.cam.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERLUND T, 1995, J BACTERIOL, V177, P6791, DOI 10.1128/jb.177.23.6791-6797.1995; Alberts B., 2002, MOL BIOL CELL; Balding C, 2006, PLASMID, V56, P68, DOI 10.1016/j.plasmid.2005.12.001; Bansal T, 2010, P NATL ACAD SCI USA, V107, P228, DOI 10.1073/pnas.0906112107; Chant EL, 2007, MOL MICROBIOL, V63, P35, DOI 10.1111/j.1365-2958.2006.05481.x; Chimerel C, 2012, BIOCH BIOPHYSICA ACT, V1818; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Di Martino P, 2003, CAN J MICROBIOL, V49, P443, DOI 10.1139/W03-056; Hirakawa H, 2005, MOL MICROBIOL, V55, P1113, DOI 10.1111/j.1365-2958.2004.04449.x; Hirakawa H, 2010, MICROB PATHOGENESIS, V49, P90, DOI 10.1016/j.micpath.2010.05.002; Kamaraju K, 2011, BIOCHEMISTRY-US, V50, P6983, DOI 10.1021/bi200684z; Lacour S, 2004, J BACTERIOL, V186, P7186, DOI 10.1128/JB.186.21.7186-7195.2004; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; Li G, 2013, MICROBIOL-SGM, V159, P402, DOI 10.1099/mic.0.064139-0; NEWTON WA, 1962, P NATL ACAD SCI USA, V48, P1431, DOI 10.1073/pnas.48.8.1431; PATIENT ME, 1993, MOL MICROBIOL, V9, P1089, DOI 10.1111/j.1365-2958.1993.tb01238.x; Pinero-Fernandez S, 2011, J BACTERIOL, V193, P1793, DOI 10.1128/JB.01477-10; REID DF, 1966, J BACTERIOL, V92, P639, DOI 10.1128/JB.92.3.639-644.1966; SUMMERS DK, 1984, CELL, V36, P1097, DOI 10.1016/0092-8674(84)90060-6; Vazquez JL, 2001, INT J PHARMACEUT, V220, P53, DOI 10.1016/S0378-5173(01)00646-9; Volkmer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023126	21	41	44	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93168	10.1371/journal.pone.0093168	http://dx.doi.org/10.1371/journal.pone.0093168			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695245	Green Published, gold			2022-12-25	WOS:000334103000044
J	Chen, JH; Jin, EH; He, W; Zhao, LQ				Chen, Jiang-Hong; Jin, Er-Hu; He, Wen; Zhao, Li-Qin			Combining Automatic Tube Current Modulation with Adaptive Statistical Iterative Reconstruction for Low-Dose Chest CT Screening	PLOS ONE			English	Article							FILTERED BACK-PROJECTION; IMAGE-QUALITY; COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; REDUCTION; ALGORITHM; PATIENT; IMPACT; SIZE	Objective: To reduce radiation dose while maintaining image quality in low-dose chest computed tomography (CT) by combining adaptive statistical iterative reconstruction (ASIR) and automatic tube current modulation (ATCM). Methods: Patients undergoing cancer screening (n = 200) were subjected to 64-slice multidetector chest CT scanning with ASIR and ATCM. Patients were divided into groups 1, 2, 3, and 4 (n = 50 each), with a noise index (NI) of 15, 20, 30, and 40, respectively. Each image set was reconstructed with 4 ASIR levels (0% ASIR, 30% ASIR, 50% ASIR, and 80% ASIR) in each group. Two radiologists assessed subjective image noise, image artifacts, and visibility of the anatomical structures. Objective image noise and signal-to-noise ratio (SNR) were measured, and effective dose (ED)was recorded. Results: Increased NI was associated with increased subjective and objective image noise results (P<0.001), and SNR decreased with increasing NI (P<0.001). These values improved with increased ASIR levels (P, <0.001). Images from all 4 groups were clinically diagnosable. Images with NI = 30 and 50% ASIR had average subjective image noise scores and nearly average anatomical structure visibility scores, with a mean objective image noise of 23.42 HU. The EDs for groups 1, 2, 3 and 4 were 2.79 +/- 1.17, 1.69 +/- 0.59, 0.74 +/- 0.29, and 0.37 +/- 0.22 mSv, respectively. Compared to group 1 (NI = 15), the ED reductions were 39.43%, 73.48%, and 86.74% for groups 2, 3, and 4, respectively. Conclusions: Using NI = 30 with 50% ASIR in the chest CT protocol, we obtained average or above-average image quality but a reduced ED.	[Chen, Jiang-Hong; Jin, Er-Hu; He, Wen; Zhao, Li-Qin] Capital Med Univ, Beijing Friendship Hosp, Dept Radiol, Beijing, Peoples R China	Capital Medical University	Jin, EH (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Dept Radiol, Beijing, Peoples R China.	erhujin1@hotmail.com						Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Baumueller S, 2012, EUR RADIOL, V22, P2597, DOI 10.1007/s00330-012-2524-0; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Carr SR, 2012, J THORAC CARDIOV SUR, V143, P390, DOI 10.1016/j.jtcvs.2011.10.023; Church TR, 2013, NEW ENGL J MED, V368, P1980, DOI 10.1056/NEJMoa1209120; Deak PD, 2010, RADIOLOGY, V257, P158, DOI 10.1148/radiol.10100047; Desai GS, 2012, EUR RADIOL, V22, P1631, DOI 10.1007/s00330-012-2424-3; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Ghetti C, 2012, PHYS MEDICA, V28, P161, DOI 10.1016/j.ejmp.2011.03.003; Hall EJ, 2008, BRIT J RADIOL, V81, P362, DOI 10.1259/bjr/01948454; Hara AK, 2009, AM J ROENTGENOL, V193, P764, DOI 10.2214/AJR.09.2397; Heyer CM, 2007, RADIOLOGY, V245, P577, DOI 10.1148/radiol.2452061919; Hu XH, 2011, CLIN RADIOL, V66, P1023, DOI 10.1016/j.crad.2011.04.008; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kalra MK, 2004, RADIOLOGY, V232, P409, DOI 10.1148/radiol.2322031151; Kalra MK, 2004, RADIOLOGY, V230, P619, DOI 10.1148/radiol.2303021726; Katsura M, 2013, INVEST RADIOL, V48, P206, DOI 10.1097/RLI.0b013e31827efc3a; Kubo T, 2008, AM J ROENTGENOL, V190, P335, DOI 10.2214/AJR.07.2556; Lee CI, 2004, RADIOLOGY, V231, P393, DOI 10.1148/radiol.2312030767; Lee Y, 2012, J COMPUT ASSIST TOMO, V36, P512, DOI 10.1097/RCT.0b013e318260ce39; Leipsic J, 2010, AM J ROENTGENOL, V195, P1095, DOI 10.2214/AJR.09.4050; Marin D, 2010, RADIOLOGY, V254, P145, DOI 10.1148/radiol.09090094; May MS, 2011, INVEST RADIOL, V46, P465, DOI 10.1097/RLI.0b013e31821690a1; McCollough CH, 2006, RADIOGRAPHICS, V26, P503, DOI 10.1148/rg.262055138; Mitsumori LM, 2012, EUR RADIOL, V22, P138, DOI 10.1007/s00330-011-2186-3; Neroladaki A, 2013, EUR RADIOL, V23, P360, DOI 10.1007/s00330-012-2627-7; Pontana F, 2011, EUR RADIOL, V21, P627, DOI 10.1007/s00330-010-1990-5; Pontana F, 2011, EUR RADIOL, V21, P636, DOI 10.1007/s00330-010-1991-4; Prakash P, 2010, RADIOLOGY, V256, P261, DOI 10.1148/radiol.10091487; Prakash P, 2010, J COMPUT ASSIST TOMO, V34, P40, DOI 10.1097/RCT.0b013e3181b26c67; Prakash P, 2010, KOREAN J RADIOL, V11, P46, DOI 10.3348/kjr.2010.11.1.46; Rampado O, 2012, EUR J RADIOL, V81, P3172, DOI 10.1016/j.ejrad.2012.06.017; Sagara Y, 2010, AM J ROENTGENOL, V195, P713, DOI 10.2214/AJR.09.2989; Singh S, 2011, RADIOLOGY, V259, P565, DOI 10.1148/radiol.11101450; Uppot RN, 2006, RADIOLOGY, V240, P435, DOI 10.1148/radiol.2402051110; Yanagawa M, 2012, EUR J RADIOL, V81, P2877, DOI 10.1016/j.ejrad.2011.09.011	37	22	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92414	10.1371/journal.pone.0092414	http://dx.doi.org/10.1371/journal.pone.0092414			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691208	gold, Green Published, Green Submitted			2022-12-25	WOS:000334101100022
J	Chung, LP; Baltic, S; Ferreira, M; Temple, S; Waterer, G; Thompson, PJ				Chung, Li Ping; Baltic, Svetlana; Ferreira, Manuel; Temple, Suzanna; Waterer, Grant; Thompson, Philip J.			Beta2 Adrenergic Receptor (ADRb beta) Haplotype Pair (2/4) Is Associated with Severe Asthma	PLOS ONE			English	Article							HUMAN BETA(2)-ADRENERGIC RECEPTOR; BETA-2-ADRENERGIC RECEPTOR; BRONCHODILATOR RESPONSE; CROHNS-DISEASE; CD14 PROMOTER; TOTAL IGE; POLYMORPHISMS; GENE; GENOTYPE; ALBUTEROL	Background: ss 2 adrenergic receptor (ADRb2) polymorphisms including ADRb2+46G > A have been reported to cause adverse outcomes in mild asthmatics. The extent to which ADRb2 polymorphisms and in particular their haplotypes contribute to severe asthma is unknown. Objective: To determine the association of ADRb2 polymorphisms and haplotypes with asthma severity. Methods: Caucasians (n = 2979) were genotyped for 11 ADRb2 polymorphisms. The cohort (mean age 39.6, 60% female) included 2296 non-asthmatics, 386 mild asthmatics, 172 moderate asthmatics and 125 severe asthmatics. Haplotype frequency and haplotype pair for each subject was determined using the PHASE algorithm. Results: The three asthmatic cohorts were comparable in age and gender but were distinguishable from each other in terms of symptoms, spirometry, medication use and health care utilisation (p < 0.001). None of the polymorphisms showed a genotypic or allelic association with asthma diagnosis or severity. Nine haplotypes were identified and no association was found with asthma diagnosis or severity per se. Haplotype pair 2/4 was associated with asthma severity (Trend Test, OR 1.42, p = 0.0008) but not with asthma per se. Prevalence of haplotype pair 2/2 appeared to decrease with asthma severity ( Trend Test, OR 0.78, p = 0.067). Two new haplotypes were identified, occurring exclusively in asthmatics at a frequency of >= 1%. In addition, a positive association between carriage of ADRb2 +523*C and increased risk of atopy was discovered. Conclusions: ADRb2 haplotype pair 2/4 is associated with severe asthma and is consistent with findings of poor bronchodilator response in mild asthmatics who are also haplotype 2/4.	[Chung, Li Ping; Baltic, Svetlana; Temple, Suzanna; Thompson, Philip J.] Univ Western Australia, Lung Inst Western Australia, Mol Genet & Inflammat Unit, Nedlands, WA 6009, Australia; [Chung, Li Ping; Baltic, Svetlana; Temple, Suzanna; Thompson, Philip J.] Univ Western Australia, Ctr Asthma Allergy & Resp Res, Nedlands, WA 6009, Australia; [Chung, Li Ping; Baltic, Svetlana; Temple, Suzanna; Waterer, Grant; Thompson, Philip J.] Univ Western Australia, Sch Med & Pharmacol, Crawley, WA, Australia; [Ferreira, Manuel] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Thompson, Philip J.] Royal Perth Hosp, Dept Resp Med, Perth, WA 6001, Australia	University of Western Australia; University of Western Australia; University of Western Australia; QIMR Berghofer Medical Research Institute; Royal Perth Hospital; University of Western Australia	Chung, LP (corresponding author), Univ Western Australia, Lung Inst Western Australia, Mol Genet & Inflammat Unit, Nedlands, WA 6009, Australia.	lichung@liwa.uwa.edu.au	Ferreira, Manuel A R/D-3609-2013; Waterer, Grant/AAG-2385-2021	Ferreira, Manuel A R/0000-0001-9059-1825; Baltic, Svetlana/0000-0002-3428-940X	Lung Institute of Western Australia	Lung Institute of Western Australia	The funding for this report was derived from the Lung Institute of Western Australia as part of a PhD project. There were no external sources of funding that would otherwise affect the study design, data collection and analysis, decision to publish or presentation of the manuscript.	Anderson HR, 2005, BRIT MED J, V330, P117, DOI 10.1136/bmj.38316.729907.8F; Barbato E, 2007, HEART, V93, P856, DOI 10.1136/hrt.2006.091959; Beghe B, 2003, CLIN EXP ALLERGY, V33, P1111, DOI 10.1046/j.1365-2222.2003.01731.x; Bleecker ER, 2007, LANCET, V370, P2118, DOI 10.1016/S0140-6736(07)61906-0; Bleecker ER, 2006, J ALLERGY CLIN IMMUN, V118, P809, DOI 10.1016/j.jaci.2006.06.036; Brest P, 2010, CURR MOL MED, V10, P486, DOI 10.2174/156652410791608252; Brodde OE, 2001, CIRCULATION, V103, P1048, DOI 10.1161/01.CIR.103.8.1048; Buckova D, 2003, ALLERGY, V58, P1023, DOI 10.1034/j.1398-9995.2003.00271.x; Carroll CL, 2012, J ASTHMA, V49, P563, DOI 10.3109/02770903.2012.701362; Chung L, 2010, CLIN EXP AL IN PRESS; Deretic V, 2011, CURR OPIN IMMUNOL; Drazen JM, 2000, BRIT MED BULL, V56, P1054, DOI 10.1258/0007142001903535; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; Evans WE, 2003, NEW ENGL J MED, V348, P538, DOI 10.1056/NEJMra020526; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; GREEN SA, 1994, BIOCHEMISTRY-US, V33, P9414, DOI 10.1021/bi00198a006; GREEN SA, 1993, J BIOL CHEM, V268, P23116; Hawkins GA, 2006, AM J RESP CRIT CARE, V174, P1101, DOI 10.1164/rccm.200509-1405OC; Heinzmann A, 2003, J ALLERGY CLIN IMMUN, V112, P735, DOI 10.1016/S0091-6749(03)01887-6; Holloway JW, 2000, CLIN EXP ALLERGY, V30, P1097; Israel E, 2004, LANCET, V364, P1505, DOI 10.1016/S0140-6736(04)17273-5; Israel E, 2001, INT ARCH ALLERGY IMM, V124, P183, DOI 10.1159/000053705; Kabesch M, 2004, CLIN EXP ALLERGY, V34, P340, DOI 10.1111/j.1365-2222.2004.01860.x; Kabesch M, 2003, J ALLERGY CLIN IMMUN, V112, P893, DOI 10.1016/j.jaci.2003.08.033; Kedda MA, 2004, J ALLERGY CLIN IMMUN, V113, P889, DOI 10.1016/j.jaci.2004.02.008; KOBILKA BK, 1987, J BIOL CHEM, V262, P7321; Leung TF, 2003, PEDIAT ALLERG IMM-UK, V14, P255, DOI 10.1034/j.1399-3038.2003.00048.x; Manoharan A, 2013, ANN ALLERG ASTHMA IM, V110, P161, DOI 10.1016/j.anai.2012.12.019; Martinez FD, 1997, J CLIN INVEST, V100, P3184, DOI 10.1172/JCI119874; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; McGraw DW, 1998, J CLIN INVEST, V102, P1927, DOI 10.1172/JCI4862; Moffatt MF, 2004, CLIN EXP ALLERGY, V34, P325, DOI 10.1111/j.1365-2222.2004.01915.x; Moore PE, 2008, CTS-CLIN TRANSL SCI, V1, P155, DOI 10.1111/j.1752-8062.2008.00036.x; O'Donnell AR, 2004, AM J RESP CRIT CARE, V169, P615, DOI 10.1164/rccm.200302-278OC; Palmer CNA, 2006, THORAX, V61, P940, DOI 10.1136/thx.2006.059386; Panebra A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011819; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Proceedings of the ATS workshop on refractory asthma, 2000, AM J RESP CRIT CARE, V162, P2341, DOI DOI 10.1164/AJRCCM.162.6.ATS9-00; Qiu YY, 2010, ALLERGY ASTHMA PROC, V31, pE91, DOI 10.2500/aap.2010.31.3371; REIHSAUS E, 1993, AM J RESP CELL MOL, V8, P334, DOI 10.1165/ajrcmb/8.3.334; Silverman EK, 2003, J ALLERGY CLIN IMMUN, V112, P870, DOI 10.1016/S0091-6749(03)02023-2; Tan S, 1997, LANCET, V350, P995, DOI 10.1016/S0140-6736(97)03211-X; Taylor DR, 2000, THORAX, V55, P762, DOI 10.1136/thorax.55.9.762; Taylor DR, 2005, AM J RESP CRIT CARE, V172, P700, DOI 10.1164/rccm.200501-092OC; Torjussen TM, 2013, ACTA PAEDIATR, V102, P727, DOI 10.1111/apa.12221; Wan YI, 2012, THORAX, V67, P762, DOI 10.1136/thoraxjnl-2011-201262; Wechsler ME, 2006, AM J RESP CRIT CARE, V173, P519, DOI 10.1164/rccm.200509-1519OC; Wechsler ME, 2009, LANCET, V374, P1754, DOI 10.1016/S0140-6736(09)61492-6; Weir TD, 1998, AM J RESP CRIT CARE, V158, P787, DOI 10.1164/ajrccm.158.3.9801035; Weiss ST, 2006, PHARMACOGENOMICS J, V6, P311, DOI 10.1038/sj.tpj.6500387; Westland R, 2004, IMMUNOGENETICS, V56, P625, DOI 10.1007/s00251-004-0732-8; Wilson AM, 2006, ALLERGY, V61, P254, DOI 10.1111/j.1398-9995.2006.01001.x; Woo JG, 2003, J ALLERGY CLIN IMMUN, V112, P438, DOI 10.1067/mai.2003.1634; Woszczek G, 2005, ALLERGY, V60, P1412, DOI 10.1111/j.1398-9995.2005.00869.x	54	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93695	10.1371/journal.pone.0093695	http://dx.doi.org/10.1371/journal.pone.0093695			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691493	Green Published, Green Submitted, gold			2022-12-25	WOS:000334101100127
J	Han, S; Meng, LX; Han, S; Wang, YJ; Wu, AH				Han, Sheng; Meng, Lingxuan; Han, Shuai; Wang, Yunjie; Wu, Anhua			Plasma IGFBP-2 Levels after Postoperative Combined Radiotherapy and Chemotherapy Predict Prognosis in Elderly Glioblastoma Patients	PLOS ONE			English	Article							FACTOR-BINDING PROTEIN-2; SERUM-LEVELS; GROWTH; EXPRESSION; PROLIFERATION; SURVIVAL; CELLS; TEMOZOLOMIDE; PROGRESSION; MARKERS	It has been found that preoperative plasma IGFBP-2 levels correlate with prognosis in glioma patients. The prognostic value of plasma IGFBP-2 after postoperative combined radiotherapy and chemotherapy in glioma patients is unknown. Plasma IGFBP-2 levels in 83 glioblastoma patients after postoperative radiotherapy plus chemotherapy were analyzed using an IGFBP-2 ELISA kit. We found that after standard therapy plasma IGFBP-2 levels significantly correlated with the patient's age (R =0.738, P < 0.001) and Karnofsky performance status (KPS, R = -0.633, P < 0.05). Cox proportional hazards models were used to calculate hazard ratios (HRs) of death according to plasma IGFBP-2 levels adjusted for patient clinical characteristics. Plasma IGFBP-2 levels significantly correlated with overall survival in glioblastoma patients (multivariate HR=1.035; 95% CI, 1.024-1.047; P < 0.001). The effect of plasma IGFBP-2 levels on survival seemed to differ according to patients' age. Among patients older than 60, high plasma IGFBP-2 levels were associated with a significant increase in overall mortality (HR = 1.097; 95% CI, 1.055-1.140; P < 0.001). In contrast, plasma IGFBP-2 levels conferred no significant effect on mortality among patients younger than 60. Elevated plasma IGFBP-2 levels after combined postoperative radiotherapy and chemotherapy in elderly glioblastoma patients correlate with poor KPS score and predicts poor prognosis.	[Han, Sheng; Meng, Lingxuan; Han, Shuai; Wang, Yunjie; Wu, Anhua] China Med Univ, Hosp 1, Dept Neurosurg, Shenyang, Peoples R China	China Medical University	Wu, AH (corresponding author), China Med Univ, Hosp 1, Dept Neurosurg, Shenyang, Peoples R China.	cmuwuanhua@aliyun.com			National High Technology Research and Development Program of China (863) [2012AA02A508]; National Natural Science Foundation of China [81172409]; Science and Technology Department of Liaoning Province [2011225034]	National High Technology Research and Development Program of China (863)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Liaoning Province	This work was supported by grants from the National High Technology Research and Development Program of China (863) (No. 2012AA02A508), National Natural Science Foundation of China (No. 81172409) and Science and Technology Department of Liaoning Province (No. 2011225034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin S, 2007, J BONE MINER RES, V22, P799, DOI 10.1359/JBMR.070306; Azar WJ, 2014, ONCOGENE, V33, P578, DOI 10.1038/onc.2012.630; Carico C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033684; Chakrabarty S, 2006, CANCER BIOL THER, V5, P189, DOI 10.4161/cbt.5.2.2333; Chatterjee S, 2004, INT J UROL, V11, P876, DOI 10.1111/j.1442-2042.2004.00898.x; Clemmons DR, 2007, ENDOCRIN METAB CLIN, V36, P109, DOI 10.1016/j.ecl.2006.11.008; Duarte CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029653; Foulstone EJ, 2013, ENDOCRINOLOGY, V154, P1780, DOI 10.1210/en.2012-1970; Han S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.433; Han S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076717; Hoeflich A, 2003, HORM METAB RES, V35, P816; Hoeflich A, 2001, CANCER RES, V61, P8601; Hu DL, 2009, J AM GERIATR SOC, V57, P1213, DOI 10.1111/j.1532-5415.2009.02318.x; Iliadis G, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-3; Kitszel A, 2007, ADV MED SCI-POLAND, V52, P147; Kulkarni A, 2012, PATHOL ONCOL RES, V18, P961, DOI 10.1007/s12253-012-9526-8; Lancaster JM, 2006, INT J GYNECOL CANCER, V16, P1529, DOI 10.1111/j.1525-1438.2006.00623.x; Li SW, 2012, NEURO-ONCOLOGY, V14, P109, DOI 10.1093/neuonc/nor185; Lin Y, 2009, NEURO-ONCOLOGY, V11, P468, DOI 10.1215/15228517-2008-114; Malkoun N, 2012, J NEURO-ONCOL, V106, P127, DOI 10.1007/s11060-011-0643-0; Mattsson A, 2008, GROWTH HORM IGF RES, V18, P506, DOI 10.1016/j.ghir.2008.04.005; Natsume A, 2012, ONCOGENE, V31, P2715, DOI 10.1038/onc.2011.466; Quaranta M, 2007, TUMORI J, V93, P275; Russo VC, 2005, ENDOCRINOLOGY, V146, P4445, DOI 10.1210/en.2005-0467; Santosh V, 2010, CANCER EPIDEM BIOMAR, V19, P1399, DOI 10.1158/1055-9965.EPI-09-1213; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; van den Beld AW, 2003, EUR J ENDOCRINOL, V148, P627, DOI 10.1530/eje.0.1480627; Wang YZ, 2012, NEURO-ONCOLOGY, V14, P518, DOI 10.1093/neuonc/nor232; Zhang JX, 2011, NEURO-ONCOLOGY, V13, P600, DOI 10.1093/neuonc/nor034; Zhang W, 2002, BRAIN PATHOL, V12, P87; Zhou YH, 2005, NEURO-ONCOLOGY, V7, P485, DOI 10.1215/S1152851704000730	31	15	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93791	10.1371/journal.pone.0093791	http://dx.doi.org/10.1371/journal.pone.0093791			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690948	Green Published, Green Submitted, gold			2022-12-25	WOS:000334101100135
J	Provencal, N; Suderman, MJ; Guillemin, C; Vitaro, F; Cote, SM; Hallett, M; Tremblay, RE; Szyf, M				Provencal, Nadine; Suderman, Matthew J.; Guillemin, Claire; Vitaro, Frank; Cote, Sylvana M.; Hallett, Michael; Tremblay, Richard E.; Szyf, Moshe			Association of Childhood Chronic Physical Aggression with a DNA Methylation Signature in Adult Human T Cells	PLOS ONE			English	Article							GLUCOCORTICOID-RECEPTOR; DEVELOPMENTAL ORIGINS; CHROMATIN-STRUCTURE; PRENATAL EXPOSURE; TRAJECTORIES; WIDE; BEHAVIOR; EXPRESSION; SEROTONIN; DOPAMINE	Background: Chronic physical aggression ( CPA) is characterized by frequent use of physical aggression from early childhood to adolescence. Observed in approximately 5% of males, CPA is associated with early childhood adverse environments and long-term negative consequences. Alterations in DNA methylation, a covalent modification of DNA that regulates genome function, have been associated with early childhood adversity. Aims: To test the hypothesis that a trajectory of chronic physical aggression during childhood is associated with a distinct DNA methylation profile during adulthood. Methods: We analyzed genome-wide promoter DNA methylation profiles of T cells from two groups of adult males assessed annually for frequency of physical aggression between 6 and 15 years of age: a group with CPA and a control group. Methylation profiles covering the promoter regions of 20 000 genes and 400 microRNAs were generated using MeDIP followed by hybridization to microarrays. Results: In total, 448 distinct gene promoters were differentially methylated in CPA. Functionally, many of these genes have previously been shown to play a role in aggression and were enriched in biological pathways affected by behavior. Their locations in the genome tended to form clusters spanning millions of bases in the genome. Conclusions: This study provides evidence of clustered and genome-wide variation in promoter DNA methylation in young adults that associates with a history of chronic physical aggression from 6 to 15 years of age. However, longitudinal studies of methylation during early childhood will be necessary to determine if and how this methylation variation in T cells DNA plays a role in early development of chronic physical aggression.	[Provencal, Nadine; Suderman, Matthew J.; Guillemin, Claire; Szyf, Moshe] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Provencal, Nadine; Guillemin, Claire; Vitaro, Frank; Cote, Sylvana M.; Tremblay, Richard E.] Univ Montreal, Res Unit Childrens Psychosocial Maladjustment, Montreal, PQ, Canada; [Provencal, Nadine; Guillemin, Claire; Vitaro, Frank; Cote, Sylvana M.; Tremblay, Richard E.] Univ Montreal, St Justine Hosp Res Ctr, Montreal, PQ, Canada; [Provencal, Nadine; Suderman, Matthew J.; Guillemin, Claire; Szyf, Moshe] McGill Univ, Sackler Program Epigenet & Psychobiol, Montreal, PQ, Canada; [Tremblay, Richard E.] Univ Montreal, Dept Psychol & Pediat, Montreal, PQ, Canada; [Tremblay, Richard E.] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Populat Sci, Dublin, Ireland; [Suderman, Matthew J.; Hallett, Michael] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada; [Vitaro, Frank] Univ Montreal, Sch Psychoeduc, Montreal, PQ, Canada; [Cote, Sylvana M.] Univ Montreal, Sch Social & Prevent Med, Montreal, PQ, Canada	McGill University; Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; McGill University; Universite de Montreal; University College Dublin; McGill University; Universite de Montreal; Universite de Montreal	Tremblay, RE (corresponding author), Univ Montreal, Res Unit Childrens Psychosocial Maladjustment, Montreal, PQ, Canada.	richard.tremblay@ucd.ie; moshe.szyf@mcgill.ca	Tremblay, Richard E./O-1360-2014; Côté, Sylvana M./T-4600-2019; Cote, Silvana Maria/O-1356-2014	Côté, Sylvana M./0000-0001-7944-0647; Suderman, Matthew/0000-0002-2715-9930; Hallett, Michael/0000-0001-6738-6786; Provencal, Nadine/0000-0002-2079-8393	Genes, Environment, and Health Training Program from CIHR; Quebec Training Network in Perinatal Research (QTNPR) Program from CIHR; Canadian Institutes of Health Research; Social Sciences Humanities Research Council of Canada; Quebec Health Research Fund (FRSQ); Quebec Social Science and Culture Fund (FQRSC); Canadian Institutes of Health Research [MOP-42411]; Sackler Program in Psychobiology and Epigenetics at McGill University; Canadian Institute for Advanced Research	Genes, Environment, and Health Training Program from CIHR(Canadian Institutes of Health Research (CIHR)); Quebec Training Network in Perinatal Research (QTNPR) Program from CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Social Sciences Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Quebec Health Research Fund (FRSQ)(Fonds de la Recherche en Sante du Quebec); Quebec Social Science and Culture Fund (FQRSC); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Sackler Program in Psychobiology and Epigenetics at McGill University; Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR))	This work was supported by a fellowship from the Genes, Environment, and Health Training Program from CIHR to NP; a fellowship from the Quebec Training Network in Perinatal Research (QTNPR) Program from CIHR to CG; grants from the Canadian Institutes of Health Research; the Social Sciences Humanities Research Council of Canada; the Quebec Health Research Fund (FRSQ) and the Quebec Social Science and Culture Fund (FQRSC) to RET and SMC; and grants from the Canadian Institutes of Health Research MOP-42411, the Sackler Program in Psychobiology and Epigenetics at McGill University, and the Canadian Institute for Advanced Research to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alink LRA, 2006, CHILD DEV, V77, P954, DOI 10.1111/j.1467-8624.2006.00912.x; Alleva E, 1998, EUR J NEUROSCI, V10, P3664, DOI 10.1046/j.1460-9568.1998.00377.x; Arsenio W. F., 2004, MONOGRAPHS SOC RES C, V69, P1, DOI DOI 10.1111/J.0037-976X.2004.00312.X; Barker ED, 2008, ARCH GEN PSYCHIAT, V65, P1185, DOI 10.1001/archpsyc.65.10.1185; Barker ED, 2007, ARCH GEN PSYCHIAT, V64, P592, DOI 10.1001/archpsyc.64.5.592; Bell CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014040; Bennett AJ, 2002, MOL PSYCHIATR, V7, P118, DOI 10.1038/sj/mp/4000949; Berlivet S, 2012, HUM GENET; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Borghol N, 2006, GENOMICS, V87, P417, DOI 10.1016/j.ygeno.2005.10.008; Borghol N, 2012, INT J EPIDEMIOL, V41, P62, DOI 10.1093/ije/dyr147; Brendgen M, 2008, CHILD DEV, V79, P13, DOI 10.1111/j.1467-8624.2007.01108.x; Broidy LM, 2003, DEV PSYCHOL, V39, P222, DOI 10.1037/0012-1649.39.2.222; Campbell SB, 2006, J CHILD PSYCHOL PSYC, V47, P791, DOI 10.1111/j.1469-7610.2006.01636.x; Campbell SB, 2010, DEV PSYCHOPATHOL, V22, P133, DOI 10.1017/S0954579409990319; Cheng ASL, 2008, CANCER RES, V68, P1786, DOI 10.1158/0008-5472.CAN-07-5547; Cheung HH, 2010, BRIT J CANCER, V102, P419, DOI 10.1038/sj.bjc.6605505; Cote SM, 2007, ARCH GEN PSYCHIAT, V64, P1305, DOI 10.1001/archpsyc.64.11.1305; Cote SM, 2006, J ABNORM CHILD PSYCH, V34, P71, DOI 10.1007/s10802-005-9001-z; David S, 2011, CANCER BIOMARK, V9, P493, DOI 10.3233/CBM-2011-0169; de Almeida RMM, 2005, EUR J PHARMACOL, V526, P51, DOI 10.1016/j.ejphar.2005.10.004; Dionne G, 2003, DEV PSYCHOL, V39, P261, DOI 10.1037/0012-1649.39.2.261; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; Falkenberg VR, 2011, NEUROMOL MED, V13, P66, DOI 10.1007/s12017-010-8138-2; Feber A, 2011, GENOME RES, V21, P515, DOI 10.1101/gr.109678.110; Ferris CF, 2006, PHARMACOL BIOCHEM BE, V83, P169, DOI 10.1016/j.pbb.2006.01.001; Ferris Craig, 2005, Novartis Foundation Symposium, V268, P190; Flanagan JM, 2010, AM J HUM GENET, V86, P420, DOI 10.1016/j.ajhg.2010.02.008; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gunther T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000935; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; Guo G, 2007, HUM GENET, V121, P125, DOI 10.1007/s00439-006-0244-8; Hassanain M, 2005, BRAIN RES, V1048, P1, DOI 10.1016/j.brainres.2005.04.086; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Hicks BM, 2004, ARCH GEN PSYCHIAT, V61, P922, DOI 10.1001/archpsyc.61.9.922; Hiura H, 2010, NUCLEIC ACIDS RES, V38, P4929, DOI 10.1093/nar/gkq200; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Jia Jinsong, 2010, BMC Res Notes, V3, P240, DOI 10.1186/1756-0500-3-240; Jin SG, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq223; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Ke X, 2006, PHYSIOL GENOMICS, V25, P16, DOI 10.1152/physiolgenomics.00093.2005; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; Kim-Cohen J, 2006, MOL PSYCHIATR, V11, P903, DOI 10.1038/sj.mp.4001851; Kinnally EL, 2011, BRAIN BEHAV IMMUN; Klengel T, 2013, NAT NEUROSCI, V16, P33, DOI 10.1038/nn.3275; Kokko K, 2009, J RES ADOLESCENCE, V19, P9, DOI 10.1111/j.1532-7795.2009.00579.x; Lempiainen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018216; Liu YL, 2009, EPIGENETICS-US, V4, P500, DOI 10.4161/epi.4.7.9925; MacLennan NK, 2004, PHYSIOL GENOMICS, V18, P43, DOI 10.1152/physiolgenomics.00042.2004; McGowan PO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014739; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Miczek KA, 2005, BIOL AGGRESSION; Morris MR, 2011, ONCOGENE, V30, P1390, DOI 10.1038/onc.2010.525; Movassagh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008564; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Murphy DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008154; Nagin D, 1999, CHILD DEV, V70, P1181, DOI 10.1111/1467-8624.00086; Nagin DS, 2001, ARCH GEN PSYCHIAT, V58, P389, DOI 10.1001/archpsyc.58.4.389; Nair SS, 2011, EPIGENETICS-US, V6, P34, DOI 10.4161/epi.6.1.13313; Navarro JF, 2006, EUR J PHARMACOL, V551, P67, DOI 10.1016/j.ejphar.2006.08.055; Nelson RJ, 2001, TRENDS NEUROSCI, V24, P713, DOI 10.1016/S0166-2236(00)01996-2; Ngwa Julius S, 2011, BMC Proc, V5 Suppl 9, pS18, DOI 10.1186/1753-6561-5-S9-S18; Novak JP, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-27; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Pavlov KA, 2011, J APPL GENET; Pesce M, 2011, J BIOL REG HOMEOS AG, V25, P323; Pingault JB, 2011, AM J PSYCHIAT; Provencal N, 2012, J NEUROSCI; Provencal N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071691; Provencal N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069481; Rajendram R, 2011, EPIGENETICS-US, V6, P410, DOI 10.4161/epi.6.4.14763; RAZIN A, 1984, BIOCHIM BIOPHYS ACTA, V782, P331, DOI 10.1016/0167-4781(84)90043-5; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; Robinson MD, 2010, GENOME RES, V20, P1719, DOI 10.1101/gr.110601.110; Rossi RL, 2011, NAT IMMUNOL, V12, P796, DOI 10.1038/ni.2057; Seguin JR, 1999, J CHILD PSYCHOL PSYC, V40, P1197, DOI 10.1111/1469-7610.00536; Siegel A, 2007, CURR NEUROPHARMACOL, V5, P135, DOI 10.2174/157015907780866929; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Smith AK, 2011, AM J MED GENET B, V156B, P700, DOI 10.1002/ajmg.b.31212; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sweet RA, 1998, ARCH NEUROL-CHICAGO, V55, P1335, DOI 10.1001/archneur.55.10.1335; Szyf M, 2011, EPIGENETICS-US, V6, P971, DOI 10.4161/epi.6.8.16793; Takahashi A., 2012, CURR TOP BEHAV NEURO; Takeshima H, 2009, GENOME RES, V19, P1974, DOI 10.1101/gr.093310.109; Tomazou EM, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-19; Tremblay RE, 2010, EPIGENOMICS-UK, V2, P495, DOI 10.2217/EPI.10.40; Tremblay RE, 2010, J CHILD PSYCHOL PSYC, V51, P341, DOI 10.1111/j.1469-7610.2010.02211.x; Tsai KW, 2009, EPIGENETICS-US, V4, P587, DOI 10.4161/epi.4.8.10230; Tsui DWY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015069; Uddin M, 2011, PSYCHOL MED, V41, P997, DOI 10.1017/S0033291710001674; Uddin M, 2010, P NATL ACAD SCI USA, V107, P9470, DOI 10.1073/pnas.0910794107; Vage J, 2010, GENES BRAIN BEHAV, V9, P372, DOI 10.1111/j.1601-183X.2010.00568.x; van Ijzendoorn MH, 2010, BIOL PSYCHIAT, V68, P405, DOI 10.1016/j.biopsych.2010.05.008; van Lier PAC, 2007, J CHILD PSYCHOL PSYC, V48, P601, DOI 10.1111/j.1469-7610.2006.01724.x; Vaughn MG, 2009, CRIM JUSTICE BEHAV, V36, P1113, DOI 10.1177/0093854809342839; Wang DX, 2012, AQUAT ECOSYST HEALTH, V15, P4, DOI 10.1080/14634988.2012.663631; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Weaver ICG, 2004, ANN NY ACAD SCI, V1024, P182, DOI 10.1196/annals.1321.099; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Yang L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-10; Yukawa K, 2005, INT J MOL MED, V15, P819; Zalcman SS, 2006, BRAIN BEHAV IMMUN, V20, P507, DOI 10.1016/j.bbi.2006.05.002; Zhang S, 2006, STAT APPL GENET MOL, V5	107	62	64	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e89839	10.1371/journal.pone.0089839	http://dx.doi.org/10.1371/journal.pone.0089839			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6KM	24691403	Green Published, gold			2022-12-25	WOS:000334101100006
J	Sridhar, A; de Boer, HL; van den Berg, A; Le Gac, S				Sridhar, Adithya; de Boer, Hans L.; van den Berg, Albert; Le Gac, Severine			Microstamped Petri Dishes for Scanning Electrochemical Microscopy Analysis of Arrays of Microtissues	PLOS ONE			English	Article							OXYGEN-CONSUMPTION; CELLULAR-ACTIVITY; SOFT LITHOGRAPHY; EMBRYOID BODIES; LIVING CELLS; CULTURE; RESPIRATION; TISSUE; MOLDS; CHIP	While scanning electrochemical microscopy (SECM) is a powerful technique for non-invasive analysis of cells, SECM-based assays remain scarce and have been mainly limited so far to single cells, which is mostly due to the absence of suitable platform for experimentation on 3D cellular aggregates or microtissues. Here, we report stamping of a Petri dish with a microwell array for large-scale production of microtissues followed by their in situ analysis using SECM. The platform is realized by hot embossing arrays of microwells (200 mu m depth; 400 mu m diameter) in commercially available Petri dishes, using a PDMS stamp. Microtissues form spontaneously in the microwells, which is demonstrated here using various cell lines (e. g., HeLa, C2C12, HepG2 and MCF-7). Next, the respiratory activity of live HeLa microtissues is assessed by monitoring the oxygen reduction current in constant height mode and at various distances above the platform surface. Typically, at a 40 mu m distance from the microtissue, a 30% decrease in the oxygen reduction current is measured, while above 250 mu m, no influence of the presence of the microtissues is detected. After exposure to a model drug (50% ethanol), no such changes in oxygen concentration are found at any height in solution, which reflects that microtissues are not viable anymore. This is furthermore confirmed using conventional live/dead fluorescent stains. This live/dead assay demonstrates the capability of the proposed approach combining SECM and microtissue arrays formed in a stamped Petri dish for conducting cellular assays in a non-invasive way on 3D cellular models.	[Sridhar, Adithya; de Boer, Hans L.; van den Berg, Albert; Le Gac, Severine] Univ Twente, MESA Inst Nanotechnol, BIOS Lab Chip Grp, NL-7500 AE Enschede, Netherlands	University of Twente	Le Gac, S (corresponding author), Univ Twente, MESA Inst Nanotechnol, BIOS Lab Chip Grp, POB 217, NL-7500 AE Enschede, Netherlands.	s.legac@utwente.nl	van den Berg, Albert/B-4648-2013; Sridhar, Adithya/AAU-9891-2021; Le Gac, Séverine/B-7806-2013	van den Berg, Albert/0000-0001-9019-933X; Sridhar, Adithya/0000-0003-2986-4884; Le Gac, Séverine/0000-0002-4546-6184	eLab4Life ERC advanced grant	eLab4Life ERC advanced grant	This work is supported by the eLab4Life ERC advanced grant of Prof. van den Berg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amphlett JL, 1998, J PHYS CHEM B, V102, P9946, DOI 10.1021/jp982829u; Beaulieu I, 2011, ANAL CHEM, V83, P1485, DOI 10.1021/ac101906a; Bergner S, 2013, ANAL CHIM ACTA, V775, P1, DOI 10.1016/j.aca.2012.12.042; Berthier E, 2012, LAB CHIP, V12, P1224, DOI 10.1039/c2lc20982a; Date Y, 2011, BIOSENS BIOELECTRON, V30, P100, DOI 10.1016/j.bios.2011.08.037; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Goral VN, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/1/017002; Higuchi A, 2006, J BIOMED MATER RES A, V79A, P380, DOI 10.1002/jbm.a.30773; Ino K, 2012, ANGEW CHEM INT EDIT, V51, P6648, DOI 10.1002/anie.201201602; Kaya T, 2003, BIOSENS BIOELECTRON, V18, P1379, DOI 10.1016/S0956-5663(03)00083-6; Kuss S, 2013, P NATL ACAD SCI USA, V110, P9249, DOI 10.1073/pnas.1214809110; Li X, 2009, J ELECTROANAL CHEM, V628, P35, DOI 10.1016/j.jelechem.2009.01.002; Liu B, 2000, P NATL ACAD SCI USA, V97, P9855, DOI 10.1073/pnas.97.18.9855; Malek CK, 2007, MICROSYST TECHNOL, V13, P475, DOI 10.1007/s00542-006-0184-1; Matsumae Y, 2013, CHEM COMMUN, V49, P6498, DOI 10.1039/c3cc43126f; Mauzeroll J, 2003, ANAL CHEM, V75, P3880, DOI 10.1021/ac034088l; Mehta G, 2012, J CONTROL RELEASE, V164, P192, DOI 10.1016/j.jconrel.2012.04.045; Mehta G, 2009, ANAL CHEM, V81, P3714, DOI 10.1021/ac802178u; Moresco J, 2010, SENSOR ACTUAT B-CHEM, V145, P698, DOI 10.1016/j.snb.2010.01.020; Obregon R, 2012, TALANTA, V94, P30, DOI 10.1016/j.talanta.2012.01.059; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Rivron NC, 2009, MICRO TAS, V2009, P9; Rivron NC, 2012, P NATL ACAD SCI USA, V109, P6886, DOI 10.1073/pnas.1201626109; Roberts WS, 2007, BIOSENS BIOELECTRON, V23, P301, DOI 10.1016/j.bios.2007.06.020; Shiku H, 2004, ANAL CHIM ACTA, V522, P51, DOI 10.1016/j.aca.2004.06.054; Shiku H, 2001, ANAL CHEM, V73, P3751, DOI 10.1021/ac010339j; Shiku H, 2009, ANALYST, V134, P182, DOI 10.1039/b808428a; Stephens DJ, 2003, SCIENCE, V300, P82, DOI 10.1126/science.1082160; Sun P, 2007, PHYS CHEM CHEM PHYS, V9, P802, DOI 10.1039/b612259k; Torisawa YS, 2007, BIOMATERIALS, V28, P559, DOI 10.1016/j.biomaterials.2006.08.054; Tung YC, 2011, ANALYST, V136, P473, DOI 10.1039/c0an00609b; Wang YL, 2011, LAB CHIP, V11, P3089, DOI 10.1039/c1lc20281b; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Yasukawa T, 1998, CHEM LETT, P767, DOI 10.1246/cl.1998.767; Young EWK, 2011, ANAL CHEM, V83, P1408, DOI 10.1021/ac102897h; Zhan DP, 2013, J ELECTROANAL CHEM, V688, P61, DOI 10.1016/j.jelechem.2012.07.008	36	24	26	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93618	10.1371/journal.pone.0093618	http://dx.doi.org/10.1371/journal.pone.0093618			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690887	Green Submitted, Green Published, gold			2022-12-25	WOS:000334101100112
J	Perler, FB; Allewell, NM				Perler, Francine B.; Allewell, Norma M.			Evolution, Mechanisms, and Applications of Intein-mediated Protein Splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review								Intein-mediated protein splicing raises questions and creates opportunities in many scientific areas. Evolutionary biologists question whether inteins are primordial enzymes or simply selfish elements, whereas biochemists seek to understand how inteins work. Synthetic chemists exploit inteins in the semi-synthesis of proteins with or without nonribosomal modifications, whereas biotechnologists use modified inteins in an ever increasing variety of applications. The four minireviews in this series explore these themes. The first minireview focuses on the evolution and biological function of inteins, whereas the second describes the mechanisms that underlie the remarkable ability of inteins to perform complex sets of choreographed enzymatic reactions. The third explores the relationship between the three-dimensional structure and dynamics of inteins and their biochemical capabilities. The fourth describes intein applications that have moved beyond simple technology development to utilizing inteins in more sophisticated applications, such as biosensors for identifying ligands of human hormone receptors or improved methods of biofuel and plant-based sugar production.	[Perler, Francine B.] New England Biolabs Inc, Ipswich, MA 01938 USA; [Allewell, Norma M.] Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA	New England Biolabs; University System of Maryland; University of Maryland College Park	Perler, FB (corresponding author), New England Biolabs Inc, Ipswich, MA 01938 USA.	perler@neb.com						Eryilmaz E, 2014, J BIOL CHEM, V289, P14506, DOI 10.1074/jbc.R113.540302; Hall TMT, 1997, CELL, V91, P85, DOI 10.1016/S0092-8674(01)80011-8; Mills KV, 2014, J BIOL CHEM, V289, P14498, DOI 10.1074/jbc.R113.540310; Novikova O, 2014, J BIOL CHEM, V289, P14490, DOI 10.1074/jbc.R114.548255; Wood DW, 2014, J BIOL CHEM, V289, P14512, DOI 10.1074/jbc.R114.552653	5	7	7	1	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14488	14489		10.1074/jbc.R114.570531	http://dx.doi.org/10.1074/jbc.R114.570531			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24695739	hybrid, Green Published			2022-12-25	WOS:000337248100006
J	Sileikyte, J; Blachly-Dyson, E; Sewell, R; Carpi, A; Menabo, R; Di Lisa, F; Ricchelli, F; Bernardi, P; Forte, M				Sileikyte, Justina; Blachly-Dyson, Elizabeth; Sewell, Randall; Carpi, Andrea; Menabo, Roberta; Di Lisa, Fabio; Ricchelli, Fernanda; Bernardi, Paolo; Forte, Michael			Regulation of the Mitochondrial Permeability Transition Pore by the Outer Membrane Does Not Involve the Peripheral Benzodiazepine Receptor ( Translocator Protein of 18 kDa ( TSPO))	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drug Action; Gene Knockout; Mitochondria; Mitochondrial Permeability Transition; Porphyrin; Photodynamic Effect	DEPENDENT ANION CHANNEL; CYTOCHROME-C RELEASE; ATP SYNTHASE; CYCLOPHILIN-D; CHOLESTEROL-BINDING; PHOTODYNAMIC-ACTION; MOLECULAR TARGET; CELL-DEATH; LIGANDS; INHIBITION	Background: TSPO has been proposed to be a critical regulator of the permeability transition pore (PTP). Results: TSPO-null mitochondria and cardiac tissue show no difference from controls in pore function, response to ligands, or response to ischemia/reperfusion injury. Conclusion: Regulation of the PTP by the outer membrane must rely on unknown proteins. Significance: Our results call into question studies implicating TSPO in pathological processes through the PTP. Translocator protein of 18 kDa (TSPO) is a highly conserved, ubiquitous protein localized in the outer mitochondrial membrane, where it is thought to play a key role in the mitochondrial transport of cholesterol, a key step in the generation of steroid hormones. However, it was first characterized as the peripheral benzodiazepine receptor because it appears to be responsible for high affinity binding of a number of benzodiazepines to non-neuronal tissues. Ensuing studies have employed natural and synthetic ligands to assess the role of TSPO function in a number of natural and pathological circumstances. Largely through the use of these compounds and biochemical associations, TSPO has been proposed to play a role in the mitochondrial permeability transition pore (PTP), which has been associated with cell death in many human pathological conditions. Here, we critically assess the role of TSPO in the function of the PTP through the generation of mice in which the Tspo gene has been conditionally eliminated. Our results show that 1) TSPO plays no role in the regulation or structure of the PTP, 2) endogenous and synthetic ligands of TSPO do not regulate PTP activity through TSPO, 3) outer mitochondrial membrane regulation of PTP activity occurs though a mechanism that does not require TSPO, and 4) hearts lacking TSPO are as sensitive to ischemia-reperfusion injury as hearts from control mice. These results call into question a wide variety of studies implicating TSPO in a number of pathological processes through its actions on the PTP.	[Sileikyte, Justina; Carpi, Andrea; Menabo, Roberta; Di Lisa, Fabio; Bernardi, Paolo] Univ Padua, Consiglio Nazl Ric Inst Neurosci, I-35121 Padua, Italy; [Sileikyte, Justina; Carpi, Andrea; Menabo, Roberta; Di Lisa, Fabio; Bernardi, Paolo] Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy; [Blachly-Dyson, Elizabeth; Sewell, Randall; Forte, Michael] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Ricchelli, Fernanda] Univ Padua, Dept Biol, Consiglio Nazl Ric Inst Biomed Technol, I-35121 Padua, Italy	University of Padua; University of Padua; Oregon Health & Science University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Padua	Bernardi, P (corresponding author), Univ Padua, Consiglio Nazl Ric Inst Neurosci, Via Ugo Bassi 58-B, I-35121 Padua, Italy.	bernardi@bio.unipd.it; forte@ohsu.edu	Bernardi, Paolo/C-3656-2008	Bernardi, Paolo/0000-0001-9187-3736; Di Lisa, Fabio/0000-0001-9757-8818; Sileikyte, Justina/0000-0002-6795-6344	National Institutes of Health [1R01GM069883]; Telethon; Associazione Italiana per la Ricerca sul Cancro; Ministero dell'Istruzione; dell'Universita e della Ricerca; University of Padova Progetto Strategico di Ateneo; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Telethon(Fondazione Telethon); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Istruzione(Ministry of Education, Universities and Research (MIUR)); dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); University of Padova Progetto Strategico di Ateneo; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01GM069883. This work was also supported by Telethon, Associazione Italiana per la Ricerca sul Cancro, Ministero dell'Istruzione, dell'Universita e della Ricerca, and the University of Padova Progetto Strategico di Ateneo "Models of Mitochondrial Diseases."	ALLEN RD, 1989, J CELL BIOL, V108, P2233, DOI 10.1083/jcb.108.6.2233; ANHOLT RRH, 1986, J BIOL CHEM, V261, P576; Azarashvili T, 2007, CELL CALCIUM, V42, P27, DOI 10.1016/j.ceca.2006.11.004; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Barsukova A, 2011, EUR J NEUROSCI, V33, P831, DOI 10.1111/j.1460-9568.2010.07576.x; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Bernardi Paolo, 2007, Novartis Found Symp, V287, P157; Bernardi P, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00095; Bernardi P, 2012, CELL CALCIUM, V52, P22, DOI 10.1016/j.ceca.2012.03.004; Berson A, 2001, J PHARMACOL EXP THER, V299, P793; Bono F, 1999, BIOCHEM BIOPH RES CO, V265, P457, DOI 10.1006/bbrc.1999.1683; Chelli B, 2001, BIOCHEM PHARMACOL, V61, P695, DOI 10.1016/S0006-2952(00)00588-8; Cleary J, 2007, BIOORG MED CHEM LETT, V17, P1667, DOI 10.1016/j.bmcl.2006.12.102; Davies KM, 2012, P NATL ACAD SCI USA, V109, P13602, DOI 10.1073/pnas.1204593109; Davies KM, 2011, P NATL ACAD SCI USA, V108, P14121, DOI 10.1073/pnas.1103621108; Di Lisa F, 2001, J BIOL CHEM, V276, P2571, DOI 10.1074/jbc.M006825200; Dudkina NV, 2006, FEBS LETT, V580, P3427, DOI 10.1016/j.febslet.2006.04.097; Elrod JW, 2010, J CLIN INVEST, V120, P3680, DOI 10.1172/JCI43171; Fan J, 2012, CURR MOL MED, V12, P369; Fan JJ, 2009, J BIOL CHEM, V284, P30484, DOI 10.1074/jbc.M109.029876; FARGES R, 1994, MOL PHARMACOL, V46, P1160; Gastaldello A, 2010, AUTOPHAGY, V6, P607, DOI 10.4161/auto.6.5.11964; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; GRIFFITHS EJ, 1995, BIOCHEM J, V307, P93, DOI 10.1042/bj3070093; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; HIRSCH JD, 1989, MOL PHARMACOL, V35, P157; HUNTER DR, 1976, J BIOL CHEM, V251, P5069; Huser J, 1999, BIOCHEM J, V343, P311, DOI 10.1042/0264-6021:3430311; Ichas F, 1997, CELL, V89, P1145, DOI 10.1016/S0092-8674(00)80301-3; Johnson KM, 2005, CHEM BIOL, V12, P485, DOI 10.1016/j.chembiol.2005.02.012; KINNALLY KW, 1989, J BIOENERG BIOMEMBR, V21, P497, DOI 10.1007/BF00762521; KINNALLY KW, 1993, P NATL ACAD SCI USA, V90, P1374, DOI 10.1073/pnas.90.4.1374; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Krauskopf A, 2006, BBA-BIOENERGETICS, V1757, P590, DOI 10.1016/j.bbabio.2006.02.007; Krishnamurthy P, 2007, PHARMACOL THERAPEUT, V114, P345, DOI 10.1016/j.pharmthera.2007.02.001; Lacapere JJ, 2003, STEROIDS, V68, P569, DOI 10.1016/S0039-128X(03)00101-6; LEFUR G, 1983, LIFE SCI, V33, P449, DOI 10.1016/0024-3205(83)90794-4; LENARTOWICZ E, 1991, J BIOENERG BIOMEMBR, V23, P679, DOI 10.1007/BF00785817; LEQUOC K, 1982, ARCH BIOCHEM BIOPHYS, V216, P639, DOI 10.1016/0003-9861(82)90254-5; LEQUOC K, 1985, J BIOL CHEM, V260, P7422; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Li H, 2001, P NATL ACAD SCI USA, V98, P1267, DOI 10.1073/pnas.031461598; Li JY, 2007, EUR J PHARMACOL, V560, P117, DOI 10.1016/j.ejphar.2006.12.027; Madesh M, 2001, J CELL BIOL, V155, P1003, DOI 10.1083/jcb.200105057; MCENERY MW, 1992, P NATL ACAD SCI USA, V89, P3170, DOI 10.1073/pnas.89.8.3170; Miller WL, 2013, MOL CELL ENDOCRINOL, V379, P62, DOI 10.1016/j.mce.2013.04.014; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Moreno G, 2001, ARCH BIOCHEM BIOPHYS, V386, P243, DOI 10.1006/abbi.2000.2200; Morohaku K, 2014, ENDOCRINOLOGY, V155, P89, DOI 10.1210/en.2013-1556; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Papadopoulos V, 1997, J BIOL CHEM, V272, P32129, DOI 10.1074/jbc.272.51.32129; Papadopoulos V, 2012, BEST PRACT RES CL EN, V26, P771, DOI 10.1016/j.beem.2012.05.002; Parker MA, 2002, J NEUROSCI RES, V69, P39, DOI 10.1002/jnr.10235; PASTORINO JG, 1994, J BIOL CHEM, V269, P31041; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; PETRONILLI V, 1989, FEBS LETT, V259, P137, DOI 10.1016/0014-5793(89)81513-3; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; Petronilli V, 2009, BBA-BIOENERGETICS, V1787, P897, DOI 10.1016/j.bbabio.2009.03.014; Pinton P, 2014, NAT CHEM BIOL, V10, P89, DOI 10.1038/nchembio.1440; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; Pocock SJ, 2006, BRIT MED J, V332, P1256, DOI 10.1136/bmj.332.7552.1256; Rapizzi E, 2002, J CELL BIOL, V159, P613, DOI 10.1083/jcb.200205091; Ravagnan L, 1999, ONCOGENE, V18, P2537, DOI 10.1038/sj.onc.1202625; Ricchelli F, 2011, BBA-BIOENERGETICS, V1807, P482, DOI 10.1016/j.bbabio.2011.02.012; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; ROMEO E, 1992, J PHARMACOL EXP THER, V262, P971; Salet C, 1997, J BIOL CHEM, V272, P21938, DOI 10.1074/jbc.272.35.21938; Scarf AM, 2012, CURR MOL MED, V12, P488; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; SCHLUTER KD, 1991, AM J PHYSIOL, V261, pH416, DOI 10.1152/ajpheart.1991.261.2.H416; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Seneviratne MSD, 2012, CURR MOL MED, V12, P476; Sileikyte J, 2011, J BIOL CHEM, V286, P1046, DOI 10.1074/jbc.M110.172486; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Stelzer AC, 2010, BIOPOLYMERS, V93, P85, DOI 10.1002/bip.21306; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; Surinkaew S, 2011, CAN J CARDIOL, V27, DOI 10.1016/j.cjca.2010.12.023; SZABO I, 1991, J BIOL CHEM, V266, P3376; VERMA A, 1988, MOL PHARMACOL, V34, P800; VERMA A, 1987, P NATL ACAD SCI USA, V84, P2256, DOI 10.1073/pnas.84.8.2256; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073; Zoratti M, 2005, BBA-BIOENERGETICS, V1706, P40, DOI 10.1016/j.bbabio.2004.10.006	86	140	142	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13769	13781		10.1074/jbc.M114.549634	http://dx.doi.org/10.1074/jbc.M114.549634			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24692541	Green Published, hybrid			2022-12-25	WOS:000335984600011
J	Celik, S; Li, Y; O'Neill, C				Celik, Selcen; Li, Yan; O'Neill, Chris			The Exit of Mouse Embryonic Fibroblasts from the Cell-Cycle Changes the Nature of Solvent Exposure of the 5 '-Methylcytosine Epitope within Chromatin	PLOS ONE			English	Article							DNA METHYLATION; CONSTITUTIVE HETEROCHROMATIN; CYTOSINE METHYLATION; PATERNAL GENOME; DEMETHYLATION; INHERITANCE; QUIESCENCE; 5-HYDROXYMETHYLCYTOSINE; PROLIFERATION; EMBRYOGENESIS	The methylation of CpG dinucleotides is a pervasive epigenetic signature with critical roles governing genomic stability and lineage-specific patterns of gene expression. Reprogramming the patterns of CpG methylation accompanies key developmental transitions and the onset of some pathologies, such as cancer. In this study we show that levels of immuno-detectable 5meC decreased as mouse embryonic fibroblasts withdraw from the cell-cycle (became mitotically quiescent), but increased as they aged in culture. Two pools of 5meC epitope were found to exist, one solvent exposed after acid-induced denaturation of chromatin and another that required the additional step of tryptic digestion for detection. Proliferative cells displayed a relatively greater accumulation of detectable 5meC within the trypsin-sensitive pool than did quiescent cells. A substantial proportion of the 5meC was associated with a large number of heterochromatic foci scattered throughout nuclei, yet much of this was masked in a trypsin-sensitive manner, particularly in young proliferative cells. This study showed that the growth status of cells changed the level of solvent exposure of 5meC in fibroblasts and the long-accepted conventional methods of immunolocalization underestimate the level of 5meC in cells. This resulted in an artefactual assessment of the levels and patterns of nuclear localization of the antigen. The use of an additional tryptic digestion step improved antigen retrieval and revealed a more dynamic response of 5meC levels and distribution patterns to changes in the cell's growth state. This discovery will provide a basis for investigating the role of changes in chromatin structure that underlie this dynamism.	[Celik, Selcen; Li, Yan; O'Neill, Chris] Univ Sydney, Sydney Med Sch, Kolling Inst Med Res, Human Reprod & Dev Unit, Sydney, NSW 2006, Australia	University of Sydney; Kolling Institute of Medical Research	O'Neill, C (corresponding author), Univ Sydney, Sydney Med Sch, Kolling Inst Med Res, Human Reprod & Dev Unit, Sydney, NSW 2006, Australia.	chris.oneill@sydney.edu.au	Celik, Selcen/AAW-3014-2020	Celik, Selcen/0000-0002-9558-7048; O'Neill, Christopher/0000-0003-4003-8727	Australian National Health and Medical Research Council; Turkish Government Postgraduate Scholarship	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Turkish Government Postgraduate Scholarship	This work was supported by grants from the Australian National Health and Medical Research Council to CO and a Turkish Government Postgraduate Scholarship to SC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2000, J CELL SCI, V113, P4463; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Brown SE, 2008, NEUROSCI LETT, V440, P49, DOI 10.1016/j.neulet.2008.05.028; Chan FL, 2012, NUCLEIC ACIDS RES, V40, P11178, DOI 10.1093/nar/gks921; Clouaire T, 2010, NUCLEIC ACIDS RES, V38, P4620, DOI 10.1093/nar/gkq228; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Evertts AG, 2013, MOL BIOL CELL, V24, P3025, DOI 10.1091/mbc.E12-07-0529; Festenstein R, 2003, SCIENCE, V299, P719, DOI 10.1126/science.1078694; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Grigoryev SA, 2004, J CELL SCI, V117, P6153, DOI 10.1242/cs.01537; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hajkova P, 2010, CURR OPIN CELL BIOL, V22, P342, DOI 10.1016/j.ceb.2010.04.011; Huang Y., 2010, PLOS ONE, V5; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Kang YK, 2001, FEBS LETT, V498, P1, DOI 10.1016/S0014-5793(01)02472-3; Koch CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016679; LATHAM KE, 1992, DEV BIOL, V149, P457, DOI 10.1016/0012-1606(92)90300-6; Li Y, 2012, PLOS ONE, V7; Li Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063689; Li Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030687; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Lu J, 2007, J CELL BIOL, V179, P411, DOI 10.1083/jcb.200706176; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; MILLER OJ, 1974, NATURE, V251, P636, DOI 10.1038/251636a0; Momparler RL, 2000, J CELL PHYSIOL, V183, P145, DOI 10.1002/(SICI)1097-4652(200005)183:2<145::AID-JCP1>3.0.CO;2-V; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Ooi SKT, 2009, J CELL SCI, V122, P2787, DOI 10.1242/jcs.015123; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Probst AV, 2011, TRENDS GENET, V27, P177, DOI 10.1016/j.tig.2011.02.002; Probst AV, 2009, NAT REV MOL CELL BIO, V10, P192, DOI 10.1038/nrm2640; Rountree MR, 2001, ONCOGENE, V20, P3156, DOI 10.1038/sj.onc.1204339; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; WILSON VL, 1983, SCIENCE, V220, P1054; Wongtawan T, 2011, J CELL SCI, V124, P1878, DOI 10.1242/jcs.080721; Wossidlo M, 2010, EMBO J, V29, P1877, DOI 10.1038/emboj.2010.80; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027	40	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e92523	10.1371/journal.pone.0092523	http://dx.doi.org/10.1371/journal.pone.0092523			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705067	Green Published, gold, Green Submitted			2022-12-25	WOS:000334107500018
J	Kagaayi, J; Gray, RH; Whalen, C; Fu, PF; Neuhauser, D; McGrath, JW; Sewankambo, NK; Serwadda, D; Kigozi, G; Nalugoda, F; Reynolds, SJ; Wawer, MJ; Singer, ME				Kagaayi, Joseph; Gray, Ronald H.; Whalen, Christopher; Fu, Pingfu; Neuhauser, Duncan; McGrath, Janet W.; Sewankambo, Nelson K.; Serwadda, David; Kigozi, Godfrey; Nalugoda, Fred; Reynolds, Steven J.; Wawer, Maria J.; Singer, Mendel E.			Indices to Measure Risk of HIV Acquisition in Rakai, Uganda	PLOS ONE			English	Article							MALE CIRCUMCISION; COST-EFFECTIVENESS; PREEXPOSURE PROPHYLAXIS; AIDS-PREVENTION; COMMUNITY TRIAL; UNITED-STATES; RURAL UGANDA; ALCOHOL-USE; INFECTION; WOMEN	Introduction: Targeting most-at-risk individuals with HIV preventive interventions is cost-effective. We developed gender-specific indices to measure risk of HIV among sexually active individuals in Rakai, Uganda. Methods: We used multivariable Cox proportional hazards models to estimate time-to-HIV infection associated with candidate predictors. Reduced models were determined using backward selection procedures with Akaike's information criterion (AIC) as the stopping rule. Model discrimination was determined using Harrell's concordance index (c index). Model calibration was determined graphically. Nomograms were used to present the final prediction models. Results: We used samples of 7,497 women and 5,783 men. 342 new infections occurred among females (incidence 1.11/100 person years,) and 225 among the males (incidence 1.00/100 person years). The final model for men included age, education, circumcision status, number of sexual partners, genital ulcer disease symptoms, alcohol use before sex, partner in high risk employment, community type, being unaware of a partner's HIV status and community HIV prevalence. The Model's optimism-corrected c index was 69.1 percent (95% CI = 0.66, 0.73). The final women's model included age, marital status, education, number of sex partners, new sex partner, alcohol consumption by self or partner before sex, concurrent sexual partners, being employed in a high-risk occupation, having genital ulcer disease symptoms, community HIV prevalence, and perceiving oneself or partner to be exposed to HIV. The models optimism-corrected c index was 0.67 (95% CI = 0.64, 0.70). Both models were well calibrated. Conclusion: These indices were discriminative and well calibrated. This provides proof-of-concept that population-based HIV risk indices can be developed. Further research to validate these indices for other populations is needed.	[Kagaayi, Joseph] Rakai Hlth Sci Program, Entebbe, Uganda; [Kagaayi, Joseph; Fu, Pingfu; Neuhauser, Duncan; Kigozi, Godfrey; Nalugoda, Fred; Singer, Mendel E.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Gray, Ronald H.; Wawer, Maria J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [McGrath, Janet W.] Case Western Reserve Univ, Dept Anthropol, Cleveland, OH 44106 USA; [Whalen, Christopher] Univ Georgia, Dept Epidemiol & Biostat, Athens, GA 30602 USA; [Sewankambo, Nelson K.; Serwadda, David] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Reynolds, Steven J.] NIAID, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Reynolds, Steven J.] Johns Hopkins Sch Med, Baltimore, MD USA	Rakai Health Sciences Program; Case Western Reserve University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Case Western Reserve University; University System of Georgia; University of Georgia; Makerere University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Johns Hopkins Medicine	Kagaayi, J (corresponding author), Rakai Hlth Sci Program, Entebbe, Uganda.	jxk597@case.edu	Fu, Pingfu/O-5415-2019; Singer, Mendel/S-8775-2019	Fu, Pingfu/0000-0002-2334-5218; Kagaayi, Joseph/0000-0003-4101-3038; Singer, Mendel/0000-0002-3331-3340; Sewankambo, Nelson/0000-0001-9362-053X; Reynolds, Steven/0000-0002-5403-2759	National Institute of Child Health and Human Development of the National Institutes of Health [RO1HD050180]; National Institutes of Health [U01AI075115]; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI075115, ZIAAI001040] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by National Institute of Child Health and Human Development of the National Institutes of Health; grant number RO1HD050180; and National Institutes of Health; grant number U01AI075115; and in part (SJR) by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas UL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000875; Arora P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044094; ATKINSON AC, 1980, BIOMETRIKA, V67, P413, DOI 10.1093/biomet/67.2.413; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bautista-Arredondo S, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327625.69974.08; Chemaitelly H, 2013, AIDS, V27, P251, DOI 10.1097/QAD.0b013e32835ad459; Commission UNA, 2009, UG HIV MOD TRANSM PR; Cremin I, 2013, AIDS, V27, P447, DOI 10.1097/QAD.0b013e32835ca2dd; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; Fox J, 2011, AIDS, V25, P1065, DOI 10.1097/QAD.0b013e328344fe4a; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Gray RH, 2000, AIDS, V14, P2371, DOI 10.1097/00002030-200010200-00019; Gray R, 2011, AIDS, V25, P863, DOI 10.1097/QAD.0b013e3283448790; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harrell FE Jr, REGRESSION MODELLING, V2nd; Herida M, 2006, AIDS, V20, P1753, DOI 10.1097/01.aids.0000242822.74624.5f; Hughes D, 1996, J Health Serv Res Policy, V1, P205; Juusola JL, 2012, ANN INTERN MED, V156, P541, DOI [10.7326/0003-4819-156-8-201204170-00004, 10.7326/0003-4819-156-8-201204170-00001]; Kahle EM, 2012, J ACQUIR IMMUNE DEFI; Kahn JG, 1996, AM J PUBLIC HEALTH, V86, P1709, DOI 10.2105/AJPH.86.12.1709; Kelly RJ, 2003, JAIDS-J ACQ IMM DEF, V32, P446, DOI 10.1097/00126334-200304010-00016; Koenig MA, 2004, SOC SCI MED, V58, P787, DOI 10.1016/S0277-9536(03)00244-2; Long EF, 2010, ANN INTERN MED, V153, P778, DOI 10.7326/0003-4819-153-12-201012210-00004; Marrazzo J.M., 2015, C RETR OPP INF ATL M, P509; Matovu JKB, 2005, AIDS, V19, P503, DOI 10.1097/01.aids.0000162339.43310.33; Santelli JS, 2013, JAIDS-J ACQ IMM DEF, V63, P393, DOI 10.1097/QAI.0b013e3182926795; Steyerberg E., 2010, CLIN PREDICTION MODE; Steyerberg EW, 2007, J UROLOGY, V177, P107, DOI 10.1016/j.juro.2006.08.068; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; VANHOUWELINGEN JC, 1990, STAT MED, V9, P1303, DOI 10.1002/sim.4780091109; Wawer MJ, 1998, AIDS, V12, P1211, DOI 10.1097/00002030-199810000-00014; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; Wojcicki JM, 2005, J BIOSOC SCI, V37, P1, DOI 10.1017/S0021932004006534; Youngkong S, 2012, HEALTH RES POLICY SY, V10, DOI 10.1186/1478-4505-10-6; Zablotska IB, 2006, AIDS, V20, P1191, DOI 10.1097/01.aids.0000226960.25589.72; Zablotska IB, 2009, AIDS BEHAV, V13, P225, DOI 10.1007/s10461-007-9333-5	40	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e92015	10.1371/journal.pone.0092015	http://dx.doi.org/10.1371/journal.pone.0092015			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24704778	Green Published, gold, Green Submitted			2022-12-25	WOS:000334107500012
J	Lee, ZQ; Hsu, WJ; Lin, M				Lee, Zhuo Qi; Hsu, Wen-Jing; Lin, Miao			Estimating Mean First Passage Time of Biased Random Walks with Short Relaxation Time on Complex Networks	PLOS ONE			English	Article								Biased random walk has been studied extensively over the past decade especially in the transport and communication networks communities. The mean first passage time (MFPT) of a biased random walk is an important performance indicator in those domains. While the fundamental matrix approach gives precise solution to MFPT, the computation is expensive and the solution lacks interpretability. Other approaches based on the Mean Field Theory relate MFPT to the node degree alone. However, nodes with the same degree may have very different local weight distribution, which may result in vastly different MFPT. We derive an approximate bound to the MFPT of biased random walk with short relaxation time on complex network where the biases are controlled by arbitrarily assigned node weights. We show that the MFPT of a node in this general case is closely related to not only its node degree, but also its local weight distribution. The MFPTs obtained from computer simulations also agree with the new theoretical analysis. Our result enables fast estimation of MFPT, which is useful especially to differentiate between nodes that have very different local node weight distribution even though they share the same node degrees.	[Lee, Zhuo Qi; Hsu, Wen-Jing; Lin, Miao] Nanyang Technol Univ, Sch Comp Engn, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Lee, ZQ (corresponding author), Nanyang Technol Univ, Sch Comp Engn, Singapore 639798, Singapore.	zqlee1@e.ntu.edu.sg	Hsu, Wen-Jing J/A-3702-2011		Ministry of Education, Singapore, through School of Computer Engineering, Nanyang Technological University, Singapore	Ministry of Education, Singapore, through School of Computer Engineering, Nanyang Technological University, Singapore	This work was supported by the scholarship awarded by Ministry of Education, Singapore, through School of Computer Engineering, Nanyang Technological University, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 1999, PHYSICA A, V272, P173, DOI 10.1016/S0378-4371(99)00291-5; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Benichou O, 2010, NAT CHEM, V2, P472, DOI [10.1038/nchem.622, 10.1038/NCHEM.622]; Chen SY, 2012, MATH PROBL ENG, V2012, DOI 10.1155/2012/732698; Condamin S, 2007, NATURE, V450, P77, DOI 10.1038/nature06201; COPPERSMITH D, 1990, J SYMB COMPUT, V9, P251, DOI 10.1016/S0747-7171(08)80013-2; Dan Wang ZL, 2012, COMMUNICATIONS INFOR; David A, 2009, MARKOV CHAINS MIXING; De Martino D, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.015101; Erik van Doorn PP, 2011, COMMUNICATION; Even-Dar E, 2007, LECT NOTES COMPUT SC, V4858, P281; Fronczak A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016107; GILBERT EN, 1959, ANN MATH STAT, V30, P1141, DOI 10.1214/aoms/1177706098; Hwang S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.088701; Hwang S, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.056110; Kleinberg J., 2006, P INT C MATH ICM; Krioukov D, 2012, NATURE SCI REPORTS, V2; Lau HW, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/40005; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; Ling X, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.016113; Page L., 1999, 199966 STANF INFOLAB; Samukhin AN, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036115; Snell, 2003, INTRO PROBABILITY; Yan G, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.046108	24	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93348	10.1371/journal.pone.0093348	http://dx.doi.org/10.1371/journal.pone.0093348			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699325	Green Published, gold			2022-12-25	WOS:000334105000055
J	Storbeck, J; Stefanucci, JK				Storbeck, Justin; Stefanucci, Jeanine K.			Conditions under which Arousal Does and Does Not Elevate Height Estimates	PLOS ONE			English	Article							EMOTIONAL AROUSAL; PERCEPTION; BEHAVIOR; ATTENTION; MEMORY; FEAR; MISATTRIBUTION; MOTIVATION; EXCITATION; STRESS	We present a series of experiments that explore the boundary conditions for how emotional arousal influences height estimates. Four experiments are presented, which investigated the influence of context, situation-relevance, intensity, and attribution of arousal on height estimates. In Experiment 1, we manipulated the environmental context to signal either danger (viewing a height from above) or safety (viewing a height from below). High arousal only increased height estimates made from above. In Experiment 2, two arousal inductions were used that contained either 1) height-relevant arousing images or 2) height-irrelevant arousing images. Regardless of theme, arousal increased height estimates compared to a neutral group. In Experiment 3, arousal intensity was manipulated by inserting an intermediate or long delay between the induction and height estimates. A brief, but not a long, delay from the arousal induction served to increase height estimates. In Experiment 4, an attribution manipulation was included, and those participants who were made aware of the source of their arousal reduced their height estimates compared to participants who received no attribution instructions. Thus, arousal that is attributed to its true source is discounted from feelings elicited by the height, thereby reducing height estimates. Overall, we suggest that misattributed, embodied arousal is used as a cue when estimating heights from above that can lead to overestimation.	[Storbeck, Justin] CUNY Queens Coll, Dept Psychol, Flushing, NY 11367 USA; [Stefanucci, Jeanine K.] Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA	City University of New York (CUNY) System; Queens College NY (CUNY); Utah System of Higher Education; University of Utah	Storbeck, J (corresponding author), CUNY Queens Coll, Dept Psychol, Flushing, NY 11367 USA.	justin.storbeck@qc.cuny.edu			British Heart Foundation Funding Source: Medline; NHLBI NIH HHS [R01HL36310] Funding Source: Medline; NIA NIH HHS [R01AG013196] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013196] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 2006, DISS ABSTR INT B; Balcetis E, 2014, CONTROL MOTIVATION I; Balcetis E, 2007, PSYCHOL SCI, V18, P917, DOI 10.1111/j.1467-9280.2007.02000.x; Bargh JA, 2006, EUR J SOC PSYCHOL, V36, P147, DOI 10.1002/ejsp.336; Bocanegra BR, 2009, PSYCHOL SCI, V20, P707, DOI 10.1111/j.1467-9280.2009.02354.x; Bradley M. M., 2007, HDB EMOTION ELICITAT, P29; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; Cahill L, 2003, LEARN MEMORY, V10, P270, DOI 10.1101/lm.62403; CANTOR JR, 1975, J PERS SOC PSYCHOL, V32, P69, DOI 10.1037/h0076784; Casper K, 2001, THEORIES MOOD COGNIT, P27; CHRISTIANSON SA, 1992, HDB EMOTION MEMORY R, P307; COHEN DC, 1977, BEHAV THER, V8, P17, DOI 10.1016/S0005-7894(77)80116-0; Cole S, 2013, PSYCHOL SCI, V24, P34, DOI 10.1177/0956797612446953; DARLEY JM, 1966, J PERS SOC PSYCHOL, V4, P73, DOI 10.1037/h0023508; DUTTON DG, 1974, J PERS SOC PSYCHOL, V30, P510, DOI 10.1037/h0037031; EASTERBROOK JA, 1959, PSYCHOL REV, V66, P183, DOI 10.1037/h0047707; EPSTEIN W, 1973, PERCEPTION, V2, P267, DOI 10.1068/p020267; Firestone C, 2013, PERSPECT PSYCHOL SCI, V8, P455, DOI 10.1177/1745691613489835; Gable PA, 2010, EMOTION, V10, P599, DOI 10.1037/a0018426; Gasper K, 1998, J PERS SOC PSYCHOL, V74, P1350, DOI 10.1037/0022-3514.74.5.1350; Gasper K, 2000, PERS SOC PSYCHOL B, V26, P698, DOI 10.1177/0146167200268005; HEUER F, 1990, MEM COGNITION, V18, P496, DOI 10.3758/BF03198482; Jackson RE, 2008, EVOL HUM BEHAV, V29, P299, DOI 10.1016/j.evolhumbehav.2008.03.001; Jackson RE, 2009, P R SOC B, V276, P1665, DOI 10.1098/rspb.2009.0004; Lang P, 1980, TECHNOLOGY MENTAL HL, P119, DOI DOI 10.1016/J.LINDIF.2013.01.005; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; Lang PJ, 2008, A8 U FLORIDA; Low A, 2008, PSYCHOL SCI, V19, P865, DOI 10.1111/j.1467-9280.2008.02170.x; Mandler G., 1992, HDB EMOTION MEMORY R, P93; Mather M, 2011, PERSPECT PSYCHOL SCI, V6, P114, DOI 10.1177/1745691611400234; Payne JD, 2002, MEMORY, V10, P1, DOI 10.1080/09658210143000119; Phelps EA, 2006, PSYCHOL SCI, V17, P292, DOI 10.1111/j.1467-9280.2006.01701.x; Proffitt DR, 2006, PERSPECT PSYCHOL SCI, V1, P110, DOI 10.1111/j.1745-6916.2006.00008.x; Riener CR, 2011, COGNITION EMOTION, V25, P174, DOI 10.1080/02699931003738026; Rolls Edmund T., 1995, P1091; Russell JA, 1999, J PERS SOC PSYCHOL, V76, P805, DOI 10.1037/0022-3514.76.5.805; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Schneirla TC, 1959, NEBRASKA S MOTIVATIO, P1; SCHWARZ N, 1983, J PERS SOC PSYCHOL, V45, P513, DOI 10.1037/0022-3514.45.3.513; Stefanucci JK, 2011, SOC PERSONAL PSYCHOL, V5, P296, DOI 10.1111/j.1751-9004.2011.00352.x; Stefanucci JK, 2009, J EXP PSYCHOL HUMAN, V35, P424, DOI 10.1037/a0013894; Stefanucci JK, 2009, J EXP PSYCHOL GEN, V138, P131, DOI 10.1037/a0014797; Storbeck J, 2008, SOC PERSONAL PSYCHOL, V2, P1824, DOI 10.1111/j.1751-9004.2008.00138.x; Teachman BA, 2008, EMOTION, V8, P296, DOI 10.1037/1528-3542.8.2.296; Tsuchiya N, 2007, TRENDS COGN SCI, V11, P158, DOI 10.1016/j.tics.2007.01.005; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Wundt W.M., 1886, ETHIK EINE UNTERSUCH; ZILLMANN D, 1971, J EXP SOC PSYCHOL, V7, P419, DOI 10.1016/0022-1031(71)90075-8	48	9	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e92024	10.1371/journal.pone.0092024	http://dx.doi.org/10.1371/journal.pone.0092024			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LR	24699393	Green Published, gold			2022-12-25	WOS:000334105000019
J	Wang, SJ; Gong, H; Jiang, GL; Ye, Y; Wu, J; You, JY; Zhang, GP; Sun, AJ; Komuro, I; Ge, JB; Zou, YZ				Wang, Shijun; Gong, Hui; Jiang, Guoliang; Ye, Yong; Wu, Jian; You, Jieyun; Zhang, Guoping; Sun, Aijun; Komuro, Issei; Ge, Junbo; Zou, Yunzeng			Src Is Required for Mechanical Stretch-Induced Cardiomyocyte Hypertrophy through Angiotensin II Type 1 Receptor-Dependent beta-Arrestin2 Pathways	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; SMOOTH-MUSCLE-CELLS; CARDIAC-HYPERTROPHY; PROTEIN-KINASE; AT1 RECEPTOR; INDEPENDENT ACTIVATION; NUCLEAR TRANSLOCATION; TYROSINE KINASES; RAT-HEART; MYOCYTES	Angiotensin II (AngII) type 1 receptor (AT1-R) can be activated by mechanical stress (MS) without the involvement of AngII during the development of cardiomyocyte hypertrophy, in which G protein-independent pathways are critically involved. Although beta-arrestin2-biased signaling has been speculated, little is known about how AT1-R/beta-arrestin2 leads to ERK1/2 activation. Here, we present a novel mechanism by which Src kinase mediates AT1-R/beta-arrestin2-dependent ERK1/2 phosphorylation in response to MS. Differing from stimulation by AngII, MS-triggered ERK1/2 phosphorylation is neither suppressed by overexpression of RGS4 (the negative regulator of the G-protein coupling signal) nor by inhibition of G proportional to q downstream protein kinase C (PKC) with GF109203X. The release of inositol 1,4,5-triphosphate (IP3) is increased by AngII but not by MS. These results collectively suggest that MS-induced ERK1/2 activation through AT1-R might be independent of G-protein coupling. Moreover, either knockdown of beta-arrestin2 or overexpression of a dominant negative mutant of beta-arrestin2 prevents MS-induced activation of ERK1/2. We further identifies a relationship between Src, a non-receptor tyrosine kinase and b-arrestin2 using analyses of co-immunoprecipitation and immunofluorescence after MS stimulation. Furthermore, MS, but not AngII-induced ERK1/2 phosphorylation is attenuated by Src inhibition, which also significantly improves pressure overload-induced cardiac hypertrophy and dysfunction in mice lacking AngII. Finally, MS-induced Src activation and hypertrophic response are abolished by candesartan but not by valsartan whereas AngII-induced responses can be abrogated by both blockers. Our results suggest that Src plays a critical role in MS-induced cardiomyocyte hypertrophy through beta-arrestin2-associated angiotensin II type 1 receptor signaling.	[Wang, Shijun; Gong, Hui; Sun, Aijun; Ge, Junbo; Zou, Yunzeng] Fudan Univ, Zhongshan Hosp, Shanghai Inst Cardiovasc Dis, Shanghai 200433, Peoples R China; [Wang, Shijun; Gong, Hui; Jiang, Guoliang; Ye, Yong; Wu, Jian; You, Jieyun; Zhang, Guoping; Sun, Aijun; Ge, Junbo; Zou, Yunzeng] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan	Fudan University; Fudan University; University of Tokyo	Zou, YZ (corresponding author), Fudan Univ, Zhongshan Hosp, Shanghai Inst Cardiovasc Dis, Shanghai 200433, Peoples R China.	zou.yunzeng@zs-hospital.sh.cn		Wu, Jian/0000-0003-4259-8322	National Natural Science Fund of China [81220108003, 81000041]; China Doctoral Foundation [20110071110051]; Technology Commission of Shanghai Municipality [11JC1402400]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); China Doctoral Foundation; Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National Natural Science Fund of China (81220108003; 81000041); China Doctoral Foundation (20110071110051) and Technology Commission of Shanghai Municipality (11JC1402400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa H, 2009, MOL CELL ENDOCRINOL, V302, P140, DOI 10.1016/j.mce.2008.11.007; Boutahar N, 2004, J BIOL CHEM, V279, P30588, DOI 10.1074/jbc.M313244200; Chen P, 2013, INT J MOL MED, V32, P165, DOI 10.3892/ijmm.2013.1382; DOSTAL DE, 1992, AM J HYPERTENS, V5, P276; Godin CM, 2012, MINI-REV MED CHEM, V12, P812; Kim J, 2009, J BIOL CHEM, V284, P11953, DOI 10.1074/jbc.M808176200; Kobayashi H, 2005, CELL SIGNAL, V17, P1248, DOI 10.1016/j.cellsig.2004.12.014; KOMURO I, 1988, CIRC RES, V62, P1075, DOI 10.1161/01.RES.62.6.1075; Li L, 2010, HYPERTENS RES, V33, P1289, DOI 10.1038/hr.2010.182; Lorell BH, 1999, AM J CARDIOL, V83, p48H; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Miller WE, 2000, J BIOL CHEM, V275, P11312, DOI 10.1074/jbc.275.15.11312; Mukhopadhyay S, 1999, P NATL ACAD SCI USA, V96, P9539, DOI 10.1073/pnas.96.17.9539; MURPHY TJ, 1991, NATURE, V351, P233, DOI 10.1038/351233a0; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Pullamsetti SS, 2012, ARTERIOSCL THROM VAS, V32, P1354, DOI 10.1161/ATVBAHA.112.248500; Purdy KE, 2001, J AM SOC NEPHROL, V12, P19, DOI 10.1681/ASN.V12119; Rajagopal K, 2006, P NATL ACAD SCI USA, V103, P16284, DOI 10.1073/pnas.0607583103; Rakesh K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000769; Reineke EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053395; SADOSHIMA J, 1993, CIRC RES, V73, P413, DOI 10.1161/01.RES.73.3.413; Seta K, 2002, J BIOL CHEM, V277, P9268, DOI 10.1074/jbc.M109221200; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Tamirisa P, 1999, CIRCULATION, V99, P441, DOI 10.1161/01.CIR.99.3.441; Tokudome T, 2008, CIRCULATION, V117, P2329, DOI 10.1161/CIRCULATIONAHA.107.732990; Yan YB, 1997, J BIOL CHEM, V272, P11924, DOI 10.1074/jbc.272.18.11924; Yasuda N, 2008, N-S ARCH PHARMACOL, V377, P393, DOI 10.1007/s00210-007-0215-1; Yasuda N, 2008, EMBO REP, V9, P179, DOI 10.1038/sj.embor.7401157; Zhai PY, 2006, CIRC RES, V99, P528, DOI 10.1161/01.RES.0000240147.49390.61; Zhai PY, 2005, J CLIN INVEST, V115, P3045, DOI 10.1172/JCI25330; Zhang P, 2011, BIOMED PHARMACOTHER, V65, P590, DOI 10.1016/j.biopha.2009.12.001; Zhou N, 2010, BIOCHEM BIOPH RES CO, V397, P263, DOI 10.1016/j.bbrc.2010.05.097; Zou YZ, 2004, NAT CELL BIOL, V6, P499, DOI 10.1038/ncb1137; Zou YZ, 1996, J BIOL CHEM, V271, P33592, DOI 10.1074/jbc.271.52.33592	34	14	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e92926	10.1371/journal.pone.0092926	http://dx.doi.org/10.1371/journal.pone.0092926			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699426	Green Submitted, gold, Green Published			2022-12-25	WOS:000334105000037
J	Agassandian, K; Patel, M; Agassandian, M; Steren, KE; Rahmouni, K; Sheffield, VC; Card, JP				Agassandian, Khristofor; Patel, Milan; Agassandian, Marianna; Steren, Karina E.; Rahmouni, Kamal; Sheffield, Val C.; Card, J. Patrick			Ciliopathy Is Differentially Distributed in the Brain of a Bardet-Biedl Syndrome Mouse Model	PLOS ONE			English	Article							TYPE-3 ADENYLYL-CYCLASE; PRIMARY CILIA; SYNDROME PROTEINS; NULL MICE; NEURONS; DISEASE; COMPLEX; ROOTLET; MEMORY; ABNORMALITIES	Bardet-Biedl syndrome (BBS) is a genetically heterogeneous inherited human disorder displaying a pleotropic phenotype. Many of the symptoms characterized in the human disease have been reproduced in animal models carrying deletions or knock-in mutations of genes causal for the disorder. Thinning of the cerebral cortex, enlargement of the lateral and third ventricles, and structural changes in cilia are among the pathologies documented in these animal models. Ciliopathy is of particular interest in light of recent studies that have implicated primary neuronal cilia (PNC) in neuronal signal transduction. In the present investigation, we tested the hypothesis that areas of the brain responsible for learning and memory formation would differentially exhibit PNC abnormalities in animals carrying a deletion of the Bbs4 gene (Bbs4(-/-)). Immunohistochemical localization of adenylyl cyclase-III (ACIII), a marker restricted to PNC, revealed dramatic alterations in PNC morphology and a statistically significant reduction in number of immunopositive cilia in the hippocampus and amygdala of Bbs4(-/-) mice compared to wild type (WT) littermates. Western blot analysis confirmed the decrease of ACIII levels in the hippocampus and amygdala of Bbs4(-/-) mice, and electron microscopy demonstrated pathological alterations of PNC in the hippocampus and amygdala. Importantly, no neuronal loss was found within the subregions of amygdala and hippocampus sampled in Bbs4(-/-) mice and there were no statistically significant alterations of ACIII immunopositive cilia in other areas of the brain not known to contribute to the BBS phenotype. Considered with data documenting a role of cilia in signal transduction these findings support the conclusion that alterations in cilia structure or neurochemical phenotypes may contribute to the cognitive deficits observed in the Bbs4(-/-) mouse mode.	[Agassandian, Khristofor; Patel, Milan; Steren, Karina E.; Card, J. Patrick] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA; [Agassandian, Marianna] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Rahmouni, Kamal] Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA; [Rahmouni, Kamal] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Sheffield, Val C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Sheffield, Val C.] Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Iowa; University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa	Agassandian, K (corresponding author), Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA.	khrisag@pitt.edu	Rahmouni, Kamal/Y-1788-2019	Card, John/0000-0002-6148-7364; Rahmouni, Kamal/0000-0001-5136-6748; Sheffield, Val/0000-0002-6282-0835	National Institutes of Health (NIH) [1RO1HL093134, PO1HL084207]; NIH [R01-EY-11298]; NATIONAL EYE INSTITUTE [R01EY017168, R01EY011298] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL084207, R01HL093134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083543] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The research reported in this manuscript was supported by National Institutes of Health (NIH) grants 1RO1HL093134 to J.P. Card and PO1HL084207 to K. Rahmouni. V.C. Sheffield acknowledges NIH support from R01-EY-11298 and is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 2004, ESSENTIAL CELL BIOL; Amador-Arjona A, 2011, J NEUROSCI, V31, P9933, DOI 10.1523/JNEUROSCI.1062-11.2011; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Baker K, 2011, AM J MED GENET A, V155A, P1, DOI 10.1002/ajmg.a.33773; Baker K, 2009, AM J MED GENET C, V151C, P281, DOI 10.1002/ajmg.c.30231; Bardet G, 1920, DTSCH MED WOCHENSCHR; Barnett S, 2002, J Med Genet, V39, pe76, DOI 10.1136/jmg.39.12.e76; Beales PL, 1999, J MED GENET, V36, P437; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Biedl A., 1922, DEUT MED WOCHENSCHR, V48, P1630; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Carter CS, 2012, NAT MED, V18, P1797, DOI 10.1038/nm.2996; Chamling X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059101; Davis RE, 2007, P NATL ACAD SCI USA, V104, P19422, DOI 10.1073/pnas.0708571104; Dominguez-Bendala J, 2011, CURR OPIN ORGAN TRAN, V16, P76, DOI 10.1097/MOT.0b013e32834252b5; Eichers ER, 2006, HUM GENET, V120, P211, DOI 10.1007/s00439-006-0197-y; Fath MA, 2005, HUM MOL GENET, V14, P1109, DOI 10.1093/hmg/ddi123; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Guadiana SM, 2013, J NEUROSCI, V33, P2626, DOI 10.1523/JNEUROSCI.2906-12.2013; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Keppler-Noreuil KM, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-101; Keryer G, 2011, J CLIN INVEST, V121, P4372, DOI 10.1172/JCI57552; Kumamoto N, 2012, NAT NEUROSCI, V15, P399, DOI 10.1038/nn.3042; Laurence J.Z., 1866, OPHTHALMIC REV, V2, P32; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Leroux MR, 2007, CELL, V129, P1041, DOI 10.1016/j.cell.2007.05.049; Loktev AV, 2008, DEV CELL, V15, P854, DOI 10.1016/j.devcel.2008.11.001; Massinen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020580; Mykytyn K, 2004, P NATL ACAD SCI USA, V101, P8664, DOI 10.1073/pnas.0402354101; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nishimura DY, 2004, P NATL ACAD SCI USA, V101, P16588, DOI 10.1073/pnas.0405496101; PARE D, 1993, NEUROSCIENCE, V57, P1077, DOI 10.1016/0306-4522(93)90050-P; Peyron C, 1998, J NEUROSCI, V18, P9996; Praetorius HA, 2005, ANNU REV PHYSIOL, V67, P515, DOI 10.1146/annurev.physiol.67.040403.101353; Rahmouni K, 2008, J CLIN INVEST, V118, P1458, DOI 10.1172/JCI32357; Rooryck C, 2007, NEUROPEDIATRICS, V38, P5, DOI 10.1055/s-2007-981466; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Scheidecker S, 2013, J MED GENETICS; Seeley ES, 2010, J CELL SCI, V123, P511, DOI 10.1242/jcs.061093; Seo S, 2010, P NATL ACAD SCI USA, V107, P1488, DOI 10.1073/pnas.0910268107; Sheffield VC, 2008, BARDET BIEDL SYNDROM; SHU SY, 1988, NEUROSCI LETT, V85, P169, DOI 10.1016/0304-3940(88)90346-1; Swiderski RE, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-22; Veland IR, 2009, NEPHRON PHYSIOL, V111, P39, DOI 10.1159/000208212; Wang ZS, 2011, J NEUROSCI, V31, P5557, DOI 10.1523/JNEUROSCI.6561-10.2011; WATSON RE, 1986, PEPTIDES, V7, P155, DOI 10.1016/0196-9781(86)90076-8; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X; Yang J, 2005, MOL CELL BIOL, V25, P4129, DOI 10.1128/MCB.25.10.4129-4137.2005; Yang J, 2002, J CELL BIOL, V159, P431, DOI 10.1083/jcb.200207153; Yang J, 2005, EXP CELL RES, V309, P379, DOI 10.1016/j.yexcr.2005.05.026; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	55	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93484	10.1371/journal.pone.0093484	http://dx.doi.org/10.1371/journal.pone.0093484			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695551	Green Published, Green Accepted, gold			2022-12-25	WOS:000334103000078
J	Chisti, MJ; Graham, SM; Duke, T; Ahmed, T; Ashraf, H; Faruque, ASG; La Vincente, S; Banu, S; Raqib, R; Salam, MA				Chisti, Mohammod Jobayer; Graham, Stephen M.; Duke, Trevor; Ahmed, Tahmeed; Ashraf, Hasan; Faruque, Abu Syed Golam; La Vincente, Sophie; Banu, Sayera; Raqib, Rubhana; Salam, Mohammed Abdus			A Prospective Study of the Prevalence of Tuberculosis and Bacteraemia in Bangladeshi Children with Severe Malnutrition and Pneumonia Including an Evaluation of Xpert MTB/RIF Assay	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; CHILDHOOD TUBERCULOSIS; MALNOURISHED CHILDREN; INDUCED SPUTUM; DIAGNOSIS; MORTALITY; DIARRHEA; INFANTS; HIV; INFECTIONS	Background: Severe malnutrition is a risk factor for pneumonia due to a wide range of pathogens but aetiological data are limited and the role of Mycobacterium tuberculosis is uncertain. Methods: We prospectively investigated severely malnourished young children (<5 years) with radiological pneumonia admitted over a 15-month period. Investigations included blood culture, sputa for microscopy and mycobacterial culture. Xpert MTB/RIF assay was introduced during the study. Study children were followed for 12 weeks following their discharge from the hospital. Results: 405 eligible children were enrolled, with a median age of 10 months. Bacterial pathogens were isolated from blood culture in 18 (4.4%) children, of which 72% were Gram negatives. Tuberculosis was confirmed microbiologically in 7% (27/396) of children that provided sputum - 10 by culture, 21 by Xpert MTB/RIF assay, and 4 by both tests. The diagnostic yield from induced sputum was 6% compared to 3.5% from gastric aspirate. Sixty (16%) additional children had tuberculosis diagnosed clinically that was not microbiologically confirmed. Most confirmed tuberculosis cases did not have a positive contact history or positive tuberculin test. The sensitivity and specificity of Xpert MTB/RIF assay compared to culture was 67% (95% CI: 24-94) and 92% (95% CI: 87-95) respectively. Overall case-fatality rate was 17% and half of the deaths occurred in home following discharge from the hospital. Conclusion and Significance: TB was common in severely malnourished Bangladeshi children with pneumonia. X-pert MTB/RIF assay provided higher case detection rate compared to sputum microscopy and culture. The high mortality among the study children underscores the need for further research aimed at improved case detection and management for better outcomes.	[Chisti, Mohammod Jobayer; Ahmed, Tahmeed; Ashraf, Hasan; Faruque, Abu Syed Golam; Banu, Sayera; Raqib, Rubhana; Salam, Mohammed Abdus] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Chisti, Mohammod Jobayer; Graham, Stephen M.; Duke, Trevor; La Vincente, Sophie] Univ Melbourne, Ctr Int Child Hlth, Dept Paediat, Melbourne, Vic, Australia; [Chisti, Mohammod Jobayer; Graham, Stephen M.; Duke, Trevor; La Vincente, Sophie] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; Int Union TB & Lung Dis, Paris, France	International Centre for Diarrhoeal Disease Research (ICDDR); University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Graham, SM (corresponding author), Univ Melbourne, Ctr Int Child Hlth, Dept Paediat, Melbourne, Vic, Australia.	steve.graham@rch.org.au	Chisti, Mohammod J/A-7216-2018	Raqib, Rubhana/0000-0002-8116-4511; Banu, Sayera/0000-0002-5121-1962; Graham, Stephen/0000-0003-3525-2294	Dhaka Hospital of International Centre for Diarrhoeal Disease Research, Bangladesh (icddr, b) [Gr-00233]	Dhaka Hospital of International Centre for Diarrhoeal Disease Research, Bangladesh (icddr, b)	This research study was funded by the Dhaka Hospital of International Centre for Diarrhoeal Disease Research, Bangladesh (icddr, b; grant no Gr-00233) and its donors, which provide unrestricted support to icddr, b for its operations and research. Current donors providing unrestricted support include: Australian Agency for International Development (AusAID), Government of the People's Republic of Bangladesh, Canadian International Development Agency, Swedish International Development Cooperation Agency, and the Department for International Development, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T, 1999, LANCET, V353, P1919, DOI 10.1016/S0140-6736(98)07499-6; [Anonymous], 2012, NAT GUID MAN TUB CHI; [Anonymous], COTR PROPH SEV MALN; [Anonymous], 2011, TUB DIAGN AUT DNA TE; Azim T, 2008, INT J STD AIDS, V19, P327, DOI 10.1258/ijsa.2007.007269; Banu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040545; Bates M, 2012, LANCET INFECT DIS; Bates M, 2013, CURR OPIN PULM MED, V19, P229, DOI 10.1097/MCP.0b013e32835f4fe4; BERKOWITZ FE, 1992, PEDIATR INFECT DIS J, V11, P750, DOI 10.1097/00006454-199209000-00015; Carrol ED, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021042; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Chisti MJ, 2010, PEDIATR CRIT CARE ME, V11, P92, DOI 10.1097/PCC.0b013e3181b063e1; Chisti MJ, 2013, J HEALTH POPUL NUTR, V31, P308; Chisti MJ, 2010, PEDIATR INFECT DIS J, V29, P174, DOI 10.1097/INF.0b013e3181b9a4d5; Chisti MJ, 2009, TROP MED INT HEALTH, V14, P1173, DOI 10.1111/j.1365-3156.2009.02364.x; Grant LR, 2012, CLIN INFECT DIS, V54, pS140, DOI [10.1093/cid/cir1069, 10.1093/cid/cir1073]; Jaganath D, 2012, J INFECT DIS, V206, P1809, DOI 10.1093/infdis/jis608; Kim BJ, 1999, J CLIN MICROBIOL, V37, P1714, DOI 10.1128/JCM.37.6.1714-1720.1999; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; McNally LM, 2007, LANCET, V369, P1440, DOI 10.1016/S0140-6736(07)60670-9; Nantongo JM, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-16; Nguyen TQN, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-31; Nicol MP, 2011, LANCET INFECT DIS, V11, P819, DOI 10.1016/S1473-3099(11)70167-0; Punia RS, 2012, TROP DOCT, V42, P46, DOI 10.1258/td.2011.110314; Rachow A, 2012, CLIN INFECT DIS, V54, P1388, DOI 10.1093/cid/cis190; Shata AMA, 1996, ARCH DIS CHILD, V74, P535, DOI 10.1136/adc.74.6.535; UNICEF, 2013, STAT WORLDS CHILDR 2; Waterlow JC, 1997, CLIN NUTR, V16, P3, DOI 10.1016/S0261-5614(97)80043-X; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wiersma HE, 2000, ARCH DIS CHILD, V83, P278; World Health Organisation, 2006, GUID NAT TUB PROGR M; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C; Zar HJ, 2005, LANCET, V365, P130, DOI 10.1016/S0140-6736(05)17702-2	33	48	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93776	10.1371/journal.pone.0093776	http://dx.doi.org/10.1371/journal.pone.0093776			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695758	gold, Green Published, Green Submitted			2022-12-25	WOS:000334103000120
J	Cai, X; Wang, JF; Huang, X; Fu, WL; Xia, WR; Zou, MJ; Wang, YY; Wang, JX; Xu, DG				Cai, Xin; Wang, JinFeng; Huang, Xin; Fu, Wenliang; Xia, Wenrong; Zou, Minji; Wang, YuanYuan; Wang, Jiaxi; Xu, Donggang			Identification and Characterization of MT-1X as a Novel FHL3-Binding Partner	PLOS ONE			English	Article							METALLOTHIONEIN EXPRESSION; BINDING PROTEIN; LIM DOMAIN; CELL-CYCLE; FHL3; CARCINOMA; APOPTOSIS; FAMILY; CANCER; ROLES	Four and a half LIM domain protein 3 ( FHL3) is a member of the FHL protein family that plays roles in the regulation of cell survival, cell adhesion and signal transduction. However, the mechanism of action for FHL3 is not yet clear. The aim of present study was to identify novel binding partner of FHL3 and to explore the underlying mechanism. With the use of yeast two-hybrid screening system, FHL3 was used as the bait to screen human fetal hepatic cDNA library for interacting proteins. Methionine-1X was identified as a novel FHL3 binding partner. The interaction between FHL3 and the full length MT-1X was further confirmed by yeast two-hybrid assay, co-immunoprecipitation and GST pull-down assays. Furthermore, the result demonstrated that MT-1X knockdown promoted the FHL3-induced inhibitory effect on HepG2 cells by regulating FHL3-mediated Smad signaling and involving in the modulation the expression of G2/M phase-related proteins through interaction with FHL3. These findings suggest that functional interactions between FHL3 and MT-1X may provide some clues to the mechanisms of FHL3-regulated cell proliferation.	[Cai, Xin; Wang, JinFeng; Huang, Xin; Fu, Wenliang; Xia, Wenrong; Zou, Minji; Wang, YuanYuan; Wang, Jiaxi; Xu, Donggang] Beijing Inst Basic Med Sci, Lab Genome Engn, Beijing, Peoples R China	Academy of Military Medical Sciences - China	Xu, DG (corresponding author), Beijing Inst Basic Med Sci, Lab Genome Engn, Beijing, Peoples R China.	xudg@bmi.ac.cn	Lv, Yuanjie/AER-0767-2022		China Natural Scientific Foundation [81001175, 81071928]	China Natural Scientific Foundation(National Natural Science Foundation of China (NSFC))	This research was supported by China Natural Scientific Foundation (NO. 81001175; NO. No. 81071928). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Baba HA, 2000, J HEART LUNG TRANSPL, V19, P668, DOI 10.1016/S1053-2498(00)00074-7; Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; Cazzalini O, 2010, MUTAT RES-REV MUTAT, V704, P12, DOI 10.1016/j.mrrev.2010.01.009; Cherian MG, 2003, MUTAT RES-FUND MOL M, V533, P201, DOI 10.1016/j.mrfmmm.2003.07.013; Coghill ID, 2003, J BIOL CHEM, V278, P24139, DOI 10.1074/jbc.M213259200; Cottle DL, 2007, J CELL SCI, V120, P1423, DOI 10.1242/jcs.004739; Coyle P, 2002, CELL MOL LIFE SCI, V59, P627, DOI 10.1007/s00018-002-8454-2; Ding LH, 2009, J CLIN INVEST, V119, P349, DOI 10.1172/JCI35930; Dulic V, 1998, MOL CELL BIOL, V18, P546, DOI 10.1128/MCB.18.1.546; Endo T, 2004, J GASTROENTEROL, V39, P1196, DOI 10.1007/s00535-004-1471-1; Fimia GM, 2000, MOL CELL BIOL, V20, P8613, DOI 10.1128/MCB.20.22.8613-8622.2000; Greenbaum LE, 2004, CANCER BIOL THER, V3, P1200, DOI 10.4161/cbt.3.12.1392; Han W, 2013, J CLIN INVEST, V123, P2103, DOI 10.1172/JCI61820; Henkel G, 2004, CHEM REV, V104, P801, DOI 10.1021/cr020620d; Huang X, 2009, BIOTECHNOL LETT, V31, P1499, DOI 10.1007/s10529-009-0054-x; Hubbi ME, 2012, J BIOL CHEM, V287, P6139, DOI 10.1074/jbc.M111.278630; Jacob ST, 2002, ENVIRON HEALTH PERSP, V110, P827, DOI 10.1289/ehp.02110s5827; Johannessen M, 2006, CELL MOL LIFE SCI, V63, P268, DOI 10.1007/s00018-005-5438-z; KAGI JHR, 1988, BIOCHEMISTRY-US, V27, P8509, DOI 10.1021/bi00423a001; Mao J, 2012, CARCINOGENESIS, V33, P2568, DOI 10.1093/carcin/bgs287; Meeson AP, 2007, EMBO J, V26, P1902, DOI 10.1038/sj.emboj.7601635; Mils V, 2003, EXP CELL RES, V285, P99, DOI 10.1016/S0014-4827(03)00018-1; Moleirinho A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018487; Morgan MJ, 2000, BIOCHEM BIOPH RES CO, V273, P776, DOI 10.1006/bbrc.2000.3006; Morgan MJ, 1996, BIOCHEM BIOPH RES CO, V225, P632, DOI 10.1006/bbrc.1996.1222; Niu C, 2011, IUBMB LIFE, V63, P764, DOI 10.1002/iub.502; Romero-Isart N, 2002, J INORG BIOCHEM, V88, P388, DOI 10.1016/S0162-0134(01)00347-6; Ruttkay-Nedecky B, 2013, INT J MOL SCI, V14, P6044, DOI 10.3390/ijms14036044; Singhal S, 2005, CLIN CANCER RES, V11, P3974, DOI 10.1158/1078-0432.CCR-04-2661; Takahashi K, 2005, BIOCHEM J, V386, P191, DOI 10.1042/BJ20040775; Tao X, 2007, HEPATOL RES, V37, P820, DOI 10.1111/j.1872-034X.2007.00113.x; Theocharis SE, 2004, HISTOPATHOLOGY, V45, P103, DOI 10.1111/j.1365-2559.2004.01922.x; Vasak M, 2005, J TRACE ELEM MED BIO, V19, P13, DOI 10.1016/j.jtemb.2005.03.003; Xia WR, 2012, GENE, V504, P233, DOI 10.1016/j.gene.2012.05.019; Xu K, 2011, ANTI-CANCER DRUG, V22, P875, DOI 10.1097/CAD.0b013e328349597d	36	1	1	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93723	10.1371/journal.pone.0093723	http://dx.doi.org/10.1371/journal.pone.0093723			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690879	Green Published, gold, Green Submitted			2022-12-25	WOS:000334101100131
J	Fujita, H; Aoki, S; Kawaguchi, M				Fujita, Hironori; Aoki, Seishiro; Kawaguchi, Masayoshi			Evolutionary Dynamics of Nitrogen Fixation in the Legume-Rhizobia Symbiosis	PLOS ONE			English	Article							CONTINUOUS PRISONERS-DILEMMA; PARTNER CHOICE; MUTUALISM STABILITY; MIXED INFECTIONS; SNOWDRIFT GAME; COOPERATION; SANCTIONS; POPULATIONS; TRIFOLII; NEGOTIATION	The stabilization of host-symbiont mutualism against the emergence of parasitic individuals is pivotal to the evolution of cooperation. One of the most famous symbioses occurs between legumes and their colonizing rhizobia, in which rhizobia extract nutrients (or benefits) from legume plants while supplying them with nitrogen resources produced by nitrogen fixation (or costs). Natural environments, however, are widely populated by ineffective rhizobia that extract benefits without paying costs and thus proliferate more efficiently than nitrogen-fixing cooperators. How and why this mutualism becomes stabilized and evolutionarily persists has been extensively discussed. To better understand the evolutionary dynamics of this symbiosis system, we construct a simple model based on the continuous snowdrift game with multiple interacting players. We investigate the model using adaptive dynamics and numerical simulations. We find that symbiotic evolution depends on the cost-benefit balance, and that cheaters widely emerge when the cost and benefit are similar in strength. In this scenario, the persistence of the symbiotic system is compatible with the presence of cheaters. This result suggests that the symbiotic relationship is robust to the emergence of cheaters, and may explain the prevalence of cheating rhizobia in nature. In addition, various stabilizing mechanisms, such as partner fidelity feedback, partner choice, and host sanction, can reinforce the symbiotic relationship by affecting the fitness of symbionts in various ways. This result suggests that the symbiotic relationship is cooperatively stabilized by various mechanisms. In addition, mixed nodule populations are thought to encourage cheater emergence, but our model predicts that, in certain situations, cheaters can disappear from such populations. These findings provide a theoretical basis of the evolutionary dynamics of legume-rhizobia symbioses, which is extendable to other single-host, multiple-colonizer systems.	[Fujita, Hironori; Kawaguchi, Masayoshi] Natl Inst Nat Sci, Natl Inst Basic Biol, Div Symbiot Syst, Okazaki, Aichi 4448585, Japan; [Aoki, Seishiro] Univ Tokyo, Grad Sch Arts & Sci, Dept Gen Syst Studies, Meguro Ku, Tokyo, Japan; [Kawaguchi, Masayoshi] Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); University of Tokyo; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB)	Fujita, H (corresponding author), Natl Inst Nat Sci, Natl Inst Basic Biol, Div Symbiot Syst, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	hfujita@nibb.ac.jp		Kawaguchi, Masayoshi/0000-0002-1032-6261; Fujita, Hironori/0000-0003-4916-2994	Ministry of Education, Culture, Sports, Science and Technology of Japan [22128006]; Grants-in-Aid for Scientific Research [26660057] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Grants-in-Aid for Scientific Research (22128006) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay E, 2007, P ROY SOC B-BIOL SCI, V274, P25, DOI 10.1098/rspb.2006.3689; Akcay E, 2011, AM NAT, V178, P1, DOI 10.1086/659997; Archetti M, 2011, ECOL LETT, V14, P1300, DOI 10.1111/j.1461-0248.2011.01697.x; Bever JD, 2000, HEREDITY, V85, P366, DOI 10.1046/j.1365-2540.2000.00772.x; BOTTOMLEY PJ, 1983, SOIL SCI SOC AM J, V47, P1153, DOI 10.2136/sssaj1983.03615995004700060019x; Brannstrom A, 2011, J MATH BIOL, V63, P263, DOI 10.1007/s00285-010-0367-3; Burdon JJ, 1999, J APPL ECOL, V36, P398, DOI 10.1046/j.1365-2664.1999.00409.x; DEMEZAS DH, 1986, APPL ENVIRON MICROB, V52, P1020, DOI 10.1128/AEM.52.5.1020-1025.1986; Denison RF, 2004, FEMS MICROBIOL LETT, V237, P187, DOI 10.1016/j.femsle.2004.07.013; Denison RF, 2000, AM NAT, V156, P567, DOI 10.1086/316994; Doebeli M, 2004, SCIENCE, V306, P859, DOI 10.1126/science.1101456; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Douglas AE, 2008, NEW PHYTOL, V177, P849, DOI 10.1111/j.1469-8137.2007.02326.x; Ezoe H, 2012, J THEOR BIOL, V314, P138, DOI 10.1016/j.jtbi.2012.08.037; Friesen ML, 2010, J EVOLUTION BIOL, V23, P323, DOI 10.1111/j.1420-9101.2009.01902.x; Friesen ML, 2012, NEW PHYTOL, V194, P1096, DOI 10.1111/j.1469-8137.2012.04099.x; Friesen ML, 2012, METHODS MOL BIOL, V804, P481, DOI 10.1007/978-1-61779-361-5_24; Gage DJ, 2002, J BACTERIOL, V184, P7042, DOI 10.1128/JB.184.24.7042-7046.2002; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; GIBSON AH, 1975, SOIL BIOL BIOCHEM, V7, P95, DOI 10.1016/0038-0717(75)90005-X; Gubry-Rangin C, 2010, P ROY SOC B-BIOL SCI, V277, P1947, DOI 10.1098/rspb.2009.2072; Kiers ET, 2008, ANNU REV ECOL EVOL S, V39, P215, DOI 10.1146/annurev.ecolsys.39.110707.173423; Kiers ET, 2011, P NATL ACAD SCI USA, V108, pE7, DOI 10.1073/pnas.1014546108; Kiers ET, 2003, NATURE, V425, P78, DOI 10.1038/nature01931; Killingback T, 1999, P ROY SOC B-BIOL SCI, V266, P1723, DOI 10.1098/rspb.1999.0838; Laguerre G, 2012, NEW PHYTOL, V195, P437, DOI 10.1111/j.1469-8137.2012.04159.x; Le S, 2007, J THEOR BIOL, V245, P258, DOI 10.1016/j.jtbi.2006.09.016; Marco DE, 2009, J THEOR BIOL, V259, P423, DOI 10.1016/j.jtbi.2009.03.033; Marco DE, 2009, ACTA OECOL, V35, P664, DOI 10.1016/j.actao.2009.06.005; Moawad H, 1998, PLANT SOIL, V204, P95, DOI 10.1023/A:1004335112402; MOAWAD M, 1987, BIOL FERT SOILS, V5, P112, DOI 10.1007/BF00257644; Nowak MA, 2004, SCIENCE, V303, P793, DOI 10.1126/science.1093411; Oono R, 2009, NEW PHYTOL, V183, P967, DOI 10.1111/j.1469-8137.2009.02941.x; Parvinen K, 2011, B MATH BIOL, V73, P2605, DOI 10.1007/s11538-011-9638-4; Provorov NA, 2000, J THEOR BIOL, V205, P105, DOI 10.1006/jtbi.2000.2051; Provorov NA, 2006, THEOR POPUL BIOL, V70, P262, DOI 10.1016/j.tpb.2006.06.002; Provorov NA, 2008, THEOR POPUL BIOL, V74, P345, DOI 10.1016/j.tpb.2008.09.005; ROLFE BG, 1980, AUST J BIOL SCI, V33, P491; Sachs JL, 2010, J EVOLUTION BIOL, V23, P1919, DOI 10.1111/j.1420-9101.2010.02056.x; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; Schumpp O, 2010, TRENDS PLANT SCI, V15, P189, DOI 10.1016/j.tplants.2010.01.001; Simms EL, 2006, P ROY SOC B-BIOL SCI, V273, P77, DOI 10.1098/rspb.2005.3292; Simms EL, 2002, INTEGR COMP BIOL, V42, P369, DOI 10.1093/icb/42.2.369; Wahl LM, 1999, J THEOR BIOL, V200, P307, DOI 10.1006/jtbi.1999.0996; Waxman D, 2005, J EVOLUTION BIOL, V18, P1139, DOI 10.1111/j.1420-9101.2005.00948.x; West SA, 2002, J EVOLUTION BIOL, V15, P830, DOI 10.1046/j.1420-9101.2002.00441.x; West SA, 2002, P ROY SOC B-BIOL SCI, V269, P685, DOI 10.1098/rspb.2001.1878; Weyl EG, 2011, P NATL ACAD SCI USA, V108, pE8, DOI 10.1073/pnas.1015734108; Weyl EG, 2010, P NATL ACAD SCI USA, V107, P15712, DOI 10.1073/pnas.1005294107; Zhong LX, 2008, CHINESE PHYS LETT, V25, P2315, DOI 10.1088/0256-307X/25/6/107	50	22	22	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93670	10.1371/journal.pone.0093670	http://dx.doi.org/10.1371/journal.pone.0093670			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691447	gold, Green Submitted, Green Published			2022-12-25	WOS:000334101100125
J	Hohmann, N; Wei, WW; Dahmen, U; Dirsch, O; Deutsch, A; Voss-Bohme, A				Hohmann, Nadine; Wei Weiwei; Dahmen, Uta; Dirsch, Olaf; Deutsch, Andreas; Voss-Boehme, Anja			How Does a Single Cell Know When the Liver Has Reached Its Correct Size?	PLOS ONE			English	Article							SHEAR-STRESS; REGENERATION	The liver is a multi-functional organ that regulates major physiological processes and that possesses a remarkable regeneration capacity. After loss of functional liver mass the liver grows back to its original, individual size through hepatocyte proliferation and apoptosis. How does a single hepatocyte 'know' when the organ has grown to its final size? This work considers the initial growth phase of liver regeneration after partial hepatectomy in which the mass is restored. There are strong and valid arguments that the trigger of proliferation after partial hepatectomy is mediated through the portal blood flow. It remains unclear, if either or both the concentration of metabolites in the blood or the shear stress are crucial to hepatocyte proliferation and liver size control. A cell-based mathematical model is developed that helps discriminate the effects of these two potential triggers. Analysis of the mathematical model shows that a metabolic load and a hemodynamical hypothesis imply different feedback mechanisms at the cellular scale. The predictions of the developed mathematical model are compared to experimental data in rats. The assumption that hepatocytes are able to buffer the metabolic load leads to a robustness against short-term fluctuations of the trigger which can not be achieved with a purely hemodynamical trigger.	[Hohmann, Nadine; Deutsch, Andreas; Voss-Boehme, Anja] Tech Univ Dresden, Ctr Informat Serv & High Performance Comp, D-01062 Dresden, Germany; [Wei Weiwei; Dahmen, Uta] Univ Hosp Jena, Dept Gen Visceral & Transplantat Surg, Jena, Germany; [Dirsch, Olaf] Univ Hosp Jena, Inst Pathol, Jena, Germany	Technische Universitat Dresden; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Hohmann, N (corresponding author), Tech Univ Dresden, Ctr Informat Serv & High Performance Comp, D-01062 Dresden, Germany.	nadine.hohmann@tu-dresden.de	Voss-Böhme, Anja/O-6869-2017	Voss-Böhme, Anja/0000-0001-6510-8694	German Ministry of Education and Research (BMBF); German Research Foundation; Open Access Publication Funds of TU Dresden	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of TU Dresden	This research was supported by the German Ministry of Education and Research (BMBF) in the program "Virtual Liver Network". The authors acknowledge support by the German Research Foundation and the Open Access Publication Funds of TU Dresden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abshagen K, 2012, LANGENBECK ARCH SURG, V397, P579, DOI 10.1007/s00423-012-0913-0; Aegerter-Wilmsen T, 2007, MECH DEV, V124; Alberts B., 2008, MOL BIOL CELL REFERE; Baumann U, 2009, DIS LIVER BILIARY SY, P117; Binder BJ, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.031912; Dahmen U, 2008, J SURG RES, V149, P15, DOI 10.1016/j.jss.2007.09.010; Day SJ, 2000, DEVELOPMENT, V127, P2977; Dell Ralph B, 2002, ILAR J, V43, P207; Dirsch O, 2008, J INVEST SURG, V21, P288, DOI 10.1080/08941930802216823; Eipel C, 2010, TRANSPLANT INT, V23; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fausto N, 2005, J HEPATO-BILIARY-PAN, V12, P181, DOI 10.1007/s00534-005-0979-y; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Furchtgott LA, 2009, BIOPHYS J, V96, P3926, DOI 10.1016/j.bpj.2009.01.061; Gebhardt R, 2010, DEV DYNAM, V239, P45, DOI 10.1002/dvdy.22041; Gock M, 2011, MICROVASC RES, V81, P274, DOI 10.1016/j.mvr.2011.03.005; Huang H, 2010, LAB ANIM-UK, V44, P254, DOI 10.1258/la.2009.009055; Hufnagel L, 2007, P NATL ACAD SCI USA, V104, P3835, DOI 10.1073/pnas.0607134104; Jin H, 2012, EUR SURG RES, V49, P53, DOI 10.1159/000333395; KAM I, 1987, HEPATOLOGY, V7, P362, DOI 10.1002/hep.1840070225; Klauss T., 2008, MATH MODELING BIOL S, VII, P353, DOI DOI 10.1007/978-0-8176-4556-4_31; Koniaris LG, 2003, J AM COLL SURGEONS, V197, P634, DOI 10.1016/S1072-7515(03)00374-0; Liggett T. M, 1985, INTERACTING PARTICLE, V276; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Mortensen KE, 2011, EUR SURG RES, V46, P1, DOI 10.1159/000321361; Niiya T, 1999, J HEPATOBILIARY PANC, V6; Nijhout HF, 2003, DEV BIOL, V261; Papp V, 2009, LIVER TRANSPLANT, V15, P177, DOI 10.1002/lt.21665; Rabes H M, 1977, Ciba Found Symp, P31; Sato Y, 1997, SURG TODAY, V27, P518, DOI 10.1007/BF02385805; Sato Y, 1999, SURG TODAY, V29, P1, DOI 10.1007/BF02482962; Schoen JM, 2001, NITRIC OXIDE-BIOL CH, V5, P453, DOI 10.1006/niox.2001.0373; Schulte-Hermann R, 1974, CRC CR REV TOXICOL, V3; Schwank G, 2009, COLD SPRING HARB PER, V2; STARZL TE, 1993, LANCET, V341, P65, DOI 10.1016/0140-6736(93)92553-6; Taira K, 2001, EUR SURG RES, V33, P334, DOI 10.1159/000049727; Vogel G, 2013, SCIENCE, V340, P1156, DOI 10.1126/science.340.6137.1156-b; Voss-Bohme A, 2010, J THEOR BIOL, V263, P419, DOI 10.1016/j.jtbi.2009.12.011; Wartlick O, 2011, SCIENCE, V331, P1154, DOI 10.1126/science.1200037	41	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93207	10.1371/journal.pone.0093207	http://dx.doi.org/10.1371/journal.pone.0093207			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690888	Green Submitted, Green Published, gold			2022-12-25	WOS:000334101100052
J	Jacquemin, SJ; Doll, JC				Jacquemin, Stephen J.; Doll, Jason C.			Body Size and Geographic Range Do Not Explain Long Term Variation in Fish Populations: A Bayesian Phylogenetic Approach to Testing Assembly Processes in Stream Fish Assemblages	PLOS ONE			English	Article							NICHE CONSERVATISM; ABUNDANCE; EVOLUTION; HABITAT; RIVER; DIVERSIFICATION; VARIABLES; ECOLOGY; BREADTH; TRAITS	We combine evolutionary biology and community ecology to test whether two species traits, body size and geographic range, explain long term variation in local scale freshwater stream fish assemblages. Body size and geographic range are expected to influence several aspects of fish ecology, via relationships with niche breadth, dispersal, and abundance. These traits are expected to scale inversely with niche breadth or current abundance, and to scale directly with dispersal potential. However, their utility to explain long term temporal patterns in local scale abundance is not known. Comparative methods employing an existing molecular phylogeny were used to incorporate evolutionary relatedness in a test for covariation of body size and geographic range with long term (1983 - 2010) local scale population variation of fishes in West Fork White River (Indiana, USA). The Bayesian model incorporating phylogenetic uncertainty and correlated predictors indicated that neither body size nor geographic range explained significant variation in population fluctuations over a 28 year period. Phylogenetic signal data indicated that body size and geographic range were less similar among taxa than expected if trait evolution followed a purely random walk. We interpret this as evidence that local scale population variation may be influenced less by species-level traits such as body size or geographic range, and instead may be influenced more strongly by a taxon's local scale habitat and biotic assemblages.	[Jacquemin, Stephen J.] Wright State Univ, Dept Biol Sci, Celina, OH 45822 USA; [Doll, Jason C.] Ball State Univ, Dept Biol, Muncie, IN 47306 USA	University System of Ohio; Wright State University Dayton; Ball State University	Jacquemin, SJ (corresponding author), Wright State Univ, Dept Biol Sci, Lake Campus, Celina, OH 45822 USA.	stephen.jacquemin@wright.edu; jcdoll@bsu.edu						Betancur-R R, 2013, PLOS CURRENTS TREE L; BLACKBURN TM, 1993, J ANIM ECOL, V62, P519, DOI 10.2307/5201; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; de Villemereuil P, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-102; Doosey MH, 2010, MOL PHYLOGENET EVOL, V54, P1028, DOI 10.1016/j.ympev.2009.06.006; Frimpong EA, 2009, FISHERIES, V34, P487, DOI 10.1577/1548-8446-34.10.487; GASTON KJ, 1988, AM NAT, V132, P662, DOI 10.1086/284881; Gaston KJ, 1996, J ANIM ECOL, V65, P701, DOI 10.2307/5669; Gelman A., 2004, BAYESIAN DATA ANAL; GORMAN OT, 1978, ECOLOGY, V59, P507, DOI 10.2307/1936581; Grossman GD, 1998, ECOL MONOGR, V68, P395, DOI 10.1890/0012-9615(1998)068[0395:AOISFE]2.0.CO;2; GROSSMAN GD, 1982, AM NAT, V120, P423, DOI 10.1086/284004; Harding JS, 1998, P NATL ACAD SCI USA, V95, P14843, DOI 10.1073/pnas.95.25.14843; Hardman M, 2008, SYST BIOL, V57, P116, DOI 10.1080/10635150801902193; Jackson DA, 2001, CAN J FISH AQUAT SCI, V58, P157, DOI 10.1139/cjfas-58-1-157; Jacquemin SJ, 2013, ECOL FRESHW FISH, V22, P280, DOI 10.1111/eff.12025; Jacquemin SJ, 2011, J BIOGEOGR, V38, P982, DOI 10.1111/j.1365-2699.2010.02457.x; Johnson MTJ, 2007, TRENDS ECOL EVOL, V22, P250, DOI 10.1016/j.tree.2007.01.014; Jonsson T, 2005, ADV ECOL RES, V36, P1, DOI 10.1016/S0065-2504(05)36001-6; Kraft NJB, 2007, AM NAT, V170, P271, DOI 10.1086/519400; LAWTON JH, 1993, TRENDS ECOL EVOL, V8, P409, DOI 10.1016/0169-5347(93)90043-O; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Mayden RL, 2006, STUDIES N AM DESERT; Near TJ, 2011, SYST BIOL, V60, P565, DOI 10.1093/sysbio/syr052; Near TJ, 2005, EVOLUTION, V59, P1768, DOI 10.1111/j.0014-3820.2005.tb01825.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Plummer M., 2013, RJAGS BAYESIAN GRAPH; Plummer M., 2003, P 3 INT WORKSH DISTR; Pyron M, 1999, J BIOGEOGR, V26, P549, DOI 10.1046/j.1365-2699.1999.00303.x; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rabinowitz D., 1981, 7 FORMS RARITY BIOLO; Schonhuth S, 2010, MOL PHYLOGENET EVOL, V55, P77, DOI 10.1016/j.ympev.2009.10.030; Simon TP, 1997, 905R96002 US EPA WAT; Simons AM, 2003, ZOOL J LINN SOC-LOND, V139, P63, DOI 10.1046/j.1096-3642.2003.00076.x; Slatyer R. A., 2013, ECOL LETT, DOI 10.1111/ele.12140; Smith C.L, 1971, American Mus Novit, VNo. 2458, P1; Strong D.R., 1984, ECOLOGICAL COMMUNITI; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Trautman M.B., 1981, FISHES OHIO; Trumpickas J, 2011, AQUAT CONSERV, V21, P338, DOI 10.1002/aqc.1192; van Kleunen M, 2007, PROG PHYS GEOG, V31, P447, DOI 10.1177/0309133307081295; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Waite IR, 2000, T AM FISH SOC, V129, P754, DOI 10.1577/1548-8659(2000)129<0754:AAFASA>2.3.CO;2; White EP, 2007, TRENDS ECOL EVOL, V22, P323, DOI 10.1016/j.tree.2007.03.007; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431	48	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93522	10.1371/journal.pone.0093522	http://dx.doi.org/10.1371/journal.pone.0093522			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691075	Green Published, gold			2022-12-25	WOS:000334101100097
J	Magaye, R; Zhou, Q; Bowman, L; Zou, BB; Mao, GC; Xu, J; Castranova, V; Zhao, JS; Ding, M				Magaye, Ruth; Zhou, Qi; Bowman, Linda; Zou, Baobo; Mao, Guochuan; Xu, Jin; Castranova, Vincent; Zhao, Jinshun; Ding, Min			Metallic Nickel Nanoparticles May Exhibit Higher Carcinogenic Potential than Fine Particles in JB6 Cells	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATOR PROTEIN-1; LUNG; P53; GENOTOXICITY; APOPTOSIS; GROWTH; TRANSFORMATION; MECHANISMS; INHIBITION	While numerous studies have described the pathogenic and carcinogenic effects of nickel compounds, little has been done on the biological effects of metallic nickel. Moreover, the carcinogenetic potential of metallic nickel nanoparticles is unknown. Activator protein-1 (AP- 1) and nuclear factor-kappa B (NF-kappa B) have been shown to play pivotal roles in tumor initiation, promotion, and progression. Mutation of the p53 tumor suppressor gene is considered to be one of the steps leading to the neoplastic state. The present study examines effects of metallic nickel fine and nanoparticles on tumor promoter or suppressor gene expressions as well as on cell transformation in JB6 cells. Our results demonstrate that metallic nickel nanoparticles caused higher activation of AP- 1 and NF-kappa B, and a greater decrease of p53 transcription activity than fine particles. Western blot indicates that metallic nickel nanoparticles induced a higher level of protein expressions for R-Ras, c-myc, C-Jun, p65, and p50 in a time-dependent manner. In addition, both metallic nickel nano- and fine particles increased anchorage-independent colony formation in JB6 P+ cells in the soft agar assay. These results imply that metallic nickel fine and nanoparticles are both carcinogenetic in vitro in JB6 cells. Moreover, metallic nickel nanoparticles may exhibit higher carcinogenic potential, which suggests that precautionary measures should be taken in the use of nickel nanoparticles or its compounds in nanomedicine.	[Magaye, Ruth; Zhou, Qi; Zou, Baobo; Mao, Guochuan; Xu, Jin; Zhao, Jinshun] Ningbo Univ, Sch Med, Dept Publ Hlth, Zhejiang Prov Key Lab Pathol & Physiol Technol, Ningbo 315211, Zhejiang, Peoples R China; [Bowman, Linda; Castranova, Vincent; Zhao, Jinshun; Ding, Min] NIOSH, Hlth Effects Lab Div, Pathol & Physiol Res Branch, Morgantown, WV USA	Ningbo University; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Zhao, JS (corresponding author), Ningbo Univ, Sch Med, Dept Publ Hlth, Zhejiang Prov Key Lab Pathol & Physiol Technol, Ningbo 315211, Zhejiang, Peoples R China.	zhaojinshun@nbu.edu.cn; mid5@cdc.gov		Magaye, Ruth Rebecca/0000-0002-8296-8466	National Nature Science Foundation of China [81273111]; Foundations of Innovative Research Team of Educational Commission of Zhejiang Province [T200907]; Nature Science Foundation of Ningbo city [2012A610185]; Ningbo Scientific Project [2012C5019, SZX11073]; Scientific Innovation Team Project of Ningbo [2011B82014]; Innovative Research Team of Ningbo [2009B21002]; K.C. Wong Magna Fund in Ningbo University	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundations of Innovative Research Team of Educational Commission of Zhejiang Province; Nature Science Foundation of Ningbo city; Ningbo Scientific Project; Scientific Innovation Team Project of Ningbo; Innovative Research Team of Ningbo; K.C. Wong Magna Fund in Ningbo University	This work was supported by the National Nature Science Foundation of China (Grant No. 81273111), the Foundations of Innovative Research Team of Educational Commission of Zhejiang Province (T200907), the Nature Science Foundation of Ningbo city (Grant No. 2012A610185), the Ningbo Scientific Project (Grant No. 2012C5019 and SZX11073), the Scientific Innovation Team Project of Ningbo (No. 2011B82014), Innovative Research Team of Ningbo (2009B21002) and K.C. Wong Magna Fund in Ningbo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Assar O, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-13; Al-Qubaisi MS, 2013, INT J NANOMED, V8, P2497, DOI 10.2147/IJN.S42367; BENSON JM, 1989, TOXICOLOGY, V57, P255, DOI 10.1016/0300-483X(89)90115-7; BERNSTEIN LR, 1989, SCIENCE, V244, P566, DOI 10.1126/science.2541502; Bode A M, 2000, Lancet Oncol, V1, P181, DOI 10.1016/S1470-2045(00)00029-2; Bredel M, 1999, BRAIN RES REV, V29, P232, DOI 10.1016/S0165-0173(98)00057-5; Cai WB, 2008, NANOTECHNOL SCI APPL, V1, P17, DOI 10.2147/NSA.S3788; COLBURN NH, 1981, P NATL ACAD SCI-BIOL, V78, P6912, DOI 10.1073/pnas.78.11.6912; COOGAN TP, 1989, CRC CR REV TOXICOL, V19, P341, DOI 10.3109/10408448909029327; Cosse JPJ, 2009, NEOPLASIA, V11, P976, DOI 10.1593/neo.09632; Cummins EP, 2005, PFLUG ARCH EUR J PHY, V450, P363, DOI 10.1007/s00424-005-1413-7; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Ding M, 2006, J BIOL CHEM, V281, P17359, DOI 10.1074/jbc.M600861200; DONG ZG, 1994, P NATL ACAD SCI USA, V91, P609, DOI 10.1073/pnas.91.2.609; DRISCOLL KE, 1990, TOXICOL APPL PHARM, V106, P88, DOI 10.1016/0041-008X(90)90109-8; Enriquez GG, 2013, INT J NANOMED, V8, P1393, DOI 10.2147/IJN.S43479; Feng RT, 2005, J BIOL CHEM, V280, P27888, DOI 10.1074/jbc.M503347200; HARTWIG A, 1994, TOXICOL LETT, V72, P353, DOI 10.1016/0378-4274(94)90048-5; Huang LE, 2008, CELL DEATH DIFFER, V15, P672, DOI 10.1038/sj.cdd.4402302; Kasprzak KS, 2003, MUTAT RES-FUND MOL M, V533, P67, DOI 10.1016/j.mrfmmm.2003.08.021; Ke QD, 2008, CARCINOGENESIS, V29, P1276, DOI 10.1093/carcin/bgn084; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li JJ, 1997, CANCER RES, V57, P3569; Lim Eun-Kyung, 2013, Pharmaceutics, V5, P294, DOI 10.3390/pharmaceutics5020294; Long TC, 2007, ENVIRON HEALTH PERSP, V115, P1631, DOI 10.1289/ehp.10216; Lu HT, 2005, MOL CELL BIOCHEM, V279, P45, DOI 10.1007/s11010-005-8215-2; Magaye R, 2012, ENVIRON TOXICOL PHAR, V34, P644, DOI 10.1016/j.etap.2012.08.012; Magaye R, 2012, EXP THER MED, V4, P551, DOI 10.3892/etm.2012.656; Maynard AD, 2005, J NANOPART RES, V7, P587, DOI 10.1007/s11051-005-6770-9; Mudshinge SR, 2011, SAUDI PHARM J, V19, P129, DOI 10.1016/j.jsps.2011.04.001; NiPERA, 2013, NAT NAN PROGR PROP L, P4; NIPERA, 2008, SAF US NICK WORKPL; O'Donnell JL, 2006, CANCER TREAT REV, V32, P407, DOI 10.1016/j.ctrv.2006.05.003; Oberdorster G, 2001, INT ARCH OCC ENV HEA, V74, P1; OBERDORSTER G, 1994, ENVIRON HEALTH PERSP, V102, P173, DOI 10.2307/3432080; OREN M, 1992, CANCER METAST REV, V11, P141, DOI 10.1007/BF00048060; Rosen J.E., 2011, J NANOMED NANOTECHNO, V2, P1; Roy HK, 2002, CARCINOGENESIS, V23, P201, DOI 10.1093/carcin/23.1.201; Santarpia L, 2008, J CLIN ENDOCR METAB, V93, P278, DOI 10.1210/jc.2007-1076; Shen GX, 2005, ANTIOXID REDOX SIGN, V7, P1648, DOI 10.1089/ars.2005.7.1648; Sivulka DJ, 2005, REGUL TOXICOL PHARM, V43, P117, DOI 10.1016/j.yrtph.2005.06.014; US Department of Health and Human Services PHS National Toxicology Program, 2009, REP CARC; Vormer TL, 2008, MOL CELL BIOL, V28, P7263, DOI 10.1128/MCB.00313-08; Wang LY, 2005, AM J PHYSIOL-LUNG C, V288, pL488, DOI 10.1152/ajplung.00123.2003; Wong VC, 2013, TOXICOL APPL PHARM, V269, P233, DOI 10.1016/j.taap.2013.03.023; Young MR, 1999, P NATL ACAD SCI USA, V96, P9827, DOI 10.1073/pnas.96.17.9827; Zhang QW, 2003, J OCCUP HEALTH, V45, P23, DOI 10.1539/joh.45.23; Zhang ZW, 1999, WORLD J GASTROENTERO, V5, P369; Zhao JS, 2009, J TOXICOL ENV HEAL A, V72, P1141, DOI 10.1080/15287390903091764; Zhao Jinshun, 2009, Journal of Nanobiotechnology, V7, P2, DOI 10.1186/1477-3155-7-2	51	33	34	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92418	10.1371/journal.pone.0092418	http://dx.doi.org/10.1371/journal.pone.0092418			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691273	Green Published, gold			2022-12-25	WOS:000334101100023
J	Sun, W; Zhang, K; Liu, GW; Ding, W; Zhao, CQ; Xie, YZ; Yuan, JJ; Sun, XJ; Li, H; Liu, CS; Tang, TT; Zhao, J				Sun, Wei; Zhang, Kai; Liu, Guangwang; Ding, Wei; Zhao, Changqing; Xie, Youzhuan; Yuan, Junjie; Sun, Xiaojiang; Li, Hua; Liu, Changsheng; Tang, Tingting; Zhao, Jie			Sox9 Gene Transfer Enhanced Regenerative Effect of Bone Marrow Mesenchymal Stem Cells on the Degenerated Intervertebral Disc in a Rabbit Model	PLOS ONE			English	Article							IN-VITRO; CHONDROGENIC DIFFERENTIATION; MORPHOGENETIC PROTEIN-4; CARTILAGE FORMATION; TRANSPLANTATION; THERAPY; TGF-BETA-1; SCAFFOLDS; HYDROGELS; DISEASE	Objective: The effect of Sox9 on the differentiation of bone marrow mesenchymal stem cells (BMSCs) to nucleus pulposus (NP)-like (chondrocyte-like) cells in vitro has been demonstrated. The objective of this study is to investigate the efficacy and feasibility of Sox9-transduced BMSCs to repair the degenerated intervertebral disc in a rabbit model. Materials and Methods: Fifty skeletally mature New Zealand white rabbits were used. In the treatment groups, NP tissue was aspirated from the L2-L3, L3-L4, and L4-L5 discs in accordance with a previously validated rabbit model of intervertebral disc degeneration and then treated with thermogelling chitosan (C/Gp), GFP-transduced autologous BMSCs with C/Gp or Sox9-transduced autologous BMSCs with C/Gp. The role of Sox9 in the chondrogenic differentiation of BMSCs embedded in C/Gp gels in vitro and the repair effect of Sox9-transduced BMSCs on degenerated discs were evaluated by real-time PCR, conventional and quantitative MRI, macroscopic appearance, histology and immunohistochemistry. Results: Sox9 could induce the chondrogenic differentiation of BMSCs in C/Gp gels and BMSCs could survive in vivo for at least 12 weeks. A higher T2-weighted signal intensity and T2 value, better preserved NP structure and greater amount of extracellular matrix were observed in discs treated with Sox9-transduced BMSCs compared with those without transduction. Conclusion: Sox9 gene transfer could significantly enhance the repair effect of BMSCs on the degenerated discs.	[Sun, Wei; Zhang, Kai; Ding, Wei; Zhao, Changqing; Xie, Youzhuan; Yuan, Junjie; Sun, Xiaojiang; Li, Hua; Tang, Tingting; Zhao, Jie] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Dept Orthopaed Surg, Shanghai 200030, Peoples R China; [Sun, Wei; Zhang, Kai; Zhao, Changqing; Xie, Youzhuan; Yuan, Junjie; Sun, Xiaojiang; Li, Hua; Tang, Tingting; Zhao, Jie] Shanghai Key Lab Orthopaed Implants, Shanghai, Peoples R China; [Sun, Wei] Affiliated Hosp, Xuzhou Med Coll, Dept Orthopaed Surg, Xuzhou, Peoples R China; [Liu, Guangwang] Southeast Univ, Affiliated Hosp, Cent Hosp Xuzhou, Coll Med,Dept Orthopaed Surg, Xuzhou, Peoples R China; [Liu, Changsheng] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China	Shanghai Jiao Tong University; Xuzhou Medical University; Southeast University - China; East China University of Science & Technology	Zhao, J (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Dept Orthopaed Surg, Shanghai 200030, Peoples R China.	prozhaojie@163.com	Tang, Tingting/B-1361-2013	Tang, Tingting/0000-0002-1670-7452	National Natural Science Foundation of China [81071453, 81071503, 81272038]; Program for Innovative Research Team of Shanghai Municipal Education Commission; Fund for Key Discipline of Shanghai Municipal Education Commission [J50206]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Innovative Research Team of Shanghai Municipal Education Commission; Fund for Key Discipline of Shanghai Municipal Education Commission	This research was supported by the National Natural Science Foundation of China (grant no. 81071453, 81071503 and 81272038), Program for Innovative Research Team of Shanghai Municipal Education Commission, and Fund for Key Discipline of Shanghai Municipal Education Commission (J50206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Cao L, 2011, BIOMATERIALS, V32, P3910, DOI 10.1016/j.biomaterials.2011.02.014; Diao HJ, 2009, TISSUE ENG PT A, V15, P2687, DOI [10.1089/ten.tea.2008.0621, 10.1089/ten.TEA.2008.0621]; Gruber HE, 2005, SPINE, V30, P625, DOI 10.1097/01.brs.0000155420.01444.c6; Henriksson HB, 2009, SPINE, V34, P141, DOI 10.1097/BRS.0b013e31818f8c20; Hiyama A, 2008, J ORTHOP RES, V26, P589, DOI 10.1002/jor.20584; Ju WJ, 2000, J BONE MINER RES, V15, P1889, DOI 10.1359/jbmr.2000.15.10.1889; Kupcsik L, 2010, TISSUE ENG PT A, V16, P1845, DOI [10.1089/ten.tea.2009.0531, 10.1089/ten.TEA.2009.0531]; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2198; Link TM, 2007, EUR RADIOL, V17, P1135, DOI 10.1007/s00330-006-0453-5; Luoma K, 2000, SPINE, V25, P487, DOI 10.1097/00007632-200002150-00016; Marinelli NL, 2009, SPINE, V34, P520, DOI 10.1097/BRS.0b013e318195dd44; Masuda K, 2005, SPINE, V30, P5, DOI 10.1097/01.brs.0000148152.04401.20; Miljkovic ND, 2008, OSTEOARTHR CARTILAGE, V16, P1121, DOI 10.1016/j.joca.2008.03.003; NENADOVICH N, 2002, SPINE, V2, P50; O'Halloran DM, 2007, TISSUE ENG, V13, P1927, DOI 10.1089/ten.2005.0608; Okuma M, 2000, J ORTHOPAED RES, V18, P988, DOI 10.1002/jor.1100180620; Paul R, 2003, SPINE, V28, P755, DOI 10.1097/00007632-200304150-00006; Pereira DR, 2013, J TISSUE ENG REGEN M, V7, P85, DOI 10.1002/term.500; Richardson SM, 2006, STEM CELLS, V24, P707, DOI 10.1634/stemcells.2005-0205; Richardson SM, 2006, BIOMATERIALS, V27, P4069, DOI 10.1016/j.biomaterials.2006.03.017; Richardson SM, 2008, BIOMATERIALS, V29, P85, DOI 10.1016/j.biomaterials.2007.09.018; Risbud MV, 2004, SPINE, V29, P2627, DOI 10.1097/01.brs.0000146462.92171.7f; Rodrigues-Pinto R, 2013, BONE JOINT RES, V2, P169, DOI 10.1302/2046-3758.28.2000184; Roughley P, 2006, BIOMATERIALS, V27, P388, DOI 10.1016/j.biomaterials.2005.06.037; Sakai D, 2006, BIOMATERIALS, V27, P335, DOI 10.1016/j.biomaterials.2005.06.038; Sakai D, 2003, BIOMATERIALS, V24, P3531, DOI 10.1016/S0142-9612(03)00222-9; Sakai D, 2008, EUR SPINE J, V17, pS452, DOI 10.1007/s00586-008-0743-5; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; Sive JI, 2002, J CLIN PATHOL-MOL PA, V55, P91, DOI 10.1136/mp.55.2.91; Sobajima S, 2008, SPINE J, V8, P888, DOI 10.1016/j.spinee.2007.09.011; Steck E, 2005, STEM CELLS, V23, P403, DOI 10.1634/stemcells.2004-0107; Steinert AF, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2822; Sun W, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-357; Toh WS, 2005, GROWTH FACTORS, V23, P313, DOI 10.1080/08977190500252763; Tsuchiya H, 2003, BIOCHEM BIOPH RES CO, V301, P338, DOI 10.1016/S0006-291X(02)03026-7; Vadala G, 2012, J TISSUE ENG REGEN M, V6, P348, DOI 10.1002/term.433; van Beuningen HM, 2000, OSTEOARTHR CARTILAGE, V8, P25, DOI 10.1053/joca.1999.0267; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Yan JH, 2010, J BIOMATER APPL, V24, P625, DOI 10.1177/0885328208100536; Yang HN, 2009, BIOMATERIALS, V30, P6374, DOI 10.1016/j.biomaterials.2009.07.062; Zhang YG, 2005, CLIN ORTHOP RELAT R, P219, DOI 10.1097/01.blo.0000146534.31120.cf; Zhao CQ, 2007, AGEING RES REV, V6, P247, DOI 10.1016/j.arr.2007.08.001	44	26	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93570	10.1371/journal.pone.0093570	http://dx.doi.org/10.1371/journal.pone.0093570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691466	Green Published, gold, Green Submitted			2022-12-25	WOS:000334101100105
J	Xu, GW; Toth, JI; da Silva, SR; Paiva, SL; Lukkarila, JL; Hurren, R; Maclean, N; Sukhai, MA; Bhattacharjee, RN; Goard, CA; Gunning, PT; Dhe-Paganon, S; Petroski, MD; Schimmer, AD				Xu, G. Wei; Toth, Julia I.; da Silva, Sara R.; Paiva, Stacey-Lynn; Lukkarila, Julie L.; Hurren, Rose; Maclean, Neil; Sukhai, Mahadeo A.; Bhattacharjee, Rabindra N.; Goard, Carolyn A.; Gunning, Patrick T.; Dhe-Paganon, Sirano; Petroski, Matthew D.; Schimmer, Aaron D.			Mutations in UBA3 Confer Resistance to the NEDD8-Activating Enzyme Inhibitor MLN4924 in Human Leukemic Cells	PLOS ONE			English	Article							UBIQUITIN-LIKE PROTEINS; SUBSTRATE-ASSISTED INHIBITION; MULTIDRUG-RESISTANCE; ACTIVATING ENZYME; NEDD8; CANCER; CONJUGATION; IDENTIFICATION; REREPLICATION; APOPTOSIS	The NEDD8-activating enzyme (NAE) initiates neddylation, the cascade of post-translational NEDD8 conjugation onto target proteins. MLN4924, a selective NAE inhibitor, has displayed preclinical anti-tumor activity in vitro and in vivo, and promising clinical activity has been reported in patients with refractory hematologic malignancies. Here, we sought to understand the mechanisms of resistance to MLN4924. K562 and U937 leukemia cells were exposed over a 6 month period to MLN4924 and populations of resistant cells (R-K562(MLN), R-U937(MLN)) were selected. R-K562(MLN) and R-U937(MLN) cells contain I310N and Y352H mutations in the NAE catalytic subunit UBA3, respectively. Biochemical analyses indicate that these mutations increase the enzyme's affinity for ATP while decreasing its affinity for NEDD8. These mutations effectively contribute to decreased MLN4924 potency in vitro while providing for sufficient NAE function for leukemia cell survival. Finally, R-K562(MLN) cells showed cross-resistance to other NAE-selective inhibitors, but remained sensitive to a pan-E1 (activating enzyme) inhibitor. Thus, our work provides insight into mechanisms of MLN4924 resistance to facilitate the development of more effective second-generation NAE inhibitors.	[Xu, G. Wei; Hurren, Rose; Maclean, Neil; Sukhai, Mahadeo A.; Bhattacharjee, Rabindra N.; Goard, Carolyn A.; Schimmer, Aaron D.] Univ Hlth Network, Princess Margaret Canc Ctr, Ontario Canc Inst, Toronto, ON, Canada; [Toth, Julia I.; Petroski, Matthew D.] Sanford Burnham Med Res Inst, NCI Designated Canc Ctr, La Jolla, CA 92037 USA; [da Silva, Sara R.; Paiva, Stacey-Lynn; Lukkarila, Julie L.; Gunning, Patrick T.] Univ Toronto, Dept Chem, Mississauga, ON L5L 1C6, Canada; [Lukkarila, Julie L.] Sheridan Inst Technol & Adv Learning, HalTech Reg Innovat Ctr, Oakville, ON, Canada; [Dhe-Paganon, Sirano] Harvard Univ, Childrens Hosp, Sch Med, Div Nephrol, Boston, MA 02115 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Sanford Burnham Prebys Medical Discovery Institute; University of Toronto; University Toronto Mississauga; Harvard University; Boston Children's Hospital; Harvard Medical School	Petroski, MD (corresponding author), Sanford Burnham Med Res Inst, NCI Designated Canc Ctr, La Jolla, CA 92037 USA.	petroski@sanfordburnham.org; aaron.schimmer@utoronto.ca		Paiva, Stacey-Lynn/0000-0002-6639-5303; Medeiros, Bruno/0000-0001-6972-8137; Schimmer, Aaron/0000-0003-4023-3899	Canadian Cancer Society Research Institute; Leukemia & Lymphoma Society; American Cancer Society; V Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); American Cancer Society(American Cancer Society); V Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Canadian Cancer Society Research Institute, the Leukemia & Lymphoma Society, the American Cancer Society (M.D.P.), and the V Foundation for Cancer Research (M.D.P.). M.D.P. is an American Cancer Society Research Scholar (RSG-11-224-01-DMC). A.D.S. is a Leukemia and Lymphoma Society Scholar in Clinical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir RE, 2002, J BIOL CHEM, V277, P23253, DOI 10.1074/jbc.M200967200; Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; Bruzzese FJ, 2012, METHODS MOL BIOL, V832, P577, DOI 10.1007/978-1-61779-474-2_40; Chen JJ, 2011, J BIOL CHEM, V286, P40867, DOI 10.1074/jbc.M111.279984; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Innis MA, 1990, PCR PROTOCOLS GUIDE; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Lin JJ, 2010, CANCER RES, V70, P10310, DOI 10.1158/0008-5472.CAN-10-2062; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Lukkarila JL, 2011, ACS MED CHEM LETT, V2, P577, DOI 10.1021/ml2000615; McMillin DW, 2012, MOL CANCER THER, V11, P942, DOI 10.1158/1535-7163.MCT-11-0563; Milhollen MA, 2012, CANCER CELL, V21, P388, DOI 10.1016/j.ccr.2012.02.009; Milhollen MA, 2011, CANCER RES, V71, P3042, DOI 10.1158/0008-5472.CAN-10-2122; Milhollen MA, 2010, BLOOD, V116, P1515, DOI 10.1182/blood-2010-03-272567; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Persidis A, 1999, NAT BIOTECHNOL, V17, P94, DOI 10.1038/5289; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Podust VN, 2000, P NATL ACAD SCI USA, V97, P4579, DOI 10.1073/pnas.090465597; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Soucy Teresa A, 2010, Genes Cancer, V1, P708, DOI 10.1177/1947601910382898; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Swords RT, 2010, BLOOD, V115, P3796, DOI 10.1182/blood-2009-11-254862; Toth JI, 2012, BLOOD, V116, P658; Toth JI, 2012, CELL REP, V1, P309, DOI 10.1016/j.celrep.2012.02.006; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Watson IR, 2011, CANCER CELL, V19, P168, DOI 10.1016/j.ccr.2011.01.002; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105	35	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93530	10.1371/journal.pone.0093530	http://dx.doi.org/10.1371/journal.pone.0093530			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691136	Green Published, gold			2022-12-25	WOS:000334101100099
J	Yu, YL; Su, KJ; Hsieh, MJ; Wang, SS; Wang, PH; Weng, WC; Yang, SF				Yu, Yung-Luen; Su, Kuo-Jung; Hsieh, Ming-Ju; Wang, Shian-Shiang; Wang, Po-Hui; Weng, Wei-Chun; Yang, Shun-Fa			Impact of EZH2 Polymorphisms on Urothelial Cell Carcinoma Susceptibility and Clinicopathologic Features	PLOS ONE			English	Article							POLYCOMB GROUP PROTEIN; INCREASED EXPRESSION; BREAST-CANCER; GROUP GENE; BLADDER; IMMUNOTHERAPY; REPRESSION; RISK	Background: The gene EZH2, the polycomb group protein enhancer of zeste 2, encodes a transcriptional repressor that also serves as a histone methyltransferase that is associated with progression to more advanced disease in a variety of malignancies. EZH2 expression level in urothelial cell carcinoma (UCC) is highly correlated with tumor aggressiveness, but it has not been determined if specific EZH2 genetic variants are associated with UCC risk. This study investigated the potential associations of EZH2 single-nucleotide polymorphisms with UCC susceptibility and its clinicopathologic characteristics. Methodology/Principal Findings: A total of 233 UCC patients and 552 cancer-free controls, all of whom were from Taiwan, were analyzed for four EZH2 single-nucleotide polymorphisms (rs6950683, rs2302427, rs3757441, and rs41277434) using real-time PCR genotyping. After adjusting for other co-variants, we found that individuals carrying at least one C allele at EZH2 rs6950683 had a lower risk of developing UCC than did major allele carriers. The CCCA or TGTA haplotype among the four EZH2 sites was also associated with a reduced risk of UCC. Furthermore, UCC patients who carried at least one G allele at rs2302427 had a lower invasive tumor stage than did patients carrying the major allele. Conclusions: The rs6950683 SNPs of EZH2 might contribute to the prediction of UCC susceptibility. This is the first study to provide insight into risk factors associated with EZH2 variants in carcinogenesis of UCC in Taiwan.	[Yu, Yung-Luen] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Yu, Yung-Luen] China Med Univ, Ctr Mol Med, Taichung, Taiwan; [Yu, Yung-Luen; Su, Kuo-Jung] China Med Univ, Program Canc Biol & Drug Discovery, Taichung, Taiwan; [Yu, Yung-Luen] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Hsieh, Ming-Ju; Wang, Shian-Shiang; Wang, Po-Hui; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Hsieh, Ming-Ju] Changhua Christian Hosp, Canc Res Ctr, Changhua, Taiwan; [Wang, Shian-Shiang] Taichung Vet Gen Hosp, Dept Surg, Div Urol, Taichung, Taiwan; [Wang, Po-Hui] Chung Shan Med Univ Hosp, Dept Obstet & Gynecol, Taichung, Taiwan; [Weng, Wei-Chun] Tungs Taichung MetroHarbor Hosp, Dept Surg, Div Urol, Taichung, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; Chung Shan Medical University; Changhua Christian Hospital; Taichung Veterans General Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Tungs' Taichung MetroHarbor Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital	Weng, WC (corresponding author), Tungs Taichung MetroHarbor Hosp, Dept Surg, Div Urol, Taichung, Taiwan.	wcweng27@gmail.com; ysf@csmu.edu.tw	Yang, Shun-Fa/AAN-1519-2020; Hsieh, Ming-Ju/GQB-3025-2022	Yang, Shun-Fa/0000-0002-0365-7927; Hsieh, Ming-Ju/0000-0001-9726-3234	Chung Shan Medical University and Tungs' Taichung Metro Harbor Hospital [CSMU-TTM-102-01];  [NSC-101-2321-B-039-004];  [NHRI-EX102-10245BI]	Chung Shan Medical University and Tungs' Taichung Metro Harbor Hospital; ; 	This work was supported by the following grants: NSC-101-2321-B-039-004, NHRI-EX102-10245BI and Chung Shan Medical University and Tungs' Taichung Metro Harbor Hospital (CSMU-TTM-102-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aben KKH, 2002, INT J CANCER, V98, P274, DOI 10.1002/ijc.10191; [Anonymous], 2003, NATURE, V426, P789; Arisan S, 2005, UROL INT, V75, P252, DOI 10.1159/000087804; Cantone I, 2013, NAT STRUCT MOL BIOL, V20, P282, DOI 10.1038/nsmb.2489; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Cardoso C, 2000, EUR J HUM GENET, V8, P174, DOI 10.1038/sj.ejhg.5200439; Chung TT, 2011, CARCINOGENESIS, V32, P1063, DOI 10.1093/carcin/bgr083; Chung YT, 2009, CARCINOGENESIS, V30, P286, DOI 10.1093/carcin/bgn283; Crea F, 2012, ANN ONCOL, V23, P1207, DOI 10.1093/annonc/mdr387; Di Paolo A, 2004, PHARMACOL RES, V49, P331, DOI 10.1016/j.phrs.2003.05.002; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Gu J, 2011, PERS MED, V8, P365, DOI 10.2217/PME.11.15; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Heyn H, 2013, CANCER CELL, V23, P563, DOI 10.1016/j.ccr.2013.04.028; Hinz S, 2008, J CANCER RES CLIN, V134, P331, DOI 10.1007/s00432-007-0288-8; Hosking L, 2004, EUR J HUM GENET, V12, P395, DOI 10.1038/sj.ejhg.5201164; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Lauss M, 2012, EPIGENETICS-US, V7, P858, DOI 10.4161/epi.20837; Raman JD, 2005, CLIN CANCER RES, V11, P8570, DOI 10.1158/1078-0432.CCR-05-1047; Ren G, 2012, CANCER RES, V72, P3091, DOI 10.1158/0008-5472.CAN-11-3546; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Shastry BS, 2002, J HUM GENET, V47, P561, DOI 10.1007/s100380200086; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Stenzl A, 2011, EUR UROL, V59, P1009, DOI 10.1016/j.eururo.2011.03.023; Wu CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039466; Yiang GT, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-47; Yoon KA, 2010, J THORAC ONCOL, V5, P10, DOI 10.1097/JTO.0b013e3181c422d9; Yu YL, 2012, J BIOL CHEM, V287, P31015, DOI 10.1074/jbc.M112.358077; Yu YL, 2012, J CELL PHYSIOL, V227, P213, DOI 10.1002/jcp.22719; Yu YL, 2010, INT J ONCOL, V36, P365, DOI 10.3892/ijo_00000508	31	15	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93635	10.1371/journal.pone.0093635	http://dx.doi.org/10.1371/journal.pone.0093635			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691023	gold, Green Submitted, Green Published			2022-12-25	WOS:000334101100116
J	Li, Y; Xu, SS; Gao, J; Pan, S; Wang, GX				Li, Yan; Xu, Shan-Shan; Gao, Jing; Pan, Sha; Wang, Gen-Xuan			Chlorella Induces Stomatal Closure via NADPH Oxidase-Dependent ROS Production and Its Effects on Instantaneous Water Use Efficiency in Vicia faba	PLOS ONE			English	Article							OXYGEN SPECIES PRODUCTION; ABSCISIC-ACID; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; GUARD-CELLS; DEFICIT IRRIGATION; METHYL JASMONATE; INNATE IMMUNITY; PLANT STOMATA; NITRIC-OXIDE	Reactive oxygen species (ROS) have been established to participate in stomatal closure induced by live microbes and microbe-associated molecular patterns (MAMPs). Chlorella as a beneficial microorganism can be expected to trigger stomatal closure via ROS production. Here, we reported that Chlorella induced stomatal closure in a dose-and time-dependent manner in epidermal peels of Vicia faba. Using pharmacological methods in this work, we found that the Chlorella-induced stomatal closure was almost completely abolished by a hydrogen peroxide (H2O2) scavenger, catalase (CAT), significantly suppressed by an NADPH oxidase inhibitor, diphenylene iodonium chloride (DPI), and slightly affected by a peroxidase inhibitor, salicylhydroxamic acid (SHAM), suggesting that ROS production involved in Chlorella-induced stomatal closure is mainly mediated by DPI-sensitive NADPH oxidase. Additionally, Exogenous application of optimal concentrations of Chlorella suspension improved instantaneous water use efficiency (WUEi) in Vicia faba via a reduction in leaf transpiration rate (E) without a parallel reduction in net photosynthetic rate (P-n) assessed by gas-exchange measurements. The chlorophyll fluorescence and content analysis further demonstrated that short-term use of Chlorella did not influence plant photosynthetic reactions center. These results preliminarily reveal that Chlorella can trigger stomatal closure via NADPH oxidase-dependent ROS production in epidermal strips and improve WUEi in leave levels.	[Li, Yan; Xu, Shan-Shan; Gao, Jing; Pan, Sha; Wang, Gen-Xuan] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Wang, GX (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	11207018@zju.edu.cn			National High-Tech R & D Program (863 Program) for the 12th Five-Year Plan [2011AA100503]; Natural Science Fund of China [31330010]; Zhejiang Provincial Natural Science Foundation of China [LZ13C030002]	National High-Tech R & D Program (863 Program) for the 12th Five-Year Plan; Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work is supported by the National High-Tech R & D Program (863 Program) for the 12th Five-Year Plan (2011AA100503), Natural Science Fund of China (31330010), and Zhejiang Provincial Natural Science Foundation of China (LZ13C030002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya B, 2009, PLANT MOL BIOL, V69, P451, DOI 10.1007/s11103-008-9427-0; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Bright J, 2006, PLANT J, V45, P113, DOI 10.1111/j.1365-313X.2005.02615.x; Chaves MM, 2007, ANN APPL BIOL, V150, P237, DOI 10.1111/j.1744-7348.2006.00123.x; Chaves MM, 2004, J EXP BOT, V55, P2365, DOI 10.1093/jxb/erh269; Cherng JY, 2005, LIFE SCI, V77, P980, DOI 10.1016/j.lfs.2004.12.036; Cona A, 2006, TRENDS PLANT SCI, V11, P80, DOI 10.1016/j.tplants.2005.12.009; Condon AG, 2004, J EXP BOT, V55, P2447, DOI 10.1093/jxb/erh277; Condon AG, 2002, CROP SCI, V42, P122, DOI 10.2135/cropsci2002.0122; Cuevas JC, 2004, FUNCT PLANT BIOL, V31, P921, DOI 10.1071/FP04007; de Souza CR, 2005, J EXP BOT, V56, P2163, DOI 10.1093/jxb/eri216; del Rio LA, 2002, J EXP BOT, V53, P1255, DOI 10.1093/jexbot/53.372.1255; Desikan R, 2004, FUNCT PLANT BIOL, V31, P913, DOI 10.1071/FP04035; Desikan R, 2006, PLANT J, V47, P907, DOI 10.1111/j.1365-313X.2006.02842.x; Gao J, 2013, PLANT PHYSIOL BIOCH, V65, P27, DOI 10.1016/j.plaphy.2013.01.008; Gerken HG, 2013, PLANTA, V237, P239, DOI 10.1007/s00425-012-1765-0; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Grimmer MK, 2012, J EXP BOT, V63, P4321, DOI 10.1093/jxb/ers143; Guidi L, 2005, PLANT SCI, V168, P153, DOI 10.1016/j.plantsci.2004.07.027; Guzman S, 2001, PHYTOTHER RES, V15, P224, DOI 10.1002/ptr.715; He JM, 2013, PLANT PHYSIOL, V161, P1570, DOI 10.1104/pp.112.211623; He JM, 2011, J EXP BOT, V62, P2657, DOI 10.1093/jxb/erq431; Henderson RK, 2008, WATER RES, V42, P3435, DOI 10.1016/j.watres.2007.10.032; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Hoque TS, 2012, J PLANT PHYSIOL, V169, P979, DOI 10.1016/j.jplph.2012.02.007; Iriti M, 2009, ENVIRON EXP BOT, V66, P493, DOI 10.1016/j.envexpbot.2009.01.004; Jiang K, 2012, PLANT CELL, V24, P2031, DOI 10.1105/tpc.112.096263; Joo JH, 2005, PLANT CELL, V17, P957, DOI 10.1105/tpc.104.029603; Keffer JE, 2002, J IND MICROBIOL BIOT, V29, P275, DOI 10.1038/sj.jim.7000313; Khokon MAR, 2011, PLANT CELL ENVIRON, V34, P1900, DOI 10.1111/j.1365-3040.2011.02385.x; Khokon MAR, 2011, PLANT CELL ENVIRON, V34, P434, DOI 10.1111/j.1365-3040.2010.02253.x; Khokon MAR, 2010, BIOSCI BIOTECH BIOCH, V74, P2313, DOI 10.1271/bbb.100340; Khokon MAR, 2010, PLANT CELL PHYSIOL, V51, P1915, DOI 10.1093/pcp/pcq145; Koers S, 2011, PLANT J, V68, P670, DOI 10.1111/j.1365-313X.2011.04719.x; Koscielniak J, 2006, PHOTOSYNTHETICA, V44, P174, DOI 10.1007/s11099-006-0003-z; Krupenina NA, 2008, PHOTOCH PHOTOBIO SCI, V7, P681, DOI 10.1039/b802243g; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Lawlor DW, 2002, PLANT CELL ENVIRON, V25, P275, DOI 10.1046/j.0016-8025.2001.00814.x; Lee HS, 2009, J MED FOOD, V12, P1029, DOI 10.1089/jmf.2008.1269; Lee S, 1999, PLANT PHYSIOL, V121, P147, DOI 10.1104/pp.121.1.147; Li X, 2010, JIANGSU AGR SCI, V4, P160; Macho AP, 2012, PLANT PHYSIOL, V159, P1845, DOI 10.1104/pp.112.199810; Marino D, 2012, TRENDS PLANT SCI, V17, P9, DOI 10.1016/j.tplants.2011.10.001; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Melotto M, 2008, ANNU REV PHYTOPATHOL, V46, P101, DOI 10.1146/annurev.phyto.121107.104959; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Miller G, 2008, PHYSIOL PLANTARUM, V133, P481, DOI 10.1111/j.1399-3054.2008.01090.x; Miranda M S, 2001, Boll Chim Farm, V140, P165; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Mori IC, 2001, PLANT CELL PHYSIOL, V42, P1383, DOI 10.1093/pcp/pce176; Munemasa S, 2007, PLANT PHYSIOL, V143, P1398, DOI 10.1104/pp.106.091298; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Neill S, 2008, J EXP BOT, V59, P165, DOI 10.1093/jxb/erm293; Park JY, 2005, CLIN CHIM ACTA, V351, P185, DOI 10.1016/j.cccn.2004.09.013; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Pereira EG, 2013, PLANT SCI, V201, P81, DOI 10.1016/j.plantsci.2012.12.003; Rivero RM, 2009, PLANT PHYSIOL, V150, P1530, DOI 10.1104/pp.109.139378; Sawinski K, 2013, MOL PLANT MICROBE IN, V26, P626, DOI 10.1094/MPMI-12-12-0288-CR; Schulze-Lefert P, 2006, CELL, V126, P831, DOI 10.1016/j.cell.2006.08.020; Silva Junior JMd, 2012, ACTA SCI-AGRON, V35, P65; Suhita D, 2004, PLANT PHYSIOL, V134, P1536, DOI 10.1104/pp.103.032250; TREJO CL, 1993, PLANT PHYSIOL, V102, P497, DOI 10.1104/pp.102.2.497; Underwood W, 2007, CELL MICROBIOL, V9, P1621, DOI 10.1111/j.1462-5822.2007.00938.x; Vahisalu T, 2010, PLANT J, V62, P442, DOI 10.1111/j.1365-313X.2010.04159.x; Vranova E, 2002, J EXP BOT, V53, P1227, DOI 10.1093/jexbot/53.372.1227; Wan JX, 2009, CROP SCI, V49, P1539, DOI 10.2135/cropsci2008.09.0568; Wang GX, 2001, PLANT SCI, V160, P1007, DOI 10.1016/S0168-9452(01)00344-2; Yang HM, 2003, PLANT SCI, V165, P1117, DOI 10.1016/S0168-9452(03)00319-4; Yun H, 2011, J HEALTH SCI, V57, P245, DOI 10.1248/jhs.57.245; Zeng WQ, 2010, CURR OPIN BIOTECH, V21, P599, DOI 10.1016/j.copbio.2010.05.006; Zhang HM, 2008, PLANT J, V56, P264, DOI 10.1111/j.1365-313X.2008.03593.x; Zhang X, 2001, PLANT PHYSIOL, V126, P1438, DOI 10.1104/pp.126.4.1438; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	76	6	10	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2014	9	3							e93290	10.1371/journal.pone.0093290	http://dx.doi.org/10.1371/journal.pone.0093290			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GP	24687099	gold, Green Submitted, Green Published			2022-12-25	WOS:000340842300006
J	Faye, MD; Beug, ST; Graber, TE; Earl, N; Xiang, X; Wild, B; Langlois, S; Michaud, J; Cowan, KN; Korneluk, RG; Holcik, M				Faye, M. D.; Beug, S. T.; Graber, T. E.; Earl, N.; Xiang, X.; Wild, B.; Langlois, S.; Michaud, J.; Cowan, K. N.; Korneluk, R. G.; Holcik, M.			IGF2BP1 controls cell death and drug resistance in rhabdomyosarcomas by regulating translation of cIAP1	ONCOGENE			English	Article							RNA-BINDING PROTEINS; ENDOPLASMIC-RETICULUM STRESS; ALPHA-DEPENDENT APOPTOSIS; LIGAND-INDUCED APOPTOSIS; RIBOSOME ENTRY SITES; NF-KAPPA-B; MESSENGER-RNA; SMAC MIMETICS; TNF; CANCER	Rhabdomyosarcoma (RMS), a neoplasm characterised by undifferentiated myoblasts, is the most common soft tissue tumour of childhood. Although aggressive treatment of RMS could provide long-term benefit, resistance to current therapies is an ongoing problem. We report here that insulin-like growth factor 2-binding protein 1 (IGF2BP1), an oncofetal protein, is expressed in RMS patient-derived cell lines and in primary tumours where it drives translation of the cellular inhibitor of apoptosis 1 (cIAP1), a key regulator of the nuclear factor-kappa B signalling pathway and of caspase-8-mediated cell death. We demonstrate that reducing the levels of cIAP1 in RMS, either by IGF2BP1 knockdown or by IAP antagonists, sensitises these cells to tumour necrosis factor-alpha-mediated cell death. Finally, we show that targeting cIAP1 by IAP antagonists delays RMS tumour growth and improve survival in mice. Our results identify IGF2BP1 as a critical translational regulator of cIAP1-mediated apoptotic resistance in RMS and advocate for the combined use of IAP antagonists and tumour necrosis factor-a as a therapeutic approach for this type of cancer.	[Faye, M. D.; Beug, S. T.; Graber, T. E.; Earl, N.; Xiang, X.; Wild, B.; Langlois, S.; Cowan, K. N.; Korneluk, R. G.; Holcik, M.] Childrens Hosp Eastern Ontario, Apoptosis Res Ctr, Res Inst, Ottawa, ON K1H 8L1, Canada; [Faye, M. D.; Korneluk, R. G.; Holcik, M.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Xiang, X.; Wild, B.; Cowan, K. N.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Langlois, S.; Cowan, K. N.] Univ Ottawa, Dept Surg, Ottawa, ON, Canada; [Michaud, J.] Univ Ottawa, Dept Pathol & Lab Med, Ottawa, ON, Canada; [Korneluk, R. G.; Holcik, M.] Univ Ottawa, Dept Pediat, Ottawa, ON K1N 6N5, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa	Holcik, M (corresponding author), Childrens Hosp Eastern Ontario, Apoptosis Res Ctr, Res Inst, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada.	martin@arc.cheo.ca	Graber, Tyson/K-9385-2019; Holcik, Martin/AAC-6660-2019	Graber, Tyson/0000-0002-5337-3404; Holcik, Martin/0000-0002-1922-5299; Xiang, Xiao/0000-0002-3969-1668; Cowan, Kyle/0000-0003-0109-7716	Canadian Institutes of Health Research [FRN 74740]; Cancer Research Society (CRS); Vanier Canada Graduate Scholarship; Frederick Banting Graduate Scholarship Doctoral Award; Charles Best Canada Graduate Scholarship Doctoral Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Research Society (CRS); Vanier Canada Graduate Scholarship; Frederick Banting Graduate Scholarship Doctoral Award; Charles Best Canada Graduate Scholarship Doctoral Award	We thank the members of the Apoptosis Research Centre and Dr Eric LaCasse in particular for critical discussions. We are grateful to Novartis Pharmaceuticals for providing LCL161 compound and Dr P Houghton (Department of Hematology-Oncology, St Jude Children's Research Hospital, Memphis, TN, USA) for the gift of RMS cell lines. This work forms part of the PhD dissertation of MDF and was supported by an operating grant from the Canadian Institutes of Health Research (FRN 74740) and Cancer Research Society (CRS) to MH. MDF was supported by the Vanier Canada Graduate Scholarship. TEG was supported by the Frederick Banting and Charles Best Canada Graduate Scholarships Doctoral Award.	Baird SD, 2007, NUCLEIC ACIDS RES, V35, P4664, DOI 10.1093/nar/gkm483; Basit F, 2012, J BIOL CHEM, V287, P38767, DOI 10.1074/jbc.M112.398966; Bell JL, 2013, CELL MOL LIFE SCI, V70, P2657, DOI 10.1007/s00018-012-1186-z; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Beug ST, 2014, NAT BIOTECHNOL, V32, P182, DOI 10.1038/nbt.2806; Dai N, 2013, GENE DEV, V27, P301, DOI 10.1101/gad.209130.112; Dai N, 2011, GENE DEV, V25, P1159, DOI 10.1101/gad.2042311; Farina KL, 2003, J CELL BIOL, V160, P77, DOI 10.1083/jcb.200206003; Faye MD, 2013, MOL CELL BIOL, V33, P307, DOI 10.1128/MCB.00546-12; Finlay D, 2013, MOL CANC THERAP; Fotin-Mleczek M, 2002, J CELL SCI, V115, P2757; Fulda S, 2012, SARCOMA, V2012; Graber TE, 2010, CELL DEATH DIFFER, V17, P719, DOI 10.1038/cdd.2009.164; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hansen TVO, 2004, MOL CELL BIOL, V24, P4448, DOI 10.1128/MCB.24.10.4448-4464.2004; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Holcik M, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-5; Houghton PJ, 2012, PEDIATR BLOOD CANCER, V58, P636, DOI 10.1002/pbc.23167; Huh WW, 2010, CURR ONCOL REP, V12, P402, DOI 10.1007/s11912-010-0130-3; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Izeradjene K, 2004, CANCER RES, V64, P8036, DOI 10.1158/0008-5472.CAN-04-0762; Izeradjene K, 2004, CLIN CANCER RES, V10, P6650, DOI 10.1158/1078-0432.CCR-04-0576; Jonson L, 2007, MOL CELL PROTEOMICS, V6, P798, DOI 10.1074/mcp.M600346-MCP200; King HA, 2010, BIOCHEM SOC T, V38, P1581, DOI 10.1042/BST0381581; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; Lewis SM, 2008, NUCLEIC ACIDS RES, V36, P168, DOI 10.1093/nar/gkm1007; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Mongroo PS, 2011, CANCER RES, V71, P2172, DOI 10.1158/0008-5472.CAN-10-3295; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Petak I, 2000, CLIN CANCER RES, V6, P4119; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Pommier Y, 2004, ONCOGENE, V23, P2934, DOI 10.1038/sj.onc.1207515; Ross AF, 1997, MOL CELL BIOL, V17, P2158, DOI 10.1128/MCB.17.4.2158; Saab R, 2011, CURR TOP DEV BIOL, V94, P197, DOI 10.1016/B978-0-12-380916-2.00007-3; Stohr N, 2006, J CELL BIOL, V175, P527, DOI 10.1083/jcb.200608071; Stohr N, 2012, GENE DEV, V26, P176, DOI 10.1101/gad.177642.111; Tessier CR, 2004, CANCER RES, V64, P209, DOI 10.1158/0008-5472.CAN-03-2927; Vagner S, 2001, EMBO REP, V2, P893, DOI 10.1093/embo-reports/kve208; Van Eden ME, 2004, RNA, V10, P469, DOI 10.1261/rna.5156804; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Warnakulasuriyarachchi D, 2004, J BIOL CHEM, V279, P17148, DOI 10.1074/jbc.M308737200; Weidensdorfer D, 2009, RNA, V15, P104, DOI 10.1261/rna.1175909; Weingartner M, 2002, J BIOL CHEM, V277, P34853, DOI 10.1074/jbc.M205149200; Weinlich S, 2009, RNA, V15, P1528, DOI 10.1261/rna.1578409; Weisberg E, 2010, LEUKEMIA, V24, P2100, DOI 10.1038/leu.2010.212; Yaniv K, 2002, GENE, V287, P49, DOI 10.1016/S0378-1119(01)00866-6; Yisraeli JK, 2005, BIOL CELL, V97, P87	50	31	32	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 19	2015	34	12					1532	1541		10.1038/onc.2014.90	http://dx.doi.org/10.1038/onc.2014.90			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CD9KI	24704827				2022-12-25	WOS:000351416800006
J	Liu, W; Cai, MJ; Zheng, CC; Wang, JX; Zhao, XF				Liu, Wen; Cai, Mei-Juan; Zheng, Chuan-Chuan; Wang, Jin-Xing; Zhao, Xiao-Fan			Phospholipase C gamma 1 Connects the Cell Membrane Pathway to the Nuclear Receptor Pathway in Insect Steroid Hormone Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Signaling; Gene Transcription; Phosphotyrosine; Protein Phosphorylation; Steroid Hormone Receptor; 20-Hydroxyecdysone; Calcium Influx; Phospholipase C1	PROTEIN-COUPLED RECEPTOR; IN-VITRO; TYROSINE PHOSPHORYLATION; ECDYSTEROID RECEPTOR; NONGENOMIC ACTION; GROWTH-FACTOR; PLC-GAMMA; ACTIVATION; KINASE; SURAMIN	Background: PLCG1 plays an important role in calcium signaling. Results: PLCG1 up-regulates 20E-induced calcium signaling and regulates USP1 PKC phosphorylation in the lepidopteran insect Helicoverpa armigera. Conclusion: 20E activates PLCG1 to induce calcium influx to regulate USP1 PKC phosphorylation for gene expression. Significance: Our study establishes a link between the nongenomic pathway and genomic pathway in steroid hormone 20E signaling. In addition to the classical nuclear receptor pathway, there is a nongenomic pathway in the cell membrane that regulates gene expression in animal steroid hormone signaling; however, this mechanism is unclear. Here, we report that the insect steroid hormone 20-hydroxyecdysone (20E) regulates calcium influx via phospholipase C1 (PLCG1) to modulate the protein kinase C phosphorylation of the transcription factor ultraspiracle (USP1) in the lepidopteran insect Helicoverpa armigera. The PLCG1 mRNA levels are increased during the molting and metamorphic stages. The depletion of PLCG1 by RNA interference can block 20E-enhanced pupation, cause larvae death and pupation defects, and repress 20E-induced gene expression. 20E may induce the tyrosine phosphorylation of PLCG1 at the cytosolic tyrosine kinase (Src) homology 2 domains and then determine the migration of PLCG1 toward the plasma membrane. The G-protein-coupled receptor (GPCR) inhibitor suramin, Src family kinase inhibitor PP2, and the depletions of ecdysone-responsible GPCR (ErGPCR) and G(q) restrain the 20E-induced tyrosine phosphorylation of PLCG1. PLCG1 participates in the 20E-induced Ca2+ influx. The inhibition of GPCR, PLC, inositol 1,4,5-trisphosphate receptor, and calcium channels represses the 20E-induced Ca2+ influx. Through calcium signaling, PLCG1 mediates the transcriptional activation driven by the ecdysone-response element. Through PLCG1 and calcium signaling, 20E regulates PKC phosphorylation of USP1 at Ser-21 to determine its ecdysone-response element binding activity. These results suggest that 20E activates PLCG1 via the ErGPCR and Src family kinases to regulate Ca2+ influx and PKC phosphorylation of USP1 to subsequently modulate gene transcription for metamorphosis.	[Liu, Wen; Cai, Mei-Juan; Zheng, Chuan-Chuan; Wang, Jin-Xing; Zhao, Xiao-Fan] Shandong Univ, Shandong Prov Key Lab Anim Cells & Dev Biol, Key Lab Plant Cell Engn & Germplasm Innovat, Minist Educ,Sch Life Sci, Jinan 250100, Shandong, Peoples R China	Shandong University	Zhao, XF (corresponding author), Shandong Univ, Sch Life Sci, Jinan 250100, Shandong, Peoples R China.	xfzhao@sdu.edu.cn	Zhao, Xiao-Fan/AGW-9886-2022; Wang, Jin-Xing/AAU-1514-2021; Liu, Wen/S-8027-2019	Liu, Wen/0000-0002-4985-0618; Wang, Jin-Xing/0000-0003-0283-3930; Zhao, Xiao-Fan/0000-0003-1809-4730	National Natural Science Foundation of China [31230067]; National Basic Research Program of China 973 Program [2012CB114101]; Ph.D. Programs Foundation of Ministry of Education of China [20120131110025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China 973 Program(National Basic Research Program of China); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China)	This work was supported by National Natural Science Foundation of China Grant 31230067, National Basic Research Program of China 973 Program, Grant 2012CB114101, and Ph.D. Programs Foundation of Ministry of Education of China Grant 20120131110025.	Abdollahi A, 2003, CANCER RES, V63, P3755; Beindl W, 1996, MOL PHARMACOL, V50, P415; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buitrago C, 2002, EUR J BIOCHEM, V269, P2506, DOI 10.1046/j.1432-1033.2002.02915.x; BUTLER SJ, 1988, BIOCHEM J, V251, P201, DOI 10.1042/bj2510201; Cai MJ, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-9; CHATILA T, 1989, J IMMUNOL, V143, P1283; Chmura SJ, 2000, CLIN CANCER RES, V6, P737; Chung WC, 2005, J PHARMACOL EXP THER, V313, P191, DOI 10.1124/jpet.104.078311; De Smet P, 1999, CELL CALCIUM, V26, P9; Dedos SG, 1999, MOL CELL ENDOCRINOL, V154, P63, DOI 10.1016/S0303-7207(99)00082-9; Devarakonda S, 2003, EMBO J, V22, P5827, DOI 10.1093/emboj/cdg569; FAVARON M, 1990, P NATL ACAD SCI USA, V87, P1983, DOI 10.1073/pnas.87.5.1983; Gorelick-Feldman J, 2010, STEROIDS, V75, P632, DOI 10.1016/j.steroids.2010.03.008; Haendeler J, 2003, J BIOL CHEM, V278, P49936, DOI 10.1074/jbc.M307317200; Hiruma K, 2009, INSECT BIOCHEM MOLEC, V39, P245, DOI 10.1016/j.ibmb.2009.01.008; HUANG RRC, 1990, MOL PHARMACOL, V37, P304; Iga M, 2007, MOL CELL ENDOCRINOL, V263, P18, DOI 10.1016/j.mce.2006.08.005; Janetopoulos C, 2006, J CELL BIOL, V174, P485, DOI 10.1083/jcb.200603156; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; Lan Q, 1999, MOL CELL BIOL, V19, P4897; Lehmann N, 2002, BIOPHYS J, V82, P793, DOI 10.1016/S0006-3495(02)75441-6; Liu DY, 2009, HYPERTENSION, V53, P70, DOI 10.1161/HYPERTENSIONAHA.108.116947; Liu W, 2014, ENDOCRINOLOGY, V155, P1738, DOI 10.1210/en.2013-2020; Liu W, 2013, BBA-GEN SUBJECTS, V1830, P5184, DOI 10.1016/j.bbagen.2013.06.037; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Manaboon M, 2009, J INSECT PHYSIOL, V55, P122, DOI 10.1016/j.jinsphys.2008.10.013; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Morris DD, 1998, APPL ENVIRON MICROB, V64, P1759; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Nicolai M, 2000, INSECT MOL BIOL, V9, P241, DOI 10.1046/j.1365-2583.2000.00181.x; NISHIBE S, 1990, SCIENCE, V250, P1253, DOI 10.1126/science.1700866; Panner A, 2005, CELL CALCIUM, V37, P105, DOI 10.1016/j.ceca.2004.07.002; Prossnitz ER, 2008, ANNU REV PHYSIOL, V70, P165, DOI 10.1146/annurev.physiol.70.113006.100518; Putney JW, 2002, NAT CELL BIOL, V4, pE280, DOI 10.1038/ncb1202-e280; Rauch P, 1998, INSECT BIOCHEM MOLEC, V28, P265, DOI 10.1016/S0965-1748(98)00026-5; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Schauer S, 2011, J STEROID BIOCHEM, V124, P84, DOI 10.1016/j.jsbmb.2011.01.013; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Selbach M, 2002, J BIOL CHEM, V277, P6775, DOI 10.1074/jbc.C100754200; Shao HL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003127; Singh A, 2010, BRIT J PHARMACOL, V160, P1464, DOI 10.1111/j.1476-5381.2010.00786.x; Srivastava DP, 2005, J NEUROSCI, V25, P6145, DOI 10.1523/JNEUROSCI.1005-05.2005; Stoica B, 1998, J IMMUNOL, V160, P1059; Terland O, 1999, NEUROPHARMACOLOGY, V38, P879, DOI 10.1016/S0028-3908(98)00233-0; von Essen MR, 2010, NAT IMMUNOL, V11, P344, DOI 10.1038/ni.1851; Waldhoer M, 1998, MOL PHARMACOL, V53, P808; Wang S, 2012, J PROTEOME RES, V11, P6187, DOI 10.1021/pr3008804; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Yamanaka N, 2013, ANNU REV ENTOMOL, V58, P497, DOI 10.1146/annurev-ento-120811-153608; YULE DI, 1992, J BIOL CHEM, V267, P13830; Zhao XF, 1998, INSECT BIOCHEM MOLEC, V28, P259, DOI 10.1016/S0965-1748(98)00015-0; Zheng WW, 2010, MOL CELL ENDOCRINOL, V315, P282, DOI 10.1016/j.mce.2009.10.018	57	43	46	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13026	13041		10.1074/jbc.M113.547018	http://dx.doi.org/10.1074/jbc.M113.547018			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24692553	Green Published, hybrid			2022-12-25	WOS:000335522800007
J	Chiyo, PI; Grieneisen, LE; Wittemyer, G; Moss, CJ; Lee, PC; Douglas-Hamilton, I; Archie, EA				Chiyo, Patrick I.; Grieneisen, Laura E.; Wittemyer, George; Moss, Cynthia J.; Lee, Phyllis C.; Douglas-Hamilton, Iain; Archie, Elizabeth A.			The Influence of Social Structure, Habitat, and Host Traits on the Transmission of Escherichia coli in Wild Elephants	PLOS ONE			English	Article							SPRINGS-NATIONAL-RESERVES; POPULATION-STRUCTURE; AFRICAN ELEPHANTS; PHYLOGENETIC DISTRIBUTION; GENETIC-STRUCTURE; SPATIAL STRUCTURE; NETWORK ANALYSIS; ESTIMATING AGE; COLONIZATION; DYNAMICS	Social structure is proposed to influence the transmission of both directly and environmentally transmitted infectious agents. However in natural populations, many other factors also influence transmission, including variation in individual susceptibility and aspects of the environment that promote or inhibit exposure to infection. We used a population genetic approach to investigate the effects of social structure, environment, and host traits on the transmission of Escherichia coli infecting two populations of wild elephants: one in Amboseli National Park and another in Samburu National Reserve, Kenya. If E. coli transmission is strongly influenced by elephant social structure, E. coli infecting elephants from the same social group should be genetically more similar than E. coli sampled from members of different social groups. However, we found no support for this prediction. Instead, E. coli was panmictic across social groups, and transmission patterns were largely dominated by habitat and host traits. For instance, habitat overlap between elephant social groups predicted E. coli genetic similarity, but only in the relatively drier habitat of Samburu, and not in Amboseli, where the habitat contains large, permanent swamps. In terms of host traits, adult males were infected with more diverse haplotypes, and males were slightly more likely to harbor strains with higher pathogenic potential, as compared to adult females. In addition, elephants from similar birth cohorts were infected with genetically more similar E. coli than elephants more disparate in age. This age-structured transmission may be driven by temporal shifts in genetic structure of E. coli in the environment and the effects of age on bacterial colonization. Together, our results support the idea that, in elephants, social structure often will not exhibit strong effects on the transmission of generalist, fecal-oral transmitted bacteria. We discuss our results in the context of social, environmental, and host-related factors that influence transmission patterns.	[Chiyo, Patrick I.; Grieneisen, Laura E.; Archie, Elizabeth A.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Wittemyer, George] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Moss, Cynthia J.; Lee, Phyllis C.] Amboseli Trust Elephants, Nairobi, Kenya; [Lee, Phyllis C.] Univ Stirling, Dept Psychol, Behav & Evolut Res Grp, Stirling FK9 4LA, Scotland; [Douglas-Hamilton, Iain] Save Elephants, Nairobi, Kenya	University of Notre Dame; Colorado State University; University of Stirling	Archie, EA (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	earchie@nd.edu	Archie, Elizabeth/AAE-7456-2022; Wittemyer, George/AFQ-1840-2022	Lee, Phyllis/0000-0002-4296-3513	Clare Boothe Luce Foundation; Amboseli Trust for Elephants	Clare Boothe Luce Foundation; Amboseli Trust for Elephants	This research was supported by funds from the Clare Boothe Luce Foundation to EAA, as well as the Amboseli Trust for Elephants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts SC, 2005, CAM S BIO EVOL ANTHR, V44, P157, DOI 10.1017/CBO9780511542343.007; Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Alm EW, 2011, POPULATION GENETICS OF BACTERIA: A TRIBUTE TO THOMAS S. WHITTAM, P69; Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; ANDERSON R M, 1991; Archie EA, 2006, P ROY SOC B-BIOL SCI, V273, P513, DOI 10.1098/rspb.2005.3361; Badgley BD, 2011, WATER RES, V45, P721, DOI 10.1016/j.watres.2010.08.041; Bansal S, 2007, J R SOC INTERFACE, V4, P879, DOI 10.1098/rsif.2007.1100; Benavides JA, 2012, APPL ENVIRON MICROB, V78, P4281, DOI 10.1128/AEM.07593-11; Bergholz PW, 2011, APPL ENVIRON MICROB, V77, P211, DOI 10.1128/AEM.01880-10; Berthe T, 2013, APPL ENVIRON MICROB, V79, P4684, DOI 10.1128/AEM.00698-13; Blyton MDJ, 2013, ENVIRON MICROBIOL, V15, P2162, DOI 10.1111/1462-2920.12088; Boudailliez B, 1997, PEDIATR NEPHROL, V11, P36, DOI 10.1007/s004670050229; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; Brennan FP, 2010, APPL ENVIRON MICROB, V76, P1449, DOI 10.1128/AEM.02335-09; Bull CM, 2012, MOL ECOL, V21, P4386, DOI 10.1111/j.1365-294X.2012.05653.x; Byappanahalli MN, 2009, WATER RES, V43, P806, DOI 10.1016/j.watres.2008.11.012; Caillaud D, 2006, MICROBES INFECT, V8, P2477, DOI 10.1016/j.micinf.2006.06.003; Caillaud D, 2006, CURR BIOL, V16, pR489, DOI 10.1016/j.cub.2006.06.017; Carlos C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-161; CAUGANT DA, 1984, J HYG-CAMBRIDGE, V92, P377, DOI 10.1017/S0022172400064597; Cesaris L, 2007, FOODBORNE PATHOG DIS, V4, P473, DOI 10.1089/fpd.2007.0038; Charif RA, 2005, BEHAV ECOL SOCIOBIOL, V57, P327, DOI 10.1007/s00265-004-0867-5; Contreras CA, 2011, J MED MICROBIOL, V60, P639, DOI 10.1099/jmm.0.026666-0; Corner LAL, 2003, PREV VET MED, V59, P147, DOI 10.1016/S0167-5877(03)00075-8; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159; Croze H, 2011, AMBOSELI ELEPHANTS L; DEAN EA, 1989, INFECT IMMUN, V57, P82, DOI 10.1128/IAI.57.1.82-87.1989; Degnan PH, 2012, P NATL ACAD SCI USA, V109, P13034, DOI 10.1073/pnas.1110994109; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Douglas-Hamilton I, 2005, NATURWISSENSCHAFTEN, V92, P158, DOI 10.1007/s00114-004-0606-9; Drewe JA, 2011, PREV VET MED, V101, P113, DOI 10.1016/j.prevetmed.2011.05.006; Eames KTD, 2008, THEOR POPUL BIOL, V73, P104, DOI 10.1016/j.tpb.2007.09.007; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ezenwa VO, 2004, BEHAV ECOL, V15, P446, DOI 10.1093/beheco/arh028; Ezenwa VO, 2003, PARASITOLOGY, V126, P379, DOI 10.1017/S0031182002002913; Feil EJ, 2001, ANNU REV MICROBIOL, V55, P561, DOI 10.1146/annurev.micro.55.1.561; Ferrari N, 2004, ECOL LETT, V7, P88, DOI 10.1046/j.1461-0248.2003.00552.x; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Fowler M, 2006, BIOL MED SURG ELEPHA; Fraser C, 2005, P NATL ACAD SCI USA, V102, P1968, DOI 10.1073/pnas.0406993102; FREELAND W J, 1976, Biotropica, V8, P12, DOI 10.2307/2387816; FREELAND WJ, 1979, ECOLOGY, V60, P719, DOI 10.2307/1936609; Godfrey SS, 2009, BEHAV ECOL SOCIOBIOL, V63, P1045, DOI 10.1007/s00265-009-0730-9; Goldberg TL, 2007, BIOL CONSERV, V135, P511, DOI 10.1016/j.biocon.2006.10.048; Goldberg TL, 2006, APPL ENVIRON MICROB, V72, P6049, DOI 10.1128/AEM.00355-06; Gordon DM, 2008, ENVIRON MICROBIOL, V10, P2484, DOI 10.1111/j.1462-2920.2008.01669.x; Gordon DM, 2003, MICROBIOL-SGM, V149, P3575, DOI 10.1099/mic.0.26486-0; Gordon DM, 1997, MICROBIOL-UK, V143, P2039, DOI 10.1099/00221287-143-6-2039; Gordon DM, 2001, MICROBIOL-SGM, V147, P1079, DOI 10.1099/00221287-147-5-1079; Graham AL, 2008, P NATL ACAD SCI USA, V105, P566, DOI 10.1073/pnas.0707221105; Hamede RK, 2009, ECOL LETT, V12, P1147, DOI 10.1111/j.1461-0248.2009.01370.x; Hansen DL, 2009, APPL ENVIRON MICROB, V75, P1546, DOI 10.1128/AEM.00444-08; JACHMANN H, 1988, AFR J ECOL, V26, P51, DOI 10.1111/j.1365-2028.1988.tb01127.x; Janmaat KRL, 2009, INT J PRIMATOL, V30, P443, DOI 10.1007/s10764-009-9352-3; JIMENEZ L, 1989, J APPL BACTERIOL, V67, P61, DOI 10.1111/j.1365-2672.1989.tb04955.x; Johnson JR, 2008, J INFECT DIS, V197, P218, DOI 10.1086/524844; Johnson JR, 2009, ANTIMICROB AGENTS CH, V53, P2733, DOI 10.1128/AAC.00297-09; Johnson JR, 2001, J INFECT DIS, V183, P78, DOI 10.1086/317656; Judge J, 2005, APPL ENVIRON MICROB, V71, P6033, DOI 10.1128/AEM.71.10.6033-6038.2005; Keeling MJ, 1999, P ROY SOC B-BIOL SCI, V266, P859, DOI 10.1098/rspb.1999.0716; Lee P.C., 2011, AMBOSELI ELEPHANTS L; LEE PC, 1995, J ZOOL, V236, P29, DOI 10.1111/j.1469-7998.1995.tb01782.x; Lee PC, 2012, AFR J ECOL, V50, P9, DOI 10.1111/j.1365-2028.2011.01286.x; LEVINE MM, 1993, AM J EPIDEMIOL, V138, P849, DOI 10.1093/oxfordjournals.aje.a116788; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; LOEHLE C, 1995, ECOLOGY, V76, P326, DOI 10.2307/1941192; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Mbise A. N., 1998, Bulletin of Animal Health and Production in Africa, V46, P95; Meric G, 2013, ENVIRON MICROBIOL, V15, P487, DOI 10.1111/j.1462-2920.2012.02852.x; Moss C.J., 2011, AMBOSELI ELEPHANTS L, DOI DOI 10.7208/CHICAGO/9780226542263.001.0001; Moss CJ, 1983, PRIMATE SOCIAL RELAT, P315; Moss Cynthia J., 2011, P205; Nunn CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021677; Nunn CL, 2009, PHILOS T R SOC B, V364, P61, DOI 10.1098/rstb.2008.0148; OCHMAN H, 1984, J BACTERIOL, V157, P690, DOI 10.1128/JB.157.2.690-693.1984; Picard B, 1999, INFECT IMMUN, V67, P546, DOI 10.1128/IAI.67.2.546-553.1999; POOLE JH, 1989, SYM ZOOL S, V61, P111; Rasmussen HB, 2005, AFR J ECOL, V43, P215, DOI 10.1111/j.1365-2028.2005.00571.x; ROUTMAN E, 1985, APPL ENVIRON MICROB, V50, P749, DOI 10.1128/AEM.50.4.749-754.1985; Rwego IB, 2008, CONSERV BIOL, V22, P1600, DOI 10.1111/j.1523-1739.2008.01018.x; Skorping A, 2004, TRENDS ECOL EVOL, V19, P219, DOI 10.1016/j.tree.2004.02.006; Slutsker L, 1997, ANN INTERN MED, V126, P505, DOI 10.7326/0003-4819-126-7-199704010-00002; Smith JM, 2000, BIOESSAYS, V22, P1115, DOI 10.1002/1521-1878(200012)22:12&lt;1115::AID-BIES9&gt;3.0.CO;2-R; Steens A, 2011, AM J EPIDEMIOL, V174, P1307, DOI 10.1093/aje/kwr245; SU CY, 1995, ANN INTERN MED, V123, P698, DOI 10.7326/0003-4819-123-9-199511010-00009; Tande D, 2010, J ANTIMICROB CHEMOTH, V65, P859, DOI 10.1093/jac/dkq068; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Valverde A, 2008, J CLIN MICROBIOL, V46, P2796, DOI 10.1128/JCM.01008-08; VanderWaal KL, 2014, J ANIM ECOL, V83, P406, DOI 10.1111/1365-2656.12137; Walk ST, 2007, ENVIRON MICROBIOL, V9, P2274, DOI 10.1111/j.1462-2920.2007.01341.x; Walter J, 2011, ANNU REV MICROBIOL, V65, P411, DOI 10.1146/annurev-micro-090110-102830; Whittam Thomas S., 1992, Current Biology, V2, P676, DOI 10.1016/0960-9822(92)90140-6; WHITTAM TS, 1989, A VAN LEEUW J MICROB, V55, P23, DOI 10.1007/BF02309616; Wilson M., 2008, BACTERIOLOGY HUMANS; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wittemyer G, 2007, BEHAV ECOL SOCIOBIOL, V61, P1919, DOI 10.1007/s00265-007-0432-0; Wittemyer G, 2005, ANIM BEHAV, V69, P1357, DOI 10.1016/j.anbehav.2004.08.018; Wittemyer G, 2005, AFR J ECOL, V43, P44, DOI 10.1111/j.1365-2028.2004.00543.x; Wittemyer G, 2001, AFR J ECOL, V39, P357, DOI 10.1046/j.1365-2028.2001.00324.x; Wittemyer G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053726; Wittemyer G, 2009, P ROY SOC B-BIOL SCI, V276, P3513, DOI 10.1098/rspb.2009.0941; Young JK, 2008, J MAMMAL, V89, P1094, DOI 10.1644/07-MAMM-A-198.1	104	24	25	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93408	10.1371/journal.pone.0093408	http://dx.doi.org/10.1371/journal.pone.0093408			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705319	Green Published, gold			2022-12-25	WOS:000334107500036
J	Li, N; Pasha, Z; Ashraf, M				Li, Ning; Pasha, Zeeshan; Ashraf, Muhammad			Reversal of Ischemic Cardiomyopathy with Sca-1(+) Stem Cells Modified with Multiple Growth Factors	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; DIFFERENTIATION; TRANSPLANTATION; ANGIOGENESIS; EXPRESSION; REPAIR; HEART; ENGRAFTMENT; MECHANISMS; SURVIVAL	We hypothesized that bone marrow derived Sca-1(+) stem cells (BM Sca-1(+)) transduced with multiple therapeutic cytokines with diverse effects will induce faster angiomyogenic differentiation in the infarcted myocardium. Methods and Results: BM Sca-1(+) were purified from transgenic male mice expressing GFP. Plasmids encoding for select quartet of growth factors, i. e., human IGF-1, VEGF, SDF-1 alpha and HGF were prepared and used for genetic modification of Sca1(+) cells ((GF)Sca-1(+)). Scramble transfected cells ((Sc)Sca-1(+)) were used as a control. RT-PCR and western blotting showed significantly higher expression of the growth factors in (GF)Sca-1(+). Besides the quartet of the therapeutic growth factors, PCR based growth factor array showed upregulation of multiple angiogenic and prosurvival factors such as Ang-1, Ang-2, MMP9, Cx43, BMP2, BMP5, FGF2, and NGF in (GF)Sca-1+ (p, 0.01 vs (Sc)Sca-1(+)). LDH and TUNEL assays showed enhanced survival of (GF)Sca-1(+) under lethal anoxia (p, 0.01 vs Sc Sca-1(+)). MTS assay showed significant increased cell proliferation in (GF)Sca-1(+) (p, 0.05 vs (Sc)Sca-1(+)). For in vivo study, female mice were grouped to receive the intramyocardial injection of 15 ml DMEM without cells (group-1) or containing 2.5610 5 (Sc)Sca-1(+) (group-2) or (GF)Sca-1(+) (group-3) immediately after coronary artery ligation. As indicated by Sry gene, a higher survival of (GF)Sca-1(+) in group-3 on day4 (2.3 fold higher vs group-2) was observed with massive mobilization of stem and progenitor cells (cKit+, Mdr1+, Cxcr4+ cells). Heart tissue sections immunostained for actinin and Cx43 at 4 weeks post engraftment showed extensive myofiber formation and expression of gap junctions. Immunostaining for vWF showed increased blood vessel density in both peri-infarct and infarct regions in group-3. Infarct size was attenuated and the global heart function was improved in group-3 as compared to group-2. Conclusions: Administration of BM Sca-1+ transduced with multiple genes is a novel approach to treat infarcted heart for its regeneration.	[Li, Ning] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Pasha, Zeeshan; Ashraf, Muhammad] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA	University System of Ohio; Ohio State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Ashraf, M (corresponding author), Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA.	ashrafm2@uic.edu	Ashraf, Muhammad/ABB-3463-2021		NHLBI NIH HHS [HL-087246, R01 HL087246, R01 HL095375] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087246, R01HL095375] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Anversa P, 2006, CIRCULATION, V113, P1451, DOI 10.1161/CIRCULATIONAHA.105.595181; Chavakis E, 2010, CIRCULATION, V121, P325, DOI 10.1161/CIRCULATIONAHA.109.901405; Danesh SM, 2009, GENE EXPR PATTERNS, V9, P255, DOI 10.1016/j.gep.2009.04.002; Ellison GM, 2011, J AM COLL CARDIOL, V58, P977, DOI 10.1016/j.jacc.2011.05.013; Elmadbouh I, 2007, J MOL CELL CARDIOL, V42, P792, DOI 10.1016/j.yjmcc.2007.02.001; Fan BS, 2011, GENE, V485, P167, DOI 10.1016/j.gene.2011.06.027; Fedak PWM, 2008, SEMIN THORAC CARDIOV, V20, P87, DOI 10.1053/j.semtcvs.2008.04.001; Gao F, 2007, CAN J CARDIOL, V23, P891; Ghadge SK, 2011, PHARMACOL THERAPEUT, V129, P97, DOI 10.1016/j.pharmthera.2010.09.011; GHERARDI E, 1991, CANCER CELL-MON REV, V3, P227; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Haider HK, 2008, CIRC RES, V103, P1300, DOI 10.1161/CIRCRESAHA.108.186742; Hao Q, 2011, STROKE, V42, P453, DOI 10.1161/STROKEAHA.110.596452; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Holmes C, 2007, STEM CELLS, V25, P1339, DOI 10.1634/stemcells.2006-0644; Jayasankar V, 2005, J CARDIAC SURG, V20, P93, DOI 10.1111/j.0886-0440.2005.200373.x; Kajstura J, 2005, CIRC RES, V96, P127, DOI 10.1161/01.RES.0000151843.79801.60; Kanemitsu N, 2006, J HEART LUNG TRANSPL, V25, P1253, DOI 10.1016/j.healun.2006.05.012; Kofidis T, 2004, STEM CELLS, V22, P1239, DOI 10.1634/stemcells.2004-0127; Langenfeld EM, 2004, MOL CANCER RES, V2, P141; Lu G, 2009, CIRCULATION, V119, P2587, DOI 10.1161/CIRCULATIONAHA.108.827691; Martin-Rendon E, 2008, EUR HEART J, V29, P1807, DOI 10.1093/eurheartj/ehn220; Maulik N, 2008, J MOL CELL CARDIOL, V44, P219, DOI 10.1016/j.yjmcc.2007.11.012; Meloni M, 2010, CIRC RES, V106, P1275, DOI 10.1161/CIRCRESAHA.109.210088; Mozid AM, 2011, BRIT MED BULL, V98, P143, DOI 10.1093/bmb/ldr014; Nesselmann C, 2008, J CELL MOL MED, V12, P1795, DOI 10.1111/j.1582-4934.2008.00457.x; Ono K, 1997, CIRCULATION, V95, P2552, DOI 10.1161/01.CIR.95.11.2552; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Pasha Z, 2008, CARDIOVASC RES, V77, P134, DOI 10.1093/cvr/cvm025; Pasha Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023667; Perez VADJ, 2009, J CELL BIOL, V184, P83, DOI 10.1083/jcb.200806049; Piepoli MF, 2010, EUR J HEART FAIL, V12, P172, DOI 10.1093/eurjhf/hfp183; Rosenblatt-Velin N, 2005, J CLIN INVEST, V115, P1724, DOI 10.1172/JCI23418; Rothhammer T, 2007, ONCOGENE, V26, P4158, DOI 10.1038/sj.onc.1210182; Shake JG, 2002, ANN THORAC SURG, V73, P1919, DOI 10.1016/S0003-4975(02)03517-8; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Song H, 2010, EXPERT OPIN BIOL TH, V10, P309, DOI 10.1517/14712590903455997; Song YH, 2007, BIOCHEM BIOPH RES CO, V354, P999, DOI 10.1016/j.bbrc.2007.01.095; Uemura R, 2006, CIRC RES, V98, P1414, DOI 10.1161/01.RES.0000225952.61196.39; Virag JAI, 2007, AM J PATHOL, V171, P1431, DOI 10.2353/ajpath.2007.070003; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wang YG, 2004, J MOL CELL CARDIOL, V37, P1041, DOI 10.1016/j.yjmcc.2004.09.004; Wang YG, 2006, J MOL CELL CARDIOL, V40, P736, DOI 10.1016/j.yjmcc.2006.02.004; Wen ZZ, 2011, J CELL MOL MED, V15, P1032, DOI 10.1111/j.1582-4934.2010.01255.x; Wiley DM, 2011, SEMIN CELL DEV BIOL, V22, P1012, DOI 10.1016/j.semcdb.2011.10.005; Yasuda S, 2000, J AM COLL CARDIOL, V36, P115, DOI 10.1016/S0735-1097(00)00675-6; Yu JX, 2009, J VASC SURG, V50, P608, DOI 10.1016/j.jvs.2009.05.049; Zisa D, 2009, BIOCHEM BIOPH RES CO, V390, P834, DOI 10.1016/j.bbrc.2009.10.058	50	7	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93645	10.1371/journal.pone.0093645	http://dx.doi.org/10.1371/journal.pone.0093645			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705272	Green Submitted, Green Published, gold			2022-12-25	WOS:000334107500051
J	Guo, XY; Lin, MY; Rockowitz, S; Lachman, HM; Zheng, DY				Guo, Xingyi; Lin, Mingyan; Rockowitz, Shira; Lachman, Herbert M.; Zheng, Deyou			Characterization of Human Pseudogene- Derived Non- Coding RNAs for Functional Potential	PLOS ONE			English	Article							REGULATE GENE-EXPRESSION; SMALL INTERFERING RNAS; GENOME-WIDE SURVEY; PROCESSED PSEUDOGENES; NONCODING RNAS; TRANSCRIBED PSEUDOGENE; MESSENGER-RNAS; ANTISENSE; PROTEIN; REVEALS	Thousands of pseudogenes exist in the human genome and many are transcribed, but their functional potential remains elusive and understudied. To explore these issues systematically, we first developed a computational pipeline to identify transcribed pseudogenes from RNA-Seq data. Applying the pipeline to datasets from 16 distinct normal human tissues identified,3,000 pseudogenes that could produce non-coding RNAs in a manner of low abundance but high tissue specificity under normal physiological conditions. Cross-tissue comparison revealed that the transcriptional profiles of pseudogenes and their parent genes showed mostly positive correlations, suggesting that pseudogene transcription could have a positive effect on the expression of their parent genes, perhaps by functioning as competing endogenous RNAs (ceRNAs), as previously suggested and demonstrated with the PTEN pseudogene, PTENP1. Our analysis of the ENCODE project data also found many transcriptionally active pseudogenes in the GM12878 and K562 cell lines; moreover, it showed that many human pseudogenes produced small RNAs (sRNAs) and some pseudogene-derived sRNAs, especially those from antisense strands, exhibited evidence of interfering with gene expression. Further integrated analysis of transcriptomics and epigenomics data, however, demonstrated that trimethylation of histone 3 at lysine 9 (H3K9me3), a posttranslational modification typically associated with gene repression and heterochromatin, was enriched at many transcribed pseudogenes in a transcription-level dependent manner in the two cell lines. The H3K9me3 enrichment was more prominent in pseudogenes that produced sRNAs at pseudogene loci and their adjacent regions, an observation further supported by the co- enrichment of SETDB1 ( a H3K9 methyltransferase), suggesting that pseudogene sRNAs may have a role in regional chromatin repression. Taken together, our comprehensive and systematic characterization of pseudogene transcription uncovers a complex picture of how pseudogene ncRNAs could influence gene and pseudogene expression, at both epigenetic and post-transcriptional levels.	[Guo, Xingyi; Zheng, Deyou] Albert Einstein Coll Med, Saul R Korey Dept Neurol, New York, NY USA; [Lin, Mingyan; Rockowitz, Shira; Lachman, Herbert M.; Zheng, Deyou] Albert Einstein Coll Med, Dept Genet, New York, NY USA; [Lachman, Herbert M.; Zheng, Deyou] Albert Einstein Coll Med, Dept Neurosci, New York, NY USA; [Lachman, Herbert M.] Albert Einstein Coll Med, Dept Psychiat & Behav Sci, New York, NY USA	Yeshiva University; Yeshiva University; Yeshiva University; Yeshiva University	Zheng, DY (corresponding author), Albert Einstein Coll Med, Saul R Korey Dept Neurol, New York, NY USA.	deyou.zheng@einstein.yu.edu	lin, mingyan/HDL-9420-2022	Zheng, Deyou/0000-0003-4354-5337	NIH/NIMH [R21MH099452]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH099452] Funding Source: NIH RePORTER	NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a grant from the NIH/NIMH (R21MH099452). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blahnik KR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017121; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Chan WL, 2013, NUCLEIC ACIDS RES, V41, P3734, DOI 10.1093/nar/gkt047; Chen L, 2012, EPIGENETICS-US, V7, P758, DOI 10.4161/epi.20706; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Frith MC, 2006, PLOS GENET, V2, P504, DOI 10.1371/journal.pgen.0020023; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Gertz J, 2012, GENOME RES, V22, P134, DOI 10.1101/gr.127373.111; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Guo XY, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000449; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Han J, 2007, P NATL ACAD SCI USA, V104, P12422, DOI 10.1073/pnas.0701635104; Han YJ, 2011, FASEB J, V25, P2305, DOI 10.1096/fj.10-177808; Harrison PM, 2005, NUCLEIC ACIDS RES, V33, P2374, DOI 10.1093/nar/gki531; Hawkins PG, 2010, TRANSCR-AUSTIN, V1, P165, DOI 10.4161/trns.1.3.13332; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Hon G.C., 2011, GENOME RES; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; Johnsson P, 2013, NAT STRUCT MOL BIOL, V20, P440, DOI 10.1038/nsmb.2516; Kalyana-Sundaram S, 2012, CELL, V149, P1622, DOI 10.1016/j.cell.2012.04.041; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kerin T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003479; Khachane AN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-435; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Korneev SA, 2005, J NEUROSCI, V25, P1188, DOI 10.1523/JNEUROSCI.4671-04.2005; Korneev SA, 1999, J NEUROSCI, V19, P7711; Korneev SA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01027; Lam HYK, 2009, NUCLEIC ACIDS RES, V37, pD738, DOI 10.1093/nar/gkn758; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Maida Y, 2011, BIOL CHEM, V392, P299, DOI 10.1515/BC.2011.035; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Malecova B, 2010, CURR OPIN MOL THER, V12, P214; Marques AC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r102; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Matzke M, 2007, CURR OPIN PLANT BIOL, V10, P512, DOI 10.1016/j.pbi.2007.06.007; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mighell AJ, 2000, FEBS LETT, V468, P109, DOI 10.1016/S0014-5793(00)01199-6; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Muro EM, 2011, BIOCHIMIE, V93, P1916, DOI 10.1016/j.biochi.2011.07.024; Muro EM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-338; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Ohshima K, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r74; Olovnikov I, 2012, CURR OPIN GENET DEV, V22, P164, DOI 10.1016/j.gde.2012.01.002; OTA T, 1995, MOL BIOL EVOL, V12, P94, DOI 10.1093/oxfordjournals.molbev.a040194; Ozsolak F, 2009, NATURE, V461, P814, DOI 10.1038/nature08390; Pei BK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r51; Peng JC, 2013, CURR OPIN CELL BIOL, V25, P190, DOI 10.1016/j.ceb.2013.01.010; Pink RC, 2011, RNA, V17, P792, DOI 10.1261/rna.2658311; Poliseno L, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002858; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Rubio-Somoza I, 2011, CELL, V147, P1431, DOI 10.1016/j.cell.2011.12.003; Sakai H, 2007, GENE, V389, P196, DOI 10.1016/j.gene.2006.11.007; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sasidharan R, 2008, NATURE, V453, P729, DOI 10.1038/453729a; Seitz H, 2009, CURR BIOL, V19, P870, DOI 10.1016/j.cub.2009.03.059; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Svensson O, 2006, PLOS COMPUT BIOL, V2, P358, DOI 10.1371/journal.pcbi.0020046; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Ting AH, 2005, NAT GENET, V37, P906, DOI 10.1038/ng1611; Torrents D, 2003, GENOME RES, V13, P2559, DOI 10.1101/gr.1455503; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Trinklein ND, 2007, GENOME RES, V17, P720, DOI 10.1101/gr.5716607; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang XX, 2006, PLOS BIOL, V4, P366, DOI 10.1371/journal.pbio.0040052; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Wen YZ, 2011, P NATL ACAD SCI USA, V108, P8345, DOI 10.1073/pnas.1103894108; Wierzbicki AT, 2012, GENE DEV, V26, P1825, DOI 10.1101/gad.197772.112; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141; Yano Y, 2004, J MOL MED, V82, P414, DOI 10.1007/s00109-004-0550-3; Yu N, 2004, GENETICS, V166, P1375, DOI 10.1534/genetics.166.3.1375; Zhang ZL, 2006, BIOINFORMATICS, V22, P1437, DOI 10.1093/bioinformatics/btl116; Zhang ZL, 2004, CURR OPIN GENET DEV, V14, P328, DOI 10.1016/j.gde.2004.06.003; Zhang ZL, 2003, GENOME RES, V13, P2541, DOI 10.1101/gr.1429003; Zheng DY, 2007, TRENDS GENET, V23, P219, DOI 10.1016/j.tig.2007.03.003; Zheng DY, 2007, GENOME RES, V17, P839, DOI 10.1101/gr.5586307; Zheng DY, 2005, J MOL BIOL, V349, P27, DOI 10.1016/j.jmb.2005.02.072; Zhong XH, 2012, NAT STRUCT MOL BIOL, V19, P870, DOI 10.1038/nsmb.2354; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033; Zhu JC, 2007, PLOS COMPUT BIOL, V3, P2498, DOI 10.1371/journal.pcbi.0030247	99	45	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93972	10.1371/journal.pone.0093972	http://dx.doi.org/10.1371/journal.pone.0093972			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699680	gold, Green Published, Green Submitted			2022-12-25	WOS:000334105000130
J	Maes, P; Harries, AD; Van den Bergh, R; Noor, A; Snow, RW; Tayler-Smith, K; Hinderaker, SG; Zachariah, R; Allan, R				Maes, Peter; Harries, Anthony D.; Van den Bergh, Rafael; Noor, Abdisalan; Snow, Robert W.; Tayler-Smith, Katherine; Hinderaker, Sven Gudmund; Zachariah, Rony; Allan, Richard			Can Timely Vector Control Interventions Triggered by Atypical Environmental Conditions Prevent Malaria Epidemics? A Case-Study from Wajir County, Kenya	PLOS ONE			English	Article							RIFT-VALLEY FEVER; OUTBREAK	Background: Atypical environmental conditions with drought followed by heavy rainfall and flooding in arid areas in sub-Saharan Africa can lead to explosive epidemics of malaria, which might be prevented through timely vector-control interventions. Objectives: Wajir County in Northeast Kenya is classified as having seasonal malaria transmission. The aim of this study was to describe in Wajir town the environmental conditions, the scope and timing of vector-control interventions and the associated resulting burden of malaria at two time periods (1996-1998 and 2005-2007). Methods: This is a cross-sectional descriptive and ecological study using data collected for routine program monitoring and evaluation. Results: In both time periods, there were atypical environmental conditions with drought and malnutrition followed by massive monthly rainfall resulting in flooding and animal/human Rift Valley Fever. In 1998, this was associated with a large and explosive malaria epidemic (weekly incidence rates peaking at 54/1,000 population/week) with vector-control interventions starting over six months after the massive rainfall and when the malaria epidemic was abating. In 2007, vector-control interventions started sooner within about three months after the massive rainfall and no malaria epidemic was recorded with weekly malaria incidence rates never exceeding 0.5 per 1,000 population per week. Discussion and Conclusion: Did timely vector-control interventions in Wajir town prevent a malaria epidemic? In 2007, the neighboring county of Garissa experienced similar climatic events as Wajir, but vector-control interventions started six months after the heavy un-seasonal rainfall and large scale flooding resulted in a malaria epidemic with monthly incidence rates peaking at 40/1,000 population. In conclusion, this study suggests that atypical environmental conditions can herald a malaria outbreak in certain settings. In turn, this should alert responsible stakeholders about the need to act rapidly and preemptively with appropriate and wide-scale vector-control interventions to mitigate the risk.	[Maes, Peter] Operat Ctr Brussels, Water Hyg & Sanitat Unit, Dept Med, Brussels, Belgium; [Harries, Anthony D.] Int Union TB & Lung Dis Union, Paris, France; [Harries, Anthony D.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Van den Bergh, Rafael; Tayler-Smith, Katherine; Zachariah, Rony] Operat Ctr Brussels, Operat Res Unit LuxOR, Dept Med, Luxembourg, Luxembourg; [Noor, Abdisalan; Snow, Robert W.] KEMRI Univ Oxford Wellcome Trust Collaborat Progr, Malaria Publ Hlth Dept, Nairobi, Kenya; [Noor, Abdisalan; Snow, Robert W.] Univ Oxford, Ctr Trop Med, Oxford, England; [Hinderaker, Sven Gudmund] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Allan, Richard] Mentor Initiat, Crawley, England	University of London; London School of Hygiene & Tropical Medicine; University of Oxford; University of Bergen	Maes, P (corresponding author), Operat Ctr Brussels, Water Hyg & Sanitat Unit, Dept Med, Brussels, Belgium.	Peter.Maes@brussels.msf.org	Snow, Robert William/AFR-1436-2022	Snow, Robert William/0000-0003-3725-6088; zachariah, rony/0000-0002-2915-9328; Van den Bergh, Rafael/0000-0001-6277-8713	Department for International Development, UK; Medecins Sans Frontieres, Luxembourg; Wellcome Trust [095127, 079080, 092654]	Department for International Development, UK; Medecins Sans Frontieres, Luxembourg; Wellcome Trust(Wellcome TrustEuropean Commission)	Funding for the course was from the innumerable donors who collectively provide in 85% of the total MSF budget; was from the Department for International Development, UK; and was from Medecins Sans Frontieres, Luxembourg. AMN is supported by the Wellcome Trust as an Intermediate Fellow (# 095127); RWS is supported by the Wellcome Trust as Principal Research Fellow (# 079080) and both acknowledge the support provided by the Wellcome Trust Major Overseas Programme grant to the KEMRI/Wellcome Trust Research Programme (#092654). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba S, 2011, INT J EPIDEMIOL, V40, P405, DOI 10.1093/ije/dyq240; Allan R, 1998, LANCET, V351, P1966, DOI 10.1016/S0140-6736(05)78661-X; Allan R, 2013, BASIC DATA SHEET EXT; Brown V, 1998, LANCET, V352, P1356, DOI 10.1016/S0140-6736(05)60747-7; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Githeko AK, 2000, B WORLD HEALTH ORGAN, V78, P1136; Grandesso F, 2007, INVESTIGATION RIFT V, P3; Hay S, 2003, TRENDS PARASITOL, V19, P394, DOI 10.1016/S1471-4922(03)00190-9; Hay SI, 2001, TRENDS PARASITOL, V17, P95, DOI 10.1016/S1471-4922(00)01763-3; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; Khogali M, 2011, PUBLIC HEALTH ACTION, V1, P16, DOI 10.5588/pha.11.0008; Lengeler C, 2009, COCHRANE LIB; LINTHICUM KJ, 1983, MOSQ NEWS, V43, P464; Nguku PM, 2010, AM J TROP MED HYG, V83, P5, DOI 10.4269/ajtmh.2010.09-0288; Okiro Emelda A, 2009, BMC Med, V7, P75, DOI 10.1186/1741-7015-7-75; Peterson AT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-59; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Reiter P, 2004, LANCET INFECT DIS, V4, P323, DOI 10.1016/S1473-3099(04)01038-2; Sang R, 2010, AM J TROP MED HYG, V83, P28, DOI 10.4269/ajtmh.2010.09-0319; Snow B, 2006, RAPID SITUATION ANAL; Snow R. W., 1999, EPIDEMIOLOGY POLITIC; USAID, 2006, UND NUTR DAT CAUS MA; WHO (World Health Organization), 2001, WHOCDSRBM200132; Woods CW, 2002, EMERG INFECT DIS, V8, P138, DOI 10.3201/eid0802.010023; World Health Organization, 2011, WHO GLOB MAL REP 201; Zhou G, 2004, P NATL ACAD SCI USA, V101, P2375, DOI 10.1073/pnas.0308714100	27	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e92386	10.1371/journal.pone.0092386	http://dx.doi.org/10.1371/journal.pone.0092386			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699034	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000334105000024
J	Matsumoto, M; Hagio, M; Inoue, R; Mitani, T; Yajima, M; Hara, H; Yajima, T				Matsumoto, Megumi; Hagio, Masahito; Inoue, Ryo; Mitani, Tomohiro; Yajima, Masako; Hara, Hiroshi; Yajima, Takaji			Long-Term Oral Feeding of Lutein-Fortified Milk Increases Voluntary Running Distance in Rats	PLOS ONE			English	Article							GREEN TEA EXTRACT; PHYSICAL-ACTIVITY; METABOLIC SYNDROME; SKELETAL-MUSCLE; DIETARY LUTEIN; VITAMIN-E; EXERCISE; MICE; SUPPLEMENTATION; PLASMA	To evaluate the effects of lutein-fortified milk administration on running exercise, a voluntary wheel-running model was performed in rats. Four-week-old F344 rats were administered test milk (10 mL/kg) daily following a 4-h fasting period, and their running distances were measured each day for a 9-week period. Total weekly running distance significantly increased from the sixth week until the end of the test period in lutein-supplemented rats (lutein-fortified milk administered) compared with control rats (vehicle administered). This increase was not apparent in rats administered lutein alone. In the lutein-fortified-milk exercise group compared with the sedentary control group, carnitine palitroyltransferase 1 (CPT-1), total AMP-activated protein kinase (tAMPK), and phosphorylated AMP-activated protein kinase (pAMPK) contents were significantly increased in the gastrocnemius muscle, with a concomitant decrease in triglyceride and total cholesterol levels in the blood and liver. Furthermore, the lutein level in blood of lutein-administered rats significantly decreased with exercise. These results suggest that lutein-fortified milk may enhance the effect of exercise by effective utilization of lipids when combined with voluntary running.	[Matsumoto, Megumi] Nihon Univ, Coll Humanities & Sci, Dept Phys Educ, Setagaya Ku, Tokyo, Japan; [Hagio, Masahito; Mitani, Tomohiro; Hara, Hiroshi] Hokkaido Univ, Res Fac Agr, Kita Ku, Sapporo, Hokkaido, Japan; [Hagio, Masahito] Toyo Univ, Fac Life Sci, Itakura, Gunma, Japan; [Inoue, Ryo] Kyoto Prefectural Univ, Lab Anim Sci, Shimogamo, Kyoto, Japan; [Yajima, Masako; Yajima, Takaji] Hokkaido Univ, Grad Sch Med, Kita Ku, Sapporo, Hokkaido, Japan	Hokkaido University; Toyo University; Hokkaido University	Matsumoto, M (corresponding author), Nihon Univ, Coll Humanities & Sci, Dept Phys Educ, Setagaya Ku, 3-25-40 Sakurajosui, Tokyo, Japan.	matsumegrace@gmail.com	HARA, HIROSHI/A-4581-2012	HARA, HIROSHI/0000-0001-5925-5751	Meiji Co.	Meiji Co.	The work was funded by Meiji Co. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoi W, 2008, BIOCHEM BIOPH RES CO, V366, P892, DOI 10.1016/j.bbrc.2007.12.019; Arias EB, 2007, AM J PHYSIOL-ENDOC M, V292, pE1191, DOI 10.1152/ajpendo.00602.2006; Bo S, 2008, EUR J ENDOCRINOL, V159, P685, DOI 10.1530/EJE-08-0334; Calderon F, 2007, J DAIRY SCI, V90, P5651, DOI 10.3168/jds.2007-0264; Call JA, 2008, J APPL PHYSIOL, V105, P923, DOI 10.1152/japplphysiol.00028.2008; Cureton KJ, 2009, J APPL PHYSIOL, V107, P1095, DOI 10.1152/japplphysiol.00234.2009; FOLCH J, 1957, J BIOL CHEM, V226, P497; Granado-Lorencio F, 2010, J NUTR BIOCHEM, V21, P133, DOI 10.1016/j.jnutbio.2008.12.002; Hagio M, 2010, J APPL PHYSIOL, V109, P663, DOI 10.1152/japplphysiol.00777.2009; Hammond BR, 2008, NUTR REV, V66, P695, DOI 10.1111/j.1753-4887.2008.00121.x; Hayes K, 2001, AM J CLIN NUTR, V74, P211; Hulshof PJM, 2006, J FOOD COMPOS ANAL, V19, P67, DOI 10.1016/j.jfca.2005.04.005; Jeneson JAL, 2007, ACTA PHYSIOL, V190, P151, DOI 10.1111/j.1748-1716.2007.01680.x; Johnson EJ, 2008, NUTR NEUROSCI, V11, P75, DOI 10.1179/147683008X301450; Kanda A, 2012, J AGR FOOD CHEM, V60, P11403, DOI 10.1021/jf302277a; KEREN G, 1980, J SPORT MED PHYS FIT, V20, P145; Lee SP, 2009, EUR J APPL PHYSIOL, V107, P587, DOI 10.1007/s00421-009-1159-6; Li L, 2010, J NUTR BIOCHEM, V21, P544, DOI 10.1016/j.jnutbio.2009.03.002; Liu SM, 2001, CURR OPIN LIPIDOL, V12, P395, DOI 10.1097/00041433-200108000-00005; MANGELS AR, 1993, J AM DIET ASSOC, V93, P284, DOI 10.1016/0002-8223(93)91553-3; Matsumoto M, 2009, BRIT J NUTR, V102, P1324, DOI 10.1017/S0007114509990365; McAnulty SR, 2005, J NUTR BIOCHEM, V16, P530, DOI 10.1016/j.jnutbio.2005.02.001; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Mirmiran P, 2005, INT J OBESITY, V29, P115, DOI 10.1038/sj.ijo.0802838; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Moreno FS, 2007, CHEM-BIOL INTERACT, V168, P221, DOI 10.1016/j.cbi.2007.04.011; Murase T, 2006, AM J PHYSIOL-REG I, V290, pR1550, DOI 10.1152/ajpregu.00752.2005; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Orozco LJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003054.pub3; Pal S, 2010, OBESITY, V18, P1354, DOI 10.1038/oby.2009.397; Perseghin G, 2007, DIABETES CARE, V30, P683, DOI 10.2337/dc06-2032; Pfeuffer M, 2007, OBES REV, V8, P109, DOI 10.1111/j.1467-789X.2006.00265.x; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; SALLIS JF, 1986, PREV MED, V15, P331, DOI 10.1016/0091-7435(86)90001-0; Sommerburg O, 1998, BRIT J OPHTHALMOL, V82, P907, DOI 10.1136/bjo.82.8.907; Speakman JR, 2003, P NUTR SOC, V62, P621, DOI 10.1079/PNS2003282; Sumida S, 1997, FREE RADICAL RES, V27, P607, DOI 10.3109/10715769709097864; Yajima M, 2013, BIOMED RES-TOKYO, V34, P197, DOI 10.2220/biomedres.34.197	39	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93529	10.1371/journal.pone.0093529	http://dx.doi.org/10.1371/journal.pone.0093529			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699440	gold, Green Published, Green Submitted			2022-12-25	WOS:000334105000065
J	Rhein, C; Muhle, C; Richter-Schmidinger, T; Alexopoulos, P; Doerfler, A; Kornhuber, J				Rhein, Cosima; Muehle, Christiane; Richter-Schmidinger, Tanja; Alexopoulos, Panagiotis; Doerfler, Arnd; Kornhuber, Johannes			Neuroanatomical Correlates of Intelligence in Healthy Young Adults: The Role of Basal Ganglia Volume	PLOS ONE			English	Article							FALSE DISCOVERY RATE; GENERAL INTELLIGENCE; CRYSTALLIZED INTELLIGENCE; COGNITIVE FUNCTIONS; PARKINSONS-DISEASE; HIPPOCAMPAL VOLUME; GENETIC DISSECTION; FLUID INTELLIGENCE; PREFRONTAL CORTEX; AGE-DIFFERENCES	Background: In neuropsychiatric diseases with basal ganglia involvement, higher cognitive functions are often impaired. In this exploratory study, we examined healthy young adults to gain detailed insight into the relationship between basal ganglia volume and cognitive abilities under non-pathological conditions. Methodology/Principal Findings: We investigated 137 healthy adults that were between the ages of 21 and 35 years with similar educational backgrounds. Magnetic resonance imaging (MRI) was performed, and volumes of basal ganglia nuclei in both hemispheres were calculated using FreeSurfer software. The cognitive assessment consisted of verbal, numeric and figural aspects of intelligence for either the fluid or the crystallised intelligence factor using the intelligence test Intelligenz-Struktur- Test (I-S-T 2000 R). Our data revealed significant correlations of the caudate nucleus and pallidum volumes with figural and numeric aspects of intelligence, but not with verbal intelligence. Interestingly, figural intelligence associations were dependent on sex and intelligence factor; in females, the pallidum volumes were correlated with crystallised figural intelligence (r=0.372, p=0.01), whereas in males, the caudate volumes were correlated with fluid figural intelligence (r=0.507, p=0.01). Numeric intelligence was correlated with right-lateralised caudate nucleus volumes for both females and males, but only for crystallised intelligence (r=0.306, p=0.04 and r=0.459, p=0.04, respectively). The associations were not mediated by prefrontal cortical subfield volumes when controlling with partial correlation analyses. Conclusions/Significance: The findings of our exploratory analysis indicate that figural and numeric intelligence aspects, but not verbal aspects, are strongly associated with basal ganglia volumes. Unlike numeric intelligence, the type of figural intelligence appears to be related to distinct basal ganglia nuclei in a sex-specific manner. Subcortical brain structures thus may contribute substantially to cognitive performance.	[Rhein, Cosima; Muehle, Christiane; Richter-Schmidinger, Tanja; Alexopoulos, Panagiotis; Kornhuber, Johannes] Univ Erlangen Nurnberg, Univ Hosp, Dept Psychiat & Psychotherapy, D-91054 Erlangen, Germany; [Alexopoulos, Panagiotis] Tech Univ Munich, Klinikum Rechts Isar, Dept Psychiat & Psychotherapy, D-80290 Munich, Germany; [Doerfler, Arnd] Univ Erlangen Nurnberg, Univ Hosp, Dept Neuroradiol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; Technical University of Munich; University of Munich; University of Erlangen Nuremberg	Rhein, C (corresponding author), Univ Erlangen Nurnberg, Univ Hosp, Dept Psychiat & Psychotherapy, D-91054 Erlangen, Germany.	Cosima.Rhein@uk-erlangen.de	Kornhuber, Johannes/B-9613-2014; MÃhle, Christiane/AAE-7043-2019	Kornhuber, Johannes/0000-0002-8096-3987; Rhein, Cosima/0000-0002-3010-2169; Muhle, Christiane/0000-0001-7517-9154	Deutsche Forschungsgemeinschaft; Friedrich-Alexander-University Erlangen-Nuremberg; Department of Psychiatry	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander-University Erlangen-Nuremberg; Department of Psychiatry	Intramural funding sources of the Department of Psychiatry. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-University Erlangen-Nuremberg within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos P, 2011, J ALZHEIMERS DIS, V26, P207, DOI 10.3233/JAD-2011-110356; ANDREASEN NC, 1993, AM J PSYCHIAT, V150, P130; Benjamini Y, 2005, GENETICS, V171, P783, DOI 10.1534/genetics.104.036699; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blinkhorn S, 2005, NATURE, V438, P31, DOI 10.1038/438031a; Burgaleta M, 2013, HUM BRAIN MAPP  0802; Burgaleta M, 2012, INTELLIGENCE, V40, P60, DOI 10.1016/j.intell.2011.10.006; CATTELL RB, 1963, J EDUC PSYCHOL, V54, P1, DOI 10.1037/h0046743; Colom R, 2006, NEUROIMAGE, V31, P1359, DOI 10.1016/j.neuroimage.2006.01.006; Colom R, 2013, INTELLIGENCE, V41, P129, DOI 10.1016/j.intell.2013.01.002; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Duff BJ, 2013, SCHIZOPHR RES, V147, P1, DOI 10.1016/j.schres.2013.03.015; Feng J, 2007, PSYCHOL SCI, V18, P850, DOI 10.1111/j.1467-9280.2007.01990.x; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Flynn JR, 2011, PERS INDIV DIFFER, V50, P799, DOI 10.1016/j.paid.2010.12.035; Geary D. C., 2005, ORIGIN MIND EVOLUTIO, DOI DOI 10.1037/10871-000; Gong QY, 2005, NEUROIMAGE, V25, P1175, DOI 10.1016/j.neuroimage.2004.12.044; Grahn JA, 2008, PROG NEUROBIOL, V86, P141, DOI 10.1016/j.pneurobio.2008.09.004; Haier RJ, 2005, NEUROIMAGE, V25, P320, DOI 10.1016/j.neuroimage.2004.11.019; HORN JL, 1967, ACTA PSYCHOL, V26, P107, DOI 10.1016/0001-6918(67)90011-X; Humblet O, 2013, ENVIRON HEALTH PERSP, V121, P111, DOI 10.1289/ehp.1205278; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Langen M, 2013, BIOL PSYCHIAT   0930; Lawrence AD, 1998, TRENDS COGN SCI, V2, P379, DOI 10.1016/S1364-6613(98)01231-5; Lewis SJG, 2003, J NEUROSCI, V23, P6351, DOI 10.1523/jneurosci.23-15-06351.2003; Liang SY, 2013, NEURO-ONCOLOGY, V15, P1543, DOI 10.1093/neuonc/not127; Liepmann D.V., 2001, INTELLIGENZ STRUKTUR; LINN MC, 1985, CHILD DEV, V56, P1479, DOI 10.2307/1130467; Luders E, 2009, INTELLIGENCE, V37, P156, DOI 10.1016/j.intell.2008.07.002; McDaniel MA, 2005, INTELLIGENCE, V33, P337, DOI 10.1016/j.intell.2004.11.005; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Middleton FA, 2000, BRAIN COGNITION, V42, P183, DOI 10.1006/brcg.1999.1099; Moffat SD, 2007, CEREB CORTEX, V17, P1274, DOI 10.1093/cercor/bhl036; Moore AB, 2013, BRAIN LANG, V125, P316, DOI 10.1016/j.bandl.2012.05.003; Navas-Sanchez FJ, 2013, HUM BRAIN MAPP  0903; Neisser U, 1996, AM PSYCHOL, V51, P77, DOI 10.1037/0003-066X.51.2.77; Neubauer AC, 2002, INTELLIGENCE, V30, P515, DOI 10.1016/S0160-2896(02)00091-0; Nisbett RE, 2012, AM PSYCHOL, V67, P130, DOI 10.1037/a0026699; O'Dwyer L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048895; Osborn MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072737; Ragozzino ME, 2002, BRAIN RES, V953, P205, DOI 10.1016/S0006-8993(02)03287-0; Raz N, 2008, CEREB CORTEX, V18, P718, DOI 10.1093/cercor/bhm108; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Richter-Schmidinger T, 2011, J NEURAL TRANSM, V118, P249, DOI 10.1007/s00702-010-0539-8; Rojas DC, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-56; Sears LL, 1999, PROG NEURO-PSYCHOPH, V23, P613, DOI 10.1016/S0278-5846(99)00020-2; Sidiropoulos C, 2011, ACTA NEUROPSYCHIATR, V23, P132, DOI 10.1111/j.1601-5215.2011.00546.x; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; Stanfield AC, 2008, EUR PSYCHIAT, V23, P289, DOI 10.1016/j.eurpsy.2007.05.006; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; van Asselen M, 2009, NEUROPSYCHOLOGIA, V47, P1269, DOI 10.1016/j.neuropsychologia.2009.01.008; Van Petten C, 2004, NEUROPSYCHOLOGIA, V42, P1394, DOI 10.1016/j.neuropsychologia.2004.04.006; Weller JI, 1998, GENETICS, V150, P1699; Wolff JJ, 2013, J NEURODEV DISORD, V5, DOI 10.1186/1866-1955-5-12	54	25	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93623	10.1371/journal.pone.0093623	http://dx.doi.org/10.1371/journal.pone.0093623			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699871	Green Submitted, Green Published, gold			2022-12-25	WOS:000334105000081
J	Al-Kuhlani, M; Rothchild, J; Pal, S; de la Maza, LM; Ouburg, S; Morre, SA; Dean, D; Ojcius, DM				Al-Kuhlani, Mufadhal; Rothchild, James; Pal, Sukumar; de la Maza, Luis M.; Ouburg, Sander; Morre, Servaas A.; Dean, Deborah; Ojcius, David M.			TRAIL-R1 Is a Negative Regulator of Pro-Inflammatory Responses and Modulates Long-Term Sequelae Resulting from Chlamydia trachomatis Infections in Humans	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; NF-KAPPA-B; TOLL-LIKE RECEPTOR-4; PROTEIN-KINASE PKR; EPITHELIAL-CELLS; IMMUNE-RESPONSES; ACTIVATION; WOMEN; MICE; DEATH	The immune system eliminates Chlamydia trachomatis infection through inflammation. However, uncontrolled inflammation can enhance pathology. In mice, TNF-related apoptosis-inducing ligand receptor (TRAIL-R), known for its effects on apoptosis, also regulates inflammation. In humans, the four homologues of TRAIL-R had never been investigated for effects on inflammation. Here, we examined whether TRAIL-R regulates inflammation during chlamydial infection. We examined TRAIL-R1 single nucleotide polymorphisms (SNPs) in an Ecuadorian cohort with and without C. trachomatis infections. There was a highly significant association for the TRAIL+626 homozygous mutant GG for infection vs no infection in this population. To confirm the results observed in the human population, primary lung fibroblasts and bone marrow-derived macrophages (BMDMs) were isolated from wildtype (WT) and TRAIL-R-deficient mice, and TRAIL-R1 levels in human cervical epithelial cells were depleted by RNA interference. Infection of BMDMs and primary lung fibroblasts with C. trachomatis strain L-2, or the murine pathogen C. muridarum, led to higher levels of MIP2 mRNA expression or IL-1 beta secretion from TRAIL-R-deficient cells than WT cells. Similarly, depletion of TRAIL-R1 expression in human epithelial cells resulted in a higher level of IL-8 mRNA expression and protein secretion during C. trachomatis infection. We conclude that human TRAIL-R1 SNPs and murine TRAIL-R modulate the innate immune response against chlamydial infection. This is the first evidence that human TRAIL-R1 is a negative regulator of inflammation and plays a role in modulating Chlamydia pathogenesis.	[Al-Kuhlani, Mufadhal; Ojcius, David M.] Univ Calif Merced, Dept Mol Cell Biol, Merced, CA 95343 USA; [Al-Kuhlani, Mufadhal; Ojcius, David M.] Univ Calif Merced, Hlth Sci Res Inst, Merced, CA USA; [Pal, Sukumar; de la Maza, Luis M.] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA USA; [Ouburg, Sander; Morre, Servaas A.] Vrije Univ Amsterdam, Med Ctr, Res Sch V ICI, Lab Immunogenet Med Microbiol & Infect Prevent, Amsterdam, Netherlands; [Morre, Servaas A.] Univ Maastricht, Res Sch GROW, Dept Genet & Cell Biol, Inst Publ Hlth Genom, Maastricht, Netherlands; [Rothchild, James; Dean, Deborah] Childrens Hosp Oakland, Res Inst, Ctr Immunobiol & Vaccine Dev, Oakland, CA 94609 USA; [Dean, Deborah] Univ Calif Berkeley, Grad Program Bioengn, Berkeley, CA 94720 USA; [Dean, Deborah] Univ Calif San Francisco, Grad Program Bioengn, San Francisco, CA 94143 USA; [Dean, Deborah] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California Merced; University of California System; University of California Merced; University of California System; University of California Irvine; Vrije Universiteit Amsterdam; Maastricht University; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ojcius, DM (corresponding author), Univ Calif Merced, Dept Mol Cell Biol, Merced, CA 95343 USA.	david.ojcius@gmail.com	Ouburg, Sander/H-5775-2019; Ojcius, David/ABE-6557-2020	Ouburg, Sander/0000-0002-2092-0002; Ojcius, David/0000-0003-1461-4495	Public Health Service grant from the National Institutes of Health [R56 AI078419]; University of California; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI078419, R01AI032248] Funding Source: NIH RePORTER	Public Health Service grant from the National Institutes of Health; University of California(University of California System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by Public Health Service grant from the National Institutes of Health R56 AI078419 and a University of California Presidential Chair for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Sater AA, 2010, MICROBES INFECT, V12, P652, DOI 10.1016/j.micinf.2010.04.008; Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; Ashkenazi A, 2008, J CLIN ONCOL, V26, P3621, DOI 10.1200/JCO.2007.15.7198; Atik B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003600; Azenabor AA, 2003, J INFECTION, V46, P120, DOI 10.1053/jinf.2002.1098; Bailey RL, 2009, DRUG TODAY, V45, P45; Bannerman DD, 2002, J CLIN INVEST, V109, P419, DOI 10.1172/JCI14774; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Buchholz KR, 2006, CELL MICROBIOL, V8, P1768, DOI 10.1111/j.1462-5822.2006.00747.x; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Byrne GI, 2010, J INFECT DIS, V201, pS126, DOI 10.1086/652398; Cabanski M, 2008, AM J RESP CELL MOL, V38, P26, DOI 10.1165/rcmb.2007-0010OC; CAMPBELL LA, 1993, FERTIL STERIL, V59, P45; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Centers for Disease Control, 2010, SEX TRANSM DIS SURV; Clayton D, 2002, PROGRAM ESTIMATING F; Coll RC, 2010, J INNATE IMMUN, V2, P406, DOI 10.1159/000315469; Cretney E, 2003, J EXP MED, V198, P491, DOI 10.1084/jem.20030634; Darville T, 2003, J IMMUNOL, V171, P6187, DOI 10.4049/jimmunol.171.11.6187; Dean D, 2008, PLOS MED, V5, P57, DOI 10.1371/journal.pmed.0050014; den Hartog JE, 2009, DRUG TODAY, V45, P75; Dessus-Babus S, 2000, CELL MICROBIOL, V2, P317, DOI 10.1046/j.1462-5822.2000.00058.x; Diehl GE, 2004, IMMUNITY, V21, P877, DOI 10.1016/j.immuni.2004.11.008; ECKMANN L, 1993, INFECT IMMUN, V61, P4569, DOI 10.1128/IAI.61.11.4569-4574.1993; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Gomes JP, 2007, GENOME RES, V17, P50, DOI 10.1101/gr.5674706; Herring A, 2006, SEX TRANSM INFECT, V82, P23, DOI 10.1136/sti.2006.023143; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; Iwami K, 2000, J IMMUNOL, V165, P6682, DOI 10.4049/jimmunol.165.12.6682; Janssens S, 2002, CURR BIOL, V12, P467, DOI 10.1016/S0960-9822(02)00712-1; Joyee AG, 2008, CURR PHARM DESIGN, V14, P593, DOI 10.2174/138161208783885344; Karimi O, 2009, DRUG TODAY, V45, P67; Kim SO, 2003, J EXP MED, V197, P1441, DOI 10.1084/jem.20021842; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; KIVIAT NB, 1986, AM J OBSTET GYNECOL, V154, P865, DOI 10.1016/0002-9378(86)90473-4; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kuang AA, 2000, J BIOL CHEM, V275, P25065, DOI 10.1074/jbc.C000284200; La Verda D, 1994, Immunol Ser, V60, P381; Lamhamedi-Cherradi SE, 2003, NAT IMMUNOL, V4, P255, DOI 10.1038/ni894; LeBouder E, 2003, J IMMUNOL, V171, P6680, DOI 10.4049/jimmunol.171.12.6680; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lu B., 2012, NATURE; Lu H, 2000, J IMMUNOL, V165, P1463, DOI 10.4049/jimmunol.165.3.1463; McCartney-Francis N, 2004, J IMMUNOL, V172, P3814, DOI 10.4049/jimmunol.172.6.3814; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Meissner TB, 2012, MICROBES INFECT, V14, P477, DOI 10.1016/j.micinf.2011.12.007; Miller WC, 2004, JAMA-J AM MED ASSOC, V291, P2229, DOI 10.1001/jama.291.18.2229; Ouburg S, 2009, DRUG TODAY, V45, P83; Pal S, 2005, INFECT IMMUN, V73, P8153, DOI 10.1128/IAI.73.12.8153-8160.2005; Perfettini JL, 2003, J BIOL CHEM, V278, P9496, DOI 10.1074/jbc.M211275200; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ramsey KH, 1998, INFECT IMMUN, V66, P835, DOI 10.1128/IAI.66.2.835-838.1998; Ramsey KH, 2009, INFECT IMMUN, V77, P3284, DOI 10.1128/IAI.00147-09; Rasmussen SJ, 1997, J CLIN INVEST, V99, P77, DOI 10.1172/JCI119136; Richards KH, 2011, MICROBES INFECT, V13, P291, DOI 10.1016/j.micinf.2010.12.007; Said-Sadier Najwane, 2012, Biomed J, V35, P437, DOI 10.4103/2319-4170.104408; Said-Sadier N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010008; Schaefer U, 2007, FRONT BIOSCI, V12, P3813, DOI 10.2741/2354; Shimada K, 2012, MICROBES INFECT, V14, P1301, DOI 10.1016/j.micinf.2012.08.004; Srinivasan T, 2012, J BACTERIOL, V194, P617, DOI 10.1128/JB.06268-11; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sun RL, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.178798; Taylor BD, 2013, J INFECT DIS, V207, P940, DOI 10.1093/infdis/jis922; Taylor BD, 2012, J INFECT DIS, V205, P603, DOI 10.1093/infdis/jir822; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Wang S, 2008, ONCOGENE, V27, P6207, DOI 10.1038/onc.2008.298; Welter-Stahl L, 2006, CELL MICROBIOL, V8, P1047, DOI 10.1111/j.1462-5822.2006.00686.x; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wu GS, 1999, CANCER RES, V59, P2770; WYRICK PB, 1978, INFECT IMMUN, V19, P1054, DOI 10.1128/IAI.19.3.1054-1060.1978; Ying Songmin, 2007, Curr Immunol Rev, V3, P31, DOI 10.2174/157339507779802179; Zamanian-Daryoush M, 2000, MOL CELL BIOL, V20, P1278, DOI 10.1128/MCB.20.4.1278-1290.2000; Zhande R, 2007, MOL CELL BIOL, V27, P7394, DOI 10.1128/MCB.00600-07	76	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93939	10.1371/journal.pone.0093939	http://dx.doi.org/10.1371/journal.pone.0093939			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695582	Green Published, gold			2022-12-25	WOS:000334103000132
J	Bellinger, MA; Bean, JS; Rader, MA; Heinz-Taheny, KM; Nunes, JS; Haas, JV; Michael, LF; Rekhter, MD				Bellinger, Melissa A.; Bean, James S.; Rader, Melissa A.; Heinz-Taheny, Kathleen M.; Nunes, Jairo S.; Haas, Joseph V.; Michael, Laura F.; Rekhter, Mark D.			Concordant Changes of Plasma and Kidney MicroRNA in the Early Stages of Acute Kidney Injury: Time Course in a Mouse Model of Bilateral Renal Ischemia-Reperfusion	PLOS ONE			English	Article							TARGETS; BIOMARKERS; EXPRESSION; DIAGNOSIS; MIRBASE; URINE	Background: Acute kidney injury (AKI) is a syndrome characterized by the rapid loss of the kidney excretory function and is strongly associated with increased early and long-term patient morbidity and mortality. Early diagnosis of AKI is challenging; therefore we profiled plasma microRNA in an effort to identify potential diagnostic circulating markers of renal failure. The goal of the present study was to investigate the dynamic relationship of circulating and renal microRNA profiles within the first 24 hours after bilateral ischemia-reperfusion kidney injury in mice. Methodology/Principal Findings: Bilateral renal ischemia was induced in C57Bl/6 mice (n = 10 per group) by clamping the renal pedicle for 27 min. Ischemia-reperfusion caused highly reproducible, progressive, concordant elevation of miR-714, miR-1188, miR-1897-3p, miR-877*, and miR-1224 in plasma and kidneys at 3, 6 and 24 hours after acute kidney injury compared to the sham-operated mice (n = 5). These dynamics correlated with histologic findings of kidney injury and with a conventional plasma marker of renal dysfunction (creatinine). Pathway analysis revealed close association between miR1897-3p and Nucks1 gene expression, which putative downstream targets include genes linked to renal injury, inflammation and apoptosis. Conclusions/Significance: Systematic profiling of renal and plasma microRNAs in the early stages of experimental AKI provides the first step in advancing circulating microRNAs to the level of promising novel biomarkers.	[Bellinger, Melissa A.; Bean, James S.; Rader, Melissa A.; Michael, Laura F.; Rekhter, Mark D.] Eli Lilly & Co, Lilly Res Labs, Cardiometab Dis & Diabet Complicat, Indianapolis, IN 46285 USA; [Heinz-Taheny, Kathleen M.] Eli Lilly & Co, Lilly Res Labs, Invest Pathol, Indianapolis, IN 46285 USA; [Nunes, Jairo S.] Covance Labs, Greenfield, IN USA; [Haas, Joseph V.] Eli Lilly & Co, Lilly Res Labs, Stat Discovery Dev, Indianapolis, IN 46285 USA	Eli Lilly; Eli Lilly; Covance; Eli Lilly	Rekhter, MD (corresponding author), Eli Lilly & Co, Lilly Res Labs, Cardiometab Dis & Diabet Complicat, Indianapolis, IN 46285 USA.	rekhter_mark@lilly.com			Lilly Research Laboratories	Lilly Research Laboratories(Eli Lilly)	The work is funded by Lilly Research Laboratories that employs all the authors except JSN. Lilly Research Laboratories supported preparation of the manuscript and its submission. The funder has no role in study design, data collection and analysis.	Aronson D, 2012, PHARMACOL THERAPEUT, V135, P1, DOI 10.1016/j.pharmthera.2012.03.002; Basile DP, 1996, AM J PHYSIOL-RENAL, V270, pF500, DOI 10.1152/ajprenal.1996.270.3.F500; Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Chandrasekaran K, 2012, KIDNEY INT, V81, P617, DOI 10.1038/ki.2011.448; De Guire V, 2013, CLIN BIOCHEM, V46, P846, DOI 10.1016/j.clinbiochem.2013.03.015; Du J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063390; Etheridge A, 2011, MUTAT RES-FUND MOL M, V717, P85, DOI 10.1016/j.mrfmmm.2011.03.004; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Godwin JG, 2010, P NATL ACAD SCI USA, V107, P14339, DOI 10.1073/pnas.0912701107; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gui T, 2012, LAB INVEST, V92, P1250, DOI 10.1038/labinvest.2012.85; Hollander M, 1973, NONPARAMETRIC STAT M; Hunsberger JG, 2012, AM J TRANSL RES, V4, P316; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kriegel AJ, 2012, CLIN SCI, V122, P439, DOI 10.1042/CS20110159; Lan YF, 2012, J AM SOC NEPHROL, V23, P2012, DOI 10.1681/ASN.2012050438; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JYZ, 2010, NEPHROLOGY, V15, P599, DOI 10.1111/j.1440-1797.2010.01363.x; Lorenzen JM, 2011, CLIN J AM SOC NEPHRO, V6, P1540, DOI 10.2215/CJN.00430111; Millikin GJ, 2009, ANAL MESSY DATA; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Rayner KJ, 2013, J LIPID RES; Saikumar J, 2012, TOXICOL SCI, V129, P256, DOI 10.1093/toxsci/kfs210; Shapiro MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023011; Vanmassenhove J, 2013, NEPHROL DIAL TRANSPL, V28, P254, DOI 10.1093/ndt/gfs380; Vlaskou D, 2000, CLIN CHIM ACTA, V297, P103, DOI 10.1016/S0009-8981(00)00238-2; Wang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051140; Xu L, 2013, J CELL PHYSIOL, V228, P1713, DOI 10.1002/jcp.24344; Xu XL, 2012, KIDNEY INT, V82, P1167, DOI 10.1038/ki.2012.241	35	39	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93297	10.1371/journal.pone.0093297	http://dx.doi.org/10.1371/journal.pone.0093297			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695114	Green Published, Green Submitted, gold			2022-12-25	WOS:000334103000057
J	da Silva, VC; Fernandes, L; Haseyama, EJ; Agamme, ALDA; Shinohara, EMG; Muniz, MTC; D'Almeida, V				da Silva, Vanessa Cavalcante; Fernandes, Leandro; Haseyama, Eduardo Jun; Dias Abdo Agamme, Ana Luiza; Guerra Shinohara, Elvira Maria; Cartaxo Muniz, Maria Tereza; D'Almeida, Vania			Effect of Vitamin B Deprivation during Pregnancy and Lactation on Homocysteine Metabolism and Related Metabolites in Brain and Plasma of Mice Offspring	PLOS ONE			English	Article							SEX-DIFFERENCES; FOLIC-ACID; S-ADENOSYLHOMOCYSTEINE; GLUTATHIONE SYNTHESIS; FOLATE-DEFICIENCY; DNA METHYLATION; RISK FACTOR; HYPERHOMOCYSTEINEMIA; SERUM; RATS	Epidemiological and experimental studies indicate that the altered fetal and neonatal environment influences physiological functions and may increase the risk of developing chronic diseases in adulthood. Because homocysteine (Hcy) metabolic imbalance is considered a risk factor for neurodegenerative diseases, we investigated whether maternal Vitamin B deficiency during early development alters the offspring's methionine-homocysteine metabolism in their brain. To this end, the dams were submitted to experimental diet one month before and during pregnancy or pregnancy/lactation. After birth, the offspring were organized into the following groups: control (CT), deficient diet during pregnancy and lactation (DPL) and deficient diet during pregnancy (DP). The mice were euthanized at various stages of development. Hcy, cysteine, glutathione (GSH), S-adenosylmethionine (SAM), S-adenosylhomocysteine (SAH), folate and cobalamin concentrations were measured in the plasma and/or brain. At postnatal day (PND) 0, total brain of female and male offspring exhibited decreased SAM/SAH ratios. Moreover, at PND 28, we observed decreased GSH/GSSG ratios in both females and males in the DPL group. Exposure to a Vitamin B-deficient diet during the ontogenic plasticity period had a negative impact on plasma folate and brain cortex SAM concentrations in aged DPL males. We also observed decreased plasma GSH concentrations in both DP and DPL males (PND 210). Additionally, this manipulation seemed to affect the female and male offspring differently. The decreased plasma GSH concentration may reflect redox changes in tissues and the decreased brain cortex SAM may be involved in changes of gene expression, which could contribute to neurodegenerative diseases over the long term.	[da Silva, Vanessa Cavalcante; D'Almeida, Vania] Univ Fed Sao Paulo, Dept Pediat, Sao Paulo, Brazil; [da Silva, Vanessa Cavalcante; Fernandes, Leandro; Haseyama, Eduardo Jun; Dias Abdo Agamme, Ana Luiza; D'Almeida, Vania] Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, Brazil; [Guerra Shinohara, Elvira Maria] Univ Sao Paulo, Sch Pharmaceut Sci, Sao Paulo, Brazil; [Cartaxo Muniz, Maria Tereza] Univ Pernambuco, Pediat Hematol & Oncol Ctr, Inst Biol Sci, Recife, PE, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Pernambuco (UPE)	D'Almeida, V (corresponding author), Univ Fed Sao Paulo, Dept Pediat, Sao Paulo, Brazil.	vaniadalmeida@uol.com.br	D'Almeida, Vânia/AAV-3955-2020; Guerra-Shinohara, Elvira M/E-5610-2012; Silva, Vanessa C/A-8441-2015; D'Almeida, Vania/AAB-7115-2020	D'Almeida, Vânia/0000-0003-0947-5312; Guerra-Shinohara, Elvira M/0000-0001-6681-2210; cartaxo muniz, maria tereza/0000-0001-9498-5223	FAPESP [2010/00075-2]; CAPES; CNPq; AFIP	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); AFIP	This work was supported by FAPESP (Process # 2010/00075-2 and scholarship to EJH), CAPES (scholarship to VCS and LF), CNPq (fellowship to VDA) and AFIP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman G, 2001, REV INVEST CLIN, V53, P141; Amouzou EK, 2004, AM J CLIN NUTR, V79, P619; Barbosa PR, 2008, CLIN CHIM ACTA, V388, P139, DOI 10.1016/j.cca.2007.10.023; BARKER DJP, 1986, LANCET, V1, P1077; Blaise S, 2005, PEDIATR RES, V57, P777, DOI 10.1203/01.PDR.0000161406.19231.98; Blaise SA, 2007, AM J PATHOL, V170, P667, DOI 10.2353/ajpath.2007.060339; Bolton JL, 2012, FASEB J, V26, P4743, DOI 10.1096/fj.12-210989; Botto LD, 2005, BMJ-BRIT MED J, V330, P571, DOI 10.1136/bmj.38336.664352.82; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; CUNNINGHAM FG, 1993, WILLIAMS OBSTET, P209; da Silva VC, 2006, ARQ NEURO-PSIQUIAT, V64, P941, DOI 10.1590/S0004-282X2006000600010; DORNER G, 1988, EXP CLIN ENDOCRINOL, V91, P247; DURNIN JVGA, 1976, P NUTR SOC, V35, P145, DOI 10.1079/PNS19760026; Fahrenkrog S, 2004, J NUTR, V134, P648, DOI 10.1093/jn/134.3.648; Galdieri LC, 2007, ARCH MED RES, V38, P212, DOI 10.1016/j.arcmed.2006.09.012; Garcia MM, 2011, J PATHOL, V225, P324, DOI 10.1002/path.2881; GoddijnWessel TAW, 1996, EUR J OBSTET GYN R B, V66, P23, DOI 10.1016/0301-2115(96)02383-4; Grigore D, 2008, GENDER MED, V5, pS121, DOI 10.1016/j.genm.2008.03.012; Guerra-Shinohara EM, 2004, AM J CLIN NUTR, V80, P1312, DOI 10.1093/ajcn/80.5.1312; Guerra-Shinohara EM, 2002, BJOG-INT J OBSTET GY, V109, P784, DOI 10.1111/j.1471-0528.2002.01307.x; Halicioglu O, 2011, INT J VITAM NUTR RES, V81, P328, DOI 10.1024/0300-9831/a000080; HIRAYAMA K, 1987, BIOCHEM PHARMACOL, V36, P1919; HOYENGA KB, 1982, PHYSIOL BEHAV, V28, P545, DOI 10.1016/0031-9384(82)90153-6; JATHAR VS, 1970, ARCH DIS CHILD, V45, P236, DOI 10.1136/adc.45.240.236; Jones DP, 2002, METHOD ENZYMOL, V348, P93, DOI 10.1016/S0076-6879(02)48630-2; Khan LY, 2003, HYPERTENSION, V41, P168, DOI 10.1161/01.HYP.0000047511.97879.FC; Kim JM, 2009, J NUTR BIOCHEM, V20, P172, DOI 10.1016/j.jnutbio.2008.01.010; Kruman II, 2000, J NEUROSCI, V20, P6920, DOI 10.1523/JNEUROSCI.20-18-06920.2000; Kulkarni A, 2011, DNA CELL BIOL, V30, P79, DOI 10.1089/dna.2010.1084; Lu SC, 1999, FASEB J, V13, P1169, DOI 10.1096/fasebj.13.10.1169; Maler JM, 2003, NEUROSCI LETT, V347, P85, DOI 10.1016/S0304-3940(03)00655-4; McCaddon A, 1998, INT J GERIATR PSYCH, V13, P235, DOI 10.1002/(SICI)1099-1166(199804)13:4<235::AID-GPS761>3.0.CO;2-8; Mislanova C, 2011, REPRODUCTION, V142, P467, DOI 10.1530/REP-10-0484; Nelen WLDM, 2000, FERTIL STERIL, V74, P1196, DOI 10.1016/S0015-0282(00)01595-8; OBROIN S, 1992, J CLIN PATHOL, V45, P344, DOI 10.1136/jcp.45.4.344; Pfeiffer CM, 1999, CLIN CHEM, V45, P290; Pliushch G, 2010, AM J PATHOL, V176, P1084, DOI 10.2353/ajpath.2010.090764; RALLS K, 1976, Q REV BIOL, V51, P245, DOI 10.1086/409310; REED DJ, 1986, BIOCHEM PHARMACOL, V35, P7, DOI 10.1016/0006-2952(86)90545-9; Reis EA, 2002, METAB BRAIN DIS, V17, P211, DOI 10.1023/A:1019982223034; Roy S, 2013, BRAIN DEV; Sandovici I, 2011, P NATL ACAD SCI USA, V108, P5449, DOI 10.1073/pnas.1019007108; Stead LM, 2006, AM J CLIN NUTR, V83, P5; Steenweg-de Graaff J, 2012, AM J CLIN NUTR, V95, P1413, DOI 10.3945/ajcn.111.030791; Vitvitsky V, 2003, REDOX REP, V8, P57, DOI 10.1179/135100003125001260; Vitvitsky V, 2007, AM J PHYSIOL-RENAL, V293, pF594, DOI 10.1152/ajprenal.00171.2007; Vollset SE, 2000, AM J CLIN NUTR, V71, P962; Wilcken B, 2003, J MED GENET, V40, P619, DOI 10.1136/jmg.40.8.619; Yi P, 2000, J BIOL CHEM, V275, P29318, DOI 10.1074/jbc.M002725200	50	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e92683	10.1371/journal.pone.0092683	http://dx.doi.org/10.1371/journal.pone.0092683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695104	Green Published, Green Submitted, gold			2022-12-25	WOS:000334103000024
J	Smura, T; Blomqvist, S; Vuorinen, T; Ivanova, O; Samoilovich, E; Al-Hello, H; Savolainen-Kopra, C; Hovi, T; Roivainen, M				Smura, Teemu; Blomqvist, Soile; Vuorinen, Tytti; Ivanova, Olga; Samoilovich, Elena; Al-Hello, Haider; Savolainen-Kopra, Carita; Hovi, Tapani; Roivainen, Merja			The Evolution of Vp1 Gene in Enterovirus C Species Sub-Group That Contains Types CVA-21, CVA-24, EV-C95, EV-C96 and EV-C99	PLOS ONE			English	Article							NON-POLIO ENTEROVIRUSES; MOLECULAR CHARACTERIZATION; PHYLOGENETIC ANALYSIS; POPULATION-DYNAMICS; COXSACKIEVIRUS A21; HIGH-FREQUENCY; IDENTIFICATION; EPIDEMIOLOGY; SELECTION; ADAPTATION	Genus Enterovirus (Family Picornaviridae,) consists of twelve species divided into genetically diverse types by their capsid protein VP1 coding sequences. Each enterovirus type can further be divided into intra-typic sub-clusters (genotypes). The aim of this study was to elucidate what leads to the emergence of novel enterovirus clades (types and genotypes). An evolutionary analysis was conducted for a sub-group of Enterovirus C species that contains types Coxsackievirus A21 (CVA-21), CVA-24, Enterovirus C95 (EV-C95), EV-C96 and EV-C99. VP1 gene datasets were collected and analysed to infer the phylogeny, rate of evolution, nucleotide and amino acid substitution patterns and signs of selection. In VP1 coding gene, high intra-typic sequence diversities and robust grouping into distinct genotypes within each type were detected. Within each type the majority of nucleotide substitutions were synonymous and the non-synonymous substitutions tended to cluster in distinct highly polymorphic sites. Signs of positive selection were detected in some of these highly polymorphic sites, while strong negative selection was indicated in most of the codons. Despite robust clustering to intra-typic genotypes, only few genotype-specific 'signature' amino acids were detected. In contrast, when different enterovirus types were compared, there was a clear tendency towards fixation of type-specific 'signature' amino acids. The results suggest that permanent fixation of type-specific amino acids is a hallmark associated with evolution of different enterovirus types, whereas neutral evolution and/or (frequency-dependent) positive selection in few highly polymorphic amino acid sites are the dominant forms of evolution when strains within an enterovirus type are compared.	[Smura, Teemu; Blomqvist, Soile; Al-Hello, Haider; Savolainen-Kopra, Carita; Hovi, Tapani; Roivainen, Merja] Natl Inst Hlth & Welf THL, Dept Infect Dis Surveillance & Control, Helsinki, Finland; [Smura, Teemu] Univ Helsinki, Fac Med, Haartman Inst, Dept Virol, Helsinki, Finland; [Vuorinen, Tytti] Univ Turku, Dept Virol, Turku, Finland; [Ivanova, Olga] Russian Acad Med Sci, MP Chumakov Inst Poliomyelitis & Viral Encephalit, Moscow, Russia; [Samoilovich, Elena] Republican Res & Pract Ctr Epidemiol & Microbiol, Minsk, BELARUS	Finland National Institute for Health & Welfare; University of Helsinki; University of Turku; Russian Academy of Medical Sciences	Smura, T (corresponding author), Natl Inst Hlth & Welf THL, Dept Infect Dis Surveillance & Control, Helsinki, Finland.	Teemu.Smura@thl.fi	Smura, Teemu/K-6421-2012; Ivanova, Olga E/D-9734-2014; Hovi, Tapani/AAJ-4828-2020; Hovi, Tapani/AAG-9156-2020; Smura, Teemu P/C-4063-2016	Smura, Teemu/0000-0002-9187-3151; Ivanova, Olga E/0000-0003-1784-4827; Al-Hello, Haider/0000-0001-8206-1226	Academy of Finland	Academy of Finland(Academy of Finland)	This study was supported by Academy of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostol LN, 2012, J MED VIROL, V84, P624, DOI 10.1002/jmv.23242; Apostol LNG, 2012, VIRUS GENES, V45, P207, DOI 10.1007/s11262-012-0776-z; Arita M, 2005, J VIROL, V79, P12650, DOI 10.1128/JVI.79.20.12650-12657.2005; Bailly JL, 2011, INFECT GENET EVOL, V11, P276, DOI 10.1016/j.meegid.2010.06.019; Bailly JL, 2009, INFECT GENET EVOL, V9, P699, DOI 10.1016/j.meegid.2008.04.009; Bessaud M, 2012, J CLIN MICROBIOL, V50, P1650, DOI 10.1128/JCM.06657-11; Bessaud M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024823; Bhatt S, 2011, MOL BIOL EVOL, V28, P2443, DOI 10.1093/molbev/msr044; Bhatt S, 2010, INFECT GENET EVOL, V10, P421, DOI 10.1016/j.meegid.2009.06.001; Bingjun T, 2008, J MED VIROL, V80, P670, DOI 10.1002/jmv.21122; Biologicals DoVa, 2003, GUID ENV SURV POL CI; Blomqvist S, 2008, J CLIN MICROBIOL, V46, P2410, DOI 10.1128/JCM.00313-08; Brown B, 2003, J VIROL, V77, P8973, DOI 10.1128/JVI.77.16.8973-8984.2003; Brown BA, 2009, J GEN VIROL, V90, P1713, DOI 10.1099/vir.0.008540-0; Bull RA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000831; Cabrerizo M, 2014, J MED VIROL, V86, P857, DOI 10.1002/jmv.23741; Cabrerizo M, 2012, ARCH VIROL, V157, P551, DOI 10.1007/s00705-011-1207-5; Chu PY, 2011, INFECT GENET EVOL, V11, P1426, DOI 10.1016/j.meegid.2011.05.010; Chu PY, 2010, INFECT GENET EVOL, V10, P777, DOI 10.1016/j.meegid.2010.04.004; Chu PY, 2009, J CLIN VIROL, V45, P285, DOI 10.1016/j.jcv.2009.04.013; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Egea R, 2008, NUCLEIC ACIDS RES, V36, pW157, DOI 10.1093/nar/gkn337; Gullberg M, 2010, J VIROL, V84, P9695, DOI 10.1128/JVI.00071-10; Henquell C, 2013, J VIROL, V87, P12249, DOI 10.1128/JVI.02075-13; HOGLE JM, 1985, SCIENCE, V229, P1358, DOI 10.1126/science.2994218; Hovi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066836; Howley PM, 2007, FIELDS VIROLOGY, V1, P839; Jegouic S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000412; Jiang P, 2007, P NATL ACAD SCI USA, V104, P9457, DOI 10.1073/pnas.0700451104; Jorba J, 2008, J VIROL, V82, P4429, DOI 10.1128/JVI.02354-07; Khetsuriani Nino, 2006, Morbidity and Mortality Weekly Report, V55, P18; Kumar S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-357; Leitch ECM, 2012, J VIROL, V86, P2676, DOI 10.1128/JVI.06065-11; Leitch ECM, 2010, J VIROL, V84, P9292, DOI 10.1128/JVI.00783-10; Leitch ECM, 2009, J VIROL, V83, P2109, DOI 10.1128/JVI.02109-08; LENNETTE EH, 1958, AM J HYG, V68, P272, DOI 10.1093/oxfordjournals.aje.a119969; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lukashev AN, 2012, J GEN VIROL, V93, P2357, DOI 10.1099/vir.0.043216-0; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; MIRKOVIC RR, 1974, INTERVIROLOGY, V4, P119, DOI 10.1159/000149850; Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030; Oberste MS, 2013, J VIROL, V87, P558, DOI 10.1128/JVI.00837-12; Oberste MS, 2003, J CLIN VIROL, V26, P375, DOI 10.1016/S1386-6532(03)00004-0; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Oberste MS, 2000, J CLIN MICROBIOL, V38, P1170, DOI 10.1128/JCM.38.3.1170-1174.2000; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Rakoto-Andrianarivelo M, 2005, J CLIN MICROBIOL, V43, P242, DOI 10.1128/JCM.43.1.242-249.2005; Rakoto-Andrianarivelo M, 2007, PLOS PATHOG, V3, P1950, DOI 10.1371/journal.ppat.0030191; Rambaut A, 2007, TRACER V 1 4; Sadeuh-Mba SA, 2013, J CLIN MICROBIOL, V51, P759, DOI 10.1128/JCM.02119-12; Samoilovich E, 2003, J MED VIROL, V71, P274, DOI 10.1002/jmv.10480; Savolainen-Kopra C, 2011, VIRUS GENES, V42, P28, DOI 10.1007/s11262-010-0536-x; Smura T, 2007, J GEN VIROL, V88, P2520, DOI 10.1099/vir.0.82866-0; Smura T, 2013, INFECT GENET EVOL, V16, P234, DOI 10.1016/j.meegid.2013.02.011; Smura T, 2011, FUTURE VIROL, V6, P109, DOI 10.2217/FVL.10.62; Smura T, 2009, ARCH VIROL, V154, P1157, DOI 10.1007/s00705-009-0418-5; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; Tee KK, 2010, J VIROL, V84, P3339, DOI 10.1128/JVI.01019-09; Williamson S, 2003, MOL BIOL EVOL, V20, P1318, DOI 10.1093/molbev/msg144; Xiang ZC, 2012, EMERG INFECT DIS, V18, P821, DOI 10.3201/eid1805.111376; Xiao CA, 2005, STRUCTURE, V13, P1019, DOI 10.1016/j.str.2005.04.011; Xu AQ, 2011, VIRUS GENES, V42, P323, DOI 10.1007/s11262-011-0584-x	67	11	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93737	10.1371/journal.pone.0093737	http://dx.doi.org/10.1371/journal.pone.0093737			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695547	Green Published, gold, Green Submitted			2022-12-25	WOS:000334103000114
J	Wang, F; Tian, XZ; Zhou, YH; Tan, DX; Zhu, SE; Dai, YP; Liu, GS				Wang, Feng; Tian, XiuZhi; Zhou, YanHua; Tan, DunXian; Zhu, ShiEn; Dai, YunPing; Liu, GuoShi			Melatonin Improves the Quality of In Vitro Produced (IVP) Bovine Embryos: Implications for Blastocyst Development, Cryotolerance, and Modifications of Relevant Gene Expression	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; CULTURE SYSTEM; OOCYTE MATURATION; CATTLE EMBRYOS; SEX-RATIO; VIVO; PROTEIN; DIFFERENTIATION; FERTILIZATION; INCREASES	To evaluate the potential effects of melatonin on the kinetics of embryo development and quality of blastocyst during the process of in vitro bovine embryo culture. Bovine cumulus-oocyte complexes (COCs) were fertilized after in vitro maturation. The presumed zygotes were cultured in in vitro culture medium supplemented with or without 10(-7) M melatonin. The cleavage rate, 8-cell rate and blastocyst rate were examined to identify the kinetics of embryo development. The hatched blastocyst rate, mortality rate after thawing and the relevant transcript abundance were measured to evaluate the quality of blastocyst. The results showed that melatonin significantly promoted the cleavage rate and 8-cell embryo yield of in vitro produced bovine embryo. In addition, significantly more blastocysts were observed by Day 7 of embryo culture at the presence of melatonin. These results indicated that melatonin accelerated the development of in vitro produced bovine embryos. Following vitrification at Day 7 of embryo culture, melatonin (10(-7) M) significantly increased the hatched blastocyst rate from 24 h to 72 h and decreased the mortality rate from 48 h to 72 h after thawing. The presence of melatonin during the embryo culture resulted in a significant increase in the gene expressions of DNMT3A, OCC, CDH1 and decrease in that of AQP3 after thawing. In conclusion, melatonin not only promoted blastocyst yield and accelerated in vitro bovine embryo development, but also improved the quality of blastocysts which was indexed by an elevated cryotolerance and the up-regulated expressions of developmentally important genes.	[Wang, Feng; Tian, XiuZhi; Zhou, YanHua; Zhu, ShiEn; Liu, GuoShi] China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding,Minist Agr, State Key Lab Anim Nutr,Key Lab Anim Genet & Bree, Beijing 100094, Peoples R China; [Tan, DunXian] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Dai, YunPing] China Agr Univ, Coll Biol Sci, State Key Labs Agrobiotechnol, Beijing 100094, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; University of Texas System; University of Texas Health San Antonio; China Agricultural University	Liu, GS (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding,Minist Agr, State Key Lab Anim Nutr,Key Lab Anim Genet & Bree, Beijing 100094, Peoples R China.	gshliu@cau.edu.cn			National Natural Science Foundation of China [31372306]; Beijing Natural Science Foundation [6122019]; Beijing dairy industry and technology system; New Century Excellent Talents in University [NETC-10-0782];  [2011BAD19B02-4]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing dairy industry and technology system; New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); 	This research was supported by Program for the National Natural Science Foundation of China (31372306), Beijing Natural Science Foundation (6122019), Beijing dairy industry and technology system, New Century Excellent Talents in University (NETC-10-0782), and other national grants as follows: 2011BAD19B02-4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecia JA, 2002, VET RES COMMUN, V26, P151, DOI 10.1023/A:1014099719034; Assou S, 2010, MOL HUM REPROD, V16, P531, DOI 10.1093/molehr/gaq032; Boni R, 1999, BIOL REPROD, V61, P1050, DOI 10.1095/biolreprod61.4.1050; Bonilla E, 2004, J PINEAL RES, V36, P73, DOI 10.1046/j.1600-079X.2003.00105.x; Crosier AE, 2001, BIOL REPROD, V64, P1375, DOI 10.1095/biolreprod64.5.1375; Doherty AS, 2000, BIOL REPROD, V62, P1526, DOI 10.1095/biolreprod62.6.1526; Duby R. T., 1997, Theriogenology, V47, P332, DOI 10.1016/S0093-691X(97)82459-4; Enright BP, 2000, THERIOGENOLOGY, V54, P659, DOI 10.1016/S0093-691X(00)00381-2; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Galli C, 2003, THERIOGENOLOGY, V59, P599, DOI 10.1016/S0093-691X(02)01243-8; Galli C, 2001, THERIOGENOLOGY, V55, P1341, DOI 10.1016/S0093-691X(01)00486-1; Gao C, 2012, J PINEAL RES, V52, P305, DOI 10.1111/j.1600-079X.2011.00944.x; Gutierrez-Adan A, 2001, THERIOGENOLOGY, V55, P1117, DOI 10.1016/S0093-691X(01)00471-X; Hasler JF, 2000, HUM REPROD, V15, P47, DOI 10.1093/humrep/15.suppl_5.47; HASLER JF, 1995, THERIOGENOLOGY, V43, P141, DOI 10.1016/0093-691X(94)00020-U; Hussain SA, 2006, SAUDI MED J, V27, P1483; Ishizuka B, 2000, J PINEAL RES, V28, P48, DOI 10.1034/j.1600-079x.2000.280107.x; Jablonski EM, 2007, CANCER LETT, V250, P36, DOI 10.1016/j.canlet.2006.09.013; Kaidi S, 1998, ANIM REPROD SCI, V52, P39, DOI 10.1016/S0378-4320(98)00089-X; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kang JT, 2009, J PINEAL RES, V46, P22, DOI 10.1111/j.1600-079X.2008.00602.x; Khurana NK, 2000, BIOL REPROD, V62, P847, DOI 10.1095/biolreprod62.4.847; Kim J, 2004, MOL CELLS, V17, P248; Knijn HM, 2005, REPROD FERT DEVELOP, V17, P775, DOI 10.1071/RD05038; Knijn HM, 2002, REPRODUCTION, V124, P365, DOI 10.1530/rep.0.1240365; Kuzmany A, 2011, THERIOGENOLOGY, V75, P482, DOI 10.1016/j.theriogenology.2010.09.016; LEIBFRIEDRUTLEDGE ML, 1987, BIOL REPROD, V36, P376, DOI 10.1095/biolreprod36.2.376; LEIBO SP, 1993, THERIOGENOLOGY, V39, P81, DOI 10.1016/0093-691X(93)90025-Z; Lonergan P, 1999, J REPROD FERTIL, V117, P159, DOI 10.1530/jrf.0.1170159; Lopes AS, 2007, THERIOGENOLOGY, V68, P223, DOI 10.1016/j.theriogenology.2007.04.055; Manjunatha BM, 2009, REPROD DOMEST ANIM, V44, P12, DOI 10.1111/j.1439-0531.2007.00982.x; Mehaisen GMK, 2013, ZYGOTE, V28, P1; Minami N, 2001, BIOL REPROD, V64, P30, DOI 10.1095/biolreprod64.1.30; Niemann H, 2000, THERIOGENOLOGY, V53, P21, DOI 10.1016/S0093-691X(99)00237-X; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Papis K, 2007, J PINEAL RES, V43, P321, DOI 10.1111/j.1600-079X.2007.00479.x; Pappolla MA, 2000, J NEURAL TRANSM, V107, P203, DOI 10.1007/s007020050018; Pomar FJR, 2005, THERIOGENOLOGY, V63, P2254, DOI 10.1016/j.theriogenology.2004.10.015; Reiter RJ, 2009, BIOL REPROD, V81, P445, DOI 10.1095/biolreprod.108.075655; Rizos D, 2003, BIOL REPROD, V68, P236, DOI 10.1095/biolreprod.102.007799; Rizos D, 2002, BIOL REPROD, V66, P589, DOI 10.1095/biolreprod66.3.589; Rizos D, 2002, MOL REPROD DEV, V61, P234, DOI 10.1002/mrd.1153; Rizos D, 2001, THERIOGENOLOGY, V56, P1, DOI 10.1016/S0093-691X(01)00538-6; Rodriguez-Osorio N, 2007, J PINEAL RES, V43, P283, DOI 10.1111/j.1600-079X.2007.00475.x; Sandra O, 2012, REPROD FERT DEVELOP, V24, P68, DOI 10.1071/RD11908; Sheth B, 2000, MECH DEVELOP, V97, P93, DOI 10.1016/S0925-4773(00)00416-0; Shi JM, 2009, J PINEAL RES, V47, P318, DOI 10.1111/j.1600-079X.2009.00717.x; SHIELS A, 1993, CURR EYE RES, V12, P913, DOI 10.3109/02713689309020398; Tamura H, 2009, FERTIL STERIL, V92, P328, DOI 10.1016/j.fertnstert.2008.05.016; Thompson JG, 1997, REPROD FERT DEVELOP, V9, P341, DOI 10.1071/R96079; VanSoom A, 1997, BIOL REPROD, V57, P1041, DOI 10.1095/biolreprod57.5.1041; Vazquez MI, 2010, THERIOGENOLOGY, V74, P618, DOI 10.1016/j.theriogenology.2010.03.007; Viuff D, 2001, BIOL REPROD, V65, P204, DOI 10.1095/biolreprod65.1.204; Wang F, 2014, J PINEAL RES, V56, P333, DOI 10.1111/jpi.12126; Wang F, 2013, J PINEAL RES, V55, P267, DOI 10.1111/jpi.12069; Wrenzycki C, 2001, HUM REPROD, V16, P893, DOI 10.1093/humrep/16.5.893; Yoshioka K, 1997, THERIOGENOLOGY, V48, P997, DOI 10.1016/S0093-691X(97)00326-9	57	51	52	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93641	10.1371/journal.pone.0093641	http://dx.doi.org/10.1371/journal.pone.0093641			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695534	Green Published, gold, Green Submitted			2022-12-25	WOS:000334103000096
J	Wang, J; Ge, Y; Chen, T; Bai, Y; Qian, BY; Zhang, CB				Wang, Jiang; Ge, Yuan; Chen, Tong; Bai, Yi; Qian, Bao Ying; Zhang, Chong Bang			Facilitation Drives the Positive Effects of Plant Richness on Trace Metal Removal in a Biodiversity Experiment	PLOS ONE			English	Article							SPECIES RICHNESS; PRODUCTIVITY RELATIONSHIPS; FUNCTIONAL DIVERSITY; STRESS; SELECTION; MALONDIALDEHYDE; COMPLEMENTARITY; COMPETITION; ECOSYSTEMS; SUCCESSION	Background: Phytoextraction is an environmentally acceptable and inexpensive technique for mine tailing rehabilitation that uses metallophyte plants. These plants reduce the soil trace metal contents to environmentally acceptable levels by accumulating trace metals. Recently, whether more trace metals can be removed by species-rich communities of these plants received great attention, as species richness has been reported having positive effects on ecosystem functions. However, how the species richness affects trace metals removal of plant communities of mine tailing is rarely known. Methodology/Principal Findings: We examined the effects of species richness on soil trace metal removal in both natural and experimental plant communities. The root lengths and stem heights of each plant species were measured in order to calculate the functional diversity indices. Our results showed that trace metal (Cu, Cd, Pb and Zn) concentrations in mine tailing soil declined as species richness increased in both the natural and experimental plant communities. Species richness, rather than functional diversity, positively affected the mineralomass of the experimental plant communities. The intensity of plant-plant facilitation increased with the species richness of experimental communities. Due to the incremental role of plant-plant facilitation, most of the species had higher biomasses, higher trace metal concentrations in their plant tissues and lower malondialdehyde concentrations in their leaves. Consequently, the positive effects of species richness on mineralomass were mostly attributable to facilitation among plants. Conclusions/Significance: Our results provide clear evidence that, due to plant-plant facilitation, species richness positively affects the removal of trace metals from mine tailing soil through phytoextraction and provides further information on diversity conservation and environmental remediation in a mine tailing environment.	[Wang, Jiang; Chen, Tong; Bai, Yi; Qian, Bao Ying; Zhang, Chong Bang] Taizhou Univ, Sch Life Sci, Linhai, Peoples R China; [Ge, Yuan] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Earth Res Inst, Santa Barbara, CA 93106 USA	Taizhou University; University of California System; University of California Santa Barbara	Ge, Y (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Earth Res Inst, Santa Barbara, CA 93106 USA.	gyuan@bren.ucsb.edu	Ge, Yuan/D-2997-2009	Ge, Yuan/0000-0003-0234-5638	National Natural Science Foundation of China [31000256]; Natural Science Foundation of Zhejiang Province, China [Y13C030015]; Ecology Key Disciplines of Zhejiang Province in Taizhou University [EKD2013-04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province); Ecology Key Disciplines of Zhejiang Province in Taizhou University	This research was financially supported by the National Natural Science Foundation of China (Project 31000256), the Natural Science Foundation of Zhejiang Province, China (Y13C030015) and the Ecology Key Disciplines of Zhejiang Province in Taizhou University (EKD2013-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armas C, 2004, ECOLOGY, V85, P2682, DOI 10.1890/03-0650; Baumeister D, 2006, ECOLOGY, V87, P1816, DOI 10.1890/0012-9658(2006)87[1816:FBPFDS]2.0.CO;2; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; Cardinale BJ, 2013, ECOLOGY IN PRESS; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Choler P, 2001, ECOLOGY, V82, P3295, DOI 10.1890/0012-9658(2001)082[3295:FACOGI]2.0.CO;2; Choudhary M, 2007, ECOTOX ENVIRON SAFE, V66, P204, DOI 10.1016/j.ecoenv.2006.02.002; Cooke SJ, 2008, BIOSCIENCE, V58, P957, DOI 10.1641/B581009; Dhir B, 2004, AQUAT TOXICOL, V66, P141, DOI 10.1016/j.aquatox.2003.08.005; Drake JM, 2003, P ROY SOC B-BIOL SCI, V270, P1713, DOI 10.1098/rspb.2003.2423; Fargione J, 2007, P ROY SOC B-BIOL SCI, V274, P871, DOI 10.1098/rspb.2006.0351; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Gomez-Sagasti MT, 2012, WATER AIR SOIL POLL, V223, P3249, DOI 10.1007/s11270-012-1106-8; He Q, 2013, ECOL LETT, V16, P695, DOI 10.1111/ele.12080; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hector A, 2002, ECOL LETT, V5, P502, DOI 10.1046/j.1461-0248.2002.00337.x; Heemsbergen DA, 2004, SCIENCE, V306, P1019, DOI 10.1126/science.1101865; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Huston M A, 2000, Science, V289, P1255; Kaneryd L, 2012, ECOL EVOL, V2, P858, DOI 10.1002/ece3.218; Kawai T, 2007, P R SOC B, V274, P2503, DOI 10.1098/rspb.2007.0871; Kennedy TA, 2002, NATURE, V417, P636, DOI 10.1038/nature00776; Kondratyev K., 2002, GLOBAL ENV CHANGE MO; Lei PF, 2012, OECOLOGIA, V169, P1105, DOI 10.1007/s00442-012-2259-2; Li SP, 2012, J APPL ECOL, V49, P261, DOI 10.1111/j.1365-2664.2011.02091.x; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Maestre FT, 2012, SCIENCE, V335, P214, DOI 10.1126/science.1215442; Maestre FT, 2010, PHILOS T R SOC B, V365, P2057, DOI 10.1098/rstb.2010.0016; Maestre FT, 2005, J ECOL, V93, P748, DOI 10.1111/j.1365-2745.2005.01017.x; MCGRATH SP, 1985, J SCI FOOD AGR, V36, P794, DOI 10.1002/jsfa.2740360906; Meeinkuirt W, 2012, INT J PHYTOREMEDIAT, V14, P925, DOI 10.1080/15226514.2011.636403; Michalet R, 2006, ECOL LETT, V9, P767, DOI 10.1111/j.1461-0248.2006.00935.x; Midgley GF, 2012, SCIENCE, V335, P174, DOI 10.1126/science.1217245; Mulder CPH, 2001, P NATL ACAD SCI USA, V98, P6704, DOI 10.1073/pnas.111055298; Naeem S., 2000, B ECOL SOC AM, V81, P241; Novo LAB, 2013, INT J MIN RECLAM ENV, V27, P215, DOI 10.1080/17480930.2013.779061; Odadi WO, 2011, SCIENCE, V333, P1753, DOI 10.1126/science.1208468; Page AL, 1982, SOIL ANAL PART, V2, P595; Parraga-Aguado I, 2013, ENVIRON POLLUT, V176, P134, DOI 10.1016/j.envpol.2013.01.023; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Sheng XF, 2008, J HAZARD MATER, V155, P17, DOI 10.1016/j.jhazmat.2007.10.107; Spaekova I, 2001, ECOL LETT, V4, P585, DOI 10.1046/j.1461-0248.2001.00277.x; Suran J, 2013, J ENVIRON SCI HEAL B, V48, P147, DOI 10.1080/03601234.2013.727672; Thompson PL, 2012, J ANIM ECOL, V81, P251, DOI 10.1111/j.1365-2656.2011.01908.x; TILMAN D, 2001, FUNCTIONAL CONSEQUEN, P9; Walker B, 1999, ECOSYSTEMS, V2, P95, DOI 10.1007/s100219900062; Wang J, 2013, OECOLOGIA, V171, P227, DOI 10.1007/s00442-012-2400-2; Wang JA, 2011, ENVIRON EARTH SCI, V62, P779, DOI 10.1007/s12665-010-0565-8; Zhang SJ, 2012, ENVIRON SCI POLLUT R, V19, P3879, DOI 10.1007/s11356-012-1060-4	52	13	14	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93733	10.1371/journal.pone.0093733	http://dx.doi.org/10.1371/journal.pone.0093733			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695538	Green Published, gold, Green Submitted			2022-12-25	WOS:000334103000113
J	Lu, DF; Yao, Y; Su, ZZ; Zeng, ZH; Xing, XW; He, ZY; Zhang, CX				Lu, Dong-feng; Yao, Yan; Su, Zi-zhuo; Zeng, Zhao-hua; Xing, Xiao-wen; He, Zhi-yu; Zhang, Chunxiang			Downregulation of HDAC1 Is Involved in the Cardiomyocyte Differentiation from Mesenchymal Stem Cells in a Myocardial Microenvironment	PLOS ONE			English	Article								Under myocardial microenvironment, bone marrow-derived mesenchymal stem cells (MSCs) can transdifferentiate into cardiomyocytes (CMs). However, the role of histone deacetylase 1 (HDAC1) in this directed differentiation process remains unclear. The current study is to determine the acetylation regulatory mechanisms that may be involved in the directed CM differentiation from MSCs. MSCs isolated from male Sprague-Dawley (SD) rats were marked with Ad-EGFP and co-cultured with CMs. Flow cytometry was used to sort EGFP-positive (EGFP+) MSCs from the co-culture system. Then, the expression of cardiac troponin T (cTnT) in these MSCs was detected by immunofluorescence assay. In addition, HDAC1 levels at different co-culture times were measured by quantitative real-time polymerase chain reaction (QT-PCR) and Western blotting. At 4 days after co-culture with CMs, the MSCs began to expression detectable levels of cTnT. The expression of HDAC1 in CMs was much lower than that in MSCs. After co-culture with CMs, the expression of HDAC1 in MSCs was significantly decreased in a time dependent manner. In addition, our recent study has also identified that knockdown of the HDAC1 could promote the directed differentiation of MSCs into CMs. The results suggest that HDAC1 has a negative correlation with cardiac cell differentiation from MSCs under a myocardial microenvironment. HDAC1 might play an important role in the directed differentiation of MSCs into CMs in heart.	[Lu, Dong-feng; Yao, Yan; Su, Zi-zhuo; Zeng, Zhao-hua; Xing, Xiao-wen; He, Zhi-yu] Guangzhou Med Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou, Guangdong, Peoples R China; [Lu, Dong-feng; Yao, Yan; Su, Zi-zhuo; Zeng, Zhao-hua; Xing, Xiao-wen; He, Zhi-yu] Guangzhou Med Univ, Affiliated Hosp 1, Sino US Cardiovas Res Ctr, Guangzhou, Guangdong, Peoples R China; [Zhang, Chunxiang] Rush Univ, Rush Med Coll, Dept Pharmacol, Chicago, IL 60612 USA; [Zhang, Chunxiang] Rush Univ, Rush Med Coll, Cardiovasc Res Ctr, Chicago, IL 60612 USA	Guangzhou Medical University; Guangzhou Medical University; Rush University; Rush University	Lu, DF (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou, Guangdong, Peoples R China.	497440817@qq.com; chunxiang_zhang@rush.edu	zhang, xiang chun/HCH-7063-2022	zhang, xiang chun/0000-0001-8303-6495	Scientific Foundation of Guangdong, China [2009B030801358, 10151009504000008, 2012A030400028, 7003080]	Scientific Foundation of Guangdong, China	This research was supported by the Scientific Foundation of Guangdong, China (No. 2009B030801358; No. 10151009504000008; No. 2012A030400028; No. 7003080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng YH, 2010, CARDIOVASC RES, V87, P431, DOI 10.1093/cvr/cvq082; Cheng YH, 2010, CLIN SCI, V119, P87, DOI 10.1042/CS20090645; Collas P, 2009, BBA-GEN SUBJECTS, V1790, P900, DOI 10.1016/j.bbagen.2008.10.006; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Feng C, 2009, EXP CELL RES, V315, P3044, DOI 10.1016/j.yexcr.2009.05.005; Haberland M, 2010, J BIOL CHEM, V285, P14663, DOI 10.1074/jbc.M109.081679; Huang XP, 2010, CIRCULATION, V122, P2419, DOI 10.1161/CIRCULATIONAHA.110.955971; Leu YW, 2013, ADV EXP MED BIOL, V754, P195, DOI 10.1007/978-1-4419-9967-2_10; Li HW, 2006, BIOCHEM BIOPH RES CO, V341, P320, DOI 10.1016/j.bbrc.2005.12.182; Liu ZQ, 2009, BBA-MOL CELL RES, V1793, P300, DOI 10.1016/j.bbamcr.2008.08.013; Mahapatra Saswati, 2010, Ethn Dis, V20, pS1; Muscari C, 2008, J CELL BIOCHEM, V103, P1046, DOI 10.1002/jcb.21683; Snykers S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-24; Wang JP, 2011, DIFFERENTIATION, V81, P119, DOI 10.1016/j.diff.2010.10.003; Xu MF, 2004, CIRCULATION, V110, P2658, DOI 10.1161/01.CIR.0000145609.20435.36; Xu S, 2013, ACTA PHARMACOL SIN, V34, P699, DOI 10.1038/aps.2012.182; Zhu Jing, 2006, Zhonghua Yixue Yichuanxue Zazhi, V23, P43	17	15	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93222	10.1371/journal.pone.0093222	http://dx.doi.org/10.1371/journal.pone.0093222			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690943	gold, Green Published, Green Submitted			2022-12-25	WOS:000334101100054
J	Miao, YL; Ma, HS; Guo, WZ; Wu, JG; Liu, Y; Shi, WZ; Wang, XP; Mi, WD; Fang, WW				Miao, Yu-Liang; Ma, Hua-Song; Guo, Wen-Zhi; Wu, Ji-Gong; Liu, Yan; Shi, Wen-Zhu; Wang, Xiao-Ping; Mi, Wei-Dong; Fang, Wei-Wu			The Efficacy and Cost-Effectiveness of Cell Saver Use in Instrumented Posterior Correction and Fusion Surgery for Scoliosis in School-Aged Children and Adolescents	PLOS ONE			English	Article							ADULT LUMBAR FUSION; BLOOD-TRANSFUSIONS; SPINE SURGERY; AUTOTRANSFUSION	Posterior spinal instrumentation and fusion surgery in school- aged children and adolescents is associated with the potential for massive intraoperative blood loss, which requires significant allogeneic blood transfusion. Until now, the intraoperative use of the cell saver has been extensively adopted; however, its efficacy and cost- effectiveness have not been well established. Therefore, the aim of this study is to determine the efficacy and cost- effectiveness of intraoperative cell saver use. This study was a single- center, retrospective study of 247 school- aged and adolescent patients who underwent posterior spinal instrumentation and fusion surgery between August 2007 and June 2013. A cell saver was used intraoperatively in 67 patients and was not used in 180 patients. Matched case- control pairs were selected using a propensity score to balance potential confounders in baseline characteristics. Allogeneic red blood cell ( RBC) and plasma transfusions as well as blood transfusion costs were analyzed. The propensity score matching produced 60 matched pairs. Compared to the control group, the cell saver group had significantly fewer intraoperative allogeneic RBC transfusions (P=0.012). However, when the combined postoperative and total perioperative periods were evaluated for the use of allogeneic RBC transfusion, no significant differences were observed between the two groups (P=0.813 and P= 0.101, respectively). With regard to the total cost of perioperative transfusion of all blood products (RBC and plasma), costs for the control group were slightly lower than those of the cell saver group, but this variance did not reach statistical significance (P=0.095). The use of the cell saver in posterior spinal instrumentation and fusion surgery in school-aged children and adolescents was able to decrease the amount of intraoperative allogeneic RBC transfusion but failed to decrease total perioperative allogeneic RBC transfusion. Moreover, the use of the cell saver was not cost- effective.	[Miao, Yu-Liang; Shi, Wen-Zhu; Mi, Wei-Dong] Chinese Peoples Liberat Army Gen Hosp, Anesthesia & Operat Ctr, Beijing, Peoples R China; [Miao, Yu-Liang; Liu, Yan; Fang, Wei-Wu] Chinese PLA, Hosp 360, Dept Anesthesiol, Beijing, Peoples R China; [Ma, Hua-Song; Wu, Ji-Gong; Wang, Xiao-Ping] Chinese PLA, Hosp 360, Dept Orthopaed & Spine Surg, Beijing, Peoples R China; [Guo, Wen-Zhi] Beijing Mil Gen Hosp, PLA, Dept Anesthesiol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Mi, WD (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Anesthesia & Operat Ctr, Beijing, Peoples R China.	elite2005gg@163.com; ranger1999@163.com						Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; Bowen RE, 2010, SPINE, V35, P246, DOI 10.1097/BRS.0b013e3181bdf22a; Canan CE, 2013, SPINE, V38, P703, DOI 10.1097/BRS.0b013e3182767c8c; Carless PA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001888.pub4; Chanda A, 2002, J NEUROSURG, V96, P298, DOI 10.3171/spi.2002.96.3.0298; Elgafy H, 2010, SPINE, V35, pS47, DOI 10.1097/BRS.0b013e3181d833f6; Ersen Omer, 2012, Musculoskelet Surg, V96, P107, DOI 10.1007/s12306-012-0203-6; Gause PR, 2008, SPINE, V33, P571, DOI 10.1097/BRS.0b013e3181657cc1; Guo S. Y., 2009, PROPENSITY SCORE ANA; Hill GE, 2003, J TRAUMA, V54, P908, DOI 10.1097/01.TA.0000022460.21283.53; Joseph SA, 2008, SPINE, V33, P2310, DOI 10.1097/BRS.0b013e31818047f2; Lavoie J, 2011, PEDIATR ANESTH, V21, P14, DOI 10.1111/j.1460-9592.2010.03470.x; Owens RK, 2013, SPINE, V38, pE217, DOI 10.1097/BRS.0b013e31827f044e; Reitman CA, 2004, SPINE, V29, P1580, DOI 10.1097/01.BRS.0000131433.05946.4F; Savvidou C, 2009, TRANSFUSION MED, V19, P202, DOI 10.1111/j.1365-3148.2009.00929.x; Shander A, 2010, TRANSFUSION, V50, P753, DOI 10.1111/j.1537-2995.2009.02518.x; Thompson ME, 2013, SPINE, V18; Weiss JM, 2007, J CHILD ORTHOP, V1, P221, DOI 10.1007/s11832-007-0032-6; [杨宁 Yang Ning], 2013, [中国组织工程研究, Chinese Journal of Tissue Engineering Research], V17, P4161; Yu XR, 2013, SPINE, V38, P350, DOI 10.1097/BRS.0b013e31826c63cb	20	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92997	10.1371/journal.pone.0092997	http://dx.doi.org/10.1371/journal.pone.0092997			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691056	Green Published, gold, Green Submitted			2022-12-25	WOS:000334101100038
J	Salinas, M; Besson, T; Delettre, Q; Diochot, S; Boulakirba, S; Douguet, D; Lingueglia, E				Salinas, Miguel; Besson, Thomas; Delettre, Quentin; Diochot, Sylvie; Boulakirba, Sonia; Douguet, Dominique; Lingueglia, Eric			Binding Site and Inhibitory Mechanism of the Mambalgin-2 Pain-relieving Peptide on Acid-sensing Ion Channel 1a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acid-sensing Ion Channels (ASIC); Pain; Pharmacology; Sodium Channels; Toxins	TARANTULA TOXIN PSALMOTOXIN-1; INFLAMMATORY PAIN; ASIC1A; TARGET; SELECTIVITY; NEURONS; COMPLEX; SENSOR; STATE; ZDOCK	Background: Mambalgin-2 is a snake venom peptide that blocks acid-sensing ion channels (ASICs) to relieve pain. Results: Mambalgin-2 interacts with at least three different regions of ASICs and exerts both stimulatory and inhibitory effects. Conclusion: Binding of mambalgin-2 into the pH sensor traps the channels in the closed conformation. Significance: This might allow development of optimized blockers of ASICs of therapeutic value. Acid-sensing ion channels (ASICs) are neuronal proton-gated cation channels associated with nociception, fear, depression, seizure, and neuronal degeneration, suggesting roles in pain and neurological and psychiatric disorders. We have recently discovered black mamba venom peptides called mambalgin-1 and mambalgin-2, which are new three-finger toxins that specifically inhibit with the same pharmacological profile ASIC channels to exert strong analgesic effects in vivo. We now combined bioinformatics and functional approaches to uncover the molecular mechanism of channel inhibition by the mambalgin-2 pain-relieving peptide. Mambalgin-2 binds mainly in a region of ASIC1a involving the upper part of the thumb domain (residues Asp-349 and Phe-350), the palm domain of an adjacent subunit, and the -ball domain (residues Arg-190, Asp-258, and Gln-259). This region overlaps with the acidic pocket (pH sensor) of the channel. The peptide exerts both stimulatory and inhibitory effects on ASIC1a, and we propose a model where mambalgin-2 traps the channel in a closed conformation by precluding the conformational change of the palm and -ball domains that follows proton activation. These data help to understand inhibition by mambalgins and provide clues for the development of new optimized blockers of ASIC channels.	[Salinas, Miguel; Besson, Thomas; Delettre, Quentin; Diochot, Sylvie; Boulakirba, Sonia; Douguet, Dominique; Lingueglia, Eric] CNRS, Inst Pharmacol Mol & Cellulaire, UMR 7275, F-06560 Valbonne, France; [Salinas, Miguel; Besson, Thomas; Delettre, Quentin; Diochot, Sylvie; Boulakirba, Sonia; Douguet, Dominique; Lingueglia, Eric] Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; [Salinas, Miguel; Besson, Thomas; Diochot, Sylvie; Lingueglia, Eric] CNRS, Inst Pharmacol Mol & Cellulaire, LabEx Ion Channel Sci & Therapeut, F-06560 Valbonne, France; [Salinas, Miguel; Besson, Thomas; Diochot, Sylvie; Lingueglia, Eric] Univ Nice Sophia Antipolis, F-06560 Valbonne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Lingueglia, E (corresponding author), CNRS UNS, Inst Pharmacol Mol & Cellulaire, UMR7275, 660 Route Lucioles, F-06560 Valbonne, France.	lingueglia@ipmc.cnrs.fr	LINGUEGLIA, Eric/F-5509-2013; Diochot, Sylvie/ABG-5495-2020; SALINAS, Miguel/N-6380-2016; douguet, dominique/D-5644-2017	LINGUEGLIA, Eric/0000-0003-3902-3405; SALINAS, Miguel/0000-0002-7445-123X; boulakirba, sonia/0000-0001-7089-0860	Fondation pour la Recherche Medicale; Agence Nationale de la Recherche [ANR-13-BSV4-0009]; Association Francaise contre les Myopathies	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	This work was supported by the Fondation pour la Recherche Medicale, Agence Nationale de la Recherche Grant ANR-13-BSV4-0009, and the Association Francaise contre les Myopathies.	Baconguis I, 2014, CELL, V156, P717, DOI 10.1016/j.cell.2014.01.011; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Bargeton B, 2010, J BIOL CHEM, V285, P13816, DOI 10.1074/jbc.M109.086843; Baron A, 2013, TOXICON, V75, P187, DOI 10.1016/j.toxicon.2013.04.008; Blanchard MG, 2012, BRIT J PHARMACOL, V165, P2167, DOI 10.1111/j.1476-5381.2011.01674.x; Bohlen CJ, 2011, NATURE, V479, P410, DOI 10.1038/nature10607; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chen R, 2003, PROTEINS, V52, P68, DOI 10.1002/prot.10388; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen XM, 2006, J GEN PHYSIOL, V127, P267, DOI 10.1085/jgp.200509409; Chen XM, 2005, J GEN PHYSIOL, V126, P71, DOI 10.1085/jgp.200509303; Chen XM, 2010, NEUROPHARMACOLOGY, V58, P1045, DOI 10.1016/j.neuropharm.2010.01.011; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Deval E, 2011, J NEUROSCI, V31, P6059, DOI 10.1523/JNEUROSCI.5266-10.2011; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; Diochot S, 2004, EMBO J, V23, P1516, DOI 10.1038/sj.emboj.7600177; Diochot S, 2012, NATURE, V490, P552, DOI 10.1038/nature11494; Duan B, 2007, J NEUROSCI, V27, P11139, DOI 10.1523/JNEUROSCI.3364-07.2007; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Karczewski J, 2010, BRIT J PHARMACOL, V161, P950, DOI 10.1111/j.1476-5381.2010.00918.x; Liechti LA, 2010, J BIOL CHEM, V285, P16315, DOI 10.1074/jbc.M109.092015; Mazzuca M, 2007, NAT NEUROSCI, V10, P943, DOI 10.1038/nn1940; Noel Jacques, 2010, Expert Rev Clin Pharmacol, V3, P331, DOI 10.1586/ecp.10.13; Peigneur S, 2012, FASEB J, V26, P5141, DOI 10.1096/fj.12-218479; Salinas M, 2006, J PHYSIOL-LONDON, V570, P339, DOI 10.1113/jphysiol.2005.095810; Samways DSK, 2009, CELL CALCIUM, V45, P319, DOI 10.1016/j.ceca.2008.12.002; Schroeder CI, 2014, ANGEW CHEM INT EDIT, V53, P1017, DOI 10.1002/anie.201308898; Sherwood TW, 2011, J NEUROSCI, V31, P9723, DOI 10.1523/JNEUROSCI.1665-11.2011; Sluka KA, 2009, CURR OPIN DRUG DISC, V12, P693; Smoller JW, 2014, BIOL PSYCHIAT, V76, P902, DOI 10.1016/j.biopsych.2013.12.018; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; Wemmie JA, 2013, NAT REV NEUROSCI, V14, P461, DOI 10.1038/nrn3529; Woolf CJ, 2013, LANCET NEUROL, V12, P18, DOI 10.1016/S1474-4422(12)70287-9; Yang HY, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000151	40	44	45	1	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13363	13373		10.1074/jbc.M114.561076	http://dx.doi.org/10.1074/jbc.M114.561076			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24695733	Green Published, hybrid			2022-12-25	WOS:000335522800035
J	Tonin, Y; Heckel, AM; Vysokikh, M; Dovydenko, I; Meschaninova, M; Rotig, A; Munnich, A; Venyaminova, A; Tarassov, I; Entelis, N				Tonin, Yann; Heckel, Anne-Marie; Vysokikh, Mikhail; Dovydenko, Ilya; Meschaninova, Mariya; Roetig, Agnes; Munnich, Arnold; Venyaminova, Alya; Tarassov, Ivan; Entelis, Nina			Modeling of Antigenomic Therapy of Mitochondrial Diseases by Mitochondrially Addressed RNA Targeting a Pathogenic Point Mutation in Mitochondrial DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fibroblast; Mitochondrial Diseases; Mitochondrial DNA; Mitochondrial Transport; Respiratory Chain; RNA Transport; Heteroplasmy; RNA-based Therapeutics; Cybrid Cells	RESPIRATORY COMPLEX I; 5S RIBOSOMAL-RNA; RESTRICTION-ENDONUCLEASE; COLOCALIZATION ANALYSIS; MTDNA HETEROPLASMY; FREQUENT CAUSE; ND5 SUBUNIT; DEFICIENCY; IMPORT; CELLS	Background: Point mutations in mitochondrial genome cause severe clinical disorders. Results: We designed recombinant RNA molecules imported into mitochondria of human cells, which are able to decrease the proportion of mitochondrial DNA molecules bearing a pathogenic point mutation. Conclusion: Imported recombinant RNAs can function as anti-replicative agents in human mitochondria. Significance: This is a new approach for therapy of mitochondrial diseases. Defects in mitochondrial genome can cause a wide range of clinical disorders, mainly neuromuscular diseases. Presently, no efficient therapeutic treatment has been developed against this class of pathologies. Because most of deleterious mitochondrial mutations are heteroplasmic, meaning that wild type and mutated forms of mitochondrial DNA (mtDNA) coexist in the same cell, the shift in proportion between mutant and wild type molecules could restore mitochondrial functions. Recently, we developed mitochondrial RNA vectors that can be used to address anti-replicative oligoribonucleotides into human mitochondria and thus impact heteroplasmy level in cells bearing a large deletion in mtDNA. Here, we show that this strategy can be also applied to point mutations in mtDNA. We demonstrate that specifically designed RNA molecules containing structural determinants for mitochondrial import and 20-nucleotide sequence corresponding to the mutated region of mtDNA, are able to anneal selectively to the mutated mitochondrial genomes. After being imported into mitochondria of living human cells in culture, these RNA induced a decrease of the proportion of mtDNA molecules bearing a pathogenic point mutation in the mtDNA ND5 gene.	[Tonin, Yann; Heckel, Anne-Marie; Vysokikh, Mikhail; Dovydenko, Ilya; Tarassov, Ivan; Entelis, Nina] Strasbourg Univ, CNRS, UMR Genet Mol Genom Microbiol 7156, F-67084 Strasbourg, France; [Dovydenko, Ilya; Meschaninova, Mariya; Venyaminova, Alya] Inst Chem Biol & Fundamental Med SB RAS, Lab RNA Chem, Novosibirsk 630090, Russia; [Roetig, Agnes; Munnich, Arnold] Univ Paris 05, Sorbonne Paris Cite, Hop Necker Enfants Malad, INSERM,U781, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Entelis, N (corresponding author), Univ Strasbourg, CNRS, UMR 7156, 21 Rue Rene Descartes, F-67084 Strasbourg, France.	n.entelis@unistra.fr	Rötig, Agnès/G-9592-2017; Vyssokikh, Mikhail/H-4744-2014; Meschaninova, Mariya I/G-3496-2013	Rötig, Agnès/0000-0003-0589-0703; Vyssokikh, Mikhail/0000-0002-4047-6201; Meschaninova, Mariya I/0000-0003-0045-2413; Dovydenko, Ilya/0000-0002-6890-4538; Entelis, Nina/0000-0002-7915-5528; Tarassov, Ivan/0000-0001-8763-6703	CNRS; University of Strasbourg; Association Francaise contre les Myopathies; Agence Nationale de la Recherche [ANR-06-MRAR-37-01, BLAN08-2-309449]; Fondation pour la Recherche Medicale [DEQ20081214003]; ARCUS/Suprachem Collaboration Program; LIA Collaboration Program (ARNmitocure); French National Research Agency; Fondation pour la Recherche Medicale	CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Strasbourg; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); ARCUS/Suprachem Collaboration Program; LIA Collaboration Program (ARNmitocure); French National Research Agency(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	The work was supported by CNRS, the University of Strasbourg, Association Francaise contre les Myopathies, Agence Nationale de la Recherche (ANR-06-MRAR-37-01; BLAN08-2-309449), Fondation pour la Recherche Medicale (DEQ20081214003), ARCUS/Suprachem Collaboration Program and LIA Collaboration Program (ARNmitocure). This work has also been published under the framework of the LABEX ANR-11-LABX-0057_MITOCROSS and is supported by the state managed by the French National Research Agency as part of the Investment for the Future program.; Supported by Fondation pour la Recherche Medicale and Association Francaise contre les Myopathies Ph.D. fellowships.	Bacman SR, 2007, GENE THER, V14, P1309, DOI 10.1038/sj.gt.3302981; Bacman SR, 2010, GENE THER, V17, P713, DOI 10.1038/gt.2010.25; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102; Bellon L, 2001, CURRENT PROTOCOLS NU, V1:3.6.1-3.6.13; Blok MJ, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.045716; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200; Brautbar A, 2008, MOL GENET METAB, V94, P485, DOI 10.1016/j.ymgme.2008.04.004; Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006; Burnett JC, 2012, CHEM BIOL, V19, P60, DOI 10.1016/j.chembiol.2011.12.008; Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188; Comte C, 2013, NUCLEIC ACIDS RES, V41, P418, DOI 10.1093/nar/gks965; Corona P, 2001, ANN NEUROL, V49, P106, DOI 10.1002/1531-8249(200101)49:1<106::AID-ANA16>3.0.CO;2-T; Davidson Sean M, 2007, Methods Mol Biol, V372, P421, DOI 10.1007/978-1-59745-365-3_30; Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602; Efremov RG, 2012, BBA-BIOENERGETICS, V1817, P1785, DOI 10.1016/j.bbabio.2012.02.015; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Gowher A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066228; Karicheva OZ, 2011, NUCLEIC ACIDS RES, V39, P8173, DOI 10.1093/nar/gkr546; Kohrer C, 2001, P NATL ACAD SCI USA, V98, P14310, DOI 10.1073/pnas.251438898; Kolesnikova OA, 2004, HUM MOL GENET, V13, P2519, DOI 10.1093/hmg/ddh267; Kolesnikova O, 2010, RNA, V16, P926, DOI 10.1261/rna.1914110; Mager-Heckel Anne-Marie, 2007, Methods Mol Biol, V372, P235, DOI 10.1007/978-1-59745-365-3_17; Manfredi G, 2002, NAT GENET, V30, P394, DOI 10.1038/ng851; Muratovska A, 2001, NUCLEIC ACIDS RES, V29, P1852, DOI 10.1093/nar/29.9.1852; Ohnishi T, 2012, BBA-BIOENERGETICS, V1817, P1803, DOI 10.1016/j.bbabio.2012.03.032; Perales-Clemente E, 2011, NUCLEIC ACIDS RES, V39, P225, DOI 10.1093/nar/gkq769; Presley AD, 2003, J CHROMATOGR B, V793, P141, DOI 10.1016/S1570-0232(03)00371-4; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Rustin P, 2007, M S-MED SCI, V23, P519, DOI 10.1051/medsci/2007235519; Schneider A, 2011, ANNU REV BIOCHEM, V80, P1033, DOI 10.1146/annurev-biochem-060109-092838; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Smirnov AV, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1418, DOI 10.1134/S000629790813004X; Smirnov A, 2008, RNA, V14, P749, DOI 10.1261/rna.952208; Sudo A, 2004, J HUM GENET, V49, P92, DOI 10.1007/s10038-003-0116-1; Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Taylor RW, 1997, NAT GENET, V15, P212, DOI 10.1038/ng0297-212; Tonin Y, 2014, BIOCHIMIE, V100, P192, DOI 10.1016/j.biochi.2013.08.020; Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002; Zinchuk V, 2009, PROG HISTOCHEM CYTO, V44, P125, DOI 10.1016/j.proghi.2009.03.001; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	44	30	32	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13323	13334		10.1074/jbc.M113.528968	http://dx.doi.org/10.1074/jbc.M113.528968			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24692550	Green Published, hybrid			2022-12-25	WOS:000335522800031
J	Hung, CY; Sun, PL; Chiang, SJ; Jaw, FS				Hung, Chien-Ya; Sun, Pei-Lun; Chiang, Shu-Jen; Jaw, Fu-Shan			In Vitro Differential Diagnosis of Clavus and Verruca by a Predictive Model Generated from Electrical Impedance	PLOS ONE			English	Article							BASAL-CELL CARCINOMA; STRATUM-CORNEUM; SKIN IMPEDANCE; CANCER; TISSUES; LESIONS; TOOL	Background: Similar clinical appearances prevent accurate diagnosis of two common skin diseases, clavus and verruca. In this study, electrical impedance is employed as a novel tool to generate a predictive model for differentiating these two diseases. Materials and Methods: We used 29 clavus and 28 verruca lesions. To obtain impedance parameters, a LCR-meter system was applied to measure capacitance (C), resistance (Re), impedance magnitude (Z), and phase angle (h). These values were combined with lesion thickness (d) to characterize the tissue specimens. The results from clavus and verruca were then fitted to a univariate logistic regression model with the generalized estimating equations (GEE) method. In model generation, log Z(SD) and theta(SD) were formulated as predictors by fitting a multiple logistic regression model with the same GEE method. The potential nonlinear effects of covariates were detected by fitting generalized additive models (GAM). Moreover, the model was validated by the goodness-of-fit (GOF) assessments. Results: Significant mean differences of the index d, Re, Z, and h are found between clavus and verruca (p<0.001). A final predictive model is established with Z and h indices. The model fits the observed data quite well. In GOF evaluation, the area under the receiver operating characteristics (ROC) curve is 0.875 (>0.7), the adjusted generalized R-2 is 0.512 (>0.3), and the p value of the Hosmer-Lemeshow GOF test is 0.350 (>0.05). Conclusions: This technique promises to provide an approved model for differential diagnosis of clavus and verruca. It could provide a rapid, relatively low-cost, safe and non-invasive screening tool in clinic use.	[Hung, Chien-Ya; Jaw, Fu-Shan] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan; [Sun, Pei-Lun] Mackay Mem Hosp, Dept Dermatol, Taipei, Taiwan; [Chiang, Shu-Jen] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan	National Taiwan University; Mackay Memorial Hospital; Academia Sinica - Taiwan; National Taiwan University	Jaw, FS (corresponding author), Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan.	jaw@ntu.edu.tw			National Science Council, Taiwan [NSC 100-2923-E-002-007-MY3, NSC 101-2221-E-002-016]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the National Science Council (NSC 100-2923-E-002-007-MY3, and NSC 101-2221-E-002-016), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg P, 2003, SKIN RES TECHNOL, V9, P257, DOI 10.1034/j.1600-0846.2003.00017.x; Aberg P, 2004, IEEE T BIO-MED ENG, V51, P2097, DOI 10.1109/TBME.2004.836523; Beetner DG, 2003, IEEE T BIO-MED ENG, V50, P1020, DOI 10.1109/TBME.2003.814534; Birgersson U, 2011, PHYSIOL MEAS, V32, P1, DOI 10.1088/0967-3334/32/1/001; Curdy C, 2004, INT J PHARMACEUT, V271, P251, DOI 10.1016/j.ijpharm.2003.11.016; DeLauro TM, 2012, FITZPATRICKS DERMATO, P1111; Dua R, 2004, IEEE T BIO-MED ENG, V51, P66, DOI 10.1109/TBME.2003.820387; Emtestam L, 1998, DERMATOLOGY, V197, P313, DOI 10.1159/000018023; Faes TJC, 1999, PHYSIOL MEAS, V20, pR1, DOI 10.1088/0967-3334/20/4/201; Glickman YA, 2003, SKIN RES TECHNOL, V9, P262, DOI 10.1034/j.1600-0846.2003.00022.x; Goldsmith L, 2012, FITZPATRICKS DERMATO, V8th, P2421; GRIMNES S, 1983, MED BIOL ENG COMPUT, V21, P739, DOI 10.1007/BF02464037; Gupta D, 2004, AM J CLIN NUTR, V80, P1634, DOI 10.1093/ajcn/80.6.1634; Johnsen Gorm Krogh, 2009, Open Biomed Eng J, V3, P8, DOI 10.2174/1874120700903010008; Kuzmina N, 2005, SKIN RES TECHNOL, V11, P196, DOI 10.1111/j.1600-0846.2005.00120.x; Lindholm-Sethson B, 1998, CHEMOMETR INTELL LAB, V44, P381, DOI 10.1016/S0169-7439(98)00164-6; Martinsen OG, 1997, MED BIOL ENG COMPUT, V35, P172, DOI 10.1007/BF02530033; Martinsen OG, 2001, DERMATOLOGY, V202, P87, DOI 10.1159/000051604; Miklavcic D, 2006, WILEY ENCY BIOMEDICA, P1; MIZE MM, 1989, ARCH DERMATOL, V125, P647, DOI 10.1001/archderm.125.5.647; Nicander I, 1997, Skin Res Technol, V3, P252, DOI 10.1111/j.1600-0846.1997.tb00194.x; Nicander I, 1996, BRIT J DERMATOL, V134, P221; Nicander I, 1998, Skin Res Technol, V4, P213, DOI 10.1111/j.1600-0846.1998.tb00113.x; Nyren M, 2003, J AM ACAD DERMATOL, V48, P394, DOI 10.1067/mjd.2003.96; OLLMAR S, 1994, BRIT J DERMATOL, V130, P29, DOI 10.1111/j.1365-2133.1994.tb06878.x; OTT M, 1995, J ACQ IMMUN DEF SYND, V9, P20; Team RDC, 2010, R LANG ENV STAT COMP; Wirth R, 2010, ARCH GERONTOL GERIAT, V51, P290, DOI 10.1016/j.archger.2009.12.002; YAMAMOTO T, 1976, MED BIOL ENG, V14, P151, DOI 10.1007/BF02478741	29	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93647	10.1371/journal.pone.0093647	http://dx.doi.org/10.1371/journal.pone.0093647			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705282	Green Published, Green Submitted, gold			2022-12-25	WOS:000334107500052
J	Ma, CY; Li, Y; Zeng, J; Wu, XL; Liu, XM; Wang, YJ				Ma, Chunyan; Li, Yong; Zeng, Jin; Wu, Xiaoling; Liu, Xiaoming; Wang, Yujiong			Mycobacterium bovis BCG Triggered MyD88 Induces miR-124 Feedback Negatively Regulates Immune Response in Alveolar Epithelial Cells	PLOS ONE			English	Article							MICRORNAS; TUBERCULOSIS; MACROPHAGES; QUANTIFICATION; PROLIFERATION; TRANSITION; SUPPRESSOR; INDUCTION; PATHWAYS; ALPHA	The emerging roles of microRNAs (miRNAs) and pulmonary epithelial cells in regulating the immune response against microbial invasion has attracted increasing attention in recent years, however, the immunoregulatory roles of miRNAs in the pulmonary epithelial cells in response to mycobacterial infection has not been fully demonstrated. In this study, we show that miR-124 expression is induced upon Mycobacterium bovis Bacillus Calmette-Guerin (BCG) infection in A549 alveolar epithelial cells and murine lungs. miR-124 is able to modulate Toll-like receptor (TLR) signaling in A459 cells. In this regard, multiple components, including TLR6, myeloid differentiation factor 88 (MyD88), TNFR-associated factor 6 and tumor necrosis factor-a of the TLR signaling cascade are directly regulated by miR-124 in response to BCG stimulation. In addition, miR-124 expression was induced upon MyD88 overexpression and/or BCG stimulation, while silencing MyD88 expression by small interfering RNA dramatically down-regulated miR-124 transcription in A549 cells. These results indicate an underlying negative feedback mechanism between miR-124 and MyD88 in alveolar epithelial cells to prevent an excessive inflammatory response during mycobacterial infection. These observations suggest that miR-124 is a potential target for preventive and therapeutic intervention against the pulmonary tuberculosis, an infectious disease caused by Mycobacterium tuberculosis infection.	[Ma, Chunyan; Li, Yong; Zeng, Jin; Wu, Xiaoling; Liu, Xiaoming; Wang, Yujiong] Minist Educ Conservat & Utilizat Special Biol Res, Key Lab, Ningxia, Peoples R China; [Ma, Chunyan; Li, Yong; Zeng, Jin; Wu, Xiaoling; Liu, Xiaoming; Wang, Yujiong] Ningxia Univ, Coll Life Sci, Ningxia, Peoples R China	Ningxia University	Liu, XM (corresponding author), Minist Educ Conservat & Utilizat Special Biol Res, Key Lab, Ningxia, Peoples R China.	lxm1966@nxu.edu.cn; wyj@nxu.edu.cn		LIU, XIAOMING/0000-0002-3902-9105	National Key Basic Research Program of China [2012CB126301, 2012CB518801]; National Natural Science Foundation of China [31172278, 31160515, 31260615, 31060335]; National program for scientific and technological support of China [2012BAD12B07-4]; Doctoral fund of Ministry of Education of China [20126401110001]; Natural Science Foundation of Ningxia Hui Autonomous Region of China [NZ1042]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National program for scientific and technological support of China; Doctoral fund of Ministry of Education of China(Ministry of Education, China); Natural Science Foundation of Ningxia Hui Autonomous Region of China	This work was supported by grants (Nos. 2012CB126301 and 2012CB518801) from National Key Basic Research Program of China, grants (Nos. 31172278, 31160515, 31260615 and 31060335) from National Natural Science Foundation of China, a grant from National program for scientific and technological support of China (No. 2012BAD12B07-4), a grant from Doctoral fund of Ministry of Education of China (No. 20126401110001) and a grant from Natural Science Foundation of Ningxia Hui Autonomous Region of China (Grant No: NZ1042). The funders had no role in study design, data collection and analysis, decision for publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bermudez LE, 1996, INFECT IMMUN, V64, P1400, DOI 10.1128/IAI.64.4.1400-1406.1996; Chen JF, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-694; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Chuquimia OD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032125; Diamond G, 2000, IMMUNOL REV, V173, P27, DOI 10.1034/j.1600-065X.2000.917304.x; Gereke M, 2009, AM J RESP CRIT CARE, V179, P344, DOI 10.1164/rccm.200804-592OC; Gottipati S, 2008, CELL SIGNAL, V20, P269, DOI 10.1016/j.cellsig.2007.08.009; Guilliams M, 2013, MUCOSAL IMMUNOL, V6, P464, DOI 10.1038/mi.2013.14; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kaufmann SHE, 2005, J EXP MED, V201, P1693, DOI 10.1084/jem.20050842; Koch M, 2012, P NATL ACAD SCI USA, V109, pE1153, DOI 10.1073/pnas.1116125109; Koukos G, 2013, GASTROENTEROLOGY, V145, P842, DOI 10.1053/j.gastro.2013.07.001; Lee MR, 2010, STEM CELLS, V28, P1550, DOI 10.1002/stem.490; Lewin A, 2003, J VET MED B, V50, P505, DOI 10.1046/j.1439-0450.2003.00715.x; Li T, 2010, NAT IMMUNOL, V11, P799, DOI 10.1038/ni.1918; Li Y, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/791392; Liang YJ, 2013, CARCINOGENESIS, V34, P713, DOI 10.1093/carcin/bgs383; Lin YG, 1998, INFECT IMMUN, V66, P1121, DOI 10.1128/IAI.66.3.1121-1126.1998; Liu KJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/867537; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; Mayer AK, 2007, ARCH IMMUNOL THER EX, V55, P353, DOI 10.1007/s00005-007-0041-7; McCoy CE, 2011, FRONT BIOSCI-LANDMRK, V16, P2161, DOI 10.2741/3845; MCDONOUGH KA, 1995, INFECT IMMUN, V63, P4802, DOI 10.1128/IAI.63.12.4802-4811.1995; Mendez-Samperio P, 2008, CELL IMMUNOL, V251, P37, DOI 10.1016/j.cellimm.2008.03.002; Mendez-Samperio P, 2008, ARCH MED RES, V39, P33, DOI 10.1016/j.arcmed.2007.06.019; Nahid MA, 2011, J IMMUNOL, V186, P1723, DOI 10.4049/jimmunol.1002311; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poirier V, 2012, MICROBES INFECT, V14, P1211, DOI 10.1016/j.micinf.2012.07.001; Quesniaux V, 2004, MICROBES INFECT, V6, P946, DOI 10.1016/j.micinf.2004.04.016; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tang B, 2010, FEBS LETT, V584, P1481, DOI 10.1016/j.febslet.2010.02.063; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Wang P, 2010, J IMMUNOL, V185, P6226, DOI 10.4049/jimmunol.1000491; Wei J, 2013, CANCER RES, V73, P3913, DOI 10.1158/0008-5472.CAN-12-4318; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Xia HP, 2012, J BIOL CHEM, V287, P9962, DOI 10.1074/jbc.M111.332627; Zheng F, 2012, GUT, V61, P278, DOI 10.1136/gut.2011.239145; ZHU SY, 2013, HYPERFINE INTERACT, V220, P1, DOI DOI 10.1007/s10751-012-0749-6	45	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e92419	10.1371/journal.pone.0092419	http://dx.doi.org/10.1371/journal.pone.0092419			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705038	gold, Green Published, Green Submitted			2022-12-25	WOS:000334107500017
J	Rutar, M; Valter, K; Natoli, R; Provis, JM				Rutar, Matt; Valter, Krisztina; Natoli, Riccardo; Provis, Jan M.			Synthesis and Propagation of Complement C3 by Microglia/Monocytes in the Aging Retina	PLOS ONE			English	Article							SENILE MACULAR DEGENERATION; FACTOR-H POLYMORPHISM; PARA-INFLAMMATION; GENE-EXPRESSION; IMMUNE; CELLS; DEFICIENCY; RISK; MICROGLIA; RECRUITMENT	Introduction: Complement activation is thought to contribute to the pathogenesis of age-related macular degeneration (AMD), which may be mediated in part by para-inflammatory processes. We aimed to investigate the expression and localization of C3, a crucial component of the complement system, in the retina during the course of aging. Methods: SD rats were born and reared in low-light conditions, and euthanized at post-natal (P) days 100, 450, or 750. Expression of C3, IBA1, and Ccl- and Cxcl- chemokines was assessed by qPCR, and in situ hybridization. Thickness of the ONL was assessed in retinal sections as a measure of photoreceptor loss, and counts were made of C3-expressing monocytes. Results: C3 expression increased significantly at P750, and correlated with thinning of the ONL, at P750, and up-regulation of GFAP. In situ hybridization showed that C3 was expressed by microglia/monocytes, mainly from within the retinal vasculature, and occasionally the ONL. The number of C3-expressing microglia increased significantly by P750, and coincided spatiotemporally with thinning of the ONL, and up-regulation of Ccl- and Cxcl- chemokines. Conclusions: Our data suggest that recruited microglia/monocytes contribute to activation of complement in the aging retina, through local expression of C3 mRNA. C3 expression coincides with age-related thinning of the ONL at P750, although it is unclear whether the C3-expressing monocytes are a cause or consequence. These findings provide evidence of activation of complement during natural aging, and may have relevance to cellular events underling the pathogenesis of age-related retinal diseases.	[Rutar, Matt; Valter, Krisztina; Natoli, Riccardo; Provis, Jan M.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Valter, Krisztina; Natoli, Riccardo; Provis, Jan M.] Australian Natl Univ, Sch Med, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research; Australian National University	Rutar, M (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia.	matt.rutar@anu.edu.au	Valter, Krisztina/L-3015-2016; Provis, Jan/C-9529-2009	Natoli, Riccardo/0000-0002-9350-0439; Valter, Krisztina/0000-0002-2033-0408; Provis, Jan/0000-0002-6405-2868; Rutar, Matthew/0000-0002-8893-5120	Australian Research Council Centres of Excellence Program Grant [CE0561903]	Australian Research Council Centres of Excellence Program Grant(Australian Research Council)	Funding provided by Australian Research Council Centres of Excellence Program Grant (CE0561903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Ambati J, 2011, INVEST OPHTH VIS SCI, V52, P2166, DOI 10.1167/iovs.11-7328; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Bonnel S, 2003, EXP GERONTOL, V38, P825, DOI 10.1016/S0531-5565(03)00093-7; Botto M, 1998, EXP CLIN IMMUNOGENET, V15, P231, DOI 10.1159/000019076; Brennan FH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-137; Cashman SM, 2011, INVEST OPHTH VIS SCI, V52, P3436, DOI 10.1167/iovs.10-6002; Chen M, 2007, EXP EYE RES, V84, P635, DOI 10.1016/j.exer.2006.11.015; Chen M, 2012, GLIA, V60, P833, DOI 10.1002/glia.22315; Chen M, 2010, INVEST OPHTH VIS SCI, V51, P5888, DOI 10.1167/iovs.09-5103; Cherepanoff S, 2010, BRIT J OPHTHALMOL, V94, P918, DOI 10.1136/bjo.2009.165563; Coffey PJ, 2007, P NATL ACAD SCI USA, V104, P16651, DOI 10.1073/pnas.0705079104; Cornish EE, 2005, VISUAL NEUROSCI, V22, P447, DOI 10.1017/S0952523805224069; DAVIES KA, 1994, SPRINGER SEMIN IMMUN, V15, P397, DOI 10.1007/BF01837367; Despriet DDG, 2009, OPHTHALMOLOGY, V116, P474, DOI 10.1016/j.ophtha.2008.09.055; DIAZARAYA CM, 1995, J COMP NEUROL, V363, P53, DOI 10.1002/cne.903630106; Donoso LA, 2006, SURV OPHTHALMOL, V51, P137, DOI 10.1016/j.survophthal.2005.12.001; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Espinosa-Heidmann DG, 2003, INVEST OPHTH VIS SCI, V44, P3586, DOI 10.1167/iovs.03-0038; Ezzat MK, 2008, BRIT J OPHTHALMOL, V92, P976, DOI 10.1136/bjo.2007.129742; GAO H, 1992, INVEST OPHTH VIS SCI, V33, P1; GARTNER S, 1981, BRIT J OPHTHALMOL, V65, P23, DOI 10.1136/bjo.65.1.23; Gasque P, 2004, MOL IMMUNOL, V41, P1089, DOI 10.1016/j.molimm.2004.06.011; Gasque P, 2000, IMMUNOPHARMACOLOGY, V49, P171, DOI 10.1016/S0162-3109(00)80302-1; Gullstrand B, 2009, CLIN EXP IMMUNOL, V156, P303, DOI 10.1111/j.1365-2249.2009.03896.x; Gupta N, 2003, EXP EYE RES, V76, P463, DOI 10.1016/S0014-4835(02)00332-9; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Hollyfield JG, 2010, INVEST OPHTH VIS SCI, V51, P1276, DOI 10.1167/iovs.09-4478; Jakobsdottir J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002199; Joly S, 2009, AM J PATHOL, V174, P2310, DOI 10.2353/ajpath.2009.090023; Kaneko H, 2008, INVEST OPHTH VIS SCI, V49, P4162, DOI 10.1167/iovs.08-1738; Karagianni N, 2010, ADV EXP MED BIOL, V703, P1, DOI 10.1007/978-1-4419-5635-4_1; Kennedy CJ, 1995, EYE, V9, P763, DOI 10.1038/eye.1995.192; Klein R, 2005, MACULAR DEGENERATION, P79; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Korb LC, 1997, J IMMUNOL, V158, P4525; Lau LI, 2011, INVEST OPHTH VIS SCI, V52, P6832, DOI 10.1167/iovs.11-7815; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; Ma W, 2012, NEUROBIOL AGING; Ma WX, 2013, NEUROBIOL AGING, V34, P2310, DOI 10.1016/j.neurobiolaging.2013.03.022; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Natoli R, 2008, MOL VIS, V14, P1983; Navratil JS, 1999, IMMUNOPHARMACOLOGY, V42, P47, DOI 10.1016/S0162-3109(99)00018-1; Newman AM, 2012, GENOME MED, V4, DOI [10.1186/gm315, 10.1186/PREACCEPT-1418491035586234]; Paidassi H, 2008, J IMMUNOL, V180, P2329, DOI 10.4049/jimmunol.180.4.2329; Park KH, 2009, INVEST OPHTH VIS SCI, V50, P3386, DOI 10.1167/iovs.08-3231; Patel M, 2008, SEMIN IMMUNOPATHOL, V30, P97, DOI 10.1007/s00281-008-0112-9; PENFOLD P, 1984, AUST J OPHTHALMOL, V12, P23; PENFOLD PL, 1987, GRAEF ARCH CLIN EXP, V225, P70, DOI 10.1007/BF02155808; PENFOLD PL, 1986, INVEST OPHTH VIS SCI, V27, P364; PENFOLD PL, 1985, GRAEF ARCH CLIN EXP, V223, P69, DOI 10.1007/BF02150948; Penfold PL, 2001, PROG RETIN EYE RES, V20, P385, DOI 10.1016/S1350-9462(00)00025-2; Rapp L, 1985, RETINAL DEGENERATION, P421; Rein DB, 2009, ARCH OPHTHALMOL-CHIC, V127, P533, DOI 10.1001/archophthalmol.2009.58; Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487; Rutar M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-221; Rutar M, 2011, INVEST OPHTH VIS SCI, V52, P5347, DOI 10.1167/iovs.10-7119; Rutar M, 2011, INVEST OPHTH VIS SCI, V52, P2379, DOI 10.1167/iovs.10-6010; Rutar M, 2010, CURR EYE RES, V35, P631, DOI 10.3109/02713681003682925; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; Sennlaub F, 2013, EMBO MOL MED, V5, P1775, DOI 10.1002/emmm.201302692; Sim RB, 2007, IMMUNOBIOLOGY, V212, P355, DOI 10.1016/j.imbio.2007.04.001; SLAGBOOM PE, 1990, MECH AGEING DEV, V53, P243, DOI 10.1016/0047-6374(90)90042-E; Spencer KL, 2008, HUM MOL GENET, V17, P1821, DOI 10.1093/hmg/ddn075; Taylor PR, 2000, J EXP MED, V192, P359, DOI 10.1084/jem.192.3.359; Trouw LA, 2008, MOL IMMUNOL, V45, P1199, DOI 10.1016/j.molimm.2007.09.008; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Wong JG, 2001, INVEST OPHTH VIS SCI, V42, pS227; Wu KHC, 2003, BRIT J OPHTHALMOL, V87, P1159, DOI 10.1136/bjo.87.9.1159; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Yoshida S, 2002, INVEST OPHTH VIS SCI, V43, P2554	76	37	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93343	10.1371/journal.pone.0093343	http://dx.doi.org/10.1371/journal.pone.0093343			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705166	Green Published, gold			2022-12-25	WOS:000334107500032
J	Faryammanesh, R; Lange, T; Magbanua, E; Haas, S; Meyer, C; Wicklein, D; Schumacher, U; Hahn, U				Faryammanesh, Rassa; Lange, Tobias; Magbanua, Eileen; Haas, Sina; Meyer, Cindy; Wicklein, Daniel; Schumacher, Udo; Hahn, Ulrich			SDA, a DNA Aptamer Inhibiting E- and P-Selectin Mediated Adhesion of Cancer and Leukemia Cells, the First and Pivotal Step in Transendothelial Migration during Metastasis Formation	PLOS ONE			English	Article							IN-VITRO SELECTION; MOLECULES; INSIGHTS; LIGANDS; BINDING; MODEL	Endothelial (E-) and platelet (P-) selectin mediated adhesion of tumor cells to vascular endothelium is a pivotal step of hematogenous metastasis formation. Recent studies have demonstrated that selectin deficiency significantly reduces metastasis formation in vivo. We selected an E-and P-Selectin specific DNA Aptamer (SDA) via SELEX (Systematic Evolution of Ligands by EXponential enrichment) with a K-d value of approximately 100 nM and the capability of inhibiting the interaction between selectin and its ligands. Employing human colorectal cancer (HT29) and leukemia (EOL-1) cell lines we could demonstrate an anti-adhesive effect for SDA in vitro. Under physiological shear stress conditions in a laminar flow adhesion assay, SDA inhibited dynamic tumor cell adhesion to immobilized E-or P-selectin. The stability of SDA for more than two hours allowed its application in cell-cell adhesion assays in cell culture medium. When adhesion of HT29 cells to TNF alpha-stimulated E-selectin presenting human pulmonary microvascular endothelial cells was analyzed, inhibition via SDA could be demonstrated as well. In conclusion, SDA is a potential new therapeutic agent that antagonizes selectin-mediated adhesion during metastasis formation in human malignancies.	[Faryammanesh, Rassa; Magbanua, Eileen; Haas, Sina; Meyer, Cindy; Hahn, Ulrich] Univ Hamburg, MIN Fac, Inst Biochem & Mol Biol, Dept Chem, Hamburg, Germany; [Lange, Tobias; Wicklein, Daniel; Schumacher, Udo] Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr, Inst Anat & Expt Morphol, Hamburg, Germany	University of Hamburg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Hahn, U (corresponding author), Univ Hamburg, MIN Fac, Inst Biochem & Mol Biol, Dept Chem, Hamburg, Germany.	uli.hahn@uni-hamburg.de	Hahn, Ulrich/E-8069-2010; Lange, Tobias/K-8689-2015	Hahn, Ulrich/0000-0002-6526-0693; Meyer, Cindy/0000-0003-3807-8383	Forschungs- und Wissenschaftsstiftung Hamburg in the Forschungsverbund "Cell surface targeting"; FAZIT-STIFTUNG	Forschungs- und Wissenschaftsstiftung Hamburg in the Forschungsverbund "Cell surface targeting"; FAZIT-STIFTUNG	Forschungs- und Wissenschaftsstiftung Hamburg in the Forschungsverbund "Cell surface targeting". Grant of the FAZIT-STIFTUNG to R. F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238; BRANDLEY BK, 1990, CELL, V63, P861, DOI 10.1016/0092-8674(90)90487-Y; Burnette AD, 2011, NUCLEIC ACID THER, V21, P275, DOI 10.1089/nat.2010.0270; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; ERBE DV, 1993, J CELL BIOL, V120, P1227, DOI 10.1083/jcb.120.5.1227; Ernst B, 2009, NAT REV DRUG DISCOV, V8, P661, DOI 10.1038/nrd2852; FIDLER IJ, 1978, CANCER RES, V38, P2651; Gebauer F, 2013, GUT, V62, P741, DOI 10.1136/gutjnl-2011-300629; Gutsaeva DR, 2011, BLOOD, V117, P727, DOI 10.1182/blood-2010-05-285718; Jenison RD, 1998, ANTISENSE NUCLEIC A, V8, P265, DOI 10.1089/oli.1.1998.8.265; Keefe AD, 2008, CURR OPIN PHARMACOL, V8, P147, DOI 10.1016/j.coph.2007.12.005; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Kohler S, 2010, BRIT J CANCER, V102, P602, DOI 10.1038/sj.bjc.6605492; LARSEN GR, 1992, J BIOL CHEM, V267, P11104; LASKY LA, 1991, J CELL BIOCHEM, V45, P139, DOI 10.1002/jcb.240450204; Mann AP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013050; MARCHUK D, 1991, NUCLEIC ACIDS RES, V19, P1154, DOI 10.1093/nar/19.5.1154; Mayer Guenter, 2009, V535, P19, DOI 10.1007/978-1-59745-557-2_2; Pendergrast P Shannon, 2005, J Biomol Tech, V16, P224; Revelle BM, 1996, J BIOL CHEM, V271, P4289; Reymond N, 2013, NAT REV CANCER, V13, P858, DOI 10.1038/nrc3628; Richter U, 2012, HISTOCHEM CELL BIOL, V137, P687, DOI 10.1007/s00418-012-0916-5; Richter U, 2011, HISTOCHEM CELL BIOL, V135, P499, DOI 10.1007/s00418-011-0804-4; ROBERTSON DL, 1990, NATURE, V344, P467, DOI 10.1038/344467a0; Sheikh S, 2003, BLOOD, V102, P2828, DOI 10.1182/blood-2003-01-0080; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Strell Carina, 2008, Cell Commun Signal, V6, P10, DOI 10.1186/1478-811X-6-10; Sun ChengLong, 2011, Agricultural Science & Technology - Hunan, V12, P363; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wicklein D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070139; ZUKER M, 1989, SCIENCE, V244, P48, DOI 10.1126/science.2468181; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	34	24	28	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93173	10.1371/journal.pone.0093173	http://dx.doi.org/10.1371/journal.pone.0093173			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699049	Green Published, gold, Green Submitted			2022-12-25	WOS:000334105000044
J	Kwok, L; Zhang, JC; Guo, Z; Gesudu, QM; Zheng, Y; Qiao, JM; Huo, DX; Zhang, HP				Kwok, Lai-yu; Zhang, Jiachao; Guo, Zhuang; Gesudu, Qimu; Zheng, Yi; Qiao, Jianmin; Huo, Dongxue; Zhang, Heping			Characterization of Fecal Microbiota across Seven Chinese Ethnic Groups by Quantitative Polymerase Chain Reaction	PLOS ONE			English	Article							REAL-TIME PCR; GROUP-SPECIFIC PRIMERS; HUMAN GUT MICROBIOME; HUMAN FECES; PREDOMINANT BACTERIA; GENETIC-RELATIONSHIP; DNA-EXTRACTION; HAN CHINESE; POPULATIONS; HEALTH	The human gut microbiota consists of complex microbial communities, which possibly play crucial roles in physiological functioning and health maintenance. China has evolved into a multicultural society consisting of the major ethnic group, Han, and 55 official ethnic minority groups. Nowadays, these minority groups inhabit in different Chinese provinces and some of them still keep their unique culture and lifestyle. Currently, only limited data are available on the gut microbiota of these Chinese ethnic groups. In this study, 10 major fecal bacterial groups of 314 healthy individuals from 7 Chinese ethnic origins were enumerated by quantitative polymerase chain reaction. Our data confirmed that the selected bacterial groups were common to all 7 surveyed ethnicities, but the amount of the individual bacterial groups varied to different degree. By principal component and canonical variate analyses of the 314 individuals or the 91 Han subjects, no distinct group clustering pattern was observed. Nevertheless, weak differences were noted between the Han and Zhuang from other ethnic minority groups, and between the Heilongjiang Hans from those of the other provinces. Thus, our results suggest that the ethnic origin may contribute to shaping the human gut microbiota.	[Kwok, Lai-yu; Zhang, Jiachao; Guo, Zhuang; Gesudu, Qimu; Zheng, Yi; Qiao, Jianmin; Huo, Dongxue; Zhang, Heping] Inner Mongolia Agr Univ, Dept Food Sci & Engn, Educ Minist PR China, Key Lab Dairy Biotechnol & Bioengn, Hohhot, Inner Mongolia, Peoples R China		Zhang, HP (corresponding author), Inner Mongolia Agr Univ, Dept Food Sci & Engn, Educ Minist PR China, Key Lab Dairy Biotechnol & Bioengn, Hohhot, Inner Mongolia, Peoples R China.	hepingdd@vip.sina.com	Zhang, jiachao/L-1332-2013; Zhang, He/GXN-0028-2022	Zhang, jiachao/0000-0001-8099-6749; Zhang, Jiachao/0000-0002-3339-7345	National Natural Science Foundation of China [31025019]; Innovation Team Development of the Ministry of Education of China [IRT0967]; China Agriculture Research System [CARS-37]; Key Laboratory Major Open Project Fund of Inner Mongolia [20130902]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Team Development of the Ministry of Education of China; China Agriculture Research System; Key Laboratory Major Open Project Fund of Inner Mongolia	This research was supported by the National Natural Science Foundation of China (Grant No. 31025019), the Innovation Team Development of the Ministry of Education of China (Grant No. IRT0967), the China Agriculture Research System (Grant No. CARS-37), and the Key Laboratory Major Open Project Fund of Inner Mongolia (Grant No. 20130902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Baquero F, 2012, CLIN MICROBIOL INFEC, V18, P2, DOI 10.1111/j.1469-0691.2012.03916.x; Bartosch S, 2004, APPL ENVIRON MICROB, V70, P3575, DOI 10.1128/AEM.70.6.3575-3581.2004; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Duncan SH, 2013, MATURITAS; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fite A, 2004, GUT, V53, P523, DOI 10.1136/gut.2003.031245; Ge KY, 1997, AM J CLIN NUTR, V65, P1290, DOI 10.1093/ajcn/65.4.1290S; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hormannsperger G, 2012, J ALLERGY CLIN IMMUN, V129, P1452, DOI 10.1016/j.jaci.2011.12.993; Inglis GD, 2012, J AOAC INT, V95, P5, DOI 10.5740/jaoacint.SGE_Inglis; Kikuchi E, 2002, MICROBIOL IMMUNOL, V46, P353, DOI 10.1111/j.1348-0421.2002.tb02706.x; Kirkma TW, 1996, STAT USE; Kuwahara T, 2011, DNA RES, V18, P291, DOI 10.1093/dnares/dsr022; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Lay C, 2005, APPL ENVIRON MICROB, V71, P4153, DOI 10.1128/AEM.71.7.4153-4155.2005; Lin HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009895; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Matsuda K, 2007, APPL ENVIRON MICROB, V73, P32, DOI 10.1128/AEM.01224-06; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P7220, DOI 10.1128/AEM.70.12.7220-7228.2004; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Maukonen J, 2012, FEMS MICROBIOL ECOL, V79, P697, DOI 10.1111/j.1574-6941.2011.01257.x; Mueller S, 2006, APPL ENVIRON MICROB, V72, P1027, DOI 10.1128/AEM.72.2.1027-1033.2006; Nam YD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022109; Nechvatal JM, 2008, J MICROBIOL METH, V72, P124, DOI 10.1016/j.mimet.2007.11.007; Peris-Bondia F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022448; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Scher JU, 2011, NAT REV RHEUMATOL, V7, P569, DOI 10.1038/nrrheum.2011.121; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Unger J, 1997, B CONCERN ASIA SCHOL, V29, P67; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Yao YG, 2002, AM J PHYS ANTHROPOL, V118, P63, DOI 10.1002/ajpa.10052; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; Yao YG, 2004, MOL BIOL EVOL, V21, P2265, DOI 10.1093/molbev/msh238; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhai Fengying, 2007, Wei Sheng Yan Jiu, V36, P539	44	29	32	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93631	10.1371/journal.pone.0093631	http://dx.doi.org/10.1371/journal.pone.0093631			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699404	Green Published, Green Submitted, gold			2022-12-25	WOS:000334105000083
J	Palafox, B; Patouillard, E; Tougher, S; Goodman, C; Hanson, K; Kleinschmidt, I; Rueda, ST; Kiefer, S; O'Connell, KA; Zinsou, C; Phok, S; Akulayi, L; Arogundade, E; Buyungo, P; Mpasela, F; Chavasse, D				Palafox, Benjamin; Patouillard, Edith; Tougher, Sarah; Goodman, Catherine; Hanson, Kara; Kleinschmidt, Immo; Rueda, Sergio Torres; Kiefer, Sabine; O'Connell, Kathryn A.; Zinsou, Cyprien; Phok, Sochea; Akulayi, Louis; Arogundade, Ekundayo; Buyungo, Peter; Mpasela, Felton; Chavasse, Desmond			Understanding Private Sector Antimalarial Distribution Chains: A Cross-Sectional Mixed Methods Study in Six Malaria-Endemic Countries	PLOS ONE			English	Article							COMBINATION THERAPIES; FEBRILE ILLNESS; CASE-MANAGEMENT; ANTI-MALARIALS; RETAIL SECTOR; MARKET SHARE; DRUG SHOPS; HEALTH; PROVIDERS; AVAILABILITY	Background: Private for-profit outlets are important treatment sources for malaria in most endemic countries. However, these outlets constitute only the last link in a chain of businesses that includes manufacturers, importers and wholesalers, all of which influence the availability, price and quality of antimalarials patients can access. We present evidence on the composition, characteristics and operation of these distribution chains and of the businesses that comprise them in six endemic countries (Benin, Cambodia, Democratic Republic of Congo, Nigeria, Uganda and Zambia). Methods and Findings: We conducted nationally representative surveys of antimalarial wholesalers during 2009-2010 using an innovative sampling approach that captured registered and unregistered distribution channels, complemented by in-depth interviews with a range of stakeholders. Antimalarial distribution chains were pyramidal in shape, with antimalarials passing through a maximum of 4-6 steps between manufacturer and retailer; however, most likely pass through 2-3 steps. Less efficacious non-artemisinin therapies (e. g. chloroquine) dominated weekly sales volumes among African wholesalers, while volumes for more efficacious artemisinin-based combination therapies (ACTs) were many times smaller. ACT sales predominated only in Cambodia. In all countries, consumer demand was the principal consideration when selecting products to stock. Selling prices and reputation were key considerations regarding supplier choice. Business practices varied across countries, with large differences in the proportions of wholesalers offering credit and delivery services to customers, and the types of distribution models adopted by businesses. Regulatory compliance also varied across countries, particularly with respect to licensing. The proportion of wholesalers possessing any up-to-date licence from national regulators was lowest in Benin and Nigeria, where vendors in traditional markets are important antimalarial supply sources. Conclusions: The structure and characteristics of antimalarial distribution chains vary across countries; therefore, understanding the wholesalers that comprise them should inform efforts aiming to improve access to quality treatment through the private sector.	[Palafox, Benjamin; Patouillard, Edith; Tougher, Sarah; Goodman, Catherine; Hanson, Kara; Kleinschmidt, Immo; Rueda, Sergio Torres] London Sch Hyg & Trop Med, London WC1, England; [Kiefer, Sabine] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [O'Connell, Kathryn A.; Chavasse, Desmond] Populat Serv Int, Malaria & Child Survival Dept, Nairobi, Kenya; [Zinsou, Cyprien] Populat Serv Int, Assoc Beninoise Mkt Social, Cotonou, Benin; [Phok, Sochea] Populat Serv Int Cambodia, Phnom Penh, Cambodia; [Akulayi, Louis] Assoc Sante Familiale, Kinshasa, DEM REP CONGO; [Arogundade, Ekundayo] Soc Family Hlth, Abuja, Nigeria; [Buyungo, Peter] Programme Accessible Hlth Commun & Educ, Kampala, Uganda; [Mpasela, Felton] Soc Family Hlth, Lusaka, Zambia	University of London; London School of Hygiene & Tropical Medicine; University of Basel; Swiss Tropical & Public Health Institute	Palafox, B (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	benjamin.palafox@lshtm.ac.uk		Tougher, Sarah/0000-0001-7990-4368; Goodman, Catherine/0000-0002-2241-3485; Patouillard, Edith/0000-0001-7347-2824	Bill and Melinda Gates Foundation [058992]; Medical Research Council [MR/K012126/1] Funding Source: researchfish	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	ACTwatch is funded by the Bill and Melinda Gates Foundation (www.gatesfoundation.org, grant #058992). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-163; Awor P, 2012, AM J TROP MED HYG, V87, P92, DOI 10.4269/ajtmh.2012.11-0791; Berman P, 1996, HEALTH POLICY PLANN, V11, P142, DOI 10.1093/heapol/11.2.142; Chaturvedi HK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-301; Cohen JM, 2012, SCIENCE, V338, P612, DOI 10.1126/science.1229045; Djankov S, 2002, Q J ECON, V117, P1, DOI 10.1162/003355302753399436; Hanson K, 1998, HEALTH POLICY PLANN, V13, P195, DOI 10.1093/heapol/13.3.195; Hanson K, 2011, GLOBAL HLTH DIS PROG; Kahabuka C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058789; Kamat V. R., 1997, PRIVATE HLTH PROVIDE, P124; Kangwana BP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000437; Kaplan WA, 2005, LOCAL PRODUCTION PHA; Lalchhuanawma R, 2012, INT HEALTH, V4, P314, DOI 10.1016/j.inhe.2012.06.003; Littrell M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-328; Littrell M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-327; Nonaka D, 2009, ACTA TROP, V112, P283, DOI 10.1016/j.actatropica.2009.08.013; Noor AM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-100; O'Cathain A, 2006, QUALITATIVE RES HLTH; O'Connell KA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-326; Okeke TA, 2010, HEALTH POLICY, V95, P62, DOI 10.1016/j.healthpol.2009.11.005; Onwujekwe O, 2010, HEALTH POLICY, V94, P144, DOI 10.1016/j.healthpol.2009.09.010; Orem JN, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-175; Patouillard E, 2012, EC ANAL MARKET MALAR; Patouillard E, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-50; Pope C, 2006, QUALITATIVE RES HLTH; Rutebemberwa E, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-45; Rutta Edmund, 2009, Prog Community Health Partnersh, V3, P145, DOI 10.1353/cpr.0.0063; Sabot OJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006857; Shewchuk T, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-325; Smith N, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-316; StataCorp, 2011, STAT STAT SOFTW REL, P173; StataCorp, 2019, STATA STAT SOFTWARE; Talisuna AO, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-356; Taylor J., 2009, PUSH LOCAL PRODUCTIO; Tougher S, 2012, LANCET, V380, P1916, DOI 10.1016/S0140-6736(12)61732-2; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Yeung S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-243	37	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93763	10.1371/journal.pone.0093763	http://dx.doi.org/10.1371/journal.pone.0093763			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699934	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000334105000102
J	Sidaway, P; Teramoto, N				Sidaway, Peter; Teramoto, Noriyoshi			L-Type Ca2+ Channel Sparklets Revealed by TIRF Microscopy in Mouse Urinary Bladder Smooth Muscle	PLOS ONE			English	Article							RYANODINE RECEPTORS; CALCIUM-CHANNELS; CA(V)1.2 CHANNELS; HEART-CELLS; CONTRACTION; ACTIVATION; MECHANISMS; EXCITATION; RELEASE; SIGNALS	Calcium is a ubiquitous second messenger in urinary bladder smooth muscle (UBSM). In this study, small discrete elevations of intracellular Ca2+, referred to as Ca2+ sparklets have been detected in an intact detrusor smooth muscle electrical syncytium using a TIRF microscopy Ca2+ imaging approach. Sparklets were virtually abolished by the removal of extracellular Ca2+ (0.035 +/- 0.01 vs. 0.23 +/- 0.07 Hz/mm(2); P<0.05). Co-loading of smooth muscle strips with the slow Ca2+ chelator EGTA-AM (10 mM) confirmed that Ca2+ sparklets are restricted to the cell membrane. Ca2+ sparklets were inhibited by the calcium channel inhibitors R-(+)-Bay K 8644 (1 mu M) (0.034 +/- 0.02 vs. 0.21 +/- 0.08 Hz/mm(2); P<0.05), and diltiazem (10 mu M) (0.097 +/- 0.04 vs. 0.16 +/- 0.06 Hz/mm(2); P<0.05). Ca2+ sparklets were unaffected by inhibition of P2X(1) receptors a, alpha,beta-meATP (10 mu M) whilst sparklet frequencies were significantly reduced by atropine (1 mu M). Ca2+ sparklet frequency was significantly reduced by PKC inhibition with Go6976 (100 nM) (0.030 +/- 0.01 vs. 0.30 +/- 0.1 Hz/mm(2); P<0.05), demonstrating that Ca2+ sparklets are PKC dependant. In the presence of CPA (10 mu M), there was no apparent change in the overall frequency of Ca2+ sparklets, although the sparklet frequencies of each UBSM became statistically independent of each other (Spearman's rank correlation 0.2, P>0.05), implying that Ca2+ store mediated signals regulate Ca2+ sparklets. Under control conditions, inhibition of store operated Ca2+ entry using ML-9 (100 mu M) had no significant effect. Amplitudes of Ca2+ sparklets were unaffected by any agonists or antagonists, suggesting that these signals are quantal events arising from activation of a single channel, or complex of channels. The effects of CPA and ML-9 suggest that Ca2+ sparklets regulate events in the cell membrane, and contribute to cytosolic and sarcoplasmic Ca2+ concentrations.	[Sidaway, Peter; Teramoto, Noriyoshi] Saga Univ, Fac Med, Dept Pharmacol, Saga 840, Japan	Saga University	Sidaway, P (corresponding author), Saga Univ, Fac Med, Dept Pharmacol, Saga 840, Japan.	psidaway439@gmail.com			Japan Society for the Promotion of Science (JSPS) [PE12064]; JSPS [LS096]; Grants-in-Aid for Scientific Research [26282148] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Dr. Peter Sidaway was awarded by a Grant-in-Aid from the Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowship (Short-Term) for Foreign Researcher, PE12064 to Prof. Noriyoshi Teramoto). The research was also supported by the JSPS Funding Program for Next Generation World-Leading Researchers (Prof. Noriyoshi Teramoto, Grant Number LS096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberg GC, 2007, J PHYSIOL-LONDON, V579, P187, DOI 10.1113/jphysiol.2006.124420; Berridge MJ, 2008, J PHYSIOL-LONDON, V586, P5047, DOI 10.1113/jphysiol.2008.160440; Cheng HP, 2002, FRONT BIOSCI, V7, pD1867, DOI 10.2741/cheng; Choppin A, 2001, BRIT J PHARMACOL, V133, P1035, DOI 10.1038/sj.bjp.0704165; Francis M, 2012, AM J PHYSIOL-CELL PH, V303, pC236, DOI 10.1152/ajpcell.00016.2012; Ganitkevich VY, 1999, CELL CALCIUM, V25, P29, DOI 10.1054/ceca.1998.0001; Hashitani H, 2001, J PHYSIOL-LONDON, V530, P273, DOI 10.1111/j.1469-7793.2001.0273l.x; Hill-Eubanks DC, 2011, COLD SPRING HARB PER, V3, P2; Karaki H, 1997, PHARMACOL REV, V49, P157; Kiselyov K, 2001, BIOCHEM J, V360, P17, DOI 10.1042/0264-6021:3600017; Kobayter S, 2012, BRIT J PHARMACOL, V165, P401, DOI 10.1111/j.1476-5381.2011.01543.x; Liu L, 2006, AM J PHYSIOL-CELL PH, V290, pC1239, DOI 10.1152/ajpcell.00440.2005; McCarron JG, 2009, J GEN PHYSIOL, V133, P439, DOI 10.1085/jgp.200810189; Meng E, 2008, NEUROUROL URODYNAM, V27, P79, DOI 10.1002/nau.20456; Navedo MF, 2007, AM J PHYSIOL-HEART C, V293, pH1359, DOI 10.1152/ajpheart.00450.2007; Navedo MF, 2006, J GEN PHYSIOL, V127, P611, DOI 10.1085/jgp.200609519; Navedo MF, 2005, P NATL ACAD SCI USA, V102, P11112, DOI 10.1073/pnas.0500360102; Nieves-Cintron M, 2008, P NATL ACAD SCI USA, V105, P15623, DOI 10.1073/pnas.0808759105; Ouanounou A, 1999, J NEUROSCI, V19, P906; Park CY, 2010, SCIENCE, V330, P101, DOI 10.1126/science.1191027; Parker I, 2010, J GEN PHYSIOL, V136, P119, DOI 10.1085/jgp.200910390; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Rubart M, 1996, J GEN PHYSIOL, V107, P459, DOI 10.1085/jgp.107.4.459; Sanders KM, 2008, NEUROGASTROENT MOTIL, V20, P39, DOI 10.1111/j.1365-2982.2008.01108.x; Smyth JT, 2010, J CELL MOL MED, V14, P2337, DOI 10.1111/j.1582-4934.2010.01168.x; Sonkusare SK, 2012, SCIENCE, V336, P597, DOI 10.1126/science.1216283; Takeda Y, 2011, AM J PHYSIOL-HEART C, V301, pH2285, DOI 10.1152/ajpheart.00488.2011; Trepakova ES, 2001, J BIOL CHEM, V276, P7782, DOI 10.1074/jbc.M010104200; Vial C, 2000, BRIT J PHARMACOL, V131, P1489, DOI 10.1038/sj.bjp.0703720; Wang SQ, 2001, NATURE, V410, P592, DOI 10.1038/35069083; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Willmott NJ, 1996, FEBS LETT, V394, P159, DOI 10.1016/0014-5793(96)00939-8; Wu C, 2001, AM J PHYSIOL-CELL PH, V280, pC1090, DOI 10.1152/ajpcell.2001.280.5.C1090; Yamamura H, 2012, BIOCHEM BIOPH RES CO, V427, P54, DOI 10.1016/j.bbrc.2012.08.145; Young JS, 2008, J PHYSIOL-LONDON, V586, P5743, DOI 10.1113/jphysiol.2008.162040	35	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93803	10.1371/journal.pone.0093803	http://dx.doi.org/10.1371/journal.pone.0093803			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699670	Green Published, Green Submitted, gold			2022-12-25	WOS:000334105000109
J	Siqueiros-Garcia, JM; Hernandez-Lemus, E; Garcia-Herrera, R; Robina-Galatas, A				Siqueiros-Garcia, Jesus M.; Hernandez-Lemus, Enrique; Garcia-Herrera, Rodrigo; Robina-Galatas, Andrea			Mapping the Structure and Dynamics of Genomics-Related MeSH Terms Complex Networks	PLOS ONE			English	Article							CYTOSCAPE	It has been proposed that the history and evolution of scientific ideas may reflect certain aspects of the underlying sociocognitive frameworks in which science itself is developing. Systematic analyses of the development of scientific knowledge may help us to construct models of the collective dynamics of science. Aiming at scientific rigor, these models should be built upon solid empirical evidence, analyzed with formal tools leading to ever-improving results that support the related conclusions. Along these lines we studied the dynamics and structure of the development of research in genomics as represented by the entire collection of genomics related scientific papers contained in the PubMed database. The analyzed corpus consisted in more than 49,000 articles published in the years 1987 (first appeareance of the term Genomics) to 2011, categorized by means of the Medical Subheadings (MeSH) content-descriptors. Complex networks were built where two MeSH terms were connected if they are descriptors of the same article(s). The analysis of such networks revealed a complex structure and dynamics that to certain extent resembled small-world networks. The evolution of such networks in time reflected interesting phenomena in the historical development of genomic research, including what seems to be a phase-transition in a period marked by the completion of the first draft of the Human Genome Project. We also found that different disciplinary areas have different dynamic evolution patterns in their MeSH connectivity networks. In the case of areas related to science, changes in topology were somewhat fast while retaining a certain core-stucture, whereas in the humanities, the evolution was pretty slow and the structure resulted highly redundant and in the case of technology related issues, the evolution was very fast and the structure remained tree-like with almost no overlapping terms.	[Siqueiros-Garcia, Jesus M.; Robina-Galatas, Andrea] Natl Inst Genom Med, Eth Legal & Social Studies Dept, Mexico City, DF, Mexico; [Hernandez-Lemus, Enrique; Garcia-Herrera, Rodrigo] Natl Inst Genom Med, Computat Genom Dept, Mexico City, DF, Mexico; [Hernandez-Lemus, Enrique] Univ Nacl Autonoma Mexico, Ctr Complex Sci, Mexico City 04510, DF, Mexico	Instituto Nacional de Medicina Genomica; Instituto Nacional de Medicina Genomica; Universidad Nacional Autonoma de Mexico	Siqueiros-Garcia, JM (corresponding author), Natl Inst Genom Med, Eth Legal & Social Studies Dept, Mexico City, DF, Mexico.	jsiqueiros@inmegen.gob.mx	Siqueiros-García, Jesús Mario/ABG-7535-2021	Siqueiros-García, Jesús Mario/0000-0001-8008-6198; Hernandez-Lemus, Enrique/0000-0002-1872-1397; Garcia Herrera, Ricardo/0000-0003-2456-4727; Garcia-Herrera, Rodrigo/0000-0002-7972-5746				[Anonymous], 2014, INTRO MESH; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2012, NAT PHYS, V8, P14, DOI 10.1038/nphys2188; Cardillo A, 2006, PHYSICA A, V372, P333, DOI 10.1016/j.physa.2006.08.059; Christakis Nicholas, 2013, NY TIMES; Dorogovtsev S.N., 2004, PHYSICS, V71, P47; Dupr? John., 2008, GENOMES WHAT MAKE TH; Hagberg A, 2008, EXPLORING NETWORK ST, P11, DOI DOI 10.25080/ISSN.2575-9752; Keller Evelyn Fox, 2000, CENTURY GENE; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lancichinetti A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011976; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Pan RK, 2012, SCI REP-UK, V2, DOI 10.1038/srep00551; Pan RK, 2012, SCI REP-UK, V2, DOI 10.1038/srep00902; Pan RK, 2009, EPL-EUROPHYS LETT, V85, DOI 10.1209/0295-5075/85/68006; Perc M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01720; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sun XL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01069; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yan EJ, 2012, J AM SOC INF SCI TEC, V63, P1313, DOI 10.1002/asi.22680; Yousefi-Nooraie Reza, 2008, Health Res Policy Syst, V6, P9, DOI 10.1186/1478-4505-6-9	27	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e92639	10.1371/journal.pone.0092639	http://dx.doi.org/10.1371/journal.pone.0092639			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699262	Green Submitted, gold, Green Published			2022-12-25	WOS:000334105000031
J	Ferraresso, S; Bresolin, S; Arico, A; Comazzi, S; Gelain, ME; Riondato, F; Bargelloni, L; Marconato, L; Kronnie, GT; Aresu, L				Ferraresso, Serena; Bresolin, Silvia; Arico, Arianna; Comazzi, Stefano; Gelain, Maria Elena; Riondato, Fulvio; Bargelloni, Luca; Marconato, Laura; Kronnie, Geertruy te; Aresu, Luca			Epigenetic Silencing of TFPI-2 in Canine Diffuse Large B-Cell Lymphoma	PLOS ONE			English	Article							FACTOR PATHWAY INHIBITOR-2; TUMOR-SUPPRESSOR GENE; PROMOTER HYPERMETHYLATION; FUNDAMENTAL ROLE; DNA METHYLATION; CPG ISLAND; CANCER; EXPRESSION; MODEL; PROGRESSION	Epigenetic modifications are important early events during carcinogenesis. In particular, hypermethylation of CpG islands in the promoter region of tumor suppressor genes is a well-known mechanism of gene silencing that contributes to cancer development and progression. Tissue factor pathway inhibitor 2 (TFPI-2) is a tumor suppressor involved in invasiveness inhibition. Although TFPI-2 transcriptional silencing, through promoter hypermethylation, has been widely reported in several human malignancies, it has never been explored in lymphoma. In the present study TFPI-2 methylation and gene expression have been investigated in canine Diffuse Large B-cell lymphomas (cDLBCL). The methylation level of 23 CpGs located within the TFPI-2 promoter was investigated by bisulfite-specific PCR and next generation amplicon deep sequencing (GS Junior 454, Roche) in 22 cDLBCLs and 9 controls. For the same specimens, TFPI-2 gene expression was assessed by means of Real-time RT-PCR. Sequence analysis clearly demonstrated that TFPI2 is frequently hypermethylated in cDLBCL. Hypermethylation of the TFPI-2 promoter was found in 77% of DLBCLs ( 17 out of 22) and in one normal lymph node. Globally, dogs with DLBCL showed a mean methylation level significantly increased compared to controls (p<0.01) and analysis of hypermethylation by site identified 19 loci out of 23 ( 82%) with mean methylation levels from 2- to 120-fold higher in cDLBCL. Gene expression analysis confirmed a significant down-regulation of TFPI-2 ( p<0.05) in DLBCLs compared with normal lymph nodes, suggesting that TFPI-2 hypermethylation negatively regulates its transcription. In addition, a significant positive correlation ( p<0.01) was found between TFPI-2 methylation levels and age providing the first indication of age-associated epigenetic modifications in canine DLBCL. To conclude, our findings demonstrated that epigenetic dysregulation of TFPI-2, leading to its reduced expression, is frequently detected in canine DLBCL. In the next future, the aberrant TFPI-2 promoter hypermethylation may be considered in association with prognosis and therapy.	[Ferraresso, Serena; Arico, Arianna; Gelain, Maria Elena; Bargelloni, Luca; Aresu, Luca] Univ Padua, Dept Comparat Biomed & Food Sci, Padua, Italy; [Bresolin, Silvia; Kronnie, Geertruy te] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy; [Comazzi, Stefano] Univ Milan, Dept Anim Pathol Hyg & Vet Publ Hlth, Milan, Italy; [Riondato, Fulvio] Univ Turin, Dept Vet Sci, Turin, Italy; [Marconato, Laura] Ctr Oncol Vet, Sasso Marconi, Italy	University of Padua; University of Padua; University of Milan; University of Turin	Ferraresso, S (corresponding author), Univ Padua, Dept Comparat Biomed & Food Sci, Padua, Italy.	serena.ferraresso@unipd.it	Bresolin, Silvia/K-6576-2016; riondato, fulvio/AAE-5929-2021; Marconato, Laura/AAD-7263-2020; Kronnie, Geertruy te/L-1014-2016; Aresu, Luca/J-9788-2018; Comazzi, Stefano/K-8062-2017; Arico, Arianna/J-4873-2018	Bresolin, Silvia/0000-0001-7677-7084; Marconato, Laura/0000-0002-7843-615X; Aresu, Luca/0000-0002-7893-1740; Comazzi, Stefano/0000-0002-1567-8055; te Kronnie, Geertruy/0000-0001-7143-4795; /0000-0001-5636-1006; Arico, Arianna/0000-0002-2397-0064; Ferraresso, Serena/0000-0001-5928-9361; riondato, fulvio/0000-0002-4814-2273; gelain, maria elena/0000-0002-8633-0988	Ministry of Health (PRIN)	Ministry of Health (PRIN)(Ministry of Education, Universities and Research (MIUR))	This work was founded by a grant from Ministry of Health (PRIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aresu L, 2014, VET COMP ONCOL, V12, P29, DOI 10.1111/j.1476-5829.2012.00328.x; Arico A, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-94; Bresolin S, 2013, HAEMATOLOGICA, V98, P353; Bryan JN, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-73; Clozel T, 2013, CANCER DISCOV, V3, P1002, DOI 10.1158/2159-8290.CD-13-0117; Daniel FI, 2011, CANCER-AM CANCER SOC, V117, P677, DOI 10.1002/cncr.25482; Galm O, 2006, BLOOD REV, V20, P1, DOI 10.1016/j.blre.2005.01.006; Gaud G, 2011, J CELL MOL MED, V15, P196, DOI 10.1111/j.1582-4934.2009.00989.x; Gaurnier-Hausser A, 2011, CLIN CANCER RES, V17, P4661, DOI 10.1158/1078-0432.CCR-10-3310; Glockner SC, 2009, CANCER RES, V69, P4691, DOI 10.1158/0008-5472.CAN-08-0142; Guo HS, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-110; Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Herman MP, 2001, J CLIN INVEST, V107, P1117, DOI 10.1172/JCI10403; Hibi K, 2010, ANTICANCER RES, V30, P4131; Hube F, 2003, BIOL CHEM, V384, P1029, DOI 10.1515/BC.2003.115; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jian P, 2012, J PEDIAT HEMATOL ONC, V34, P43, DOI 10.1097/MPH.0b013e3182277276; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Keller U, 2005, ONCOGENE, V24, P6231, DOI 10.1038/sj.onc.1208779; Konduri SD, 2003, INT J ONCOL, V22, P1277; Lavergne M, 2013, FEBS OPEN BIO, V3, P291, DOI 10.1016/j.fob.2013.06.004; Lutsik P, 2011, NUCLEIC ACIDS RES, V39, pW551, DOI 10.1093/nar/gkr312; Marconato L, 2014, CLIN CANCER RES, V20, P668, DOI 10.1158/1078-0432.CCR-13-2283; Mudaliar MAV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072591; Ponce F, 2010, VET PATHOL, V47, P414, DOI 10.1177/0300985810363902; Rosenwald A, 2003, LEUKEMIA LYMPHOMA, V44, pS41, DOI 10.1080/10428190310001623775; Schoofs T, 2013, LEUKEMIA IN PRESS; Sun YN, 2006, LARYNGOSCOPE, V116, P596, DOI 10.1097/01.mlg.0000205589.84020.d2; Takada H, 2010, CANCER GENET CYTOGEN, V197, P16, DOI 10.1016/j.cancergencyto.2009.11.004; Wang SM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-617; Wong CM, 2007, HEPATOLOGY, V45, P1129, DOI 10.1002/hep.21578; Zinn RL, 2007, CANCER RES, V67, P194, DOI 10.1158/0008-5472.CAN-06-3396	34	25	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e92707	10.1371/journal.pone.0092707	http://dx.doi.org/10.1371/journal.pone.0092707			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695110	Green Published, gold			2022-12-25	WOS:000334103000026
J	Gardiner, JM; Atema, J; Hueter, RE; Motta, PJ				Gardiner, Jayne M.; Atema, Jelle; Hueter, Robert E.; Motta, Philip J.			Multisensory Integration and Behavioral Plasticity in Sharks from Different Ecological Niches	PLOS ONE			English	Article							ANTERIOR LATERAL-LINE; MEXICAN CAVE FISH; PREY-CAPTURE; MOTTLED SCULPIN; SENSORY BASIS; NURSE SHARK; OYSTER TOADFISH; FLOW; ELECTRORECEPTION; CONSEQUENCES	The underwater sensory world and the sensory systems of aquatic animals have become better understood in recent decades, but typically have been studied one sense at a time. A comprehensive analysis of multisensory interactions during complex behavioral tasks has remained a subject of discussion without experimental evidence. We set out to generate a general model of multisensory information extraction by aquatic animals. For our model we chose to analyze the hierarchical, integrative, and sometimes alternate use of various sensory systems during the feeding sequence in three species of sharks that differ in sensory anatomy and behavioral ecology. By blocking senses in different combinations, we show that when some of their normal sensory cues were unavailable, sharks were often still capable of successfully detecting, tracking and capturing prey by switching to alternate sensory modalities. While there were significant species differences, odor was generally the first signal detected, leading to upstream swimming and wake tracking. Closer to the prey, as more sensory cues became available, the preferred sensory modalities varied among species, with vision, hydrodynamic imaging, electroreception, and touch being important for orienting to, striking at, and capturing the prey. Experimental deprivation of senses showed how sharks exploit the many signals that comprise their sensory world, each sense coming into play as they provide more accurate information during the behavioral sequence of hunting. The results may be applicable to aquatic hunting in general and, with appropriate modification, to other types of animal behavior.	[Gardiner, Jayne M.; Motta, Philip J.] Univ S Florida, Dept Integrat Biol, Tampa, FL 33606 USA; [Gardiner, Jayne M.; Hueter, Robert E.] Mote Marine Lab, Ctr Shark Res, Sarasota, FL 34236 USA; [Atema, Jelle] Boston Univ, Dept Biol, Boston, MA 02215 USA	State University System of Florida; University of South Florida; Mote Marine Laboratory & Aquarium; Boston University	Gardiner, JM (corresponding author), Univ S Florida, Dept Integrat Biol, Tampa, FL 33606 USA.	jayne@mote.org		Gardiner, Jayne/0000-0002-9989-2891	National Science Foundation [IOS-0843440, IOS-0841478, IOS-081502]; Lerner-Gray Grant for Marine Research; American Elasmobranch Society Donald R. Nelson Behavior Research Award; American Society for Ichthyologists and Herpetologists Raney Fund Award; Porter Family Foundation; University of South Florida Presidential Doctoral Fellowship	National Science Foundation(National Science Foundation (NSF)); Lerner-Gray Grant for Marine Research; American Elasmobranch Society Donald R. Nelson Behavior Research Award; American Society for Ichthyologists and Herpetologists Raney Fund Award; Porter Family Foundation; University of South Florida Presidential Doctoral Fellowship	This work was funded by a collaborative National Science Foundation grant, www.nsf.gov [IOS-0843440 to JA, IOS-0841478 to REH, and IOS-081502 to PJM]; a Lerner-Gray Grant for Marine Research to JMG, www.amnh.org; an American Elasmobranch Society Donald R. Nelson Behavior Research Award to JMG, www.elasmo.org, an American Society for Ichthyologists and Herpetologists Raney Fund Award to JMG, www.asih.org; and by the Porter Family Foundation. JMG was supported by a University of South Florida Presidential Doctoral Fellowship, www.usf.edu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD GP, 1974, BIOL REV, V49, P515, DOI 10.1111/j.1469-185X.1974.tb01173.x; ARNOLD SJ, 1983, AM ZOOL, V23, P347, DOI 10.1093/icb/23.2.347; ARONSON LR, 1967, B MAR SCI, V17, P249; Atema J., 1988, SENSORY BIOL AQUATIC; Atema J, 2012, CHEMICAL ECOLOGY IN AQUATIC SYSTEMS, P1; Baker CF, 1999, J COMP PHYSIOL A, V184, P519, DOI 10.1007/s003590050351; Baker CF, 2002, J COMP PHYSIOL A, V188, P553, DOI 10.1007/s00359-002-0329-3; Barry KP, 2002, THESIS LOUISIANA STA; Bateson William, 1890, J MAR BIOL ASSOC UK, V1, P225, DOI [DOI 10.1017/S0025315400072118, 10.1017/S0025315400072118]; Bedore CN, 2014, ZOOLOGY IN PRESS; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blaxter J.H.S., 1989, P481; Castro JI, 1996, B MAR SCI, V59, P508; Castro JI, 2000, ENVIRON BIOL FISH, V58, P1, DOI 10.1023/A:1007698017645; Chagnaud BP, 2008, J NEUROSCI, V28, P4479, DOI 10.1523/JNEUROSCI.4959-07.2008; Collin S. P., 2003, SENSORY PROCESSING A; COOMBS S, 1994, J EXP BIOL, V190, P109; Coombs S, 2001, J EXP BIOL, V204, P337; Cornett AD, 2006, ECOMORPHOLOGY SHARK; Cortes E, 1996, B MAR SCI, V58, P353; Curio E., 1976, ETHOLOGY PREDATION; Denton E.J., 1988, P595; DUNTLEY SQ, 1963, J OPT SOC AM, V53, P214, DOI 10.1364/JOSA.53.000214; Faucher K, 2006, AQUAT TOXICOL, V76, P278, DOI 10.1016/j.aquatox.2005.10.004; Faucher K, 2006, AQUACULTURE, V252, P462, DOI 10.1016/j.aquaculture.2005.07.004; Faucher K, 2010, ANIM BEHAV, V79, P679, DOI 10.1016/j.anbehav.2009.12.020; Ferry-Graham LA, 1998, J EXP BIOL, V201, P2433; Ferry-Graham LA, 2001, J MORPHOL, V248, P99, DOI 10.1002/jmor.1023; Ferry-Graham LA, 2003, ZOOLOGY, V106, P159, DOI 10.1078/0944-2006-00110; Fouts WR, 1999, COPEIA, P304; FRAZZETTA TH, 1987, COPEIA, P979, DOI 10.2307/1445562; Gardiner J.M., 2014, FLOW SENSING AIR WAT, P127, DOI [10.1007/978-3-642-41446-6_5, DOI 10.1007/978-3-642-41446-6_5]; Gardiner JM, 2007, J EXP BIOL, V210, P1925, DOI 10.1242/jeb.000075; Gardiner JM, 2012, ZOOLOGY, V115, P78, DOI 10.1016/j.zool.2011.09.004; Gardiner JM, 2010, CURR BIOL, V20, P1187, DOI 10.1016/j.cub.2010.04.053; Gardiner JM, 2012, THESIS U S FLORIDA T; Grasso FW, 2002, ENVIRON FLUID MECH, V2, P95, DOI 10.1023/A:1016275516949; Haine OS, 2001, MAR FRESHWATER RES, V52, P291, DOI 10.1071/MF00036; Hamasaki D. I., 1965, Bulletin of Marine Science of the Gulf and Caribbean, V15, P1051; Hassan E.S., 1989, P217; HASSAN ES, 1992, J COMP PHYSIOL A, V171, P413; Haverly JE, 1996, COPEIA, P419; Higham TE, 2005, J EXP BIOL, V208, P2653, DOI 10.1242/jeb.01682; Higham TE, 2006, J EXP BIOL, V209, P2713, DOI 10.1242/jeb.02315; HOBSON EDMUND S., 1963, PACIFIC SCI, V17, P171; HODGSON ES, 1971, ANN NY ACAD SCI, V188, P175, DOI 10.1111/j.1749-6632.1971.tb13096.x; Holzman R, 2009, LIMNOL OCEANOGR, V54, P2201, DOI 10.4319/lo.2009.54.6.2201; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hueter RE, 1991, J EXP ZOOL         S, V5, P130; Janssen J, 1996, ENVIRON BIOL FISH, V47, P51, DOI 10.1007/BF00002379; JANSSEN J, 1990, ENVIRON BIOL FISH, V29, P43, DOI 10.1007/BF00000567; Jordan LK, 2009, J EXP BIOL, V212, P3044, DOI 10.1242/jeb.028738; Kajiura SM, 2003, MAR BIOL, V143, P603, DOI 10.1007/s00227-003-1099-3; Kajiura SM, 2002, J EXP BIOL, V205, P3609; Kajiura SM, 2001, ENVIRON BIOL FISH, V61, P125, DOI 10.1023/A:1011028312787; Kajiura SM, 2009, ZOOLOGY, V112, P241, DOI 10.1016/j.zool.2008.07.001; Kalmijn A.J., 1988, P83; Kalmijn A.J., 1974, P147; KALMIJN AJ, 1971, J EXP BIOL, V55, P371; KALMIJN AJ, 1982, SCIENCE, V218, P916, DOI 10.1126/science.7134985; KALMIJN AJ, 1972, SCRIPPS I OCEANOGRAP, V72, P1; KAUS S, 1987, ACTA OTO-LARYNGOL, V103, P291, DOI 10.3109/00016488709107796; Konietschke F., 2012, NPARCOMP PERFORM MUL; KROESE ABA, 1982, HEARING RES, V6, P183, DOI 10.1016/0378-5955(82)90053-3; Lyon EP, 1904, AM J PHYSIOL, V12, P149, DOI 10.1152/ajplegacy.1904.12.2.149; Mann DA, 2007, MAR ECOL PROG SER, V338, P307, DOI 10.3354/meps338307; MATHEWSON RF, 1972, COMP BIOCHEM PHYSIOL, V42, P79, DOI 10.1016/0300-9629(72)90369-6; MATSUURA S, 1971, JPN J PHYSIOL, V21, P579; McComb DM, 2009, J EXP BIOL, V212, P4010, DOI 10.1242/jeb.032615; MCFALLNGAI MJ, 1990, AM ZOOL, V30, P175; McGowan DW, 2009, J EXP BIOL, V212, P1544, DOI 10.1242/jeb.025247; Monroy JA, 2011, J EXP ZOOL PART A, V315A, P61, DOI 10.1002/jez.601; MOSS SA, 1972, AM MIDL NAT, V88, P496, DOI 10.2307/2424384; Motta PJ, 2008, J MORPHOL, V269, P1041, DOI 10.1002/jmor.10626; Motta PJ, 2012, CRC MAR BIOL SER, P153; MYRBERG AA, 1972, B MAR SCI, V22, P926; Myrberg AA, 2001, ENVIRON BIOL FISH, V60, P31; MYRBERG AA, 1974, COPEIA, P358; Nauwelaerts S, 2007, J R SOC INTERFACE, V4, P341, DOI 10.1098/rsif.2006.0180; NELSON DONALD R., 1963, SCIENCE, V142, P975, DOI 10.1126/science.142.3594.975; Packard GC, 1999, COMP BIOCHEM PHYS A, V122, P37, DOI 10.1016/S1095-6433(98)10170-8; Page RA, 2012, NATURWISSENSCHAFTEN, V99, P505, DOI 10.1007/s00114-012-0920-6; Palmer LM, 2005, J EXP BIOL, V208, P3441, DOI 10.1242/jeb.01766; Palmer LM, 2004, J NEUROPHYSIOL, V92, P1034, DOI 10.1152/jn.01151.2003; PARKER GH, 1914, B US BUR FISH, V33, P61; Peach MB, 2003, J FISH BIOL, V62, P793, DOI 10.1046/j.1095-8649.2003.00065.x; Piep M, 2008, ANIM BEHAV, V75, P871, DOI 10.1016/j.anbehav.2007.07.008; Pinheiro J., 2019, NLME LINEAR NONLINEA; Pohlmann K, 2004, J EXP BIOL, V207, P2971, DOI 10.1242/jeb.01129; Raguso RA, 2005, CHEM SENSES, V30, pI295, DOI 10.1093/chemse/bjh231; Roberts B.L., 1978, P331; Ruxton GD, 2009, PHILOS T R SOC B, V364, P549, DOI 10.1098/rstb.2008.0228; Sheldon RE, 1911, J EXP ZOOL, V10, P51, DOI 10.1002/jez.1400100105; Sokal R. R., 2012, BIOMETRY; Srisuradetchai P, 2013, SKILLINGS MACK SKILL; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Team RC, 2013, R LANGUAGE ENV STAT; Tester AL., 1963, SHARKS SURVIVAL, P255; TESTER ALBERT L., 1963, PACIFIC SCI, V17, P145; Tierney KB, 2010, AQUAT TOXICOL, V96, P2, DOI 10.1016/j.aquatox.2009.09.019; Torisawa S, 2011, J FISH BIOL, V79, P1291, DOI 10.1111/j.1095-8649.2011.03113.x; Vasconcelos RO, 2007, J EXP BIOL, V210, P2104, DOI 10.1242/jeb.004317; Vergassola M, 2007, NATURE, V445, P406, DOI 10.1038/nature05464; Vickers NJ, 2000, BIOL BULL, V198, P203, DOI 10.2307/1542524; Viitasalo M, 1998, MAR ECOL PROG SER, V175, P129, DOI 10.3354/meps175129; von Uexkull Joseph D., 2010, FORAY WORLDS ANIMALS; Webster D. R., 2007, TRACE CHEM SENSING E, P109; Wilga CD, 2000, J EXP BIOL, V203, P2781; Windsor SP, 2010, J EXP BIOL, V213, P3819, DOI 10.1242/jeb.040741; Windsor SP, 2010, J EXPT BIOL, V213; Wueringer BE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041605	111	47	48	38	277	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93036	10.1371/journal.pone.0093036	http://dx.doi.org/10.1371/journal.pone.0093036			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695492	Green Published, gold, Green Submitted			2022-12-25	WOS:000334103000034
J	Johnson, H; Solensky, MJ; Satterfield, DA; Davis, AK				Johnson, Haley; Solensky, Michelle J.; Satterfield, Dara A.; Davis, Andrew K.			Does Skipping a Meal Matter to a Butterfly's Appearance? Effects of Larval Food Stress on Wing Morphology and Color in Monarch Butterflies	PLOS ONE			English	Article							LEPIDOPTERA; NUTRITION; MIGRATION; DENSITY; TRAITS; FLIGHT; MELANIZATION; POPULATIONS; SELECTION; MELANISM	In animals with complex life cycles, all resources needed to form adult tissues are procured at the larval stage. For butterflies, the proper development of wings involves synthesizing tissue during metamorphosis based on the raw materials obtained by larvae. Similarly, manufacture of pigment for wing scales also requires resources acquired by larvae. We conducted an experiment to test the effects of food deprivation in the larval stage on multiple measures of adult wing morphology and coloration of monarch butterflies (Danaus plexippus), a species in which long distance migration makes flight efficiency critical. In a captive setting, we restricted food (milkweed) from late-stage larvae for either 24 hrs or 48 hrs, then after metamorphosis we used image analysis methods to measure forewing surface area and elongation (length/width), which are both important for migration. We also measured the brightness of orange pigment and the intensity of black on the wing. There were correlations between several wing features, including an unexpected association between wing elongation and melanism, which will require further study to fully understand. The clearest effect of food restriction was a reduction in adult wing size in the high stress group (by approximately 2%). Patterns observed for other wing traits were ambiguous: monarchs in the low stress group (but not the high) had less elongated and paler orange pigmentation. There was no effect on wing melanism. Although some patterns obtained in this study were unclear, our results concerning wing size have direct bearing on the monarch migration. We show that if milkweed is limited for monarch larvae, their wings become stunted, which could ultimately result in lower migration success.	[Johnson, Haley; Solensky, Michelle J.] Univ Jamestown, Dept Biol, Jamestown, ND USA; [Satterfield, Dara A.; Davis, Andrew K.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Davis, AK (corresponding author), Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.	akdavis@uga.edu	Satterfield, Dara/N-4484-2017	Satterfield, Dara/0000-0003-3036-5580				Altizer SM, 2000, ECOL ENTOMOL, V25, P125, DOI 10.1046/j.1365-2311.2000.00246.x; Altizer S, 2010, EVOLUTION, V64, P1018, DOI 10.1111/j.1558-5646.2010.00946.x; Atterholt AL, 2010, J ENTOMOL SCI, V45, P366, DOI 10.18474/0749-8004-45.4.366; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Barros-Bellanda Helen C. H., 2002, Iheringia, Sér. Zool., V92, P93, DOI 10.1590/S0073-47212002000100009; Bauerfeind SS, 2009, ENTOMOL EXP APPL, V130, P229, DOI 10.1111/j.1570-7458.2008.00814.x; Boggs CL, 2005, OECOLOGIA, V144, P353, DOI 10.1007/s00442-005-0076-6; Bowlin MS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002154; Brower Lincoln P., 1995, Journal of the Lepidopterists' Society, V49, P304; Clusella Trullas S, 2007, J THERM BIOL, V32, P235, DOI 10.1016/j.jtherbio.2007.01.013; Copete JL, 1999, BIRD STUDY, V46, P100, DOI 10.1080/00063659909461119; Davis A.K., 2009, PSYCHE, V2009, P705780, DOI [10.1155/2009/705780, DOI 10.1155/2009/705780]; Davis AK, 2005, J THERM BIOL, V30, P410, DOI 10.1016/j.jtherbio.2005.04.003; Davis AK, 2007, ANN ENTOMOL SOC AM, V100, P339, DOI 10.1603/0013-8746(2007)100[339:WCPFMS]2.0.CO;2; Davis AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041323; Dmitriew C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017399; Ellers J, 2004, BIOL J LINN SOC, V82, P79, DOI 10.1111/j.1095-8312.2004.00319.x; Ethier J, 2012, J INSECT PHYSIOL, V58, P67, DOI 10.1016/j.jinsphys.2011.09.018; Flockhart DTT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045080; GIBO DL, 1993, CAN J ZOOL, V71, P76, DOI 10.1139/z93-012; GIBO DL, 1979, CAN J ZOOL, V57, P1393, DOI 10.1139/z79-180; Hahn DA, 2005, J INSECT PHYSIOL, V51, P1210, DOI 10.1016/j.jinsphys.2005.06.011; Hanley D, 2013, BEHAV ECOL, V24, P1108, DOI 10.1093/beheco/art037; Howard E, 2004, MONARCH BUTTERFLY BIOLOGY AND CONSERVATION, P105; Kemp DJ, 2008, EVOLUTION, V62, P2346, DOI 10.1111/j.1558-5646.2008.00461.x; Knuttel H, 2001, J EXP BIOL, V204, P2447; LAFONT R, 1977, J INSECT PHYSIOL, V23, P277, DOI 10.1016/0022-1910(77)90042-7; Lindsey E, 2009, ECOL ENTOMOL, V34, P551, DOI 10.1111/j.1365-2311.2009.01107.x; McCord JW, 2010, J INSECT BEHAV, V23, P405, DOI 10.1007/s10905-010-9224-x; Nijhout HF, 2010, SCIENCE, V330, P1693, DOI 10.1126/science.1197292; Pellegroms B, 2009, ECOL ENTOMOL, V34, P387, DOI 10.1111/j.1365-2311.2009.01090.x; Pleasants JM, 2013, INSECT CONSERV DIVER, V6, P135, DOI 10.1111/j.1752-4598.2012.00196.x; Sander Sarah E., 2013, Insects, V4, P447, DOI 10.3390/insects4030447; Satterfield DA, ANIMAL MIGR IN PRESS; Satterfield DA, 2013, CURR ZOOL, V59, P393, DOI 10.1093/czoolo/59.3.393; SCOTT DE, 1994, ECOLOGY, V75, P1383, DOI 10.2307/1937462; Statistica, 2003, STAT VERS 6 1; Talloen W, 2004, EVOLUTION, V58, P360, DOI 10.1111/j.0014-3820.2004.tb01651.x; Telang A, 2004, J INSECT PHYSIOL, V50, P677, DOI 10.1016/j.jinsphys.2004.05.001; Tigreros N, 2013, EVOL ECOL, V27, P1145, DOI 10.1007/s10682-013-9647-x; Tigreros N, 2013, FUNCT ECOL, V27, P145, DOI 10.1111/1365-2435.12006; Van Dyck H, 1998, ECOL ENTOMOL, V23, P465, DOI 10.1046/j.1365-2311.1998.00151.x	42	17	17	1	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93492	10.1371/journal.pone.0093492	http://dx.doi.org/10.1371/journal.pone.0093492			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695643	Green Published, Green Submitted, gold			2022-12-25	WOS:000334103000081
J	Riquelme, C; Acuna, MJ; Torrejon, J; Rebolledo, D; Cabrera, D; Santos, RA; Brandan, E				Riquelme, Cecilia; Jose Acuna, Maria; Torrejon, Javiera; Rebolledo, Daniela; Cabrera, Daniel; Santos, Robson A.; Brandan, Enrique			ACE2 Is Augmented in Dystrophic Skeletal Muscle and Plays a Role in Decreasing Associated Fibrosis	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; DUCHENNE MUSCULAR-DYSTROPHY; MOLECULAR-MECHANISMS; ANGIOTENSIN-(1-7); OVEREXPRESSION; REGENERATION; ANGIOTENSIN-CONVERTING-ENZYME-2; FIBROBLASTS; DECORIN; PATHWAY	Duchenne muscular dystrophy (DMD) is the most common inherited neuromuscular disease and is characterized by absence of the cytoskeletal protein dystrophin, muscle wasting, and fibrosis. We previously demonstrated that systemic infusion or oral administration of angiotensin-(1-7) (Ang-(1-7)), a peptide with opposing effects to angiotensin II, normalized skeletal muscle architecture, decreased local fibrosis, and improved muscle function in mdx mice, a dystrophic model for DMD. In this study, we investigated the presence, activity, and localization of ACE2, the enzyme responsible for Ang-(1-7) production, in wild type (wt) and mdx skeletal muscle and in a model of induced chronic damage in wt mice. All dystrophic muscles studied showed higher ACE2 activity than wt muscle. Immunolocalization studies indicated that ACE2 was localized mainly at the sarcolemma and, to a lesser extent, associated with interstitial cells. Similar results were observed in the model of chronic damage in the tibialis anterior (TA) muscle. Furthermore, we evaluated the effect of ACE2 overexpression in mdx TA muscle using an adenovirus containing human ACE2 sequence and showed that expression of ACE2 reduced the fibrosis associated with TA dystrophic muscles. Moreover, we observed fewer inflammatory cells infiltrating the mdx muscle. Finally, mdx gastrocnemius muscles from mice infused with Ang-(1-7), which decreases fibrosis, contain less ACE2 associated with the muscle. This is the first evidence supporting ACE2 as an important therapeutic target to improve the dystrophic skeletal muscle phenotype.	[Riquelme, Cecilia; Jose Acuna, Maria; Torrejon, Javiera; Rebolledo, Daniela; Cabrera, Daniel; Brandan, Enrique] Catholic Univ Chile, Fac Biol Sci, CARE Chile UC, Ctr Aging & Regenerat, Santiago, Chile; [Riquelme, Cecilia; Jose Acuna, Maria; Torrejon, Javiera; Rebolledo, Daniela; Cabrera, Daniel; Brandan, Enrique] Catholic Univ Chile, Fac Biol Sci, Dept Cell & Mol Biol, Santiago, Chile; [Santos, Robson A.] Univ Fed Minas Gerais, INCT Nanobio Far, Inst Biol Sci, Dept Physiol & Biophys, Belo Horizonte, MG, Brazil	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Universidade Federal de Minas Gerais	Brandan, E (corresponding author), Catholic Univ Chile, Fac Biol Sci, CARE Chile UC, Ctr Aging & Regenerat, Santiago, Chile.	ebrandan@bio.puc.cl	Acuna, Maria Jose/V-5926-2019; CABRERA, DANIEL/AAR-5027-2020; Rebolledo, Daniela/GXG-6724-2022; Santos, Robson A S/C-9336-2011; Brandan, Enrique/A-7063-2017	Acuna, Maria Jose/0000-0002-7117-3844; CABRERA, DANIEL/0000-0001-9634-725X; Rebolledo, Daniela/0000-0002-6240-6669; Santos, Robson A S/0000-0001-8738-5852; Brandan, Enrique/0000-0002-6820-5059	FONDECYT [1110426]; CARE [PFB12/2007]; Fundacion Chilena para Biologia Celular	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CARE; Fundacion Chilena para Biologia Celular	This study was supported by research grants from FONDECYT 1110426, CARE PFB12/2007 and Fundacion Chilena para Biologia Celular. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna MJ, 2013, HUM MOL GENET; Alvarez K, 2002, J CELL BIOCHEM, V85, P703, DOI 10.1002/jcb.10184; Bader M, 2012, J RENIN-ANGIO-ALDO S, V13, P505, DOI 10.1177/1470320312466519; Bedair HS, 2008, AM J SPORT MED, V36, P1548, DOI 10.1177/0363546508315470; BENTER IF, 1995, AM J PHYSIOL-HEART C, V269, pH313, DOI 10.1152/ajpheart.1995.269.1.H313; BRANDAN E, 1992, J NEUROSCI RES, V32, P51, DOI 10.1002/jnr.490320107; Brandan E, 2013, FEBS J; Burks TN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002227; Cabello-Verrugio C, 2011, J CELL MOL MED; Caceres S, 2000, EUR J CELL BIOL, V79, P173, DOI 10.1078/S0171-9335(04)70020-5; Casar JC, 2004, J CELL SCI, V117, P73, DOI 10.1242/jcs.00828; De la Porte S, 1999, INT REV CYTOL, V191, P99, DOI 10.1016/S0074-7696(08)60158-8; Desguerre I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004347; Dias-Peixoto MF, 2008, HYPERTENSION, V52, P542, DOI 10.1161/HYPERTENSIONAHA.108.114280; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Echeverria-Rodriguez O, 2014, PEPTIDES, V51, P26, DOI 10.1016/j.peptides.2013.10.022; Epelman S, 2008, J AM COLL CARDIOL, V52, P750, DOI 10.1016/j.jacc.2008.02.088; Epelman S, 2009, J CARD FAIL, V15, P565, DOI 10.1016/j.cardfail.2009.01.014; Fadic R, 2005, BIOL RES, V38, P375, DOI 10.4067/S0716-97602005000400010; Fadic R, 2006, J CELL MOL MED, V10, P758, DOI 10.1111/j.1582-4934.2006.tb00435.x; Fernandes T, 2010, BRAZ J MED BIOL RES, V43, P837, DOI 10.1590/S0100-879X2010000900005; Ferrario CM, 2011, CURR OPIN NEPHROL HY, V20, P1, DOI 10.1097/MNH.0b013e3283406f57; Ferrario CM, 2005, AM J PHYSIOL-HEART C, V289, pH2281, DOI 10.1152/ajpheart.00618.2005; Ferreira AJ, 2001, HYPERTENSION, V38, P665, DOI 10.1161/01.HYP.38.3.665; Fraga-Silva RA, 2012, THROMB HAEMOSTASIS, V108, P1089, DOI 10.1160/TH12-06-0396; Morales MG, 2011, J PATHOL, V225, P490, DOI 10.1002/path.2952; Grobe JL, 2007, CLIN SCI, V113, P357, DOI 10.1042/CS20070160; Grobe JL, 2007, AM J PHYSIOL-HEART C, V292, pH736, DOI 10.1152/ajpheart.00937.2006; Guo LT, 2005, NEUROMUSCULAR DISORD, V15, P786, DOI 10.1016/j.nmd.2005.06.019; Henderson NC, 2013, NAT MED, V19, P1617, DOI 10.1038/nm.3282; Iwata M, 2005, AM J PHYSIOL-HEART C, V289, pH2356, DOI 10.1152/ajpheart.00317.2005; Jin HY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042432, 10.1371/journal.pone.0038502]; Jorgensen LH, 2007, AM J PATHOL, V171, P1599, DOI 10.2353/ajpath.2007.070435; MacDonald EM, 2012, CURR OPIN RHEUMATOL, V24, P628, DOI 10.1097/BOR.0b013e328358df34; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; Marangoni RA, 2006, PEPTIDES, V27, P1770, DOI 10.1016/j.peptides.2006.02.002; Mercure C, 2008, CIRC RES, V103, P1319, DOI 10.1161/CIRCRESAHA.108.184911; Morales MG, 2013, HUM MOL GENET UNPUB; Murca TM, 2012, REGUL PEPTIDES, V177, P107, DOI 10.1016/j.regpep.2012.05.093; Paulis L, 2012, NAT REV CARDIOL, V9, P276, DOI 10.1038/nrcardio.2012.33; Pessina P, 2014, SKELETAL MU IN PRESS; Porter JD, 2004, HUM MOL GENET, V13, P257, DOI 10.1093/hmg/ddh033; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Santos RAS, 2008, EXP PHYSIOL, V93, P519, DOI 10.1113/expphysiol.2008.042002; Serrano AL, 2010, EXP CELL RES, V316, P3050, DOI 10.1016/j.yexcr.2010.05.035; Simoes ESAC, 2013, BR J PHARM; Steckelings UM, 2012, CURR OPIN NEPHROL HY, V21, P142, DOI 10.1097/MNH.0b013e328350261b; Tallant EA, 2005, AM J PHYSIOL-HEART C, V289, pH1560, DOI 10.1152/ajpheart.00941.2004; Varga G, 2005, FIBROSIS RES METHODS, P117; Vickers C, 2002, J BIOL CHEM, V277, P14838, DOI 10.1074/jbc.M200581200; Watchko JF, 2002, J APPL PHYSIOL, V93, P407, DOI 10.1152/japplphysiol.01242.2001; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Xia HJ, 2013, CIRC RES, V113, P1087, DOI 10.1161/CIRCRESAHA.113.301811; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Zhou L, 2010, J NEUROPATH EXP NEUR, V69, P771, DOI 10.1097/NEN.0b013e3181e9a34b	56	49	49	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93449	10.1371/journal.pone.0093449	http://dx.doi.org/10.1371/journal.pone.0093449			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695436	Green Published, Green Submitted, gold			2022-12-25	WOS:000334103000074
J	Tranquilla, LAM; Montevecchi, WA; Fifield, DA; Hedd, A; Gaston, AJ; Robertson, GJ; Phillips, RA				Tranquilla, Laura A. McFarlane; Montevecchi, William A.; Fifield, David A.; Hedd, April; Gaston, Anthony J.; Robertson, Gregory J.; Phillips, Richard A.			Individual Winter Movement Strategies in Two Species of Murre ( Uria spp.) in the Northwest Atlantic	PLOS ONE			English	Article							TRANS-EQUATORIAL MIGRATION; HABITAT USE; PHENOTYPIC PLASTICITY; LAYING DATE; SEABIRD; TRACKING; OCEAN; DIET; REPEATABILITIES; DECISIONS	Individual wintering strategies and patterns of winter site fidelity in successive years are highly variable among seabird species. Yet, an understanding of consistency in timing of movements and the degree of site fidelity is essential for assessing how seabird populations might be influenced by, and respond to, changing conditions on wintering grounds. To explore annual variation in migratory movements and wintering areas, we applied bird-borne geolocators on Thick-billed Murres (Uria lomvia, n = 19) and Common Murres (U. aalge, n = 20) from 5 colonies in the Northwest Atlantic for 2-4 consecutive years. Thick-billed Murres ranged widely and among-individual wintering strategies were highly variable, whereas most Common Murres wintered relatively near their colonies, with among-individual variation represented more by the relative use of inshore vs. offshore habitat. Within individuals, some aspects of the wintering strategy were more repeatable than others: colony arrival and departure dates were more consistent by individual Common than Thick-billed Murres, while the sizes of home ranges (95% utilization distributions) and distances travelled to wintering area were more repeatable for both species. In consecutive years, individual home ranges overlapped from 0- 64% (Thick-billed Murres) and 0-95% (Common Murres); and the winter centroids were just 239 km and 169 km apart (respectively). Over the 3-4 year timescale of our study, individuals employed either fixed or flexible wintering strategies; although most birds showed high winter site fidelity, some shifted core ranges after 2 or 3 years. The capacity among seabird species for a combination of fidelity and flexibility, in which individuals may choose from a range of alternative strategies, deserves further, longer term attention.	[Tranquilla, Laura A. McFarlane; Montevecchi, William A.; Fifield, David A.; Hedd, April] Mem Univ Newfoundland, Dept Psychol, St John, NF, Canada; [Gaston, Anthony J.] Carleton Univ, Natl Wildlife Res Ctr, Environm Canada, Ottawa, ON K1S 5B6, Canada; [Robertson, Gregory J.] Environm Canada, Wildlife Res Div, Mt Pearl, NF, Canada; [Phillips, Richard A.] British Antarctic Survey, NERC, Cambridge CB3 0ET, England	Memorial University Newfoundland; Carleton University; Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada; Environment & Climate Change Canada; Canadian Wildlife Service; Wildlife Research Division - Environment Canada; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Tranquilla, LAM (corresponding author), Mem Univ Newfoundland, Dept Psychol, St John, NF, Canada.	lat@alumni.sfu.ca	Robertson, Greg/AAI-5849-2020	Robertson, Greg/0000-0001-8452-5506; Hedd, April/0000-0003-2222-2627	National Sciences and Engineering Research Council (NSERC); Wildlife Habitat Canada and Bird Studies Canada Murre Fund of Newfoundland and Labrador; Government of Canada's International Polar Year; Northern Scientific Training Programs; Polar Continental Shelf Project of Natural Resources Canada; NSERC PGS-D Scholarship; Environment Canada; Natural Environment Research Council [bas0100025] Funding Source: researchfish; NERC [bas0100025] Funding Source: UKRI	National Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Wildlife Habitat Canada and Bird Studies Canada Murre Fund of Newfoundland and Labrador; Government of Canada's International Polar Year; Northern Scientific Training Programs; Polar Continental Shelf Project of Natural Resources Canada; NSERC PGS-D Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Environment Canada(CGIAR); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by a National Sciences and Engineering Research Council (NSERC) Discovery Grant (WAM); the Wildlife Habitat Canada and Bird Studies Canada Murre Fund of Newfoundland and Labrador (WAM); the Government of Canada's International Polar Year (WAM, AJG) and Northern Scientific Training Programs (LMT), the Polar Continental Shelf Project of Natural Resources Canada (AJG), an NSERC PGS-D Scholarship (LMT) and by logistical and financial support from Environment Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agashe D, 2010, P ROY SOC B-BIOL SCI, V277, P2915, DOI 10.1098/rspb.2010.0232; AINLEY DG, 2002, BIRDS N AM, V666; Araujo MS, 2011, ECOL LETT, V14, P948, DOI 10.1111/j.1461-0248.2011.01662.x; BAKER RR, 1980, BIRD STUDY, V27, P41, DOI 10.1080/00063658009476655; BIRKHEAD TR, 1982, ECOLOGY, V63, P300, DOI 10.2307/1938946; Bogdanova MI, 2011, P ROY SOC B-BIOL SCI, V278, P2412, DOI 10.1098/rspb.2010.2601; Burke CM, 2011, ARCTIC, V64, P302; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Catry P, 1999, OIKOS, V84, P473, DOI 10.2307/3546426; Catry P, 2013, ECOLOGY, V94, P1230, DOI 10.1890/12-2177.1; Conklin JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054535; Croxall JP, 2005, SCIENCE, V307, P249, DOI 10.1126/science.1106042; DeForest LN, 1996, ECOLOGY, V77, P1501, DOI 10.2307/2265547; Dias MP, 2011, P ROY SOC B-BIOL SCI, V278, P1786, DOI 10.1098/rspb.2010.2114; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; Esler D, 2000, CONSERV BIOL, V14, P366, DOI 10.1046/j.1523-1739.2000.98147.x; Fifield DA, 2013, ORNITHHOL M IN PRESS; Fort J, 2013, DIVERS DISTRIB, V19, P1322, DOI 10.1111/ddi.12105; Fort J, 2013, J AVIAN BIOL, V44, P255, DOI 10.1111/j.1600-048X.2012.00128.x; Fort J, 2012, FRONT ECOL ENVIRON, V10, P237, DOI 10.1890/110194; Frederiksen M, 2012, DIVERS DISTRIB, V18, P530, DOI 10.1111/j.1472-4642.2011.00864.x; GASTON AJ, 2000, BIRDS N AM, V497; Gaston AJ, 2002, 106 CAN WILDL SERV; Gaston AJ, 2011, MAR BIOL, V158, P1929, DOI 10.1007/s00227-011-1704-9; Gonzalez-Solis J, 2007, FRONT ECOL ENVIRON, V5, P297, DOI 10.1890/1540-9295(2007)5[297:TMAMIT]2.0.CO;2; Guilford T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021336; Harris MP, 1996, BIRD STUDY, V43, P220, DOI 10.1080/00063659609461014; Harrison XA, 2011, J ANIM ECOL, V80, P4, DOI 10.1111/j.1365-2656.2010.01740.x; Hedd A, 2011, ANIM CONSERV, V14, P630, DOI 10.1111/j.1469-1795.2011.00479.x; Hedd A, 2012, MAR ECOL PROG SER, V449, P277, DOI 10.3354/meps09538; HILL R.D., 2001, ELECT TAGGING TRACKI; Kernaleguen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032916; Kopp M, 2011, MAR ECOL PROG SER, V435, P263, DOI 10.3354/meps09229; Kubetzki U, 2009, MAR ECOL PROG SER, V391, P257, DOI 10.3354/meps08254; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Lisovski S, 2012, METHODS ECOL EVOL, V3, P603, DOI 10.1111/j.2041-210X.2012.00185.x; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Oppel S, 2009, J ANIM ECOL, V78, P524, DOI 10.1111/j.1365-2656.2008.01513.x; Phillips RA, 2005, ECOLOGY, V86, P2386, DOI 10.1890/04-1885; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Phillips RA, 2009, OECOLOGIA, V160, P795, DOI 10.1007/s00442-009-1342-9; Pulido F, 2007, CLIM RES, V35, P5, DOI 10.3354/cr00711; Quillfeldt P, 2010, BEHAV ECOL SOCIOBIOL, V64, P1157, DOI 10.1007/s00265-010-0931-2; *R COR DEV TEAM, 2012, R LANG ENV STAT COMP; Reed TE, 2010, P ROY SOC B-BIOL SCI, V277, P3391, DOI 10.1098/rspb.2010.0771; Reed TE, 2009, J ANIM ECOL, V78, P376, DOI 10.1111/j.1365-2656.2008.01503.x; Regular PM, 2013, ANIM BEHAV, V86, P545, DOI 10.1016/j.anbehav.2013.06.008; Roshier DA, 2008, OECOLOGIA, V156, P465, DOI 10.1007/s00442-008-0987-0; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Smith PA, 2012, MAR ECOL PROG SER, V454, P237, DOI 10.3354/meps09589; Sorensen MC, 2009, J ANIM ECOL, V78, P460, DOI 10.1111/j.1365-2656.2008.01492.x; Stenhouse IJ, 2012, IBIS, V154, P42, DOI 10.1111/j.1474-919X.2011.01180.x; Tranquilla LAM, 2013, MAR ECOL PROG SER, V472, P287, DOI 10.3354/meps10053; Tuck L.M, 1961, CANADIAN WILDLIFE SE, V1; WANLESS S, 1988, ORNIS SCAND, V19, P205, DOI 10.2307/3676560; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Woo KJ, 2008, J ANIM ECOL, V77, P1082, DOI 10.1111/j.1365-2656.2008.01429.x	57	44	44	0	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e90583	10.1371/journal.pone.0090583	http://dx.doi.org/10.1371/journal.pone.0090583			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24694734	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000334103000009
J	Zhou, Y; Liu, P; Liu, BJ; Liu, XJ; Zhang, XM; Wang, F; Yang, HS				Zhou, Yi; Liu, Peng; Liu, Bingjian; Liu, Xujia; Zhang, Xiaomei; Wang, Feng; Yang, Hongsheng			Restoring Eelgrass (Zostera marina L.) Habitats Using a Simple and Effective Transplanting Technique	PLOS ONE			English	Article							CHESAPEAKE BAY; SEAGRASS ECOSYSTEMS; NATURAL-WATERS; RESTORATION; TEMPERATURE; PHOSPHORUS; AUSTRALIA; SEDIMENTS; MARYLAND; SULFIDE	Eelgrass beds in coastal waters of China have declined substantially over the past 30 years. In this study, a simple new transplanting technique was developed for eelgrass ( Zostera marina L.) restoration. To assist in anchoring single shoots, several rhizomes of rooted shoots were bound to a small elongate stone ( 50-150 g) with biodegradable thread ( cotton or hemp), and then the bound packet was buried at an angle in the sediments at a depth of 2-4 cm. This stone anchoring method was used to transplant eelgrass in early November 2009 and late May 2010 in Huiquan Bay, Qingdao. The method led to high success. Three month survivorship of the transplanted shoots at the two transplant sites was >95%. From April 20 to November 19, 2012, the following characteristics of the 2009 and 2010 transplanted eelgrass beds were monitored: morphological changes, shoot density, shoot height, leaf biomass, and sediment particle size. Results showed that the sexual reproduction period of the planted eelgrass was from April to August, and vegetative reproduction reached its peak in autumn. Maximum shoot height and biomass were observed in June and July. After becoming established, the transplanted eelgrass beds were statistically equal to natural eelgrass beds nearby in terms of shoot height, biomass, and seasonal variations. This indicates that the transplant technique is effective for eelgrass restoration in coastal waters.	[Zhou, Yi; Liu, Peng; Liu, Bingjian; Liu, Xujia; Zhang, Xiaomei; Wang, Feng; Yang, Hongsheng] Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China; [Liu, Peng; Liu, Bingjian; Zhang, Xiaomei; Wang, Feng] Univ Chinese Acad Sci, Beijing, Peoples R China; [Liu, Xujia] Guangxi Inst Oceanol, Key Lab Marine Biol Technol, Beihai, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhou, Y (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China.	yizhou@qdio.ac.cn	Liu, Peng/AAC-4167-2021; Zhou, Yi/F-4219-2011	Liu, Peng/0000-0002-3347-649X; Zhou, Yi/0000-0001-7300-0173	National Natural Science Foundation of China [41121064/41176140]; National Marine Public Welfare Research Project [201305043/201005009]; Key Projects in the National Science & Technology Pillar Program [2011BAD13B06]; Science & Technology Development Project of Qingdao City South District [2009517HY]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Marine Public Welfare Research Project; Key Projects in the National Science & Technology Pillar Program; Science & Technology Development Project of Qingdao City South District	This research was supported by the National Natural Science Foundation of China (No. 41121064/41176140), the National Marine Public Welfare Research Project (201305043/201005009), the Key Projects in the National Science & Technology Pillar Program during the 12th Five-year Plan Period (2011BAD13B06), and the Science & Technology Development Project of Qingdao City South District (2009517HY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, SEAGRASSES BIOL ECOL, DOI DOI 10.1007/978-1-4020-2983-7; Balestri E, 2012, J APPL ECOL, V49, P1426, DOI 10.1111/j.1365-2664.2012.02197.x; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Bastyan GR, 2008, ESTUAR COAST SHELF S, V79, P289, DOI 10.1016/j.ecss.2008.04.012; Bell SS, 2008, RESTOR ECOL, V16, P407, DOI 10.1111/j.1526-100X.2007.00308.x; Bos AR, 2007, ESTUAR COAST SHELF S, V74, P344, DOI 10.1016/j.ecss.2007.04.006; Bouma TJ, 2005, ECOLOGY, V86, P2187, DOI 10.1890/04-1588; Bradley MP, 2006, AQUAT BOT, V84, P121, DOI 10.1016/j.aquabot.2005.08.003; Busch KE, 2010, RESTOR ECOL, V18, P490, DOI 10.1111/j.1526-100X.2010.00690.x; Calleja ML, 2007, ESTUAR COAST SHELF S, V73, P583, DOI 10.1016/j.ecss.2007.02.016; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Cunha AH, 2012, RESTOR ECOL, V20, P427, DOI 10.1111/j.1526-100X.2012.00878.x; Davis RC, 1997, AQUAT BOT, V59, P1, DOI 10.1016/S0304-3770(97)00034-X; Duarte Carlos M., 2008, P281, DOI 10.1017/CBO9780511751790.025; Fishman JR, 2004, RESTOR ECOL, V12, P214, DOI 10.1111/j.1061-2971.2004.00314.x; Fishman JR, 1996, J EXP MAR BIOL ECOL, V198, P11, DOI 10.1016/0022-0981(95)00176-X; FONSECA M. S., 1994, RESTOR ECOL, V2, P198, DOI DOI 10.1111/J.1526-100X.1994.TB00067.X; Fourqurean JW, 2012, NAT GEOSCI, V5, P505, DOI 10.1038/ngeo1477; Golden RR, 2010, RESTOR ECOL, V18, P501, DOI 10.1111/j.1526-100X.2010.00691.x; Greiner JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072469; Harwell MC, 1999, AQUAT BOT, V64, P51, DOI 10.1016/S0304-3770(99)00008-X; Heck KL, 2006, J EXP MAR BIOL ECOL, V330, P420, DOI 10.1016/j.jembe.2005.12.044; Hemminga M.A., 2000, SEAGRASS ECOLOGY, DOI [10.1017/CBO9780511525551, DOI 10.1017/CBO9780511525551]; Koch MS, 2007, J EXP MAR BIOL ECOL, V341, P91, DOI 10.1016/j.jembe.2006.10.004; Lavery PS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073748; Lee KS, 2008, MAR POLLUT BULL, V56, P1015, DOI 10.1016/j.marpolbul.2008.02.010; Lee KS, 2007, J EXP MAR BIOL ECOL, V350, P144, DOI 10.1016/j.jembe.2007.06.016; Liu XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058293; Orth RJ, 2000, MAR ECOL PROG SER, V200, P277, DOI 10.3354/meps200277; Orth RJ, 1999, AQUAT BOT, V64, P77, DOI 10.1016/S0304-3770(99)00007-8; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Orth RJ, 2009, AQUAT BOT, V90, P204, DOI 10.1016/j.aquabot.2008.07.004; Paling EI, 2001, ECOL ENG, V16, P331, DOI 10.1016/S0925-8574(00)00119-1; Park JI, 2010, ECOL ENG, V36, P450, DOI 10.1016/j.ecoleng.2009.11.012; Phillips R., 1990, SEAGRASS RES METHODS; PHILLIPS RC, 1974, AQUACULTURE, V4, P161, DOI 10.1016/0044-8486(74)90031-3; Shafer D, 2010, RESTOR ECOL, V18, P481, DOI 10.1111/j.1526-100X.2010.00689.x; Short F, 2007, J EXP MAR BIOL ECOL, V350, P3, DOI 10.1016/j.jembe.2007.06.012; Short FT, 2011, BIOL CONSERV, V144, P1961, DOI 10.1016/j.biocon.2011.04.010; Short FT, 1996, ENVIRON CONSERV, V23, P17, DOI 10.1017/S0376892900038212; Short FT, 2002, MAR ECOL PROG SER, V227, P253, DOI 10.3354/meps227253; SOLORZANO L, 1980, LIMNOL OCEANOGR, V25, P754, DOI 10.4319/lo.1980.25.4.0754; van der Heide T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042060; van Katwijk MM, 2000, CHALLENGES WADDEN SE; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; WEST RJ, 1990, MAR POLLUT BULL, V21, P197, DOI 10.1016/0025-326X(90)90502-Y; Zhou Y, 2003, WATER RES, V37, P3875, DOI 10.1016/S0043-1354(03)00267-7	47	31	35	2	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e92982	10.1371/journal.pone.0092982	http://dx.doi.org/10.1371/journal.pone.0092982			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695414	Green Published, gold, Green Submitted			2022-12-25	WOS:000334103000032
J	Bao, YB; Zhang, LL; Dong, YH; Lin, ZH				Bao, Yongbo; Zhang, Lili; Dong, Yinghui; Lin, Zhihua			Identification and Comparative Analysis of the Tegillarca granosa Haemocytes MicroRNA Transcriptome in Response to Cd Using a Deep Sequencing Approach	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; HEAVY-METALS; CADMIUM; EXPRESSION; TARGETS; PHYTOCHELATINS; DROSOPHILA; EVOLUTION; MIR-100; STRESS	Background: MicroRNAs (miRNAs) are endogenous non-coding small RNAs (sRNAs) that can base pair with their target mRNAs, which represses their translation or induces their degradation in various biological processes. To identify miRNAs regulated by heavy metal stress, we constructed two sRNA libraries for the blood clam Tegillarca granosa: one for organisms exposed to toxic levels of cadmium (Cd) and one for a control group. Results: Sequencing of the two libraries and subsequent analysis revealed 215 conserved and 39 new miRNAs. Most of the new miRNAs in T. granosa were up-or down-regulated in response to Cd exposure. There were significant differences in expression between the Cd and control groups for 16 miRNAs. Of these, five miRNAs were significantly up-regulated and 11 were significantly down-regulated in the Cd stress library. Potential targets were predicted for the 16 differential miRNAs in pre-miRNAs identified according to sequence homology. Some of the predicted miRNA targets are associated with regulation of the response to stress induced by heavy metals. Five differentially expressed miRNAs (Tgr-nmiR-8, Tgr-nmiR-21, Tgr-miR-2a, Tgr-miR-10a-5p, and Tgr-miR-184b) were validated by qRT-PCR. Conclusion: Our study is the first large-scale identification of miRNAs in T. granosa haemocytes. Our findings suggest that some miRNAs and their target genes and pathways may play critical roles in the responses of this species to environmental heavy metal stresses.	[Bao, Yongbo; Zhang, Lili; Dong, Yinghui; Lin, Zhihua] Zhejiang Wanli Univ, Zhejiang Key Lab Aquat Germplasm Resources, Ningbo, Zhejiang, Peoples R China	Zhejiang Wanli University	Bao, YB (corresponding author), Zhejiang Wanli Univ, Zhejiang Key Lab Aquat Germplasm Resources, Ningbo, Zhejiang, Peoples R China.	bobbao2001@gmail.com; zhihua9988@126.com			National High-tech R&D Program of China [2012AA10A410]; Chinese Agriculture Research System [CARS-48]; Zhejiang Major Program of Science and Technology [2012C12907-4]; Ningbo Innovation Team of Marine Shellfish Science and Technology [2011B82017]	National High-tech R&D Program of China(National High Technology Research and Development Program of China); Chinese Agriculture Research System; Zhejiang Major Program of Science and Technology; Ningbo Innovation Team of Marine Shellfish Science and Technology	This research was supported by National High-tech R&D Program of China (2012AA10A410), Chinese Agriculture Research System (CARS-48), Zhejiang Major Program of Science and Technology (2012C12907-4) and Ningbo Innovation Team of Marine Shellfish Science and Technology (2011B82017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboobaker AA, 2005, P NATL ACAD SCI USA, V102, P18017, DOI 10.1073/pnas.0508823102; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blaudez D, 2003, PLANT CELL, V15, P2911, DOI 10.1105/tpc.017541; BOQUIST L, 1971, GEN COMP ENDOCR, V17, P236, DOI 10.1016/0016-6480(71)90172-9; Campbell SJ, 2012, J BIOL CHEM, V287, P23900, DOI 10.1074/jbc.M112.359653; Cobbett CS, 2000, PLANT PHYSIOL, V123, P825, DOI 10.1104/pp.123.3.825; Cristino AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019350; Ding YF, 2009, BIOCHEM BIOPH RES CO, V386, P6, DOI 10.1016/j.bbrc.2009.05.137; Enright AJ, 2004, GENOME BIOL, V5; Ernst WHO, 2008, PLANT CELL ENVIRON, V31, P123, DOI 10.1111/j.1365-3040.2007.01746.x; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Guzman F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049811; Hammond-Martel I, 2012, CELL SIGNAL, V24, P410, DOI 10.1016/j.cellsig.2011.10.009; Han FXX, 2002, NATURWISSENSCHAFTEN, V89, P497, DOI 10.1007/s00114-002-0373-4; Harada E, 2002, J PLANT PHYSIOL, V159, P445, DOI 10.1078/0176-1617-00733; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Herbette S, 2006, BIOCHIMIE, V88, P1751, DOI 10.1016/j.biochi.2006.04.018; Huang SQ, 2009, J INORG BIOCHEM, V103, P282, DOI 10.1016/j.jinorgbio.2008.10.019; Jiao Y, 2014, MAR BIOTECHNOL, V16, P54, DOI 10.1007/s10126-013-9528-x; Kefaloyianni E, 2005, J EXP BIOL, V208, P4427, DOI 10.1242/jeb.01924; Li BH, 2011, EUR J CANCER, V47, P2166, DOI 10.1016/j.ejca.2011.04.037; Li CH, 2012, FISH SHELLFISH IMMUN, V33, P436, DOI 10.1016/j.fsi.2012.04.013; Li P, 2011, MOL BIOL REP, V38, P355, DOI 10.1007/s11033-010-0115-1; Lund AH, 2010, CELL DEATH DIFFER, V17, P209, DOI 10.1038/cdd.2009.58; Marco A, 2012, RNA BIOL, V9, P242, DOI 10.4161/rna.19160; Martinez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019523; MERALI Z, 1976, BRIT J PHARMACOL, V57, P573, DOI 10.1111/j.1476-5381.1976.tb10387.x; Nagaraja AK, 2010, MOL ENDOCRINOL, V24, P447, DOI 10.1210/me.2009-0295; Nolo R, 2006, CURR BIOL, V16, P1895, DOI 10.1016/j.cub.2006.08.057; Pal R, 2010, APPL BIOCHEM BIOTECH, V160, P945, DOI 10.1007/s12010-009-8565-4; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Schmidt Ulrike, 2013, Front Psychiatry, V4, P66, DOI 10.3389/fpsyt.2013.00066; Schulte LN, 2011, EMBO J, V30, P1977, DOI 10.1038/emboj.2011.94; Shan Z, 2013, CHINESE MED J-PEKING, V126, P515, DOI 10.3760/cma.j.issn.0366-6999.20122289; Skalsky RL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-119; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Sun YM, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-6; Takiguchi M, 2003, EXP CELL RES, V286, P355, DOI 10.1016/S0014-4827(03)00062-4; VIARENGO A, 1993, COMP BIOCHEM PHYS C, V104, P355, DOI 10.1016/0742-8413(93)90001-2; Wang C, 2011, PHYSIOL PLANTARUM, V143, P64, DOI 10.1111/j.1399-3054.2011.01481.x; Wang SL, 2013, MAR POLLUT BULL, V76, P7, DOI 10.1016/j.marpolbul.2013.08.025; Wei YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r6; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; Wu ZH, 2012, ENVIRON EARTH SCI, V66, P2417, DOI 10.1007/s12665-011-1466-1; Zhou ZS, 2012, J EXP BOT, V63, P4597, DOI 10.1093/jxb/ers136; Zhou ZS, 2012, PLANT CELL ENVIRON, V35, P86, DOI 10.1111/j.1365-3040.2011.02418.x	46	16	21	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93619	10.1371/journal.pone.0093619	http://dx.doi.org/10.1371/journal.pone.0093619			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690903	Green Submitted, gold, Green Published			2022-12-25	WOS:000334101100113
J	Fagyas, M; Uri, K; Siket, IM; Fulop, GA; Csato, V; Darago, A; Boczan, J; Banyai, E; Szentkiralyi, IE; Maros, TM; Szerafin, T; Edes, I; Papp, Z; Toth, A				Fagyas, Miklos; Uri, Katalin; Siket, Ivetta M.; Fueloep, Gabor A.; Csato, Viktoria; Darago, Andrea; Boczan, Judit; Banyai, Emese; Szentkiralyi, Istvan Elek; Maros, Tamas Miklos; Szerafin, Tamas; Edes, Istvan; Papp, Zoltan; Toth, Attila			New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) II: Albumin Suppresses Angiotensin Converting Enzyme (ACE) Activity in Human	PLOS ONE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; HUMAN-SERUM-ALBUMIN; EUROPEAN-SOCIETY; TASK-FORCE; TRYPTIC HYDROLYSATE; ENDOGENOUS INHIBITOR; CARDIOLOGY ESC; GUIDELINES; ASSOCIATION; DISEASE	About 8% of the adult population is taking angiotensin-converting enzyme (ACE) inhibitors to treat cardiovascular disease including hypertension, myocardial infarction and heart failure. These drugs decrease mortality by up to one-fifth in these patients. We and others have reported previously that endogenous inhibitory substances suppress serum ACE activity, in vivo, similarly to the ACE inhibitor drugs. Here we have made an effort to identify this endogenous ACE inhibitor substance. ACE was crosslinked with interacting proteins in human sera. The crosslinked products were immunoprecipitated and subjected to Western blot. One of the crosslinked products was recognized by both anti-ACE and anti-HSA (human serum albumin) antibodies. Direct ACE-HSA interaction was confirmed by binding assays using purified ACE and HSA. HSA inhibited human purified (circulating) and human recombinant ACE with potencies (IC50) of 5.7 +/- 0.7 and 9.5 +/- 1.1 mg/mL, respectively. Effects of HSA on the tissue bound native ACE were tested on human saphenous vein samples. Angiotensin I evoked vasoconstriction was inhibited by HSA in this vascular tissue (maximal force with HSA: 6.14 +/- 1.34 mN, without HSA: 13.54 +/- 2.63 mN), while HSA was without effects on angiotensin II mediated constrictions (maximal force with HSA: 18.73 +/- 2.17 mN, without HSA: 19.22 +/- 3.50 mN). The main finding of this study is that HSA was identified as a potent physiological inhibitor of the ACE. The enzymatic activity of ACE appears to be almost completely suppressed by HSA when it is present in its physiological concentration. These data suggest that angiotensin I conversion is limited by low physiological ACE activities, in vivo.	[Fagyas, Miklos; Uri, Katalin; Siket, Ivetta M.; Fueloep, Gabor A.; Csato, Viktoria; Darago, Andrea; Edes, Istvan; Papp, Zoltan; Toth, Attila] Univ Debrecen, Inst Cardiol, Div Clin Physiol, H-4012 Debrecen, Hungary; [Boczan, Judit] Univ Debrecen, Dept Neurol, H-4012 Debrecen, Hungary; [Banyai, Emese] Univ Debrecen, Div Nephrol, Inst Internal Med, H-4012 Debrecen, Hungary; [Szentkiralyi, Istvan Elek; Maros, Tamas Miklos; Szerafin, Tamas] Univ Debrecen, Inst Cardiol, Dept Cardiac Surg, H-4012 Debrecen, Hungary	University of Debrecen; University of Debrecen; University of Debrecen; University of Debrecen	Toth, A (corresponding author), Univ Debrecen, Inst Cardiol, Div Clin Physiol, H-4012 Debrecen, Hungary.	atitoth@med.unideb.hu	Fagyas, Miklós/AAQ-1013-2020; Tóth, Attila/F-4859-2010	Fagyas, Miklós/0000-0003-3262-884X; Tóth, Attila/0000-0001-6503-3653	Hungarian Academy of Sciences OTKA [K84300]; Hungarian Ministry of Health [ETT 377/2009]; MSD Magyarorszag Kft; Pfizer Magyarorszag Kft; European Social Fund; National Innovation Office of Hungary; Bolyai Janos Research Scholarship of the Hungarian Academy of Sciences;  [TAMOP 4.2.1./B-09/1/KONV-2010-0007];  [TAMOP-4.2.2.A-11/1/KONV-2012-0045];  [REG-EA-09-1-2009-0013]	Hungarian Academy of Sciences OTKA(Hungarian Academy of SciencesOrszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Ministry of Health; MSD Magyarorszag Kft; Pfizer Magyarorszag Kft; European Social Fund(European Social Fund (ESF)); National Innovation Office of Hungary; Bolyai Janos Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); ; ; 	The study was supported by the Hungarian Academy of Sciences OTKA (K84300 toAT) and by the Hungarian Ministry of Health (ETT 377/2009 to AT); the work is supported by the TAMOP 4.2.1./B-09/1/KONV-2010-0007 TAMOP-4.2.2.A-11/1/KONV-2012-0045, REG-EA-09-1-2009-0013 projects (to AT, IE and ZP); MSD Magyarorszag Kft, Pfizer Magyarorszag Kft also supported some of the research. The project is implemented through the New Hungary Development Plan, co-financed by the European Social Fund; and by the National Innovation Office of Hungary (Baross Gabor Project, EletMent). Finally, AT was supported by the Bolyai Janos Research Scholarship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, PLOS ONE; BENETEAU B, 1986, CLIN CHEM, V32, P884; Brecher AS, 1996, ARCH INT PHARMACOD T, V331, P301; Carmona AK, 2006, NAT PROTOC, V1, P1971, DOI 10.1038/nprot.2006.306; CORVOL P, 1995, J HYPERTENS, V13, pS3, DOI 10.1097/00004872-199509003-00002; CUSHMAN DW, 1971, BIOCHIM BIOPHYS ACTA, V250, P261, DOI 10.1016/0005-2744(71)90142-2; Davidson NC, 1996, CIRCULATION, V93, P1155, DOI 10.1161/01.CIR.93.6.1155; Dzau VJ, 2001, AM J CARDIOL, V88, p1L; Fagyas M, 2014, PLOS ONE; Fagyas M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087843; Fox KM, 2003, LANCET, V362, P782; GREENBERG B, 1995, CIRCULATION, V91, P2573, DOI 10.1161/01.CIR.91.10.2573; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Hoogwerf BJ, 2000, CLEV CLIN J MED, V67, P287, DOI 10.3949/ccjm.67.4.287; Howard G, 2001, ANAESTH INTENS CARE, V29, P591, DOI 10.1177/0310057X0102900604; HUBERT C, 1991, J BIOL CHEM, V266, P15377; IKEMOTO F, 1989, BIOCHEM BIOPH RES CO, V159, P1093, DOI 10.1016/0006-291X(89)92221-3; KLAUSER RJ, 1979, HYPERTENSION, V1, P281, DOI 10.1161/01.HYP.1.3.281; Leon-Ruiz V, 2013, FOOD FUNCT, V4, P1617, DOI 10.1039/c3fo60221d; LIEBERMAN J, 1986, CHEST, V90, P869, DOI 10.1378/chest.90.6.869; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Nakagomi K, 1998, FEBS LETT, V438, P255, DOI 10.1016/S0014-5793(98)01311-8; Nakagomi K, 2000, BIOL PHARM BULL, V23, P879; OPPONG SY, 1993, BIOCHEM J, V292, P597, DOI 10.1042/bj2920597; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; ROGERSON FM, 1989, NEUROPEPTIDES, V14, P213, DOI 10.1016/0143-4179(89)90048-6; Ryan J W, 1979, Adv Exp Med Biol, V120B, P599; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; SNYDER RA, 1986, BIOCHIM BIOPHYS ACTA, V871, P1, DOI 10.1016/0167-4838(86)90125-1; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Tauzin J, 2002, FEBS LETT, V531, P369, DOI 10.1016/S0014-5793(02)03576-7; Taylor J, 2012, EUR HEART J, V33, P1539, DOI 10.1093/eurheartj/ehs137; Tendera M, 2012, TURK KARDIYOL DERN A, V40, P5, DOI 10.1093/eurheartj/ehr211; Thevananther S, 1999, CAN J PHYSIOL PHARM, V77, P216, DOI 10.1139/cjpp-77-3-216; van Dijk MA, 2000, J CARDIOVASC PHARM, V35, P484, DOI 10.1097/00005344-200003000-00020; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; WEI L, 1991, J BIOL CHEM, V266, P5540	37	26	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e87844	10.1371/journal.pone.0087844	http://dx.doi.org/10.1371/journal.pone.0087844			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691203	Green Published, Green Submitted, gold			2022-12-25	WOS:000334101100003
J	Song, HM; Liu, Y; Li, Q; Gao, N; Ma, YY; Zhang, YH				Song, Huiming; Liu, Yu; Li, Qiang; Gao, Na; Ma, Yongyong; Zhang, Yanhua			Tree-Ring Based May-July Temperature Reconstruction Since AD 1630 on the Western Loess Plateau, China	PLOS ONE			English	Article							DROUGHT RECONSTRUCTION; CLIMATE; PRECIPITATION; RECORDS; SUN	Tree-ring samples from Chinese Pine (Pinus tabulaeformis Carr.) collected at Mt. Shimen on the western Loess Plateau, China, were used to reconstruct the mean May-July temperature during AD 1630-2011. The regression model explained 48% of the adjusted variance in the instrumentally observed mean May-July temperature. The reconstruction revealed significant temperature variations at interannual to decadal scales. Cool periods observed in the reconstruction coincided with reduced solar activities. The reconstructed temperature matched well with two other tree-ring based temperature reconstructions conducted on the northern slope of the Qinling Mountains (on the southern margin of the Loess Plateau of China) for both annual and decadal scales. In addition, this study agreed well with several series derived from different proxies. This reconstruction improves upon the sparse network of high-resolution paleoclimatic records for the western Loess Plateau, China.	[Song, Huiming; Liu, Yu; Li, Qiang; Ma, Yongyong; Zhang, Yanhua] Chinese Acad Sci, Inst Earth Environm, State Key Lab Loess & Quaternary Geol, Xian, Peoples R China; [Liu, Yu] Xi An Jiao Tong Univ, Sch Human Settlements & Civil Engn, Dept Environm Sci & Technol, Xian 710049, Peoples R China; [Song, Huiming; Ma, Yongyong; Zhang, Yanhua] Univ Chinese Acad Sci, Beijing, Peoples R China; [Gao, Na] China Earthquake Adm, Inst Geol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Earth Environment, CAS; Xi'an Jiaotong University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; China Earthquake Administration	Liu, Y (corresponding author), Chinese Acad Sci, Inst Earth Environm, State Key Lab Loess & Quaternary Geol, Xian, Peoples R China.	liuyu@loess.llqg.ac.cn	Liu, Yu/I-8125-2014; Liu, Yu/AAA-6165-2019	liu, yu/0000-0002-1402-0737	National Basic Research Program of China [2013CB955900]; Chinese Academy of Sciences [KZZD - EW - 04 - 01]; CAS/SAFEA International Partnership Program for Creative Research Teams [KZZD - EW - TZ - 03]; CAS; Institute of Earth Environment; State Key Laboratory of Loess and Quaternary Geology (SKLLQG)	National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences); CAS(Chinese Academy of Sciences); Institute of Earth Environment; State Key Laboratory of Loess and Quaternary Geology (SKLLQG)(Chinese Academy of Sciences)	This study was supported by grants from the National Basic Research Program of China (no. 2013CB955900), the Chinese Academy of Sciences (KZZD - EW - 04 - 01), the CAS/SAFEA International Partnership Program for Creative Research Teams (KZZD - EW - TZ - 03), the CAS Hundred Talents Program, the Key Project of the Institute of Earth Environment and the Project of State Key Laboratory of Loess and Quaternary Geology (SKLLQG). This research is an initiative of the Sino-Swedish Tree-Ring Research Center (SISTRR): Contribution (No. 025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beer J, 2000, QUATERNARY SCI REV, V19, P403, DOI 10.1016/S0277-3791(99)00072-4; Cai QF, 2008, SCI CHINA SER D, V51, P1099, DOI 10.1007/s11430-008-0084-6; Cayan DR, 1998, J CLIMATE, V11, P3148, DOI 10.1175/1520-0442(1998)011<3148:DVOPOW>2.0.CO;2; Cook ER, 1990, METHODS DENDROCHRONO, DOI DOI 10.1007/978-94-015-7879-0; Dai A, 2004, J HYDROMETEOROL, V5, P1117, DOI 10.1175/JHM-386.1; Deng Y, 2013, CLIMATE RES IN PRESS; Fan ZM, 2012, PROCEDIA ENVIRON SCI, V13, P715, DOI 10.1016/j.proenv.2012.01.064; Fang KY, 2010, INT J CLIMATOL, V30, P1137, DOI 10.1002/joc.1974; Fritts HC, 1976, TREE RINGS CLIMATES; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Kang SY, 2012, CLIMATIC CHANGE, V115, P519, DOI 10.1007/s10584-012-0440-6; Li JB, 2007, INT J CLIMATOL, V27, P903, DOI 10.1002/joc.1450; Li Q, 2013, QUATERN INT, V283, P11, DOI 10.1016/j.quaint.2012.03.017; Li Z, 2010, QUATERN INT, V226, P92, DOI 10.1016/j.quaint.2010.03.003; Liang EY, 2008, GLOBAL PLANET CHANGE, V61, P313, DOI 10.1016/j.gloplacha.2007.10.008; Liang EY, 2003, ANN FOREST SCI, V60, P145, DOI 10.1051/forest:2003007; Lin X, 2013, CHINESE SCI BULL, V58, P4497, DOI 10.1007/s11434-013-5969-x; Liu Y, 2007, TREE-RING RES, V63, P3, DOI 10.3959/1536-1098-63.1.3; Liu Y, 2013, INT J BIOMETEOROL, V57, P927, DOI 10.1007/s00484-012-0618-7; Liu Y, 2009, BOREAS, V38, P285, DOI 10.1111/j.1502-3885.2008.00065.x; Mishra AK, 2010, J HYDROL, V391, P204, DOI 10.1016/j.jhydrol.2010.07.012; Oberhuber W, 1998, TREES-STRUCT FUNCT, V13, P19; Qian L. Q., 1991, CLIMATE LOESS PLATEA; Rehman S, 2010, INT J CLIMATOL, V30, P445, DOI 10.1002/joc.1907; SNEE RD, 1977, TECHNOMETRICS, V19, P415, DOI 10.2307/1267881; Song HM, 2013, QUATERN INT, V283, P30, DOI 10.1016/j.quaint.2012.03.033; Song HM, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016220; Stokes M.A., 1996, INTRO TREE RING DATI; Tan LC, 2008, CLIM PAST, V4, P19; [田沁花 TIAN Qinhua], 2009, [地理学报, Acta Geographica Sinica], V64, P879; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Yang YH, 2012, THEOR APPL CLIMATOL, V107, P143, DOI 10.1007/s00704-011-0467-z; Yi L, 2012, CLIMATIC CHANGE, V110, P469, DOI 10.1007/s10584-011-0052-6; Zhang PZ, 2008, SCIENCE, V322, P940, DOI 10.1126/science.1163965	34	22	28	7	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93504	10.1371/journal.pone.0093504	http://dx.doi.org/10.1371/journal.pone.0093504			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690885	Green Published, Green Submitted, gold			2022-12-25	WOS:000334101100092
J	Valles, AS; Aveldano, MI; Furland, NE				Valles, Ana S.; Aveldano, Marta I.; Furland, Natalia E.			Altered Lipid Homeostasis in Sertoli Cells Stressed by Mild Hyperthermia	PLOS ONE			English	Article							APOPTOTIC SPERMATOGENIC CELLS; POLYENOIC FATTY-ACIDS; LONG-CHAIN; IN-VITRO; MITOCHONDRIAL DYSFUNCTION; PHAGOCYTIC FUNCTION; DROPLET FORMATION; MEMBRANE BARRIER; HEAT-STRESS; RAT TESTIS	Spermatogenesis is known to be vulnerable to temperature. Exposures of rat testis to moderate hyperthermia result in loss of germ cells with survival of Sertoli cells (SC). Because SC provide structural and metabolic support to germ cells, our aim was to test the hypothesis that these exposures affect SC functions, thus contributing to germ cell damage. In vivo, regularly repeated exposures (one of 15 min per day, once a day during 5 days) of rat testes to 43 degrees C led to accumulation of neutral lipids. This SC-specific lipid function took 1-2 weeks after the last of these exposures to be maximal. In cultured SC, similar daily exposures for 15 min to 43 degrees C resulted in significant increase in triacylglycerol levels and accumulation of lipid droplets. After incubations with [H-3] arachidonate, the labeling of cardiolipin decreased more than that of other lipid classes. Another specifically mitochondrial lipid metabolic function, fatty acid oxidation, also declined. These lipid changes suggested that temperature affects SC mitochondrial physiology, which was confirmed by significantly increased degrees of membrane depolarization and ROS production. This concurred with reduced expression of two SC-specific proteins, transferrin, and Wilms' Tumor 1 protein, markers of SC secretion and differentiation functions, respectively, and with an intense SC cytoskeletal perturbation, evident by loss of microtubule network (alpha-tubulin) and microfilament (f-actin) organization. Albeit temporary and potentially reversible, hyperthermia-induced SC structural and metabolic alterations may be long-lasting and/or extensive enough to respond for the decreased survival of the germ cells they normally foster.	[Furland, Natalia E.] Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Bahi Blanca, Bahia Blanca, Buenos Aires, Argentina; Univ Nacl Sur, RA-8000 Bahia Blanca, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South	Furland, NE (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Bahi Blanca, Bahia Blanca, Buenos Aires, Argentina.	nfurland@criba.edu.ar	Vallés, Ana Sofía/GVU-5374-2022		Consejo Nacional de Investigaciones Cientificas y Tecnicas; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT); Universidad Nacional del Sur, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT)(ANPCyT); Universidad Nacional del Sur, Argentina	This work was supported by grants from Consejo Nacional de Investigaciones Cientificas y Tecnicas, Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT), and Universidad Nacional del Sur, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk A, 2006, NEUROCHEM INT, V49, P407, DOI 10.1016/j.neuint.2006.01.025; Appaix F, 2003, EXP PHYSIOL, V88, P175, DOI 10.1113/eph8802511; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boren J, 2012, CELL DEATH DIFFER, V19, P1561, DOI 10.1038/cdd.2012.34; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Butler A, 2002, AM J PATHOL, V161, P1061, DOI 10.1016/S0002-9440(10)64267-8; CHEMES H, 1986, ENDOCRINOLOGY, V119, P1673, DOI 10.1210/endo-119-4-1673; Chen M, 2008, ENDOCRINOLOGY, V149, P4871, DOI 10.1210/en.2007-1093; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Connerth M, 2012, SCIENCE, V338, P815, DOI 10.1126/science.1225625; Furland NE, 2007, BIOL REPROD, V77, P181, DOI 10.1095/biolreprod.106.056556; Furland NE, 2011, LIPIDS, V46, P443, DOI 10.1007/s11745-011-3527-3; Gao F, 2006, P NATL ACAD SCI USA, V103, P11987, DOI 10.1073/pnas.0600994103; Guitton N, 1999, INT J RADIAT BIOL, V75, P327, DOI 10.1080/095530099140500; Hikim APS, 1999, REV REPROD, V4, P38; Hikim APS, 2003, ENDOCRINOLOGY, V144, P3167, DOI 10.1210/en.2003-0175; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Houtkooper RH, 2008, CELL MOL LIFE SCI, V65, P2493, DOI 10.1007/s00018-008-8030-5; Kanter M, 2013, TOXICOL IND HEALTH, V29, P99, DOI 10.1177/0748233711425082; KERR JB, 1974, J REPROD FERTIL, V36, P439; Kiebish MA, 2013, J LIPID RES, V54, P1312, DOI 10.1194/jlr.M034728; Kiebish MA, 2012, J BIOL CHEM, V287, P25086, DOI 10.1074/jbc.M112.340521; Linden D, 2004, J LIPID RES, V45, P1279, DOI 10.1194/jlr.M400010-JLR200; Liu MX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045694; Lue YH, 1999, ENDOCRINOLOGY, V140, P1709, DOI 10.1210/en.140.4.1709; Lue YH, 2000, ENDOCRINOLOGY, V141, P1414, DOI 10.1210/en.141.4.1414; Maguire SM, 1997, J MOL ENDOCRINOL, V19, P67, DOI 10.1677/jme.0.0190067; MATHER JP, 1980, BIOL REPROD, V23, P243, DOI 10.1095/biolreprod23.1.243; Moore CR, 1924, SCIENCE, V59, P41, DOI 10.1126/science.59.1515.41; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakanishi Y, 2004, BIOL PHARM BULL, V27, P13, DOI 10.1248/bpb.27.13; Nauciene Z, 2012, MEDICINA-LITHUANIA, V48, P249, DOI 10.3390/medicina48050036; Oresti GM, 2013, REPRODUCTION, V146, P471, DOI 10.1530/REP-13-0199; Oresti GM, 2010, J LIPID RES, V51, P2909, DOI 10.1194/jlr.M006429; Oresti GM, 2010, J LIPID RES, V51, P2600, DOI 10.1194/jlr.M006395; Paradies G, 2010, FREE RADICAL BIO MED, V48, P1286, DOI 10.1016/j.freeradbiomed.2010.02.020; PINEAU C, 1991, CELL TISSUE RES, V264, P589, DOI 10.1007/BF00319048; POORTHUIS BJHM, 1976, J LIPID RES, V17, P433; Ritzen E.M, 1989, TESTIS, P269; Rockett JC, 2001, BIOL REPROD, V65, P229, DOI 10.1095/biolreprod65.1.229; RUSSELL LD, 1977, ANAT RECORD, V187, P347, DOI 10.1002/ar.1091870307; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Scharnhorst V, 2001, GENE, V273, P141, DOI 10.1016/S0378-1119(01)00593-5; Setchell BP, 1998, J REPROD FERTIL, V114, P179, DOI 10.1530/jrf.0.1140179; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; SKINNER MK, 1980, J BIOL CHEM, V255, P9523; Tatsuta T, 2014, TRENDS CELL BIOL, V24, P44, DOI 10.1016/j.tcb.2013.07.011; Vance D. E., 1991, BIOCH LIPIDS LIPOPRO; Wang HZ, 2006, REPRODUCTION, V132, P485, DOI 10.1530/rep.1.01213; Xiong WP, 2009, REPRODUCTION, V137, P469, DOI 10.1530/REP-08-0343; Yamamoto CM, 2000, BIOL REPROD, V63, P1683, DOI 10.1095/biolreprod63.6.1683; Yin HY, 2012, FREE RADICAL RES, V46, P959, DOI 10.3109/10715762.2012.676642; Zukiene R, 2010, INT J HYPERTHER, V26, P56, DOI 10.3109/02656730903262140	53	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e91127	10.1371/journal.pone.0091127	http://dx.doi.org/10.1371/journal.pone.0091127			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690895	Green Published, Green Submitted, gold			2022-12-25	WOS:000334101100013
J	Alkoby, D; Rimon, A; Burdak, M; Patino-Ruiz, M; Calinescu, O; Fendler, K; Padan, E				Alkoby, Dudu; Rimon, Abraham; Burdak, Maral; Patino-Ruiz, Miyer; Calinescu, Octavian; Fendler, Klaus; Padan, Etana			NhaA Na+/H+ Antiporter Mutants That Hardly React to the Membrane Potential	PLOS ONE			English	Article							ESCHERICHIA-COLI; STRUCTURAL INTERACTIONS; PHYSIOLOGICAL-ROLE; ION-TRANSPORT; PH REGULATION; SODIUM; PROTEIN; GENE; IV; EXCHANGERS	pH and Na+ homeostasis in all cells requires Na+/H+ antiporters. The crystal structure, obtained at pH 4, of NhaA, the main antiporter of Escherichia coli, has provided general insights into an antiporter mechanism and its unique pH regulation. Here, we describe a general method to select various NhaA mutants from a library of randomly mutagenized NhaA. The selected mutants, A167P and F267C are described in detail. Both mutants are expressed in Escherichia coli EP432 cells at 70-95% of the wild type but grow on selective medium only at neutral pH, A167P on Li+ (0.1 M) and F267C on Na+ (0.6 M). Surprising for an electrogenic secondary transporter, and opposed to wild type NhaA, the rates of A167P and F267C are almost indifferent to membrane potential. Detailed kinetic analysis reveals that in both mutants the rate limiting step of the cation exchange cycle is changed from an electrogenic to an electroneutral reaction.	[Alkoby, Dudu; Rimon, Abraham; Padan, Etana] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Burdak, Maral; Patino-Ruiz, Miyer; Calinescu, Octavian; Fendler, Klaus] Max Planck Inst Biophys, Dept Biophys Chem, Frankfurt, Germany	Hebrew University of Jerusalem; Max Planck Society	Padan, E (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	etana@vms.huji.ac.il	Calinescu, Octavian/P-4278-2014	Calinescu, Octavian/0000-0001-8003-0442; Patino-Ruiz, Miyer Fabian/0000-0003-0607-4281; Fendler, Klaus/0000-0002-5699-7060	ISRAEL SCIENCE FOUNDATION [284/12]; Deutsche Forschungsgemeinschaft [SFB 807]	ISRAEL SCIENCE FOUNDATION(Israel Science Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	ISRAEL SCIENCE FOUNDATION (grant No. 284/12) to EP and by the Deutsche Forschungsgemeinschaft SFB 807 to KF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boudker O, 2010, TRENDS PHARMACOL SCI, V31, P418, DOI 10.1016/j.tips.2010.06.004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; DAVIS BD, 1950, J BACTERIOL, V60, P17, DOI 10.1128/JB.60.1.17-28.1950; Fliegel L, 2008, J MOL CELL CARDIOL, V44, P228, DOI 10.1016/j.yjmcc.2007.11.016; Galili L, 2004, J BIOL CHEM, V279, P23104, DOI 10.1074/jbc.M400288200; Galili L, 2002, BIOCHEMISTRY-US, V41, P609, DOI 10.1021/bi011655v; GOLDBERG EB, 1987, P NATL ACAD SCI USA, V84, P2615, DOI 10.1073/pnas.84.9.2615; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Jardetzky O, 1996, PROG BIOPHYS MOL BIO, V65, P171, DOI 10.1016/S0079-6107(96)00010-7; Kozachkov L, 2007, BIOCHEMISTRY-US, V46, P2419, DOI 10.1021/bi602393s; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Maes M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.391128; Mager T, 2013, J BIOL CHEM, V288, P24666, DOI 10.1074/jbc.M113.484071; Mager T, 2011, J BIOL CHEM, V286, P23570, DOI 10.1074/jbc.M111.230235; Mitchell P., 1968, CHEMIOSMOTIC COUPLIN; Nozaki K, 1998, BBA-BIOMEMBRANES, V1369, P213, DOI 10.1016/S0005-2736(97)00223-X; OHYAMA T, 1994, J BACTERIOL, V176, P4311, DOI 10.1128/jb.176.14.4311-4315.1994; Olami Y, 1997, J BIOL CHEM, V272, P1761, DOI 10.1074/jbc.272.3.1761; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Orlowski J, 2007, CURR OPIN CELL BIOL, V19, P483, DOI 10.1016/j.ceb.2007.06.001; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; PADAN E, 1989, J BIOL CHEM, V264, P20297; Padan E, 2001, BBA-BIOENERGETICS, V1505, P144, DOI 10.1016/S0005-2728(00)00284-X; PADAN E, 1976, EUR J BIOCHEM, V63, P533, DOI 10.1111/j.1432-1033.1976.tb10257.x; Padan E, 2014, BIOCH BIOPH IN PRESS; Padan E, 2008, TRENDS BIOCHEM SCI, V33, P435, DOI 10.1016/j.tibs.2008.06.007; Padan E, 2009, J EXP BIOL, V212, P1593, DOI 10.1242/jeb.026708; PINNER E, 1993, J BIOL CHEM, V268, P1729; PINNER E, 1994, J BIOL CHEM, V269, P26274; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Radchenko MV, 2006, J BIOL CHEM, V281, P19822, DOI 10.1074/jbc.M600333200; Rimon A, 1998, J BIOL CHEM, V273, P26470, DOI 10.1074/jbc.273.41.26470; Rimon A, 2012, BIOCHEMISTRY-US, V51, P9560, DOI 10.1021/bi301030x; ROSEN BP, 1986, METHOD ENZYMOL, V125, P328; SCHULDINER S, 1978, BIOCHEMISTRY-US, V17, P706, DOI 10.1021/bi00597a023; Schulz P, 2008, METHODS, V46, P97, DOI 10.1016/j.ymeth.2008.07.002; Shi YG, 2013, ANNU REV BIOPHYS, V42, P51, DOI 10.1146/annurev-biophys-083012-130429; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; TAGLICHT D, 1993, J BIOL CHEM, V268, P5382; Tsuboi Y, 2003, J BIOL CHEM, V278, P21467, DOI 10.1074/jbc.M301932200; Tzubery T, 2004, J BIOL CHEM, V279, P3265, DOI 10.1074/jbc.M309021200; Tzubery T, 2008, J BIOL CHEM, V283, P15975, DOI 10.1074/jbc.M800482200; Wakabayashi S, 2003, J BIOL CHEM, V278, P43580, DOI 10.1074/jbc.M306690200; Zuber D, 2005, BBA-BIOENERGETICS, V1709, P240, DOI 10.1016/j.bbabio.2005.07.009	46	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93200	10.1371/journal.pone.0093200	http://dx.doi.org/10.1371/journal.pone.0093200			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699187	Green Published, gold, Green Submitted			2022-12-25	WOS:000334105000046
J	Hetz, S; Acikgoez, A; Voss, U; Nieber, K; Holland, H; Hegewald, C; Till, H; Metzger, R; Metzger, M				Hetz, Susan; Acikgoez, Ali; Voss, Ulrike; Nieber, Karen; Holland, Heidrun; Hegewald, Cindy; Till, Holger; Metzger, Roman; Metzger, Marco			In Vivo Transplantation of Neurosphere-Like Bodies Derived from the Human Postnatal and Adult Enteric Nervous System: A Pilot Study	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; NEURAL PROGENITORS; RAT; GUT; THERAPY; DIFFERENTIATE; NEUROGENESIS; BIOLOGY; PLEXUS; FETAL	Recent advances in the in vitro characterization of human adult enteric neural progenitor cells have opened new possibilities for cell-based therapies in gastrointestinal motility disorders. However, whether these cells are able to integrate within an in vivo gut environment is still unclear. In this study, we transplanted neural progenitor-containing neurosphere-like bodies (NLBs) in a mouse model of hypoganglionosis and analyzed cellular integration of NLB-derived cell types and functional improvement. NLBs were propagated from postnatal and adult human gut tissues. Cells were characterized by immunohistochemistry, quantitative PCR and subtelomere fluorescence in situ hybridization (FISH). For in vivo evaluation, the plexus of murine colon was damaged by the application of cationic surfactant benzalkonium chloride which was followed by the transplantation of NLBs in a fibrin matrix. After 4 weeks, grafted human cells were visualized by combined in situ hybridization (Alu) and immunohistochemistry (PGP9.5, GFAP, SMA). In addition, we determined nitric oxide synthase (NOS)-positive neurons and measured hypertrophic effects in the ENS and musculature. Contractility of treated guts was assessed in organ bath after electrical field stimulation. NLBs could be reproducibly generated without any signs of chromosomal alterations using subtelomere FISH. NLB-derived cells integrated within the host tissue and showed expected differentiated phenotypes i.e. enteric neurons, glia and smooth muscle-like cells following in vivo transplantation. Our data suggest biological effects of the transplanted NLB cells on tissue contractility, although robust statistical results could not be obtained due to the small sample size. Further, it is unclear, which of the NLB cell types including neural progenitors have direct restoring effects or, alternatively may act via 'bystander' mechanisms in vivo. Our findings provide further evidence that NLB transplantation can be considered as feasible tool to improve ENS function in a variety of gastrointestinal disorders.	[Hetz, Susan; Holland, Heidrun; Hegewald, Cindy; Metzger, Marco] Univ Leipzig, Translat Ctr Regenerat Med, D-04109 Leipzig, Germany; [Hetz, Susan] Fraunhofer Inst Cell Therapy & Immunol, Clin Oriented Therapy Assessment Unit, Leipzig, Germany; [Acikgoez, Ali] St Georges Hosp Leipzig, Dept Gen & Visceral Surg, Leipzig, Germany; [Voss, Ulrike; Nieber, Karen] Univ Leipzig, Inst Pharm, D-04109 Leipzig, Germany; [Till, Holger] Med Univ Graz, Dept Pediat & Adolescent Surg, Graz, Austria; [Metzger, Roman] Salzburg Cty Hosp, Dept Pediat & Adolescent Med, Salzburg, Austria; [Metzger, Marco] Univ Hosp Wurzburg, Fraunhofer IGB Project Grp Regenerat Technol Onco, Wurzburg, Germany	Leipzig University; Fraunhofer Gesellschaft; Leipzig University; Medical University of Graz; University of Wurzburg	Metzger, M (corresponding author), Univ Leipzig, Translat Ctr Regenerat Med, D-04109 Leipzig, Germany.	marco.metzger@igb.fraunhofer.de	Metzger, Marco/F-9706-2019		German Federal Ministry of Education and Research (BMBF) [0313909]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The work presented in this paper was funded by the German Federal Ministry of Education and Research (BMBF, PtJ-Bio, 0313909; to S. H., H. H., C. H. and M. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almond S, 2007, GUT, V56, P489, DOI 10.1136/gut.2006.094565; Amiel J, 2001, J MED GENET, V38, P729, DOI 10.1136/jmg.38.11.729; Anitha M, 2008, GASTROENTEROLOGY, V134, P1424, DOI 10.1053/j.gastro.2008.02.018; Azan G, 2011, CELL TISSUE RES, V344, P217, DOI 10.1007/s00441-011-1130-9; Bondurand N, 2003, DEVELOPMENT, V130, P6387, DOI 10.1242/dev.00857; Brothman AR, 2009, CYTOGENET GENOME RES, V127, P1, DOI 10.1159/000279442; Burns AJ, 2004, NEUROGASTROENT MOTIL, V16, P3, DOI 10.1111/j.1743-3150.2004.00466.x; Cracco C, 1997, ADV EXP MED BIOL, V429, P159; De GR, 2004, NEUROGASTROENTERO S1, V16, P143; Di Nardo G, 2008, ALIMENT PHARM THER, V28, P25, DOI 10.1111/j.1365-2036.2008.03707.x; Dong YL, 2008, TRANSPL P, V40, P3646, DOI 10.1016/j.transproceed.2008.06.107; Estrada-Mondaca S, 2007, DEV DYNAM, V236, P20, DOI 10.1002/dvdy.20954; Geisbauer CL, 2012, J SURG RES, V176, P20, DOI 10.1016/j.jss.2011.05.014; Gershon MD, 2007, GUT, V56, P459, DOI 10.1136/gut.2006.107748; Hanani M, 2003, J COMP NEUROL, V462, P315, DOI 10.1002/cne.10721; Heanue TA, 2011, STEM CELLS, V29, P128, DOI 10.1002/stem.557; Hegewald C, 2011, NEUROGASTROENT MOTIL, V23, pE412, DOI 10.1111/j.1365-2982.2011.01761.x; Holland H, 2012, PATHOL RES PRACT, V208, P325, DOI 10.1016/j.prp.2012.03.010; Hotta R, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2009.01411.x; Hotta R, 2011, CURR OPIN PHARMACOL, V11, P617, DOI 10.1016/j.coph.2011.09.004; Hotta R, 2009, SEMIN PEDIATR SURG, V18, P263, DOI 10.1053/j.sempedsurg.2009.07.008; Just L, 2003, J NEUROSCI METH, V126, P69, DOI 10.1016/S0165-0270(03)00065-7; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Kulkarni S, 2012, GUT, V61, P613, DOI 10.1136/gut.2010.235614; Lindley RM, 2008, GASTROENTEROLOGY, V135, P205, DOI 10.1053/j.gastro.2008.03.035; Liu MT, 2009, J NEUROSCI, V29, P9683, DOI 10.1523/JNEUROSCI.1145-09.2009; Liu W, 2007, NEUROGASTROENT MOTIL, V19, P1001, DOI 10.1111/j.1365-2982.2007.00981.x; Martucciello G, 2007, EUR J PEDIATR SURG, V17, P34, DOI 10.1055/s-2007-964952; Metzger M, 2010, ARCH ITAL BIOL, V148, P73; Metzger M, 2009, GASTROENTEROLOGY, V137, P2063, DOI 10.1053/j.gastro.2009.06.038; Metzger M, 2009, GASTROENTEROLOGY, V136, P2214, DOI 10.1053/j.gastro.2009.02.048; Micci MA, 2007, DEV DYNAM, V236, P33, DOI 10.1002/dvdy.20975; Pan WK, 2011, J SURG RES, V167, pE221, DOI 10.1016/j.jss.2011.01.016; Poli E, 2001, NEUROCHEM RES, V26, P1085, DOI 10.1023/A:1012313424144; Rauch U, 2006, INT J COLORECTAL DIS, V21, P554, DOI 10.1007/s00384-005-0051-z; Schafer KH, 2009, NEUROGASTROENT MOTIL, V21, P103, DOI 10.1111/j.1365-2982.2008.01257.x; Silva AT, 2008, BRAIN RES, V1218, P47, DOI 10.1016/j.brainres.2008.04.051; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; Suarez-Rodriguez R, 2004, STEM CELLS, V22, P1373, DOI 10.1634/stemcells.2003-0049; Suslov ON, 2002, P NATL ACAD SCI USA, V99, P14506, DOI 10.1073/pnas.212525299; Thapar N, 2009, J PEDIATR GASTR NUTR, V48, pS92, DOI 10.1097/MPG.0b013e3181a15d62; Tsai YH, 2011, NEUROGASTROENT MOTIL, V23, P362, DOI 10.1111/j.1365-2982.2010.01656.x; Wallace AS, 2009, NEUROGASTROENT MOTIL, V21, P768, DOI 10.1111/j.1365-2982.2009.01309.x; Young HM, 2005, GASTROENTEROLOGY, V129, P2092, DOI 10.1053/j.gastro.2005.10.033; Young HM, 2003, J COMP NEUROL, V456, P1, DOI 10.1002/cne.10448	45	40	42	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93605	10.1371/journal.pone.0093605	http://dx.doi.org/10.1371/journal.pone.0093605			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699866	gold, Green Published, Green Submitted			2022-12-25	WOS:000334105000080
J	Honkavuori, KS; Briese, T; Krauss, S; Sanchez, MD; Jain, K; Hutchison, SK; Webster, RG; Lipkin, WI				Honkavuori, Kirsi S.; Briese, Thomas; Krauss, Scott; Sanchez, Maria D.; Jain, Komal; Hutchison, Stephen K.; Webster, Robert G.; Lipkin, W. Ian			Novel Coronavirus and Astrovirus in Delaware Bay Shorebirds	PLOS ONE			English	Article							POULT ENTERITIS SYNDROME; AVIAN NEPHRITIS VIRUS; INFLUENZA-A VIRUSES; WILD AQUATIC BIRDS; MOLECULAR CHARACTERIZATION; GUINEA-FOWL; INFECTION; TURKEY	Background: Wild birds are an important but to some extent under-studied reservoir for emerging pathogens. We used unbiased sequencing methods for virus discovery in shorebird samples from the Delaware Bay, USA; an important feeding ground for thousands of migratory birds. Findings: Analysis of shorebird fecal samples indicated the presence of a novel astrovirus and coronavirus. A sanderling sample yielded sequences with distant homology to avian nephritis virus 1, an astrovirus associated with acute nephritis in poultry. A ruddy turnstone sample yielded sequences with homology to deltacoronaviruses. Conclusions: Our findings highlight shorebirds as a virus reservoir and the need to closely monitor wild bird populations for the emergence of novel virus variants.	[Honkavuori, Kirsi S.; Briese, Thomas; Sanchez, Maria D.; Jain, Komal; Lipkin, W. Ian] Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY 10027 USA; [Krauss, Scott; Webster, Robert G.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Hutchison, Stephen K.] 454 Life Sci, Branford, CT USA	Columbia University; St Jude Children's Research Hospital	Briese, T (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY 10027 USA.	thomas.briese@columbia.edu	Lipkin, W. Ian/ABE-6216-2020	Lipkin, W. Ian/0000-0002-8768-9386	National Institutes of Health [AI57158, HHSN266200700005C]; National Institute of Allergy and Infectious Diseases; United States Agency for International Development's (USAID) Emerging Pandemic Threats (EPT) Program; PREDICT project [GHN-A-OO-09-00010-00]; Google.org; US Department of Defense; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United States Agency for International Development's (USAID) Emerging Pandemic Threats (EPT) Program(United States Agency for International Development (USAID)); PREDICT project; Google.org; US Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant AI57158 (Northeast Biodefense Center-Lipkin) and contract number HHSN266200700005C, the National Institute of Allergy and Infectious Diseases, the United States Agency for International Development's (USAID) Emerging Pandemic Threats (EPT) Program, PREDICT project, under terms of Cooperative Agreement Number GHN-A-OO-09-00010-00, and awards from Google.org and the US Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Cheung PP, 2009, J CLIN VIROL, V46, P90, DOI 10.1016/j.jcv.2009.06.016; Chu DKW, 2011, J VIROL, V85, P12815, DOI 10.1128/JVI.05838-11; De Battisti C, 2012, ARCH VIROL, V157, P1329, DOI 10.1007/s00705-012-1311-1; Fu Y, 2009, J GEN VIROL, V90, P1104, DOI 10.1099/vir.0.008599-0; Hanson BA, 2008, J WILDLIFE DIS, V44, P351, DOI 10.7589/0090-3558-44.2.351; Imada T, 2000, J VIROL, V74, P8487, DOI 10.1128/JVI.74.18.8487-8493.2000; Jindal N, 2010, POULTRY SCI, V89, P217, DOI 10.3382/ps.2009-00424; Jindal N, 2009, POULTRY SCI, V88, P949, DOI 10.3382/ps.2008-00490; Koci MD, 2002, AVIAN PATHOL, V31, P213, DOI 10.1080/03079450220136521; Kofstad T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025964; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Krauss S, 2010, P ROY SOC B-BIOL SCI, V277, P3373, DOI 10.1098/rspb.2010.1090; Lai M.M.C., 2007, FIELDS VIROLOGY, P1305; Mendez E., 2007, FIELDS VIROLOGY, V5, P981; Muradrasoli S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013640; NICHOLAS RAJ, 1988, VET REC, V123, P398, DOI 10.1136/vr.123.15.398; Palacios G, 2007, EMERG INFECT DIS, V13, P73, DOI 10.3201/eid1301.060837; Pantin-Jackwood MJ, 2011, ARCH VIROL, V156, P235, DOI 10.1007/s00705-010-0849-z; Pantin-Jackwood MJ, 2006, AVIAN DIS, V50, P397, DOI 10.1637/7512-020606R.1; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Reed Kurt D, 2003, Clin Med Res, V1, P5; Takase K, 2000, J VET MED SCI, V62, P1327, DOI 10.1292/jvms.62.1327; Toffan A, 2012, AVIAN PATHOL, V41, P429, DOI 10.1080/03079457.2012.704980; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Weiss SR, 2005, MICROBIOL MOL BIOL R, V69, P635, DOI 10.1128/MMBR.69.4.635-664.2005; Woo PCY, 2012, J VIROL, V86, P3995, DOI 10.1128/JVI.06540-11; Zhao W, 2011, ARCH VIROL, V156, P1559, DOI 10.1007/s00705-011-1034-8; Zhao W, 2011, AVIAN PATHOL, V40, P361, DOI 10.1080/03079457.2011.587792	29	17	19	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93395	10.1371/journal.pone.0093395	http://dx.doi.org/10.1371/journal.pone.0093395			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699424	Green Submitted, Green Published, gold			2022-12-25	WOS:000334105000057
J	Loiselle, S; Cozar, A; Adgo, E; Ballatore, T; Chavula, G; Descy, JP; Harper, DM; Kansiime, F; Kimirei, I; Langenberg, V; Ma, RH; Sarmento, H; Odada, E				Loiselle, Steven; Cozar, Andres; Adgo, Enyew; Ballatore, Thomas; Chavula, Geoffrey; Descy, Jean Pierre; Harper, David M.; Kansiime, Frank; Kimirei, Ismael; Langenberg, Victor; Ma, Ronghua; Sarmento, Hugo; Odada, Eric			Decadal Trends and Common Dynamics of the Bio-Optical and Thermal Characteristics of the African Great Lakes	PLOS ONE			English	Article							DECREASED PRIMARY PRODUCTIVITY; RAINFALL VARIABILITY; DISSOLVED SILICA; CLIMATE-CHANGE; TANGANYIKA; TRANSPARENCY	The Great Lakes of East Africa are among the world's most important freshwater ecosystems. Despite their importance in providing vital resources and ecosystem services, the impact of regional and global environmental drivers on this lacustrine system remains only partially understood. We make a systematic comparison of the dynamics of the bio-optical and thermal properties of thirteen of the largest African lakes between 2002 and 2011. Lake surface temperatures had a positive trend in all Great Lakes outside the latitude of 0 degrees to 8 degrees south, while the dynamics of those lakes within this latitude range were highly sensitive to global inter-annual climate drivers (i.e. El Nino Southern Oscillation). Lake surface temperature dynamics in nearly all lakes were found to be sensitive to the latitudinal position of the Inter Tropical Convergence Zone. Phytoplankton dynamics varied considerably between lakes, with increasing and decreasing trends. Intra-lake differences in both surface temperature and phytoplankton dynamics occurred for many of the larger lakes. This inter-comparison of bio-optical and thermal dynamics provides new insights into the response of these ecosystems to global and regional drivers.	[Loiselle, Steven] Univ Siena, Consorzio Sviluppo Sistemi Grande Interfase, Dipartimento Biotecnol Chim & Farm, I-53100 Siena, Italy; [Cozar, Andres] Univ Cadiz, Dept Biol, Puerto Real, Spain; [Adgo, Enyew] Bahir Dar Univ, Coll Agr & Environm Sci, Bahir Dar, Ethiopia; [Ballatore, Thomas] Lake Basin Act Network, Moriyama, Japan; [Chavula, Geoffrey] Univ Malawi Polytech, Dept Civil Engn, Blantrye, Malawi; [Descy, Jean Pierre] Univ Namur, Dept Biol, Namur, Belgium; [Harper, David M.] Univ Leicester, Dept Biol, Leicester, Leics, England; [Kansiime, Frank] Makerere Univ, Dept Environm Management, Kampala, Uganda; [Kimirei, Ismael] Tanzanian Fisheries Res Inst, Kigoma Res Ctr, Kigoma, Tanzania; [Langenberg, Victor] DELTARES, Delft, Netherlands; [Ma, Ronghua] Chinese Acad Sci, Nanjing Inst Geog & Limnol, Nanjing, Jiangsu, Peoples R China; [Sarmento, Hugo] Univ Fed Sao Carlos, Dept Hydrobiol, BR-13560 Sao Carlos, SP, Brazil; [Odada, Eric] Univ Nairobi, Dept Geol, Nairobi, Kenya	University of Siena; Universidad de Cadiz; Bahir Dar University; University of Namur; University of Leicester; Makerere University; Deltares; Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; Universidade Federal de Sao Carlos; University of Nairobi	Loiselle, S (corresponding author), Univ Siena, Consorzio Sviluppo Sistemi Grande Interfase, Dipartimento Biotecnol Chim & Farm, Via Laterina 8, I-53100 Siena, Italy.	loiselle@unisi.it	Kimirei, Ismael Aaron/F-7385-2012; Loiselle, Steven/ABA-3324-2020; Sarmento, Hugo/W-3805-2019; ma, rong/GVU-3096-2022; Sarmento, Hugo/A-7655-2008; Harper, David M/A-1765-2011; Cozar, Andres/G-2141-2016	Kimirei, Ismael Aaron/0000-0002-1101-5262; Loiselle, Steven/0000-0001-7414-0389; Sarmento, Hugo/0000-0001-5220-7992; Sarmento, Hugo/0000-0001-5220-7992; Cozar, Andres/0000-0003-1370-9935; Descy, Jean-Pierre/0000-0003-1649-7800	NERC ESPA grant [NE/1003266/1]; AGLOM project [CGL2010-11556-E]; Natural Environment Research Council [NE/I003266/1] Funding Source: researchfish; NERC [NE/I003266/1] Funding Source: UKRI	NERC ESPA grant; AGLOM project; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was supported by the NERC ESPA grant (NE/1003266/1) AND THE AGLOM project (CGL2010-11556-E). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker J.G., 2007, EOS T AGU, V88, P14, DOI [DOI 10.1029/2007EO020003, 10.1029/2007EO020003]; Bergamino N, 2010, REMOTE SENS ENVIRON, V114, P772, DOI 10.1016/j.rse.2009.11.013; Bergamino N, 2007, ECOL MODEL, V204, P156, DOI 10.1016/j.ecolmodel.2006.12.031; Bosilovich MG, 2008, J APPL METEOROL CLIM, V47, P2279, DOI 10.1175/2008JAMC1921.1; Coulter GW., 1991, LAKE TANGANYIKA ITS, P49; Cozar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029962; Descy JP, 2010, HYDROBIOLOGIA, V653, P29, DOI 10.1007/s10750-010-0343-3; Hecky RE, 2010, FRESHWATER BIOL, V55, P19, DOI 10.1111/j.1365-2427.2009.02374.x; Hecky R.E., 1987, Advances in Limnology, V25, P197; Horion S, 2010, REMOTE SENS ENVIRON, V114, P781, DOI 10.1016/j.rse.2009.11.012; Hulme M, 2001, CLIM RES, V17, P145, DOI 10.3354/cr017145; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Lele MI, 2010, J CLIMATE, V23, P3984, DOI 10.1175/2010JCLI3277.1; Nicholson SE, 2000, GLOBAL PLANET CHANGE, V26, P137, DOI 10.1016/S0921-8181(00)00040-0; O'Reilly CM, 2003, NATURE, V424, P766, DOI 10.1038/nature01833; OgutuOhwayo R, 1997, ENVIRON BIOL FISH, V50, P117, DOI 10.1023/A:1007320932349; Olaka LA, 2010, J PALEOLIMNOL, V44, P629, DOI 10.1007/s10933-010-9442-4; Pasche N, 2010, J PALEOLIMNOL, V44, P931, DOI 10.1007/s10933-010-9465-x; PATTERSON G, 1995, FISHERY POTENTIAL PR, P1; Plisnier PD, 1999, HYDROBIOLOGIA, V407, P45, DOI 10.1023/A:1003762119873; Sarmento H, 2012, AQUAT ECOL SER, V5, P67, DOI 10.1007/978-94-007-4243-7_5; Sarvala J, 2006, INT VER THEOR ANGEW, V29, P2339; Sorensen K, 2008, ESA; Stager JC, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008362; Stager JC, 2009, QUATERNARY RES, V72, P47, DOI 10.1016/j.yqres.2009.04.003; Talling J.F., 1998, ECOLOGICAL DYNAMICS; Tierney JE, 2011, EARTH PLANET SC LETT, V307, P103, DOI 10.1016/j.epsl.2011.04.038; Tierney JE, 2010, NAT GEOSCI, V3, P422, DOI [10.1038/ngeo865, 10.1038/NGEO865]; Verburg P, 2006, INT VER THEOR ANGEW, V29, P2335; Verburg P, 2011, LIMNOL OCEANOGR, V56, P910, DOI 10.4319/lo.2011.56.3.0910; Wolff C, 2011, SCIENCE, V333, P743, DOI 10.1126/science.1203724; Wolter K, 2011, INT J CLIMATOL, V31, P1074, DOI 10.1002/joc.2336	32	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93656	10.1371/journal.pone.0093656	http://dx.doi.org/10.1371/journal.pone.0093656			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699528	Green Published, gold, Green Submitted			2022-12-25	WOS:000334105000087
J	Morganti, JM; Jopson, TD; Liu, S; Gupta, N; Rosi, S				Morganti, Josh M.; Jopson, Timothy D.; Liu, Sharon; Gupta, Nalin; Rosi, Susanna			Cranial Irradiation Alters the Brain's Microenvironment and Permits CCR2(+) Macrophage Infiltration	PLOS ONE			English	Article							CHEMOKINE RECEPTOR 2; TRANSGENIC MOUSE MODEL; COGNITIVE IMPAIRMENTS; IONIZING-RADIATION; RAT-BRAIN; MICROVASCULAR NETWORKS; CYTOKINE PRODUCTION; AMYLOID PATHOLOGY; MYELOID CELLS; BONE-MARROW	Therapeutic irradiation is commonly used to treat primary or metastatic central nervous system tumors. It is believed that activation of neuroinflammatory signaling pathways contributes to the development of common adverse effects, which may ultimately contribute to cognitive dysfunction. Recent studies identified the chemokine (C-C motif) receptor (CCR2), constitutively expressed by cells of the monocyte-macrophage lineage, as a mediator of cognitive impairments induced by irradiation. In the present study we utilized a unique reporter mouse (CCR2(RFP/+) CX3CR1(GFP/+)) to accurately delineate the resident (CX3CR1(+)) versus peripheral (CCR2(+)) innate immune response in the brain following cranial irradiation. Our results demonstrate that a single dose of 10Gy cranial gamma-irradiation induced a significant decrease in the percentage of resident microglia, while inducing an increase in the infiltration of peripherally derived CCR2(+) macrophages. Although reduced in percentage, there was a significant increase in F4/80(+) activated macrophages in irradiated animals compared to sham. Moreover, we found that there were altered levels of pro-inflammatory cytokines, chemokines, adhesion molecules, and growth factors in the hippocampi of wild type irradiated mice as compared to sham. All of these molecules are implicated in the recruitment, adhesion, and migration of peripheral monocytes to injured tissue. Importantly, there were no measureable changes in the expression of multiple markers associated with blood-brain barrier integrity; implicating the infiltration of peripheral CCR2(+) macrophages may be due to inflammatory induced chemotactic signaling. Cumulatively, these data provide evidence that therapeutic levels of cranial radiation are sufficient to alter the brain's homeostatic balance and permit the influx of peripherally-derived CCR2(+) macrophages as well as the regional susceptibility of the hippocampal formation to ionizing radiation.	[Morganti, Josh M.; Jopson, Timothy D.; Rosi, Susanna] Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA; [Morganti, Josh M.; Jopson, Timothy D.; Rosi, Susanna] Univ Calif San Francisco, Dept Phys Therapy, San Francisco, CA 94143 USA; [Morganti, Josh M.; Jopson, Timothy D.; Rosi, Susanna] Univ Calif San Francisco, Dept Rehabil Sci, San Francisco, CA 94143 USA; [Liu, Sharon; Gupta, Nalin; Rosi, Susanna] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Rosi, S (corresponding author), Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA.	rosis@ptrehab.ucsf.edu	Morganti, Josh/AAL-9727-2020	Morganti, Josh/0000-0002-4183-0049	NIH-NCI [R01 CA133216]; Pediatric Brain Tumor Foundation; NATIONAL CANCER INSTITUTE [R01CA133216] Funding Source: NIH RePORTER	NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pediatric Brain Tumor Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NIH-NCI R01 CA133216 (SR) and the Pediatric Brain Tumor Foundation (NG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abayomi OK, 1996, ACTA ONCOL, V35, P659, DOI 10.3109/02841869609083995; Andres RH, 2011, STROKE, V42, P2923, DOI 10.1161/STROKEAHA.110.606368; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Babcock AA, 2003, J NEUROSCI, V23, P7922; Banisadr G, 2005, J COMP NEUROL, V492, P178, DOI 10.1002/cne.20729; Belarbi K, 2013, CANCER RES, V73, P1201, DOI 10.1158/0008-5472.CAN-12-2989; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Cardona AE, 2006, NAT PROTOC, V1, P1947, DOI 10.1038/nprot.2006.327; Chen M, 2012, GLIA, V60, P833, DOI 10.1002/glia.22315; Dimitrijevic OB, 2006, J CEREBR BLOOD F MET, V26, P797, DOI 10.1038/sj.jcbfm.9600229; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Fauquette W, 2012, BRAIN RES, V1433, P114, DOI 10.1016/j.brainres.2011.11.022; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421; Gilmore SA, 2003, EXP NEUROL, V182, P169, DOI 10.1016/S0014-4886(03)00118-3; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Kim SH, 2002, J KOREAN MED SCI, V17, P242, DOI 10.3346/jkms.2002.17.2.242; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; LEE SC, 1993, J IMMUNOL, V150, P2659; Lee WH, 2011, RADIAT RES, V176, P753, DOI 10.1667/RR2647.1; Lerman OZ, 2010, BLOOD, V116, P3669, DOI 10.1182/blood-2009-03-213629; Linard C, 2004, INT J RADIAT ONCOL, V58, P427, DOI 10.1016/j.ijrobp.2003.09.039; LJUBIMOVA NV, 1991, BRIT J RADIOL, V64, P934, DOI 10.1259/0007-1285-64-766-934; Lloyd CM, 2008, J IMMUNOL METHODS, V334, P70, DOI 10.1016/j.jim.2008.02.005; Lund EL, 2004, INT J CANCER, V108, P833, DOI 10.1002/ijc.11662; Mahad D, 2006, BRAIN, V129, P212, DOI 10.1093/brain/awh655; Man SM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003197; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Mildner A, 2011, J NEUROSCI, V31, P11159, DOI 10.1523/JNEUROSCI.6209-10.2011; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Mizumatsu S, 2003, CANCER RES, V63, P4021; Mizutani M, 2012, J IMMUNOL, V188, P29, DOI 10.4049/jimmunol.1100421; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Moravan MJ, 2011, RADIAT RES, V176, P459, DOI 10.1667/RR2587.1; Morganti JM, 2012, J NEUROSCI, V32, P14592, DOI 10.1523/JNEUROSCI.0539-12.2012; Naert G, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00051; Naert G, 2012, MOL MED, V18, P297, DOI 10.2119/molmed.2011.00306; Naert G, 2011, J NEUROSCI, V31, P6208, DOI 10.1523/JNEUROSCI.0299-11.2011; Nguyen V, 2000, RADIAT RES, V154, P531, DOI 10.1667/0033-7587(2000)154[0531:LEOIRO]2.0.CO;2; Nordal RA, 2005, INT J RADIAT ONCOL, V62, P279, DOI 10.1016/j.ijrobp.2005.01.039; Olah M, 2012, GLIA, V60, P306, DOI 10.1002/glia.21266; Panagiotakos G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000588; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Prinz M, 2010, J NEUROIMMUNOL, V224, P80, DOI 10.1016/j.jneuroim.2010.05.015; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Roberts TK, 2012, LAB INVEST, V92, P1213, DOI 10.1038/labinvest.2012.80; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Rosi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031094; Rosi S, 2008, CANCER RES, V68, P9763, DOI 10.1158/0008-5472.CAN-08-1861; Roth NM, 1999, RADIAT RES, V151, P270, DOI 10.2307/3579938; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Schellenberg AE, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-10; Schilling M, 2009, BRAIN RES, V1289, P79, DOI 10.1016/j.brainres.2009.06.054; Semple BD, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-67; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P459, DOI 10.1038/jcbfm.2009.240; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Stamatovic SM, 2005, J CEREBR BLOOD F MET, V25, P593, DOI 10.1038/sj.jcbfm.9600055; Stamatovic SM, 2012, MOL CELL BIOL, V32, P3414, DOI 10.1128/MCB.06678-11; Stasinopoulos I, 2009, CANCER BIOL THER, V8, P31, DOI 10.4161/cbt.8.1.7079; Steiner J, 2008, NEUROSCIENCE, V154, P496, DOI 10.1016/j.neuroscience.2008.03.060; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Szmydynger-Chodobska J, 2012, J CEREBR BLOOD F MET, V32, P93, DOI 10.1038/jcbfm.2011.111; Takeshita Y, 2012, IMMUNOL REV, V248, P228, DOI 10.1111/j.1600-065X.2012.01127.x; Varol C, 2009, IMMUNOL CELL BIOL, V87, P30, DOI 10.1038/icb.2008.90; Varvel NH, 2012, P NATL ACAD SCI USA, V109, P18150, DOI 10.1073/pnas.1210150109; Westin K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030525; Wu GF, 2006, CARDIOVASC RES, V69, P512, DOI 10.1016/j.cardiores.2005.09.019; Wu KL, 2010, INT J RADIAT ONCOL, V76, P220, DOI 10.1016/j.ijrobp.2009.08.017; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003; Zuurman MW, 2003, GLIA, V41, P327, DOI 10.1002/glia.10156	79	67	69	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93650	10.1371/journal.pone.0093650	http://dx.doi.org/10.1371/journal.pone.0093650			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695541	gold, Green Published, Green Submitted			2022-12-25	WOS:000334103000097
J	Jiang, W; Li, YQ; Liu, N; Sun, Y; He, QM; Jiang, N; Xu, YF; Chen, L; Ma, J				Jiang, Wei; Li, Ying-Qin; Liu, Na; Sun, Ying; He, Qing-Mei; Jiang, Ning; Xu, Ya-Fei; Chen, Lei; Ma, Jun			5-Azacytidine Enhances the Radiosensitivity of CNE2 and SUNE1 Cells In Vitro and In Vivo Possibly by Altering DNA Methylation	PLOS ONE			English	Article							SUPPRESSES TUMOR-GROWTH; GENE-EXPRESSION; CANCER; 5-AZA-2'-DEOXYCYTIDINE; APOPTOSIS; REPRIMO; PROTEIN; HEAD; PHOSPHORYLATION; DEMETHYLATION	The radioresistance of tumor cells remains a major cause of treatment failure in nasopharyngeal carcinoma (NPC). Recently, several reports have highlighted the importance of epigenetic changes in radiation-induced responses. Here, we investigated whether the demethylating agent 5-azacytidine (5-azaC) enhances the radiosensitivity of NPC cells. The NPC cell lines CNE2 and SUNE1 were treated with 1 mu mol/L 5-azaC for 24 h before irradiation (IR); clonogenic survival was then assessed. Tumor growth was investigated in a mouse xenograft model in vivo. The apoptosis, cell cycle progression and DNA damage repair were examined using flow cytometry, immunofluorescent staining and western blotting. Promoter methylation and the expression of four genes epigenetically silenced during the development of NPC were evaluated by pyrosequencing and real-time PCR. We found that pretreatment with 5-azaC significantly decreased clonogenic survival after IR compared to IR alone; the sensitivity-enhancement ratio of 5-azaC was 1.4 and 1.2 for CNE2 and SUNE1 cells, respectively. The combined administration of 5-azaC and IR significantly inhibited tumor growth in the mouse xenograft model, and enhanced radiation-induced apoptosis in vitro compared to 5-azaC alone or IR alone. 5-AzaC also decreased promoter methylation and upregulated the expression of genes which are epigenetically silenced both in vitro and in vivo in NPC. Thus, 5-azaC enhance the radiosensitivity of both the CNE2 and SUNE1 cell lines, possibly by altering DNA methylation levels and increasing the ability of irradiated cells to undergo apoptosis. The use of 5-azaC combined with IR maybe represent an attractive strategy for the treatment of NPC.	[Jiang, Wei; Li, Ying-Qin; Liu, Na; Sun, Ying; He, Qing-Mei; Jiang, Ning; Xu, Ya-Fei; Chen, Lei; Ma, Jun] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University	Ma, J (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China.	drjunma@hotmail.com		Liu, Na/0000-0001-8654-3636	Guangdong Province Universities; Colleges Pearl River Scholar Funded Scheme [2050205]; National Natural Science Foundation of China [81230056]; Innovation Team Development Plan of the Ministry of Education [IRT1297]; Science and Technology Project of Guangzhou City [12BppZXaa2060002]; Guangdong Translational Medicine Public Platform [4202037]	Guangdong Province Universities; Colleges Pearl River Scholar Funded Scheme; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Team Development Plan of the Ministry of Education; Science and Technology Project of Guangzhou City; Guangdong Translational Medicine Public Platform	This work was supported by grants from the Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2011, 2050205), the National Natural Science Foundation of China (No. 81230056), the Innovation Team Development Plan of the Ministry of Education (No. IRT1297), the Science and Technology Project of Guangzhou City (No. 12BppZXaa2060002), and the Guangdong Translational Medicine Public Platform (No. 4202037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khalaf HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021111; Andorfer P, 2011, ONCOGENE, V30, P2679, DOI 10.1038/onc.2010.639; Barendsen GW, 1997, INT J RADIAT BIOL, V71, P649, DOI 10.1080/095530097143653; Brieger J, 2012, INT J MOL MED, V29, P505, DOI 10.3892/ijmm.2011.843; Carr M, 2011, MOL CELL BIOCHEM, V353, P205, DOI 10.1007/s11010-011-0788-3; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; De Schutter H, 2009, INT J RADIAT ONCOL, V73, P904, DOI 10.1016/j.ijrobp.2008.10.032; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; FOWLER JF, 1989, BRIT J RADIOL, V62, P679, DOI 10.1259/0007-1285-62-740-679; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Fueyo J, 1998, NAT MED, V4, P685, DOI 10.1038/nm0698-685; Hofstetter B, 2010, INT J RADIAT ONCOL, V76, P1512, DOI 10.1016/j.ijrobp.2009.10.037; Italiano A, 2009, CLIN CANCER RES, V15, P5696, DOI 10.1158/1078-0432.CCR-08-3185; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Karam JA, 2007, INT J CANCER, V120, P1795, DOI 10.1002/ijc.22405; Kim HJ, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-39; Kwong J, 2002, CLIN CANCER RES, V8, P131; Lee AWM, 2012, ORAL ONCOL, V48, P768, DOI 10.1016/j.oraloncology.2012.02.017; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo KW, 2004, CANCER CELL, V5, P423, DOI 10.1016/S1535-6108(04)00119-9; Malpeli G, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-351; Muschel RJ, 1998, ONCOGENE, V17, P3359, DOI 10.1038/sj.onc.1202580; NAITO S, 1986, CANCER RES, V46, P4109; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Patties I, 2009, STRAHLENTHER ONKOL, V185, P331, DOI 10.1007/s00066-009-1956-1; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Qiu H, 2009, CANCER SCI, V100, P181, DOI 10.1111/j.1349-7006.2008.01004.x; Redon CE, 2011, METHODS MOL BIOL, V682, P249, DOI 10.1007/978-1-60327-409-8_18; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sato N, 2006, CANCER-AM CANCER SOC, V107, P251, DOI 10.1002/cncr.21977; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang GL, 1999, BRIT J CANCER, V81, P1122, DOI 10.1038/sj.bjc.6690818; Wang XM, 1998, ANN SURG, V227, P922, DOI 10.1097/00000658-199806000-00016; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Wong TS, 2005, INT J CANCER, V117, P697, DOI 10.1002/ijc.21208; Xing JL, 2008, CANCER-AM CANCER SOC, V112, P2756, DOI 10.1002/cncr.23533; Xu M, 2012, ENDOCRINOLOGY, V153, P2963, DOI 10.1210/en.2011-2021; Yang HL, 2006, MOL CANCER THER, V5, P253, DOI 10.1158/1535-7163.MCT-05-0395; Yang QF, 2002, ANTICANCER RES, V22, P2753; Zheng ZX, 2012, FASEB J, V26, P449, DOI 10.1096/fj.11-190025	43	24	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93273	10.1371/journal.pone.0093273	http://dx.doi.org/10.1371/journal.pone.0093273			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691157	Green Published, Green Submitted, gold			2022-12-25	WOS:000334101100060
J	Jin, J; Xu, GX; Yuan, ZL				Jin, Ji; Xu, Guo-xu; Yuan, Zhi-lan			Influence of the Hypothalamic Arcuate Nucleus on Intraocular Pressure and the Role of Opioid Peptides	PLOS ONE			English	Article							OCULAR HYDRODYNAMICS; NATRIURETIC-PEPTIDE; NITRIC-OXIDE; STIMULATION; BREMAZOCINE; INHIBITION; MODULATION; ACTIVATION; REDUCTION; RECEPTORS	Background: An opioid peptide neuron/humoral feedback regulation might be involved in changes of intraocular pressure (IOP). The aims of this study are to investigate the effects of arcuate nucleus (ARC) and opioid peptides on intraocular pressure (IOP). Methods: Fifty-four healthy purebred New Zealand white rabbits (108eyes) were randomly divided into 4 groups, including control group, electrical stimulation group, [D-Ala2, N-Me-Phe4, Gly5-ol]-enkephalin (DAMGO) group, and [D-Pen 2, D-Pen5]-enkephalin (DPDPE) group. Bilateral IOP was measured after unilateral electrical stimulation of the ARC or unilateral microinjection into the ARC of the selective mu-opioid receptor agonist DAMGO or the selective delta opioid receptor agonist DPDPE, both alone and after pre-administration of either the non-selective opioid receptor antagonist naloxone or saline. Results: Both electrical stimulation in ARC and micro-injection either mu or delta opioid receptor agonists, DAMGO or DPDPE, respectively, caused a significant bilateral reduction in IOP (P<0.05) which was more pronounced in the ipsilateral than in the contralateral eye. Pretreatment with naloxone prevented some, but not all IOP reductions. Conclusion: The ARC takes part in the negative regulation of IOP, an action that may involve opioid neurons.	[Jin, Ji; Xu, Guo-xu] Soochow Univ, Affiliated Hosp 2, Dept Ophthalmol, Suzhou, Jiangsu, Peoples R China; [Yuan, Zhi-lan] Nanjing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China	Soochow University - China; Nanjing Medical University	Yuan, ZL (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China.	zhilanyuan@vip.sina.com						Bonfiglio V, 2006, EUR J PHARMACOL, V534, P227, DOI 10.1016/j.ejphar.2006.01.045; Bucolo C, 2012, BIOCHEM PHARMACOL, V83, P680, DOI 10.1016/j.bcp.2011.11.031; Chu TC, 2002, J OCUL PHARMACOL TH, V18, P293, DOI 10.1089/10807680260218461; Dortch-Carnes J, 2006, PHARMACOLOGY, V77, P17, DOI 10.1159/000091993; DRAGO F, 1980, N-S ARCH PHARMACOL, V315, P1, DOI 10.1007/BF00504223; FANCIULLACCI M, 1980, EUR J PHARMACOL, V61, P319, DOI 10.1016/0014-2999(80)90136-3; Fuxe K, 1997, NEUROSCI LETT, V225, P49, DOI 10.1016/S0304-3940(97)00184-5; Georgiou AL, 2012, VISUAL NEUROSCI, V29, P237, DOI 10.1017/S0952523812000193; Ludwig M, 2000, NEUROSCI LETT, V281, P195, DOI 10.1016/S0304-3940(00)00846-6; MAO LM, 1990, PEPTIDES, V11, P1045, DOI 10.1016/0196-9781(90)90032-Z; Miagkov A V, 2002, Ross Fiziol Zh Im I M Sechenova, V88, P972; Myagkov A V, 2004, Neurosci Behav Physiol, V34, P97, DOI 10.1023/B:NEAB.0000003252.77752.40; Myagkov AV, 2004, B EXP BIOL MED+, V137, P132, DOI 10.1023/B:BEBM.0000028121.61962.6a; Ostermeier AM, 2000, ANESTHESIOLOGY, V93, P1053, DOI 10.1097/00000542-200010000-00029; Potter DE, 2004, J PHARMACOL EXP THER, V309, P548, DOI 10.1124/jpet.103.063107; ROHDE BH, 1993, OPHTHALMIC RES, V25, P378, DOI 10.1159/000267340; Russell KRM, 2000, EXP EYE RES, V70, P675, DOI 10.1006/exer.2000.0832; Russell KRM, 2002, EXP EYE RES, V75, P259, DOI 10.1006/exer.2002.2024; Russell-Randall KR, 2011, INVEST OPHTH VIS SCI, V52, P5233, DOI 10.1167/iovs.10-6613; Salomone S, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00009; Selbach JM, 2005, J ANAT, V206, P237, DOI 10.1111/j.1469-7580.2005.00379.x; Suzuki T, 2000, EUR J PHARMACOL, V396, P23, DOI 10.1016/S0014-2999(00)00183-7; Wang J, 2001, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V17, P153	23	19	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e82315	10.1371/journal.pone.0082315	http://dx.doi.org/10.1371/journal.pone.0082315			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691128	Green Submitted, gold, Green Published			2022-12-25	WOS:000334101100001
J	McIntosh, JD; Manning, K; Chokshi, S; Naoumov, NV; Fraser, JD; Dunbar, PR; Taylor, JA				McIntosh, Julie D.; Manning, Kristy; Chokshi, Shilpa; Naoumov, Nikolai V.; Fraser, John D.; Dunbar, P. Rod; Taylor, John A.			An Engineered Non-Toxic Superantigen Increases Cross Presentation of Hepatitis B Virus Nucleocapsids by Human Dendritic Cells	PLOS ONE			English	Article							ANTIGEN PRESENTATION; CORE ANTIGEN; ENDOPLASMIC-RETICULUM; ESCHERICHIA-COLI; IMMUNE-RESPONSE; CAPSID PROTEIN; RECEPTOR; PARTICLES; EPITOPES; PEPTIDE	Virus like particles (VLPs) are potent immunogens capable of priming strong protective antibody responses due to their repetitive structural arrangement and affinity for specific B cell receptors. By contrast, T cell responses to VLPs can be weak due to inefficient uptake and processing by antigen presenting cells. We report here a novel strategy for increasing the T cell reactivity of a VLP, the nucleocapsid of hepatitis B virus, through covalent coupling of M1, an engineered form of the Streptococcal superantigen SMEZ2, that binds MHC II with high affinity but lacks its T cell mitogenic capability. M1: HBcAg conjugates bound to dendritic cells and were efficiently endocytosed into late endosomes. Human dendritic cells pulsed with M1: HBcAgs stimulated HBV-specific CD8(+) T cells more effectively than cells pulsed with native capsids indicating that the modified VLP was more effectively cross presented by APCs. Coupling of M1 was also able to induce significantly greater reactivity of human CD4(-) T cells specific for a common T-helper epitope. These studies indicate the potential of recombinant superantigens to act as flexible molecular adjuvants that can be incorporated into various subunit vaccine platforms leading to enhanced T cell reactivity in humans.	[McIntosh, Julie D.; Manning, Kristy; Dunbar, P. Rod; Taylor, John A.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [McIntosh, Julie D.; Manning, Kristy; Dunbar, P. Rod; Taylor, John A.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1, New Zealand; [Fraser, John D.] Univ Auckland, Sch Med Sci, Auckland 1, New Zealand; [Chokshi, Shilpa; Naoumov, Nikolai V.] UCL, Inst Hepatol, London, England	University of Auckland; University of Auckland; University of Auckland; University of London; University College London	Taylor, JA (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.	ja.taylor@auckland.ac.nz	Dunbar, Rod/C-2570-2012	Dunbar, Rod/0000-0001-9626-2600	Health Research Council of New Zealand [05/252]	Health Research Council of New Zealand(Health Research Council of New Zealand)	This research was funded by a Project Grant awarded by the Health Research Council of New Zealand (05/252). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman AL, 2005, NAT IMMUNOL, V6, P107, DOI 10.1038/ni1147; Ackerman AL, 2003, P NATL ACAD SCI USA, V100, P12889, DOI 10.1073/pnas.1735556100; Akbar SMF, 2012, ANTIVIR RES, V96, P59, DOI 10.1016/j.antiviral.2012.07.011; Arcus VL, 2000, J MOL BIOL, V299, P157, DOI 10.1006/jmbi.2000.3725; Bachmann MF, 1997, ANNU REV IMMUNOL, V15, P235, DOI 10.1146/annurev.immunol.15.1.235; Basha G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003247; Bertoletti A, 2000, CURR OPIN IMMUNOL, V12, P403, DOI 10.1016/S0952-7915(00)00108-4; Birkholz K, 2010, BLOOD, V116, P2277, DOI 10.1182/blood-2010-02-268425; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Boscardin SB, 2006, J EXP MED, V203, P599, DOI 10.1084/jem.20051639; Broos K, 2007, PROTEIN EXPRES PURIF, V54, P30, DOI 10.1016/j.pep.2007.02.006; Burgdorf S, 2008, NAT IMMUNOL, V9, P558, DOI 10.1038/ni.1601; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; CLARKE BE, 1987, NATURE, V330, P381, DOI 10.1038/330381a0; COHEN BJ, 1982, NATURE, V296, P677, DOI 10.1038/296677a0; Cooper A, 2005, J IMMUNOL, V175, P3165, DOI 10.4049/jimmunol.175.5.3165; Dickgreber N, 2009, J IMMUNOL, V182, P1260, DOI 10.4049/jimmunol.182.3.1260; Freire T, 2010, BLOOD, V116, P3526, DOI 10.1182/blood-2010-04-279133; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Gehring AJ, 2007, J VIROL, V81, P2940, DOI 10.1128/JVI.02415-06; GORGA JC, 1987, J BIOL CHEM, V262, P16087; Gromme M, 1999, P NATL ACAD SCI USA, V96, P10326, DOI 10.1073/pnas.96.18.10326; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Heathcote J, 1999, HEPATOLOGY, V30, P531, DOI 10.1002/hep.510300208; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; ILAN Y, 1993, GASTROENTEROLOGY, V104, P1818, DOI 10.1016/0016-5085(93)90664-X; Jegerlehner A, 2002, VACCINE, V20, P3104, DOI 10.1016/S0264-410X(02)00266-9; Lau GKK, 2002, GASTROENTEROLOGY, V122, P614, DOI 10.1053/gast.2002.31887; Lazdina U, 2001, J VIROL, V75, P6367, DOI 10.1128/JVI.75.14.6367-6374.2001; Lee RS, 1998, EUR J IMMUNOL, V28, P2726, DOI 10.1002/(SICI)1521-4141(199809)28:09<2726::AID-IMMU2726>3.3.CO;2-N; Liu SG, 1997, CLIN BIOCHEM, V30, P455, DOI 10.1016/S0009-9120(97)00049-0; Lunde E, 1999, NAT BIOTECHNOL, V17, P670, DOI 10.1038/10883; Lunde E, 2002, J IMMUNOL, V168, P2154, DOI 10.4049/jimmunol.168.5.2154; Lunde E, 2001, BIOMOL ENG, V18, P109, DOI 10.1016/S1389-0344(01)00091-0; Mayer S, 2002, IMMUNOBIOLOGY, V205, P282, DOI 10.1078/0171-2985-00131; Menne S, 2007, J VIROL, V81, P10614, DOI 10.1128/JVI.00691-07; Mizukoshi E, 2004, J IMMUNOL, V173, P5863, DOI 10.4049/jimmunol.173.9.5863; Proft T, 2007, J INTERF CYTOK RES, V27, P553, DOI 10.1089/jir.2006.0173; Rigopoulou EI, 2005, HEPATOLOGY, V42, P1028, DOI 10.1002/hep.20888; Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x; Schatz D, 1998, CLIN DIAGN LAB IMMUN, V5, P894, DOI 10.1128/CDLI.5.6.894-896.1998; Song R, 1996, J IMMUNOL, V156, P4182; STAHL S, 1982, P NATL ACAD SCI-BIOL, V79, P1606, DOI 10.1073/pnas.79.5.1606; Storni T, 2002, J IMMUNOL, V168, P2880, DOI 10.4049/jimmunol.168.6.2880; Susumu S, 2008, CANCER SCI, V99, P107, DOI 10.1111/j.1349-7006.2007.00654.x; Tacken PJ, 2007, NAT REV IMMUNOL, V7, P790, DOI 10.1038/nri2173; Trumpfheller C, 2006, J EXP MED, V203, P607, DOI 10.1084/jem.20052005; Wang XH, 2005, CANCER IMMUNOL IMMUN, V54, P971, DOI 10.1007/s00262-005-0662-9; Watts NR, 2002, EMBO J, V21, P876, DOI 10.1093/emboj/21.5.876; Win SJ, 2011, IMMUNOL CELL BIOL, V89, P681, DOI 10.1038/icb.2010.161; Zlotnick A, 1996, BIOCHEMISTRY-US, V35, P7412, DOI 10.1021/bi9604800	52	8	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93598	10.1371/journal.pone.0093598	http://dx.doi.org/10.1371/journal.pone.0093598			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690680	Green Published, Green Submitted, gold			2022-12-25	WOS:000334101100109
J	Ren, LY; Qian, XC; Zhai, LJ; Sun, M; Miao, ZG; Li, JZ; Xu, XS				Ren, Liyan; Qian, Xuanchen; Zhai, Lijing; Sun, Miao; Miao, Zhigang; Li, Jizhen; Xu, Xingshun			Loss of Ahi1 Impairs Neurotransmitter Release and Causes Depressive Behaviors in Mice	PLOS ONE			English	Article							TAIL SUSPENSION TEST; BRAIN; GENE; PATHOPHYSIOLOGY; CEREBELLAR; MUTATIONS; SUPPORT	Major depression is becoming one of the most prevalent forms of psychiatric disorders. However, the mechanisms of major depression are still not well-understood. Most antidepressants are only effective in some patients and produce some serious side effects. Animal models of depression are therefore essential to unravel the mechanisms of depression and to develop novel therapeutic strategies. Our previous studies showed that Abelson helper integration site-1 (Ahi1) deficiency causes depression-like behaviors in mice. In this study, we characterized the biochemical and behavioral changes in Ahi1 knockout (KO) mice. In Ahi1 KO mice, neurotransmitters including serotonin and dopamine were significantly decreased in different brain regions. However, glutamate and GABA levels were not affected by Ahi1 deficiency. The antidepressant imipramine attenuated depressive behaviors and partially restored brain serotonin level in Ahi1 KO mice. Our findings suggest that Ahi1 KO mice can be used for studying the mechanisms of depression and screening therapeutic targets.	[Ren, Liyan; Qian, Xuanchen; Zhai, Lijing; Xu, Xingshun] Soochow Univ, Affiliated Hosp 2, Dept Neurol, Suzhou, Jiangsu, Peoples R China; [Ren, Liyan; Qian, Xuanchen; Zhai, Lijing; Xu, Xingshun] Soochow Univ, Affiliated Hosp 2, Jiangsu Key Lab Translat Res & Therapy Neuro Psyc, Suzhou, Jiangsu, Peoples R China; [Sun, Miao] Soochow Univ, Affiliated Hosp 1, Inst Fetol, Suzhou, Jiangsu, Peoples R China; [Miao, Zhigang; Xu, Xingshun] Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China; [Li, Jizhen] Suzhou Kowloon Hosp, Dept Neurol, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China	Xu, XS (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Neurol, Suzhou, Jiangsu, Peoples R China.	Xingshunxu@suda.edu.cn	miao, sun/E-2834-2018; Xu, Xingshun/AAF-8183-2020; Miao, Zhigang/AHD-1316-2022	Xu, Xingshun/0000-0003-0205-6342	National Natural Science Foundation of China [81071095, 81120108011, 813111078]; Suzhou science and technology development program [SYS201232]; Priority Academic Program Development of Jiangsu Higher Education Institutions of China; Jiangsu Province's Key Provincial Talents Program; National Basic Research Program of China (973 Program) [2013CB945401]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Suzhou science and technology development program; Priority Academic Program Development of Jiangsu Higher Education Institutions of China; Jiangsu Province's Key Provincial Talents Program; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This study was supported by grants 81071095, 81120108011, and 813111078 (to XX) from the National Natural Science Foundation of China, Suzhou science and technology development program (SYS201232), the Priority Academic Program Development of Jiangsu Higher Education Institutions of China, Jiangsu Province's Key Provincial Talents Program (to XX), and the National Basic Research Program of China (973 Program, 2013CB945401, to MS). The funders, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Retuerto AI, 2008, HUM MOL GENET, V17, P3887, DOI 10.1093/hmg/ddn291; Amann-Zalcenstein D, 2006, EUR J HUM GENET, V14, P1111, DOI 10.1038/sj.ejhg.5201675; Bakish D, 2001, J CLIN PSYCHIAT, V62, P5; Caspi A1, 2003, GENE SCI, V301; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Dixon-Salazar T, 2004, AM J HUM GENET, V75, P979, DOI 10.1086/425985; Dunlop BW, 2007, ARCH GEN PSYCHIAT, V64, P327, DOI 10.1001/archpsyc.64.3.327; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; GUZE SB, 1970, BRIT J PSYCHIAT, V117, P437, DOI 10.1192/bjp.117.539.437; Hasler G, 2004, NEUROPSYCHOPHARMACOL, V29, P1765, DOI 10.1038/sj.npp.1300506; Ingason A, 2007, EUR J HUM GENET, V15, P988, DOI 10.1038/sj.ejhg.5201848; Ingason A, 2010, HUM MOL GENET, V19, P1379, DOI 10.1093/hmg/ddq009; Meyer JH, 2006, ARCH GEN PSYCHIAT, V63, P1209, DOI 10.1001/archpsyc.63.11.1209; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Pothion S, 2004, BEHAV BRAIN RES, V155, P135, DOI 10.1016/j.bbr.2004.04.008; Ressler KJ, 2000, DEPRESS ANXIETY, V12, P2, DOI 10.1002/1520-6394(2000)12:1+<2::AID-DA2>3.3.CO;2-W; SCHILDKRAUT JJ, 1965, AM J PSYCHIAT, V122, P509, DOI 10.1176/ajp.122.5.509; SHAW DM, 1967, BRIT J PSYCHIAT, V113, P1407, DOI 10.1192/bjp.113.505.1407; Sheng G, 2008, J CLIN INVEST, V118, P2785, DOI 10.1172/JCI35339; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Tomida S, 2009, NAT GENET, V41, P688, DOI 10.1038/ng.344; Willner P, 2002, BEHAV PHARMACOL, V13, P169, DOI 10.1097/00008877-200205000-00001; Xu XS, 2010, P NATL ACAD SCI USA, V107, P19126, DOI 10.1073/pnas.1013032107; Youdim MBH, 2006, NAT REV NEUROSCI, V7, P295, DOI 10.1038/nrn1883	24	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93640	10.1371/journal.pone.0093640	http://dx.doi.org/10.1371/journal.pone.0093640			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691070	Green Published, gold, Green Submitted			2022-12-25	WOS:000334101100117
J	Sharma, R; Callaway, D; Vanegas, D; Bendele, M; Lopez-Cruzan, M; Horn, D; Guda, T; Fajardo, R; Abboud-Werner, S; Herman, B				Sharma, Ramaswamy; Callaway, Danielle; Vanegas, Difernando; Bendele, Michelle; Lopez-Cruzan, Marisa; Horn, Diane; Guda, Teja; Fajardo, Roberto; Abboud-Werner, Sherry; Herman, Brian			Caspase-2 Maintains Bone Homeostasis by Inducing Apoptosis of Oxidatively-Damaged Osteoclasts	PLOS ONE			English	Article							CELL-DEATH; ISOCITRATE DEHYDROGENASE; HYDROGEN-PEROXIDE; MINERAL DENSITY; CYTOCHROME-C; CRUCIAL ROLE; IN-VITRO; STRESS; OSTEOPOROSIS; MICE	Osteoporosis is a silent disease, characterized by a porous bone micro-structure that enhances risk for fractures and associated disabilities. Senile, or age-related osteoporosis ( SO), affects both men and women, resulting in increased morbidity and mortality. However, cellular and molecular mechanisms underlying senile osteoporosis are not fully known. Recent studies implicate the accumulation of reactive oxygen species (ROS) and increased oxidative stress as key factors in SO. Herein, we show that loss of caspase-2, a cysteine aspartate protease involved in oxidative stress-induced apoptosis, results in total body and femoral bone loss in aged mice (20% decrease in bone mineral density), and an increase in bone fragility (30% decrease in fracture strength). Importantly, we demonstrate that genetic ablation or selective inhibition of caspase-2 using zVDVAD-fmk results in increased numbers of bone-resorbing osteoclasts and enhanced tartrate-resistant acid phosphatase ( TRAP) activity. Conversely, transfection of osteoclast precursors with wild type caspase-2 but not an enzymatic mutant, results in a decrease in TRAP activity. We demonstrate that caspase-2 expression is induced in osteoclasts treated with oxidants such as hydrogen peroxide and that loss of caspase-2 enhances resistance to oxidants, as measured by TRAP activity, and decreases oxidative stress-induced apoptosis of osteoclasts. Moreover, oxidative stress, quantified by assessment of the lipid peroxidation marker, 4-HNE, is increased in Casp2 (-/-) bone, perhaps due to a decrease in antioxidant enzymes such as SOD2. Taken together, our data point to a critical and novel role for caspase-2 in maintaining bone homeostasis by modulating ROS levels and osteoclast apoptosis during conditions of enhanced oxidative stress that occur during aging.	[Sharma, Ramaswamy; Callaway, Danielle; Vanegas, Difernando; Bendele, Michelle; Lopez-Cruzan, Marisa; Herman, Brian] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Horn, Diane; Abboud-Werner, Sherry] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Fajardo, Roberto] Univ Texas Hlth Sci Ctr San Antonio, Dept Orthoped, San Antonio, TX 78229 USA; [Guda, Teja] Univ Texas San Antonio, Dept Biomed Engn, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas at San Antonio (UTSA)	Herman, B (corresponding author), Univ Minnesota, Off Vice President Res, Minneapolis, MN 55455 USA.	herman@umn.edu	Guda, Teja/A-7286-2009; Guda, Teja/AAZ-5176-2020	Guda, Teja/0000-0002-3218-2916; Guda, Teja/0000-0002-3218-2916; Lopez-Cruzan, Marisa/0000-0003-0285-1012	National Institute of Aging [AG 007218, P01-AG19316]; NATIONAL INSTITUTE ON AGING [P01AG019316, R01AG045040, R37AG007218, R01AG007218] Funding Source: NIH RePORTER	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by grants (AG 007218 and P01-AG19316) from the National Institute of Aging (NIA;www.nia.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida M, 2007, J BIOL CHEM, V282, P27285, DOI 10.1074/jbc.M702810200; Altindag O, 2008, RHEUMATOL INT, V28, P317, DOI 10.1007/s00296-007-0452-0; Ambrogini E, 2010, CELL METAB, V11, P136, DOI 10.1016/j.cmet.2009.12.009; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Blair HC, 1998, BIOESSAYS, V20, P837, DOI 10.1002/(SICI)1521-1878(199810)20:10<837::AID-BIES9>3.0.CO;2-D; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Braga M, 2008, APOPTOSIS, V13, P822, DOI 10.1007/s10495-008-0216-7; Cooper C., 1997, AM J MED, V103, p17S; Cooper Cyrus, 1997, American Journal of Medicine, V103, p12S, DOI 10.1016/S0002-9343(97)90022-X; Deng FY, 2011, J BONE MINER RES, V26, P2695, DOI 10.1002/jbmr.471; GARRETT IR, 1990, J CLIN INVEST, V85, P632, DOI 10.1172/JCI114485; Kil IS, 2005, J BIOL CHEM, V280, P10846, DOI 10.1074/jbc.M411306200; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Lean JM, 2005, ENDOCRINOLOGY, V146, P728, DOI 10.1210/en.2004-1021; Lean JM, 2003, J CLIN INVEST, V112, P915, DOI 10.1172/JCI200318859; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Lee SM, 2001, BIOCHIMIE, V83, P1057, DOI 10.1016/S0300-9084(01)01351-7; Li Q, 2006, FREE RADICAL BIO MED, V40, P173, DOI 10.1016/j.freeradbiomed.2005.09.037; Luckman SP, 1998, J BONE MINER RES, V13, P581, DOI 10.1359/jbmr.1998.13.4.581; Manolagas SC, 2010, TRENDS ENDOCRIN MET, V21, P369, DOI 10.1016/j.tem.2010.01.010; Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024; Miyazaki T, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.385369; Monroe DG, 2002, MOL ENDOCRINOL, V16, P1322, DOI 10.1210/me.16.6.1322; Muthusami S, 2005, CLIN CHIM ACTA, V360, P81, DOI 10.1016/j.cccn.2005.04.014; Nojiri H, 2011, J BONE MINER RES, V26, P2682, DOI 10.1002/jbmr.489; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Oursler MJ, 2005, AM J PHYSIOL-CELL PH, V288, pC156, DOI 10.1152/ajpcell.00092.2004; Sanchez-Rodriguez MA, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-124; Sato N, 1997, GENE, V202, P127, DOI 10.1016/S0378-1119(97)00463-0; Seales EC, 2006, J CELL BIOCHEM, V97, P45, DOI 10.1002/jcb.20659; Sendur OF, 2009, JOINT BONE SPINE, V76, P514, DOI 10.1016/j.jbspin.2009.02.005; SHALINI S, 2012, CELL DEATH DIFFER; Smietana MJ, 2010, BIOCHEM BIOPH RES CO, V403, P149, DOI 10.1016/j.bbrc.2010.11.006; Szymczyk KH, 2006, J CELL PHYSIOL, V209, P836, DOI 10.1002/jcp.20770; Tiwari M, 2011, J BIOL CHEM, V286, P8493, DOI 10.1074/jbc.M110.163824; Uchibayashi R, 2011, J NEUROSCI RES, V89, P1783, DOI 10.1002/jnr.22691; Vashishth D, 2001, BONE, V28, P195, DOI 10.1016/S8756-3282(00)00434-8; Wakeyama H, 2007, J BONE MINER RES, V22, P1631, DOI 10.1359/JBMR.070619; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; Wauquier F, 2009, TRENDS MOL MED, V15, P468, DOI 10.1016/j.molmed.2009.08.004; Wu XJ, 2003, ENDOCRINOLOGY, V144, P5545, DOI 10.1210/en.2003-0296; Yalin S, 2005, CLIN EXP RHEUMATOL, V23, P689; Zhang YP, 2007, MECH AGEING DEV, V128, P213, DOI 10.1016/j.mad.2006.11.030; Zhang YP, 2002, EXP GERONTOL, V37, P777, DOI 10.1016/S0531-5565(02)00013-X	45	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93696	10.1371/journal.pone.0093696	http://dx.doi.org/10.1371/journal.pone.0093696			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691516	gold, Green Published, Green Submitted			2022-12-25	WOS:000334101100128
J	Westerholz, J; Schack, T; Schutz, C; Koester, D				Westerholz, Jan; Schack, Thomas; Schuetz, Christoph; Koester, Dirk			Habitual vs Non- Habitual Manual Actions: An ERP Study on Overt Movement Execution	PLOS ONE			English	Article							END-STATE COMFORT; COMPONENTS; PRECISION; SELECTION; COGNITION	This study explored the neurophysiological mechanisms underlying the planning and execution of an overt goal- related handle rotation task. More specifically, we studied the neural basis of motor actions concerning the influence of the grasp choice. The aim of the present study was to differentiate cerebral activity between grips executed in a habitual and a nonhabitual mode, and between specified and free grip choices. To our knowledge, this is the first study to differentiate cerebral activity underlying overt goal-related actions executed with a focus on the habitual mode. In a handle rotation task, participants had to use thumb-toward (habitual) or thumb- away ( non- habitual) grips to rotate a handle to a given target position. Reaction and reach times were shorter for the habitual compared to the non- habitual mode indicating that the habitual mode requires less cognitive processing effort than the non- habitual mode. Neural processes for action execution ( measured by event-related potentials ( ERPs)) differed between habitual and non-habitual conditions. We found differential activity between habitual and non- habitual conditions in left and right frontal areas from -600 to 200 ms time- locked to reaching the target position. No differential neural activity could be traced for the specification of the grip. The results suggested that the frontal negativity reflected increased difficulty in movement precision control in the non- habitual mode compared to the habitual mode during the homing in phase of grasp and rotation actions.	[Westerholz, Jan; Schack, Thomas; Koester, Dirk] CITEC, Bielefeld, Germany; [Westerholz, Jan; Schack, Thomas; Schuetz, Christoph; Koester, Dirk] Univ Bielefeld, Fac Psychol & Sports Sci, Neurocognit & Act Res Grp, D-33615 Bielefeld, Germany; [Schack, Thomas] Res Inst Cognit & Robot, CoR Lab, Bielefeld, Germany	University of Bielefeld	Westerholz, J (corresponding author), CITEC, Bielefeld, Germany.	jwesterh@cit-ec.uni-bielefeld.de	Koester, Dirk/B-2438-2008	Koester, Dirk/0000-0003-3940-8559	German Research Foundation [DFG EXC 277]; Deutsche Forschungsgemeinschaft; Open Access Publication Funds of Bielefeld University Library	German Research Foundation(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Funds of Bielefeld University Library	This research was supported by German Research Foundation Grant DFG EXC 277 "Cognitive Interaction Technology" (CITEC). The authors acknowledge support for the Article Processing Charge by the Deutsche Forschungsgemeinschaft and the Open Access Publication Funds of Bielefeld University Library. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOTWINICK J, 1966, J EXP PSYCHOL, V71, P9, DOI 10.1037/h0022634; Bozzacchi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047783; Bozzacchi C, 2012, BIOL PSYCHOL, V89, P503, DOI 10.1016/j.biopsycho.2011.12.020; Cohen RG, 2004, EXP BRAIN RES, V157, P486, DOI 10.1007/s00221-004-1862-9; Elliott D, 2010, PSYCHOL BULL, V136, P1023, DOI 10.1037/a0020958; Filimon F, 2010, NEUROSCIENTIST, V16, P388, DOI 10.1177/1073858410375468; Fleming SM, 2009, CEREB CORTEX, V19, P2352, DOI 10.1093/cercor/bhn252; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Herbort O, 2011, EXP BRAIN RES, V213, P371, DOI 10.1007/s00221-011-2787-8; Hughes CML, 2012, J MOTOR BEHAV, V44, P195, DOI 10.1080/00222895.2012.672483; Kunzell S, 2013, ACTA PSYCHOL, V143, P310, DOI 10.1016/j.actpsy.2013.04.013; Lange JJ, 1999, BIOL PSYCHOL, V50, P203, DOI 10.1016/S0301-0511(99)00009-5; MARTENIUK RG, 1990, HUM MOVEMENT SCI, V9, P149, DOI 10.1016/0167-9457(90)90025-9; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; ROSENBAUM DA, 1992, J EXP PSYCHOL LEARN, V18, P1058, DOI 10.1037/0278-7393.18.5.1058; ROSENBAUM DA, 1993, ATTENTION PERFORM, V14, P803; ROSENBAUM DA, 1990, ATTENTION PERFORM, V8, P321; Rosenbaum DA, 1996, ACTA PSYCHOL, V94, P59, DOI 10.1016/0001-6918(95)00062-3; ROSENBAUM DA, 1992, HUM MOVEMENT SCI, V11, P61, DOI 10.1016/0167-9457(92)90050-L; Rosenbaum DA, 2012, PSYCHOL BULL, V138, P924, DOI 10.1037/a0027839; Short MW, 1999, ACTA PSYCHOL, V100, P243, DOI 10.1016/S0001-6918(98)00020-1; van Elk M, 2008, EXP BRAIN RES, V189, P99, DOI 10.1007/s00221-008-1408-7; van Elk M, 2012, EXP BRAIN RES, V218, P189, DOI 10.1007/s00221-012-3016-9; van Schie HT, 2007, BRAIN RES, V1148, P183, DOI 10.1016/j.brainres.2007.02.085; Waszak F, 2012, NEUROSCI BIOBEHAV R, V36, P943, DOI 10.1016/j.neubiorev.2011.11.004; Weigelt M, 2007, EXP BRAIN RES, V179, P191, DOI 10.1007/s00221-006-0780-4; Weigelt M, 2006, EXP PSYCHOL, V53, P143, DOI 10.1027/1618-3169.53.2.143; Westerholz J, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068501, DOI 10.1371/JOURNAL.PONE. 0068501]	29	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93116	10.1371/journal.pone.0093116	http://dx.doi.org/10.1371/journal.pone.0093116			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6KM	24691654	Green Submitted, Green Published, gold			2022-12-25	WOS:000334101100048
J	Zhang, YT; Xu, LH; Lu, Q; Liu, KP; Liu, PY; Ji, F; Liu, XM; Ouyang, DY; He, XH				Zhang, Yan-Ting; Xu, Li-Hui; Lu, Qun; Liu, Kun-Peng; Liu, Pei-Yan; Ji, Fang; Liu, Xiao-Ming; Ouyang, Dong-Yun; He, Xian-Hui			VASP Activation via the G alpha 13/RhoA/PKA Pathway Mediates Cucurbitacin-B-Induced Actin Aggregation and Cofilin-Actin Rod Formation	PLOS ONE			English	Article							VASODILATOR-STIMULATED-PHOSPHOPROTEIN; BREAST-CANCER CELLS; POTENT ANTITUMOR-ACTIVITY; ENA/VASP PROTEINS; CARCINOMA-CELLS; CYCLE ARREST; IN-VIVO; PHOSPHORYLATION; CYTOSKELETON; INHIBITOR	Cucurbitacin B (CuB), a potent antineoplastic agent of cucurbitacin triterpenoids, induces rapid disruption of actin cytoskeleton and aberrant cell cycle inhibiting carcinogenesis. However, the underlying molecular mechanism of such anticancer effects remains incompletely understood. In this study, we showed that CuB treatment rapidly induced vasodilator-stimulated phosphoprotein (VASP) phosphorylation (i.e. activation) at the Ser157 residue and generated VASP clumps which were co-localized with amorphous actin aggregates prior to the formation of highly-ordered cofilin-actin rods in melanoma cells. Knockdown of VASP or inhibition of VASP activation using PKA-specific inhibitor H89 suppressed CuB-induced VASP activation, actin aggregation and cofilin-actin rod formation. The VASP activation was mediated by cAMP-independent PKA activation as CuB decreased the levels of cAMP while MDL12330A, an inhibitor of adenylyl cyclase, had weak effect on VASP activation. Knockdown of either G alpha 13 or RhoA not only suppressed VASP activation, but also ameliorated CuB-induced actin aggregation and abrogated cofilin-actin rod formation. Collectively, our studies highlighted that the CuB-induced actin aggregation and cofilin-actin rod formation was mediated via the G alpha 13/RhoA/PKA/VASP pathway.	[Zhang, Yan-Ting; Liu, Kun-Peng; Ouyang, Dong-Yun; He, Xian-Hui] Jinan Univ, Dept Immunobiol, Guangzhou, Guangdong, Peoples R China; [Xu, Li-Hui] Jinan Univ, Dept Cell Biol, Guangzhou, Guangdong, Peoples R China; [Lu, Qun] E Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, Greenville, NC USA; [Liu, Pei-Yan] Jinan Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China; [Ji, Fang] Guangdong Entomol Inst, Guangzhou, Guangdong, Peoples R China; [Liu, Xiao-Ming] Southern China Primate Res Ctr, Guangzhou, Guangdong, Peoples R China	Jinan University; Jinan University; University of North Carolina; East Carolina University; Jinan University; Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences	Ouyang, DY (corresponding author), Jinan Univ, Dept Immunobiol, Guangzhou, Guangdong, Peoples R China.	dongyun1967@aliyun.com; thexh@jnu.edu.cn	Liu, Kunpeng/AAR-7582-2021; Ouyang, Dong-Yun/P-7305-2019; He, Xian-Hui/H-3153-2019; Ouyang, dong-yun/GSD-5233-2022	Liu, Kunpeng/0000-0003-3452-880X; Ouyang, Dong-Yun/0000-0002-4743-942X; He, Xian-Hui/0000-0001-7433-7392; Xu, Li-hui/0000-0002-2633-9999	National Natural Science Foundation of China [81173604]; Specialized Research Program of "Twelfth Five-Year Plan" of China [2011ZX09307-303-03]; Fundamental Research Funds for the Central Universities [21611387]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Program of "Twelfth Five-Year Plan" of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Natural Science Foundation of China (No. 81173604), the Specialized Research Program of "Twelfth Five-Year Plan" of China (2011ZX09307-303-03), and the Fundamental Research Funds for the Central Universities (21611387). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bear JE, 2009, J CELL SCI, V122, P1947, DOI 10.1242/jcs.038125; Benz PM, 2008, J CELL BIOL, V180, P205, DOI 10.1083/jcb.200709181; Benz PM, 2009, J CELL SCI, V122, P3954, DOI 10.1242/jcs.044537; Blaskovich MA, 2003, CANCER RES, V63, P1270; Boykin C, 2011, BRIT J CANCER, V104, P781, DOI 10.1038/bjc.2011.10; Chan KT, 2010, CANCER LETT, V289, P46, DOI 10.1016/j.canlet.2009.07.015; Chen XP, 2012, ANTI-CANCER DRUG, V23, P777, DOI 10.1097/CAD.0b013e3283541384; Chern YJ, 2000, CELL SIGNAL, V12, P195, DOI 10.1016/S0898-6568(99)00084-4; Dinan L, 1997, BIOCHEM J, V327, P643, DOI 10.1042/bj3270643; Duncan KLK, 1996, BIOCHEM PHARMACOL, V52, P1553, DOI 10.1016/S0006-2952(96)00557-6; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Harbeck B, 2000, J BIOL CHEM, V275, P30817, DOI 10.1074/jbc.M005066200; Haritunians T, 2008, LEUKEMIA RES, V32, P1366, DOI 10.1016/j.leukres.2008.01.019; Juneja J, 2009, BRIT J PHARMACOL, V158, P32, DOI 10.1111/j.1476-5381.2009.00180.x; Kataoka A, 2011, PURINERG SIGNAL, V7, P403, DOI 10.1007/s11302-011-9237-8; Knecht DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014039; KONOSHIMA T, 1995, BIOL PHARM BULL, V18, P284, DOI 10.1248/bpb.18.284; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Kwiatkowski AV, 2003, TRENDS CELL BIOL, V13, P386, DOI 10.1016/S0962-8924(03)00130-2; Lang AE, 2011, N-S ARCH PHARMACOL, V383, P227, DOI 10.1007/s00210-010-0579-5; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lopez-Haber C, 2013, MOL PHARMACOL, V83, P1141, DOI 10.1124/mol.112.084293; Lui VWY, 2009, CARCINOGENESIS, V30, P2085, DOI 10.1093/carcin/bgp253; Mannock DA, 2010, CHEM PHYS LIPIDS, V163, P403, DOI 10.1016/j.chemphyslip.2010.03.011; Momma K, 2008, CYTOTECHNOLOGY, V56, P33, DOI 10.1007/s10616-007-9100-5; Nakashima S, 2010, BIOORG MED CHEM LETT, V20, P2994, DOI 10.1016/j.bmcl.2010.02.062; Oates J, 2011, CURR OPIN STRUC BIOL, V21, P802, DOI 10.1016/j.sbi.2011.09.007; Paila YD, 2009, GLYCOCONJUGATE J, V26, P711, DOI 10.1007/s10719-008-9218-5; Profirovic J, 2005, J BIOL CHEM, V280, P32866, DOI 10.1074/jbc.M501361200; Promkan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055732; Ren S, 2012, CANCER CHEMOTH PHARM, V70, P415, DOI 10.1007/s00280-012-1921-z; Sun JZ, 2005, ONCOGENE, V24, P3236, DOI 10.1038/sj.onc.1208470; Tannin-Spitz T, 2007, BIOCHEM PHARMACOL, V73, P56, DOI 10.1016/j.bcp.2006.09.012; Thoennissen NH, 2009, CANCER RES, V69, P5876, DOI 10.1158/0008-5472.CAN-09-0536; Thomson DM, 2011, BIOCHEM BIOPH RES CO, V414, P215, DOI 10.1016/j.bbrc.2011.09.059; Trichet L, 2008, J CELL BIOL, V181, P19, DOI 10.1083/jcb.200710168; Wakimoto N, 2008, CANCER SCI, V99, P1793, DOI 10.1111/j.1349-7006.2008.00899.x; Walders-Harbeck B, 2002, FEBS LETT, V529, P275, DOI 10.1016/S0014-5793(02)03356-2; Yin D, 2008, INT J CANCER, V123, P1364, DOI 10.1002/ijc.23648; Zhang YT, 2013, J CELL BIOCHEM, V114, P2415, DOI 10.1002/jcb.24587; Zhang YT, 2011, ACTA BIOCH BIOPH SIN, V43, P556, DOI 10.1093/abbs/gmr042; Zhu JS, 2012, PHARMACOLOGY, V89, P348, DOI 10.1159/000338757	43	21	21	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93547	10.1371/journal.pone.0093547	http://dx.doi.org/10.1371/journal.pone.0093547			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691407	Green Published, Green Submitted, gold			2022-12-25	WOS:000334101100103
J	Lin, JW; Chang, YJ; Yang, WB; Yu, AL; Wong, CH				Lin, Juway; Chang, Ya-Jen; Yang, Wen-Bin; Yu, Alice L.; Wong, Chi-Huey			The Multifaceted Effects of Polysaccharides Isolated from Dendrobium huoshanense on Immune Functions with the Induction of Interleukin-1 Receptor Antagonist (IL-1ra) in Monocytes	PLOS ONE			English	Article							CHRONIC DESTRUCTIVE ARTHRITIS; JUVENILE CHRONIC ARTHRITIS; ANTI-CYTOKINE THERAPY; ACUTE-PHASE PROTEIN; GANODERMA-LUCIDUM; SEPSIS SYNDROME; REISHI POLYSACCHARIDES; SIGNAL-TRANSDUCTION; URINE INHIBITOR; GENE-EXPRESSION	Dendrobium huoshanense is a valuable and versatile Chinese herbal medicine with the anecdotal claims of cancer prevention and anti-inflammation. However, its immunological activities are limited to in vitro studies on a few cytokines and immune cell functions. First, we investigated the effects of polysaccharides isolated from DH (DH-PS) on inducing a panel of cytokines/chemokines in mice in vivo and human in vitro. We found that DH polysaccharides (DH-PS) induced TH1, TH2, inflammatory cytokines and chemokines in mouse in vivo and human cells in vitro. Secondly, we demonstrated that DH-PS expanded mouse splenocytes in vivo including CD4(+) T cells, CD8(+) T cells, B cells, NK cells, NKT cells, monocytes/ macrophages, granulocytes and regulatory T cells. Notably, DH-PS induced an anti-inflammatory molecule, IL-1ra, in mouse and human immune cells, especially monocytes. The serum level of IL-1ra elicited by the injection of DH-PS was over 10 folds of IL-1 beta, suggesting that DH-PS-induced anti-inflammatory activities might over-ride the inflammatory ones mediated by IL-1 beta. The signaling pathways of DH-PS-induced IL-1ra production was shown to involve ERK/ELK, p38 MAPK, PI3K and NF kappa B. Finally, we observed that IL-1ra level induced by DH-PS was significantly higher than that by F3, a polysaccharide extract isolated from another popular Chinese herbal medicine, Ganoderma lucidum. These results indicated that DH-PS might have potential applications for ameliorating IL-1-induced pathogenic conditions.	[Lin, Juway] Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan; [Lin, Juway; Yang, Wen-Bin; Yu, Alice L.; Wong, Chi-Huey] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Chang, Ya-Jen] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Yu, Alice L.] Univ Calif San Diego, Ctr Med, Dept Pediat Hematol Oncol, San Diego, CA 92103 USA; [Yu, Alice L.] Chang Gung Mem Hosp, Ctr Stem Cell & Translat Canc Res, Taoyuan, Taiwan; [Wong, Chi-Huey] Scripps Res Inst, La Jolla, CA 92037 USA	National Taiwan University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; University of California System; University of California San Diego; Chang Gung Memorial Hospital; Scripps Research Institute	Yu, AL (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan.	aliceyu@ucsd.edu; chwong@gate.sinica.edu.tw	Chang, Ya-Jen/O-1584-2018	Chang, Ya-Jen/0000-0003-1377-6142; yu, alice/0000-0003-2444-0505	Academia Sinica and National Science Council [NSC 101-2325-B-001-025]	Academia Sinica and National Science Council	This work is supported by Academia Sinica and National Science Council grants for A. L. Yu (NSC 101-2325-B-001-025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER HR, 1992, SURGERY, V112, P188; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27; AREND WP, 1993, ADV IMMUNOL, V54, P167, DOI 10.1016/S0065-2776(08)60535-0; BALAVOINE JF, 1986, J CLIN INVEST, V78, P1120, DOI 10.1172/JCI112669; Bendele AM, 2000, ARTHRITIS RHEUM-US, V43, P2648, DOI 10.1002/1529-0131(200012)43:12<2648::AID-ANR4>3.0.CO;2-M; Brennan FM, 2001, ARTHRITIS RES, V3, P211, DOI 10.1186/ar302; Chen X, 2006, INT IMMUNOPHARMACOL, V6, P499, DOI 10.1016/j.intimp.2005.08.026; Darragh J, 2010, BIOCHEM J, V425, P595, DOI 10.1042/BJ20091062; DEBenedetti F, 1995, CLIN EXP RHEUMATOL, V13, P779; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; DINARELLO CA, 1991, BLOOD, V77, P1627; DINARELLO CA, 1991, IMMUNOL TODAY, V12, P404, DOI 10.1016/0167-5699(91)90142-G; Dreyer MG, 2003, BIOCHEM J, V370, P591, DOI 10.1042/BJ20021270; DRIPPS DJ, 1991, J BIOL CHEM, V266, P10331; FISCHER E, 1992, BLOOD, V79, P2196; FISHER CJ, 1994, JAMA-J AM MED ASSOC, V271, P1836, DOI 10.1001/jama.271.23.1836; FISHER CJ, 1994, CRIT CARE MED, V22, P12, DOI 10.1097/00003246-199401000-00008; Flo TH, 2000, J IMMUNOL, V164, P2064, DOI 10.4049/jimmunol.164.4.2064; GABAY C, 1994, ARTHRITIS RHEUM, V37, P1744, DOI 10.1002/art.1780371206; Gabay C, 1997, J CLIN INVEST, V99, P2930, DOI 10.1172/JCI119488; Gao YH, 2005, IMMUNOL INVEST, V34, P171, DOI 10.1081/IMM-200055813; GRANOWTIZ EV, 1992, CYTOKINE, V4, P353, DOI 10.1016/1043-4666(92)90078-6; Grzelak I, 1996, J CLIN IMMUNOL, V16, P159, DOI 10.1007/BF01540914; Guthridge CJ, 1997, MOL CELL BIOL, V17, P1118, DOI 10.1128/MCB.17.3.1118; Hagaman DD, 2001, AM J RESP CELL MOL, V25, P685, DOI 10.1165/ajrcmb.25.6.4541; Hsieh YSY, 2008, BIOORGAN MED CHEM, V16, P6054, DOI 10.1016/j.bmc.2008.04.042; Hsu HY, 2004, J IMMUNOL, V173, P5989, DOI 10.4049/jimmunol.173.10.5989; Hsu MJ, 2003, BRIT J PHARMACOL, V139, P289, DOI 10.1038/sj.bjp.0705243; Hua KF, 2007, J CELL PHYSIOL, V212, P537, DOI 10.1002/jcp.21050; Irikura VM, 2002, J IMMUNOL, V169, P393, DOI 10.4049/jimmunol.169.1.393; Joosten LAB, 1996, ARTHRITIS RHEUM, V39, P797, DOI 10.1002/art.1780390513; KUPPER TS, 1987, J CLIN INVEST, V80, P430, DOI 10.1172/JCI113090; Lai CY, 2010, VACCINE, V28, P4945, DOI 10.1016/j.vaccine.2010.05.037; LENNARD AC, 1995, CRIT REV IMMUNOL, V15, P77, DOI 10.1615/CritRevImmunol.v15.i1.30; Liao SF, 2013, P NATL ACAD SCI USA, V110, P13809, DOI 10.1073/pnas.1312457110; Malyak M, 1998, J IMMUNOL, V161, P2004; MCCARTHY PL, 1991, BLOOD, V78, P1915; Meng LZ, 2013, MOLECULES, V18, P5779, DOI 10.3390/molecules18055779; MIYAZAKI T, 1981, CHEM PHARM BULL, V29, P3611; Molnarfi N, 2005, J IMMUNOL, V174, P2974, DOI 10.4049/jimmunol.174.5.2974; Ohmori Y, 1996, J IMMUNOL, V157, P2058; PRIEUR AM, 1987, LANCET, V2, P1240; Pruitt JH, 1996, BLOOD, V87, P3282; Puri P, 1993, CLIN EXP IMMUNOL, V93, P218; SECKINGER P, 1987, Annales de l'Institut Pasteur Immunology, V138, P486; SECKINGER P, 1987, J IMMUNOL, V139, P1541; SECKINGER P, 1987, J IMMUNOL, V139, P1546; So A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2143; STYLIANOU E, 1992, J BIOL CHEM, V267, P15836; THOMPSON RC, 1991, AGENT ACTION SUPPL, V35, P41; van den Berg WB, 2001, ARTHRITIS RES, V3, P18, DOI 10.1186/ar136; Vey E, 1997, CYTOKINE, V9, P480, DOI 10.1006/cyto.1997.0191; Wang SY, 1997, INT J CANCER, V70, P699, DOI 10.1002/(SICI)1097-0215(19970317)70:6&lt;699::AID-IJC12&gt;3.0.CO;2-5; Wang YY, 2002, BIOORGAN MED CHEM, V10, P1057, DOI 10.1016/S0968-0896(01)00377-7; Wei M, 2007, BIOTECHNOL LETT, V29, P495, DOI 10.1007/s10529-006-9248-7; Zha XQ, 2007, PHARM BIOL, V45, P71, DOI 10.1080/13880200601028420	57	63	71	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94040	10.1371/journal.pone.0094040	http://dx.doi.org/10.1371/journal.pone.0094040			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705413	Green Published, gold, Green Submitted			2022-12-25	WOS:000334107500114
J	Ruchonnet-Metrailler, I; Bessieres, B; Bonnet, D; Vibhushan, S; Delacourt, C				Ruchonnet-Metrailler, Isabelle; Bessieres, Bettina; Bonnet, Damien; Vibhushan, Shamila; Delacourt, Christophe			Pulmonary Hypoplasia Associated with Congenital Heart Diseases: A Fetal Study	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; LUNG-FUNCTION; EXERCISE CAPACITY; VEGF-A; TETRALOGY; FALLOT; SURGERY; REPAIR; MORPHOGENESIS; CIRCULATION	Background: Abnormalities of the fetal pulmonary vasculature may affect lung morphogenesis. Postnatal studies have suggested that pulmonary hypoplasia (PH) may be associated with congenital heart diseases (CHDs). Objective: To determine the prevalence of PH associated with CHDs, and to evaluate whether CHDs with right outflow obstruction were associated with the highest risk of lung growth impairment. Methods: Between January 2006 and December 2010, fetuses with CHD obtained following the termination of pregnancies due to fetal abnormalities were examined in a prospective manner for the detection of heart and lung defects. CHDs were classified into five pathophysiological groups. Lung weight (LW), body weight (BW), and LW/BW ratio were analyzed for each case. The expression of CD31 and VEGF in the lung was evaluated by immunohistochemistry. Results: Fetuses with CHDs and right outflow obstruction had significantly lower LW for a given BW, and significantly lower LW/BW ratios for a given gestational age. When defining PH as a fetal LW/BW ratio <0.015 before 28 weeks, and <0.012 after 28 weeks, PH was detected in 15 of the 119 fetuses analyzed (13%). It was significantly associated with CHD with right outflow obstruction, independently of chromosomal abnormalities and associated extracardiac abnormalities (p<0.03). Right outflow obstruction was detected in 60% of the fetuses with CHD and PH, but in only 32% of those with CHD but no PH. In fetuses with right outflow obstruction, no difference was observed between those with PH and those without PH, in terms of the ratio of pulmonary artery diameter to aortic diameter, lung CD31 expression, or lung VEGF expression. Conclusion: CHDs with right outflow obstruction are a significant risk factor for prenatally acquired PH. The occurrence of fetal PH is not correlated with abnormalities of the pulmonary vasculature, suggesting the involvement of perfusion-independent mechanisms.	[Ruchonnet-Metrailler, Isabelle; Delacourt, Christophe] Hop Necker Enfants Malad, AP HP, Serv Pneumol Pediat, Ctr Reference Malad Resp Rares Enfant, Paris, France; [Bessieres, Bettina] Hop Necker Enfants Malad, AP HP, Serv Histoembryol & Cytogenet, Paris, France; [Bessieres, Bettina; Delacourt, Christophe] INSERM UMR 781, Paris, France; [Bonnet, Damien] Hop Necker Enfants Malad, AP HP, Ctr Reference Malformat Cardiaques Congenitale Co, Paris, France; [Bonnet, Damien; Delacourt, Christophe] Univ Paris 05, Paris, France; [Vibhushan, Shamila] INSERM, IMRB, Equipe 04, U955, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Delacourt, C (corresponding author), Hop Necker Enfants Malad, AP HP, Serv Pneumol Pediat, Ctr Reference Malad Resp Rares Enfant, Paris, France.	christophe.delacourt@nck.aphp.fr	Delacourt, Christophe/K-6161-2019; Ruchonnet-Métrailler, Isabelle/E-9921-2017	Ruchonnet-Métrailler, Isabelle/0000-0003-4771-875X; Vibhushan, Shamila/0000-0001-6196-2295	INSERM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This study is funded by INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeson AL, 2003, DEV BIOL, V264, P443, DOI 10.1016/j.ydbio.2003.09.004; Boucherat O, 2010, AM J PHYSIOL-LUNG C, V298, pL849, DOI 10.1152/ajplung.00333.2009; DETROYER A, 1977, CIRCULATION, V56, P647, DOI 10.1161/01.CIR.56.4.647; Ercisli M, 2005, CHEST, V128, P1010, DOI 10.1378/chest.128.2.1010; Filby CE, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-42; GAULTIER C, 1986, CHEST, V89, P561, DOI 10.1378/chest.89.4.561; Greenberg JM, 2002, DEV DYNAM, V224, P144, DOI 10.1002/dvdy.10095; HAWORTH SG, 1977, THORAX, V32, P129, DOI 10.1136/thx.32.2.129; Izbicki G, 2008, ISR MED ASSOC J, V10, P564; JOHNSON RJ, 1982, THORAX, V37, P893, DOI 10.1136/thx.37.12.893; JONSSON H, 1994, J THORAC CARDIOV SUR, V108, P1002, DOI 10.1016/S0022-5223(94)70141-5; Khoshnood B, 2012, HEART, V98, P1667, DOI 10.1136/heartjnl-2012-302543; Laudy JAM, 2000, ULTRASOUND OBST GYN, V16, P482, DOI 10.1046/j.1469-0705.2000.00252.x; Lazarus A, 2011, DEVELOPMENT, V138, P2359, DOI 10.1242/dev.060723; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Pianosi PT, 2009, CONGENIT HEART DIS, V4, P2, DOI 10.1111/j.1747-0803.2008.00244.x; RABINOVITCH M, 1981, CIRCULATION, V64, P1234, DOI 10.1161/01.CIR.64.6.1234; ROWE SA, 1991, J AM COLL CARDIOL, V17, P461, DOI 10.1016/S0735-1097(10)80116-0; Rudolph AM, 2010, ARCH DIS CHILD-FETAL, V95, pF132, DOI 10.1136/adc.2007.128777; Sandaite I, 2013, PRENATAL DIAG, V33, P318, DOI 10.1002/pd.4070; Sulc J, 1996, PEDIATR CARDIOL, V17, P1, DOI 10.1007/BF02505804; Sulc J, 1998, HEART, V80, P484; Trojnarska O, 2010, INT J CARDIOL, V139, P241, DOI 10.1016/j.ijcard.2008.10.025; Velozo LF, 2010, PEDIATR DEVEL PATHOL, V13, P95, DOI 10.2350/08-02-0422.1; Voelkel NF, 2006, AM J PHYSIOL-LUNG C, V290, pL209, DOI 10.1152/ajplung.00185.2005; WALLEN LD, 1994, AM J RESP CRIT CARE, V149, P1005, DOI 10.1164/ajrccm.149.4.8143035; Warburton D, 2010, CURR TOP DEV BIOL, V90, P73, DOI 10.1016/S0070-2153(10)90003-3; WEIBEL ER, 1997, LUNG SCI FDN, P333; WESSEL HU, 1981, J THORAC CARDIOV SUR, V82, P616; WIGGLESWORTH JS, 1981, ARCH DIS CHILD, V56, P601, DOI 10.1136/adc.56.8.601; Xu YQ, 2012, EXP LUNG RES, V38, P355, DOI 10.3109/01902148.2012.708385; Yamamoto H, 2007, DEV BIOL, V308, P44, DOI 10.1016/j.ydbio.2007.04.042; Zeng X, 1998, DEV DYNAM, V211, P215, DOI 10.1002/(SICI)1097-0177(199803)211:3<215::AID-AJA3>3.0.CO;2-K	33	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93557	10.1371/journal.pone.0093557	http://dx.doi.org/10.1371/journal.pone.0093557			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699523	Green Published, Green Submitted, gold			2022-12-25	WOS:000334105000068
J	Allen, SJ; Tyne, JA; Kobryn, HT; Bejder, L; Pollock, KH; Loneragan, NR				Allen, Simon J.; Tyne, Julian A.; Kobryn, Halina T.; Bejder, Lars; Pollock, Kenneth H.; Loneragan, Neil R.			Patterns of Dolphin Bycatch in a North-Western Australian Trawl Fishery	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; MARINE MAMMALS; NEW-ZEALAND; BY-CATCH; DELPHINUS-DELPHIS; HECTORS DOLPHIN; MANAGEMENT; BEHAVIOR; POPULATIONS; EXTINCTION	The bycatch of small cetaceans in commercial fisheries is a global wildlife management problem. We used data from skippers' logbooks and independent observers to assess common bottlenose dolphin (Tursiops truncatus) bycatch patterns between 2003 and 2009 in the Pilbara Trawl Fishery, Western Australia. Both datasets indicated that dolphins were caught in all fishery areas, across all depths and throughout the year. Over the entire datasets, observer reported bycatch rates (n = 52 dolphins in 4,124 trawls, or 12.6 dolphins/1,000 trawls) were ca. double those reported by skippers (n = 180 dolphins in 27,904 trawls, or 6.5 dolphins/1,000 trawls). Generalised Linear Models based on observer data, which better explained the variation in dolphin bycatch, indicated that the most significant predictors of dolphin catch were: (1) vessel - one trawl vessel caught significantly more dolphins than three others assessed; (2) time of day - the lowest dolphin bycatch rates were between 00: 00 and 05: 59; and (3) whether nets included bycatch reduction devices (BRDs) - the rate was reduced by ca. 45%, from 18.8 to 10.3 dolphins/1,000 trawls, after their introduction. These results indicated that differences among vessels (or skippers' trawling techniques) and dolphin behavior (a diurnal pattern) influenced the rates of dolphin capture; and that spatial or seasonal adjustments to trawling effort would be unlikely to significantly reduce dolphin bycatch. Recent skipper's logbook data show that dolphin bycatch rates have not declined since those reported in 2006, when BRDs were introduced across the fishery. Modified BRDs, with top-opening escape hatches from which dolphins might escape to the surface, may be a more effective means of further reducing dolphin bycatch. The vulnerability of this dolphin population to trawling-related mortality cannot be assessed in the absence of an ongoing observer program and without information on trawler-associated dolphin community size, broader dolphin population size and connectivity with adjacent populations.	[Allen, Simon J.; Tyne, Julian A.; Kobryn, Halina T.; Bejder, Lars; Pollock, Kenneth H.; Loneragan, Neil R.] Murdoch Univ, Sch Vet & Life Sci, Ctr Fish Fisheries & Aquat Ecosyst Res, Cetacean Res Unit, Murdoch, WA 6150, Australia; [Pollock, Kenneth H.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA	Murdoch University; University of North Carolina; North Carolina State University	Allen, SJ (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Ctr Fish Fisheries & Aquat Ecosyst Res, Cetacean Res Unit, Murdoch, WA 6150, Australia.	S.Allen@murdoch.edu.au	Loneragan, Neil/A-3386-2008; Bejder, Lars/D-1772-2017; Kobryn, Halina/E-5051-2012	Loneragan, Neil/0000-0003-2536-8656; Bejder, Lars/0000-0001-8138-8606; Allen, Simon/0000-0002-2260-8143; Tyne, Julian/0000-0002-0676-5659; Kobryn, Halina/0000-0003-1004-7593	Australian Government's Fisheries Research and Development Corporation; Western Australian Government's Development of Better Industry Fund; Nickol Bay Professional Fishers Association Inc. through the FRDC's Tactical Research Fund [2008/048]	Australian Government's Fisheries Research and Development Corporation(Fisheries R&D Corp); Western Australian Government's Development of Better Industry Fund; Nickol Bay Professional Fishers Association Inc. through the FRDC's Tactical Research Fund	The Australian Government's Fisheries Research and Development Corporation (http://frdc.com.au/Pages/home.aspx), the Western Australian Government's Development of Better Industry Fund, and the Nickol Bay Professional Fishers Association Inc. funded this research through the FRDC's Tactical Research Fund (Project No. 2008/048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allen S, 2010, REDUCING DOLPHIN BYC; Allen Simon J., 2012, Pacific Conservation Biology, V18, P56; Althaus F, 2006, 10 N W SHELF JOINT E; [Anonymous], [No title captured]; Ansmann IC, 2012, ANIM BEHAV, V84, P575, DOI 10.1016/j.anbehav.2012.06.009; Bannister J, 1996, ACTION PLAN AUSTR CE; Brewer D, 2006, FISH RES, V81, P176, DOI 10.1016/j.fishres.2006.07.009; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Chilvers BL, 2001, P ROY SOC B-BIOL SCI, V268, P1901, DOI 10.1098/rspb.2001.1732; Cox TM, 2004, BIOL CONSERV, V115, P203, DOI 10.1016/S0006-3207(03)00108-3; Cramer KL, 2008, MAR ECOL PROG SER, V369, P273, DOI 10.3354/meps07606; Daura-Jorge FG, 2012, BIOL LETTERS, V8, P702, DOI 10.1098/rsbl.2012.0174; Dawson S, 2001, MAR MAMMAL SCI, V17, P366, DOI 10.1111/j.1748-7692.2001.tb01278.x; Dawson SM, 2013, ENDANGER SPECIES RES, V19, P201, DOI 10.3354/esr00464; Diver G, 2012, 2009048 FRDC DIV; Donaldson R., 2010, Pacific Conservation Biology, V16, P157; Fernandez-Contreras MM, 2010, ICES J MAR SCI, V67, P1732, DOI 10.1093/icesjms/fsq077; Fletcher W.J., 2013, STATUS REPORTS FISHE; Fletcher WJ, 2011, 201011 DEP FISH; Hale P, 2008, MAMMALS AUSTR, P839; Hall MA, 2000, MAR POLLUT BULL, V41, P204, DOI 10.1016/S0025-326X(00)00111-9; Hall MA, 1998, REV FISH BIOL FISHER, V8, P1, DOI 10.1023/A:1008854816580; Hamer DJ, 2013, BIOL CONSERV, V157, P386, DOI 10.1016/j.biocon.2012.07.010; Hamer D. J., 2011, Endangered Species Research, V14, P203, DOI 10.3354/esr00353; Hamer DJ, 2008, BIOL CONSERV, V141, P2865, DOI 10.1016/j.biocon.2008.08.024; Heithaus MR, 2002, ECOLOGY, V83, P480, DOI 10.1890/0012-9658(2002)083[0480:FAATSP]2.0.CO;2; Jaiteh VF, 2013, MAR MAMMAL SCI, V29, pE266, DOI 10.1111/j.1748-7692.2012.00620.x; Jaramillo-Legorreta A, 2007, CONSERV BIOL, V21, P1653, DOI 10.1111/j.1523-1739.2007.00825.x; Kelleher Kieran, 2005, FAO FISHERIES TECHNI; KENNELLY SJ, 1995, REV FISH BIOL FISHER, V5, P213; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Lusseau D, 2005, MAR ECOL PROG SER, V295, P265, DOI 10.3354/meps295265; Lyle JM, 2008, DOLPHIN SEAL INTERAC; Moore JE, 2010, BIOL CONSERV, V143, P795, DOI 10.1016/j.biocon.2009.12.023; Northridge S., 2003, MF0726 DEFRA; Northridge S, 2011, BYCATCH VULNERABLE S; Northridge SP, 1991, 251 FAO, P1; Northridge SP, 2005, DOLPHIN BYCATCH OBSE; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Perrin William F., 1994, Reports of the International Whaling Commission Special Issue, V15, P1; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rayment W, 2011, MAR MAMMAL SCI, V27, P398, DOI 10.1111/j.1748-7692.2010.00407.x; Read AJ, 2006, CONSERV BIOL, V20, P163, DOI 10.1111/j.1523-1739.2006.00338.x; Read AJ, 2008, J MAMMAL, V89, P541, DOI 10.1644/07-MAMM-S-315R1.1; Reeves RR, 2013, ENDANGER SPECIES RES, V20, P71, DOI 10.3354/esr00481; Rice D. W., 1998, SPECIAL PUBLICATION, V4; Ross G.J., 2006, REV CONSERVATION STA; Sainsbury KJ, 1987, BIOL FISHERIES MANAG; SHANE SH, 1986, MAR MAMMAL SCI, V2, P34, DOI 10.1111/j.1748-7692.1986.tb00026.x; Shaughnessy Peter, 2003, P136; Slooten E, 2006, BIOL CONSERV, V128, P576, DOI 10.1016/j.biocon.2005.10.013; Slooten E, 2013, ENDANGER SPECIES RES, V20, P121, DOI 10.3354/esr00483; Smith H, 2008, TOURISM MANAGE, V29, P994, DOI 10.1016/j.tourman.2008.01.001; Soto AB, 2013, ENDANGER SPECIES RES, V20, P271, DOI 10.3354/esr00495; Stephenson P., 2006, 171 DEP FISH, P24; Stephenson P.C., 2003, BYCATCH PILBARA TRAW; Stephenson PC, 2006, 173 DEP FISH FISH RE; Svane I, 2005, FISH RES, V76, P317, DOI 10.1016/j.fishres.2005.07.012; Thompson S. K., 2002, SAMPLING, VSecond; Turvey ST, 2007, BIOL LETTERS, V3, P537, DOI 10.1098/rsbl.2007.0292; Waples DM, 2013, BIOL CONSERV, V157, P163, DOI 10.1016/j.biocon.2012.07.012; WARING GT, 1990, FISH B-NOAA, V88, P347; Zeeberg J, 2006, FISH RES, V78, P186, DOI 10.1016/j.fishres.2006.01.012	64	28	28	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93178	10.1371/journal.pone.0093178	http://dx.doi.org/10.1371/journal.pone.0093178			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695338	gold, Green Published			2022-12-25	WOS:000334103000045
J	Botta, V; Louppe, G; Geurts, P; Wehenkel, L				Botta, Vincent; Louppe, Gilles; Geurts, Pierre; Wehenkel, Louis			Exploiting SNP Correlations within Random Forest for Genome-Wide Association Studies	PLOS ONE			English	Article							COMPLEX TRAITS	The primary goal of genome-wide association studies (GWAS) is to discover variants that could lead, in isolation or in combination, to a particular trait or disease. Standard approaches to GWAS, however, are usually based on univariate hypothesis tests and therefore can account neither for correlations due to linkage disequilibrium nor for combinations of several markers. To discover and leverage such potential multivariate interactions, we propose in this work an extension of the Random Forest algorithm tailored for structured GWAS data. In terms of risk prediction, we show empirically on several GWAS datasets that the proposed T-Trees method significantly outperforms both the original Random Forest algorithm and standard linear models, thereby suggesting the actual existence of multivariate non-linear effects due to the combinations of several SNPs. We also demonstrate that variable importances as derived from our method can help identify relevant loci. Finally, we highlight the strong impact that quality control procedures may have, both in terms of predictive power and loci identification. Variable importance results and T-Trees source code are all available at www.montefiore.ulg.ac.be/similar to botta/ttrees/ and github.com/0asa/TTree-source respectively.	[Botta, Vincent] Univ Liege, Dept EE & CS, B-4000 Liege, Belgium; Univ Liege, GIGA Res, B-4000 Liege, Belgium	University of Liege; University of Liege	Botta, V (corresponding author), Univ Liege, Dept EE & CS, B-4000 Liege, Belgium.	vincent.botta@ulg.ac.be	Louppe, Gilles/D-1923-2017	Louppe, Gilles/0000-0002-2082-3106	Wellcome Trust Case-Control Consortium; Wellcome Trust [076113, 085475]; Belgian Fonds de la Recherche Scientifique (FNRS); French Community of Belgium (ARC REFRACT)	Wellcome Trust Case-Control Consortium(Wellcome Trust); Wellcome Trust(Wellcome Trust); Belgian Fonds de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); French Community of Belgium (ARC REFRACT)	This study makes use of data generated by the Wellcome Trust Case-Control Consortium. A full list of the investigators who contributed to the generation of the data is available from www.wtccc.org.uk. Funding for the project was provided by the Wellcome Trust under awards 076113 and 085475. Gilles Louppe is a research fellow of the Belgian Fonds de la Recherche Scientifique (FNRS) and acknowledges its financial support. This work was partially funded by the French Community of Belgium (ARC REFRACT). Part of this work was done when Vincent Botta was a research fellow of the Fund of Research in Industry and Agriculture (FRIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham G, 2013, GENET EPIDEMIOL, V37, P184, DOI 10.1002/gepi.21698; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bewick V, 2004, CRIT CARE, V8, P46, DOI 10.1186/cc2428; Botta V, 2013, WALK RANDOM FORESTS; Botta V, 2008, P MLSB 2008 2 WORKSH; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2002, MANUAL SETTING USING; Breiman L., 2017, CLASSIFICATION REGRE; Bureau A, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S64; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; De Lobel L, 2010, EUR J HUM GENET, V18, P1127, DOI 10.1038/ejhg.2010.48; Geurts P, 2006, MACH LEARN, V63, P3, DOI 10.1007/s10994-006-6226-1; Goldstein BA, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-49; Gonzalez-Recio O, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-7; Hailpern SM, 2003, INTERPRETATION, V318, P0356; Heidema AG, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-23; Jiang R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S65; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Louppe G, 2013, ADV NEURAL INFORM PR, V26, P9; Lunetta KL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-32; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Meng YA, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-78; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Murthy S. K., 1994, CS9408103 ARXIV; Nicodemus KK, 2011, BRIEF BIOINFORM, V12, P369, DOI 10.1093/bib/bbr016; Nicodemus KK, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-110; Nicodemus KK, 2009, BIOINFORMATICS, V25, P1884, DOI 10.1093/bioinformatics/btp331; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; Pedregosa F., 2011, J MACH LEARN RES, V12, P2825; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramos EM, 2013, EUROPEAN J HUMAN GEN; Touw WG, 2012, BRIEFINGS BIOINFORMA; Wang H, 2012, GENET RES, V94, P73, DOI 10.1017/S0016672312000274; Wei Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000678; Winham SJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-164; Ziegler A, 2011, BREAST CANCER RES TR, V128, P197, DOI 10.1007/s10549-010-1295-z	40	45	47	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93379	10.1371/journal.pone.0093379	http://dx.doi.org/10.1371/journal.pone.0093379			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695491	gold, Green Published, Green Submitted			2022-12-25	WOS:000334103000064
J	Choi, SS; Lee, HJ; Lim, I; Satoh, J; Kim, SU				Choi, Sung S.; Lee, Hong J.; Lim, Inja; Satoh, Jun-ichi; Kim, Seung U.			Human Astrocytes: Secretome Profiles of Cytokines and Chemokines	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; CENTRAL-NERVOUS-SYSTEM; NF-KAPPA-B; EXPRESSION; TRANSCRIPTION; RECEPTORS; INDUCTION; MICROGLIA; NEURONS; RANTES	Astrocytes play a key role in maintenance of neuronal functions in the central nervous system by producing various cytokines,chemokines, and growth factors, which act as a molecular coordinator of neuron-glia communication. At the site of neuroinflammation, astrocyte-derived cytokines and chemokines play both neuroprotective and neurotoxic roles in brain lesions of human neurological diseases. At present, the comprehensive profile of human astrocyte-derived cytokines and chemokines during inflammation remains to be fully characterized. We investigated the cytokine secretome profile of highly purified human astrocytes by using a protein microarray. Non-stimulated human astrocytes in culture expressed eight cytokines, including G-CSF, GM-CSF, GRO alpha (CXCL1), IL-6, IL-8 (CXCL8), MCP-1 (CCL2), MIF and Serpin E1. Following stimulation with IL-1 beta and TNF-alpha, activated astrocytes newly produced IL-1 beta, IL-1ra, TNF-alpha, IP-10 (CXCL10), MIP-1 alpha (CCL3) and RANTES (CCL5), in addition to the induction of sICAM-1 and complement component 5. Database search indicated that most of cytokines and chemokines produced by non-stimulated and activated astrocytes are direct targets of the transcription factor NF-kappa B. These results indicated that cultured human astrocytes express a distinct set of NF-kB-target cytokines and chemokines in resting and activated conditions, suggesting that the NF-kappa B signaling pathway differentially regulates gene expression of cytokines and chemokines in human astrocytes under physiological and inflammatory conditions.	[Choi, Sung S.; Lee, Hong J.; Kim, Seung U.] Chung Ang Univ, Coll Med, Med Res Inst, Seoul 156756, South Korea; [Lim, Inja] Chung Ang Univ, Coll Med, Dept Physiol, Seoul 156756, South Korea; [Satoh, Jun-ichi] Meiji Pharmaceut Univ, Dept Bioinformat & Mol Neuropathol, Kiyose, Japan; [Kim, Seung U.] Univ British Columbia, UBC Hosp, Dept Med, Div Neurol, Vancouver, BC, Canada	Chung Ang University; Chung Ang University Hospital; Chung Ang University; Chung Ang University Hospital; Meiji Pharmaceutical University; University of British Columbia	Kim, SU (corresponding author), Chung Ang Univ, Coll Med, Med Res Inst, Seoul 156756, South Korea.	sukim@mail.ubc.ca			Korea Healthcare Technology RD Project [HI12C0167 (A120214)]; Canadian Myelin Research Initiative	Korea Healthcare Technology RD Project; Canadian Myelin Research Initiative	The present study was supported by the Korea Healthcare Technology R&D Project HI12C0167 (A120214) and Canadian Myelin Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALOISI F, 1992, J IMMUNOL, V149, P2358; Bajetto A, 2002, J NEUROCHEM, V82, P1311, DOI 10.1046/j.1471-4159.2002.01091.x; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; CARNEY DF, 1991, J BIOL CHEM, V266, P18786; Chen LH, 2009, ATHEROSCLEROSIS, V207, P428, DOI 10.1016/j.atherosclerosis.2009.05.021; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Hua LWL, 2000, GLIA, V30, P74, DOI 10.1002/(SICI)1098-1136(200003)30:1<74::AID-GLIA8>3.0.CO;2-C; Kim MO, 2004, J NEUROCHEM, V90, P297, DOI 10.1111/j.1471-4159.2004.02487.x; KIM SU, 1986, J NEUROSCI RES, V15, P303, DOI 10.1002/jnr.490150303; Kitai R, 2000, J NEUROIMMUNOL, V110, P230, DOI 10.1016/S0165-5728(00)00315-5; LEE SC, 1993, J IMMUNOL, V150, P2659; Meeuwsen S, 2003, GLIA, V43, P243, DOI 10.1002/glia.10259; Rothwarf D M, 1999, Sci STKE, V1999, pRE1, DOI 10.1126/stke.1999.5.re1; SATOH J, 1995, J NEUROPATH EXP NEUR, V54, P504, DOI 10.1097/00005072-199507000-00004; Satoh J, 2014, MULT SCLER RELAT DIS, V3, P94, DOI 10.1016/j.msard.2013.04.005; Schabitz WR, 2008, J CEREBR BLOOD F MET, V28, P29, DOI 10.1038/sj.jcbfm.9600496; Simpson JE, 1998, J NEUROIMMUNOL, V84, P238, DOI 10.1016/S0165-5728(97)00208-7; Skalnikova H, 2011, PROTEOMICS, V11, P691, DOI 10.1002/pmic.201000402; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sorensen TL, 1999, J CLIN INVEST, V103, P807, DOI 10.1172/JCI5150; Takeshita Y, 2012, IMMUNOL REV, V248, P228, DOI 10.1111/j.1600-065X.2012.01127.x; Tokami H, 2013, BRAIN RES, V1517, P122, DOI 10.1016/j.brainres.2013.04.022; UEDA A, 1994, J IMMUNOL, V153, P2052; Xia MQ, 2000, J NEUROIMMUNOL, V108, P227, DOI 10.1016/S0165-5728(00)00285-X	25	222	224	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92325	10.1371/journal.pone.0092325	http://dx.doi.org/10.1371/journal.pone.0092325			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691121	Green Published, Green Submitted, gold			2022-12-25	WOS:000334101100019
J	He, F; Li, B; Zhao, ZX; Zhou, YM; Hu, GP; Zou, WF; Hong, W; Zou, YM; Jiang, CB; Zhao, DX; Ran, PX				He, Fang; Li, Bing; Zhao, Zhuxiang; Zhou, Yumin; Hu, Guoping; Zou, Weifeng; Hong, Wei; Zou, Yimin; Jiang, Changbin; Zhao, Dongxing; Ran, Pixin			The Pro-Proliferative Effects of Nicotine and Its Underlying Mechanism on Rat Airway Smooth Muscle Cells	PLOS ONE			English	Article							EPIDERMAL GROWTH-FACTOR; CIGARETTE-SMOKE; LIPOPOLYSACCHARIDE EXPOSURE; ACETYLCHOLINE-RECEPTORS; ACTIVATION; EXPRESSION; AKT; APOPTOSIS; PATHWAY; ANGIOGENESIS	Recent studies have shown that nicotine, a major component of cigarette smoke, can stimulate the proliferation of non-neuronal cells. Cigarette smoking can promote a variety of pulmonary and cardiovascular diseases, such as chronic obstructive pulmonary disease (COPD), atherosclerosis, and cancer. A predominant feature of COPD is airway remodeling, which includes increased airway smooth muscle (ASM) mass. The mechanisms underlying ASM remodeling in COPD have not yet been fully elucidated. Here, we show that nicotine induces a profound and time-dependent increase in DNA synthesis in rat airway smooth muscle cells (RASMCs) in vitro. Nicotine also significantly increased the number of RASMCs, which was associated with the increased expression of Cyclin D1, phosphorylation of the retinoblastoma protein (RB) and was dependent on the activation of Akt. The activation of Akt by nicotine occurred within minutes and depended upon the nicotinic acetylcholine receptors (nAchRs). Activated Akt increased the phosphorylation of downstream substrates such as GSK3 beta. Our data suggest that the binding of nicotine to the nAchRs on RASMCs can regulate cellular proliferation by activating the Akt pathway.	[He, Fang; Zhao, Zhuxiang; Zhou, Yumin; Hu, Guoping; Zou, Weifeng; Hong, Wei; Zou, Yimin; Jiang, Changbin; Zhao, Dongxing; Ran, Pixin] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, Guangzhou, Guangdong, Peoples R China; [Li, Bing] Guangzhou Med Univ, Res Ctr Expt Med, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University	Li, B (corresponding author), Guangzhou Med Univ, Res Ctr Expt Med, Guangzhou, Guangdong, Peoples R China.	libing@gzhmc.edu.cn; pxran@vip.163.com		Zhao, Dongxing/0000-0002-4080-4754	National Natural Science Foundation of China [81170043]; National Natural Science Foundation of Guangdong [S2011020002789]; Ministry of Education of China [20104423110001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province); Ministry of Education of China(Ministry of Education, China)	This work was supported by National Natural Science Foundation of China (81170043), National Natural Science Foundation of Guangdong (S2011020002789), Doctoral Fund of Ministry of Education of China (20104423110001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMITAGE AK, 1975, BRIT MED J, V4, P313, DOI 10.1136/bmj.4.5992.313; Brass DM, 2003, AM J PHYSIOL-LUNG C, V285, pL755, DOI 10.1152/ajplung.00001.2003; Brognard J, 2001, CANCER RES, V61, P3986; Carlisle DL, 2007, PULM PHARMACOL THER, V20, P629, DOI 10.1016/j.pupt.2006.07.001; Churg A, 2007, THORAX, V62, P706, DOI 10.1136/thx.2006.068353; Clunes LA, 2008, J ANAL TOXICOL, V32, P201, DOI 10.1093/jat/32.3.201; CONTITRONCONI BM, 1994, CRIT REV BIOCHEM MOL, V29, P69, DOI 10.3109/10409239409086798; Cucina A, 2008, J SURG RES, V150, P227, DOI 10.1016/j.jss.2007.10.019; Dasgupta P, 2006, J CLIN INVEST, V116, P3083, DOI 10.1172/JCI28164C1; Dasgupta P, 2006, CELL CYCLE, V5, P2324, DOI 10.4161/cc.5.20.3366; Fu XW, 2011, AM J RESP CELL MOL, V44, P222, DOI 10.1165/rcmb.2010-0109OC; Grando SA, 1996, J INVEST DERMATOL, V107, P412, DOI 10.1111/1523-1747.ep12363399; Heeschen C, 2001, NAT MED, V7, P833, DOI 10.1038/89961; Hogg JC, 2009, ANNU REV PATHOL-MECH, V4, P435, DOI 10.1146/annurev.pathol.4.110807.092145; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Lam DCL, 2007, CANCER RES, V67, P4638, DOI 10.1158/0008-5472.CAN-06-4628; Li XW, 2006, LIFE SCI, V78, P1863, DOI 10.1016/j.lfs.2005.08.031; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Limsirichaikul S, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp023; LINDELL G, 1993, SCAND J GASTROENTERO, V28, P487, DOI 10.3109/00365529309098254; Lindstrom J, 1997, MOL NEUROBIOL, V15, P193, DOI 10.1007/BF02740634; MacNee W, 2007, CLIN CHEST MED, V28, P479, DOI 10.1016/j.ccm.2007.06.008; Minna JD, 2003, J CLIN INVEST, V111, P31, DOI 10.1172/JCI200317492; Morikawa-Futamatsu K, 2006, LIFE SCI, V79, P1380, DOI 10.1016/j.lfs.2006.04.005; Nakayama H, 2002, J NEUROCHEM, V83, P1372, DOI 10.1046/j.1471-4159.2002.01248.x; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Ouyang WM, 2007, J CELL BIOCHEM, V101, P969, DOI 10.1002/jcb.21279; Pera T, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-48; RUSSELL MAH, 1980, BMJ-BRIT MED J, V280, P972, DOI 10.1136/bmj.280.6219.972; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Takahashi-Yanaga F, 2008, CELL SIGNAL, V20, P581, DOI 10.1016/j.cellsig.2007.10.018; TARRONI P, 1992, FEBS LETT, V312, P66, DOI 10.1016/0014-5793(92)81411-E; Toward TJ, 2002, J PHARMACOL EXP THER, V302, P814, DOI 10.1124/jpet.102.033951; Tsurutani J, 2005, CARCINOGENESIS, V26, P1182, DOI 10.1093/carcin/bgi072; Vernooy JHJ, 2002, AM J RESP CELL MOL, V26, P152, DOI 10.1165/ajrcmb.26.1.4652; Wang F, 2012, J CELL BIOCHEM, V113, P2989, DOI 10.1002/jcb.24176; Wang R, 2012, J CELL BIOCHEM, V113, P349, DOI 10.1002/jcb.23361; Wang Y, 2001, MOL PHARMACOL, V60, P1201, DOI 10.1124/mol.60.6.1201; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Wongtrakool C, 2012, AM J RESP CELL MOL, V46, P695, DOI 10.1165/rcmb.2011-0028OC; Wright JL, 2007, INHAL TOXICOL, V19, P915, DOI 10.1080/08958370701515563; Xu Y, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-13; Ye L, 2009, J EPITHELIAL BIOL PH, V2, P44; Yu J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007040; Zevin S, 1998, CLIN DERMATOL, V16, P557, DOI 10.1016/S0738-081X(98)00038-8; Zhang WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031450; Zou WF, 2013, AM J PHYSIOL-LUNG C, V304, pL199, DOI 10.1152/ajplung.00094.2012	49	15	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93508	10.1371/journal.pone.0093508	http://dx.doi.org/10.1371/journal.pone.0093508			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690900	Green Published, Green Submitted			2022-12-25	WOS:000334101100093
J	Reed, DM; Foldes, G; Gatheral, T; Paschalaki, KE; Lendvai, Z; Bagyura, Z; Nemeth, T; Skopal, J; Merkely, B; Telcian, AG; Gogsadze, L; Edwards, MR; Gough, PJ; Bertin, J; Johnston, SL; Harding, SE; Mitchell, JA				Reed, Daniel M.; Foldes, Gabor; Gatheral, Timothy; Paschalaki, Koralia E.; Lendvai, Zsuzsanna; Bagyura, Zsolt; Nemeth, Tamas; Skopal, Judit; Merkely, Bela; Telcian, Aurica G.; Gogsadze, Leila; Edwards, Michael R.; Gough, Peter J.; Bertin, John; Johnston, Sebastian L.; Harding, Sian E.; Mitchell, Jane A.			Pathogen Sensing Pathways in Human Embryonic Stem Cell Derived-Endothelial Cells: Role of NOD1 Receptors	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; CORONARY-ARTERY-DISEASE; PROGENITOR CELLS; NITRIC-OXIDE; IN-VIVO; INFECTION; BLOOD; ATHEROSCLEROSIS; TRANSPLANTATION; ACTIVATION	Human embryonic stem cell-derived endothelial cells (hESC-EC), as well as other stem cell derived endothelial cells, have a range of applications in cardiovascular research and disease treatment. Endothelial cells sense Gram-negative bacteria via the pattern recognition receptors (PRR) Toll-like receptor (TLR)-4 and nucleotide-binding oligomerisation domain-containing protein (NOD)-1. These pathways are important in terms of sensing infection, but TLR4 is also associated with vascular inflammation and atherosclerosis. Here, we have compared TLR4 and NOD1 responses in hESC-EC with those of endothelial cells derived from other stem cells and with human umbilical vein endothelial cells (HUVEC). HUVEC, endothelial cells derived from blood progenitors (blood outgrowth endothelial cells; BOEC), and from induced pluripotent stem cells all displayed both a TLR4 and NOD1 response. However, hESC-EC had no TLR4 function, but did have functional NOD1 receptors. In vivo conditioning in nude rats did not confer TLR4 expression in hESC-EC. Despite having no TLR4 function, hESC-EC sensed Gram-negative bacteria, a response that was found to be mediated by NOD1 and the associated RIP2 signalling pathways. Thus, hESC-EC are TLR4 deficient but respond to bacteria via NOD1. This data suggests that hESC-EC may be protected from unwanted TLR4-mediated vascular inflammation, thus offering a potential therapeutic advantage.	[Reed, Daniel M.; Gatheral, Timothy; Mitchell, Jane A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Cardiothorac Pharmacol, London, England; [Foldes, Gabor; Harding, Sian E.] Univ London Imperial Coll Sci Technol & Med, Imperial Ctr Translat & Expt Med, Dept Cardiac Pharmacol, London, England; [Foldes, Gabor; Lendvai, Zsuzsanna; Bagyura, Zsolt; Nemeth, Tamas; Skopal, Judit] Semmelweis Univ, Heart & Vasc Ctr, H-1085 Budapest, Hungary; [Paschalaki, Koralia E.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Airway Dis Sect, London, England; [Telcian, Aurica G.; Gogsadze, Leila; Edwards, Michael R.; Johnston, Sebastian L.] Univ London Imperial Coll Sci Technol & Med, MRC, London, England; [Telcian, Aurica G.; Gogsadze, Leila; Edwards, Michael R.; Johnston, Sebastian L.] Univ London Imperial Coll Sci Technol & Med, Asthma UK Ctr Allerg Mech Asthma, London, England; [Telcian, Aurica G.; Gogsadze, Leila; Edwards, Michael R.; Johnston, Sebastian L.] Univ London Imperial Coll Sci Technol & Med, Ctr Resp Infect, Natl Heart & Lung Inst, London, England; [Gough, Peter J.; Bertin, John] GlaxoSmithKline, Pattern Recognit Receptor Discovery Performance U, Immuno Inflammat Therapeut Area, Philadelphia, PA USA	Imperial College London; Imperial College London; Semmelweis University; Imperial College London; Imperial College London; Imperial College London; University of London; King's College London; Imperial College London; GlaxoSmithKline	Mitchell, JA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Cardiothorac Pharmacol, London, England.	j.a.mitchell@imperial.ac.uk	Johnston, Sebastian Lennox/I-2423-2012; Paschalaki, Koralia/B-4465-2018	Johnston, Sebastian Lennox/0000-0003-3009-9200; Paschalaki, Koralia/0000-0002-4114-6140; Reed, Daniel/0000-0002-8326-5957; Gatheral, Timothy/0000-0003-2677-8729; Edwards, Michael Robert/0000-0001-6837-0532; Harding, Sian/0000-0002-3651-6354	Wellcome Trust [0852551Z108/Z]; British Heart Foundation [PG/09/078, FS/09/017/26810]; MRC studentship; Asthma UK [CH11SJ]; MRC Centre [G1000758]; ERC [233015]; Wellcome Trust; Hungarian Scientific Research Fund [MBOA 81237, 105555]; MRC [MR/L012618/1] Funding Source: UKRI; British Heart Foundation [PG/09/078/27985] Funding Source: researchfish; Medical Research Council [G1000758B, 1252436, G1000758, MR/L012618/1] Funding Source: researchfish; Asthma UK [MRC-AsthmaUKCentre, RF07/04] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); MRC studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Asthma UK; MRC Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ERC(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK	This work was funded by a program grant from the Wellcome Trust (0852551Z108/Z; JAM) and the British Heart Foundation (PG/09/078 and FS/09/017/26810). DMR is funded by an MRC studentship. SLJ is a recipient of a Chair from Asthma UK (CH11SJ) and supported by an MRC Centre Grant G1000758, ERC FP7 Advanced grant 233015 (to SLJ) and the Wellcome Trust sponsored Centre for Respiratory Infection (CRI). GF and BM are recipients of funding from the Hungarian Scientific Research Fund (MBOA 81237, 105555). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andraws R, 2005, JAMA-J AM MED ASSOC, V293, P2641, DOI 10.1001/jama.293.21.2641; Brito-Martins M, 2008, BRIT J PHARMACOL, V153, P751, DOI 10.1038/sj.bjp.0707619; Cho SW, 2007, CIRCULATION, V116, P2409, DOI 10.1161/CIRCULATIONAHA.106.687038; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/circ.105.10.1158; Ferreira LS, 2007, CIRC RES, V101, P286, DOI 10.1161/CIRCRESAHA.107.150201; Fishman JA, 2007, NEW ENGL J MED, V357, P2601, DOI 10.1056/NEJMra064928; Fishman JA, 2012, CLIN INFECT DIS, V55, P720, DOI 10.1093/cid/cis519; Fishman JA, 2010, INFECT DIS CLIN N AM, V24, P273, DOI 10.1016/j.idc.2010.01.005; Foldes G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010501; Gatheral T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042386; Hirano T, 2009, INT J PEDIATR OTORHI, V73, P1657, DOI 10.1016/j.ijporl.2009.08.015; Houliston RA, 2002, THROMB HAEMOSTASIS, V88, P321; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Kobari L, 2012, HAEMATOL-HEMATOL J, V97, P1795, DOI 10.3324/haematol.2011.055566; Krull M, 1999, J IMMUNOL, V162, P4834; Lee J, 2009, J BIOL CHEM, V284, P23818, DOI 10.1074/jbc.M109.033670; Libby P, 1997, CIRCULATION, V96, P4095; Martin-Ramirez J, 2012, NAT PROTOC, V7, P1709, DOI 10.1038/nprot.2012.093; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Michelsen KS, 2004, J IMMUNOL, V173, P5901, DOI 10.4049/jimmunol.173.10.5901; Mitchell JA, 2008, EXP PHYSIOL, V93, P141, DOI 10.1113/expphysiol.2007.038588; Mitchell JA, 2007, J ENDOCRINOL, V193, P323, DOI 10.1677/JOE-07-0067; Opitz B, 2007, THROMB HAEMOSTASIS, V98, P319, DOI 10.1160/TH06-12-0694; Opitz B, 2009, THROMB HAEMOSTASIS, V102, P1103, DOI 10.1160/TH09-05-0323; Paschalaki KE, 2013, STEM CELLS, V31, P2813, DOI 10.1002/stem.1488; Paul-Clark MJ, 2012, PHARM THER; Ratner AJ, 2007, CELL MICROBIOL, V9, P1343, DOI 10.1111/j.1462-5822.2006.00878.x; Reed DM, 2012, BR J CLIN PHARM; Rezania A, 2012, DIABETES, V61, P2016, DOI 10.2337/db11-1711; SAIKKU P, 1988, LANCET, V2, P983, DOI 10.1016/S0140-6736(88)90741-6; Starke RD, 2010, BLOOD; Starke RD, 2013, BLOOD, V121, P2773, DOI 10.1182/blood-2012-06-435727; Thill M, 2008, INVEST OPHTH VIS SCI, V49, P2696, DOI 10.1167/iovs.07-0955; Ward MR, 2011, MOL THER, V19, P1323, DOI 10.1038/mt.2011.52; Zeuke S, 2002, CARDIOVASC RES, V56, P126, DOI 10.1016/S0008-6363(02)00512-6	35	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e91119	10.1371/journal.pone.0091119	http://dx.doi.org/10.1371/journal.pone.0091119			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690886	Green Published, gold, Green Submitted			2022-12-25	WOS:000334101100012
J	Willis, A; Rivers, P; Gray, LJ; Davies, M; Khunti, K				Willis, Andrew; Rivers, Peter; Gray, Laura J.; Davies, Melanie; Khunti, Kamlesh			The Effectiveness of Screening for Diabetes and Cardiovascular Disease Risk Factors in a Community Pharmacy Setting	PLOS ONE			English	Article							BLOOD-PRESSURE; PROGRAM; PREVALENCE; SERVICE; HEALTH; ADULTS	Risk factors for cardiovascular disease including diabetes have seen a large rise in prevalence in recent years. This has prompted interest in prevention through the identifying individuals at risk of both diabetes and cardiovascular disease and has seen increased investment in screening interventions taking place in primary care. Community pharmacies have become increasingly involved in the provision of such interventions and this systematic review and meta-analysis aims to gather and analyse the existing literature assessing community pharmacy based screening for risk factors for diabetes and those with a high cardiovascular disease risk. Methods: We conducted systematic searches of electronic databases using MeSH and free text terms from 1950 to March 2012. For our analysis two outcomes were assessed. They were the percentage of those screened who were referred for further assessment by primary care and the uptake of this referral. Results: Sixteen studies fulfilled our inclusion criteria comprising 108,414 participants screened. There was significant heterogeneity for all included outcomes. Consequently we have not presented summary statistics and present forest plots with I-2 and p values to describe heterogeneity. We found that all included studies suffered from high rates of attrition between pharmacy screening and follow up. We have also identified a strong trend towards higher rates for referral in more recent studies. Conclusions: Our results show that pharmacies are feasible sites for screening for diabetes and those at risk of cardiovascular disease. A significant number of previously unknown cases of cardiovascular disease risk factors such as hypertension, hypercholesterolemia and diabetes are identified, however a significant number of referred participants at high risk do not attend their practitioner for follow up. Research priorities should include methods of increasing uptake to follow up testing and early intervention, to maximise the efficacy of screening interventions based in community pharmacies.	[Willis, Andrew; Gray, Laura J.; Davies, Melanie; Khunti, Kamlesh] Univ Leicester, Diabet Res Unit, Leicester, Leics, England; [Rivers, Peter] DeMontford Univ, Leicester, Leics, England	University of Leicester; De Montfort University	Willis, A (corresponding author), Univ Leicester, Diabet Res Unit, Leicester, Leics, England.	aw187@le.ac.uk	/ABC-9527-2021	Davies, Melanie/0000-0002-9987-9371; Khunti, Kamlesh/0000-0003-2343-7099; Rivers, Peter/0000-0001-9409-3137; Willis, Andrew/0000-0002-9671-2162; Gray, Laura/0000-0002-9284-9321	National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care - East Midlands (NIHR CLAHRC - EM); Leicester Clinical Trials Unit; NIHR Leicester-Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit	National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care - East Midlands (NIHR CLAHRC - EM); Leicester Clinical Trials Unit; NIHR Leicester-Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit	The authors acknowledge support from the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care - East Midlands (NIHR CLAHRC - EM), the Leicester Clinical Trials Unit and the NIHR Leicester-Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit which is a partnership between University Hospitals of Leicester NHS Trust, Loughborough University and the University of Leicester. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Agency for Healthcare Research and Quality US Preventive Services Task Force Evidence Syntheses formerly Systematic Evidence Reviews, 2009, US PREV SERV TASK FO; Anderson C, 2000, PATIENT EDUC COUNS, V39, P285, DOI 10.1016/S0738-3991(99)00025-7; Blenkinsopp A, 2003, J PUBLIC HEALTH MED, V25, P144, DOI 10.1093/pubmed/fdg030; Buijsse B, 2011, EPIDEMIOL REV, V33, P46, DOI 10.1093/epirev/mxq019; Chamnan P, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1693; Chatterjee R, 2010, DIABETES CARE, V33, P1484, DOI 10.2337/dc10-0054; Colagiuri S, 2012, DIABETES RES CLIN PR; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Donyai P, 2009, PHARM WORLD SCI, V31, P643, DOI 10.1007/s11096-009-9338-4; Earle KA, 2001, J HUM HYPERTENS, V15, P529, DOI 10.1038/sj.jhh.1001220; Edwards AGK, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001865.pub2; Edwards C, 1981, J R Coll Gen Pract, V31, P674; GARDNER SF, 1995, PHARMACOTHERAPY, V15, P292; Hersberger KE, 2006, PHARM WORLD SCI, V28, P171, DOI 10.1007/s11096-006-9034-6; Horgan JMP, 2010, J PUBLIC HEALTH-UK, V32, P110, DOI 10.1093/pubmed/fdp092; Hourihan Fleur, 2003, Aust J Rural Health, V11, P28, DOI 10.1046/j.1440-1584.2003.00468.x; Hunt BD, 2013, J PUBLIC HEALTH-UK, V35, P440, DOI 10.1093/pubmed/fdt017; HUTCHISON JC, 1979, ANGIOLOGY, V30, P568, DOI 10.1177/000331977903000807; International Diabetes Foundation, 2011, DIABETES ATLAS; Jafari M, 2001, PHARMACOTHERAPY, V21, P1403, DOI 10.1592/phco.21.17.1403.34416; Karwalajtys T, 2009, J HUM HYPERTENS, V23, P585, DOI 10.1038/jhh.2008.163; Krass I, 2007, DIABETES RES CLIN PR, V75, P339, DOI 10.1016/j.diabres.2006.06.022; Madejski R M, 1996, J Am Pharm Assoc (Wash), VNS36, P243; Mangum Stacy A, 2003, J Am Pharm Assoc (Wash), V43, P50, DOI 10.1331/10865800360467042; May AL, 2012, PEDIATRICS, V129, P1035, DOI 10.1542/peds.2011-1082; McElnay J, 1993, INT J PHARM PRACTICE, V2, P95; National Health and Medical Research Council, 2009, NAT EV BAS GUID CAS; Office for National Statistics, 2011, HLTH SURV ENGL; Olenak JL, 2010, J AM PHARM ASSOC, V50, P32, DOI 10.1331/JAPhA.2010.08104; Peterson GM, 2010, PHARM WORLD SCI, V32, P373, DOI 10.1007/s11096-010-9379-8; Pongwecharak J, 2010, PHARM WORLD SCI, V32, P329, DOI 10.1007/s11096-010-9373-1; Popham F, 2011, HEALTH PLACE, V17, P1132, DOI 10.1016/j.healthplace.2011.05.008; Sargeant LA, 2010, DIABETIC MED, V27, P995, DOI 10.1111/j.1464-5491.2010.03056.x; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Teh R, 2001, INT J PHARM PRACT, V9, P261; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; World Health Organisation, 2011, GLOB ATL CARD DIS PR; Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026	39	70	71	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e91157	10.1371/journal.pone.0091157	http://dx.doi.org/10.1371/journal.pone.0091157			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690919	Green Published, Green Submitted, gold			2022-12-25	WOS:000334101100014
J	Xu, ZF; Hansen, MA; Hansen, LH; Jacquiod, S; Sorensen, SJ				Xu, Zhuofei; Hansen, Martin Asser; Hansen, Lars H.; Jacquiod, Samuel; Sorensen, Soren J.			Bioinformatic Approaches Reveal Metagenomic Characterization of Soil Microbial Community	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; DIVERSITY; DISCOVERY; SEQUENCE; LIBRARIES; PATTERNS; SEARCH; SERVER; GENES	As is well known, soil is a complex ecosystem harboring the most prokaryotic biodiversity on the Earth. In recent years, the advent of high-throughput sequencing techniques has greatly facilitated the progress of soil ecological studies. However, how to effectively understand the underlying biological features of large-scale sequencing data is a new challenge. In the present study, we used 33 publicly available metagenomes from diverse soil sites (i.e. grassland, forest soil, desert, Arctic soil, and mangrove sediment) and integrated some state-of-the-art computational tools to explore the phylogenetic and functional characterizations of the microbial communities in soil. Microbial composition and metabolic potential in soils were comprehensively illustrated at the metagenomic level. A spectrum of metagenomic biomarkers containing 46 taxa and 33 metabolic modules were detected to be significantly differential that could be used as indicators to distinguish at least one of five soil communities. The co-occurrence associations between complex microbial compositions and functions were inferred by network-based approaches. Our results together with the established bioinformatic pipelines should provide a foundation for future research into the relation between soil biodiversity and ecosystem function.	[Xu, Zhuofei; Hansen, Martin Asser; Hansen, Lars H.; Jacquiod, Samuel; Sorensen, Soren J.] Univ Copenhagen, Dept Biol, Microbiol Sect, Copenhagen, Denmark	University of Copenhagen	Sorensen, SJ (corresponding author), Univ Copenhagen, Dept Biol, Microbiol Sect, Copenhagen, Denmark.	SJS@bio.ku.dk	Sørensen, Søren Johannes/N-2120-2019; Sørensen, Søren J/J-5015-2014; Jacquiod, Samuel/M-2259-2014	Sørensen, Søren Johannes/0000-0001-6227-9906; Sørensen, Søren J/0000-0001-6227-9906; Jacquiod, Samuel/0000-0002-0713-7996; Hestbjerg Hansen, Lars/0000-0003-0027-1524	EU ITN project TRAINBIODIVERSE; Center for Environmental and Agricultural Microbiology (CREAM); Villum Foundation	EU ITN project TRAINBIODIVERSE; Center for Environmental and Agricultural Microbiology (CREAM); Villum Foundation(Villum Fonden)	This work was partly funded by the EU ITN project TRAINBIODIVERSE and the Center for Environmental and Agricultural Microbiology (CREAM) funded by The Villum Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andreote FD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038600; Barberan A, 2012, ISME J, V6, P343, DOI 10.1038/ismej.2011.119; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Daniel R, 2005, NAT REV MICROBIOL, V3, P470, DOI 10.1038/nrmicro1160; DeAngelis KM, 2010, BIOENERG RES, V3, P146, DOI 10.1007/s12155-010-9089-z; Dedysh SN, 2009, MICROBIOLOGY+, V78, P655, DOI 10.1134/S0026261709060010; Dedysh SN, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00184; Delmont TO, 2012, ISME J, V6, P1677, DOI 10.1038/ismej.2011.197; Delmont TO, 2011, APPL ENVIRON MICROB, V77, P1315, DOI 10.1128/AEM.01526-10; Desrosiers DC, 2007, MOL MICROBIOL, V65, P137, DOI 10.1111/j.1365-2958.2007.05771.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Empadinhas N, 2011, ENVIRON MICROBIOL, V13, P2056, DOI 10.1111/j.1462-2920.2010.02390.x; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Gevers D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001377; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Henne A, 1999, APPL ENVIRON MICROB, V65, P3901; Imhoff J. F., 2005, BERGEYS MANUAL SYSTE, V2, P41; Jang I, 2006, ECOL RES, V21, P849, DOI 10.1007/s11284-006-0041-9; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kaneko T, 2002, DNA RES, V9, P189, DOI 10.1093/dnares/9.6.189; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lau E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056993; Maeda H, 2012, ANNU REV PLANT BIOL, V63, P73, DOI 10.1146/annurev-arplant-042811-105439; Maloney GS, 2010, PLANT PHYSIOL, V153, P925, DOI 10.1104/pp.110.154922; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD123, DOI 10.1093/nar/gkr975; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mulkidjanian AY, 2006, P NATL ACAD SCI USA, V103, P13126, DOI 10.1073/pnas.0605709103; OJIMA DS, 1993, CHEMOSPHERE, V26, P675, DOI 10.1016/0045-6535(93)90452-B; Oksanen J., 2011, MULTIVARIATE ANAL EC, P1, DOI DOI 10.1016/0169-5347(88)90124-3; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; R Development Core Team, 2007, R LANG ENV STAT COMP; Rainey FA., 2005, BERGEYS MANUAL SYSTE, P988; Rondon MR, 2000, APPL ENVIRON MICROB, V66, P2541, DOI 10.1128/AEM.66.6.2541-2547.2000; Sarkar SK, 1997, J AM STAT ASSOC, V92, P1601, DOI 10.2307/2965431; Segata N, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.22; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stewart FJ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r26; Sun SL, 2011, NUCLEIC ACIDS RES, V39, pD546, DOI 10.1093/nar/gkq1102; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; Vogel TM, 2009, NAT REV MICROBIOL, V7, P252, DOI 10.1038/nrmicro2119; WOLOSIUK RA, 1993, FASEB J, V7, P622, DOI 10.1096/fasebj.7.8.8500687; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444; Ye YZ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000465; Yergeau E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030058	53	46	51	9	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93445	10.1371/journal.pone.0093445	http://dx.doi.org/10.1371/journal.pone.0093445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691166	Green Published, gold, Green Submitted			2022-12-25	WOS:000334101100082
J	Chiu, J; Wong, JWH; Hogg, PJ				Chiu, Joyce; Wong, Jason W. H.; Hogg, Philip J.			Redox Regulation of Methionine Aminopeptidase 2 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLOSTERIC DISULFIDE BONDS; INHIBITION; LIBRARIES; TNP-470	Protein translation is initiated with methionine in eukaryotes, and the majority of proteins have their N-terminal methionine removed by methionine aminopeptidases (MetAP1 and MetAP2) prior to action. Methionine removal can be important for protein function, localization, or stability. No mechanism of regulation of MetAP activity has been identified. MetAP2, but not MetAP1, contains a single Cys(228)-Cys(448) disulfide bond that has an -RHStaple configuration and links two beta-loop structures, which are hallmarks of allosteric disulfide bonds. From analysis of crystal structures and using mass spectrometry and activity assays, we found that the disulfide bond exists in oxidized and reduced states in the recombinant enzyme. The disulfide has a standard redox potential of -261mV and is efficiently reduced by the protein reductant, thioredoxin, with a rate constant of 16,180 M-1 s(-1). The MetAP2 disulfide bond also exists in oxidized and reduced states in glioblastoma tumor cells, and stressing the cells by oxygen or glucose deprivation results in more oxidized enzyme. The Cys(228)-Cys(448) disulfide is at the rim of the active site and is only three residues distant from the catalytic His(231), which suggested that cleavage of the bond would influence substrate hydrolysis. Indeed, oxidized and reduced isoforms have different catalytic efficiencies for hydrolysis of MetAP2 peptide substrates. These findings indicate that MetAP2 is post-translationally regulated by an allosteric disulfide bond, which controls substrate specificity and catalytic efficiency.	[Hogg, Philip J.] Univ New S Wales, Lowy Canc Res Ctr, Sydney, NSW 2052, Australia; Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW 2052, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Hogg, PJ (corresponding author), Univ New S Wales, Lowy Canc Res Ctr, Level 2, Sydney, NSW 2052, Australia.	p.hogg@unsw.edu.au	Chiu, Joyce/H-7772-2017; Wong, Jason/A-9466-2008	Chiu, Joyce/0000-0001-8910-8664; Wong, Jason/0000-0003-2953-7728; Hogg, Philip/0000-0001-6486-2863	National Health and Medical Research Council; Cancer Council New South Wales; New South Wales Government as part of its co-investment in the National Collaborative Research Infrastructure Strategy	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council New South Wales(Cancer Council New South Wales); New South Wales Government as part of its co-investment in the National Collaborative Research Infrastructure Strategy(Australian GovernmentDepartment of Industry, Innovation and Science)	This work was supported by grants from the National Health and Medical Research Council and the Cancer Council New South Wales. Mass spectrometric analysis for this work was carried out at the Bioanalytical Mass Spectrometry Facility, University of New South Wales, and was supported in part by infrastructure funding from the New South Wales Government as part of its co-investment in the National Collaborative Research Infrastructure Strategy.	Bradshaw RA, 1998, TRENDS BIOCHEM SCI, V23, P263, DOI 10.1016/S0968-0004(98)01227-4; Burnet NG, 2005, BRIT J CANCER, V92, P241, DOI 10.1038/sj.bjc.6602321; Butera D, 2014, BLOOD, V123, P2000, DOI 10.1182/blood-2014-01-549816; Catalano A, 2001, AM J PATHOL, V159, P721, DOI 10.1016/S0002-9440(10)61743-9; Cook KM, 2013, J BIOL CHEM, V288, P34920, DOI 10.1074/jbc.M113.523506; Cook KM, 2013, ANTIOXID REDOX SIGN, V18, P1987, DOI 10.1089/ars.2012.4807; Craig R, 2006, J PROTEOME RES, V5, P1843, DOI 10.1021/pr0602085; Craig R, 2005, RAPID COMMUN MASS SP, V19, P1844, DOI 10.1002/rcm.1992; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dummitt B, 2003, J CELL BIOCHEM, V89, P964, DOI 10.1002/jcb.10566; Ganderton T, 2011, BLOOD, V118, P5312, DOI 10.1182/blood-2011-06-360297; Garg SK, 2010, METHODS IN REDOX SIGNALING, P7; Garrabrant Thomas, 2004, Angiogenesis, V7, P91, DOI 10.1007/s10456-004-6089-7; Giglione C, 2004, CELL MOL LIFE SCI, V61, P1455, DOI 10.1007/s00018-004-3466-8; Hogg PJ, 2013, NAT REV CANCER, V13, P425, DOI 10.1038/nrc3519; Hu XY, 2006, P NATL ACAD SCI USA, V103, P18148, DOI 10.1073/pnas.0608389103; JACKSON R, 1970, NATURE, V227, P672, DOI 10.1038/227672a0; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Li X, 1995, P NATL ACAD SCI USA, V92, P12357, DOI 10.1073/pnas.92.26.12357; Liu SP, 1998, SCIENCE, V282, P1324, DOI 10.1126/science.282.5392.1324; Nonato MC, 2006, BIOORG MED CHEM LETT, V16, P2580, DOI 10.1016/j.bmcl.2006.02.047; Polevoda B, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-5-reviews0006; ROTHWARF DM, 1992, P NATL ACAD SCI USA, V89, P7944, DOI 10.1073/pnas.89.17.7944; Schmidt B, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-49; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Schwertassek U., 2007, SCI STKE, V2007, P18; Schwertassek U, 2007, EMBO J, V26, P3086, DOI 10.1038/sj.emboj.7601746; Selvakumar P, 2006, BBA-REV CANCER, V1765, P148, DOI 10.1016/j.bbcan.2005.11.001; Turk BE, 1999, CHEM BIOL, V6, P823, DOI 10.1016/S1074-5521(99)80129-X; Warder SE, 2008, J PROTEOME RES, V7, P4807, DOI 10.1021/pr800388p; Wong J.W.H., 2010, J THROMB HAEMOSTASIS, V8, P2345, DOI [10.1111/j.1538-7836.2010.03894.x, DOI 10.1111/J.1538-7836.2010.03894.X]; Xiao Q, 2010, BIOCHEMISTRY-US, V49, P5588, DOI 10.1021/bi1005464; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P6427, DOI 10.1073/pnas.97.12.6427	33	16	16	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					15035	15043		10.1074/jbc.M114.554253	http://dx.doi.org/10.1074/jbc.M114.554253			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24700462	hybrid, Green Published			2022-12-25	WOS:000337248100055
J	Bernard, MP; Lin, W; Kholodovych, V; Moyle, WR				Bernard, Michael P.; Lin, Win; Kholodovych, Vladyslav; Moyle, William R.			Human Lutropin ( hLH) and Choriogonadotropin ( CG) Are Assembled by Different Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycoprotein Hormones; Mutagenesis; Protein Chimeras; Protein Cross-linking; Protein Folding; Human Choriogonadotropin; Human Follitropin; Human Lutropin; Human Thyrotropin	HUMAN CHORIONIC-GONADOTROPIN; FOLLICLE-STIMULATING-HORMONE; FREE ALPHA-SUBUNIT; BETA-SUBUNIT; ENDOPLASMIC-RETICULUM; GLYCOPROTEIN HORMONE; LUTEINIZING-HORMONE; SECRETION; PROTEIN; RECEPTOR	Background: Lutropin and choriogonadotropin are essential for human fertility. Results: Human lutropin and choriogonadotropin assemble by two separate folding pathways. Conclusion: The -subunit of lutropin has a key role in -subunit folding. Significance: The unique folding properties of LH were retained by having an evolutionary advantage for most vertebrate fertility. The glycoprotein hormones are all structurally related heterodimers consisting of an -subunit and a ligand-specific -subunit that confers their unique biological activity. Crystal structures showed how the -subunit surrounds a part of the -subunit, and we showed the existence of the two mechanisms responsible for that assembly. In human choriogonadotropin, the -subunit is folded before the subunits dock, and the -subunit becomes incorporated into the dimer by a mechanism we termed threading, passing between parts of the preassembled -subunit. Here, we show that the human lutropin -subunit is not folded completely prior to its interaction with the -subunit and show that docking of the subunits enables the -subunit to serve as a chaperone to the -subunit. Based on data described here, we propose that the -subunit facilitates formation of the human lutropin -subunit by two mechanisms. First, the cystine knot of the -subunit potentiates formation of the -subunit cystine knot, and second, contacts between -subunit loop 2 and a hydrophobic tail in the -subunit facilitate formation of the seatbelt latch disulfide, which stabilizes the heterodimer. The primary influence of the -subunit was seen when the hydrophobic tail was present or absent, but the secondary mechanism was required only when the hydrophobic tail of the -subunit was present. During the evolution of human choriogonadotropin, neither of these -subunit roles was necessary for folding of the -subunit. The complex mechanism for lutropin assembly may be required to provide an additional control on its positive feedback function in vertebrate reproduction.	Rutgers Biomed & Hlth Sci, Robert Wood Johnson Med Sch, Dept Obstet Gynecol & Reprod Sci, Piscataway, NJ 08854 USA; [Kholodovych, Vladyslav] Rutgers Biomed & Hlth Sci, Robert Wood Johnson Med Sch, Off Informat Technol OIT High Performance & Res C, Piscataway, NJ 08854 USA; [Kholodovych, Vladyslav] Rutgers Biomed & Hlth Sci, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center		moyle@rwjms.rutgers.edu						BOUSFIELD GR, 1987, J BIOL CHEM, V262, P8610; CAMPBELL RK, 1991, P NATL ACAD SCI USA, V88, P760, DOI 10.1073/pnas.88.3.760; COLE LA, 1983, ENDOCRINOLOGY, V113, P1176, DOI 10.1210/endo-113-3-1176; DeBeer T, 1996, EUR J BIOCHEM, V241, P229; Dos Santos S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-332; FIDDES JC, 1980, NATURE, V286, P684, DOI 10.1038/286684a0; Fox KM, 2001, MOL ENDOCRINOL, V15, P378, DOI 10.1210/me.15.3.378; Jablonka-Shariff A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065002; Jablonka-Shariff A, 2011, MOL CELL ENDOCRINOL, V339, P7, DOI 10.1016/j.mce.2011.03.013; LAPTHORN AJ, 1994, NATURE, V369, P455, DOI 10.1038/369455a0; MATZUK MM, 1988, J CELL BIOL, V106, P1049, DOI 10.1083/jcb.106.4.1049; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Moyle W.R., 1996, REPROD ENDOCRINOLOGY, P683; MOYLE WR, 1994, NATURE, V368, P251, DOI 10.1038/368251a0; MOYLE WR, 1987, J BIOL CHEM, V262, P16920; MOYLE WR, 1982, P NATL ACAD SCI-BIOL, V79, P2245, DOI 10.1073/pnas.79.7.2245; Muller T, 2004, J MOL ENDOCRINOL, V32, P115, DOI 10.1677/jme.0.0320115; Muyan M, 1996, MOL ENDOCRINOL, V10, P1678, DOI 10.1210/me.10.12.1678; Nakabayashi K, 2002, J CLIN INVEST, V109, P1445, DOI 10.1172/JCI200214340; Okayama H, 1991, Methods Mol Biol, V7, P15, DOI 10.1385/0-89603-178-0:15; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; REEVE JR, 1975, BIOCHEM BIOPH RES CO, V67, P149, DOI 10.1016/0006-291X(75)90295-8; Ruddon RW, 1996, PROTEIN SCI, V5, P1443, DOI 10.1002/pro.5560050801; WEISS J, 1990, ENDOCRINOLOGY, V127, P2364, DOI 10.1210/endo-127-5-2364; WU H, 1994, STRUCTURE, V2, P545, DOI 10.1016/S0969-2126(00)00054-X; Xing YN, 2004, J BIOL CHEM, V279, P35449, DOI 10.1074/jbc.M403054200; Xing YN, 2004, J BIOL CHEM, V279, P35437, DOI 10.1074/jbc.M403053200; Xing YN, 2004, J BIOL CHEM, V279, P35458, DOI 10.1074/jbc.M403055200; Xing YN, 2004, J BIOL CHEM, V279, P35426, DOI 10.1074/jbc.M403052200; Xing YN, 2001, J BIOL CHEM, V276, P46953, DOI 10.1074/jbc.M108374200; Xing YN, 2001, PROTEIN SCI, V10, P226, DOI 10.1110/ps.25901	31	3	3	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14360	14369		10.1074/jbc.M113.535609	http://dx.doi.org/10.1074/jbc.M113.535609			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24692561	Green Published, hybrid			2022-12-25	WOS:000335984600061
J	Gooskens, J; Zevenhoven-Dobbe, JC; Claas, EC; Kroes, ACM; Posthuma, CC				Gooskens, Jairo; Zevenhoven-Dobbe, Jessika C.; Claas, Eric C.; Kroes, Aloys C. M.; Posthuma, Clara C.			Mass Spectrometry-Based Comparative Sequence Analysis for the Genetic Monitoring of Influenza A(H1N1) pdm09 Virus	PLOS ONE			English	Article							PANDEMIC INFLUENZA; A VIRUS; RESISTANT; TRANSMISSION	The pandemic influenza A (H1N1) 2009 virus (pH1N1) contains novel gene segments of zoonotic origin that lack virulence and antiviral resistance markers. We aimed to evaluate the applicability and accuracy of mass spectrometry-based comparative sequence analysis (MSCSA) to detect genetic mutations associated with increased virulence or antiviral resistance in pH1N1. During the 2009 H1N1 pandemic, routine surveillance specimens and clinical antiviral resistance monitoring specimens were analyzed. Routine surveillance specimens obtained from 70 patients with pH1N1 infection were evaluated for mutations associated with increased virulence (PB1-F2, PB2 and NS1 genes) or antiviral resistance (neuraminidase gene, NA) using MSCSA and Sanger sequencing. MSCSA and Sanger sequencing results revealed a high concordance (nucleotides >99%, SNPs similar to 94%). Virulence or resistance markers were not detected in routine surveillance specimens: all identified SNPs encoded for silent mutations or non-relevant amino acid substitutions. In a second study population, the presence of H275Y oseltamivir resistant virus was identified by real-time PCR in 19 of 35 clinical antiviral resistance monitoring specimens obtained from 4 immunocompromised patients with >14 days prolonged pH1N1 excretion. MSCSA detected H275Y in 24% (4/19) of positive specimens and Sanger sequencing in 89% (17/19). MSCSA only detected H275Y when the mutation was dominant in the analyzed specimens. In conclusion, MSCSA may be used as a rapid screening tool during molecular surveillance of pH1N1. The low sensitivity for the detection of H275Y mutation in mixed viral populations suggests that MSCSA is not suitable for antiviral resistance monitoring in the clinical setting.	[Gooskens, Jairo; Zevenhoven-Dobbe, Jessika C.; Claas, Eric C.; Kroes, Aloys C. M.; Posthuma, Clara C.] Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Posthuma, CC (corresponding author), Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands.	c.c.posthuma@lumc.nl		Kroes, Aloysius/0000-0002-9866-2461; Gooskens, Jairo/0000-0002-8381-7870				Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Carr S, 2011, PEDIATR INFECT DIS J, V30, P284, DOI 10.1097/INF.0b013e3181ff863b; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Deyde VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013293; Deyde VM, 2010, ANTIMICROB AGENTS CH, V54, P1102, DOI 10.1128/AAC.01417-09; European Commission, 2009, OFFICIAL J EUROPEAN, V110; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; Gooskens J, 2009, J INFECT DIS, V199, P1435, DOI 10.1086/598684; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Harvala H, 2010, EURO SURVEILL, V15; Honisch C, 2007, P NATL ACAD SCI USA, V104, P10649, DOI 10.1073/pnas.0704152104; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Jeng K, 2012, J CLIN VIROL, V54, P332, DOI 10.1016/j.jcv.2012.05.002; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Liu QF, 2012, J VIROL, V86, P1233, DOI 10.1128/JVI.05699-11; McAuley JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001014; Meijer A, 2009, J CLIN VIROL, V45, P179, DOI 10.1016/j.jcv.2009.06.003; Moore C, 2011, J INFECT DIS, V203, P18, DOI 10.1093/infdis/jiq007; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Octaviani CP, 2011, VIRUS RES, V156, P147, DOI 10.1016/j.virusres.2010.12.014; Ozawa M, 2011, J VIROL, V85, P4596, DOI 10.1128/JVI.00029-11; Pascalis H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043742; Pizzorno A, 2011, J INFECT DIS, V203, P25, DOI 10.1093/infdis/jiq010; Posthuma CC, 2011, J CLIN VIROL, V51, P25, DOI 10.1016/j.jcv.2011.01.015; Rahamat-Langendoen JC, 2012, J CLIN VIROL, V54, P135, DOI 10.1016/j.jcv.2012.02.010; Renaud C, 2011, EMERG INFECT DIS, V17, P653, DOI 10.3201/eid1704.101429; Seibert CW, 2010, J VIROL, V84, P11219, DOI 10.1128/JVI.01424-10; Tramontana AR, 2010, EMERG INFECT DIS, V16, P1068, DOI 10.3201/eid1607.091691; Tu WW, 2010, J VIROL, V84, P6527, DOI 10.1128/JVI.00519-10; van der Vries E, 2010, J CLIN VIROL, V47, P34, DOI 10.1016/j.jcv.2009.09.030; Wise HM, 2009, J VIROL, V83, P8021, DOI 10.1128/JVI.00826-09; World Health Organization, 2010, PAND H1N1 2009 UPD 1; Yamada S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001034	34	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e92970	10.1371/journal.pone.0092970	http://dx.doi.org/10.1371/journal.pone.0092970			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699508	Green Submitted, gold, Green Published			2022-12-25	WOS:000334105000038
J	Orlic-Milacic, M; Kaufman, L; Mikhailov, A; Cheung, AYL; Mahmood, H; Ellis, J; Gianakopoulos, PJ; Minassian, BA; Vincent, JB				Orlic-Milacic, Marija; Kaufman, Liana; Mikhailov, Anna; Cheung, Aaron Y. L.; Mahmood, Huda; Ellis, James; Gianakopoulos, Peter J.; Minassian, Berge A.; Vincent, John B.			Over-Expression of Either MECP2_e1 or MECP2_e2 in Neuronally Differentiated Cells Results in Different Patterns of Gene Expression	PLOS ONE			English	Article							SEVERE MENTAL-RETARDATION; RETT-SYNDROME PHENOTYPES; CPG-BINDING PROTEIN-2; CONGENITAL VARIANT; LANGUAGE DISORDER; FOXG1 MUTATIONS; TARGET GENES; COPY NUMBER; ISOFORM; AUTISM	Mutations in MECP2 are responsible for the majority of Rett syndrome cases. MECP2 is a regulator of transcription, and has two isoforms, MECP2_e1 and MECP2_e2. There is accumulating evidence that MECP2_e1 is the etiologically relevant variant for Rett. In this study we aim to detect genes that are differentially transcribed in neuronal cells over-expressing either of these two MECP2 isoforms. The human neuroblastoma cell line SK-N-SH was stably infected by lentiviral vectors over-expressing MECP2_e1, MECP2_e2, or eGFP, and were then differentiated into neurons. The same lentiviral constructs were also used to infect mouse Mecp2 knockout (Mecp2(tm1.1Bird)) fibroblasts. RNA from these cells was used for microarray gene expression analysis. For the human neuronal cells, similar to 800 genes showed >three-fold change in expression level with the MECP2_e1 construct, and similar to 230 with MECP2_e2 (unpaired t-test, uncorrected p value <0.05). We used quantitative RT-PCR to verify microarray results for 41 of these genes. We found significant up-regulation of several genes resulting from overexpression of MECP2_e1 including SRPX2, NAV3, NPY1R, SYN3, and SEMA3D. DOCK8 was shown via microarray and qRT-PCR to be upregulated in both SK-N-SH cells and mouse fibroblasts. Both isoforms up-regulated GABRA2, KCNA1, FOXG1 and FOXP2. Down-regulation of expression in the presence of MECP2_e1 was seen with UNC5C and RPH3A. Understanding the biology of these differentially transcribed genes and their role in neurodevelopment may help us to understand the relative functions of the two MECP2 isoforms, and ultimately develop a better understanding of RTT etiology and determine the clinical relevance of isoform-specific mutations.	[Orlic-Milacic, Marija; Kaufman, Liana; Mikhailov, Anna; Mahmood, Huda; Gianakopoulos, Peter J.; Vincent, John B.] Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Mol Neuropsychiat & Dev Lab, Toronto, ON, Canada; [Cheung, Aaron Y. L.; Ellis, James] Hosp Sick Children, Dev & Stem Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Minassian, Berge A.] Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON M5G 1X8, Canada; [Minassian, Berge A.] Hosp Sick Children, Dept Paediat, Div Neurol, Toronto, ON M5G 1X8, Canada; [Vincent, John B.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Vincent, John B.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Vincent, JB (corresponding author), Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Mol Neuropsychiat & Dev Lab, Toronto, ON, Canada.	john.vincent@camh.ca	Ellis, James/F-4789-2011	Ellis, James/0000-0002-4400-0091; Orlic-Milacic, Marija/0000-0002-3218-5631	International Rett Syndrome Foundation; Ontario Mental Health Foundation; Cure Autism Now	International Rett Syndrome Foundation; Ontario Mental Health Foundation; Cure Autism Now	This work was supported by funding from International Rett Syndrome Foundation, Ontario Mental Health Foundation, and Cure Autism Now to JBV and BAM. JBV is a National Alliance for Research on Schizophrenia and Depression Independent Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ariani F, 2008, AM J HUM GENET, V83, P89, DOI 10.1016/j.ajhg.2008.05.015; Bi WM, 2002, GENOME RES, V12, P713, DOI 10.1101/gr.73702; Bissonnette JM, 2007, AUTON NEUROSCI-BASIC, V136, P82, DOI 10.1016/j.autneu.2007.04.007; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Dastidar SG, 2012, J NEUROSCI, V32, P2846, DOI 10.1523/JNEUROSCI.5841-11.2012; Dragich JM, 2007, J COMP NEUROL, V501, P526, DOI 10.1002/cne.21264; Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677; Fatemi SH, 2009, J AUTISM DEV DISORD, V39, P223, DOI 10.1007/s10803-008-0646-7; Fichou Y, 2009, NEUROGENETICS, V10, P127, DOI 10.1007/s10048-008-0161-1; Filges I, 2011, CLIN GENET, V79, P79, DOI 10.1111/j.1399-0004.2010.01590.x; Gianakopoulos PJ, 2012, AM J MED GENET B, V159B, P210, DOI 10.1002/ajmg.b.32015; Griggs BL, 2008, GENOMICS, V91, P195, DOI 10.1016/j.ygeno.2007.10.011; GRUNDEMAR L, 1993, GEN PHARMACOL-VASC S, V24, P785, DOI 10.1016/0306-3623(93)90151-M; HERZOG H, 1992, P NATL ACAD SCI USA, V89, P5794, DOI 10.1073/pnas.89.13.5794; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Itoh M, 2012, J BIOL CHEM, V287, P13859, DOI 10.1074/jbc.M111.309864; Kakinuma H, 2008, AM J MED GENET B, V147B, P973, DOI 10.1002/ajmg.b.30663; Kerr B, 2012, EUR J HUM GENET, V20, P69, DOI 10.1038/ejhg.2011.145; Kortum F, 2011, J MED GENET, V48, P396, DOI 10.1136/jmg.2010.087528; Kriaucionis S, 2004, NUCLEIC ACIDS RES, V32, P1818, DOI 10.1093/nar/gkh349; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Le Meur N, 2010, J MED GENET, V47, P22, DOI 10.1136/jmg.2009.069732; Lin CC, 2007, J CELL PHYSIOL, V211, P316, DOI 10.1002/jcp.20938; Liu Y, 2005, J NEUROSCI, V25, P10556, DOI 10.1523/JNEUROSCI.2710-05.2005; Ma DQ, 2005, AM J HUM GENET, V77, P377, DOI 10.1086/433195; McGill BE, 2006, P NATL ACAD SCI USA, V103, P18267, DOI 10.1073/pnas.0608702103; Meinnel T, 2005, BIOCHIMIE, V87, P701, DOI 10.1016/j.biochi.2005.03.011; Mencarelli MA, 2010, J MED GENET, V47, P49, DOI 10.1136/jmg.2009.067884; Mnatzakanian GN, 2004, NAT GENET, V36, P339, DOI 10.1038/ng1327; Nectoux J, 2010, J CELL MOL MED, V14, P1962, DOI 10.1111/j.1582-4934.2010.01107.x; Neul JL, 2010, ANN NEUROL, V68, P944, DOI 10.1002/ana.22124; Noor A, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001267; Philippe C, 2010, J MED GENET, V47, P59, DOI 10.1136/jmg.2009.067355; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; PREIS PN, 1988, CANCER RES, V48, P6530; Rastegar M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006810; Roll P, 2006, HUM MOL GENET, V15, P1195, DOI 10.1093/hmg/ddl035; Roll P, 2010, HUM MOL GENET, V19, P4848, DOI 10.1093/hmg/ddq415; Saunders CJ, 2009, AM J MED GENET A, V149A, P1019, DOI 10.1002/ajmg.a.32776; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Smith R, 2007, J NEUROCHEM, V103, P115, DOI 10.1111/j.1471-4159.2007.04703.x; STANLEY BG, 1989, PHYSIOL BEHAV, V46, P173, DOI 10.1016/0031-9384(89)90251-5; Vargha-Khadem F, 1998, P NATL ACAD SCI USA, V95, P12695, DOI 10.1073/pnas.95.21.12695; Vincent JB, 2006, J MED GENET, V43, P429, DOI 10.1136/jmg.2005.039693; Wolman MA, 2004, J NEUROSCI, V24, P8428, DOI 10.1523/JNEUROSCI.2349-04.2004; Yakabe S, 2008, GENES GENET SYST, V83, P199, DOI 10.1266/ggs.83.199; Yasui DH, 2014, HUM MOL GENET; Zhang Q, 2009, NEW ENGL J MED, V361, P2046, DOI 10.1056/NEJMoa0905506; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071; Zweier M, 2010, HUM MUTAT, V31, P722, DOI 10.1002/humu.21253	54	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e91742	10.1371/journal.pone.0091742	http://dx.doi.org/10.1371/journal.pone.0091742			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699272	gold, Green Submitted, Green Published			2022-12-25	WOS:000334105000015
J	Trappl, K; Mathew, MA; Joseph, S				Trappl, Krista; Mathew, Merrill A.; Joseph, Simpson			Thermodynamic and Kinetic Insights into Stop Codon Recognition by Release Factor	PLOS ONE			English	Article							POLYPEPTIDE RELEASE; TRANSLATION TERMINATION; MESSENGER-RNA; RIBOSOME; TRANSLOCATION; BINDING; RF2	Stop codon recognition is a crucial event during translation termination and is performed by class I release factors (RF1 and RF2 in bacterial cells). Recent crystal structures showed that stop codon recognition is achieved mainly through a network of hydrogen bonds and stacking interactions between the stop codon and conserved residues in domain II of RF1/RF2. Additionally, previous studies suggested that recognition of stop codons is coupled to proper positioning of RF1 on the ribosome, which is essential for triggering peptide release. In this study we mutated four conserved residues in Escherichia coli RF1 (Gln185, Arg186, Thr190, and Thr198) that are proposed to be critical for discriminating stop codons from sense codons. Our thermodynamic and kinetic analysis of these RF1 mutants showed that the mutations inhibited the binding of RF1 to the ribosome. However, the mutations in RF1 did not affect the rate of peptide release, showing that imperfect recognition of the stop codon does not affect the proper positioning of RF1 on the ribosome.	[Trappl, Krista; Mathew, Merrill A.; Joseph, Simpson] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Joseph, S (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	sjoseph@ucsd.edu			National Science Foundation [1158127]; Max Kade Foundation, Inc.	National Science Foundation(National Science Foundation (NSF)); Max Kade Foundation, Inc.	This work was supported by National Science Foundation grant 1158127 to SJ and a postdoctoral research exchange grant from the Max Kade Foundation, Inc. to KT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.nsf.gov http://maxkadefoundation.org	BEAUDET AL, 1970, NATURE, V227, P38, DOI 10.1038/227038a0; CAPECCHI MR, 1970, NATURE, V226, P1029, DOI 10.1038/2261029a0; Feinberg JS, 2006, RNA, V12, P580, DOI 10.1261/rna.2290706; Field A, 2010, BIOCHEMISTRY-US, V49, P9385, DOI 10.1021/bi1012047; Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; He SL, 2010, NAT STRUCT MOL BIOL, V17, P465, DOI 10.1038/nsmb.1766; Hetrick B, 2009, BIOCHEMISTRY-US, V48, P11178, DOI 10.1021/bi901577d; Ito K, 2000, NATURE, V403, P680, DOI 10.1038/35001115; Ito K, 1998, P NATL ACAD SCI USA, V95, P8165, DOI 10.1073/pnas.95.14.8165; Korostelev A, 2010, EMBO J, V29, P2577, DOI 10.1038/emboj.2010.139; Korostelev A, 2008, P NATL ACAD SCI USA, V105, P19684, DOI 10.1073/pnas.0810953105; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; POWERS T, 1991, EMBO J, V10, P2203, DOI 10.1002/j.1460-2075.1991.tb07756.x; SCOLNICK E, 1968, P NATL ACAD SCI USA, V61, P768, DOI 10.1073/pnas.61.2.768; Studer SM, 2003, J MOL BIOL, V327, P369, DOI 10.1016/S0022-2836(03)00146-3; Sund J, 2010, NATURE, V465, P947, DOI 10.1038/nature09082; Uno M, 2002, P NATL ACAD SCI USA, V99, P1819, DOI 10.1073/pnas.032457599; Weixlbaumer A, 2008, SCIENCE, V322, P953, DOI 10.1126/science.1164840; Yoshimura K, 1999, GENES CELLS, V4, P253, DOI 10.1046/j.1365-2443.1999.00260.x	19	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e94058	10.1371/journal.pone.0094058	http://dx.doi.org/10.1371/journal.pone.0094058			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699820	Green Submitted, Green Published, gold			2022-12-25	WOS:000334105000136
J	Cotten, M; Munnink, BO; Canuti, M; Deijs, M; Watson, SJ; Kellam, P; van der Hoek, L				Cotten, Matthew; Munnink, Bas Oude; Canuti, Marta; Deijs, Martin; Watson, Simon J.; Kellam, Paul; van der Hoek, Lia			Full Genome Virus Detection in Fecal Samples Using Sensitive Nucleic Acid Preparation, Deep Sequencing, and a Novel Iterative Sequence Classification Algorithm	PLOS ONE			English	Article							HEPATITIS NON-A; B-ASSOCIATED SUBSTANCE; IMMUNODEFICIENCY-VIRUS; METAGENOMIC ANALYSIS; DIVERSITY; VIROME; DIARRHEA; IDENTIFICATION; VIDISCA-454; GENOTYPES	We have developed a full genome virus detection process that combines sensitive nucleic acid preparation optimised for virus identification in fecal material with Illumina MiSeq sequencing and a novel post-sequencing virus identification algorithm. Enriched viral nucleic acid was converted to double-stranded DNA and subjected to Illumina MiSeq sequencing. The resulting short reads were processed with a novel iterative Python algorithm SLIM for the identification of sequences with homology to known viruses. De novo assembly was then used to generate full viral genomes. The sensitivity of this process was demonstrated with a set of fecal samples from HIV-1 infected patients. A quantitative assessment of the mammalian, plant, and bacterial virus content of this compartment was generated and the deep sequencing data were sufficient to assembly 12 complete viral genomes from 6 virus families. The method detected high levels of enteropathic viruses that are normally controlled in healthy adults, but may be involved in the pathogenesis of HIV-1 infection and will provide a powerful tool for virus detection and for analyzing changes in the fecal virome associated with HIV-1 progression and pathogenesis.	[Cotten, Matthew; Watson, Simon J.; Kellam, Paul] Wellcome Trust Sanger Inst, Hinxton, England; [Munnink, Bas Oude; Canuti, Marta; Deijs, Martin; van der Hoek, Lia] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Med Microbiol,Lab Expt Virol, NL-1105 AZ Amsterdam, Netherlands; [Kellam, Paul] UCL, Dept Infect, London, England	Wellcome Trust Sanger Institute; University of Amsterdam; Academic Medical Center Amsterdam; University of London; University College London	Cotten, M (corresponding author), Wellcome Trust Sanger Inst, Hinxton, England.	mc13@sanger.ac.uk	Canuti, Marta/I-3145-2019; van der Hoek, Lia/Y-6412-2019	Canuti, Marta/0000-0002-9959-128X; Kellam, Paul/0000-0003-3166-4734; Cotten, Matthew/0000-0002-3361-3351	European Community [223498]	European Community(European Commission)	This work was supported by the Wellcome Trust and the European Community's Seventh Framework Programme (FP7/2007_2013) under the project EMPERIE, European Community grant agreement number 223498. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; BURCKHARDT J, 1988, IMMUN INFEKT, V16, P97; BURCKHARDT J, 1988, IMMUN INFEKT, V16, P91; Cantalupo PG, 2011, MBIO, V2, DOI 10.1128/mBio.00180-11; Canuti M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029140; Chu DKW, 2012, J CLIN VIROL, V55, P209, DOI 10.1016/j.jcv.2012.07.001; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; de Villiers EM, 2011, J VIROL, V85, P7284, DOI 10.1128/JVI.02472-10; de Vries M, 2008, J CLIN MICROBIOL, V46, P759, DOI 10.1128/JCM.02009-07; de Vries M, 2012, VIRUSES-BASEL, V4, P1328, DOI 10.3390/v4081328; de Vries M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016118; Delcher Arthur L, 2003, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1003s00; Donaldson EF, 2010, J VIROL, V84, P13004, DOI 10.1128/JVI.01255-10; Endoh D, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni064; Ge XY, 2012, J VIROL, V86, P4620, DOI 10.1128/JVI.06671-11; Handley SA, 2012, CELL, V151, P253, DOI 10.1016/j.cell.2012.09.024; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Jelcic I, 2004, J VIROL, V78, P7498, DOI 10.1128/JVI.78.14.7498-7507.2004; Kapoor A, 2008, P NATL ACAD SCI USA, V105, P20482, DOI 10.1073/pnas.0807979105; Kapusinszky B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036685; Law J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060595; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li LL, 2011, J VIROL, V85, P9909, DOI 10.1128/JVI.05026-11; Li LL, 2010, J VIROL, V84, P6955, DOI 10.1128/JVI.00501-10; Malboeuf CM, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks794; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Munnink BBO, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-22; Munnink BBO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078454; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; Phan TG, 2012, J VIROL, V86, P11024, DOI 10.1128/JVI.01427-12; Phan TG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002218; Rousseau GM, 2009, APPL ENVIRON MICROB, V75, P5336, DOI 10.1128/AEM.00761-09; SEELIG R, 1983, DEV BIOL STAND, V54, P497; SEELIG R, 1988, IMMUN INFEKT, V16, P85; Shan TL, 2011, J VIROL, V85, P11697, DOI 10.1128/JVI.05217-11; Snijders F, 1997, CLIN INFECT DIS, V24, P1107, DOI 10.1086/513643; Terry FFN, 2012, J VIROL, V86, P12161, DOI 10.1128/JVI.00869-12; Phan TG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072787; van der Heijden M, 2012, J VIROL METHODS, V185, P152, DOI 10.1016/j.jviromet.2012.05.019; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; Watson SJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0205; Woolhouse M, 2012, PHILOS T R SOC B, V367, P2864, DOI 10.1098/rstb.2011.0354; Yu GX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049449; Zhao GY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078470	45	55	56	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93269	10.1371/journal.pone.0093269	http://dx.doi.org/10.1371/journal.pone.0093269			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695106	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000334103000055
J	Mott, KR; Allen, SJ; Zandian, M; Konda, B; Sharifi, BG; Jones, C; Wechsler, SL; Town, T; Ghiasi, H				Mott, Kevin R.; Allen, Sariah J.; Zandian, Mandana; Konda, Bindu; Sharifi, Behrooz G.; Jones, Clinton; Wechsler, Steven L.; Town, Terrence; Ghiasi, Homayon			CD8 alpha Dendritic Cells Drive Establishment of HSV-1 Latency	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-1; CD8(+) T-CELLS; TRIGEMINAL GANGLIA; CROSS-PRESENTATION; STROMAL KERATITIS; LANGERHANS CELLS; GAMMA-INTERFERON; INFECTION; REACTIVATION; CD4(+)	It is generally accepted that CD8 T cells play the key role to maintain HSV-1 latency in trigeminal ganglia of ocularly infected mice. Yet, comparably little is known about the role of innate immunity in establishment of viral latency. In the current study, we investigated whether CD8 alpha DCs impact HSV-1 latency by examining latency in the trigeminal ganglia (TG) of wildtype (WT) C57BL/6 versus CD8 alpha(-/-) (lack functional CD8 T cells and CD8 alpha(+) DCs), CD8 beta(-/-) (have functional CD8 alpha(+) T cells and CD8 alpha(+) DCs), and beta 2m(-/-) (lack functional CD8 T cells but have CD8 alpha(+) DCs) mice as well as BXH2 (have functional CD8 T cells but lack CD8 alpha(+) DCs) versus WT C3H (have functional CD8 alpha T cells and CD8 alpha(+) DCs) mice. We also determined whether the phenotype of CD8 alpha(-/-) and BXH2 mice could be restored to that of WT mice by adoptive transfer of WT CD8(+) T cells or bone marrow (BM) derived CD8 alpha(+) DCs. Our results clearly demonstrate that CD8 alpha DCs, rather than CD8 T cells, are responsible for enhanced viral latency and recurrences.	[Mott, Kevin R.; Allen, Sariah J.; Zandian, Mandana; Ghiasi, Homayon] Cedars Sinai Burns & Allen Res Inst, Ctr Neurobiol & Vaccine Dev, Dept Surg, Los Angeles, CA 90048 USA; [Konda, Bindu] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA; [Konda, Bindu] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Sharifi, Behrooz G.] Cedars Sinai Med Ctr, Dept Med, Div Cardiol, Los Angeles, CA 90048 USA; [Jones, Clinton] Univ Nebraska, Sch Vet Med & Biomed Sci, Nebraska Ctr Virol, Lincoln, NE USA; [Wechsler, Steven L.] Univ Calif Irvine, Sch Med, Gavin Herbert Eye Inst, Dept Ophthalmol,Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; [Wechsler, Steven L.] Univ Calif Irvine, Sch Med, Ctr Virus Res, Irvine, CA 92717 USA; [Town, Terrence] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Physiol, Los Angeles, CA 90033 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of Nebraska System; University of Nebraska Lincoln; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Southern California	Ghiasi, H (corresponding author), Cedars Sinai Burns & Allen Res Inst, Ctr Neurobiol & Vaccine Dev, Dept Surg, Los Angeles, CA 90048 USA.	ghiasih@cshs.org		Allen, Sariah J./0000-0001-8118-2413	Public Health Service [AI093941, EY13615, T32 AI89553]; NATIONAL EYE INSTITUTE [R01EY013615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI089553, R21AI093941] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grants AI093941, EY13615, and T32 AI89553. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED R, 1987, J VIROL, V61, P1571, DOI 10.1128/JVI.61.5.1571-1576.1987; Alaniz RC, 2004, J IMMUNOL, V172, P3725, DOI 10.4049/jimmunol.172.6.3725; Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Allen SJ, 2011, J VIROL, V85, P4184, DOI 10.1128/JVI.02290-10; Allenspach EJ, 2008, IMMUNITY, V29, P795, DOI 10.1016/j.immuni.2008.08.013; Balkhi MY, 2004, J LEUKOCYTE BIOL, V75, P874, DOI 10.1189/jlb.1003476; BARRON BA, 1994, OPHTHALMOLOGY, V101, P1871; Belz GT, 2012, NAT REV IMMUNOL, V12, P101, DOI 10.1038/nri3149; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861; Braaten Douglas C, 2006, PLoS Pathog, V2, pe37, DOI 10.1371/journal.ppat.0020037; Brown DM, 2012, J VIROL, V86, P6792, DOI 10.1128/JVI.07172-11; COREY L, 1994, SEX TRANSM DIS, V21, pS38; CROOKS MEC, 1994, IMMUNITY, V1, P277; Dawson C R, 1984, Clin Dermatol, V2, P56, DOI 10.1016/0738-081X(84)90066-X; den Haan JMM, 2002, J EXP MED, V196, P817, DOI 10.1084/jem.20020295; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Devine L, 2000, J IMMUNOL, V164, P833, DOI 10.4049/jimmunol.164.2.833; DOBSON AT, 1990, NEURON, V5, P353, DOI 10.1016/0896-6273(90)90171-B; DOYMAZ MZ, 1992, INVEST OPHTH VIS SCI, V33, P2165; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Edelson BT, 2011, IMMUNITY, V35, P236, DOI 10.1016/j.immuni.2011.06.012; Engelmayer J, 1999, J IMMUNOL, V163, P6762; Frank GM, 2012, J IMMUNOL, V188, P1350, DOI 10.4049/jimmunol.1101968; FRASER NW, 1993, MICROB PATHOGENESIS, V15, P83, DOI 10.1006/mpat.1993.1059; FUNGLEUNG WP, 1991, CELL, V65, P443, DOI 10.1016/0092-8674(91)90462-8; Ganguly D, 2013, NAT REV IMMUNOL, V13, P566, DOI 10.1038/nri3477; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Gilliet M, 2002, J EXP MED, V195, P953, DOI 10.1084/jem.20020045; GORDON YJ, 1990, ADV EXP MED BIOL, V278, P205; GORMAN SD, 1988, J IMMUNOL, V140, P3646; Granelli-Piperno A, 1998, J VIROL, V72, P2733, DOI 10.1128/JVI.72.4.2733-2737.1998; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Kaufman HE, 2005, INVEST OPHTH VIS SCI, V46, P241, DOI 10.1167/iovs.04-0614; Kautz-Neu K, 2011, J EXP MED, V208, P885, DOI 10.1084/jem.20102318; Kawamura K, 2006, BLOOD, V107, P1031, DOI 10.1182/blood-2005-04-1737; Khanna KM, 2003, IMMUNITY, V18, P593, DOI 10.1016/S1074-7613(03)00112-2; Kobelt D, 2003, CURR TOP MICROBIOL, V276, P145; Kruse M, 2000, J VIROL, V74, P7127, DOI 10.1128/JVI.74.15.7127-7136.2000; Lee HK, 2009, J EXP MED, V206, P359, DOI 10.1084/jem.20080601; Liu T, 2000, J EXP MED, V191, P1459, DOI 10.1084/jem.191.9.1459; Liu T, 2001, J VIROL, V75, P11178, DOI 10.1128/JVI.75.22.11178-11184.2001; Lombardi V, 2012, MUCOSAL IMMUNOL, V5, P432, DOI 10.1038/mi.2012.20; Maldonado-Lopez R, 2001, SEMIN IMMUNOL, V13, P275, DOI 10.1006/smim.2001.0323; Mott KR, 2008, J VIROL, V82, P9870, DOI 10.1128/JVI.00566-08; Mott KR, 2007, J VIROL, V81, P12962, DOI 10.1128/JVI.01442-07; Mott KR, 2007, MOL VIS, V13, P1802; Mott KR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-56; Mott KR, 2009, J VIROL, V83, P2246, DOI 10.1128/JVI.02234-08; Mott KR, 2008, CLIN VACCINE IMMUNOL, V15, P1859, DOI 10.1128/CVI.00318-08; Oh J O, 1976, Surv Ophthalmol, V21, P106, DOI 10.1016/0039-6257(76)90087-4; Osorio Y, 2003, J VIROL, V77, P5774, DOI 10.1128/JVI.77.10.5774-5783.2003; Paroli M, 2000, J NEUROIMMUNOL, V107, P201, DOI 10.1016/S0165-5728(00)00228-9; PAVANLANGSTON D, 1983, MED CLIN N AM, V67, P973, DOI 10.1016/S0025-7125(16)31162-2; PERNG GC, 1994, J VIROL, V68, P8045, DOI 10.1128/JVI.68.12.8045-8055.1994; ROCK DL, 1987, J VIROL, V61, P3820, DOI 10.1128/JVI.61.12.3820-3826.1987; Salio M, 1999, EUR J IMMUNOL, V29, P3245, DOI 10.1002/(SICI)1521-4141(199910)29:10<3245::AID-IMMU3245>3.3.CO;2-O; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Stefanidou M, 2013, J VIROL, V87, P1443, DOI 10.1128/JVI.01302-12; Steiner I, 1996, IMMUNOL REV, V152, P157, DOI 10.1111/j.1600-065X.1996.tb00915.x; STEVENS JG, 1989, MICROBIOL REV, V53, P318, DOI 10.1128/MMBR.53.3.318-332.1989; Tailor P, 2008, BLOOD, V111, P1942, DOI 10.1182/blood-2007-07-100750; Turcotte K, 2004, BLOOD, V103, P2343, DOI 10.1182/blood-2003-06-1852; WECHSLER SL, 1988, J GEN VIROL, V69, P3101, DOI 10.1099/0022-1317-69-12-3101; Wilhelmus KR, 1996, BRIT J OPHTHALMOL, V80, P969, DOI 10.1136/bjo.80.11.969; Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553; ZAMOYSKA R, 1994, IMMUNITY, V1, P243, DOI 10.1016/1074-7613(94)90075-2; Zhou Y, 2012, J EXP MED, V209, P1481, DOI 10.1084/jem.20111906; [No title captured]	71	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93444	10.1371/journal.pone.0093444	http://dx.doi.org/10.1371/journal.pone.0093444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695322	Green Published, gold			2022-12-25	WOS:000334103000072
J	Passaris, I; Ghosh, A; Cenens, W; Michiels, CW; Lammertyn, J; Aertsen, A				Passaris, Ioannis; Ghosh, Anirban; Cenens, William; Michiels, Chris W.; Lammertyn, Jeroen; Aertsen, Abram			Isolation and Validation of an Endogenous Fluorescent Nucleoid Reporter in Salmonella Typhimurium	PLOS ONE			English	Article							ESCHERICHIA-COLI CHROMOSOME; COMPLETE GENOME SEQUENCE; RIBOSOMAL-RNA OPERONS; ACTIVE TRANSCRIPTION; ORGANIZATION; PROTEIN; GENE; BACTERIA; SEGREGATION; EXPRESSION	In this study we adapted a Mud-based delivery system to construct a random yfp reporter gene (encoding the yellow fluorescent protein) insertion library in the genome of Salmonella Typhimurium LT2, and used fluorescence activated cell sorting and fluorescence microscopy to screen for translational fusions that were able to clearly and specifically label the bacterial nucleoid. Two such fusions were obtained, corresponding to a translational yfp insertion in iscR and iolR, respectively. Both fusions were further validated, and the IscR::YFP fluorescent nucleoid reporter together with time-lapse fluorescence microscopy was subsequently used to monitor nucleoid dynamics in response to the filamentation imposed by growth of LT2 at high hydrostatic pressure (40-45 MPa). As such, we were able to reveal that upon decompression the apparently entangled LT2 chromosomes in filamentous cells rapidly and efficiently segregate, after which septation of the filament occurs. In the course of the latter process, however, cells with a "trilobed" nucleoid were regularly observed, indicative for an imbalance between septum formation and chromosome segregation.	[Aertsen, Abram] Univ Leuven, Fac Biosci Engn, Dept Microbial & Mol Syst M2S, Lab Food Micobiol,KU Leuven, Louvain, Belgium; [Lammertyn, Jeroen] Univ Leuven, KU Leuven, Fac Biosci Engn, BIOSYST MeBios, Louvain, Belgium	KU Leuven; KU Leuven	Aertsen, A (corresponding author), Univ Leuven, Fac Biosci Engn, Dept Microbial & Mol Syst M2S, Lab Food Micobiol,KU Leuven, Louvain, Belgium.	abram.aertsen@biw.kuleuven.be	Cenens, William/J-6345-2015; Michiels, Chris/I-6847-2013	Cenens, William/0000-0002-0856-4703; Michiels, Chris/0000-0002-7710-6802; Aertsen, Abram/0000-0002-1897-2305	Flemish Agency for Innovation by Science and Technology (IWT-Vlaanderen); Erasmus Mundus External Cooperation Window [EMECW13-Eurindia]; KU Leuven Research Fund [STRT1/10/036, IDO/10/012, DBOF/12/035]; Research Foundation of Flanders (FWO-Vlaanderen) [G.0580.11]	Flemish Agency for Innovation by Science and Technology (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Erasmus Mundus External Cooperation Window; KU Leuven Research Fund(KU Leuven); Research Foundation of Flanders (FWO-Vlaanderen)(FWO)	This work was supported by doctoral fellowships from the Flemish Agency for Innovation by Science and Technology (IWT-Vlaanderen; to IP) and the Erasmus Mundus External Cooperation Window (EMECW13-Eurindia; to AG), and grants from the KU Leuven Research Fund (STRT1/10/036, IDO/10/012 and DBOF/12/035) and the Research Foundation of Flanders (FWO-Vlaanderen; G.0580.11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aertsen A, 2008, BIOCHEM BIOPH RES CO, V367, P435, DOI 10.1016/j.bbrc.2007.12.151; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Cabrera JE, 2006, J BACTERIOL, V188, P4007, DOI 10.1128/JB.01893-05; Cabrera JE, 2009, J BACTERIOL, V191, P4180, DOI 10.1128/JB.01707-08; Cenens W, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003269; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis R., 1980, ADV BACTERIAL GENETI; Dorman CJ, 2013, NAT REV MICROBIOL, V11, P349, DOI 10.1038/nrmicro3007; Esnault E, 2007, PLOS GENET, V3, P2486, DOI 10.1371/journal.pgen.0030226; Fisher JK, 2013, CELL, V153, P882, DOI 10.1016/j.cell.2013.04.006; Giel JL, 2006, MOL MICROBIOL, V60, P1058, DOI 10.1111/j.1365-2958.2006.05160.x; HUGHES KT, 1988, GENETICS, V119, P9; Keyamura K, 2013, J BIOL CHEM; KLECKNER N, 1991, METHOD ENZYMOL, V204, P139; Kroger C, 2009, J BACTERIOL, V191, P545, DOI 10.1128/JB.01253-08; Kwon YM, 2000, J MICROBIOL METH, V41, P195, DOI 10.1016/S0167-7012(00)00159-7; Lindner AB, 2008, P NATL ACAD SCI USA, V105, P3076, DOI 10.1073/pnas.0708931105; Maloy SR., 1996, GENETIC ANAL PATHOGE; Marston AL, 1999, MOL CELL, V4, P673, DOI 10.1016/S1097-2765(00)80378-0; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Nagashima K, 2006, J BIOL CHEM, V281, P30941, DOI 10.1074/jbc.M606566200; Petrushenko ZM, 2010, EMBO J, V29, P1126, DOI 10.1038/emboj.2009.414; Postow L, 2004, GENE DEV, V18, P1766, DOI 10.1101/gad.1207504; Rajagopalan S, 2013, STUDIES ISCR REVEAL; Rovinskiy N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002845; Sambrook J, 2001, MOL CLONING LAB MANU; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; SUSSKIND MM, 1980, J MOL BIOL, V138, P685, DOI 10.1016/0022-2836(80)90060-1; von Freiesleben U, 2000, EMBO J, V19, P6240, DOI 10.1093/emboj/19.22.6240; Wang WQ, 2011, SCIENCE, V333, P1445, DOI 10.1126/science.1204697; Wang XD, 2013, NAT REV GENET, V14, P191, DOI 10.1038/nrg3375; Wilson K., 2001, CURR PROTOC MOL BIOL, V56, P2, DOI [10.1002/0471142727.mb0204s56, DOI 10.1002/0471142727.MB0204S56]; Yazdi NH, 2012, MOL MICROBIOL, V86, P1318, DOI 10.1111/mmi.12071; Zahradka K, 2009, J BACTERIOL, V191, P1677, DOI 10.1128/JB.01877-07; ZOBELL CE, 1964, J BACTERIOL, V87, P710, DOI 10.1128/JB.87.3.710-719.1964	37	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93785	10.1371/journal.pone.0093785	http://dx.doi.org/10.1371/journal.pone.0093785			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695782	Green Published, Green Submitted, gold			2022-12-25	WOS:000334103000121
J	Rueness, EK; Naidenko, S; Trosvik, P; Stenseth, NC				Rueness, Eli K.; Naidenko, Sergei; Trosvik, Pal; Stenseth, Nils Chr.			Large-Scale Genetic Structuring of a Widely Distributed Carnivore - The Eurasian Lynx (Lynx lynx)	PLOS ONE			English	Article							MITOCHONDRIAL-DNA PHYLOGEOGRAPHY; POPULATION-STRUCTURE; HOLARCTIC PHYLOGEOGRAPHY; POSTGLACIAL COLONIZATION; LINKAGE DISEQUILIBRIUM; CLIMATIC OSCILLATIONS; ICE-AGE; DISPERSAL; DIFFERENTIATION; PLEISTOCENE	Over the last decades the phylogeography and genetic structure of a multitude of species inhabiting Europe and North America have been described. The flora and fauna of the vast landmasses of north-eastern Eurasia are still largely unexplored in this respect. The Eurasian lynx is a large felid that is relatively abundant over much of the Russian sub-continent and the adjoining countries. Analyzing 148 museum specimens collected throughout its range over the last 150 years we have described the large-scale genetic structuring in this highly mobile species. We have investigated the spatial genetic patterns using mitochondrial DNA sequences (D-loop and cytochrome b) and 11 microsatellite loci, and describe three phylogenetic clades and a clear structuring along an east-west gradient. The most likely scenario is that the contemporary Eurasian lynx populations originated in central Asia and that parts of Europe were inhabited by lynx during the Pleistocene. After the Last Glacial Maximum (LGM) range expansions lead to colonization of north-western Siberia and Scandinavia from the Caucasus and north-eastern Siberia from a refugium further east. No evidence of a Berinigan refugium could be detected in our data. We observed restricted gene flow and suggest that future studies of the Eurasian lynx explore to what extent the contemporary population structure may be explained by ecological variables.	[Rueness, Eli K.; Trosvik, Pal; Stenseth, Nils Chr.] Univ Oslo, Dept Biosci, CEES, Oslo, Norway; [Naidenko, Sergei] Russian Acad Sci, AN Severtsov Inst Ecol & Evolut, Moscow, Russia	University of Oslo; Russian Academy of Sciences; Saratov Scientific Center of the Russian Academy of Sciences; Severtsov Institute of Ecology & Evolution	Rueness, EK (corresponding author), Univ Oslo, Dept Biosci, CEES, Oslo, Norway.	e.k.rueness@ibv.uio.no	Stenseth, Nils Chr./G-5212-2016	Stenseth, Nils Chr./0000-0002-1591-5399	Research Counsel of Norways, Centre for Ecological and Evolutionary Synthesis [RCN 179569/V40]	Research Counsel of Norways, Centre for Ecological and Evolutionary Synthesis	The study was funded by the Research Counsel of Norways project RCN 179569/V40, Centre for Ecological and Evolutionary Synthesis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alroy J, 2002, SYNONYMIES REIDENTIF; [Anonymous], 1995, PLANN PEOPL PROSP; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bannikova AA, 2010, BIOL J LINN SOC, V101, P721, DOI 10.1111/j.1095-8312.2010.01510.x; Barnes I, 2002, SCIENCE, V295, P2267, DOI 10.1126/science.1067814; Baryshnikov GF, 2011, QUATERN INT, V245, P350, DOI 10.1016/j.quaint.2011.02.035; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; BREITENMOSER U, 1993, J ZOOL, V231, P449, DOI 10.1111/j.1469-7998.1993.tb01931.x; Brunhoff C, 2003, MOL ECOL, V12, P957, DOI 10.1046/j.1365-294X.2003.01796.x; Croteau EK, 2010, CAN J ZOOL, V88, P536, DOI 10.1139/Z10-024; Din JU, 2010, J ANIM PLANT SCI, V20, P17; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elias SA, 1996, NATURE, V382, P60, DOI 10.1038/382060a0; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fedorov VB, 2008, MOL ECOL, V17, P598, DOI 10.1111/j.1365-294X.2007.03595.x; Fedorov VB, 2003, MOL ECOL, V12, P725, DOI 10.1046/j.1365-294X.2003.01776.x; Flagstad O, 2003, EVOLUTION, V57, P658; Greenacre M.J., 1984, THEORY APPL CORRES A; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Gugolz D, 2008, J ZOOL, V275, P201, DOI 10.1111/j.1469-7998.2008.00428.x; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hellborg L, 2002, CONSERV GENET, V3, P97, DOI 10.1023/A:1015217723287; Heptner VG, 1992, MAMMALS SOVIET UNION, VII; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hubberten HW, 2004, QUATERNARY SCI REV, V23, P1333, DOI 10.1016/j.quascirev.2003.12.012; Hundertmark KJ, 2002, MOL PHYLOGENET EVOL, V22, P375, DOI 10.1006/mpev.2001.1058; JANCZEWSKI DN, 1995, MOL BIOL EVOL, V12, P690; Jedrzejewski W, 1996, ECOGRAPHY, V19, P122, DOI 10.1111/j.1600-0587.1996.tb00163.x; Johnson WE, 2006, SCIENCE, V311, P73, DOI 10.1126/science.1122277; JUKES T H, 1969, P21; Korsten M, 2009, MOL ECOL, V18, P1963, DOI 10.1111/j.1365-294X.2009.04163.x; Kurten B., 1980, PLEISTOCENE MAMMALS; Kutschera VE, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-114; Leonard JA, 2000, P NATL ACAD SCI USA, V97, P1651, DOI 10.1073/pnas.040453097; Linnell JDC, 2001, ENVIRON MANAGE, V27, P869; Lister A, 2004, PHILOS T R SOC B, V359, P195; Ludt CJ, 2004, MOL PHYLOGENET EVOL, V31, P1064, DOI 10.1016/j.ympev.2003.10.003; MANTEL N, 1967, CANCER RES, V27, P209; Marmi J, 2006, MOL ECOL, V15, P1007, DOI 10.1111/j.1365-294X.2006.02747.x; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Munoz-Fuentes V, 2009, J BIOGEOGR, V36, P1516, DOI 10.1111/j.1365-2699.2008.02067.x; Nenadic O., 2007, J STAT SOFTW, V20, P3, DOI [DOI 10.18637/JSS.V020.I03, DOI 10.3354/MEPS086063]; Nowell K., 1996, WILD CATS; Pilot M, 2012, PLOS ONE, P7; Pilot M, 2006, MOL ECOL, V15, P4533, DOI 10.1111/j.1365-294X.2006.03110.x; Poole KG, 1997, J WILDLIFE MANAGE, V61, P497, DOI 10.2307/3802607; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A., 2007, TRACER V1 5; Ratkiewicz M, 2012, ANIM CONSERV, V15, P603, DOI 10.1111/j.1469-1795.2012.00556.x; Reding DM, 2012, MOL ECOL, V21, P3078, DOI 10.1111/j.1365-294X.2012.05595.x; Row JR, 2012, CONSERV GENET, V13, P1259, DOI 10.1007/s10592-012-0369-3; Rueness EK, 2003, NATURE, V425, P69, DOI 10.1038/nature01942; Rueness EK, 2003, MOL ECOL, V12, P2623, DOI 10.1046/j.1365-294X.2003.01952.x; Ruiz-Gonzalez A, 2013, BIOL J LINN SOC, V109, P1, DOI 10.1111/bij.12046; Sacks BN, 2008, MOL BIOL EVOL, V25, P1384, DOI 10.1093/molbev/msn082; Samelius G, 2012, J ZOOL, V286, P120, DOI 10.1111/j.1469-7998.2011.00857.x; Schmidt K, 1998, ACTA THERIOL, V43, P391, DOI 10.4098/AT.arch.98-50; Schmidt K, 2009, CONSERV GENET, V10, P497, DOI 10.1007/s10592-008-9795-7; Sharma DK, 2004, P ROY SOC B-BIOL SCI, V271, pS1, DOI 10.1098/rsbl.2003.0071; Slatkin M, 1996, HEREDITY, V76, P377, DOI 10.1038/hdy.1996.55; SLATKIN M, 1994, GENETICS, V137, P331; Sommer RS, 2006, MAMMAL REV, V36, P251, DOI 10.1111/j.1365-2907.2006.00093.x; Stenseth NC, 2004, P NATL ACAD SCI USA, V101, P10632, DOI 10.1073/pnas.0308674101; Stenseth NC, 2004, P NATL ACAD SCI USA, V101, P6056, DOI 10.1073/pnas.0307123101; Sunquist ME, 2002, WILD CATS WORLD; Svendsen JI, 2004, QUATERNARY SCI REV, V23, P1229, DOI 10.1016/j.quascirev.2003.12.008; Taberlet P, 1999, BIOL J LINN SOC, V68, P41, DOI 10.1111/j.1095-8312.1999.tb01157.x; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tarkhnishvili D, 2012, BIOL J LINN SOC, V105, P231, DOI 10.1111/j.1095-8312.2011.01788.x; Teacher AGF, 2011, BMC EVOLUTIONARY BIO, P11; Tsoukala Evangelia, 1999, Beitraege zur Palaeontologie, V24, P207; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Vila C, 1999, MOL ECOL, V8, P2089, DOI 10.1046/j.1365-294x.1999.00825.x; Wandeler P, 2007, TRENDS ECOL EVOL, V22, P634, DOI 10.1016/j.tree.2007.08.017; WASER PM, 1983, Q REV BIOL, V58, P355, DOI 10.1086/413385	82	29	31	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93675	10.1371/journal.pone.0093675	http://dx.doi.org/10.1371/journal.pone.0093675			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695745	Green Submitted, Green Published, gold			2022-12-25	WOS:000334103000102
J	Anderson, LN; Briollais, L; Atkinson, HC; Marsh, JA; Xu, JX; Connor, KL; Matthews, SG; Pennell, CE; Lye, SJ				Anderson, Laura N.; Briollais, Laurent; Atkinson, Helen C.; Marsh, Julie A.; Xu, Jingxiong; Connor, Kristin L.; Matthews, Stephen G.; Pennell, Craig E.; Lye, Stephen J.			Investigation of Genetic Variants, Birthweight and Hypothalamic- Pituitary- Adrenal Axis Function Suggests a Genetic Variant in the SERPINA6 Gene Is Associated with Corticosteroid Binding Globulin in the Western Australia Pregnancy Cohort ( Raine) Study	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; PLASMA-CORTISOL CONCENTRATIONS; SALIVARY CORTISOL; HPA AXIS; METABOLIC SYNDROME; STRESS RESPONSES; GENOME-WIDE; BODY-SIZE; CHILDREN; OBESITY	Background: The hypothalamic-pituitary-adrenal (HPA) axis regulates stress responses and HPA dysfunction has been associated with several chronic diseases. Low birthweight may be associated with HPA dysfunction in later life, yet human studies are inconclusive. The primary study aim was to identify genetic variants associated with HPA axis function. A secondary aim was to evaluate if these variants modify the association between birthweight and HPA axis function in adolescents. Methods: Morning fasted blood samples were collected from children of the Western Australia Pregnancy Cohort (Raine) at age 17 ( n =1077). Basal HPA axis function was assessed by total cortisol, corticosteroid binding globulin (CBG), and adrenocorticotropic hormone ( ACTH). The associations between 124 tag single nucleotide polymorphisms ( SNPs) within 16 HPA pathway candidate genes and each hormone were evaluated using multivariate linear regression and penalized linear regression analysis using the HyperLasso method. Results: The penalized regression analysis revealed one candidate gene SNP, rs11621961 in the CBG encoding gene ( SERPINA6), significantly associated with total cortisol and CBG. No other candidate gene SNPs were significant after applying the penalty or adjusting for multiple comparisons; however, several SNPs approached significance. For example, rs907621 (p=0.002) and rs3846326 (p=0.003) in the mineralocorticoid receptor gene ( NR3C2) were associated with ACTH and SERPINA6 SNPs rs941601 (p=0.004) and rs11622665 (p=0.008), were associated with CBG. To further investigate our findings for SERPINA6, rare and common SNPs in the gene were imputed from the 1,000 genomes data and 8 SNPs across the gene were significantly associated with CBG levels after adjustment for multiple comparisons. Birthweight was not associated with any HPA outcome, and none of the gene- birthweight interactions were significant after adjustment for multiple comparisons. Conclusions: Our study suggests that genetic variation in the SERPINA6 gene may be associated with altered CBG levels during	[Anderson, Laura N.; Briollais, Laurent; Xu, Jingxiong; Connor, Kristin L.; Lye, Stephen J.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Atkinson, Helen C.; Marsh, Julie A.; Pennell, Craig E.] Univ Western Australia, Sch Womens & Infants Hlth, Crawley, WA, Australia; [Matthews, Stephen G.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Lye, Stephen J.] Univ Toronto, Fraser Mustard Inst Human Dev, Toronto, ON, Canada; [Lye, Stephen J.] Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Western Australia; University of Toronto; University of Toronto; University of Toronto	Anderson, LN (corresponding author), Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada.	Lye@lunenfeld.ca	Briollais, Laurent/A-2941-2013; Atkinson, Helen/B-9246-2015; Pennell, Craig/ABD-6902-2020; Study, Raine/G-9547-2015; Anderson, Laura/K-4707-2019; Lye, Stephen J/E-7269-2013; Matthews, Stephen G/N-7555-2018; Matthews, Stephen/R-5147-2019	Atkinson, Helen/0000-0002-2172-3780; Pennell, Craig/0000-0002-0937-6165; Anderson, Laura/0000-0002-6106-5073; Lye, Stephen J/0000-0002-3305-4406; Matthews, Stephen G/0000-0002-9654-9940; Matthews, Stephen/0000-0002-9654-9940; Marsh, Julie/0000-0001-8984-6907	National Health and Medical Research Council of Australia [353514, 572613, 403981]; Canadian Institutes of Health Research [MOP82893]; University of Western Australia (UWA); Raine Medical Research Foundation; Telethon Institute for Child Health Research; UWA Faculty of Medicine; Dentistry and Health Sciences; Women and Infants Research Foundation; Curtin University	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Western Australia (UWA); Raine Medical Research Foundation; Telethon Institute for Child Health Research; UWA Faculty of Medicine; Dentistry and Health Sciences; Women and Infants Research Foundation; Curtin University	This work was supported by funding for the 17-year follow-up and genotyping provided by the National Health and Medical Research Council of Australia (353514, 572613, 403981) and the Canadian Institutes of Health Research (MOP82893). Core funding for the Raine Study is provided by the University of Western Australia (UWA), Raine Medical Research Foundation, the Telethon Institute for Child Health Research, UWA Faculty of Medicine, Dentistry and Health Sciences, the Women and Infants Research Foundation and Curtin University. LNA and KLC are funded by Canadian Institutes of Health Research postdoctoral fellowship awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayers KL, 2010, GENET EPIDEMIOL, V34, P879, DOI 10.1002/gepi.20543; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Bose M, 2009, CURR OPIN ENDOCRINOL, V16, P340, DOI 10.1097/MED.0b013e32832fa137; COOLENS JL, 1987, J STEROID BIOCHEM, V26, P197, DOI 10.1016/0022-4731(87)90071-9; EDWARDS CRW, 1993, LANCET, V341, P355, DOI 10.1016/0140-6736(93)90148-A; Evans S, 1996, EARLY HUM DEV, V45, P203, DOI 10.1016/0378-3782(96)01728-8; Fall CH, 1995, BMJ-BRIT MED J, V210, P17; Fall CHD, 2002, J CLIN ENDOCR METAB, V87, P2001, DOI 10.1210/jc.87.5.2001; Gagliardi L, 2010, MOL CELL ENDOCRINOL, V316, P24, DOI 10.1016/j.mce.2009.07.015; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; HANNA CE, 1993, J CLIN ENDOCR METAB, V76, P384, DOI 10.1210/jc.76.2.384; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Hoggart CJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000130; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Hunter AL, 2011, STRESS, V14, P614, DOI 10.3109/10253890.2011.577848; Kajantie E, 2004, CLIN ENDOCRINOL, V60, P201, DOI 10.1046/j.1365-2265.2003.01965.x; Kajantie E, 2003, EUR J ENDOCRINOL, V149, P569, DOI 10.1530/eje.0.1490569; Kajantie E, 2007, J CLIN ENDOCR METAB, V92, P4094, DOI 10.1210/jc.2007-1539; Koupil I, 2005, CLIN ENDOCRINOL, V62, P661, DOI 10.1111/j.1365-2265.2005.02275.x; Kudielka BM, 2003, PSYCHOSOM MED, V65, P313, DOI 10.1097/01.PSY.0000058374.50240.BF; Lin HY, 2012, J CLIN ENDOCR METAB, V97, pE678, DOI 10.1210/jc.2011-3141; McMillen IC, 2009, ADV EXP MED BIOL, V646, P71, DOI 10.1007/978-1-4020-9173-5_8; Michels KB, 2003, J WOMEN HEALTH GEN-B, V12, P157, DOI 10.1089/154099903321576556; Moisan MP, 2010, MOL CELL ENDOCRINOL, V316, P35, DOI 10.1016/j.mce.2009.07.017; Mormede P, 2011, ANN NY ACAD SCI, V1220, P127, DOI 10.1111/j.1749-6632.2010.05902.x; NEWNHAM JP, 1993, LANCET, V342, P887, DOI 10.1016/0140-6736(93)91944-H; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; Parmar PG, 2012, J DEV ORIGINS HLTH D; Pasquali R, 2006, ANN NY ACAD SCI, V1083, P111, DOI 10.1196/annals.1367.009; Phillips DIW, 1998, J CLIN ENDOCR METAB, V83, P757, DOI 10.1210/jc.83.3.757; Phillips DIW, 2000, HYPERTENSION, V35, P1301, DOI 10.1161/01.HYP.35.6.1301; Phillips DIW, 2006, J PHYSIOL-LONDON, V572, P45, DOI 10.1113/jphysiol.2005.104695; Rautanen A, 2006, J CLIN ENDOCR METAB, V91, P4544, DOI 10.1210/jc.2006-1065; Reynolds RM, 2010, J STEROID BIOCHEM, V122, P3, DOI 10.1016/j.jsbmb.2010.01.009; Reynolds RM, 2005, EUR J ENDOCRINOL, V152, P249, DOI 10.1530/eje.1.01846; Reynolds RM, 2012, PSYCHONEURO IN PRESS; Robinson M, 2010, BJOG-INT J OBSTET GY, V117, P1139, DOI 10.1111/j.1471-0528.2010.02596.x; Rosmalen JGM, 2005, PSYCHONEUROENDOCRINO, V30, P483, DOI 10.1016/j.psyneuen.2004.12.007; Rutters F, 2011, CLIN ENDOCRINOL, V74, P679, DOI 10.1111/j.1365-2265.2011.03985.x; van Leeuwen N, 2010, PSYCHONEUROENDOCRINO, V35, P339, DOI 10.1016/j.psyneuen.2009.07.006; Velders FP, 2011, PSYCHONEUROENDOCRINO, V36, P1053, DOI 10.1016/j.psyneuen.2011.01.003; Ward AMV, 2004, J CLIN ENDOCR METAB, V89, P1227, DOI 10.1210/jc.2003-030978; Williams LA, 1997, BRIT MED J, V314, P1864, DOI 10.1136/bmj.314.7098.1864	43	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92957	10.1371/journal.pone.0092957	http://dx.doi.org/10.1371/journal.pone.0092957			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691024	gold, Green Submitted, Green Published			2022-12-25	WOS:000334101100037
J	Chakravarti, LJ; Cotton, PA				Chakravarti, Leela J.; Cotton, Peter A.			The Effects of a Competitor on the Foraging Behaviour of the Shore Crab Carcinus maenas	PLOS ONE			English	Article							ENERGY MAXIMIZATION; FEEDING-BEHAVIOR; MYTILUS-EDULIS; PREDATION; RISK; PREY; DIET; CONSTRAINTS; SIZE; TIME	Optimal Diet Theory suggests that individuals make foraging decisions that maximise net energy intake. Many studies provide qualitative support for this, but factors such as digestive constraints, learning, predation-risk and competition can influence foraging behaviour and lead to departures from quantitative predictions. We examined the effects of intraspecific competition within a classic model of optimal diet - the common shore crab, Carcinus maenas, feeding on the mussel, Mytilus edulis. Unexpectedly, we found that breaking time (Tb), eating time (Te), and handling time (Th) all decreased significantly in the presence of a conspecific. Reduced handling time in the presence of a competitor resulted in an increased rate of energy intake, raising the question of why crabs do not always feed in such a way. We suggest that the costs of decreased shell breaking time may be increased risk of claw damage and that crabs may be trading-off the potential loss of food to a competitor with the potential to damage their claw whilst breaking the shell more rapidly. It is well documented that prey-size selection by crabs is influenced by both the risk of claw damage and competition. However, our results are the first to demonstrate similar effects on prey handling times. We suggest that crabs maximise their long-term rate of energy intake at a scale far greater than individual foraging events and that in order to minimise claw damage, they typically break shells at a rate below their maximum. In the presence of a competitor, crabs appear to become more risk-prone and handle their food more rapidly, minimising the risk of kleptoparasitism.	[Chakravarti, Leela J.; Cotton, Peter A.] Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England	University of Plymouth	Chakravarti, LJ (corresponding author), Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England.	leelajchakravarti@gmail.com		Cotton, Peter/0000-0002-4830-0868				ABELLO P, 1994, MAR BIOL, V121, P247, DOI 10.1007/BF00346732; ABRAMS P, 1983, ANNU REV ECOL SYST, V14, P359, DOI 10.1146/annurev.es.14.110183.002043; Atema J., 1980, P409; ATEMA J, 1986, CAN J FISH AQUAT SCI, V43, P2283, DOI 10.1139/f86-279; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; CUNNINGHAM PN, 1984, MAR ECOL PROG SER, V16, P21, DOI 10.3354/meps016021; DILL LM, 1984, BEHAV ECOL SOCIOBIOL, V16, P65, DOI 10.1007/BF00293105; Ellis JC, 2012, J EXP MAR BIOL ECOL, V416, P84, DOI 10.1016/j.jembe.2012.02.014; ELNER RW, 1978, OECOLOGIA, V36, P333, DOI 10.1007/BF00348059; ELNER RW, 1978, J ANIM ECOL, V47, P103, DOI 10.2307/3925; EMLEN JM, 1966, AM NAT, V100, P611, DOI 10.1086/282455; Gillette R, 2000, P NATL ACAD SCI USA, V97, P3585, DOI 10.1073/pnas.97.7.3585; Hartnoll R.G., 1982, P111; HAZLETT BA, 1986, CRUSTACEANA, V51, P107, DOI 10.1163/156854086X00124; HOLBROOK SJ, 1992, ECOLOGY, V73, P402, DOI 10.2307/1940748; HUBER ME, 1985, MAR BEHAV PHYSIOL, V12, P19, DOI 10.1080/10236248509378630; HUGHES RN, 1979, AM NAT, V113, P209, DOI 10.1086/283380; Innes DJ, 1999, MAR BIOL, V133, P691, DOI 10.1007/s002270050510; JUANES F, 1990, ECOLOGY, V71, P744, DOI 10.2307/1940327; LAWTON P, 1992, AM ZOOL, V32, P396; League-Pike PE, 2009, J CRUSTACEAN BIOL, V29, P350, DOI 10.1651/08-3066.1; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; LUCAS JR, 1985, AM NAT, V126, P680, DOI 10.1086/284447; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; MAGNHAGEN C, 1988, MAR ECOL PROG SER, V49, P21, DOI 10.3354/meps049021; Matheson K, 2012, J EXP MAR BIOL ECOL, V414, P6, DOI 10.1016/j.jembe.2012.01.006; MILINSKI M, 1982, BEHAV ECOL SOCIOBIOL, V11, P109, DOI 10.1007/BF00300099; MILINSKI M, 1978, NATURE, V275, P642, DOI 10.1038/275642a0; Milinski M, 1986, BEHAV TELEOST FISHES, P294; Mukherjee S, 2013, BIOL REV, V88, P550, DOI 10.1111/brv.12014; PARKER GA, 1990, NATURE, V348, P27, DOI 10.1038/348027a0; PULLIAM HR, 1974, AM NAT, V108, P59, DOI 10.1086/282885; Salmon M., 1983, P143; SEKKELSTEN GI, 1988, OIKOS, V51, P131, DOI 10.2307/3565635; SIH A, 1980, SCIENCE, V210, P1041, DOI 10.1126/science.210.4473.1041; Smallegange IM, 2003, J ANIM ECOL, V72, P599, DOI 10.1046/j.1365-2656.2003.00729.x; Smallegange IM, 2006, OIKOS, V113, P157, DOI 10.1111/j.0030-1299.2006.14172.x; Smallegange IM, 2007, BEHAV ECOL, V18, P215, DOI 10.1093/beheco/arl071; Smallegange IM, 2008, J EXP MAR BIOL ECOL, V367, P157, DOI 10.1016/j.jembe.2008.09.011; Spooner EH, 2007, MAR ECOL-EVOL PERSP, V28, P394, DOI 10.1111/j.1439-0485.2007.00186.x; VERLINDEN C, 1989, EVOL ECOL, V3, P264, DOI 10.1007/BF02270727; WALLACE JC, 1972, COMP BIOCHEM PHYSIOL, V41, P523, DOI 10.1016/0300-9629(72)90010-2; Whelan CJ, 2005, OIKOS, V110, P481, DOI 10.1111/j.0030-1299.2005.13387.x; Wirsing AJ, 2007, ANIM BEHAV, V74, P1085, DOI 10.1016/j.anbehav.2007.02.009; Wong BBM, 2005, BEHAV ECOL SOCIOBIOL, V58, P345, DOI 10.1007/s00265-005-0955-1	46	11	11	3	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93546	10.1371/journal.pone.0093546	http://dx.doi.org/10.1371/journal.pone.0093546			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691360	Green Published, gold, Green Submitted			2022-12-25	WOS:000334101100102
J	Escudero, B; Lucas, D; Albo, C; Dhup, S; Bacher, JW; Sanchez-Munoz, A; Fernandez, M; Rivera-Torres, J; Carmona, RM; Fuster, E; Carreiro, C; Bernad, R; Gonzales, MA; Andres, V; Blanco, L; Roche, E; Fabregat, I; Samper, E; Bernad, A				Escudero, Beatriz; Lucas, Daniel; Albo, Carmen; Dhup, Suveera; Bacher, Jeff W.; Sanchez-Munoz, Aranzazu; Fernandez, Margarita; Rivera-Torres, Jose; Carmona, Rosa M.; Fuster, Encarnacio; Carreiro, Candelas; Bernad, Raquel; Gonzales, Manuel A.; Andres, Vicente; Blanco, Luis; Roche, Enrique; Fabregat, Isabel; Samper, Enrique; Bernad, Antonio			Pol mu Deficiency Increases Resistance to Oxidative Damage and Delays Liver Aging	PLOS ONE			English	Article							DNA-POLYMERASE-MU; STRAND BREAK REPAIR; PATHWAY; CANCER; CELLS; MECHANISMS; LONGEVITY; DEFINES; HEALTH; ROLES	pol mu an error- prone PoIX polymerase that contributes to classical NHEJ DNA repair. Mice lacking Pol mu (Pol mu (-/-)) show altered hematopoiesis homeostasis Pol mu 2/ 2 mice have increased learning capacity at old ages, suggesting delayed brain aging. Here we investigated the effect of Pol mu 2/ 2 deficiency on liver aging. We found that old Pol mu (-/-) mice (> 20 month) have greater liver regenerative capacity compared with wt animals. Old Pol mu (-/-) liver showed reduced genomic instability and increased apoptosis resistance. However, Pol mu (-/-) mice did not show an extended life span and other organs ( e. g., heart) aged normally. Our results suggest that Pol mu deficiency activates transcriptional networks that reduce constitutive apoptosis, leading to enhanced liver repair at old age.	[Escudero, Beatriz; Albo, Carmen; Dhup, Suveera; Carmona, Rosa M.; Carreiro, Candelas; Gonzales, Manuel A.; Samper, Enrique; Bernad, Antonio] CNIC, Dept Cardiol Regenerat, Madrid, Spain; [Escudero, Beatriz; Lucas, Daniel; Carmona, Rosa M.; Bernad, Raquel; Gonzales, Manuel A.; Samper, Enrique; Bernad, Antonio] Campus Univ Auto noma Madrid, CSIC, Ctr Nacl Biotecnol, Dept Inmunol & Oncol, Madrid, Spain; [Bacher, Jeff W.] Promega Corp, Genet Anal Grp, Madison, WI USA; [Sanchez-Munoz, Aranzazu; Fernandez, Margarita] Univ Complutense, Dept Bioquim & Biol Mol 2, E-28040 Madrid, Spain; [Rivera-Torres, Jose; Andres, Vicente] Ctr Nacl Invest Cardiovasc, Dept Epidemiol Aterotrombosis & Imagen, Madrid, Spain; [Fuster, Encarnacio; Roche, Enrique] Miguel Hernandez Univ, Inst Bioengn, Elche, Alicante, Spain; [Blanco, Luis] CSIC, Ctr Biol Mol Severo Ochoa, Canto Blanco, Madrid, Spain; [Roche, Enrique] CIBERobn CB12 03 30038 Inst Salud Carlos, Madrid, Spain; [Fabregat, Isabel] Hosp Llobregat, Bellvitge Biomed Res Inst IDIBELL, Barcelona, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Promega Corporation; Complutense University of Madrid; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Universidad Miguel Hernandez de Elche; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Bernad, A (corresponding author), CNIC, Dept Cardiol Regenerat, Madrid, Spain.	abernad@cnic.es	Sánchez, Aránzazu/H-7810-2015; Dhup, Suveera/AAU-7630-2021; Rivera-Torres, José/P-2793-2015; Bernad, Antonio/P-8573-2017; Lucas, Daniel/ABB-6893-2021; Blanco, Luis/I-1848-2015; Fernández, Margarita/H-9077-2015; Andres, Vicente/I-6440-2014; Fabregat, Isabel/H-7038-2015; Roche, Enrique/V-5738-2017	Sánchez, Aránzazu/0000-0001-9145-6633; Rivera-Torres, José/0000-0003-0365-9604; Lucas, Daniel/0000-0002-0147-5425; Fernández, Margarita/0000-0001-7207-2028; Andres, Vicente/0000-0002-0125-7209; Fabregat, Isabel/0000-0003-0136-8440; Dhup, Suveera/0000-0002-6689-6597; Roche, Enrique/0000-0001-5128-1672; Bernad, Antonio/0000-0003-0620-9668	Ministry of Science and Innovation [SAF 2008-02099, PLE2009-0147, PSE-010000-2009-3]; Comunidad Autonoma de Madrid [S2010/BMD-2420]; European Commission [FP7-HEALTH-2009/CARE-MI]; Spanish Ministry of Economy and Competiveness; Pro-CNIC Foundation	Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad Autonoma de Madrid(Comunidad de Madrid); European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministry of Economy and Competiveness(Spanish Government); Pro-CNIC Foundation	This work was supported by grants to AB from the Ministry of Science and Innovation (SAF 2008-02099; PLE2009-0147 and PSE-010000-2009-3), Comunidad Autonoma de Madrid (S2010/BMD-2420), and the European Commission (FP7-HEALTH-2009/CARE-MI. CC is supported by The Spanish Ministry of Economy and Competiveness and the Pro-CNIC Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade P, 2009, P NATL ACAD SCI USA, V106, P16203, DOI 10.1073/pnas.0908492106; Bacher JW, 2005, MOL CARCINOGEN, V44, P285, DOI 10.1002/mc.20146; Bertocci B, 2003, IMMUNITY, V19, P203, DOI 10.1016/S1074-7613(03)00203-6; Bokov AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026891; Brown-Borg HM, 2006, AGE, V28, P145, DOI 10.1007/s11357-006-9003-y; Burtner CR, 2010, NAT REV MOL CELL BIO, V11, P567, DOI 10.1038/nrm2944; Celton-Morizur S, 2010, ADV EXP MED BIOL, V676, P123; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chayot R, 2010, DNA REPAIR, V9, P1187, DOI 10.1016/j.dnarep.2010.09.001; Dominguez O, 2000, EMBO J, V19, P1731, DOI 10.1093/emboj/19.7.1731; Factor VM, 2010, PLOS ONE, V16, P5, DOI DOI 10.1371/J0URNAL.P0NE.0012739; Guirouilh-Barbat J, 2004, MOL CELL, V14, P611, DOI 10.1016/j.molcel.2004.05.008; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Holzenberger M, 2004, EXP GERONTOL, V39, P1761, DOI 10.1016/j.exger.2004.08.017; Huffman DM, 2010, INTERD T GERONT GERI, V37, P1, DOI 10.1159/000319991; Lapointe J, 2010, CELL MOL LIFE SCI, V67, P1, DOI 10.1007/s00018-009-0138-8; Li H, 2007, MOL CELL BIOL, V27, P8205, DOI 10.1128/MCB.00785-07; Lucas D, 2005, EUR J IMMUNOL, V35, P1601, DOI 10.1002/eji.200526015; Lucas D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053243; Lucas D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000389; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; McElhinny SAN, 2005, MOL CELL, V19, P357, DOI 10.1016/j.molcel.2005.06.012; Neal JA, 2011, MOL CELL BIOL, V31, P1719, DOI 10.1128/MCB.01298-10; Peterson MJ, 2010, METAB SYNDR RELAT D, V8, P317, DOI 10.1089/met.2009.0090; Ruiz JF, 2004, NUCLEIC ACIDS RES, V32, P5861, DOI 10.1093/nar/gkh929; Schumacher B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000161; Serrano M, 2007, NAT REV MOL CELL BIO, V8, P715, DOI 10.1038/nrm2242; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Yu QJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021770; Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013; Zhang LL, 2008, HEPATOLOGY, V48, P1598, DOI 10.1002/hep.22516	32	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93074	10.1371/journal.pone.0093074	http://dx.doi.org/10.1371/journal.pone.0093074			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691161	Green Published, gold			2022-12-25	WOS:000334101100041
J	Konig, S; Nitzki, F; Uhmann, A; Dittmann, K; Theiss-Suennemann, J; Herrmann, M; Reichardt, HM; Schwendener, R; Pukrop, T; Schulz-Schaeffer, W; Hahn, H				Koenig, Simone; Nitzki, Frauke; Uhmann, Anja; Dittmann, Kai; Theiss-Suennemann, Jennifer; Herrmann, Markus; Reichardt, Holger M.; Schwendener, Reto; Pukrop, Tobias; Schulz-Schaeffer, Walter; Hahn, Heidi			Depletion of Cutaneous Macrophages and Dendritic Cells Promotes Growth of Basal Cell Carcinoma in Mice	PLOS ONE			English	Article							REGRESSION; CANCER; BISPHOSPHONATES; FIBROBLASTS; METASTASES; SPECTRUM	Basal cell carcinoma (BCC) belongs to the group of non-melanoma skin tumors and is the most common tumor in the western world. BCC arises due to mutations in the tumor suppressor gene Patched1 (Ptch). Analysis of the conditional Ptch knockout mouse model for BCC reveals that macrophages and dendritic cells (DC) of the skin play an important role in BCC growth restraining processes. This is based on the observation that a clodronate-liposome mediated depletion of these cells in the tumor-bearing skin results in significant BCC enlargement. The depletion of these cells does not modulate Ki67 or K10 expression, but is accompanied by a decrease in collagen-producing cells in the tumor stroma. Together, the data suggest that cutaneous macrophages and DC in the tumor microenvironment exert an antitumor effect on BCC.	[Koenig, Simone; Nitzki, Frauke; Uhmann, Anja; Hahn, Heidi] Genet Univ Med Ctr, Inst Human Genet, Gottingen, Germany; [Dittmann, Kai; Theiss-Suennemann, Jennifer; Reichardt, Holger M.] Univ Med Ctr, Inst Cellular & Mol Immunol, Gottingen, Germany; [Herrmann, Markus] Univ Med Ctr, Dept Radiat Oncol, Gottingen, Germany; [Schwendener, Reto] Univ Zurich, Inst Mol Canc Res, Zurich, Switzerland; [Pukrop, Tobias] Univ Med Ctr, Dept Hematol & Oncol, Gottingen, Germany; [Schulz-Schaeffer, Walter] Univ Med Ctr, Dept Neuropathol, Gottingen, Germany	University of Gottingen; University of Gottingen; University of Zurich; University of Gottingen; University of Gottingen	Hahn, H (corresponding author), Genet Univ Med Ctr, Inst Human Genet, Gottingen, Germany.	hhahn@gwdg.de	Schwendener, Reto A/F-6373-2011; Reichardt, Holger/AAF-3048-2020	Reichardt, Holger/0000-0003-4647-057X	Deutsche Forschungsgemeinschaft [FOR942 HA 2197/5-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/; FOR942 HA 2197/5-2 to Heidi Hahn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Chow FY, 2004, NEPHROL DIAL TRANSPL, V19, P2987, DOI 10.1093/ndt/gfh441; CLAASSEN I, 1990, J IMMUNOL METHODS, V134, P153, DOI 10.1016/0022-1759(90)90376-7; CURSON C, 1979, J CUTAN PATHOL, V6, P432, DOI 10.1111/j.1600-0560.1979.tb01166.x; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; Ferron M, 2005, GENESIS, V41, P138, DOI 10.1002/gene.20108; Fleming JM, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3215; Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159; Ginhoux F, 2012, CURR TOP MICROBIOL, V351, P1, DOI 10.1007/82_2010_115; Gnant M, 2012, RECENT RESULTS CANC, V192, P65, DOI 10.1007/978-3-642-21892-7_3; GOLDNER JACQUES, 1938, AMER JOUR PATH, V14, P237; Hameyer D, 2007, PHYSIOL GENOMICS, V31, P32, DOI 10.1152/physiolgenomics.00019.2007; Handoko HY, 2013, J INVEST DERMATOL, V133, P1803, DOI 10.1038/jid.2013.9; HUNT MJ, 1994, BRIT J DERMATOL, V130, P1, DOI 10.1111/j.1365-2133.1994.tb06873.x; Kataru RP, 2009, BLOOD, V113, P5650, DOI 10.1182/blood-2008-09-176776; Konig S, 2013, CANC IMMUNOL IMMUNOT; KURIMOTO I, 1994, IMMUNOLOGY, V83, P281; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Morgan G, 2010, SEMIN ONCOL, V37, pS30, DOI 10.1053/j.seminoncol.2010.10.005; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nestle FO, 1998, J INVEST DERMATOL, V110, P762, DOI 10.1046/j.1523-1747.1998.00189.x; Nitzki F, 2012, J SKIN CANCER, V2012, DOI 10.1155/2012/907543; Nitzki F, 2010, CANCER RES, V70, P2739, DOI 10.1158/0008-5472.CAN-09-3743; Rasmussen JW, 2006, INFECT IMMUN, V74, P6590, DOI 10.1128/IAI.00868-06; Romano E, 2011, CLIN CANCER RES, V17, P1984, DOI 10.1158/1078-0432.CCR-10-3421; Saarto T, 2001, J CLIN ONCOL, V19, P10, DOI 10.1200/JCO.2001.19.1.10; So PL, 2006, EXP DERMATOL, V15, P742, DOI 10.1111/j.1600-0625.2006.00465.x; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Uhmann A, 2007, BLOOD, V110, P1814, DOI 10.1182/blood-2007-02-075648; Urosevic M, 2003, ARCH DERMATOL, V139, P1325, DOI 10.1001/archderm.139.10.1325; Valladeau J, 2005, SEMIN IMMUNOL, V17, P273, DOI 10.1016/j.smim.2005.05.009; Walter C, 2010, CLIN ORAL INVEST, V14, P35, DOI 10.1007/s00784-009-0266-4; Wang HL, 2006, J CLIN INVEST, V116, P2105, DOI 10.1172/JCI27180; Ward NL, 2011, BRIT J DERMATOL, V164, P750, DOI 10.1111/j.1365-2133.2010.10129.x; Wong DA, 2000, BRIT J DERMATOL, V143, P91, DOI 10.1046/j.1365-2133.2000.03596.x; Wysowski DK, 2009, NEW ENGL J MED, V360, P89, DOI 10.1056/NEJMc0808738; Yanofsky VR, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/624123; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240; Zibat A, 2009, CARCINOGENESIS, V30, P918, DOI 10.1093/carcin/bgp068	39	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93555	10.1371/journal.pone.0093555	http://dx.doi.org/10.1371/journal.pone.0093555			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691432	Green Accepted, Green Published, gold			2022-12-25	WOS:000334101100104
J	Kuroda, N; Inoue, K; Ikeda, T; Hara, Y; Wake, K; Sato, T				Kuroda, Noriyuki; Inoue, Kouji; Ikeda, Tadayuki; Hara, Yaiko; Wake, Kenjiro; Sato, Tetsuji			Apoptotic Response through a High Mobility Box 1 Protein-Dependent Mechanism in LPS/GaIN-Induced Mouse Liver Failure and Glycyrrhizin-Mediated Inhibition	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; GLYCATION END-PRODUCTS; REPERFUSION INJURY; LIPOPOLYSACCHARIDE/D-GALACTOSAMINE; INTRAVENOUS GLYCYRRHIZIN; INFLAMMATORY RESPONSES; ISCHEMIA-REPERFUSION; EMBRYONIC LETHALITY; SIGNALING PATHWAYS; DENDRITIC CELLS	HMGB1 is a nuclear component involved in nucleosome stabilization and transcription regulation, but extracellularly it is able to serve as a potential late mediator of lethality. In the present study, we explored inflammation- promoting activity of HMGB1 and blockade of extracellular release of HMGB1 by glycyrrhizin ( GL) in LPS/ GaIN- triggered mouse liver injury. At 1 to 10 h after LPS/ GaIN- treatment, mice were anesthetized to collect blood from heart puncture, and serum transaminase and HMGB1 were evaluated. Administration of LPS/ GalN precipitated tissue injury associated with time- dependent alteration in HMGB1 serum levels. At 8 h nuclear immunoreactive products were remarkably reduced and extracellular HMGB1 expression was found exclusively in the pericentral foci. The treatment with GL significantly down- regulated the serum levels of ALT, AST, and HMGB1 in addition to the strong inhibition of tissue injury and extracellular immunoreactivity to HMGB1 and to acetylated- lysine. Furthermore, GL brought about a significant decrease in the number of apoptotic hepatocytes labeled with TUNEL- method. On the basis of these results, three apoptosis- associated genes were identified with microarray analysis and real- time PCR. The ChIP- assay revealed the binding of HMGB1 protein to Gsto1 promoter sequence in LPS/ GaIN- treated mice and the remarkable decrease in combined HMGB1 protein by GL. The current findings claim that a single injection of LPS/ GalN might stimulate apoptosis of hepatocytes through the binding of HMGB1 protein to Gsto1 promoter region and that GL- treatment might prevent the apoptosis and inflammatory infiltrates caused with LPS/ GaIN- injection by disturbing the binding of HMGB1 protein to Gsto1 promoter sequence.	[Kuroda, Noriyuki; Hara, Yaiko; Wake, Kenjiro; Sato, Tetsuji] Tsurumi Univ, Sch Dent Med, Dept Anat & Histocytol, Yokohama, Kanagawa, Japan; [Inoue, Kouji] Tsurumi Univ, Sch Dent Med, Res Ctr Electron Microscopy, Yokohama, Kanagawa, Japan; [Ikeda, Tadayuki] Tsurumi Univ, Sch Dent Med, Dept Geriatr Dent, Yokohama, Kanagawa, Japan; [Wake, Kenjiro] Minophagen Pharmaceut Co Ltd, Liver Res Unit, Tokyo, Japan	Tsurumi University; Tsurumi University; Tsurumi University	Sato, T (corresponding author), Tsurumi Univ, Sch Dent Med, Dept Anat & Histocytol, Yokohama, Kanagawa, Japan.	sato-t@tsurumi-u.ac.jp		KURODA, Noriyuki/0000-0002-4263-1367				Abe K, 2008, J PHARM PHARMACOL, V60, P91, DOI 10.1211/jpp.60.1.0012; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Arase Y, 1997, CANCER, V79, P1494, DOI 10.1002/(SICI)1097-0142(19970415)79:8<1494::AID-CNCR8>3.0.CO;2-B; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bell CW, 2006, AM J PHYSIOL-CELL PH, V291, pC1318, DOI 10.1152/ajpcell.00616.2005; Board PG, 1997, BIOCHEM J, V328, P929; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; BUSTIN M, 1978, J BIOL CHEM, V253, P1694; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Chen GQ, 2004, J LEUKOCYTE BIOL, V76, P994, DOI 10.1189/jlb.0404242; Cinatl J, 2003, LANCET, V361, P2045, DOI 10.1016/S0140-6736(03)13615-X; Daemen MARC, 1999, J CLIN INVEST, V104, P541, DOI 10.1172/JCI6974; Dumitriu IE, 2005, J IMMUNOL, V174, P7506, DOI 10.4049/jimmunol.174.12.7506; Elenkov I, 2011, INT J BIOL SCI, V7, P691, DOI 10.7150/ijbs.7.691; Evankovich J, 2010, J BIOL CHEM, V285, P39888, DOI 10.1074/jbc.M110.128348; Fiuza C, 2003, BLOOD, V101, P2652, DOI 10.1182/blood-2002-05-1300; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; Gujral JS, 2001, HEPATOLOGY, V33, P397, DOI 10.1053/jhep.2001.22002; Hofmann MA, 2002, GENES IMMUN, V3, P123, DOI 10.1038/sj.gene.6363861; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hoppe G, 2006, EXP CELL RES, V312, P3526, DOI 10.1016/j.yexcr.2006.07.020; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Ikeda K, 2006, DIGEST DIS SCI, V51, P603, DOI 10.1007/s10620-006-3177-0; Ikeda T, 2008, ARCH HISTOL CYTOL, V71, P163, DOI 10.1679/aohc.71.163; Ilmakunnas M, 2008, LIVER TRANSPLANT, V14, P1517, DOI 10.1002/lt.21573; Ito I, 2007, J BIOL CHEM, V282, P16336, DOI 10.1074/jbc.M608467200; Itokazu Y, 2000, J PHARM PHARMACOL, V52, P531, DOI 10.1211/0022357001774327; Ivanov S, 2007, BLOOD, V110, P1970, DOI 10.1182/blood-2006-09-044776; JOHNS EW, 1964, BIOCHEM J, V93, P161, DOI 10.1042/bj0930161; Kimura M, 2001, EUR J PHARMACOL, V431, P151, DOI 10.1016/S0014-2999(01)01424-8; Kislinger T, 1999, J BIOL CHEM, V274, P31740, DOI 10.1074/jbc.274.44.31740; Kodym R, 1999, J BIOL CHEM, V274, P5131, DOI 10.1074/jbc.274.8.5131; Kubes P, 1999, HEPATO-GASTROENTEROL, V46, P1458; Liu PT, 1998, AM J PHYSIOL-HEART C, V275, pH2191, DOI 10.1152/ajpheart.1998.275.6.H2191; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Manns MP, 2012, J VIRAL HEPATITIS, V19, P537, DOI 10.1111/j.1365-2893.2011.01579.x; Mollica L, 2007, CHEM BIOL, V14, P431, DOI 10.1016/j.chembiol.2007.03.007; NAITO M, 1991, LAB INVEST, V64, P664; Nowak M, 2000, AM J PHYSIOL-REG I, V278, pR1202, DOI 10.1152/ajpregu.2000.278.5.R1202; OHUCHI K, 1981, PROSTAG LEUKOTR ESS, V7, P457, DOI 10.1016/0161-4630(81)90033-1; Okamoto T, 2000, EUR J PHARMACOL, V387, P229, DOI 10.1016/S0014-2999(99)00807-9; Okamoto T, 1999, INT J MOL MED, V4, P149; Oshima G, 2012, EUR SURG RES, V48, P154, DOI 10.1159/000338363; Piaggi S, 2010, CARCINOGENESIS, V31, P804, DOI 10.1093/carcin/bgq031; Ploeger B, 2001, DRUG METAB REV, V33, P125, DOI 10.1081/DMR-100104400; Rouhiainen A, 2004, BLOOD, V104, P1174, DOI 10.1182/blood-2003-10-3536; Rovere-Querini P, 2004, EMBO REP, V5, P825, DOI 10.1038/sj.embor.7400205; Sass G, 2002, CYTOKINE, V19, P115, DOI 10.1006/cyto.2002.1948; Sato T, 1998, CELL TISSUE RES, V294, P503, DOI 10.1007/s004410051201; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; Semino C, 2005, BLOOD, V106, P609, DOI 10.1182/blood-2004-10-3906; Sha YG, 2008, J IMMUNOL, V180, P2531, DOI 10.4049/jimmunol.180.4.2531; Shin YW, 2007, PLANTA MED, V73, P257, DOI 10.1055/s-2007-967126; Smolarczyk R, 2012, ARCH IMMUNOL THER EX, V60, P391, DOI 10.1007/s00005-012-0183-0; STERNER R, 1979, J BIOL CHEM, V254, P1577; Sunden-Cullberg J, 2005, CRIT CARE MED, V33, P564, DOI [10.1097/01.CCM.0000155991.88802.4D, 10.1097/01.ccm.0000155991.88802.4D]; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; van Beijnum JR, 2008, ANGIOGENESIS, V11, P91, DOI 10.1007/s10456-008-9093-5; Van Rossum TGJ, 1999, J GASTROEN HEPATOL, V14, P1093, DOI 10.1046/j.1440-1746.1999.02008.x; van Rossum TGJ, 1999, CLIN THER, V21, P2080, DOI 10.1016/S0149-2918(00)87239-2; van Rossum TGJ, 2001, AM J GASTROENTEROL, V96, P2432, DOI 10.1111/j.1572-0241.2001.04049.x; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang Y, 2001, CANCER RES, V61, P4112; Xu H, 2010, J IMMUNOL, V184, P1492, DOI 10.4049/jimmunol.0902660; Yadav SS, 1999, HEPATOLOGY, V29, P1494, DOI 10.1002/hep.510290505; Yang H, 2005, J LEUKOCYTE BIOL, V78, P1, DOI 10.1189/jlb.1104648; Yoshida T, 2007, EUR J PHARMACOL, V576, P136, DOI 10.1016/j.ejphar.2007.08.012; Youn JH, 2006, J IMMUNOL, V177, P7889, DOI 10.4049/jimmunol.177.11.7889; Zeng S, 2004, HEPATOLOGY, V39, P422, DOI 10.1002/hep.20045; Zhang XH, 2008, J IMMUNOL, V181, P5015, DOI 10.4049/jimmunol.181.7.5015; Zwacka RM, 1997, J CLIN INVEST, V100, P279, DOI 10.1172/JCI119533	78	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92884	10.1371/journal.pone.0092884	http://dx.doi.org/10.1371/journal.pone.0092884			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690901	Green Published, Green Submitted, gold			2022-12-25	WOS:000334101100034
J	Lai, YH; Beaver, JM; Lorente, K; Melo, J; Ramjagsingh, S; Agoulnik, IU; Zhang, ZZ; Liu, Y				Lai, Yanhao; Beaver, Jill M.; Lorente, Karla; Melo, Jonathan; Ramjagsingh, Shyama; Agoulnik, Irina U.; Zhang, Zunzhen; Liu, Yuan			Base Excision Repair of Chemotherapeutically-Induced Alkylated DNA Damage Predominantly Causes Contractions of Expanded GAA Repeats Associated with Friedreich's Ataxia	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; DOT-TTC REPEATS; TRIPLET-REPEAT; FRATAXIN GENE; EPIGENETIC CHANGES; OXIDATIVE STRESS; SOMATIC INSTABILITY; STICKY DNA; EXPANSION; TRANSCRIPTION	Expansion of GAA center dot TTC repeats within the first intron of the frataxin gene is the cause of Friedreich's ataxia (FRDA), an autosomal recessive neurodegenerative disorder. However, no effective treatment for the disease has been developed as yet. In this study, we explored a possibility of shortening expanded GAA repeats associated with FRDA through chemotherapeutically-induced DNA base lesions and subsequent base excision repair (BER). We provide the first evidence that alkylated DNA damage induced by temozolomide, a chemotherapeutic DNA damaging agent can induce massive GAA repeat contractions/deletions, but only limited expansions in FRDA patient lymphoblasts. We showed that temozolomide-induced GAA repeat instability was mediated by BER. Further characterization of BER of an abasic site in the context of (GAA)(20) repeats indicates that the lesion mainly resulted in a large deletion of 8 repeats along with small expansions. This was because temozolomide-induced single-stranded breaks initially led to DNA slippage and the formation of a small GAA repeat loop in the upstream region of the damaged strand and a small TTC loop on the template strand. This allowed limited pol beta DNA synthesis and the formation of a short 5'-GAA repeat flap that was cleaved by FEN1, thereby leading to small repeat expansions. At a later stage of BER, the small template loop expanded into a large template loop that resulted in the formation of a long 5'-GAA repeat flap. Pol beta then performed limited DNA synthesis to bypass the loop, and FEN1 removed the long repeat flap ultimately causing a large repeat deletion. Our study indicates that chemotherapeutically-induced alkylated DNA damage can induce large contractions/deletions of expanded GAA repeats through BER in FRDA patient cells. This further suggests the potential of developing chemotherapeutic alkylating agents to shorten expanded GAA repeats for treatment of FRDA.	[Lai, Yanhao; Zhang, Zunzhen] Sichuan Univ, West China Sch Publ Hlth, Dept Environm Hlth, Chengdu 610064, Sichuan, Peoples R China; [Lai, Yanhao; Beaver, Jill M.; Lorente, Karla; Melo, Jonathan; Ramjagsingh, Shyama; Liu, Yuan] Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA; [Agoulnik, Irina U.] Florida Int Univ, Dept Cellular Biol & Pharmacol, Miami, FL 33199 USA	Sichuan University; State University System of Florida; Florida International University; State University System of Florida; Florida International University	Zhang, ZZ (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Dept Environm Hlth, Chengdu 610064, Sichuan, Peoples R China.	zhangzunzhen@163.com; yualiu@fiu.edu	Agoulnik, Irina/AAD-4687-2020; Lai, Yanhao/AAD-3392-2019	Agoulnik, Irina/0000-0003-4889-0324; 	National Institutes of Health [ES023569, ES017476]; National Natural Science Foundation of China [81172632]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES017476, R01ES023569] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grants ES023569 and ES017476 to Y.L. and was partially supported by the grant No. 81172632 from the National Natural Science Foundation of China to Z.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Armstrong JS, 2010, FASEB J, V24, P2152, DOI 10.1096/fj.09-143222; Biade S, 1998, J BIOL CHEM, V273, P898, DOI 10.1074/jbc.273.2.898; Bourn RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047085; Bradley JL, 2000, HUM MOL GENET, V9, P275, DOI 10.1093/hmg/9.2.275; Calabrese V, 2005, J NEUROL SCI, V233, P145, DOI 10.1016/j.jns.2005.03.012; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Castaldo I, 2008, J MED GENET, V45, P808, DOI 10.1136/jmg.2008.058594; Chandok GS, 2012, NUCLEIC ACIDS RES, V40, P3964, DOI 10.1093/nar/gks021; Davies Peter A, 2002, Methods Mol Biol, V187, P51; De Biase I, 2007, GENOMICS, V90, P1, DOI 10.1016/j.ygeno.2007.04.001; De Biase I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007914; De Blase I, 2007, ANN NEUROL, V61, P55, DOI 10.1002/ana.21052; De Michele G, 1998, HUM MOL GENET, V7, P1901, DOI 10.1093/hmg/7.12.1901; Dinnes J, 2002, BRIT J CANCER, V86, P501, DOI 10.1038/sj.bjc.6600135; Ditch S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000704; Du JT, 2012, J BIOL CHEM, V287, P29861, DOI 10.1074/jbc.M112.391961; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Emond M, 2000, NEUROLOGY, V55, P1752, DOI 10.1212/WNL.55.11.1752; Entezam A, 2010, HUM MUTAT, V31, P611, DOI 10.1002/humu.21237; Evans-Galea MV, 2012, ANN NEUROL, V71, P487, DOI 10.1002/ana.22671; Festenstein R, 1996, SCIENCE, V271, P1123, DOI 10.1126/science.271.5252.1123; Filla A, 1996, AM J HUM GENET, V59, P554; Follonier C, 2013, NAT STRUCT MOL BIOL, V20, P486, DOI 10.1038/nsmb.2520; Friedman HS, 2000, CLIN CANCER RES, V6, P2585; Gottesfeld JM, 2013, J NEUROCHEM, V126, P147, DOI 10.1111/jnc.12302; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P2815, DOI 10.1093/nar/28.14.2815; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P4930, DOI 10.1093/nar/28.24.4930; Grabczyk E, 2007, NUCLEIC ACIDS RES, V35, P5351, DOI 10.1093/nar/gkm589; Greene E, 2007, NUCLEIC ACIDS RES, V35, P3383, DOI 10.1093/nar/gkm271; Halabi A, 2012, J BIOL CHEM, V287, P29958, DOI 10.1074/jbc.M112.356758; Hashem VI, 2004, NUCLEIC ACIDS RES, V32, P6334, DOI 10.1093/nar/gkh976; Hashem VI, 2002, MUTAT RES-FUND MOL M, V508, P107, DOI 10.1016/S0027-5107(02)00190-2; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Hick A, 2013, DIS MODEL MECH, V6, P608, DOI 10.1242/dmm.010900; Jain A, 2002, J BIOMOL STRUCT DYN, V19, P691, DOI 10.1080/07391102.2002.10506775; Jakupciak JP, 2000, IUBMB LIFE, V50, P355, DOI 10.1080/152165400300089358; KANG SM, 1995, J BIOL CHEM, V270, P27014, DOI 10.1074/jbc.270.45.27014; Kim HM, 2008, EMBO J, V27, P2896, DOI 10.1038/emboj.2008.205; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Krasilnikova MM, 2004, MOL CELL BIOL, V24, P2286, DOI 10.1128/MCB.24.6.2286-2295.2004; Ku S, 2010, CELL STEM CELL, V7, P631, DOI 10.1016/j.stem.2010.09.014; Lai YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056960; Liu Y, 2005, J BIOL CHEM, V280, P3665, DOI 10.1074/jbc.M412922200; Liu Y, 2012, TRENDS BIOCHEM SCI, V37, P162, DOI 10.1016/j.tibs.2011.12.002; Liu Y, 2009, J BIOL CHEM, V284, P28352, DOI 10.1074/jbc.M109.050286; Mariappan SVS, 1999, J MOL BIOL, V285, P2035, DOI 10.1006/jmbi.1998.2435; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Monros E, 1997, AM J HUM GENET, V61, P101, DOI 10.1086/513887; Mrugala MM, 2008, NAT CLIN PRACT ONCOL, V5, P476, DOI 10.1038/ncponc1155; Ohshima K, 1998, J BIOL CHEM, V273, P14588, DOI 10.1074/jbc.273.23.14588; OLIVE PL, 1990, RADIAT RES, V122, P86, DOI 10.2307/3577587; OLIVE PL, 1995, EXP CELL RES, V221, P19, DOI 10.1006/excr.1995.1348; Oussatcheva EA, 2001, J BIOL CHEM, V276, P30878, DOI 10.1074/jbc.M104697200; Pastore A, 2013, J NEUROCHEM, V126, P43, DOI 10.1111/jnc.12220; Pianese L, 2004, J NEUROL NEUROSUR PS, V75, P1061, DOI 10.1136/jnnp.2003.028605; Pollard LM, 2008, NUCLEIC ACIDS RES, V36, P489, DOI 10.1093/nar/gkm1066; Punga T, 2010, EMBO MOL MED, V2, P120, DOI 10.1002/emmm.201000064; Richanison TE, 2013, BRAIN RES, V1514, P91, DOI 10.1016/j.brainres.2013.04.005; Sakamoto N, 1999, MOL CELL, V3, P465, DOI 10.1016/S1097-2765(00)80474-8; Sakamoto N, 2001, J BIOL CHEM, V276, P27171, DOI 10.1074/jbc.M101879200; Santos R, 2010, ANTIOXID REDOX SIGN, V13, P651, DOI 10.1089/ars.2009.3015; Saveliev A, 2003, NATURE, V422, P909, DOI 10.1038/nature01596; Schulz JB, 2000, NEUROLOGY, V55, P1719, DOI 10.1212/WNL.55.11.1719; Schulz JB, 2009, NAT REV NEUROL, V5, P222, DOI 10.1038/nrneurol.2009.26; Shah KA, 2012, CELL REP, V2, P1088, DOI 10.1016/j.celrep.2012.10.006; Sharma R, 2002, HUM MOL GENET, V11, P2175, DOI 10.1093/hmg/11.18.2175; Sharma R, 2004, ANN NEUROL, V56, P898, DOI 10.1002/ana.20333; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Sobol RW, 2001, PROG NUCLEIC ACID RE, V68, P57; Soragni E, 2008, NUCLEIC ACIDS RES, V36, P6056, DOI 10.1093/nar/gkn604; Tang JB, 2011, NEURO-ONCOLOGY, V13, P471, DOI 10.1093/neuonc/nor011; Tang W, 2013, DNA REPAIR, V12, P10, DOI 10.1016/j.dnarep.2012.10.001; Trivedi RN, 2005, CANCER RES, V65, P6394, DOI 10.1158/0008-5472.CAN-05-0715; Wells RD, 2005, NUCLEIC ACIDS RES, V33, P3785, DOI 10.1093/nar/gki697; Wells RD, 2007, TRENDS BIOCHEM SCI, V32, P271, DOI 10.1016/j.tibs.2007.04.003; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Xu Meng, 2013, Nucleic Acids Res, V41, P1684, DOI 10.1093/nar/gks1306; Zouari M, 1998, NEUROMUSCULAR DISORD, V8, P416, DOI 10.1016/S0960-8966(98)00051-0	79	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93464	10.1371/journal.pone.0093464	http://dx.doi.org/10.1371/journal.pone.0093464			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691413	Green Published, gold, Green Submitted			2022-12-25	WOS:000334101100085
J	Lu, LJ; Wang, RJ; Ran, L; Gan, L; Bai, Y; Jin, LB; Yao, ZX; Liu, SC; Ren, GS; Wu, KN; Li, HY; Kong, LQ				Lu, Lin-jie; Wang, Rui-jue; Ran, Liang; Gan, Lu; Bai, Yang; Jin, Liang-bin; Yao, Zi-xiang; Liu, Sheng-chun; Ren, Guo-sheng; Wu, Kai-nan; Li, Hong-yuan; Kong, Ling-quan			On the Status and Comparison of Glucose Intolerance in Female Breast Cancer Patients at Initial Diagnosis and during Chemotherapy through an Oral Glucose Tolerance Test	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; ADJUVANT CHEMOTHERAPY; LIFE-STYLE; IMPACT; RISK; PREVENTION	Aims: This study is to estimate the status and comparison of glucose intolerance in female breast cancer patients at initial diagnosis and during chemotherapy through an oral glucose tolerance test (OGTT), as well as to learn the effect of chemotherapy on the glucose metabolism of breast cancer patients. Methods: All the 79 breast cancer patients at initial diagnosis, with the mean age of 53.2 years, and 96 breast cancer patients before the 5th or 6th cycle of chemotherapy, with the mean age of 51.5 years, participated in the study from December 2012 to October 2013. After an overnight fast, participants underwent OGTT test, and fasting and 2-hour glucose levels were measured to identify undiagnosed diabetes and prediabetes (i.e., impaired fasting glucose or impaired glucose tolerance) in them. Previously diagnosed diabetes among the female breast cancer patients was determined on the self-report and the medical record. Results: The overall incidences of total normal glucose tolerance, prediabetes, diabetes in female breast cancer patients at initial diagnosis and during chemotherapy were 24.1% and 38.5% (p<0.05), 50.6% and 28.1% (p<0.05), and 25.3% and 33.3% (p>0.05), respectively, and the differences of normal glucose tolerance and prediabetes instead of diabetes between the two groups were statistically significant. About 84% of the total diabetes and prediabetes in the female breast cancer patients at initial diagnosis and 79.7% of those during chemotherapy need to be diagnosed with OGTT. Conclusions: Breast cancer patients have high incidences of diabetes and prediabetes. After chemotherapy even with steroids, some breast cancer patients with abnormal glucose metabolism may even become normal. Isolated hyperglycemia 2 hours after glucose loading is common, and OGTT should be made for breast cancer patients at initial diagnosis and during chemotherapy.	[Lu, Lin-jie; Wang, Rui-jue; Ran, Liang; Gan, Lu; Bai, Yang; Jin, Liang-bin; Yao, Zi-xiang; Liu, Sheng-chun; Ren, Guo-sheng; Wu, Kai-nan; Li, Hong-yuan; Kong, Ling-quan] Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China	Chongqing Medical University	Wu, KN (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China.	wukainanwaiwu@126.com; hongy_li@hotmail.com; huihuikp@163.com		Kong, Ling-quan/0000-0001-5705-9001	National Natural Science Foundation of China (NSFC) [81372851]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (NSFC)(81372851) (Ling-quan Kong). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2007, ARCH INTERN MED, V167, P2091, DOI 10.1001/archinte.167.19.2091; Arif JM, 2011, ASIAN PAC J CANCER P, V12, P589; Buysschaert M, 2013, DIABETES METAB SYND, V7, P247, DOI 10.1016/j.dsx.2013.08.001; Erickson K, 2011, J CLIN ONCOL, V29, P54, DOI 10.1200/JCO.2010.29.3183; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Furnary Anthony P, 2004, Endocr Pract, V10 Suppl 2, P21; Hickish T, 2009, J NATL CANCER I, V101, P537, DOI 10.1093/jnci/djp025; Ioannidis JPA, 2000, J CLIN ONCOL, V18, P3409, DOI 10.1200/JCO.2000.18.19.3409; Ji GY, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0687-4; Jia WP, 2007, DIABETOLOGIA, V50, P286, DOI 10.1007/s00125-006-0503-1; Levitzky YS, 2008, J AM COLL CARDIOL, V51, P264, DOI 10.1016/j.jacc.2007.09.038; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Lipscombe LL, 2008, BREAST CANCER RES TR, V109, P389, DOI 10.1007/s10549-007-9654-0; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Malek Mojtaba, 2013, ISRN Endocrinol, V2013, P636927, DOI 10.1155/2013/636927; Marble A, 1934, NEW ENGL J MED, V211, P339, DOI 10.1056/NEJM193408232110801; MUNCK A, 1971, PERSPECT BIOL MED, V14, P265; Norhammar A, 2013, DIABETOLOGIA, V56, P1, DOI 10.1007/s00125-012-2694-y; Oyer David S, 2006, J Support Oncol, V4, P479; Qiao Q, 2000, DIABETOLOGIA, V43, P1470, DOI 10.1007/s001250051557; Saydah SH, 2003, AM J EPIDEMIOL, V157, P1092, DOI 10.1093/aje/kwg100; Schmidt MI, 2005, DIABETES CARE, V28, P2013, DOI 10.2337/diacare.28.8.2013; Schott S, 2010, EXP CLIN ENDOCR DIAB, V118, P673, DOI 10.1055/s-0030-1254116; Schrauder MG, 2011, J CANCER RES CLIN, V137, P975, DOI 10.1007/s00432-010-0960-2; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Srokowski TP, 2009, J CLIN ONCOL, V27, P2170, DOI 10.1200/JCO.2008.17.5935; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wolf I, 2005, LANCET ONCOL, V6, P103, DOI 10.1016/S1470-2045(05)01736-5; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yerrabothala S, 2013, PATHOL ONCOL RES; Zhang PH, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-567	31	6	8	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93630	10.1371/journal.pone.0093630	http://dx.doi.org/10.1371/journal.pone.0093630			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690937	Green Published, gold, Green Submitted			2022-12-25	WOS:000334101100114
J	Verma, S; Rao, BJ				Verma, Shalini; Rao, Basuthkar J.			Uncovering the Basis of ATP Hydrolysis Activity in Purified Human p53 Protein: A Reinvestigation	PLOS ONE			English	Article							HUMAN RAD51 PROTEIN; DNA; BINDING; PURIFICATION; STABILITY; CLEAVAGE; ENZYMES; STRESS	p53 is one of the most well studied tumor suppressor proteins and regarded as the guardian of the genome. The protein mediates cell-cycle arrest, apoptosis in response to myriads of cellular stresses including DNA damage via its trascriptional as well as non-transcriptional roles. ATP binding/hydrolysis by p53 had been implicated in its DNA binding functions. However, till date, no ATP binding/hydrolysis domains have been mapped in p53. In the current study, we have reinvestigated the ATP hydrolysis activity associated with recombinant human p53 protein expressed and purified from E. coli. We confirmed the source of ATPase activity using various deletion constructs of p53 and an In-gel ATPase assay followed by LC-ESI-MS/MS analysis of the activity band. The activity was associated with Hsp70 homologue in E. coli, DnaK, a known interactor of p53. We clarify that wildtype human p53, expressed in E. coli BL21 (DE3) strain, carries no ATPase activity.	[Verma, Shalini; Rao, Basuthkar J.] Inst Fundamental Res, Dept Biol Sci, Bombay, Maharashtra, India		Rao, BJ (corresponding author), Inst Fundamental Res, Dept Biol Sci, Bombay, Maharashtra, India.	bjrao@tifr.res.in			Tata Institute of Fundamental Research (Department of Atomic Energy); Department of Science and Technology (JC Bose Award grant), India	Tata Institute of Fundamental Research (Department of Atomic Energy); Department of Science and Technology (JC Bose Award grant), India(Department of Science & Technology (India))	This work was supported by the Tata Institute of Fundamental Research (Department of Atomic Energy) and Department of Science and Technology (JC Bose Award grant), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARDWELL JCA, 1984, P NATL ACAD SCI-BIOL, V81, P848, DOI 10.1073/pnas.81.3.848; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; BENSON FE, 1994, EMBO J, V13, P5764, DOI 10.1002/j.1460-2075.1994.tb06914.x; BRAIN R, 1994, ONCOGENE, V9, P1775; Carvajal LA, 2013, EMBO REP, V14, P414, DOI 10.1038/embor.2013.25; Chi P, 2006, DNA REPAIR, V5, P381, DOI 10.1016/j.dnarep.2005.11.005; CLARKE CF, 1988, MOL CELL BIOL, V8, P1206, DOI 10.1128/MCB.8.3.1206; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Kiianitsa K, 2003, ANAL BIOCHEM, V321, P266, DOI 10.1016/S0003-2697(03)00461-5; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Meek DW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000950; Molinari M, 1996, ONCOGENE, V13, P2077; Okorokov AL, 1999, MOL CELL BIOL, V19, P7501; Okorokov AL, 1997, EMBO J, V16, P6008, DOI 10.1093/emboj/16.19.6008; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; PAVLETICH NP, 1993, GENE DEV, V7, P2556, DOI 10.1101/gad.7.12b.2556; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Verma S, 2013, J BIOCHEM, V154, P237, DOI 10.1093/jb/mvt040; Walerych D, 2009, ONCOGENE, V28, P4284, DOI 10.1038/onc.2009.281; Warnock LJ, 2004, CANCER BIOL THER, V3, P634, DOI 10.4161/cbt.3.7.915; Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131; ZYLICZ M, 1983, P NATL ACAD SCI-BIOL, V80, P6431, DOI 10.1073/pnas.80.21.6431	27	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93652	10.1371/journal.pone.0093652	http://dx.doi.org/10.1371/journal.pone.0093652			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691158	gold, Green Submitted, Green Published			2022-12-25	WOS:000334101100120
J	Zahn, D; Bitzek, E				Zahn, Dirk; Bitzek, Erik			Shearing in a Biomimetic Apatite-Protein Composite: Molecular Dynamics of Slip Zone Formation, Plastic Flow and Backcreep Mechanisms	PLOS ONE			English	Article								We report molecular dynamics simulations of shear in a biomimetic hydroxyapatite-collagen composite. Our model exhibits elastic properties fully dominated by the inorganic component. However, beyond the elastic regime the biomolecules along with the hierarchical nature of the composite account for the formation of structure-inherent slip zones. These accommodate shear without compromising the overall structure and lead to the sliding of intrinsically defined rods at roughly constant restoring force. Upon releasing load, rod displacement is reversible and backcreep is observed as gradual ionic rearrangement in the slip zone, subjected to an activation barrier.	[Zahn, Dirk] Univ Erlangen Nurnberg, Comp Chem Ctr, Lehrstuhl Theoret Chem, D-91054 Erlangen, Germany; [Bitzek, Erik] Univ Erlangen Nurnberg, Dept Mat Sci & Engn, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Zahn, D (corresponding author), Univ Erlangen Nurnberg, Comp Chem Ctr, Lehrstuhl Theoret Chem, D-91054 Erlangen, Germany.	dirk.zahn@chemie.uni-erlangen.de; erik.bitzek@ww.uni-erlangen.de	Bitzek, Erik/F-5464-2015	Bitzek, Erik/0000-0001-7430-3694; Zahn, Dirk/0000-0002-4303-3422	DFG [ZA 420-7]; cluster of excellence 'engineering of advanced materials' [EXC 315]	DFG(German Research Foundation (DFG)); cluster of excellence 'engineering of advanced materials'	The authors gratefully acknowledge DFG grant ZA 420-7, and the cluster of excellence 'engineering of advanced materials' EXC 315. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Duchstein P, 2011, J MOL MODEL, V17, P73, DOI 10.1007/s00894-010-0707-7; He LH, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2450649; He LH, 2007, J DENT, V35, P431, DOI 10.1016/j.jdent.2006.12.002; He LH, 2009, J BIOMED MATER RES A, V91A, P352, DOI 10.1002/jbm.a.32223; Kawska A, 2008, ANGEW CHEM, V120, P5060; Kniep R, 2007, TOP CURR CHEM, V270, P73, DOI 10.1007/128_053; Maas MC, 1999, EVOL ANTHROPOL, V8, P133; Tlatlik H, 2006, ANGEW CHEM INT EDIT, V45, P1905, DOI 10.1002/anie.200503610; Zahn D, 2007, J MATER SCI, V42, P8966, DOI 10.1007/s10853-007-1586-x; Zahn D, 2010, ANGEW CHEM INT EDIT, V49, P9405, DOI 10.1002/anie.201002663	10	3	3	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93309	10.1371/journal.pone.0093309	http://dx.doi.org/10.1371/journal.pone.0093309			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691379	Green Submitted, Green Published, gold			2022-12-25	WOS:000334101100063
J	Ryan, AE; Colleran, A; O'Gorman, A; O'Flynn, L; Pindjacova, J; Lohan, P; O'Malley, G; Nosov, M; Mureau, C; Egan, LJ				Ryan, A. E.; Colleran, A.; O'Gorman, A.; O'Flynn, L.; Pindjacova, J.; Lohan, P.; O'Malley, G.; Nosov, M.; Mureau, C.; Egan, L. J.			Targeting colon cancer cell NF-kappa B promotes an anti-tumour M1-like macrophage phenotype and inhibits peritoneal metastasis	ONCOGENE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; COLORECTAL-CANCER; CYTOREDUCTIVE SURGERY; MOUSE MODEL; T-CELLS; INFLAMMATION; ALPHA; CARCINOMATOSIS; MONOCYTES; GROWTH	In a model of peritoneal metastasis in immune-competent mice, we show that nuclear factor (NF)-kappa B inhibition in CT26 colon cancer cells prevents metastasis. NF-kappa B inhibition, by stable overexpression of I kappa B-a super-repressor, induced differential polarization of co-cultured macrophages to an M1-like anti-tumour phenotype in vitro. NF-kappa B-deficient cancer cell-conditioned media (CT26/I kappa B-alpha SR) induced interleukin (IL)-12 and nitric oxide (NO) synthase (inducible NO synthase (iNOS)) expression in macrophages. Control cell (CT26/EV) conditioned media induced high levels of IL-10 and arginase in macrophages. In vivo, this effect translated to reduction in metastasis in mice injected with CT26/I kappa B-alpha SR cells and was positively associated with increased CD8(+)CD44(+)CD62L- and CD4(+)CD44(+)CD62L-effector T cells. Furthermore, inhibition of NF-kappa B activity induced high levels of NO in infiltrating immune cells and decreases in matrix metalloproteinase-9 expression, simultaneous with increases in tissue inhibitor of metalloproteinases 1 and 2 within tumours. CT26/I kappa B-alpha SR tumours displayed increased pro-inflammatory gene expression, low levels of angiogenesis and extensive intratumoral apoptosis, consistent with the presence of an anti-tumour macrophage phenotype. Macrophage depletion reduced tumour size in CT26/EV-injected animals and increased tumour size in CT26/I kappa B-alpha SR cells compared with untreated tumours. Our data demonstrate, for the first time, that an important implication of targeting tumour cell NF-kappa B is skewing of macrophage polarization to an anti-tumour phenotype. This knowledge offers novel therapeutic opportunities for anticancer treatment.	[Ryan, A. E.; Colleran, A.; O'Gorman, A.; O'Malley, G.; Mureau, C.; Egan, L. J.] Natl Univ Ireland, Sch Med, Discipline Pharmacol & Therapeut, Galway, Ireland; [Ryan, A. E.; O'Flynn, L.; Pindjacova, J.; Lohan, P.; O'Malley, G.; Nosov, M.] Natl Univ Ireland, Sch Med, NCBES, Regenerat Med Inst REMEDI, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Egan, LJ (corresponding author), Univ Hosp Galway, Inst Clin Sci, Newcastle Rd, Galway, Ireland.	laurence.egan@nuigalway.ie	Ryan, Aideen/H-3909-2019	Ryan, Aideen/0000-0002-5831-6783	Irish Cancer Society [CRF12RYA]; Science Foundation Ireland [04/IN3/B748]; Irish Cancer Society	Irish Cancer Society; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Cancer Society	This work was supported by funding from the Irish Cancer Society to AER (CRF12RYA) and from the Science Foundation Ireland (04/IN3/B748) and the Irish Cancer Society to LJE.	Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Camus M, 2009, CANCER RES, V69, P2685, DOI 10.1158/0008-5472.CAN-08-2654; Cintron JR, 1996, SEMIN SURG ONCOL, V12, P267, DOI 10.1002/(SICI)1098-2388(199607/08)12:4<267::AID-SSU6>3.0.CO;2-3; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; De Palma M, 2008, CANCER CELL, V14, P299, DOI 10.1016/j.ccr.2008.09.004; DeNardo DG, CANC METASTASIS REV, V29, P309; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Eaden J, 2003, ALIMENT PHARM THER, V18, P15, DOI 10.1046/j.1365-2036.18.s2.3.x; Egan LJ, 1999, J BIOL CHEM, V274, P26448, DOI 10.1074/jbc.274.37.26448; Flemming A, 2011, NAT REV DRUG DISCOV, V10, DOI 10.1038/nrd3399; Foran E, MOL CANC RES, V8, P471; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Hallam S, 2009, J PATHOL, V219, P143, DOI 10.1002/path.2602; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kianmanesh R, 2007, ANN SURG, V245, P597, DOI 10.1097/01.sla.0000255561.87771.11; Klug F, 2013, CANCER CELL, V24, P589, DOI 10.1016/j.ccr.2013.09.014; Kojima M, 2004, ANTICANCER RES, V24, P675; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Koppe MJ, 2006, ANN SURG, V243, P212, DOI 10.1097/01.sla.0000197702.46394.16; Koppelman B, 1997, IMMUNITY, V7, P861, DOI 10.1016/S1074-7613(00)80404-5; Kubota Y, 2009, J EXP MED, V206, P1089, DOI 10.1084/jem.20081605; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Lin Y, 2010, EXPERT OPIN THER TAR, V14, P45, DOI 10.1517/14728220903431069; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; MANCINO A, CLIN CANC RES, V16, P784; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Matsuzaki S, 2005, ALLERGY, V60, P780, DOI 10.1111/j.1398-9995.2005.00793.x; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; O'Gorman A, 2010, AM J PHYSIOL-GASTR L, V299, pG96, DOI 10.1152/ajpgi.00460.2009; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Ridnour LA, 2007, P NATL ACAD SCI USA, V104, P16898, DOI 10.1073/pnas.0702761104; Rolny C, 2011, CANCER CELL, V19, P31, DOI 10.1016/j.ccr.2010.11.009; Ryan AE, 2014, MOL THER, V22, P655, DOI 10.1038/mt.2013.261; Shen P, 2004, ANN SURG ONCOL, V11, P178, DOI 10.1245/ASO.2004.05.009; Soudja SM, 2012, IMMUNITY, V37, P549, DOI 10.1016/j.immuni.2012.05.029; Toruner M, 2006, J BIOL CHEM, V281, P8686, DOI 10.1074/jbc.M512178200; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Wang YC, 2010, CANCER RES, V70, P4840, DOI 10.1158/0008-5472.CAN-10-0269; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522; Zins K, 2007, CANCER RES, V67, P1038, DOI 10.1158/0008-5472.CAN-06-2295	49	35	39	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 19	2015	34	12					1563	1574		10.1038/onc.2014.86	http://dx.doi.org/10.1038/onc.2014.86			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CD9KI	24704833				2022-12-25	WOS:000351416800009
J	Zhang, J; Pan, YF; Ding, ZW; Yang, GZ; Tan, YX; Yang, C; Jiang, TY; Liu, LJ; Zhang, B; Han, T; Cao, D; Yang, T; Yang, N; Wu, MC; Dong, LW; Wang, HY				Zhang, J.; Pan, Y-F; Ding, Z-W; Yang, G-Z; Tan, Y-X; Yang, C.; Jiang, T-Y; Liu, L-J; Zhang, B.; Han, T.; Cao, D.; Yang, T.; Yang, N.; Wu, M-C; Dong, L-W; Wang, H-Y			RMP promotes venous metastases of hepatocellular carcinoma through promoting IL-6 transcription	ONCOGENE			English	Article							RNA-POLYMERASE-II; VIRUS X PROTEIN; NF-KAPPA-B; CANCER-CELLS; LIVER-CANCER; HEPATITIS-B; SERUM INTERLEUKIN-6; STEM-CELLS; EXPRESSION; PROLIFERATION	Hepatocellular carcinoma (HCC) is believed to arise from tumor-initiating cells (T-ICs), which are responsible for tumor relapse and metastases. Portal vein tumor thrombus (PVTT) is raised from HCC and strongly correlated to a poor prognosis. However, the mechanism underling the formation of PVTT is largely unknown. Herein, we provide evidence that RNA polymerase II subunit 5 (RPB5)-mediating protein (RMP) was progressively upregulated in PVTT and overexpressed RMP appeared to increase T-ICs self-renewal. Moreover, RMP promoted metastases of PVTT cells and HCC cells in vitro and in vivo. Knockdown of RMP attenuated T-ICs self-renewal and reversed epithelial-mesenchymal transition (EMT) in HCC and PVTT cells. The neutralizing assays suggested that interleukin-6 (IL-6) had an indispensable role in RMP regulating metastases and self-renewal of HCC cells. Furthermore, the transcription of IL-6 was verified to be modulated by RMP via interaction with p65 and RPB5, through which expanding the T-IC/cancer stem cell populations, as well as inducing EMT was promoted. These results suggested that RMP may promote PVTT formation by promoting IL-6 transcription. Thus, RMP serves as a potent factor contributed to develop PVTT and a promising therapeutic target for HCC patients.	[Zhang, J.; Pan, Y-F; Ding, Z-W; Yang, G-Z; Tan, Y-X; Yang, C.; Jiang, T-Y; Liu, L-J; Zhang, B.; Han, T.; Cao, D.; Dong, L-W; Wang, H-Y] Natl Ctr Liver Canc, Shanghai, Peoples R China; [Zhang, J.; Pan, Y-F; Ding, Z-W; Yang, G-Z; Tan, Y-X; Yang, C.; Jiang, T-Y; Liu, L-J; Zhang, B.; Han, T.; Cao, D.; Dong, L-W; Wang, H-Y] Second Mil Med Univ, Eastern Hepatobiliary Surg Inst, Int Cooperat Lab Signal Transduct, Shanghai 200438, Peoples R China; [Yang, T.; Yang, N.; Wu, M-C] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Surg, Shanghai 200438, Peoples R China; [Wang, H-Y] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Shanghai Canc Inst,State Key Lab Oncogenes & Rela, Shanghai 200030, Peoples R China	Naval Medical University; Naval Medical University; Shanghai Jiao Tong University	Wang, HY (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Inst, Int Cooperat Lab Signal Transduct, 225 Changhai Rd, Shanghai 200438, Peoples R China.	donliwei@126.com; hywangk@vip.sina.com	Yang, Tian/W-6668-2019; Yang, Tian/M-5484-2018	Yang, Tian/0000-0003-1544-0976; Dong, Li-Wei/0000-0003-2116-1674	National Natural Science Foundation of China [81370066, 81372355, 81001075, 91229205, BWS11J036]; Funds for Creative Research Groups of China [81221061]; State Key Project for Liver Cancer [2012ZX10002-009, 2013ZX10002-010]; Stem Cell and Medicine Research Center's Innovation Research Program of the Second Military Medical University [SCMRC1306]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Funds for Creative Research Groups of China(Science Fund for Creative Research Groups); State Key Project for Liver Cancer; Stem Cell and Medicine Research Center's Innovation Research Program of the Second Military Medical University	We thank Liang Tang, Dong-Ping Hu, Shan-Na Huang, Dan-Dan Huang, Shan-Hua Tang, Lin-Na Guo and Huan-Lin Sun for technical assistance. We thank Dr Xiao-Ni Kong for providing luciferase reporter constructs and Ad-caSTAT3 virus. This work was supported by grants from National Natural Science Foundation of China (81370066, 81372355, 81001075, 91229205, BWS11J036), the Funds for Creative Research Groups of China (81221061) and the State Key Project for Liver Cancer (2012ZX10002-009, 2013ZX10002-010), Stem Cell and Medicine Research Center's Innovation Research Program of the Second Military Medical University (SCMRC1306).	Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; dGM Acker J, 1997, J BIOL CHEM, V272, P16815; Dong LW, 2011, AUTOPHAGY, V7, P1222, DOI 10.4161/auto.7.10.16610; Dorjsuren D, 1998, MOL CELL BIOL, V18, P7546, DOI 10.1128/MCB.18.12.7546; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; He GB, 2013, CELL, V155, P384, DOI 10.1016/j.cell.2013.09.031; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; Iliopoulos D, 2011, P NATL ACAD SCI USA, V108, P1397, DOI 10.1073/pnas.1018898108; Jang JW, 2012, CYTOKINE, V60, P686, DOI 10.1016/j.cyto.2012.07.017; Ji JF, 2012, SEMIN ONCOL, V39, P461, DOI 10.1053/j.seminoncol.2012.05.011; JOHNSON C, 2012, NATL GEOGR, V222, P6; Lee TKW, 2011, CELL STEM CELL, V9, P50, DOI 10.1016/j.stem.2011.06.005; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Nakagawa H, 2009, INT J CANCER, V125, P2264, DOI 10.1002/ijc.24720; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Parusel CT, 2006, DEVELOPMENT, V133, P621, DOI 10.1242/dev.02235; Portolani N, 2006, ANN SURG, V243, P229, DOI 10.1097/01.sla.0000197706.21803.a1; Spooren A, 2010, CELL SIGNAL, V22, P871, DOI 10.1016/j.cellsig.2010.01.018; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Theurillat JP, 2011, CANCER CELL, V19, P317, DOI 10.1016/j.ccr.2011.01.019; Wang Q, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-271; Wang T, 2010, BRIT J CANCER, V102, P1618, DOI 10.1038/sj.bjc.6605689; Wei WX, 2001, J BIOL CHEM, V276, P12266, DOI 10.1074/jbc.M009634200; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Wong CM, 2005, CANCER RES, V65, P8861, DOI 10.1158/0008-5472.CAN-05-1318; Wong VWS, 2009, INT J CANCER, V124, P2766, DOI 10.1002/ijc.24281; Xiang WQ, 2011, J HEPATOL, V54, P26, DOI 10.1016/j.jhep.2010.08.006; Yamashita T, 2010, CANCER RES, V70, P4687, DOI 10.1158/0008-5472.CAN-09-4210; Yang SJ, 2013, INT J BIOL SCI, V9, P637, DOI 10.7150/ijbs.6439; Yoon S, 2010, AUTOPHAGY, V6, P1125, DOI 10.4161/auto.6.8.13547; Zhang YQ, 2010, CLIN CANCER RES, V16, P1423, DOI 10.1158/1078-0432.CCR-09-2405	31	28	32	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 19	2015	34	12					1575	1583		10.1038/onc.2014.84	http://dx.doi.org/10.1038/onc.2014.84			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CD9KI	24704835				2022-12-25	WOS:000351416800010
J	Lan, JP; Zhu, YY; Xu, LL; Yu, HJ; Yu, J; Liu, X; Fu, CH; Wang, XG; Ke, YW; Huang, H; Dou, Z				Lan, Jianping; Zhu, Yuanyuan; Xu, Leilei; Yu, Huijuan; Yu, Jian; Liu, Xing; Fu, Chuanhai; Wang, Xiaogang; Ke, Yuwen; Huang, He; Dou, Zhen			The 68-kDa Telomeric Repeat Binding Factor 1 ( TRF1)-associated Protein ( TAP68) Interacts with and Recruits TRF1 to the Spindle Pole during Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Centriole; Mitosis; Phosphorylation; Telomeres; Nek2A Kinase; TAP68; TRF1	FISSION YEAST; FUNCTIONAL-CHARACTERIZATION; CENTROSOME ABERRATIONS; MITOTIC SPINDLE; DOMAIN PROTEIN; NEK2 KINASE; HUMAN-CELLS; PHOSPHORYLATION; CHECKPOINT; TANKYRASE	Background: The significance of telomeric protein translocation to the spindle pore is unknown. Results: TAP68 mediates TRF1 transit to the centrosome in mitotic cells. Conclusion: Repression of TAP68 induces genomic instability possibly through inhibition of TRF1 and tankyrase recruitment to centrosomes. Significance: Identifying TRF1-interacting proteins that regulate its localization is crucial for understanding the role of telomeric proteins in mitosis. The telomere capping protein TRF1 is a component of the multiprotein complex shelterin, which organizes the telomere into a high order structure. Besides telomere maintenance, telomere-associated proteins also have nontelomeric functions. For example, tankyrase 1 and TRF1 are required for the maintenance of faithful mitotic progression. However, the functional relevance of their centrosomal localization has not been established. Here, we report the identification of a TRF1-binding protein, TAP68, that interacts with TRF1 in mitotic cells. TAP68 contains two coiled-coil domains and a structural maintenance of chromosome motifs and co-localizes with TRF1 to telomeres during interphase. Immediately after nuclear envelope breakdown, TAP68 translocates toward the spindle poles followed by TRF1. Dissociation of TAP68 from the telomere is concurrent with the Nek2A-dependent phosphorylation at Thr-221. Biochemical characterization demonstrated that the first coiled-coil domain of TAP68 binds and recruits TRF1 to the centrosome. Inhibition of TAP68 expression by siRNA blocked the localization of TRF1 and tankyrase 1 to the centrosome. Furthermore, siRNA-mediated depletion of TAP68 perturbed faithful chromosome segregation and genomic stability. These findings suggest that TAP68 functions in mediating TRF1-tankyrase 1 localization to the centrosome and in mitotic regulation.	[Lan, Jianping; Wang, Xiaogang] Zhejiang Prov Peoples Hosp, Dept Hematol, Hangzhou 310014, Zhejiang, Peoples R China; [Lan, Jianping; Wang, Xiaogang] Zhejiang Prov Peoples Hosp, Hematopoiet Stem Cell Transplant Ctr, Hangzhou 310014, Zhejiang, Peoples R China; [Zhu, Yuanyuan; Yu, Jian; Huang, He] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hematol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhu, Yuanyuan; Yu, Jian; Huang, He] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplant Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Leilei; Yu, Huijuan; Liu, Xing; Fu, Chuanhai; Ke, Yuwen; Dou, Zhen] Univ Sci & Technol China, Anhui Key Lab Cellular Dynam, Hefei 230027, Peoples R China; [Xu, Leilei; Yu, Huijuan; Liu, Xing; Fu, Chuanhai; Ke, Yuwen; Dou, Zhen] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Peoples R China	Zhejiang Provincial People's Hospital; Zhejiang Provincial People's Hospital; Zhejiang University; Zhejiang University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Dou, Z (corresponding author), Univ Sci & Technol China, Anhui Key Lab Cellular Dynam, Hefei 230027, Peoples R China.	douzhen@ustc.edu.cn	DOU, ZHEN/N-2022-2013; Fu, Chuanhai/G-8303-2016; Liu, Xing/H-2989-2018	Fu, Chuanhai/0000-0003-4354-3796; Liu, Xing/0000-0002-7480-5085; DOU, ZHEN/0000-0003-3303-9393	Chinese 973 Project [2002CB713704, 2012CB917204, 2013CB911203]; National Natural Science Foundation of China [30871109, 30770919, 30900640, 81000896, 81300418, 31371363]; Zhejiang Provincial Natural Science Foundation of China [Y2090885]	Chinese 973 Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported by Chinese 973 Project Grants 2002CB713704, 2012CB917204, and 2013CB911203, National Natural Science Foundation of China Grants 30871109, 30770919, 30900640, 81000896, 81300418, and 31371363, and Zhejiang Provincial Natural Science Foundation of China Grant Y2090885.	Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Chang P, 2005, NAT CELL BIOL, V7, P1133, DOI 10.1038/ncb1322; Chang P, 2004, NATURE, V432, P645, DOI 10.1038/nature03061; Chang P, 2009, MOL BIOL CELL, V20, P4575, DOI 10.1091/mbc.E09-06-0477; Chang W, 2005, BIOCHEM J, V391, P177, DOI 10.1042/BJ20050885; Cheng Z, 2008, ONCOGENE, V27, P931, DOI 10.1038/sj.onc.1210710; Chu YJ, 2011, J MOL CELL BIOL, V3, P260, DOI 10.1093/jmcb/mjq037; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Du J, 2008, ONCOGENE, V27, P4107, DOI 10.1038/onc.2008.34; Dynek JN, 2004, SCIENCE, V304, P97, DOI 10.1126/science.1094754; Fang ZY, 2006, MOL CELL PROTEOMICS, V5, P1437, DOI 10.1074/mcp.M600050-MCP200; Faragher AJ, 2003, MOL BIOL CELL, V14, P2876, DOI 10.1091/mbc.E03-02-0108; Flory MR, 2004, MOL CELL, V16, P619, DOI 10.1016/j.molcel.2004.10.027; FRY AM, 1995, J BIOL CHEM, V270, P12899, DOI 10.1074/jbc.270.21.12899; Fu GS, 2007, CELL RES, V17, P608, DOI 10.1038/cr.2007.55; Ha GH, 2012, CELL DEATH DIFFER, V19, P321, DOI 10.1038/cdd.2011.101; Karlseder J, 2003, MOL CELL BIOL, V23, P6533, DOI 10.1128/MCB.23.18.6533-6541.2003; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Kramer A, 2005, LEUKEMIA, V19, P1142, DOI 10.1038/sj.leu.2403780; Lee TH, 2009, NAT CELL BIOL, V11, P97, DOI 10.1038/ncb1818; Lou Y, 2004, J BIOL CHEM, V279, P20049, DOI 10.1074/jbc.M314205200; Lu KP, 1996, NATURE, V380, P544; Mardin BR, 2010, NAT CELL BIOL, V12, P1166, DOI 10.1038/ncb2120; Munoz P, 2009, MOL CELL BIOL, V29, P1608, DOI 10.1128/MCB.01339-08; Nakamura M, 2002, FEBS LETT, V514, P193, DOI 10.1016/S0014-5793(02)02363-3; Nakamura M, 2001, CURR BIOL, V11, P1512, DOI 10.1016/S0960-9822(01)00456-0; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Nishiyama A, 2006, EMBO J, V25, P575, DOI 10.1038/sj.emboj.7600964; Ohishi T, 2010, CANCER RES, V70, P2041, DOI 10.1158/0008-5472.CAN-09-2008; Prime G, 2005, CELL CYCLE, V4, P121, DOI 10.4161/cc.4.1.1351; Riffell JL, 2012, NAT REV DRUG DISCOV, V11, P923, DOI 10.1038/nrd3868; Schneider RP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2946; Silk AD, 2009, J CELL BIOL, V184, P677, DOI 10.1083/jcb.200810091; Smith S, 2000, CURR BIOL, V10, P1299, DOI 10.1016/S0960-9822(00)00752-1; Smith S, 1999, J CELL SCI, V112, P3649; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Tao YY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1779; Tomaska L, 2004, J BIOL CHEM, V279, P50764, DOI 10.1074/jbc.M409790200; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Wang C, 2010, EUR J CELL BIOL, V89, P748, DOI 10.1016/j.ejcb.2010.05.005; Wei R, 2011, MOL BIOL CELL, V22, P3584, DOI 10.1091/mbc.E11-01-0012; Wu ZQ, 2008, J BIOL CHEM, V283, P25503, DOI 10.1074/jbc.M803304200; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; Yonekawa T, 2012, MOL CELL BIOL, V32, P1387, DOI 10.1128/MCB.05641-11; Yuan K, 2009, J BIOL CHEM, V284, P23072, DOI 10.1074/jbc.M109.001990; Zhang LY, 2011, J BIOL CHEM, V286, P3033, DOI 10.1074/jbc.M110.165340; Zhou RH, 2003, MOL BIOL CELL, V14, P1097, DOI 10.1091/mbc.E02-07-0425; Zhou XZ, 2001, CELL, V107, P347, DOI 10.1016/S0092-8674(01)00538-4; Zhu QB, 2009, J CELL BIOL, V185, P827, DOI 10.1083/jcb.200812121	54	7	8	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14145	14156		10.1074/jbc.M113.526244	http://dx.doi.org/10.1074/jbc.M113.526244			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24692559	Green Published, hybrid			2022-12-25	WOS:000335984600042
J	Esposito, F; Otto, T; Zijlstra, FRH; Goebel, R				Esposito, Fabrizio; Otto, Tobias; Zijlstra, Fred R. H.; Goebel, Rainer			Spatially Distributed Effects of Mental Exhaustion on Resting-State FMRI Networks	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; BOLD SIGNAL FLUCTUATIONS; FUNCTIONAL CONNECTIVITY; SUSTAINED ATTENTION; ASL PERFUSION; ALPHA-BAND; BASE-LINE; ACTIVATION; FATIGUE; PERFORMANCE	Brain activity during rest is spatially coherent over functional connectivity networks called resting-state networks. In restingstate functional magnetic resonance imaging, independent component analysis yields spatially distributed network representations reflecting distinct mental processes, such as intrinsic (default) or extrinsic (executive) attention, and sensory inhibition or excitation. These aspects can be related to different treatments or subjective experiences. Among these, exhaustion is a common psychological state induced by prolonged mental performance. Using repeated functional magnetic resonance imaging sessions and spatial independent component analysis, we explored the effect of several hours of sustained cognitive performances on the resting human brain. Resting-state functional magnetic resonance imaging was performed on the same healthy volunteers in two days, with and without, and before, during and after, an intensive psychological treatment (skill training and sustained practice with a flight simulator). After each scan, subjects rated their level of exhaustion and performed an N-back task to evaluate eventual decrease in cognitive performance. Spatial maps of selected resting-state network components were statistically evaluated across time points to detect possible changes induced by the sustained mental performance. The intensive treatment had a significant effect on exhaustion and effort ratings, but no effects on N-back performances. Significant changes in the most exhausted state were observed in the early visual processing and the anterior default mode networks (enhancement) and in the fronto-parietal executive networks (suppression), suggesting that mental exhaustion is associated with a more idling brain state and that internal attention processes are facilitated to the detriment of more extrinsic processes. The described application may inspire future indicators of the level of fatigue in the neural attention system.	[Esposito, Fabrizio] Univ Salerno, Dept Med & Surg, I-84100 Salerno, Italy; [Esposito, Fabrizio; Goebel, Rainer] Maastricht Univ, Dept Cognit Neurosci, Maastricht, Netherlands; [Otto, Tobias; Zijlstra, Fred R. H.] Maastricht Univ, Dept Work & Social Psychol, Maastricht, Netherlands; [Goebel, Rainer] Netherlands Inst Neurosci, Dept Vis & Cognit, Amsterdam, Netherlands	University of Salerno; Maastricht University; Maastricht University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Esposito, F (corresponding author), Univ Salerno, Dept Med & Surg, I-84100 Salerno, Italy.	faesposito@unisa.it	Esposito, Fabrizio/M-8555-2015	Esposito, Fabrizio/0000-0002-5099-9786; Zijlstra, Fred/0000-0002-3505-9753; Goebel, Rainer/0000-0003-1780-2467				Ackerman PL, 2009, J EXP PSYCHOL-APPL, V15, P163, DOI 10.1037/a0015719; Albert NB, 2009, CURR BIOL, V19, P1023, DOI 10.1016/j.cub.2009.04.028; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Barnes A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006626; BARTLETT EJ, 1988, J CEREBR BLOOD F MET, V8, P502, DOI 10.1038/jcbfm.1988.91; Birn RM, 2008, HUM BRAIN MAPP, V29, P740, DOI 10.1002/hbm.20577; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Boksem MAS, 2006, BIOL PSYCHOL, V72, P123, DOI 10.1016/j.biopsycho.2005.08.007; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Calhoun VD, 2009, NEUROIMAGE, V45, pS163, DOI 10.1016/j.neuroimage.2008.10.057; Colby CL, 1996, COGNITIVE BRAIN RES, V5, P105, DOI 10.1016/S0926-6410(96)00046-8; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Coull JT, 1998, NEUROPSYCHOLOGIA, V36, P1325, DOI 10.1016/S0028-3932(98)00035-9; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Demeter E, 2011, NEUROIMAGE, V54, P1518, DOI 10.1016/j.neuroimage.2010.09.026; Duff EP, 2008, HUM BRAIN MAPP, V29, P778, DOI 10.1002/hbm.20601; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Esposito F, 2005, NEUROIMAGE, V25, P193, DOI 10.1016/j.neuroimage.2004.10.042; Esposito F, 2013, BRAIN, V136, P710, DOI 10.1093/brain/awt007; Esposito F, 2011, CURR OPIN NEUROL, V24, P378, DOI 10.1097/WCO.0b013e32834897a5; Esposito F, 2010, NEUROIMAGE, V53, P534, DOI 10.1016/j.neuroimage.2010.06.061; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; GEVINS A, 1993, ELECTROEN CLIN NEURO, V87, P128, DOI 10.1016/0013-4694(93)90119-G; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Gordon EM, 2012, HUMAN BRAIN MAPPING; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2008, HUM BRAIN MAPP, V29, P839, DOI 10.1002/hbm.20537; Grigg O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013311; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; HACKER W, 1978, ERGONOMICS, V21, P187, DOI 10.1080/00140137808931712; Hockey GRJ, 1997, BIOL PSYCHOL, V45, P73; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Kamei T, 1998, PERCEPT MOTOR SKILL, V87, P1419, DOI 10.2466/pms.1998.87.3f.1419; Khalili-Mahani N., 2011, HUM BRAIN MAPP; Kim J, 2006, NEUROIMAGE, V31, P376, DOI 10.1016/j.neuroimage.2005.11.035; Koric L, 2011, HUM BRAIN MAPP; Langdon DW, 2011, CURR OPIN NEUROL, V24, P244, DOI 10.1097/WCO.0b013e328346a43b; Lee HL, 2013, NEUROIMAGE, V65, P216, DOI 10.1016/j.neuroimage.2012.10.015; Lewin JS, 1996, J COMPUT ASSIST TOMO, V20, P695, DOI 10.1097/00004728-199609000-00002; Lewis JW, 2011, HUM BRAIN MAPP, V32, P2241, DOI 10.1002/hbm.21185; Licata SC, 2013, NEUROIMAGE, V70, P211, DOI 10.1016/j.neuroimage.2012.12.055; Lim JL, 2013, NEUROIMAGE, V76, P81, DOI 10.1016/j.neuroimage.2013.03.018; Lim J, 2010, NEUROIMAGE, V49, P3426, DOI 10.1016/j.neuroimage.2009.11.020; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Ogg RJ, 2008, MAGN RESON IMAGING, V26, P504, DOI 10.1016/j.mri.2007.09.004; Pfurtscheller G, 1996, INT J PSYCHOPHYSIOL, V24, P39, DOI 10.1016/S0167-8760(96)00066-9; Schrauf M., 2011, P HUMAN FACTORS ERGO, DOI [10.1177/1071181311551045, DOI 10.1177/1071181311551045]; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Soares JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066500; Sonnentag S, 2006, J APPL PSYCHOL, V91, P330, DOI 10.1037/0021-9010.91.2.330; Tamaki M, 1999, PSYCHIAT CLIN NEUROS, V53, P273, DOI 10.1046/j.1440-1819.1999.00548.x; Vahdat S, 2011, J NEUROSCI, V31, P16907, DOI 10.1523/JNEUROSCI.2737-11.2011; Valdez P, 2008, MIND BRAIN EDUC, V2, P7, DOI 10.1111/j.1751-228X.2008.00023.x; van de Ven VG, 2004, HUM BRAIN MAPP, V22, P165, DOI 10.1002/hbm.20022; van de Ven V, 2009, NEUROIMAGE, V47, P1982, DOI 10.1016/j.neuroimage.2009.05.057; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; van der Linden D, 2003, ACTA PSYCHOL, V113, P45, DOI 10.1016/S0001-6918(02)00150-6; Waites AB, 2005, HUM BRAIN MAPP, V24, P59, DOI 10.1002/hbm.20069; Worden MS, 2000, J NEUROSCI, V20; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zijlstra F. R. H., 1993, EFFICIENCY WORK BEHA	73	30	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94222	10.1371/journal.pone.0094222	http://dx.doi.org/10.1371/journal.pone.0094222			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705397	Green Published, Green Submitted, gold			2022-12-25	WOS:000334107500134
J	Durrwald, R; Kolodziejek, J; Weissenbock, H; Nowotny, N				Duerrwald, Ralf; Kolodziejek, Jolanta; Weissenboeck, Herbert; Nowotny, Norbert			The Bicolored White-Toothed Shrew Crocidura leucodon (HERMANN 1780) Is an Indigenous Host of Mammalian Borna Disease Virus	PLOS ONE			English	Article							INFECTION; RESERVOIR; ANTIBODIES; TRANSMISSION; CONSERVATION; ORGANIZATION; SEQUENCES; SYSTEM; BIRDS; FIELD	Borna disease (BD) is a sporadic neurologic disease of horses and sheep caused by mammalian Borna disease virus (BDV). Its unique epidemiological features include: limited occurrence in certain endemic regions of central Europe, yearly varying disease peaks, and a seasonal pattern with higher disease frequencies in spring and a disease nadir in autumn. It is most probably not directly transmitted between horses and sheep. All these features led to the assumption that an indigenous virus reservoir of BDV other than horses and sheep may exist. The search for such a reservoir had been unsuccessful until a few years ago five BDV-infected shrews were found in a BD-endemic area in Switzerland. So far, these data lacked further confirmation. We therefore initiated a study in shrews in endemic areas of Germany. Within five years 107 shrews of five different species were collected. BDV infections were identified in 14 individuals of the species bicolored white-toothed shrew (Crocidura leucodon, HERMANN 1780), all originating from BD-endemic territories. Immunohistological analysis showed widespread distribution of BDV antigen both in the nervous system and in epithelial and mesenchymal tissues without pathological alterations. Large amounts of virus, demonstrated by presence of viral antigen in epithelial cells of the oral cavity and in keratinocytes of the skin, may be a source of infection for natural and spill-over hosts. Genetic analyses reflected a close relationship of the BDV sequences obtained from the shrews with the regional BDV cluster. At one location a high percentage of BDV-positive shrews was identified in four consecutive years, which points towards a self-sustaining infection cycle in bicolored white-toothed shrews. Analyses of behavioral and population features of this shrew species revealed that the bicolored white-toothed shrew may indeed play an important role as an indigenous host of BDV.	[Duerrwald, Ralf] IDT Biol GmbH IDT, Dessau Rosslau, Germany; [Kolodziejek, Jolanta; Nowotny, Norbert] Univ Vet Med Vienna, Inst Virol, Dept Pathobiol, Viral Zoonoses Emerging & Vector Borne Infect Grp, Vienna, Austria; [Weissenboeck, Herbert] Univ Vet Med Vienna, Inst Pathol & Forens Vet Med, Dept Pathobiol, Vienna, Austria; [Nowotny, Norbert] Sultan Qaboos Univ, Dept Microbiol & Immunol, Coll Med & Hlth Sci, Muscat, Oman	IDT Biologika; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; Sultan Qaboos University	Nowotny, N (corresponding author), Univ Vet Med Vienna, Inst Virol, Dept Pathobiol, Viral Zoonoses Emerging & Vector Borne Infect Grp, Vienna, Austria.	Norbert.Nowotny@vetmeduni.ac.at	Nowotny, Norbert/A-5474-2019	Nowotny, Norbert/0000-0002-3548-571X; Weissenbock, Herbert/0000-0001-8197-6379	Institute of Virology, University of Veterinary Medicine, Vienna	Institute of Virology, University of Veterinary Medicine, Vienna	This study was funded by own institutional funds of the Institute of Virology, University of Veterinary Medicine, Vienna, granted to NN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Authenrieth CF, 1823, UEBER HITZIGE K S19P; Balloux F, 1998, EVOLUTION, V52, P1230, DOI 10.1111/j.1558-5646.1998.tb01851.x; Belyi VA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001030; Berg M, 2001, EPIDEMIOL INFECT, V127, P173, DOI 10.1017/S0950268801005702; Billich C, 2002, BIOL PSYCHIAT, V51, P979, DOI 10.1016/S0006-3223(02)01387-2; BODE L, 1992, J MED VIROL, V36, P309, DOI 10.1002/jmv.1890360414; Bourg M, 2013, EMERG INFECT DIS, V19, P2064, DOI 10.3201/eid1912.131076; BRIESE T, 1994, P NATL ACAD SCI USA, V91, P4362, DOI 10.1073/pnas.91.10.4362; CANTONI D, 1989, ANIM BEHAV, V38, P205, DOI 10.1016/S0003-3472(89)80083-1; Caplazi P, 1999, SCHWEIZ ARCH TIERH, V141, P521; Chvala S, 2004, J COMP PATHOL, V131, P176, DOI 10.1016/j.jcpa.2004.03.004; CORBET G, 1980, MAMMALS BRITAIN EURO; CUBITT B, 1994, J VIROL, V68, P1382, DOI 10.1128/JVI.68.3.1382-1396.1994; D?rrwald R., 1993, THESIS FREIE U BERLI; Duarte LC, 2003, EVOLUTION, V57, P638; Durrwald R, 2007, REV MED VIROL, V17, P181, DOI 10.1002/rmv.530; Durrwald R, 2006, MICROBES INFECT, V8, P917, DOI 10.1016/j.micinf.2005.08.013; Durrwald R, 1997, J VET MED B, V44, P147, DOI 10.1111/j.1439-0450.1997.tb00962.x; Duwel D, 1957, THESIS TIERARZTLICHE; Encarnacao JA, 2013, J WILDLIFE DIS, V49, P860, DOI 10.7589/2012-10-262; Favre L, 1997, P ROY SOC B-BIOL SCI, V264, P127, DOI 10.1098/rspb.1997.0019; GOSZTONYI G, 1995, CURR TOP MICROBIOL, V190, P39; Gungor S, 2005, PEDIATR INFECT DIS J, V24, P833, DOI 10.1097/01.inf.0000178307.70429.75; Hausmann J, 1999, P NATL ACAD SCI USA, V96, P9769, DOI 10.1073/pnas.96.17.9769; Herter K, 1977, GRZIMEKS TIERLEBEN E, V1, P169; HERZOG S, 1984, MED MICROBIOL IMMUN, V173, P171, DOI 10.1007/BF02122108; HERZOG S, 1991, J GEN VIROL, V72, P535, DOI 10.1099/0022-1317-72-3-535; Hilbe M, 2006, EMERG INFECT DIS, V12, P675, DOI 10.3201/eid1204.051418; Holmes EC, 2002, VIROLOGY, V292, P247, DOI 10.1006/viro.2001.1271; Horie M, 2010, NATURE, V463, P84, DOI 10.1038/nature08695; Hornig M, 2012, MOL PSYCHIATR, V17, P486, DOI 10.1038/mp.2011.179; Ihlenburg H, 1957, ARCH EXP VETERINARME, V11, P635; Jacobsen B, 2010, J COMP PATHOL, V143, P203, DOI 10.1016/j.jcpa.2010.01.009; Joest E, 1911, Z INF KRKH HAUSTIERE, P198; Karasek E., 1963, Monatshefte fur Veterinarmedizin, V18, P868; Katz JB, 1998, J VET DIAGN INVEST, V10, P338, DOI 10.1177/104063879801000405; Katzourakis A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001191; Kinnunen PM, 2007, J CLIN VIROL, V38, P64, DOI 10.1016/j.jcv.2006.10.003; Kinnunen PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023622; Kistler AL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-88; Kobayashi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024403; Kolodziejek J, 2005, J GEN VIROL, V86, P385, DOI 10.1099/vir.0.80587-0; Kraft R, 2008, MAUSE SPITZMAUSE BAY; Kraft Richard, 1999, Bonner Zoologische Beitraege, V49, P115; Leistner E, 1948, THESIS LUDWIG MAXIMI; MACPHEE RDE, 1993, MAMMAL PHYLOGENY : PLACENTALS, P13; MARTENS JM, 1980, Z SAUGETIERKD, V45, P188; Metzler A, 1976, Schweiz Arch Tierheilkd, V118, P483; Netzer F, 1952, THESIS LUDWIG MAXIMI; Nowotny N, 2000, J VIROL, V74, P5655, DOI 10.1128/JVI.74.12.5655-5658.2000; Okamoto M, 2003, ARCH VIROL, V148, P1557, DOI 10.1007/s00705-003-0120-y; Pleschka S, 2001, J GEN VIROL, V82, P2681, DOI 10.1099/0022-1317-82-11-2681; Pletnikov Mikhail V., 2002, P125; Priestnall SL, 2011, VET REC, V168, P380, DOI 10.1136/vr.c6405; Puorger ME, 2010, VET PATHOL, V47, P236, DOI 10.1177/0300985809351849; Reichelt U, 2009, THESIS FREIE U BERLI; Richter H., 1963, Zoologische Abhandlungen, V26, P219; Sauder C, 2003, J VIROL, V77, P12886, DOI 10.1128/JVI.77.23.12886-12890.2003; SCHNEIDER PA, 1994, J VIROL, V68, P63, DOI 10.1128/JVI.68.1.63-68.1994; Schuppel K-F, 1994, 36 INT S ERKR ZOOT K, P11; Schwemmle M, 1999, LANCET, V354, P1973, DOI 10.1016/S0140-6736(99)04703-0; Schwemmle M, 2005, VIRUS TAXONOMY, P615; SORG I, 1995, J CLIN MICROBIOL, V33, P821, DOI 10.1128/JCM.33.4.821-823.1995; Staeheli P, 2000, J GEN VIROL, V81, P2123, DOI 10.1099/0022-1317-81-9-2123; Staeheli P, 2010, J VIROL, V84, P6269, DOI 10.1128/JVI.02567-09; Stitz L, 1998, J VIROL, V72, P8884, DOI 10.1128/JVI.72.11.8884-8892.1998; STITZ L, 1991, J IMMUNOL, V147, P3581; STITZ L, 1991, J VIROL, V65, P457, DOI 10.1128/JVI.65.1.457-460.1991; Suchy A, 2000, EQUINE PRACT, V22, P26; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vahlenkamp TW, 2002, J VIROL, V76, P9735, DOI 10.1128/JVI.76.19.9735-9743.2002; Weaver SC, 1999, J VIROL, V73, P4316, DOI 10.1128/JVI.73.5.4316-4326.1999; WEAVER SC, 1992, CURR TOP MICROBIOL, V176, P99; Weber B, 1983, SAUGETIERKD INF, V2, P69; Weissenbock H, 1998, VET REC, V143, P21, DOI 10.1136/vr.143.1.21; Weissenbock H, 1998, J CLIN MICROBIOL, V36, P2127; Weissenbock H, 2000, BRAIN PATHOL, V10, P260, DOI 10.1111/j.1750-3639.2000.tb00259.x; Weissenbock H, 2009, J VIROL, V83, P11367, DOI 10.1128/JVI.01343-09; Weissenbock H, 2009, EMERG INFECT DIS, V15, P1453, DOI 10.3201/eid1509.090353; Zimmermann G, 1953, THESIS LUDWIG MAXIMI; Zwick W., 1939, HDB VIRUSKRANKHEITEN, P254	81	35	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93659	10.1371/journal.pone.0093659	http://dx.doi.org/10.1371/journal.pone.0093659			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699636	Green Published, gold, Green Submitted			2022-12-25	WOS:000334105000088
J	Zhang, CL; Xu, YJ; Zhong, QN; Li, XP; Gao, P; Feng, CY; Chu, Q; Chen, Y; Liu, D				Zhang, Chengliang; Xu, Yanjiao; Zhong, Qiaoni; Li, Xiping; Gao, Ping; Feng, Chengyang; Chu, Qian; Chen, Yuan; Liu, Dong			In Vitro Evaluation of the Inhibitory Potential of Pharmaceutical Excipients on Human Carboxylesterase 1A and 2	PLOS ONE			English	Article							P-GLYCOPROTEIN FUNCTION; CREMOPHOR EL; TRANSCRIPTIONAL REGULATION; INTESTINAL TRANSPORT; SITU ABSORPTION; COA REDUCTASE; POLOXAMER 407; C57BL/6 MICE; RAT; METABOLISM	Two major forms of human carboxylesterase (CES), CES1A and CES2, dominate the pharmacokinetics of most prodrugs such as imidapril and irinotecan (CPT-11). Excipients, largely used as insert vehicles in formulation, have been recently reported to affect drug enzyme activity. The influence of excipients on the activity of CES remains undefined. In this study, the inhibitory effects of 25 excipients on the activities of CES1A1 and CES2 were evaluated. Imidapril and CPT-11 were used as substrates and cultured with liver microsomes in vitro. Imidapril hydrolase activities of recombinant CES1A1 and human liver microsomes (HLM) were strongly inhibited by sodium lauryl sulphate (SLS) and polyoxyl 40 hydrogenated castor oil (RH40) [Inhibition constant (K-i) = 0.04 +/- 0.01 mu g/ml and 0.20 +/- 0.09 mu g/ml for CES1A1, and 0.12 +/- 0.03 mu g/ml and 0.76 +/- 0.33 mu g/ml, respectively, for HLM]. The enzyme hydrolase activity of recombinant CES2 was substantially inhibited by Tween 20 and polyoxyl 35 castor oil (EL35) (K-i = 0.93 +/- 0.36 mu g/ml and 4.4 +/- 1.24 mu g/ml, respectively). Thus, these results demonstrate that surfactants such as SLS, RH40, Tween 20 and EL35 may attenuate the CES activity; such inhibition should be taken into consideration during drug administration.	[Zhang, Chengliang; Xu, Yanjiao; Li, Xiping; Feng, Chengyang; Liu, Dong] Huazhong Univ Sci & Technol, Tongji Med Sch, Tongji Hosp, Dept Pharm, Wuhan 430074, Hubei, Peoples R China; [Zhong, Qiaoni] Hubei Pharmaceut Ind Res Inst Co Ltd, Wuhan, Hubei, Peoples R China; [Gao, Ping] Wuhan Childrens Hosp, Dept Pharm, Wuhan, Hubei, Peoples R China; [Chu, Qian; Chen, Yuan] Huazhong Univ Sci & Technol, Tongji Med Sch, Tongji Hosp, Dept Oncol, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Liu, D (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Sch, Tongji Hosp, Dept Pharm, Wuhan 430074, Hubei, Peoples R China.	ld2069@outlook.com	Zhang, Cheng/GRS-8698-2022; Chu, Qian/K-2996-2017	Chu, Qian/0000-0001-8192-7630	National Natural Science Foundation of China [81301953]; Fundamental Research Funds for the Central Universities [HUST: 2013ZHYX013]; Hubei Pharmaceutical Industry Research Institute Co. Ltd.	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Hubei Pharmaceutical Industry Research Institute Co. Ltd.	This work is supported by the National Natural Science Foundation of China (No: 81301953) and the Fundamental Research Funds for the Central Universities (HUST: 2013ZHYX013). Hubei Pharmaceutical Industry Research Institute Co. Ltd. only provided support in the form of a salary for author QZ, and did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahuja N, 2007, EUR J PHARM BIOPHARM, V65, P26, DOI 10.1016/j.ejpb.2006.07.007; Blonder JM, 1999, LIFE SCI, V65, pPL261, DOI 10.1016/S0024-3205(99)00495-6; Buggins TR, 2007, ADV DRUG DELIVER REV, V59, P1482, DOI 10.1016/j.addr.2007.08.017; Cornaire G, 2004, INT J PHARMACEUT, V278, P119, DOI 10.1016/j.ijpharm.2004.03.001; EMA, 2005, EMACHMPPEG1948102005; Engel A, 2012, MOL PHARMACEUT, V9, P2577, DOI 10.1021/mp3001815; Fukami T, 2010, DRUG METAB DISPOS, V38, P2173, DOI 10.1124/dmd.110.034454; Godin SJ, 2007, DRUG METAB DISPOS, V35, P1664, DOI 10.1124/dmd.107.015388; GOLIGHTLY LK, 1988, MED TOXICOL ADV DRUG, V3, P128, DOI 10.1007/BF03259937; Gonzalez RCB, 2004, BIOPHARM DRUG DISPOS, V25, P37, DOI 10.1002/bdd.383; Hamid KA, 2009, INT J PHARMACEUT, V379, P100, DOI 10.1016/j.ijpharm.2009.06.018; Hatfield MJ, 2011, EXPERT OPIN THER PAT, V21, P1159, DOI 10.1517/13543776.2011.586339; Hirama S, 2004, TOXICOLOGY, V199, P137, DOI 10.1016/j.tox.2004.02.017; Hosokawa M, 2007, DRUG METAB REV, V39, P1, DOI 10.1080/03602530600952164; Humerickhouse R, 2000, CANCER RES, V60, P1189; Imai T, 2006, DRUG METAB PHARMACOK, V21, P173, DOI 10.2133/dmpk.21.173; Iwase K, 2004, TOXICOL LETT, V154, P143, DOI 10.1016/j.toxlet.2004.08.003; Johnston TP, 1999, J CARDIOVASC PHARM, V34, P831, DOI 10.1097/00005344-199912000-00010; JOHNSTON TP, 1993, BIOCHEM PHARMACOL, V46, P1037, DOI 10.1016/0006-2952(93)90668-M; Johnston TP, 1997, J CARDIOVASC PHARM, V29, P580, DOI 10.1097/00005344-199705000-00003; Johnston TP, 2000, ATHEROSCLEROSIS, V149, P303, DOI 10.1016/S0021-9150(99)00339-1; Lin YL, 2007, BIOL PHARM BULL, V30, P1301, DOI 10.1248/bpb.30.1301; Maruichi T, 2010, BIOCHEM PHARMACOL, V79, P288, DOI 10.1016/j.bcp.2009.08.019; Maxwell DM, 2001, J APPL TOXICOL, V21, pS103, DOI 10.1002/jat.833; Nahata MC, 2009, ARCH DIS CHILD-FETAL, V94, pF392, DOI 10.1136/adc.2009.160192; Rege BD, 2002, EUR J PHARM SCI, V16, P237, DOI 10.1016/S0928-0987(02)00055-6; Ren XH, 2009, EUR J PHARM SCI, V36, P401, DOI 10.1016/j.ejps.2008.11.002; Ross MK, 2007, J BIOCHEM MOL TOXIC, V21, P187, DOI 10.1002/jbt.20178; Sachs-Barrable K, 2007, J PHARM PHARM SCI, V10, P319; Satoh T, 2002, DRUG METAB DISPOS, V30, P488, DOI 10.1124/dmd.30.5.488; Schwer H, 1997, BIOCHEM BIOPH RES CO, V233, P117, DOI 10.1006/bbrc.1997.6413; Shen Q, 2006, INT J PHARMACEUT, V313, P49, DOI 10.1016/j.ijpharm.2006.01.020; Shen Q, 2008, J PHARM PHARMACOL, V60, P1633, DOI 10.1211/jpp/60.12.0009; Shono Y, 2004, J PHARM SCI-US, V93, P877, DOI 10.1002/jps.20017; Sintov AC, 2004, J CONTROL RELEASE, V95, P173, DOI 10.1016/j.jconrel.2003.11.004; Takahashi S, 2009, DRUG METAB DISPOS, V37, P956, DOI 10.1124/dmd.108.024331; Takahashi S, 2008, J PHARM SCI-US, V97, P5434, DOI 10.1002/jps.21376; Thackaberry EA, 2010, TOXICOL SCI, V117, P485, DOI 10.1093/toxsci/kfq207; Tompkins L, 2010, PHARM RES-DORDR, V27, P1703, DOI 10.1007/s11095-010-0170-2; Ursino MG, 2011, REGUL TOXICOL PHARM, V60, P93, DOI 10.1016/j.yrtph.2011.02.010; Vandecruys R, 2007, INT J PHARMACEUT, V342, P168, DOI 10.1016/j.ijpharm.2007.05.006; Wasan KM, 2003, J PHARM PHARM SCI, V6, P189; Watanabe A, 2009, DRUG METAB DISPOS, V37, P1513, DOI 10.1124/dmd.109.026567; Xu YJ, 2013, DRUG METAB PHARMACOK; Zhang CL, 2012, J HUAZHONG U SCI-MED, V32, P798, DOI 10.1007/s11596-012-1037-z; Zhu SJ, 2009, EUR J PHARM SCI, V37, P573, DOI 10.1016/j.ejps.2009.05.001	46	19	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93819	10.1371/journal.pone.0093819	http://dx.doi.org/10.1371/journal.pone.0093819			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699684	Green Submitted, gold, Green Published			2022-12-25	WOS:000334105000112
J	Fraisier, C; Papa, A; Granjeaud, S; Hintzen, R; Martina, B; Camoin, L; Almeras, L				Fraisier, Christophe; Papa, Anna; Granjeaud, Samuel; Hintzen, Rogier; Martina, Byron; Camoin, Luc; Almeras, Lionel			Cerebrospinal Fluid Biomarker Candidates Associated with Human WNV Neuroinvasive Disease	PLOS ONE			English	Article							WEST-NILE-VIRUS; CENTRAL-NERVOUS-SYSTEM; ENCEPHALITIS-VIRUS; PROTEIN BIOMARKERS; INNATE IMMUNITY; PEROXIREDOXIN 2; CHOROID-PLEXUS; INFECTION; DEFENSINS; BRAIN	During the last decade, the epidemiology of WNV in humans has changed in the southern regions of Europe, with high incidence of West Nile fever (WNF) cases, but also of West Nile neuroinvasive disease (WNND). The lack of human vaccine or specific treatment against WNV infection imparts a pressing need to characterize indicators associated with neurological involvement. By its intimacy with central nervous system (CNS) structures, modifications in the cerebrospinal fluid (CSF) composition could accurately reflect CNS pathological process. Until now, few studies investigated the association between imbalance of CSF elements and severity of WNV infection. The aim of the present study was to apply the iTRAQ technology in order to identify the CSF proteins whose abundances are modified in patients with WNND. Forty-seven proteins were found modified in the CSF of WNND patients as compared to control groups, and most of them are reported for the first time in the context of WNND. On the basis of their known biological functions, several of these proteins were associated with inflammatory response. Among them, Defensin-1 alpha (DEFA1), a protein reported with anti-viral effects, presented the highest increasing fold-change (FC>12). The augmentation of DEFA1 abundance in patients with WNND was confirmed at the CSF, but also in serum, compared to the control individual groups. Furthermore, the DEFA1 serum level was significantly elevated in WNND patients compared to subjects diagnosed for WNF. The present study provided the first insight into the potential CSF biomarkers associated with WNV neuroinvasion. Further investigation in larger cohorts with kinetic sampling could determine the usefulness of measuring DEFA1 as diagnostic or prognostic biomarker of detrimental WNND evolution.	[Fraisier, Christophe; Almeras, Lionel] Aix Marseille Univ, CNRS 7278, Inserm 1095,UM63, Unite Rech Malad Infect & Trop Emergentes,IRD 198, Marseille, France; [Fraisier, Christophe; Almeras, Lionel] IRBA, URBEP, Marseille, France; [Papa, Anna] Aristotle Univ Thessaloniki, Sch Med, Dept Microbiol, GR-54006 Thessaloniki, Greece; [Granjeaud, Samuel; Camoin, Luc] Inserm, CRCM, Marseille Prote, U1068, Marseille, France; [Granjeaud, Samuel] Aix Marseille Univ, UM 105, Marseille, France; [Hintzen, Rogier] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [Martina, Byron] Erasmus MC, Dept Virol, Rotterdam, Netherlands	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Aristotle University of Thessaloniki; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Almeras, L (corresponding author), Aix Marseille Univ, CNRS 7278, Inserm 1095,UM63, Unite Rech Malad Infect & Trop Emergentes,IRD 198, Marseille, France.	almeras.lionel@gmail.com	Camoin, Luc/AAB-3856-2019; Granjeaud, Samuel/AAE-6488-2022	Camoin, Luc/0000-0002-1230-4787; Granjeaud, Samuel/0000-0001-9245-1535; Martina, Byron/0000-0003-4980-4619; ALMERAS, Lionel/0000-0003-0490-5774	European Community [261466]; Delegation Generale pour l'Armement (DGA) [ArthroSer 10Ca 401]	European Community(European Commission); Delegation Generale pour l'Armement (DGA)	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007 - 2 013) under the project "VECTORIE", EC grant agreement number 261466. This study was also supported by Delegation Generale pour l'Armement (DGA, ArthroSer 10Ca 401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi F, 2006, J ALZHEIMERS DIS, V9, P293; Agerberth B, 2000, BLOOD, V96, P3086, DOI 10.1182/blood.V96.9.3086.h8003086_3086_3093; Anticona EMF, 2012, CASE REP INFECT DIS, V2012, DOI 10.1155/2012/839458; Bayer SB, 2013, FASEB J, V27, P3315, DOI 10.1096/fj.13-227298; Beasley DW, 2013, ANTIVIRAL RES; Berard JL, 2012, GLIA, V60, P1145, DOI 10.1002/glia.22342; Bi FF, 2013, P NATL ACAD SCI USA, V110, P4069, DOI 10.1073/pnas.1218497110; Botia B, 2008, J MOL NEUROSCI, V36, P61, DOI 10.1007/s12031-008-9075-5; Briolant S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-141; Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467; Carson PJ, 2003, CLIN INFECT DIS, V37, pE12, DOI 10.1086/375692; Chakraborty S, 2012, BBA-REV CANCER, V1826, P129, DOI 10.1016/j.bbcan.2012.03.008; Colpitts TM, 2012, CLIN MICROBIOL REV, V25, P635, DOI 10.1128/CMR.00045-12; Crichlow R, 2004, J AM BOARD FAM PRACT, V17, P470, DOI 10.3122/jabfm.17.6.470; DAHER KA, 1986, J VIROL, V60, P1068, DOI 10.1128/JVI.60.3.1068-1074.1986; Danis K, 2011, EMERG INFECT DIS, V17, P1868, DOI 10.3201/eid1710.110525; Dauphin G, 2007, VACCINE, V25, P5563, DOI 10.1016/j.vaccine.2006.12.005; De Filette M, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-16; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; Fraisier C, 2013, VIRUS RES IN PRESS; Fraisier C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068318; GANZ T, 1994, CURR OPIN IMMUNOL, V6, P584, DOI 10.1016/0952-7915(94)90145-7; Gasche Y, 2006, FRONT BIOSCI-LANDMRK, V11, P1289, DOI 10.2741/1883; Gonzalez H, 2009, J PROTEOMICS, V71, P670, DOI 10.1016/j.jprot.2008.11.014; Hamdan A, 2002, Transpl Infect Dis, V4, P160, DOI 10.1034/j.1399-3062.2002.01014.x; Jarczak J, 2013, HUM IMMUNOL, V74, P1069, DOI 10.1016/j.humimm.2013.05.008; Jordan I, 2000, J INFECT DIS, V182, P1214, DOI 10.1086/315847; Jordan M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/697418; Kalil AC, 2005, CLIN INFECT DIS, V40, P764, DOI 10.1086/427945; Kapoor H, 2004, J CLIN VIROL, V31, P289, DOI 10.1016/j.jcv.2004.05.017; Laspiur JP, 2007, J NEUROIMMUNOL, V192, P157, DOI 10.1016/j.jneuroim.2007.08.004; Lee S, 2011, J BIOL CHEM, V286, P43855, DOI 10.1074/jbc.M111.299248; Leis AA, 2012, MUSCLE NERVE, V45, P826, DOI 10.1002/mus.23241; Lim SM, 2011, VIRUSES-BASEL, V3, P811, DOI 10.3390/v3060811; Loginova S. Ya., 2009, Antibiotiki i Khimioterapiya, V54, P17; Markowitz J, 2013, BBA-REV CANCER, V1835, P100, DOI 10.1016/j.bbcan.2012.10.003; Marques F, 2008, J CEREBR BLOOD F MET, V28, P450, DOI 10.1038/sj.jcbfm.9600557; Marques F, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00033; Miller F, 2012, VIRULENCE, V3, P222, DOI 10.4161/viru.19697; Nacken W, 2003, MICROSC RES TECHNIQ, V60, P569, DOI 10.1002/jemt.10299; Neghina AM, 2011, VECTOR-BORNE ZOONOT, V11, P1289, DOI 10.1089/vbz.2010.0206; Nixon ML, 2006, J CLIN VIROL, V37, P174, DOI 10.1016/j.jcv.2006.07.005; Niyonsaba F, 2006, CRIT REV IMMUNOL, V26, P545, DOI 10.1615/CritRevImmunol.v26.i6.60; Omalu BI, 2003, BRAIN PATHOL, V13, P465, DOI 10.1111/j.1750-3639.2003.tb00477.x; Papa A., 2010, EUROSURVEILLANCE, V2010, P15; Papa A, 2012, EXPERT REV ANTI-INFE, V10, P743, DOI [10.1586/ERI.12.59, 10.1586/eri.12.59]; Paz S, 2013, INT J ENV RES PUB HE, V10, P3543, DOI 10.3390/ijerph10083543; Petzold A, 2010, MUSCLE NERVE, V41, P42, DOI 10.1002/mus.21448; Poynton RA, 2013, BIOCH BIOPHYS ACTA; Prince HE, 2005, CLIN DIAGN LAB IMMUN, V12, P231, DOI 10.1128/CDLI.12.1.231-233.2005; Rizzo C., 2012, EURO SURVEILL, V17; Root JJ, 2013, ARCH VIROL, V158, P735, DOI 10.1007/s00705-012-1516-3; Rossi SL, 2010, CLIN LAB MED, V30, P47, DOI 10.1016/j.cll.2009.10.006; Salvatore M, 2007, J INFECT DIS, V196, P835, DOI 10.1086/521027; Sambri V, 2013, CLIN MICROBIOL INFEC; Sathyanesan M, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.64; Sayao AL, 2004, CAN J NEUROL SCI, V31, P194, DOI 10.1017/S031716710005383X; Schutzer SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017287; Shahim P, 2013, EUR J PAEDIATR NEURO, V17, P7, DOI 10.1016/j.ejpn.2012.09.005; Sharma A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-197; Shimoni Z, 2001, EMERG INFECT DIS, V7, P759; Shores KS, 2007, J PROTEOME RES, V6, P3739, DOI 10.1021/pr070293w; Srikrishna G, 2012, J INNATE IMMUN, V4, P31, DOI 10.1159/000330095; Thibert KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050430; Tyler KL, 2006, NEUROLOGY, V66, P361, DOI 10.1212/01.wnl.0000195890.70898.1f; Unwin RD, 2010, NAT PROTOC, V5, P1574, DOI 10.1038/nprot.2010.123; Weissenbock H, 2010, VET MICROBIOL, V140, P271, DOI 10.1016/j.vetmic.2009.08.025	67	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93637	10.1371/journal.pone.0093637	http://dx.doi.org/10.1371/journal.pone.0093637			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695528	Green Published, gold, Green Submitted			2022-12-25	WOS:000334103000095
J	Sepuru, KM; Poluri, KM; Rajarathnam, K				Sepuru, Krishna Mohan; Poluri, Krishna Mohan; Rajarathnam, Krishna			Solution Structure of CXCL5-A Novel Chemokine and Adipokine Implicated in Inflammation and Obesity	PLOS ONE			English	Article							GROWTH-STIMULATING ACTIVITY; MONOMER-DIMER EQUILIBRIUM; GLYCOSAMINOGLYCAN INTERACTIONS; SIGNAL-TRANSDUCTION; BIOLOGICAL-ACTIVITY; INTERLEUKIN-8 IL-8; HYDROGEN-EXCHANGE; CXC CHEMOKINES; NMR STRUCTURE; WEB SERVER	The chemokine CXCL5 is selectively expressed in highly specialized cells such as epithelial type II cells in the lung and white adipose tissue macrophages in muscle, where it mediates diverse functions from combating microbial infections by regulating neutrophil trafficking to promoting obesity by inhibiting insulin signaling. Currently very little is known regarding the structural basis of how CXCL5 mediates its novel functions. Towards this missing knowledge, we have solved the solution structure of the CXCL5 dimer by NMR spectroscopy. CXCL5 is a member of a subset of seven CXCR2-activating chemokines (CAC) that are characterized by the highly conserved ELR motif in the N-terminal tail. The structure shows that CXCL5 adopts the typical chemokine fold, but also reveals several distinct differences in the 30 s loop and N-terminal residues; not surprisingly, crosstalk between N-terminal and 30 s loop residues have been implicated as a major determinant of receptor activity. CAC function also involves binding to highly sulfated glycosaminoglycans ( GAG), and the CXCL5 structure reveals a distinct distribution of positively charged residues, suggesting that differences in GAG interactions also influence function. The availability of the structure should now facilitate the design of experiments to better understand the molecular basis of various CXCL5 functions, and also serve as a template for the design of inhibitors for use in a clinical setting.	[Sepuru, Krishna Mohan; Poluri, Krishna Mohan; Rajarathnam, Krishna] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Rajarathnam, Krishna] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Rajarathnam, K (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	krrajara@utmb.edu	Poluri, Krishna Mohan/H-6083-2013; Sepuru, Krishna Mohan/K-5321-2014	Poluri, Krishna Mohan/0000-0003-3801-7134; Sepuru, Krishna Mohan/0000-0002-3675-6294	NIH [HL-107152]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107152] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the NIH HL-107152 grant to K. R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDWIN ET, 1991, P NATL ACAD SCI USA, V88, P502, DOI 10.1073/pnas.88.2.502; Berjanskii MV, 2006, NUCLEIC ACIDS RES, V34, pW63, DOI 10.1093/nar/gkl341; Bonecchi R, 2009, FRONT BIOSCI-LANDMRK, V14, P540, DOI 10.2741/3261; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURROWS SD, 1994, BIOCHEMISTRY-US, V33, P12741, DOI 10.1021/bi00209a002; Byeon IJL, 2003, J MOL BIOL, V333, P141, DOI 10.1016/S0022-2836(03)00928-8; Chavey C, 2009, AGING-US, V1, P674, DOI 10.18632/aging.100064; Chavey C, 2009, CELL METAB, V9, P339, DOI 10.1016/j.cmet.2009.03.002; CLARKLEWIS I, 1994, J BIOL CHEM, V269, P16075; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P1689, DOI 10.1021/bi00459a004; Colditz IG, 2007, THROMB HAEMOSTASIS, V97, P688, DOI 10.1160/TH07-02-0105; Damaj BB, 1996, J BIOL CHEM, V271, P20540, DOI 10.1074/jbc.271.34.20540; Das ST, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011754; Dawes JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002193; FAIRBROTHER WJ, 1994, J MOL BIOL, V242, P252, DOI 10.1006/jmbi.1994.1577; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Gangavarapu P, 2012, J LEUKOCYTE BIOL, V91, P259, DOI 10.1189/jlb.0511239; Goddard T. D., 2008, SPARKY 3; HESSELGESSER J, 1995, J BIOL CHEM, V270, P11472, DOI 10.1074/jbc.270.19.11472; Jeyaseelan S, 2005, AM J RESP CELL MOL, V32, P531, DOI 10.1165/rcmb.2005-0063OC; Joseph PRB, 2013, BIOCHEM J, V456, P241, DOI 10.1042/BJ20130148; Joseph PRB, 2013, BIOPHYS J, V105, P1491, DOI 10.1016/j.bpj.2013.08.008; Joseph PRB, 2010, J BIOL CHEM, V285, P29262, DOI 10.1074/jbc.M110.146555; KIM KS, 1994, J BIOL CHEM, V269, P32909; KOCH AE, 1994, J CLIN INVEST, V94, P1012, DOI 10.1172/JCI117414; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kuo PL, 2011, J CELL PHYSIOL, V226, P1224, DOI 10.1002/jcp.22445; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LEONG SR, 1994, J BIOL CHEM, V269, P19343; Levashova ZB, 2007, J AM SOC NEPHROL, V18, P2359, DOI 10.1681/ASN.2006040380; Li AH, 2011, AM J PATHOL, V178, P1340, DOI 10.1016/j.ajpath.2010.11.058; Li RH, 1999, PROTEIN SCI, V8, P1571, DOI 10.1110/ps.8.8.1571; Lowman HB, 1997, PROTEIN SCI, V6, P598; Lowman HB, 1996, J BIOL CHEM, V271, P14344, DOI 10.1074/jbc.271.24.14344; Maity H, 2005, P NATL ACAD SCI USA, V102, P4741, DOI 10.1073/pnas.0501043102; Mei JJ, 2010, IMMUNITY, V33, P106, DOI 10.1016/j.immuni.2010.07.009; Mohan PMK, 2009, PROTEINS, V75, P40, DOI 10.1002/prot.22219; Mortier A, 2010, J BIOL CHEM, V285, P29750, DOI 10.1074/jbc.M110.119388; Murphy PM, 1997, SEMIN HEMATOL, V34, P311; Nufer O, 1999, BIOCHEMISTRY-US, V38, P636, DOI 10.1021/bi981294s; O'Hayre M, 2008, BIOCHEM J, V409, P635, DOI 10.1042/BJ20071493; Park SH, 2012, NATURE, V491, P779, DOI 10.1038/nature11580; Pickens SR, 2011, ANGIOGENESIS, V14, P443, DOI 10.1007/s10456-011-9227-z; Poluri KM, 2013, J BIOL CHEM, V288, P25143, DOI 10.1074/jbc.M113.492579; Qian YQ, 1999, J MOL BIOL, V294, P1065, DOI 10.1006/jmbi.1999.3333; Rajagopalan L, 2007, BIOPHYS J, V93, P2129, DOI 10.1529/biophysj.107.108761; Rajagopalan L, 2006, BIOSCIENCE REP, V26, P325, DOI 10.1007/s10540-006-9025-9; Rajarathnam K, 1997, J BIOL CHEM, V272, P1725, DOI 10.1074/jbc.272.3.1725; Rajarathnam K, 1997, METHOD ENZYMOL, V287, P89; RAJARATHNAM K, 1995, BIOCHEMISTRY-US, V34, P12983, DOI 10.1021/bi00040a008; Rajarathnam K, 1999, BIOCHEMISTRY-US, V38, P7653, DOI 10.1021/bi990033v; Rajarathnam K, 1996, FEBS LETT, V399, P43, DOI 10.1016/S0014-5793(96)01277-X; Ravindran A, 2013, J BIOL CHEM, V288, P12244, DOI 10.1074/jbc.M112.443762; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Rot A, 2010, FRONT BIOSCI-LANDMRK, V15, P645, DOI 10.2741/3638; Salanga CL, 2011, EXP CELL RES, V317, P590, DOI 10.1016/j.yexcr.2011.01.004; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Stillie R, 2009, J LEUKOCYTE BIOL, V86, P529, DOI 10.1189/jlb.0208125; Tanino Y, 2010, J IMMUNOL, V184, P2677, DOI 10.4049/jimmunol.0903274; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Young H, 1999, BIOCHEM J, V338, P591, DOI 10.1042/0264-6021:3380591; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	64	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93228	10.1371/journal.pone.0093228	http://dx.doi.org/10.1371/journal.pone.0093228			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695525	Green Submitted, Green Published, gold			2022-12-25	WOS:000334103000050
J	Barnes, C; Speroni, L; Quinn, KP; Montevil, M; Saetzler, K; Bode-Animashaun, G; McKerr, G; Georgakoudi, I; Downes, CS; Sonnenschein, C; Howard, CV; Soto, AM				Barnes, Clifford; Speroni, Lucia; Quinn, Kyle P.; Montevil, Mael; Saetzler, Kurt; Bode-Animashaun, Gbemisola; McKerr, George; Georgakoudi, Irene; Downes, C. Stephen; Sonnenschein, Carlos; Howard, C. Vyvyan; Soto, Ana M.			From Single Cells to Tissues: Interactions between the Matrix and Human Breast Cells in Real Time	PLOS ONE			English	Article							MAMMARY-GLAND DEVELOPMENT; CANCER; MORPHOGENESIS; ARCHITECTURE; MICROSCOPY; SURVIVAL; SCAFFOLD; MOTION; MODEL	Background: Mammary gland morphogenesis involves ductal elongation, branching, and budding. All of these processes are mediated by stroma - epithelium interactions. Biomechanical factors, such as matrix stiffness, have been established as important factors in these interactions. For example, epithelial cells fail to form normal acinar structures in vitro in 3D gels that exceed the stiffness of a normal mammary gland. Additionally, heterogeneity in the spatial distribution of acini and ducts within individual collagen gels suggests that local organization of the matrix may guide morphogenesis. Here, we quantified the effects of both bulk material stiffness and local collagen fiber arrangement on epithelial morphogenesis. Results: The formation of ducts and acini from single cells and the reorganization of the collagen fiber network were quantified using time-lapse confocal microscopy. MCF10A cells organized the surrounding collagen fibers during the first twelve hours after seeding. Collagen fiber density and alignment relative to the epithelial surface significantly increased within the first twelve hours and were a major influence in the shaping of the mammary epithelium. The addition of Matrigel to the collagen fiber network impaired cell-mediated reorganization of the matrix and increased the probability of spheroidal acini rather than branching ducts. The mechanical anisotropy created by regions of highly aligned collagen fibers facilitated elongation and branching, which was significantly correlated with fiber organization. In contrast, changes in bulk stiffness were not a strong predictor of this epithelial morphology. Conclusions: Localized regions of collagen fiber alignment are required for ductal elongation and branching suggesting the importance of local mechanical anisotropy in mammary epithelial morphogenesis. Similar principles may govern the morphology of branching and budding in other tissues and organs.	[Barnes, Clifford; Saetzler, Kurt; Bode-Animashaun, Gbemisola; McKerr, George; Downes, C. Stephen; Sonnenschein, Carlos; Howard, C. Vyvyan; Soto, Ana M.] Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland; [Speroni, Lucia; Montevil, Mael; Sonnenschein, Carlos; Soto, Ana M.] Tufts Univ, Sch Med, Dept Integrat Physiol & Pathobiol, Boston, MA 02111 USA; [Quinn, Kyle P.; Georgakoudi, Irene] Tufts Univ, Dept Biomed Engn, Boston, MA 02111 USA	Ulster University; Tufts University; Tufts University	Soto, AM (corresponding author), Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland.	ana.soto@tufts.edu	Montévil, Maël/S-2378-2017	Montévil, Maël/0000-0001-7177-5995; Speroni, Lucia/0000-0003-1567-8925; Howard, Charles Vyvyan/0000-0002-6151-3446	NC3R [94744]; Avon Foundation [02-2009-093, 02-2011-095]; Breast Cancer UK [13495]; NIAMS/NIH [F32AR061933]; American Cancer Society Research Scholar Grant [RSG-09-174-01-CCE]; NIH/NIBIB [R01EB007542]; Organix grant [1-202R-0463]; NIEHS/NIH [ES 08314]; Italian Space Agency; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR061933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008314] Funding Source: NIH RePORTER	NC3R; Avon Foundation; Breast Cancer UK; NIAMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); American Cancer Society Research Scholar Grant(American Cancer Society); NIH/NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Organix grant; NIEHS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Italian Space Agency(Agenzia Spaziale Italiana (ASI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the NC3R Grant 94744 to CVH, and Avon Foundation Grants #02-2009-093 and 02-2011-095 to AMS. Additional support was provided by Breast Cancer UK 13495 to CB, NIAMS/NIH Grant F32AR061933 to KPQ, American Cancer Society Research Scholar Grant RSG-09-174-01-CCE and NIH/NIBIB grant R01EB007542 to IG, Organix grant 1-202R-0463 to CVH, NIEHS/NIH ES 08314 to AMS and the Italian Space Agency to CS. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Environmental Health Sciences or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Dewitt DD, 2009, TISSUE ENG PT A, V15, P2785, DOI [10.1089/ten.tea.2008.0406, 10.1089/ten.TEA.2008.0406]; Dhimolea E, 2010, BIOMATERIALS, V31, P3622, DOI 10.1016/j.biomaterials.2010.01.077; Guo CL, 2012, P NATL ACAD SCI USA, V109, P5576, DOI 10.1073/pnas.1114781109; Howard BA, 2013, J MAMMARY GLAND BIOL, V18, P89, DOI 10.1007/s10911-013-9296-2; Ingber DE, 2006, INT J DEV BIOL, V50, P255, DOI 10.1387/ijdb.052044di; Keyes JT, 2011, MICROSC MICROANAL, V17, P167, DOI 10.1017/S1431927610094341; Kirkpatrick ND, 2007, AM J PHYSIOL-HEART C, V292, pH3198, DOI 10.1152/ajpheart.01234.2006; Krause S, 2008, TISSUE ENG PT C-METH, V14, P261, DOI 10.1089/ten.tec.2008.0030; Krause S, 2012, TISSUE ENG PT A, V18, P520, DOI [10.1089/ten.tea.2011.0317, 10.1089/ten.TEA.2011.0317]; Lee PF, 2009, EXP CELL RES, V315, P396, DOI 10.1016/j.yexcr.2008.10.040; Lenoir T., 1982, STRATEGY LIFE TELEOL; Longo G, 2012, PROG BIOPHYS MOL BIO, V109, P108, DOI 10.1016/j.pbiomolbio.2012.06.004; Maller O, 2013, J CELL SCI, V126, P4108, DOI 10.1242/jcs.121590; Manivannan S, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt133; McLeod C, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023984; National Cancer Institute, CELL CLASS BREAST CA; Niklason LE, 2010, P NATL ACAD SCI USA, V107, P3335, DOI 10.1073/pnas.0907813106; O'Loughlin A, 2013, DIABETES, V62, P2588, DOI 10.2337/db12-1822; Ollion J, 2013, BIOINFORMATICS, V29, P1840, DOI 10.1093/bioinformatics/btt276; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Perry SW, 2012, ANN BIOMED ENG, V40, P277, DOI 10.1007/s10439-012-0512-9; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Quinn KP, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.4.046003; Quinn KP, 2008, J APPL PHYSIOL, V105, P1881, DOI 10.1152/japplphysiol.90792.2008; Sacks MS, 2003, J BIOMECH ENG-T ASME, V125, P280, DOI 10.1115/1.1544508; Sander EA, 2009, P NATL ACAD SCI USA, V106, P17675, DOI 10.1073/pnas.0903716106; Sieminski AL, 2002, TISSUE ENG, V8, P1057, DOI 10.1089/107632702320934155; Soto AM, 2013, J MAMMARY GLAND BIOL, V18, P199, DOI 10.1007/s10911-013-9293-5; Speroni L, 2014, TISSUE ENG PART C-ME, V20, P42, DOI [10.1089/ten.tec.2013.0054, 10.1089/ten.TEC.2013.0054]; Tanner K, 2012, P NATL ACAD SCI USA, V109, P1973, DOI 10.1073/pnas.1119578109; Thompson D.W, 1917, GROWTH FORM; Totonelli G, 2012, BIOMATERIALS, V33, P3401, DOI 10.1016/j.biomaterials.2012.01.012; Varner VD, 2013, INTEGR BIOL-UK, V5, P1162, DOI 10.1039/c3ib40080h; Wang H, 2013, P NATL ACAD SCI USA, V110, P163, DOI 10.1073/pnas.1201141110; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005; Xiang B, 2008, P NATL ACAD SCI USA, V105, P12463, DOI 10.1073/pnas.0805009105; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	40	34	36	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93325	10.1371/journal.pone.0093325	http://dx.doi.org/10.1371/journal.pone.0093325			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691468	Green Published, gold			2022-12-25	WOS:000334101100066
J	Fagyas, M; Uri, K; Siket, IM; Darago, A; Boczan, J; Banyai, E; Edes, I; Papp, Z; Toth, A				Fagyas, Miklos; Uri, Katalin; Siket, Ivetta M.; Darago, Andrea; Boczan, Judit; Banyai, Emese; Edes, Istvan; Papp, Zoltan; Toth, Attila			New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) III: Endogenous Inhibition of Angiotensin Converting Enzyme (ACE) Provides Protection against Cardiovascular Diseases	PLOS ONE			English	Article							INSERTION DELETION POLYMORPHISM; LEFT-VENTRICULAR DYSFUNCTION; HUMAN-SERUM-ALBUMIN; TRYPTIC HYDROLYSATE; EUROPEAN-SOCIETY; TASK-FORCE; GENE POLYMORPHISM; DRAMATIC INCREASE; CARDIOLOGY ESC; GUIDELINES	ACE inhibitor drugs decrease mortality by up to one-fifth in cardiovascular patients. Surprisingly, there are reports dating back to 1979 suggesting the existence of endogenous ACE inhibitors. Here we investigated the clinical significance of this potential endogenous ACE inhibition. ACE concentration and activity was measured in patient's serum samples (n = 151). ACE concentration was found to be in a wide range ( 47-288 ng/ mL). ACE activity decreased with the increasing concentration of the serum albumin (HSA): ACE activity was 5661 U/L in the presence of 2.4 +/- 60.3 mg/mL HSA, compared to 3961 U/L in the presence of 1261 mg/mL HSA ( values are mean-SEM). Effects of the differences in ACE concentration were suppressed in human sera: patients with ACE DD genotype exhibited a 64% higher serum ACE concentration ( range, 74-288 ng/ mL, median, 155.2 ng/ mL, n = 52) compared to patients with II genotype ( range, 47-194 ng/ mL, median, 94.5 ng/ mL, n = 28) while the difference in ACE activities was only 32% ( range, 27.3-59.8 U/L, median, 43.11 U/L, and range 15.6-55.4 U/L, median, 32.74 U/L, respectively) in the presence of 1261 mg/mL HSA. No correlations were found between serum ACE concentration ( or genotype) and cardiovascular diseases, in accordance with the proposed suppressed physiological ACE activities by HSA ( concentration in the sera of these patients: 48 +/- 560.5 mg/mL) or other endogenous inhibitors. Main implications are that ( 1) physiological ACE activity can be stabilized at a low level by endogenous ACE inhibitors, such as HSA; ( 2) angiotensin II elimination may have a significant role in angiotensin II related pathologies.	[Fagyas, Miklos; Uri, Katalin; Siket, Ivetta M.; Darago, Andrea; Edes, Istvan; Papp, Zoltan; Toth, Attila] Univ Debrecen, Inst Cardiol, Div Clin Physiol, Debrecen, Hungary; [Boczan, Judit] Univ Debrecen, Dept Neurol, Debrecen, Hungary; [Banyai, Emese] Univ Debrecen, Inst Internal Med, Div Nephrol, Debrecen, Hungary	University of Debrecen; University of Debrecen; University of Debrecen	Toth, A (corresponding author), Univ Debrecen, Inst Cardiol, Div Clin Physiol, Debrecen, Hungary.	atitoth@med.unideb.hu	Tóth, Attila/F-4859-2010; Fagyas, Miklós/AAQ-1013-2020	Tóth, Attila/0000-0001-6503-3653; Fagyas, Miklós/0000-0003-3262-884X	Hungarian Academy of Sciences OTKA [K84300]; Hungarian Ministry of Health [ETT 377/2009]; TAMOP [4.2.1./B-09/1/KONV-2010-0007, TAMOP-4.2.2, A-11/1/KONV 2012-0045, REG-EA-09-1-2009-0013]; European Social Fund; National Innovation Office of Hungary (Baross Gabor Project, EletMent); Bolyai Janos Research Scholarship of the Hungarian Academy of Sciences	Hungarian Academy of Sciences OTKA(Hungarian Academy of SciencesOrszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Ministry of Health; TAMOP; European Social Fund(European Social Fund (ESF)); National Innovation Office of Hungary (Baross Gabor Project, EletMent); Bolyai Janos Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences)	The study was supported by the Hungarian Academy of Sciences OTKA (K84300 to AT) and by the Hungarian Ministry of Health (ETT 377/2009 to AT); the work is supported by the TAMOP 4.2.1./B-09/1/KONV-2010-0007 TAMOP-4.2.2. A-11/1/KONV 2012-0045, REG-EA-09-1-2009-0013 projects (to AT, IE and ZP); MSD Magyarorsag Kft, Pfier Magyararsag Kft also supported some of the research. The project is implemented through the New Hungary Development Plan, co-financed by the European Social Fund; and by the National Innovation Office of Hungary (Baross Gabor Project, EletMent). Finally, AT was supported by the Bolyai Janos Research Scholarship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerholm-Larsen B, 2000, ARTERIOSCL THROM VAS, V20, P484, DOI 10.1161/01.ATV.20.2.484; ALHENCGELAS F, 1983, J LAB CLIN MED, V101, P83; BENETEAU B, 1986, CLIN CHEM, V32, P884; Bien BY, 2010, J MANAGE CARE PHARM, V16, P671, DOI 10.18553/jmcp.2010.16.9.671; Brecher AS, 1996, ARCH INT PHARMACOD T, V331, P301; COHN JN, 1991, NEW ENGL J MED, V325, P303, DOI 10.1056/NEJM199108013250502; COLLINS R, 1995, LANCET, V345, P669; CORVOL P, 1995, J HYPERTENS, V13, pS3, DOI 10.1097/00004872-199509003-00002; Cuspidi C, 2002, J HYPERTENS, V20, P2293, DOI 10.1097/00004872-200211000-00030; Danilov S, 1996, J HYPERTENS, V14, P719, DOI 10.1097/00004872-199606000-00007; Danser AHJ, 2007, PHARMACOL THERAPEUT, V113, P607, DOI 10.1016/j.pharmthera.2006.12.001; Davidson NC, 1996, CIRCULATION, V93, P1155, DOI 10.1161/01.CIR.93.6.1155; DeVita C, 1996, J AM COLL CARDIOL, V27, P337; Eyries M, 2001, J BIOL CHEM, V276, P5525, DOI 10.1074/jbc.M007706200; Fagyas M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087844; Fagyas M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087843; Ferdinand KC, 2003, AM J HYPERTENS, V16, p50S, DOI 10.1016/S0895-7061(03)01069-0; Ferreira AJ, 2011, EXP PHYSIOL, V96, P287, DOI 10.1113/expphysiol.2010.055277; Fox KM, 2003, LANCET, V362, P782; GREENBERG B, 1995, CIRCULATION, V91, P2573, DOI 10.1161/01.CIR.91.10.2573; Guang C, 2009, J AGR FOOD CHEM, V57, P5113, DOI 10.1021/jf900494d; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Hoogwerf BJ, 2000, CLEV CLIN J MED, V67, P287, DOI 10.3949/ccjm.67.4.287; Howard G, 2001, ANAESTH INTENS CARE, V29, P591, DOI 10.1177/0310057X0102900604; IKEMOTO F, 1989, BIOCHEM BIOPH RES CO, V159, P1093, DOI 10.1016/0006-291X(89)92221-3; Janitha PK, 2002, J AGR FOOD CHEM, V50, P6981, DOI 10.1021/jf025592e; KLAUSER RJ, 1979, HYPERTENSION, V1, P281, DOI 10.1161/01.HYP.1.3.281; Kramers C, 2001, CIRCULATION, V104, P1236, DOI 10.1161/hc3601.095932; Leon-Ruiz V, 2013, FOOD FUNCT, V4, P1617, DOI 10.1039/c3fo60221d; LIEBERMAN J, 1986, CHEST, V90, P869, DOI 10.1378/chest.90.6.869; LINDPAINTNER K, 1995, NEW ENGL J MED, V332, P706, DOI 10.1056/NEJM199503163321103; Linnebank M, 2003, NEUROLOGY, V61, P1819, DOI 10.1212/01.WNL.0000098990.12845.DA; Luders S, 2008, J HYPERTENS, V26, P1487, DOI 10.1097/HJH.0b013e3282ff8864; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Muller BR, 2002, ANN CLIN BIOCHEM, V39, P436, DOI 10.1258/000456302320314449; Nakagomi K, 2000, FEBS LETT, V467, P235, DOI 10.1016/S0014-5793(00)01163-7; Nakagomi K, 1998, FEBS LETT, V438, P255, DOI 10.1016/S0014-5793(98)01311-8; Nakagomi K, 2000, BIOL PHARM BULL, V23, P879; Nesterovitch AB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008282; Oudit GY, 2010, DIABETES, V59, P529, DOI 10.2337/db09-1218; Persu A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059537; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Rao SQ, 2012, FOOD CHEM, V135, P1245, DOI 10.1016/j.foodchem.2012.05.059; Rice GI, 2006, HYPERTENSION, V48, P914, DOI 10.1161/01.HYP.0000244543.91937.79; RIGAT B, 1992, NUCLEIC ACIDS RES, V20, P1433, DOI 10.1093/nar/20.6.1433-a; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; ROGERSON FM, 1989, NEUROPEPTIDES, V14, P213, DOI 10.1016/0143-4179(89)90048-6; Ruggenenti P, 2004, NEW ENGL J MED, V351, P1941, DOI 10.1056/NEJMoa042167; Ryan J W, 1979, Adv Exp Med Biol, V120B, P599; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; Semmler A, 2006, CLIN CHEM LAB MED, V44, P1088, DOI 10.1515/CCLM.2006.200; SNYDER RA, 1986, BIOCHIM BIOPHYS ACTA, V871, P1, DOI 10.1016/0167-4838(86)90125-1; STEVENS J, 1990, J IMMUNOL METHODS, V132, P263, DOI 10.1016/0022-1759(90)90038-W; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Tauzin J, 2002, FEBS LETT, V531, P369, DOI 10.1016/S0014-5793(02)03576-7; Taylor J, 2012, EUR HEART J, V33, P1539, DOI 10.1093/eurheartj/ehs137; Tendera M, 2012, TURK KARDIYOL DERN A, V40, P5, DOI 10.1093/eurheartj/ehr211; Thevananther S, 1999, CAN J PHYSIOL PHARM, V77, P216, DOI 10.1139/cjpp-77-3-216; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; TIRET L, 1992, AM J HUM GENET, V51, P197; Uri K, 2014, PLOS ONE; van Dijk MA, 2000, J CARDIOVASC PHARM, V35, P484, DOI 10.1097/00005344-200003000-00020; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419	63	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93719	10.1371/journal.pone.0093719	http://dx.doi.org/10.1371/journal.pone.0093719			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690767	Green Published, gold, Green Submitted			2022-12-25	WOS:000334101100130
J	Fullar, A; Baghy, K; Deak, F; Peterfia, B; Zsak, Y; Tatrai, P; Schaff, Z; Dudas, J; Kiss, I; Kovalszky, I				Fullar, Alexandra; Baghy, Kornelia; Deak, Ferenc; Peterfia, Balint; Zsak, Yvonne; Tatrai, Peter; Schaff, Zsuzsa; Dudas, Jozsef; Kiss, Ibolya; Kovalszky, Ilona			Lack of Matrilin-2 Favors Liver Tumor Development via Erk1/2 and GSK-3 beta Pathways In Vivo	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; EXTRACELLULAR-MATRIX; BETA-CATENIN; PROTEIN; EXPRESSION; INHIBITION; CELLS; P21(WAF1/CIP1); REGENERATION; ADHESION	Matrilin-2 (Matn2) is a multidomain adaptor protein which plays a role in the assembly of extracellular matrix (ECM). It is produced by oval cells during stem cell-driven liver regeneration. In our study, the impact of Matn2 on hepatocarcinogenesis was investigated in Matn2(-/-) mice comparing them with wild-type (WT) mice in a diethylnitrosamine (DEN) model. The liver tissue was analyzed macroscopically, histologically and immunohistochemically, at protein level by Proteome Profiler Arrays and Western blot analysis. Matn2(-/-) mice exhibited higher susceptibility to hepatocarcinogenesis compared to wild-type mice. In the liver of Matn2(-/-) mice, spontaneous microscopic tumor foci were detected without DEN treatment. After 15 mu g/g body weight DEN treatment, the liver of Matn2(-/-) mice contained macroscopic tumors of both larger number and size than the WT liver. In contrast with the WT liver, spontaneous phosphorylation of EGFR, Erk1/2 GSK-3 alpha/beta and retinoblastoma protein (p-Rb), decrease in p21/CIP1 level, and increase in beta-Catenin protein expression were detected in Matn2(-/-) livers. Focal Ki-67 positivity of these samples provided additional support to our presumption that the lack of Matn2 drives the liver into a pro-proliferatory state, making it prone to tumor development. This enhanced proliferative capacity was further increased in the tumor nodules of DEN-treated Matn2(-/-) livers. Our study suggests that Matn2 functions as a tumor suppressor in hepatocarcinogenesis, and in this process activation of EGFR together with that of Erk1/2, as well as inactivation of GSK-3 beta, play strategic roles.	[Fullar, Alexandra; Baghy, Kornelia; Peterfia, Balint; Tatrai, Peter; Kovalszky, Ilona] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary; [Deak, Ferenc; Zsak, Yvonne; Kiss, Ibolya] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary; [Schaff, Zsuzsa] Semmelweis Univ, Dept Pathol 2, H-1085 Budapest, Hungary; [Dudas, Jozsef] Med Univ Innsbruck, Dept Otorhinolaryngol, A-6020 Innsbruck, Austria	Semmelweis University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Semmelweis University; Medical University of Innsbruck	Kovalszky, I (corresponding author), Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary.	koval@korb1.sote.hu	Baghy, Kornélia/ABH-2549-2020; Schaff, Zsuzsa/K-5613-2017; Kovalszky, Ilona/ABH-2832-2020; Dudás, József/AAY-9352-2020; Tatrai, Peter/AAR-6014-2020	Baghy, Kornélia/0000-0002-5323-2775; Schaff, Zsuzsa/0000-0002-6429-8059; Kovalszky, Ilona/0000-0002-0179-3378; Dudás, József/0000-0002-9877-3399; Tatrai, Peter/0000-0001-9726-1992; Fullar, Alexandra/0000-0003-4368-1523	Hungarian Scientific Research Fund [OTKA 67925, 100904, OTKA T049608]; Anyos Jedlik Programme AVINOMID from the National Office for Research and Technology [OM-00087/2007]; Austrian-Hungarian Action Foundation [78ou1]; Austrian Science Fund [FWF P 22287-B13]; Austrian Science Fund (FWF) [P 25869] Funding Source: researchfish	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Anyos Jedlik Programme AVINOMID from the National Office for Research and Technology; Austrian-Hungarian Action Foundation; Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Hungarian Scientific Research Fund (OTKA 67925 and 100904 to I. Kovalszky, OTKA T049608 to I. Kiss); Anyos Jedlik Programme AVINOMID from the National Office for Research and Technology (OM-00087/2007 to PL and I. Kiss); Austrian-Hungarian Action Foundation (78ou1 to JD and I. Kovalszky); and Austrian Science Fund (FWF P 22287-B13 to JD). The authors state that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa T, 2010, BIOCHEM BIOPH RES CO, V392, P369, DOI 10.1016/j.bbrc.2010.01.027; Borgdorff V, 2010, ONCOGENE, V29, P2262, DOI 10.1038/onc.2009.497; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Daugherty RL, 2007, PHYSIOLOGY, V22, P303, DOI 10.1152/physiol.00020.2007; Deak F, 1999, MATRIX BIOL, V18, P55, DOI 10.1016/S0945-053X(98)00006-7; Deak F, 1997, J BIOL CHEM, V272, P9268; Densham RM, 2008, CELL SIGNAL, V20, P1986, DOI 10.1016/j.cellsig.2008.07.005; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Iakova P, 2004, EMBO J, V23, P406, DOI 10.1038/sj.emboj.7600052; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Jin JL, 2009, MOL CELL BIOL, V29, P3867, DOI 10.1128/MCB.00456-09; Jung P, 2009, CELL CYCLE, V8, P982, DOI 10.4161/cc.8.7.7949; Klatt AR, 2011, INT J BIOCHEM CELL B, V43, P320, DOI 10.1016/j.biocel.2010.12.010; Mann HH, 2007, MATRIX BIOL, V26, P167, DOI 10.1016/j.matbio.2006.10.010; Mates L, 2004, MATRIX BIOL, V23, P195, DOI 10.1016/j.matbio.2004.05.003; Mates L, 2002, MATRIX BIOL, V21, P163, DOI 10.1016/S0945-053X(01)00194-9; Muratoglu S, 2000, CYTOGENET CELL GENET, V90, P323, DOI 10.1159/000056797; Pan OH, 1998, J BIOL CHEM, V273, P14205, DOI 10.1074/jbc.273.23.14205; Park DH, 2009, TOXICOL LETT, V191, P321, DOI 10.1016/j.toxlet.2009.09.016; Piecha D, 1999, J BIOL CHEM, V274, P13353, DOI 10.1074/jbc.274.19.13353; Sharma MK, 2006, NEUROLOGY, V66, P127, DOI 10.1212/01.wnl.0000188667.66646.1c; Szabo E, 2008, PATHOL ONCOL RES, V14, P15, DOI 10.1007/s12253-008-9005-4; Szabo E, 2007, MATRIX BIOL, V26, P554, DOI 10.1016/j.matbio.2007.04.007; Wagener R, 2005, FEBS LETT, V579, P3323, DOI 10.1016/j.febslet.2005.03.018; Wang Q, 2006, ONCOGENE, V25, P43, DOI 10.1038/sj.onc.1209004; Wiberg C, 2002, BIOCH J, V367, P715	28	9	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93469	10.1371/journal.pone.0093469	http://dx.doi.org/10.1371/journal.pone.0093469			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691449	Green Published, Green Submitted, gold			2022-12-25	WOS:000334101100086
J	Koon, YL; Koh, CG; Chiam, KH				Koon, Yen Ling; Koh, Cheng Gee; Chiam, Keng-Hwee			Computational Modeling Reveals Optimal Strategy for Kinase Transport by Microtubules to Nerve Terminals	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; SIGNAL-TRANSDUCTION; SCAFFOLD PROTEINS; AXONAL-TRANSPORT; MAP KINASE; INTERACTING PROTEIN-1; MOLECULAR MOTORS; KINESIN; JNK; TAU	Intracellular transport of proteins by motors along cytoskeletal filaments is crucial to the proper functioning of many eukaryotic cells. Since most proteins are synthesized at the cell body, mechanisms are required to deliver them to the growing periphery. In this article, we use computational modeling to study the strategies of protein transport in the context of JNK (c-JUN NH2-terminal kinase) transport along microtubules to the terminals of neuronal cells. One such strategy for protein transport is for the proteins of the JNK signaling cascade to bind to scaffolds, and to have the whole protein-scaffold cargo transported by kinesin motors along microtubules. We show how this strategy outperforms protein transport by diffusion alone, using metrics such as signaling rate and signal amplification. We find that there exists a range of scaffold concentrations for which JNK transport is optimal. Increase in scaffold concentration increases signaling rate and signal amplification but an excess of scaffolds results in the dilution of reactants. Similarly, there exists a range of kinesin motor speeds for which JNK transport is optimal. Signaling rate and signal amplification increases with kinesin motor speed until the speed of motor translocation becomes faster than kinase/scaffold-motor binding. Finally, we suggest experiments that can be performed to validate whether, in physiological conditions, neuronal cells do indeed adopt such an optimal strategy. Understanding cytoskeletal-assisted protein transport is crucial since axonal and cell body accumulation of organelles and proteins is a histological feature in many human neurodegenerative diseases. In this paper, we have shown that axonal transport performance changes with altered transport component concentrations and transport speeds wherein these aspects can be modulated to improve axonal efficiency and prevent or slowdown axonal deterioration.	[Koon, Yen Ling; Koh, Cheng Gee; Chiam, Keng-Hwee] Natl Univ Singapore, Mechanobiol Inst, Singapore 117548, Singapore; [Koon, Yen Ling] Nanyang Technol Univ, Interdisciplinary Grad Sch, Singapore 639798, Singapore; [Koh, Cheng Gee] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Chiam, Keng-Hwee] ASTAR, Bioinformat Inst, Singapore, Singapore	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII)	Chiam, KH (corresponding author), Natl Univ Singapore, Mechanobiol Inst, Singapore 117548, Singapore.	chiamkh@bii.a-star.edu.sg	Koh, Cheng Gee/A-2215-2011; Koh, C. G./H-1122-2015	Koh, Cheng Gee/0000-0003-1905-8010; Koh, C. G./0000-0002-4779-2207	Seed Fund of the Mechanobiology Institute, Research Centre of Excellence; National Research Foundation of Singapore; Singapore Ministry of Education; Agency of Science, Technology and Research (A*STAR) of Singapore; A*STAR Graduate Scholarship	Seed Fund of the Mechanobiology Institute, Research Centre of Excellence; National Research Foundation of Singapore(National Research Foundation, Singapore); Singapore Ministry of Education(Ministry of Education, Singapore); Agency of Science, Technology and Research (A*STAR) of Singapore(Agency for Science Technology & Research (A*STAR)); A*STAR Graduate Scholarship(Agency for Science Technology & Research (A*STAR))	This work was supported by the Seed Fund of the Mechanobiology Institute, Research Centre of Excellence financed by the National Research Foundation of Singapore and the Singapore Ministry of Education, as well as the Agency of Science, Technology and Research (A*STAR) of Singapore. YLK is supported by the A*STAR Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge BB, 2006, NAT CELL BIOL, V8, P1195, DOI 10.1038/ncb1497; Banks GA, 2003, GENE THER, V10, P1766, DOI 10.1038/sj.gt.3302076; Blacque OE, 2008, FRONT BIOSCI-LANDMRK, V13, P2633, DOI 10.2741/2871; Blasius TL, 2007, J CELL BIOL, V176, P11, DOI 10.1083/jcb.200605099; Bray D, 1998, ANNU REV BIOPH BIOM, V27, P59, DOI 10.1146/annurev.biophys.27.1.59; Brown A, 2003, J CELL BIOL, V160, P817, DOI 10.1083/jcb.200212017; Bulinski JC, 2007, CURR BIOL, V17, P18; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Byrd DT, 2001, NEURON, V32, P787, DOI 10.1016/S0896-6273(01)00532-3; Cavalli V, 2005, J CELL BIOL, V168, P775, DOI 10.1083/jcb.200410136; Chapman SA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.73; Chiam KH, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.051910; Chiu JW, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.056708; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Dorner C, 1999, J BIOL CHEM, V274, P33654, DOI 10.1074/jbc.274.47.33654; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Farzan SF, 2008, CURR BIOL, V18, P1215, DOI 10.1016/j.cub.2008.07.026; Gallant PE, 2000, J NEUROCYTOL, V29, P779, DOI 10.1023/A:1010961022455; Good M, 2009, CELL, V136, P1085, DOI 10.1016/j.cell.2009.01.049; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Haugh JM, 2009, BIOPHYS J, V97, P435, DOI 10.1016/j.bpj.2009.05.014; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Horiuchi D, 2007, CURR BIOL, V17, P1313, DOI 10.1016/j.cub.2007.06.062; Inomata H, 2003, J BIOL CHEM, V278, P22946, DOI 10.1074/jbc.M212160200; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Kelkar N, 2000, MOL CELL BIOL, V20, P1030, DOI 10.1128/MCB.20.3.1030-1043.2000; Kholodenko BN, 2003, J EXP BIOL, V206, P2073, DOI 10.1242/jeb.00298; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Klann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029645; Klipp E, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-S1-S10; Klopfenstein DR, 2000, CELL, V103, P537, DOI 10.1016/S0092-8674(00)00144-6; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Lipniacki T, 2004, J THEOR BIOL, V228, P195, DOI 10.1016/j.jtbi.2004.01.001; Matsuda S, 2001, J NEUROSCI, V21, P6597; Meyer D, 1999, J BIOL CHEM, V274, P35113, DOI 10.1074/jbc.274.49.35113; Moran U, 2010, CELL, V141, P1262, DOI 10.1016/j.cell.2010.06.019; Morfini G, 2006, NAT NEUROSCI, V9, P907, DOI 10.1038/nn1717; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Neri I, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/8/085005; Neri I, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.098102; Pellet JB, 2000, EUR J NEUROSCI, V12, P621, DOI 10.1046/j.1460-9568.2000.00945.x; Roy S, 2005, ACTA NEUROPATHOL, V109, P5, DOI 10.1007/s00401-004-0952-x; Sakamoto R, 2005, MOL BIOL CELL, V16, P483, DOI 10.1091/mbc.E04-07-0553; Schnapp BJ, 2003, J CELL SCI, V116, P2125, DOI 10.1242/jcs.00488; SCHNAPP BJ, 1989, P NATL ACAD SCI USA, V86, P1548, DOI 10.1073/pnas.86.5.1548; Seitz A, 2002, EMBO J, V21, P4896, DOI 10.1093/emboj/cdf503; Shaw AS, 2009, NAT REV IMMUNOL, V9, P47, DOI 10.1038/nri2473; Stagi M, 2006, FASEB J, V20, P2573, DOI 10.1096/fj.06-6679fje; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Taru H, 2002, J BIOL CHEM, V277, P20070, DOI 10.1074/jbc.M108372200; Trinczek B, 1999, J CELL SCI, V112, P2355; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Verhey KJ, 1998, J CELL BIOL, V143, P1053, DOI 10.1083/jcb.143.4.1053; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Verhey KJ, 2009, NAT REV MOL CELL BIO, V10, P765, DOI 10.1038/nrm2782; Vershinin M, 2007, P NATL ACAD SCI USA, V104, P87, DOI 10.1073/pnas.0607919104; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Whitmarsh AJ, 2001, GENE DEV, V15, P2421, DOI 10.1101/gad.922801; Willoughby EA, 2003, J BIOL CHEM, V278, P10731, DOI 10.1074/jbc.M207324200; Yasuda J, 1999, MOL CELL BIOL, V19, P7245; Yuste SB, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.061123; Zhang WS, 2005, DEV CELL, V8, P267, DOI 10.1016/j.devcel.2005.01.001; Zhou J, 2005, INVEST OPHTH VIS SCI, V46, P3403, DOI 10.1167/iovs.04-1064	72	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92437	10.1371/journal.pone.0092437	http://dx.doi.org/10.1371/journal.pone.0092437			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691408	gold, Green Published			2022-12-25	WOS:000334101100024
J	Lee, JP; Kim, DH; Yang, SH; Hwang, JH; An, JN; Sang, IM; Ha, J; Oh, YK; Kim, YS; Lim, CS				Lee, Jung Pyo; Kim, Do Hyoung; Yang, Seung Hee; Hwang, Jin Ho; An, Jung Nam; Min, Sang Il; Ha, Jongwon; Oh, Yun Kyu; Kim, Yon Su; Lim, Chun Soo			Serum Bilirubin Affects Graft Outcomes through UDP-Glucuronosyltransferase Sequence Variation in Kidney Transplantation	PLOS ONE			English	Article							HEME OXYGENASE-1 GENE; CORONARY-ARTERY-DISEASE; OXIDATIVE STRESS; MICROSATELLITE POLYMORPHISM; PROMOTER POLYMORPHISM; INDUCE TOLERANCE; HEART-DISEASE; ASSOCIATION; SUSCEPTIBILITY; GENOTYPE	Background: Oxidative stress is a major mediator of adverse outcome after kidney transplantation. Bilirubin is produced by heme oxygenase-1 (HO-1), catalyzed by UDP-glucuronosyltransferase (UGT1A1), and has potential as an antioxidant. In this study, we investigated the effects of HO-1 and UGT1A1 sequence variations on kidney allograft outcomes. Methods: Clinical data were collected from 429 Korean recipients who underwent kidney transplantation from 1990-2008. Genotyping for UGT1A1*28 and HO-1 (A-413T) was performed. Acute rejection and graft survival were monitored as end-points. Results: Serum levels of total bilirubin were significantly increased after transplantation (0.41 +/- 0.19 mg/dL to 0.80 +/- 0.33 mg/dL, P<0.001). Post-transplant 1-year bilirubin level was higher in 6/7 or 7/7 carriers compared with 6/6 homozygotes in terms of the UGT1A1*28 polymorphism (6/6 vs. 6/7 vs. 7/7: 0.71 +/- 0.27 vs. 1.06 +/- 0.36 vs. 1.10 +/- 0.45 mg/dL, P<0.001). According to an additive model of genotype analysis, the 7-allele genotype had a protective effect on the development of acute rejection compared with the 6-allele (odds ratio 0.43, 95% CI 0.25-0.73, P for trend = 0.006). Multivariate Cox regression analysis revealed that individuals carrying the 7-allele had a decreased risk of graft loss, by a factor of 0.36 (95% CI 0.15-0.85, P = 0.019). The HO-1 (A-413T) polymorphism had no effect on serum bilirubin levels or graft outcomes. Conclusions: The UGT1A1*28 polymorphism is associated with changes in serum bilirubin and with graft outcome after kidney transplantation.	[Lee, Jung Pyo; Oh, Yun Kyu; Lim, Chun Soo] Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea; [Kim, Do Hyoung; Hwang, Jin Ho] Chung Ang Univ Hosp, Dept Internal Med, Seoul, South Korea; [Yang, Seung Hee; An, Jung Nam; Kim, Yon Su] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Yang, Seung Hee; Kim, Yon Su] Seoul Natl Univ, Coll Med, Kidney Res Inst, Seoul, South Korea; [Min, Sang Il; Ha, Jongwon] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Chung Ang University; Chung Ang University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Lim, CS (corresponding author), Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea.	cslimjy@snu.ac.kr	Kim, Do Hyoung/AAE-7557-2022; Oh, Yun Kyu/J-5542-2012; Hwang, Jin Ho/E-7203-2015	Kim, Do Hyoung/0000-0002-8664-8830; Hwang, Jin Ho/0000-0003-0829-0922	Seoul Metropolitan Government Seoul National University (SMG-SNU) Boramae Medical Center [03-2012-4]; Korean Society of Nephrology [H-1112-003-0387]	Seoul Metropolitan Government Seoul National University (SMG-SNU) Boramae Medical Center; Korean Society of Nephrology	This work was supported by a clinical research grant-in-aid from the Seoul Metropolitan Government Seoul National University (SMG-SNU) Boramae Medical Center (03-2012-4) and by a grant from the Korean Society of Nephrology (H-1112-003-0387). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2009, AM J PHYSIOL-RENAL, V297, pF1137, DOI 10.1152/ajprenal.90449.2008; Adin CA, 2005, AM J PHYSIOL-RENAL, V288, pF778, DOI 10.1152/ajprenal.00215.2004; Antolini F, 2004, CLIN NEPHROL, V62, P131; Baan C, 2004, AM J TRANSPLANT, V4, P811, DOI 10.1111/j.1600-6143.2004.00420.x; Bulmer AC, 2008, ATHEROSCLEROSIS, V199, P390, DOI 10.1016/j.atherosclerosis.2007.11.022; Campise M, 2003, TRANSPLANTATION, V76, P1474, DOI 10.1097/01.TP.0000090344.61975.F0; Chen YH, 2002, HUM GENET, V111, P1, DOI 10.1007/s00439-002-0769-4; Chen YH, 2008, DIABETES CARE, V31, P1615, DOI 10.2337/dc07-2126; Chen YH, 2011, CLIN J AM SOC NEPHRO, V6, P567, DOI 10.2215/CJN.06130710; Chin HJ, 2009, J KOREAN MED SCI, V24, pS30, DOI 10.3346/jkms.2009.24.S1.S30; Chin HJ, 2009, J KOREAN MED SCI, V24, pS22, DOI 10.3346/jkms.2009.24.S1.S22; Courtney AE, 2007, AM J TRANSPLANT, V7, P908, DOI 10.1111/j.1600-6143.2006.01726.x; Cristol JP, 1998, TRANSPLANTATION, V65, P1322, DOI 10.1097/00007890-199805270-00007; Denschlag D, 2004, MOL HUM REPROD, V10, P211, DOI 10.1093/molehr/gah024; Endler G, 2004, THROMB HAEMOSTASIS, V91, P155, DOI 10.1160/TH03-05-0291; Exner M, 2004, TRANSPLANTATION, V77, P538, DOI 10.1097/01.TP.0000113467.36269.F8; Guenegou A, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039743; Hasegawa T, 2009, AM J PHYSIOL-HEART C, V296, pH1007, DOI 10.1152/ajpheart.00498.2008; Hribova P, 2008, AM J TRANSPLANT, V8, P1077, DOI 10.1111/j.1600-6143.2008.02207.x; Ikushiro S, 1997, BIOCHEMISTRY-US, V36, P7154, DOI 10.1021/bi9702344; Joo DJ, 2010, TRANSPL P, V42, P729, DOI 10.1016/j.transproceed.2010.02.033; Kim SY, 2003, NEPHROLOGY, V8, pS2, DOI 10.1046/j.1440-1797.8.s.5.x; Kimpara T, 1997, HUM GENET, V100, P145, DOI 10.1007/s004390050480; Lee SS, 2007, FASEB J, V21, P3450, DOI 10.1096/fj.07-8472com; Lin JP, 2006, CIRCULATION, V114, P1476, DOI 10.1161/CIRCULATIONAHA.106.633206; LLESUY SF, 1994, BBA-MOL CELL RES, V1223, P9, DOI 10.1016/0167-4889(94)90067-1; Morena Marion, 2005, Hemodial Int, V9, P37, DOI 10.1111/j.1492-7535.2005.01116.x; NAKAGAMI T, 1993, BIOCHIM BIOPHYS ACTA, V1158, P189, DOI 10.1016/0304-4165(93)90013-X; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Pileggi A, 2001, DIABETES, V50, P1983, DOI 10.2337/diabetes.50.9.1983; Ribeiro MM, 2003, BIOCHEM BIOPH RES CO, V305, P876, DOI 10.1016/S0006-291X(03)00856-8; Rocuts F, 2010, CELL TRANSPLANT, V19, P443, DOI 10.3727/096368909X484680; Schillinger M, 2004, J AM COLL CARDIOL, V43, P950, DOI 10.1016/j.jacc.2003.09.058; STOCKER R, 1987, P NATL ACAD SCI USA, V84, P5918, DOI 10.1073/pnas.84.16.5918; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Sun K, 2004, TRANSPLANTATION, V77, P1683, DOI 10.1097/01.TP.0000131169.29553.B1; Turpeinen H, 2007, INT J IMMUNOGENET, V34, P253, DOI 10.1111/j.1744-313X.2007.00688.x; Vitek L, 2002, ATHEROSCLEROSIS, V160, P449, DOI 10.1016/S0021-9150(01)00601-3; Vostalova J, 2012, RENAL FAILURE, V34, P413, DOI 10.3109/0886022X.2011.649658; Wang HJ, 2006, ENDOCRINOLOGY, V147, P762, DOI 10.1210/en.2005-0632; Yamada N, 2000, AM J HUM GENET, V66, P187, DOI 10.1086/302729; Zahmatkesh M, 2010, EXP CLIN TRANSPLANT, V8, P38	42	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93633	10.1371/journal.pone.0093633	http://dx.doi.org/10.1371/journal.pone.0093633			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690955	Green Published, gold, Green Submitted			2022-12-25	WOS:000334101100115
J	Ryoo, IG; Ha, H; Kwak, MK				Ryoo, In-geun; Ha, Hunjoo; Kwak, Mi-Kyoung			Inhibitory Role of the KEAP1-NRF2 Pathway in TGF beta 1-Stimulated Renal Epithelial Transition to Fibroblastic Cells: A Modulatory Effect on SMAD Signaling	PLOS ONE			English	Article							UNILATERAL URETERAL OBSTRUCTION; SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR-BETA; TGF-BETA; MESENCHYMAL TRANSITION; OXIDATIVE STRESS; MOLECULAR-MECHANISMS; TUBULOINTERSTITIAL FIBROSIS; NRF2-KEAP1 PATHWAY; GENE-EXPRESSION	Transforming growth factor beta 1 (TGF beta 1) is a potent stimulator of epithelial-to-mesenchymal transition (EMT) and has been associated with chronic kidney diseases by activating profibrotic gene expression. In this study, we investigated the role of the KEAP1-NRF2 pathway, which is a master regulator of the cellular antioxidant system, in TGF beta 1-stimulated EMT gene changes using human renal tubular epithelial HK2. Treatment with TGF beta 1 enhanced the levels of reactive oxygen species (ROS) and TGF beta 1-stimulated EMT gene changes, including an increase in profibrotic fibronectin-1 and collagen 1A1, were diminished by the antioxidant N-acetylcysteine. In HK2, TGF beta 1 suppressed NRF2 activity and thereby reduced the expression of GSH synthesizing enzyme through the elevation of ATF3 level. Therefore, the activation of NRF2 signaling with sulforaphane effectively attenuated the TGF beta 1-stimulated increase in fibronectin-1 and collagen 1A1. Conversely, the TGF beta 1-EMT gene changes were further enhanced by NRF2 knockdown compared to the control cells. The relationship of NRF2 signaling and TGF beta 1-EMT changes was further confirmed in a stable KEAP1-knockdown HK2, which is a model of pure activation of NRF2. The TGF beta 1-mediated increase of collagen 1A1 and fibronectin-1 in KEAP1 knockdown HK2 was suppressed. In particular, TGF beta 1-SMAD signaling was modulated in KEAP1 knockdown HK2: the TGF beta 1-stimulated SMAD2/3 phosphorylation and SMAD transcriptional activity were repressed. Additionally, the protein level of SMAD7, an inhibitor of SMAD signaling, was elevated and the level of SMURF1, an E3 ubiquitin ligase for SMAD7 protein, was diminished in KEAP1 knockdown HK2. Finally, the inhibition of SMAD7 expression in KEAP1 knockdown HK2 restored TGF beta 1 response, indicating that SMURF1-SMAD7 may be a molecular signaling linking the NRF2-GSH pathway to TGF beta 1-EMT changes. Collectively, these results indicate that the KEAP1-NRF2 antioxidant system can be an effective modulator of TGF beta 1-stimulated renal epithelial transition to fibroblastic cells through the SMUR1-SMAD7 signaling, and further implies the beneficial role of NRF2 in chronic renal diseases.	[Ryoo, In-geun; Kwak, Mi-Kyoung] Catholic Univ Korea, Coll Pharm, Puchon, Gyeonggi Do, South Korea; [Ha, Hunjoo] Ewha Womans Univ, Coll Pharm, Seoul, South Korea	Catholic University of Korea; Ewha Womans University	Kwak, MK (corresponding author), Catholic Univ Korea, Coll Pharm, Puchon, Gyeonggi Do, South Korea.	mkwak@catholic.ac.kr		Ha, Hunjoo/0000-0002-5601-1265	Bio & Medical Technology Development Program of the National Research Foundation (NRF) [NRF-2013M3A9B5075839]; Ministry of Science, ICT & Future Planning; Basic Science Research Program of the NRF [2011-0003619]; Ministry of Education, Science and Technology; Research Fund of The Catholic University of Korea	Bio & Medical Technology Development Program of the National Research Foundation (NRF)(National Research Foundation of Korea); Ministry of Science, ICT & Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea); Basic Science Research Program of the NRF(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Research Fund of The Catholic University of Korea	This research was supported by the Bio & Medical Technology Development Program (NRF-2013M3A9B5075839) of the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning, and the Basic Science Research Program (2011-0003619) of the NRF funded by the Ministry of Education, Science and Technology. This work was also supported by the Research Fund, 2011 of The Catholic University of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminzadeh MA, 2013, NEPHROL DIAL TRANSPL, V28, P2038, DOI 10.1093/ndt/gft022; Artaud-Macari E, 2013, ANTIOXID REDOX SIGN, V18, P66, DOI 10.1089/ars.2011.4240; Bakin AV, 2005, FREE RADICAL BIO MED, V38, P375, DOI 10.1016/j.freeradbiomed.2004.10.033; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Biswas SK, 2009, MOL ASPECTS MED, V30, P60, DOI 10.1016/j.mam.2008.07.001; Bondi CD, 2010, J AM SOC NEPHROL, V21, P93, DOI 10.1681/ASN.2009020146; Brown SL, 2008, CANCER RES, V68, P364, DOI 10.1158/0008-5472.CAN-07-2170; Burns WC, 2010, AM J PHYSIOL-RENAL, V299, pF585, DOI 10.1152/ajprenal.00538.2009; Carew RM, 2012, CELL TISSUE RES, V347, P103, DOI 10.1007/s00441-011-1227-1; Choi HK, 2009, TOXICOL APPL PHARM, V240, P377, DOI 10.1016/j.taap.2009.07.030; Chung ACK, 2009, NEPHROL DIAL TRANSPL, V24, P1443, DOI 10.1093/ndt/gfn699; Cui WP, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/821936; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dhakshinamoorthy S, 2005, J BIOL CHEM, V280, P16891, DOI 10.1074/jbc.M500166200; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Franklin CC, 2003, FASEB J, V17, P1535, DOI 10.1096/fj.02-0867fje; Hackett TL, 2009, AM J RESP CRIT CARE, V180, P122, DOI 10.1164/rccm.200811-1730OC; Hertig A, 2006, AM J TRANSPLANT, V6, P2937, DOI 10.1111/j.1600-6143.2006.01559.x; Hu TS, 2005, AM J PHYSIOL-RENAL, V289, pF816, DOI 10.1152/ajprenal.00024.2005; Hwang M, 2006, EXP MOL PATHOL, V81, P48, DOI 10.1016/j.yexmp.2005.11.005; Inoue Y, 2008, CANCER SCI, V99, P2107, DOI 10.1111/j.1349-7006.2008.00925.x; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Jardine H, 2002, J BIOL CHEM, V277, P21158, DOI 10.1074/jbc.M112145200; Jung KA, 2013, TOXICOL LETT, V218, P39, DOI 10.1016/j.toxlet.2012.12.026; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kashihara N, 2010, CURR MED CHEM, V17, P4256, DOI 10.2174/092986710793348581; Kim HJ, 2010, AM J PHYSIOL-RENAL, V298, pF662, DOI 10.1152/ajprenal.00421.2009; Kim TH, 2011, CANCER RES, V71, P2260, DOI 10.1158/0008-5472.CAN-10-3007; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lewerenz J, 2011, ANTIOXID REDOX SIGN, V14, P1449, DOI 10.1089/ars.2010.3600; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Liu RM, 2010, FREE RADICAL BIO MED, V48, P1, DOI 10.1016/j.freeradbiomed.2009.09.026; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Margetts PJ, 2005, J AM SOC NEPHROL, V16, P425, DOI 10.1681/ASN.2004060436; Meurer SK, 2005, BIOCHEM PHARMACOL, V70, P1026, DOI 10.1016/j.bcp.2005.07.001; Michaeloudes C, 2011, AM J RESP CRIT CARE, V184, P894, DOI 10.1164/rccm.201011-1780OC; Miyata T, 2013, KIDNEY INT, V84, P693, DOI 10.1038/ki.2013.74; Monteleone G, 2008, MUCOSAL IMMUNOL, V1, pS50, DOI 10.1038/mi.2008.55; Nakamura T, 2011, AM J RESP CELL MOL, V44, P614, DOI 10.1165/rcmb.2010-0338OC; Oh CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045870; Oh CJ, 2012, FREE RADICAL BIO MED, V52, P671, DOI 10.1016/j.freeradbiomed.2011.11.012; Pat B, 2005, KIDNEY INT, V67, P931, DOI 10.1111/j.1523-1755.2005.00157.x; Ping Z, 2010, BRAIN RES, V1343, P178, DOI 10.1016/j.brainres.2010.04.036; Pohlers D, 2009, BBA-MOL BASIS DIS, V1792, P746, DOI 10.1016/j.bbadis.2009.06.004; Priya DKD, 2011, PULM PHARMACOL THER, V24, P110, DOI 10.1016/j.pupt.2010.09.002; Rastaldi MP, 2002, KIDNEY INT, V62, P137, DOI 10.1046/j.1523-1755.2002.00430.x; Rhyu DY, 2012, TRANSPL P, V44, P625, DOI 10.1016/j.transproceed.2011.12.054; Rhyu DY, 2005, J AM SOC NEPHROL, V16, P667, DOI 10.1681/ASN.2004050425; Runyan CE, 2004, J BIOL CHEM, V279, P2632, DOI 10.1074/jbc.M310412200; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Simonson MS, 2007, KIDNEY INT, V71, P846, DOI 10.1038/sj.ki.5002180; Soetikno V, 2013, MOL NUTR FOOD RES, V57, P1649, DOI 10.1002/mnfr.201200540; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yamamoto T, 2008, MOL CELL BIOL, V28, P2758, DOI 10.1128/MCB.01704-07; Yan XH, 2011, BIOCHEM J, V434, P1, DOI 10.1042/BJ20101827; Yan XH, 2009, ACTA BIOCH BIOPH SIN, V41, P263, DOI 10.1093/abbs/gmp018; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang M, 2009, LUNG, V187, P187, DOI 10.1007/s00408-009-9139-5; Zhu H, 2008, CARDIOVASC TOXICOL, V8, P71, DOI 10.1007/s12012-008-9016-0	69	50	54	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93265	10.1371/journal.pone.0093265	http://dx.doi.org/10.1371/journal.pone.0093265			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691097	Green Published, gold, Green Submitted			2022-12-25	WOS:000334101100058
J	Li, H; Jiang, X; Yu, Y; Huang, W; Xing, H; Agar, NY; Yang, HW; Yang, B; Carroll, RS; Johnson, MD				Li, H.; Jiang, X.; Yu, Y.; Huang, W.; Xing, H.; Agar, N. Y.; Yang, H. W.; Yang, B.; Carroll, R. S.; Johnson, M. D.			KAP regulates ROCK2 and Cdk2 in an RNA-activated glioblastoma invasion pathway	ONCOGENE			English	Article							CYCLIN-DEPENDENT KINASES; RHO-KINASE; HEPATOCELLULAR-CARCINOMA; PROTEIN PHOSPHATASE; CENTROSOME DUPLICATION; CELL INVASION; TUMOR-GROWTH; LIGHT-CHAIN; IN-VIVO; METASTASIS	Aberrant splicing of the cyclin-dependent kinase-associated phosphatase, KAP, promotes glioblastoma invasion in a Cdc2-dependent manner. However, the mechanism by which this occurs is unknown. Here we show that miR-26a, which is often amplified in glioblastoma, promotes invasion in phosphatase and tensin homolog (PTEN)-competent and PTEN-deficient glioblastoma cells by directly downregulating KAP expression. Mechanistically, we find that KAP binds and activates ROCK2. Thus, RNA-mediated downregulation of KAP leads to decreased ROCK2 activity and this, in turn, increases Rac1-mediated invasion. In addition, the decrease in KAP expression activates the cyclin-dependent kinase, Cdk2, and this directly promotes invasion by increasing retinoblastoma phosphorylation, E2F-dependent Cdc2 expression and Cdc2-mediated inactivation of the actomyosin inhibitor, caldesmon. Importantly, glioblastoma cell invasion mediated by this pathway can be antagonized by Cdk2/Cdc2 inhibitors in vitro and in vivo. Thus, two distinct RNA-based mechanisms activate this novel KAP/ROCK2/Cdk2-dependent invasion pathway in glioblastoma.	[Li, H.; Jiang, X.; Yu, Y.; Huang, W.; Xing, H.; Agar, N. Y.; Yang, H. W.; Yang, B.; Carroll, R. S.; Johnson, M. D.] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02446 USA; [Li, H.; Jiang, X.; Yu, Y.; Huang, W.; Xing, H.; Agar, N. Y.; Yang, H. W.; Yang, B.; Carroll, R. S.; Johnson, M. D.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Li, H.; Yang, B.] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou 450052, Peoples R China; [Johnson, M. D.] Program Neuro Oncol, Dana Farber Brigham, Boston, MA USA; [Johnson, M. D.] Womens Canc Ctr, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Zhengzhou University	Johnson, MD (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02138 USA.	mjohnson27@partners.org			National Institute of Neurological Disorders and Stroke [R01 NS062219]; National Institutes of Health Director's New Innovator Award [DP2OD002319]; Brain Science Foundation Research Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062219] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002319] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Science Foundation Research Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by R01 NS062219 from the National Institute of Neurological Disorders and Stroke, a National Institutes of Health Director's New Innovator Award (DP2OD002319) and a Brain Science Foundation Research Award to MDJ.	Amano M, 1999, J BIOL CHEM, V274, P32418, DOI 10.1074/jbc.274.45.32418; Bales E, 2005, CANCER RES, V65, P692; Berthet C, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-10; Corsino PE, 2008, NEOPLASIA, V10, P1240, DOI 10.1593/neo.08710; Ferretti R, 2010, DEV CELL, V18, P486, DOI 10.1016/j.devcel.2009.12.020; Han IS, 2007, J CELL SCI, V120, P246, DOI 10.1242/jcs.03322; HANNON GJ, 1994, P NATL ACAD SCI USA, V91, P1731, DOI 10.1073/pnas.91.5.1731; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Jacobs M, 2006, J BIOL CHEM, V281, P260, DOI 10.1074/jbc.M508847200; Joyce D, 1999, J BIOL CHEM, V274, P25245, DOI 10.1074/jbc.274.36.25245; Kim H, 2010, P NATL ACAD SCI USA, V107, P2183, DOI 10.1073/pnas.0909896107; Kim TM, 2011, CANCER RES, V71, P3387, DOI 10.1158/0008-5472.CAN-10-4117; Knights MJ, 2012, BRAIN PATHOL, V22, P592, DOI 10.1111/j.1750-3639.2012.00573.x; Kwiatkowska A, 2013, ADV EXP MED BIOL, V986, P121, DOI 10.1007/978-94-007-4719-7_7; Lee SW, 2000, MOL CELL BIOL, V20, P1723, DOI 10.1128/MCB.20.5.1723-1732.2000; Li JQ, 2002, HUM PATHOL, V33, P1006, DOI 10.1053/hupa.2002.125774; Li JQ, 2001, HUM PATHOL, V32, P945, DOI 10.1053/hupa.2001.27116; Lin WR, 2013, ONCOL REP, V29, P903, DOI 10.3892/or.2012.2208; Liu BN, 2012, BBA-MOL BASIS DIS, V1822, P1692, DOI 10.1016/j.bbadis.2012.07.019; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; Ma Z, 2006, MOL CELL BIOL, V26, P9016, DOI 10.1128/MCB.01383-06; Morrison DL, 1996, BIOCHEM CELL BIOL, V74, P549, DOI 10.1139/o96-459; Mrugala MM, 2013, DISCOV MED, V15, P221; Nalepa G, 2013, J CELL BIOL, V201, P997, DOI 10.1083/jcb.201205125; Pandithage R, 2008, J CELL BIOL, V180, P915, DOI 10.1083/jcb.200707126; Salhia B, 2005, CANCER RES, V65, P8792, DOI 10.1158/0008-5472.CAN-05-0160; SATTERWHITE LL, 1992, J CELL BIOL, V118, P595, DOI 10.1083/jcb.118.3.595; Tawara S, 2007, J CARDIOVASC PHARM, V50, P195, DOI 10.1097/FJC.0b013e31806befe6; Wang HF, 2011, CANCER RES, V71, P68, DOI 10.1158/0008-5472.CAN-10-0030; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; Yamaguchi H, 2006, STRUCTURE, V14, P589, DOI 10.1016/j.str.2005.11.024; Yang HW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-301; Yang X, 2013, HEPATOLOGY, V58, P158, DOI 10.1002/hep.26305; Yeh CT, 2000, CANCER RES, V60, P4697; Yoneda A, 2005, J CELL BIOL, V170, P443, DOI 10.1083/jcb.200412043; Yu L, 2013, ONCOL LETT, V5, P1223, DOI 10.3892/ol.2013.1173; Yu Y, 2007, CANCER RES, V67, P130, DOI 10.1158/0008-5472.CAN-06-2478	37	17	18	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 12	2015	34	11					1432	1441		10.1038/onc.2014.49	http://dx.doi.org/10.1038/onc.2014.49			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CD1AR	24704824				2022-12-25	WOS:000350806500009
J	Jespersen, L; Abildstrom, SZ; Hvelplund, A; Madsen, JK; Galatius, S; Pedersen, F; Hojberg, S; Prescott, E				Jespersen, Lasse; Abildstrom, Steen Z.; Hvelplund, Anders; Madsen, Jan K.; Galatius, Soren; Pedersen, Frants; Hojberg, Soren; Prescott, Eva			Burden of Hospital Admission and Repeat Angiography in Angina Pectoris Patients with and without Coronary Artery Disease: A Registry-Based Cohort Study	PLOS ONE			English	Article							ISCHEMIA-SYNDROME-EVALUATION; STABLE ANGINA; CHEST-PAIN; WOMEN; HEART	Aims: To evaluate risk of hospitalization due to cardiovascular disease (CVD) and repeat coronary angiography (CAG) in stable angina pectoris (SAP) with no obstructive coronary artery disease (CAD) versus obstructive CAD, and asymptomatic reference individuals. Methods and Results: We followed 11,223 patients with no prior CVD having a first-time CAG in 1998-2009 due to SAP symptoms and 5,695 asymptomatic reference individuals from the Copenhagen City Heart Study through registry linkage for 7.8 years (median). In recurrent event survival analysis, patients with SAP had 3-4-fold higher risk of hospitalization for CVD irrespective of CAG findings and cardiovascular comorbidity. Multivariable adjusted hazard ratios(95%CI) for patients with angiographically normal coronary arteries was 3.0(2.5-3.5), for angiographically diffuse non-obstructive CAD 3.9(3.3-4.6) and for 1-3-vessel disease 3.6-4.1(range)(all P<0.001). Mean accumulated hospitalization time was 3.5(3.0-4.0)(days/10 years follow-up) in reference individuals and 4.5(3.8-5.2)/7.0(5.4-8.6)/6.7(5.2-8.1)/6.1(5.2-7.4)/8.6(6.6-10.7) in patients with angiographically normal coronary arteries/angiographically diffuse non-obstructive CAD/1-, 2-, and 3-vessel disease, respectively (all P<0.05, age-adjusted). SAP symptoms predicted repeat CAG with multivariable adjusted hazard ratios for patients with angiographically normal coronary arteries being 2.3(1.9-2.9), for angiographically diffuse non-obstructive CAD 5.5(4.4-6.8) and for obstructive CAD 6.6-9.4(range)(all P<0.001). Conclusions: Patients with SAP symptoms and angiographically normal coronary arteries or angiographically diffuse non-obstructive CAD suffer from considerably greater CVD burdens in terms of hospitalization for CVD and repeat CAG compared with asymptomatic reference individuals even after adjustment for cardiac risk factors and exclusion of cardiovascular comorbidity as cause. Contrary to common perception, excluding obstructive CAD by CAG in such patients does not ensure a benign cardiovascular prognosis.	[Jespersen, Lasse; Abildstrom, Steen Z.; Hojberg, Soren; Prescott, Eva] Bispebjerg Hosp, Dept Cardiol, Copenhagen, Denmark; [Hvelplund, Anders] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Hvelplund, Anders; Madsen, Jan K.; Galatius, Soren] Gentofte Univ Hosp, Dept Cardiol, Hellerup, Denmark; [Pedersen, Frants] Copenhagen Univ Hosp, Rigshosp, Dept Cardiol, Copenhagen, Denmark; [Prescott, Eva] Bispebjerg Hosp, Copenhagen City Heart Study, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Southern Denmark; University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital	Jespersen, L (corresponding author), Bispebjerg Hosp, Dept Cardiol, Copenhagen, Denmark.	lasjes@gmail.com	Prescott, Eva/AAJ-7441-2020	Hoejberg, Soeren/0000-0001-8385-587X; Prescott, Eva/0000-0002-4134-0349	Research Unit of the Department of Cardiology, Bispebjerg University Hospital	Research Unit of the Department of Cardiology, Bispebjerg University Hospital	The work was funded by the Research Unit of the Department of Cardiology, Bispebjerg University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Suwaidi J, 2000, CIRCULATION, V101, P948, DOI 10.1161/01.CIR.101.9.948; Buchthal SD, 2000, NEW ENGL J MED, V342, P829, DOI 10.1056/NEJM200003233421201; Bugiardini R, 2004, CIRCULATION, V109, P2518, DOI 10.1161/01.CIR.0000128208.22378.E3; CANNON RO, 1988, AM J CARDIOL, V61, P1338, DOI 10.1016/0002-9149(88)91180-0; CHAMBERS J, 1990, PROG CARDIOVASC DIS, V33, P161, DOI 10.1016/0033-0620(90)90007-O; Fox K, 2006, EUR HEART J, V27, P1341, DOI 10.1093/eurheartj/ehl001; Gulati M, 2009, ARCH INTERN MED, V169, P843, DOI 10.1001/archinternmed.2009.50; Halcox JPJ, 2002, CIRCULATION, V106, P653, DOI 10.1161/01.CIR.0000025404.78001.D8; Hemingway H, 2007, EUR J CARDIOV PREV R, V14, P373, DOI 10.1097/01.hjr.0000230106.01396.a2; Jespersen L, 2013, CLIN RES CARDIOL, V102, P571, DOI 10.1007/s00392-013-0568-z; Jespersen L, 2012, EUR HEART J, V33, P734, DOI 10.1093/eurheartj/ehr331; Kleinbaum D.G., 2005, SURVIVAL ANAL SELF L; Ong P, 2012, J AM COLL CARDIOL, V59, P655, DOI 10.1016/j.jacc.2011.11.015; PAPANICOLAOU MN, 1986, AM J CARDIOL, V58, P1181, DOI 10.1016/0002-9149(86)90378-4; Pepine CJ, 2010, J AM COLL CARDIOL, V55, P2825, DOI 10.1016/j.jacc.2010.01.054; PROUDFIT WL, 1980, CIRCULATION, V62, P712, DOI 10.1161/01.CIR.62.4.712; Schnohr P, 2001, EUR HEART J SUPPL, V3, pH1; Shaw LJ, 2006, CIRCULATION, V114, P894, DOI 10.1161/CIRCULATIONAHA.105.609990	18	51	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93170	10.1371/journal.pone.0093170	http://dx.doi.org/10.1371/journal.pone.0093170			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705387	gold, Green Published, Green Submitted			2022-12-25	WOS:000334107500028
J	Segal, L; Katz, LS; Shapira, H; Sandbank, J; Geras-Raaka, E; Gershengorn, MC; Oron, Y				Segal, Liora; Katz, Liora S.; Shapira, Hagit; Sandbank, Judith; Geras-Raaka, Elizabeth; Gershengorn, Marvin C.; Oron, Yoram			PAR-3 Knockdown Enhances Adhesion Rate of PANC-1 Cells via Increased Expression of Integrin alpha v and E-Cadherin	PLOS ONE			English	Article							THROMBIN RECEPTOR EXPRESSION; CANCER INVASION	The balance between the adhesion of cancer cells to extracellular matrix and their migratory potential, as well as their proteolytic activity, are important parameters that determine cancer cells invasiveness and metastasis. Since thrombin has been implicated in cancer progression, we studied the role(s) of thrombin-activated receptors in the adhesion process. We stably knocked down proteinase-activated receptors (PARs) -1, or -3 in human pancreatic adenocarcinoma PANC-1 cells. PANC-1 cells exhibit rapid adhesion to cell culture treated plastic and much faster kinetics of adhesion to Matrigel coated surface. Knockdown of PAR-1 had no effect on cells' adhesiveness, while PAR-3 knockdowns (KDs) exhibited much faster adhesion kinetics. PAR-3 KDs also exhibited slower in vitro wound closure than vector-control and PAR-1 KD cells. To study the molecular mechanism(s) of PAR-3 KD cells' enhanced rate of adhesion, we assayed the expression of the molecules that mediate cell-surface and cell-cell adhesion. ITG alpha v, as well as ITG alpha 6 and ITG alpha 10 mRNAs, were greatly enriched (>40-fold) in a rapidly-adhering sub-population of PAR-3 KD cells. The whole population of both PAR-1 and -3 KDs exhibited enhanced expression of a number of integrins (ITGs) mRNAs. However, ITGav mRNA and protein expression was increased in PAR-3 KD and markedly decreased in PAR-1 KD. PAR-3 KD cells also expressed more E-cadherin mRNA and protein. The enhanced adhesion kinetics of PAR-3 KDs was almost fully inhibited by calcium chelation, or by a HAV-motive decapeptide that affects E-cadherin intermolecular interactions. We propose that the enhanced rate of adhesion of PAR-3 KDs results from enhanced expression of E-cadherin, leading to a greater adhesion of free-floating cells to cells rapidly bound to the surface via their integrins, and particularly ITGav.	[Segal, Liora; Oron, Yoram] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, Ramat Aviv, Israel; [Katz, Liora S.; Geras-Raaka, Elizabeth; Gershengorn, Marvin C.] NIDDK, Lab Endocrinol & Receptor Biol, NIH, Bethesda, MD 20892 USA; [Shapira, Hagit] Inst Pathol, Cent Lab, Rehovot, Israel; [Sandbank, Judith] Assaf Harofe Hosp, Inst Pathol, Ramat Aviv, Israel; [Sandbank, Judith] Tel Aviv Univ, Sackler Fac Med, Dept Pathol, Ramat Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Tel Aviv University; Sackler Faculty of Medicine	Oron, Y (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, Ramat Aviv, Israel.	medfair@post.tau.ac.il			Andy Lebach Chair of Clinical Pharmacology and Toxicology, Tel Aviv University, YO incumbent	Andy Lebach Chair of Clinical Pharmacology and Toxicology, Tel Aviv University, YO incumbent	Supported in part by the Andy Lebach Chair of Clinical Pharmacology and Toxicology, Tel Aviv University, YO incumbent. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brand R, 2004, DM-DIS MON, V50, P545, DOI 10.1016/j.disamonth.2004.09.001; Bretschneider E, 2003, THROMB HAEMOSTASIS, V90, P704, DOI 10.1160/TH03-04-0203; Canel M, 2013, J CELL SCI, V126, P393, DOI 10.1242/jcs.100115; Deshet N, 2008, J CELL PHYSIOL, V216, P632, DOI 10.1002/jcp.21441; Elste AP, 2010, J MOL HISTOL, V41, P89, DOI 10.1007/s10735-010-9274-6; Franchini M, 2012, SEMIN THROMB HEMOST, V38, P95, DOI 10.1055/s-0031-1300955; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Fujimoto D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-443; Gritsenko PG, 2012, J PATHOL, V226, P185, DOI 10.1002/path.3031; Iovanne J, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00006; Kaufmann R, 2002, INT J ONCOL, V20, P177; Kaushal V, 2006, PROSTATE, V66, P273, DOI 10.1002/pros.20326; Kobayashi N, 2006, J PHARMACOL EXP THER, V317, P309, DOI 10.1124/jpet.105.097535; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; McLaughlin JN, 2007, P NATL ACAD SCI USA, V104, P5662, DOI 10.1073/pnas.0700763104; Perlikos F, 2013, CRIT REV ONCOL HEMAT, V87, P1, DOI 10.1016/j.critrevonc.2012.12.007; Segal L, 2014, PANCREAS, V43, P103, DOI 10.1097/MPA.0b013e31829f0b81; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Zaidel-Bar R, 2010, J CELL SCI, V123, P1385, DOI 10.1242/jcs.066183	20	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93879	10.1371/journal.pone.0093879	http://dx.doi.org/10.1371/journal.pone.0093879			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699825	Green Published, Green Submitted, gold			2022-12-25	WOS:000334105000117
J	Sofeu, CL; Warszawski, J; Ndongo, FA; Penda, IC; Ndiang, ST; Guemkam, G; Makwet, N; Owona, F; Kfutwah, A; Tchendjou, P; Texier, G; Tchuente, M; Faye, A; Tejiokem, MC				Sofeu, Casimir Ledoux; Warszawski, Josiane; Ndongo, Francis Ateba; Penda, Ida Calixte; Ndiang, Suzie Tetang; Guemkam, Georgette; Makwet, Nicaise; Owona, Felicite; Kfutwah, Anfumbom; Tchendjou, Patrice; Texier, Gaetan; Tchuente, Maurice; Faye, Albert; Tejiokem, Mathurin Cyrille		ANRS-PEDIACAM Study Grp	Low Birth Weight in Perinatally HIV-Exposed Uninfected Infants: Observations in Urban Settings in Cameroon	PLOS ONE			English	Article							INFECTED PREGNANT-WOMEN; FOR-GESTATIONAL-AGE; ANTIRETROVIRAL THERAPY; PROSPECTIVE COHORT; CHILDREN BORN; FETAL-GROWTH; OUTCOMES; DISEASE; TRANSMISSION; PREVENTION	Background: The consequences of maternal HIV infection for fetal growth are controversial. Here, we estimated the frequency of small for gestational age and gender (SGAG) among neonates born to HIV-infected or uninfected mothers and assessed the contribution, if any, of maternal HIV to the risk of SGAG. Methods: The data used were obtained from the ANRS-Pediacam cohort in Cameroon. Pairs of newborns, one to a HIV-infected mother and the other to an uninfected mother, were identified during the first week of life, and matched on gender and recruitment site from 2007-2010. SGAG was defined in line with international recommendations as a birth weight Z-score adjusted for gestational age at delivery and gender more than two standard deviations below the mean (- 2SD). Considering the matched design, logistic regression modeling was adjusted on site and gender to explore the effect of perinatal HIV exposure on SGAG. Results: Among the 4104 mother-infant pairs originally enrolled, no data on birth weight and/or gestational age were available for 108; also, 259 were twins and were excluded. Of the remaining 3737 mother-infant pairs, the frequency of SGAG was 5.3% (95% CI: 4.6-6.0), and was significantly higher among HIV-infected infants (22.4% vs. 6.3%; p<.001) and lower among HIV-unexposed uninfected infants (3.5% vs. 6.3%; p<.001) than among HIV-exposed uninfected infants. Similarly, SGAG was significantly more frequent among HIV-infected infants (aOR: 4.1; 2.0-8.1) and less frequent among HIV-unexposed uninfected infants (aOR: 0.5; 0.4-0.8) than among HIV-exposed uninfected infants. Primiparity (aOR: 1.9; 1.3-2.7) and the presence of any disease during pregnancy (aOR: 1.4; 1.0-2.0) were identified as other contributors to SGAG. Conclusion: Maternal HIV infection was independently associated with SGAG for HIV-exposed uninfected infants. This provides further evidence of the need for adapted monitoring of pregnancy in HIV-infected women, especially if they are symptomatic, to minimize additional risk factors for SGAG.	[Sofeu, Casimir Ledoux; Owona, Felicite; Tchendjou, Patrice; Texier, Gaetan; Tejiokem, Mathurin Cyrille] Membre Reseau Int Inst Pasteur, Ctr Pasteur Cameroun, Serv Epidemiol & Sante Publ, Yaounde, Cameroon; [Sofeu, Casimir Ledoux; Tchuente, Maurice] Univ Yaounde I, IRD UMI UMMISCO 209, Yaounde, Cameroon; [Sofeu, Casimir Ledoux; Tchuente, Maurice] Equipe Idasco, Lab Int Rech Informat & Math Appl, Yaounde, Cameroon; [Warszawski, Josiane; Tejiokem, Mathurin Cyrille] Equipe 4 VIH & IST INSERM U1018 CESP, Le Kremlin Bicetre, France; [Warszawski, Josiane] Hop Bicetre, AP HP, Serv Epidemiol & Sante Publ, Le Kremlin Bicetre, France; [Warszawski, Josiane] Univ Paris 11, Paris, France; [Ndongo, Francis Ateba; Guemkam, Georgette] Fdn Chantal Biya, Ctr Mere & Enfant, Yaounde, Cameroon; [Penda, Ida Calixte; Makwet, Nicaise] Hop Laquintinie, Hop Jour, Douala, Cameroon; [Penda, Ida Calixte] Univ Douala, Fac Med & Sci Pharmaceut, Douala, Cameroon; [Ndiang, Suzie Tetang] Ctr Hosp Essos, Serv Pediat, Yaounde, Cameroon; [Guemkam, Georgette] Hop Cent, Yaounde, Cameroon; [Kfutwah, Anfumbom] Membre Reseau Int Inst Pasteur, Serv Virol, Ctr Pasteur Cameroun, Yaounde, Cameroon; [Texier, Gaetan] Univ Aix Marseille, SESSTIM UMR 912, Marseille, France; [Faye, Albert] Hop Robert Debre, AP HP, F-75019 Paris, France; [Faye, Albert] Univ Paris 07, Sorbonne Paris Cite, Paris, France	Centre Pasteur du Cameroun; UDICE-French Research Universities; Sorbonne Universite; Cadi Ayyad University of Marrakech; Hanoi University of Science & Technology; Institut de Recherche pour le Developpement (IRD); University Cheikh Anta Diop Dakar; University of Yaounde I; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre Pasteur du Cameroun; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Tejiokem, MC (corresponding author), Membre Reseau Int Inst Pasteur, Ctr Pasteur Cameroun, Serv Epidemiol & Sante Publ, Yaounde, Cameroon.	tejiokem@pasteur-yaounde.org		Baril, Laurence/0000-0003-2346-883X; Penda, Calixte Ida/0000-0002-1070-2108	French National Agency for Research on AIDS and Viral Hepatitis (ANRS)	French National Agency for Research on AIDS and Viral Hepatitis (ANRS)(ANRSFrench National Research Agency (ANR))	This study is sponsored by the French National Agency for Research on AIDS and Viral Hepatitis (ANRS). The authors also acknowledge the material support of the "Fondation Total'' to this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey RC, 1999, INT J EPIDEMIOL, V28, P532, DOI 10.1093/ije/28.3.532; BBS/UNICEF, 2005, NAT LOW BIRTH WEIGHT; Bernstein PS, 1997, CLIN OBSTET GYNECOL, V40, P723, DOI 10.1097/00003081-199712000-00006; Briand N, 2006, PEDIATR INFECT DIS J, V25, P325, DOI 10.1097/01.inf.0000207398.10466.0d; Briand N, 2009, AIDS, V23, P1235, DOI 10.1097/QAD.0b013e32832be0df; Castetbon K, 1999, J TROP PEDIATRICS, V45, P152, DOI 10.1093/tropej/45.3.152; Clerici M, 2000, BLOOD, V96, P3866, DOI 10.1182/blood.V96.12.3866.h8003866_3866_3871; Dreyfuss ML, 2001, AM J CLIN NUTR, V74, P814; Ebrahim GJ, 1996, J TROP PEDIATRICS, V42, P62, DOI 10.1093/tropej/42.2.62; Ekouevi DK, 2008, AIDS, V22, P1815, DOI 10.1097/QAD.0b013e32830b8ab9; Faye A, 2007, CLIN EXP IMMUNOL, V149, P430, DOI 10.1111/j.1365-2249.2007.03411.x; Filteau S, 2009, TROP MED INT HEALTH, V14, P276, DOI 10.1111/j.1365-3156.2009.02220.x; Floridia M, 2008, HIV CLIN TRIALS, V9, P287, DOI 10.1310/hct0905-287; Isanaka S, 2009, NUTR REV, V67, P343, DOI 10.1111/j.1753-4887.2009.00207.x; Kalanda B. F., 2005, Archives of Disease in Childhood Fetal and Neonatal Edition, V90, pF161, DOI 10.1136/adc.2004.054650; Kfutwah A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008114; Kourtis AP, 2001, JAMA-J AM MED ASSOC, V285, P709, DOI 10.1001/jama.285.6.709; Lee PA, 2003, PEDIATRICS, V111, P1253, DOI 10.1542/peds.111.6.1253; Lepage P, 1996, PEDIATR INFECT DIS J, V15, P479, DOI 10.1097/00006454-199606000-00003; Makasa M, 2007, TROP MED INT HEALTH, V12, P594, DOI 10.1111/j.1365-3156.2007.01836.x; Marinda E, 2007, PEDIATR INFECT DIS J, V26, P519, DOI 10.1097/01.inf.0000264527.69954.4c; McGrath CJ, 2012, J NUTR, V142, P757, DOI 10.3945/jn.111.148874; McNally LM, 2007, LANCET, V369, P1440, DOI 10.1016/S0140-6736(07)60670-9; Moye J, 1996, J PEDIATR-US, V128, P58, DOI 10.1016/S0022-3476(96)70428-6; Mwanyumba F, 2001, J Obstet Gynaecol, V21, P27, DOI 10.1080/01443610020022078; Naniche D, 2009, AM J TROP MED HYG, V80, P870, DOI 10.4269/ajtmh.2009.80.870; Ndirangu J, 2012, HUM REPROD, V27, P1846, DOI 10.1093/humrep/des090; Newell ML, 2003, JAIDS-J ACQ IMM DEF, V32, P380, DOI 10.1097/00126334-200304010-00006; Rollins NC, 2007, JAIDS-J ACQ IMM DEF, V44, P321, DOI 10.1097/QAI.0b013e31802ea4b0; RYDER RW, 1989, NEW ENGL J MED, V320, P1637, DOI 10.1056/NEJM198906223202501; Sombie I, 1999, Sante, V9, P173; Stengel B, 1995, EPIDEMIOLOGIE PRINCI; Stratton P, 1999, J ACQ IMMUN DEF SYND, V20, P179, DOI 10.1097/00042560-199902010-00011; Tejiokem MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021840; Townsend CL, 2007, AIDS, V21, P1019, DOI 10.1097/QAD.0b013e328133884b; Venkatesh KK, 2010, TROP MED INT HEALTH, V15, P1364, DOI 10.1111/j.1365-3156.2010.02634.x; Verhoeff FH, 2001, EUR J CLIN NUTR, V55, P682, DOI 10.1038/sj.ejcn.1601200; Watson-Jones D, 2007, B WORLD HEALTH ORGAN, V85, P9, DOI 10.2471/BLT.06.033258; Wei RL, 2004, PEDIATR INFECT DIS J, V23, P530, DOI 10.1097/01.inf.0000129691.42964.eb; WHO, 2006, MED ANT TRAIT FEMM E	40	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93554	10.1371/journal.pone.0093554	http://dx.doi.org/10.1371/journal.pone.0093554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24705410	Green Submitted, gold, Green Published			2022-12-25	WOS:000334105000067
J	Audouze, K; Tromelin, A; Le Bon, AM; Belloir, C; Petersen, RK; Kristiansen, K; Brunak, S; Taboureau, O				Audouze, Karine; Tromelin, Anne; Le Bon, Anne Marie; Belloir, Christine; Petersen, Rasmus Koefoed; Kristiansen, Karsten; Brunak, Soren; Taboureau, Olivier			Identification of Odorant-Receptor Interactions by Global Mapping of the Human Odorome	PLOS ONE			English	Article							FUNCTIONAL EXPRESSION; OLFACTORY RECEPTORS; MOLECULAR-BASIS; NETWORK; SMELL; DATABASE; BIOLOGY; REPERTOIRE; MODULATION; LIGANDS	The human olfactory system recognizes a broad spectrum of odorants using approximately 400 different olfactory receptors ( hORs). Although significant improvements of heterologous expression systems used to study interactions between ORs and odorant molecules have been made, screening the olfactory repertoire of hORs remains a tremendous challenge. We therefore developed a chemical systems level approach based on protein-protein association network to investigate novel hOR-odorant relationships. Using this new approach, we proposed and validated new bioactivities for odorant molecules and OR2W1, OR51E1 and OR5P3. As it remains largely unknown how human perception of odorants influence or prevent diseases, we also developed an odorant-protein matrix to explore global relationships between chemicals, biological targets and disease susceptibilities. We successfully experimentally demonstrated interactions between odorants and the cannabinoid receptor 1 (CB1) and the peroxisome proliferator-activated receptor gamma ( PPAR gamma). Overall, these results illustrate the potential of integrative systems chemical biology to explore the impact of odorant molecules on human health, i.e. human odorome.	[Audouze, Karine; Brunak, Soren; Taboureau, Olivier] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Tromelin, Anne; Le Bon, Anne Marie; Belloir, Christine] Univ Bourgogne, INRA UMR1324, CNRS UMR6265, Ctr Sci Gout & Alimentat, Dijon, France; [Petersen, Rasmus Koefoed; Kristiansen, Karsten] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Taboureau, Olivier] Paris Diderot Univ, INSERM, UMR S973, Paris, France	Technical University of Denmark; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; University of Copenhagen; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Taboureau, O (corresponding author), Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark.	otab@cbs.dtu.dk	Kristiansen, Karsten/J-5148-2014; Audouze, Karine/AAU-5996-2020; Tromelin, Anne/A-2722-2009; Brunak, Soren/O-6621-2016	Kristiansen, Karsten/0000-0002-6024-0917; Audouze, Karine/0000-0001-7525-4089; Tromelin, Anne/0000-0002-3322-951X; Brunak, Soren/0000-0003-0316-5866	GENDINOB project; Danish Council for Strategic Research; Innovative Medicines Initiative Joint Undertaking (IMI-JU) [115002]	GENDINOB project; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Innovative Medicines Initiative Joint Undertaking (IMI-JU)	The work was supported by the GENDINOB project granted by the Danish Council for Strategic Research and the Innovative Medicines Initiative Joint Undertaking (IMI-JU) for the eTOX project (115002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adipietro KA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002821; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Araneda RC, 2004, J PHYSIOL-LONDON, V555, P743, DOI 10.1113/jphysiol.2003.058040; Arctander S., 1969, PERFUME FLAVOR CHEM, VI; Audouze K, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000788; Baba T, 2011, MOVEMENT DISORD, V26, P621, DOI 10.1002/mds.23602; Bachtiar LR, 2013, NEURAL COMPUT, V25, P259, DOI 10.1162/NECO_a_00386; Baraldi PG, 2010, J MED CHEM, V53, P5085, DOI 10.1021/jm100062h; Bassaganya-Riera J, 2010, CURR OPIN CLIN NUTR, V13, P569, DOI 10.1097/MCO.0b013e32833b648e; Bellocchio L, 2006, CURR OPIN PHARMACOL, V6, P586, DOI 10.1016/j.coph.2006.09.001; Benbernou N, 2007, J HERED, V98, P500, DOI 10.1093/jhered/esm054; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Binkowski BF, 2011, METHODS MOL BIOL, V756, P263, DOI 10.1007/978-1-61779-160-4_14; Bonferroni CE, 1935, STUDI ONORE PROFESSO, P13; Boyle SM, 2013, ELIFE, V2, DOI 10.7554/eLife.01120; Breunig E, 2010, RESULTS PROBL CELL D, V52, P139, DOI 10.1007/978-3-642-14426-4_11; Brown RD, 1996, J CHEM INF COMP SCI, V36, P572, DOI 10.1021/ci9501047; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412; Cases M, 2009, DRUG DISCOV TODAY, V14, P479, DOI 10.1016/j.drudis.2009.02.010; Castro JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073289; Christensen KB, 2010, PHYTOTHER RES, V24, pS129, DOI 10.1002/ptr.3005; Cravatt BF, 2003, CURR OPIN CHEM BIOL, V7, P469, DOI 10.1016/S1367-5931(03)00079-6; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Deeb J, 2010, QJM-INT J MED, V103, P941, DOI 10.1093/qjmed/hcq142; DeMaria S, 2010, J CELL BIOL, V191, P443, DOI 10.1083/jcb.201008163; Du HZ, 2011, BRIT J PHARMACOL, V163, P1533, DOI 10.1111/j.1476-5381.2011.01444.x; Furudono Y, 2009, CHEM SENSES, V34, P151, DOI 10.1093/chemse/bjn071; Gautam H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044781; Goldsmith BR, 2011, ACS NANO, V5, P5408, DOI 10.1021/nn200489j; Golebiowski J, 2012, FLAVOUR FRAG J, V27, P445, DOI 10.1002/ffj.3121; Grandjean P, 2011, ENV HLTH, V10; Haddad R, 2008, NAT METHODS, V5, P425, DOI [10.1038/nmeth.1197, 10.1038/NMETH.1197]; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Jacquier V, 2006, J NEUROCHEM, V97, P537, DOI 10.1111/j.1471-4159.2006.03771.x; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Kessler A, 2012, FLAVOUR FRAG J, V27, P297, DOI 10.1002/ffj.3099; Khan RM, 2007, J NEUROSCI, V27, P10015, DOI 10.1523/JNEUROSCI.1158-07.2007; Kjaerulff SK, 2013, NUCLEIC ACIDS RES, V41, pD464, DOI 10.1093/nar/gks1166; Kraft P, 2000, ANGEW CHEM INT EDIT, V39, P2981; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lage K, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.36; Launay G, 2012, PROTEIN ENG DES SEL, V25, P377, DOI 10.1093/protein/gzs037; Liu XY, 2011, BIOINFORMATICS, V27, P2302, DOI 10.1093/bioinformatics/btr385; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Martinez-Mayorga K, 2011, J CHEMOMETR, V25, P550, DOI 10.1002/cem.1399; Matsui A, 2010, MOL BIOL EVOL, V27, P1192, DOI 10.1093/molbev/msq003; Mori K, 2003, BIOCHEM SOC T, V31, P134, DOI 10.1042/bst0310134; Nara K, 2011, J NEUROSCI, V31, P9179, DOI 10.1523/JNEUROSCI.1282-11.2011; Neuhaus W, 2008, PLANTA MED, V74, P1338, DOI 10.1055/s-2008-1081343; O'Donovan C, 2011, METHODS MOL BIOL, V694, P25, DOI 10.1007/978-1-60761-977-2_2; Oprea TI, 2007, NAT CHEM BIOL, V3, P447, DOI 10.1038/nchembio0807-447; Ortega-Hernandez OD, 2009, AUTOIMMUNITY, V42, P80, DOI 10.1080/08916930802366140; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Passali GC, 2008, CURR OPIN ALLERGY CL, V8, P238, DOI 10.1097/ACI.0b013e3282ffd6bb; Penkett CJ, 2006, NUCLEIC ACIDS RES, V34, pW330, DOI 10.1093/nar/gkl311; Pick H, 2009, J BIOL CHEM, V284, P30547, DOI 10.1074/jbc.M109.040964; Ruijschop RMAJ, 2010, CHEM SENSES, V35, P91, DOI 10.1093/chemse/bjp086; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Sanz G, 2008, CHEM SENSES, V33, P639, DOI 10.1093/chemse/bjn032; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; SCHIFFMAN SS, 1974, ANN NY ACAD SCI, V237, P164, DOI 10.1111/j.1749-6632.1974.tb49852.x; Schiniedeberg K, 2007, J STRUCT BIOL, V159, P400, DOI 10.1016/j.jsb.2007.04.013; Schmuker M, 2007, CHEM CENT J, V1, DOI 10.1186/1752-153X-1-11; Skoufos E, 2000, NUCLEIC ACIDS RES, V28, P341, DOI 10.1093/nar/28.1.341; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stary A, 2007, BIOCHEM BIOPH RES CO, V361, P941, DOI 10.1016/j.bbrc.2007.07.137; Stevenson RJ, 2003, PSYCHOL REV, V110, P340, DOI 10.1037/0033-295X.110.2.340; Stevenson RJ, 2005, PSYCHON B REV, V12, P244, DOI 10.3758/BF03196369; Stevenson RJ, 2001, Q J EXP PSYCHOL-A, V54, P561, DOI 10.1080/02724980042000246; Taboureau O, 2011, NUCLEIC ACIDS RES, V39, pD367, DOI 10.1093/nar/gkq906; Vandevoorde S, 2003, J MED CHEM, V46, P4373, DOI 10.1021/jm0340795; Wetzel CH, 2001, P NATL ACAD SCI USA, V98, P9377, DOI 10.1073/pnas.151103998; Zarzo M, 2007, BIOL REV, V82, P455, DOI 10.1111/j.1469-185X.2007.00019.x; Zhuang HY, 2007, J BIOL CHEM, V282, P15284, DOI 10.1074/jbc.M700386200	80	32	32	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93037	10.1371/journal.pone.0093037	http://dx.doi.org/10.1371/journal.pone.0093037			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LC	24695519	gold, Green Published			2022-12-25	WOS:000334103000035
J	Dias, T; Clemente, A; Martins-Loucao, MA; Sheppard, L; Bobbink, R; Cruz, C				Dias, Teresa; Clemente, Adelaide; Martins-Loucao, Maria Amelia; Sheppard, Lucy; Bobbink, Roland; Cruz, Cristina			Ammonium as a Driving Force of Plant Diversity and Ecosystem Functioning: Observations Based on 5 Years' Manipulation of N Dose and Form in a Mediterranean Ecosystem	PLOS ONE			English	Article							ATMOSPHERIC NITROGEN DEPOSITION; SPECIES RICHNESS; BIODIVERSITY HOTSPOTS; BIOMASS PRODUCTION; SOIL; PRODUCTIVITY; HETEROGENEITY; DECOMPOSITION; VARIABILITY; SATURATION	Enhanced nitrogen (N) availability is one of the main drivers of biodiversity loss and degradation of ecosystem functions. However, in very nutrient-poor ecosystems, enhanced N input can, in the short-term, promote diversity. Mediterranean Basin ecosystems are nutrient-limited biodiversity hotspots, but no information is available on their medium-or long-term responses to enhanced N input. Since 2007, we have been manipulating the form and dose of available N in a Mediterranean Basin maquis in south-western Europe that has low ambient N deposition (<4 kg N ha(-1) yr(-1)) and low soil N content (0.1%). N availability was modified by the addition of 40 kg N ha(-1) yr(-1) as a 1: 1 NH4Cl to (NH4)(2)SO4 mixture, and 40 and 80 kg N ha(-1) yr(-1) as NH4NO3. Over the following 5 years, the impacts on plant composition and diversity (richness and evenness) and some ecosystem characteristics (soil extractable N and organic matter, aboveground biomass and % of bare soil) were assessed. Plant species richness increased with enhanced N input and was more related to ammonium than to nitrate. Exposure to 40 kg NH4+-N ha(-1) yr(-1) (alone and with nitrate) enhanced plant richness, but did not increase aboveground biomass; soil extractable N even increased under 80 kg NH4NO3-N ha(-1) yr(-1) and the % of bare soil increased under 40 kg NH4(+)-N ha(-1) yr(-1). The treatment containing less ammonium, 40 kg NH4NO3-N ha(-1) yr(-1), did not enhance plant diversity but promoted aboveground biomass and reduced the % of bare soil. Data suggest that enhanced NHy availability affects the structure of the maquis, which may promote soil erosion and N leakage, whereas enhanced NOx availability leads to biomass accumulation which may increase the fire risk. These observations are relevant for land use management in biodiverse and fragmented ecosystems such as the maquis, especially in conservation areas.	[Dias, Teresa; Clemente, Adelaide; Martins-Loucao, Maria Amelia; Cruz, Cristina] Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, Lisbon, Portugal; [Clemente, Adelaide] Museu Nacl Histo Nat & Ciencia, Lisbon, Portugal; [Sheppard, Lucy] Ctr Ecol & Hydrol, Edinburgh, Midlothian, Scotland; [Martins-Loucao, Maria Amelia] Radboud Univ Nijmegen, B Ware Res Ctr, NL-6525 ED Nijmegen, Netherlands	Universidade de Lisboa; UK Centre for Ecology & Hydrology (UKCEH); Radboud University Nijmegen	Dias, T (corresponding author), Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, Lisbon, Portugal.	mtdias@fc.ul.pt	Dias, Teresa/E-8816-2015; Martins-Loução, Maria Amélia/H-1994-2011; Cruz, Cristina/F-2643-2011	Dias, Teresa/0000-0002-5421-4763; Martins-Loução, Maria Amélia/0000-0002-5883-2462; Bobbink, Roland/0000-0003-1994-6085; Clemente, Adelaide/0000-0002-8961-4791; Cruz, Cristina/0000-0003-3100-463X	Fundacao para a Ciencia e Tecnologia (FCT) [PTDC/BIA-BEC/099323/2008, PTDC/BIA-ECS/122214/2010]; Natural Environment Research Council [ceh010010] Funding Source: researchfish	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by the Fundacao para a Ciencia e Tecnologia (FCT) through the projects PTDC/BIA-BEC/099323/2008 and PTDC/BIA-ECS/122214/2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EB, 2005, AIR POLLUTION VEGETA; Allen EB, 2007, THESCIENTIFICWORLDJO, V7, P247, DOI 10.1100/tsw.2007.72; Blondel J., 1999, Biology and wildlife of the Mediterranean region.; Bobbink R, 2010, ECOL APPL, V20, P30, DOI 10.1890/08-1140.1; Bobbink R., 2011, REV REVISION EMPIRIC; Bonanomi G, 2006, ACTA OECOL, V30, P419, DOI 10.1016/j.actao.2006.06.007; Bonet A, 2004, PLANT ECOL, V174, P257, DOI 10.1023/B:VEGE.0000049106.96330.9c; Caldeira MC, 2005, OIKOS, V110, P115, DOI 10.1111/j.0030-1299.2005.13873.x; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Casals P, 2005, BIOGEOCHEMISTRY, V76, P477, DOI 10.1007/s10533-005-8659-1; Clemente AS, 2005, ACTA OECOL, V27, P233, DOI 10.1016/j.actao.2005.01.005; Cowling RM, 1996, TRENDS ECOL EVOL, V11, P362, DOI 10.1016/0169-5347(96)10044-6; Cruz C, 2008, ENVIRON POLLUT, V154, P414, DOI 10.1016/j.envpol.2007.12.007; De Schrijver A, 2008, NATURE, V451, pE1, DOI 10.1038/nature06578; De Schrijver A, 2011, GLOBAL ECOL BIOGEOGR, V20, P803, DOI 10.1111/j.1466-8238.2011.00652.x; Dias T, 2012, BIOGEOSCIENCES, V9, P193, DOI 10.5194/bg-9-193-2012; Dias T, 2013, SOIL BIOL BIOCHEM, V58, P163, DOI 10.1016/j.soilbio.2012.10.027; Dias T, 2011, PLANT SOIL, V347, P363, DOI 10.1007/s11104-011-0856-1; Dias T, 2011, PLANT SOIL, V341, P125, DOI 10.1007/s11104-010-0628-3; Fanelli G, 2008, PLANT ECOL, V194, P231, DOI 10.1007/s11258-007-9287-8; Fenn ME, 2010, J ENVIRON MANAGE, V91, P2404, DOI 10.1016/j.jenvman.2010.07.034; Fenn ME, 2003, BIOSCIENCE, V53, P404, DOI [10.1641/0006-3568(2003)053[0404:EEONDI]2.0.CO;2, 10.1641/0006-3568(2003)053[0391:NEDAMI]2.0.CO;2]; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Isbell F, 2013, P NATL ACAD SCI USA, V110, P11911, DOI 10.1073/pnas.1310880110; Jiang L, 2009, J ECOL, V97, P603, DOI 10.1111/j.1365-2745.2009.01503.x; Jones A, 2012, STATE SOIL EUROPE; Klausmeyer KR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006392; Knorr M, 2005, ECOLOGY, V86, P3252, DOI 10.1890/05-0150; Krebs C. J., 2014, ECOLOGICAL METHODOLO; LAVOREL S, 1994, OIKOS, V71, P75, DOI 10.2307/3546174; LAVOREL S, 1994, OIKOS, V70, P455, DOI 10.2307/3545786; Lavorel S., 1999, DIVERS DISTRIB, V5, P3, DOI [10.1046/j.1472-4642.1999.00033.x, DOI 10.1046/J.1472-4642.1999.00033.X]; Lopez-Bermudez F, 2006, NATO SCI PEACE SECUR, V3, P401; MacDougall AS, 2013, NATURE, V494, P86, DOI 10.1038/nature11869; Martins-Loucao M. A, 2000, DETERMINATION AMMONI; Matsumura S, 1999, SOIL SCI PLANT NUTR, V45, P231, DOI 10.1080/00380768.1999.10409338; Meixner T, 2006, ENVIRON SCI TECHNOL, V40, P2887, DOI 10.1021/es051268z; Meixner T, 2004, BIOGEOCHEMISTRY, V70, P331, DOI 10.1007/s10533-003-4106-3; Michalet R, 2006, ECOL LETT, V9, P767, DOI 10.1111/j.1461-0248.2006.00935.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nilsson J., 1988, CRITICAL LOADS SULPH; Ochoa-Hueso R, 2011, EFECTOS DEPOSICION A; Ochoa-Hueso R, 2011, ENVIRON POLLUT, V159, P2265, DOI 10.1016/j.envpol.2010.12.019; Padgett PE, 1999, ATMOS ENVIRON, V33, P769, DOI 10.1016/S1352-2310(98)00214-3; Phoenix GK, 2012, GLOBAL CHANGE BIOL, V18, P1197, DOI 10.1111/j.1365-2486.2011.02590.x; Phoenix GK, 2006, GLOBAL CHANGE BIOL, V12, P470, DOI 10.1111/j.1365-2486.2006.01104.x; PIMENTEL D, 1995, SCIENCE, V267, P1117, DOI 10.1126/science.267.5201.1117; RIGGAN PJ, 1988, ECOL MONOGR, V58, P155, DOI 10.2307/2937023; Rivas-Martinez S., 2004, BIOBLIMATIC MAP EURO; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sardans J, 2008, GLOBAL CHANGE BIOL, V14, P2304, DOI 10.1111/j.1365-2486.2008.01656.x; Schultz J, 1995, ECOZONES WORLD ECOLO, Vi-x, P1; Southon GE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059031; SPECHT RL, 1988, MEDITERRANEAN TYPE E; Stevens CJ, 2011, ENVIRON MANAGE, V48, P885, DOI 10.1007/s00267-011-9745-x; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; Thompson J., 2005, PLANT EVOLUTION MEDI, DOI DOI 10.1093/ACPROF:OSO/9780198515340.001.0001; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Trabaud L., 1994, ROLE FIRE MEDITERRAN, P1, DOI DOI 10.1007/978-1-4613-8395-6_1; Trabaud L, 1987, ECOLOGIA MEDITERRANE, V13, P25, DOI DOI 10.3406/ECMED.1987.1186; Tylianakis JM, 2008, PLOS BIOL, V6, P947, DOI 10.1371/journal.pbio.0060122; Vourlitis GL, 2009, ECOSYSTEMS, V12, P473, DOI 10.1007/s10021-009-9236-6; [No title captured]	65	18	18	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e92517	10.1371/journal.pone.0092517	http://dx.doi.org/10.1371/journal.pone.0092517			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695101	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000334103000020
J	Shi, Y; Luo, LF; Liu, XM; Zhou, Q; Xu, SZ; Lei, TC				Shi, Ying; Luo, Long-Fei; Liu, Xiao-Ming; Zhou, Qiong; Xu, Shi-Zheng; Lei, Tie-Chi			Premature Graying as a Consequence of Compromised Antioxidant Activity in Hair Bulb Melanocytes and Their Precursors	PLOS ONE			English	Article							STEM-CELLS; FOLLICLE PIGMENTATION; NICHE; SKIN; MELANOGENESIS; TRANSPLANTATION; KERATINOCYTES; EXPRESSION; GROWTH; REGION	Intricate coordinated mechanisms that govern the synchrony of hair growth and melanin synthesis remain largely unclear. These two events can be uncoupled in prematurely gray hair, probably due to oxidative insults that lead to the death of oxidative stress-sensitive melanocytes. In this study, we examined the gene expression profiles of middle (bulge) and lower (hair bulb) segments that had been micro-dissected from unpigmented and from normally pigmented hair follicles from the same donors using quantitative real-time RT-PCR (qPCR) arrays. We found a significant down-regulation of melanogenesis-related genes (TYR, TYRP1, MITF, PAX3, POMC) in unpigmented hair bulbs and of marker genes typical for melanocyte precursor cells (PAX3, SOX10, DCT) in unpigmented mid-segments compared with their pigmented analogues. qPCR, western blotting and spin trapping assays revealed that catalase protein expression and hydroxyl radical scavenging activities are strongly repressed in unpigmented hair follicles. These data provide the first clear evidence that compromised antioxidant activity in gray hair follicles simultaneously affects mature hair bulb melanocytes and their immature precursor cells in the bulge region.	[Shi, Ying; Luo, Long-Fei; Liu, Xiao-Ming; Zhou, Qiong; Xu, Shi-Zheng; Lei, Tie-Chi] Wuhan Univ, Renmin Hosp, Dept Dermatol, Wuhan 430072, Hubei Province, Peoples R China	Wuhan University	Lei, TC (corresponding author), Wuhan Univ, Renmin Hosp, Dept Dermatol, Wuhan 430072, Hubei Province, Peoples R China.	tchlei@whu.edu.cn	LEI, TIE-CHI/AAE-4276-2020	Lei, Tie-Chi/0000-0003-2304-827X	National Natural Science Foundation of China [8107138]; CMA-L'Oreal China Hair Grant [H2010040414]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CMA-L'Oreal China Hair Grant	This work was supported by grants from the National Natural Science Foundation of China (No. 8107138) and a CMA-L'Oreal China Hair Grant (No. H2010040414). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arck PC, 2006, FASEB J, V20, P1567, DOI 10.1096/fj.05-4039fje; Chang CY, 2013, NATURE, V495, P98, DOI 10.1038/nature11847; Choi HI, 2011, BRIT J DERMATOL, V165, P1183, DOI 10.1111/j.1365-2133.2011.10625.x; Commo S, 2004, BRIT J DERMATOL, V150, P435, DOI 10.1046/j.1365-2133.2004.05787.x; Erdogan T, 2013, INTERNAL MED, V52, P29, DOI 10.2169/internalmedicine.52.7842; Gho CG, 2010, J DERMATOL TREAT, V21, P337, DOI 10.3109/09546630903359814; Harris ML, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003644; Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jiang S, 2010, FREE RADICAL BIO MED, V48, P1144, DOI 10.1016/j.freeradbiomed.2010.01.033; Kauser S, 2011, J INVEST DERMATOL, V131, P979, DOI 10.1038/jid.2010.397; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Liu XM, 2011, FREE RADICAL BIO MED, V50, P1177, DOI 10.1016/j.freeradbiomed.2011.01.017; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Nishimura EK, 2011, PIGM CELL MELANOMA R, V24, P401, DOI 10.1111/j.1755-148X.2011.00855.x; Onda M, 2008, DERMATOL SURG, V34, P1683, DOI 10.1111/j.1524-4725.2008.34346.x; Panhard S, 2012, BRIT J DERMATOL, V167, P865, DOI 10.1111/j.1365-2133.2012.11095.x; PLONKA P, 1995, ARCH DERMATOL RES, V287, P687, DOI 10.1007/BF00371744; Plonka PM, 2009, EXP DERMATOL, V18, P472, DOI 10.1111/j.1600-0625.2009.00883.x; Rendl M, 2008, GENE DEV, V22, P543, DOI 10.1101/gad.1614408; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; Slominski A, 2005, J INVEST DERMATOL, V124, P13, DOI 10.1111/j.0022-202X.2004.23528.x; SLOMINSKI A, 1994, J INVEST DERMATOL, V102, P862, DOI 10.1111/1523-1747.ep12382606; SLOMINSKI A, 1991, J INVEST DERMATOL, V96, P172, DOI 10.1111/1523-1747.ep12460956; Sviderskaya EV, 2009, FASEB J, V23, P3179, DOI 10.1096/fj.08-123596; Tobin D. J., 2008, International Journal of Cosmetic Science, V30, P233, DOI 10.1111/j.1468-2494.2008.00456.x; Tobin DJ, 2011, PIGM CELL MELANOMA R, V24, P75, DOI 10.1111/j.1755-148X.2010.00803.x; Tobin Desmond J, 2009, Int J Trichology, V1, P83, DOI 10.4103/0974-7753.58550; Wang X, 2012, J HUAZHONG U SCI-MED, V32, P648, DOI 10.1007/s11596-012-1012-8; Waseem A, 1999, J INVEST DERMATOL, V112, P362, DOI 10.1046/j.1523-1747.1999.00535.x; Wood JM, 2009, FASEB J, V23, P2065, DOI 10.1096/fj.08-125435; Yu H, 2010, J INVEST DERMATOL, V130, P1227, DOI 10.1038/jid.2009.322	33	26	27	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93589	10.1371/journal.pone.0093589	http://dx.doi.org/10.1371/journal.pone.0093589			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695442	Green Submitted, Green Published, gold			2022-12-25	WOS:000334103000091
J	Chen, YP; Ye, Y				Chen, Yaping; Ye, Yong			Effects of Salinity and Nutrient Addition on Mangrove Excoecaria agallocha	PLOS ONE			English	Article							VS. PHOSPHORUS LIMITATION; AVICENNIA-MARINA; KANDELIA-CANDEL; SALT TOLERANCE; SPARTINA-ALTERNIFLORA; RHIZOPHORA-STYLOSA; LEAF DEMOGRAPHY; SODIUM-CHLORIDE; GROWTH; RESPONSES	Effects of salinity on seed germination and growth of young (1 month old) and old (2-year old) seedlings of Excoecaria agallocha were investigated. Combined effects of salinity and nutrient level were also examined on old seedlings. Seed germination was best at 0 and 5 psu salinity. 15 psu salinity significantly delayed root initiation and decreased final establishment rate. All seeds failed to establish at 25 psu salinity. Young seedlings performed best at 0 and 5 psu, but growth was stunned at 15 psu, and all seedlings died within 90 days at 25 psu. Old seedlings grew best at salinities below 5 psu and they survived the whole cultivation at 25 psu. This indicated that E. agallocha increased salt tolerance over time. Gas exchange was significantly compromised by salinities above 15 psu but evidently promoted by high nutrient. Proline accumulated considerably at high nutrient, and its contents increased from 0 to 15 psu but decreased at 25 psu salinity. Lipid peroxidation was aggravated by increasing salinity beyond 15 psu but markedly alleviated by nutrient addition. These responses indicated that E. agallocha was intolerant to high salinity but it can be greatly enhanced by nutrient addition.	[Chen, Yaping; Ye, Yong] Xiamen Univ, Coll Environm & Ecol, Minist Educ Coastal & Wetland Ecosyst, Key Lab, Xiamen, Fujian, Peoples R China	Xiamen University	Ye, Y (corresponding author), Xiamen Univ, Coll Environm & Ecol, Minist Educ Coastal & Wetland Ecosyst, Key Lab, Xiamen, Fujian, Peoples R China.	yeyong@xmu.edu.cn			National Natural Science Foundation of China [41276077, 41076049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by projects funded by National Natural Science Foundation of China (Grant No. 41276077 and 41076049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abari A. K., 2011, African Journal of Plant Science, V5, P52; AEBI H, 1984, METHOD ENZYMOL, V105, P121; BALL MC, 1995, FUNCT ECOL, V9, P77, DOI 10.2307/2390093; BALL MC, 1984, PLANT PHYSIOL, V74, P1, DOI 10.1104/pp.74.1.1; Ball MC, 1999, PHYSIOLOGICAL PLANT ECOLOGY, P331; BALL MC, 1986, AUST J PLANT PHYSIOL, V13, P689, DOI 10.1071/PP9860689; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Benabderrahim MA, 2011, SPAN J AGRIC RES, V9, P135; CAVALIERI AJ, 1981, OECOLOGIA, V49, P224, DOI 10.1007/BF00349192; Chandrasekaran M, 2009, WORLD J MICROB BIOT, V25, P155, DOI 10.1007/s11274-008-9869-1; Chen YP, 2013, MAR ECOL PROG SER, V482, P107, DOI 10.3354/meps10274; Cheng H, 2012, ENVIRON POLLUT, V164, P110, DOI 10.1016/j.envpol.2012.01.034; CHOW WS, 1990, AUST J PLANT PHYSIOL, V17, P563, DOI 10.1071/PP9900563; CLOUGH BF, 1989, OECOLOGIA, V79, P38, DOI 10.1007/BF00378237; CLOUGH BF, 1984, AUST J PLANT PHYSIOL, V11, P419, DOI 10.1071/PP9840419; Dasgupta N, 2012, TREES-STRUCT FUNCT, V26, P377, DOI 10.1007/s00468-011-0599-x; Dasgupta N, 2011, ACTA PHYSIOL PLANT, V33, P803, DOI 10.1007/s11738-010-0605-8; Dasgupta N, 2010, J PLANT INTERACT, V5, P211, DOI 10.1080/17429140903438076; Ellison AM, 1997, OECOLOGIA, V112, P435, DOI 10.1007/s004420050330; FEIGIN A, 1985, PLANT SOIL, V89, P285, DOI 10.1007/BF02182248; Feller IC, 2003, BIOGEOCHEMISTRY, V62, P145, DOI 10.1023/A:1021166010892; Feller IC, 1999, ECOLOGY, V80, P2193, DOI 10.1890/0012-9658(1999)080[2193:EONEOW]2.0.CO;2; FLOWERS TJ, 1977, ANNU REV PLANT PHYS, V28, P89, DOI 10.1146/annurev.pp.28.060177.000513; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; [何奋琳 He Fenlin], 2004, [环境科学与技术, Enuivonmental science and technology], V27, P81; Hoagland D.R., 1950, WATER CULTURE METHOD, V347, P1, DOI DOI 10.1007/S12374-010-9112-0; Hunt R., 1978, Plant growth analysis.; Kao WY, 2001, J PLANT PHYSIOL, V158, P841, DOI 10.1078/0176-1617-00248; Khan MA, 2003, AM J BOT, V90, P131, DOI 10.3732/ajb.90.1.131; Khan MA, 2000, J ARID ENVIRON, V45, P73, DOI 10.1006/jare.1999.0617; Krauss KW, 2003, FOREST ECOL MANAG, V176, P49, DOI 10.1016/S0378-1127(02)00219-0; Leblebici Z, 2011, WATER AIR SOIL POLL, V214, P175, DOI 10.1007/s11270-010-0413-1; Li MY, 2009, NAT PROD REP, V26, P281, DOI 10.1039/b816245j; Li NY, 2008, AQUAT BOT, V88, P303, DOI 10.1016/j.aquabot.2007.12.003; Lin CC, 2010, J HAZARD MATER, V174, P202, DOI 10.1016/j.jhazmat.2009.09.137; Lovelock CE, 2006, PLANT CELL ENVIRON, V29, P793, DOI 10.1111/j.1365-3040.2005.01446.x; Lovelock CE, 2004, FUNCT ECOL, V18, P25, DOI 10.1046/j.0269-8463.2004.00805.x; Lovelock CE, 2003, OECOLOGIA, V134, P455, DOI 10.1007/s00442-002-1118-y; Macfarlane GR, 2001, MAR POLLUT BULL, V42, P233, DOI 10.1016/S0025-326X(00)00147-8; McKee KL, 2002, ECOLOGY, V83, P1065, DOI 10.2307/3071914; Medina E, 1997, ESTUAR COAST SHELF S, V45, P337, DOI 10.1006/ecss.1996.0188; Meloni DA, 2003, ENVIRON EXP BOT, V49, P69, DOI 10.1016/S0098-8472(02)00058-8; Mimura T, 2003, PLANTA, V216, P397, DOI 10.1007/s00425-002-0878-2; MUNNS R, 1986, AUST J PLANT PHYSIOL, V13, P143, DOI 10.1071/PP9860143; Naidoo G, 2006, ANN BOT-LONDON, V97, P1095, DOI 10.1093/aob/mcl064; NAIDOO G, 1992, AM J BOT, V79, P765, DOI 10.2307/2444942; NAIDOO G, 1987, NEW PHYTOL, V107, P317, DOI 10.1111/j.1469-8137.1987.tb00183.x; Naidoo G, 2011, FLORA, V206, P814, DOI 10.1016/j.flora.2011.04.009; Nandy (Datta) Paramita, 2007, Wetlands Ecology and Management, V15, P347, DOI 10.1007/s11273-007-9036-8; Nandy (Datta) Paramita, 2009, Physiology and Molecular Biology of Plants, V15, P151, DOI 10.1007/s12298-009-0017-7; Nandy Paramita, 2005, Acta Botanica Croatica, V64, P331; Nardini A, 2000, TREES-STRUCT FUNCT, V15, P14, DOI 10.1007/s004680000071; Nemati SH., 2011, J BIOL ENV SCI, V5, P159, DOI DOI 10.1007/S12298-011-0097-Z; Parida AK, 2004, J PLANT PHYSIOL, V161, P921, DOI 10.1016/j.jplph.2003.11.006; Parida AK, 2004, TREES-STRUCT FUNCT, V18, P167, DOI 10.1007/s00468-003-0293-8; Patel NT, 2010, AQUAT BOT, V93, P9, DOI 10.1016/j.aquabot.2010.02.002; Popp M, 1996, J EXP BOT, V47, P1469, DOI 10.1093/jxb/47.10.1469; POPP M, 1985, VEGETATIO, V61, P247; POPP M, 1984, Z PFLANZENPHYSIOL, V113, P395, DOI 10.1016/S0044-328X(84)80096-3; Prochazkova D, 2007, BIOL PLANTARUM, V51, P401, DOI 10.1007/s10535-007-0088-7; Prochazkova D, 2001, PLANT SCI, V161, P765, DOI 10.1016/S0168-9452(01)00462-9; RAWSON HM, 1984, PLANT CELL ENVIRON, V7, P207; Reef R, 2010, TREE PHYSIOL, V30, P1148, DOI 10.1093/treephys/tpq048; Rehman S, 1997, SEED SCI TECHNOL, V25, P45; Satyan RS, 2010, BIOTECH HISTOCHEM, V85, P285, DOI [10.3109/10520290903202478, 10.1080/10520290903202478]; Shi GR, 2010, PLANT GROWTH REGUL, V61, P45, DOI 10.1007/s10725-010-9447-z; SRIVASTAVA DS, 1995, J ECOL, V83, P421, DOI 10.2307/2261595; Suarez N, 2005, TREES-STRUCT FUNCT, V19, P721, DOI 10.1007/s00468-005-0001-y; Tam NFY, 1998, WATER AIR SOIL POLL, V103, P245, DOI 10.1023/A:1004925700931; Tanaka Y, 1999, PLANT SCI, V148, P131, DOI 10.1016/S0168-9452(99)00133-8; Warwick NWM, 1998, AQUAT BOT, V62, P19, DOI 10.1016/S0304-3770(98)00082-5; WERNER JE, 1995, PHYSIOL PLANTARUM, V93, P659, DOI 10.1111/j.1399-3054.1995.tb05114.x; Whigham DF, 2009, ESTUAR COAST, V32, P926, DOI 10.1007/s12237-009-9184-6; Yates EJ, 2002, TREES-STRUCT FUNCT, V16, P120, DOI 10.1007/s00468-001-0145-3; Ye Y, 2005, AQUAT BOT, V83, P193, DOI 10.1016/j.aquabot.2005.06.006; Ye Y, 2005, HYDROBIOLOGIA, V539, P109, DOI 10.1007/s10750-004-3404-7; Ye Y, 2004, ACTA BOT SIN, V46, P896; [Zhang Yubin 张瑜斌], 2008, [生态学报, Acta Ecologica Sinica], V28, P1287; Zhang ZH, 2008, AQUAT BOT, V89, P57, DOI 10.1016/j.aquabot.2008.03.002	79	29	31	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93337	10.1371/journal.pone.0093337	http://dx.doi.org/10.1371/journal.pone.0093337			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691495	Green Submitted, Green Published, gold			2022-12-25	WOS:000334101100067
J	Fagyas, M; Uri, K; Siket, IM; Darago, A; Boczan, J; Banyai, E; Edes, I; Papp, Z; Toth, A				Fagyas, Miklos; Uri, Katalin; Siket, Ivetta M.; Darago, Andrea; Boczan, Judit; Banyai, Emese; Edes, Istvan; Papp, Zoltan; Toth, Attila			New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) I: Endogenous Angiotensin Converting Enzyme (ACE) Inhibition	PLOS ONE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; TRYPTIC HYDROLYSATE; EUROPEAN-SOCIETY; HUMAN-SERUM; TASK-FORCE; CARDIOVASCULAR-DISEASE; DRAMATIC INCREASE; CARDIOLOGY ESC; GUIDELINES; ASSOCIATION	Angiotensin-converting enzyme (ACE) inhibitors represent the fifth most often prescribed drugs. ACE inhibitors decrease 5-year mortality by approximately one-fifth in cardiovascular patients. Surprisingly, there are reports dating back to 1979 suggesting the existence of endogenous ACE inhibitors, which endogenous inhibitory effects are much less characterized than that for the clinically administered ACE inhibitors. Here we aimed to investigate this endogenous ACE inhibition in human sera. It was hypothesized that ACE activity is masked by an endogenous inhibitor, which dissociates from the ACE when its concentration decreases upon dilution. ACE activity was measured by FAPGG hydrolysis first. The specific (dilution corrected) enzyme activities significantly increased by dilution of human serum samples (23.2 +/- 0.7 U/L at 4-fold dilution, 51.4 +/- 0.3 U/L at 32-fold dilution, n = 3, p = 0.001), suggesting the presence of an endogenous inhibitor. In accordance, specific enzyme activities did not changed by dilution when purified renal ACE was used, where no endogenous inhibitor was present (655 +/- 145 U/L, 605 = 42 U/L, n = 3, p = 0.715, respectively). FAPGG conversion strongly correlated with angiotensin I conversion suggesting that this feature is not related to the artificial substrate. Serum samples were ultrafiltered to separate ACE (MW: 180 kDa) and the hypothesized inhibitor. Filtering through 50 kDa filters was without effect, while filtering through 100 kDa filters eliminated the inhibiting factor (ACE activity after <100 kDa filtering: 56.4 +/- 2.4 U/L, n = 4, control: 26.4 +/- 0.7 U/L, n = 4, p<0.001). Lineweaver-Burk plot indicated non-competitive inhibition of ACE by this endogenous factor. The endogenous inhibitor had higher potency on the C-terminal active site than N-terminal active site of ACE. Finally, this endogenous ACE inhibition was also present in mouse, donkey, goat, bovine sera besides men (increasing of specific ACE activity from 4-fold to 32-fold dilution: 2.8-fold, 1.7-fold, 1.5-fold, 1.8-fold, 2.6-fold, respectively). We report here the existence of an evolutionary conserved mechanism suppressing circulating ACE activity, in vivo, similarly to ACE inhibitory drugs.	[Fagyas, Miklos; Uri, Katalin; Siket, Ivetta M.; Darago, Andrea; Edes, Istvan; Papp, Zoltan; Toth, Attila] Univ Debrecen, Inst Cardiol, Div Clin Physiol, H-4012 Debrecen, Hungary; [Boczan, Judit] Univ Debrecen, Dept Neurol, H-4012 Debrecen, Hungary; [Banyai, Emese] Univ Debrecen, Div Nephrol, Inst Internal Med, H-4012 Debrecen, Hungary	University of Debrecen; University of Debrecen; University of Debrecen	Toth, A (corresponding author), Univ Debrecen, Inst Cardiol, Div Clin Physiol, H-4012 Debrecen, Hungary.	atitoth@med.unideb.hu	Tóth, Attila/F-4859-2010; Fagyas, Miklós/AAQ-1013-2020	Tóth, Attila/0000-0001-6503-3653; Fagyas, Miklós/0000-0003-3262-884X	Hungarian Academy of Sciences OTKA [K84300]; Hungarian Ministry of Health [ETT 377/2009]; MSD Magyarorszag Kft; Pfizer Magyarorszag Kft; European Social Fund; National Innovation Office of Hungary; Bolyai Janos Research Scholarship of the Hungarian Academy of Sciences;  [TAMOP 4.2.1./B-09/1/KONV-2010-0007];  [TAMOP-4.2.2.A-11/1/KONV 2012-0045];  [REG-EA 09-1-2009-0013]	Hungarian Academy of Sciences OTKA(Hungarian Academy of SciencesOrszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Ministry of Health; MSD Magyarorszag Kft; Pfizer Magyarorszag Kft; European Social Fund(European Social Fund (ESF)); National Innovation Office of Hungary; Bolyai Janos Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); ; ; 	The study was supported by the Hungarian Academy of Sciences OTKA (K84300 to AT) and by the Hungarian Ministry of Health (ETT 377/2009 to AT); the work is supported by the TAMOP 4.2.1./B-09/1/KONV-2010-0007 TAMOP-4.2.2.A-11/1/KONV 2012-0045, REG-EA 09-1-2009-0013 projects (to AT, IE and ZP); MSD Magyarorszag Kft, Pfizer Magyarorszag Kft also supported some of the research. The project is implemented through the New Hungary Development Plan, co-financed by the European Social Fund; and by the National Innovation Office of Hungary (Baross Gabor Project, EletMent). Finally, AT was supported by the Bolyai Janos Research Scholarship of the Hungarian Academy of Sciences. The authors thank David Durham for reading and language editing the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerholm-Larsen B, 2000, ARTERIOSCL THROM VAS, V20, P484, DOI 10.1161/01.ATV.20.2.484; [Anonymous], 1996, J Am Coll Cardiol, V27, P337; BENETEAU B, 1986, CLIN CHEM, V32, P884; Bien BY, 2010, J MANAGE CARE PHARM, V16, P671, DOI 10.18553/jmcp.2010.16.9.671; Brecher AS, 1996, ARCH INT PHARMACOD T, V331, P301; Carmona AK, 2006, NAT PROTOC, V1, P1971, DOI 10.1038/nprot.2006.306; COHN JN, 1991, NEW ENGL J MED, V325, P303, DOI 10.1056/NEJM199108013250502; COLLINS R, 1995, LANCET, V345, P669; CORVOL P, 1995, J HYPERTENS, V13, pS3, DOI 10.1097/00004872-199509003-00002; Cuspidi C, 2002, J HYPERTENS, V20, P2293, DOI 10.1097/00004872-200211000-00030; Danilov S, 1996, J HYPERTENS, V14, P719, DOI 10.1097/00004872-199606000-00007; Danser AHJ, 2007, PHARMACOL THERAPEUT, V113, P607, DOI 10.1016/j.pharmthera.2006.12.001; Davidson NC, 1996, CIRCULATION, V93, P1155, DOI 10.1161/01.CIR.93.6.1155; Dzau VJ, 2001, AM J CARDIOL, V88, p1L; Fagyas M, 2014, PLOS ONE; Fagyas M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087844; Fox KM, 2003, LANCET, V362, P782; GREENBERG B, 1995, CIRCULATION, V91, P2573, DOI 10.1161/01.CIR.91.10.2573; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Hoogwerf BJ, 2000, CLEV CLIN J MED, V67, P287, DOI 10.3949/ccjm.67.4.287; IKEMOTO F, 1989, BIOCHEM BIOPH RES CO, V159, P1093, DOI 10.1016/0006-291X(89)92221-3; KLAUSER RJ, 1979, HYPERTENSION, V1, P281, DOI 10.1161/01.HYP.1.3.281; Kramers C, 2001, CIRCULATION, V104, P1236, DOI 10.1161/hc3601.095932; Leon-Ruiz V, 2013, FOOD FUNCT, V4, P1617, DOI 10.1039/c3fo60221d; LIEBERMAN J, 1986, CHEST, V90, P869, DOI 10.1378/chest.90.6.869; Luders S, 2008, J HYPERTENS, V26, P1487, DOI 10.1097/HJH.0b013e3282ff8864; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Nakagomi K, 2000, FEBS LETT, V467, P235, DOI 10.1016/S0014-5793(00)01163-7; Nakagomi K, 1998, FEBS LETT, V438, P255, DOI 10.1016/S0014-5793(98)01311-8; Nakagomi K, 2000, BIOL PHARM BULL, V23, P879; Nesterovitch AB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008282; ONDETTI MA, 1977, SCIENCE, V196, P441, DOI 10.1126/science.191908; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Rice GI, 2006, HYPERTENSION, V48, P914, DOI 10.1161/01.HYP.0000244543.91937.79; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; ROGERSON FM, 1989, NEUROPEPTIDES, V14, P213, DOI 10.1016/0143-4179(89)90048-6; Ruggenenti P, 2004, NEW ENGL J MED, V351, P1941, DOI 10.1056/NEJMoa042167; Ryan J W, 1979, Adv Exp Med Biol, V120B, P599; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; SNYDER RA, 1986, BIOCHIM BIOPHYS ACTA, V871, P1, DOI 10.1016/0167-4838(86)90125-1; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Tauzin J, 2002, FEBS LETT, V531, P369, DOI 10.1016/S0014-5793(02)03576-7; Taylor J, 2012, EUR HEART J, V33, P1539, DOI 10.1093/eurheartj/ehs137; Tendera M, 2012, TURK KARDIYOL DERN A, V40, P5, DOI 10.1093/eurheartj/ehr211; Thevananther S, 1999, CAN J PHYSIOL PHARM, V77, P216, DOI 10.1139/cjpp-77-3-216; TIRET L, 1992, AM J HUM GENET, V51, P197; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419	47	19	19	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e87843	10.1371/journal.pone.0087843	http://dx.doi.org/10.1371/journal.pone.0087843			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691160	Green Published, gold, Green Submitted			2022-12-25	WOS:000334101100002
J	Ker, YB; Peng, CC; Chang, WL; Chyau, CC; Peng, RY				Ker, Yaw-Bee; Peng, Chiung-Chi; Chang, Wan-Lin; Chyau, Charng-Cherng; Peng, Robert Y.			Hepatoprotective Bioactivity of the Glycoprotein, Antrodan, Isolated from Antrodia cinnamomea Mycelia	PLOS ONE			English	Article							PROTEIN-BOUND POLYSACCHARIDE; OXIDATIVE STRESS; NITRIC-OXIDE; BETA-GLUCANS; CANCER; BASIDIOMYCETE; ACTIVATION; RESISTANCE; MECHANISM; MUSHROOM	Antrodan, a protein- bound polysaccharide isolated from Antrodia cinnamomea mycelia, was demonstrated to exhibit significant anti- inflammatory bioactivity in vitro. However, its role in hepatic injury in vivo still remains unclear. We hypothesized that antrodan may have beneficial hepatoprotective effects. To verify this, a lipopolysaccharide ( LPS)- SpragueDawley rat model was used. Antrodan protected against liver damage by suppressing LPS- stimulated serum glutamineoxaloacetic transaminase ( GOT), glutamic- pyruvic transaminase ( GPT), interleukin ( IL)- 6, hepatic thiobarbituric acid reactive substances ( TBARS), nitric oxide ( NO), inducible NO synthase ( iNOS) and nuclear factor ( NF)- kappa B, and by effectively alleviating the downregulated hepatic superoxide dismutase ( SOD), catalase, and glutathione peroxidase ( GSH- Px). Hematoxylin- eosin staining revealed that antrodan at a dosage of 40 mg/ kg was able to alleviate LPS- induced liver damage to a normal status. In addition, we identified the partial main architectural backbone of antrodan to have a 1 -> 3 linear beta- glycosidic backbone of mannan linked by b- 1 -> 3 glucosidic branches. Conclusively, antrodan can potentially ameliorate liver damage in vivo by suppressing oxidative stress induced by LPS.	[Ker, Yaw-Bee] Hungkuang Univ, Dept Appl Food Technol, Taichung, Taiwan; [Peng, Chiung-Chi] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Peng, Chiung-Chi; Chang, Wan-Lin; Chyau, Charng-Cherng; Peng, Robert Y.] Hungkuang Univ, Biotechnol Res Inst, Taichung, Taiwan	Hungkuang University; Taipei Medical University; Hungkuang University	Ker, YB (corresponding author), Hungkuang Univ, Dept Appl Food Technol, Taichung, Taiwan.	ybker@sunrise.hk.edu.tw; ccchyau@sunrise.hk.edu.tw			National Science Council, Taiwan ROC [NSC-102-2313-B-241-003]	National Science Council, Taiwan ROC(Ministry of Science and Technology, Taiwan)	Financial support by the National Science Council (NSC-102-2313-B-241-003), Taiwan ROC is gratefully acknowledged. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Akagi J, 2010, INT J CLIN ONCOL, V15, P145, DOI 10.1007/s10147-010-0033-1; AKIRA S, 1993, ADV IMMUNOL, V54, P1, DOI 10.1016/S0065-2776(08)60532-5; Bohn JA, 1995, CARBOHYD POLYM, V28, P3, DOI 10.1016/0144-8617(95)00076-3; Boveris A, 2002, FREE RADICAL BIO MED, V33, P1186, DOI 10.1016/S0891-5849(02)01009-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buege J A, 1978, Methods Enzymol, V52, P302; Carbonero ER, 2002, FEMS MICROBIOL LETT, V206, P175, DOI 10.1111/j.1574-6968.2002.tb11005.x; Chan GCF, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-25; Chen CJ, 2011, FUNGAL SCI, V16, P65; Chen HX, 2004, J AGR FOOD CHEM, V52, P3333, DOI 10.1021/jf0349679; Chen JZ, 2008, VASC HEALTH RISK MAN, V4, P1265, DOI 10.2147/VHRM.S3803; Chen JZ, 2007, MYCOL RES, V111, P635, DOI 10.1016/j.mycres.2007.02.011; Chen Y, 2008, FOOD CHEM, V107, P231, DOI 10.1016/j.foodchem.2007.08.021; Chiu CH, 2014, MOLECULES, V19, P22, DOI 10.3390/molecules19010022; DAMAS P, 1992, ANN SURG, V215, P356, DOI 10.1097/00000658-199204000-00009; Dennis JW, 2002, BBA-GEN SUBJECTS, V1573, P414, DOI 10.1016/S0304-4165(02)00411-7; Fujimiya Y, 1998, CANCER IMMUNOL IMMUN, V46, P147, DOI 10.1007/s002620050473; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gao B, 2012, J GASTROEN HEPATOL, V27, P89, DOI 10.1111/j.1440-1746.2011.07003.x; Geethangili M, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep108; GREEN SJ, 1994, IMMUNOL LETT, V43, P87, DOI 10.1016/0165-2478(94)00158-8; Hong F, 2004, J IMMUNOL, V173, P797, DOI 10.4049/jimmunol.173.2.797; Jedinak A, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-52; LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6; Lee SB, 2003, BIOMATERIALS, V24, P2503, DOI 10.1016/S0142-9612(03)00003-6; Lindequist U, 2005, EVID-BASED COMPL ALT, V2, P285, DOI 10.1093/ecam/neh107; Liu F, 1997, LIFE SCI, V60, P763, DOI 10.1016/S0024-3205(97)00004-0; Maehara Y, 2012, SURG TODAY, V42, P8, DOI 10.1007/s00595-011-0075-7; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Mizuno T., 1999, International Journal of Medicinal Mushrooms, V1, P105; Mohamadin Ahmed M, 2011, Pathophysiology, V18, P235, DOI 10.1016/j.pathophys.2011.02.003; Moradali MF, 2007, INT IMMUNOPHARMACOL, V7, P701, DOI 10.1016/j.intimp.2007.01.008; Mungrue Imran N, 2002, Heart Fail Rev, V7, P407, DOI 10.1023/A:1020762401408; Neveu WA, 2011, AM J RESP CELL MOL, V45, P1133, DOI 10.1165/rcmb.2011-0054OC; Sebai H, 2010, ECOTOX ENVIRON SAFE, V73, P1078, DOI 10.1016/j.ecoenv.2009.12.031; Song KS, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-307; Takimoto F, 2004, BIOL PHARM BULL, V27, P404; Torkelson Carolyn J, 2012, ISRN Oncol, V2012, P251632, DOI 10.5402/2012/251632; Tsuboi S, 2012, TRENDS MOL MED, V18, P224, DOI 10.1016/j.molmed.2012.02.001; TSUKAGOSHI S, 1984, CANCER TREAT REV, V11, P131, DOI 10.1016/0305-7372(84)90005-7; Wang CL, 2011, BIOTECHNOL LETT, V33, P2271, DOI 10.1007/s10529-011-0697-2; Yazar E, 2010, FREE RADICAL RES, V44, P397, DOI 10.3109/10715760903513025; Yokoyama H, 1998, ALCOHOL CLIN EXP RES, V22, p133S, DOI 10.1111/acer.1998.22.s3_part1.133s; YOSHIMURA M, 1995, P NATL ACAD SCI USA, V92, P8754, DOI 10.1073/pnas.92.19.8754; Yun CH, 2003, FEMS IMMUNOL MED MIC, V35, P67, DOI 10.1016/S0928-8244(02)00460-1	47	21	30	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93191	10.1371/journal.pone.0093191	http://dx.doi.org/10.1371/journal.pone.0093191			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690763	Green Published, gold, Green Submitted			2022-12-25	WOS:000334101100050
J	Kiss, A; Horvath, P; Rothballer, A; Kutay, U; Csucs, G				Kiss, Alexa; Horvath, Peter; Rothballer, Andrea; Kutay, Ulrike; Csucs, Gabor			Nuclear Motility in Glioma Cells Reveals a Cell-Line Dependent Role of Various Cytoskeletal Components	PLOS ONE			English	Article							NEURONAL MIGRATION DEFECTS; CYTOPLASMIC DYNEIN; FISSION YEAST; ACTIN FLOW; MYOSIN-II; CENTROSOME; ENVELOPE; MOVEMENT; MICROTUBULES; LIS1	Nuclear migration is a general term for the movement of the nucleus towards a specific site in the cell. These movements are involved in a number of fundamental biological processes, such as fertilization, cell division, and embryonic development. Despite of its importance, the mechanism of nuclear migration is still poorly understood in mammalian cells. In order to shed light on the mechanical processes underlying nuclear movements, we adapted a micro-patterning based assay. C6 rat and U87 human glioma cells seeded on fibronectin patterns - thereby forced into a bipolar morphology displayed oscillatory movements of the nucleus or the whole cell, respectively. We found that both the actomyosin system and microtubules are involved in the nuclear/cellular movements of both cell lines, but their contributions are cell-/migration-type specific. Dynein activity was necessary for nuclear migration of C6 cells but active myosin-II was dispensable. On the other hand, coupled nuclear and cellular movements of U87 cells were driven by actomyosin contraction. We explain these cell-line dependent effects by the intrinsic differences in the overall mechanical tension due to the various cytoskeletal elements inside the cell. Our observations showed that the movements of the nucleus and the centrosome are strongly correlated and display large variation, indicating a tight but flexible coupling between them. The data also indicate that the forces responsible for nuclear movements are not acting directly via the centrosome. Based on our observations, we propose a new model for nuclear oscillations in C6 cells in which dynein and microtubule dynamics are the main drivers of nuclear movements. This mechanism is similar to the meiotic nuclear oscillations of Schizosaccharomyces pombe and may be evolutionary conserved.	[Kiss, Alexa; Horvath, Peter; Rothballer, Andrea; Kutay, Ulrike; Csucs, Gabor] Swiss Fed Inst Technol, Inst Biochem, Zurich, Switzerland; [Kiss, Alexa; Horvath, Peter; Csucs, Gabor] Swiss Fed Inst Technol, Light Microscopy & Screening Ctr, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Csucs, G (corresponding author), Swiss Fed Inst Technol, Inst Biochem, Zurich, Switzerland.	csucs@lmsc.ethz.ch		Kiss, Alexa/0000-0003-4384-4396	ETH Zurich	ETH Zurich(ETH Zurich)	The work was funded by ETH Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abal M, 2002, J CELL BIOL, V159, P731, DOI 10.1083/jcb.200207076; BAKER J, 1993, J CELL BIOL, V122, P113, DOI 10.1083/jcb.122.1.113; Barnhart EL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001059; Baye LM, 2007, J NEUROSCI, V27, P10143, DOI 10.1523/JNEUROSCI.2754-07.2007; Bellion A, 2005, J NEUROSCI, V25, P5691, DOI 10.1523/JNEUROSCI.1030-05.2005; Bort R, 2006, DEV BIOL, V290, P44, DOI 10.1016/j.ydbio.2005.11.006; BROWN SS, 1981, J CELL BIOL, V88, P487, DOI 10.1083/jcb.88.3.487; Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629; Chen CS, 2003, BIOCHEM BIOPH RES CO, V307, P355, DOI 10.1016/S0006-291X(03)01165-3; Chen CS, 1999, OSTEOARTHR CARTILAGE, V7, P81, DOI 10.1053/joca.1998.0164; CHIKASHIGE Y, 1994, SCIENCE, V264, P270, DOI 10.1126/science.8146661; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Csucs G, 2003, BIOMATERIALS, V24, P1713, DOI 10.1016/S0142-9612(02)00568-9; Daga RR, 2006, CURR BIOL, V16, P1544, DOI 10.1016/j.cub.2006.06.026; Dayel MJ, 1999, BIOPHYS J, V76, P2843, DOI 10.1016/S0006-3495(99)77438-2; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; Demeter K, 2005, NEUROSCI RES, V53, P331, DOI 10.1016/j.neures.2005.08.003; Deshpande G, 2005, GENE DEV, V19, P1680, DOI 10.1101/gad.1316805; Ding DQ, 1998, J CELL SCI, V111, P701; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; Dujardin DL, 2003, J CELL BIOL, V163, P1205, DOI 10.1083/jcb.200310097; Dupin I, 2011, INT J BIOCHEM CELL B, V43, P1698, DOI 10.1016/j.biocel.2011.09.004; Dupin I, 2011, J CELL SCI, V124, P865, DOI 10.1242/jcs.076356; Dupin I, 2009, J CELL BIOL, V185, P779, DOI 10.1083/jcb.200812034; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; Fridolfsson HN, 2010, J CELL BIOL, V191, P115, DOI 10.1083/jcb.201004118; Gerashchenko MV, 2009, CELL BIOL INT, V33, P1057, DOI 10.1016/j.cellbi.2009.06.020; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Grosse AS, 2011, DEVELOPMENT, V138, P4423, DOI 10.1242/dev.065789; Hale CM, 2008, BIOPHYS J, V95, P5462, DOI 10.1529/biophysj.108.139428; Hale CM, 2011, J CELL SCI, V124, P4267, DOI 10.1242/jcs.091231; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Hollander M, 1973, NONPARAMETRIC STAT M; Hu DJK, 2013, CELL, V154, P1300, DOI 10.1016/j.cell.2013.08.024; Khatau SB, 2009, P NATL ACAD SCI USA, V106, P19017, DOI 10.1073/pnas.0908686106; Kim D, 2012, INT J MOL MED, V29, P440, DOI 10.3892/ijmm.2011.867; Kobayashi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007827; Kosodo Y, 2011, EMBO J, V30, P1690, DOI 10.1038/emboj.2011.81; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Lavelin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073549; Lei K, 2009, P NATL ACAD SCI USA, V106, P10207, DOI 10.1073/pnas.0812037106; Levy JR, 2008, J CELL SCI, V121, P3187, DOI 10.1242/jcs.033878; Lombardi ML, 2011, J BIOL CHEM, V286, P26743, DOI 10.1074/jbc.M111.233700; Luxton GWG, 2011, CURR OPIN CELL BIOL, V23, P579, DOI 10.1016/j.ceb.2011.08.001; Luxton GWG, 2010, SCIENCE, V329, P956, DOI 10.1126/science.1189072; Malone CJ, 1999, DEVELOPMENT, V126, P3171; Martini FJ, 2010, J NEUROSCI, V30, P8660, DOI 10.1523/JNEUROSCI.1962-10.2010; Mellad JA, 2011, CURR OPIN CELL BIOL, V23, P47, DOI 10.1016/j.ceb.2010.11.006; MESSIER PE, 1978, EXPERIENTIA, V34, P289, DOI 10.1007/BF01922992; Mih JD, 2012, J CELL SCI, V125, P5974, DOI 10.1242/jcs.108886; Moore JK, 2009, P NATL ACAD SCI USA, V106, P5147, DOI 10.1073/pnas.0810828106; Morris NR, 2000, J CELL BIOL, V148, P1097, DOI 10.1083/jcb.148.6.1097; Mosley-Bishop KL, 1999, CURR BIOL, V9, P1211, DOI 10.1016/S0960-9822(99)80501-6; NAGELE RG, 1979, J EXP ZOOL, V210, P89, DOI 10.1002/jez.1402100110; NEMERE I, 1985, CELL MOTIL CYTOSKEL, V5, P17, DOI 10.1002/cm.970050103; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; Pecreaux J, 2006, CURR BIOL, V16, P2111, DOI 10.1016/j.cub.2006.09.030; Pelham RJ, 1999, MOL BIOL CELL, V10, P935, DOI 10.1091/mbc.10.4.935; PENNINGROTH SM, 1982, BIOCHEM BIOPH RES CO, V104, P234, DOI 10.1016/0006-291X(82)91964-7; Poole K, 2005, J MOL BIOL, V349, P380, DOI 10.1016/j.jmb.2005.03.064; Pouthas F, 2008, J CELL SCI, V121, P2406, DOI 10.1242/jcs.026849; Reinsch S, 1998, J CELL SCI, V111, P2283; Said HM, 2007, J NEURO-ONCOL, V81, P27, DOI 10.1007/s11060-006-9205-2; Sasaki S, 2005, MOL CELL BIOL, V25, P7812, DOI 10.1128/MCB.25.17.7812-7827.2005; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Schenk J, 2009, P NATL ACAD SCI USA, V106, P16487, DOI 10.1073/pnas.0908928106; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Starr DA, 2003, J CELL SCI, V116, P211, DOI 10.1242/jcs.00248; Starr DA, 2010, ANNU REV CELL DEV BI, V26, P421, DOI 10.1146/annurev-cellbio-100109-104037; Starr DA, 2009, J CELL SCI, V122, P577, DOI 10.1242/jcs.037622; Stearns T, 1997, J CELL BIOL, V138, P957, DOI 10.1083/jcb.138.5.957; Stewart-Hutchinson PJ, 2008, EXP CELL RES, V314, P1892, DOI 10.1016/j.yexcr.2008.02.022; Suelmann R, 2000, RES MICROBIOL, V151, P247, DOI 10.1016/S0923-2508(00)00151-0; Szabo B, 2004, CELL MOTIL CYTOSKEL, V59, P38, DOI 10.1002/cm.20022; Szabo B, 2011, CYTOSKELETON, V68, P325, DOI 10.1002/cm.20515; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Thery M, 2006, CELL MOTIL CYTOSKEL, V63, P341, DOI 10.1002/cm.20126; Tran PT, 1999, BIOL BULL, V197, P262, DOI 10.2307/1542640; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Umeshima H, 2007, P NATL ACAD SCI USA, V104, P16182, DOI 10.1073/pnas.0708047104; Versaevel M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1668; Vogel SK, 2009, PLOS BIOL, V7, P918, DOI 10.1371/journal.pbio.1000087; Zhang XC, 2007, DEVELOPMENT, V134, P901, DOI 10.1242/dev.02783; Zhang XC, 2009, NEURON, V64, P173, DOI 10.1016/j.neuron.2009.08.018; Zhu J, 2010, MOL BIOL CELL, V21, P4418, DOI 10.1091/mbc.E10-07-0627	88	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93431	10.1371/journal.pone.0093431	http://dx.doi.org/10.1371/journal.pone.0093431			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691067	gold, Green Submitted, Green Published			2022-12-25	WOS:000334101100079
J	Steel, E; Murray, VL; Liu, AP				Steel, Elisabeth; Murray, Victoria L.; Liu, Allen P.			Multiplex Detection of Homo- and Heterodimerization of G Protein-Coupled Receptors by Proximity Biotinylation	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; BETA(2)-ADRENERGIC RECEPTOR; GPCR OLIGOMERIZATION; CRYSTAL-STRUCTURE; CXCR4; DIMERIZATION; CCR5; LIGAND; CELLS; REVEALS	Dimerization of G protein-coupled receptors (GPCRs) represents a potential mechanism by which GPCR functions are regulated. Several resonance energy transfer (RET)-based methods have revealed GPCR homo- and heterodimerization. However, interpretation of an increase in FRET efficiency could be attributed to either dimerization/oligomerization events or conformational changes within an already dimerized/oligomerized receptor complex. Furthermore, RET-based methods can only measure pairwise dimerization, and cannot easily achieve multiplex detection. In this study, we applied proximity-based biotinylation for detecting receptor dimerization by utilizing a specific enzyme-substrate pair that are fused to GPCRs. The biotin ligase BirA is fused to CXCR4 and site-specifically biotinylates an acceptor peptide (AP) in the presence of biotin. As a test case for our newly developed assay, we have characterized the homo-dimerization of chemokine receptor CXCR4 and heterodimerization of CXCR4 with CCR2 or CCR5. The degree of biotinylation varies with the amount of GPCR-AP as well as biotinylation time. Using enzyme/substrate receptor pairs and measuring receptor biotinylation, we demonstrate that CXCR4 can homo-dimerize and hetero-dimerize with CCR2 and CCR5. The effect of CXCL12, agonist for CXCR4, was found to decrease surface biotinylation of CXCR4-AP. This effect is due to a combination of CXCR4 endocytosis and stabilization of CXCR4 homodimers. Finally, when CXCR4-AP, CCR2-AP, and CCR5-AP were expressed together, we observed CXCR4-CXCR4 homodimers and CXCR4-CCR2 and CXCR4-CCR5 heterodimers. The newly developed assay opens new opportunity for multiplex detection for GPCR homo- and heterodimerization within the same cellular context.	[Steel, Elisabeth; Murray, Victoria L.; Liu, Allen P.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Liu, Allen P.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Liu, Allen P.] Univ Michigan, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA; [Liu, Allen P.] Univ Michigan, Biophys Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Liu, AP (corresponding author), Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.	allenliu@umich.edu	Liu, Allen P/A-1704-2011	Liu, Allen P/0000-0002-0309-7018; Steel, Elisabeth/0000-0001-6693-4285	National Institutes of Health [DP2 HL117748-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [DP2HL117748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	AL is supported by National Institutes of Health Director's New Innovator Award DP2 HL117748-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babcock GJ, 2003, J BIOL CHEM, V278, P3378, DOI 10.1074/jbc.M210140200; Balabanian K, 2005, BLOOD, V105, P2449, DOI 10.1182/blood-2004-06-2289; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Choi WT, 2012, BIOCHEMISTRY-US, V51, P7078, DOI 10.1021/bi2016712; Clapp AR, 2005, J AM CHEM SOC, V127, P18212, DOI 10.1021/ja054630i; Fernandez-Suarez M, 2008, J AM CHEM SOC, V130, P9251, DOI 10.1021/ja801445p; Ferre S, 2010, CURR OPIN PHARMACOL, V10, P1, DOI 10.1016/j.coph.2009.11.002; Ferre S, 2009, NAT CHEM BIOL, V5, P131, DOI 10.1038/nchembio0309-131; Hammad MM, 2010, J BIOL CHEM, V285, P34653, DOI 10.1074/jbc.M110.106591; Howarth M, 2008, NAT PROTOC, V3, P534, DOI 10.1038/nprot.2008.20; Isik N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003424; Issafras H, 2002, J BIOL CHEM, V277, P34666, DOI 10.1074/jbc.M202386200; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; Kerppola TK, 2009, CHEM SOC REV, V38, P2876, DOI 10.1039/b909638h; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; LaRocca TJ, 2010, J CARDIOVASC PHARM, V56, P548, DOI 10.1097/FJC.0b013e3181f713fe; Lawrence CM, 1999, SCIENCE, V286, P779, DOI 10.1126/science.286.5440.779; Lin H, 2013, NAT METHODS, V10, P140, DOI [10.1038/NMETH.2324, 10.1038/nmeth.2324]; Liu AP, 2010, J CELL BIOL, V191, P1381, DOI 10.1083/jcb.201008117; Liu DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052823; Luker KE, 2009, FASEB J, V23, P823, DOI 10.1096/fj.08-116749; Munoz LM, 2012, IMMUNOL LETT, V145, P23, DOI 10.1016/j.imlet.2012.04.012; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Mellado M, 1999, NATURE, V400, P723, DOI 10.1038/23382; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; Percherancier Y, 2005, J BIOL CHEM, V280, P9895, DOI 10.1074/jbc.M411151200; Perroy J, 2004, NAT METHODS, V1, P203, DOI 10.1038/NMETH722; Reiner S, 2010, J BIOL CHEM, V285, P36188, DOI 10.1074/jbc.M110.175604; Signoret N, 1997, J CELL BIOL, V139, P651, DOI 10.1083/jcb.139.3.651; Singer II, 2001, J VIROL, V75, P3779, DOI 10.1128/JVI.75.8.3779-3790.2001; SMYTHE E, 1992, METHOD ENZYMOL, V219, P223; Sohy D, 2009, J BIOL CHEM, V284, P31270, DOI 10.1074/jbc.M109.054809; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; Vischer HF, 2011, BRIT J PHARMACOL, V163, P246, DOI 10.1111/j.1476-5381.2011.01229.x; Wang JH, 2004, J CELL BIOCHEM, V93, P753, DOI 10.1002/jcb.20161; Wang YX, 2008, ANNU REV BIOMED ENG, V10, P1, DOI 10.1146/annurev.bioeng.010308.161731; Ward RJ, 2013, METHOD ENZYMOL, V521, P69, DOI 10.1016/B978-0-12-391862-8.00004-1; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; WILSON KP, 1992, P NATL ACAD SCI USA, V89, P9257, DOI 10.1073/pnas.89.19.9257; Zou P, 2011, ACS CHEM BIOL, V6, P308, DOI 10.1021/cb100361k	41	16	16	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93646	10.1371/journal.pone.0093646	http://dx.doi.org/10.1371/journal.pone.0093646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691126	gold, Green Submitted, Green Published			2022-12-25	WOS:000334101100119
J	Xu, Y; Zeng, FF; He, LP; Ling, WH; Chen, WQ; Chen, YM				Xu, Ying; Zeng, Fang-fang; He, Li-ping; Ling, Wen-hua; Chen, Wei-qing; Chen, Yu-ming			Comparison of Predictive Value of Cardiometabolic Indices for Subclinical Atherosclerosis in Chinese Adults	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; EARLY CAROTID ATHEROSCLEROSIS; CARDIOVASCULAR RISK-FACTORS; INSULIN-RESISTANCE SYNDROME; INTIMA MEDIA THICKNESS; MYOCARDIAL-INFARCTION; METABOLIC SYNDROME; FOLLOW-UP; BLOOD-PRESSURE; JAPANESE MEN	Objectives: Metabolic disturbances are well-known risk factors for atherosclerosis, but it remains unclear which cardiometabolic components are the predominant determinants. This study aimed to compare and identify the key determinants of carotid atherosclerosis in asymptomatic middle-aged and elderly Chinese. Methods: A community-based cross-sectional study including 3,162 apparently healthy residents aged 37-75 years was performed from July 2008 to June 2010 in Guangzhou, China. Carotid artery intima-media thickness (IMT) was assessed by B-mode ultrasound, and increased IMT was defined as IMT>1.00 mm. Obesity indices, blood pressure, fasting blood lipids, glucose and uric acid levels were determined. Principal components factor analysis was used to extract common factors underlying 11 metabolic factors. Results: Four common factors, defined as "adiposity,'' "blood lipids,'' "triglycerides/uric acid (TG/UA)'' (in men) or "triglycerides/uric acid/glucose (TG/UA/Glu)'' (in women), and "blood pressure,'' were retained for both sexes. After adjustment for potential covariates, the "adiposity'' factor showed the strongest positive association with increased IMT in men. Comparing the extreme quartiles, ORs (95% CI) of increased IMT were 4.64 (2.04-10.59) at the CCA and 2.37 (1.54-3.64) at the BIF), followed by "blood pressure'', the corresponding OR (95% CI) was 2.85 (1.37-5.90) at the CCA. Whereas, the four common factors showed comparable and weak relationship with increased IMTs, the ORs for quartile 4 vs. quartile 1 varied from 0.89 to 3.59 in women. Conclusions: Among the metabolic factors, "adiposity'' and "blood pressure'' play predominant roles in the presence of carotid atherosclerosis in men, but no key factor is identified in women.	[Xu, Ying; Zeng, Fang-fang; He, Li-ping; Ling, Wen-hua; Chen, Wei-qing; Chen, Yu-ming] Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food, Guangzhou 510275, Guangdong, Peoples R China; [Xu, Ying] Guangdong Pharmaceut Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Guangzhou, Guangdong, Peoples R China; [He, Li-ping] Guangzhou Panyu Cent Hosp, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Guangdong Pharmaceutical University	Chen, YM (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food, Guangzhou 510275, Guangdong, Peoples R China.	chenyum@mail.sysu.edu.cn	Chen, Yu/Y-3292-2019	chen, Yu-ming/0000-0003-1658-5528	Sun Yat-sen University, Guangzhou, China [2007032]; State Key Program of National Natural Science of China [81130052]	Sun Yat-sen University, Guangzhou, China; State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC))	This study was jointly supported by the 5010 Program for Clinical Researches by Sun Yat-sen University, Guangzhou, China (No. 2007032) and the State Key Program of National Natural Science of China (No. 81130052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison MA, 2008, AM J EPIDEMIOL, V167, P962, DOI 10.1093/aje/kwm402; Child D, 2006, ESSENTIALS FACTOR AN, V3rd; Cremer P, 1997, ATHEROSCLEROSIS, V129, P221, DOI 10.1016/S0021-9150(96)06030-3; De Bacquer D, 2003, EUR J CARDIOV PREV R, V10, P289, DOI 10.1097/00149831-200308000-00012; Ebrahim S, 1999, STROKE, V30, P841, DOI 10.1161/01.STR.30.4.841; Fan AZ, 2006, J ATHEROSCLER THROMB, V13, P46, DOI 10.5551/jat.13.46; Fang XH, 2001, CEREBROVASC DIS, V11, P225, DOI 10.1159/000047643; Fujii K, 2003, HYPERTENS RES, V26, P465, DOI 10.1291/hypres.26.465; Galassi A, 2006, AM J MED, V119, P812, DOI 10.1016/j.amjmed.2006.02.031; Perez-Larraya JG, 2012, J CLIN ULTRASOUND, V40, P479, DOI 10.1002/jcu.21916; HAHEIM LL, 1993, J INTERN MED, V234, P17, DOI 10.1111/j.1365-2796.1993.tb00699.x; Haring R, 2010, EXP CLIN ENDOCR DIAB, V118, P685, DOI 10.1055/s-0030-1261876; Howard BV, 2003, METABOLISM, V52, P362, DOI 10.1053/meta.2003.50057; Hwang IC, 2012, KOREAN J FAM MED, V33, P229, DOI 10.4082/kjfm.2012.33.4.229; Jonsdottir LS, 2002, J CARDIOVASC RISK, V9, P67, DOI 10.1097/00043798-200204000-00001; Jousilahti P, 1999, CIRCULATION, V99, P1165, DOI 10.1161/01.cir.99.9.1165; Kawamoto R, 2007, J ATHEROSCLER THROMB, V14, P36, DOI 10.5551/jat.14.36; MARMOT MG, 1975, AM J EPIDEMIOL, V102, P514, DOI 10.1093/oxfordjournals.aje.a112189; Meigs JB, 2000, AM J EPIDEMIOL, V152, P908, DOI 10.1093/aje/152.10.908; Menotti A, 1996, J Cardiovasc Risk, V3, P69, DOI 10.1097/00043798-199602000-00010; Moran A, 2010, CIRC-CARDIOVASC QUAL, V3, P243, DOI 10.1161/CIRCOUTCOMES.109.910711; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Qian JC, 2010, B WORLD HEALTH ORGAN, V88, P769, DOI 10.2471/BLT.09.064709; Qizilbash N, 1995, LANCET, V346, P1647; SALONEN JT, 1982, STROKE, V13, P327, DOI 10.1161/01.STR.13.3.327; SEEMAN T, 1993, AM J EPIDEMIOL, V138, P1037, DOI 10.1093/oxfordjournals.aje.a116822; Stevens J, 1986, APPL MULTIVARIATE ST, P337; Suzuki M, 1996, HYPERTENSION, V28, P593, DOI 10.1161/01.HYP.28.4.593; Touboul PJ, 2012, EUR J PREV CARDIOL, V19, P18, DOI 10.1177/2047487312448990; Tzou Wendy S, 2007, Prev Cardiol, V10, P181, DOI 10.1111/j.1520-037X.2007.06450.x; VanderLaan PA, 2004, ARTERIOSCL THROM VAS, V24, P12, DOI 10.1161/01.ATV.0000105054.43931.f0; Wang LD, 2005, LANCET, V366, P1821, DOI 10.1016/S0140-6736(05)67344-8; Wang P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032736; WONG ND, 1991, ANN INTERN MED, V115, P687, DOI 10.7326/0003-4819-115-9-687; Yang Y, 2011, CHINESE MED J-PEKING, V124, P3702, DOI 10.3760/cma.j.issn.0366-6999.2011.22.018; Yang ZJ, 2012, EUR HEART J, V33, P213, DOI 10.1093/eurheartj/ehr205; YANO K, 1988, AM J EPIDEMIOL, V127, P476, DOI 10.1093/oxfordjournals.aje.a114824; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	38	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93538	10.1371/journal.pone.0093538	http://dx.doi.org/10.1371/journal.pone.0093538			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691185	Green Published, Green Submitted, gold			2022-12-25	WOS:000334101100100
J	Feduska, JM; Aller, SG; Garcia, PL; Cramer, SL; Council, LN; van Waardenburg, RCAM; Yoon, KJ				Feduska, J. M.; Aller, S. G.; Garcia, P. L.; Cramer, S. L.; Council, L. N.; van Waardenburg, R. C. A. M.; Yoon, K. J.			ICAM-2 confers a non-metastatic phenotype in neuroblastoma cells by interaction with alpha-actinin	ONCOGENE			English	Article							INTERCELLULAR-ADHESION MOLECULE-2; CYTOPLASMIC DOMAIN; SUBCELLULAR-LOCALIZATION; LEUKOCYTE ADHESION; STRUCTURAL BASIS; BINDING; CANCER; LIGAND; EXPRESSION; ANCHORAGE	Progressive metastatic disease is a major cause of mortality for patients diagnosed with multiple types of solid tumors. One of the long-term goals of our laboratory is to identify molecular interactions that regulate metastasis, as a basis for developing agents that inhibit this process. Toward this goal, we recently demonstrated that intercellular adhesion molecule-2 (ICAM-2) converted neuroblastoma (NB) cells from a metastatic to a non-metastatic phenotype, a previously unknown function for ICAM-2. Interestingly, ICAM-2 suppressed metastatic but not tumorigenic potential in preclinical models, supporting a novel mechanism of regulating metastasis. We hypothesized that the effects of ICAM-2 on NB cell phenotype depend on the interaction of ICAM-2 with the cytoskeletal linker protein alpha-actinin. The goal of the study presented here was to evaluate the impact of alpha-actinin binding to ICAM-2 on the phenotype of NB tumor cells. We used in silico approaches to examine the likelihood that the cytoplasmic domain of ICAM-2 binds directly to alpha-actinin. We then expressed variants of ICAM-2 with mutated a-actinin-binding domains, and compared the impact of ICAM-2 and each variant on NB cell adhesion, migration, anchorage-independent growth, co-precipitation with alpha-actinin and production of localized and disseminated tumors in vivo. The in vitro and in vivo characteristics of cells expressing ICAM-2 variants with modified alpha-actinin-binding domains differed from cells expressing ICAM-2 wild type (WT) and also from cells that expressed no detectable ICAM-2. Like the WT protein, ICAM-2 variants inhibited cell adhesion, migration and colony growth in vitro. However, unlike the WT protein, ICAM-2 variants did not completely suppress development of disseminated NB tumors in vivo. The data suggest the presence of alpha-actinin-dependent and alpha-actinin-independent mechanisms, and indicate that the interaction of ICAM-2 with alpha-actinin is critical to conferring an ICAM-2-mediated non-metastatic phenotype in NB cells.	[Feduska, J. M.; Aller, S. G.; Garcia, P. L.; van Waardenburg, R. C. A. M.; Yoon, K. J.] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Birmingham, AL 35294 USA; [Cramer, S. L.] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA; [Council, L. N.] Univ Alabama Birmingham, Dept Pathol, Div Anat Pathol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Yoon, KJ (corresponding author), Univ Alabama Birmingham, Dept Pharmacol & Toxicol, 1670 Univ Blvd, Birmingham, AL 35294 USA.	kyoon@uab.edu		Aller, Stephen/0000-0003-0379-5534	University of Alabama at Birmingham-Comprehensive Cancer Center- YSB-New Faculty Development Award (YSB-NFDA) [P30 CA013148]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER	University of Alabama at Birmingham-Comprehensive Cancer Center- YSB-New Faculty Development Award (YSB-NFDA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are indebted to Dr Mary Danks for her support. We thank Dr Phil Potter for allowing us to use the mouse strain developed in his laboratory. We are also grateful to Joanna Remack and Rebecca Bush for outstanding technical assistance. This work was supported by the University of Alabama at Birmingham-Comprehensive Cancer Center- YSB-New Faculty Development Award (YSB-NFDA: P30 CA013148).	[Anonymous], 2010, PYMOL MOL GRAPHICS S; Atkinson RA, 2001, NAT STRUCT BIOL, V8, P853, DOI 10.1038/nsb1001-853; CARPEN O, 1992, J CELL BIOL, V118, P1223, DOI 10.1083/jcb.118.5.1223; Casasnovas JM, 1997, NATURE, V387, P312, DOI 10.1038/387312a0; CIFONE MA, 1980, P NATL ACAD SCI-BIOL, V77, P1039, DOI 10.1073/pnas.77.2.1039; DEFOUGEROLLES AR, 1991, J EXP MED, V174, P253, DOI 10.1084/jem.174.1.253; DELISSER HM, 1994, J CELL BIOL, V124, P195, DOI 10.1083/jcb.124.1.195; DIACOVO TG, 1994, J CLIN INVEST, V94, P1243, DOI 10.1172/JCI117442; Eccles SA, 2005, BIOTECHNOL ANN REV, V11, P391, DOI 10.1016/S1387-2656(05)11013-8; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Feduska JM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-261; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Garcia PL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078183; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; Hamada K, 2003, EMBO J, V22, P502, DOI 10.1093/emboj/cdg039; Hariharan R, 2008, PROTEINS, V71, P1853, DOI 10.1002/prot.21869; Heiska L, 1998, J BIOL CHEM, V273, P21893, DOI 10.1074/jbc.273.34.21893; Heiska L, 1996, J BIOL CHEM, V271, P26214, DOI 10.1074/jbc.271.42.26214; Hiraoka N, 2011, GASTROENTEROLOGY, V140, P310, DOI 10.1053/j.gastro.2010.10.009; Hogg N, 1999, J CLIN INVEST, V103, P97, DOI 10.1172/JCI3312; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Honda K, 2005, GASTROENTEROLOGY, V128, P51, DOI 10.1053/j.gastro.2004.10.004; Huang MT, 2005, BLOOD, V106, P1636, DOI 10.1182/blood-2004-12-4716; Humphries M. J., 2001, CURR PROTOC CELL BIO, V00, DOI DOI 10.1002/0471143030.CB0901500; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Kotovuori A, 1999, J IMMUNOL, V162, P6613; Liu J, 2004, J MOL BIOL, V338, P115, DOI 10.1016/j.jmb.2004.02.034; Liu ZY, 2009, J GASTROEN HEPATOL, V24, P900, DOI 10.1111/j.1440-1746.2008.05668.x; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Melero I, 2002, CANCER RES, V62, P3167; Mohamet L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012921; Mori S, 2009, ONCOGENE, V28, P2796, DOI 10.1038/onc.2009.139; Morton CL, 2005, CANCER CHEMOTH PHARM, V56, P629, DOI 10.1007/s00280-005-1027-y; Nishiya T, 2004, J BIOL CHEM, V279, P19008, DOI 10.1074/jbc.M311618200; NORTAMO P, 1991, EUR J IMMUNOL, V21, P2629, DOI 10.1002/eji.1830211049; Nyman-Huttunen H, 2006, J CELL SCI, V119, P3057, DOI 10.1242/jcs.03045; OTEY CA, 1993, J BIOL CHEM, V268, P21193; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; PASQUALINI R, 1994, J CELL BIOL, V125, P447, DOI 10.1083/jcb.125.2.447; Perez OD, 2002, IMMUNITY, V16, P51, DOI 10.1016/S1074-7613(02)00266-2; STAUNTON DE, 1989, NATURE, V339, P61, DOI 10.1038/339061a0; Sun CX, 2002, J CELL SCI, V115, P3991, DOI 10.1242/jcs.00094; Tovchigrechko A, 2005, PROTEINS, V60, P296, DOI 10.1002/prot.20573; Yang YT, 2004, MOL CELL, V14, P269, DOI 10.1016/S1097-2765(04)00204-7; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Yoon KJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003629	46	7	7	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 19	2015	34	12					1553	1562		10.1038/onc.2014.87	http://dx.doi.org/10.1038/onc.2014.87			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CD9KI	24704826	Green Accepted			2022-12-25	WOS:000351416800008
J	Nordman, JC; Kabbani, N				Nordman, Jacob C.; Kabbani, Nadine			Microtubule dynamics at the growth cone are mediated by alpha 7 nicotinic receptor activation of a G alpha q and IP3 receptor pathway	FASEB JOURNAL			English	Article						choline; heterotrimeric G protein; calcium stores; PIP2; EB3	INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; PROTEIN-KINASE-C; ACETYLCHOLINE-RECEPTOR; MODULATION; NEURONS; PHOSPHORYLATION; CALCINEURIN; MECHANISMS; SUBUNITS; GAMMA	The alpha 7 nicotinic receptor (alpha 7) plays an important role in neuronal growth and structural plasticity in the developing brain. We have recently characterized a G-protein-signaling pathway regulated by alpha 7 that directs the growth of neurites in developing neural cells. Now we show that choline activation of alpha 7 promotes a rise in intracellular calcium from local ER stores via G alpha q signaling, leading to IP3 receptor (IP3R) activation at the growth cone of differentiating PC12 cells. A mutant alpha 7 significantly attenuated in calcium conductance (D44A; P<0.001) was found to be unable to promote IP3R signaling and calcium store release. In addition, calcium elevation via alpha 7 correlates with a significant attenuation in the rate of microtubule invasion of the growth cone (P<0.001). This process was also attenuated in the D44A mutant and blocked by an inhibitor of the IP3R, suggesting that calcium flow through the alpha 7 channel and activation of the G alpha q pathway are necessary for growth. Taken together, the findings reveal an inhibitory mechanism of alpha 7 on cytoskeletal growth via the intracellular calcium activity of the receptor channel and the G alpha q signaling pathway at the growth cone.	[Nordman, Jacob C.; Kabbani, Nadine] George Mason Univ, Krasnow Inst Adv Study, Dept Mol Neurosci, Fairfax, VA 22030 USA	George Mason University	Kabbani, N (corresponding author), Krasnow Inst Adv Study, 4400 Univ Dr, Fairfax, VA 22030 USA.	nkabbani@gmu.edu		Nordman, Jacob/0000-0003-2513-7831	Wings for Life Spinal Cord Research grant award	Wings for Life Spinal Cord Research grant award	The authors thank Dr. Jerrel Yakel and Ms. Pattie Lamb (National Institute of Environmental Health Science, Research Triangle Park, NC, USA) for receptor constructs. The authors also thank Justin King for technical assistance. This work is supported by a Wings for Life Spinal Cord Research grant award.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Alkondon M, 1997, EUR J NEUROSCI, V9, P2734, DOI 10.1111/j.1460-9568.1997.tb01702.x; Berg DK, 2002, J NEUROBIOL, V53, P512, DOI 10.1002/neu.10116; Campbell NR, 2010, J NEUROSCI, V30, P8734, DOI 10.1523/JNEUROSCI.0931-10.2010; Changeux JP, 2010, NAT REV NEUROSCI, V11, P389, DOI 10.1038/nrn2849; Chisari M, 2009, PLOS ONE, V4, pA181, DOI 10.1371/journal.pone.0007797; Colon-Saez JO, 2014, PFLUG ARCH EUR J PHY, V466, P1571, DOI 10.1007/s00424-013-1385-y; Colon-Saez JO, 2011, J PHYSIOL-LONDON, V589, P3163, DOI 10.1113/jphysiol.2011.209494; Criado M, 2011, J NEUROCHEM, V119, P40, DOI 10.1111/j.1471-4159.2011.07398.x; del Barrio L, 2011, BRIT J PHARMACOL, V162, P94, DOI 10.1111/j.1476-5381.2010.01034.x; Dent E. W., 2011, COLD SPRING HARB PER, V3, pii; deSouza N, 2002, J BIOL CHEM, V277, P39397, DOI 10.1074/jbc.M207059200; Dwyer Jennifer B., 2008, Birth Defects Research, V84, P30, DOI 10.1002/bdrc.20118; Fernandes C, 2006, GENES BRAIN BEHAV, V5, P433, DOI 10.1111/j.1601-183X.2005.00176.x; FERRIS CD, 1991, P NATL ACAD SCI USA, V88, P2232, DOI 10.1073/pnas.88.6.2232; Fischer H, 2005, J NEUROSCI, V25, P3571, DOI 10.1523/JNEUROSCI.4971-04.2005; Gomez TM, 2006, NAT REV NEUROSCI, V7, P115, DOI 10.1038/nrn1844; GUNNING PW, 1981, J NEUROSCI, V1, P1085; He Y, 2005, J CELL BIOL, V168, P697, DOI 10.1083/jcb.200407191; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Kabbani N, 2007, P NATL ACAD SCI USA, V104, P20570, DOI 10.1073/pnas.0710314104; Kabbani N, 2013, BIOESSAYS, V35, P1025, DOI 10.1002/bies.201300082; Kalil K, 2014, NAT REV NEUROSCI, V15, P7, DOI 10.1038/nrn3650; KATER SB, 1991, J NEUROSCI, V11, P891; Kelly TAN, 2010, J NEUROSCI RES, V88, P3024, DOI 10.1002/jnr.22478; Khiroug SS, 2002, J PHYSIOL-LONDON, V540, P425, DOI 10.1113/jphysiol.2001.013847; Krizanova O, 2003, GEN PHYSIOL BIOPHYS, V22, P295; Lautermilch NJ, 2000, J NEUROSCI, V20, P315, DOI 10.1523/JNEUROSCI.20-01-00315.2000; LINDSTROM J, 1990, CIBA F SYMP, V152, P23; LINDSTROM J, 1990, CIBA F SYMP, V152, P23; Liu M, 2010, J NEUROSCI, V30, P14896, DOI 10.1523/JNEUROSCI.3739-10.2010; Liu QS, 1999, J NEUROSCI, V19, P10280; Lozada AF, 2012, J NEUROSCI, V32, P7651, DOI 10.1523/JNEUROSCI.6246-11.2012; Marx A, 2013, MOL BIOL CELL, V24, P1544, DOI 10.1091/mbc.E12-08-0573; MUKAI H, 1992, J BIOL CHEM, V267, P16237; Myatt D. R., 2008, BMC NEUROSCI S1, V9, pP81; Nadar VC, 2008, CURR BIOL, V18, P1972, DOI 10.1016/j.cub.2008.11.021; Nakata H, 2005, MOL PHARMACOL, V67, P695, DOI 10.1124/mol.104.003913; Nordman JC, 2014, J NEUROCHEM, V129, P649, DOI 10.1111/jnc.12641; Nordman JC, 2014, MOL PHARMACOL, V85, P50, DOI 10.1124/mol.113.088484; Nordman JC, 2012, J CELL SCI, V125, P5502, DOI 10.1242/jcs.110379; Placzek AN, 2005, MOL PHARMACOL, V68, P1863, DOI 10.1124/mol.105.016402; Shoop RD, 2000, J NEUROSCI, V20, P4021; Stepanova T, 2003, J NEUROSCI, V23, P2655; Vanderheyden V, 2009, BBA-MOL CELL RES, V1793, P959, DOI 10.1016/j.bbamcr.2008.12.003; Yamaguchi Y, 2006, J BIOL CHEM, V281, P31627, DOI 10.1074/jbc.M606992200; Yevenes GE, 2003, NAT NEUROSCI, V6, P819, DOI 10.1038/nn1095; Young JW, 2011, GENES BRAIN BEHAV, V10, P720, DOI 10.1111/j.1601-183X.2011.00711.x; Zhong CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082719	49	21	23	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					2995	3006		10.1096/fj.14-251439	http://dx.doi.org/10.1096/fj.14-251439			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24687992	Green Published			2022-12-25	WOS:000337949400022
J	Sarkis, J; Rocha, J; Maniti, O; Jouhet, J; Vie, V; Block, MA; Breton, C; Marechal, E; Girard-Egrot, A				Sarkis, Joe; Rocha, Joana; Maniti, Ofelia; Jouhet, Juliette; Vie, Veronique; Block, Maryse A.; Breton, Christelle; Marechal, Eric; Girard-Egrot, Agnes			The influence of lipids on MGD1 membrane binding highlights novel mechanisms for galactolipid biosynthesis regulation in chloroplasts	FASEB JOURNAL			English	Article						monogalactosyldiacylglycerol synthase; thylakoid biogenesis; plastid envelope; Langmuir monolayer; atomic force microscopy	AIR-WATER-INTERFACE; PHOSPHOLIPID MONOLAYERS; PHOSPHATE DEPRIVATION; HUMAN DYSTROPHIN; INNER ENVELOPE; PLANT-CELLS; ROD DOMAIN; SYNTHASE; PROTEINS; MONOGALACTOSYLDIACYLGLYCEROL	Mono- and digalactosyldiacylglycerol (MGDG and DGDG) are the most abundant lipids of photosynthetic membranes (thylakoids). In Arabidopsis green tissues, MGD1 is the main enzyme synthesizing MGDG. This monotopic enzyme is embedded in the inner envelope membrane of chloroplasts. DGDG synthesis occurs in the outer envelope membrane. Although the suborganellar localization of MGD1 has been determined, it is still not known how the lipid/glycolipid composition influences its binding to the membrane. The existence of a topological relationship between MGD1 and "embryonic" thylakoids is also unknown. To investigate MGD1 membrane binding, we used a Langmuir membrane model allowing the tuning of both lipid composition and packing. Surprisingly, MGD1 presents a high affinity to MGDG, its product, which maintains the enzyme bound to the membrane. This positive feedback is consistent with the low level of diacylglycerol, the substrate of MGD1, in chloroplast membranes. By contrast, MGD1 is excluded from membranes highly enriched in, or made of, pure DGDG. DGDG therefore exerts a retrocontrol, which is effective on the overall synthesis of galactolipids. Previously identified activators, phosphatidic acid and phosphatidylglycerol, also play a role on MGD1 membrane binding via electrostatic interactions, compensating the exclusion triggered by DGDG. The opposite effects of MGDG and DGDG suggest a role of these lipids on the localization of MGD1 in specific domains. Consistently, MGDG induces the self-organization of MGD1 into elongated and reticulated nanostructures scaffolding the chloroplast membrane.	[Sarkis, Joe; Maniti, Ofelia; Girard-Egrot, Agnes] Univ Lyon 1, CNRS, UMR 5246,ICBMS, Equipe Genie Enzymat Membranes Biomimet & Assembl, F-69622 Villeurbanne, France; [Rocha, Joana; Breton, Christelle] Univ Grenoble 1, CNRS, Ctr Rech Macromol Vegetales CERMAV, Grenoble, France; [Jouhet, Juliette; Block, Maryse A.; Marechal, Eric] Univ Grenoble Alpes, Commissariat Energie Atom & Energies Alternat CEA, Lab Physiol Cellulaire & Vegetale, CNRS,INRA,UMR 5168, Grenoble, France; [Vie, Veronique] Univ Rennes 1, CNRS, UMR 6251, IPR, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Rennes	Girard-Egrot, A (corresponding author), CNRS, UMR 5246, GEMBAS Team, ICBMS, Bat Curien,43 Bd 11 Novembre 1918, F-69622 Villeurbanne, France.	agnes.girard-egrot@univ-lyon1.fr	GIRARD-EGROT, Agnès/AAP-5586-2020; Maniti, Ofélia/AAQ-5624-2021	GIRARD-EGROT, Agnès/0000-0003-2612-3124; Sarkis, Joe/0000-0002-9342-7198	Agence National de la Recherche [ANR-10-BLAN-1524]	Agence National de la Recherche(French National Research Agency (ANR))	The authors are indebted to the Agence National de la Recherche for financial support of the ReGal project (grant ANR-10-BLAN-1524). The authors thank Christian Salesse for helpful discussions.	Amann KJ, 1998, J BIOL CHEM, V273, P28419, DOI 10.1074/jbc.273.43.28419; [Anonymous], METHODS CHLOROPLAST; Awai K, 2001, P NATL ACAD SCI USA, V98, P10960, DOI 10.1073/pnas.181331498; Banc A, 2007, LANGMUIR, V23, P13066, DOI 10.1021/la702037k; BLAUDEZ D, 1993, APPL SPECTROSC, V47, P869, DOI 10.1366/0003702934415273; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BLOCK MA, 1983, J BIOL CHEM, V258, P3281; Boisselier E, 2012, LANGMUIR, V28, P9680, DOI 10.1021/la301135z; Botte C, 2005, J BIOL CHEM, V280, P34691, DOI 10.1074/jbc.M505622200; Bottier C, 2007, BBA-BIOMEMBRANES, V1768, P1526, DOI 10.1016/j.bbamem.2007.02.021; Boudiere L, 2012, MOL BIOSYST, V8, P2023, DOI 10.1039/c2mb25067e; Calvez P, 2011, LANGMUIR, V27, P1373, DOI 10.1021/la104097n; Calvez P, 2009, BIOCHIMIE, V91, P718, DOI 10.1016/j.biochi.2009.03.018; CASWELL DS, 1987, J AM CHEM SOC, V109, P2796, DOI 10.1021/ja00243a037; DeWolf C, 1997, BIOPHYS J, V72, P2599, DOI 10.1016/S0006-3495(97)78903-3; Dubots E, 2010, J BIOL CHEM, V285, P6003, DOI 10.1074/jbc.M109.071928; Girard-Egrot A, 2004, J MOL BIOL, V335, P321, DOI 10.1016/j.jmb.2003.10.028; GOUNARIS K, 1983, TRENDS BIOCHEM SCI, V8, P378, DOI 10.1016/0968-0004(83)90366-3; Guillemin Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009066; Ta HP, 2011, LANGMUIR, V27, P4797, DOI 10.1021/la103788r; JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140; Jarvis P, 2000, P NATL ACAD SCI USA, V97, P8175, DOI 10.1073/pnas.100132197; Jouhet J, 2004, J CELL BIOL, V167, P863, DOI 10.1083/jcb.200407022; Jouhet J, 2003, FEBS LETT, V544, P63, DOI 10.1016/S0014-5793(03)00477-0; Joyard J., 1996, MEMBRANES SPECIALIZE, P179; Kobayashi K, 2007, P NATL ACAD SCI USA, V104, P17216, DOI 10.1073/pnas.0704680104; Lee AG, 2000, CURR BIOL, V10, pR377, DOI 10.1016/S0960-9822(00)00477-2; Legardinier S, 2009, J MOL BIOL, V389, P546, DOI 10.1016/j.jmb.2009.04.025; Miege C, 1999, EUR J BIOCHEM, V265, P990, DOI 10.1046/j.1432-1327.1999.00801.x; Pitcher WH, 2002, BBA-BIOMEMBRANES, V1564, P107, DOI 10.1016/S0005-2736(02)00405-4; Rocha J, 2013, BIOCHIMIE, V95, P700, DOI 10.1016/j.biochi.2012.11.011; ROTHSCHILD KJ, 1989, P NATL ACAD SCI USA, V86, P9832, DOI 10.1073/pnas.86.24.9832; Sarkis J, 2011, J BIOL CHEM, V286, P30481, DOI 10.1074/jbc.M111.243881; Schladitz C, 1999, BIOPHYS J, V77, P3305, DOI 10.1016/S0006-3495(99)77161-4; Venien-Bryan C, 1998, BIOPHYS J, V74, P2649, DOI 10.1016/S0006-3495(98)77970-6	35	21	22	0	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					3114	3123		10.1096/fj.14-250415	http://dx.doi.org/10.1096/fj.14-250415			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24692595				2022-12-25	WOS:000337949400032
J	Armstrong, EH; Goswami, D; Griffin, PR; Noy, N; Ortlund, EA				Armstrong, Eric H.; Goswami, Devrishi; Griffin, Patrick R.; Noy, Noa; Ortlund, Eric A.			Structural Basis for Ligand Regulation of the Fatty Acid-binding Protein 5, Peroxisome Proliferator-activated Receptor beta/delta (FABP5-PPAR beta/delta) Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOIC ACID; NUCLEAR-LOCALIZATION; PPAR-BETA/DELTA; L-FABP; ALPHA; GLUCOSE; TRANSPORT; DIFFERENTIATION; ELECTROSTATICS; PURIFICATION	Fatty acid-binding proteins (FABPs) are a widely expressed group of calycins that play a well established role in solubilizing cellular fatty acids. Recent studies, however, have recast FABPs as active participants in vital lipid-signaling pathways. FABP5, like its family members, displays a promiscuous ligand binding profile, capable of interacting with numerous long chain fatty acids of varying degrees of saturation. Certain "activating" fatty acids induce the protein's cytoplasmic to nuclear translocation, stimulating PPAR beta/delta transactivation; however, the rules that govern this process remain unknown. Using a range of structural and biochemical techniques, we show that both linoleic and arachidonic acid elicit FABP5's translocation by permitting allosteric communication between the ligand-sensing beta 2 loop and a tertiary nuclear localization signal within the alpha-helical cap of the protein. Furthermore, we show that more saturated, non-activating fatty acids inhibit nuclear localization signal formation by destabilizing this activation loop, thus implicating FABP5 specifically in cis-bonded, polyunsaturated fatty acid signaling.	[Armstrong, Eric H.; Ortlund, Eric A.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Armstrong, Eric H.; Ortlund, Eric A.] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA; [Goswami, Devrishi; Griffin, Patrick R.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Noy, Noa] Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA; [Noy, Noa] Case Western Reserve Univ, Dept Nutr, Sch Med, Cleveland, OH 44106 USA	Emory University; Emory University; Scripps Research Institute; Case Western Reserve University; Case Western Reserve University	Ortlund, EA (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	eortlun@emory.edu	Ortlund, Eric Anthony/F-4672-2014; Ortlund, Eric Anthony/P-3121-2019	Ortlund, Eric Anthony/0000-0001-8855-3029; Ortlund, Eric Anthony/0000-0001-8855-3029	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL CANCER INSTITUTE [P30CA138292] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008602] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge Alexa Mattheyses, Jason Fritz, and Debby Martinson (Integrated Cellular Imaging Core, Emory University) and Shuiliang Yu (Case Western Reserve University) for training in microscopy methods, and Katie Doud (Case Western Reserve University) for generous assistance with the PPAR beta/delta activation assays. Data for 4LKP were collected at Southeast Regional Collaborative Access Team (SER-CAT) 22-BM beamline at the Advanced Photon Source, Argonne National Laboratory. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akiyama TE, 2004, J BIOL CHEM, V279, P20874, DOI 10.1074/jbc.M312802200; AMRI EZ, 1995, J BIOL CHEM, V270, P2367, DOI 10.1074/jbc.270.5.2367; Angelucci F, 2004, BIOCHEMISTRY-US, V43, P13000, DOI 10.1021/bi048505f; Ayers SD, 2007, BIOCHEMISTRY-US, V46, P6744, DOI 10.1021/bi700047a; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BANNER CD, 1993, J LIPID RES, V34, P1583; Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299; Berry DC, 2012, MOL CELL BIOL, V32, P3164, DOI 10.1128/MCB.00505-12; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Budhu AS, 2002, MOL CELL BIOL, V22, P2632, DOI 10.1128/MCB.22.8.2632-2641.2002; Chalmers MJ, 2006, ANAL CHEM, V78, P1005, DOI 10.1021/ac051294f; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597; Cologna SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047845; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Gillilan RE, 2007, J MOL BIOL, V372, P1246, DOI 10.1016/j.jmb.2007.07.040; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; GREENFIELD S, 1973, J NEUROCHEM, V20, P1207, DOI 10.1111/j.1471-4159.1973.tb00089.x; Gutierrez-Gonzalez LH, 2002, BIOCHEM J, V364, P725, DOI 10.1042/BJ20020039; Hanhoff T, 2002, MOL CELL BIOCHEM, V239, P45, DOI 10.1023/A:1020502624234; Hertzel AV, 2009, J MED CHEM, V52, P6024, DOI 10.1021/jm900720m; Hohoff C, 1999, BIOCHEMISTRY-US, V38, P12229, DOI 10.1021/bi990305u; Hong J, 2011, ATHEROSCLEROSIS, V217, P194, DOI 10.1016/j.atherosclerosis.2011.03.002; Hostetler HA, 2010, J LIPID RES, V51, P3103, DOI 10.1194/jlr.M005041; Hostetler HA, 2009, J LIPID RES, V50, P1663, DOI 10.1194/jlr.M900058-JLR200; Jeong CY, 2012, ONCOL REP, V28, P1283, DOI 10.3892/or.2012.1922; Kaczocha M, 2012, J BIOL CHEM, V287, P3415, DOI 10.1074/jbc.M111.304907; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; Kane CD, 1996, ANAL BIOCHEM, V233, P197, DOI 10.1006/abio.1996.0028; Kannan-Thulasiraman P, 2010, J BIOL CHEM, V285, P19106, DOI 10.1074/jbc.M109.099770; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Lee CH, 2006, P NATL ACAD SCI USA, V103, P3444, DOI 10.1073/pnas.0511253103; Levi L, 2013, CANCER RES, V73, P4770, DOI 10.1158/0008-5472.CAN-13-0384; Liu RZ, 2008, GENOMICS, V92, P436, DOI 10.1016/j.ygeno.2008.08.003; Maeda K, 2003, DIABETES, V52, P300, DOI 10.2337/diabetes.52.2.300; Majumdar A, 2011, J BIOL CHEM, V286, P42749, DOI 10.1074/jbc.M111.293464; Marcelino AMC, 2006, PROTEINS, V63, P373, DOI 10.1002/prot.20860; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLane LM, 2009, IUBMB LIFE, V61, P697, DOI 10.1002/iub.194; Morgan E, 2010, PPAR RES, V2010, DOI 10.1155/2010/234629; Nadra K, 2006, MOL CELL BIOL, V26, P3266, DOI 10.1128/MCB.26.8.3266-3281.2006; Newcomer M. E., 1994, RETINOIDS BIOL CHEM, P288; OCKNER RK, 1972, SCIENCE, V177, P56, DOI 10.1126/science.177.4043.56; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pascal BD, 2012, J AM SOC MASS SPECTR, V23, P1512, DOI 10.1007/s13361-012-0419-6; Petrescu AD, 2013, BBA-MOL CELL BIOL L, V1831, P1412, DOI 10.1016/j.bbalip.2013.05.008; Petrescu AD, 2013, AM J PHYSIOL-GASTR L, V304, pG241, DOI 10.1152/ajpgi.00334.2012; RICHIERI GV, 1994, J BIOL CHEM, V269, P23918; Richieri GV, 2000, BIOCHEMISTRY-US, V39, P7197, DOI 10.1021/bi000314z; SACCHETTINI JC, 1989, P NATL ACAD SCI USA, V86, P7736, DOI 10.1073/pnas.86.20.7736; Schug TT, 2008, P NATL ACAD SCI USA, V105, P7546, DOI 10.1073/pnas.0709981105; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Seibel NM, 2007, ANAL BIOCHEM, V368, P95, DOI 10.1016/j.ab.2007.05.025; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; SIEGENTHALER G, 1994, BIOCHEM J, V302, P363, DOI 10.1042/bj3020363; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simpson MA, 1999, MOL CELL BIOCHEM, V192, P33, DOI 10.1023/A:1006819715146; Smathers Rebecca L., 2011, Human Genomics, V5, P170; Storch J, 2000, BBA-MOL CELL BIOL L, V1486, P28, DOI 10.1016/S1388-1981(00)00046-9; Storch J, 2009, J LIPID RES, V50, pS126, DOI 10.1194/jlr.R800084-JLR200; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Tan NS, 2001, GENE DEV, V15, P3263, DOI 10.1101/gad.207501; Velkov T, 2013, PPAR RES, V2013, DOI 10.1155/2013/938401; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; XU ZH, 1993, J BIOL CHEM, V268, P7874; Yeung DCY, 2008, EUR HEART J, V29, P2156, DOI 10.1093/eurheartj/ehn295	75	67	69	3	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14941	14954		10.1074/jbc.M113.514646	http://dx.doi.org/10.1074/jbc.M113.514646			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24692551	hybrid, Green Published			2022-12-25	WOS:000337248100044
J	Mukherjee, A; Mueller, GM; Kinlough, CL; Sheng, N; Wang, ZJ; Mustafa, SA; Kashlan, OB; Kleyman, TR; Hughey, RP				Mukherjee, Anindit; Mueller, Gunhild M.; Kinlough, Carol L.; Sheng, Nan; Wang, Zhijian; Mustafa, S. Atif; Kashlan, Ossama B.; Kleyman, Thomas R.; Hughey, Rebecca P.			Cysteine Palmitoylation of the gamma Subunit Has a Dominant Role in Modulating Activity of the Epithelial Sodium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acid-sensing Ion Channel (ASIC); ENaC; Gating; Ion Channels; Protein Palmitoylation	NA+ CHANNEL; ALPHA-SUBUNIT; PROTEIN PALMITOYLATION; FURIN; DISTAL; SITES; IDENTIFICATION; ACTIVATION; EXPRESSION; PROTEASES	Background: Epithelial sodium channel (ENaC) and subunits are modified by Cys palmitoylation. Results: Palmitoylation of the subunit activates ENaCs by increasing channel open probability. Conclusion: subunit palmitoylation has a dominant role in activating ENaCs compared with subunit palmitoylation. Significance: ENaC palmitoylation is an important post-translational mechanism of channel regulation. The epithelial sodium channel (ENaC) is composed of three homologous subunits (, , and ) with cytoplasmic N and C termini. Our previous work revealed that two cytoplasmic Cys residues in the subunit, Cys-43 and Cys-557, are Cys-palmitoylated. ENaCs with mutant C43A/C557A exhibit normal surface expression but enhanced Na+ self-inhibition and reduced channel open probability. Although the subunit is not palmitoylated, we now show that the two cytoplasmic Cys residues in the subunit are palmitoylated. ENaCs with mutant C33A, C41A, or C33A/C41A exhibit reduced activity compared with wild type channels but normal surface expression and normal levels of and subunit-activating cleavage. These mutant channels have significantly enhanced Na+ self-inhibition and reduced open probability compared with wild type ENaCs. Channel activity was enhanced by co-expression with the palmitoyltransferase DHHC2 that also co-immunoprecipitates with ENaCs. Secondary structure prediction of the N terminus of the subunit places Cys-33 within an -helix and Cys-44 on a coil before the first transmembrane domain within a short tract that includes a well conserved His-Gly motif, where mutations have been associated with altered channel gating. Our current and previous results suggest that palmitoylation of the and subunits of ENaCs enhances interactions of their respective cytoplasmic domains with the plasma membrane and stabilizes the open state of the channel. Comparison of activities of channels lacking palmitoylation sites in individual or multiple subunits revealed that subunit palmitoylation has a dominant role over subunit palmitoylation in modulating ENaC gating.	[Mukherjee, Anindit; Mueller, Gunhild M.; Kinlough, Carol L.; Sheng, Nan; Wang, Zhijian; Mustafa, S. Atif; Kashlan, Ossama B.; Kleyman, Thomas R.; Hughey, Rebecca P.] Univ Pittsburgh, Renal Electrolyte Div, Dept Med, Pittsburgh, PA 15261 USA; [Kleyman, Thomas R.; Hughey, Rebecca P.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Hughey, Rebecca P.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kleyman, TR (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Renal Electrolyte Div, A919 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15626 USA.	kleyman@pitt.edu	Yang, Wei/HIA-0360-2022		National Institutes of Health [R01 DK065161, K01 DK078734, P30 DK079307]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065161, P30DK079307, K01DK078734, T32DK061296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK065161, K01 DK078734, and P30 DK079307.	Ahn YJ, 1999, AM J PHYSIOL-RENAL, V277, pF121, DOI 10.1152/ajprenal.1999.277.1.F121; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Bruns JB, 2003, AM J PHYSIOL-RENAL, V285, pF600, DOI 10.1152/ajprenal.00095.2003; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Carattino MD, 2005, J BIOL CHEM, V280, P4393, DOI 10.1074/jbc.M413123200; Carattino MD, 2003, J BIOL CHEM, V278, P36202, DOI 10.1074/jbc.M300312200; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; Drisdel RC, 2006, METHODS, V40, P127, DOI 10.1016/j.ymeth.2006.04.015; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Grunder S, 1999, PFLUG ARCH EUR J PHY, V438, P709, DOI 10.1007/s004240051097; Grunder S, 1997, EMBO J, V16, P899, DOI 10.1093/emboj/16.5.899; Hughey RP, 2004, J BIOL CHEM, V279, P48491, DOI 10.1074/jbc.C400460200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kashlan OB, 2011, AM J PHYSIOL-RENAL, V301, pF684, DOI 10.1152/ajprenal.00259.2011; Kashlan OB, 2011, J BIOL CHEM, V286, P649, DOI 10.1074/jbc.M110.167098; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Korycka J, 2012, EUR J CELL BIOL, V91, P107, DOI 10.1016/j.ejcb.2011.09.013; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Maarouf AB, 2009, J BIOL CHEM, V284, P7756, DOI 10.1074/jbc.M807060200; Mueller GM, 2012, AM J PHYSIOL-RENAL, V303, pF220, DOI 10.1152/ajprenal.00493.2011; Mueller GM, 2010, J BIOL CHEM, V285, P30453, DOI 10.1074/jbc.M110.151845; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Passero CJ, 2012, AM J PHYSIOL-RENAL, V302, pF1, DOI 10.1152/ajprenal.00330.2011; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Satlin LM, 2006, AM J PHYSIOL-RENAL, V291, pF923, DOI 10.1152/ajprenal.00192.2006; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Shipston MJ, 2011, J BIOL CHEM, V286, P8709, DOI 10.1074/jbc.R110.210005; Tomatis VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015045; Tsutsumi R, 2008, PFLUG ARCH EUR J PHY, V456, P1199, DOI 10.1007/s00424-008-0465-x	34	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14351	14359		10.1074/jbc.M113.526020	http://dx.doi.org/10.1074/jbc.M113.526020			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24692558	Green Published, hybrid			2022-12-25	WOS:000335984600060
J	Mayaphi, SH; Brauer, M; Morobadi, DM; Mazanderani, AH; Mafuyeka, RT; Olorunju, SAS; Tintinger, GR; Stoltz, A				Mayaphi, Simnikiwe H.; Brauer, Marieke; Morobadi, Daniel M.; Mazanderani, Ahmad H.; Mafuyeka, Rendani T.; Olorunju, Steve A. S.; Tintinger, Gregory R.; Stoltz, Anton			Cytomegalovirus Viral Load Kinetics in Patients with HIV/AIDS Admitted to a Medical Intensive Care Unit: A Case for Pre-Emptive Therapy	PLOS ONE			English	Article							TRANSPLANT RECIPIENTS; DISEASE; CMV; RISK; QUANTIFICATION; CORRELATE; VIREMIA; BURDEN; BLOOD; PCR	Background: Cytomegalovirus (CMV) infection is associated with severe diseases in immunosuppressed patients; however, there is a lack of data for pre-emptive therapy in patients with HIV/AIDS. Method: This was a retrospective study, which enrolled patients diagnosed with HIV/AIDS (CD4 < 200 cells/mu l), who had detectable CMV viral load (VL) during their stay in an adult medical intensive care unit between 2009-2012. Results: After screening 82 patients' records, 41 patients met the enrolment criteria. Their median age was 37 (interquartile range [IQR]: 31-46), and median CD4 count was 29 cells/mu l (IQR: 5-55). Sixteen patients (39%) had serial measurements of CMV VL before treatment with ganciclovir. Patients whose baseline CMV VL values were between 1,000-3,000 copies/ml had significantly higher values (median of 14,650 copies/ml) on follow-up testing done 4-12 days later. Those with undetectable VLs at baseline testing had detectable VLs (median of 1,590 copies/ml) mostly within 20 days of follow-up testing. Patients who had VLs > 1,000 copies/ml at baseline testing had significantly higher mortality compared to those who had < 1,000 copies/ml {hazard ratio of 3.46, p=0.003 [95% confidence interval (CI): 1.55-7.71]}. Analysis of the highest CMV VL per patient showed that patients who had VLs of > 5,100 copies/ml and did not receive ganciclovir had 100% mortality compared to 58% mortality in those who received ganciclovir at VLs of > 5,100 copies/ml, 50% mortality in those who were not treated and had low VLs of < 5,100 copies/ml, and 44% mortality in those who had ganciclovir treatment at VLs of < 5,100 copies/ml (p=0.084, 0.046, 0.037, respectively). Conclusion: This study showed a significantly increased mortality in patients with HIV/AIDS who had high CMV VLs, and suggests that a threshold value of 1,000 copies/ml may be appropriate for pre-emptive treatment in this group.	[Mayaphi, Simnikiwe H.; Brauer, Marieke; Morobadi, Daniel M.; Mazanderani, Ahmad H.; Mafuyeka, Rendani T.] Univ Pretoria, Dept Med Virol, NHLS TAD, ZA-0001 Pretoria, South Africa; [Olorunju, Steve A. S.] MRC, Biostat Unit, Pretoria, South Africa; [Tintinger, Gregory R.; Stoltz, Anton] Univ Pretoria, Dept Internal Med, ZA-0002 Pretoria, South Africa	University of Pretoria; University of Pretoria	Mayaphi, SH (corresponding author), Univ Pretoria, Dept Med Virol, NHLS TAD, ZA-0001 Pretoria, South Africa.	sim.mayaphi@up.ac.za		Mayaphi, Simnikiwe/0000-0002-5453-4353; Brauer, Marieke/0000-0001-6759-4921				Atkinson C, 2011, J CLIN VIROL, V51, P219, DOI 10.1016/j.jcv.2011.04.007; Ayoub T, 2008, J ROY SOC MED, V101, P177, DOI 10.1258/jrsm.2008.070479; Barron M. A., 2005, Clinical Microbiology Newsletter, V27, P99, DOI 10.1016/j.clinmicnews.2005.06.001; Bloch EM, 2012, TRANSFUS MED REV, V26, P164, DOI 10.1016/j.tmrv.2011.07.006; Chemaly RF, 2004, J CLIN MICROBIOL, V42, P2168, DOI 10.1128/JCM.42.5.2168-2172.2004; De Keyzer K, 2011, AM J KIDNEY DIS, V58, P118, DOI 10.1053/j.ajkd.2011.04.010; de la Hoz RE, 2002, J CLIN VIROL, V25, pS1, DOI 10.1016/S1386-6532(02)00091-4; Durier N, 2013, CLIN INFECT DIS, V57, P147, DOI 10.1093/cid/cit173; Eid AJ, 2010, AM J TRANSPLANT, V10, P157, DOI 10.1111/j.1600-6143.2009.02861.x; El Amari EB, 2011, HIV MED, V12, P394, DOI 10.1111/j.1468-1293.2010.00900.x; Fielding K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025571; GALLANT JE, 1992, J INFECT DIS, V166, P1223, DOI 10.1093/infdis/166.6.1223; Ganzenmueller T, 2009, J CLIN VIROL, V46, P254, DOI 10.1016/j.jcv.2009.08.008; Griffiths PD, 2012, LANCET INFECT DIS, V12, P790, DOI 10.1016/S1473-3099(12)70197-4; Halfon P, 2011, J MED VIROL, V83, P490, DOI 10.1002/jmv.21996; Henke-Gendo C, 2012, J MED VIROL, V84, P890, DOI 10.1002/jmv.23285; Kirubakaran S. I., 2004, Clinical Microbiology Newsletter, V26, P137, DOI 10.1016/j.clinmicnews.2004.09.001; Laher F, 2012, S AFR J HIV MED, P68; Levitsky J, 2008, CLIN TRANSPLANT, V22, P222, DOI 10.1111/j.1399-0012.2007.00778.x; Li HJ, 2003, J CLIN MICROBIOL, V41, P187, DOI 10.1128/JCM.41.1.187-191.2003; Martin-Gandul C, 2013, J CLIN VIROL, V56, P13, DOI 10.1016/j.jcv.2012.09.017; Metras D, 1999, EUR J CARDIO-THORAC, V15, P490, DOI 10.1016/S1010-7940(99)00059-7; Mizushima D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065348; Mocarski ES., 2007, FIELDS VIROLOGY, P2702; Preiser W, 2001, J CLIN VIROL, V20, P59, DOI 10.1016/S1386-6532(00)00156-6; Rasmussen L, 1997, J INFECT DIS, V176, P1146, DOI 10.1086/514106; Robberts FJL, 2007, DIAGN MICR INFEC DIS, V58, P385, DOI 10.1016/j.diagmicrobio.2007.02.014; Ruell J, 2007, BONE MARROW TRANSPL, V40, P55, DOI 10.1038/sj.bmt.1705671; Spector SA, 1996, NEW ENGL J MED, V334, P1491, DOI 10.1056/NEJM199606063342302; Spector SA, 1998, J CLIN INVEST, V101, P497, DOI 10.1172/JCI1101	30	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93702	10.1371/journal.pone.0093702	http://dx.doi.org/10.1371/journal.pone.0093702			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699683	gold, Green Published, Green Submitted			2022-12-25	WOS:000334105000092
J	Shasteen, JR; Sasson, NJ; Pinkham, AE				Shasteen, Jonathon R.; Sasson, Noah J.; Pinkham, Amy E.			Eye Tracking the Face in the Crowd Task: Why Are Angry Faces Found More Quickly?	PLOS ONE			English	Article							VISUAL-SEARCH; FACIAL EXPRESSIONS; ANGER-SUPERIORITY; REAL FACES; MOVEMENTS; PARALLEL; EMOTION	Among a crowd of distractor faces, threatening or angry target faces are identified more quickly and accurately than are nonthreatening or happy target faces, a finding known as the "face in the crowd effect." Two perceptual explanations of the effect have been proposed: (1) the "target orienting" hypothesis (i.e., threatening targets orient attention more quickly than do nonthreatening targets and (2) the "distractor processing" hypothesis (i.e., nonthreatening distractors paired with a threatening target are processed more efficiently than vice versa, leading to quicker detection of threatening targets). Using a task, with real faces and multiple identities, the current study replicated the face in the crowd effect and then, via eye tracking, found greater support for the target orienting hypothesis. Across both the classical search asymmetry paradigm (i.e., one happy target in a crowd of angry distractors vs. one angry target in a crowd of happy distractors) and the constant distractor paradigm (i.e., one happy target in a crowd of neutral distractors vs. one angry target in a crowd of neutral distractors), fewer distractors were fixated before first fixating angry targets relative to happy targets, with no difference in the processing efficiency of distractors. These results suggest that the face in the crowd effect on this task is supported to a greater degree by attentional patterns associated with properties of target rather those of the crowd.	[Shasteen, Jonathon R.; Sasson, Noah J.] Univ Texas Dallas, Sch Behav & Brain Sci, Dallas, TX 75230 USA; [Pinkham, Amy E.] So Methodist Univ, Dept Psychol, Dallas, TX 75275 USA; [Pinkham, Amy E.] Univ Texas Southwestern, Sch Med, Dallas, TX USA	University of Texas System; University of Texas Dallas; Southern Methodist University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sasson, NJ (corresponding author), Univ Texas Dallas, Sch Behav & Brain Sci, Dallas, TX 75230 USA.	nsasson@utdallas.edu						Becker DV, 2011, J EXP PSYCHOL GEN, V140, P637, DOI 10.1037/a0024060; Belopolsky AV, 2011, VIS COGN, V19, P27, DOI 10.1080/13506285.2010.536186; Calvo MG, 2008, J EXP PSYCHOL GEN, V137, P471, DOI 10.1037/a0012771; Ceccarini F, 2013, VIS COGN, V21, P498, DOI 10.1080/13506285.2013.807901; Damjanovic L, 2014, Q J EXP PSYCHOL, V67, P1004, DOI 10.1080/17470218.2013.839724; Damjanovic L, 2010, J COGN CULT, V10, P85, DOI 10.1163/156853710X497185; Eastwood JD, 2001, PERCEPT PSYCHOPHYS, V63, P1004, DOI 10.3758/BF03194519; Eastwood JD, 2005, VIS COGN, V12, P159, DOI 10.1080/13506280444000175; Elfenbein HA, 2002, PSYCHOL BULL, V128, P203, DOI 10.1037//0033-2909.128.2.203; Findlay JM, 1997, VISION RES, V37, P617, DOI 10.1016/S0042-6989(96)00218-0; Fox E, 2000, COGNITION EMOTION, V14, P61, DOI 10.1080/026999300378996; Fox E, 2006, EMOTION, V6, P534, DOI 10.1037/1528-3542.6.3.534; Friesen E., 1978, CONSULTING PSYCHOL P, V3, P1; Frischen A, 2008, PSYCHOL BULL, V134, P662, DOI 10.1037/0033-2909.134.5.662; Gur RC, 2002, J NEUROSCI METH, V115, P137, DOI 10.1016/S0165-0270(02)00006-7; HAMPTON C, 1989, B PSYCHONOMIC SOC, V27, P563; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Horstmann G, 2006, EMOTION, V6, P193, DOI 10.1037/1528-3542.6.2.193; Horstmann G, 2012, J VISION, V12, DOI 10.1167/12.5.7; Juth P, 2005, EMOTION, V5, P379, DOI 10.1037/1528-3542.5.4.379; Leppanen JM, 2003, J PSYCHOPHYSIOL, V17, P113, DOI 10.1027//0269-8803.17.3.113; Lundqvist D, 2013, COGNITION E IN PRESS; Mermillod M, 2009, COGNITION, V110, P346, DOI 10.1016/j.cognition.2008.11.009; Ohman A, 2001, J PERS SOC PSYCHOL, V80, P381, DOI 10.1037//0022-3514.80.3.381; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Pinkham AE, 2014, J ABNORM PS IN PRESS; Pinkham AE, 2010, EMOTION, V10, P141, DOI 10.1037/a0017387; Purcell DG, 2010, ATTEN PERCEPT PSYCHO, V72, P2115, DOI 10.3758/APP.72.8.2115; Reynolds MG, 2009, VIS COGN, V17, P318, DOI 10.1080/13506280701623704; Salvucci D.D., 2000, P 2000 S EYE TRACK R, P71, DOI [10.1145/355017.355028, DOI 10.1145/355017.355028]; Sasson NJ, 2010, J NONVERBAL BEHAV, V34, P207, DOI 10.1007/s10919-010-0092-z; Shen J, 2001, PERCEPT PSYCHOPHYS, V63, P464, DOI 10.3758/BF03194413; Turatto M, 2000, VISION RES, V40, P1639, DOI 10.1016/S0042-6989(00)00061-4; Williams DE, 1997, CAN J EXP PSYCHOL, V51, P151, DOI 10.1037/1196-1961.51.2.151; Williams MA, 2005, VIS COGN, V12, P29, DOI 10.1080/13506280444000193; Zelinsky GJ, 1997, J EXP PSYCHOL HUMAN, V23, P244, DOI 10.1037/0096-1523.23.1.244	36	19	20	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93914	10.1371/journal.pone.0093914	http://dx.doi.org/10.1371/journal.pone.0093914			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LR	24699880	Green Published, Green Submitted			2022-12-25	WOS:000334105000120
J	Adam, C; Baeurle, A; Brodsky, JL; Wipf, P; Schrama, D; Becker, JC; Houben, R				Adam, Christian; Baeurle, Anne; Brodsky, Jeffrey L.; Wipf, Peter; Schrama, David; Becker, Jurgen Christian; Houben, Roland			The HSP70 Modulator MAL3-101 Inhibits Merkel Cell Carcinoma	PLOS ONE			English	Article							LARGE T-ANTIGEN; SV40 LARGE T; HEAT-SHOCK PROTEINS; J DOMAIN; TUMOR-SUPPRESSOR; HEAT-SHOCK-PROTEIN-70; CANCER; APOPTOSIS; MOLECULES; GROWTH	Merkel Cell Carcinoma (MCC) is a rare and highly aggressive neuroendocrine skin cancer for which no effective treatment is available. MCC represents a human cancer with the best experimental evidence for a causal role of a polyoma virus. Large T antigens (LTA) encoded by polyoma viruses are oncoproteins, which are thought to require support of cellular heat shock protein 70 (HSP70) to exert their transforming activity. Here we evaluated the capability of MAL3- 101, a synthetic HSP70 inhibitor, to limit proliferation and survival of various MCC cell lines. Remarkably, MAL3-101 treatment resulted in considerable apoptosis in 5 out of 7 MCC cell lines. While this effect was not associated with the viral status of the MCC cells, quantitative mRNA expression analysis of the known HSP70 isoforms revealed a significant correlation between MAL3- 101 sensitivity and HSC70 expression, the most prominent isoform in all cell lines. Moreover, MAL3- 101 also exhibited in vivo antitumor activity in an MCC xenograft model suggesting that this substance or related compounds are potential therapeutics for the treatment of MCC in the future.	[Adam, Christian; Baeurle, Anne; Houben, Roland] Univ Hosp Wurzberg, Dept Dermatol, Wurzburg, Germany; [Brodsky, Jeffrey L.; Wipf, Peter] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Brodsky, Jeffrey L.; Wipf, Peter] Univ Pittsburgh, Dept Biol, Pittsburgh, PA USA; [Schrama, David; Becker, Jurgen Christian] Med Univ Graz, Div Gen Dermatol, Graz, Austria	University of Wurzburg; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Medical University of Graz	Adam, C (corresponding author), Univ Hosp Wurzberg, Dept Dermatol, Wurzburg, Germany.	Adam_C@ukw.de	Wipf, Peter/AAG-1771-2021	Wipf, Peter/0000-0001-7693-5863; Houben, Roland/0000-0003-4538-2324; Schrama, David/0000-0002-6931-8194; Adam, Christian/0000-0001-7721-4144	Wilhelm-Sander-Stiftung [2007.057.3]; German Research Foundation (DFG); University of Wurzburg	Wilhelm-Sander-Stiftung; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wurzburg	This study was supported by the Wilhelm-Sander-Stiftung (grant number: 2007.057.3) (http://www.wilhelm-sander-stiftung.de). This publication was funded by the German Research Foundation (DFG) and the University of Wurzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agelli M, 2010, CURR PROB CANCER, V34, P14, DOI 10.1016/j.currproblcancer.2010.01.001; Albores-Saavedra J, 2010, J CUTAN PATHOL, V37, P20, DOI 10.1111/j.1600-0560.2009.01370.x; Arora R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003713; Bakker ABH, 1998, J IMMUNOL, V160, P5239; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Braunstein MJ, 2011, J ONCOL, V2011, DOI 10.1155/2011/232037; Brocchieri L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-19; Campbell KS, 1997, GENE DEV, V11, P1098, DOI 10.1101/gad.11.9.1098; Cheng JW, 2013, J VIROL, V87, P6118, DOI 10.1128/JVI.00385-13; Daily K, 2013, J INVEST DERMATOL, V133, pS71; Davids M, 2009, J CLIN ONCOL, V27, pE97, DOI 10.1200/JCO.2009.21.8149; DeCaprio JA, 1999, BIOLOGICALS, V27, P23, DOI 10.1006/biol.1998.0173; Duprat JP, 2011, CLINICS, V66, P1817, DOI 10.1590/S1807-59322011001000023; Fakiha M, 2010, J CANCER RES THER, V6, P382, DOI 10.4103/0973-1482.73352; Fewell SW, 2004, J BIOL CHEM, V279, P51131, DOI 10.1074/jbc.M404857200; Garrido C, 2006, CELL CYCLE, V5, P2592, DOI 10.4161/cc.5.22.3448; Gewirtz DA, 2001, ARCH BIOCHEM BIOPHYS, V388, P243, DOI 10.1006/abbi.2000.2278; GILLIS S, 1980, J EXP MED, V152, P1709, DOI 10.1084/jem.152.6.1709; GREEN D, 1971, BLOOD-J HEMATOL, V37, P47, DOI 10.1182/blood.V37.1.47.47; Gurbuxani S, 2003, ONCOGENE, V22, P6669, DOI 10.1038/sj.onc.1206794; Houben R, 2013, J INVEST DERMATOL, V133, P2453, DOI 10.1038/jid.2013.169; Houben R, 2012, INT J CANCER, V130, P847, DOI 10.1002/ijc.26076; Houben R, 2010, J VIROL, V84, P7064, DOI 10.1128/JVI.02400-09; Howard RA, 2006, CANCER EPIDEM BIOMAR, V15, P1545, DOI 10.1158/1055-9965.EPI-05-0895; Kim HY, 2001, EMBO J, V20, P295, DOI 10.1093/emboj/20.1.295; Kwun HJ, 2009, J VIROL, V83, P12118, DOI 10.1128/JVI.01336-09; Liu T, 2012, PHARMACOL THERAPEUT, V136, P354, DOI 10.1016/j.pharmthera.2012.08.014; Meier G, 2004, ONCOLOGY-BASEL, V66, P160, DOI 10.1159/000077443; Miller NJ, 2013, CURR TREAT OPTION ON, V14, P249, DOI 10.1007/s11864-013-0225-9; Moens U, 2007, CELL MOL LIFE SCI, V64, P1656, DOI 10.1007/s00018-007-7020-3; Myung Jae-Kyung, 2004, Proteome Sci, V2, P8, DOI 10.1186/1477-5956-2-8; Nylandsted J, 2000, ANN NY ACAD SCI, V926, P122; Pincelli C, 1997, J INVEST DERMATOL, V109, P757, DOI 10.1111/1523-1747.ep12340768; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Rodig SJ, 2012, J CLIN INVEST; Rodina A, 2007, NAT CHEM BIOL, V3, P498, DOI 10.1038/nchembio.2007.10; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; RONAN SG, 1993, J AM ACAD DERMATOL, V29, P715, DOI 10.1016/0190-9622(93)70236-M; Samlowski WE, 2010, AM J CLIN ONCOL-CANC, V33, P495, DOI 10.1097/COC.0b013e3181b9cf04; SAWAI ET, 1989, J VIROL, V63, P3961, DOI 10.1128/JVI.63.9.3961-3973.1989; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Schmitt E, 2006, CANCER RES, V66, P4191, DOI 10.1158/0008-5472.CAN-05-3778; Schrama D, 2012, CURR OPIN ONCOL, V24, P141, DOI 10.1097/CCO.0b013e32834fc9fe; Sheng Q, 1997, J VIROL, V71, P9410, DOI 10.1128/JVI.71.12.9410-9416.1997; Shuda M, 2008, P NATL ACAD SCI USA, V105, P16272, DOI 10.1073/pnas.0806526105; Shuda M, 2011, J CLIN INVEST, V121, P3623, DOI 10.1172/JCI46323; Sullivan CS, 2000, MOL CELL BIOL, V20, P6233, DOI 10.1128/MCB.20.17.6233-6243.2000; Sullivan CS, 2000, MOL CELL BIOL, V20, P5749, DOI 10.1128/MCB.20.15.5749-5757.2000; Tai PTH, 2000, J CLIN ONCOL, V18, P2493, DOI 10.1200/JCO.2000.18.12.2493; Tutar Yusuf, 2011, Recent Pat DNA Gene Seq, V5, P214; Van Gele M, 2002, INT J CANCER, V101, P137, DOI 10.1002/ijc.10591; Wang RE, 2011, CURR MED CHEM, V18, P4250; Wieland U, 2011, CURR OPIN ONCOL, V23, P488, DOI 10.1097/CCO.0b013e3283495a5b; Willmes C, 2012, CANCER RES, V72, P2120, DOI 10.1158/0008-5472.CAN-11-2651; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zalvide J, 1998, MOL CELL BIOL, V18, P1408, DOI 10.1128/MCB.18.3.1408	56	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e92041	10.1371/journal.pone.0092041	http://dx.doi.org/10.1371/journal.pone.0092041			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24694787	Green Published, Green Accepted, gold			2022-12-25	WOS:000334103000014
J	Dishaw, LJ; Flores-Torres, J; Lax, S; Gemayel, K; Leigh, B; Melillo, D; Mueller, MG; Natale, L; Zucchetti, I; De Santis, R; Pinto, MR; Litman, GW; Gilbert, JA				Dishaw, Larry J.; Flores-Torres, Jaime; Lax, Simon; Gemayel, Kristina; Leigh, Brittany; Melillo, Daniela; Mueller, M. Gail; Natale, Lenina; Zucchetti, Ivana; De Santis, Rosaria; Pinto, Maria Rosaria; Litman, Gary W.; Gilbert, Jack A.			The Gut of Geographically Disparate Ciona intestinalis Harbors a Core Microbiota	PLOS ONE			English	Article							AEROBIC CULTURABLE BACTERIA; COMMUNITIES; DIVERSITY; COLONIZATION; ASSOCIATIONS; MUCUS; MODEL	It is now widely understood that all animals engage in complex interactions with bacteria (or microbes) throughout their various life stages. This ancient exchange can involve cooperation and has resulted in a wide range of evolved host-microbial interdependencies, including those observed in the gut. Ciona intestinalis, a filter-feeding basal chordate and classic developmental model that can be experimentally manipulated, is being employed to help define these relationships. Ciona larvae are first exposed internally to microbes upon the initiation of feeding in metamorphosed individuals; however, whether or not these microbes subsequently colonize the gut and whether or not Ciona forms relationships with specific bacteria in the gut remains unknown. In this report, we show that the Ciona gut not only is colonized by a complex community of bacteria, but also that samples from three geographically isolated populations reveal striking similarity in abundant operational taxonomic units (OTUs) consistent with the selection of a core community by the gut ecosystem.	[Dishaw, Larry J.; Litman, Gary W.] Univ S Florida, Coll Med, USF Hlth, Dept Pediat,Div Mol Genet, St Petersburg, FL 33701 USA; [Flores-Torres, Jaime] Univ S Florida, Coll Med, USF Hlth, Div Neonatol, St Petersburg, FL 33701 USA; [Lax, Simon; Gilbert, Jack A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Gemayel, Kristina] Univ S Florida, Coll Med, PostBaccalaureate Program Interdisciplinary Med, Tampa, FL USA; [Leigh, Brittany] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Melillo, Daniela; Natale, Lenina; Zucchetti, Ivana; De Santis, Rosaria; Pinto, Maria Rosaria] Dept Anim Physiol & Evolut, Stn Zool Anton Dohrn, Naples, Italy; [Mueller, M. Gail] Univ S Florida, All Childrens Hosp, Dept Mol Genet, St Petersburg, FL 33701 USA; [Gilbert, Jack A.] Univ Chicago, Argonne Natl Lab, Biosci Div, Chicago, IL 60637 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; University of Chicago; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Stazione Zoologica Anton Dohrn di Napoli; State University System of Florida; University of South Florida; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago	Dishaw, LJ (corresponding author), Univ S Florida, Coll Med, USF Hlth, Dept Pediat,Div Mol Genet, St Petersburg, FL 33701 USA.	ldishaw@health.usf.edu	Dishaw, Larry/ABZ-9621-2022; Dishaw, Larry J/A-9930-2010; Gilbert, Jack/AAF-3270-2019	Dishaw, Larry/0000-0002-2705-4573; Dishaw, Larry J/0000-0002-2705-4573; 	U.S. Dept. of Energy [DE-AC02-06CH11357]; National Institute of Health [NIH AI23338]; All Children's Hospital Foundation Research Grant; USF College of Medicine Internal Award; Por Campania FSE Project Modo - Model Organism; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023338, R56AI023338, R37AI023338] Funding Source: NIH RePORTER	U.S. Dept. of Energy(United States Department of Energy (DOE)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); All Children's Hospital Foundation Research Grant; USF College of Medicine Internal Award; Por Campania FSE Project Modo - Model Organism(Regione Campania); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the U.S. Dept. of Energy under Contract DE-AC02-06CH11357 (JAG) and the National Institute of Health (NIH AI23338) (GWL), by an All Children's Hospital Foundation Research Grant and a USF College of Medicine Internal Award (LJD), and by Por Campania FSE 2007-2013 Project Modo - Model Organism (DM, LN, and IZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini S, 2012, CORAL REEFS, V31, P147, DOI 10.1007/s00338-011-0831-6; Bayer T, 2013, APPL ENVIRON MICROB, V79, P4759, DOI 10.1128/AEM.00695-13; Bayer T, 2013, MAR ECOL PROG SER, V479, P75, DOI 10.3354/meps10197; Blasiak LC, 2013, ISME J; Brenner DJ, 2005, BERGEYS MANUAL SYSTE; Caporaso JG, 2012, ISME J, V6, P1089, DOI 10.1038/ismej.2011.162; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caputi L, 2007, P NATL ACAD SCI USA, V104, P9364, DOI 10.1073/pnas.0610158104; Carlos C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01624; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Correa H, 2013, MICROB ECOL, V66, P972, DOI 10.1007/s00248-013-0267-3; Dishaw LJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00096; Dishaw LJ, 2011, P NATL ACAD SCI USA, V108, P16747, DOI 10.1073/pnas.1109687108; Fan L, 2012, P NATL ACAD SCI USA, V109, pE1878, DOI 10.1073/pnas.1203287109; Franzenburg S, 2013, ISME J, V7, P781, DOI 10.1038/ismej.2012.156; Gibbons SM, 2013, P NATL ACAD SCI USA, V110, P4651, DOI 10.1073/pnas.1217767110; Goffredi SK, 2007, APPL ENVIRON MICROB, V73, P2314, DOI 10.1128/AEM.01986-06; Gordon JI, 2012, SCIENCE, V336, P1251, DOI 10.1126/science.1224686; Iannelli F, 2007, TRENDS GENET, V23, P419, DOI 10.1016/j.tig.2007.07.001; IBRAHIM A, 1993, FEMS MICROBIOL LETT, V114, P173, DOI 10.1016/0378-1097(93)90515-4; Jensen S, 2010, FEMS MICROBIOL ECOL, V74, P523, DOI 10.1111/j.1574-6941.2010.00981.x; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; King GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051475; Kuczynski J, 2012, CURR PROTOC MICROBIO; Kurahashi M, 2007, SYST APPL MICROBIOL, V30, P202, DOI 10.1016/j.syapm.2006.07.003; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Li M, 2009, MICROB ECOL, V58, P892, DOI 10.1007/s00248-009-9550-8; Mao-Jones J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000345; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; McFall-Ngai MJ, 2002, DEV BIOL, V242, P1, DOI 10.1006/dbio.2001.0522; Morrow KM, 2012, APPL ENVIRON MICROB, V78, P6438, DOI 10.1128/AEM.01162-12; Nydam ML, 2010, MOL PHYLOGENET EVOL, V56, P718, DOI 10.1016/j.ympev.2010.03.042; PLANTE CJ, 1990, ANNU REV ECOL SYST, V21, P93, DOI 10.1146/annurev.es.21.110190.000521; Raina JB, 2009, APPL ENVIRON MICROB, V75, P3492, DOI 10.1128/AEM.02567-08; Rhee KJ, 2004, J IMMUNOL, V172, P1118, DOI 10.4049/jimmunol.172.2.1118; Roux C, 2013, MOL BIOL EVOL; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; Stackebrandt E, 1993, HDB NEW BACTERIAL SY, P152; Sullam KE, 2012, MOL ECOL, V21, P3363, DOI 10.1111/j.1365-294X.2012.05552.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vezzulli L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067745; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhang XC, 2013, J GEN APPL MICROBIOL, V59, P1; Zhang XC, 2012, J GEN APPL MICROBIOL, V58, P447, DOI 10.2323/jgam.58.447; Zielinski FU, 2009, ENVIRON MICROBIOL, V11, P1150, DOI 10.1111/j.1462-2920.2008.01847.x	50	86	89	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93386	10.1371/journal.pone.0093386	http://dx.doi.org/10.1371/journal.pone.0093386			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695540	Green Submitted, Green Published, gold			2022-12-25	WOS:000334103000066
J	Huang, RY; Chu, YL; Huang, QC; Chen, XM; Jiang, ZB; Zhang, X; Zeng, X				Huang, Run-Yue; Chu, Yong-Liang; Huang, Qing-Chun; Chen, Xiu-Min; Jiang, Ze-Bo; Zhang, Xian; Zeng, Xing			18 beta-Glycyrrhetinic Acid Suppresses Cell Proliferation through Inhibiting Thromboxane Synthase in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							EXPRESSION; CARCINOMA; APOPTOSIS; CYCLOOXYGENASE-2; GROWTH; A(2)	18 beta-glycyrrhetinic acid (18 beta-GA) is a bioactive component of licorice. The anti-cancer activity of 18 beta-GA has been studied in many cancer types, whereas its effects in lung cancer remain largely unknown. We first showed that 18 beta-GA effectively suppressed cell proliferation and inhibited expression as well as activity of thromboxane synthase (TxAS) in non-small cell lung cancer (NSCLC) cells A549 and NCI-H460. In addition, the administration of 18 beta-GA did not have any additional inhibitory effect on the decrease of cell proliferation induced by transfection with TxAS small interference RNA (siRNA). Moreover, 18 beta-GA failed to inhibit cell proliferation in the immortalized human bronchial epithelial cells 16HBE-T and another NSCLC cell line NCI-H23, both of which expressed minimal level of TxAS as compared to A549 and NCI-H460. However, 18 beta-GA abolished the enhancement of cell proliferation induced by transfection of NCI-H23 with pCMV6-TxAS plasmid. Further study found that the activation of both extracellular signal-regulated kinase (ERK)1/2 and cyclic adenosine monophosphate response element binding protein (CREB) induced by TxAS cDNA transfection could be totally blocked by 18 beta-GA. Altogether, we have delineated that, through inhibiting TxAS and its initiated ERK/CREB signaling, 18 beta-GA suppresses NSCLC cell proliferation. Our study has highlighted the significance of 18 beta-GA with respect to prevention and treatment of NSCLC.	[Huang, Run-Yue; Chu, Yong-Liang; Huang, Qing-Chun; Chen, Xiu-Min] Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangdong Prov Hosp Chinese Med, Dept Rheumatol, Guangzhou, Guangdong, Peoples R China; [Jiang, Ze-Bo; Zhang, Xian; Zeng, Xing] Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangdong Prov Hosp Chinese Med, Cent Lab, Guangzhou, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	Huang, RY (corresponding author), Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangdong Prov Hosp Chinese Med, Dept Rheumatol, Guangzhou, Guangdong, Peoples R China.	ry_huang@hotmail.com; zengxing-china@163.com	zhang, xu/GYE-3558-2022; Zhang, xiaoyu/GXA-3206-2022; zhang, xuan/AAN-9914-2020; zhang, xu/GRX-9733-2022; zhang, xian/GYA-0290-2022	zhang, xuan/0000-0001-8775-1699; 	National Natural Science Foundation of China [81302799]; China Postdoctoral Science Foundation [2013M531838]; Excellent Young Scientist Foundation from Guangzhou University of Chinese Medicine [KAB111133K08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Excellent Young Scientist Foundation from Guangzhou University of Chinese Medicine	Grant support: This study was supported by National Natural Science Foundation of China (No. 81302799), China Postdoctoral Science Foundation (No. 2013M531838) and 2012 Excellent Young Scientist Foundation from Guangzhou University of Chinese Medicine (No. KAB111133K08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton AW, 1999, J BIOL CHEM, V274, P35562, DOI 10.1074/jbc.274.50.35562; Cathcart MC, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-25; Cathcart MC, 2010, BBA-REV CANCER, V1805, P153, DOI 10.1016/j.bbcan.2010.01.006; Chen GG, 2006, CANCER LETT, V234, P193, DOI 10.1016/j.canlet.2005.03.032; Ekambaram P, 2011, CANCER METAST REV, V30, P397, DOI 10.1007/s10555-011-9297-9; Ermert L, 2003, CLIN CANCER RES, V9, P1604; FUJIMORI A, 1989, CALCIFIED TISSUE INT, V44, P186, DOI 10.1007/BF02556563; Homma S, 2009, CLIN CANCER RES, V15, P3423, DOI 10.1158/1078-0432.CCR-08-2822; Huang RY, 2011, ONCOGENE, V30, P106, DOI 10.1038/onc.2010.390; Huang RY, 2013, J MOL CELL BIOL, V5, P380, DOI 10.1093/jmcb/mjt038; Huang RY, 2011, BBA-REV CANCER, V1815, P158, DOI 10.1016/j.bbcan.2010.11.005; Huang Wei, 2003, Zhongguo Fei Ai Za Zhi, V6, P254, DOI 10.3779/j.issn.1009-3419.2003.04.02; Jariyawat S, 1997, BIOCHEM MOL BIOL INT, V42, P113; Kalani K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074761; Kuttan G, 2011, PHARM BIOL, V49, P995, DOI 10.3109/13880209.2011.559476; Lallemand B, 2013, J PHARM PHARMACOL, V65, P402, DOI 10.1111/j.2042-7158.2012.01603.x; Lee CS, 2010, EUR J PHARMACOL, V649, P354, DOI 10.1016/j.ejphar.2010.09.047; Lim J, 2013, MOL CELLS, V36, P340, DOI 10.1007/s10059-013-0123-9; Logashenko EB, 2011, CHEMBIOCHEM, V12, P784, DOI 10.1002/cbic.201000618; Ming LJ, 2013, NAT PROD COMMUN, V8, P415; Moussa O, 2008, ONCOGENE, V27, P55, DOI 10.1038/sj.onc.1210629; Moussa O, 2008, CANCER RES, V68, P4097, DOI 10.1158/0008-5472.CAN-07-6560; Nakahata N, 2008, PHARMACOL THERAPEUT, V118, P18, DOI 10.1016/j.pharmthera.2008.01.001; Ni YF, 2011, J SURG RES, V165, pE29, DOI 10.1016/j.jss.2010.10.004; Nie DT, 2004, AM J PATHOL, V164, P429, DOI 10.1016/S0002-9440(10)63133-1; Sakamoto KM, 2009, CLIN CANCER RES, V15, P2583, DOI 10.1158/1078-0432.CCR-08-1137; Satomi Y, 2005, ANTICANCER RES, V25, P4043; Sharma G, 2012, J CELL PHYSIOL, V227, P1923, DOI 10.1002/jcp.22920; Wei J, 2007, BIOCHEM PHARMACOL, V74, P787, DOI 10.1016/j.bcp.2007.06.008; Wei JY, 2010, LUNG CANCER, V69, P26, DOI 10.1016/j.lungcan.2009.09.009; Zarogoulidis K, 2013, J THORAC DIS, V5, pS389, DOI 10.3978/j.issn.2072-1439.2013.07.10	31	27	29	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93690	10.1371/journal.pone.0093690	http://dx.doi.org/10.1371/journal.pone.0093690			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695790	Green Published, gold, Green Submitted			2022-12-25	WOS:000334103000105
J	Matesanz, S; Theiss, KE; Holsinger, KE; Sultan, SE				Matesanz, Silvia; Theiss, Kathryn E.; Holsinger, Kent E.; Sultan, Sonia E.			Genetic Diversity and Population Structure in Polygonum cespitosum: Insights to an Ongoing Plant Invasion	PLOS ONE			English	Article							EVOLUTION; GENOTYPE; PROGRAM; HISTORY; MARKERS; DIFFERENTIATION; INCREASES; INFERENCE; PATTERNS; SHRUB	Molecular markers can help elucidate how neutral evolutionary forces and introduction history contribute to genetic variation in invaders. We examined genetic diversity, population structure and colonization patterns in the invasive Polygonum cespitosum, a highly selfing, tetraploid Asian annual introduced to North America. We used nine diploidized polymorphic microsatellite markers to study 16 populations in the introduced range ( northeastern North America), via the analyses of 516 individuals, and asked the following questions: 1) Do populations have differing levels of within-population genetic diversity? 2) Do populations form distinct genetic clusters? 3) Does population structure reflect either geographic distances or habitat similarities? We found low heterozygosity in all populations, consistent with the selfing mating system of P. cespitosum. Despite the high selfing levels, we found substantial genetic variation within and among P. cespitosum populations, based on the percentage of polymorphic loci, allelic richness, and expected heterozygosity. Inferences from individual assignment tests ( Bayesian clustering) and pairwise F-ST values indicated high among-population differentiation, which indicates that the effects of gene flow are limited relative to those of genetic drift, probably due to the high selfing rates and the limited seed dispersal ability of P. cespitosum. Population structure did not reflect a pattern of isolation by distance nor was it related to habitat similarities. Rather, population structure appears to be the result of the random movement of propagules across the introduced range, possibly associated with human dispersal. Furthermore, the high population differentiation, genetic diversity, and fine-scale genetic structure ( populations founded by individuals from different genetic sources) in the introduced range suggest that multiple introductions to this region may have occurred. High genetic diversity may further contribute to the invasive success of P. cespitosum in its introduced range.	[Matesanz, Silvia] Univ Rey Juan Carlos, Dept Biol & Geol, Area Biodiversidad & Conservac, Mostoles, Spain; [Theiss, Kathryn E.] Willamette Univ, Dept Biol, Salem, OR 97301 USA; [Theiss, Kathryn E.; Holsinger, Kent E.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT USA; [Sultan, Sonia E.] Wesleyan Univ, Dept Biol, Middletown, CT 06459 USA	Universidad Rey Juan Carlos; Willamette University; University of Connecticut; Wesleyan University	Matesanz, S (corresponding author), Univ Rey Juan Carlos, Dept Biol & Geol, Area Biodiversidad & Conservac, Mostoles, Spain.	silvia.matesanzgarcia@gmail.com	Matesanz, Silvia/L-5153-2014; Matesanz, Silvia/U-3009-2019; Holsinger, Kent/A-7435-2009	Matesanz, Silvia/0000-0003-0060-6136; Holsinger, Kent/0000-0003-4312-3804	Marie Curie IOF Fellowship (European Commission FP7); Howard Hughes Medical Institute	Marie Curie IOF Fellowship (European Commission FP7); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	The study was funded by a Marie Curie IOF Fellowship (European Commission FP7) awarded to S. Matesanz and by support from the Howard Hughes Medical Institute for student assistants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjen L., 2003, SMALL, V5, P277; BAKER H. G., 1965, The genetics of colonizing species: Proc. 1st Internat, Union biol Sci., Asilomar, California., P147; Barrett S.C.H., 1986, P21; Barrett S. C. H., 1990, Plant population genetics, breeding, and genetic resources., P254; Blair AC, 2004, ECOLOGY, V85, P3035, DOI 10.1890/04-0341; BLAKE SF, 1932, RHODORA J N ENGL BOT, V34, P146; Cmokrak P, 2002, TRENDS ECOL EVOL, V17, P501; Cornuet JM, 1996, GENETICS, V144, P2001; DeWalt SJ, 2011, AM J BOT, V98, P1128, DOI 10.3732/ajb.1000297; DeWalt SJ, 2004, AM J BOT, V91, P1155, DOI 10.3732/ajb.91.8.1155; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Dlugosch KM, 2008, ECOL LETT, V11, P701, DOI 10.1111/j.1461-0248.2008.01181.x; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Durka W, 2005, MOL ECOL, V14, P1697, DOI 10.1111/j.1365-294X.2005.02521.x; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Eckert AJ, 2010, GENETICS, V185, P969, DOI 10.1534/genetics.110.115543; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Genton BJ, 2005, MOL ECOL, V14, P4275, DOI 10.1111/j.1365-294X.2005.02750.x; Group CIPW, 2012, CONN INV PLANT LIST; Hardesty BD, 2012, DIVERS DISTRIB, V18, P147, DOI 10.1111/j.1472-4642.2011.00832.x; HUSBAND BC, 1991, HEREDITY, V66, P287, DOI 10.1038/hdy.1991.36; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kim ST, 2008, P NATL ACAD SCI USA, V105, P12370, DOI 10.1073/pnas.0805141105; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Lambrinos JG, 2004, ECOLOGY, V85, P2061, DOI 10.1890/03-8013; Latta RG, 2002, TRENDS ECOL EVOL, V17, P501, DOI 10.1016/S0169-5347(02)02601-0; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Le Roux JJ, 2008, DIVERS DISTRIB, V14, P935, DOI 10.1111/j.1472-4642.2008.00504.x; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Markwith SH, 2006, MOL ECOL NOTES, V6, P586, DOI 10.1111/j.1471-8286.2006.01345.x; Maron JL, 2004, ECOL MONOGR, V74, P261, DOI 10.1890/03-4027; Marrs RA, 2008, BIOL INVASIONS, V10, P561, DOI 10.1007/s10530-007-9153-6; Matesanz S, 2013, BIOL INVASI IN PRESS; Matesanz S, 2013, ECOLOGY, V94, P2464, DOI 10.1890/12-1359.1; Matesanz S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044955; Matesanz S, 2011, AM J BOT, V98, pE180, DOI 10.3732/ajb.1100053; McKay JK, 2002, TRENDS ECOL EVOL, V17, P285, DOI 10.1016/S0169-5347(02)02478-3; Mehrhoff L.J., 2003, IPANE INVASIVE PLANT; Merila J, 2001, J EVOLUTION BIOL, V14, P892, DOI 10.1046/j.1420-9101.2001.00348.x; Nordborg M, 2002, NAT GENET, V30, P190, DOI 10.1038/ng813; Novak SJ, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P201; NOVAK SJ, 1993, HEREDITY, V71, P167, DOI 10.1038/hdy.1993.121; Okada M, 2009, DIVERS DISTRIB, V15, P148, DOI 10.1111/j.1472-4642.2008.00530.x; Paterson A.K., 2000, BARTONIA, V60, P57; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Porcher E, 2006, GENET RES, V87, P1, DOI 10.1017/S0016672306007920; Pritchard JK, 2000, GENETICS, V155, P945; Rambuda TD, 2004, DIVERS DISTRIB, V10, P409, DOI 10.1111/j.1366-9516.2004.00100.x; Reed DH, 2001, EVOLUTION, V55, P1095, DOI 10.1111/j.0014-3820.2001.tb00629.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Saltonstall K, 2002, P NATL ACAD SCI USA, V99, P2445, DOI 10.1073/pnas.032477999; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Sultan SE, 1998, J ECOL, V86, P363, DOI 10.1046/j.1365-2745.1998.00265.x; Sultan SE, 2013, EVOL APPL, V6, P266, DOI 10.1111/j.1752-4571.2012.00287.x; Wares JP, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P229; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wichmann MC, 2009, P ROY SOC B-BIOL SCI, V276, P523, DOI 10.1098/rspb.2008.1131; Wright S, 1943, GENETICS, V28, P114; Yonekura K., 2006, FLORA JAPAN A, P122; Zhan AB, 2012, ECOL EVOL, V2, P1331, DOI 10.1002/ece3.258	65	15	16	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93217	10.1371/journal.pone.0093217	http://dx.doi.org/10.1371/journal.pone.0093217			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695495	Green Published, Green Submitted, gold			2022-12-25	WOS:000334103000049
J	Lee, JC; Gutell, RR				Lee, Jung C.; Gutell, Robin R.			Helix Capping in RNA Structure	PLOS ONE			English	Article							NUCLEAR MAGNETIC-RESONANCE; DANGLING END STACKING; UNUSUALLY STABLE RNA; RIBOSOMAL-RNA; TERMINAL MISMATCHES; INTERNAL LOOP; D-APTPGPCPAPT; FREE-ENERGY; BASE-PAIRS; STABILITY	Helices are an essential element in defining the three-dimensional architecture of structured RNAs. While internal basepairs in a canonical helix stack on both sides, the ends of the helix stack on only one side and are exposed to the loop side, thus susceptible to fraying unless they are protected. While coaxial stacking has long been known to stabilize helix ends by directly stacking two canonical helices coaxially, based on analysis of helix-loop junctions in RNA crystal structures, herein we describe helix capping, topological stacking of a helix end with a basepair or an unpaired nucleotide from the loop side, which in turn protects helix ends. Beyond the topological protection of helix ends against fraying, helix capping should confer greater stability onto the resulting composite helices. Our analysis also reveals that this general motif is associated with the formation of tertiary structure interactions. Greater knowledge about the dynamics at the helix-junctions in the secondary structure should enhance the prediction of RNA secondary structure with a richer set of energetic rules and help better understand the folding of a secondary structure into its three-dimensional structure. These together suggest that helix capping likely play a fundamental role in driving RNA folding.	[Lee, Jung C.] Milwaukee Sch Engn, Dept Chem & Phys, BioMol Engn Program, Milwaukee, WI 53202 USA; [Gutell, Robin R.] Univ Texas Austin, Inst Cellular & Mol Biol, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA; [Gutell, Robin R.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA	Milwaukee School Engineering; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Lee, JC (corresponding author), Milwaukee Sch Engn, Dept Chem & Phys, BioMol Engn Program, Milwaukee, WI 53202 USA.	lee@msoe.edu; robin.gutell@mail.utexas.edu			National Institutes of Health [GM067317, GM085337]; Microsoft Research Technical Computing Initiative [UTA08-531]; Welch Foundation [F-1427]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085337, R01GM067317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Microsoft Research Technical Computing Initiative(Microsoft); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health(GM067317 and GM085337), Microsoft Research Technical Computing Initiative grant (UTA08-531), and Welch Foundation (F-1427). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkafi M, 1998, BIOCHEMISTRY-US, V37, P7878, DOI 10.1021/bi980011t; ALKEMA D, 1981, FEBS LETT, V136, P70, DOI 10.1016/0014-5793(81)81215-X; Andreatta D, 2006, J AM CHEM SOC, V128, P6885, DOI 10.1021/ja0582105; ANTAO VP, 1991, NUCLEIC ACIDS RES, V19, P5901, DOI 10.1093/nar/19.21.5901; AURORA R, 1994, SCIENCE, V264, P1126, DOI 10.1126/science.8178170; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Borovinskaya MA, 2007, NAT STRUCT MOL BIOL, V14, P727, DOI 10.1038/nsmb1271; BOYLE J, 1980, J MOL BIOL, V139, P601, DOI 10.1016/0022-2836(80)90051-0; CARAFA YD, 1990, J MOL BIOL, V216, P835, DOI 10.1016/S0022-2836(99)80005-9; CECH TR, 1990, ANNU REV BIOCHEM, V59, P543, DOI 10.1146/annurev.bi.59.070190.002551; Chai DG, 2008, PROG NUCLEIC ACID RE, V82, P71, DOI 10.1016/S0079-6603(08)00003-2; Chen G, 2005, BIOCHEMISTRY-US, V44, P2845, DOI 10.1021/bi048079y; CHEONG CJ, 1990, NATURE, V346, P680, DOI 10.1038/346680a0; CROTHERS DM, 1974, J MOL BIOL, V87, P63, DOI 10.1016/0022-2836(74)90560-9; CROTHERS DM, 1964, J MOL BIOL, V9, P1, DOI 10.1016/S0022-2836(64)80086-3; Draper DE, 2004, RNA, V10, P335, DOI 10.1261/rna.5205404; Elgavish T, 2001, J MOL BIOL, V310, P735, DOI 10.1006/jmbi.2001.4807; FREIER SM, 1983, BIOCHEMISTRY-US, V22, P6198, DOI 10.1021/bi00295a025; FREIER SM, 1986, BIOCHEMISTRY-US, V25, P3214, DOI 10.1021/bi00359a020; FREIER SM, 1985, BIOCHEMISTRY-US, V24, P4533, DOI 10.1021/bi00338a008; FREIER SM, 1986, BIOCHEMISTRY-US, V25, P3209, DOI 10.1021/bi00359a019; Gutell RR, 2002, CURR OPIN STRUC BIOL, V12, P301, DOI 10.1016/S0959-440X(02)00339-1; Gutell RR, 2000, J MOL BIOL, V304, P335, DOI 10.1006/jmbi.2000.4172; HICKEY DR, 1985, BIOCHEMISTRY-US, V24, P3987, DOI 10.1021/bi00336a028; KIM SH, 1974, SCIENCE, V185, P435, DOI 10.1126/science.185.4149.435; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; Lee JC, 2004, J MOL BIOL, V344, P1225, DOI 10.1016/j.jmb.2004.09.072; Lee JC, 2003, J MOL BIOL, V325, P65, DOI 10.1016/S0022-2836(02)01106-3; Lee JC, 2003, THESIS U TEXAS AUSTI; Lee JC, 2006, J MOL BIOL, V360, P978, DOI 10.1016/j.jmb.2006.05.066; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; PATEL DJ, 1975, BIOCHEMISTRY-US, V14, P2651, DOI 10.1021/bi00683a014; PATEL DJ, 1974, BIOCHEMISTRY-US, V13, P2396, DOI 10.1021/bi00708a025; PETERSHEIM M, 1983, BIOCHEMISTRY-US, V22, P256, DOI 10.1021/bi00271a004; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; ROMANIUK PJ, 1978, J AM CHEM SOC, V100, P3971, DOI 10.1021/ja00480a076; SANTALUCIA J, 1991, J AM CHEM SOC, V113, P4313, DOI 10.1021/ja00011a039; SERRANO L, 1989, NATURE, V342, P296, DOI 10.1038/342296a0; SINCLAIR A, 1984, BIOCHEMISTRY-US, V23, P2656, DOI 10.1021/bi00307a018; SUGIMOTO N, 1987, BIOCHEMISTRY-US, V26, P4554, DOI 10.1021/bi00388a058; Tinoco I, 1999, J MOL BIOL, V293, P271, DOI 10.1006/jmbi.1999.3001; Tucker BJ, 2005, CURR OPIN STRUC BIOL, V15, P342, DOI 10.1016/j.sbi.2005.05.003; TUERK C, 1988, P NATL ACAD SCI USA, V85, P1364, DOI 10.1073/pnas.85.5.1364; WIMBERLY B, 1993, BIOCHEMISTRY-US, V32, P1078, DOI 10.1021/bi00055a013; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P8467, DOI 10.1073/pnas.87.21.8467; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	48	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93664	10.1371/journal.pone.0093664	http://dx.doi.org/10.1371/journal.pone.0093664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691270	Green Submitted, Green Published, gold			2022-12-25	WOS:000334101100122
J	Sharma, S; Padmaja, KL; Gupta, V; Paritosh, K; Pradhan, AK; Pental, D				Sharma, Sarita; Padmaja, K. Lakshmi; Gupta, Vibha; Paritosh, Kumar; Pradhan, Akshay K.; Pental, Deepak			Two Plastid DNA Lineages-Rapa/Oleracea and Nigra-within the Tribe Brassiceae Can Be Best Explained by Reciprocal Crosses at Hexaploidy: Evidence from Divergence Times of the Plastid Genomes and R-Block Genes of the A and B Genomes of Brassica juncea	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; MOLECULAR SYSTEMATICS; KARYOTYPE EVOLUTION; CHROMOSOME-NUMBER; NAPUS GENOME; PHYLOGENY; CHLOROPLAST; SEQUENCE; POLYPLOIDY; PATTERNS	Brassica species (tribe Brassiceae) belonging to U's triangle-B. rapa (AA), B. nigra (BB), B. oleracea (CC), B. juncea (AABB), B. napus (AACC) and B. carinata (BBCC)-originated via two polyploidization rounds: a U event producing the three allopolyploids, and a more ancient b genome-triplication event giving rise to the A-, B-, and C-genome diploid species. Molecular mapping studies, in situ hybridization, and genome sequencing of B. rapa support the genome triplication origin of tribe Brassiceae, and suggest that these three diploid species diversified from a common hexaploid ancestor. Analysis of plastid DNA has revealed two distinct lineages-Rapa/Oleracea and Nigra-that conflict with hexaploidization as a single event defining the tribe Brassiceae. We analysed an R-block region of A. thaliana present in six copies in B. juncea (AABB), three copies each on A- and B-genomes to study gene fractionation pattern and synonymous base substitution rates (Ks values). Divergence time of paralogues within the A and B genomes and homoeologues between the A and B genomes was estimated. Homoeologous R blocks of the A and B genomes exhibited high gene collinearity and a conserved gene fractionation pattern. The three progenitors of diploid Brassicas were estimated to have diverged approximately 12 mya. Divergence of B. rapa and B. nigra, calculated from plastid gene sequences, was estimated to have occurred approximately 12 mya, coinciding with the divergence of the three genomes participating in the b event. Divergence of B. juncea A and B genome homoeologues was estimated to have taken place around 7 mya. Based on divergence time estimates and the presence of distinct plastid lineages in tribe Brassiceae, it is concluded that at least two independent triplication events involving reciprocal crosses at the time of the b event have given rise to Rapa/Oleracea and Nigra lineages.	[Sharma, Sarita; Padmaja, K. Lakshmi; Gupta, Vibha; Paritosh, Kumar; Pradhan, Akshay K.; Pental, Deepak] Univ Delhi South Campus, Ctr Genet Manipulat Crop Plants, New Delhi, India; [Pradhan, Akshay K.; Pental, Deepak] Univ Delhi South Campus, Dept Genet, New Delhi, India	University of Delhi; University of Delhi	Pental, D (corresponding author), Univ Delhi South Campus, Ctr Genet Manipulat Crop Plants, South Campus, New Delhi, India.	dpental@gmail.com			National Dairy Development Board (NDDB); Centre of Excellence on Mustard Breeding by the Department of Biotechnology (DBT), Government of India; Department of Science and Technology (DST), Government of India	National Dairy Development Board (NDDB); Centre of Excellence on Mustard Breeding by the Department of Biotechnology (DBT), Government of India; Department of Science and Technology (DST), Government of India(Department of Science & Technology (India))	This work was funded by the National Dairy Development Board (NDDB) and Centre of Excellence on Mustard Breeding by the Department of Biotechnology (DBT), Government of India. DP acknowledges a J.C. Bose Fellowship from the Department of Science and Technology (DST), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shehbaz IA, 2006, PLANT SYST EVOL, V259, P89, DOI 10.1007/s00606-006-0415-z; Al-Shehbaz IA, 2012, TAXON, V61, P931, DOI 10.1002/tax.615002; Allender CJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-54; Arias T, 2012, TAXON, V61, P980, DOI 10.1002/tax.615005; Bailey CD, 2006, MOL BIOL EVOL, V23, P2142, DOI 10.1093/molbev/msl087; Cheng F, 2013, PLANT CELL, V25, P1541, DOI 10.1105/tpc.113.110486; Cheng F, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-136; Cheung F, 2009, PLANT CELL, V21, P1912, DOI 10.1105/tpc.108.060376; Cho K, 2010, PLANT J, V61, P591, DOI 10.1111/j.1365-313X.2009.04084.x; Cifuentes M, 2010, PLANT CELL, V22, P2265, DOI 10.1105/tpc.109.072991; ERICKSON LR, 1983, THEOR APPL GENET, V65, P201, DOI 10.1007/BF00308066; Hall JC, 2011, AM J BOT, V98, P1989, DOI 10.3732/ajb.1100203; Harberd D. J., 1980, Brassica crops and wild allies. [I]., P65; Inaba R, 2002, THEOR APPL GENET, V105, P1159, DOI 10.1007/s00122-002-0968-3; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Johnston JS, 2005, ANN BOT-LONDON, V95, P229, DOI 10.1093/aob/mci016; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Koch M, 2001, AM J BOT, V88, P534, DOI 10.2307/2657117; Koch MA, 2000, MOL BIOL EVOL, V17, P1483, DOI 10.1093/oxfordjournals.molbev.a026248; Lagercrantz U, 1998, GENETICS, V150, P1217; Lagercrantz U, 1996, GENETICS, V144, P1903; Liu ZQ, 2006, GENETICS, V174, P1583, DOI 10.1534/genetics.106.064071; Lysak MA, 2005, GENOME RES, V15, P516, DOI 10.1101/gr.3531105; Lysak MA, 2007, PLANT PHYSIOL, V145, P402, DOI 10.1104/pp.107.104380; Lysak MA, 2011, PLANT GENET GENOMICS, V9, P1, DOI 10.1007/978-1-4419-7118-0_1; Mandakova T, 2008, PLANT CELL, V20, P2559, DOI 10.1105/tpc.108.062166; Marhold K, 2006, PLANT SYST EVOL, V259, P143, DOI 10.1007/s00606-006-0417-x; McBreen K, 2006, TRENDS PLANT SCI, V11, P398, DOI 10.1016/j.tplants.2006.06.004; Mizushima U., 1980, Brassica crops and wild allies. [I]., P89; Mun JH, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r94; Navabi ZK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-250; NEI M, 1986, MOL BIOL EVOL, V3, P418; Panjabi P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-113; Parkin IAP, 2005, GENETICS, V171, P765, DOI 10.1534/genetics.105.042093; Pradhan AK, 2003, THEOR APPL GENET, V106, P607, DOI 10.1007/s00122-002-1083-1; PRADHAN AK, 1992, THEOR APPL GENET, V85, P331, DOI 10.1007/BF00222878; Prakash S, 1999, DEV PL GEN, V4, P59; Ramchiary N, 2007, THEOR APPL GENET, V115, P807, DOI 10.1007/s00122-007-0610-5; Sambrook J, 2001, MOL CLONING LAB MANU; Schranz ME, 2006, TRENDS PLANT SCI, V11, P535, DOI 10.1016/j.tplants.2006.09.002; Schulz O.E., 1936, NATURLICHEN PFLANZEN, V17B, P227; Smith SA, 2008, BIOINFORMATICS, V24, P715, DOI 10.1093/bioinformatics/btm619; Srivastava A, 2001, THEOR APPL GENET, V102, P193, DOI 10.1007/s001220051635; Takahata Y., 1983, Tohoku Journal of Agricultural Research, V33, P111; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang HB, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00172; Tang HB, 2012, GENETICS, V190, P1563, DOI 10.1534/genetics.111.137349; U. N., 1935, Japanese Journal of Botany, V7, P389; Wang J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-271; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Warwick SI, 2006, PLANT SYST EVOL, V259, P237, DOI 10.1007/s00606-006-0421-1; Warwick SI, 2005, CAN J BOT, V83, P467, DOI [10.1139/B05-021, 10.1139/b05-021]; WARWICK SI, 1991, THEOR APPL GENET, V82, P81, DOI 10.1007/BF00231281; Yadava SK, 2012, THEOR APPL GENET, V125, P1553, DOI 10.1007/s00122-012-1934-3; Yang TJ, 2006, PLANT CELL, V18, P1339, DOI 10.1105/tpc.105.040535; Yang YW, 1999, J MOL EVOL, V48, P597, DOI 10.1007/PL00006502	56	10	10	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93260	10.1371/journal.pone.0093260	http://dx.doi.org/10.1371/journal.pone.0093260			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691069	Green Published, Green Submitted, gold			2022-12-25	WOS:000334101100057
J	Ahmed, T; Zhang, TT; Wang, ZY; He, KL; Bai, SX				Ahmed, Tofael; Zhang, Tian-tao; Wang, Zhen-ying; He, Kang-lai; Bai, Shu-xiong			Three Amino Acid Residues Bind Corn Odorants to McinOBP1 in the Polyembryonic Endoparasitoid of Macrocentrus cingulum Brischke	PLOS ONE			English	Article							PHEROMONE-BINDING; CRYSTAL-STRUCTURE; CHEMOSENSORY PROTEINS; OSTRINIA-FURNACALIS; ANOPHELES-GAMBIAE; SEXUAL ATTRACTION; NMR STRUCTURE; GYPSY-MOTH; PLANT BUG; I-TASSER	Odorant binding proteins (OBPs) play a central role in transporting odorant molecules from the sensillum lymph to olfactory receptors to initiate behavioral responses. In this study, the OBP of Macrocentrus cingulum McinOBP1 was expressed in Escherichia coli and purified by Ni ion affinity chromatography. Real-time PCR experiments indicate that the McinOBP1 is expressed mainly in adult antennae, with expression levels differing by sex. Ligand-binding experiments using N-phenyl-naphthylamine (1-NPN) as a fluorescent probe demonstrated that the McinOBP1 can bind green-leaf volatiles, including aldehydes and terpenoids, but also can bind aliphatic alcohols with good affinity, in the order trans-2-nonenal>cis-3-hexen-1-ol>trans-caryophelle, suggesting a role of McinOBP1 in general odorant chemoreception. We chose those three odorants for further homology modeling and ligand docking based on their binding affinity. The Val58, Leu62 and Glu130 are the key amino acids in the binding pockets that bind with these three odorants. The three mutants, Val58, Leu62 and Glu130, where the valine, leucine and glutamic residues were replaced by alanine, proline and alanine, respectively; showed reduced affinity to these odorants. This information suggests, Val58, Leu62 and Glu130 are involved in the binding of these compounds, possibly through the specific recognition of ligands that forms hydrogen bonds with the ligands functional groups.	[Ahmed, Tofael; Zhang, Tian-tao; Wang, Zhen-ying; He, Kang-lai; Bai, Shu-xiong] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China; [Ahmed, Tofael] Bangladesh Sugarcane Res Inst, Ishurdi, Pabna, Bangladesh	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Bangladesh Sugarcane Research Institute (BSRI)	Wang, ZY (corresponding author), Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China.	zywang@ippcaas.cn		Zhang, Tiantao/0000-0002-7746-7931	specific fund for Agro-Scientific Research in the public interest [201303026]; China Agriculture Research System [CARS-02]	specific fund for Agro-Scientific Research in the public interest; China Agriculture Research System	This work was funded by the specific fund for Agro-Scientific Research in the public interest (201303026) and China Agriculture Research System (CARS-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED T, 2013, MICRON; Andersson MN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-198; Ban LP, 2002, BIOCHEM BIOPH RES CO, V293, P50, DOI 10.1016/S0006-291X(02)00185-7; Campanacci V, 2001, J BIOL CHEM, V276, P20078, DOI 10.1074/jbc.M100713200; Damberger FF, 2007, J MOL BIOL, V373, P811, DOI 10.1016/j.jmb.2007.07.078; Edwards OR, 1999, ECOL ENTOMOL, V24, P7, DOI 10.1046/j.1365-2311.1999.00165.x; Forstner Maike, 2009, Int J Biol Sci, V5, P745; Gong DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-332; Gong YM, 2011, CHEM SENSES, V36, P291, DOI 10.1093/chemse/bjq130; Gong Y, 2009, CHEM BIOL, V16, P162, DOI 10.1016/j.chembiol.2009.01.005; Grosse-Wilde E, 2006, CHEM SENSES, V31, P547, DOI 10.1093/chemse/bjj059; Gu SH, 2011, INSECT BIOCHEM MOLEC, V41, P254, DOI 10.1016/j.ibmb.2011.01.002; Gu SH, 2010, CHINESE SCI BULL, V55, P3911, DOI 10.1007/s11434-010-4153-9; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Hartlieb Elke, 1999, P315; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Honson NS, 2005, RECENT ADV PHYTOCHEM, V39, P227; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; Hu J, 2003, J INSECT PHYSIOL, V49, P367, DOI 10.1016/S0022-1910(03)00021-0; Huang CH, 2009, INSECT SCI, V16, P311, DOI 10.1111/j.1744-7917.2009.01257.x; HUILIN Y, 2010, ENVIRON ENTOMOL, V39, P600; Krieger J, 1999, SCIENCE, V286, P720, DOI 10.1126/science.286.5440.720; Lagarde A, 2011, J MOL BIOL, V414, P401, DOI 10.1016/j.jmb.2011.10.005; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Leal WS, 2005, P NATL ACAD SCI USA, V102, P5386, DOI 10.1073/pnas.0501447102; Leite NR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao Y, 2010, P NATL ACAD SCI USA, V107, P19102, DOI 10.1073/pnas.1012274107; Matsuo T, 2007, PLOS BIOL, V5, P985, DOI 10.1371/journal.pbio.0050118; Ochieng SA, 2000, ARTHROPOD STRUCT DEV, V29, P231, DOI 10.1016/S1467-8039(01)00008-1; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Pelosi P, 2005, CHEM SENSES, V30, pI291, DOI 10.1093/chemse/bjh229; Qiao HL, 2009, INSECT BIOCHEM MOLEC, V39, P414, DOI 10.1016/j.ibmb.2009.03.004; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Shiojiri K, 2000, APPL ENTOMOL ZOOL, V35, P87, DOI 10.1303/aez.2000.87; Spinelli S, 2012, INSECT BIOCHEM MOLEC, V42, P41, DOI 10.1016/j.ibmb.2011.10.005; Sun YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055132; Swarup S, 2011, GENES BRAIN BEHAV, V10, P648, DOI 10.1111/j.1601-183X.2011.00704.x; Tegoni M, 2004, TRENDS BIOCHEM SCI, V29, P257, DOI 10.1016/j.tibs.2004.03.003; VANDENBERG MJ, 1991, J INSECT PHYSIOL, V37, P79, DOI 10.1016/0022-1910(91)90022-R; Vincent F, 2000, J MOL BIOL, V300, P127, DOI 10.1006/jmbi.2000.3820; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Vogt RG, 2002, J EXP BIOL, V205, P719; Wang SY, 2013, INSECT MOL BIOL, V22, P172, DOI 10.1111/imb.12012; WATANABE C, 1967, Insecta Matsumurana, V30, P1; Wogulis M, 2006, BIOCHEM BIOPH RES CO, V339, P157, DOI 10.1016/j.bbrc.2005.10.191; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Xu PJ, 2010, MOL BIOL REP, V37, P2265, DOI 10.1007/s11033-009-9715-z; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Yang G, 2011, PROTEIN EXPRES PURIF, V75, P165, DOI 10.1016/j.pep.2010.09.004; Yin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033589; Zhang SA, 2009, CHEM SENSES, V34, P503, DOI 10.1093/chemse/bjp027; Zhang TT, 2011, BIOCHEM BIOPH RES CO, V407, P393, DOI 10.1016/j.bbrc.2011.03.032; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhou D.R., 1980, ACTA PHYTOPHYL SIN, V7, P113; Zhou JJ, 2010, VITAM HORM, V83, P241, DOI 10.1016/S0083-6729(10)83010-9; Zhou JJ, 2009, J MOL BIOL, V389, P529, DOI 10.1016/j.jmb.2009.04.015	60	15	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93501	10.1371/journal.pone.0093501	http://dx.doi.org/10.1371/journal.pone.0093501			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705388	Green Published, gold, Green Submitted			2022-12-25	WOS:000334107500039
J	Sharma, R; Arya, S; Patil, SD; Sharma, A; Jain, PK; Navani, NK; Pathania, R				Sharma, Rajnikant; Arya, Sankalp; Patil, Supriya Deepak; Sharma, Atin; Jain, Pradeep Kumar; Navani, Naveen Kumar; Pathania, Ranjana			Identification of Novel Regulatory Small RNAs in Acinetobacter baumannii	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS REVEALS; ESCHERICHIA-COLI; NONCODING RNAS; SOLUBLE-RNAS; MULTIDRUG-RESISTANCE; WEB SERVER; GENES; PREDICTION; VIRULENCE; SEQUENCE	Small RNA (sRNA) molecules are non-coding RNAs that have been implicated in regulation of various cellular processes in living systems, allowing them to adapt to changing environmental conditions. Till date, sRNAs have not been reported in Acinetobacter baumannii (A. baumannii), which has emerged as a significant multiple drug resistant nosocomial pathogen. In the present study, a combination of bioinformatic and experimental approach was used for identification of novel sRNAs. A total of 31 putative sRNAs were predicted by a combination of two algorithms, sRNAPredict and QRNA. Initially 10 sRNAs were chosen on the basis of lower E- value and three sRNAs (designated as AbsR11, 25 and 28) showed positive signal on Northern blot. These sRNAs are novel in nature as they do not have homologous sequences in other bacterial species. Expression of the three sRNAs was examined in various phases of bacterial growth. Further, the effect of various stress conditions on sRNA gene expression was determined. A detailed investigation revealed differential expression profile of AbsR25 in presence of varying amounts of ethidium bromide (EtBr), suggesting that its expression is influenced by environmental or internal signals such as stress response. A decrease in expression of AbsR25 and concomitant increase in the expression of bioinformatically predicted targets in presence of high EtBr was reverberated by the decrease in target gene expression when AbsR25 was overexpressed. This hints at the negative regulation of target genes by AbsR25. Interestingly, the putative targets include transporter genes and the degree of variation in expression of one of them (A1S_ 1331) suggests that AbsR25 is involved in regulation of a transporter. This study provides a perspective for future studies of sRNAs and their possible involvement in regulation of antibiotic resistance in bacteria specifically in cryptic A. baumannii.	[Sharma, Rajnikant; Arya, Sankalp; Patil, Supriya Deepak; Sharma, Atin; Navani, Naveen Kumar; Pathania, Ranjana] Indian Inst Technol Roorkee, Dept Biotechnol, Roorkee, Uttarakhand, India; [Jain, Pradeep Kumar] Natl Res Ctr Plant Biotechnol, New Delhi, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; Indian Council of Agricultural Research (ICAR); ICAR - National Institute For Plant Biotechnology (NIPB)	Pathania, R (corresponding author), Indian Inst Technol Roorkee, Dept Biotechnol, Roorkee, Uttarakhand, India.	ranjanapathania@gmail.com	Sharma, Rajnikant/AGO-9487-2022; Patil, Supriya Deepak/AAL-6757-2020; Sharma, Atin/N-5204-2015; Sharma, Atin/HII-8073-2022	Arya, Sankalp/0000-0002-9081-1485; Pathania, Ranjana/0000-0002-7965-8176; Sharma, Atin/0000-0002-9422-1853	Indian Council of Medical Research grant [AMR/15/2011-ECD-I]; National Agricultural Innovation Project of Indian Council of Agricultural Research grant [C4/C30032]; Ministry of Human Resource Development (MHRD), Government of India; Council of Scientific and Industrial Research (CSIR), Government of India	Indian Council of Medical Research grant; National Agricultural Innovation Project of Indian Council of Agricultural Research grant; Ministry of Human Resource Development (MHRD), Government of India(Ministry of Human Resource Development (MHRD), Government of India); Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Indian Council of Medical Research grant AMR/15/2011-ECD-I and National Agricultural Innovation Project of Indian Council of Agricultural Research grant C4/C30032 to Ranjana Pathania and Naveen Kumar Navani. Rajnikant Sharma is thankful to Ministry of Human Resource Development (MHRD), Government of India for financial support. Supriya Deepak Patil and Atin Sharma are thankful to the Council of Scientific and Industrial Research (CSIR), Government of India for financial support. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altier C, 2000, MOL MICROBIOL, V35, P635, DOI 10.1046/j.1365-2958.2000.01734.x; Altier C, 2000, INFECT IMMUN, V68, P6790, DOI 10.1128/IAI.68.12.6790-6797.2000; Arnvig KB, 2009, MOL MICROBIOL, V73, P397, DOI 10.1111/j.1365-2958.2009.06777.x; Backofen R, 2010, RNA BIOL, V7, P33, DOI 10.4161/rna.7.1.10655; Bohn C, 2010, NUCLEIC ACIDS RES, V38, P6620, DOI 10.1093/nar/gkq462; BOUVET PJM, 1986, INT J SYST BACTERIOL, V36, P228, DOI 10.1099/00207713-36-2-228; Burrowes E, 2005, RES MICROBIOL, V156, P7, DOI 10.1016/j.resmic.2004.07.004; Cao Y, 2009, BIOINFORMATION, V3, P364, DOI 10.6026/97320630003364; Caswell CC, 2012, MOL MICROBIOL, V85, P345, DOI 10.1111/j.1365-2958.2012.08117.x; Chen YL, 2011, MBIO, V2, DOI 10.1128/mBio.00340-10; Consales G, 2011, J CRIT CARE, V26, P453, DOI 10.1016/j.jcrc.2010.12.016; Coornaert A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003156; Coyne S, 2010, ANTIMICROB AGENTS CH, V54, P4389, DOI 10.1128/AAC.00155-10; Damier-Piolle L, 2008, ANTIMICROB AGENTS CH, V52, P557, DOI 10.1128/AAC.00732-07; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Felden B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002006; Figueroa-Bossi N, 2009, GENE DEV, V23, P2004, DOI 10.1101/gad.541609; Fournier PE, 2006, CLIN INFECT DIS, V42, P692, DOI 10.1086/500202; Geissmann T, 2009, NUCLEIC ACIDS RES, V37, P7239, DOI 10.1093/nar/gkp668; Gordon NC, 2010, INT J ANTIMICROB AG, V35, P219, DOI 10.1016/j.ijantimicag.2009.10.024; Gottesman S, 2006, COLD SPRING HARB SYM, V71, P1, DOI 10.1101/sqb.2006.71.016; Gottesman S, 2005, TRENDS GENET, V21, P399, DOI 10.1016/j.tig.2005.05.008; Heurlier K, 2004, J BACTERIOL, V186, P2936, DOI 10.1128/JB.186.10.2936-2945.2004; Higgins PG, 2010, J ANTIMICROB CHEMOTH, V65, P233, DOI 10.1093/jac/dkp428; HUNGER M, 1990, GENE, V87, P45, DOI 10.1016/0378-1119(90)90494-C; Iyer VR, 2012, MOL CELL PHARM, V4, P17; Jain R, 2004, ANN PHARMACOTHER, V38, P1449, DOI 10.1345/aph.1D592; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Koo JT, 2011, P NATL ACAD SCI USA, V108, pE709, DOI 10.1073/pnas.1101655108; Lease RA, 2004, J BACTERIOL, V186, P6179, DOI 10.1128/JB.186.18.6179-6185.2004; Lenz DH, 2005, MOL MICROBIOL, V58, P1186, DOI 10.1111/j.1365-2958.2005.04902.x; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Livermore DM, 2003, ANN MED, V35, P226, DOI 10.1080/07853890310001609; Livny J, 2005, NUCLEIC ACIDS RES, V33, P4096, DOI 10.1093/nar/gki715; Livny J, 2006, NUCLEIC ACIDS RES, V34, P3484, DOI 10.1093/nar/gkl453; Macke TJ, 2001, NUCLEIC ACIDS RES, V29, P4724, DOI 10.1093/nar/29.22.4724; Magnet S, 2001, ANTIMICROB AGENTS CH, V45, P3375, DOI 10.1128/AAC.45.12.3375-3380.2001; Marti S, 2006, ENFERM INFEC MICR CL, V24, P77, DOI 10.1157/13085012; Masse E, 2007, CURR OPIN MICROBIOL, V10, P140, DOI 10.1016/j.mib.2007.03.013; Miller PF, 1996, MOL MICROBIOL, V21, P441, DOI 10.1111/j.1365-2958.1996.tb02553.x; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Mraheil MA, 2011, NUCLEIC ACIDS RES, V39, P4235, DOI 10.1093/nar/gkr033; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Nordmann P, 2004, PATHOL BIOL, V52, P301, DOI 10.1016/j.patbio.2004.03.001; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Pichon C, 2005, P NATL ACAD SCI USA, V102, P14249, DOI 10.1073/pnas.0503838102; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Rivas E, 2001, CURR BIOL, V11, P1369, DOI 10.1016/S0960-9822(01)00401-8; Rivas E, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-8; Roca I, 2009, ANTIMICROB AGENTS CH, V53, P4013, DOI 10.1128/AAC.00584-09; Romby P, 2006, CURR OPIN MICROBIOL, V9, P229, DOI 10.1016/j.mib.2006.02.005; Sambrook J., 2001, MOL CLONING; Smith C, 2010, NUCLEIC ACIDS RES, V38, pW373, DOI 10.1093/nar/gkq316; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Sonnleitner E, 2012, RNA BIOL, V9, P364, DOI 10.4161/rna.19231; Sonnleitner E, 2011, MOL MICROBIOL, V80, P868, DOI 10.1111/j.1365-2958.2011.07620.x; Su XZ, 2005, ANTIMICROB AGENTS CH, V49, P4362, DOI 10.1128/AAC.49.10.4362-4364.2005; Tesorero RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064021; Wagenvoort JHT, 2002, EUR J CLIN MICROBIOL, V21, P326, DOI 10.1007/s10096-002-0716-2; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; Wilson SJ, 2004, AM J INFECT CONTROL, V32, P342, DOI 10.1016/j.ajic.2004.02.008; Yachie N, 2006, GENE, V372, P171, DOI 10.1016/j.gene.2005.12.034; Zimmerman JM, 2002, NUCLEIC ACIDS RES, V30, P5425, DOI 10.1093/nar/gkf687	64	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93833	10.1371/journal.pone.0093833	http://dx.doi.org/10.1371/journal.pone.0093833			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705412	gold, Green Published, Green Submitted			2022-12-25	WOS:000334107500074
J	Erdozain, AM; Morentin, B; Bedford, L; King, E; Tooth, D; Brewer, C; Wayne, D; Johnson, L; Gerdes, HK; Wigmore, P; Callado, LF; Carter, WG				Erdozain, Amaia M.; Morentin, Benito; Bedford, Lynn; King, Emma; Tooth, David; Brewer, Charlotte; Wayne, Declan; Johnson, Laura; Gerdes, Henry K.; Wigmore, Peter; Callado, Luis F.; Carter, Wayne G.			Alcohol-Related Brain Damage in Humans	PLOS ONE			English	Article							L-ISOASPARTYL METHYLTRANSFERASE; GENE-EXPRESSION; FRONTAL-CORTEX; ACETALDEHYDE ADDUCTS; NA+/K+-ATPASE; RAT-BRAIN; ETHANOL; NA,K-ATPASE; PROTEOMICS; TUBULIN	Chronic excessive alcohol intoxications evoke cumulative damage to tissues and organs. We examined prefrontal cortex (Brodmann's area (BA) 9) from 20 human alcoholics and 20 age, gender, and postmortem delay matched control subjects. H & E staining and light microscopy of prefrontal cortex tissue revealed a reduction in the levels of cytoskeleton surrounding the nuclei of cortical and subcortical neurons, and a disruption of subcortical neuron patterning in alcoholic subjects. BA 9 tissue homogenisation and one dimensional polyacrylamide gel electrophoresis (PAGE) proteomics of cytosolic proteins identified dramatic reductions in the protein levels of spectrin beta II, and alpha- and beta-tubulins in alcoholics, and these were validated and quantitated by Western blotting. We detected a significant increase in a-tubulin acetylation in alcoholics, a non-significant increase in isoaspartate protein damage, but a significant increase in protein isoaspartyl methyltransferase protein levels, the enzyme that triggers isoaspartate damage repair in vivo. There was also a significant reduction in proteasome activity in alcoholics. One dimensional PAGE of membrane-enriched fractions detected a reduction in beta-spectrin protein levels, and a significant increase in transmembranous alpha 3 (catalytic) subunit of the Na+, K+-ATPase in alcoholic subjects. However, control subjects retained stable oligomeric forms of a-subunit that were diminished in alcoholics. In alcoholics, significant loss of cytosolic alpha-and beta-tubulins were also seen in caudate nucleus, hippocampus and cerebellum, but to different levels, indicative of brain regional susceptibility to alcohol-related damage. Collectively, these protein changes provide a molecular basis for some of the neuronal and behavioural abnormalities attributed to alcoholics.	[Erdozain, Amaia M.; Brewer, Charlotte; Wayne, Declan; Johnson, Laura; Gerdes, Henry K.; Carter, Wayne G.] Univ Nottingham, Sch Med, Royal Derby Hosp Ctr, Derby, England; [Erdozain, Amaia M.; Callado, Luis F.] Univ Basque Country, Dept Pharmacol, Bilbao, Spain; [Erdozain, Amaia M.; Callado, Luis F.] Ctr Invest Biomed Red Salud Mental, Madrid, Spain; [Morentin, Benito] Basque Inst Legal Med, Sect Forens Pathol, Bilbao, Spain; [Bedford, Lynn; King, Emma; Tooth, David; Callado, Luis F.] Univ Nottingham, Sch Life Sci, Queens Med Ctr, Nottingham NG7 2RD, England	University of Nottingham; University of Basque Country; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM	Carter, WG (corresponding author), Univ Nottingham, Sch Med, Royal Derby Hosp Ctr, Derby, England.	wayne.carter@nottingham.ac.uk	Callado, Luis F./A-7024-2008; Erdozain, Amaia/AAD-1883-2021; Erdozain, Amaia M/Q-9664-2018	Callado, Luis F./0000-0001-9941-012X; CALLADO HERNANDO, LUIS FELIPE/0000-0002-5564-3447; Erdozain, Amaia Maite/0000-0003-0207-9122	Basque Government [IT-616/13, SAIOTEK S-PE10UN14]; Plan Nacional sobre Drogas [PI 2006I045]; University of the Basque Country [UFI 11/35]; Wellcome Trust; University of Nottingham; Parkinson&quot;s UK [F-0702] Funding Source: researchfish	Basque Government(Basque Government); Plan Nacional sobre Drogas; University of the Basque Country; Wellcome Trust(Wellcome TrustEuropean Commission); University of Nottingham; Parkinson&quot;s UK(Parkinson&apos;s UK)	The authors are grateful to the following funding sources: AME was a recipient of a predoctoral fellowship from the Basque Government which supported her home studies, and work undertaken in the laboratory of WGC. LJ was funded by a Wellcome Trust Summer Scholarship. LFC was supported by grants from Plan Nacional sobre Drogas, (PI 2006I045), the Basque Government (IT-616/13, SAIOTEK S-PE10UN14), and University of the Basque Country (UFI 11/35). WGC was supported by a Wellcome Trust Value in People grant and by the University of Nottingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Alexander-Kaufman K, 2006, MOL PSYCHIATR, V11, P56, DOI 10.1038/sj.mp.4001741; ASWAD DW, 1983, J NEUROCHEM, V41, P1702, DOI 10.1111/j.1471-4159.1983.tb00883.x; Bedford L, 2010, TRENDS CELL BIOL, V20, P391, DOI 10.1016/j.tcb.2010.03.007; BLANCO G, 1994, P NATL ACAD SCI USA, V91, P8542, DOI 10.1073/pnas.91.18.8542; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Botta P, 2010, NEUROPSYCHOPHARMACOL, V35, P1984, DOI 10.1038/npp.2010.76; Brust JCM, 2010, INT J ENV RES PUB HE, V7, P1540, DOI 10.3390/ijerph7041540; Carter WG, 2008, BIOCHEMISTRY-US, V47, P10757, DOI 10.1021/bi8013467; Carter WG, 2010, J CHROMATOGR B, V878, P1312, DOI 10.1016/j.jchromb.2009.10.018; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Donnet C, 2001, J BIOL CHEM, V276, P7357, DOI 10.1074/jbc.M009131200; Etheridge N, 2009, PROTEOM CLIN APPL, V3, P730, DOI 10.1002/prca.200800202; Furuchi T, 2010, CHEM BIODIVERS, V7, P1337, DOI 10.1002/cbdv.200900273; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; GOODMAN SR, 1986, AM J PHYSIOL, V250, pC347, DOI 10.1152/ajpcell.1986.250.3.C347; Harper C, 2007, HUM EXP TOXICOL, V26, P251, DOI 10.1177/0960327107070499; Harper C, 2009, ALCOHOL ALCOHOLISM, V44, P136, DOI 10.1093/alcalc/agn102; Hipolito L, 2007, CURR DRUG METAB, V8, P716, DOI 10.2174/138920007782109797; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Jung T, 2008, IUBMB LIFE, V60, P743, DOI 10.1002/iub.114; Kharbanda KK, 2007, J HEPATOL, V46, P1119, DOI 10.1016/j.jhep.2007.01.026; Kharbanda KK, 2009, BIOCHEM BIOPH RES CO, V381, P523, DOI 10.1016/j.bbrc.2009.02.082; Kirshenbaum GS, 2011, P NATL ACAD SCI USA, V108, P18144, DOI 10.1073/pnas.1108416108; Kokubo J, 2008, CELL STRUCT FUNCT, V33, P51, DOI 10.1247/csf.07038; Lewohl JM, 2000, ALCOHOL CLIN EXP RES, V24, P1873, DOI 10.1111/j.1530-0277.2000.tb01993.x; Lewohl JM, 2004, ANN NY ACAD SCI, V1025, P14, DOI 10.1196/annals.1316.002; Lingrel JB, 2007, J BIOENERG BIOMEMBR, V39, P385, DOI 10.1007/s10863-007-9107-9; Liu JW, 2007, ALCOHOL CLIN EXP RES, V31, P1460, DOI 10.1111/j.1530-0277.2007.00444.x; Liu JW, 2006, NEUROPSYCHOPHARMACOL, V31, P1574, DOI 10.1038/sj.npp.1300947; Matsumoto I, 2009, ALCOHOL ALCOHOLISM, V44, P171, DOI 10.1093/alcalc/agn104; Moseley AE, 2007, J NEUROSCI, V27, P616, DOI 10.1523/JNEUROSCI.4464-06.2007; Najbauer J, 1996, BIOCHEMISTRY-US, V35, P5183, DOI 10.1021/bi953063g; Nakamura K, 2003, ARCH TOXICOL, V77, P591, DOI 10.1007/s00204-003-0465-8; Neely MD, 1999, J NEUROCHEM, V72, P2323, DOI 10.1046/j.1471-4159.1999.0722323.x; Pielage J, 2005, CURR BIOL, V15, P918, DOI 10.1016/j.cub.2005.04.030; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Ren Y, 2003, J NEUROSCI, V23, P3316; RIEDERER BM, 1990, FEBS LETT, V277, P49, DOI 10.1016/0014-5793(90)80807-U; Rintala J, 2000, ALCOHOL ALCOHOLISM, V35, P458, DOI 10.1093/alcalc/35.5.458; Shepard BD, 2010, WORLD J GASTROENTERO, V16, P1358, DOI 10.3748/wjg.v16.i11.1358; Shepard BD, 2009, WORLD J GASTROENTERO, V15, P1219, DOI 10.3748/wjg.15.1219; SMITH SL, 1989, J CLIN INVEST, V84, P337, DOI 10.1172/JCI114159; Stewart BJ, 2007, CHEM RES TOXICOL, V20, P1111, DOI 10.1021/tx700106v; Thomson A D, 2012, Alcohol Alcohol, V47, P84, DOI 10.1093/alcalc/ags009; TUMA DJ, 1991, ANN NY ACAD SCI, V625, P786, DOI 10.1111/j.1749-6632.1991.tb33920.x; Upadhya SC, 2002, ALCOHOL CLIN EXP RES, V26, P856, DOI 10.1097/00000374-200206000-00016; Vigneswara V, 2006, J BIOL CHEM, V281, P32619, DOI 10.1074/jbc.M605421200; Zahr NM, 2011, NAT REV NEUROL, V7, P284, DOI 10.1038/nrneurol.2011.42; Zhu JX, 2006, J BIOL CHEM, V281, P33802, DOI 10.1074/jbc.M606958200	50	28	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93586	10.1371/journal.pone.0093586	http://dx.doi.org/10.1371/journal.pone.0093586			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699688	Green Published, Green Submitted, gold			2022-12-25	WOS:000334105000074
J	Harding, AMS; Kusama, N; Hattori, T; Gautam, M; Benson, CJ				Harding, Anne Marie S.; Kusama, Nobuyoshi; Hattori, Tomonori; Gautam, Mamta; Benson, Christopher J.			ASIC2 Subunits Facilitate Expression at the Cell Surface and Confer Regulation by PSD-95	PLOS ONE			English	Article							SENSING ION CHANNELS; MAMMALIAN DEGENERIN MDEG; INDUCED NEURONAL DEATH; ACID-EVOKED CURRENTS; BRAIN NA+ CHANNEL; SENSORY NEURONS; ACTIVATED CURRENTS; PROTEIN PICK1; HIPPOCAMPAL-NEURONS; SENSITIVE CHANNELS	Acid-sensing ion channels (ASICs) are Na+ channels activated by changes in pH within the peripheral and central nervous systems. Several different isoforms of ASICs combine to form trimeric channels, and their properties are determined by their subunit composition. ASIC2 subunits are widely expressed throughout the brain, where they heteromultimerize with their partnering subunit, ASIC1a. However, ASIC2 contributes little to the pH sensitivity of the channels, and so its function is not well understood. We found that ASIC2 increased cell surface levels of the channel when it is coexpressed with ASIC1a, and genetic deletion of ASIC2 reduced acid-evoked current amplitude in mouse hippocampal neurons. Additionally, ASIC2a interacted with the neuronal synaptic scaffolding protein PSD-95, and PSD-95 reduced cell surface expression and current amplitude in ASICs that contain ASIC2a. Overexpression of PSD-95 also reduced acid-evoked current amplitude in hippocampal neurons. This result was dependent upon ASIC2 since the effect of PSD-95 was abolished in ASIC2-/- neurons. These results lend support to an emerging role of ASIC2 in the targeting of ASICs to surface membranes, and allows for interaction with PSD-95 to regulate these processes.	[Harding, Anne Marie S.; Kusama, Nobuyoshi; Hattori, Tomonori; Gautam, Mamta; Benson, Christopher J.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Harding, Anne Marie S.; Gautam, Mamta; Benson, Christopher J.] Dept Vet Med Ctr, Iowa City, IA USA	University of Iowa	Benson, CJ (corresponding author), Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	chris-benson@uiowa.edu		Benson, Christopher/0000-0001-6600-8193	National Institute of Health, National Heart, Lung, and Blood Institute [R01 HL076419]; Department of Veterans Affairs [BX000776]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER	National Institute of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institute of Health, National Heart, Lung, and Blood Institute (R01 HL076419), and Department of Veterans Affairs (Merit Award BX000776). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzai N, 2002, J BIOL CHEM, V277, P16655, DOI 10.1074/jbc.M201087200; Arnadottir J, 2010, ANNU REV BIOPHYS, V39, P111, DOI 10.1146/annurev.biophys.37.032807.125836; Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Babinski K, 2000, J BIOL CHEM, V275, P28519, DOI 10.1074/jbc.M004114200; Baron A, 2002, J BIOL CHEM, V277, P50463, DOI 10.1074/jbc.M208848200; Baron A, 2002, J PHYSIOL-LONDON, V539, P485, DOI 10.1113/jphysiol.2001.014837; Baron A, 2013, TOXICON, V75, P187, DOI 10.1016/j.toxicon.2013.04.008; Bassilana F, 1997, J BIOL CHEM, V272, P28819, DOI 10.1074/jbc.272.46.28819; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Benson CJ, 1999, CIRC RES, V84, P921; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Coryell MW, 2008, J NEUROSCI, V28, P13738, DOI 10.1523/JNEUROSCI.3907-08.2008; de la Rosa DA, 2002, P NATL ACAD SCI USA, V99, P2326, DOI 10.1073/pnas.042688199; Deval E, 2006, J BIOL CHEM, V281, P1796, DOI 10.1074/jbc.M509669200; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Diochot S, 2012, NATURE, V490, P552, DOI 10.1038/nature11494; Donier E, 2008, EUR J NEUROSCI, V28, P74, DOI 10.1111/j.1460-9568.2008.06282.x; Drew LJ, 2004, J PHYSIOL-LONDON, V556, P691, DOI 10.1113/jphysiol.2003.058693; Duan B, 2012, J NEUROSCI, V32, P6351, DOI 10.1523/JNEUROSCI.4479-11.2012; Duggan A, 2002, J BIOL CHEM, V277, P5203, DOI 10.1074/jbc.M104748200; Eshcol JO, 2008, AM J PHYSIOL-CELL PH, V295, pC732, DOI 10.1152/ajpcell.00514.2007; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Gautam M, 2013, FASEB J, V27, P793, DOI 10.1096/fj.12-220400; Gregersen N, 2012, EUR J HUM GENET, V20, P84, DOI 10.1038/ejhg.2011.148; GRUNDER S, NEUROREPORT, V11, P1607; Hattori T, 2009, CIRC RES, V105, P279, DOI 10.1161/CIRCRESAHA.109.202036; Hesselager M, 2004, J BIOL CHEM, V279, P11006, DOI 10.1074/jbc.M313507200; Hruska-Hageman AM, 2002, BIOCHEM J, V361, P443, DOI 10.1042/0264-6021:3610443; Hruska-Hageman AM, 2004, J BIOL CHEM, V17, P17; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jovov B, 2003, HISTOCHEM CELL BIOL, V119, P437, DOI 10.1007/s00418-003-0525-4; Kang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035225; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kuryatov A, 1997, J NEUROSCI, V17, P9035; Lu YJ, 2009, NEURON, V64, P885, DOI 10.1016/j.neuron.2009.11.007; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 1996, J BIOL CHEM, V271, P7879, DOI 10.1074/jbc.271.14.7879; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Price MP, 2013, GENES BRAIN BEHAV; Roza C, 2004, J PHYSIOL-LONDON, V558, P659, DOI 10.1113/jphysiol.2004.066001; Sherwood TW, 2011, J NEUROSCI, V31, P9723, DOI 10.1523/JNEUROSCI.1665-11.2011; Sluka KA, 2003, PAIN, V106, P229, DOI 10.1016/S0304-3959(03)00269-0; Snyder PM, 2002, ENDOCR REV, V23, P258, DOI 10.1210/er.23.2.258; Squassina A, 2011, PHARMACOGENOMICS, V12, P1559, DOI [10.2217/PGS.11.102, 10.2217/pgs.11.102]; Stone JL, 2007, HUM MOL GENET, V16, P704, DOI 10.1093/hmg/ddm015; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1996, J BIOL CHEM, V271, P10433, DOI 10.1074/jbc.271.18.10433; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Wemmie JA, 2013, NAT REV NEUROSCI, V14, P461, DOI 10.1038/nrn3529; Wu LJ, 2004, J BIOL CHEM, V279, P43716, DOI 10.1074/jbc.M403557200; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Zeng WZ, 2013, J NEUROSCI, V33, P7066, DOI 10.1523/JNEUROSCI.5206-12.2013; Zha XM, 2006, P NATL ACAD SCI USA, V103, P16556, DOI 10.1073/pnas.0608018103; Zha XM, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-1; Zha XM, 2009, J NEUROSCI, V29, P8438, DOI 10.1523/JNEUROSCI.1284-09.2009; Zha XM, 2009, P NATL ACAD SCI USA, V106, P3573, DOI 10.1073/pnas.0813402106; Ziemann AE, 2008, NAT NEUROSCI, V11, P816, DOI 10.1038/nn.2132; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	61	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93797	10.1371/journal.pone.0093797	http://dx.doi.org/10.1371/journal.pone.0093797			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699665	gold, Green Submitted, Green Published			2022-12-25	WOS:000334105000108
J	Padwal, MK; Sarma, U; Saha, B				Padwal, Mahesh Kumar; Sarma, Uddipan; Saha, Bhaskar			Comprehensive Logic Based Analyses of Toll-Like Receptor 4 Signal Transduction Pathway	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; NECROSIS-FACTOR RECEPTOR; FUNCTIONAL-ANALYSIS; NEGATIVE-FEEDBACK; POSITIVE-FEEDBACK; CELL-SURVIVAL; C-FOS; INTERFERON; NETWORKS	Among the 13 TLRs in the vertebrate systems, only TLR4 utilizes both Myeloid differentiation factor 88 (MyD88) and Toll/Interleukin-1 receptor (TIR)-domain-containing adapter interferon-beta-inducing Factor (TRIF) adaptors to transduce signals triggering host-protective immune responses. Earlier studies on the pathway combined various experimental data in the form of one comprehensive map of TLR signaling. But in the absence of adequate kinetic parameters quantitative mathematical models that reveal emerging systems level properties and dynamic inter-regulation among the kinases/phosphatases of the TLR4 network are not yet available. So, here we used reaction stoichiometry-based and parameter independent logical modeling formalism to build the TLR4 signaling network model that captured the feedback regulations, interdependencies between signaling kinases and phosphatases and the outcome of simulated infections. The analyses of the TLR4 signaling network revealed 360 feedback loops, 157 negative and 203 positive; of which, 334 loops had the phosphatase PP1 as an essential component. The network elements' interdependency (positive or negative dependencies) in perturbation conditions such as the phosphatase knockout conditions revealed interdependencies between the dual-specific phosphatases MKP-1 and MKP-3 and the kinases in MAPK modules and the role of PP2A in the auto-regulation of Calmodulin kinase-II. Our simulations under the specific kinase or phosphatase gene-deficiency or inhibition conditions corroborated with several previously reported experimental data. The simulations to mimic Yersinia pestis and E. coli infections identified the key perturbation in the network and potential drug targets. Thus, our analyses of TLR4 signaling highlights the role of phosphatases as key regulatory factors in determining the global interdependencies among the network elements; uncovers novel signaling connections; identifies potential drug targets for infections.	[Padwal, Mahesh Kumar; Sarma, Uddipan; Saha, Bhaskar] Natl Ctr Cell Sci, Lab 5, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Sarma, U (corresponding author), Inst Mol Biol, Biol Modelling Grp, Mainz, Germany.	uddipans@gmail.com; sahab@nccs.res.in		PADWAL, MAHESH/0000-0003-4715-1108	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	The work has been funded by the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; An HZ, 2008, NAT IMMUNOL, V9, P542, DOI 10.1038/ni.1604; Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Baldwin AS, 2012, IMMUNOL REV, V246, P327, DOI 10.1111/j.1600-065X.2012.01095.x; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Bonvin C, 2002, CELL SIGNAL, V14, P123, DOI 10.1016/S0898-6568(01)00219-4; Brabletz S, 2011, EMBO J, V30, P770, DOI 10.1038/emboj.2010.349; Chaudhri VK, 2010, J BIOL CHEM, V285, P1296, DOI 10.1074/jbc.M109.055863; Chen NJ, 2008, P NATL ACAD SCI USA, V105, P12429, DOI 10.1073/pnas.0806585105; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Daley WP, 2009, DEV BIOL, V336, P169, DOI 10.1016/j.ydbio.2009.09.037; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; DePaolo RW, 2008, CELL HOST MICROBE, V4, P350, DOI 10.1016/j.chom.2008.09.004; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Funahashi Akira, 2003, Biosilico, V1, P159, DOI 10.1016/S1478-5382(03)02370-9; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kearns JD, 2006, J CELL BIOL, V173, P659, DOI 10.1083/jcb.200510155; Keating SE, 2009, J BIOL CHEM, V284, P8211, DOI 10.1074/jbc.R800038200; Klamt S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-56; Klamt S, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-2; Lu RZ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002597; Morrison DK, 1997, CURR OPIN CELL BIOL, V9, P174, DOI 10.1016/S0955-0674(97)80060-9; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Oda K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100057; Ray N, 2006, INT IMMUNOL, V18, P671, DOI 10.1093/intimm/dxl004; RONALD A, 2002, DIS MON, V113, P14; Saez-Rodriguez J, 2007, PLOS COMPUT BIOL, V3, P1580, DOI 10.1371/journal.pcbi.0030163; Saez-Rodriguez J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.87; Samaga R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000438; Sarma U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039898; Schlatter R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000595; Selvarajoo K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003430; Shankaran H, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.90; Shin SY, 2009, J CELL SCI, V122, P425, DOI 10.1242/jcs.036319; Skotheim JM, 2008, NATURE, V454, P291, DOI 10.1038/nature07118; SWANTEK JL, 2000, J IMMUNOL, V15, P1; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Vermeulen L, 2009, TRENDS BIOCHEM SCI, V34, P311, DOI 10.1016/j.tibs.2009.02.007; Werlen G, 2003, SCIENCE, V299, P1859, DOI 10.1126/science.1067833; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Yamaguchi H, 2001, ONCOGENE, V20, P7779, DOI 10.1038/sj.onc.1204984; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; Yang CH, 2005, J BIOL CHEM, V280, P31530, DOI 10.1074/jbc.M503120200; Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079; Yujiri T, 1998, SCIENCE, V282, P1911, DOI 10.1126/science.282.5395.1911	49	14	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e92481	10.1371/journal.pone.0092481	http://dx.doi.org/10.1371/journal.pone.0092481			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699232	gold, Green Submitted, Green Published			2022-12-25	WOS:000334105000028
J	Wiklund, AKE; Adolfsson-Erici, M; Liewenborg, B; Gorokhova, E				Wiklund, Ann-Kristin Eriksson; Adolfsson-Erici, Margaretha; Liewenborg, Birgitta; Gorokhova, Elena			Sucralose Induces Biochemical Responses in Daphnia magna	PLOS ONE			English	Article							OXIDATIVE STRESS; ACETYLCHOLINESTERASE ACTIVITY; SWEETENER SUCRALOSE; MULTIPLE STRESSORS; EXPOSURE; GROWTH; NEUROTOXICITY; CONTAMINANTS; ENHANCEMENT; INHIBITORS	The intense artificial sweetener sucralose has no bioconcentration properties, and no adverse acute toxic effects have been observed in standard ecotoxicity tests, suggesting negligible environmental risk. However, significant feeding and behavioural alterations have been reported in non-standard tests using aquatic crustaceans, indicating possible sublethal effects. We hypothesized that these effects are related to alterations in acetylcholinesterase (AChE) and oxidative status in the exposed animals and investigated changes in AChE and oxidative biomarkers (oxygen radical absorbing capacity, ORAC, and lipid peroxidation, TBARS) in the crustacean Daphnia magna exposed to sucralose (0.0001-5 mg L-1). The sucralose concentration was a significant positive predictor for ORAC, TBARS and AChE in the daphnids. Moreover, the AChE response was linked to both oxidative biomarkers, with positive and negative relationships for TBARS and ORAC, respectively. These joint responses support our hypothesis and suggest that exposure to sucralose may induce neurological and oxidative mechanisms with potentially important consequences for animal behaviour and physiology.	[Wiklund, Ann-Kristin Eriksson; Adolfsson-Erici, Margaretha; Liewenborg, Birgitta; Gorokhova, Elena] Stockholm Univ, Dept Appl Environm Sci, S-10691 Stockholm, Sweden	Stockholm University	Wiklund, AKE (corresponding author), Stockholm Univ, Dept Appl Environm Sci, S-10691 Stockholm, Sweden.	annkristin.eriksson@itm.su.se	Gorokhova, Elena/E-7105-2018	Gorokhova, Elena/0000-0002-4192-6956	Swedish Environmental Protection Agency	Swedish Environmental Protection Agency	This work was funded by the Swedish Environmental Protection Agency (http://www.swedishepa.se/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Donia MB, 2008, J TOXICOL ENV HEAL A, V71, P1415, DOI 10.1080/15287390802328630; Akaike A, 2010, J MOL NEUROSCI, V40, P211, DOI 10.1007/s12031-009-9236-1; Altshuler I, 2011, INTEGR COMP BIOL, V51, P623, DOI 10.1093/icb/icr103; Bainy Afonso Celso Dias, 2006, Biotemas, V19, P35; Behra M, 2002, NAT NEUROSCI, V5, P111, DOI 10.1038/nn788; Bocquene Gilles, 1998, ICES Techniques in Marine Environmental Sciences, V22, P1; Campbell AK, 2004, COMP BIOCHEM PHYS B, V139, P225, DOI 10.1016/j.cbpc.2004.07.004; CARPENTER SR, 1987, ECOLOGY, V68, P1863, DOI 10.2307/1939878; Corotto FS, 2002, J CHEM ECOL, V28, P1117, DOI 10.1023/A:1016273431866; Das KC, 2002, P NATL ACAD SCI USA, V99, P9617, DOI 10.1073/pnas.162369199; Dobson AJ, 2008, INTRO GEN LINEAR MOD; El-Merhibi A, 2004, ECOTOX ENVIRON SAFE, V57, P202, DOI 10.1016/S0147-6513(03)00082-4; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Finn JP, 2000, FOOD CHEM TOXICOL, V38, pS7, DOI 10.1016/S0278-6915(00)00024-7; Glaholt SP, 2012, SCI TOTAL ENVIRON, V432, P57, DOI 10.1016/j.scitotenv.2012.05.074; Gorokhova E, 2013, AQUAT TOXICOL, V127, P46, DOI 10.1016/j.aquatox.2012.01.022; Hjorth M, 2010, CHEM ECOL, V26, P385, DOI 10.1080/02757540.2010.504672; Holth TF, 2012, AQUAT TOXICOL, V112, P92, DOI 10.1016/j.aquatox.2011.10.019; Huggett DB, 2011, FOOD CHEM TOXICOL, V49, P2575, DOI 10.1016/j.fct.2011.06.073; JACOBS JM, 1981, NEUROTOXICOLOGY, V2, P405; Jemec A, 2007, COMP BIOCHEM PHYS C, V144, P303, DOI 10.1016/j.cbpc.2006.10.002; Johannsson OE, 2009, AQUAT BIOL, V5, P249, DOI 10.3354/ab00111; Kunz PY, 2010, REV ENVIRON CONTAM T, V205, P1, DOI 10.1007/978-1-4419-5623-1_1; Lange FT, 2012, ANAL BIOANAL CHEM, V403, P2503, DOI 10.1007/s00216-012-5892-z; Lehtonen KK, 2003, AQUAT TOXICOL, V64, P461, DOI 10.1016/S0166-445X(03)00101-2; Lillicrap A, 2011, ENVIRON TOXICOL CHEM, V30, P673, DOI 10.1002/etc.433; Lionetto MG, 2003, MAR POLLUT BULL, V46, P324, DOI 10.1016/S0025-326X(02)00403-4; Loney GC, 2012, CHEM SENSES, V37, P445, DOI 10.1093/chemse/bjr126; Loos R, 2009, J CHROMATOGR A, V1216, P1126, DOI 10.1016/j.chroma.2008.12.048; Mead RN, 2009, MAR CHEM, V116, P13, DOI 10.1016/j.marchem.2009.09.005; Melo JB, 2003, NEUROSCI RES, V45, P117, DOI 10.1016/S0168-0102(02)00201-8; Minten J, 2011, INT J ENVIRON AN CH, V91, P357, DOI 10.1080/03067310903582333; Motwani HV, 2011, FOOD CHEM TOXICOL, V49, P750, DOI 10.1016/j.fct.2010.11.037; Nussey DH, 2009, FUNCT ECOL, V23, P809, DOI 10.1111/j.1365-2435.2009.01555.x; Pan GZ, 1998, ENVIRON RES, V79, P133, DOI 10.1006/enrs.1998.3868; Penalva-Arana DC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-79; Pokhrel LR, 2013, EXPERT OPIN ENV BIOL, V2, P1; Prior RL, 2003, J AGR FOOD CHEM, V51, P3273, DOI 10.1021/jf0262256; Ranjbar A, 2002, HUM EXP TOXICOL, V21, P179, DOI 10.1191/0960327102ht238oa; Remmel EJ, 2011, LIMNOL OCEANOGR, V56, P461, DOI 10.4319/lo.2011.56.2.0461; Rodero AB, 2009, INT J MORPHOL, V27, P239, DOI 10.4067/S0717-95022009000100040; Rosemberg DB, 2010, NEUROSCIENCE, V171, P683, DOI 10.1016/j.neuroscience.2010.09.030; Schallreuter KU, 2007, LIFE SCI, V80, P2221, DOI 10.1016/j.lfs.2007.01.028; SHLAFER M, 1984, ANAL BIOCHEM, V137, P269, DOI 10.1016/0003-2697(84)90084-8; Sibley P. K., 2000, Journal of Aquatic Ecosystem Stress and Recovery, V7, P117, DOI 10.1023/A:1009967213300; Soh L, 2011, ENVIRON SCI TECHNOL, V45, P1363, DOI 10.1021/es102719d; Soreq H, 2001, NAT REV NEUROSCI, V2, P294, DOI 10.1038/35067589; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; SPECTOR AC, 1988, CHEM SENSES, V13, P95, DOI 10.1093/chemse/13.1.95; Srivatsan M, 1999, CHEM-BIOL INTERACT, V119, P371, DOI 10.1016/S0009-2797(99)00048-4; SZABO GY, 1992, J LEUKOCYTE BIOL, V52, P602, DOI 10.1002/jlb.52.6.602; Tessier AJ, 2000, ECOLOGY, V81, P826, DOI 10.1890/0012-9658(2000)081[0826:AFTOIR]2.0.CO;2; Thome GR, 2011, NICOTINE TOB RES, V13, P1210, DOI 10.1093/ntr/ntr154; Tierney M, 2008, J EXP MAR BIOL ECOL, V367, P65, DOI 10.1016/j.jembe.2008.07.046; Toiber D, 2005, NEUROCHEM RES, V30, P909, DOI 10.1007/s11064-005-6963-8; Tollefsen KE, 2012, SCI TOTAL ENVIRON, V438, P510, DOI 10.1016/j.scitotenv.2012.08.060; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Viberg H, 2011, NUTRITION, V27, P81, DOI 10.1016/j.nut.2009.10.007; Wiklund AKE, 2012, CHEMOSPHERE, V86, P50, DOI 10.1016/j.chemosphere.2011.08.049; Wilson SM, 2012, COMP BIOCHEM PHYS A, V162, P212, DOI 10.1016/j.cbpa.2012.02.023; Wu HH, 2011, CHEMOSPHERE, V83, P599, DOI 10.1016/j.chemosphere.2010.12.004; Yang D, 2008, TOXICOL APPL PHARM, V228, P32, DOI 10.1016/j.taap.2007.11.005	63	22	24	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e92771	10.1371/journal.pone.0092771	http://dx.doi.org/10.1371/journal.pone.0092771			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699280	Green Published, Green Submitted, gold			2022-12-25	WOS:000334105000034
J	Cronin, KA; Pieper, BA; van Leeuwen, EJC; Mundry, R; Haun, DBM				Cronin, Katherine A.; Pieper, Bridget A.; van Leeuwen, Edwin J. C.; Mundry, Roger; Haun, Daniel B. M.			Problem Solving in the Presence of Others: How Rank and Relationship Quality Impact Resource Acquisition in Chimpanzees (Pan troglodytes)	PLOS ONE			English	Article							WILD CHIMPANZEES; COOPERATIVE TASK; NATIONAL-PARK; BEHAVIOR; COMMUNITIES; STRATEGIES; EVOLUTION; TANZANIA; BONOBOS; PREFER	In the wild, chimpanzees ( Pan troglodytes) are often faced with clumped food resources that they may know how to access but abstain from doing so due to social pressures. To better understand how social settings influence resource acquisition, we tested fifteen semi-wild chimpanzees from two social groups alone and in the presence of others. We investigated how resource acquisition was affected by relative social dominance, whether collaborative problem solving or ( active or passive) sharing occurred amongst any of the dyads, and whether these outcomes were related to relationship quality as determined from six months of observational data. Results indicated that chimpanzees obtained fewer rewards when tested in the presence of others compared to when they were tested alone, and this loss tended to be greater when paired with a higher ranked individual. Individuals demonstrated behavioral inhibition; chimpanzees who showed proficient skill when alone often abstained from solving the task when in the presence of others. Finally, individuals with close social relationships spent more time together in the problem solving space, but collaboration and sharing were infrequent and sessions in which collaboration or sharing did occur contained more instances of aggression. Group living provides benefits and imposes costs, and these findings highlight that one cost of group living may be diminishing productive individual behaviors.	[Cronin, Katherine A.; van Leeuwen, Edwin J. C.; Haun, Daniel B. M.] Max Planck Inst Evolutionary Anthropol, Comparat Cognit Anthropol Res Grp, D-04103 Leipzig, Germany; [Cronin, Katherine A.; van Leeuwen, Edwin J. C.; Haun, Daniel B. M.] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Pieper, Bridget A.] Dane Cty Humane Soc, Madison, WI USA; [Mundry, Roger] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Haun, Daniel B. M.] Univ Portsmouth, Portsmouth, Hants, England	Max Planck Society; Max Planck Society; Max Planck Society; University of Portsmouth	Cronin, KA (corresponding author), Max Planck Inst Evolutionary Anthropol, Comparat Cognit Anthropol Res Grp, D-04103 Leipzig, Germany.	Katherine.Cronin@mpi.nl			Comparative Cognitive Anthropology Group of the Max Planck Society; Netherlands Organization for Scientific Research (Veni grant)	Comparative Cognitive Anthropology Group of the Max Planck Society; Netherlands Organization for Scientific Research (Veni grant)(Netherlands Organization for Scientific Research (NWO))	This work was financially supported by the Comparative Cognitive Anthropology Group of the Max Planck Society (www.mpg.de), and by the Netherlands Organization for Scientific Research (Veni grant to KAC, www.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOESCH C, 1989, AM J PHYS ANTHROPOL, V78, P547, DOI 10.1002/ajpa.1330780410; Boesch Christophe, 2002, BEHAV DIVERSITY CHIM; Bullinger AF, 2011, ANIM BEHAV, V82, P1135, DOI 10.1016/j.anbehav.2011.08.008; Chalmeau R, 1996, PRIMATES, V37, P39, DOI 10.1007/BF02382918; CoussiKorbel S, 1995, ANIM BEHAV, V50, P1441, DOI 10.1016/0003-3472(95)80001-8; Cronin KA, 2005, ANIM BEHAV, V69, P133, DOI 10.1016/j.anbehav.2004.02.024; Cronin KA, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S021952591250066X; de Waal FBM, 2010, PHILOS T R SOC B, V365, P2711, DOI 10.1098/rstb.2010.0119; Drea CM, 1999, P NATL ACAD SCI USA, V96, P12965, DOI 10.1073/pnas.96.22.12965; Gilby IC, 2008, ANIM BEHAV, V75, P351, DOI 10.1016/j.anbehav.2007.06.008; Gilby IC, 2013, BEHAV ECOL SOCIOBIOL, V67, P373, DOI 10.1007/s00265-012-1457-6; Gilby IC, 2006, ANIM BEHAV, V71, P953, DOI 10.1016/j.anbehav.2005.09.009; Goodall J., 1986, CHIMPANZEES GOMBE PA; Hare B, 2007, CURR BIOL, V17, P619, DOI 10.1016/j.cub.2007.02.040; Hirata S, 2007, PRIMATES, V48, P13, DOI 10.1007/s10329-006-0022-1; Humle T, 2004, INT J PRIMATOL, V25, P551, DOI 10.1023/B:IJOP.0000023575.93644.f4; Jaeggi AV, 2010, AM J PHYS ANTHROPOL, V143, P41, DOI 10.1002/ajpa.21288; Lonsdorf EV, 2005, ANIM BEHAV, V70, P673, DOI 10.1016/j.anbehav.2004.12.014; MCGREW WC, 1979, MAN, V14, P185, DOI 10.2307/2801563; Melis AP, 2006, ANIM BEHAV, V72, P275, DOI 10.1016/j.anbehav.2005.09.018; Mitani JC, 2009, ANIM BEHAV, V77, P633, DOI 10.1016/j.anbehav.2008.11.021; Nishida T., 1979, GREAT APES, P73; Nishida T., 2011, CHIMPANZEES LAKESHOR; Nishida T., 2010, CHIMPANZEE BEHAV WIL; PACKER C, 1988, AM NAT, V132, P159, DOI 10.1086/284844; PETIT O, 1992, ETHOLOGY, V90, P107; Povinelli DJ, 2000, UNDERSTANDING OTHER, P459; Reader SM, 2001, INT J PRIMATOL, V22, P787, DOI 10.1023/A:1012069500899; Rekers Y, 2011, CURR BIOL, V21, P1756, DOI 10.1016/j.cub.2011.08.066; Ron T, 1988, PRIMATES CONSERV, V9, P37; Sanz CM, 2009, INT J PRIMATOL, V30, P411, DOI 10.1007/s10764-009-9350-5; Schneider AC, 2012, P ROY SOC B-BIOL SCI, V279, P4946, DOI 10.1098/rspb.2012.1948; van Leeuwen EJC, 2012, P ROY SOC B-BIOL SCI, V279, P4362, DOI 10.1098/rspb.2012.1543; VANSCHAIK CP, 1983, BEHAVIOUR, V87, P120, DOI 10.1163/156853983X00147; WESTEBERHARD MJ, 1979, P AM PHILOS SOC, V123, P222; Whitehead H, 2008, ANAL ANIMAL SOC QUAN, DOI 10.7208/chicago/9780226895246.001.0001; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y; YAMAKOSHI G, 1995, PRIMATES, V36, P489, DOI 10.1007/BF02382871	38	15	15	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93204	10.1371/journal.pone.0093204	http://dx.doi.org/10.1371/journal.pone.0093204			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LC	24695486	Green Published, gold			2022-12-25	WOS:000334103000048
J	Haack, AK; Sheth, C; Schwager, AL; Sinclair, MS; Tandon, S; Taha, SA				Haack, Andrew K.; Sheth, Chandni; Schwager, Andrea L.; Sinclair, Michael S.; Tandon, Shashank; Taha, Sharif A.		Brain Inst	Lesions of the Lateral Habenula Increase Voluntary Ethanol Consumption and Operant Self-Administration, Block Yohimbine-Induced Reinstatement of Ethanol Seeking, and Attenuate Ethanol-Induced Conditioned Taste Aversion	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; FOS-LIKE IMMUNOREACTIVITY; DOPAMINE NEURONS; COCAINE SEEKING; LONG-EVANS; RATS; ALCOHOL; BEHAVIOR; NUCLEUS; STRESS	The lateral habenula (LHb) plays an important role in learning driven by negative outcomes. Many drugs of abuse, including ethanol, have dose-dependent aversive effects that act to limit intake of the drug. However, the role of the LHb in regulating ethanol intake is unknown. In the present study, we compared voluntary ethanol consumption and self-administration, yohimbine-induced reinstatement of ethanol seeking, and ethanol-induced conditioned taste aversion in rats with sham or LHb lesions. In rats given home cage access to 20% ethanol in an intermittent access two bottle choice paradigm, lesioned animals escalated their voluntary ethanol consumption more rapidly than sham-lesioned control animals and maintained higher stable rates of voluntary ethanol intake. Similarly, lesioned animals exhibited higher rates of responding for ethanol in operant self-administration sessions. In addition, LHb lesion blocked yohimbine-induced reinstatement of ethanol seeking after extinction. Finally, LHb lesion significantly attenuated an ethanol-induced conditioned taste aversion. Our results demonstrate an important role for the LHb in multiple facets of ethanol-directed behavior, and further suggest that the LHb may contribute to ethanol-directed behaviors by mediating learning driven by the aversive effects of the drug.	[Haack, Andrew K.; Schwager, Andrea L.; Sinclair, Michael S.; Tandon, Shashank; Taha, Sharif A.] Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA; [Haack, Andrew K.; Schwager, Andrea L.; Taha, Sharif A.] Univ Utah, Sch Med, Interdept Program Neurosci, Salt Lake City, UT USA; [Sheth, Chandni] Univ Utah, Sch Med, Dept Pharmacol & Toxicol, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Taha, SA (corresponding author), Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA.	s.taha@utah.edu		Sinclair, Michael/0000-0002-3636-5920; Haack, Andrew/0000-0003-2958-3273	National Institutes Health [MH094870]; March of Dimes Foundation; University of Utah; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094870] Funding Source: NIH RePORTER	National Institutes Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); University of Utah; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding support was provided by the National Institutes Health under award MH094870, the March of Dimes Foundation, and the University of Utah. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amat J, 2001, BRAIN RES, V917, P118, DOI 10.1016/S0006-8993(01)02934-1; Blednov YA, 2008, GENES BRAIN BEHAV, V7, P1, DOI 10.1111/j.1601-183X.2007.00309.x; Broadbent J, 2002, BEHAV NEUROSCI, V116, P138, DOI 10.1037//0735-7044.116.1.138; Brown PL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060678; Camicella S, 2009, ALCOHOL, V43, P35, DOI 10.1016/j.alcohol.2008.12.001; Carr KD, 1998, BRAIN RES, V779, P26, DOI 10.1016/S0006-8993(97)01074-3; CHRISTOPH GR, 1986, J NEUROSCI, V6, P613; DONOVICK PJ, 1970, J COMP PHYSIOL PSYCH, V71, P376, DOI 10.1037/h0029114; DONOVICK PJ, 1969, PHYSIOL BEHAV, V4, P45, DOI 10.1016/0031-9384(69)90011-0; Fowler CD, 2011, NATURE, V471, P597, DOI 10.1038/nature09797; Friedman A, 2011, NEUROPHARMACOLOGY, V60, P381, DOI 10.1016/j.neuropharm.2010.10.006; Friedman A, 2010, NEUROPHARMACOLOGY, V59, P452, DOI 10.1016/j.neuropharm.2010.06.008; Gill MJ, 2013, PHARMACOL BIOCHEM BE, V111, P24, DOI 10.1016/j.pbb.2013.08.002; Gilpin NW, 2008, ALCOHOL RES HEALTH, V31, P185; Green AS, 2008, ALCOHOL, V42, P1, DOI 10.1016/j.alcohol.2007.10.005; Heldt SA, 2006, BRAIN RES, V1073, P229, DOI 10.1016/j.brainres.2005.12.053; Jhou TC, 2013, J NEUROSCI, V33, P7501, DOI 10.1523/JNEUROSCI.3634-12.2013; Jhou TC, 2009, NEURON, V61, P786, DOI 10.1016/j.neuron.2009.02.001; King AC, 2013, BIOL PSYCHIAT; King AC, 2011, ARCH GEN PSYCHIAT, V68, P389, DOI 10.1001/archgenpsychiatry.2011.26; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Lax E, 2013, NEUROPHARMACOLOGY, V75, P246, DOI 10.1016/j.neuropharm.2013.06.034; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Matsumoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026701; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; PINEL JPJ, 1976, PHYSIOL BEHAV, V16, P693, DOI 10.1016/0031-9384(76)90238-9; Schramm-Sapyta NL, 2010, ALCOHOL CLIN EXP RES, V34, P2061, DOI 10.1111/j.1530-0277.2010.01302.x; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P184; Schulteis G, 2006, ALCOHOL, V39, P21, DOI 10.1016/j.alcohol.2006.06.008; Shabel SJ, 2012, NEURON, V74, P475, DOI 10.1016/j.neuron.2012.02.037; Shumake J, 2010, J NEUROSCI, V30, P5876, DOI 10.1523/JNEUROSCI.3604-09.2010; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; Simms JA, 2011, PSYCHOPHARMACOLOGY, V218, P101, DOI 10.1007/s00213-011-2451-9; Stamatakis AM, 2012, NAT NEUROSCI, V15, P1105, DOI 10.1038/nn.3145; THORNTON EW, 1989, PHYSIOL BEHAV, V45, P929, DOI 10.1016/0031-9384(89)90217-5; Timofeeva E, 2001, J COMP NEUROL, V441, P71, DOI 10.1002/cne.1398; Verendeev A, 2013, BEHAV PHARMACOL, V24, P363, DOI 10.1097/FBP.0b013e32836413d5; Vetter-O'Hagen C, 2009, ALCOHOL ALCOHOLISM, V44, P547, DOI 10.1093/alcalc/agp048; Watts AG, 2010, PHYSIOL BEHAV, V100, P472, DOI 10.1016/j.physbeh.2010.04.010; WEISS F, 1993, J PHARMACOL EXP THER, V267, P250; WIRTSHAFTER D, 1994, BRAIN RES, V633, P21, DOI 10.1016/0006-8993(94)91517-2; WISE RA, 1973, PSYCHOPHARMACOLOGIA, V29, P203, DOI 10.1007/BF00414034; Zapata A, 2006, NEUROPSYCHOPHARMACOL, V31, P396, DOI 10.1038/sj.npp.1300833	44	54	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e92701	10.1371/journal.pone.0092701	http://dx.doi.org/10.1371/journal.pone.0092701			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695107	Green Published, Green Submitted, gold			2022-12-25	WOS:000334103000025
J	Nawroth, C; von Borell, E; Langbein, J				Nawroth, Christian; von Borell, Eberhard; Langbein, Jan			Exclusion Performance in Dwarf Goats (Capra aegagrus hircus) and Sheep (Ovis orientalis aries)	PLOS ONE			English	Article							MONKEYS CEBUS-APELLA; FIND HIDDEN FOOD; PARROTS PSITTACUS-ERITHACUS; CHOICE TASK; GREAT APES; SEA LIONS; LOCATION; CUES; DISCRIMINATION; INFERENCES	Using a comparative approach, we investigated the ability of dwarf goats and sheep to use direct and indirect information about the location of a food reward in an object-choice task. Subjects had to choose between two cups with only one covering a reward. Before making a choice, subjects received information about the baited (direct information) or non-baited cup (indirect information). Both goats and sheep were able to use direct information (presence of food) in the object choice task. After controlling for local enhancement, we found that goats rather than sheep were able to use indirect information (i.e., the absence of food) to find a reward. The actual test setup could not clarify whether individual goats were able to inferentially reason about the content of the baited cup when only shown the content of the non-baited cup or if they simply avoided the empty cup in that situation. As browsing species, feral and wild goats exhibit highly selective feeding behaviour compared to the rather unselective grazing sheep. The potential influence of this species-specific foraging flexibility of goats and sheep for using direct and indirect information to find a food reward is discussed in relation to a higher aversion to losses in food acquisition in goats compared to sheep.	[Nawroth, Christian; von Borell, Eberhard] Univ Halle Wittenberg, Inst Agr & Nutr Sci, Dept Anim Husb & Ecol, D-06108 Halle, Germany; [Langbein, Jan] Leibniz Inst Farm Anim Biol, Inst Behav Physiol, Dummerstorf, Germany	Martin Luther University Halle Wittenberg; Forschungsinstitut fur Nutztierbiologie (FBN)	Langbein, J (corresponding author), Leibniz Inst Farm Anim Biol, Inst Behav Physiol, Dummerstorf, Germany.	langbein@fbn-dummerstorf.de	Langbein, Jan/AFO-8965-2022; Nawroth, Christian/C-4017-2018	Nawroth, Christian/0000-0003-4582-4057; Langbein, Jan/0000-0002-1170-5431	Martin-Luther-University Halle-Wittenberg	Martin-Luther-University Halle-Wittenberg	The study was internally funded from resources of the graduate program of Martin-Luther-University Halle-Wittenberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aust U, 2008, ANIM COGN, V11, P587, DOI 10.1007/s10071-008-0149-0; Beran MJ, 2002, J EXP ANAL BEHAV, V78, P497, DOI 10.1901/jeab.2002.78-497; Briefer EF, 2013, APPL ANIM BEHAV SCI, V146, P45, DOI 10.1016/j.applanim.2013.03.007; Briefer EF, 2012, P ROY SOC B-BIOL SCI, V279, P3749, DOI 10.1098/rspb.2012.0986; Call J, 2004, J COMP PSYCHOL, V118, P232, DOI 10.1037/0735-7036.118.2.232; Call J, 2006, ANIM COGN, V9, P393, DOI 10.1007/s10071-006-0037-4; Clement TS, 2003, PSYCHON B REV, V10, P959, DOI 10.3758/BF03196558; de Kort SR, 2006, P ROY SOC B-BIOL SCI, V273, P417, DOI 10.1098/rspb.2005.3350; Doyle RE, 2010, BEHAV PROCESS, V83, P349, DOI 10.1016/j.beproc.2010.01.019; Doyle RE, 2010, APPL ANIM BEHAV SCI, V122, P28, DOI 10.1016/j.applanim.2009.11.003; Erdohegyi A, 2007, ANIM BEHAV, V74, P725, DOI 10.1016/j.anbehav.2007.03.004; Gibson B, 2009, BEHAV PROCESS, V80, P278, DOI 10.1016/j.beproc.2008.11.013; Haun DBM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028801; Heilbronner SR, 2008, BIOL LETTERS, V4, P246, DOI 10.1098/rsbl.2008.0081; Heimbauer LA, 2012, ANIM COGN, V15, P45, DOI 10.1007/s10071-011-0430-5; HERMAN LM, 1984, COGNITION, V16, P129, DOI 10.1016/0010-0277(84)90003-9; HEYES CM, 1993, ANIM BEHAV, V46, P177, DOI 10.1006/anbe.1993.1173; Hill A, 2011, J COMP PSYCHOL, V125, P91, DOI 10.1037/a0020867; HOFMANN RR, 1989, OECOLOGIA, V78, P443, DOI 10.1007/BF00378733; HOSOI E, 1995, APPL ANIM BEHAV SCI, V44, P37, DOI 10.1016/0168-1591(95)00572-A; JE Davidson, 1995, NATURE INSIGHT, P465; Kamil Alan C., 1998, P1, DOI 10.1016/B978-012077030-4/50053-2; Kaminski J, 2005, ANIM BEHAV, V69, P11, DOI 10.1016/j.anbehav.2004.05.008; Kaminski J, 2004, SCIENCE, V304, P1682, DOI 10.1126/science.1097859; Kastak CR, 2002, J EXP ANAL BEHAV, V78, P449, DOI 10.1901/jeab.2002.78-449; Katz JS, 2007, COMP COGN BEHAV REV, V2, P79, DOI 10.3819/ccbr.2008.20005; KENDRICK KM, 1995, ANIM BEHAV, V49, P1665, DOI 10.1016/0003-3472(95)90088-8; Kendrick KM, 2001, NATURE, V414, P165, DOI 10.1038/35102669; Kohler W., 1925, MENTALITY APES; Kojima S, 2001, ANIM COGN, V4, P231, DOI [10.1007/s10071-001-0118-3, DOI 10.1007/S10071-001-0118-3]; Langbein J, 2007, J COMP PSYCHOL, V121, P447, DOI 10.1037/0735-7036.121.4.447; Langbein J, 2009, APPL ANIM BEHAV SCI, V120, P150, DOI 10.1016/j.applanim.2009.07.006; Macphail EM, 2001, BIOL REV, V76, P341; Maille A, 2012, ANIM COGN, V15, P1075, DOI 10.1007/s10071-012-0531-9; Meyer S, 2012, ANIM COGN, V15, P567, DOI 10.1007/s10071-012-0485-y; Mikolasch S, 2012, ANIM COGN, V15, P73, DOI 10.1007/s10071-011-0434-1; Mikolasch S, 2011, BIOL LETTERS, V7, P875, DOI 10.1098/rsbl.2011.0500; Olton D.S., 1981, P333; Paukner A, 2009, J COMP PSYCHOL, V123, P26, DOI 10.1037/a0013128; Penn DC, 2007, ANNU REV PSYCHOL, V58, P97, DOI 10.1146/annurev.psych.58.110405.085555; Pepperberg IM, 2013, J COMP PSYCHOL, V127, P272, DOI 10.1037/a0031641; PREMACK D, 1994, COGNITION, V50, P347, DOI 10.1016/0010-0277(94)90035-3; Premack D., 1995, ORIGINS HUMAN BRAIN, P286; Sabbatini G, 2008, J COMP PSYCHOL, V122, P156, DOI 10.1037/0735-7036.122.2.156; Schloegl C, 2012, P ROY SOC B-BIOL SCI, V279, P4135, DOI 10.1098/rspb.2012.1292; Schloegl C, 2011, J COMP PSYCHOL, V125, P162, DOI 10.1037/a0023045; Schloegl C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006368; Schmitt V, 2009, J COMP PSYCHOL, V123, P316, DOI 10.1037/a0016218; SCHUSTERMAN RJ, 1993, ANIM LEARN BEHAV, V21, P377, DOI 10.3758/BF03198004; Shaw RC, 2013, J COMP PSYCHOL, V127, P428, DOI 10.1037/a0032010; Stuth J.W., 1991, GRAZING MANAGEMENT E, P259; Tornick JK, 2013, ANIM COGN, V16, P583, DOI 10.1007/s10071-013-0595-1	52	37	37	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93534	10.1371/journal.pone.0093534	http://dx.doi.org/10.1371/journal.pone.0093534			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LC	24695781	Green Published, gold, Green Submitted			2022-12-25	WOS:000334103000084
J	Six, I; Okazaki, H; Gross, P; Cagnard, J; Boudot, C; Maizel, J; Drueke, TB; Massy, ZA				Six, Isabelle; Okazaki, Hirokazu; Gross, Priscilla; Cagnard, Joanna; Boudot, Cedric; Maizel, Julien; Drueke, Tilman B.; Massy, Ziad A.			Direct, Acute Effects of Klotho and FGF23 on Vascular Smooth Muscle and Endothelium	PLOS ONE			English	Article							GROWTH-FACTOR 23; NITRIC-OXIDE; PHOSPHATE; DYSFUNCTION; GENE; POPULATION; RESISTANCE; PROTECTS	Chronic kidney disease (CKD) is regarded as a state of Klotho deficiency and FGF23 excess. In patients with CKD a strong association has been found between increased serum FGF23 and mortality risk, possibly via enhanced atherosclerosis, vascular stiffness, and vascular calcification. The aim of this study was to examine the hypothesis that soluble Klotho and FGF23 exert direct, rapid effects on the vessel wall. We used three in vitro models: mouse aorta rings, human umbilical vein endothelial cells, and human vascular smooth muscle cells (HVSMC). Increasing medium concentrations of soluble Klotho and FGF23 both stimulated aorta contractions and increased ROS production in HVSMC. Klotho partially reverted FGF23 induced vasoconstriction, induced relaxation on phosphate preconstricted aorta and enhanced endothelial NO production in HUVEC. Thus Klotho increased both ROS production in HVSMC and NO production in endothelium. FGF23 induced contraction in phosphate preconstricted vessels and increased ROS production. Phosphate, Klotho and FGF23 together induced no change in vascular tone despite increased ROS production. Moreover, the three compounds combined inhibited relaxation despite increased NO production, probably owing to the concomitant increase in ROS production. In conclusion, although phosphate, soluble Klotho and FGF23 separately stimulate aorta contraction, Klotho mitigates the effects of phosphate and FGF23 on contractility via increased NO production, thereby protecting the vessel to some extent against potentially noxious effects of high phosphate or FGF23 concentrations. This novel observation is in line with the theory that Klotho deficiency is deleterious whereas Klotho sufficiency is protective against the negative effects of phosphate and FGF23 which are additive.	[Six, Isabelle; Okazaki, Hirokazu; Gross, Priscilla; Cagnard, Joanna; Boudot, Cedric; Maizel, Julien; Drueke, Tilman B.; Massy, Ziad A.] Jules Verne Univ Picardie, INSERM Unit 1088, Amiens, France; [Maizel, Julien; Massy, Ziad A.] Amiens Univ, Med Ctr, Amiens, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens	Massy, ZA (corresponding author), Jules Verne Univ Picardie, INSERM Unit 1088, Amiens, France.	ziad.massy@apr.aphp.fr	DRUEKE, Tilman B./B-4958-2010	DRUEKE, Tilman B./0000-0002-0700-7681	Conseil Regional de Picardie, Amiens, France (Marno-MPCC); Conseil Regional de Picardie, Amiens, France (Feder)	Conseil Regional de Picardie, Amiens, France (Marno-MPCC)(Region Hauts-de-France); Conseil Regional de Picardie, Amiens, France (Feder)(Region Hauts-de-France)	Hirokazu Okazaki and Priscilla Gross were supported by grants from Conseil Regional de Picardie, Amiens, France (Marno-MPCC for HO and Feder for PG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal I, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000584; Canalejo R, 2010, J AM SOC NEPHROL, V21, P1125, DOI 10.1681/ASN.2009040427; Carracedo J, 2012, MECH AGEING DEV, V133, P647, DOI 10.1016/j.mad.2012.09.002; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Galitzer H, 2010, KIDNEY INT, V77, P211, DOI 10.1038/ki.2009.464; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Izquierdo MC, 2012, NEPHROL DIAL TRANSPL, V27, piv6, DOI 10.1093/ndt/gfs426; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Lim K, 2012, CIRCULATION, V125, P2243, DOI 10.1161/CIRCULATIONAHA.111.053405; Lindberg K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060658; Matsumura Y, 1998, BIOCHEM BIOPH RES CO, V242, P626, DOI 10.1006/bbrc.1997.8019; Mirza MAI, 2009, ATHEROSCLEROSIS, V205, P385, DOI 10.1016/j.atherosclerosis.2009.01.001; Montezano AC, 2012, BASIC CLIN PHARMACOL, V110, P87, DOI 10.1111/j.1742-7843.2011.00785.x; Nagano N, 2006, KIDNEY INT, V69, P531, DOI 10.1038/sj.ki.5000020; Nakai K, 2010, J NEPHROL, V23, P619; Nakamura T, 2002, JPN J PHARMACOL, V89, P149, DOI 10.1254/jjp.89.149; Prie D, 2009, KIDNEY INT, V75, P882, DOI 10.1038/ki.2008.643; Quarles LD, 2008, J CLIN INVEST, V118, P3820, DOI 10.1172/JCI36479; Rakugi H, 2007, ENDOCRINE, V31, P82, DOI 10.1007/s12020-007-0016-9; Recio-Mayoral A, 2011, ATHEROSCLEROSIS, V216, P446, DOI 10.1016/j.atherosclerosis.2011.02.017; Saito T, 2009, INT J PEDIATR ENDOCR, DOI 10.1155/2009/496514; Saito Y, 2000, BIOCHEM BIOPH RES CO, V276, P767, DOI 10.1006/bbrc.2000.3470; Saito Y, 1998, BIOCHEM BIOPH RES CO, V248, P324, DOI 10.1006/bbrc.1998.8943; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Six I, 2012, CARDIOVASC RES, V96, P130, DOI 10.1093/cvr/cvs240; Stam F, 2006, J AM SOC NEPHROL, V17, P537, DOI 10.1681/ASN.2005080834; Yang K, 2012, TOXICOL LETT, V215, P77, DOI 10.1016/j.toxlet.2012.10.004	28	83	94	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93423	10.1371/journal.pone.0093423	http://dx.doi.org/10.1371/journal.pone.0093423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695641	gold, Green Submitted, Green Published			2022-12-25	WOS:000334103000070
J	Chatterjee, P; Bhattacharyya, M; Bandyopadhyay, S; Roy, D				Chatterjee, Paulami; Bhattacharyya, Malay; Bandyopadhyay, Sanghamitra; Roy, Debjani			Studying the System-Level Involvement of MicroRNAs in Parkinson's Disease	PLOS ONE			English	Article							THERAPEUTIC TARGET; EXPRESSION PROFILE; PANCREATIC-CANCER; MIRNA-200 FAMILY; CELL INVASION; NETWORK; GENES; TOOL; IDENTIFICATION; MOLECULES	Background : Parkinson's Disease (PD) is a progressive neurologic disorder that affects movement and balance. Recent studies have revealed the importance of microRNA (miR) in PD. However, the detailed role of miR and its regulation by Transcription Factor (TF) remain unexplored. In this work for the first time we have studied TF-miR-mRNA regulatory network as well as miR co-expression network in PD. Result: We compared the 204 differentially expressed miRs from microarray data with 73 PD related miRs obtained from literature, Human MicroRNA Disease Database and found a significant overlap of 47 PD related miRs ( p-value, 0.05). Functional enrichment analyses of these 47 common (Group1) miRs and the remaining 157 (Group2) miRs revealed similar kinds of over-representative GO Biological Processes and KEGG pathways. This strengthens the possibility that some of the Group 2 miRs can have functional roles in PD progression, hitherto unidentified in any study. In order to explore the cross talk between TF, miR and target mRNA, regulatory networks were constructed. Study of these networks resulted in 14 InterRegulatory hub miRs whereas miR co-expression network revealed 18 co-expressed hub miRs. Of these 32 hub miRs, 23 miRs were previously unidentified with respect to their association with PD. Hierarchical clustering analysis further strengthens the roles of these novel miRs in different PD pathways. Furthermore hsa-miR-92a appeared as novel hub miR in both regulatory and co-expression network indicating its strong functional role in PD. High conservation patterns were observed for most of these 23 novel hub miRs across different species including human. Thus these 23 novel hub miRs can be considered as potential biomarkers for PD. Conclusion: Our study identified 23 novel miR markers which can open up new avenues for future studies and shed lights on potential therapeutic targets for PD.	[Chatterjee, Paulami; Roy, Debjani] Bose Inst, Dept Biophys, Kolkata, India; [Bhattacharyya, Malay] Univ Kalyani, Dept CSE, Kalyani 741235, W Bengal, India; [Bandyopadhyay, Sanghamitra] Indian Stat Inst, Machine Intelligence Unit, Kolkata, India	Department of Science & Technology (India); Bose Institute; Kalyani University; Indian Statistical Institute; Indian Statistical Institute Kolkata	Roy, D (corresponding author), Bose Inst, Dept Biophys, Acharya JC Bose Centenary Bldg, Kolkata, India.	drdebjani@yahoo.com	Bandyopadhyay, Sanghamitra/AAP-4578-2020; Bhattacharyya, Malay/AAF-5036-2020; Bandyopadhyay, Sanghamitra/AAO-7010-2020; Bandyopadhyay, Sanghamitra/A-6597-2010	Bandyopadhyay, Sanghamitra/0000-0001-6370-2083; Bhattacharyya, Malay/0000-0001-7781-1264; Chatterjee, Paulami/0000-0002-2204-5459	Department of Biophysics, Bose Institute, Kalyani University; Indian Statistical Institute (ISI)	Department of Biophysics, Bose Institute, Kalyani University; Indian Statistical Institute (ISI)	The authors would like to thank the Department of Biophysics, Bose Institute, Kalyani University and the Indian Statistical Institute (ISI) for their co-operation and support.	Ab Mutalib NS, 2011, INT J MOL MED, V28, P327, DOI 10.3892/ijmm.2011.714; Abe M, 2013, TRENDS CELL BIOL, V23, P30, DOI 10.1016/j.tcb.2012.08.013; Aguda BD, 2013, ADV EXP MED BIOL, V774, P149, DOI 10.1007/978-94-007-5590-1_9; Al-Shahrour F, 2007, NUCLEIC ACIDS RES, V35, pW91, DOI 10.1093/nar/gkm260; Artzi S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-39; Bandyopadhyay S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-163; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bockmeyer CL, 2012, J HEART LUNG TRANSPL, V31, P764, DOI 10.1016/j.healun.2012.03.010; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Chen ZL, 2014, GENE, V533, P456, DOI 10.1016/j.gene.2013.09.067; Chiang YP, 2012, PATHOL ONCOL RES, V18, P585, DOI 10.1007/s12253-011-9480-x; Choi PS, 2008, NEURON, V57, P41, DOI 10.1016/j.neuron.2007.11.018; Delfino KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058608; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Du ZW, 2013, DEVELOPMENT, V140, P2611, DOI 10.1242/dev.092809; Esposito E, 2010, CURR MED CHEM, V17, P2764, DOI 10.2174/092986710791859324; Fitzgerald JC, 2008, FEBS J, V275, P5758, DOI 10.1111/j.1742-4658.2008.06708.x; FOWLKES EB, 1983, J AM STAT ASSOC, V78, P553, DOI 10.2307/2288117; Gaughwin PM, 2011, HUM MOL GENET, V20, P2225, DOI 10.1093/hmg/ddr111; Goh KI, 2002, P NATL ACAD SCI USA, V99, P12583, DOI 10.1073/pnas.202301299; Griffiths-Jones Sam, 2010, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1209s29; Gubian S, 2012, EXIMIR FUNCTIONS NOR; Han YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018286; Hsu J, 2012, CIRC-CARDIOVASC GENE, V5, P327, DOI 10.1161/CIRCGENETICS.111.961631; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khoo SK, 2012, J PARKINSON DIS, V2, P321, DOI 10.3233/JPD-012144; Kiezun Adam, 2012, BMC Res Notes, V5, P92, DOI 10.1186/1756-0500-5-92; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kisby GE, 2013, JAMA NEUROL, V70, P414, DOI 10.1001/jamaneurol.2013.1283; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lee JW, 2011, GYNECOL ONCOL, V120, P56, DOI 10.1016/j.ygyno.2010.09.022; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; Liu SG, 2013, ONCOL LETT, V5, P1639, DOI 10.3892/ol.2013.1251; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Lu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006159; Ma D, 2012, CHINESE MED J-PEKING, V125, P4270, DOI 10.3760/cma.j.issn.0366-6999.2012.23.020; Martins M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025443; Matsumoto S, 2013, CIRC RES, V113, P322, DOI 10.1161/CIRCRESAHA.113.301209; Mongroo Perry S, 2010, Cancer Biol Ther, V10, P219; Ohyagi-Hara C, 2013, AM J PATHOL, V182, P1876, DOI 10.1016/j.ajpath.2013.01.039; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Ruan JH, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-8; Satoh J, 2011, BIODATA MIN, V4, DOI 10.1186/1756-0381-4-17; Savitt JM, 2006, J CLIN INVEST, V116, P1744, DOI 10.1172/JCI29178; Sengupta D, 2013, MOL BIOSYST, V9, P1360, DOI 10.1039/c3mb25518b; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi WY, 2014, EUR REV MED PHARMACO, V18, P217; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Slaby O, 2013, MED HYPOTHESES, V80, P325, DOI 10.1016/j.mehy.2012.11.033; Song H, 2013, GENET MOL RES, V12, P4934, DOI 10.4238/2013.October.24.4; Su HF, 2014, CELL BIOL INT, V38, P318, DOI 10.1002/cbin.10202; Sun JC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002488; Sutherland GT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004955; Taguchi YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066714; Taurino C, 2010, CLIN SCI, V119, P335, DOI 10.1042/CS20100043; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uhlmann S, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.100; Vaishnavi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056781; Vergoulis T, 2012, NUCLEIC ACIDS RES, V14, P9; Wakabayashi K, 2007, NEUROPATHOLOGY, V27, P494, DOI 10.1111/j.1440-1789.2007.00803.x; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wee EJH, 2012, ONCOGENE, V31, P4182, DOI 10.1038/onc.2011.584; Xi YG, 2006, BIOMARK INSIGHTS, V1, P113; Xie P, 2012, J HUAZHONG U SCI-MED, V32, P576, DOI 10.1007/s11596-012-0099-2; Xie YF, 2011, INT J ORAL SCI, V3, P125, DOI 10.4248/IJOS11046; Xu LJ, 2014, INT J ONCOL, V44, P459, DOI 10.3892/ijo.2013.2189; Xue Q, 2014, JPN J CLIN ONCOL, V44, P13, DOI 10.1093/jjco/hyt181; Yang N, 2008, CANCER RES, V68, P10307, DOI 10.1158/0008-5472.CAN-08-1954; Yip KY, 2006, BIOINFORMATICS, V22, P2968, DOI 10.1093/bioinformatics/btl488; Yu J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-169; Yu T, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-64; Yuan L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081524; Zanetti R, 2007, CANCER EPIDEM BIOMAR, V16, P1081, DOI 10.1158/1055-9965.EPI-07-0377; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhang N, 2013, FEBS LETT, V587, P3661, DOI 10.1016/j.febslet.2013.09.018; Zovoilis A, 2011, EMBO J, V30, P4299, DOI 10.1038/emboj.2011.327	81	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93751	10.1371/journal.pone.0093751	http://dx.doi.org/10.1371/journal.pone.0093751			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690883	Green Published, Green Submitted, gold			2022-12-25	WOS:000334101100132
J	Chen, S; Liu, HJ; You, YL; Mullens, E; Hu, JJ; Yuan, Y; Huang, MY; He, L; Luo, YM; Zeng, XJ; Tang, GQ; Hong, Y				Chen, Sheng; Liu, Huijuan; You, Yalei; Mullens, Esther; Hu, Junjun; Yuan, Ye; Huang, Mengyu; He, Li; Luo, Yongming; Zeng, Xingji; Tang, Guoqiang; Hong, Yang			Evaluation of High-Resolution Precipitation Estimates from Satellites during July 2012 Beijing Flood Event Using Dense Rain Gauge Observations	PLOS ONE			English	Article							PASSIVE MICROWAVE; PRODUCTS; SYSTEM; TRMM; RADAR	Satellite-based precipitation estimates products, CMORPH and PERSIANN-CCS, were evaluated with a dense rain gauge network over Beijing and adjacent regions for an extremely heavy precipitation event on July 21 2012. CMORPH and PEERSIANN-CSS misplaced the region of greatest rainfall accumulation, and failed to capture the spatial pattern of precipitation, evidenced by a low spatial correlation coefficient ( CC). CMORPH overestimated the daily accumulated rainfall by 22.84% while PERSIANN-CCS underestimated by 72.75%. In the rainfall center, both CMORPH and PERSIANN-CCS failed to capture the temporal variation of the rainfall, and underestimated rainfall amounts by 43.43% and 87.26%, respectively. Based on our results, caution should be exercised when using CMORPH and PERSIANN-CCS as input for monitoring and forecasting floods in Beijing urban areas, and the potential for landslides in the mountainous zones west and north of Beijing.	[Chen, Sheng; Hong, Yang] Univ Oklahoma, Sch Civil Engn & Environm Sci, Norman, OK 73019 USA; [Chen, Sheng; Hong, Yang] Natl Weather Ctr, Adv Radar Res Ctr, Norman, OK USA; [Liu, Huijuan; Yuan, Ye] Anhui Weather Modificat Off, Hefei, Peoples R China; [You, Yalei] Florida State Univ, Dept Earth Sci, Tallahassee, FL 32306 USA; [You, Yalei] Florida State Univ, Dept Ocean Sci, Tallahassee, FL 32306 USA; [You, Yalei] Florida State Univ, Dept Atmospher Sci, Tallahassee, FL 32306 USA; [Mullens, Esther] Univ Oklahoma, Cooperat Inst Mesoscale Meteorol Studies, Norman, OK 73019 USA; [Mullens, Esther] Univ Oklahoma, Sch Meteorol, Norman, OK 73019 USA; [Hu, Junjun] Univ Oklahoma, Sch Comp Sci, Norman, OK 73019 USA; [Huang, Mengyu] Beijing Weather Modificat Off, Beijing, Peoples R China; [He, Li; Luo, Yongming] Natl Satellite Ctr, Remote Sensing Applicat Test Base, Gaugnxi, Peoples R China; [He, Li; Luo, Yongming] Guangxi Meteorol Bur, Disaster Mitigat Inst, Nanning, Gaugnxi, Peoples R China; [Zeng, Xingji] Guangxi Meteorol Bur, Meteorol Informat Ctr, Nanning, Gaugnxi, Peoples R China; [Tang, Guoqiang] Tsinghua Univ, Dept Hydraul Engn, Beijing 100084, Peoples R China	University of Oklahoma System; University of Oklahoma - Norman; National Oceanic Atmospheric Admin (NOAA) - USA; State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; Tsinghua University	Liu, HJ (corresponding author), Anhui Weather Modificat Off, Hefei, Peoples R China.	64230038@qq.com	Tang, Guoqiang/P-3802-2018; Hong, Yang/D-5132-2009	Tang, Guoqiang/0000-0002-0923-583X; Hong, Yang/0000-0001-8720-242X	R & D Special Foundation for Public Welfare Industry (meteorology) of China [GYHY201306040]; National Natural Science Foundation of China [40905019, 41105098, 41275030]; State Key Laboratory of Severe Weather Open Fund [2013LASW-A09]	R & D Special Foundation for Public Welfare Industry (meteorology) of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Severe Weather Open Fund	This work was supported by the R & D Special Foundation for Public Welfare Industry (meteorology) of China under Grant No. GYHY201306040; the National Natural Science Foundation of China with Grant No. 40905019, 41105098, 41275030; the State Key Laboratory of Severe Weather Open Fund 2013LASW-A09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; Barrett E., 1994, REMOTE SENS REV, V11, P23, DOI [10.1080/02757259409532257, DOI 10.1080/02757259409532257]; Change IPOC, 2007, AGENDA; Chen S, 2012, J HYDROLOGY; Chiu LS, 2006, ADV ATMOS SCI, V23, P1, DOI 10.1007/s00376-006-0001-x; Chokngamwong R, 2008, J HYDROMETEOROL, V9, P256, DOI 10.1175/2007JHM876.1; Creutin JD, 2003, HYDROL PROCESS, V17, P1453, DOI 10.1002/hyp.5122; Dinku T, 2010, COMP CMORPH TRMM 3B4; Gourley JJ, 2010, J APPL METEOROL CLIM, V49, P437, DOI 10.1175/2009JAMC2302.1; Grumm R. H., 2012, BEIJING FLOOD 21 JUL; Hirpa FA, 2010, J APPL METEOROL CLIM, V49, P1044, DOI 10.1175/2009JAMC2298.1; Hong Y, 2007, INT J REMOTE SENS, V28, P3713, DOI 10.1080/01431160701311242; Hong Y, 2004, J APPL METEOROL, V43, P1834, DOI 10.1175/JAM2173.1; Hong Y, 2007, NAT HAZARDS, V43, P285, DOI 10.1007/s11069-006-9106-x; Hong Y, 2007, IEEE T GEOSCI REMOTE, V45, P1671, DOI 10.1109/TGRS.2006.888436; Hsu KL, 1997, J APPL METEOROL, V36, P1176, DOI 10.1175/1520-0450(1997)036<1176:PEFRSI>2.0.CO;2; Huffman GJ, 2007, TRMM OTHER DATA PREC; Joyce RJ, 2004, J HYDROMETEOROL, V5, P487, DOI 10.1175/1525-7541(2004)005<0487:CAMTPG>2.0.CO;2; Kay AL, 2009, CLIMATIC CHANGE, V92, P41, DOI 10.1007/s10584-008-9471-4; Kummerow C, 1996, IEEE T GEOSCI REMOTE, V34, P1213, DOI 10.1109/36.536538; Li L, 2012, COMP GLOBAL TRMM WFD; McMillan HK, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR005995; NEGRI AJ, 1993, J APPL METEOROL, V32, P357, DOI 10.1175/1520-0450(1993)032<0357:AIOTSI>2.0.CO;2; Nicholson SE, 2003, J APPL METEOROL, V42, P1355, DOI 10.1175/1520-0450(2003)042&lt;1355:VOTAOR&gt;2.0.CO;2; [任芝花 Ren Zhihua], 2003, [气象学报, Acta Meteorologica Sinica], V61, P621; Sang YF, 2012, NAT HAZARDS, P1; Sorooshian S, 2000, B AM METEOROL SOC, V81, P2035, DOI 10.1175/1520-0477(2000)081<2035:EOPSSE>2.3.CO;2; Tian YD, 2010, J HYDROMETEOROL, V11, P566, DOI 10.1175/2009JHM1190.1; Tuttle JD, 2008, J APPL METEOROL CLIM, V47, P3264, DOI 10.1175/2008JAMC2000.1; Wang JH, 2011, HYDROLOG SCI J, V56, P84, DOI 10.1080/02626667.2010.543087; Wang K, 2013, NAT HAZARDS, P1; You YL, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015345; Zhang D-L, 2013, GEOPHYS RES LETT; Zhang X, 2012, USING NWP ANAL SATEL	34	38	41	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e89681	10.1371/journal.pone.0089681	http://dx.doi.org/10.1371/journal.pone.0089681			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691358	Green Submitted, Green Published, gold			2022-12-25	WOS:000334101100005
J	Ganan-Gomez, I; Wei, Y; Yang, H; Pierce, S; Bueso-Ramos, C; Calin, G; Boyano-Adanez, MD; Garcia-Manero, G				Ganan-Gomez, Irene; Wei, Yue; Yang, Hui; Pierce, Sherry; Bueso-Ramos, Carlos; Calin, George; del Carmen Boyano-Adanez, Maria; Garcia-Manero, Guillermo			Overexpression of miR-125a in Myelodysplastic Syndrome CD34(+) Cells Modulates NF-kappa B Activation and Enhances Erythroid Differentiation Arrest	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; PATTERN-RECOGNITION RECEPTORS; ACUTE MYELOID-LEUKEMIA; SINGLE-STRANDED RNA; TOLL-LIKE RECEPTORS; MICRORNA EXPRESSION; BONE-MARROW; CIRCULATING MICRORNAS; MYELOGENOUS LEUKEMIA; PROGENITOR CELLS	Myelodysplastic syndromes (MDS) are characterized by impaired proliferation and differentiation of hematopoietic stem cells. The participation of toll-like receptor (TLR)-mediated signaling in MDS is well documented. Increased TLR signaling leads to the constitutive activation of NF-kappa B, which mediates inflammation, cell proliferation and apoptosis. In addition, the TLR pathway induces the expression of miRNAs which participate in the fine-tuning of the inflammatory response. miRNAs also regulate other biological processes, including hematopoiesis. miR-125a and miR-125b are known modulators of hematopoiesis and are abnormally expressed in several hematologic malignancies. However, little is known about their role in MDS. NF-kappa B-activating ability has been described for both miRNAs. We studied the role of miR-125a/miR-125b in MDS and their relationship with TLR signaling and hematopoietic differentiation. Our results indicate that miR-125a is significantly overexpressed in MDS patients and correlates negatively with patient survival. Expression of miR-99b, which is clustered with miR-125a, is also directly correlated with prognosis of MDS. Both miR-125a and miR-99b activated NF-kappa B in vitro; however, we observed a negative correlation between miR-99b expression and the levels of TLR2, TLR7 and two downstream genes, suggesting that NF-kappa B activation by the miRNA cluster occurs in the absence of TLR signaling. We also show that TLR7 is negatively correlated with patient survival in MDS. In addition, our data suggest that miR-125a may act as an NF-kappa B inhibitor upon TLR stimulation. These results indicate that miR-125a is involved in the fine-tuning of NF-kappa B activity and that its effects may depend on the status of the TLR pathway. Furthermore, we observed that miR-125a inhibits erythroid differentiation in leukemia and MDS cell lines. Therefore, this miRNA could serve as a prognostic marker and a potential therapeutic target in MDS.	[Ganan-Gomez, Irene; del Carmen Boyano-Adanez, Maria] Univ Alcala De Henares, Dept Syst Biol, Madrid, Spain; [Wei, Yue; Yang, Hui; Pierce, Sherry; Garcia-Manero, Guillermo] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Bueso-Ramos, Carlos] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Calin, George] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Div Canc Med, Houston, TX 77030 USA	Universidad de Alcala; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Ganan-Gomez, I (corresponding author), Univ Alcala De Henares, Dept Syst Biol, Madrid, Spain.	irene.ganan@edu.uah.es; ggarciam@mdanderson.org	Calin, George/E-9390-2011; Ganan-Gomez, Irene/GRF-3018-2022	Ganan-Gomez, Irene/0000-0001-8354-3139; Calin, George/0000-0001-6704-5615; Calin, George/0000-0002-7427-0578	Ruth and Ken Arnold Leukemia Fund; Edward P. Evans Foundation; MD Anderson Cancer Center Support Grant (CCSG) [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Ruth and Ken Arnold Leukemia Fund; Edward P. Evans Foundation; MD Anderson Cancer Center Support Grant (CCSG); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Ruth and Ken Arnold Leukemia Fund, the Edward P. Evans Foundation, the generous philanthropic contributions to The University of Texas MD Anderson Moon Shots Program and the MD Anderson Cancer Center Support Grant (CCSG) CA016672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bousquet M, 2008, J EXP MED, V205, P2499, DOI 10.1084/jem.20080285; Bousquet M, 2012, HAEMATOL-HEMATOL J, V97, P1713, DOI 10.3324/haematol.2011.061515; Chapiro E, 2010, LEUKEMIA, V24, P1362, DOI 10.1038/leu.2010.93; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; CHEN W, 1989, LEUKEMIA, V3, P264; Cherfils-Vicini J, 2010, J CLIN INVEST, V120, P1285, DOI 10.1172/JCI36551; COOPER MC, 1974, P NATL ACAD SCI USA, V71, P1677, DOI 10.1073/pnas.71.5.1677; Corey SJ, 2007, NAT REV CANCER, V7, P118, DOI 10.1038/nrc2047; De Luca K, 2009, LEUKEMIA, V23, P2063, DOI 10.1038/leu.2009.155; Dimicoli S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071120; Erdogan B, 2011, EXP HEMATOL, V39, P915, DOI 10.1016/j.exphem.2011.06.002; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109; GALLAGHER R, 1979, BLOOD, V54, P713; Garofalo M, 2011, ANNU REV PHARMACOL, V51, P25, DOI 10.1146/annurev-pharmtox-010510-100517; Garzon R, 2008, BLOOD, V111, P3183, DOI 10.1182/blood-2007-07-098749; Gerrits A, 2012, BLOOD, V119, P377, DOI 10.1182/blood-2011-01-331686; Guiducci C, 2010, NATURE, V465, P937, DOI 10.1038/nature09102; Guo SQ, 2012, P NATL ACAD SCI USA, V109, P16636, DOI 10.1073/pnas.1213196109; Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107; Gupta G, 2010, J BLOOD MED, V1, P171, DOI 10.2147/JBM.S12257; Haferlach T, 2012, LEUKEMIA RES, V36, P1459, DOI 10.1016/j.leukres.2012.08.009; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Horwich MD, 2008, NAT PROTOC, V3, P1537, DOI 10.1038/nprot.2008.145; Huang JJ, 2012, MED ONCOL, V29, P2402, DOI 10.1007/s12032-012-0210-3; Hussein K, 2010, LEUKEMIA RES, V34, P1169, DOI 10.1016/j.leukres.2010.04.012; Jongen-Lavrencic M, 2008, BLOOD, V111, P5078, DOI 10.1182/blood-2008-01-133355; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim SW, 2012, P NATL ACAD SCI USA, V109, P7865, DOI 10.1073/pnas.1200081109; KOEFFLER HP, 1978, SCIENCE, V200, P1153, DOI 10.1126/science.306682; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kuninaka N, 2010, EXP MOL PATHOL, V88, P293, DOI 10.1016/j.yexmp.2010.01.009; Lee J, 2009, BIOCHEM J, V421, P301, DOI 10.1042/BJ20090013; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lionetti M, 2009, BLOOD, V114, pE20, DOI 10.1182/blood-2009-08-237495; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; LUISIDELUCA C, 1984, J CLIN INVEST, V74, P821, DOI 10.1172/JCI111498; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maratheftis CI, 2007, CLIN CANCER RES, V13, P1154, DOI 10.1158/1078-0432.CCR-06-2108; Megraw M, 2007, NUCLEIC ACIDS RES, V35, pD149, DOI 10.1093/nar/gkl904; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Nakamura S, 2000, CYTOKINES CELL MOL T, V6, P61, DOI 10.1080/13684730050515787; Nimer SD, 2008, BLOOD, V111, P4841, DOI 10.1182/blood-2007-08-078139; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Connell RM, 2010, P NATL ACAD SCI USA, V107, P14235, DOI 10.1073/pnas.1009798107; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; OGURA M, 1985, BLOOD, V66, P1384; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Pons A, 2009, LEUKEMIA LYMPHOMA, V50, P1854, DOI 10.3109/10428190903147645; San Jose-Eneriz E, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-69; Sawanobori M, 2003, LEUKEMIA RES, V27, P583, DOI 10.1016/S0145-2126(02)00095-4; Schepers H, 2006, HAEMATOLOGICA, V91, P1710; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Seca H, 2010, EUR J CANCER, V46, P1520, DOI 10.1016/j.ejca.2010.03.031; Shaham L, 2012, LEUKEMIA, V26, P2011, DOI 10.1038/leu.2012.90; Sioud M, 2006, J MOL BIOL, V364, P945, DOI 10.1016/j.jmb.2006.09.054; Sokol L, 2011, BRIT J HAEMATOL, V153, P24, DOI 10.1111/j.1365-2141.2011.08581.x; Starczynowski DT, 2010, HEMATOL ONCOL CLIN N, V24, P343, DOI 10.1016/j.hoc.2010.02.008; Starczynowski DT, 2010, NAT MED, V16, P49, DOI 10.1038/nm.2054; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tan GY, 2012, J BIOL CHEM, V287, P33036, DOI 10.1074/jbc.M112.383273; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Vasilatou D, 2013, LEUKEMIA RES, V37, P251, DOI 10.1016/j.leukres.2012.11.011; Votavova H, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-1; Wang HL, 2012, TRANSL RES, V160, P198, DOI 10.1016/j.trsl.2012.04.002; Wei Y, 2013, LEUKEMIA, V27, P2177, DOI 10.1038/leu.2013.91; Whitehead Institute for Biomedical Research, 2012, TARGETSCAN HUM 6 2 P; Wieser R, 2010, GENE CHROMOSOME CANC, V49, P193, DOI 10.1002/gcc.20740; Yu S, 2012, J CLIN ENDOCR METAB, V97, P2084, DOI 10.1210/jc.2011-3059; Zhang YL, 2008, MOL IMMUNOL, V45, P1184, DOI 10.1016/j.molimm.2007.07.014; Zhou R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000681; Zimmerman EI, 2010, MOL PHARMACOL, V78, P811, DOI 10.1124/mol.110.066258	79	37	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93404	10.1371/journal.pone.0093404	http://dx.doi.org/10.1371/journal.pone.0093404			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690917	gold, Green Submitted, Green Published			2022-12-25	WOS:000334101100075
J	Harsch, MA; McGlone, MS; Wilmshurst, JM				Harsch, Melanie A.; McGlone, Matt S.; Wilmshurst, Janet M.			Winter Climate Limits Subantarctic Low Forest Growth and Establishment	PLOS ONE			English	Article							WARMING EVENTS; NEW-ZEALAND; TEMPERATURE VARIABILITY; PINUS-SYLVESTRIS; VEGETATION; TREELINE; IMPACTS; HISTORY; TRENDS; SPREAD	Campbell Island, an isolated island 600 km south of New Zealand mainland (52 degrees S, 169 degrees E) is oceanic (Conrad Index of Continentality = -5) with small differences between mean summer and winter temperatures. Previous work established the unexpected result that a mean annual climate warming of c. 0.6 degrees C since the 1940's has not led to upward movement of the forest limit. Here we explore the relative importance of summer and winter climatic conditions on growth and age-class structure of the treeline forming species, Dracophyllum longifolium and Dracophyllum scoparium over the second half of the 20th century. The relationship between climate and growth and establishment were evaluated using standard dendroecological methods and local climate data from a meteorological station on the island. Growth and establishment were correlated against climate variables and further evaluated within hierarchical regression models to take into account the effect of plot level variables. Winter climatic conditions exerted a greater effect on growth and establishment than summer climatic conditions. Establishment is maximized under warm (mean winter temperatures >7 degrees C), dry winters (total winter precipitation <400 mm). Growth, on the other hand, is adversely affected by wide winter temperature ranges and increased rainfall. The contrasting effect of winter warmth on growth and establishment suggests that winter temperature affects growth and establishment through differing mechanisms. We propose that milder winters enhance survival of seedlings and, therefore, recruitment, but increases metabolic stress on established plants, resulting in lower growth rates. Future winter warming may therefore have complex effects on plant growth and establishment globally.	[Harsch, Melanie A.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [McGlone, Matt S.; Wilmshurst, Janet M.] Landcare Res, Ecosyst & Global Change, Lincoln, NE USA	University of Washington; University of Washington Seattle	Harsch, MA (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	harsch.melanie@gmail.com	Wilmshurst, Janet/O-8611-2019; Wilmshurst, Janet M/C-2209-2009	Wilmshurst, Janet/0000-0002-4474-8569; Wilmshurst, Janet M/0000-0002-4474-8569	New Zealand Ministry of Business, Innovation and Employment's Science and Innovation Group; Direct For Biological Sciences [1103734] Funding Source: National Science Foundation	New Zealand Ministry of Business, Innovation and Employment's Science and Innovation Group(New Zealand Ministry of Business, Innovation and Employment (MBIE)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded Core funding for Crown Research Institutes from the New Zealand Ministry of Business, Innovation and Employment's Science and Innovation Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1968, TREE RING DATING; Balling RC, 1998, CLIMATE RES, V9, P175, DOI 10.3354/cr009175; Batllori E, 2009, J VEG SCI, V20, P814, DOI 10.1111/j.1654-1103.2009.01085.x; Bestic KL, 2005, NEW ZEAL J ECOL, V29, P291; Bestic KL, 2002, DRACOPHYLLUM SCRUB E; Bjerke JW, 2011, J ECOL, V99, P1481, DOI 10.1111/j.1365-2745.2011.01859.x; Bokhorst S, 2011, GLOBAL CHANGE BIOL, V17, P2817, DOI 10.1111/j.1365-2486.2011.02424.x; Bokhorst S, 2010, PHYSIOL PLANTARUM, V140, P128, DOI 10.1111/j.1399-3054.2010.01386.x; Bokhorst SF, 2009, J ECOL, V97, P1408, DOI 10.1111/j.1365-2745.2009.01554.x; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Bunn A, 2010, DENDROCHRONOLOGY PRO; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Cook E.R., 2013, METHODS DENDROCHRONO; COUTTS MP, 1990, FORESTRY, V63, P143, DOI 10.1093/forestry/63.2.143; Crawford RMM, 2003, ANN BOT-LONDON, V91, P213, DOI 10.1093/aob/mcf185; Crawford RMM, 2000, NEW PHYTOL, V147, P257, DOI 10.1046/j.1469-8137.2000.00705.x; CRAWFORD RMM, 1981, FLORA, V171, P338; Crawford RMM, 1996, FOLIA GEOBOT PHYTOTX, V31, P7, DOI 10.1007/BF02803990; Crawford RMM, 2005, P ROY IRISH ACAD, V105B, P129; Crawford RMM, 2005, ENV CHALLENGES ARCTI, P85; D'Arrigo RD, 1998, CLIM DYNAM, V14, P191, DOI 10.1007/s003820050217; Diffenbaugh NS, 2013, NAT CLIM CHANGE, V3, P379, DOI [10.1038/nclimate1732, 10.1038/NCLIMATE1732]; Dullinger S, 2004, J ECOL, V92, P241, DOI 10.1111/j.0022-0477.2004.00872.x; Fritter AH, 1999, OECOLOGIA, V120, P575; Gelman A., 2007, DATA ANAL USING REGR; Giesecke T, 2010, J BIOGEOGR, V37, P1394, DOI 10.1111/j.1365-2699.2010.02296.x; Grace J, 1977, PLANT RESPONSES WIND; Harsch MA, 2011, GLOBAL ECOL BIOGEOGR, V20, P582, DOI 10.1111/j.1466-8238.2010.00622.x; Harsch MA, 2009, ECOL LETT, V12, P1040, DOI 10.1111/j.1461-0248.2009.01355.x; Juntunen V, 2002, ARCTIC, V55, P348, DOI 10.14430/arctic719; Kirchhefer AJ, 2001, HOLOCENE, V11, P41, DOI 10.1191/095968301670181592; Kreyling J, 2010, ECOLOGY, V91, P1939, DOI 10.1890/09-1160.1; Kullman L, 2007, J ECOL, V95, P41, DOI 10.1111/j.1365-2745.2006.01190.x; LAVOIE C, 1992, ARCTIC ALPINE RES, V24, P40, DOI 10.2307/1551318; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Luterbacher J, 2004, SCIENCE, V303, P1499, DOI 10.1126/science.1093877; McDowell NG, 2011, PLANT PHYSIOL, V155, P1051, DOI 10.1104/pp.110.170704; McGlone M, 2007, EARTH ENV SCI T R SO, V98, P71, DOI 10.1017/S1755691007000060; McGlone MS, 2002, QUATERNARY SCI REV, V21, P683, DOI 10.1016/S0277-3791(01)00044-0; Mote PW, 2005, B AM METEOROL SOC, V86, P39, DOI 10.1175/BAMS-86-1-39; Nicoll BC, 1998, TREES-STRUCT FUNCT, V12, P241, DOI 10.1007/s004680050147; Niessner A, 2013, STEM GROWTH DYNAMICS; NIWA, 2009, CLIFLO NIWAS NAT CLI; Ogren E, 1996, FUNCT ECOL, V10, P724, DOI 10.2307/2390507; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Salinger MJ, 2001, INT J CLIMATOL, V21, P1437, DOI 10.1002/joc.694; Skre O, 2008, ENVIRON EXP BOT, V62, P254, DOI 10.1016/j.envexpbot.2007.09.005; Thomas A., 2006, R NEWS, V6, P12, DOI DOI 10.1159/000323281; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Wilmshurst JM, 2004, J BIOGEOGR, V31, P401, DOI 10.1046/j.0305-0270.2003.01029.x; Zuur Alain F., 2009, P1	51	11	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93241	10.1371/journal.pone.0093241	http://dx.doi.org/10.1371/journal.pone.0093241			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691026	Green Published, gold, Green Submitted			2022-12-25	WOS:000334101100056
J	Kadra, G; Dean, K; Hotopf, M; Hatch, SL				Kadra, Giouliana; Dean, Kimberlie; Hotopf, Matthew; Hatch, Stephani L.			Investigating Exposure to Violence and Mental Health in a Diverse Urban Community Sample: Data from the South East London Community Health (SELCoH) Survey	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; INTERPERSONAL VIOLENCE; STANDARDIZED ASSESSMENT; PSYCHIATRIC-DISORDER; RISK-FACTORS; LIFE EVENTS; VICTIMIZATION; POPULATION; GENDER; PREVALENCE	Background: General population surveys have seldom examined violence as a multidimensional concept and in relation to an array of mental disorders. Methods: Data from the South East London Community Health Study was used to examine the prevalence, overlap and distribution of proximal witnessed, victimised and perpetrated violence and their association with current mental disorders. We further investigated the cumulative effect of lifetime exposure to violence on current mental disorders. Unadjusted and adjusted (for confounders and violence) models were examined. Results: In the last twelve months, 7.4% reported witnessing violence, 6.3% victimisation and 3.2% perpetration of violence. There was a significant overlap across violence types, with some shared correlates across the groups such as being younger and male. Witnessing violence in the past year was associated with current common mental disorders (CMD) and posttraumatic stress disorder (PTSD) symptoms. Proximal perpetration was associated with current CMD, PTSD symptoms and past 12 months drug use; whereas proximal victimisation was associated with lifetime and past 12 months drug use. Lifetime exposure to two or more types of violence was associated with increased risk for all mental health outcomes, suggesting a cumulative effect. Conclusion: Exposure to violence needs to be examined in a multi-faceted manner: i) as discrete distal and proximal events, which may have distinct patterns of association with mental health and ii) as a concept with different but overlapping dimensions, thus also accounting for possible cumulative effects.	[Kadra, Giouliana] Kings Coll London, Biomed Res Ctr Nucleus, Inst Psychiat, Dept Psychol Med, London, England; [Dean, Kimberlie] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; [Dean, Kimberlie] Justice Hlth & Forens Mental Hlth Network, Sydney, NSW, Australia; [Hotopf, Matthew; Hatch, Stephani L.] Kings Coll London, Inst Psychiat, Dept Psychol Med, London, England	University of London; King's College London; University of New South Wales Sydney; University of London; King's College London	Kadra, G (corresponding author), Kings Coll London, Biomed Res Ctr Nucleus, Inst Psychiat, Dept Psychol Med, London, England.	giouliana.kadra@kcl.ac.uk	Hatch, Stephani L/B-4235-2010; Hotopf, Matthew/E-4971-2010; Kadra, Giouliana/G-8346-2017	Kadra, Giouliana/0000-0003-3182-905X; Hatch, Stephani/0000-0001-9103-2427; Hotopf, Matthew/0000-0002-3980-4466	Biomedical Research Nucleus data management and informatics facility at South London and Maudsley NHS Foundation Trust; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust; King's College London; Guy's and St Thomas' Charity; Maudsley Charity; Justice Health AMP; Forensic Mental Health Network, New South Wales, Australia	Biomedical Research Nucleus data management and informatics facility at South London and Maudsley NHS Foundation Trust; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust; King's College London; Guy's and St Thomas' Charity; Maudsley Charity; Justice Health AMP; Forensic Mental Health Network, New South Wales, Australia	This research was supported by the Biomedical Research Nucleus data management and informatics facility at South London and Maudsley NHS Foundation Trust, which is funded by the National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London and a joint infrastructure grant from Guy's and St Thomas' Charity and the Maudsley Charity. G Kadra, SL Hatch and M Hotopf receive salary support from the National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. K Dean receives salary support from the Justice Health & Forensic Mental Health Network, New South Wales, Australia. The funders did not have a role in the study design; collection, analysis or interpretation of data; the writing of the manuscript; or in the decision to submit the manuscript for publication.	Acierno R, 1997, BEHAV MED, V23, P53, DOI 10.1080/08964289709596729; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Andrade LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031879; Barrett EL, 2011, ADDICT BEHAV, V36, P721, DOI 10.1016/j.addbeh.2011.02.005; Boden JM, 2012, DRUG ALCOHOL DEPEN, V122, P135, DOI 10.1016/j.drugalcdep.2011.09.023; Breslau N, 1998, ARCH GEN PSYCHIAT, V55, P626, DOI 10.1001/archpsyc.55.7.626; Breslau N, 1999, AM J PSYCHIAT, V156, P902, DOI 10.1176/ajp.156.6.902; Budd T., 2005, OFFENDING ENGLAND WA; Chaplin R, 2011, HOME OFFICE STAT B; Choe JY, 2008, PSYCHIAT SERV, V59, P153, DOI 10.1176/ps.2008.59.2.153; Clark C, 2008, J URBAN HEALTH, V85, P22, DOI 10.1007/s11524-007-9229-8; Colbert SJ, 2009, HEALTH EDUC BEHAV, V36, P259, DOI 10.1177/1090198107303310; DoH, 2012, HLTH PROF LAMB 2012; DoH, 2012, HLTH PROF SOUTHW 201; Dunn EC, 2012, DEPRESS ANXIETY, V29, P392, DOI 10.1002/da.21916; Duque LF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-628; Faergemann C, 2010, SCAND J PUBLIC HEALT, V38, P524, DOI 10.1177/1403494810370234; Fazel S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000120; Fergusson DM, 2000, ADDICTION, V95, P1525, DOI 10.1046/j.1360-0443.2000.951015257.x; Fok M, 2013, J PERS DISORD, V27, P119; Goldmann E, 2011, J TRAUMA STRESS, V24, P747, DOI 10.1002/jts.20705; Hart C, 2012, SOC PSYCH PSYCH EPID, V47, P1581, DOI 10.1007/s00127-011-0464-7; Hatch SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048012; Hatch SL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-861; Hedtke KA, 2008, J CONSULT CLIN PSYCH, V76, P633, DOI 10.1037/0022-006X.76.4.633; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P10, DOI 10.1177/1403494810380774; Hiday VA, 2001, INT J LAW PSYCHIAT, V24, P559, DOI 10.1016/S0160-2527(01)00091-7; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Holman EA, 2000, ARCH FAM MED, V9, P802, DOI 10.1001/archfami.9.9.802; Khalifeh H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055952; Khalifeh H, 2010, INT REV PSYCHIATR, V22, P535, DOI 10.3109/09540261.2010.506185; Knudsen AK, 2010, AM J EPIDEMIOL, V172, P1306, DOI 10.1093/aje/kwq257; Krug EG, 2002, LANCET, V360, P1083, DOI 10.1016/S0140-6736(02)11133-0; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; Lipsky S, 2011, SOC PSYCH PSYCH EPID, V46, P843, DOI 10.1007/s00127-010-0258-3; McDonald CC, 2008, J PSYCHIATR MENT HLT, V15, P833, DOI 10.1111/j.1365-2850.2008.01321.x; McGruder-Johnson AK, 2000, J INTERPERS VIOLENCE, V15, P205, DOI 10.1177/088626000015002006; Monahan J, 2005, PSYCHIAT SERV, V56, P810, DOI 10.1176/appi.ps.56.7.810; Moran P, 2003, BRIT J PSYCHIAT, V183, P228, DOI 10.1192/bjp.183.3.228; Mulvey EP, 1997, VIOLENT BEHAV MENTAL, P14; ONS, 2011, CENS 2011 ETHN GROUP; Porcerelli JH, 2003, J AM BOARD FAM PRACT, V16, P32, DOI 10.3122/jabfm.16.1.32; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Ribeiro WS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063545; Scarpa A, 2001, J INTERPERS VIOLENCE, V16, P36, DOI 10.1177/088626001016001003; Sharp C, 2003, CRIME JUSTICE SURVEY; Silove D, 1997, BRIT J PSYCHIAT, V170, P351, DOI 10.1192/bjp.170.4.351; Silver E, 2005, AM J PUBLIC HEALTH, V95, P2015, DOI 10.2105/AJPH.2003.021436; Slopen N, 2012, SOC PSYCH PSYCH EPID, V47, P1591, DOI 10.1007/s00127-011-0466-5; StataCorp, 2019, STATA STAT SOFTWARE; Sundaram V, 2004, J EPIDEMIOL COMMUN H, V58, P65, DOI 10.1136/jech.58.1.65; Sundquist J, 2000, J NERV MENT DIS, V188, P357, DOI 10.1097/00005053-200006000-00006; Tarling R., 2000, VICTIM WITNESS INTIM, V124; ten Have M, 2014, PSYCHOL MED, V44, P1485, DOI 10.1017/S0033291713002262; Turner RJ, 1995, J HEALTH SOC BEHAV, V36, P360, DOI 10.2307/2137325; Turner RJ, 2004, ARCH GEN PSYCHIAT, V61, P481, DOI 10.1001/archpsyc.61.5.481; Walsh E, 2003, BRIT J PSYCHIAT, V183, P233, DOI 10.1192/bjp.183.3.233; Whiting JB, 2009, J FAM VIOLENCE, V24, P639, DOI 10.1007/s10896-009-9262-3	58	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93660	10.1371/journal.pone.0093660	http://dx.doi.org/10.1371/journal.pone.0093660			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6KM	24691206	Green Published, gold			2022-12-25	WOS:000334101100121
J	Yi, X; Long, L; Yang, CZ; Lu, YY; Cheng, ML				Yi, Xu; Long, Li; Yang, Chunzhang; Lu, Yingying; Cheng, Mingliang			Maotai Ameliorates Diethylnitrosamine-Initiated Hepatocellular Carcinoma Formation in Mice	PLOS ONE			English	Article							GLUTAMATE-CYSTEINE LIGASE; OXIDATIVE STRESS; DIAGNOSTIC-VALUE; GLYPICAN-3 EXPRESSION; ALCOHOL-CONSUMPTION; 2-RELATED FACTOR-2; GENE-EXPRESSION; LIVER FIBROSIS; METALLOTHIONEIN; NRF2	Consumption of alcohol is closely related to liver disease, such as hepatic fibrosis or even hepatocellular carcinoma (HCC). However, epidemiological and experimental studies indicated that consumption of Maotai, one of the famous liquors in China, exhibits no significant correlation with hepatic fibrosis or cirrhosis as other beverage sources do. This study detected the relationship of Maotai consumption and HCC development in a diethylnitrosamine (DEN)-initiated HCC animal model. DEN was given to mice at a dose of 100 mg/kg, ip, and 50 mg/kg, ip in the following week. Mice were simultaneously given Maotai or an equal amount of ethanol (53%, 5 ml/kg/day, 5days/week for up to 35weeks). At 3-week and 35-week of the experiment, serum and livers were collected for biochemical and histopathological examination of liver injury and incidence of HCC. Real-time RT-PCR, immunohistochemistry and Western blotting were used to examine the expression of metallothionein-1/2 (MT-1/2), NF-E2-related factor 2 (Nrf2), glutamate-cysteine ligase catalytic subunit (GCLC) and modified subunit (GCLM). We identified tissue damage and dysfunction of liver in ethanol + DEN-treated mice, whereas the extent of injury was reduced in Maotai+ DEN-treated mice. Significant Glypican-3(GPC3) expression and precancerous injury or HCC were seen in approximately 50% of mice with ethanol+ DEN, but barely be seen in Maotai + DEN-treated mice. A higher expression of MT-1/2, Nrf2 and GCLC could be seen in Maotai + DEN-treated mice. Thus, Maotai liquor ameliorates the formation of DEN-induced HCC in mice, and the protection mechanism is possibly related with the activation of anti-oxidation factors, such as MTs, Nrf2 and GCLC.	[Yi, Xu; Long, Li; Cheng, Mingliang] Guiyang Med Coll Hosp, Guiyang, Guizhou, Peoples R China; [Yang, Chunzhang] NINDS, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA; [Lu, Yingying] Beijing 302 Hosp, Ctr Therapeut Res Hepatocellular Carcinoma, Beijing, Peoples R China	Guizhou Medical University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Fifth Medical Center of Chinese PLA General Hospital	Cheng, ML (corresponding author), Guiyang Med Coll Hosp, Guiyang, Guizhou, Peoples R China.	mlcheng@yeah.net			project 973, Department of Science and Technology, Government of China [2011CB512114]	project 973, Department of Science and Technology, Government of China	Supported by a grant from the project 973, Department of Science and Technology, Government of China (2011CB512114). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Basra S, 2011, WORLD J HEPATOL, V3, P108, DOI 10.4254/wjh.v3.i5.108; Bataille AM, 2012, CLIN PHARMACOL THER, V92, P340, DOI 10.1038/clpt.2012.110; Bishayee A, 2010, CANCER PREV RES, V3, P753, DOI 10.1158/1940-6207.CAPR-09-0171; Brandon-Warner E, 2012, ALCOHOL CLIN EXP RES, V36, P641, DOI 10.1111/j.1530-0277.2011.01660.x; Cheng Ming-Liang, 2004, Hepatobiliary Pancreat Dis Int, V3, P93; Cheng ML, 2002, WORLD J GASTROENTERO, V8, P520, DOI 10.3748/wjg.v8.i3.520; Dayoub R, 2013, MOL MED, V19, P237, DOI 10.2119/molmed.2013.00027; Di Tommaso L, 2007, HEPATOLOGY, V45, P725, DOI 10.1002/hep.21531; Diaz-Hernandez JI, 2005, J BIOL CHEM, V280, P38992, DOI 10.1074/jbc.M507065200; Dong H, 2005, WORLD J GASTROENTERO, V11, P1339, DOI 10.3748/wjg.v11.i9.1339; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Ghoshal K, 2000, J BIOL CHEM, V275, P539, DOI 10.1074/jbc.275.1.539; Gordillo-Bastidas D, 2013, WORLD J GASTROENTERO, V19, P9020, DOI 10.3748/wjg.v19.i47.9020; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Jin Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087930; Kaplan MM, 1979, PROBLEMS LIVER DISEA, P79; Kubo S, 2005, HEPATOL RES, V31, P73, DOI 10.1016/j.hepres.2004.09.008; Lamle J, 2008, GASTROENTEROLOGY, V134, P1159, DOI 10.1053/j.gastro.2008.01.011; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Libbrecht L, 2006, AM J SURG PATHOL, V30, P1405, DOI 10.1097/01.pas.0000213323.97294.9a; Liu H, 2010, WORLD J GASTROENTERO, V16, P4410, DOI 10.3748/wjg.v16.i35.4410; Liu J, 2006, EXP BIOL MED, V231, P1535, DOI 10.1177/153537020623100913; Liu J, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/305861; Majumder S, 2010, CANCER RES, V70, P10265, DOI 10.1158/0008-5472.CAN-10-2839; Markovic D, 2013, BRAZ J MED BIOL RES, V46, P1014, DOI 10.1590/1414-431X20132814; McKillop IH, 2009, SEMIN LIVER DIS, V29, P222, DOI 10.1055/s-0029-1214377; MOHR U, 1997, IRAC SCI PUBLICATION, V122; Mukamal KJ, 2003, NEW ENGL J MED, V348, P109, DOI 10.1056/NEJMoa022095; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; Okada K, 2013, J GASTROENTEROL, V48, P620, DOI 10.1007/s00535-012-0659-z; Orr WC, 2005, J BIOL CHEM, V280, P37331, DOI 10.1074/jbc.M508272200; PEGG AE, 1990, CANCER RES, V50, P6119; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Ruttkay-Nedecky B, 2013, INT J MOL SCI, V14, P6044, DOI 10.3390/ijms14036044; SCHARL A, 1990, ARCH GYNECOL OBSTET, V247, P63, DOI 10.1007/BF02390663; Shimozono R, 2013, MOL PHARMACOL, V84, P62, DOI 10.1124/mol.112.084269; Shin SM, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/763257; Singal AK, 2007, J CLIN GASTROENTEROL, V41, P761, DOI 10.1097/MCG.0b013e3180381584; Singal AK, 2011, EUR J GASTROEN HEPAT, V23, P204, DOI 10.1097/MEG.0b013e328343b085; Sookoian S, 2014, GUT, V63, P530, DOI 10.1136/gutjnl-2013-305718; Stampfer MJ, 2005, NEW ENGL J MED, V352, P245, DOI 10.1056/NEJMoa041152; Tao X, 2007, HEPATOL RES, V37, P820, DOI 10.1111/j.1872-034X.2007.00113.x; Teoh NC, 2008, HEPATOLOGY, V47, P2078, DOI 10.1002/hep.22194; Thirumoorthy N, 2007, WORLD J GASTROENTERO, V13, P993, DOI 10.3748/wjg.v13.i7.993; Voigt Michael D, 2005, Clin Liver Dis, V9, P151, DOI 10.1016/j.cld.2004.10.003; Wang XY, 2006, HUM PATHOL, V37, P1435, DOI 10.1016/j.humpath.2006.05.016; Wu J, 2002, WORLD J GASTROENTERO, V8, P571, DOI 10.3748/wjg.v8.i3.571; Xu WH, 2008, LAB INVEST, V88, P1068, DOI 10.1038/labinvest.2008.75; Yang JJ, 2013, FOOD CHEM TOXICOL, V59, P421, DOI 10.1016/j.fct.2013.06.018; Zhang DY, 2006, MOL CELL BIOCHEM, V293, P161, DOI 10.1007/s11010-006-9238-z; Zhang YKJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059122; Zhou ZX, 2002, EXP BIOL MED, V227, P214, DOI 10.1177/153537020222700310; Zima T, 2001, J BIOMED SCI, V8, P59, DOI 10.1159/000054014	54	16	18	6	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93599	10.1371/journal.pone.0093599	http://dx.doi.org/10.1371/journal.pone.0093599			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690765	Green Submitted, Green Published, gold			2022-12-25	WOS:000334101100110
J	Zhang, Y; Gong, Y; Hu, D; Zhu, P; Wang, N; Zhang, Q; Wang, M; Aldeewan, A; Xia, H; Qu, X; Ring, BZ; Minato, N; Su, L				Zhang, Y.; Gong, Y.; Hu, D.; Zhu, P.; Wang, N.; Zhang, Q.; Wang, M.; Aldeewan, A.; Xia, H.; Qu, X.; Ring, B. Z.; Minato, N.; Su, L.			Nuclear SIPA1 activates integrin beta 1 promoter and promotes invasion of breast cancer cells	ONCOGENE			English	Article							DOWN-REGULATION; FOCAL ADHESION; MATRIX-METALLOPROTEINASE-9 SECRETION; SUBCELLULAR-LOCALIZATION; TUMOR PROGRESSION; MELANOMA-CELLS; RAP1 GTPASE; EXPRESSION; METASTASIS; MIGRATION	SIPA1 (signal-induced proliferation-associated protein 1) is a GTPase activation protein that can catalyze the hydrolysis of Rap1 bound GTP to GDP. Recently attention has been paid to a potential role for SIPA1 in cancer metastasis; however, the underlying mechanism of how changes in SIPA1 levels may lead to increased metastasis remains poorly understood. In this study, we showed that SIPA1 was mainly localized to the nuclei in highly invasive breast cancer tumor tissue and MDA-MB-231 cells. Knockdown of SIPA1 in MDA-MB-231 altered cell morphology and cell proliferation ability. Furthermore, this study is the first to establish that nuclear SIPA1 can interact with the integrin beta 1 promoter and activate its transcription; this interaction appears to be important for SIPA1-dependent MDA-MB-231 cell adhesion and invasion. We also demonstrated that the phosphorylation of FAK, Akt and the expression of MMP9, downstream signaling molecules of integrin beta 1, were decreased upon SIPA1 knockdown, and MDA-MB-231 cell invasion was impaired. Taken together, these results suggest nuclear SIPA1 contributes to breast cancer cell invasion through the regulation of integrin beta 1 signaling.	[Zhang, Y.; Hu, D.; Zhu, P.; Wang, N.; Zhang, Q.; Aldeewan, A.; Su, L.] Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Peoples R China; [Gong, Y.] Hubei Canc Hosp, Dept Breast Surg, Wuhan, Peoples R China; [Wang, M.; Xia, H.] Hubei Canc Hosp, Dept Pathol, Wuhan, Peoples R China; [Qu, X.] Huazhong Univ Sci & Technol, Union Hosp Tongji Med Coll, Dept Thyroid & Breast Surg, Wuhan 430074, Peoples R China; [Ring, B. Z.] Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Inst Genom & Personalized Med, Wuhan 430074, Peoples R China; [Minato, N.] Kyoto Univ, Grad Sch Med, Dept Immunol & Cell Biol, Kyoto, Japan	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Kyoto University	Su, L (corresponding author), Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Minist Educ, Key Lab Mol Biophys, 1037 Luoyu Rd, Wuhan 430074, Peoples R China.	lisu@mail.hust.edu.cn	Zhang, Yilei/I-8997-2014	Zhang, Yilei/0000-0003-1407-0301	National Basic Research Program of China [2011CB910401]; NSFC [31271504]; Ministry of Science and Technology, China [2009DFA31940]	National Basic Research Program of China(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology, China(Ministry of Science and Technology, China)	This work was supported partly by grants of National Basic Research Program of China (2011CB910401), NSFC (31271504) and 2009DFA31940 from The Ministry of Science and Technology, China.	Alsarraj J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080746; Alsarraj J, 2011, CANCER RES, V71, P3121, DOI 10.1158/0008-5472.CAN-10-4417; Bailey CL, 2009, CANCER RES, V69, P4962, DOI 10.1158/0008-5472.CAN-08-4269; Bivona TG, 2004, J CELL BIOL, V164, P461, DOI 10.1083/jcb.200311093; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Camp RL, 1999, CANCER, V86, P2259, DOI 10.1002/(SICI)1097-0142(19991201)86:11<2259::AID-CNCR13>3.0.CO;2-2; Carmona G, 2009, BLOOD, V113, P488, DOI 10.1182/blood-2008-02-138438; Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Cayrol C, 2006, ONCOGENE, V25, P4421, DOI 10.1038/sj.onc.1209484; Chen C, 2009, BIOMATERIALS, V30, P2912, DOI 10.1016/j.biomaterials.2009.02.010; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009931; Colzani E, 2011, J CLIN ONCOL, V29, P4014, DOI 10.1200/JCO.2010.32.6462; Crawford NPS, 2008, P NATL ACAD SCI USA, V105, P6380, DOI 10.1073/pnas.0710331105; Crawford NPS, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1389; Drukker CA, 2013, INT J CANCER, V133, P929, DOI 10.1002/ijc.28082; Farina A, 2004, MOL CELL BIOL, V24, P9059, DOI 10.1128/MCB.24.20.9059-9069.2004; FREEMAN GH, 1951, BIOMETRIKA, V38, P141, DOI 10.2307/2332323; Gao L, 2006, CANCER RES, V66, P7880, DOI 10.1158/0008-5472.CAN-06-0254; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hernandez-Varas P, 2011, J BIOL CHEM, V286, P18492, DOI 10.1074/jbc.M110.189811; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Hsu TI, 2012, ONCOGENE, V31, P3973, DOI 10.1038/onc.2011.568; Hung MC, 2011, J CELL SCI, V124, P3381, DOI 10.1242/jcs.089110; Ji K, 2012, CANCER GENOM PROTEOM, V9, P321; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Keely S, 2009, FASEB J, V23, P1338, DOI 10.1096/fj.08-125344; Kunapuli P, 2003, ONCOGENE, V22, P3985, DOI 10.1038/sj.onc.1206584; Kurachi H, 1997, J BIOL CHEM, V272, P28081, DOI 10.1074/jbc.272.44.28081; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lindberg K, 2010, J CELL PHYSIOL, V222, P156, DOI 10.1002/jcp.21932; Liu JF, 2002, BIOCHEM BIOPH RES CO, V293, P1174, DOI 10.1016/S0006-291X(02)00350-9; Lyle KS, 2008, CELL SIGNAL, V20, P1104, DOI 10.1016/j.cellsig.2008.01.018; Maity G, 2011, TUMOR BIOL, V32, P129, DOI 10.1007/s13277-010-0106-9; Maity G, 2010, MOL CELL BIOCHEM, V336, P65, DOI 10.1007/s11010-009-0256-5; Malchinkhuu E, 2009, MOL BIOL CELL, V20, P5156, DOI 10.1091/mbc.E09-08-0692; Marques IJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-128; Mathieu V, 2012, ONCOTARGET, V3, P399; McSherry EA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2853; Mitra RS, 2008, CANCER RES, V68, P3959, DOI 10.1158/0008-5472.CAN-07-2755; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mizugaki H, 2012, BRIT J CANCER, V106, P1953, DOI 10.1038/bjc.2012.178; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Park YG, 2005, NAT GENET, V37, P1055, DOI 10.1038/ng1635; Redig AJ, 2013, J INTERN MED, V274, P113, DOI 10.1111/joim.12084; Ruoslahti E, 1999, ADV CANCER RES, V76, P1, DOI 10.1016/S0065-230X(08)60772-1; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; Scott MS, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-317; Sen T, 2010, BIOCHIMIE, V92, P1422, DOI 10.1016/j.biochi.2010.07.005; Shimizu Y, 2011, CANCER SCI, V102, P828, DOI 10.1111/j.1349-7006.2011.01876.x; Su L, 2003, J BIOL CHEM, V278, P15232, DOI 10.1074/jbc.M211888200; Tsukamoto N, 1999, J BIOL CHEM, V274, P18463, DOI 10.1074/jbc.274.26.18463; Tsygankova OA, 2007, MOL CELL BIOL, V27, P6647, DOI 10.1128/MCB.00155-07; Tu HJ, 2010, J NEUROSCI, V30, P749, DOI 10.1523/JNEUROSCI.2343-09.2010; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Valles AM, 2004, J BIOL CHEM, V279, P44490, DOI 10.1074/jbc.M405144200; Zheng H, 2009, CANCER RES, V69, P449, DOI 10.1158/0008-5472.CAN-08-2399; Zuo H, 2010, CANCER RES, V70, P1389, DOI 10.1158/0008-5472.CAN-09-2812	59	33	33	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 12	2015	34	11					1451	1462		10.1038/onc.2014.36	http://dx.doi.org/10.1038/onc.2014.36			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CD1AR	24704834				2022-12-25	WOS:000350806500011
J	Gupta, R; Ghosh, S; Monks, B; DeOliveira, RB; Tzeng, TC; Kalantari, P; Nandy, A; Bhattacharjee, B; Chan, JN; Ferreira, F; Rathinam, V; Sharma, S; Lien, E; Silverman, N; Fitzgerald, K; Firon, A; Trieu-Cuot, P; Henneke, P; Golenbock, DT				Gupta, Rahul; Ghosh, Shubhendu; Monks, Brian; DeOliveira, Rosane B.; Tzeng, Te-Chen; Kalantari, Parisa; Nandy, Anubhab; Bhattacharjee, Bornali; Chan, Jennie; Ferreira, Fabianno; Rathinam, Vijay; Sharma, Shruti; Lien, Egil; Silverman, Neal; Fitzgerald, Katherine; Firon, Arnaud; Trieu-Cuot, Patrick; Henneke, Philipp; Golenbock, Douglas T.			RNA and beta-Hemolysin of Group B Streptococcus Induce Interleukin-1 beta ( IL-1 beta) by Activating NLRP3 Inflammasomes in Mouse Macrophages*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Immunology; Innate Immunity; Interleukin; RNA	NALP3 INFLAMMASOME; DNA; HELICASE; CELLS	Background: Group B Streptococcus (GBS) activates the NLRP3 inflammasome. Results: GBS RNA escapes the phagolysosome and activates the NLRP3 inflammasome in a -hemolysin-dependent fashion. RNA-NLRP3 interaction and activation are enhanced by lysosomal leakage. Conclusion: RNA activates the NLRP3 inflammasome in synergy with phagolysosomal proteins. Significance: The NLRP3 inflammasome responds to bacterial invasion via RNA recognition subsequent to phagolysosomal degradation. The inflammatory cytokine IL-1 is critical for host responses against many human pathogens. Here, we define Group B Streptococcus (GBS)-mediated activation of the Nod-like receptor-P3 (NLRP3) inflammasome in macrophages. NLRP3 activation requires GBS expression of the cytolytic toxin, -hemolysin, lysosomal acidification, and leakage. These processes allow the interaction of GBS RNA with cytosolic NLRP3. The present study supports a model in which GBS RNA, along with lysosomal components including cathepsins, leaks out of lysosomes and interacts with NLRP3 to induce IL-1 production.	[Gupta, Rahul; Ghosh, Shubhendu; Monks, Brian; DeOliveira, Rosane B.; Tzeng, Te-Chen; Kalantari, Parisa; Nandy, Anubhab; Bhattacharjee, Bornali; Chan, Jennie; Rathinam, Vijay; Sharma, Shruti; Lien, Egil; Silverman, Neal; Fitzgerald, Katherine; Golenbock, Douglas T.] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Firon, Arnaud; Trieu-Cuot, Patrick] Inst Pasteur, Unite Biol Bacteries Pathogenes Gram Positif, F-75724 Paris 15, France; [Ferreira, Fabianno] Univ Fed Rio de Janeiro, Lab Inflamacao & Imunidade, Dept Imunol, Inst Microbiol, BR-21941902 Rio De Janeiro, Brazil; [Henneke, Philipp] Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency, D-79106 Freiburg Im Breisgau, Germany; [Henneke, Philipp] Univ Med Ctr Freiburg, Ctr Pediat & Adolescent Med, D-79106 Freiburg Im Breisgau, Germany	University of Massachusetts System; University of Massachusetts Worcester; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universidade Federal do Rio de Janeiro	Golenbock, DT (corresponding author), Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA.	Douglas.Golenbock@umassmed.edu	Fitzgerald, Katherine/ABE-6317-2020; Rathinam, Vijay/ABE-7544-2020; Dutra, Fabianno F/C-1387-2015; Monks, Brian/B-8362-2015; Ferreira Dutra, Fabianno/AAE-2895-2022	Rathinam, Vijay/0000-0002-8009-3977; Dutra, Fabianno F/0000-0003-3106-7585; Monks, Brian/0000-0003-4008-3093; Ferreira Dutra, Fabianno/0000-0003-3106-7585; Bhattacharjee, Bornali/0000-0002-0801-1543; FIRON, Arnaud/0000-0002-5323-5212; Silverman, Neal/0000-0002-4259-456X; Fitzgerald, Kate/0000-0003-3175-609X; TRIEU-CUOT, Patrick/0000-0002-2768-9587; Gupta, Rahul/0000-0001-8634-2439	National Institutes of Health [RO1 AI52455, U24 AI082663]; German Research Council [DFG HE 3127/5-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U24AI082663, R01AI052455, T32AI095213] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Council(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI52455 (to D. T. G., P. H., and P. T.-C.) and U24 AI082663 (to D. T. G., N.S., E. L., and S. G.) and by the German Research Council (DFG HE 3127/5-1 to P.H.).	BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; Charrel-Dennis M, 2008, CELL HOST MICROBE, V4, P543, DOI 10.1016/j.chom.2008.11.002; Costa A, 2012, J IMMUNOL, V188, P1953, DOI 10.4049/jimmunol.1102543; Deshmukh SD, 2011, EMBO REP, V12, P71, DOI 10.1038/embor.2010.189; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; EDWARDS MS, 1985, J PEDIATR-US, V106, P717, DOI 10.1016/S0022-3476(85)80342-5; Eigenbrod T, 2012, J IMMUNOL, V189, P328, DOI 10.4049/jimmunol.1103258; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Henneke P, 2002, J IMMUNOL, V169, P3970, DOI 10.4049/jimmunol.169.7.3970; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kim T, 2010, P NATL ACAD SCI USA, V107, P15181, DOI 10.1073/pnas.1006539107; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mitoma H, 2013, IMMUNITY, V39, P123, DOI 10.1016/j.immuni.2013.07.001; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Sharma S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001310; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Whidbey C, 2013, J EXP MED, V210, P1265, DOI 10.1084/jem.20122753	17	54	57	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13701	13705		10.1074/jbc.C114.548982	http://dx.doi.org/10.1074/jbc.C114.548982			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24692555	Green Published, hybrid			2022-12-25	WOS:000335984600002
J	Kaczocha, M; Rebecchi, MJ; Ralph, BP; Teng, YHG; Berger, WT; Galbavy, W; Elmes, MW; Glaser, ST; Wang, LQ; Rizzo, RC; Deutsch, DG; Ojima, I				Kaczocha, Martin; Rebecchi, Mario J.; Ralph, Brian P.; Teng, Yu-Han Gary; Berger, William T.; Galbavy, William; Elmes, Matthew W.; Glaser, Sherrye T.; Wang, Liqun; Rizzo, Robert C.; Deutsch, Dale G.; Ojima, Iwao			Inhibition of Fatty Acid Binding Proteins Elevates Brain Anandamide Levels and Produces Analgesia	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-ALPHA; CANNABINOID RECEPTOR; AMIDE HYDROLASE; MULTIPLE-SCLEROSIS; COST-EFFECTIVENESS; INFLAMMATORY PAIN; NUCLEAR RECEPTORS; MOUSE-BRAIN; MICE; ATHEROSCLEROSIS	The endocannabinoid anandamide (AEA) is an antinociceptive lipid that is inactivated through cellular uptake and subsequent catabolism by fatty acid amide hydrolase (FAAH). Fatty acid binding proteins (FABPs) are intracellular carriers that deliver AEA and related N-acylethanolamines (NAEs) to FAAH for hydrolysis. The mammalian brain expresses three FABP subtypes: FABP3, FABP5, and FABP7. Recent work from our group has revealed that pharmacological inhibition of FABPs reduces inflammatory pain in mice. The goal of the current work was to explore the effects of FABP inhibition upon nociception in diverse models of pain. We developed inhibitors with differential affinities for FABPs to elucidate the subtype(s) that contributes to the antinociceptive effects of FABP inhibitors. Inhibition of FABPs reduced nociception associated with inflammatory, visceral, and neuropathic pain. The antinociceptive effects of FABP inhibitors mirrored their affinities for FABP5, while binding to FABP3 and FABP7 was not a predictor of in vivo efficacy. The antinociceptive effects of FABP inhibitors were mediated by cannabinoid receptor 1 (CB1) and peroxisome proliferator-activated receptor alpha (PPAR(proportional to)) and FABP inhibition elevated brain levels of AEA, providing the first direct evidence that FABPs regulate brain endocannabinoid tone. These results highlight FABPs as novel targets for the development of analgesic and antiinflammatory therapeutics.	[Kaczocha, Martin; Rebecchi, Mario J.; Galbavy, William] SUNY Stony Brook, Dept Anesthesiol, Stony Brook, NY 11794 USA; [Ralph, Brian P.; Elmes, Matthew W.; Wang, Liqun; Deutsch, Dale G.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Teng, Yu-Han Gary; Berger, William T.; Ojima, Iwao] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Teng, Yu-Han Gary; Berger, William T.; Ojima, Iwao] SUNY Stony Brook, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA; [Glaser, Sherrye T.] Kingsborough Community Coll, Dept Biol Sci, Brooklyn, NY USA; [Rizzo, Robert C.] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; City University of New York (CUNY) System; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Kaczocha, M (corresponding author), SUNY Stony Brook, Dept Anesthesiol, Stony Brook, NY 11794 USA.	Martin.Kaczocha@Stonybrook.edu		Galbavy, William/0000-0003-0948-9538; Kaczocha, Martin/0000-0002-2527-1398; Ojima, Iwao/0000-0002-3628-1161	National Institutes of Health [DA035923, DA032232, DA016419]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA035923, R01DA016419, R21DA032232] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants DA035923, DA032232, and DA016419. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Ahn K, 2009, CHEM BIOL, V16, P411, DOI 10.1016/j.chembiol.2009.02.013; Babaev VR, 2011, ARTERIOSCL THROM VAS, V31, P1283, DOI 10.1161/ATVBAHA.111.225839; Balius TE, 2013, J COMPUT CHEM, V34, P1226, DOI 10.1002/jcc.23245; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Berger WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050968; Bestard JA, 2010, PAIN PRACT; Binas B, 1999, FASEB J, V13, P805, DOI 10.1096/fasebj.13.8.805; Boneva NB, 2010, NEUROSCI RES, V68, P94, DOI 10.1016/j.neures.2010.07.2028; Boneva NB, 2011, HIPPOCAMPUS, V21, P162, DOI 10.1002/hipo.20732; Booker L, 2012, BRIT J PHARMACOL, V165, P2485, DOI 10.1111/j.1476-5381.2011.01445.x; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; Clapper JR, 2010, NAT NEUROSCI, V13, P1265, DOI 10.1038/nn.2632; Cravatt BF, 2004, J NEUROBIOL, V61, P149, DOI 10.1002/neu.20080; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; DeLeon M, 1996, J NEUROSCI RES, V44, P283; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Dinh TP, 2004, MOL PHARMACOL, V66, P1260, DOI 10.1124/mol.104.002071; Egertova M, 2003, NEUROSCIENCE, V119, P481, DOI 10.1016/S0306-4522(03)00145-3; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Flachenecker P, 2013, EXPERT REV NEUROTHER, V13, P15, DOI [10.1586/ern.13.1, 10.1586/ERN.13.1]; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Furuhashi M, 2008, J CLIN INVEST, V118, P2640, DOI 10.1172/JCI34750; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Gaskin DJ, 2012, J PAIN, V13, P715, DOI 10.1016/j.jpain.2012.03.009; Gerstner JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015890; Hanhoff T, 2002, MOL CELL BIOCHEM, V239, P45, DOI 10.1023/A:1020502624234; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Hui XY, 2010, J BIOL CHEM, V285, P10273, DOI 10.1074/jbc.M109.097907; Kaczocha M, 2012, J BIOL CHEM, V287, P3415, DOI 10.1074/jbc.M111.304907; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; Kinsey SG, 2011, NEUROPHARMACOLOGY, V60, P244, DOI 10.1016/j.neuropharm.2010.09.004; Lichtman AH, 2004, PAIN, V109, P319, DOI 10.1016/j.pain.2004.01.022; Liu JW, 2008, J NEUROCHEM, V106, P2015, DOI 10.1111/j.1471-4159.2008.05507.x; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; LoVerme J, 2006, J PHARMACOL EXP THER, V319, P1051, DOI 10.1124/jpet.106.111385; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Mishra SK, 2011, EMBO J, V30, P582, DOI 10.1038/emboj.2010.325; Mukherjee S, 2010, J CHEM INF MODEL, V50, P1986, DOI 10.1021/ci1001982; Notcutt W, 2012, MULT SCLER J, V18, P219, DOI 10.1177/1352458511419700; Owada Y, 1996, J CHEM NEUROANAT, V12, P113, DOI 10.1016/S0891-0618(96)00192-5; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reynolds JM, 2007, J IMMUNOL, V179, P313, DOI 10.4049/jimmunol.179.1.313; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Shioda N, 2010, J NEUROSCI, V30, P3146, DOI 10.1523/JNEUROSCI.4140-09.2010; SMITH PB, 1994, J PHARMACOL EXP THER, V270, P219; Sulsky R, 2007, BIOORG MED CHEM LETT, V17, P3511, DOI 10.1016/j.bmcl.2006.12.044; Turk DC, 2002, CLIN J PAIN, V18, P355, DOI 10.1097/00002508-200211000-00003; Yamamoto T, 2009, BIOTECHNOL LETT, V31, P1695, DOI 10.1007/s10529-009-0065-7	53	89	94	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94200	10.1371/journal.pone.0094200	http://dx.doi.org/10.1371/journal.pone.0094200			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705380	gold, Green Published			2022-12-25	WOS:000334107500132
J	Pan, HS; Liu, B; Lu, YH; Desneux, N				Pan, Hongsheng; Liu, Bing; Lu, Yanhui; Desneux, Nicolas			Identification of the Key Weather Factors Affecting Overwintering Success of Apolygus lucorum Eggs in Dead Host Tree Branches	PLOS ONE			English	Article							HEMIPTERA-MIRIDAE; MEYER-DUR; BT COTTON; SEASONAL ABUNDANCE; LOW-TEMPERATURE; CLIMATE-CHANGE; LYGUS-LUCORUM; PLANT BUG; POPULATION; OUTBREAKS	Understanding the effects of weather on insect population dynamics is crucial to simulate and forecast pest outbreaks, which is becoming increasingly important with the effects of climate change. The mirid bug Apolygus lucorum is an important pest on cotton, fruit trees and other crops in China, and primarily lays its eggs on dead parts of tree branches in the fall for subsequent overwintering. As such, the eggs that hatch the following spring are most strongly affected by ambient weather factors, rather than by host plant biology. In this study, we investigated the effects of three major weather factors: temperature, relative humidity and rainfall, on the hatching rate of A. lucorum eggs overwintering on dead branches of Chinese date tree (Ziziphus jujuba). Under laboratory conditions, rainfall (simulated via soaking) was necessary for the hatching of overwintering A. lucorum eggs. In the absence of rainfall (unsoaked branches), very few nymphs successfully emerged under any of the tested combinations of temperature and relative humidity. In contrast, following simulated rainfall, the hatching rate of the overwintering eggs increased dramatically. Hatching rate and developmental rate were positively correlated with relative humidity and temperature, respectively. Under field conditions, the abundance of nymphs derived from overwintering eggs was positively correlated with rainfall amount during the spring seasons of 2009-2013, while the same was not true for temperature and relative humidity. Overall, our findings indicate that rainfall is the most important factor affecting the hatching rate of overwintering A. lucorum eggs on dead plant parts and nymph population levels during the spring season. It provides the basic information for precisely forecasting the emergence of A. lucorum and subsequently timely managing its population in spring, which will make it possible to regional control of this insect pest widely occurring in multiple crops in summer.	[Pan, Hongsheng; Liu, Bing; Lu, Yanhui] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Desneux, Nicolas] French Natl Inst Agr Res INRA, Sophia Antipolis, France	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; INRAE	Lu, YH (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	yhlu@ippcaas.cn	Desneux, Nicolas/J-6262-2013	Lu, Yanhui/0000-0002-6552-0248	Special Fund for Agro-scientific Research in the Public Interest [201103012]; National Natural Science Funds [31222046, 31321004]	Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Funds(National Natural Science Foundation of China (NSFC))	This research was supported by the Special Fund for Agro-scientific Research in the Public Interest (201103012) and the National Natural Science Funds (No. 31222046, 31321004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreadis SS, 2013, J PEST SCI, V86, P409, DOI 10.1007/s10340-013-0490-1; [Anonymous], 2007, AR4 CLIM CHANG 2007; Boggs CL, 2012, ECOL LETT, V15, P502, DOI 10.1111/j.1461-0248.2012.01766.x; Cannon RJC, 1998, GLOBAL CHANGE BIOL, V4, P785, DOI 10.1046/j.1365-2486.1998.00190.x; Cao C. Y., 1983, MANAGEMENT COTTON MI; [陈培育 CHEN Pei-yu], 2010, [河南农业大学学报, Journal of Henan Agricultural University], V44, P83; CHU H. F., 1958, ACTA ENT SINICA, V8, P97; Day WH, 2006, T AM ENTOMOL SOC, V132, P445; Dong YC, 2013, J PEST SCI, V86, P429, DOI 10.1007/s10340-013-0493-y; Feng HQ, 2012, ENVIRON ENTOMOL, V41, P1606, DOI 10.1603/EN12099; Geng HH, 2012, APPL ENTOMOL ZOOL, V47, P191, DOI 10.1007/s13355-012-0107-9; Guo K, 2009, GLOBAL CHANGE BIOL, V15, P2539, DOI 10.1111/j.1365-2486.2009.01861.x; Gutierrez AP, 2008, J APPL ECOL, V45, P524, DOI 10.1111/j.1365-2664.2007.01356.x; Jepsen JU, 2008, J ANIM ECOL, V77, P257, DOI 10.1111/j.1365-2656.2007.01339.x; Liu HM, 1991, ACTA PHYTOPHYL SIN, V18, P147; Liu XF, 2013, J PEST SCI, V86, P449, DOI 10.1007/s10340-013-0488-8; Lu Y., 2008, BIOL CONTROL COTTON; Lu YH, 2008, CROP PROT, V27, P465, DOI 10.1016/j.cropro.2007.07.017; Lu YanHui, 2011, Outlooks on Pest Management, V22, P248, DOI 10.1564/22dec02; Lu YH, 2011, APPL ENTOMOL ZOOL, V46, P421, DOI 10.1007/s13355-011-0058-6; Lu YH, 2010, APPL ENTOMOL ZOOL, V45, P387, DOI 10.1303/aez.2010.387; Lu YH, 2010, CROP PROT, V29, P1026, DOI 10.1016/j.cropro.2010.03.017; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; MATTSON WJ, 1987, BIOSCIENCE, V37, P110, DOI 10.2307/1310365; Men Xing-Yuan, 2008, Acta Entomologica Sinica, V51, P1216; Morimoto N, 1998, APPL ENTOMOL ZOOL, V33, P147, DOI 10.1303/aez.33.147; Mullens BA, 2005, J MED ENTOMOL, V42, P705, DOI 10.1603/0022-2585(2005)042[0705:RBRASF]2.0.CO;2; Niu SG, 2011, ACTA AGR JIANGXI, V23, P97; Pan HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068980; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Pizzol J, 2010, J PEST SCI, V83, P447, DOI 10.1007/s10340-010-0327-0; Shang ZhaoTang, 2012, Agricultural Science & Technology - Hunan, V13, P784; [商兆堂 Shang Zhaotang], 2010, [植物保护, Plant Protection], V36, P92; Shang ZT, 2012, AGR SCI TECHNOL, V13, P887; Simoglou KB, 2012, J PEST SCI, V85, P169, DOI 10.1007/s10340-012-0418-1; Ting YQ, 1964, ACTA ENTOMOL SINICA, V13, P298; Wang ZhenLiang, 2011, Journal of Northwest A & F University - Natural Science Edition, V39, P148; Wheeler Jr A. G., 2001, BIOL PLANT BUGS; White TCR, 2008, BIOL REV, V83, P227, DOI 10.1111/j.1469-185X.2008.00041.x; WILLMER PG, 1982, ADV INSECT PHYSIOL, V16, P1, DOI 10.1016/S0065-2806(08)60151-4; Wilstermann A, 2013, J PEST SCI, V86, P419, DOI 10.1007/s10340-013-0496-8; Wu Gang, 2011, Chinese Journal of Applied Entomology, V48, P1170; Wu K, 2002, CROP PROT, V21, P997, DOI 10.1016/S0261-2194(02)00080-7; Zhuo De-Gan, 2011, Acta Entomologica Sinica, V54, P136; [No title captured]	46	6	8	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94190	10.1371/journal.pone.0094190	http://dx.doi.org/10.1371/journal.pone.0094190			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705353	Green Published, gold, Green Submitted			2022-12-25	WOS:000334107500131
J	Chagne, D; Crowhurst, RN; Pindo, M; Thrimawithana, A; Deng, C; Ireland, H; Fiers, M; Dzierzon, H; Cestaro, A; Fontana, P; Bianco, L; Lu, A; Storey, R; Knabel, M; Saeed, M; Montanari, S; Kim, YK; Nicolini, D; Larger, S; Stefani, E; Allan, AC; Bowen, J; Harvey, I; Johnston, J; Malnoy, M; Troggio, M; Perchepied, L; Sawyer, G; Wiedow, C; Won, K; Viola, R; Hellens, RP; Brewer, L; Bus, VGM; Schaffer, RJ; Gardiner, SE; Velasco, R				Chagne, David; Crowhurst, Ross N.; Pindo, Massimo; Thrimawithana, Amali; Deng, Cecilia; Ireland, Hilary; Fiers, Mark; Dzierzon, Helge; Cestaro, Alessandro; Fontana, Paolo; Bianco, Luca; Lu, Ashley; Storey, Roy; Knaebel, Mareike; Saeed, Munazza; Montanari, Sara; Kim, Yoon Kyeong; Nicolini, Daniela; Larger, Simone; Stefani, Erika; Allan, Andrew C.; Bowen, Judith; Harvey, Isaac; Johnston, Jason; Malnoy, Mickael; Troggio, Michela; Perchepied, Laure; Sawyer, Greg; Wiedow, Claudia; Won, Kyungho; Viola, Roberto; Hellens, Roger P.; Brewer, Lester; Bus, Vincent G. M.; Schaffer, Robert J.; Gardiner, Susan E.; Velasco, Riccardo			The Draft Genome Sequence of European Pear (Pyrus communis L. 'Bartlett')	PLOS ONE			English	Article							WALL-MODIFYING ENZYMES; GENETIC-LINKAGE MAPS; EXPANSIN GENES; APPLE; EXPRESSION; CLASSIFICATION; IDENTIFICATION; ALIGNMENT; ETHYLENE; JAPANESE	We present a draft assembly of the genome of European pear (Pyrus communis) `Bartlett'. Our assembly was developed employing second generation sequencing technology (Roche 454), from single-end, 2 kb, and 7 kb insert paired-end reads using Newbler (version 2.7). It contains 142,083 scaffolds greater than 499 bases (maximum scaffold length of 1.2 Mb) and covers a total of 577.3 Mb, representing most of the expected 600 Mb Pyrus genome. A total of 829,823 putative single nucleotide polymorphisms (SNPs) were detected using re-sequencing of `Louise Bonne de Jersey' and `Old Home'. A total of 2,279 genetically mapped SNP markers anchor 171 Mb of the assembled genome. Ab initio gene prediction combined with prediction based on homology searching detected 43,419 putative gene models. Of these, 1219 proteins (556 clusters) are unique to European pear compared to 12 other sequenced plant genomes. Analysis of the expansin gene family provided an example of the quality of the gene prediction and an insight into the relationships among one class of cell wall related genes that control fruit softening in both European pear and apple (Malusxdomestica). The `Bartlett' genome assembly v1.0 (http://www.rosaceae.org/species/pyrus/pyrus_communis/genome_v1.0) is an invaluable tool for identifying the genetic control of key horticultural traits in pear and will enable the wide application of marker-assisted and genomic selection that will enhance the speed and efficiency of pear cultivar development.	[Chagne, David; Dzierzon, Helge; Knaebel, Mareike; Saeed, Munazza; Montanari, Sara; Sawyer, Greg; Wiedow, Claudia; Gardiner, Susan E.] New Zealand Inst Plant & Food Res Ltd Plant & Foo, Palmerston North Res Ctr, Palmerston North, New Zealand; [Crowhurst, Ross N.; Thrimawithana, Amali; Deng, Cecilia; Ireland, Hilary; Storey, Roy; Allan, Andrew C.; Bowen, Judith; Harvey, Isaac; Johnston, Jason; Hellens, Roger P.; Schaffer, Robert J.] DSIR, Mt Albert Res Ctr, Auckland, New Zealand; [Pindo, Massimo; Cestaro, Alessandro; Fontana, Paolo; Bianco, Luca; Montanari, Sara; Nicolini, Daniela; Larger, Simone; Stefani, Erika; Malnoy, Mickael; Troggio, Michela; Viola, Roberto; Velasco, Riccardo] FEM, Res & Innovat Ctr, IASMA, Trento, Italy; [Fiers, Mark; Lu, Ashley] Lincoln Res Ctr, Lincoln, NE, New Zealand; [Knaebel, Mareike; Allan, Andrew C.; Schaffer, Robert J.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Saeed, Munazza] Massey Univ, Inst Food Nutr & Human Hlth, Palmerston North, New Zealand; [Montanari, Sara; Perchepied, Laure] INRA, IRHS, F-49000 Angers, France; [Kim, Yoon Kyeong; Won, Kyungho] RDA, NIHHS, Naju, South Korea; [Brewer, Lester] Motueka Res Ctr, Motueka, New Zealand; [Bus, Vincent G. M.] Hawkes Bay Res Ctr, Havelock North, New Zealand	New Zealand Institute for Plant & Food Research Ltd; New Zealand Institute for Plant & Food Research Ltd; Fondazione Edmund Mach; University of Auckland; Massey University; INRAE; Universite d'Angers; National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; Rural Development Administration (RDA), Republic of Korea	Chagne, D (corresponding author), New Zealand Inst Plant & Food Res Ltd Plant & Foo, Palmerston North Res Ctr, Palmerston North, New Zealand.	David.Chagne@plantandfood.co.nz	Ireland, Hilary/I-6314-2015; Wiedow, Claudia/O-9291-2016; Sawyer, Gregory M/G-1979-2012; Deng, Cecilia Hong/O-2891-2017; Crowhurst, Ross N/N-8892-2017; Gardiner, Susan Elizabeth/A-2477-2010; Fiers, Mark WEJ/E-6755-2010; Johnston, Jason/D-5947-2016; Knaebel, Mareike/O-5631-2016; Allan, Andrew C/L-3253-2016; malnoy, mickael/C-5007-2012; Chagne, David/A-2596-2010; Schaffer, Robert J/D-1018-2011; Thrimawithana, Amali H/O-4702-2017; Malnoy, Mickael/AAO-5431-2021; Bus, Vincent/B-1318-2011; Viola, Roberto/F-3657-2014	Ireland, Hilary/0000-0001-5072-7206; Wiedow, Claudia/0000-0003-3402-5460; Sawyer, Gregory M/0000-0002-8784-9327; Deng, Cecilia Hong/0000-0002-2954-762X; Crowhurst, Ross N/0000-0003-0608-2134; Gardiner, Susan Elizabeth/0000-0002-4884-8743; Fiers, Mark WEJ/0000-0001-5694-2409; Johnston, Jason/0000-0002-6326-4885; Knaebel, Mareike/0000-0002-0293-1250; Allan, Andrew C/0000-0003-1944-7067; malnoy, mickael/0000-0002-5158-534X; Chagne, David/0000-0003-4018-0694; Thrimawithana, Amali H/0000-0001-6325-2334; Malnoy, Mickael/0000-0002-5158-534X; Bus, Vincent/0000-0003-4071-4457; Viola, Roberto/0000-0002-8202-8503; Bianco, Luca/0000-0002-0196-8422; Schaffer, Robert/0000-0003-1272-667X; Pindo, Massimo/0000-0002-8516-9010; Hellens, Roger/0000-0003-2094-0887; Montanari, Sara/0000-0001-9224-056X; Cestaro, Alessandro/0000-0003-1439-5165; Storey, Roy/0000-0003-1375-7136; Velasco, Riccardo/0000-0002-8760-5031	research office of the Provincia autonoma di Trento; IASMA-FEM GMPF joint PhD school; Plant & Food Research internal investment 'Blue Skies' project; New Zealand Ministry of Science and Innovation [CO6X0705, 26015, CO6X0812]; NIHHS of RDA, Korea	research office of the Provincia autonoma di Trento; IASMA-FEM GMPF joint PhD school; Plant & Food Research internal investment 'Blue Skies' project; New Zealand Ministry of Science and Innovation; NIHHS of RDA, Korea	This project was supported by the research office of the Provincia autonoma di Trento, IASMA-FEM GMPF joint PhD school, a Plant & Food Research internal investment 'Blue Skies' project, New Zealand Ministry of Science and Innovation projects "Pipfruit: a juicy future" (Contract# CO6X0705), "Pipfruit Research Consortium 2" (Contract# 26015) and "HortGenomics" (Contract# CO6X0812), and NIHHS of RDA, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrusan G, 2009, BIOINFORMATICS, V25, P1329, DOI 10.1093/bioinformatics/btp084; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Brummell DA, 1999, PLANT CELL, V11, P2203, DOI 10.1105/tpc.11.11.2203; Celton Jean-Marc, 2009, BMC Res Notes, V2, P182, DOI 10.1186/1756-0500-2-182; Chagne D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031745; Costa F, 2008, TREE GENET GENOMES, V4, P575, DOI 10.1007/s11295-008-0133-5; Crowhurst RN, 2006, BIOVIEW ENTERPRISE B; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fonseca S, 2005, J EXP BOT, V56, P2029, DOI 10.1093/jxb/eri201; Garcia-Mas J, 2012, P NATL ACAD SCI USA, V109, P11872, DOI 10.1073/pnas.1205415109; Goulao LF, 2008, POSTHARVEST BIOL TEC, V48, P37, DOI 10.1016/j.postharvbio.2007.09.022; Guo SG, 2013, NAT GENET, V45, P51, DOI 10.1038/ng.2470; Hiwasa K, 2003, PHYSIOL PLANTARUM, V117, P564, DOI 10.1034/j.1399-3054.2003.00064.x; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Illa E, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-9; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jung S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-129; Kende H, 2004, PLANT MOL BIOL, V55, P311, DOI 10.1007/s11103-004-0158-6; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kumar S, 2012, TREE GENET GENOMES, V8, P1, DOI 10.1007/s11295-011-0425-z; Kumar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036674; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li Y, 2002, PLANT PHYSIOL, V128, P854, DOI 10.1104/pp.010658; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Montanari S., 2013, PLOS ONE, V8; Mulder Nicola, 2007, V396, P59; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Potter D, 2007, PLANT SYST EVOL, V266, P5, DOI 10.1007/s00606-007-0539-9; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schaffer RJ, 2012, ANN BOT PLANTS; Schaffer RJ, 2007, PLANT PHYSIOL, V144, P1899, DOI 10.1104/pp.106.093765; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Smit A, 1996, REPEATMASKER OPEN 30; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Tacken E, 2010, PLANT PHYSIOL, V153, P294, DOI 10.1104/pp.109.151092; Terakami S, 2006, THEOR APPL GENET, V113, P743, DOI 10.1007/s00122-006-0344-9; Trujillo DI, 2012, TREE GENET GENOMES, V8, P27, DOI 10.1007/s11295-011-0417-z; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; van Bakel H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r102; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Verde I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035668; Wakasa Y, 2003, EUR J HORTIC SCI, V68, P253; Wang J, 2008, PROTOCOL EXCHANGE; Wu J, 2012, GENOME RES; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Yamamoto T, 2002, THEOR APPL GENET, V106, P9, DOI 10.1007/s00122-002-0966-5; Yamamoto T, 2002, EUPHYTICA, V124, P129, DOI 10.1023/A:1015677505602; Yamamoto T, 2007, BREEDING SCI, V57, P321, DOI 10.1270/jsbbs.57.321	61	171	186	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e92644	10.1371/journal.pone.0092644	http://dx.doi.org/10.1371/journal.pone.0092644			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699266	Green Submitted, Green Published, gold			2022-12-25	WOS:000334105000032
J	Huang, LK; Yan, HD; Jiang, XM; Yin, GH; Zhang, XQ; Qi, X; Zhang, Y; Yan, YH; Ma, X; Peng, Y				Huang, Linkai; Yan, Haidong; Jiang, Xiaomei; Yin, Guohua; Zhang, Xinquan; Qi, Xiao; Zhang, Yu; Yan, Yanhong; Ma, Xiao; Peng, Yan			Identification of Candidate Reference Genes in Perennial Ryegrass for Quantitative RT-PCR under Various Abiotic Stress Conditions	PLOS ONE			English	Article							SUPERIOR REFERENCE GENES; REVERSE TRANSCRIPTION; HOUSEKEEPING GENES; INTERNAL CONTROL; DROUGHT STRESS; EXPRESSION; VALIDATION; NORMALIZATION; RNA; QUANTIFICATION	Background: Quantitative real-time reverse-transcriptase PCR (qRT-PCR) is an important technique for analyzing differences gene expression due to its sensitivity, accuracy and specificity. However, the stability of the expression of reference genes is necessary to ensure accurate qRT-PCR assessment of expression in genes of interest. Perennial ryegrass (Lolium perenne L.) is important forage and turf grass species in temperate regions, but the expression stability of its reference genes under various stresses has not been well-studied. Methodology/Principal Findings: In this study, 11 candidate reference genes were evaluated for use as controls in qRT-PCR to quantify gene expression in perennial ryegrass under drought, high salinity, heat, waterlogging, and ABA (abscisic acid) treatments. Four approaches - Delta C-T, geNorm, BestKeeper and Normfinder were used to determine the stability of expression in these reference genes. The results are consistent with the idea that the best reference genes depend on the stress treatment under investigation. Eukaryotic initiation factor 4 alpha (eIF4A), Transcription elongation factor 1 (TEF1) and Tat binding protein-1 (TBP-1) were the three most stably expressed genes under drought stress and were also the three best genes for studying salt stress. eIF4A, TBP-1, and Ubiquitin-conjugating enzyme (E2) were the most suitable reference genes to study heat stress, while eIF4A, TEF1, and E2 were the three best reference genes for studying the effects of ABA. Finally, Ubiquitin (UBQ), TEF1, and eIF4A were the three best reference genes for waterlogging treatments. Conclusions/Significance: These results will be helpful in choosing the best reference genes for use in studies related to various abiotic stresses in perennial ryegrass. The stability of expression in these reference genes will enable better normalization and quantification of the transcript levels for studies of gene expression in such studies.	[Huang, Linkai; Yan, Haidong; Jiang, Xiaomei; Zhang, Xinquan; Zhang, Yu; Yan, Yanhong; Ma, Xiao; Peng, Yan] Sichuan Agr Univ, Anim Sci & Technol Coll, Dept Grassland Sci, Yaan, Sichuan, Peoples R China; [Yin, Guohua] Univ Arizona, Coll Agr & Life Sci, Tucson, AZ USA; [Qi, Xiao] Minist Agr, Natl Anim Husb Serv, Beijing, Peoples R China	Sichuan Agricultural University; University of Arizona; Ministry of Agriculture & Rural Affairs	Zhang, XQ (corresponding author), Sichuan Agr Univ, Anim Sci & Technol Coll, Dept Grassland Sci, Yaan, Sichuan, Peoples R China.	zhangxq@sicau.edu.cn	Yin, Guohua/B-6314-2014	Yin, Guohua/0000-0001-8327-061X	National Basic Research Program of China (973 Program) [2014CB138705]; Earmarked Fund for the Modern Agro-Industry Technology Research System [CARS-35-05]; National and Province Students Innovation Plan [201310626002]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Earmarked Fund for the Modern Agro-Industry Technology Research System; National and Province Students Innovation Plan	This work was supported by the National Basic Research Program of China (973 Program) (2014CB138705), the Earmarked Fund for the Modern Agro-Industry Technology Research System (#CARS-35-05) and the National and Province Students Innovation Plan (No. 201310626002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiard V, 2003, PLANT PHYSIOL, V132, P2218, DOI 10.1104/pp.103.022335; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; [Anonymous], 1991, TURFGRASS MANAGEMENT; Ayers Duncan, 2007, BMC Vet Res, V3, P7; Bogdanovic MD, 2013, PLANT MOL BIOL REP, V31, P55, DOI 10.1007/s11105-012-0474-y; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Cassan-Wang H, 2012, PLANT CELL PHYSIOL, V53, P2101, DOI 10.1093/pcp/pcs152; Chao WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042839; Cheng T, 2012, J PLANT PHYSIOL, V169, P1134, DOI 10.1016/j.jplph.2012.04.006; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; de Oliveira LA, 2012, PLANT CELL PHYSIOL, V53, P405, DOI 10.1093/pcp/pcr187; Dean JD, 2002, PLANT MOL BIOL REP, V20, P347, DOI 10.1007/BF02772122; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Forster JW, 2008, PLANT GENOTYPING II: SNP TECHNOLOGY, P154, DOI 10.1079/9781845933821.0154; Fujii H, 2011, P NATL ACAD SCI USA, V108, P1717, DOI 10.1073/pnas.1018367108; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Han XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043084; Holland MJ, 2002, J BIOL CHEM, V277, P14363, DOI 10.1074/jbc.C200101200; Holmes William, 1980, GRASS ITS PRODUCTION; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Hong SM, 2010, PLANT CELL PHYSIOL, V51, P1694, DOI 10.1093/pcp/pcq128; Iskandar HM, 2004, PLANT MOL BIOL REP, V22, P325, DOI 10.1007/BF02772676; Jagadeeswaran G, 2009, PLANTA, V229, P1009, DOI 10.1007/s00425-009-0889-3; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jarosova J, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-146; Jia XY, 2009, PLANT MOL BIOL, V71, P51, DOI 10.1007/s11103-009-9508-8; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Kim BR, 2003, BIOTECHNOL LETT, V25, P1869, DOI 10.1023/A:1026298032009; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046487; Lee JM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-8; Liebao H, 2007, DROUGHT TOLERANT TRA, P273; Liu SW, 2010, PHYSIOL PLANTARUM, V139, P375, DOI 10.1111/j.1399-3054.2010.01374.x; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; Martin RC, 2008, CROP SCI, V48, P1881, DOI 10.2135/cropsci2007.10.0597; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; NORRIS IB, 1985, GRASS FORAGE SCI, V40, P151, DOI 10.1111/j.1365-2494.1985.tb01732.x; OLLERENSHAW JH, 1985, PLANT SOIL, V85, P131, DOI 10.1007/BF02197806; Pearson A, 2011, THEOR APPL GENET, V122, P609, DOI 10.1007/s00122-010-1473-8; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Tamura K, 2007, THEOR APPL GENET, V114, P273, DOI 10.1007/s00122-006-0430-z; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vandesompele Jo, 2009, P47; [袁伟 Wei Yuan], 2012, [植物学报, Chinese Bulletin of Botany], V47, P427; WILKINS PW, 1991, EUPHYTICA, V52, P201, DOI 10.1007/BF00029397; Wilkins PW, 2003, J AGR SCI-CAMBRIDGE, V140, P129, DOI 10.1017/S0021859603003058; Xiong YW, 2007, MOL BREEDING, V19, P125, DOI 10.1007/s11032-006-9050-1; Yu XQ, 2013, J EXP BOT, V64, P1537, DOI 10.1093/jxb/ert018; Zhang YQ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031849, 10.1371/journal.pone.0030262]; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044405	59	61	62	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93724	10.1371/journal.pone.0093724	http://dx.doi.org/10.1371/journal.pone.0093724			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699822	Green Submitted, Green Published, gold			2022-12-25	WOS:000334105000096
J	Latino, L; Essoh, C; Blouin, Y; Thien, HV; Pourcel, C				Latino, Libera; Essoh, Christiane; Blouin, Yann; Hoang Vu Thien; Pourcel, Christine			A novel Pseudomonas aeruginosa Bacteriophage, Ab31, a Chimera Formed from Temperate Phage PAJU2 and P. putida Lytic Phage AF: Characteristics and Mechanism of Bacterial Resistance	PLOS ONE			English	Article							CYSTIC-FIBROSIS; MUCOID CONVERSION; GENOMIC ANALYSIS; GENE-EXPRESSION; LAMBDA-RECEPTOR; VIRULENCE; SEQUENCE; PROTEIN; PERSISTENCE; EVOLUTION	A novel temperate bacteriophage of Pseudomonas aeruginosa, phage vB_PaeP_Tr60_Ab31 (alias Ab31) is described. Its genome is composed of structural genes related to those of lytic P. putida phage AF, and regulatory genes similar to those of temperate phage PAJU2. The virion structure resembles that of phage AF and other lytic Podoviridae (S. enterica Epsilon 15 and E. coli phiv10) with similar tail spikes. Ab31 was able to infect P. aeruginosa strain PA14 and two genetically related strains called Tr60 and Tr162, out of 35 diverse strains from cystic fibrosis patients. Analysis of resistant host variants revealed different phenotypes, including induction of pigment and alginate overproduction. Whole genome sequencing of resistant variants highlighted the existence of a large deletion of 234 kbp in two strains, encompassing a cluster of genes required for the production of CupA fimbriae. Stable lysogens formed by Ab31 in strain Tr60, permitted the identification of the insertion site. During colonization of the lung in cystic fibrosis patients, P. aeruginosa adapts by modifying its genome. We suggest that bacteriophages such as Ab31 may play an important role in this adaptation by selecting for bacterial characteristics that favor persistence of bacteria in the lung.	[Latino, Libera; Essoh, Christiane; Blouin, Yann; Pourcel, Christine] Univ Paris 11, Inst Genet & Microbiol, UMR 8621, F-91405 Orsay, France; [Latino, Libera; Essoh, Christiane; Blouin, Yann; Pourcel, Christine] CNRS, F-91405 Orsay, France; [Hoang Vu Thien] Hop Armand Trousseau, AP HP, Paris, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite	Pourcel, C (corresponding author), Univ Paris 11, Inst Genet & Microbiol, UMR 8621, F-91405 Orsay, France.	christine.pourcel@u-psud.fr	Pourcel, Christine/E-4949-2017	Pourcel, Christine/0000-0002-8951-466X	Direction Generale de l'Armement (DGA); Paris Saclay "Initiative d'excellence'' (IDEX)	Direction Generale de l'Armement (DGA); Paris Saclay "Initiative d'excellence'' (IDEX)	LL holds a PhD fellowship co-financed by the Direction Generale de l'Armement (DGA) and by the Paris Saclay "Initiative d'excellence'' (IDEX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDUJAILI AH, 1975, J HYG-CAMBRIDGE, V75, P195, DOI 10.1017/S0022172400047227; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Braid MD, 2004, J BACTERIOL, V186, P6560, DOI 10.1128/JB.186.19.6560-6574.2004; BROKOPP CD, 1977, J CLIN MICROBIOL, V5, P640; Brussow H, 2012, MBIO, V3, DOI 10.1128/mBio.00061-12; Brussow H, 2002, CELL, V108, P13, DOI 10.1016/S0092-8674(01)00637-7; CAMERON JR, 1977, NUCLEIC ACIDS RES, V4, P1429, DOI 10.1093/nar/4.5.1429; Casjens SR, 2012, ADV EXP MED BIOL, V726, P143, DOI 10.1007/978-1-4614-0980-9_7; Casjens SR, 2005, CURR OPIN MICROBIOL, V8, P451, DOI 10.1016/j.mib.2005.06.014; Ceyssens PJ, 2010, FUTURE MICROBIOL, V5, P1041, DOI 10.2217/FMB.10.66; Cornelissen A, 2012, VIROLOGY; Cornelissen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018597; Cramer N, 2011, ENVIRON MICROBIOL, V13, P1690, DOI 10.1111/j.1462-2920.2011.02483.x; CROSA JH, 1989, MICROBIOL REV, V53, P517, DOI 10.1128/MMBR.53.4.517-530.1989; DEVRIES GE, 1984, P NATL ACAD SCI-BIOL, V81, P6080, DOI 10.1073/pnas.81.19.6080; Essoh C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060575; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Friman VP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075380; Hanlon GW, 2001, APPL ENVIRON MICROB, V67, P2746, DOI 10.1128/AEM.67.6.2746-2753.2001; Hatfull GF, 2011, CURR OPIN VIROL, V1, P298, DOI 10.1016/j.coviro.2011.06.009; Hatfull GF, 2008, CURR OPIN MICROBIOL, V11, P447, DOI 10.1016/j.mib.2008.09.004; Hogardt M, 2010, INT J MED MICROBIOL, V300, P557, DOI 10.1016/j.ijmm.2010.08.008; HOLLOWAY BW, 1955, J GEN MICROBIOL, V13, P572, DOI 10.1099/00221287-13-3-572; Hossain MJ, 2012, MICROBIOL-SGM, V158, P474, DOI 10.1099/mic.0.054866-0; Hosseinidoust Z, 2013, APPL ENVIRON MICROB, V79, P6110, DOI 10.1128/AEM.01421-13; Hosseinidoust Z, 2013, APPL ENVIRON MICROB, V79, P2862, DOI 10.1128/AEM.03817-12; Jiang XF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-194; Juhala RJ, 2000, J MOL BIOL, V299, P27, DOI 10.1006/jmbi.2000.3729; Kropinski AM, 2007, VIROLOGY, V369, P234, DOI 10.1016/j.virol.2007.07.027; Krylov S V, 2012, Genetika, V48, P1057; Kwan T, 2006, J BACTERIOL, V188, P1184, DOI 10.1128/JB.188.3.1184-1187.2006; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; Llanes C, 2013, J ANTIMICROB CHEMOTH, V68, P1763, DOI 10.1093/jac/dkt115; Lu SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062933; MILLER RV, 1984, J CLIN MICROBIOL, V19, P717, DOI 10.1128/JCM.19.5.717-719.1984; Mooij MJ, 2007, MICROBIOL-SGM, V153, P1790, DOI 10.1099/mic.0.2006/003533-0; PENKETH ARL, 1987, THORAX, V42, P526, DOI 10.1136/thx.42.7.526; Perry LL, 2009, FEMS MICROBIOL LETT, V292, P182, DOI 10.1111/j.1574-6968.2009.01511.x; Qiu DR, 2007, P NATL ACAD SCI USA, V104, P8107, DOI 10.1073/pnas.0702660104; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; RANDALLH.L, 1973, J BACTERIOL, V116, P1436, DOI 10.1128/JB.116.3.1436-1446.1973; Rau MH, 2012, ENVIRON MICROBIOL, V14, P2200, DOI 10.1111/j.1462-2920.2012.02795.x; Rice SA, 2009, ISME J, V3, P271, DOI 10.1038/ismej.2008.109; Rodriguez-Rojas A, 2009, MICROBIOL-SGM, V155, P1050, DOI 10.1099/mic.0.024745-0; ROMLING U, 1994, APPL ENVIRON MICROB, V60, P1734; Roos WH, 2007, CELL MOL LIFE SCI, V64, P1484, DOI 10.1007/s00018-007-6451-1; Ruer S, 2007, J BACTERIOL, V189, P3547, DOI 10.1128/JB.00093-07; Schurks N, 2002, INT J BIOL MACROMOL, V30, P105, DOI 10.1016/S0141-8130(02)00002-8; STEVEN AC, 1988, J MOL BIOL, V200, P351, DOI 10.1016/0022-2836(88)90246-X; Uchiyama J, 2012, ARCH VIROL, V157, P733, DOI 10.1007/s00705-011-1210-x; Uchiyama J, 2009, VIRUS RES, V139, P131, DOI 10.1016/j.virusres.2008.10.005; Vallet-Gely I, 2007, J BACTERIOL, V189, P8667, DOI 10.1128/JB.01344-07; Van Domselaar GH, 2005, NUCLEIC ACIDS RES, V33, pW455, DOI 10.1093/nar/gki593; Vu-Thien H, 2007, J CLIN MICROBIOL, V45, P3175, DOI 10.1128/JCM.00702-07; Webb JS, 2004, J BACTERIOL, V186, P8066, DOI 10.1128/JB.186.23.8066-8073.2004; Wei H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn182; WOZNIAK DJ, 1994, J BACTERIOL, V176, P6007, DOI 10.1128/jb.176.19.6007-6014.1994; Xu JL, 2013, J BACTERIOL, V195, P798, DOI 10.1128/JB.01770-12	58	23	24	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93777	10.1371/journal.pone.0093777	http://dx.doi.org/10.1371/journal.pone.0093777			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699529	Green Published, gold, Green Submitted			2022-12-25	WOS:000334105000106
J	Ngufor, C; N'Guessan, R; Fagbohoun, J; Odjo, A; Malone, D; Akogbeto, M; Rowland, M				Ngufor, Corine; N'Guessan, Raphael; Fagbohoun, Josias; Odjo, Abibatou; Malone, David; Akogbeto, Martin; Rowland, Mark			Olyset Duo (R) (a Pyriproxyfen and Permethrin Mixture Net): An Experimental Hut Trial against Pyrethroid Resistant Anopheles gambiae and Culex quinquefasciatus in Southern Benin	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; COMBINATION NET; POTENTIAL USE; MOSQUITOS; DIPTERA; CARBAMATE; EFFICACY	Background: Alternative compounds which can complement pyrethroids on long-lasting insecticidal nets (LN) in the control of pyrethroid resistant malaria vectors are urgently needed. Pyriproxyfen (PPF), an insect growth regulator, reduces the fecundity and fertility of adult female mosquitoes. LNs containing a mixture of pyriproxyfen and pyrethroid could provide personal protection through the pyrethroid component and reduce vector abundance in the next generation through the sterilizing effect of pyriproxyfen. Method: The efficacy of Olyset Duo, a newly developed mixture LN containing pyriproxyfen and permethrin, was evaluated in experimental huts in southern Benin against pyrethroid resistant Anopheles gambiae and Culex quinquefasciatus. Comparison was made with Olyset Net (R) (permethrin alone) and a LN with pyriproxyfen alone (PPF LN). Laboratory tunnel tests were performed to substantiate the findings in the experimental huts. Results: Overall mortality of wild pyrethroid resistant An. gambiae s.s. was significantly higher with Olyset Duo than with Olyset Net (50% vs. 27%, P=0.01). Olyset DUO was more protective than Olyset Net (71% vs. 3%, P < 0.001). The oviposition rate of surviving blood-fed An. gambiae from the control hut was 37% whereas none of those from Olyset Duo and PPF LN huts laid eggs. The tunnel test results were consistent with the experimental hut results. Olyset Duo was more protective than Olyset Net in the huts against wild pyrethroid resistant Cx. quinquefasciatus although mortality rates of this species did not differ significantly between Olyset Net and Olyset Duo. There was no sterilizing effect on surviving blood-fed Cx. quinquefasciatus with the PPF-treated nets. Conclusion: Olyset Duo was superior to Olyset Net in terms of personal protection and killing of pyrethroid resistant An. gambiae, and sterilized surviving blood-fed mosquitoes. Mixing pyrethroid and pyriproxyfen on a LN shows potential for malaria control and management of pyrethroid resistant vectors by preventing further selection of pyrethroid resistant phenotypes.	[Ngufor, Corine; N'Guessan, Raphael; Rowland, Mark] London Sch Hyg & Trop Med, London WC1, England; [Ngufor, Corine; N'Guessan, Raphael; Fagbohoun, Josias; Odjo, Abibatou; Akogbeto, Martin] CREC, Cotonou, Benin; [Ngufor, Corine; N'Guessan, Raphael; Rowland, Mark] Pan African Malaria Vector Res Consortium PAMVERC, London, England; [Malone, David] Innovat Vector Control Consortium IVCC, Liverpool, Merseyside, England	University of London; London School of Hygiene & Tropical Medicine; Entomological Research Center of Cotonou (CREC)	Ngufor, C (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	corine.ngufor@lshtm.ac.uk		Ngufor, Corine/0000-0002-7755-9609	Innovative Vector Control Consortium, Liverpool, UK; Bill & Melinda Gates Foundation	Innovative Vector Control Consortium, Liverpool, UK; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Project grant from Innovative Vector Control Consortium, Liverpool, UK funded by a programme grant of the Bill & Melinda Gates Foundation. http://www.ivcc.com/. The Bill & Melinda Gates Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However, the IVCC did advise on the study design via their Expert Scientific Committee.	Aiku A O, 2006, West Afr J Med, V25, P22; [Anonymous], 2006, PEST THEIR APPL CONT; [Anonymous], 2019, GUID LAB FIELD TEST; Asidi A, 2012, EMERG INFECT DIS, V18, P1101, DOI 10.3201/eid1807.120218; Asidi AN, 2004, MED VET ENTOMOL, V18, P134, DOI 10.1111/j.0269-283X.2004.00485.x; Chandre F, 1998, MED VET ENTOMOL, V12, P359, DOI 10.1046/j.1365-2915.1998.00120.x; Corbel V, 2007, ACTA TROP, V101, P207, DOI 10.1016/j.actatropica.2007.01.005; CURTIS CF, 1985, B ENTOMOL RES, V75, P259, DOI 10.1017/S0007485300014346; DENHOLM I, 1992, ANNU REV ENTOMOL, V37, P91, DOI 10.1146/annurev.en.37.010192.000515; Dhadialla TS, 1998, ANNU REV ENTOMOL, V43, P545, DOI 10.1146/annurev.ento.43.1.545; Favia G, 1997, INSECT MOL BIOL, V6, P377, DOI 10.1046/j.1365-2583.1997.00189.x; Harris C, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-144; Hill J, 2006, ADV PARASIT, V61, P77, DOI 10.1016/S0065-308X(05)61003-2; Invest J. F., 2008, 6th International Conference on Urban Pests, Budapest, Hungary, 13-16 July 2008, P239; Malima RC, 2009, MED VET ENTOMOL, V23, P317, DOI 10.1111/j.1365-2915.2009.00837.x; N'Guessan R, 2007, J MED ENTOMOL, V44, P270, DOI 10.1603/0022-2585(2007)44[270:EOIAOI]2.0.CO;2; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; N'Guessan R, 2010, T ROY SOC TROP MED H, V104, P758, DOI 10.1016/j.trstmh.2010.08.008; N'Guessan R, 2009, TROP MED INT HEALTH, V14, P389, DOI 10.1111/j.1365-3156.2009.02245.x; Ohashi K, 2012, J MED ENTOMOL, V49, P1052, DOI 10.1603/ME12006; Ohba S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067045; Oxborough RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055781; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Sihuincha M, 2005, J MED ENTOMOL, V42, P620, DOI 10.1603/0022-2585(2005)042[0620:PUOPFC]2.0.CO;2; Tungu P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-21; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2010, WOR HEALT REP, P1; WHO, 2006, WHO SPEC EV PUBL HLT; WHO, 2008, PYR DRINK WAT US VEC; World Health Organization, 2012, WHO GLOB MAL PROGR G	30	47	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93603	10.1371/journal.pone.0093603	http://dx.doi.org/10.1371/journal.pone.0093603			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699827	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000334105000079
J	Xiao, YM; Esser, L; Zhou, F; Li, C; Zhou, YH; Yu, CA; Qin, ZH; Xia, D				Xiao, Yu-Mei; Esser, Lothar; Zhou, Fei; Li, Chang; Zhou, Yi-Hui; Yu, Chang-An; Qin, Zhao-Hai; Xia, Di			Studies on Inhibition of Respiratory Cytochrome bc(1) Complex by the Fungicide Pyrimorph Suggest a Novel Inhibitory Mechanism	PLOS ONE			English	Article							X-RAY-STRUCTURE; MITOCHONDRIAL RESPIRATION; ELECTRON-TRANSFER; OXIDATION SITE; SUBUNIT; PROTEIN; MODE; SENSITIVITY; INVOLVEMENT; QUINONE	The respiratory chain cytochrome bc(1) complex (cyt bc(1)) is a major target of numerous antibiotics and fungicides. All cyt bc(1) inhibitors act on either the ubiquinol oxidation (Q(P)) or ubiquinone reduction (Q(N)) site. The primary cause of resistance to bc(1) inhibitors is target site mutations, creating a need for novel agents that act on alternative sites within the cyt bc(1) to overcome resistance. Pyrimorph, a synthetic fungicide, inhibits the growth of a broad range of plant pathogenic fungi, though little is known concerning its mechanism of action. In this study, using isolated mitochondria from pathogenic fungus Phytophthora capsici, we show that pyrimorph blocks mitochondrial electron transport by affecting the function of cyt bc(1). Indeed, pyrimorph inhibits the activities of both purified 11-subunit mitochondrial and 4-subunit bacterial bc(1) with IC50 values of 85.0 mu M and 69.2 mu M, respectively, indicating that it targets the essential subunits of cyt bc(1) complexes. Using an array of biochemical and spectral methods, we show that pyrimorph acts on an area near the Q(P) site and falls into the category of a mixed-type, noncompetitive inhibitor with respect to the substrate ubiquinol. In silico molecular docking of pyrimorph to cyt b from mammalian and bacterial sources also suggests that pyrimorph binds in the vicinity of the quinol oxidation site.	[Xiao, Yu-Mei; Li, Chang; Zhou, Yi-Hui; Qin, Zhao-Hai] China Agr Univ, Dept Appl Chem, Beijing 100094, Peoples R China; [Xiao, Yu-Mei; Esser, Lothar; Zhou, Fei; Zhou, Yi-Hui; Xia, Di] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Yu, Chang-An] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA	China Agricultural University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Oklahoma State University System; Oklahoma State University - Stillwater	Qin, ZH (corresponding author), China Agr Univ, Dept Appl Chem, Beijing 100094, Peoples R China.	qinzhaohai@263.net; xiad@mail.nih.gov			Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; National Basic Research Science Foundation of China [2010CB126100]; NATIONAL CANCER INSTITUTE [ZIABC010319] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Basic Research Science Foundation of China(National Basic Research Program of China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research, and by a grant from the National Basic Research Science Foundation of China (2010CB126100) to ZQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Berry EA, 2004, PHOTOSYNTH RES, V81, P251, DOI 10.1023/B:PRES.0000036888.18223.0e; Berry EA, 2010, BBA-BIOENERGETICS, V1797, P360, DOI 10.1016/j.bbabio.2009.12.003; Blum M, 2010, MOL PLANT PATHOL, V11, P227, DOI 10.1111/j.1364-3703.2009.00604.x; Bolgunas S, 2006, J MED CHEM, V49, P4762, DOI 10.1021/jm060408s; Brasseur G, 1996, BBA-BIOENERGETICS, V1275, P61, DOI 10.1016/0005-2728(96)00051-5; Chen Xiao-xia, 2007, Nongyaoxue Xuebao, V9, P229; Dosnon-Olette R, 2011, ENVIRON SCI POLLUT R, V18, P1015, DOI 10.1007/s11356-011-0460-1; Du YN, 2008, MODERN AGROCHEM, V7, P44; Esser L, 2004, J MOL BIOL, V341, P281, DOI 10.1016/j.jmb.2004.05.065; Esser L, 2013, CURR PHARM DES; Esser L, 2008, J BIOL CHEM, V283, P2846, DOI 10.1074/jbc.M708608200; Garrett R. H., 1999, BIOCHEMISTRY; Gaur M, 2005, J MOL MICROB BIOTECH, V9, P3, DOI 10.1159/000088141; Hatefi Y, 1978, Methods Enzymol, V53, P21; Hill P, 2003, ANTIMICROB AGENTS CH, V47, P2725, DOI 10.1128/AAC.47.9.2725-2731.2003; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Jordan DB, 1999, PESTIC SCI, V55, P105, DOI 10.1002/(SICI)1096-9063(199902)55:2&lt;105::AID-PS879&gt;3.0.CO;2-D; Keilin D, 1925, P R SOC LOND B-CONTA, V98, P312, DOI 10.1098/rspb.1925.0039; Kleinschroth T, 2011, BBA-BIOENERGETICS, V1807, P1606, DOI 10.1016/j.bbabio.2011.09.017; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Leadbeater A, 2011, FUNGICIDE RESISTANCE IN CROP PROTECTION: RISK AND MANAGEMENT, P141, DOI 10.1079/9781845939052.0141; LINK TA, 1993, J BIOENERG BIOMEMBR, V25, P221, DOI 10.1007/BF00762584; MATHER MW, 1995, J BIOL CHEM, V270, P28668, DOI 10.1074/jbc.270.48.28668; Mitani S, 2001, PESTIC BIOCHEM PHYS, V71, P107, DOI 10.1006/pest.2001.2569; MITCHELL P, 1975, FEBS LETT, V56, P1, DOI 10.1016/0014-5793(75)80098-6; Mu CW, 2007, CHEM J CHINESE U, V28, P1902; Nicklaus M.C SM, 2012, CADD GROUP CHEM TOOL; Pang ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056513; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Steinfeld U, 2001, PEST MANAG SCI, V57, P787, DOI 10.1002/ps.356; Sun HY, 2010, J PHYTOPATHOL, V158, P244, DOI 10.1111/j.1439-0434.2009.01606.x; Tian H, 1997, J BIOL CHEM, V272, P23722, DOI 10.1074/jbc.272.38.23722; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; TRUMPOWER BL, 1990, J BIOL CHEM, V265, P11409; TRUMPOWER BL, 1990, MICROBIOL REV, V54, P101, DOI 10.1128/MMBR.54.2.101-129.1990; VONJAGOW G, 1986, METHOD ENZYMOL, V126, P253; VONJAGOW G, 1984, J BIOL CHEM, V259, P6318; VONJAGOW G, 1981, FEBS LETT, V136, P19, DOI 10.1016/0014-5793(81)81206-9; Wang HC, 2009, PLANT PATHOLOGY; Wood PM, 2003, PEST MANAG SCI, V59, P499, DOI 10.1002/ps.655; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Yan XJ, 2010, J AGR FOOD CHEM, V58, P2720, DOI 10.1021/jf902410x; Yoshida T, 2007, BIOCHEMISTRY-US, V46, P10365, DOI 10.1021/bi7010306; YU CA, 1982, BIOCHEMISTRY-US, V21, P4096, DOI 10.1021/bi00260a028; YU L, 1991, BIOCHEMISTRY-US, V30, P4934, DOI 10.1021/bi00234a014; Yu LD, 2009, METHOD ENZYMOL, V456, P459, DOI 10.1016/S0076-6879(08)04425-X; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	50	23	24	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93765	10.1371/journal.pone.0093765	http://dx.doi.org/10.1371/journal.pone.0093765			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699450	Green Published, gold, Green Submitted			2022-12-25	WOS:000334105000104
J	Carapella, V; Bordas, R; Pathmanathan, P; Lohezic, M; Schneider, JE; Kohl, P; Burrage, K; Grau, V				Carapella, Valentina; Bordas, Rafel; Pathmanathan, Pras; Lohezic, Maelene; Schneider, Jurgen E.; Kohl, Peter; Burrage, Kevin; Grau, Vicente			Quantitative Study of the Effect of Tissue Microstructure on Contraction in a Computational Model of Rat Left Ventricle	PLOS ONE			English	Article							MAGNETIC-RESONANCE; HEART; ARCHITECTURE; FIBER; ARRANGEMENT; STRESS; HEALTH; STRAIN; TOOLS	Tissue microstructure, in particular the alignment of myocytes ( fibre direction) and their lateral organisation into sheets, is fundamental to cardiac function. We studied the effect of microstructure on contraction in a computational model of rat left ventricular electromechanics. Different fibre models, globally rule-based or locally optimised to DT-MRI data, were compared, in order to understand whether a subject-specific fibre model would enhance the predictive power of our model with respect to the global ones. We also studied the impact of sheets on ventricular deformation by comparing: ( a) a transversely isotropic versus an orthotropic material law and (b) a linear model with a bimodal model of sheet transmural variation. We estimated ejection fraction, wall thickening and base-to-apex shortening and compared them with measures from cine-MRI. We also evaluated Lagrangian strains as local metrics of cardiac deformation. Our results show that the subject-specific fibre model provides little improvement in the metric predictions with respect to global fibre models while material orthotropy allows closer agreement with measures than transverse isotropy. Nonetheless, the impact of sheets in our model is smaller than that of fibres. We conclude that further investigation of the modelling of sheet dynamics is necessary to fully understand the impact of tissue structure on cardiac deformation.	[Carapella, Valentina; Bordas, Rafel; Pathmanathan, Pras; Burrage, Kevin] Univ Oxford, Dept Comp Sci, Oxford, England; [Lohezic, Maelene; Schneider, Jurgen E.] Univ Oxford, Radcliffe Dept Med, Div Cardiovasc Med, Oxford, England; [Schneider, Jurgen E.; Kohl, Peter] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Grau, Vicente] Univ Oxford, Inst Biomed Engn, Dept Engn Sci, Oxford, England	University of Oxford; University of Oxford; Imperial College London; University of Oxford	Carapella, V (corresponding author), Univ Oxford, Dept Comp Sci, Oxford, England.	valentina.carapella@dtc.ox.ac.uk		Carapella, Valentina/0000-0001-9750-9425; Grau, Vicente/0000-0001-8139-3480; Burrage, Kevin/0000-0002-8111-1137; Kohl, Peter/0000-0003-0416-6270; Bordas, Rafel/0000-0002-0856-544X	BBSRC [E003443, BB/I012117]; British Heart Foundation New Horizon grant [NH/13/30238]; EPSRC [EP/J013250/1]; Systems Biology Doctoral Training Centre; EU FP7 AirPROM project [270194]; British Heart Foundation; European Research Council; Biotechnology and Biological Sciences Research Council [BB/I012117/1] Funding Source: researchfish; British Heart Foundation [FS/11/50/29038, NH/13/1/30238, FS/12/17/29532] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/J013250/1] Funding Source: researchfish; BBSRC [BB/I012117/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation New Horizon grant; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Systems Biology Doctoral Training Centre; EU FP7 AirPROM project; British Heart Foundation(British Heart Foundation); European Research Council(European Research Council (ERC)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work presented here was supported by BBSRC grants E003443 and BB/I012117, by the British Heart Foundation New Horizon grant NH/13/30238, and by EPSRC grant EP/J013250/1. VC was partially funded by the EPSRC and would like to thank the Systems Biology Doctoral Training Centre. RB was funded by the EU FP7 AirPROM project (grant agreement no. 270194). JES is a BHF Senior Basic Science Research Fellow. PK acknowledges additional support by the British Heart Foundation and the European Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado-Sierra J, 2011, PROG BIOPHYS MOL BIO, V107, P147, DOI 10.1016/j.pbiomolbio.2011.06.014; Bishop MJ, 2009, LECT NOTES COMPUT SC, V5528, P87, DOI 10.1007/978-3-642-01932-6_10; Bourgeois EB, 2009, IEEE T BIO-MED ENG, V56, P855, DOI 10.1109/TBME.2008.2007501; Bovendeerd PHM, 2009, AM J PHYSIOL-HEART C, V297, pH1058, DOI 10.1152/ajpheart.01334.2008; Burton RAB, 2006, ANN NY ACAD SCI, V1080, P301, DOI 10.1196/annals.1380.023; Carapella V, 2013, LECT NOTES COMPUT SC, V7945, P46, DOI 10.1007/978-3-642-38899-6_6; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Cheng A, 2008, CIRCULATION, V118, P713, DOI 10.1161/CIRCULATIONAHA.107.744623; Connelly KA, 2006, AM J PHYSIOL-HEART C, V290, pH1699, DOI 10.1152/ajpheart.00577.2005; Coppola Benjamin A., 2008, Molecular & Cellular Biomechanics, V5, P183; DURRER D, 1970, CIRCULATION, V41, P899, DOI 10.1161/01.CIR.41.6.899; Eriksson TSE, 2013, MATH MECH SOLIDS, V18, P592, DOI 10.1177/1081286513485779; Geerts L, 2003, FUNCTIONAL IMAGING M, V2674, P1006; Geuzaine C, 2009, INT J NUMER METH ENG, V79, P1309, DOI 10.1002/nme.2579; Gilbert SH, 2007, EUR J CARDIO-THORAC, V32, P231, DOI 10.1016/j.ejcts.2007.03.032; Hales PW, 2012, PROG BIOPHYS MOL BIO, V110, P319, DOI 10.1016/j.pbiomolbio.2012.07.014; Hooks DA, 2007, CIRC RES, V101, pE103, DOI 10.1161/CIRCRESAHA.107.161075; Karadag IE, 2011, LECT NOTES COMPUT SC, V6666, P294, DOI 10.1007/978-3-642-21028-0_36; Kerckhoffs RCP, 2003, ANN BIOMED ENG, V31, P536, DOI 10.1114/1.1566447; Kohl P, 2010, CLIN PHARMACOL THER, V88, P25, DOI 10.1038/clpt.2010.92; Kroon W, 2009, MED IMAGE ANAL, V13, P346, DOI 10.1016/j.media.2008.06.015; LEGRICE IJ, 1995, AM J PHYSIOL-HEART C, V269, pH571, DOI 10.1152/ajpheart.1995.269.2.H571; Lin DHS, 1998, J BIOMECH ENG-T ASME, V120, P504, DOI 10.1115/1.2798021; Mirams GR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002970; Niederer SA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000371; OMENS JH, 1993, J BIOMECH, V26, P665, DOI 10.1016/0021-9290(93)90030-I; Pathmanathan P, 2009, ANN BIOMED ENG, V37, P860, DOI 10.1007/s10439-009-9663-8; Plank G, 2009, PHILOS T R SOC A, V367, P2257, DOI 10.1098/rsta.2009.0056; Satoh H, 1996, BIOPHYS J, V70, P1494, DOI 10.1016/S0006-3495(96)79711-4; Scollan DF, 1998, AM J PHYSIOL-HEART C, V275, pH2308, DOI 10.1152/ajpheart.1998.275.6.H2308; STREETER DD, 1969, CIRC RES, V24, P339, DOI 10.1161/01.RES.24.3.339; Usyk TP, 2000, J ELASTICITY, V61, P143, DOI 10.1023/A:1010883920374; Vadakkumpadan F, 2010, WIRES SYST BIOL MED, V2, P489, DOI 10.1002/wsbm.76; Wang LJ, 2008, AM J PHYSIOL-HEART C, V294, pH2565, DOI 10.1152/ajpheart.01376.2007; Wise RG, 1998, J PHYSIOL-LONDON, V513, P873, DOI 10.1111/j.1469-7793.1998.873ba.x; Zhong XD, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-83	36	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e92792	10.1371/journal.pone.0092792	http://dx.doi.org/10.1371/journal.pone.0092792			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695115	Green Published, gold			2022-12-25	WOS:000334103000028
J	Karpurapu, M; Ranjan, R; Deng, J; Chung, SW; Lee, YG; Xiao, L; Nirujogi, TS; Jacobson, JR; Park, GY; Christman, JW				Karpurapu, Manjula; Ranjan, Ravi; Deng, Jing; Chung, Sangwoon; Lee, Yong Gyu; Xiao, Lei; Nirujogi, Teja Srinivas; Jacobson, Jeffrey R.; Park, Gye Young; Christman, John W.			Kruppel Like Factor 4 Promoter Undergoes Active Demethylation during Monocyte/Macrophage Differentiation	PLOS ONE			English	Article							DNA DEMETHYLATION; LINEAGE COMMITMENT; PU.1; METHYLATION; EXCISION; GENE; ACTIVATION; PROTEINS; KEY; 5-METHYLCYTOSINE	The role of different lineage specific transcription factors in directing hematopoietic cell fate towards myeloid lineage is well established but the status of epigenetic modifications has not been defined during this important developmental process. We used non proliferating, PU.1 inducible myeloid progenitor cells and differentiating bone marrow derived macrophages to study the PU.1 dependent KLF4 transcriptional regulation and its promoter demethylation during monocyte/macrophage differentiation. Expression of KLF4 was regulated by active demethylation of its promoter and PU.1 specifically bound to KLF4 promoter oligo harboring the PU.1 consensus sequence. Methylation specific quantitative PCR and Bisulfite sequencing indicated demethylation of CpG residues most proximal to the transcription start site of KLF4 promoter. Cloned KLF4 promoter in pGL3 Luciferase and CpG free pcpgf-bas vectors showed accentuated reporter activity when co-transfected with the PU.1 expression vector. In vitro methylation of both KLF4 promoter oligo and cloned KLF4 promoter vectors showed attenuated in vitro DNA binding activity and Luciferase/mouse Alkaline phosphotase reporter activity indicating the negative influence of KLF4 promoter methylation on PU.1 binding. The Cytosine deaminase, Activation Induced Cytidine Deaminase (AICDA) was found to be critical for KLF4 promoter demethylation. More importantly, knock down of AICDA resulted in blockade of KLF4 promoter demethylation, decreased F4/80 expression and other phenotypic characters of macrophage differentiation. Our data proves that AICDA mediated active demethylation of the KLF4 promoter is necessary for transcriptional regulation of KLF4 by PU.1 during monocyte/macrophage differentiation.	[Karpurapu, Manjula; Deng, Jing; Chung, Sangwoon; Lee, Yong Gyu; Nirujogi, Teja Srinivas; Christman, John W.] Ohio State Univ, Wexner Med Ctr, Davis Heart & Lung Res Inst, Sect Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA; [Ranjan, Ravi; Xiao, Lei; Park, Gye Young] Univ Illinois, Coll Med, Sect Pulm Crit Care Sleep & Allergy, Chicago, IL USA; [Jacobson, Jeffrey R.] Univ Illinois, Dept Med, Inst Personalized Resp Med, Chicago, IL USA	University System of Ohio; Ohio State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Christman, JW (corresponding author), Ohio State Univ, Wexner Med Ctr, Davis Heart & Lung Res Inst, Sect Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA.	John.Christman@osumc.edu	Ranjan, Ravi/D-1614-2016	Ranjan, Ravi/0000-0002-8768-549X	National Institutes of Health [R01 HL075557, HL 103643, T32 HL082547]; Department of Veterans Affairs merit review grant [1I01BX000108]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075557, T32HL082547, R01HL103643] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs merit review grant(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Institutes of Health (grants R01 HL075557, HL 103643, and T32 HL082547) and a Department of Veterans Affairs merit review grant (1I01BX000108, J.W.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder JK, 2008, J IMMUNOL, V180, P5645, DOI 10.4049/jimmunol.180.8.5645; Arioka Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045031; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Cadet J, 2014, MUTAT RES-GEN TOX EN, V764, P18, DOI 10.1016/j.mrgentox.2013.09.001; Cao ZX, 2010, BLOOD, V116, P4404, DOI 10.1182/blood-2010-05-285353; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Dahl R, 2003, BLOOD CELL MOL DIS, V31, P229, DOI 10.1016/S1079-9796(03)00152-9; Dalton SR, 2012, EPIGENOMICS-UK, V4, P459, DOI [10.2217/EPI.12.36, 10.2217/epi.12.36]; de la Rica L, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r99; Engel N, 2009, EPIGENETICS-US, V4, P98, DOI 10.4161/epi.4.2.7858; Feinberg MW, 2007, EMBO J, V26, P4138, DOI 10.1038/sj.emboj.7601824; Fisher RC, 1998, STEM CELLS, V16, P25, DOI 10.1002/stem.160025; Fritz EL, 2010, GENE DEV, V24, P2107, DOI 10.1101/gad.1963010; Fu Y, 2012, CURR OPIN CHEM BIOL, V16, P516, DOI 10.1016/j.cbpa.2012.10.002; Gavin DP, 2013, NEUROPHARMACOLOGY, V75, P233, DOI 10.1016/j.neuropharm.2013.07.036; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; Karpurapu M, 2011, BLOOD, V118, P5255, DOI 10.1182/blood-2011-03-341123; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Lehtonen A, 2005, J IMMUNOL, V175, P6570, DOI 10.4049/jimmunol.175.10.6570; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li YP, 2010, ARTHRITIS RHEUM-US, V62, P1438, DOI 10.1002/art.27363; Liu S, 2013, NUCLEIC ACIDS RES, V41, P6421, DOI 10.1093/nar/gkt360; Ma DKK, 2009, CELL CYCLE, V8, P1526, DOI 10.4161/cc.8.10.8500; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Nagamura-Inoue T, 2001, Int Rev Immunol, V20, P83, DOI 10.3109/08830180109056724; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Sanz LA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-110; Schafer A, 2013, ADV EXP MED BIOL, V793, P35, DOI 10.1007/978-1-4614-8289-5_3; Schmitz KM, 2009, MOL CELL, V33, P344, DOI 10.1016/j.molcel.2009.01.015; Schuetz A, 2011, CELL MOL LIFE SCI, V68, P3121, DOI 10.1007/s00018-010-0618-x; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Singh H, 1999, COLD SPRING HARB SYM, V64, P13, DOI 10.1101/sqb.1999.64.13; Teperek-Tkacz M, 2011, REPRODUCTION, V142, P621, DOI 10.1530/REP-11-0148; Pham TH, 2013, NUCLEIC ACIDS RES, V41, P6391, DOI 10.1093/nar/gkt355; Pham TH, 2012, BLOOD, V119, pE161, DOI 10.1182/blood-2012-01-402453; Tshori S, 2012, BBA-MOL BASIS DIS, V1822, P42, DOI 10.1016/j.bbadis.2010.12.024; Walsh JC, 2002, IMMUNITY, V17, P665, DOI 10.1016/S1074-7613(02)00452-1; Wolff L, 2013, STEM CELLS, V31, P1237, DOI 10.1002/stem.1379; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205	47	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93362	10.1371/journal.pone.0093362	http://dx.doi.org/10.1371/journal.pone.0093362			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695324	Green Published, gold, Green Submitted			2022-12-25	WOS:000334103000060
J	Moores, G; Shakarian, P; Macdonald, B; Howard, N				Moores, Geoffrey; Shakarian, Paulo; Macdonald, Brian; Howard, Nicholas			Finding Near-Optimal Groups of Epidemic Spreaders in a Complex Network	PLOS ONE			English	Article								In this paper, we present algorithms to find near-optimal sets of epidemic spreaders in complex networks. We extend the notion of local-centrality, a centrality measure previously shown to correspond with a node's ability to spread an epidemic, to sets of nodes by introducing combinatorial local centrality. Though we prove that finding a set of nodes that maximizes this new measure is NP-hard, good approximations are available. We show that a strictly greedy approach obtains the best approximation ratio unless P = NP and then formulate a modified version of this approach that leverages qualities of the network to achieve a faster runtime while maintaining this theoretical guarantee. We perform an experimental evaluation on samples from several different network structures which demonstrate that our algorithm maximizes combinatorial local centrality and consistently chooses the most effective set of nodes to spread infection under the SIR model, relative to selecting the top nodes using many common centrality measures. We also demonstrate that the optimized algorithm we develop scales effectively.	[Moores, Geoffrey; Shakarian, Paulo] US Mil Acad, Elect Engn & Comp Sci Dept, West Point, NY 10996 USA; [Macdonald, Brian; Howard, Nicholas] US Mil Acad, Dept Math Sci, West Point, NY 10996 USA; [Moores, Geoffrey; Shakarian, Paulo; Macdonald, Brian; Howard, Nicholas] US Mil Acad, Network Sci Ctr, West Point, NY 10996 USA	United States Department of Defense; United States Army; United States Military Academy; United States Department of Defense; United States Army; United States Military Academy; United States Department of Defense; United States Army; United States Military Academy	Shakarian, P (corresponding author), US Mil Acad, Elect Engn & Comp Sci Dept, West Point, NY 10996 USA.	paulo@shakarian.net	Shakarian, Paulo/GPK-6176-2022; Macdonald, Brian/AAY-5603-2021	Shakarian, Paulo/0000-0002-3159-4660; Macdonald, Brian/0000-0003-4229-9752	Army Research Office	Army Research Office	This work is funded by the Army Research Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; Arenas A., 2009, JAZZ MUSICIANS NETWO; Barabasi AL, 2007, NETWORK DATABASES; Borgatti S. P., 2006, Computational & Mathematical Organization Theory, V12, P21, DOI 10.1007/s10588-006-7084-x; Borge-Holthoefer J, 2011, PHYS SOC; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Castellano, 2012, SCI REPORTS; Chen DB, 2012, PHYSICA A, V391, P1777, DOI 10.1016/j.physa.2011.09.017; Chen W, 2010, P 16 ACM SIGKDD INT, P1029, DOI DOI 10.1145/1835804.1835934; Easley D, 2010, NETWORKS CROWDS MARK; Feige U, 1998, J ACM, V45, P634, DOI 10.1145/285055.285059; Garey M.R., 1979, COMPUTERS INTRACTABI; Gleeson JP, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.056103; Kang C, 2012, P 2012 IEEE ACM INT; Kempe D, 2003, P 9 ACM SIGKDD INT C, V2003, P137, DOI DOI 10.1145/956750.956769; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Klemm K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00292; Leskovec J., 2012, STANFORD NETWORK ANA; Leskovec J, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P420; NEMHAUSER GL, 1978, MATH PROGRAM, V14, P265, DOI 10.1007/BF01588971; Ortiz-Arroyo D, 2008, LECT NOTES COMPUT SC, V5376, P15, DOI 10.1007/978-3-540-89900-6_5; Rocha LEC, 2010, P NATL ACAD SCI; Swart P, 2013, NETWORKX; Zafarani R., 2009, SOCIAL COMPUTING DAT; Zafarani R, 2009, SOCIAL COMPUTING REP	25	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e90303	10.1371/journal.pone.0090303	http://dx.doi.org/10.1371/journal.pone.0090303			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24694693	Green Published, gold			2022-12-25	WOS:000334103000007
J	Peng, JL; Hao, BH; Liu, L; Wang, SM; Ma, BG; Yang, Y; Xie, FL; Li, YG				Peng, Jieli; Hao, Baohai; Liu, Liu; Wang, Shanming; Ma, Binguang; Yang, Yi; Xie, Fuli; Li, Youguo			RNA-Seq and Microarrays Analyses Reveal Global Differential Transcriptomes of Mesorhizobium huakuii 7653R between Bacteroids and Free-Living Cells	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; NODULE-SPECIFIC GENES; AMINO-ACID PERMEASE; SINORHIZOBIUM-MELILOTI; RHIZOBIUM-LEGUMINOSARUM; NITROGEN-FIXATION; BRADYRHIZOBIUM-JAPONICUM; EXPRESSION PATTERNS; MEDICAGO-TRUNCATULA; CYCLE PROGRESSION	Mesorhizobium huakuii 7653R occurs either in nitrogen-fixing symbiosis with its host plant, Astragalus sinicus, or free-living in the soil. The M. huakuii 7653R genome has recently been sequenced. To better understand the complex biochemical and developmental changes that occur in 7653R during bacteroid development, RNA-Seq and Microarrays were used to investigate the differential transcriptomes of 7653R bacteroids and free-living cells. The two approaches identified several thousand differentially expressed genes. The most prominent up-regulation occurred in the symbiosis plasmids, meanwhile gene expression is concentrated to a set of genes (clusters) in bacteroids to fulfill corresponding functional requirements. The results suggested that the main energy metabolism is active while fatty acid metabolism is inactive in bacteroid and that most of genes relevant to cell cycle are down-regulated accordingly. For a global analysis, we reconstructed a protein-protein interaction (PPI) network for 7653R and integrated gene expression data into the network using Cytoscape. A highly inter-connected subnetwork, with function enrichment for nitrogen fixation, was found, and a set of hubs and previously uncharacterized genes participating in nitrogen fixation were identified. The results described here provide a broader biological landscape and novel insights that elucidate rhizobial bacteroid differentiation, nitrogen fixation and related novel gene functions.	[Peng, Jieli; Liu, Liu; Wang, Shanming; Xie, Fuli; Li, Youguo] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China; [Hao, Baohai; Ma, Binguang; Yang, Yi] Huazhong Agr Univ, Sch Life Sci & Technol, Ctr Bioinformat, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Li, YG (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China.	youguoli@mail.hzau.edu.cn			National Basic Research Program of China (973 program) [2010CB126502]; Research Fund for the Doctoral Program of Higher Education of China [20110146110012]; National Natural Science Foundation of China [31371549, 31100602]; Fundamental Research Funds for the Central Universities [2009PY020, 2010QC016, 2011QC066]	National Basic Research Program of China (973 program)(National Basic Research Program of China); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by funds from the National Basic Research Program of China (973 program grant no. 2010CB126502), Research Fund for the Doctoral Program of Higher Education of China (20110146110012), the National Natural Science Foundation of China (grant no. 31371549 and 31100602), and the Fundamental Research Funds for the Central Universities (2009PY020, 2010QC016 and 2011QC066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampe F, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r15; ANDERSON AJ, 1990, MICROBIOL REV, V54, P450, DOI 10.1128/MMBR.54.4.450-472.1990; Arcondeguy T, 2001, MICROBIOL MOL BIOL R, V65, P80, DOI 10.1128/MMBR.65.1.80-105.2001; Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Barnes M, 2005, NUCLEIC ACIDS RES, V33, P5914, DOI 10.1093/nar/gki890; Barnett MJ, 2004, P NATL ACAD SCI USA, V101, P16636, DOI 10.1073/pnas.0407269101; Barnett MJ, 2001, J BACTERIOL, V183, P3204, DOI 10.1128/JB.183.10.3204-3210.2001; Becker A, 2004, MOL PLANT MICROBE IN, V17, P292, DOI 10.1094/MPMI.2004.17.3.292; BECKERANDRE M, 1989, NUCLEIC ACIDS RES, V17, P9437, DOI 10.1093/nar/17.22.9437; Beckering CL, 2002, J BACTERIOL, V184, P6395, DOI 10.1128/JB.184.22.6395-6402.2002; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Brechenimacher L, 2008, MOL PLANT MICROBE IN, V21, P631, DOI 10.1094/MPMI-21-5-0631; Capela D, 2006, MOL PLANT MICROBE IN, V19, P363, DOI 10.1094/MPMI-19-0363; Chen DS, 2007, PLANT CELL REP, V26, P1421, DOI 10.1007/s00299-007-0346-3; Chiaretti S, 2004, BLOOD, V103, P2771, DOI 10.1182/blood-2003-09-3243; deLivron MA, 2008, J BACTERIOL, V190, P5944, DOI 10.1128/JB.00763-08; Dixon R, 2004, NAT REV MICROBIOL, V2, P621, DOI 10.1038/nrmicro954; Farris M, 1998, MOL MICROBIOL, V28, P265, DOI 10.1046/j.1365-2958.1998.00793.x; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; GLAZEBROOK J, 1993, GENE DEV, V7, P1485, DOI 10.1101/gad.7.8.1485; Gonzalez V, 2006, P NATL ACAD SCI USA, V103, P3834, DOI 10.1073/pnas.0508502103; Gonzalez-Ballester D, 2010, PLANT CELL, V22, P2058, DOI 10.1105/tpc.109.071167; Goodner B, 2001, SCIENCE, V294, P2323, DOI 10.1126/science.1066803; Grant AJ, 2003, MOL MICROBIOL, V48, P507, DOI 10.1046/j.1365-2958.2003.t01-1-03447.x; Green LS, 2000, J BACTERIOL, V182, P2838, DOI 10.1128/JB.182.10.2838-2844.2000; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hentschel U, 2000, TRENDS MICROBIOL, V8, P226, DOI 10.1016/S0966-842X(00)01758-3; Hosie AHF, 2002, J BACTERIOL, V184, P4071, DOI 10.1128/JB.184.15.4071-4080.2002; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Ivanov S, 2010, CURR OPIN PLANT BIOL, V13, P372, DOI 10.1016/j.pbi.2010.04.005; Jenal U, 1998, EMBO J, V17, P5658, DOI 10.1093/emboj/17.19.5658; Kaneko T, 2000, DNA RES, V7, P381, DOI 10.1093/dnares/7.6.381; Karunakaran R, 2009, J BACTERIOL, V191, P4002, DOI 10.1128/JB.00165-09; Kiss E, 2004, MOL PLANT MICROBE IN, V17, P235, DOI 10.1094/MPMI.2004.17.3.235; Kogenaru S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-629; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Krummenacher P, 2000, GENE, V241, P247, DOI 10.1016/S0378-1119(99)00490-4; Laub MT, 2000, SCIENCE, V290, P2144, DOI 10.1126/science.290.5499.2144; Laub MT, 2002, P NATL ACAD SCI USA, V99, P4632, DOI 10.1073/pnas.062065699; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li YJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080475, 10.1371/journal.pone.0070390]; Lindemann A, 2010, FEMS MICROBIOL LETT, V312, P184, DOI 10.1111/j.1574-6968.2010.02115.x; Lodwig E, 2003, CRIT REV PLANT SCI, V22, P37, DOI 10.1080/713610850; Lodwig EM, 2003, NATURE, V422, P722, DOI 10.1038/nature01527; Lodwig EM, 2005, MOL PLANT MICROBE IN, V18, P67, DOI 10.1094/MPMI-18-0067; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; McGrath PT, 2006, CELL, V124, P535, DOI 10.1016/j.cell.2005.12.033; Mercer RG, 2010, J BACTERIOL, V192, P2701, DOI 10.1128/JB.00160-10; Mergaert P, 2006, P NATL ACAD SCI USA, V103, P5230, DOI 10.1073/pnas.0600912103; Mergaert P, 2003, PLANT PHYSIOL, V132, P161, DOI 10.1104/pp.102.018192; Miller TR, 2006, ENVIRON MICROBIOL, V8, P1648, DOI 10.1111/j.1462-2920.2006.01071.x; Mitsui H, 2004, MOL GENET GENOMICS, V271, P416, DOI 10.1007/s00438-004-0992-x; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Neidig A, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-77; Oldroyd GED, 2008, ANNU REV PLANT BIOL, V59, P519, DOI 10.1146/annurev.arplant.59.032607.092839; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Pessi G, 2007, MOL PLANT MICROBE IN, V20, P1353, DOI 10.1094/MPMI-20-11-1353; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Prell J, 2006, TRENDS MICROBIOL, V14, P161, DOI 10.1016/j.tim.2006.02.005; Prell J, 2009, P NATL ACAD SCI USA, V106, P12477, DOI 10.1073/pnas.0903653106; Quon KC, 1996, CELL, V84, P83, DOI 10.1016/S0092-8674(00)80995-2; Resendis-Antonio O, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-120; Rodriguez-Llorente I, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-63; ROMANOV VI, 1994, APPL ENVIRON MICROB, V60, P2339, DOI 10.1128/AEM.60.7.2339-2342.1994; RONSON CW, 1984, J BACTERIOL, V160, P903, DOI 10.1128/JB.160.3.903-909.1984; Ryan RP, 2010, P NATL ACAD SCI USA, V107, P5989, DOI 10.1073/pnas.0912839107; Sarma AD, 2006, PROTEOMICS, V6, P3008, DOI 10.1002/pmic.200500783; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Scott K, 2003, BRIT J BIOMED SCI, V60, P168, DOI 10.1080/09674845.2003.11978047; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shimoda Y, 2008, DNA RES, V15, P13, DOI 10.1093/dnares/dsm028; Skerker JM, 2004, NAT REV MICROBIOL, V2, P325, DOI 10.1038/nrmicro864; Streeter JG, 2006, APPL ENVIRON MICROB, V72, P4250, DOI 10.1128/AEM.00256-06; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Tal R, 1998, J BACTERIOL, V180, P4416, DOI 10.1128/JB.180.17.4416-4425.1998; Tan XJ, 2009, APPL MICROBIOL BIOT, V84, P519, DOI 10.1007/s00253-009-1959-y; Tate R, 1998, MOL PLANT MICROBE IN, V11, P188, DOI 10.1094/MPMI.1998.11.3.188; Terpolilli JJ, 2012, ADV MICROB PHYSIOL, V60, P325, DOI 10.1016/B978-0-12-398264-3.00005-X; Tsolis RM, 2002, P NATL ACAD SCI USA, V99, P12503, DOI 10.1073/pnas.212508599; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uchiumi T, 2004, J BACTERIOL, V186, P2439, DOI 10.1128/JB.186.8.2439-2448.2004; Van de Velde W, 2010, SCIENCE, V327, P1122, DOI 10.1126/science.1184057; Van der Henst C, 2012, J BACTERIOL, V194, P5305, DOI 10.1128/JB.00699-12; Vercruysse M, 2011, MOL PLANT MICROBE IN, V24, P1553, DOI 10.1094/MPMI-05-11-0140; Walshaw DL, 1996, MOL MICROBIOL, V21, P1239, DOI 10.1046/j.1365-2958.1996.00078.x; Wang CX, 2007, J BACTERIOL, V189, P9050, DOI 10.1128/JB.01190-07; Wang SCE, 2006, J BACTERIOL, V188, P1497, DOI 10.1128/JB.188.4.1497-1508.2006; Wang YW, 2010, ACTA BIOCH BIOPH SIN, V42, P410, DOI 10.1093/abbs/gmq034; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wojciechowski MF, 2004, AM J BOT, V91, P1846, DOI 10.3732/ajb.91.11.1846; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Yoder-Himes DR, 2009, P NATL ACAD SCI USA, V106, P3976, DOI 10.1073/pnas.0813403106; Young JPW, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r34; Yurgel SN, 2004, FEMS MICROBIOL REV, V28, P489, DOI 10.1016/j.femsre.2004.04.002	99	16	23	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93626	10.1371/journal.pone.0093626	http://dx.doi.org/10.1371/journal.pone.0093626			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695521	Green Submitted, Green Published, gold			2022-12-25	WOS:000334103000094
J	Zgraggen, S; Huggenberger, R; Kerl, K; Detmar, M				Zgraggen, Silvana; Huggenberger, Reto; Kerl, Katrin; Detmar, Michael			An Important Role of the SDF-1/CXCR4 Axis in Chronic Skin Inflammation	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CELL-DERIVED FACTOR; CHEMOKINE RECEPTOR CXCR4; T-CELL; IFN-GAMMA; VEGF; EXPRESSION; PSORIASIS; AMD3100; DISEASE	Inflammatory angiogenesis and vascular remodeling play key roles in the chronic inflammatory skin disease psoriasis, but little is known about the molecular mediators of vascular activation. Based on the reported elevated mRNA levels of the angiogenic chemokine stromal cell-derived factor-1 (SDF-1) and its receptor CXCR4 in psoriasis, we investigated the relevance of the SDF-1/CXCR4 axis in two experimental models of chronic psoriasis-like skin inflammation. The cutaneous expression of both SDF-1 and CXCR4 was upregulated in the inflamed skin of K14-VEGF-A transgenic mice and in imiquimod-induced skin inflammation, with expression of CXCR4 by blood vessels and macrophages. Treatment with the CXCR4 antagonist AMD3100 potently inhibited skin inflammation in both models, associated with reduced inflammatory angiogenesis and inflammatory cell accumulation, including dermal CD4(+) cells and intraepidermal CD8(+) T cells. Similar anti-inflammatory effects were seen after treatment with a neutralizing anti-SDF-1 antibody. In vitro, inhibition of CXCR4 blocked SDF-1-induced chemotaxis of CD11b(+) splenocytes, in agreement with the reduced number of macrophages after in vivo CXCR4 blockade. Our results reveal an important role of the SDF-1/CXCR4 axis in skin inflammation and inflammatory angiogenesis, and they indicate that inhibition of the SDF-1/CXCR4 axis might serve as a novel therapeutic strategy for chronic inflammatory skin diseases.	[Zgraggen, Silvana; Huggenberger, Reto; Detmar, Michael] Swiss Fed Inst Technol, Inst Pharmaceut Sci, Swiss Fed Inst Technol, Zurich, Switzerland; [Kerl, Katrin] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital	Detmar, M (corresponding author), Swiss Fed Inst Technol, Inst Pharmaceut Sci, Swiss Fed Inst Technol, Zurich, Switzerland.	michael.detmar@pharma.ethz.ch			National Institutes of Health [CA69184]; Swiss National Science Foundation [3100A0-108207, 31003A_130627]; Commission of the European Communities [LSHC-CT-2005-518178]; Advanced European Research Council Grant LYVICAM; Leducq Foundation Transatlantic Network of Excellence grant Lymph Vessels in Obesity and Cardiovascular Disease, Oncosuisse; Krebsliga Zurich; NATIONAL CANCER INSTITUTE [R01CA069184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Commission of the European Communities(European Commission); Advanced European Research Council Grant LYVICAM; Leducq Foundation Transatlantic Network of Excellence grant Lymph Vessels in Obesity and Cardiovascular Disease, Oncosuisse(Leducq Foundation); Krebsliga Zurich; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant CA69184, Swiss National Science Foundation grants 3100A0-108207 and 31003A_130627, Commission of the European Communities grant LSHC-CT-2005-518178, Advanced European Research Council Grant LYVICAM, the Leducq Foundation Transatlantic Network of Excellence grant Lymph Vessels in Obesity and Cardiovascular Disease, Oncosuisse and Krebsliga Zurich (to M.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanesi C, 2009, J EXP MED, V206, P249, DOI 10.1084/jem.20080129; Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037; Bhushan M, 1999, BRIT J DERMATOL, V141, P1054, DOI 10.1046/j.1365-2133.1999.03205.x; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; De Klerck B, 2005, ARTHRITIS RES THER, V7, pR1208, DOI 10.1186/ar1806; DETMAR M, 1994, J EXP MED, V180, P1141, DOI 10.1084/jem.180.3.1141; Detmar M, 1998, J INVEST DERMATOL, V111, P1, DOI 10.1046/j.1523-1747.1998.00262.x; Forster R, 1998, J IMMUNOL, V160, P1522; Fuentes-Duculan J, 2010, J INVEST DERMATOL, V130, P2412, DOI 10.1038/jid.2010.165; Halin C, 2008, AM J PATHOL, V173, P265, DOI 10.2353/ajpath.2008.071074; Halin C, 2007, BLOOD, V110, P3158, DOI 10.1182/blood-2007-01-066811; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; Hendrix CW, 2004, JAIDS-J ACQ IMM DEF, V37, P1253, DOI 10.1097/01.qai.0000137371.80695.ef; Hirakawa S, 2003, AM J PATHOL; Huggenberger R, 2011, J INVEST DERM SYMP P, V15, P24, DOI 10.1038/jidsymp.2011.5; Huggenberger R, 2010, J EXP MED, V207, P2255, DOI 10.1084/jem.20100559; Kanazawa S, 2001, AM J GASTROENTEROL, V96, P822; Kerfoot SM, 2008, AM J PHYSIOL-HEART C, V294, pH2524, DOI 10.1152/ajpheart.00984.2007; KIEFER F, 2011, JCELL MOL LIFE SCI, V68, P2811; Kryczek I, 2008, J IMMUNOL, V181, P4733, DOI 10.4049/jimmunol.181.7.4733; Kuhn DJ, 2011, BLOOD, V118, P421; Kunstfeld R, 2004, BLOOD, V104, P1048, DOI 10.1182/blood-2003-08-2964; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Lukacs NW, 2002, AM J PATHOL, V160, P1353, DOI 10.1016/S0002-9440(10)62562-X; Matthys P, 2001, J IMMUNOL, V167, P4686, DOI 10.4049/jimmunol.167.8.4686; Mikami S, 2008, J PHARMACOL EXP THER, V327, P383, DOI 10.1124/jpet.108.141085; Mirshahi F, 2000, THROMB RES, V99, P587, DOI 10.1016/S0049-3848(00)00292-9; Nanki T, 2000, J IMMUNOL, V165, P6590, DOI 10.4049/jimmunol.165.11.6590; Pablos JL, 1999, AM J PATHOL, V155, P1577, DOI 10.1016/S0002-9440(10)65474-0; Perera GK, 2012, ANNU REV PATHOL-MECH, V7, P385, DOI 10.1146/annurev-pathol-011811-132448; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Salcedo R, 1999, AM J PATHOL, V154, P1125, DOI 10.1016/S0002-9440(10)65365-5; Samarasekera EJ, 2013, J INVEST DERMATOL, V133, P2340, DOI 10.1038/jid.2013.149; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schonthaler HB, 2009, P NATL ACAD SCI USA, V106, P21264, DOI 10.1073/pnas.0907550106; Senger DR, 1996, AM J PATHOL, V149, P293; Suarez-Farinas M, 2011, J INVEST DERMATOL, V131, P391, DOI 10.1038/jid.2010.280; Van Belle AB, 2012, J IMMUNOL, V188, P462, DOI 10.4049/jimmunol.1102224; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Volin MV, 1998, BIOCHEM BIOPH RES CO, V242, P46, DOI 10.1006/bbrc.1997.7890; Xia YP, 2003, BLOOD, V102, P161, DOI 10.1182/blood-2002-12-3793; Zgraggen S, 2013, J ALLERGY, V2013, DOI DOI 10.1155/2013/672381; Zhou XH, 2003, PHYSIOL GENOMICS, V13, P69, DOI 10.1152/physiolgenomics.00157.2002	43	47	52	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93665	10.1371/journal.pone.0093665	http://dx.doi.org/10.1371/journal.pone.0093665			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695674	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000334103000101
J	Zhu, XB; Richael, C; Chamberlain, P; Busse, JS; Bussan, AJ; Jiang, JM; Bethke, PC				Zhu, Xiaobiao; Richael, Craig; Chamberlain, Patrick; Busse, James S.; Bussan, Alvin J.; Jiang, Jiming; Bethke, Paul C.			Vacuolar Invertase Gene Silencing in Potato (Solanum tuberosum L.) Improves Processing Quality by Decreasing the Frequency of Sugar-End Defects	PLOS ONE			English	Article							RUSSET-BURBANK POTATOES; FREE AMINO-ACIDS; ACRYLAMIDE FORMATION; MAILLARD REACTION; REDUCING SUGAR; BASAL PORTIONS; STARCH CONTENT; DNA VARIATION; FRENCH FRIES; WATER-STRESS	Sugar-end defect is a tuber quality disorder and persistent problem for the French fry processing industry that causes unacceptable darkening of one end of French fries. This defect appears when environmental stress during tuber growth increases post-harvest vacuolar acid invertase activity at one end of the tuber. Reducing sugars produced by invertase form dark-colored Maillard reaction products during frying. Acrylamide is another Maillard reaction product formed from reducing sugars and acrylamide consumption has raised health concerns worldwide. Vacuolar invertase gene (VInv) expression was suppressed in cultivars Russet Burbank and Ranger Russet using RNA interference to determine if this approach could control sugar-end defect formation. Acid invertase activity and reducing sugar content decreased at both ends of tubers. Sugar-end defects and acrylamide in fried potato strips were strongly reduced in multiple transgenic potato lines. Thus vacuolar invertase silencing can minimize a long-standing French fry quality problem while providing consumers with attractive products that reduce health concerns related to dietary acrylamide.	[Zhu, Xiaobiao; Chamberlain, Patrick; Bussan, Alvin J.; Jiang, Jiming; Bethke, Paul C.] Univ Wisconsin, Dept Hort, Madison, WI 53706 USA; [Richael, Craig] JR Simplot Co, Simplot Plant Sci, Boise, ID 83707 USA; [Busse, James S.; Bethke, Paul C.] USDA, Vegetable Crops Res Unit, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA)	Richael, C (corresponding author), JR Simplot Co, Simplot Plant Sci, Boise, ID 83707 USA.	Craig.Richael@simplot.com; jjiang1@wisc.edu; paul.bethke@ars.usda.gov	Jiang, Jiming/A-9614-2009; Jiang, Jiming/V-6060-2019	Jiang, Jiming/0000-0002-6435-6140; Jiang, Jiming/0000-0002-6435-6140; Bethke, Paul/0000-0001-7507-9962	WI DATCP Specialty Crop Research Initiative Block Grant Program; USDA NIFA Specialty Crop Research Initiative; Hatch funds	WI DATCP Specialty Crop Research Initiative Block Grant Program; USDA NIFA Specialty Crop Research Initiative; Hatch funds	This research was supported by grants from the WI DATCP Specialty Crop Research Initiative Block Grant Program and the USDA NIFA Specialty Crop Research Initiative to A.J.B., J.J., and P.C.B., and Hatch funds to J.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrein TM, 2003, J AGR FOOD CHEM, V51, P5556, DOI 10.1021/jf034344v; Becalski A, 2004, J AGR FOOD CHEM, V52, P3801, DOI 10.1021/jf0349376; Bethke PC, 2013, AM J POTATO RES, V90, P403, DOI 10.1007/s12230-013-9321-4; Bhaskar PB, 2010, PLANT PHYSIOL, V154, P939, DOI 10.1104/pp.110.162545; Chawla R, 2012, PLANT BIOTECHNOL J, V10, P913, DOI 10.1111/j.1467-7652.2012.00720.x; Chen X, 2001, THEOR APPL GENET, V102, P284, DOI 10.1007/s001220051645; Chuda Y, 2003, BIOSCI BIOTECH BIOCH, V67, P1188, DOI 10.1271/bbb.67.1188; Draffehn AM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-271; EC, 2011, COMM REC 10 1 2011 I; Eldredge EP, 1996, AM POTATO J, V73, P517, DOI 10.1007/BF02851697; Halford NG, 2012, J AGR FOOD CHEM, V60, P12044, DOI 10.1021/jf3037566; HEDLEY PE, 1994, GENE, V145, P211, DOI 10.1016/0378-1119(94)90007-8; Hogervorst JGF, 2010, CRIT REV TOXICOL, V40, P485, DOI 10.3109/10408440903524254; IRITANI WM, 1973, AM POTATO J, V50, P389, DOI 10.1007/BF02852203; IRITANI WM, 1973, AM POTATO J, V50, P24, DOI 10.1007/BF02851516; IRITANI WM, 1978, AM POTATO J, V55, P239, DOI 10.1007/BF02852131; IRITANI WM, 1973, AM POTATO J, V50, P223, DOI 10.1007/BF02849356; IRITANI WM, 1981, AM POTATO J, V58, P71, DOI 10.1007/BF02855381; Jackson LS, 2009, J AGR FOOD CHEM, V57, P8161, DOI 10.1021/jf900628u; KINCAID DC, 1993, AM POTATO J, V70, P711, DOI 10.1007/BF02848677; Kumar D, 2004, ANN APPL BIOL, V145, P247, DOI 10.1111/j.1744-7348.2004.tb00380.x; Li L, 2005, GENETICS, V170, P813, DOI 10.1534/genetics.104.040006; Li L, 2008, THEOR APPL GENET, V116, P1167, DOI 10.1007/s00122-008-0746-y; Li L, 2013, THEOR APPL GENET, V126, P1039, DOI 10.1007/s00122-012-2035-z; Lineback DR, 2012, ANNU REV FOOD SCI T, V3, P15, DOI 10.1146/annurev-food-022811-101114; Liu X, 2011, MOL GENET GENOMICS, V286, P109, DOI 10.1007/s00438-011-0632-1; LOISELLE F, 1990, AM POTATO J, V67, P633, DOI 10.1007/BF03043449; Mottram DS, 2002, NATURE, V419, P448, DOI 10.1038/419448a; NASS USDA, 2012, CROP PROD NOV 2012; National Potato Council (US), 2012, 2012 POT STAT YB; Parker JK, 2012, J AGR FOOD CHEM, V60, P9321, DOI 10.1021/jf302415n; Pavlista A.D., 1997, PROCESSING VEGETABLE, P237; PRITCHARD MK, 1992, AM POTATO J, V69, P805, DOI 10.1007/BF02854188; Richael CM, 2008, TRANSGENIC RES, V17, P905, DOI 10.1007/s11248-008-9175-6; Roitsch T, 2004, TRENDS PLANT SCI, V9, P606, DOI 10.1016/j.tplants.2004.10.009; SHOCK CC, 1994, AM POTATO J, V71, P77, DOI 10.1007/BF02849111; SHOCK CC, 1993, AM POTATO J, V70, P227, DOI 10.1007/BF02849311; SHOCK CC, 1992, AM POTATO J, V69, P793, DOI 10.1007/BF02854186; SOWOKINOS JR, 1985, PLANT PHYSIOL, V78, P489, DOI 10.1104/pp.78.3.489; Sowokinos JR, 2000, AM J POTATO RES, V77, P47, DOI 10.1007/BF02853661; Sowokinos JR, 2001, AM J POTATO RES, V78, P221, DOI 10.1007/BF02883548; Stadler RH, 2002, NATURE, V419, P449, DOI 10.1038/419449a; Stark J.C, 2003, POTATO PRODUCTION SY; Tareke E, 2002, J AGR FOOD CHEM, V50, P4998, DOI 10.1021/jf020302f; Thompson AL, 2008, AM J POTATO RES, V85, P375, DOI 10.1007/s12230-008-9034-2; van Boekel MAJS, 2006, BIOTECHNOL ADV, V24, P230, DOI 10.1016/j.biotechadv.2005.11.004; Vinci RM, 2012, FOOD CHEM, V133, P1138, DOI 10.1016/j.foodchem.2011.08.001; Wu L, 2011, CROP SCI, V51, P981, DOI 10.2135/cropsci2010.08.0473; Ye J, 2010, J AGR FOOD CHEM, V58, P12162, DOI 10.1021/jf1032262; ZHOU DB, 1994, PLANT PHYSIOL, V106, P397, DOI 10.1104/pp.106.1.397; Zrenner R, 1996, PLANTA, V198, P246, DOI 10.1007/BF00206250	51	28	32	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93381	10.1371/journal.pone.0093381	http://dx.doi.org/10.1371/journal.pone.0093381			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695527	Green Published, Green Submitted, gold			2022-12-25	WOS:000334103000065
J	Dawson, TF; Boone, AN; Senatore, A; Piticaru, J; Thiyagalingam, S; Jackson, D; Davison, A; Spafford, JD				Dawson, Taylor F.; Boone, Adrienne N.; Senatore, Adriano; Piticaru, Joshua; Thiyagalingam, Shano; Jackson, Daniel; Davison, Angus; Spafford, J. David			Gene Splicing of an Invertebrate Beta Subunit ( LCav beta) in the N-Terminal and HOOK Domains and Its Regulation of LCav1 and LCav2 Calcium Channels	PLOS ONE			English	Article							T-TYPE; PHYLOGENETIC ANALYSIS; CA2+ CHANNELS; MODULATION; INACTIVATION; EXPRESSION; IDENTIFICATION; MECHANISM; DEPLETION; COMPLEX	The accessory beta subunit ( Ca-v beta) of calcium channels first appear in the same genome as Ca(v)1 L- type calcium channels in single-celled coanoflagellates. The complexity of this relationship expanded in vertebrates to include four different possible Ca-v beta subunits ( beta 1, beta 2, beta 3, beta 4) which associate with four Ca(v)1 channel isoforms (Ca(v)1.1 to Ca(v)1.4) and three Ca-v channel isoforms ( Cav2.1 to Cav2.3). Here we assess the fundamentally- shared features of the Ca-v beta subunit in an invertebrate model ( pond snail Lymnaea stagnalis) that bears only three homologous genes: ( LCa(v)1, LCa(v)2, and LCav beta). Invertebrate Ca-v beta subunits ( in flatworms, snails, squid and honeybees) slow the inactivation kinetics of Ca(v)2 channels, and they do so with variable N- termini and lacking the canonical palmitoylation residues of the vertebrate b2a subunit. Alternative splicing of exon 7 of the HOOK domain is a primary determinant of a slow inactivation kinetics imparted by the invertebrate LCav beta subunit. LCav beta will also slow the inactivation kinetics of LCav beta T- type channels, but this is likely not physiologically relevant in vivo. Variable N- termini have little influence on the voltage- dependent inactivation kinetics of differing invertebrate Cavb subunits, but the expression pattern of N- terminal splice isoforms appears to be highly tissue specific. Molluscan LCav beta subunits have an N- terminal "A'' isoform (coded by exons: 1a and 1b) that structurally resembles the muscle specific variant of vertebrate b1a subunit, and has a broad mRNA expression profile in brain, heart, muscle and glands. A more variable "B'' N- terminus ( exon 2) in the exon position of mammalian b3 and has a more brain- centric mRNA expression pattern. Lastly, we suggest that the facilitation of closed- state inactivation ( e. g. observed in Ca(v)2.2 and Ca-v beta 3 subunit combinations) is a specialization in vertebrates, because neither snail subunit ( LCa(v)2 nor LCavCa beta) appears to be compatible with this observed property.	[Dawson, Taylor F.; Boone, Adrienne N.; Senatore, Adriano; Piticaru, Joshua; Thiyagalingam, Shano; Spafford, J. David] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Jackson, Daniel; Davison, Angus] Univ Nottingham, Sch Biol, Inst Genet, Nottingham NG7 2RD, England	University of Waterloo; University of Nottingham	Spafford, JD (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada.	spafford@uwaterloo.ca	Jackson, Daniel J./J-5158-2012; Davison, Angus/C-3156-2009	Jackson, Daniel J./0000-0001-9045-381X; Davison, Angus/0000-0003-2554-8585	Heart and Stroke Foundation of Canada; NSERC; NSERC Canada Graduate Scholarship; Ontario Graduate Scholarship award; Biotechnology and Biological Sciences Research Council [BB/F018940/1] Funding Source: researchfish; BBSRC [BB/F018940/1] Funding Source: UKRI	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Canada Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship award(Ontario Graduate Scholarship); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded through a Heart and Stroke Foundation of Canada Grant-In-Aid and NSERC Discovery Grant to J.D.S. and an NSERC Canada Graduate Scholarship and Ontario Graduate Scholarship award to A. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagor L, 2012, J NEUROSCI, V32, P7602, DOI 10.1523/JNEUROSCI.5727-11.2012; Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Arias JM, 2005, FEBS LETT, V579, P3907, DOI 10.1016/j.febslet.2005.06.008; Bae J, 2010, MOL CELLS, V30, P185, DOI 10.1007/s10059-010-0106-z; Berjukow S, 1996, BRIT J PHARMACOL, V118, P748, DOI 10.1111/j.1476-5381.1996.tb15463.x; Buraei Z, 2012, BIOCH BIOPHYS ACTA; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Canti C, 2001, BIOPHYS J, V81, P1439, DOI 10.1016/S0006-3495(01)75799-2; Cens T, 2013, PFLUG ARCH EUR J PHY, V465, P985, DOI 10.1007/s00424-013-1223-2; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; Christel C, 2012, BBA-GEN SUBJECTS, V1820, P1243, DOI 10.1016/j.bbagen.2011.12.012; Cohen RM, 2005, AM J PHYSIOL-HEART C, V288, pH2363, DOI 10.1152/ajpheart.00348.2004; Currie KPM, 2010, CHANNELS, V4, P497, DOI 10.4161/chan.4.6.12871; de Mendoza A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-93; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DEWAARD M, 1995, J BIOL CHEM, V270, P12056, DOI 10.1074/jbc.270.20.12056; Dolphin AC, 2012, BIOCH BIOPHYS ACTA; Dolphin AC, 2012, NAT REV NEUROSCI, V13, P542, DOI 10.1038/nrn3311; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; Dubel SJ, 2004, J BIOL CHEM, V279, P29263, DOI 10.1074/jbc.M313450200; Ebert AM, 2008, PHYSIOL GENOMICS, V35, P133, DOI 10.1152/physiolgenomics.90264.2008; Ebert AM, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-38; Fang K, 2011, J PHYSIOL-LONDON, V589, P4437, DOI 10.1113/jphysiol.2011.214247; Foell JD, 2004, PHYSIOL GENOMICS, V17, P183, DOI 10.1152/physiolgenomics.00207.2003; Fux J, ACCESSORY BETA SUBUN; Hanlon MR, 1999, FEBS LETT, V445, P366, DOI 10.1016/S0014-5793(99)00156-8; Hanlon MR, 2002, BIOCHEMISTRY-US, V41, P2886, DOI 10.1021/bi0119565; Harry JB, 2004, J BIOL CHEM, V279, P46367, DOI 10.1074/jbc.M409523200; Herzig S, 2007, FASEB J, V21, P1527, DOI 10.1096/fj.06-7377com; Hibino H, 2003, P NATL ACAD SCI USA, V100, P307, DOI 10.1073/pnas.0136791100; Huang X, 2010, J EXP BIOL, V213, P2094, DOI 10.1242/jeb.042242; Jangsangthong W, 2010, PFLUG ARCH EUR J PHY, V459, P399, DOI 10.1007/s00424-009-0738-z; Kimura T, 2003, NEUROSCI RES, V46, P105, DOI 10.1016/S0168-0102(03)00038-5; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; LACERDA AE, 1994, BIOPHYS J, V66, P1833, DOI 10.1016/S0006-3495(94)80977-4; Lambert RC, 1997, J NEUROSCI, V17, P6621; Leuranguer V, 1998, NEUROPHARMACOLOGY, V37, P701, DOI 10.1016/S0028-3908(98)00060-4; Li J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-337; Ly CV, 2008, J CELL BIOL, V181, P157, DOI 10.1083/jcb.200712152; Mangubat EZ, 2003, J MOL MICROB BIOTECH, V5, P216, DOI 10.1159/000071073; Miranda-Laferte E, 2012, J BIOL CHEM, V287, P32588, DOI 10.1074/jbc.M112.362509; Murakami M, 2007, BRAIN RES, V1160, P102, DOI 10.1016/j.brainres.2007.05.041; Obermair GJ, 2008, CURR OPIN PHARMACOL, V8, P311, DOI 10.1016/j.coph.2008.01.008; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Patil PG, 1998, NEURON, V20, P1027, DOI 10.1016/S0896-6273(00)80483-3; Patino GA, 2010, NEUROSCI LETT, V486, P53, DOI 10.1016/j.neulet.2010.06.050; Pongs O, 2010, PHYSIOL REV, V90, P755, DOI 10.1152/physrev.00020.2009; Qin N, 1998, P NATL ACAD SCI USA, V95, P4690, DOI 10.1073/pnas.95.8.4690; Restituito S, 2000, J NEUROSCI, V20, P9046; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richards MW, 2007, CHANNELS, V1, P92, DOI 10.4161/chan.4145; Rougier JS, 2011, J BIOL CHEM, V286, P8829, DOI 10.1074/jbc.M110.166520; Sadamoto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042546; Salvador-Recatala Vicenta, 2008, BMC Physiology, V8, P6, DOI 10.1186/1472-6793-8-6; Schredelseker J, 2005, P NATL ACAD SCI USA, V102, P17219, DOI 10.1073/pnas.0508710102; Senatore A., 2012, WIRES MEMBR TRANSP S, V1, P467, DOI DOI 10.1002/WMTS.41; Senatore A, 2013, CHANNELS AUSTIN, P7; Senatore A, 2014, J BIOL CHEM; Senatore A, 2011, JOVE-J VIS EXP, DOI 10.3791/2314; Senatore A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037409; Senatore A, 2011, CHANNELS, V5, P173, DOI 10.4161/chan.5.2.15141; Senatore A, 2010, J BIOL CHEM, V285, P7447, DOI 10.1074/jbc.M109.090753; Shepard S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007853; Spafford JD, 2006, J NEUROPHYSIOL, V95, P42, DOI 10.1152/jn.00658.2005; Spafford JD, 2004, J BIOL CHEM, V279, P41157, DOI 10.1074/jbc.M403781200; Spafford JD, 2003, J BIOL CHEM, V278, P21178, DOI 10.1074/jbc.M302212200; Subramanyam P, 2009, CHANNELS, V3, P343, DOI 10.4161/chan.3.5.9696; Taiakina V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061765; Tareilus E, 1997, P NATL ACAD SCI USA, V94, P1703, DOI 10.1073/pnas.94.5.1703; Tseng TT, 2007, J MOL MICROB BIOTECH, V12, P249, DOI 10.1159/000099646; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Velthuis AJWT, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-129; Vitko I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003560; Waithe D, 2011, J BIOL CHEM, V286, P9598, DOI 10.1074/jbc.M110.195909; WITCHER DR, 1993, SCIENCE, V261, P486, DOI 10.1126/science.8392754; Xu XF, 2011, J BIOL CHEM, V286, P9677, DOI 10.1074/jbc.M110.187864; Yasuda T, 2004, J GEN PHYSIOL, V123, P401, DOI 10.1085/jgp.200308967; Yasuda T, 2004, EUR J NEUROSCI, V20, P1, DOI 10.1111/j.1460-9568.2004.03434.x; Zhang Y, 2010, J BIOL CHEM, V285, P2527, DOI 10.1074/jbc.M109.022236; Zhang Y, 2008, J NEUROSCI, V28, P14176, DOI 10.1523/JNEUROSCI.1350-08.2008	81	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92941	10.1371/journal.pone.0092941	http://dx.doi.org/10.1371/journal.pone.0092941			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690951	gold, Green Published, Green Submitted			2022-12-25	WOS:000334101100036
J	Herrera, M; Salva, S; Villena, J; Barbieri, N; Marranzino, G; Alvarez, S				Herrera, Matias; Salva, Susana; Villena, Julio; Barbieri, Natalia; Marranzino, Gabriela; Alvarez, Susana			Dietary Supplementation with Lactobacilli Improves Emergency Granulopoiesis in Protein-Malnourished Mice and Enhances Respiratory Innate Immune Response	PLOS ONE			English	Article							BONE-MARROW; STREPTOCOCCUS-PNEUMONIAE; INFECTION; CASEI; MOBILIZATION; INFLAMMATION; GRANULOCYTE; EXPRESSION; CHEMOKINES; MOLECULES	This work studied the effect of protein malnutrition on the hemato-immune response to the respiratory challenge with Streptococcus pneumoniae and evaluated whether the dietary recovery with a probiotic strain has a beneficial effect in that response. Three important conclusions can be inferred from the results presented in this work: a) protein-malnutrition significantly impairs the emergency myelopoiesis induced by the generation of the innate immune response against pneumococcal infection; b) repletion of malnourished mice with treatments including nasally or orally administered Lactobacillus rhamnosus CRL1505 are able to significantly accelerate the recovery of granulopoiesis and improve innate immunity and; c) the immunological mechanisms involved in the protective effect of immunobiotics vary according to the route of administration. The study demonstrated that dietary recovery of malnourished mice with oral or nasal administration of L. rhamnosus CRL1505 improves emergency granulopoiesis and that CXCR4/CXCR12 signaling would be involved in this effect. Then, the results summarized here are a starting point for future research and open up broad prospects for future applications of probiotics in the recovery of immunocompromised malnourished hosts.	[Herrera, Matias; Salva, Susana; Villena, Julio; Barbieri, Natalia; Marranzino, Gabriela; Alvarez, Susana] Reference Ctr Lactobacilli CERELA CONICET, Immunobiot Res Grp, San Miguel De Tucuman, Argentina; [Herrera, Matias; Salva, Susana; Villena, Julio; Barbieri, Natalia; Alvarez, Susana] Reference Ctr Lactobacilli CERELA CONICET, Lab Immunobiotechnol, San Miguel De Tucuman, Argentina; [Alvarez, Susana] Tucuman Univ, Inst Appl Biochem, San Miguel De Tucuman, Argentina; [Marranzino, Gabriela] Natl Univ Tucuman, INSIBIO CONICET, San Miguel De Tucuman, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de Tucuman	Alvarez, S (corresponding author), Reference Ctr Lactobacilli CERELA CONICET, Immunobiot Res Grp, San Miguel De Tucuman, Argentina.	salvarez@cerela.org.ar		Salva, Susana/0000-0001-9571-1259	PIP [632-2009]; CIUNT [26 D/403]; PICT [1381]	PIP; CIUNT; PICT(ANPCyT)	This work was supported by grants from PIP 632-2009, CIUNT 26 D/403 and PICT 2010 No 1381. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero G, 2006, NUTRITION, V22, P810, DOI 10.1016/j.nut.2006.03.013; Alvarez S., 2009, RES ADV INFECT IMMUN, P1; Baldridge MT, 2011, TRENDS IMMUNOL, V32, P57, DOI 10.1016/j.it.2010.12.003; Barbieri N, 2013, J NUTR, V143, P227, DOI 10.3945/jn.112.165811; Benguigui Yehuda, 2006, Semin Pediatr Infect Dis, V17, P80, DOI 10.1053/j.spid.2006.04.006; Cain DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019957; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Czerkinsky C, 1999, IMMUNOL REV, V170, P197, DOI 10.1111/j.1600-065X.1999.tb01339.x; Czerkinsky C, 2012, CURR TOP MICROBIOL, V354, P1, DOI 10.1007/82_2010_112; Delano MJ, 2011, J IMMUNOL, V187, P911, DOI 10.4049/jimmunol.1100588; Dominis-Kramaric M, 2011, INFLAMMATION, V34, P471, DOI 10.1007/s10753-010-9255-7; Fillion I, 2001, J IMMUNOL, V166, P7353, DOI 10.4049/jimmunol.166.12.7353; Granick JL, 2012, BONE MARROW RES, DOI 10.1155/2012/165107; Kaushansky K, 2006, CYTOKINE GROWTH F R, V17, P423, DOI 10.1016/j.cytogfr.2006.09.005; Kim HK, 2006, BLOOD, V108, P812, DOI 10.1182/blood-2005-10-4162; Kirby AC, 2009, J IMMUNOL, V183, P1983, DOI 10.4049/jimmunol.0901089; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Link DC, 2005, IMMUNOL RES, V32, P169, DOI 10.1385/IR:32:1-3:169; Martin C, 2003, IMMUNITY, V19, P583, DOI 10.1016/S1074-7613(03)00263-2; Mestecky J, 2010, J REPROD IMMUNOL, V85, P81, DOI 10.1016/j.jri.2010.02.003; Metcalf D, 2008, BLOOD, V111, P485, DOI 10.1182/blood-2007-03-079681; Nie L, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-82; Okuno Y, 2002, P NATL ACAD SCI USA, V99, P6246, DOI 10.1073/pnas.092027799; Pavot V, 2012, VACCINE, V30, P142, DOI 10.1016/j.vaccine.2011.11.003; Racedo S, 2006, MICROBES INFECT, V8, P2359, DOI 10.1016/j.micinf.2006.04.022; Rodriguez L, 2011, J NEUROSCI REV, V31, P8373; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Salva S, 2008, FOOD AGR IMMUNOL, V19, P195, DOI 10.1080/09540100802247243; Salva S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031171; Salva S, 2011, J SCI FOOD AGR, V91, P2355, DOI 10.1002/jsfa.4467; Salva S, 2010, INT J FOOD MICROBIOL, V141, P82, DOI 10.1016/j.ijfoodmicro.2010.03.013; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Ueda Y, 2009, J IMMUNOL, V182, P6477, DOI 10.4049/jimmunol.0803961; Villena J, 2006, BRIT J NUTR, V95, P591, DOI 10.1079/BJN20051663; Villena J, 2005, J NUTR, V135, P1462, DOI 10.1093/jn/135.6.1462; Villena J., 2012, International Journal of Biotechnology for Wellness Industries, V1, P189; Villena J, 2011, INT IMMUNOPHARMACOL, V11, P1633, DOI 10.1016/j.intimp.2011.06.004; Vinderola G, 2006, CYTOKINE, V36, P254, DOI 10.1016/j.cyto.2007.01.003; Vituri CL, 2000, BRAZ J MED BIOL RES, V33, P889, DOI 10.1590/S0100-879X2000000800004; Wang EJ, 2001, INFECT IMMUN, V69, P5294, DOI 10.1128/IAI.69.9.5294-5304.2001; Yankelevich M, 2008, EXP HEMATOL, V36, P9, DOI 10.1016/j.exphem.2007.08.019; Zhang Z, 2003, EMBO J, V22, P4759, DOI 10.1093/emboj/cdg464; Zhu J, 2004, BIOESSAYS, V26, P595, DOI 10.1002/bies.20052	45	17	17	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e90227	10.1371/journal.pone.0090227	http://dx.doi.org/10.1371/journal.pone.0090227			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691464	Green Submitted, Green Published, gold			2022-12-25	WOS:000334101100008
J	Wang, Z; Wang, B; Shi, Y; Xu, C; Xiao, HL; Ma, LN; Xu, SL; Yang, L; Wang, QL; Dang, WQ; Cui, W; Yu, SC; Ping, YF; Cui, YH; Kung, HF; Qian, C; Zhang, X; Bian, XW				Wang, Z.; Wang, B.; Shi, Y.; Xu, C.; Xiao, H. L.; Ma, L. N.; Xu, S. L.; Yang, L.; Wang, Q. L.; Dang, W. Q.; Cui, W.; Yu, S. C.; Ping, Y. F.; Cui, Y. H.; Kung, H. F.; Qian, C.; Zhang, X.; Bian, X. W.			Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2	ONCOGENE			English	Article							FORMYLPEPTIDE RECEPTOR; MICRORNA POLYCISTRON; MIR-17-92 CLUSTER; TUMOR PROGRESSION; CANCER; PROLIFERATION; EXPRESSION; INVASION; BRAIN; DIFFERENTIATION	Emerging evidence has shown that cancer stem cells (CSCs) are the cellular determinants to promote cancer invasion and metastasis. However, the mechanism underlying CSC invasion remains unknown. MicroRNAs are evolutionally conserved small noncoding RNAs that are critical for the regulation of gene expression, and their expressions are often dysregulated in cancers. In the present study, we demonstrated that two functionally related microRNAs, miR-20a and -106a (miR-20a/106a), were capable of enhancing the invasiveness of CD133(+) glioma stem cells (GSCs) isolated from both glioblastoma cell line U87 and primary human glioma specimens. We found that the level of miR-20a/106a in GSCs was significantly higher than that in the committed CD133(-) glioma cells, and correlated with the invasive capability of GSCs. By bioinformatic analysis, we identified tissue inhibitor of metalloproteinases-2 (TIMP-2) as one of the miR-20a/106a-targeted genes. TIMP-2 level correlated inversely with miR-20/106 expression. Directly targeting by miR-20a/106a on 3'-untranslation region (3'-UTR) of TIMP-2 mRNA was confirmed by 3'-UTR dual-luciferase reporter assay. Knockdown of miR-20a/106a in GSCs increased endogenous TIMP-2 protein abundance, thereby inhibiting GSC invasion. We also found that Nordy, a synthetic lipoxygenase inhibitor, inhibited GSC invasiveness by elevating the expression of TIMP-2 via downregulation of miR-20a/106a. Our results indicate that miR-20a/106a has a key role in GSC invasion and may serve as targets for treatment of glioblastoma.	[Zhang, X.] Third Mil Med Univ, Southwest Hosp, Inst Pathol, Key Lab Tumor Immunopathol,Minist Educ China, Chongqing 400038, Peoples R China; Third Mil Med Univ, Southwest Hosp, Southwest Canc Ctr, Chongqing 400038, Peoples R China	Army Medical University; Ministry of Education, China; Army Medical University	Zhang, X (corresponding author), Third Mil Med Univ, Southwest Hosp, Inst Pathol, Key Lab Tumor Immunopathol,Minist Educ China, 30 Gaotanyan, Chongqing 400038, Peoples R China.	zhangxia45@gmail.com; zhangxia45@gmail.com; bianxiuwu@263.net	Zhang, Xia/B-8152-2008; Bian, Xiu-Wu/D-4736-2017	Zhang, Xia/0000-0002-9040-1486; Bian, Xiu-Wu/0000-0003-4383-0197; XU, CHUAN/0000-0002-5320-2277	National Natural Science Foundation of China (NSFC) [81101606, 81101631, 30725035, 30930103]; National Basic Research Program of China (973 Program) [2010CB529403]; Natural Science Foundation Project of CQ CSTC [CSTC2012JJA10124]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation Project of CQ CSTC(Natural Science Foundation Project of CQ CSTC)	We are grateful to our colleagues for helpful comments. This work was supported by the grants from National Natural Science Foundation of China (NSFC, Nos. 81101606, 81101631, 30725035 and 30930103), National Basic Research Program of China (973 Program, No. 2010CB529403) and Natural Science Foundation Project of CQ CSTC (CSTC2012JJA10124).	ALBINI A, 1991, J NATL CANCER I, V83, P775, DOI 10.1093/jnci/83.11.775; Ara T, 1998, J PEDIATR SURG, V33, P1272, DOI 10.1016/S0022-3468(98)90167-1; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bian XW, 2008, PROTEOMICS, V8, P484, DOI 10.1002/pmic.200700054; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Caraglia M, 2012, CURR CANCER DRUG TAR, V12, P185, DOI 10.2174/156800912799277458; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen JH, 2006, BIOCHEM BIOPH RES CO, V342, P1368, DOI 10.1016/j.bbrc.2006.02.113; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Croce CM, 2011, NAT MED, V17, P935, DOI 10.1038/nm0811-935; Davis F G, 2001, Expert Rev Anticancer Ther, V1, P395, DOI 10.1586/14737140.1.3.395; DECLERCK YA, 1991, CANCER RES, V51, P2151; Drappatz J, 2009, EXPERT REV NEUROTHER, V9, P519, DOI [10.1586/ern.09.10, 10.1586/ERN.09.10]; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Foshay KM, 2009, DEV BIOL, V326, P431, DOI 10.1016/j.ydbio.2008.11.016; Furstenberger G, 2006, INT J CANCER, V119, P2247, DOI 10.1002/ijc.22153; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Gunther HS, 2008, ONCOGENE, V27, P2897, DOI 10.1038/sj.onc.1210949; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hossain A, 2006, MOL CELL BIOL, V26, P8191, DOI 10.1128/MCB.00242-06; Hyde CAC, 2009, INT IMMUNOPHARMACOL, V9, P701, DOI 10.1016/j.intimp.2009.02.003; Imren S, 1996, CANCER RES, V56, P2891; Le Mercier M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045475; Legler JM, 1999, JNCI-J NATL CANCER I, V91, P1382, DOI 10.1093/jnci/91.16.1382; Li F, 2007, CELL RES, V17, P3, DOI 10.1038/sj.cr.7310118; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Liu JQ, 2011, CLIN CANCER RES, V17, P3638, DOI 10.1158/1078-0432.CCR-10-2456; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Nakada M, 2007, CELL MOL LIFE SCI, V64, P458, DOI 10.1007/s00018-007-6342-5; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Pidgeon GP, 2007, CANCER METAST REV, V26, P503, DOI 10.1007/s10555-007-9098-3; Ping YF, 2011, CURR MOL MED, V11, P69, DOI 10.2174/156652411794474383; Ping YF, 2011, J PATHOL, V224, P344, DOI 10.1002/path.2908; Ping YF, 2011, STEM CELLS, V29, P888, DOI 10.1002/stem.650; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Slack FJ, 2008, NEW ENGL J MED, V359, P2720, DOI 10.1056/NEJMe0808667; Uziel T, 2009, P NATL ACAD SCI USA, V106, P2812, DOI 10.1073/pnas.0809579106; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang B, 2011, STEM CELL REV REP, V7, P458, DOI 10.1007/s12015-010-9175-9; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Wong P, 2010, CANCER RES, V70, P3833, DOI 10.1158/0008-5472.CAN-09-3268; Xu C, 2013, CANCER RES, V73, P3181, DOI 10.1158/0008-5472.CAN-12-4403; Yang XJ, 2013, INT IMMUNOPHARMACOL, V15, P191, DOI 10.1016/j.intimp.2012.12.002; Yao XH, 2008, J PATHOL, V215, P369, DOI 10.1002/path.2356; Ye XZ, 2012, J IMMUNOL, V189, P444, DOI 10.4049/jimmunol.1103248; Yi L, 2007, MODERN PATHOL, V20, P1061, DOI 10.1038/modpathol.3800942; Yu SC, 2008, CANCER LETT, V265, P124, DOI 10.1016/j.canlet.2008.02.010; Yu SC, 2009, STEM CELL REV REP, V5, P66, DOI 10.1007/s12015-008-9047-8; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; Zhao Y, 2012, BIOCHEM BIOPH RES CO, V418, P647, DOI 10.1016/j.bbrc.2012.01.068	58	99	106	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 12	2015	34	11					1407	1419		10.1038/onc.2014.75	http://dx.doi.org/10.1038/onc.2014.75			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CD1AR	24704830				2022-12-25	WOS:000350806500007
J	Balasubramanian, A; Kawahara, G; Gupta, VA; Rozkalne, A; Beauvais, A; Kunkel, LM; Gussoni, E				Balasubramanian, Anuradha; Kawahara, Genri; Gupta, Vandana A.; Rozkalne, Anete; Beauvais, Ariane; Kunkel, Louis M.; Gussoni, Emanuela			Fam65b is important for formation of the HDAC6-dysferlin protein complex during myogenic cell differentiation	FASEB JOURNAL			English	Article						myoblast; acetylation; zebrafish; muscular dystrophy	GIRDLE MUSCULAR-DYSTROPHY; HISTONE DEACETYLASE INHIBITORS; MEF2 TRANSCRIPTION FACTOR; MYOBLAST FUSION; MUSCLE DIFFERENTIATION; SKELETAL MYOGENESIS; ADHESION MOLECULE; ZEBRAFISH EMBRYOS; MEMBRANE REPAIR; NUCLEAR EXPORT	Previously, we identified family with sequence similarity 65, member B (Fam65b), as a protein transiently up-regulated during differentiation and fusion of human myogenic cells. Silencing of Fam65b expression results in severe reduction of myogenin expression and consequent lack of myoblast fusion. The molecular function of Fam65b and whether misregulation of its expression could be causative of muscle diseases are unknown. Protein pulldowns were used to identify Fam65b-interacting proteins in differentiating human muscle cells and regenerating muscle tissue. In vitro, human muscle cells were treated with histone-deacetylase (HDAC) inhibitors, and expression of Fam65b and interacting proteins was studied. Nontreated cells were used as controls. In vivo, expression of Fam65b was downregulated in developing zebrafish to determine the effects on muscle development. Fam65b binds to HDAC6 and dysferlin, the protein mutated in limb girdle muscular dystrophy 2B. The tricomplex Fam65b-HDAC6-dysferlin is transient, and Fam65b expression is necessary for the complex to form. Treatment of myogenic cells with pan-HDAC or HDAC6-specific inhibitors alters Fam65b expression, while dysferlin expression does not change. Inhibition of Fam65b expression in developing zebrafish results in abnormal muscle, with low birefringence, tears at the myosepta, and increased embryo lethality. Fam65b is an essential component of the HDAC6-dysferlin complex. Down-regulation of Fam65b in developing muscle causes changes consistent with muscle disease.	[Balasubramanian, Anuradha; Kawahara, Genri; Gupta, Vandana A.; Rozkalne, Anete; Kunkel, Louis M.; Gussoni, Emanuela] Boston Childrens Hosp, Program Genom, Boston, MA 02115 USA; [Balasubramanian, Anuradha; Kawahara, Genri; Gupta, Vandana A.; Rozkalne, Anete; Kunkel, Louis M.; Gussoni, Emanuela] Boston Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Kunkel, Louis M.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Beauvais, Ariane] Ottawa Hosp Res Inst, Regenerat Med Program, Ottawa, ON, Canada; [Kunkel, Louis M.; Gussoni, Emanuela] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University of Ottawa; Ottawa Hospital Research Institute; Harvard University; Harvard Medical School	Gussoni, E (corresponding author), Boston Childrens Hosp, Div Genet & Genom, 3 Blackfan Circle, Boston, MA 02115 USA.	gussoni@enders.tch.harvard.edu	Gussoni, Emanuela/AAL-6150-2021	Gussoni, Emanuela/0000-0002-9915-3677; Gupta, Vandana/0000-0002-4057-8451	U.S. National Institute of Child Health and Human Development; U.S. National Institutes of Health [1R01AR060317-01]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR062601, R01AR060317] Funding Source: NIH RePORTER	U.S. National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors are grateful to Dr. Matthew Alexander, Dr. Natassia Vieira, and Dr. Angela Lek for helpful discussions. The authors thank Suzan Lazo-Kallanian (Hematologic Neoplasia Core facility, Dana Farber Cancer Institute, Boston, MA, USA) for assistance with the FACS isolation of primary myoblasts. The F59 antibody developed by F. E. Stockdale was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the U.S. National Institute of Child Health and Human Development and maintained by the University of Iowa (Iowa City, IA, USA). The authors thank Dr. Stuart L. Schreiber and Dr. Ralph Mazitschek (Harvard University, Cambridge, MA, USA) for their generous gift of tubacin and niltubacin inhibitors. This work was supported by the U.S. National Institutes of Health (1R01AR060317-01 to E. G.). The authors declare no conflicts of interest.	Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; Azakir BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010122; Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Bakay M, 2006, BRAIN, V129, P996, DOI 10.1093/brain/awl023; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Bassett DI, 2003, DEVELOPMENT, V130, P5851, DOI 10.1242/dev.00799; Bassett DI, 2003, HUM MOL GENET, V12, pR265, DOI 10.1093/hmg/ddg279; Bentzinger CF, 2012, COLD SPRING HARB PER, V4; BISCHOFF R, 1969, J CELL BIOL, V41, P188, DOI 10.1083/jcb.41.1.188; Boyault C, 2007, ONCOGENE, V26, P5468, DOI 10.1038/sj.onc.1210614; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Cerletti M, 2006, J CELL SCI, V119, P3117, DOI 10.1242/jcs.03056; Chang SR, 2005, P NATL ACAD SCI USA, V102, P8120, DOI 10.1073/pnas.0503275102; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Colussi C, 2010, PROTEOM CLIN APPL, V4, P71, DOI 10.1002/prca.200900116; Conacci-Sorrell M, 2011, CELL CYCLE, V10, P604, DOI 10.4161/cc.10.4.14794; Conacci-Sorrell M, 2010, CELL, V142, P480, DOI 10.1016/j.cell.2010.06.037; Consalvi S, 2011, MOL MED, V17, P457, DOI 10.2119/molmed.2011.00049; Davis DB, 2000, HUM MOL GENET, V9, P217, DOI 10.1093/hmg/9.2.217; de Luna N, 2006, J BIOL CHEM, V281, P17092, DOI 10.1074/jbc.M601885200; Demonbreun AR, 2010, FASEB J, V24, P1284, DOI 10.1096/fj.09-136309; di Bari MG, 2006, EMBO REP, V7, P727, DOI 10.1038/sj.embor.7400700; Di Fulvio S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028563; Doherty KR, 2005, DEVELOPMENT, V132, P5565, DOI 10.1242/dev.02155; Etard C, 2010, J CELL BIOL, V189, P527, DOI 10.1083/jcb.200912125; Glover LE, 2010, ANN NEUROL, V67, P384, DOI 10.1002/ana.21926; GUNDERSEN GG, 1989, J CELL BIOL, V109, P2275, DOI 10.1083/jcb.109.5.2275; Guyon JR, 2007, BBA-MOL BASIS DIS, V1772, P205, DOI 10.1016/j.bbadis.2006.07.003; Guyon JR, 2005, EXP CELL RES, V304, P105, DOI 10.1016/j.yexcr.2004.10.032; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Iezzi S, 2004, DEV CELL, V6, P673, DOI 10.1016/S1534-5807(04)00107-8; Kawahara G, 2011, BIOCHEM BIOPH RES CO, V413, P358, DOI 10.1016/j.bbrc.2011.08.105; Kawahara G, 2010, HUM MOL GENET, V19, P623, DOI 10.1093/hmg/ddp528; KONIGSBERG IR, 1971, DEV BIOL, V26, P133, DOI 10.1016/0012-1606(71)90113-8; Kozikowski AP, 2008, J MED CHEM, V51, P4370, DOI 10.1021/jm8002894; Lapan AD, 2012, HUM MOL GENET, V21, P3668, DOI 10.1093/hmg/dds196; Lapan AD, 2012, METHODS MOL BIOL, V798, P3, DOI 10.1007/978-1-61779-343-1_1; Lek A, 2013, J NEUROSCI, V33, P5085, DOI 10.1523/JNEUROSCI.3560-12.2013; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Lo HP, 2008, NEUROMUSCULAR DISORD, V18, P34, DOI 10.1016/j.nmd.2007.08.009; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2001, MOL CELL BIOL, V21, P6312, DOI 10.1128/MCB.21.18.6312-6321.2001; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Nebbioso A, 2020, EMBO REP, V21, DOI [10.1038/embor.2009.88, 10.15252/embr.202051028]; Nguyen DX, 2004, EMBO J, V23, P1609, DOI 10.1038/sj.emboj.7600176; Nishino TG, 2008, BIOCHEM BIOPH RES CO, V377, P852, DOI 10.1016/j.bbrc.2008.10.079; Rahimov F, 2011, PHYSIOL GENOMICS, V43, P398, DOI 10.1152/physiolgenomics.00223.2010; Rey M, 2011, EUR J CELL BIOL, V90, P128, DOI 10.1016/j.ejcb.2010.09.004; Rochlin K, 2010, DEV BIOL, V341, P66, DOI 10.1016/j.ydbio.2009.10.024; Schejter ED, 2010, CURR OPIN CELL BIOL, V22, P566, DOI 10.1016/j.ceb.2010.08.009; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; von der Hagen M, 2005, NEUROMUSCULAR DISORD, V15, P863, DOI 10.1016/j.nmd.2005.09.002; Welle S, 2009, AM J PHYSIOL-ENDOC M, V296, pE567, DOI 10.1152/ajpendo.90862.2008; Wu Y, 2010, J BIOL CHEM, V285, P3554, DOI 10.1074/jbc.M109.063354; YAFFE D, 1965, DEV BIOL, V11, P300, DOI 10.1016/0012-1606(65)90062-X; Yoon S, 2007, DEV BIOL, V301, P70, DOI 10.1016/j.ydbio.2006.11.002; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zilberman Y, 2009, J CELL SCI, V122, P3531, DOI 10.1242/jcs.046813	66	16	23	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					2955	2969		10.1096/fj.13-246470	http://dx.doi.org/10.1096/fj.13-246470			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24687993	Green Published			2022-12-25	WOS:000337949400019
J	Sotelo, P; Farfan, P; Benitez, ML; Bu, GJ; Marzolo, MP				Sotelo, Pablo; Farfan, Pamela; Luisa Benitez, Maria; Bu, Guojun; Marzolo, Maria-Paz			Sorting Nexin 17 Regulates ApoER2 Recycling and Reelin Signaling	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; AMYLOID PRECURSOR PROTEIN; TYROSINE PHOSPHORYLATION; SYNAPTIC PLASTICITY; GAMMA-SECRETASE; P-SELECTIN; COFILIN PHOSPHORYLATION; HIPPOCAMPAL-NEURONS; PLASMA-MEMBRANE; BETA PRODUCTION	ApoER2 is a member of the low density-lipoprotein receptor (LDL-R) family. As a receptor for reelin, ApoER2 participates in neuronal migration during development as well as synaptic plasticity and survival in the adult brain. A previous yeast two-hybrid screen showed that ApoER2 is a binding partner of sorting nexin 17 (SNX17) -a cytosolic adaptor protein that regulates the trafficking of several membrane proteins in the endosomal pathway, including LRP1, P-selectin and integrins. However, no further studies have been performed to investigate the role of SNX17 in ApoER2 trafficking and function. In this study, we present evidence based on GST pull-down and inmunoprecipitation assays that the cytoplasmic NPxY endocytosis motif of ApoER2 interacts with the FERM domain of SNX17. SNX17 stimulates ApoER2 recycling in different cell lines including neurons without affecting its endocytic rate and also facilitates the transport of ApoER2 from the early endosomes to the recycling endosomes. The reduction of SNX17 was associated with accumulation of an ApoER2 carboxyterminal fragment (CTF). In addition, in SNX17 knockdown cells, constitutive ApoER2 degradation was not modified, whereas reelin-induced ApoER2 degradation was increased, implying that SNX17 is a regulator of the receptor's half-life. Finally, in SNX17 silenced hippocampal and cortical neurons, we underscored a positive role of this endosomal protein in the development of the dendritic tree and reelin signaling. Overall, these results establish the role of SNX17 in ApoER2 trafficking and function and aid in identifying new links between endocytic trafficking and receptor signaling.	[Sotelo, Pablo; Farfan, Pamela; Luisa Benitez, Maria; Marzolo, Maria-Paz] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Cellular & Mol Biol, Millenium Nucleus Renerat Biol MINREB, Santiago, Chile; [Bu, Guojun] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA	Pontificia Universidad Catolica de Chile; Mayo Clinic	Marzolo, MP (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Cellular & Mol Biol, Millenium Nucleus Renerat Biol MINREB, Santiago, Chile.	mmarzolo@bio.puc.cl	Torres, Pablo Hernán Sotelo/X-7012-2019	Torres, Pablo Hernán Sotelo/0000-0002-6473-2134	Fondo Nacional de Ciencia y Tecnologia, FONDECYT [1110382]; Millenium Nucleus in Regenerative Biology (MINREB) [P-07-011-F]; NATIONAL INSTITUTE ON AGING [R01AG027924, P01AG030128] Funding Source: NIH RePORTER	Fondo Nacional de Ciencia y Tecnologia, FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Millenium Nucleus in Regenerative Biology (MINREB); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Fondo Nacional de Ciencia y Tecnologia, FONDECYT, grant # 1110382 and the Millenium Nucleus in Regenerative Biology (MINREB), P-07-011-F (Iniciativa Cientifica Milenio, Ministerio de Economia, Fomento y Turismo) to MPM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi H, 2010, BBA-MOL CELL RES, V1803, P553, DOI 10.1016/j.bbamcr.2010.02.011; Aniento Fernando, 2004, Curr Protoc Protein Sci, VChapter 4, DOI 10.1002/0471140864.ps0403s32; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Beffert U, 2006, J NEUROSCI, V26, P2041, DOI 10.1523/JNEUROSCI.4566-05.2006; Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; Beffert U, 2002, J BIOL CHEM, V277, P49958, DOI 10.1074/jbc.M209205200; Benhayon D, 2003, MOL BRAIN RES, V112, P33, DOI 10.1016/S0169-328X(03)00032-9; Betts GN, 2008, J BIOL CHEM, V283, P15656, DOI 10.1074/jbc.M709514200; Bock HH, 2003, J BIOL CHEM, V278, P38772, DOI 10.1074/jbc.M306416200; Bottcher RT, 2012, NAT CELL BIOL, V14, P584, DOI 10.1038/ncb2501; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Burden JJ, 2004, J BIOL CHEM, V279, P16237, DOI 10.1074/jbc.M313689200; Carlton JG, 2005, CURR BIOL, V15, pR819, DOI 10.1016/j.cub.2005.10.012; Chai Xuejun, 2009, Commun Integr Biol, V2, P375; Chai XJ, 2009, J NEUROSCI, V29, P288, DOI 10.1523/JNEUROSCI.2934-08.2009; Chen Y, 2005, J NEUROSCI, V25, P8209, DOI 10.1523/JNEUROSCI.1951-05.2005; Chyung JH, 2003, J BIOL CHEM, V278, P51035, DOI 10.1074/jbc.M304989200; Cuitino L, 2005, TRAFFIC, V6, P820, DOI 10.1111/j.1600-0854.2005.00320.x; Czubayko M, 2006, BIOCHEM BIOPH RES CO, V345, P1264, DOI 10.1016/j.bbrc.2006.04.129; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; Donoso M, 2009, MOL BIOL CELL, V20, P481, DOI 10.1091/mbc.E08-08-0805; Duit S, 2010, J BIOL CHEM, V285, P4896, DOI 10.1074/jbc.M109.025973; Dumanchin C, 1999, HUM MOL GENET, V8, P1263, DOI 10.1093/hmg/8.7.1263; Farfan P, 2013, TRAFFIC, V14, P823, DOI 10.1111/tra.12076; Florian V, 2001, BIOCHEM BIOPH RES CO, V281, P1045, DOI 10.1006/bbrc.2001.4467; Frotscher M, 2003, CEREB CORTEX, V13, P634, DOI 10.1093/cercor/13.6.634; Frykman S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008948; Fuentealba RA, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-14; Fuentealba RA, 2009, J BIOL CHEM, V284, P34045, DOI 10.1074/jbc.M109.021030; Ghai R, 2013, P NATL ACAD SCI USA, V110, pE643, DOI 10.1073/pnas.1216229110; Ghai R, 2011, P NATL ACAD SCI USA, V108, P7763, DOI 10.1073/pnas.1017110108; He XY, 2007, J NEUROSCI, V27, P4052, DOI 10.1523/JNEUROSCI.3993-06.2007; Herrick TM, 2004, MOL BRAIN RES, V126, P121, DOI 10.1016/j.molbrainres.2004.03.022; Herz J, 2006, NAT REV NEUROSCI, V7, P850, DOI 10.1038/nrn2009; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Hoe HS, 2006, J BIOL CHEM, V281, P3425, DOI 10.1074/jbc.M509380200; Hoe HS, 2005, MOL BRAIN RES, V137, P31, DOI 10.1016/j.molbrainres.2005.02.013; Hoe HS, 2008, J BIOL CHEM, V283, P6288, DOI 10.1074/jbc.M704140200; Hoe HS, 2007, J NEUROSCI, V27, P10895, DOI 10.1523/JNEUROSCI.3135-07.2007; Hoe HS, 2006, J BIOL CHEM, V281, P35176, DOI 10.1074/jbc.M602162200; Hoe HS, 2006, J BIOL CHEM, V281, P24521, DOI 10.1074/jbc.M600728200; Hoe HS, 2009, J NEUROSCI, V29, P7459, DOI 10.1523/JNEUROSCI.4872-08.2009; Hong C, 2010, J BIOL CHEM, V285, P19720, DOI 10.1074/jbc.M110.123729; Howell BW, 2000, CURR BIOL, V10, P877, DOI 10.1016/S0960-9822(00)00608-4; Kim DH, 1996, J BIOL CHEM, V271, P8373, DOI 10.1074/jbc.271.14.8373; Knauth P, 2005, J MOL BIOL, V347, P813, DOI 10.1016/j.jmb.2005.02.004; Kruger MT, 2010, EUR J NEUROSCI, V32, P1611, DOI 10.1111/j.1460-9568.2010.07433.x; Lah JJ, 2000, MOL CELL NEUROSCI, V16, P111, DOI 10.1006/mcne.2000.0861; Larios Jorge A, 2012, [Frontiers in Biology, 生物学前沿], V7, P113; Lee JY, 2008, J BIOL CHEM, V283, P11501, DOI 10.1074/jbc.M800642200; Lorenzetto E, 2008, EUR J NEUROSCI, V27, P12, DOI 10.1111/j.1460-9568.2007.05978.x; Mangasarian A, 1997, IMMUNITY, V6, P67, DOI 10.1016/S1074-7613(00)80243-5; Marzolo MP, 2009, SEMIN CELL DEV BIOL, V20, P191, DOI 10.1016/j.semcdb.2008.10.005; May P, 2003, J BIOL CHEM, V278, P37386, DOI 10.1074/jbc.M305858200; May P, 2004, MOL CELL BIOL, V24, P8872, DOI 10.1128/MCB.24.20.8872-8883.2004; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Niu S, 2004, NEURON, V41, P71, DOI 10.1016/S0896-6273(03)00819-5; Niu SY, 2008, J NEUROSCI, V28, P10339, DOI 10.1523/JNEUROSCI.1917-08.2008; Novak S, 1996, J BIOL CHEM, V271, P11732, DOI 10.1074/jbc.271.20.11732; Prekeris R, 1998, J CELL BIOL, V143, P957, DOI 10.1083/jcb.143.4.957; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Sacre SM, 2003, FEBS LETT, V540, P181, DOI 10.1016/S0014-5793(03)00261-8; Senturk A, 2011, NATURE, V472, P356, DOI 10.1038/nature09874; Sinagra M, 2005, J NEUROSCI, V25, P6127, DOI 10.1523/JNEUROSCI.1757-05.2005; Steinberg F, 2012, J CELL BIOL, V197, P219, DOI 10.1083/jcb.201111121; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Stockinger W, 2002, EMBO J, V21, P4259, DOI 10.1093/emboj/cdf435; Strasser V, 2004, MOL CELL BIOL, V24, P1378, DOI 10.1128/MCB.24.3.1378-1386.2004; Trischler M, 1999, J CELL SCI, V112, P4773; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; van Kerkhof P, 2005, EMBO J, V24, P2851, DOI 10.1038/sj.emboj.7600756; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Williams R, 2004, MOL BIOL CELL, V15, P3095, DOI 10.1091/mbc.E04-02-0143; Wu P, 2008, BRAIN RES, V1208, P1, DOI 10.1016/j.brainres.2008.02.092; Yuseff MI, 2007, TRAFFIC, V8, P1215, DOI 10.1111/j.1600-0854.2007.00601.x; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974	80	27	27	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93672	10.1371/journal.pone.0093672	http://dx.doi.org/10.1371/journal.pone.0093672			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705369	Green Published, gold, Green Submitted			2022-12-25	WOS:000334107500054
J	Xiang, QJ; Judelson, HS				Xiang, Qijun; Judelson, Howard S.			Myb Transcription Factors and Light Regulate Sporulation in the Oomycete Phytophthora infestans	PLOS ONE			English	Article							ASEXUAL SPORULATION; GENE-EXPRESSION; SPORANGIA; SEQUENCES; PCR; REVEALS; FUNGI; STAGE; CYCLE	Life cycle progression in eukaryotic microbes is often influenced by environment. In the oomycete Phytophthora infestans, which causes late blight on potato and tomato, sporangia have been reported to form mostly at night. By growing P. infestans under different light regimes at constant temperature and humidity, we show that light contributes to the natural pattern of sporulation by delaying sporulation until the following dark period. However, illumination does not permanently block sporulation or strongly affect the total number of sporangia that ultimately form. Based on measurements of sporulation-induced genes such as those encoding protein kinase Pks1 and Myb transcription factors Myb2R1 and Myb2R3, it appears that most spore-associated transcripts start to rise four to eight hours before sporangia appear. Their mRNA levels oscillate with the light/dark cycle and increase with the amount of sporangia. An exception to this pattern of expression is Myb2R4, which is induced several hours before the other genes and declines after cultures start to sporulate. Transformants over-expressing Myb2R4 produce twice the number of sporangia and ten-fold higher levels of Myb2R1 mRNA than wildtype, and chromatin immunoprecipitation showed that Myb2R4 binds the Myb2R1 promoter in vivo. Myb2R4 thus appears to be an early regulator of sporulation. We attempted to silence eight Myb genes by DNA-directed RNAi, but succeeded only with Myb2R3, which resulted in suppressed sporulation. Ectopic expression studies of seven Myb genes revealed that over-expression frequently impaired vegetative growth, and in the case of Myb3R6 interfered with sporangia dormancy. We observed that the degree of silencing induced by a hairpin construct was correlated with its copy number, and ectopic expression was often unstable due to epigenetic silencing and transgene excision.	[Xiang, Qijun; Judelson, Howard S.] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Judelson, HS (corresponding author), Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA.	howard.judelson@ucr.edu			National Institute of Agriculture of the United States Department of Agriculture; National Science Foundation; Div Of Molecular and Cellular Bioscience [1120225] Funding Source: National Science Foundation	National Institute of Agriculture of the United States Department of Agriculture; National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by awards to H.S.J. from the National Institute of Agriculture of the United States Department of Agriculture and the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ah-Fong AMV, 2008, FUNGAL GENET BIOL, V45, P1197, DOI 10.1016/j.fgb.2008.05.009; Ah-Fong AMV, 2011, FUNGAL BIOL-UK, V115, P882, DOI 10.1016/j.funbio.2011.07.001; Aylor DE, 2001, PHYTOPATHOLOGY, V91, P1189, DOI 10.1094/PHYTO.2001.91.12.1189; Bahn YS, 2007, NAT REV MICROBIOL, V5, P57, DOI 10.1038/nrmicro1578; Barrantes I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-115; BERGMAN K, 1972, PLANTA, V107, P53, DOI 10.1007/BF00398014; Blanco FA, 2005, MOL MICROBIOL, V56, P638, DOI 10.1111/j.1365-2958.2005.04575.x; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; COHEN Y, 1975, CAN J BOT, V53, P2680, DOI 10.1139/b75-296; Collick A, 1996, EMBO J, V15, P1163, DOI 10.1002/j.1460-2075.1996.tb00455.x; DAHLBERG KR, 1982, ANNU REV PHYTOPATHOL, V20, P281, DOI 10.1146/annurev.py.20.090182.001433; Daiyasu H, 2004, GENES CELLS, V9, P479, DOI 10.1111/j.1356-9597.2004.00738.x; DE WEILLE G. A., 1963, EUROPEAN POTATO JOUR, V6, P121; DEKKER EJ, 1993, MECH DEVELOP, V40, P3, DOI 10.1016/0925-4773(93)90083-A; Erwin D. C., 1996, Phytophthora diseases worldwide.; Fladung M, 1999, MOL GEN GENET, V260, P574, DOI 10.1007/s004380050931; Fong AMVA, 2003, MOL MICROBIOL, V50, P487, DOI 10.1046/j.1365-2958.2003.03735.x; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Gaulin E, 2007, CAN J MICROBIOL, V53, P152, DOI 10.1139/W06-090; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hardham AR, 1997, ADV BOT RES, V24, P353; HARNISH WN, 1965, MYCOLOGIA, V57, P85, DOI 10.2307/3756711; HARRISON JG, 1989, PLANT PATHOL, V38, P585, DOI 10.1111/j.1365-3059.1989.tb01455.x; Judelson HS, 2008, MOL PLANT MICROBE IN, V21, P433, DOI 10.1094/MPMI-21-4-0433; Judelson HS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-700; JUDELSON HS, 1995, CURR GENET, V28, P571, DOI 10.1007/BF00518171; JUDELSON HS, 1992, MOL GEN GENET, V234, P138, DOI 10.1007/BF00272355; JUDELSON HS, 1993, MOL GEN GENET, V239, P241, DOI 10.1007/BF00281624; Jung T, 2002, MYCOL RES, V106, P397, DOI 10.1017/S0953756202005622; Kim KS, 2003, EUKARYOT CELL, V2, P1376, DOI 10.1128/EC.2.6.1376-1385.2003; Latijnhouwers M, 2003, EUKARYOT CELL, V2, P971, DOI 10.1128/EC.2.5.971-977.2003; MALTESE CE, 1995, MYCOL RES, V99, P1175, DOI 10.1016/S0953-7562(09)80273-6; Medeiros AO, 2009, FRESHWATER BIOL, V54, P142, DOI 10.1111/j.1365-2427.2008.02101.x; Mizubuti ESG, 2000, PHYTOPATHOLOGY, V90, P78, DOI 10.1094/PHYTO.2000.90.1.78; Nielsen B. J., 2007, Proceedings of the Tenth Workshop of an European Network for Development of an Integrated Control Strategy of Potato Late Blight, Bologna, Italy, 2-5 May 2007, P211; OERTEL B, 1986, PROTOPLASMA, V135, P173, DOI 10.1007/BF01277011; Olmedo M, 2013, FUNGAL BIOL REV, V27, P10, DOI 10.1016/j.fbr.2013.02.004; Park HS, 2012, CURR OPIN MICROBIOL, V15, P669, DOI 10.1016/j.mib.2012.09.006; Ribeiro OK., 1983, PHYTOPHTHORA ITS BIO, P55; Rodriguez-Romero J, 2010, ANNU REV MICROBIOL, V64, P585, DOI 10.1146/annurev.micro.112408.134000; ROTEM J, 1978, ANNU REV PHYTOPATHOL, V16, P83, DOI 10.1146/annurev.py.16.090178.000503; Ruger-Herreros C, 2011, GENETICS, V188, P809, DOI 10.1534/genetics.111.130096; Sakai R, 1957, ANN PHYTOPATHOL SOC, V22, P211; SARGENT ML, 1972, PLANT PHYSIOL, V50, P171, DOI 10.1104/pp.50.1.171; Sheppard DC, 2005, MOL BIOL CELL, V16, P5866, DOI 10.1091/mbc.E05-07-0617; Smaczniak C, 2012, P NATL ACAD SCI USA, V109, P1560, DOI 10.1073/pnas.1112871109; Stam M, 1997, ANN BOT-LONDON, V79, P3, DOI 10.1006/anbo.1996.0295; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Tani S, 2004, MOL PLANT MICROBE IN, V17, P330, DOI 10.1094/MPMI.2004.17.3.330; Tooley PW, 1997, APPL ENVIRON MICROB, V63, P1467, DOI 10.1128/AEM.63.4.1467-1475.1997; Tyler BM, 2002, ANNU REV PHYTOPATHOL, V40, P137, DOI 10.1146/annurev.phyto.40.120601.125310; Van der Horst MA, 2004, ACCOUNTS CHEM RES, V37, P13, DOI 10.1021/ar020219d; WALLIN JR, 1953, PHYTOPATHOLOGY, V43, P505; Whisson SC, 2005, MOL PLANT PATHOL, V6, P153, DOI 10.1111/J.1364-3703.2005.00272.X; Xiang QJ, 2010, GENE, V453, P1, DOI 10.1016/j.gene.2009.12.006; Xiang QJ, 2009, FUNGAL GENET BIOL, V46, P400, DOI 10.1016/j.fgb.2009.02.006; Yan HZ, 2006, FUNGAL GENET BIOL, V43, P430, DOI 10.1016/j.fgb.2006.01.010; Yarwood CE, 1937, J AGRIC RES, V54, P0365; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Zhang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040246	60	26	27	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e92086	10.1371/journal.pone.0092086	http://dx.doi.org/10.1371/journal.pone.0092086			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24704821	gold, Green Published, Green Submitted			2022-12-25	WOS:000334107500013
J	Yuan, XL; Wang, W; Wang, J; Yin, XH; Zhai, XY; Wang, LN; Li, K; Li, ZL				Yuan, Xiaoli; Wang, Wei; Wang, Juan; Yin, Xiaohui; Zhai, Xiaoyue; Wang, Lining; Li, Kai; Li, Zilong			Down-Regulation of Integrin beta 1 and Focal Adhesion Kinase in Renal Glomeruli under Various Hemodynamic Conditions	PLOS ONE			English	Article							IN-VIVO CRYOTECHNIQUE; ALPHA-3-BETA-1 INTEGRIN; PODOCYTE ADHESION; ISCHEMIC-INJURY; EXPRESSION; RATS; KIDNEY; GLOMERULOSCLEROSIS; NEPHROPATHY; EFFACEMENT	Given that integrin beta 1 is an important component of the connection to maintain glomerular structural integrity, by binding with multiple extracellular matrix proteins and mediating intracellular signaling. Focal adhesion kinase (FAK) is the most essential intracellular integrator in the integrin beta 1-FAK signalling pathway. Here, we investigated the changes of the two molecules and visualized the possbile interaction between them under various hemodynamic conditions in podocytes. Mice kidney tissues were prepared using in vivo cryotechnique (IVCT) and then were stained and observed using light microscopy, confocal laser scanning microscopy and immunoelectron microscopy. The expression of these molecules were examined by western blot. Under the normal condition, integrin beta 1 stained continually and evenly at the membrane, and FAK was located in the cytoplasm and nuclei of the podocytes. There were significant colocalized plaques of two molecules. But under acute hypertensive and cardiac arrest conditions, integrin beta 1 decreased and stained intermittently. Similarly, FAK decreased and appeared uneven. Additionally, FAK translocated to the nuclei of the podocytes. As a result, the colocalization of integrin beta 1 and FAK reduced obviously under these conditions. Western blot assay showed a consistent result with the immunostaining. Collectively, the abnormal redistribution and decreased expressions of integrin beta 1 and FAK are important molecular events in regulating the functions of podocytes under abnormal hemodynamic conditions. IVCT could offer considerable advantages for morphological analysis when researching renal diseases.	[Yuan, Xiaoli; Wang, Wei; Wang, Juan; Yin, Xiaohui; Wang, Lining; Li, Zilong] China Med Univ, Affiliated Hosp 1, Dept Nephrol, Shenyang, Peoples R China; [Zhai, Xiaoyue] China Med Univ, Dept Histol & Embryol, Inst Pathol & Pathophysiol, Shenyang, Peoples R China; [Li, Kai] China Med Univ, Affiliated Hosp 1, Dept Surg Oncol, Shenyang, Peoples R China; [Yuan, Xiaoli] Shanxi Med Univ, Gen Hosp Tisco, Dept Nephrol, Taiyuan, Peoples R China	China Medical University; China Medical University; China Medical University; Shanxi Medical University	Li, ZL (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Nephrol, Shenyang, Peoples R China.	lzl1017@yahoo.com			Natural Science Foundation of Liaoning Province, China [20110294]	Natural Science Foundation of Liaoning Province, China(Natural Science Foundation of Liaoning Province)	This work was supported by Grants-in-Aid for Scientific Research from the Natural Science Foundation of Liaoning Province, China (20110294). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ay C, 2012, SENSORS-BASEL, V12, P5951, DOI 10.3390/s120505951; BARALDI A, 1994, NEPHRON, V66, P295, DOI 10.1159/000187826; Birn H, 2000, J CLIN INVEST, V105, P1353, DOI 10.1172/JCI8862; Brukamp K, 2007, AM J PHYSIOL-RENAL, V293, pF1397, DOI 10.1152/ajprenal.00133.2007; Chen CA, 2006, J LAB CLIN MED, V147, P74, DOI 10.1016/j.lab.2005.08.011; Chen HC, 2000, LIFE SCI, V67, P2345, DOI 10.1016/S0024-3205(00)00815-8; Christiansen REF, 2004, NEPHROL DIAL TRANSPL, V19, P1083, DOI 10.1093/ndt/gfh101; Dandapani SV, 2007, J BIOL CHEM, V282, P467, DOI 10.1074/jbc.M605024200; Dessapt C, 2009, NEPHROL DIAL TRANSPL, V24, P2645, DOI 10.1093/ndt/gfp204; GRIFFITH LD, 1967, LAB INVEST, V16, P220; Guerrot D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031974; HOLTHOFER H, 1991, LAB INVEST, V65, P548; Kojima K, 2000, AM J KIDNEY DIS, V35, P1175, DOI 10.1016/S0272-6386(00)70056-4; KRETZLER M, 1994, VIRCHOWS ARCH, V425, P181; Li Z, 2005, HISTOL HISTOPATHOL, V20, P807, DOI 10.14670/HH-20.807; Li Zhan-yu, 2007, Chinese Journal of Pathology, V36, P677; Li ZL, 2006, ARCH HISTOL CYTOL, V69, P147, DOI 10.1679/aohc.69.147; Li ZL, 2013, MICROSC RES TECHNIQ, V76, P113, DOI 10.1002/jemt.22149; Ma H, 2010, J AM SOC NEPHROL, V21, P1145, DOI 10.1681/ASN.2009090991; Michael KE, 2009, MOL BIOL CELL, V20, P2508, DOI 10.1091/mbc.E08-01-0076; Miner JH, 2011, PEDIATR NEPHROL, V26, P1413, DOI 10.1007/s00467-011-1785-1; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Ofstad J, 2005, AM J PHYSIOL-RENAL, V288, pF665, DOI 10.1152/ajprenal.00226.2004; Ohno S, 1996, VIRCHOWS ARCH, V427, P519; Pagtalunan ME, 1999, J AM SOC NEPHROL, V10, P366; RACUSEN LC, 1984, AM J PATHOL, V114, P157; Remuzzi G, 1998, NEW ENGL J MED, V339, P1448, DOI 10.1056/NEJM199811123392007; Wagner MC, 2008, J BIOL CHEM, V283, P35579, DOI 10.1074/jbc.M805507200; Wang G, 2009, AM J HYPERTENS, V22, P300, DOI 10.1038/ajh.2008.360; Xu JK, 2012, J BIOL CHEM, V287, P26200, DOI 10.1074/jbc.M112.349811; Yi XP, 2003, HYPERTENSION, V41, P1317, DOI 10.1161/01.HYP.0000072772.74183.5F; Zou MS, 2010, INTERNAL MED, V49, P2677, DOI 10.2169/internalmedicine.49.4174	32	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94212	10.1371/journal.pone.0094212	http://dx.doi.org/10.1371/journal.pone.0094212			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705394	gold, Green Published, Green Submitted			2022-12-25	WOS:000334107500133
J	Liu, SJ; Sun, J; Chen, X; Yu, YY; Liu, X; Liu, CM				Liu, Shijiang; Sun, Jie; Chen, Xing; Yu, Yingying; Liu, Xuan; Liu, Cunming			The Application of Transcutaneous CO2 Pressure Monitoring in the Anesthesia of Obese Patients Undergoing Laparoscopic Bariatric Surgery	PLOS ONE			English	Article							CARBON-DIOXIDE TENSION; GENERAL-ANESTHESIA; MECHANICAL VENTILATION; ARTERIAL; CHOLECYSTECTOMY; INFANTS; ADULTS	To investigate the correlation and accuracy of transcutaneous carbon dioxide partial pressure (PTCCO2) with regard to arterial carbon dioxide partial pressure (PaCO2) in severe obese patients undergoing laparoscopic bariatric surgery. Twenty-one patients with BMI>35 kg/m(2) were enrolled in our study. Their PaCO2, end-tidal carbon dioxide partial pressure (PetCO2), as well as PTCCO2 values were measured at before pneumoperitoneum and 30 min, 60 min, 120 min after pneumoperitoneum respectively. Then the differences between each pair of values (PetCO2-PaCO2) and. (PTCCO2-PaCO2) were calculated. Bland-Altman method, correlation and regression analysis, as well as exact probability method and two way contingency table were employed for the data analysis. 21 adults (aged 19-54 yr, mean 29, SD 9 yr; weight 86-160 kg, mean 119.3, SD 22.1 kg; BMI 35.3-51.1 kg/m(2), mean 42.1,SD 5.4 kg/m(2)) were finally included in this study. One patient was eliminated due to the use of vaso-excitor material phenylephrine during anesthesia induction. Eighty-four sample sets were obtained. The average PaCO2-PTCCO2 difference was 0.9 +/- 1.3 mmHg (mean +/- SD). And the average PaCO2-PetCO2 difference was 10.3 +/- 2.3 mmHg (mean +/- SD). The linear regression equation of PaCO2-PetCO2 is PetCO2 = 11.58+0.57xP(a)CO(2) (r(2) = 0.64, P<0.01), whereas the one of PaCO2-PTCCO2 is PTCCO2 = 0.60+0.97xP(a)CO(2) (r(2) = 0.89). The LOA (limits of agreement) of 95% average PaCO2-PetCO2 difference is 10.3 +/- 4.6 mmHg (mean +/- 1.96 SD), while the LOA of 95% average PaCO2-P(TC)CO2 difference is 0.9 +/- 2.6 mmHg (mean +/- 1.96 SD). In conclusion, transcutaneous carbon dioxide monitoring provides a better estimate of PaCO2 than PetCO2 in severe obese patients undergoing laparoscopic bariatric surgery.	[Liu, Shijiang] Nanjing Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Nanjing, Jiangsu, Peoples R China; [Sun, Jie] Nanjing Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Nanjing, Jiangsu, Peoples R China; [Chen, Xing] Jiangsu New Energy Dev Co, Jiangsu Guoxin Investment Grp, Dept Project Management, Nanjing, Jiangsu, Peoples R China; [Liu, Xuan] Gen Hosp TISCO, Dept Anesthesiol, Taiyuan, Peoples R China; [Liu, Cunming] Nanjing Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Shanxi Medical University; Nanjing Medical University	Liu, CM (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Nanjing, Jiangsu, Peoples R China.	mingliu870@sohu.com	yu, yingying/GRR-7851-2022		Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported by a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkenbosch JW, 2001, ANESTH ANALG, V92, P1427; Bozkurt P, 1999, ANAESTHESIA, V54, P831; CAPAN LM, 1985, CRIT CARE MED, V13, P810, DOI 10.1097/00003246-198510000-00007; Casati A, 2006, J CLIN ANESTH, V18, P436, DOI 10.1016/j.jclinane.2006.02.007; Cuvelier A, 2005, CHEST, V127, P1744, DOI 10.1378/chest.127.5.1744; Gandara V, 1997, SURG ENDOSC, V11, P707, DOI 10.1007/s004649900432; Girardis M, 1996, ANESTH ANALG, V83, P134, DOI 10.1097/00000539-199607000-00024; Griffin J, 2003, BRIT J ANAESTH, V91, P498, DOI 10.1093/bja/aeg217; Gursoy S, 2006, EUR J ANAESTH, V23, P496, DOI 10.1017/S0265021506000172; Maniscalco M, 2008, INTENS CARE MED, V34, P1340, DOI 10.1007/s00134-008-1078-8; Mizushima Akio, 2002, Masui, V51, P1331; MUZI M, 1992, ANESTH ANALG, V74, P877; Nishiyama T, 2006, EUR J ANAESTH, V23, P1049, DOI 10.1017/S0265021506001116; Nishiyama T, 2011, J CLIN MONIT COMPUT, V25, P323, DOI 10.1007/s10877-011-9311-3; Nishiyama T, 2007, J ANESTH, V21, P317, DOI 10.1007/s00540-006-0525-3; REID CW, 1992, CAN J ANAESTH, V39, P31, DOI 10.1007/BF03008669; RITHALIA SVS, 1982, RESUSCITATION, V10, P13, DOI 10.1016/0300-9572(82)90003-X; Rodriguez P, 2006, INTENS CARE MED, V32, P309, DOI 10.1007/s00134-005-0006-4; Rohling R, 1999, J CLIN MONITOR COMP, V15, P23, DOI 10.1023/A:1009950425204; Schroeder R, 2011, AM FAM PHYSICIAN, V84, P805; Sorensen LC, 2011, SCAND J CLIN LAB INV, V71, P548, DOI 10.3109/00365513.2011.590601; Tobias JD, 1997, ANESTH ANALG, V85, P55, DOI 10.1097/00000539-199707000-00010; Xue QS, 2010, ANESTH ANALG, V111, P417, DOI 10.1213/ANE.0b013e3181e30b54	23	11	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e91563	10.1371/journal.pone.0091563	http://dx.doi.org/10.1371/journal.pone.0091563			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699267	Green Submitted, Green Published, gold			2022-12-25	WOS:000334105000014
J	Nikhil, K; Sharan, S; Chakraborty, A; Roy, P				Nikhil, Kumar; Sharan, Shruti; Chakraborty, Ajanta; Roy, Partha			Pterostilbene-Isothiocyanate Conjugate Suppresses Growth of Prostate Cancer Cells Irrespective of Androgen Receptor Status	PLOS ONE			English	Article							INDUCED APOPTOSIS; DOWN-REGULATION; INDUCTION; INHIBITION; EXPRESSION; PATHWAY; KINASE; CYCLE; PROLIFERATION; SULFORAPHANE	Chemotherapy and anti-hormonal therapies are the most common treatments for non-organ-confined prostate cancer (PCa). However, the effectiveness of these therapies is limited, thus necessitating the development of alternative approaches. The present study focused on analyzing the role of pterostilbene (PTER)-isothiocyanate (ITC) conjugate - a novel class of hybrid compound synthesized by appending an ITC moiety on PTER backbone - in regulating the functions of androgen receptor (AR), thereby causing apoptosis of PCa cells. The conjugate molecule caused 50% growth inhibition (IC50) at 40 +/- 1.12 and 45 +/- 1.50 mu M in AR positive (LNCaP) and negative (PC-3) cells, respectively. The reduced proliferation of PC-3 as well as LNCaP cells by conjugate correlated with accumulation of cells in G2/M phase and induction of caspase dependent apoptosis. Both PI3K/Akt and MAPK/ERK pathways played an important and differential role in conjugate-induced apoptosis of these PCa cells. While the inhibitor of Akt (A6730) or Akt-specific small interference RNA (siRNA) greatly sensitized PC-3 cells to conjugate-induced apoptosis, on the contrary, apoptosis was accelerated by inhibition of ERK (by PD98059 or ERK siRNA) in case of LNCaP cells, both ultimately culminating in the expression of cleaved caspase-3 protein. Moreover, anti-androgenic activity of the conjugate was mediated by decreased expression of AR and its co-activators (SRC-1, GRIP-1), thus interfering in their interactions with AR. All these data suggests that conjugate-induced inhibition of cell proliferation and induction of apoptosis are partly mediated by the down regulation of AR, Akt, and ERK signaling. These observations provide a rationale for devising novel therapeutic approaches for treating PCa by using conjugate alone or in combination with other therapeutics.	[Nikhil, Kumar; Sharan, Shruti; Chakraborty, Ajanta; Roy, Partha] Indian Inst Technol Roorkee, Dept Biotechnol, Mol Endocrinol Lab, Roorkee, Uttarakhand, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee	Roy, P (corresponding author), Indian Inst Technol Roorkee, Dept Biotechnol, Mol Endocrinol Lab, Roorkee, Uttarakhand, India.	paroyfbs@iitr.ernet.in		NIKHIL, KUMAR/0000-0002-9438-6578; SHARAN, SHRUTI/0000-0003-0405-8560	Council for Scientific and Industrial Research; Ministry of Human Resources and Development (MHRD), Government of India; Department of Biotechnology [BT/PR14836/AAQ/01/455/2010]; Department of Science and Technology [SR/SO/HS-39/2009]	Council for Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Ministry of Human Resources and Development (MHRD), Government of India(Ministry of Human Resource Development (MHRD), Government of India); Department of Biotechnology; Department of Science and Technology(Department of Science & Technology (India))	This work was supported by research grants from Council for Scientific and Industrial Research and Ministry of Human Resources and Development (MHRD), Government of India as research fellowships to KN and project assistantship to PR, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Further PR would also like to tank other funding agencies, Department of Biotechnology (BT/PR14836/AAQ/01/455/2010) and Department of Science and Technology (SR/SO/HS-39/2009) for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addanki PK, 2003, NEOPLASIA, V5, P255; Agarwal ML, 1998, J BIOL CHEM, V273, P1, DOI 10.1074/jbc.273.1.1; Agoulnik IU, 2005, CANCER RES, V65, P7959, DOI 10.1158/0008-5472.CAN-04-3541; Alosi JA, 2010, J SURG RES, V161, P195, DOI 10.1016/j.jss.2009.07.027; Ballif BA, 2001, CELL GROWTH DIFFER, V12, P397; Baniahmad A, 2005, J STEROID BIOCHEM, V93, P89, DOI 10.1016/j.jsbmb.2004.12.012; Bracarda S, 2005, CRIT REV ONCOL HEMAT, V56, P379, DOI 10.1016/j.critrevonc.2005.03.010; Caraglia M, 2007, J CELL PHYSIOL, V211, P533, DOI 10.1002/jcp.20960; Carter LG, 2014, ENDOCR-RELAT CANCER, V21, pR209, DOI 10.1530/ERC-13-0171; Cavell BE, 2011, BIOCHEM PHARMACOL, V81, P327, DOI 10.1016/j.bcp.2010.10.005; Cha TL, 2005, CANCER RES, V65, P2287, DOI 10.1158/0008-5472.CAN-04-3250; Chakraborty A, 2012, MOL CELL ENDOCRINOL, V355, P25, DOI 10.1016/j.mce.2012.01.009; Chakraborty A, 2010, TOXICOL IN VITRO, V24, P1215, DOI 10.1016/j.tiv.2010.02.007; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chiao JW, 2002, INT J ONCOL, V20, P631; Chiu FL, 2008, PROSTATE, V68, P61, DOI 10.1002/pros.20690; delPeso L, 1997, SCIENCE, V278, P687; Fimognari C, 2004, BIOCHEM PHARMACOL, V68, P1133, DOI 10.1016/j.bcp.2004.03.044; Fimognari C, 2012, MUTAT RES-REV MUTAT, V750, P107, DOI 10.1016/j.mrrev.2011.12.001; Fimognari C, 2009, ENVIRON MOL MUTAGEN, V50, P171, DOI 10.1002/em.20447; Gan Y, 2010, ONCOGENE, V29, P4947, DOI 10.1038/onc.2010.240; Gao H, 2006, P NATL ACAD SCI USA, V103, P14477, DOI 10.1073/pnas.0606836103; Gregory CW, 2001, CANCER RES, V61, P4315; Grigoryev DN, 2000, J STEROID BIOCHEM, V75, P1, DOI 10.1016/S0960-0760(00)00131-X; Harada N, 2007, J NUTR SCI VITAMINOL, V53, P556, DOI 10.3177/jnsv.53.556; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; HEINLEIN CA, 2002, ENDOCR REV, V23, P175, DOI DOI 10.1210/ER.23.2.175; Henderson BE, 2000, CARCINOGENESIS, V21, P427, DOI 10.1093/carcin/21.3.427; Ho SM, 2004, J CELL BIOCHEM, V91, P491, DOI 10.1002/jcb.10759; Hsu JC, 2005, CARCINOGENESIS, V26, P1896, DOI 10.1093/carcin/bgi155; Jasinski M, 2013, ANGIOGENESIS, V56, P60; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kang HY, 2001, P NATL ACAD SCI USA, V98, P3018, DOI 10.1073/pnas.061305498; Kapetanovic IM, 2011, CANCER CHEMOTH PHARM, V68, P593, DOI 10.1007/s00280-010-1525-4; Keum YS, 2004, MUTAT RES-FUND MOL M, V555, P191, DOI 10.1016/j.mrfmmm.2004.05.024; Kris-Etherton Penny M., 2002, American Journal of Medicine, V113, p71S; Li K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057542; Lin VCH, 2012, J AGR FOOD CHEM, V60, P6399, DOI 10.1021/jf301499e; Liu Chengfei, 2011, Genes Cancer, V2, P151, DOI 10.1177/1947601911409744; Nikhil K, 2014, EXP CELL RES, V320, P311, DOI 10.1016/j.yexcr.2013.10.015; ONATE SA, 1995, SCIENCE, V270, P1354; Pan MH, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep093; Papaioannou M, 2005, ANDROLOGIA, V37, P211, DOI 10.1111/j.1439-0272.2005.00690.x; Ren FG, 2000, ONCOGENE, V19, P1924, DOI 10.1038/sj.onc.1203511; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Sheikh MS, 2000, J CELL PHYSIOL, V182, P171, DOI 10.1002/(SICI)1097-4652(200002)182:2<171::AID-JCP5>3.0.CO;2-3; Taplin ME, 2004, J CELL BIOCHEM, V91, P483, DOI 10.1002/jcb.10653; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Wang LG, 2006, CARCINOGENESIS, V27, P2124, DOI 10.1093/carcin/bgl075; Wang LG, 2004, INT J ONCOL, V24, P187; Wang TTY, 2010, MOL NUTR FOOD RES, V54, P335, DOI 10.1002/mnfr.200900143; Wang YM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-8; Wen Y, 2000, CANCER RES, V60, P6841; Wu X, 2009, ACTA PHARMACOL SIN, V30, P501, DOI 10.1038/aps.2009.50; Xiao D, 2002, CANCER RES, V62, P3615; Yeh SY, 1999, P NATL ACAD SCI USA, V96, P5458, DOI 10.1073/pnas.96.10.5458; Yuan HQ, 2005, CARCINOGENESIS, V26, P793, DOI 10.1093/carcin/bgi021; Zelivianski S, 2003, INT J CANCER, V107, P478, DOI 10.1002/ijc.11413	58	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93335	10.1371/journal.pone.0093335	http://dx.doi.org/10.1371/journal.pone.0093335			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699278	Green Published, Green Submitted, gold			2022-12-25	WOS:000334105000053
J	Ren, Y; Wu, H; Ma, Y; Yuan, J; Liang, H; Liu, D				Ren, Yu; Wu, Haiqing; Ma, Yuzhen; Yuan, Jianlong; Liang, Hao; Liu, Dongjun			Potential of Adipose-Derived Mesenchymal Stem Cells and Skeletal Muscle-Derived Satellite Cells for Somatic Cell Nuclear Transfer Mediated Transgenesis in Arbas Cashmere Goats	PLOS ONE			English	Article							MARROW STROMAL CELLS; BONE-MARROW; TRANSFER EMBRYOS; PIG CLONING; DIFFERENTIATION; EXPRESSION; FIBROBLAST; EFFICIENCY; CATTLE; CYCLE	Somatic cell nuclear transfer is used to generate genetic models for research and new, genetically modified livestock varieties. Goat fetal fibroblast cells (gFFCs) are the predominant nuclear donors in Cashmere goat transgenic cloning, but have disadvantages. We evaluated the potential of goat adipose-derived mesenchymal stem cells (gADSCs) and goat skeletal muscle-derived satellite cells (gMDSCs) for somatic cell nuclear transfer, evaluating their proliferation, pluripotency, transfection efficiency and capacity to support full term development of embryos after additive gene transfer or homologous recombination. gADSCs and gMDSCs were isolated by enzyme digestion and differentiated into neurocytes, myotube cells and insulin-producing cells. Neuron-specific enolase, fast muscle myosin and insulin expression were determined by immunohistochemistry. Following somatic cell nuclear transfer with donor cells derived from gADSCs, gMDSCs and gFFCs, transfection and cloning efficiencies were compared. Red fluorescent protein levels were determined by quantitative PCR and western blotting. 5-Methylcytosine, H4K5, H4K12 and H3K18 were determined immunohistochemically. gADSCs and gMDSCs were maintained in culture for up to 65 passages, whereas gFFCs could be passaged barely more than 15 times. gADSCs and gMDSCs had higher fluorescent colony forming efficiency and greater convergence (20%) and cleavage (10%) rates than gFFCs, and exhibited differing H4K5 histone modification patterns after somatic cell nuclear transfer and in vitro cultivation. After transfection with a pDsRed2-1 expression plasmid, the integrated exogenous genes did not influence the pluripotency of gADSCs-pDsRed2-1 or gMDSCs-pDsRed2-1. DsRed2 mRNA expression by cloned embryos derived from gADSCs-pDsRed2-1 or gMDSCs-pDsRed2-1 was more than twice that of gFFCs-pDsRed2-1 embryos (P<0.01). Pregnancy rates of gADSCs-pDsRed2-1 and gMDSCs-pDsRed2-1 recipients were higher than those of gFFCs-pDsRed2-1 recipients (P<0.01). With their high proliferative capacity and transfection efficiency, gADSCs and gMDSCs are a valuable cell source for breeding new, genetically modified varieties of livestock by somatic cell nuclear transfer.	[Ren, Yu; Wu, Haiqing; Yuan, Jianlong; Liang, Hao; Liu, Dongjun] Inner Mongolia Univ, Minist Educ, Key Lab Mammalian Reprod Biol & Biotechnol, Hohhot, Inner Mongolia, Peoples R China; [Ma, Yuzhen] Inner Mongolia Peoples Hosp, Hohhot, Inner Mongolia, Peoples R China	Inner Mongolia University	Liu, D (corresponding author), Inner Mongolia Univ, Minist Educ, Key Lab Mammalian Reprod Biol & Biotechnol, Hohhot, Inner Mongolia, Peoples R China.	nmliudongjun@sina.com			National Genetically Modified Organisms Breeding Major Projects [2013ZX08008-002]	National Genetically Modified Organisms Breeding Major Projects	The National Genetically Modified Organisms Breeding Major Projects (Grant No. 2013ZX08008-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner B, 2010, J MOL MED, V88, P653, DOI 10.1007/s00109-010-0610-9; Aigner B, 2010, CURR OPIN ORGAN TRAN, V15, P201, DOI 10.1097/MOT.0b013e328336ba4a; Black IB, 2001, BLOOD CELL MOL DIS, V27, P632, DOI 10.1006/bcmd.2001.0423; Campbell KHS, 2005, REPROD DOMEST ANIM, V40, P256, DOI 10.1111/j.1439-0531.2005.00591.x; Chang YF, 2012, FOOD CHEM TOXICOL, V50, P3433, DOI 10.1016/j.fct.2012.07.032; Dai XP, 2010, J BIOL CHEM, V285, P31002, DOI 10.1074/jbc.M110.136085; Deng WW, 2001, BIOCHEM BIOPH RES CO, V282, P148, DOI 10.1006/bbrc.2001.4570; Faast R, 2006, CLONING STEM CELLS, V8, P166, DOI 10.1089/clo.2006.8.166; GIBSON MC, 1983, MUSCLE NERVE, V6, P574, DOI 10.1002/mus.880060807; Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463; Guo XD, 2009, SCI CHINA SER C, V52, P390, DOI 10.1007/s11427-009-0041-4; Hermann A, 2006, J NEUROSCI RES, V83, P1502, DOI 10.1002/jnr.20840; Huard Johnny, 2003, Birth Defects Research, V69, P230, DOI 10.1002/bdrc.10020; Inoue K, 2003, BIOL REPROD, V69, P1394, DOI 10.1095/biolreprod.103.017731; Jin HF, 2007, INT J DEV BIOL, V51, P85, DOI 10.1387/ijdb.062165hj; Klymiuk N, 2012, DIABETES, V61, P1527, DOI 10.2337/db11-1325; Klymiuk N, 2012, FASEB J, V26, P1086, DOI 10.1096/fj.11-185041; Kumar BM, 2007, DEV DYNAM, V236, P435, DOI 10.1002/dvdy.21042; Lakshmipathy U, 2004, STEM CELLS, V22, P531, DOI 10.1634/stemcells.22-4-531; Li ZC, 2013, CELL REPROGRAM, V15, P35, DOI 10.1089/cell.2012.0042; Lu J, 2006, NEUROSCI LETT, V398, P12, DOI 10.1016/j.neulet.2005.12.053; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Pandey A, 2010, CELL REPROGRAM, V12, P357, DOI 10.1089/cell.2009.0083; Petersen B, 2008, CLONING STEM CELLS, V10, P355, DOI 10.1089/clo.2008.0026; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Powell AM, 2004, BIOL REPROD, V71, P210, DOI 10.1095/biolreprod.104.027193; Ren Y, 2012, RES VET SCI, V93, P404, DOI 10.1016/j.rvsc.2011.08.014; Rogers CS, 2008, J CLIN INVEST, V118, P1571, DOI 10.1172/JCI34773; Safford KM, 2004, EXP NEUROL, V187, P319, DOI 10.1016/j.expneurol.2004.01.027; Salem SA, 2013, MALAYS J MED SCI, V20, P80; Tian J, 2012, REPROD DOMEST ANIM, V47, P544, DOI 10.1111/j.1439-0531.2011.01915.x; Urnov FD, 2001, ONCOGENE, V20, P2991, DOI 10.1038/sj.onc.1204323; Wang FC, 2007, BIOL REPROD, V77, P1007, DOI 10.1095/biolreprod.107.063149; Wells DN, 2003, THERIOGENOLOGY, V59, P45, DOI 10.1016/S0093-691X(02)01273-6; Wolf E, 2000, EXP PHYSIOL, V85, P615, DOI 10.1017/S0958067000021102; Wu HQ, 2012, CELL BIOL INT, V36, P579, DOI 10.1042/CBI20110487	36	10	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93583	10.1371/journal.pone.0093583	http://dx.doi.org/10.1371/journal.pone.0093583			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699686	Green Submitted, gold, Green Published			2022-12-25	WOS:000334105000073
J	Borsetti, A; Ferrantelli, F; Maggiorella, MT; Sernicola, L; Bellino, S; Gallinaro, A; Farcomeni, S; Mee, ET; Rose, NJ; Cafaro, A; Titti, F; Ensoli, B				Borsetti, Alessandra; Ferrantelli, Flavia; Maggiorella, Maria T.; Sernicola, Leonardo; Bellino, Stefania; Gallinaro, Alessandra; Farcomeni, Stefania; Mee, Edward T.; Rose, Nicola J.; Cafaro, Aurelio; Titti, Fausto; Ensoli, Barbara			Effect of MHC Haplotype on Immune Response upon Experimental SHIVSF162P4cy Infection of Mauritian Cynomolgus Macaques	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; CLASS-I; DISEASE PROGRESSION; ALPHA-DEFENSINS; HIV-INFECTION; INNATE IMMUNITY; IL-10; SUSCEPTIBILITY; RESOLUTION; POINT	Little is known about the effects of Major Histocompatibility Complex (MHC) haplotypes on immunity to primate lentiviruses involving both acquired and innate immune responses. We present statistical evidence of the influence of MHC polymorphism on antiviral immunity of Mauritian cynomolgus macaques (MCM) following simian/human immunodeficiency virus SHIVSF162P4cy infection, involving the production of pro-and anti-inflammatory cytokines and alpha-defensins, which may modulate acquired immune responses. During the acute phase of infection, IL-10 correlated positively with viral load and negatively with CD4+T cell counts. Furthermore, alpha-defensins production was directly correlated with plasma viral RNA, particularly at peak of viral load. When the effects of the MHC were analyzed, a significant association between lower anti-Env binding and neutralizing antibody levels with class IB M4 haplotype and with class IA, IB M4 haplotype, respectively, was observed in the post-acute phase. Lower antibody responses may have resulted into a poor control of infection thus explaining the previously reported lower CD4 T cell counts in these monkeys. Class II M3 haplotype displayed significantly lower acute and post-acute IL-10 levels. In addition, significantly lower levels of alpha-defensins were detected in class IA M3 haplotype monkeys than in non-M3 macaques, in the post-acute phase of infection. These data indicate that the MHC could contribute to the delicate balance of pro-inflammatory mechanisms, particularly with regard to the association between IL-10 and alpha-defensins in lentivirus infection. Our results show that host genetic background, virological and immunological parameters should be considered for the design and interpretation of HIV-1 vaccine efficacy studies.	[Borsetti, Alessandra; Ferrantelli, Flavia; Maggiorella, Maria T.; Sernicola, Leonardo; Bellino, Stefania; Gallinaro, Alessandra; Farcomeni, Stefania; Cafaro, Aurelio; Titti, Fausto; Ensoli, Barbara] Ist Super Sanita, Natl AIDS Ctr, I-00161 Rome, Italy; [Mee, Edward T.; Rose, Nicola J.] Med & Healthcare Prod Regulatory Agcy, Natl Inst Biol Stand & Control, Div Virol, S Mimms, Herts, England	Istituto Superiore di Sanita (ISS); National Institute for Biological Standards & Control; The Medicines & Healthcare Products Regulatory Agency	Borsetti, A (corresponding author), Ist Super Sanita, Natl AIDS Ctr, Viale Regina Elena 299, I-00161 Rome, Italy.	alessandra.borsetti@iss.it	Ensoli, Barbara/J-9169-2016; maggiorella, maria teresa/K-4072-2016; Rose, Nicola/E-9366-2013; Cafaro, Aurelio/K-5314-2016; borsetti, alessandra/K-4103-2016; Gallinaro, Alessandra/J-2063-2018; Ferrantelli, Flavia/J-7794-2016; farcomeni, stefania/K-4640-2016	Ensoli, Barbara/0000-0002-0545-8737; maggiorella, maria teresa/0000-0001-5058-476X; borsetti, alessandra/0000-0002-5401-135X; Gallinaro, Alessandra/0000-0001-7618-8896; Ferrantelli, Flavia/0000-0002-0768-1078; farcomeni, stefania/0000-0001-5058-476X; Rose, Nicola/0000-0003-1102-5062; Bellino, Stefania/0000-0003-1149-3835; Cafaro, Aurelio/0000-0001-9675-6344	National Aids Program, Italian Ministry of Health [3H/5]; Italian Concerted Action on HIV-AIDS Vaccine Development (ICAV), European Commission [LSHP-CT-2004503487]; NIHR Centre for Research in Health Protection at the Health Protection Agency (UK)	National Aids Program, Italian Ministry of Health; Italian Concerted Action on HIV-AIDS Vaccine Development (ICAV), European Commission; NIHR Centre for Research in Health Protection at the Health Protection Agency (UK)	This work was supported by grants from the National Aids Program, Italian Ministry of Health (contract 3H/5), the Italian Concerted Action on HIV-AIDS Vaccine Development (ICAV), European Commission (LSHP-CT-2004503487), and in part by the NIHR Centre for Research in Health Protection at the Health Protection Agency (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnink A, 2011, IMMUNOGENETICS, V63, P267, DOI 10.1007/s00251-010-0504-6; Ahmed RKS, 2005, MOL IMMUNOL, V42, P251, DOI 10.1016/j.molimm.2004.06.027; Baroncelli S, 2007, AIDS RES HUM RETROV, V23, P287, DOI 10.1089/aid.2006.0142; Basu D, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-76; Borsetti A, 2008, ARCH VIROL, V153, P463, DOI 10.1007/s00705-007-0009-2; Borsetti A, 2012, TISSUE ANTIGENS, V80, P36, DOI 10.1111/j.1399-0039.2012.01875.x; Budde ML, 2010, IMMUNOGENETICS, V62, P773, DOI 10.1007/s00251-010-0481-9; Eberly MD, 2009, J IMMUNOL, V182, P1439, DOI 10.4049/jimmunol.182.3.1439; Evans DT, 1999, IMMUNOL LETT, V66, P53, DOI 10.1016/S0165-2478(98)00151-5; Ferrantelli F, 2011, VACCINE, V29, P2918, DOI 10.1016/j.vaccine.2011.02.006; Filippi CM, 2008, J PATHOL, V214, P224, DOI 10.1002/path.2272; Furci L, 2007, BLOOD, V109, P2928, DOI 10.1182/blood-2006-05-024489; Giraldo-Vela JP, 2008, J VIROL, V82, P859, DOI 10.1128/JVI.01816-07; Haigwood NL, 2004, AIDS REV, V6, P187; Iwasaki A, 2012, IMMUNITY, V37, P389, DOI 10.1016/j.immuni.2012.08.011; Jan MS, 2006, JAIDS-J ACQ IMM DEF, V41, P6, DOI 10.1097/01.qai.0000188336.94090.14; Jenne CN, 2012, CELL HOST MICROBE, V12, P5, DOI 10.1016/j.chom.2012.07.002; Kaur G, 2009, TISSUE ANTIGENS, V73, P289, DOI 10.1111/j.1399-0039.2009.01220.x; Kwon DS, 2010, EUR CYTOKINE NETW, V21, P208, DOI 10.1684/ecn.2010.0201; Lifson JD, 1997, J VIROL, V71, P9508, DOI 10.1128/JVI.71.12.9508-9514.1997; Mackewicz CE, 2003, AIDS, V17, pF23, DOI 10.1097/00002030-200309260-00001; Mee ET, 2010, TISSUE ANTIGENS, V76, P223, DOI 10.1111/j.1399-0039.2010.01500.x; Mee ET, 2009, IMMUNOGENETICS, V61, P327, DOI 10.1007/s00251-009-0369-8; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Mueller YM, 2010, EUR CYTOKINE NETW, V21, P219, DOI 10.1684/ecn.2010.0198; Muhl T, 2002, J IMMUNOL, V169, P3438, DOI 10.4049/jimmunol.169.6.3438; Naicker DD, 2009, J INFECT DIS, V200, P448, DOI 10.1086/600072; Norris PJ, 2006, AIDS RES HUM RETROV, V22, P757, DOI 10.1089/aid.2006.22.757; Oleksyk TK, 2009, GENES IMMUN, V10, P309, DOI 10.1038/gene.2009.9; Pantaleo G, 1997, P NATL ACAD SCI USA, V94, P254, DOI 10.1073/pnas.94.1.254; Peppoloni Samuele, 2003, Expert Rev Vaccines, V2, P285, DOI 10.1586/14760584.2.2.285; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Ploquin MJY, 2012, AIDS, V26, P1269, DOI 10.1097/QAD.0b013e328353e46b; Saitoh T, 2012, CELL HOST MICROBE, V12, P109, DOI 10.1016/j.chom.2012.05.015; Sauermann U, 2000, J INFECT DIS, V182, P716, DOI 10.1086/315800; Schmitz JE, 2003, J VIROL, V77, P2165, DOI 10.1128/JVI.77.3.2165-2173.2003; Shlomchik, 2002, IMMUNOBIOLOGY; Song W, 2011, AIDS RES HUM RETROV, V27, P639, DOI 10.1089/AID.2010.0161; Stone M, 2010, J VIROL, V84, P7083, DOI 10.1128/JVI.00481-10; Stylianou E, 1999, CLIN EXP IMMUNOL, V116, P115; Trowsdale J, 2011, IMMUNOL LETT, V137, P1, DOI 10.1016/j.imlet.2011.01.002; Wojcechowskyi JA, 2007, J VIROL, V81, P406, DOI 10.1128/JVI.01636-06; Zaragoza MM, 2011, J IMMUNOL, V186, P1589, DOI 10.4049/jimmunol.1002021	43	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93235	10.1371/journal.pone.0093235	http://dx.doi.org/10.1371/journal.pone.0093235			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695530	Green Published, gold, Green Submitted			2022-12-25	WOS:000334103000051
J	Collste, O; Tornvall, P; Sundin, O; Alam, M; Frick, M				Collste, Olov; Tornvall, Per; Sundin, Orjan; Alam, Mahbubul; Frick, Mats			No Myocardial Vulnerability to Mental Stress in Takotsubo Stress Cardiomyopathy	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; TISSUE DOPPLER-ECHOCARDIOGRAPHY; RIGHT-VENTRICULAR INVOLVEMENT; APICAL BALLOONING SYNDROME; SYMPATHOVAGAL INTERACTION; PERFORMANCE INDEX; SPECTRAL-ANALYSIS; INFARCTION; MORTALITY; PRESSURE	Objectives: Due to the frequent use of coronary angiography the awareness of Takotsubo stress cardiomyopathy (TSC) has increased although the exact pathophysiology of TSC is still largely unknown. Our objective was to investigate the effects of mental stress on myocardial function, heart rate variability (HRV) and salivary cortisol (SC) in TSC patients. Design: This study is a case-control study and a sub-study of the Stockholm Myocardial Infarction with Normal Coronaries (SMINC) study. Setting: Mental stress test was performed more than 6 months after the acute event in TSC patients and age- and sex-matched controls. Standard echocardiography and tissue Doppler imaging (TDI) - derived time-phases of cardiac cycle were recorded to calculate myocardial performance index (MPI) to assess ventricular function before and during mental stress. Holter-ECG recording was made to estimate HRV before, during and after mental stress. SC was measured at baseline, before and 20 minutes after mental stress. Subjects: Twenty-two TSC patients and 22 sex-and age- matched controls were recruited from the SMINC-study and investigated with a mental stress test. All TSC patients had a previous normal cardiovascular magnetic resonance investigation. Results: There were no significant differences at rest or during mental stress for left and right ventricular MPI or other standard diastolic variables between TSC patients and controls. HRV did not differ between TSC patients and controls. There was a trend towards less increase in SC after mental stress in TSC patients compared to controls. Conclusion: Mental stress did not induce a significant difference in myocardial function or HRV response between TSC and controls. Moreover, no significant difference could be seen in SC response at baseline, during or after mental stress. This study indicates that myocardial vulnerability to mental stress does not persist in TSC patients.	[Collste, Olov; Tornvall, Per; Frick, Mats] Karolinska Inst, Dept Clin Sci, Sodersjukhuset, Stockholm, Sweden; [Collste, Olov; Tornvall, Per; Frick, Mats] Karolinska Inst, Dept Educ, Sodersjukhuset, Stockholm, Sweden; [Alam, Mahbubul] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Stockholm, Sweden; [Sundin, Orjan] Mid Sweden Univ, Dept Psychol, Ostersund, Sweden	Karolinska Institutet; Sodersjukhuset Hospital; Karolinska Institutet; Sodersjukhuset Hospital; Danderyds Hospital; Karolinska Institutet; Mid-Sweden University	Collste, O (corresponding author), Karolinska Inst, Dept Clin Sci, Sodersjukhuset, Stockholm, Sweden.	olov.collste@sodersjukhuset.se		Sundin, Orjan/0000-0002-4116-5501	Swedish Heart-Lung Foundation	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation)	This study was supported by the Swedish Heart-Lung Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnlov J, 2005, AM HEART J, V149, P902, DOI 10.1016/j.ahj.2004.07.022; Barutcu I, 2005, ANN NONINVAS ELECTRO, V10, P324, DOI 10.1111/j.1542-474X.2005.00636.x; CALLISTER R, 1992, J PHYSIOL-LONDON, V454, P373, DOI 10.1113/jphysiol.1992.sp019269; Collste O, 2013, J INTERN MED, V273, P189, DOI 10.1111/j.1365-2796.2012.02567.x; COLLSTE O, 2013, VULNERABILITY UNPUB; DeBeck LD, 2010, AM J PHYSIOL-REG I, V299, pR80, DOI 10.1152/ajpregu.00246.2009; Delaney JPA, 2000, PERCEPT MOTOR SKILL, V91, P515, DOI 10.2466/PMS.91.6.515-524; Duzenli MA, 2009, HEART VESSELS, V24, P8, DOI 10.1007/s00380-008-1069-2; Elesber AA, 2006, J AM COLL CARDIOL, V47, P1082, DOI 10.1016/j.jacc.2005.12.004; Haghi D, 2006, EUR HEART J, V27, P2433, DOI 10.1093/eurheartj/ehl274; Hellhammer DH, 2009, PSYCHONEUROENDOCRINO, V34, P163, DOI 10.1016/j.psyneuen.2008.10.026; IRONSON G, 1992, AM J CARDIOL, V70, P281, DOI 10.1016/0002-9149(92)90605-X; KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8; Krstacic G, 2012, MED BIOL ENG COMPUT, V50, P1037, DOI 10.1007/s11517-012-0947-z; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; LAWLER KA, 1995, PSYCHOSOM MED, V57, P357, DOI 10.1097/00006842-199507000-00007; Margey R, 2009, EUR J ECHOCARDIOGR, V10, P395, DOI 10.1093/ejechocard/jen292; MASAOKA S, 1985, DIABETES CARE, V8, P64, DOI 10.2337/diacare.8.1.64; Mrdovic I, 2010, J AM COLL CARDIOL, V55, P1750, DOI 10.1016/j.jacc.2009.02.098; Nijm J, 2007, J INTERN MED, V262, P375, DOI 10.1111/j.1365-2796.2007.01817.x; PAGANI M, 1991, CIRCULATION, V83, P43; Pagani M, 1984, J Hypertens Suppl, V2, pS383; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; Pilgrim TM, 2008, INT J CARDIOL, V124, P283, DOI 10.1016/j.ijcard.2007.07.002; SCHNEIDERMAN N, 1989, HDB RES METHODS CARD, P349; Sharkey SW, 2010, J AM COLL CARDIOL, V55, P333, DOI 10.1016/j.jacc.2009.08.057; Sicari R, 2008, EUR J ECHOCARDIOGR, V9, P415, DOI 10.1093/ejechocard/jen175; Silberbauer John, 2008, Eur J Echocardiogr, V9, P136; Su HM, 2006, ECHOCARDIOGR-J CARD, V23, P287, DOI 10.1111/j.1540-8175.2006.00222.x; Tei C, 1995, J Cardiol, V26, P357; Tekten T, 2003, ECHOCARDIOGR-J CARD, V20, P503, DOI 10.1046/j.1540-8175.2003.03086.x; TOWNEND JN, 1992, AM J CARDIOL, V69, P1587, DOI 10.1016/0002-9149(92)90708-7; TSUJI H, 1994, CIRCULATION, V90, P878, DOI 10.1161/01.CIR.90.2.878	33	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93697	10.1371/journal.pone.0093697	http://dx.doi.org/10.1371/journal.pone.0093697			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LC	24695370	Green Published, Green Submitted, gold			2022-12-25	WOS:000334103000106
J	Couvillon, MJ; Schurch, R; Ratnieks, FLW				Couvillon, Margaret J.; Schuerch, Roger; Ratnieks, Francis L. W.			Waggle Dance Distances as Integrative Indicators of Seasonal Foraging Challenges	PLOS ONE			English	Article							POLLINATION SERVICES; HONEYBEE COLONIES; DECLINES; BUMBLEBEES; DURATION	Even as demand for their services increases, honey bees (Apis mellifera) and other pollinating insects continue to decline in Europe and North America. Honey bees face many challenges, including an issue generally affecting wildlife: landscape changes have reduced flower-rich areas. One way to help is therefore to supplement with flowers, but when would this be most beneficial? We use the waggle dance, a unique behaviour in which a successful forager communicates to nestmates the location of visited flowers, to make a 2-year survey of food availability. We "eavesdropped'' on 5097 dances to track seasonal changes in foraging, as indicated by the distance to which the bees as economic foragers will recruit, over a representative rural-urban landscape. In year 3, we determined nectar sugar concentration. We found that mean foraging distance/area significantly increase from springs (493 m, 0.8 km(2)) to summers (2156 m, 15.2 km(2)), even though nectar is not better quality, before decreasing in autumns (1275 m, 5.1 km(2)). As bees will not forage at long distances unnecessarily, this suggests summer is the most challenging season, with bees utilizing an area 22 and 6 times greater than spring or autumn. Our study demonstrates that dancing bees as indicators can provide information relevant to helping them, and, in particular, can show the months when additional forage would be most valuable.	[Couvillon, Margaret J.; Schuerch, Roger; Ratnieks, Francis L. W.] Univ Sussex, Sch Life Sci, Lab Apiculture & Social Insects, Brighton, E Sussex, England; [Schuerch, Roger] Univ Sussex, Sch Life Sci, Lab Social Evolut, Brighton, E Sussex, England	University of Sussex; University of Sussex	Couvillon, MJ (corresponding author), Univ Sussex, Sch Life Sci, Lab Apiculture & Social Insects, Brighton, E Sussex, England.	M.Couvillon@Sussex.ac.uk	Schurch, Roger/J-8744-2019	Schurch, Roger/0000-0001-9075-8912	Nineveh Charitable Trust; Swiss National Science Foundation [PA00P3_139731]; Waitrose Ltd.; Burt's Bees; Body Shop Foundation	Nineveh Charitable Trust; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Waitrose Ltd.; Burt's Bees; Body Shop Foundation	MJC is funded by the Nineveh Charitable Trust, and RS is funded by the Swiss National Science Foundation (Grant PA00P3_139731). Additional research funding was provided by Waitrose Ltd., Burt's Bees, and the Body Shop Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Allsopp MH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003128; Amdam GV, 2004, J ECON ENTOMOL, V97, P741, DOI 10.1603/0022-0493(2004)097[0741:APIWHB]2.0.CO;2; Beekman M, 2004, FUNCT ECOL, V18, P829, DOI 10.1111/j.0269-8463.2004.00924.x; Beekman M, 2000, FUNCT ECOL, V14, P490, DOI 10.1046/j.1365-2435.2000.00443.x; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Biesmeijer JC, 2006, APIDOLOGIE, V37, P240, DOI 10.1051/apido:2006014; BOCH R, 1957, Z VERGL PHYSIOL, V40, P289, DOI 10.1007/BF00340572; Brittain C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2767; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2157, DOI 10.1098/rstb.2010.0107; Carvell C, 2006, BIOL CONSERV, V132, P481, DOI 10.1016/j.biocon.2006.05.008; Couvillon MJ, 2012, INSECT SOC, V59, P297, DOI 10.1007/s00040-012-0224-z; Couvillon MJ, 2012, BIOL OPEN, V1, P467, DOI 10.1242/bio.20121099; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Frisch K. v., 1946, OESTERREICH ZOOL ZEITSCHR [ VIENNA], V1, P1; Garbuzov M, 2013, IVY UNDERAPPRECIATED; Gruter C, 2010, CURR BIOL, V20, pR683, DOI 10.1016/j.cub.2010.06.052; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kluser S., 2011, UNEP EMERGING ISSUES; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Levy S, 2011, NATURE, V479, P164, DOI 10.1038/479164a; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Nowakowski M, 2011, OPERATION POLLINATOR; Pebesma E, 2005, R NEWS, V5, P9, DOI DOI 10.1007/978-1-4614-7618-4_2; Plummer M, 2012, RJAGS BAYESIAN GRAPH; Plummer M., 2003, JAGS PROGRAM ANAL BA, P20; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; R Core Team, 2012, R LANG ENV STAT COMP; Robinson RA, 2002, J APPL ECOL, V39, P157, DOI 10.1046/j.1365-2664.2002.00695.x; SCHMIDHEMPEL P, 1987, J ANIM ECOL, V56, P219, DOI 10.2307/4811; SCHMIDHEMPEL P, 1987, J ANIM ECOL, V56, P209, DOI 10.2307/4810; Schurch R, 2013, J COMP PHYSIOL A, P1; Seeley T., 1995, WISDOM HIVE; Seeley TD, 2000, J COMP PHYSIOL A, V186, P813, DOI 10.1007/s003590000134; SEELEY TD, 1994, BEHAV ECOL SOCIOBIOL, V34, P51, DOI 10.1007/BF00175458; Srinivasan MV, 2000, SCIENCE, V287, P851, DOI 10.1126/science.287.5454.851; Steffan-Dewenter I, 2005, TRENDS ECOL EVOL, V20, P651, DOI 10.1016/j.tree.2005.09.004; Steffan-Dewenter I, 2003, P ROY SOC B-BIOL SCI, V270, P569, DOI 10.1098/rspb.2002.2292; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; VISSCHER PK, 1982, ECOLOGY, V63, P1790, DOI 10.2307/1940121; von Frisch K., 1967, DANCE LANGUAGE ORIEN; WADDINGTON KD, 1994, BEHAV ECOL SOCIOBIOL, V35, P423, DOI 10.1007/BF00165845; Walsh B., 2014, TIME; Westphal C, 2006, ECOL ENTOMOL, V31, P389, DOI 10.1111/j.1365-2311.2006.00801.x; Winfree R, 2011, ANNU REV ECOL EVOL S, V42, P1, DOI 10.1146/annurev-ecolsys-102710-145042; Wright CK, 2013, P NATL ACAD SCI USA, V110, P4134, DOI 10.1073/pnas.1215404110; [No title captured]	50	106	108	8	137	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93495	10.1371/journal.pone.0093495	http://dx.doi.org/10.1371/journal.pone.0093495			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695678	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000334103000082
J	Mangieri, LR; Mader, BJ; Thomas, CE; Taylor, CA; Luker, AM; Tse, TE; Huisingh, C; Shacka, JJ				Mangieri, Leandra R.; Mader, Burton J.; Thomas, Cailin E.; Taylor, Charles A.; Luker, Austin M.; Tse, Tonia E.; Huisingh, Carrie; Shacka, John J.			ATP6V0C Knockdown in Neuroblastoma Cells Alters Autophagy-Lysosome Pathway Function and Metabolism of Proteins that Accumulate in Neurodegenerative Disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; H+-ATPASE-C; ALPHA-SYNUCLEIN; V-ATPASE; DEGRADATION; BAFILOMYCIN; PARKINSONS; SUBUNIT; MODELS; DEATH	ATP6V0C is the bafilomycin A1-binding subunit of vacuolar ATPase, an enzyme complex that critically regulates vesicular acidification. We and others have shown previously that bafilomycin A1 regulates cell viability, autophagic flux and metabolism of proteins that accumulate in neurodegenerative disease. To determine the importance of ATP6V0C for autophagy-lysosome pathway function, SH-SY5Y human neuroblastoma cells differentiated to a neuronal phenotype were nucleofected with non-target or ATP6V0C siRNA and following recovery were treated with either vehicle or bafilomycin A1 (0.3-100 nM) for 48 h. ATP6V0C knockdown was validated by quantitative RT-PCR and by a significant decrease in Lysostracker Red staining. ATP6V0C knockdown significantly increased basal levels of microtubule-associated protein light chain 3-II (LC3-II), alpha-synuclein high molecular weight species and APP C-terminal fragments, and inhibited autophagic flux. Enhanced LC3 and LAMP-1 co-localization following knockdown suggests that autophagic flux was inhibited in part due to lysosomal degradation and not by a block in vesicular fusion. Knockdown of ATP6V0C also sensitized cells to the accumulation of autophagy substrates and a reduction in neurite length following treatment with 1 nM bafilomycin A1, a concentration that did not produce such alterations in non-target control cells. Reduced neurite length and the percentage of propidium iodide-positive dead cells were also significantly greater following treatment with 3 nM bafilomycin A1. Together these results indicate a role for ATP6V0C in maintaining constitutive and stress-induced ALP function, in particular the metabolism of substrates that accumulate in age-related neurodegenerative disease and may contribute to disease pathogenesis.	[Mangieri, Leandra R.; Mader, Burton J.; Thomas, Cailin E.; Taylor, Charles A.; Luker, Austin M.; Tse, Tonia E.; Shacka, John J.] Univ Alabama Birmingham, Dept Pathol, Div Neuropathol, Birmingham, AL 35294 USA; [Huisingh, Carrie; Shacka, John J.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA; [Mader, Burton J.] Birmingham Vet Adm Med Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Shacka, JJ (corresponding author), Univ Alabama Birmingham, Dept Pathol, Div Neuropathol, Birmingham, AL 35294 USA.	shacka@uab.edu		Mangieri, Leandra/0000-0001-8981-0103; Huisingh, Carrie/0000-0002-7010-2024	VA Merit Award [1 I01 BX000957-01]; UAB Dept. Pathology; UAB Comprehensive Center for Healthy Aging; Alzheimer's of Central Alabama; UAB Center for Clinical and Translational Science (CCTS)	VA Merit Award(US Department of Veterans Affairs); UAB Dept. Pathology; UAB Comprehensive Center for Healthy Aging; Alzheimer's of Central Alabama; UAB Center for Clinical and Translational Science (CCTS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Support was provided by: 1) VA Merit Award 1 I01 BX000957-01 to John J. Shacka. Role: provided funds to carry out studies submitted for publication. 2) a pilot study from the UAB Center for Clinical and Translational Science (CCTS, co-sponsored by the UAB Dept. Pathology and the UAB Comprehensive Center for Healthy Aging), to John J. Shacka (URL: www.uab.edu/ccts). Role: provided funds to carry out studies submitted for publication. 3) a grant from Alzheimer's of Central Alabama to Burton J. Mader (URL: www.alzca.org). Role: provided funds to carry out studies submitted for publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baars TL, 2007, MOL BIOL CELL, V18, P3873, DOI 10.1091/mbc.E07-03-0205; Bayer MJ, 2003, J CELL BIOL, V162, P211, DOI 10.1083/jcb.200212004; Bowman BJ, 2002, J BIOL CHEM, V277, P3965, DOI 10.1074/jbc.M109756200; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Byun YJ, 2007, NEUROSCI LETT, V425, P183, DOI 10.1016/j.neulet.2007.08.027; Byun YJ, 2011, J CELL BIOCHEM, V112, P1985, DOI 10.1002/jcb.23105; Di Giovanni J, 2010, NEURON, V67, P268, DOI 10.1016/j.neuron.2010.06.024; Ebrahimi-Fakhari D, 2012, ACTA NEUROPATHOL, V124, P153, DOI 10.1007/s00401-012-1004-6; Ebrahimi-Fakhari D, 2011, J NEUROSCI, V31, P14508, DOI 10.1523/JNEUROSCI.1560-11.2011; El Far O, 2011, J NEUROCHEM, V117, P603, DOI 10.1111/j.1471-4159.2011.07234.x; Esposito LA, 2011, METHODS MOL BIOL, V670, P71, DOI 10.1007/978-1-60761-744-0_6; Evin G, 2003, J NEUROSCI RES, V74, P386, DOI 10.1002/jnr.10745; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Harris H, 2012, NAT REV NEUROL, V8, P108, DOI 10.1038/nrneurol.2011.200; Jin D, 2012, NEUROCHEM INT, V61, P907, DOI 10.1016/j.neuint.2011.12.021; Kaur G, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00079; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Klucken J, 2012, AUTOPHAGY, V8, P754, DOI 10.4161/auto.19371; Kurzawa-Akanbi M, 2012, J NEUROCHEM, V123, P298, DOI 10.1111/j.1471-4159.2012.07879.x; Lee HJ, 2004, J NEUROSCI, V24, P1888, DOI 10.1523/JNEUROSCI.3809-03.2004; Lim JH, 2007, MOL PHARMACOL, V71, P942, DOI 10.1124/mol.106.030296; Liu QY, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-4; Lovati MR, 2013, FASEB J, V27; Mader BJ, 2012, ACS CHEM NEUROSCI, V3, P1063, DOI 10.1021/cn300145z; Marzinke MA, 2013, ARCH BIOCHEM BIOPHYS, V540, P94, DOI 10.1016/j.abb.2013.10.012; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; Moriya K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037892; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Nixon RA, 2011, NEUROBIOL DIS, V43, P38, DOI 10.1016/j.nbd.2011.01.021; Pena-Llopis S, 2011, EMBO J, V30, P3242, DOI 10.1038/emboj.2011.257; Pivtoraiko VN, 2010, J NEUROCHEM, V114, P1193, DOI 10.1111/j.1471-4159.2010.06838.x; Pivtoraiko VN, 2009, ANTIOXID REDOX SIGN, V11, P481, DOI [10.1089/ars.2008.2263, 10.1089/ARS.2008.2263]; Plowey ED, 2008, JNEUROCHEM; Qiao L., 2008, MOL BRAIN, V1, P1; Ruan QM, 2010, NEUROBIOL DIS, V37, P330, DOI 10.1016/j.nbd.2009.10.011; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Shacka JJ, 2006, MOL PHARMACOL, V69, P1125, DOI 10.1124/mol.105.018408; Shacka JJ, 2008, FRONT BIOSCI-LANDMRK, V13, P718, DOI 10.2741/2714; Shacka JJ, 2012, BRAIN RES BULL, V88, P43, DOI 10.1016/j.brainresbull.2012.03.003; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Sun-Wada GH, 2000, DEV BIOL, V228, P315, DOI 10.1006/dbio.2000.9963; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; Tofaris GK, 2012, MOVEMENT DISORD, V27, P1364, DOI 10.1002/mds.25136; Vingtdeux V, 2007, NEUROBIOL DIS, V25, P686, DOI 10.1016/j.nbd.2006.09.019; Wang YR, 2005, J BIOL CHEM, V280, P40481, DOI 10.1074/jbc.M509106200; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; You HY, 2009, CANCER LETT, V280, P110, DOI 10.1016/j.canlet.2009.02.023; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	52	39	42	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93257	10.1371/journal.pone.0093257	http://dx.doi.org/10.1371/journal.pone.0093257			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695574	gold, Green Published, Green Submitted			2022-12-25	WOS:000334103000054
J	Pugno, NM				Pugno, Nicola M.			The "Egg of Columbus" for Making the World's Toughest Fibres	PLOS ONE			English	Article							CARBON-NANOTUBE FIBERS; COMPOSITE FIBERS; GRAPHENE OXIDE; SINGLE; KNOTS; TRANSPARENT; PROTEINS; YARNS	In this letter we present the "Egg of Columbus" for making fibres with unprecedented toughness: a slider, in the simplest form just a knot, is introduced as frictional element to dissipate additional energy and thus demonstrating the existence of a previously "hidden" toughness. The proof of concept is experimentally realized making the world's toughest fibre, increasing the toughness modulus of a commercial Endumax macroscopic fibre from 44 J/g up to 1070 J/g ( and of a zylon microfiber from 20 J/g up to 1400 J/g). The ideal upperbound toughness is expected for graphene, with a theoretical value of similar to 10(5) J/g. This new concept, able of maximizing ( one fold increment) the structural robustness, could explain the mysterious abundance of knot formations, in spite of their incremental energy cost and topological difficulty, in biological evolved structures, such as DNA strands and proteins.	[Pugno, Nicola M.] Univ Trento, Dept Civil Environm & Mech Engn, Lab Bioinspired & Graphene Nanomech, Trento, Italy; [Pugno, Nicola M.] Fdn Bruno Kessler, Ctr Mat & Microsyst, Povo, Trento, Italy; [Pugno, Nicola M.] Queen Marys Univ Hosp, Sch Engn & Mat Sci, London, England	University of Trento; Fondazione Bruno Kessler; FBK-CMM - Centre for Materials & Microsystems; University of London; Queen Mary University London	Pugno, NM (corresponding author), Univ Trento, Dept Civil Environm & Mech Engn, Lab Bioinspired & Graphene Nanomech, Trento, Italy.	nicola.pugno@unitn.it			European Research Council (ERC); European Commission under the Graphene Flagship	European Research Council (ERC)(European Research Council (ERC)); European Commission under the Graphene Flagship	NMP is supported by the European Research Council (ERC) thanks to the following 3 projects: ERC Starting Grant 2011 BIHSNAM on "Bio-inspired hierarchical super nano materials''; ERC Proof of Concept 2013-1 REPLICA2 on "Large-area replication of biological anti-adhesive nano surfaces''; ERC Proof of Concept 2013-2 KNOTOUGH on "Super-tough knotted fibers; and by the European Commission under the Graphene Flagship. The author particularly thanks the support on this specific idea just received from the ERC. The initial version of this paper was posted in the archive and commented by the MIT Technology Review at: http://www.technologyreview.com/view/514316/simple-trick-turns-commercial-polymer-into-worlds-toughest-fiber/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011234; Baughman RH, 1999, SCIENCE, V284, P1340, DOI 10.1126/science.284.5418.1340; Berger C, 2006, SCIENCE, V312, P1191, DOI 10.1126/science.1125925; BUCK D, 2008, P S APPL MATH, V66; Cranford SW, 2012, NATURE, V482, P72, DOI 10.1038/nature10739; Dalton AB, 2003, NATURE, V423, P703, DOI 10.1038/423703a; Delbruck M., 1962, P S APPL MATH, V14, P55; Dikin DA, 2007, NATURE, V448, P457, DOI 10.1038/nature06016; Endo M, 2005, NATURE, V433, P476, DOI 10.1038/433476a; Ericson LM, 2004, SCIENCE, V305, P1447, DOI 10.1126/science.1101398; Jiang KL, 2002, NATURE, V419, P801, DOI 10.1038/419801a; King NP, 2007, J MOL BIOL, V373, P153, DOI 10.1016/j.jmb.2007.07.042; Koziol K, 2007, SCIENCE, V318, P1892, DOI 10.1126/science.1147635; Li YL, 2004, SCIENCE, V304, P276, DOI 10.1126/science.1094982; Lua RC, 2006, PLOS COMPUT BIOL, V2, P350, DOI 10.1371/journal.pcbi.0020045; MANSFIELD ML, 1994, NAT STRUCT BIOL, V1, P213, DOI 10.1038/nsb0494-213; Miaudet P, 2005, NANO LETT, V5, P2212, DOI 10.1021/nl051419w; Micheletti C, 2008, BIOPHYS J, V95, P3591, DOI [10.1529/biophysj.108.137653, 10.1529/biophysj.l08.137653]; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Pugno NM, 2010, J MECH PHYS SOLIDS, V58, P1397, DOI 10.1016/j.jmps.2010.05.007; RYBENKOV VV, 1993, P NATL ACAD SCI USA, V90, P5307, DOI 10.1073/pnas.90.11.5307; Shin MK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1661; Stankovich S, 2006, NATURE, V442, P282, DOI 10.1038/nature04969; Sulkowska JI, 2009, P NATL ACAD SCI USA, V106, P3119, DOI 10.1073/pnas.0811147106; Sulkowska JI, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.058106; Sulkowska JI, 2008, P NATL ACAD SCI USA, V105, P19714, DOI 10.1073/pnas.0805468105; Vilatela JJ, 2010, ADV MATER, V22, P4959, DOI 10.1002/adma.201002131; Virnau P, 2006, PLOS COMPUT BIOL, V2, P1074, DOI 10.1371/journal.pcbi.0020122; Wang SR, 2007, ADV MATER, V19, P1257, DOI 10.1002/adma.200602140; Wu JY, 2013, SMALL, V9, P3561, DOI 10.1002/smll.201202830; Wu JY, 2013, J AM CHEM SOC, V135, P13775, DOI 10.1021/ja404330q; Wu ZC, 2004, SCIENCE, V305, P1273, DOI 10.1126/science.1101243; Zhang M, 2005, SCIENCE, V309, P1215, DOI 10.1126/science.1115311; Zhang M, 2004, SCIENCE, V306, P1358, DOI 10.1126/science.1104276; Zhu HW, 2002, SCIENCE, V296, P884, DOI 10.1126/science.1066996	35	19	19	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93079	10.1371/journal.pone.0093079	http://dx.doi.org/10.1371/journal.pone.0093079			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695084	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000334103000038
J	Yadav, V; Sainburg, RL				Yadav, Vivek; Sainburg, Robert L.			Limb Dominance Results from Asymmetries in Predictive and Impedance Control Mechanisms	PLOS ONE			English	Article							HUMAN MULTIJOINT ARM; MANUAL ASYMMETRIES; MOVEMENT CONTROL; HEMISPHERIC-ASYMMETRY; MOTOR LATERALIZATION; JOINT MOVEMENTS; RIGHT-HANDERS; HANDEDNESS; STIFFNESS; POSITION	Handedness is a pronounced feature of human motor behavior, yet the underlying neural mechanisms remain unclear. We hypothesize that motor lateralization results from asymmetries in predictive control of task dynamics and in control of limb impedance. To test this hypothesis, we present an experiment with two different force field environments, a field with a predictable magnitude that varies with the square of velocity, and a field with a less predictable magnitude that varies linearly with velocity. These fields were designed to be compatible with controllers that are specialized in predicting limb and task dynamics, and modulating position and velocity dependent impedance, respectively. Because the velocity square field does not change the form of the equations of motion for the reaching arm, we reasoned that a forward dynamic-type controller should perform well in this field, while control of linear damping and stiffness terms should be less effective. In contrast, the unpredictable linear field should be most compatible with impedance control, but incompatible with predictive dynamics control. We measured steady state final position accuracy and 3 trajectory features during exposure to these fields: Mean squared jerk, Straightness, and Movement time. Our results confirmed that each arm made straighter, smoother, and quicker movements in its compatible field. Both arms showed similar final position accuracies, which were achieved using more extensive corrective sub-movements when either arm performed in its incompatible field. Finally, each arm showed limited adaptation to its incompatible field. Analysis of the dependence of trajectory errors on field magnitude suggested that dominant arm adaptation occurred by prediction of the mean field, thus exploiting predictive mechanisms for adaptation to the unpredictable field. Overall, our results support the hypothesis that motor lateralization reflects asymmetries in specific motor control mechanisms associated with predictive control of limb and task dynamics, and modulation of limb impedance.	[Sainburg, Robert L.] Penn State Milton S Hershey Med Ctr, Dept Neurol, Hershey, PA USA; [Sainburg, Robert L.] Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Hershey, PA 17033 USA; [Yadav, Vivek; Sainburg, Robert L.] Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Yadav, V (corresponding author), Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA.	vxy10@psu.edu; rls45@psu.edu		Sainburg, Robert/0000-0003-2627-1258	National Institutes of Health (NIH): NICHD [R01 HD059783]; American Heart Association's, Great Rivers Affiliate, Post-doctoral Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059783] Funding Source: NIH RePORTER	National Institutes of Health (NIH): NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); American Heart Association's, Great Rivers Affiliate, Post-doctoral Fellowship(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by #R01 HD059783 from the National Institutes of Health (NIH): NICHD, and American Heart Association's, Great Rivers Affiliate, Post-doctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNETT J, 1979, Q J EXP PSYCHOL, V31, P641, DOI 10.1080/14640747908400755; Bagesteiro LB, 2003, J NEUROPHYSIOL, V90, P1503, DOI 10.1152/jn.00189.2003; Bagesteiro LB, 2002, J NEUROPHYSIOL, V88, P2408, DOI 10.1152/jn.00901.2001; Berret B, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000194; BOROD JC, 1984, BRIT J PSYCHOL, V75, P177, DOI 10.1111/j.2044-8295.1984.tb01889.x; Boulinguez P, 2001, CORTEX, V37, P101, DOI 10.1016/S0010-9452(08)70561-6; BRYDEN MP, 1977, NEUROPSYCHOLOGIA, V15, P617, DOI 10.1016/0028-3932(77)90067-7; CARSON RG, 1990, NEUROPSYCHOLOGIA, V28, P1215, DOI 10.1016/0028-3932(90)90056-T; Duff SV, 2007, EXP BRAIN RES, V179, P551, DOI 10.1007/s00221-006-0811-1; ELLIOTT D, 1993, CAN J EXP PSYCHOL, V47, P570, DOI 10.1037/h0078856; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Franklin DW, 2007, J NEUROSCI, V27, P7705, DOI 10.1523/JNEUROSCI.0968-07.2007; Franklin DW, 2003, EXP BRAIN RES, V152, P211, DOI 10.1007/s00221-003-1540-3; Franklin DW, 2003, EXP BRAIN RES, V151, P145, DOI 10.1007/s00221-003-1443-3; Gomi H, 1998, J NEUROSCI, V18, P8965; Gottlieb G L, 1996, Exerc Sport Sci Rev, V24, P1; GOTTLIEB GL, 1993, J MOTOR BEHAV, V25, P153, DOI 10.1080/00222895.1993.9942046; Gottlieb GL, 1998, J NEUROPHYSIOL, V80, P1860, DOI 10.1152/jn.1998.80.4.1860; Haaland KY, 2004, J COGNITIVE NEUROSCI, V16, P621, DOI 10.1162/089892904323057344; Haaland KY, 2007, MOTOR CONTROL S, V11, pS7; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hellige JB, 1996, ACTA NEUROBIOL EXP, V56, P485; HIRAYAMA M, 1993, J MOTOR BEHAV, V25, P162, DOI 10.1080/00222895.1993.9942047; Hogan N, 2009, J MOTOR BEHAV, V41, P529, DOI 10.3200/35-09-004-RC; KIM SG, 1993, SCIENCE, V261, P615, DOI 10.1126/science.8342027; Mani S, 2013, BRAIN, V136, P1288, DOI 10.1093/brain/aws283; Mutha PK, 2007, HUM MOVEMENT SCI, V26, P808, DOI 10.1016/j.humov.2007.06.001; Mutha PK, 2011, BRAIN, V134, P3644, DOI 10.1093/brain/awr275; Mutha PK, 2011, J NEUROSCI, V31, P6972, DOI 10.1523/JNEUROSCI.6432-10.2011; Mutha PK, 2008, BRAIN RES, V1246, P54, DOI 10.1016/j.brainres.2008.09.061; NELSON WL, 1983, BIOL CYBERN, V46, P135, DOI 10.1007/BF00339982; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Osu R, 1999, J NEUROPHYSIOL, V81, P1458, DOI 10.1152/jn.1999.81.4.1458; Przybyla A, 2013, NEUROSCIENCE, V228, P349, DOI 10.1016/j.neuroscience.2012.10.046; ROY EA, 1989, Q J EXP PSYCHOL-A, V41, P501, DOI 10.1080/14640748908402379; ROY EA, 1986, CAN J PSYCHOL, V40, P109, DOI 10.1037/h0080087; Sainburg R. L., 2010, VISION GOAL DIRECTED, P219; Sainburg RL, 2005, EXERC SPORT SCI REV, V33, P206, DOI 10.1097/00003677-200510000-00010; Sainburg RL, 2000, J NEUROPHYSIOL, V83, P2661, DOI 10.1152/jn.2000.83.5.2661; Sainburg RL, 2002, EXP BRAIN RES, V142, P241, DOI 10.1007/s00221-001-0913-8; Schabowsky CN, 2007, EXP BRAIN RES, V182, P567, DOI 10.1007/s00221-007-1017-x; Schaefer SY, 2007, MOTOR CONTROL S, V11, pS113; Schaefer SY, 2005, DIFFERENTIAL HEMISPH; Schaefer SY, 2007, SOC NEUR ABSTR; Schaefer SY, 2007, BRAIN, V130, P2146, DOI 10.1093/brain/awm145; Schaefer SY, 2012, CEREB CORTEX, V22, P1407, DOI 10.1093/cercor/bhr237; Schaefer SY, 2009, BRAIN RES, V1298, P78, DOI 10.1016/j.brainres.2009.08.063; Schaefer SY, 2009, NEUROPSYCHOLOGIA, V47, P2953, DOI 10.1016/j.neuropsychologia.2009.06.025; Scheidt RA, 2001, J NEUROPHYSIOL, V86, P971, DOI 10.1152/jn.2001.86.2.971; Scheidt RA, 2007, J NEUROPHYSIOL, V98, P3600, DOI 10.1152/jn.00121.2007; Scott SH, 2012, TRENDS COGN SCI, V16, P541, DOI 10.1016/j.tics.2012.09.008; Shabbott BA, 2008, J NEUROPHYSIOL, V100, P565, DOI 10.1152/jn.90349.2008; SHADMEHR R, 1992, BIOL CYBERN, V66, P463, DOI 10.1007/BF00204111; Takahashi CD, 2001, J NEUROPHYSIOL, V86, P1047, DOI 10.1152/jn.2001.86.2.1047; TODOR JI, 1980, J MOTOR BEHAV, V12, P57; TODOR JI, 1985, J MOTOR BEHAV, V17, P355, DOI 10.1080/00222895.1985.10735354; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; Wang, 2008, EXP BRAIN RES, V187, P2790, DOI [10.1007/s00221-008-1393-x, DOI 10.1007/S00221-008-1393-X]; Wang JS, 2004, J NEUROPHYSIOL, V92, P349, DOI 10.1152/jn.00960.2003; Wei KL, 2010, J NEUROPHYSIOL, V104, P3053, DOI 10.1152/jn.01025.2009; WINSTEIN CJ, 1995, EXP BRAIN RES, V105, P163; Winstein CJ, 1997, J NEUROPHYSIOL, V77, P1581, DOI 10.1152/jn.1997.77.3.1581; Yadav V, 2011, NEUROSCIENCE, V196, P153, DOI 10.1016/j.neuroscience.2011.08.039	64	38	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93892	10.1371/journal.pone.0093892	http://dx.doi.org/10.1371/journal.pone.0093892			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LC	24695543	Green Published, gold, Green Submitted			2022-12-25	WOS:000334103000130
J	Zimov, S; Zimov, N				Zimov, Sergey; Zimov, Nikita			Role of Megafauna and Frozen Soil in the Atmospheric CH4 Dynamics	PLOS ONE			English	Article							ABRUPT CLIMATE-CHANGE; LAST GLACIAL MAXIMUM; CARBON STORAGE; METHANE; GREENLAND; LAKES; PERMAFROST; ANTARCTICA; GRADIENT; RECORDS	Modern wetlands are the world's strongest methane source. But what was the role of this source in the past? An analysis of global C-14 data for basal peat combined with modelling of wetland succession allowed us to reconstruct the dynamics of global wetland methane emission through time. These data show that the rise of atmospheric methane concentrations during the Pleistocene-Holocene transition was not connected with wetland expansion, but rather started substantially later, only 9 thousand years ago. Additionally, wetland expansion took place against the background of a decline in atmospheric methane concentration. The isotopic composition of methane varies according to source. Owing to ice sheet drilling programs past dynamics of atmospheric methane isotopic composition is now known. For example over the course of Pleistocene-Holocene transition atmospheric methane became depleted in the deuterium isotope, which indicated that the rise in methane concentrations was not connected with activation of the deuterium-rich gas clathrates. Modelling of the budget of the atmospheric methane and its isotopic composition allowed us to reconstruct the dynamics of all main methane sources. For the late Pleistocene, the largest methane source was megaherbivores, whose total biomass is estimated to have exceeded that of present-day humans and domestic animals. This corresponds with our independent estimates of herbivore density on the pastures of the late Pleistocene based on herbivore skeleton density in the permafrost. During deglaciation, the largest methane emissions originated from degrading frozen soils of the mammoth steppe biome. Methane from this source is unique, as it is depleted of all isotopes. We estimated that over the entire course of deglaciation (15,000 to 6,000 year before present), soils of the mammoth steppe released 300-550 Pg (10(15) g) of methane. From current study we conclude that the Late Quaternary Extinction significantly affected the global methane cycle.	[Zimov, Sergey; Zimov, Nikita] Russian Acad Sci, Pacific Inst Geog, Northeast Sci Stn, Cherskii, Russia	Pacific Geographical Institute of the Far Eastern Branch of the Russian Academy of Sciences; Russian Academy of Sciences	Zimov, S (corresponding author), Russian Acad Sci, Pacific Inst Geog, Northeast Sci Stn, Cherskii, Russia.	sazimov55@mail.ru	Zimov, Sergey/K-3009-2018	Zimov, Sergey/0000-0002-0053-6599	Directorate For Geosciences [1107892] Funding Source: National Science Foundation	Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Adams JM, 1998, GLOBAL PLANET CHANGE, V17, P3; ADAMS JM, 1990, NATURE, V348, P711, DOI 10.1038/348711a0; Anthony KMW, 2012, NAT GEOSCI, V5, P419, DOI [10.1038/ngeo1480, 10.1038/NGEO1480]; Bousquet P, 2011, ATMOS CHEM PHYS, V11, P3689, DOI 10.5194/acp-11-3689-2011; Brook EJ, 2000, GLOBAL BIOGEOCHEM CY, V14, P559, DOI 10.1029/1999GB001182; Brosius LS, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001810; Chappellaz J, 1997, J GEOPHYS RES-ATMOS, V102, P15987, DOI 10.1029/97JD01017; CHAPPELLAZ J, 1993, NATURE, V366, P443, DOI 10.1038/366443a0; Cicerone RJ, 1988, GLOBAL BIOGEOCHEM CY, V2, P299, DOI 10.1029/GB002i004p00299; CRUTZEN P J, 1986, Tellus Series B Chemical and Physical Meteorology, V38, P271; Dallenbach A, 2000, GEOPHYS RES LETT, V27, P1005, DOI 10.1029/1999GL010873; Ferretti DF, 2005, SCIENCE, V309, P1714, DOI 10.1126/science.1115193; Fischer H, 2008, NATURE, V452, P864, DOI 10.1038/nature06825; Gajewski K, 2001, GLOBAL BIOGEOCHEM CY, V15, P297, DOI 10.1029/2000GB001286; Gill JL, 2009, SCIENCE, V326, P1100, DOI 10.1126/science.1179504; Johnson CN, 2008, P R SOC B, DOI [10.1098/rsb.2008.1921, DOI 10.1098/RSB.2008.1921]; Kennet JP, 2003, METHANE HYDRATES QUA; Kennett JP, 2000, SCIENCE, V288, P128, DOI 10.1126/science.288.5463.128; Kessler JD, 2011, SCIENCE, V331, P312, DOI 10.1126/science.1199697; MacDonald GM, 2006, SCIENCE, V314, P285, DOI 10.1126/science.1131722; Marlon JR, 2009, P NATL ACAD SCI USA, V106, P2519, DOI 10.1073/pnas.0808212106; Petrenko VV, 2009, SCIENCE, V324, P506, DOI 10.1126/science.1168909; Quay P, 1999, GLOBAL BIOGEOCHEM CY, V13, P445, DOI 10.1029/1998GB900006; Rivkina E.M., 2006, EARTH CRYOSPHERE, V10, P23; Ruddiman WF, 2008, QUATERNARY SCI REV, V27, P1291, DOI 10.1016/j.quascirev.2008.03.007; Schirrmeister L, 2002, QUATERN INT, V89, P97, DOI 10.1016/S1040-6182(01)00083-0; Severinghaus JP, 1998, NATURE, V391, P141, DOI 10.1038/34346; Shakhova N, 2010, SCIENCE, V327, P1246, DOI 10.1126/science.1182221; Smith FA, 2010, NAT GEOSCI, V3, P374, DOI 10.1038/ngeo877; Sowers T, 2006, SCIENCE, V311, P838, DOI 10.1126/science.1121235; Sowers T, 2010, QUATERNARY SCI REV, V29, P213, DOI 10.1016/j.quascirev.2009.05.023; Syroechkovskii V.E., 1986, SEVERNII OLEN AGROPR; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; VANDEWATER PK, 1994, SCIENCE, V264, P239, DOI 10.1126/science.264.5156.239; Vasilchuk Y.K., 2000, PRINCIPLES ISOTOPE G, P616; Vera Frans W.M., 2009, British Wildlife, V20, P28; Walter Anthony KM, 2014, NATURE UNPUB; Walter KM, 2007, SCIENCE, V318, P633, DOI 10.1126/science.1142924; Walter KM, 2006, NATURE, V443, P71, DOI 10.1038/nature05040; YU ZC, 2010, GEOPHYS RES LETT, V37, DOI DOI 10.1029/2010GL043584; Zech, 2010, CLIM DISCUSS, V6, P2199, DOI [10.5194/CPD-6-2199-2010, DOI 10.5194/CPD-6-2199-2010]; Zeng N, 2003, ADV ATMOS SCI, V20, P677, DOI 10.1007/BF02915395; Zimov NS, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036332; Zimov SA, 2012, QUATERNARY SCI REV, V57, P26, DOI 10.1016/j.quascirev.2012.10.005; Zimov SA, 1999, SCIENCE, V284, P1973, DOI 10.1126/science.284.5422.1973; Zimov SA, 1997, SCIENCE, V277, P800, DOI 10.1126/science.277.5327.800; Zimov SA, 2005, SCIENCE, V308, P796, DOI 10.1126/science.1113442; Zimov SA., 2001, PERMAFROST RESPONSE, Vvol 76, P511; Zimov SA, 2006, SCIENCE, V312, P1612, DOI 10.1126/science.1128908; Zimov Sergey A., 2012, P193	50	9	9	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93331	10.1371/journal.pone.0093331	http://dx.doi.org/10.1371/journal.pone.0093331			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695117	Green Published, Green Submitted, gold			2022-12-25	WOS:000334103000058
J	Tran, B; Falster, MO; Douglas, K; Blyth, F; Jorm, LR				Bich Tran; Falster, Michael O.; Douglas, Kirsty; Blyth, Fiona; Jorm, Louisa R.			Health Behaviours and Potentially Preventable Hospitalisation: A Prospective Study of Older Australian Adults	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; CARE SENSITIVE CONDITIONS; LIFE-STYLE FACTORS; MEDITERRANEAN DIET; RISK-FACTORS; AVOIDABLE HOSPITALIZATION; ALCOHOL-CONSUMPTION; PROSPECTIVE COHORT; PHYSICAL-ACTIVITY; COMBINED IMPACT	Objective : Several Studies have demonstrated the effetcs of health behaviors on risk of chronic diseases and mortality , but none have investigated their contribution to potentially preventable hospitalisation (PPH). We aimed to quantify the effects on risk of PPH of six health behaviours: smoking; alcohol consumption; physical activity; fruit and vegetables consumption; sitting time; and sleeping time. Design/ Setting: Prospective observational study in New South Wales, Australia. Subjects: 267,006 men and women aged 45 years and over. Outcome Measures: PPH admissions and mortality during follow- up according to individual positive health behaviours ( non- smoking < 14 alcoholic drinks per week, >= 2.5 hours of physical activity per week, >= 2 servings of fruit and 5 servings of vegetables per day < 8 hours sitting and >= 7 hours sleeping per day) and the total number of these behaviours. Results: During an average of 3 years follow- up, 20971 ( 8%) participants had at least one PPH admission. After adjusting for potential confounders, participants who reported all six positive health behaviours at baseline had 46% lower risk of PPH admission ( 95% CI 0.48-0.61), compared to those who reported having only one of these behaviours. Based on these risk estimates, approximately 29% of PPH admissions in Australians aged 45 years and over were attributable to not adhering to the six health behaviours. Estimates were similar for acute, chronic and vaccine- preventable categories of PPH admissions. Conclusions: Individual and combined positive health behaviours were associated with lower risk of PPH admission. These findings suggest that there is a significant opportunity to reduce PPH by promoting healthy behaviours.	[Bich Tran; Falster, Michael O.; Jorm, Louisa R.] Univ Western Sydney, Sch Med, Ctr Hlth Res, Campbelltown, NSW, Australia; [Douglas, Kirsty] Australian Natl Univ, Canberra, ACT, Australia; [Blyth, Fiona] Sax Inst, Haymarket, NSW, Australia; [Blyth, Fiona] Univ Sydney, Concord Clin Sch, Sydney, NSW, Australia	Western Sydney University; Australian National University; University of Sydney; University of Sydney	Tran, B (corresponding author), Univ Western Sydney, Sch Med, Ctr Hlth Res, Campbelltown, NSW, Australia.	b.tran@uws.edu.au	Douglas, Kirsty/E-3083-2017; Jorm, Louisa/AAN-6874-2020; Falster, Michael/X-7118-2019	Douglas, Kirsty/0000-0003-0174-782X; Jorm, Louisa/0000-0003-0390-661X; Falster, Michael/0000-0001-6444-7272; Blyth, Fiona/0000-0003-1128-6756	National Health and Medical Research Council [1036858]; Australian Commission on Safety and Quality in Health Care; Agency for Clinical Innovation; NSW Bureau of Health Information	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Commission on Safety and Quality in Health Care; Agency for Clinical Innovation; NSW Bureau of Health Information	The study was funded by a National Health and Medical Research Council Partnership Project Grant (#1036858) and by partner agencies the Australian Commission on Safety and Quality in Health Care, the Agency for Clinical Innovation and the NSW Bureau of Health Information. The funders play no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, NATIONAL HEALTHCARE; Ansari Z, 2007, AUST J PRIM HEALTH, V13, P91, DOI 10.1071/PY07043; Australian Government, 2005, PHYSICAL ACTIVITY GU; Australian Health Survey, 2011, AUSTRALIAN HEALTH SU; Australian Institute of Health and Welfare, 2004, RURAL REGIONAL AND R; Australian Institute of Health and Welfare, 2003, THE ACTIVE AUSTRALIA; Babitsch B, 2012, RE REVISITING ANDERS, V9, pDoc11; Banks E, 2008, INT J EPIDEMIOL, V37, P941, DOI 10.1093/ije/dym184; BINDMAN AB, 1995, JAMA-J AM MED ASSOC, V274, P305, DOI 10.1001/jama.274.4.305; Buckland G, 2008, OBES REV, V9, P582, DOI 10.1111/j.1467-789X.2008.00503.x; Calderon-Larranaga A, 2011, THORAX, V66, P191, DOI 10.1136/thx.2010.147058; Callaway LK, 2006, MED J AUSTRALIA, V184, P56, DOI 10.5694/j.1326-5377.2006.tb00115.x; Chiuve SE, 2008, CIRCULATION, V118, P947, DOI 10.1161/CIRCULATIONAHA.108.781062; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Daly LE, 1998, AM J EPIDEMIOL, V147, P783; Ezzati M, 2003, LANCET, V362, P847, DOI 10.1016/S0140-6736(03)14338-3; Feldman C, 2013, J INFECTION, V67, P169, DOI 10.1016/j.jinf.2013.05.004; Ford ES, 2011, AM J PUBLIC HEALTH, V101, P1922, DOI [10.2105/AJPH.2011.300167, 10.2105//AJPH.2011.300167]; Forey BA, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-36; George ES, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-20; Hanley JA, 2001, J EPIDEMIOL COMMUN H, V55, P508, DOI 10.1136/jech.55.7.508; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Jackson G, 2001, AUST NZ J PUBL HEAL, V25, P212, DOI 10.1111/j.1467-842X.2001.tb00565.x; Jorm LR, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-002344; Katteri R, 2013, PHC RIS POLICY ISSUE; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; Korda RJ, 2013, INT J OBESITY, V37, P790, DOI 10.1038/ijo.2012.155; Kornum JB, 2010, EUR RESPIR J, V36, P1330, DOI 10.1183/09031936.00184209; Kubo A, 2009, GASTROENTEROLOGY, V136, P806, DOI 10.1053/j.gastro.2008.11.042; Kvaavik E, 2010, ARCH INTERN MED, V170, P711, DOI 10.1001/archinternmed.2010.76; Magee CA, 2013, SLEEP MED, V14, P591, DOI 10.1016/j.sleep.2013.02.002; Mealing NM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-26; Muenchberger H, 2010, J PUBLIC HEALTH POL, V31, P150, DOI 10.1057/jphp.2010.3; National Health and Medical Research Council, 2013, AUSTRALIAN DIETARY G; National Health and Medical Research Council (NHMRC), 2009, AUSTRALIAN GUIDELINE; Niti M, 2003, J EPIDEMIOL COMMUN H, V57, P17, DOI 10.1136/jech.57.1.17; Northcote J, 2011, ALCOHOL ALCOHOLISM, V46, P709, DOI 10.1093/alcalc/agr138; Pavey TG, 2012, BRIT J SPORT MED, V0, P1, DOI DOI 10.1136/BJSP0RTS-2012-091676; Pelegrino NRG, 2013, AM J MED SCI, V345, P440, DOI 10.1097/MAJ.0b013e31825f32a7; POIKOLAINEN K, 1985, BRIT J ADDICT, V80, P215; Ponsonby AL, 1996, AUST NZ J PUBL HEAL, V20, P54, DOI 10.1111/j.1467-842X.1996.tb01336.x; Reid MC, 2003, AM J ADDICTION, V12, P211, DOI 10.1111/j.1521-0391.2003.tb00649.x; Roos LL, 2005, HEALTH SERV RES, V40, P1167, DOI 10.1111/j.1475-6773.2005.00407.x; Rosano A, 2013, EUR J PUBLIC HEALTH, V23, P356, DOI 10.1093/eurpub/cks053; Strasser B, 2013, ANN NY ACAD SCI, V1281, P141, DOI 10.1111/j.1749-6632.2012.06785.x; Thiebaut ACM, 2004, STAT MED, V23, P3803, DOI 10.1002/sim.2098; Thrift AP, 2011, AM J GASTROENTEROL, V106, P1220, DOI 10.1038/ajg.2011.89; Tomlin AM, 2008, DIABETES RES CLIN PR, V80, P244, DOI 10.1016/j.diabres.2007.12.017; van Dam RM, 2008, BRIT MED J, V337, pa1440, DOI [DOI 10.1136/BMJ.A1440, 10.1136/bmj.a1440]; van den Brandt PA, 2011, AM J CLIN NUTR, V94, P913, DOI 10.3945/ajcn.110.008250; van der Ploeg HP, 2012, ARCH INTERN MED, V172, P494, DOI 10.1001/archinternmed.2011.2174; Veugelers PJ, 2006, DIS ESOPHAGUS, V19, P321, DOI 10.1111/j.1442-2050.2006.00602.x; Vgontzas AN, 2010, SLEEP, V33, P1159, DOI 10.1093/sleep/33.9.1159; Zheng XY, 2012, CURR MED RES OPIN, V28, P1791, DOI 10.1185/03007995.2012.722991	55	16	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93111	10.1371/journal.pone.0093111	http://dx.doi.org/10.1371/journal.pone.0093111			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6KM	24691471	Green Published, Green Submitted, gold			2022-12-25	WOS:000334101100046
J	Engel, J; Blanchet, L; Engelke, UFH; Wevers, RA; Buydens, LMC				Engel, Jasper; Blanchet, Lionel; Engelke, Udo F. H.; Wevers, Ron A.; Buydens, Lutgarde M. C.			Towards the Disease Biomarker in an Individual Patient Using Statistical Health Monitoring	PLOS ONE			English	Article							METABONOMICS; CHEMOMETRICS	In metabolomics, identification of complex diseases is often based on application of ( multivariate) statistical techniques to the data. Commonly, each disease requires its own specific diagnostic model, separating healthy and diseased individuals, which is not very practical in a diagnostic setting. Additionally, for orphan diseases such models cannot be constructed due to a lack of available data. An alternative approach adapted from industrial process control is proposed in this study: statistical health monitoring ( SHM). In SHM the metabolic profile of an individual is compared to that of healthy people in a multivariate manner. Abnormal metabolite concentrations, or abnormal patterns of concentrations, are indicated by the method. Subsequently, this biomarker can be used for diagnosis. A tremendous advantage here is that only data of healthy people is required to construct the model. The method is applicable in current- population based - clinical practice as well as in personalized health applications. In this study, SHM was successfully applied for diagnosis of several orphan diseases as well as detection of metabotypic abnormalities related to diet and drug intake.	[Engel, Jasper; Blanchet, Lionel; Buydens, Lutgarde M. C.] Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 ED Nijmegen, Netherlands; [Engelke, Udo F. H.; Wevers, Ron A.] Radboud Univ Nijmegen Med Ctr, Dept Lab Med, Lab Genet Endocrine & Metab Dis, Nijmegen, Netherlands; [Blanchet, Lionel] Radboud Univ Nijmegen Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Engel, J (corresponding author), Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 ED Nijmegen, Netherlands.	j.engel@science.ru.nl	Blanchet, Lionel/H-3150-2019; Engelke, U.F.H./L-4293-2015; Blanchet, Lionel/C-8829-2011; Buydens, Lutgarde M.C./D-4338-2012; Wevers, Ron A./H-8116-2014	Blanchet, Lionel/0000-0003-2284-8101; Blanchet, Lionel/0000-0003-2284-8101; Wevers, Ron A./0000-0003-2278-9746; Engel, Jasper/0000-0001-6087-1711	Radboud University Nijmegen; Radboud University Medical Centre	Radboud University Nijmegen; Radboud University Medical Centre	The research was funded by the Radboud University Nijmegen and the Radboud University Medical Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcala CF, 2011, J PROCESS CONTR, V21, P322, DOI 10.1016/j.jprocont.2010.10.005; Bersimis S, 2007, QUAL RELIAB ENG INT, V23, P517, DOI 10.1002/qre.829; Chen T., 2013, EVID-BASED COMPL ALT, V2013, P11; Dunn WB, 2005, ANALYST, V130, P606, DOI 10.1039/b418288j; Engelke U, 2007, HDB 1H NMR SPECTROSC; Henry RC, 1999, CHEMOMETR INTELL LAB, V48, P91, DOI 10.1016/S0169-7439(99)00015-5; Holmes E, 2008, CELL, V134, P714, DOI 10.1016/j.cell.2008.08.026; KENNARD RW, 1969, TECHNOMETRICS, V11, P137, DOI 10.2307/1266770; Lenz EM, 2007, J PROTEOME RES, V6, P443, DOI 10.1021/pr0605217; Lindon J. C., 2007, HDB METABONOMICS MET; Lindon JC, 2007, FEBS J, V274, P1140, DOI 10.1111/j.1742-4658.2007.05673.x; Louwerse DJ, 2000, CHEM ENG SCI, V55, P1225, DOI 10.1016/S0009-2509(99)00408-X; Madsen R, 2010, ANAL CHIM ACTA, V659, P23, DOI 10.1016/j.aca.2009.11.042; Melnikova I, 2012, NAT REV DRUG DISCOV, V11, P267, DOI 10.1038/nrd3654; Nicholson JK, 2012, NATURE, V491, P384, DOI 10.1038/nature11708; Qin SJ, 2003, J CHEMOMETR, V17, P480, DOI 10.1002/cem.800; Smolinska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038163; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; Wise B., 1992, PLS TOOLBOX USE MATL	19	12	13	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92452	10.1371/journal.pone.0092452	http://dx.doi.org/10.1371/journal.pone.0092452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691487	Green Published, gold, Green Submitted			2022-12-25	WOS:000334101100026
J	Fan, XT; Zhang, Q; You, C; Qian, YX; Gao, J; Liu, P; Chen, HQ; Song, HF; Chen, Y; Chen, KP; Zhou, YJ				Fan, Xiaoting; Zhang, Qian; You, Chao; Qian, Yuanxia; Gao, Jing; Liu, Peng; Chen, Huiqing; Song, Huifang; Chen, Yan; Chen, Keping; Zhou, Yajing			Proteolysis of the Human DNA Polymerase Delta Smallest Subunit p12 by mu-Calpain in Calcium-Triggered Apoptotic HeLa Cells	PLOS ONE			English	Article							DAMAGE; ACTIVATION; CLEAVAGE; PROTEIN; REPAIR; PCNA; PROTEASES; ENZYME; DEATH; PHOSPHORYLATION	Degradation of p12 subunit of human DNA polymerase delta (Pol delta) that results in an interconversion between Pol delta 4 and Pol delta 3 forms plays a significant role in response to replication stress or genotoxic agents triggered DNA damage. Also, the p12 is readily degraded by human calpain in vitro. However, little has been done for the investigation of its degree of participation in any of the more common apoptosis. Here, we first report that the p12 subunit is a substrate of mu-calpain. In calcium-triggered apoptotic HeLa cells, the p12 is degraded at 12 hours post-induction (hpi), restored thereafter by 24 hpi, and then depleted again after 36 hpi in a time-dependent manner while the other three subunits are not affected. It suggests a dual function of Pol delta by its interconversion between Pol delta 4 and Pol delta 3 that is involved in a novel unknown apoptosis mechanism. The proteolysis of p12 could be efficiently blocked by both calpain inhibitor ALLN and proteasome inhibitor MG132. In vitro pull down and co-immunoprecipitation assays show that the mu-calpain binds to p12 through the interaction of mu-calpain with Pol delta other three subunits, not p12 itself, and PCNA, implying that the proteolysis of p12 by mu-calpain might be through a Pol delta 4/PCNA complex. The p12 cleavage sites by mu-calpain are further determined as the location within a 16-amino acids peptide 28-43 by in vitro cleavage assays. Thus, the p12/Pol delta is a target as a nuclear substrate of mu-calpain in a calcium-triggered apoptosis and appears to be a potential marker in the study of the chemotherapy of cancer therapies.	[Fan, Xiaoting; Zhang, Qian; You, Chao; Liu, Peng; Chen, Huiqing; Song, Huifang; Chen, Yan; Chen, Keping; Zhou, Yajing] Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China; [Qian, Yuanxia; Gao, Jing] Jiangsu Univ, Sch Pharm, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University	Zhou, YJ (corresponding author), Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China.	yajingzhou@ujs.edu.cn			National Natural Science Foundation of China [31370790, 30970612, 31100118]; Natural Science Foundation of Jiangsu Province [BK2011495]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by the National Natural Science Foundation of China (31370790, 30970612, 31100118), and Natural Science Foundation of Jiangsu Province (BK2011495). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An B, 1996, CANCER RES, V56, P438; Andersen PL, 2011, MOL BIOL CELL, V22, P2373, DOI 10.1091/mbc.E10-12-0938; BANIK NL, 1994, J NEUROSCI RES, V37, P489, DOI 10.1002/jnr.490370408; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Camins A, 2006, CNS DRUG REV, V12, P135, DOI 10.1111/j.1527-3458.2006.00135.x; Chea J, 2012, CELL CYCLE, V11, P2885, DOI 10.4161/cc.21280; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Cuerrier D, 2005, J BIOL CHEM, V280, P40632, DOI 10.1074/jbc.M506870200; duVerle DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019035; Friedrich P, 2005, BIOL CHEM, V386, P609, DOI 10.1515/BC.2005.071; Fritz G, 2006, CURR CANCER DRUG TAR, V6, P1, DOI 10.2174/156800906775471752; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Glading A, 2000, J BIOL CHEM, V275, P2390, DOI 10.1074/jbc.275.4.2390; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; Glading A, 2001, J BIOL CHEM, V276, P23341, DOI 10.1074/jbc.M008847200; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Harwood SM, 2005, ANN CLIN BIOCHEM, V42, P415, DOI 10.1258/000456305774538238; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Johnson DE, 2000, LEUKEMIA, V14, P1695, DOI 10.1038/sj.leu.2401879; Kaina B, 2003, BIOCHEM PHARMACOL, V66, P1547, DOI 10.1016/S0006-2952(03)00510-0; Kannouche P, 2006, METHOD ENZYMOL, V408, P407, DOI 10.1016/S0076-6879(06)08025-6; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kidd VJ, 2000, SEMIN CELL DEV BIOL, V11, P191, DOI 10.1006/scdb.2000.0165; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P9870, DOI 10.1073/pnas.152336999; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Kusakawa G, 2000, J BIOL CHEM, V275, P17166, DOI 10.1074/jbc.M907757199; Lakshmikuttyamma A, 2004, CANCER EPIDEM BIOMAR, V13, P1604; LAZEBNIK YA, 1995, P NATL ACAD SCI USA, V92, P9042, DOI 10.1073/pnas.92.20.9042; Li H, 2006, J BIOL CHEM, V281, P14748, DOI 10.1074/jbc.M600322200; Liu W, 2000, NUCLEIC ACIDS RES, V28, P4180, DOI 10.1093/nar/28.21.4180; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Mani SK, 2009, AM J PHYSIOL-HEART C, V297, pH1744, DOI 10.1152/ajpheart.00338.2009; Meng X, 2010, BIOCHEMISTRY-US, V49, P3545, DOI 10.1021/bi100042b; Meng X, 2009, NUCLEIC ACIDS RES, V37, P647, DOI 10.1093/nar/gkn1000; Michetti M, 1996, FEBS LETT, V392, P11, DOI 10.1016/0014-5793(96)00775-2; Momeni HR, 2011, CELL J, V13, P65; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Podust VN, 2002, J BIOL CHEM, V277, P3894, DOI 10.1074/jbc.M109684200; PRELICH G, 1987, NATURE, V326, P517, DOI 10.1038/326517a0; Rahmeh AA, 2012, BIOCHEMISTRY-US, V51, P416, DOI 10.1021/bi201638e; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Wang YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027092; Xiao TT, 2013, FOOD CHEM TOXICOL, V53, P364, DOI 10.1016/j.fct.2012.12.022; Zhang SF, 2007, J BIOL CHEM, V282, P15330, DOI 10.1074/jbc.M610356200; Zhang SF, 2013, J BIOL CHEM, V288, P29550, DOI 10.1074/jbc.M113.490466; Zhang SF, 2013, J BIOL CHEM, V288, P2941, DOI 10.1074/jbc.M112.423392; Zhang WW, 2011, FEBS LETT, V585, P2786, DOI 10.1016/j.febslet.2011.04.044; Zhang ZT, 2012, CELL CYCLE, V11, P2128, DOI 10.4161/cc.20595; Zhou YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039156; Zhou YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022224	55	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93642	10.1371/journal.pone.0093642	http://dx.doi.org/10.1371/journal.pone.0093642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691096	Green Published, gold, Green Submitted			2022-12-25	WOS:000334101100118
J	Hong, EJ; Park, JS; Kim, Y; Lee, HS				Hong, Eun-Ji; Park, Joon-Song; Kim, Younhee; Lee, Heung-Shick			Role of Corynebacterium glutamicum sprA Encoding a Serine Protease in glxR-Mediated Global Gene Regulation	PLOS ONE			English	Article							DNA-BINDING SITES; ESCHERICHIA-COLI; TRANSCRIPTIONAL REGULATOR; ACETATE METABOLISM; ISOCITRATE DEHYDROGENASE; ENZYMATIC-SYNTHESIS; BACILLUS-SUBTILIS; GENOME SEQUENCE; AMINO-ACIDS; IN-VITRO	The global regulator glxR of Corynebacterium glutamicum is involved in many cellular activities. Considering its role, the GlxR protein likely interacts with other proteins to obtain, maintain, and control its activity. To isolate proteins interacting with GlxR, we used a two-hybrid system with GlxR as the bait. Subsequently, the partner, a subtilisin-like serine protease, was isolated from a C. glutamicum genomic library. Unlike glxR, which showed constitutive expression, the expression of sprA, encoding a serine protease, was maximal in the log phase. Purified His(6)-SprA protein underwent self-proteolysis and proteolyzed purified GlxR. The proteolytic action of SprA on GlxR was not observed in the presence of cyclic adenosine monophosphate, which modulates GlxR activity. The C. glutamicum sprA deletion mutant (Delta sprA) and sprA-overexpressing (P-180-sprA) strains showed reduced growth. The activity of isocitrate dehydrogenase (a tricarboxylic acid cycle enzyme) in these strains decreased to 30-50% of that in the wild-type strain. In the P-180-sprA strain, proteins involved in diverse cellular functions such as energy and carbon metabolism (NCgl2809), nitrogen metabolism (NCgl0049), methylation reactions (NCgl0719), and peptidoglycan biosynthesis (NCgl1267), as well as stress, starvation, and survival (NCgl0938) were affected and showed decreased transcription. Taken together, these data suggest that SprA, as a serine protease, performs a novel regulatory role not only in glxR-mediated gene expression but also in other areas of cell physiology. In addition, the tight control of SprA and GlxR availability may indicate their importance in global gene regulation.	[Hong, Eun-Ji; Park, Joon-Song; Lee, Heung-Shick] Korea Univ, Dept Biotechnol & Bioinformat, Sejong Si, South Korea; [Kim, Younhee] Semyung Univ, Dept Oriental Med, Checheon, Chungbuk, South Korea	Korea University; Semyung University	Lee, HS (corresponding author), Korea Univ, Dept Biotechnol & Bioinformat, Sejong Si, South Korea.	hlee@korea.ac.kr	Kim, Younhee/A-2143-2015		National Research Foundation of Korea (NRF); Ministry of Education [NRF-2013R1A1A4A01004556]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A4A01004556) (URL: http://nrf.re.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auchter M, 2011, J BIOTECHNOL, V154, P126, DOI 10.1016/j.jbiotec.2010.07.001; Barzantny H, 2012, J BIOTECHNOL, V159, P235, DOI 10.1016/j.jbiotec.2012.01.021; Becker J, 2009, APPL ENVIRON MICROB, V75, P7866, DOI 10.1128/AEM.01942-09; Bonnet M, 2013, FEBS LETT, V587, P88, DOI 10.1016/j.febslet.2012.11.014; Brown GD, 2000, GENE, V254, P147, DOI 10.1016/S0378-1119(00)00277-8; Bussmann M, 2009, J BIOTECHNOL, V143, P173, DOI 10.1016/j.jbiotec.2009.06.025; Chao GL, 1997, J BACTERIOL, V179, P4299, DOI 10.1128/jb.179.13.4299-4304.1997; Chen X, 2012, APPL ENVIRON MICROB, V78, P5796, DOI 10.1128/AEM.01588-12; Cramer A, 2006, J BACTERIOL, V188, P2554, DOI 10.1128/JB.188.7.2554-2567.2006; DELAHABA G, 1959, J BIOL CHEM, V234, P603; EIKMANNS BJ, 1995, J BACTERIOL, V177, P774, DOI 10.1128/jb.177.3.774-782.1995; Engels S, 2004, MOL MICROBIOL, V52, P285, DOI 10.1111/j.1365-2958.2003.03979.x; FOLLETTIE MT, 1993, J BACTERIOL, V175, P4096, DOI 10.1128/JB.175.13.4096-4103.1993; Fuhrer T, 2007, J BACTERIOL, V189, P8073, DOI 10.1128/JB.01027-07; GARNAK M, 1979, J BIOL CHEM, V254, P7915; Gerstmeir R, 2004, J BACTERIOL, V186, P2798, DOI 10.1128/JB.186.9.2798-2809.2004; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Han SO, 2008, MICROBIOLOGY; Han SO, 2007, MICROBIOL-SGM, V153, P2190, DOI 10.1099/mic.0.2006/004366-0; Ikeda M, 2003, APPL MICROBIOL BIOT, V62, P99, DOI 10.1007/s00253-003-1328-1; Jenal U, 2003, CURR OPIN MICROBIOL, V6, P163, DOI 10.1016/S1369-5274(03)00029-8; JETTEN MSM, 1994, APPL ENVIRON MICROB, V60, P2501, DOI 10.1128/AEM.60.7.2501-2507.1994; Jungwirth B, 2008, FEMS MICROBIOL LETT, V281, P190, DOI 10.1111/j.1574-6968.2008.01098.x; Jungwirth B, 2013, MICROBIOL-SGM, V159, P12, DOI 10.1099/mic.0.062059-0; Kalinowski J, 2003, J BIOTECHNOL, V104, P5, DOI 10.1016/S0168-1656(03)00154-8; KANEKO R, 1989, J BACTERIOL, V171, P5232, DOI 10.1128/jb.171.9.5232-5236.1989; Kim HJ, 2004, J BACTERIOL, V186, P3453, DOI 10.1128/JB.186.11.3453-3460.2004; Kohl TA, 2008, J BIOTECHNOL, V135, P340, DOI 10.1016/j.jbiotec.2008.05.011; Kohl TA, 2009, J BIOTECHNOL, V143, P239, DOI 10.1016/j.jbiotec.2009.08.005; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; Lee JY, 2012, FEMS MICROBIOL LETT, V327, P103, DOI 10.1111/j.1574-6968.2011.02463.x; Letek M, 2006, J BACTERIOL, V188, P409, DOI 10.1128/JB.188.2.409-423.2006; Leuchtenberger W, 2005, APPL MICROBIOL BIOT, V69, P1, DOI 10.1007/s00253-005-0155-y; Ludke A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-6; Mettert EL, 2005, J MOL BIOL, V354, P220, DOI 10.1016/j.jmb.2005.09.066; Nakano S, 2002, J BACTERIOL, V184, P3664, DOI 10.1128/JB.184.13.3664-3670.2002; NEUHAUS FC, 1962, J BIOL CHEM, V237, P3128; Nishimura T, 2011, MICROBIOL-SGM, V157, P21, DOI 10.1099/mic.0.044552-0; Ohol YM, 2010, CELL HOST MICROBE, V7, P210, DOI 10.1016/j.chom.2010.02.006; Pan Q, 2012, BIOCHEMISTRY-US, V51, P5061, DOI 10.1021/bi2018688; Panhorst M, 2011, J BIOTECHNOL, V154, P149, DOI 10.1016/j.jbiotec.2010.07.015; Park JS, 2012, FEMS MICROBIOL LETT, V331, P63, DOI 10.1111/j.1574-6968.2012.02554.x; Park JS, 2011, FEMS MICROBIOL LETT, V322, P8, DOI 10.1111/j.1574-6968.2011.02318.x; Park SD, 2004, J MICROBIOL BIOTECHN, V14, P789; Park SD, 2008, MICROBIOL-SGM, V154, P915, DOI 10.1099/mic.0.2007/012690-0; PARK SS, 1989, J BACTERIOL, V171, P2657, DOI 10.1128/jb.171.5.2657-2665.1989; Park SY, 2010, FEMS MICROBIOL LETT, V304, P107, DOI 10.1111/j.1574-6968.2009.01884.x; Polgar L, 2005, CELL MOL LIFE SCI, V62, P2161, DOI 10.1007/s00018-005-5160-x; Prost JF, 1999, J BACTERIOL, V181, P893, DOI 10.1128/JB.181.3.893-898.1999; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schroder J, 2010, FEMS MICROBIOL REV, V34, P685, DOI 10.1111/j.1574-6976.2010.00228.x; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Strosser J, 2004, MOL MICROBIOL, V54, P132, DOI 10.1111/j.1365-2958.2004.04247.x; Teramoto H, 2011, J BIOTECHNOL, V154, P114, DOI 10.1016/j.jbiotec.2011.01.016; Toyoda K, 2011, J BACTERIOL, V193, P4123, DOI 10.1128/JB.00384-11; Toyoda K, 2009, J BACTERIOL, V191, P968, DOI 10.1128/JB.01425-08; Tripathi LP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-549; van Ooyen J, 2011, J BIOTECHNOL, V154, P140, DOI 10.1016/j.jbiotec.2010.07.004; VONDEROSTEN CH, 1989, J AM CHEM SOC, V111, P3924, DOI 10.1021/ja00193a025; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Xu QP, 2012, J BACTERIOL, V194, P2987, DOI 10.1128/JB.00038-12; Yukawa H, 2007, MICROBIOL-SGM, V153, P1042, DOI 10.1099/mic.0.2006/003657-0	62	7	7	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93587	10.1371/journal.pone.0093587	http://dx.doi.org/10.1371/journal.pone.0093587			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691519	Green Published, Green Submitted, gold			2022-12-25	WOS:000334101100107
J	Kasinski, A; Dong, X; Khuri, FR; Boss, J; Fu, HA				Kasinski, Andrea; Dong, Xueyuan; Khuri, Fadlo R.; Boss, Jeremy; Fu, Haian			Transcriptional Regulation of YWHAZ, the Gene Encoding 14-3-3 zeta	PLOS ONE			English	Article							HUMAN-MELANOMA CELLS; GENOME-WIDE ANALYSIS; NF-KAPPA-B; LUNG-CANCER; IN-VIVO; KINASE-ACTIVITY; BREAST-CANCER; TUMOR-GROWTH; PROTEINS; BINDING	Aberrant expression of oncogenic 14-3-3 proteins is correlated with poor survival of cancer patients. While the underlying mechanism of the abnormal expression in tumors remains elusive for the six oncogenic 14-3-3 isoforms; the potential involvement of a transcriptional component has been suggested. Unfortunately, little experimental data has been reported to support this hypothesis. In this study we describe the genetic structure of YWHAZ, the gene encoding 14-3-3 zeta, including the identification of previously unreported transcript variants. In total, five transcript variants were revealed and their expressions confirmed in a panel of cell lines. Expressed sequence tag (EST) database mining and in vitro rapid-amplification of cDNA ends (RACE) confirmed that one variant, 1c, represents >80% of the expressed transcripts, which is also the most efficiently translated. An analysis of the proximal promoter of this variant revealed a functional Cyclic-AMP Response Element (CRE). Factors that bound to the CRE element were recognized through fractionation and subsequent EMSAs. This analysis identified CREB and ATF-1 as the trans-interacting factors. Cell-based assays confirm that ATF-1, and to a lesser extent CREB, bind the endogenous YWHAZ promoter especially under TNF-alpha stimulating conditions. In support of a role of ATF-1 in the regulation of YWHAZ, silencing of ATF-1 resulted in a marked reduction in two of the five YWHAZ transcripts. These data suggest a novel mechanism for the transcriptional regulation of a major pro-survival gene, YWHAZ, by ATF-1.	[Kasinski, Andrea] Emory Univ, Program Genet & Mol Biol, Atlanta, GA 30322 USA; [Kasinski, Andrea; Dong, Xueyuan; Fu, Haian] Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA; [Boss, Jeremy] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Khuri, Fadlo R.] Emory Univ, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University	Fu, HA (corresponding author), Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA.	hfu@emory.edu	Khuri, Fadlo R./AAU-4942-2020; Kasinski, Andrea L/E-7951-2014; Kasinski, Andrea/AAF-3864-2021	Khuri, Fadlo R./0000-0002-8638-7618; Kasinski, Andrea/0000-0002-9602-7827	US National Institutes of Health [P01 CA116676, RO1 GM47310]; Georgia Cancer Coalition; Georgia Research Alliance; NATIONAL CANCER INSTITUTE [P01CA116676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047310] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Cancer Coalition; Georgia Research Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in authors' laboratories was supported in part by the US National Institutes of Health grants P01 CA116676 (to F.R.K. and H.F.) and RO1 GM47310 (to J.M.B.), Georgia Cancer Coalition (to F.R.K. and H.F.), and Georgia Research Alliance (H.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajjappala BS, 2009, J IMMUNOL, V182, P1050, DOI 10.4049/jimmunol.182.2.1050; Beresford GW, 2001, NAT IMMUNOL, V2, P652, DOI 10.1038/89810; BRASELMANN S, 1995, EMBO J, V14, P4839, DOI 10.1002/j.1460-2075.1995.tb00165.x; Cao L, 2008, NEUROSCI LETT, V432, P94, DOI 10.1016/j.neulet.2007.11.071; Coblitz B, 2006, FEBS LETT, V580, P1531, DOI 10.1016/j.febslet.2006.02.014; Fan T, 2007, CANCER RES, V67, P7901, DOI 10.1158/0008-5472.CAN-07-0090; Ferguson AT, 2000, P NATL ACAD SCI USA, V97, P6049, DOI 10.1073/pnas.100566997; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Ganguly S, 2005, P NATL ACAD SCI USA, V102, P1222, DOI 10.1073/pnas.0406871102; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; IGUCHIARIGA SMM, 1989, GENE DEV, V3, P612, DOI 10.1101/gad.3.5.612; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Jean D, 2000, MOL CELL BIOCHEM, V212, P19, DOI 10.1023/A:1007128101751; Jean D, 1998, J BIOL CHEM, V273, P24884, DOI 10.1074/jbc.273.38.24884; Jean D, 2001, CRIT REV IMMUNOL, V21, P275; Jornot L, 1997, FEBS LETT, V416, P381, DOI 10.1016/S0014-5793(97)01244-1; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kasinski A, 2011, 14 3 3 ZETA AFCS NAT; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee J, 2001, MOL BIOL CELL, V12, P551, DOI 10.1091/mbc.12.3.551; Leonard MO, 2008, AM J RESP CRIT CARE, V178, P977, DOI 10.1164/rccm.200712-1890OC; Li ZG, 2008, P NATL ACAD SCI USA, V105, P162, DOI 10.1073/pnas.0710905105; Lopez-Girona A, 1999, NATURE, V397, P172, DOI 10.1038/16488; Matta A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-169; MORRISON DK, 1993, J BIOL CHEM, V268, P17309; Murata T, 2012, CLIN CANCER RES, V18, P5617, DOI 10.1158/1078-0432.CCR-12-0281; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Neal CL, 2009, CANCER RES, V69, P3425, DOI 10.1158/0008-5472.CAN-08-2765; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Pomerantz JL, 2002, MOL CELL, V10, P693, DOI 10.1016/S1097-2765(02)00697-4; Powell DW, 2003, MOL CELL BIOL, V23, P5376, DOI 10.1128/MCB.23.15.5376-5387.2003; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Qi WQ, 2005, INT J CANCER, V113, P359, DOI 10.1002/ijc.20492; SHAPIRO DJ, 1988, DNA-J MOLEC CELL BIO, V7, P47, DOI 10.1089/dna.1988.7.47; Thorson JA, 1998, MOL CELL BIOL, V18, P5229, DOI 10.1128/MCB.18.9.5229; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; vanHeusden GPH, 1996, FEBS LETT, V391, P252, DOI 10.1016/0014-5793(96)00746-6; Vincenz C, 1996, J BIOL CHEM, V271, P20029, DOI 10.1074/jbc.271.33.20029; Woodcock JM, 2003, J BIOL CHEM, V278, P36323, DOI 10.1074/jbc.M304689200; Xie SH, 1997, ONCOGENE, V15, P2069, DOI 10.1038/sj.onc.1201358; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; Yang YM, 1996, ONCOGENE, V12, P2223; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102	45	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93480	10.1371/journal.pone.0093480	http://dx.doi.org/10.1371/journal.pone.0093480			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690670	Green Submitted, Green Published, gold			2022-12-25	WOS:000334101100089
J	Li, XF; Zhang, X; Chen, Y; Zhang, KL; Liu, XJ; Li, JP				Li, Xiao-Feng; Zhang, Xu; Chen, Yang; Zhang, Kun-Lian; Liu, Xiang-Jun; Li, Jian-Ping			An Analysis of HLA- A, - B, and-DRB1 Allele and Haplotype Frequencies of 21,918 Residents Living in Liaoning, China	PLOS ONE			English	Article							HAN POPULATION; CLASS-I; POLYMORPHISM; GENE; DRB1	HLA-A,-B and - DRB1 allele frequencies and their haplotype frequencies in 21,918 Chinese residents living in Liaoning Province, who were registered as volunteer donors of China Marrow Donor Registry, were investigated. They are composed of 93.37% Han Chinese, 5.1% Manchus, 0.57% Mongols, 0.46% Hui persons, 0.29% Koreans and 0.14% Xibe ethnic group. In total eighteen different HLA-A alleles, forty- eight different HLA- B alleles and fourteen different HLA- DRB1 alleles have been identified. Their frequencies are in agreement with the Hardy- Weinberg equilibrium. For Han Chinese in Liaoning, 1,534 different HLA- A- B- DRB1 haplotypes were identified, with a frequency of higher than 0.01%. A* 30- B* 13- DRB1* 07, A* 02- B* 46DRB1* 09 and A* 02- B* 13- DRB1* 12 are the most frequent haplotypes among Liaoning Han. While Liaoning Han, Liaoning Manchu, Liaoning Mongol, Liaoning Hui and Liaoning Korean share the northern Han characteristic haplotypes, all minority ethnic groups with the exception of Liaoning Manchu have developed their own unique HLA profiles. This dataset characterizes the HLA allele and haplotype frequencies in the Liaoning area and suggests that it is different from those in other parts of China and ethnic groups, which implicates transplant donor searching strategies and studies on population genetics.	[Li, Xiao-Feng; Zhang, Xu; Chen, Yang; Zhang, Kun-Lian; Li, Jian-Ping] HLA Lab, Liaoning Blood Ctr, Shenyang, Liaoning, Peoples R China; [Li, Xiao-Feng; Zhang, Xu; Chen, Yang; Zhang, Kun-Lian; Li, Jian-Ping] Liaoning Key Lab Blood Safety Res, Shenyang, Liaoning, Peoples R China; [Liu, Xiang-Jun] BFR Diagnost LTD, Beijing, Peoples R China; [Li, Jian-Ping] Shenyang Res Ctr Stem Cell Clin Applicat, Shenyang, Liaoning, Peoples R China		Li, JP (corresponding author), HLA Lab, Liaoning Blood Ctr, Shenyang, Liaoning, Peoples R China.	ljp_63@163.com		Li, Xiaofeng/0000-0002-3888-6359; Li, Jianping/0000-0002-5392-0471	Shenyang Science and Technology Foundation [F10-206-1-00]; China marrow donor program (CMDP)	Shenyang Science and Technology Foundation; China marrow donor program (CMDP)	This study was supported in part by a grant from Shenyang Science and Technology Foundation (F10-206-1-00), and China marrow donor program (CMDP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen R, 1993, Yi Chuan Xue Bao, V20, P389; Chen Yang, 2006, Zhonghua Yixue Yichuanxue Zazhi, V23, P461; [程良红 CHENG Lianghong], 2009, [中国输血杂志, Chinese Journal of Blood Transfusion], V22, P196; Danzer M, 2007, HUM IMMUNOL, V68, P915, DOI 10.1016/j.humimm.2007.10.005; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; HASHIMOTO M, 1994, TISSUE ANTIGENS, V44, P166, DOI 10.1111/j.1399-0039.1994.tb02375.x; HATTEMER HH, 1982, THEOR APPL GENET, V62, P219, DOI 10.1007/BF00276242; Hong WG, 2007, HUM IMMUNOL, V68, P439, DOI 10.1016/j.humimm.2007.01.020; Jiang B, 2006, FORENSIC SCI INT, V162, P66, DOI 10.1016/j.forsciint.2006.06.041; [金士正 JIN Shixheng], 2006, [广东医学, Guangdong Medical Journal], V27, P1289; Kupatawintu P, 2010, TISSUE ANTIGENS, V75, P730, DOI 10.1111/j.1399-0039.2010.01450.x; LO YMD, 1992, NUCLEIC ACIDS RES, V20, P1005, DOI 10.1093/nar/20.5.1005; Miao KR, 2007, INT J IMMUNOGENET, V34, P419, DOI 10.1111/j.1744-313X.2007.00713.x; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NIJENHUIS LE, 1985, TISSUE ANTIGENS, V26, P215, DOI 10.1111/j.1399-0039.1985.tb00963.x; PETERSDORF EW, 1991, TISSUE ANTIGENS, V38, P169, DOI 10.1111/j.1399-0039.1991.tb01891.x; Qu Zhe, 2006, Zhonghua Yixue Yichuanxue Zazhi, V23, P349; Robinson J, 2013, NUCLEIC ACIDS RES, V41, pD1222, DOI 10.1093/nar/gks949; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANTAMARIA P, 1993, HUM IMMUNOL, V37, P39, DOI 10.1016/0198-8859(93)90141-M; Shaw CK, 1999, TISSUE ANTIGENS, V53, P51, DOI 10.1034/j.1399-0039.1999.530106.x; Shen Chun-Mei, 2008, Yichuan, V30, P164, DOI 10.3724/SP.J.1005.2008.00164; Shen CM, 2008, CROAT MED J, V49, P476, DOI 10.3325/cmj.2008.4.476; Trachtenberg E, 2007, TISSUE ANTIGENS, V70, P455, DOI 10.1111/j.1399-0039.2007.00932.x; Wang C.Q., 2009, J MOL DIAGN THER, V1, P165; Wu Qiang-Ju, 2007, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V15, P357; Yao Y, 2009, TISSUE ANTIGENS, V73, P561, DOI 10.1111/j.1399-0039.2009.01237.x; Yoon JH, 2010, TISSUE ANTIGENS, V75, P170, DOI 10.1111/j.1399-0039.2009.01418.x; Zeng J, 2005, CHIN J BLOOD TRANSFU, V18, P384; ZETTERQUIST H, 1992, HUM IMMUNOL, V34, P64, DOI 10.1016/0198-8859(92)90086-3; Zhu BF, 2010, J ZHEJIANG UNIV-SC B, V11, P127, DOI 10.1631/jzus.B0900232; 曲喆, 2005, [中国法医学杂志, Chinese Journal of Forensic Medicine], V20, P355	34	10	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93082	10.1371/journal.pone.0093082	http://dx.doi.org/10.1371/journal.pone.0093082			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691290	Green Published, Green Submitted, gold			2022-12-25	WOS:000334101100043
J	Qi, JP; Zhang, Q; Zhu, Y; Qi, J				Qi, Jin-Peng; Zhang, Qing; Zhu, Ying; Qi, Jie			A Novel Method for Fast Change-Point Detection on Simulated Time Series and Electrocardiogram Data	PLOS ONE			English	Article								Although Kolmogorov-Smirnov (KS) statistic is a widely used method, some weaknesses exist in investigating abrupt Change Point (CP) problems, e. g. it is time-consuming and invalid sometimes. To detect abrupt change from time series fast, a novel method is proposed based on Haar Wavelet (HW) and KS statistic (HWKS). First, the two Binary Search Trees (BSTs), termed TcA and TcD, are constructed by multi-level HW from a diagnosed time series; the framework of HWKS method is implemented by introducing a modified KS statistic and two search rules based on the two BSTs; and then fast CP detection is implemented by two HWKS-based algorithms. Second, the performance of HWKS is evaluated by simulated time series dataset. The simulations show that HWKS is faster, more sensitive and efficient than KS, HW, and T methods. Last, HWKS is applied to analyze the electrocardiogram (ECG) time series, the experiment results show that the proposed method can find abrupt change from ECG segment with maximal data fluctuation more quickly and efficiently, and it is very helpful to inspect and diagnose the different state of health from a patient's ECG signal.	[Qi, Jin-Peng; Qi, Jie] Donghua Univ, Coll Informat Sci & Technol, Shanghai, Peoples R China; [Qi, Jin-Peng; Zhang, Qing] CSIRO, Australia E Hlth Res Ctr, Brisbane, Qld, Australia; [Zhu, Ying] Royal N Shore Hosp, Hunter New England Hlth, St Leonards, NSW, Australia	Donghua University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Royal North Shore Hospital	Qi, JP (corresponding author), Donghua Univ, Coll Informat Sci & Technol, Shanghai, Peoples R China.	qipengkai@dhu.edu.cn	Qi, Jinpeng/HDL-6725-2022		National Natural Science Foundation of China [61104154]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This paper is supported by National Natural Science Foundation of China (No. 61104154), and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 1998, MAGNET RESON MED, V39, P500, DOI 10.1002/mrm.1910390322; Alarcon-Aquino V, 2001, IEE P-COMMUN, V148, P355, DOI 10.1049/ip-com:20010659; Alarcon-Aquino V, 2009, LAT AM APPL RES, V39, P145; Bolton RJ, 2002, STAT SCI, V17, P235; Brodsky BE, 1993, NONPARAMETRIC METHOD; Brown JR, 2008, J STAT SOFTW, V26, P1; Darkhovski B. S., 1994, IMS LECT NOTES MONOG, V23, P99; Fell J, 2000, ACTA NEUROBIOL EXP, V60, P87; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Greenwald S. D, 1986, DEV ANAL VENTRICULAR; Gustafsson F, 1996, IEEE T AUTOMAT CONTR, V41, P66, DOI 10.1109/9.481608; Gustafsson F, 2000, ADAPTIVE FILTERING C; Hall LD, 2004, MECH SYST SIGNAL PR, V18, P849, DOI 10.1016/S0888-3270(03)00050-5; Hardle W., 2004, NONPARAMETRIC SEMIPA; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Ide T., 2004, P 10 ACM SIGKDD INT; Kawahara Y, 2007, DAT MIN 2007 ICDM 20; Khalil M, 1999, SIGNAL PROCESS, V75, P239, DOI 10.1016/S0165-1684(98)00236-9; Kifer Daniel, 2004, VLDB, DOI DOI 10.1016/B978-012088469-8/50019-X; Kobayashi M, 2001, NONLINEAR ANAL-THEOR, V47, P1749, DOI 10.1016/S0362-546X(01)00307-8; Lin HD, 2007, IMAGE VISION COMPUT, V25, P1785, DOI 10.1016/j.imavis.2007.02.002; Marsaglia G., 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i14, DOI 10.18637/JSS.V008.I18, 10.18637/jss.v008.i18]; Meagher M, 2007, IEEE INT CONF INF VI, P601; MOODY G, 1984, COMPUT CARDIOL, V0011; Murad U, 1999, LECT NOTES ARTIF INT, V1704, P251; Percival D.B., 2006, WAVELET METHODS TIME; Percival D.B., 2008, NONLINEAR TIME SERIE, DOI DOI 10.1007/978-3-540-78938-3_4; Qi JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022228; Raimondo M, 2004, STAT SINICA, V14, P395; Salam M, 2008, INT J COMPUTER SCI S, V2, P23; Sharifzadeh M, 2005, LECT NOTES COMPUT SC, V3633, P127; Simard R, 2011, J STAT SOFTW, V39, P1, DOI 10.18637/jss.v039.i11; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; STEPHENS MA, 1974, J AM STAT ASSOC, V69, P730, DOI 10.2307/2286009; Tseng VS, 2006, DAT MIN WORKSH 2006; Walker J.S., 2002, PRIMER WAVELETS THEI; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020060; Yamanishi K, 2004, DATA MIN KNOWL DISC, V8, P275, DOI 10.1023/B:DAMI.0000023676.72185.7c; Yamanishi K, 2002, P 8 ACM SIGKDD INT C	40	14	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93365	10.1371/journal.pone.0093365	http://dx.doi.org/10.1371/journal.pone.0093365			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690633	Green Submitted, Green Published, gold			2022-12-25	WOS:000334101100069
J	Li, N; Lee, K; Xi, Y; Zhu, B; Gary, BD; Ramirez-Alcantara, V; Gurpinar, E; Canzoneri, JC; Fajardo, A; Sigler, S; Piazza, JT; Chen, X; Andrews, J; Thomas, M; Lu, W; Li, Y; Laan, DJ; Moyer, MP; Russo, S; Eberhardt, BT; Yet, L; Keeton, AB; Grizzle, WE; Piazza, GA				Li, N.; Lee, K.; Xi, Y.; Zhu, B.; Gary, B. D.; Ramirez-Alcantara, V.; Gurpinar, E.; Canzoneri, J. C.; Fajardo, A.; Sigler, S.; Piazza, J. T.; Chen, X.; Andrews, J.; Thomas, M.; Lu, W.; Li, Y.; Laan, D. J.; Moyer, M. P.; Russo, S.; Eberhardt, B. T.; Yet, L.; Keeton, A. B.; Grizzle, W. E.; Piazza, G. A.			Phosphodiesterase 10A: a novel target for selective inhibition of colon tumor cell growth and beta-catenin-dependent TCF transcriptional activity	ONCOGENE			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; PROTEIN-KINASE-G; SULINDAC SULFIDE; EXPRESSION; EXISULIND; APOPTOSIS; CANCER; ACTIVATION; PDE10A; LOCALIZATION	The cyclic nucleotide phosphodiesterase 10A (PDE10) has been mostly studied as a therapeutic target for certain psychiatric and neurological conditions, although a potential role in tumorigenesis has not been reported. Here we show that PDE10 is elevated in human colon tumor cell lines compared with normal colonocytes, as well as in colon tumors from human clinical specimens and intestinal tumors from Apc(Min/+) mice compared with normal intestinal mucosa, respectively. An isozyme and tumor-selective role of PDE10 were evident by the ability of small-molecule inhibitors and small interfering RNA knockdown to suppress colon tumor cell growth with reduced sensitivity of normal colonocytes. Stable knockdown of PDE10 by short hairpin RNA also inhibits colony formation and increases doubling time of colon tumor cells. PDE10 inhibition selectively activates cGMP/cGMP-dependent protein kinase signaling to suppress beta-catenin levels and T-cell factor (TCF) transcriptional activity in colon tumor cells. Conversely, ectopic expression of PDE10 in normal and precancerous colonocytes increases proliferation and activates TCF transcriptional activity. These observations suggest a novel role of PDE10 in colon tumorigenesis and that inhibitors may be useful for the treatment or prevention of colorectal cancer.	[Li, N.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL USA; [Lee, K.; Xi, Y.; Zhu, B.; Gary, B. D.; Ramirez-Alcantara, V.; Canzoneri, J. C.; Fajardo, A.; Sigler, S.; Piazza, J. T.; Chen, X.; Andrews, J.; Thomas, M.; Russo, S.; Keeton, A. B.; Piazza, G. A.] Univ S Alabama, Drug Discovery Res Ctr, Mitchell Canc Inst, Dept Oncol Sci & Pharmacol, Mobile, AL 36004 USA; [Gurpinar, E.] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Birmingham, AL USA; [Lu, W.; Li, Y.] So Res Inst, Drug Discovery Div, Birmingham, AL 35255 USA; [Laan, D. J.] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA; [Moyer, M. P.] INCELL Corp LLC, San Antonio, TX USA; [Eberhardt, B. T.; Yet, L.] Univ S Alabama, Dept Chem, Mobile, AL 36004 USA; [Grizzle, W. E.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of South Alabama; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of South Alabama; University of Alabama System; University of Alabama Birmingham	Piazza, GA (corresponding author), Univ S Alabama, Drug Discovery Res Ctr, Mitchell Canc Inst, Dept Oncol Sci & Pharmacol, 1660 Springhill Ave,Suite 3029, Mobile, AL 36004 USA.	gpiazza@health.southalabama.edu	Li, Nan/I-3589-2015; Ramirez-Alcantara, Verónica/AAM-5424-2020	Xi, Yaguang/0000-0003-3681-9352; Piazza, Gary/0000-0003-4418-887X	National Institutes of Health [1R01CA131378, 1R01CA148817, 1R01CA155638]; NATIONAL CANCER INSTITUTE [R01CA155638, R01CA131378, R01CA148817] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R24HL123767] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Dr Graeme Bolger for critical reading of the manuscript. We also thank Dr Marian from Medical University Vienna, Austria for the generous gift of LT97 adenoma cell line and Dr Dan Dixon from University of Kansas Cancer Center for providing specimens from the Apc<SUP>Min/+</SUP> mouse model. We are also grateful to Dr Darren Browning from Georgia Regents University Cancer Center for providing the CTNNB1 luciferase reporter construct. This work was supported by National Institutes of Health Grants, 1R01CA131378, 1R01CA148817 and 1R01CA155638 to GAP.	Anderson CB, 2002, P NATL ACAD SCI USA, V99, P8683, DOI 10.1073/pnas.122235399; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Chappie TA, 2007, J MED CHEM, V50, P182, DOI 10.1021/jm060653b; Coskran TM, 2006, J HISTOCHEM CYTOCHEM, V54, P1205, DOI 10.1369/JHC.6A6930.2006; D'Andrea MR, 2005, J HISTOCHEM CYTOCHEM, V53, P895, DOI 10.1369/jhc.5A6625.2005; Deguchi A, 2004, CANCER RES, V64, P3966, DOI 10.1158/0008-5472.CAN-03-3740; Deguchi A, 2002, MOL CANCER THER, V1, P803; Francis SH, 2011, PHYSIOL REV, V91, P651, DOI 10.1152/physrev.00030.2010; Fujishige K, 1999, J BIOL CHEM, V274, P18438, DOI 10.1074/jbc.274.26.18438; Gudi T, 1997, MOL CELL BIOL, V17, P5244, DOI 10.1128/MCB.17.9.5244; Hou YL, 2006, CANCER LETT, V240, P60, DOI 10.1016/j.canlet.2005.08.035; Kim PJ, 2003, LANCET, V362, P205, DOI 10.1016/S0140-6736(03)13910-4; Kwon IK, 2010, ONCOGENE, V29, P3423, DOI 10.1038/onc.2010.91; Kwon IK, 2008, CANCER-AM CANCER SOC, V112, P1462, DOI 10.1002/cncr.23334; Li N, 2013, MOL CANCER THER, V12, P1848, DOI 10.1158/1535-7163.MCT-13-0048; Li QJ, 2004, GENOMICS, V83, P231, DOI 10.1016/j.ygeno.2003.08.004; Li X, 2012, ONCOGENE, V31, P4979, DOI 10.1038/onc.2011.655; Liu L, 2001, J PHARMACOL EXP THER, V299, P583; Loughney K, 1999, GENE, V234, P109, DOI 10.1016/S0378-1119(99)00171-7; Lucas KA, 2000, PHARMACOL REV, V52, P375; Marko D, 2000, CHEM RES TOXICOL, V13, P944, DOI 10.1021/tx000090l; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Moyer MP, 1996, IN VITRO CELL DEV-AN, V32, P315; Piazza GA, 2001, CANCER RES, V61, P3961; Pitari GM, 2001, P NATL ACAD SCI USA, V98, P7846, DOI 10.1073/pnas.141124698; Pusztai L, 2003, J CLIN ONCOL, V21, P3454, DOI 10.1200/JCO.2003.02.114; Richter M, 2002, EUR J CANCER, V38, P1937, DOI 10.1016/S0959-8049(02)00158-2; Saravani R, 2012, CELL PROLIFERAT, V45, P199, DOI 10.1111/j.1365-2184.2012.00819.x; Savai R, 2010, EXPERT OPIN INV DRUG, V19, P117, DOI 10.1517/13543780903485642; Shailubhai K, 2000, CANCER RES, V60, P5151; Shimizu K, 2009, ANTICANCER RES, V29, P1119; Siuciak JA, 2006, NEUROPHARMACOLOGY, V51, P386, DOI 10.1016/j.neuropharm.2006.04.013; Siuciak JA, 2006, NEUROPHARMACOLOGY, V51, P374, DOI 10.1016/j.neuropharm.2006.01.012; Smolenski A, 1998, J BIOL CHEM, V273, P20029, DOI 10.1074/jbc.273.32.20029; Soderling SH, 1999, P NATL ACAD SCI USA, V96, P7071, DOI 10.1073/pnas.96.12.7071; Steinbrecher KA, 2000, BIOCHEM BIOPH RES CO, V273, P225, DOI 10.1006/bbrc.2000.2917; Thompson WJ, 2000, CANCER RES, V60, P3338; Tian X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018136; Tinsley HN, 2010, CANCER PREV RES, V3, P1303, DOI 10.1158/1940-6207.CAPR-10-0030; Tinsley HN, 2009, MOL CANCER THER, V8, P3331, DOI 10.1158/1535-7163.MCT-09-0758; Whitehead CM, 2003, MOL CANCER THER, V2, P479; Whitt JD, 2012, CANCER PREV RES, V5, P822, DOI 10.1158/1940-6207.CAPR-11-0559; Xie Z, 2006, NEUROSCIENCE, V139, P597, DOI 10.1016/j.neuroscience.2005.12.042; Zhang LZ, 2008, P NATL ACAD SCI USA, V105, P19532, DOI 10.1073/pnas.0806152105	44	47	49	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 19	2015	34	12					1499	1509		10.1038/onc.2014.94	http://dx.doi.org/10.1038/onc.2014.94			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CD9KI	24704829	Green Accepted			2022-12-25	WOS:000351416800003
J	Lee, JH; Kwon, JH; Jeon, YH; Ko, KY; Lee, SR; Kim, IY				Lee, Jea Hwang; Kwon, Joon Hyun; Jeon, Yeong Ha; Ko, Kwan Young; Lee, Seung-Rock; Kim, Ick Young			Pro(178) and Pro(183) of Selenoprotein S Are Essential Residues for Interaction with p97( VCP) during Endoplasmic Reticulum-associated Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ER Stress; ER-associated Degradation; Protein-Protein Interactions; Selenium; Selenoprotein; p97(VCP)	STRESS-INDUCED APOPTOSIS; AAA-ATPASE; MEMBRANE-PROTEIN; QUALITY-CONTROL; DROSOPHILA-MELANOGASTER; MULTIPROTEIN COMPLEXES; MISFOLDED PROTEINS; MAMMALIAN-CELLS; ER; UBIQUITIN	Background: SelS is a binding partner of p97(VCP) for endoplasmic reticulum-associated degradation (ERAD). Results: The proline mutants at SelS positions at 178 or 183 did not interact with p97(VCP). Conclusion: Both Pro(178) and Pro(183) of SelS are essential for SelS function during ERAD. Significance: The essential SelS amino acid residues for binding to p97(VCP) are identified. During endoplasmic reticulum (ER)-associated degradation, p97(VCP) is recruited to the ER membrane through interactions with transmembrane proteins, such as selenoprotein S (SelS), selenoprotein K (SelK), hrd1, and gp78. SelS has a single-spanning transmembrane domain and protects cells from ER stress-induced apoptosis through interaction with p97(VCP). The cytosolic tail of SelS consists of a coiled-coil domain, a putative VCP-interacting motif (VIM), and an unpronounced glycine- and proline-rich secondary structure. To understand the regulatory mechanism of SelS during ER stress, we investigated the interaction of the protein with p97(VCP) using mouse neuroblastoma cells and human embryonic kidney 293 cells. The SelS expression level increased when ER stress was induced. In addition, the effect of ER stress was enhanced, and recruitment of p97(VCP) to the ER membrane was inhibited in SelS knockdown cells. The effect of SelS knockdown was rescued by ectopic expression of SelS U188C. p97(VCP) interacted with SelS U188C and was recruited to the ER membrane. The expression of SelS[VIM], which is a VIM deletion mutant of SelS, also showed both a recovery effect and an interaction with p97(VCP) in cells. However, mutants in which the proline residue positions 178 or 183 of SelS were changed to alanine or were deleted did not interact with p97(VCP). The proline mutants did not rescue ER stress in SelS knockdown cells. These results suggest that both Pro(178) and Pro(183) of SelS play important roles in the translocation of p97(VCP) to the ER membrane and protect cells from ER stress.	[Lee, Jea Hwang; Kwon, Joon Hyun; Jeon, Yeong Ha; Ko, Kwan Young; Kim, Ick Young] Korea Univ, Div Life Sci, Lab Cellular & Mol Biochem, Seoul 136701, South Korea; [Lee, Seung-Rock] Chonnam Natl Univ, Sch Med,Res Inst Med Sci, Dept Biochem, Dept Biomed Sci,Res Ctr Aging & Geriatr, Kwangju 501190, South Korea	Korea University; Chonnam National University	Kim, IY (corresponding author), Korea Univ, Div Life Sci, 1,5 Ka, Seoul 136701, South Korea.	ickkim@korea.ac.kr			Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning [2013R1A2A2A01067149]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea, which was funded by Ministry of Science, ICT, and Future Planning Grant 2013R1A2A2A01067149.	Arner ESJ, 2010, EXP CELL RES, V316, P1296, DOI 10.1016/j.yexcr.2010.02.032; Ballar P, 2006, J BIOL CHEM, V281, P35359, DOI 10.1074/jbc.M603355200; Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; Castellano S, 2001, EMBO REP, V2, P697, DOI 10.1093/embo-reports/kve151; Chen CL, 2006, BIOCHEM BIOPH RES CO, V348, P1296, DOI 10.1016/j.bbrc.2006.07.203; Christensen LC, 2012, J BIOL CHEM, V287, P26388, DOI 10.1074/jbc.M112.346775; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Du SQ, 2010, ARCH BIOCHEM BIOPHYS, V502, P137, DOI 10.1016/j.abb.2010.08.001; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Ewens CA, 2010, BIOCHEM CELL BIOL, V88, P41, DOI [10.1139/O09-128, 10.1139/o09-128]; Foldi I, 2013, NEUROCHEM INT, V62, P58, DOI 10.1016/j.neuint.2012.11.003; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Gao Y, 2004, FEBS LETT, V563, P185, DOI 10.1016/S0014-5793(04)00296-0; Hanzelmann P, 2011, J BIOL CHEM, V286, P38679, DOI 10.1074/jbc.M111.274506; Hetz C, 2003, EMBO J, V22, P5435, DOI 10.1093/emboj/cdg537; Jeon YH, 2013, BBA-MOL CELL RES, V1833, P2135, DOI 10.1016/j.bbamcr.2013.05.005; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kim KH, 2007, BIOCHEM BIOPH RES CO, V354, P127, DOI 10.1016/j.bbrc.2006.12.183; Kim KS, 2010, J BIOL CHEM, V285, P40294, DOI 10.1074/jbc.M110.126821; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Kogel D, 2003, J NEUROCHEM, V87, P248, DOI 10.1046/j.1471-4159.2003.02000.x; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kwon JH, 2012, J IMMUNOL, V188, P5665, DOI 10.4049/jimmunol.1102306; LEE BJ, 1989, J BIOL CHEM, V264, P9724; Lee JJ, 2013, J BIOL CHEM, V288, P6998, DOI 10.1074/jbc.M112.417576; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Liu J, 2013, BIOCHEMISTRY-US, V52, P5514, DOI 10.1021/bi400741c; Liu J, 2012, PROTEIN EXPRES PURIF, V86, P27, DOI 10.1016/j.pep.2012.08.014; Lu CL, 2006, FEBS LETT, V580, P5189, DOI 10.1016/j.febslet.2006.08.065; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Min KW, 2003, J BIOL CHEM, V278, P15905, DOI 10.1074/jbc.M213070200; Morgan AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053785; Morozova N, 2003, GENES CELLS, V8, P963, DOI 10.1046/j.1365-2443.2003.00687.x; Park YH, 2012, BBA-MOL CELL RES, V1823, P2217, DOI 10.1016/j.bbamcr.2012.09.001; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Shchedrina VA, 2011, J BIOL CHEM, V286, P42937, DOI 10.1074/jbc.M111.310920; Shchedrina VA, 2010, ANTIOXID REDOX SIGN, V12, P839, DOI 10.1089/ars.2009.2865; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Stapf C, 2011, J BIOL CHEM, V286, P38670, DOI 10.1074/jbc.M111.274472; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Yamanaka K, 2012, BBA-MOL CELL RES, V1823, P130, DOI 10.1016/j.bbamcr.2011.07.001; Yang M, 1998, J EXP MED, V187, P835, DOI 10.1084/jem.187.6.835; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	55	32	33	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13758	13768		10.1074/jbc.M113.534529	http://dx.doi.org/10.1074/jbc.M113.534529			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24700463	hybrid, Green Published			2022-12-25	WOS:000335984600010
J	Ma, XJ; Espana-Serrano, L; Kim, WJ; Purayil, HT; Nie, ZZ; Daaka, Y				Ma, Xiaojie; Espana-Serrano, Laura; Kim, Wan-ju; Purayil, Hamsa Thayele; Nie, Zhongzhen; Daaka, Yehia			beta Arrestin1 Regulates the Guanine Nucleotide Exchange Factor RasGRF2 Expression and the Small GTPase Rac- mediated Formation of Membrane Protrusion and Cell Motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Arrestin; Cell Migration; G Protein-coupled Receptors (GPCR); Guanine Nucleotide Exchange Factor (GEF); Rac; Protrusion	COFILIN PHOSPHORYLATION; BETA-ARRESTINS; LIM-KINASE; RECEPTOR; IDENTIFICATION; DOWNSTREAM; MIGRATION; PATHWAY; SIGNAL; GENES	Background: G protein-coupled receptors (GPCRs) and arrestins have been shown to regulate cell motility. Results: Arrestin1 regulates cell migration through RasGRF2 (a dual guanine nucleotide exchange factor) gene expression and the small GTPase Rac activity. Conclusion: Arrestin1 may regulate cellular functions at the gene expression level. Significance: Arrestins may function at transcriptional and post-translational levels to regulate cell migration. Arrestin proteins shuttle between the cytosol and nucleus and have been shown to regulate G protein-coupled receptor signaling, actin remodeling, and gene expression. Here, we tested the hypothesis that arrestin1 regulates actin remodeling and cell migration through the small GTPase Rac. Depletion of arrestin1 promotes Rac activation, leading to the formation of multipolar protrusions and increased cell circularity, and overexpression of a dominant negative form of Rac reverses these morphological changes. Small interfering RNA library screen identifies RasGRF2 as a target of arrestin1. RasGRF2 gene and protein expression levels are elevated following depletion of arrestin1, and the consequent activation of Rac results in dephosphorylation of cofilin that can promote actin polymerization and formation of multipolar protrusions, thereby retarding cell migration and invasion. Together, these results suggest that arrestin1 regulates rasgrf2 gene expression and Rac activation to affect membrane protrusion and cell migration and invasion.	[Ma, Xiaojie; Espana-Serrano, Laura; Kim, Wan-ju; Purayil, Hamsa Thayele; Nie, Zhongzhen; Daaka, Yehia] Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Nie, ZZ (corresponding author), NIGMS, NIH, Div Cell Biol & Biophys, 45 Ctr Dr,Rm 2AS13H,MSC6200, Bethesda, MD 20892 USA.	niezhong@nigms.nih.gov	PURAYIL, HAMSA THAYELE/E-7533-2015	THAYELE PURAYIL, HAMSA/0000-0002-7211-3659	National Institutes of Health from USPHS [K22CA124578]; NCI [R01CA129155]; NATIONAL CANCER INSTITUTE [R01CA129155, K22CA124578] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants K22CA124578 from USPHS (to Z. N.) and R01CA129155 from NCI (to Y. D.).	Anthony DF, 2011, MOL CELL BIOL, V31, P1066, DOI 10.1128/MCB.00883-10; Barnes WG, 2005, J BIOL CHEM, V280, P8041, DOI 10.1074/jbc.M412924200; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Calvo F, 2011, NAT CELL BIOL, V13, P819, DOI 10.1038/ncb2271; Cernuda-Morollon E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012393; Charest PG, 2007, BIOCHEM J, V401, P377, DOI 10.1042/BJ20061432; Chen H, 2006, ONCOL REP, V15, P1281; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Cotton M, 2009, CELL SIGNAL, V21, P1045, DOI 10.1016/j.cellsig.2009.02.008; DeFea KA, 2007, ANNU REV PHYSIOL, V69, P535, DOI 10.1146/annurev.physiol.69.022405.154804; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Fan WT, 1998, CURR BIOL, V8, P935, DOI 10.1016/S0960-9822(07)00376-4; Feig Larry A, 2011, Genes Cancer, V2, P306, DOI 10.1177/1947601911408077; Fereshteha M, 2012, P NATL ACAD SCI USA, V109, P12532, DOI 10.1073/pnas.1209815109; Fernandez-Medarde A, 2011, BBA-REV CANCER, V1815, P170, DOI 10.1016/j.bbcan.2010.11.001; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Guilluy C, 2010, NAT MED, V16, P183, DOI 10.1038/nm.2079; Hagihara A, 2004, ONCOGENE, V23, P8705, DOI 10.1038/sj.onc.1207783; Hara MR, 2011, NATURE, V477, P349, DOI 10.1038/nature10368; Hoeppner CZ, 2012, J BIOL CHEM, V287, P8932, DOI 10.1074/jbc.M111.294058; Jacinto FV, 2007, CANCER RES, V67, P11481, DOI 10.1158/0008-5472.CAN-07-2687; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Kim JS, 2010, MICROFLOW CYTOMETER, P1, DOI 10.1201/b11115; Kligys K, 2007, J BIOL CHEM, V282, P32520, DOI 10.1074/jbc.M707041200; Lakshmikanthan V, 2009, P NATL ACAD SCI USA, V106, P9379, DOI 10.1073/pnas.0900258106; Li TT, 2009, MOL CANCER RES, V7, P1064, DOI 10.1158/1541-7786.MCR-08-0578; Ma XJ, 2012, J BIOL CHEM, V287, P18925, DOI 10.1074/jbc.M112.352260; Michal AM, 2011, BREAST CANCER RES TR, V130, P791, DOI 10.1007/s10549-011-1374-9; Mo W, 2008, MOL CELL, V31, P695, DOI 10.1016/j.molcel.2008.06.017; Moniri NH, 2007, BIOCHEM PHARMACOL, V74, P64, DOI 10.1016/j.bcp.2007.03.016; Mythreye K, 2009, CELL CYCLE, V8, P3069, DOI 10.4161/cc.8.19.9419; Oser M, 2009, J CELL BIOCHEM, V108, P1252, DOI 10.1002/jcb.22372; Pandey D, 2009, BLOOD, V114, P415, DOI 10.1182/blood-2008-10-183582; Qiu CP, 2003, ONCOGENE, V22, P1253, DOI 10.1038/sj.onc.1206233; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Ruiz S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008229; Scott MGH, 2002, J BIOL CHEM, V277, P37693, DOI 10.1074/jbc.M207552200; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Xiao KH, 2010, P NATL ACAD SCI USA, V107, P15299, DOI 10.1073/pnas.1008461107; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Zoudilova M, 2007, J BIOL CHEM, V282, P20634, DOI 10.1074/jbc.M701391200; Zoudilova M, 2010, J BIOL CHEM, V285, P14318, DOI 10.1074/jbc.M109.055806	44	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13638	13650		10.1074/jbc.M113.511360	http://dx.doi.org/10.1074/jbc.M113.511360			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24692549	hybrid, Green Published			2022-12-25	WOS:000335522800057
J	Malhotra, A; Nair, P; Dhawan, DK				Malhotra, Anshoo; Nair, Praveen; Dhawan, Devinder Kumar			Study to Evaluate Molecular Mechanics behind Synergistic Chemo-Preventive Effects of Curcumin and Resveratrol during Lung Carcinogenesis	PLOS ONE			English	Article							CANCER; P53; GROWTH; INHIBITION; EXPRESSION; APOPTOSIS; TUMORS; CELLS	Background: The combination approach is the future of the war against cancer and the present study evaluated molecular mechanics behind the synergistic effects of curcumin and resveratrol during lung carcinogenesis. Methods: The mice were segregated into five groups which included normal control, Benzo[a] pyrene[BP] treated, BP+ curcumin treated, BP+ resveratrol treated and BP+ curcumin+resveratrol treated. Results: The morphological analyses of tumor nodules confirmed lung carcinogenesis in mice after 22 weeks of single intraperitoneal[i.p] injection of BP at a dose of 100 mg/Kg body weight. The BP treatment resulted in a significant increase in the protein expressions of p53 in the BP treated mice. Also, a significant increase in the protein expression of phosphorylated p53[ser15] confirmed p53 hyper-phosphorylation in BP treated mice. On the other hand, enzyme activities of caspase 3 and caspase 9 were noticed to be significantly decreased following BP treatment. Further, radiorespirometric studies showed a significant increase in the C-14-glucose turnover as well as C-14-gulcose uptake in the lung slices of BP treated mice. Moreover, a significant rise in the cell proliferation was confirmed indirectly by enhanced uptake of H-3-thymidine in the lung slices of BP treated mice. Interestingly, combined treatment of curcumin and resveratrol to BP treated animals resulted in a significant decrease in p53 hyper-phosphorylation, C-14 glucose uptakes/turnover and H-3-thymidine uptake in the BP treated mice. However, the enzyme activities of caspase 3 and caspase 9 showed a significant increase upon treatment with curcumin and resveratrol. Conclusion: The study, therefore, concludes that molecular mechanics behind chemo-preventive synergism involved modulation of p53 hyper-phosphorylation, regulation of caspases and cellular metabolism enzymes.	[Malhotra, Anshoo] PGIMER, Dept Biophys, Chandigarh, India; [Nair, Praveen; Dhawan, Devinder Kumar] Panjab Univ, Dept Biophys, Chandigarh 160014, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Panjab University	Dhawan, DK (corresponding author), Panjab Univ, Dept Biophys, Chandigarh 160014, India.	coordnucmed@pu.ac.in						[Anonymous], METHODS ENZYMATIC AN; Aziz MH, 2005, FASEB J, V19, P1193, DOI 10.1096/fj.04-3582fje; Bergmeyer H. U., 1963, METHOD ENZYMAT AN, P283; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Boyle P, 2000, BRIT MED J, V321, P805, DOI 10.1136/bmj.321.7264.805; Chung F. L., 2006, Alcohol, tobacco and cancer, P268, DOI 10.1159/000095078; CRANE RK, 1960, BIOCHIM BIOPHYS ACTA, V45, P460, DOI 10.1016/0006-3002(60)91482-7; FRIEDMAN PN, 1993, P NATL ACAD SCI USA, V90, P3319, DOI 10.1073/pnas.90.8.3319; Gallo D, 2008, J NUTR, V138, P1360, DOI 10.1093/jn/138.7.1360; Gunning WT, 2003, CLIN CANCER RES, V9, P1927; Liu RH, 2004, J NUTR, V134, p3479S, DOI 10.1093/jn/134.12.3479S; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Malhotra A, 2012, HUM EXP TOXICOL, V31, P1199, DOI 10.1177/0960327112440113; Malhotra A, 2012, ULTRASTRUCT PATHOL, V36, P179, DOI 10.3109/01913123.2011.652765; Malhotra A, 2011, EUR J CANCER PREV, V20, P411, DOI 10.1097/CEJ.0b013e3283481d71; Malhotra A, 2010, PHYTOTHER RES, V24, P1271, DOI 10.1002/ptr.3087; Melnikova VO, 2003, ONCOGENE, V22, P5958, DOI 10.1038/sj.onc.1206595; Olivier Magali, 2004, IARC Sci Publ, P247; Panani AD, 2008, CANCER LETT, V266, P99, DOI 10.1016/j.canlet.2008.02.053; Parker B., 2004, CHEST, V125, P123; Peng ZH, 2001, WORLD J GASTROENTERO, V7, P88; Pise-Masison CA, 2000, AIDS RES HUM RETROV, V16, P1669, DOI 10.1089/08892220050193128; Sen S, 2005, BIOCHEM BIOPH RES CO, V331, P1245, DOI 10.1016/j.bbrc.2005.04.044; SHRIVASTAVA GC, 1962, NATURE, V196, P876, DOI 10.1038/196876a0; Swarnakar S, 2005, J BIOL CHEM, V280, P9409, DOI 10.1074/jbc.M413398200; Xiao B, 2000, WORLD J GASTROENTERO, V6, P89, DOI 10.3748/wjg.v6.i1.89; Zhu JW, 2002, WORLD J GASTROENTERO, V8, P153, DOI 10.3748/wjg.v8.i1.153	27	47	48	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93820	10.1371/journal.pone.0093820	http://dx.doi.org/10.1371/journal.pone.0093820			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705375	Green Published, gold, Green Submitted			2022-12-25	WOS:000334107500072
J	Manco, M; Castagneto-Gissey, L; Arrighi, E; Carnicelli, A; Brufani, C; Luciano, R; Mingrone, G				Manco, Melania; Castagneto-Gissey, Lidia; Arrighi, Eugenio; Carnicelli, Annamaria; Brufani, Claudia; Luciano, Rosa; Mingrone, Geltrude			Insulin Dynamics in Young Women with Polycystic Ovary Syndrome and Normal Glucose Tolerance across Categories of Body Mass Index	PLOS ONE			English	Article							BETA-CELL DYSFUNCTION; FAMILY-HISTORY; PLASMA-GLUCOSE; SENSITIVITY; RESISTANCE; SECRETION; DEFECTS; OBESITY; INTOLERANCE; PREVALENCE	Background: Evidence favours insulin resistance and compensatory hyperinsulinemia as the predominant, perhaps primary, defects in polycystic ovary syndrome (PCOS). The aim of the present study was to evaluate insulin metabolism in young women with PCOS but normal glucose tolerance as compared with age, body mass index and insulin resistance-matched controls to answer the question whether women with PCOS hypersecrete insulin in comparison to appropriately insulin resistance-matched controls. Research Design and Methods: Sixty-nine cases were divided according to their body mass index (BMI) in normal-weight (N = 29), overweight (N = 24) and obese patients (N = 16). Controls were 479 healthy women (age 16-49 y). Whole body Insulin Sensitivity (WBISI), fasting, and total insulin secretion were estimated following an oral glucose tolerance test (C-peptide deconvolution method). Results: Across classes of BMI, PCOS patients had greater insulin resistance than matched controls (p<0.0001 for all the comparisons), but they showed higher fasting and total insulin secretion than their age, BMI and insulin resistance-matched peers (p<0.0001 for all the comparisons). Conclusion: Women with PCOS show higher insulin resistance but also larger insulin secretion to maintain normal glucose homeostasis than age-, BMI- and insulin resistance-matched controls.	[Manco, Melania; Brufani, Claudia; Luciano, Rosa] Bambino Gesu Children Hosp, Res Unit Multifactorial Dis Obes & Diabet, Sci Directorate, Rome, Italy; [Castagneto-Gissey, Lidia; Arrighi, Eugenio; Carnicelli, Annamaria; Mingrone, Geltrude] Univ Cattolica Sacro Cuore, Sch Med, Dept Internal Med, I-00168 Rome, Italy	IRCCS Bambino Gesu; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Manco, M (corresponding author), Bambino Gesu Children Hosp, Res Unit Multifactorial Dis Obes & Diabet, Sci Directorate, Rome, Italy.	melania.manco@opbg.net	Castagneto-Gissey, Lidia/AAH-1506-2019; Mingrone, Geltrude/AAB-9681-2019; Manco, Melania/M-1058-2013	Castagneto-Gissey, Lidia/0000-0002-3800-167X; Carnicelli, Annamaria/0000-0003-3980-2898; Manco, Melania/0000-0002-6581-975X; Mingrone, Geltrude/0000-0003-2021-528X	Italian Ministry of Health [RF-OPG-2008-1142374, GR-2010 2304957]; European Community [FP7-ICT-2012-600932 MD PAEDIGREE, FP7-ICT-2012-610440 DAPHNE]	Italian Ministry of Health(Ministry of Health, Italy); European Community(European Commission)	Melania Manco received funds from the Italian Ministry of Health (RF-OPG-2008-1142374; GR-2010 2304957) and from the European Community (FP7-ICT-2012-600932 MD PAEDIGREE; FP7-ICT-2012-610440 DAPHNE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 1998, J CLIN ENDOCR METAB, V83, P3350, DOI 10.1210/jc.83.9.3350; American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5; Arslanian SA, 2001, J CLIN ENDOCR METAB, V86, P66, DOI 10.1210/jc.86.1.66; Best JD, 1996, DIABETES CARE, V19, P1018, DOI 10.2337/diacare.19.9.1018; Carmina E, 1999, J CLIN ENDOCR METAB, V84, P1897, DOI 10.1210/jc.84.6.1897; Ciampelli M, 1997, HUM REPROD, V12, P1897, DOI 10.1093/humrep/12.9.1897; Cibula D, 2002, HUM REPROD, V17, P76, DOI 10.1093/humrep/17.1.76; DIAMANTIKANDARAKIS E, 1995, METABOLISM, V44, P525, DOI 10.1016/0026-0495(95)90062-4; Dunaif A, 1999, ENDOCRIN METAB CLIN, V28, P341, DOI 10.1016/S0889-8529(05)70073-6; DUNAIF A, 1989, DIABETES, V38, P1165, DOI 10.2337/diabetes.38.9.1165; Dunaif A, 1996, J CLIN ENDOCR METAB, V81, P942, DOI 10.1210/jc.81.3.942; DUNAIF A, 1992, DIABETES, V41, P1257, DOI 10.2337/diabetes.41.10.1257; Ehrmann DA, 1999, DIABETES CARE, V22, P141, DOI 10.2337/diacare.22.1.141; EHRMANN DA, 1995, J CLIN INVEST, V96, P520, DOI 10.1172/JCI118064; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; FERRIMAN D, 1961, J CLIN ENDOCR METAB, V21, P1440, DOI 10.1210/jcem-21-11-1440; Gennarelli G, 2000, HUM REPROD, V15, P2098, DOI 10.1093/humrep/15.10.2098; HOLTE J, 1995, J CLIN ENDOCR METAB, V80, P2586, DOI 10.1210/jc.80.9.2586; Legro RS, 2001, AM J MED, V111, P607, DOI 10.1016/S0002-9343(01)00948-2; Manco M, 2012, ACTA DIABETOL, V49, P435, DOI 10.1007/s00592-012-0384-3; Manco M, 2010, DIABETES CARE, V33, P2090, DOI 10.2337/dc09-2261; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Mingrone G, 2008, DIABETES CARE, V31, P1872, DOI 10.2337/dc08-0432; Morin-Papunen LC, 2000, HUM REPROD, V15, P1266, DOI 10.1093/humrep/15.6.1266; Nolfe G, 2012, EUR J ENDOCRINOL, V166, P107, DOI 10.1530/EJE-11-0827; OMEARA NM, 1993, J CLIN ENDOCR METAB, V76, P1241, DOI 10.1210/jc.76.5.1241; OVESEN P, 1993, J CLIN ENDOCR METAB, V77, P1636, DOI 10.1210/jc.77.6.1636; Randeva HS, 2012, ENDOCR REV, V33, P812, DOI 10.1210/er.2012-1003; Retnakaran R, 2011, EUR J ENDOCRINOL, V165, P323; Toprak S, 2001, HORM RES, V55, P65, DOI 10.1159/000049972; VANCAUTER E, 1992, DIABETES, V41, P368, DOI 10.2337/diabetes.41.3.368; Vrbikova J, 2008, PHYSIOL RES, V57, P547, DOI 10.33549/physiolres.931275	32	22	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e92995	10.1371/journal.pone.0092995	http://dx.doi.org/10.1371/journal.pone.0092995			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705280	Green Published, gold, Green Submitted			2022-12-25	WOS:000334107500024
J	Valadez, JJ; Jeffery, C; Davis, R; Ouma, J; Lwanga, SK; Moxon, S				Valadez, Joseph J.; Jeffery, Caroline; Davis, Rosemary; Ouma, Joseph; Lwanga, Stephen K.; Moxon, Sarah			Putting the C Back into the ABCs: A Multi-Year, Multi-Region Investigation of Condom Use by Ugandan Youths 2003-2010	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; SEXUAL-BEHAVIOR; SCHOOL-STUDENTS; RISK-REDUCTION; HIV PREVENTION; ASSOCIATION; ADOLESCENTS; WOMEN; INTERVENTIONS; INTERCOURSE	A major strategy for preventing transmission of HIV and other STIs is the consistent use of condoms during sexual intercourse. Condom use among youths is particularly important to reduce the number of new cases and the national prevalence. Condom use has been often promoted by the Uganda National AIDS Commission. Although a number of studies have established an association between condom use at one's sexual debut and future condom use, few studies have explored this association over time, and whether the results are generalizable across multiple locations. This multi time point, multi district study assesses the relationship between sexual debut and condom use and consistent use of condoms thereafter. Uganda has used Lot Quality Assurance Sampling surveys since 2003 to monitor district level HIV programs and improve access to HIV health services. This study includes 4518 sexually active youths interviewed at five time points (20032010) in up to 23 districts located across Uganda. Using logistic regression, we measured the association of condom use at first sexual intercourse on recent condom usage, controlling for several factors including: age, sex, education, marital status, age at first intercourse, geographical location, and survey year. The odds of condom use at last intercourse, using a condom at last intercourse with a non-regular partner, and consistently using a condom are, respectively, 9.63 (95%WaldCI = 8.03-11.56), 3.48 (95%WaldCI = 2.27-5.33), and 11.12 (95%WaldCI = 8.95-13.81) times more likely for those individuals using condoms during their sexual debut. These values did not decrease by more than 20% when controlling for potential confounders. The results suggest that HIV prevention programs should encourage condom use among youth during sexual debut. Success with this outcome may have a lasting influence on preventing HIV and other STIs later in life.	[Valadez, Joseph J.; Jeffery, Caroline; Davis, Rosemary; Moxon, Sarah] Monitoring & Evaluat Tech Assistance & Res Grp, Liverpool Sch Trop Med, Dept Int Publ Hlth, Liverpool, Merseyside, England; [Ouma, Joseph; Lwanga, Stephen K.] Management Sci Hlth, Kampala, Uganda; [Valadez, Joseph J.; Jeffery, Caroline; Davis, Rosemary; Ouma, Joseph; Lwanga, Stephen K.; Moxon, Sarah] Lot Qual Assurance Sampling STAR E LQAS Project, Strengthening TB & AIDS Response Eastern Region, Kampala, Uganda	Liverpool School of Tropical Medicine	Jeffery, C (corresponding author), Monitoring & Evaluat Tech Assistance & Res Grp, Liverpool Sch Trop Med, Dept Int Publ Hlth, Liverpool, Merseyside, England.	cjeffery@liv.ac.uk	Jeffery, Caroline/H-9975-2012	Jeffery, Caroline/0000-0002-8023-0708; Ameyan, Rosemary/0000-0003-1374-5514	United States Agency for International Development (USAID) [617-A-00-09-00006-00-LATH]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This study is made possible by the generous support of the American people through the United States Agency for International Development (USAID) through Sub-award Number: 617-A-00-09-00006-00-LATH. The contents are the responsibility of the Liverpool School of Tropical Medicine and Management Science for Health and do not necessarily reflect the views of USAID or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramsky T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-109; Babalola Stella, 2006, Int J Adolesc Med Health, V18, P287; Baele J, 2001, J ADOLESCENT HEALTH, V28, P421, DOI 10.1016/S1054-139X(00)00215-9; Baker DP, 2011, AIDS BEHAV, V15, P1319, DOI 10.1007/s10461-010-9717-9; Bankole A, 2009, AM J MENS HEALTH, V3, P60, DOI 10.1177/1557988308322394; Bellan SE, 2013, LANCET, V381, P1561, DOI 10.1016/S0140-6736(12)61960-6; Berer M, 2006, REPROD HEALTH MATTER, V14, P6, DOI 10.1016/S0968-8080(06)28278-8; Beyeza-Kashesya J, 2011, BMC INFECT DIS, V11; Bogale GW, 2010, AIDS CARE, V22, P851, DOI 10.1080/09540120903483026; Cherutich P, 2008, AIDS BEHAV, V12, P923, DOI 10.1007/s10461-008-9445-6; Chin HB, 2012, AM J PREV MED, V42, P272, DOI 10.1016/j.amepre.2011.11.006; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; DiClemente RJ, 2004, JAMA-J AM MED ASSOC, V292, P171, DOI 10.1001/jama.292.2.171; Dodge HF, 1929, BELL SYST TECH J, V8, P613, DOI 10.1002/j.1538-7305.1929.tb01240.x; Foss AM, 2007, SEX TRANSM INFECT, V83, P510, DOI 10.1136/sti.2007.027144; Foss AM, 2004, BRIT MED J, V329, P185, DOI 10.1136/bmj.329.7459.185; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hendriksen ES, 2007, AM J PUBLIC HEALTH, V97, P1241, DOI 10.2105/AJPH.2006.086009; Hirsl-Hecej V, 2001, COLLEGIUM ANTROPOL, V25, P195; Kabiru CW, 2009, J SCHOOL HEALTH, V79, P425, DOI 10.1111/j.1746-1561.2009.00430.x; Kayiki Simon P, 2011, Afr J Reprod Health, V15, P57; Klavs I, 2005, AIDS, V19, P1215, DOI 10.1097/01.aids.0000176223.78979.26; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; Maharaj P, 2005, WOMEN HEALTH, V41, P31, DOI 10.1300/J013v41n02_03; Maharaj P, 2006, REPROD HEALTH MATTER, V14, P104, DOI 10.1016/S0968-8080(06)28253-3; Maticka-Tyndale E, 2010, SOC SCI MED, V71, P616, DOI 10.1016/j.socscimed.2010.03.049; Ministry of Health ICF International Centers for Disease Control and Prevention U. S. Agency for International Development and WHO Uganda, 2012, UG AIDS IND SURV; Miranda AE, 2011, INT J STD AIDS, V22, P590, DOI 10.1258/ijsa.2009.009104; Msamanga Gernard, 2009, East Afr J Public Health, V6, P175; Mukaire J, 2004, ASSESSMENT HIV AIDS; Oyediran KA, 2011, J HEALTH POPUL NUTR, V29, P273, DOI 10.3329/jhpn.v29i3.7875; Papo JK, 2011, AIDS, V25, P247, DOI 10.1097/QAD.0b013e328341b9b8; Prata N, 2005, INT FAM PLAN PERSPEC, V31, P192, DOI 10.1363/3119205; Reid AE, 2011, PSYCHOL HEALTH, V26, P1499, DOI 10.1080/08870446.2011.572259; Rijsdijk LE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-334; Robertson SE, 2006, SOC SCI MED, V63, P1648, DOI 10.1016/j.socscimed.2006.04.011; Robertson Susan E., 1997, World Health Statistics Quarterly, V50, P199; Saile R, 2013, SOC SCI MED, V86, P17, DOI 10.1016/j.socscimed.2013.02.046; Schaalma H, 2009, SCAND J PUBLIC HEALT, V37, P87, DOI 10.1177/1403494808090632; Shafii T, 2007, AM J PUBLIC HEALTH, V97, P1090, DOI 10.2105/AJPH.2005.068437; Siegler AJ, 2012, SOC SCI MED, V75, P1685, DOI 10.1016/j.socscimed.2012.07.010; Smoak ND, 2006, JAIDS-J ACQ IMM DEF, V41, P374, DOI 10.1097/01.qai.0000185575.36591.fc; Sneed CD, 2001, AIDS CARE, V13, P303, DOI 10.1080/09540120120043955; Steiner MJ, 2006, NEW ENGL J MED, V354, P2642, DOI 10.1056/NEJMp068111; Stulhofer A, 2010, SOC SCI MED, V70, P2080, DOI 10.1016/j.socscimed.2010.02.030; Teixeira Ana Maria Ferreira Borges, 2006, Cad. Saúde Pública, V22, P1385, DOI 10.1590/S0102-311X2006000700004; The World Bank, 2007, IMPL COMPL REP UG HI; *UNAIDS, 2007, SUBS AFR AIDS EP UPD; UNAIDS, 2010, 2010 UNAIDS REP GLOB; Valadez JJ, 2007, ASSESSING COMMUNITY, V115; Valadez JJ, 1991, ASSESSING CHILD SURV; Wellings K, 2006, LANCET, V368, P1706, DOI 10.1016/S0140-6736(06)69479-8; Yotebieng M, 2009, SAHARA J-J SOC ASP H, V6, P9, DOI 10.1080/17290376.2009.9724924; Younge SN, 2008, ADOLESCENCE, V43, P927	54	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93083	10.1371/journal.pone.0093083	http://dx.doi.org/10.1371/journal.pone.0093083			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6MJ	24705381	Green Accepted, Green Published, gold			2022-12-25	WOS:000334107500027
J	Baranowski, E; Bergonier, D; Sagne, E; Hygonenq, MC; Ronsin, P; Berthelot, X; Citti, C				Baranowski, Eric; Bergonier, Dominique; Sagne, Eveline; Hygonenq, Marie-Claude; Ronsin, Patricia; Berthelot, Xavier; Citti, Christine			Experimental Infections with Mycoplasma agalactiae Identify Key Factors Involved in Colonization	PLOS ONE			English	Article							ELONGATION-FACTOR TU; CONTAGIOUS AGALACTIA; BINDING PROTEINS; GENES; PHASE; PATHOGENICITY; EVOLUTION; SUBUNIT; ENOLASE; SYSTEM	Mechanisms underlying pathogenic processes in mycoplasma infections are poorly understood, mainly because of limited sequence similarities with classical, bacterial virulence factors. Recently, large-scale transposon mutagenesis in the ruminant pathogen Mycoplasma agalactiae identified the NIF locus, including nifS and nifU, as essential for mycoplasma growth in cell culture, while dispensable in axenic media. To evaluate the importance of this locus in vivo, the infectivity of two knock-out mutants was tested upon experimental infection in the natural host. In this model, the parental PG2 strain was able to establish a systemic infection in lactating ewes, colonizing various body sites such as lymph nodes and the mammary gland, even when inoculated at low doses. In these PG2-infected ewes, we observed over the course of infection (i) the development of a specific antibody response and (ii) dynamic changes in expression of M. agalactiae surface variable proteins (Vpma), with multiple Vpma profiles co-existing in the same animal. In contrast and despite a sensitive model, none of the knock-out mutants were able to survive and colonize the host. The extreme avirulent phenotype of the two mutants was further supported by the absence of an IgG response in inoculated animals. The exact role of the NIF locus remains to be elucidated but these data demonstrate that it plays a key role in the infectious process of M. agalactiae and most likely of other pathogenic mycoplasma species as many carry closely related	[Baranowski, Eric; Bergonier, Dominique; Sagne, Eveline; Hygonenq, Marie-Claude; Berthelot, Xavier; Citti, Christine] INRA, IHAP, UMR 1225, F-31931 Toulouse, France; [Baranowski, Eric; Bergonier, Dominique; Sagne, Eveline; Hygonenq, Marie-Claude; Ronsin, Patricia; Berthelot, Xavier; Citti, Christine] Univ Toulouse, INP ENVT, UMR 1225, IHAP, Toulouse, France	INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse	Citti, C (corresponding author), INRA, IHAP, UMR 1225, F-31931 Toulouse, France.	c.citti@envt.fr	Baranowski, Eric/I-2655-2013	BERTHELOT, Xavier/0000-0001-8508-4343; Citti, Christine/0000-0003-4754-6003; Baranowski, Eric/0000-0003-0660-1854	INRA (Animal Health Division, AAP); ENVT	INRA (Animal Health Division, AAP); ENVT	This work was supported by grants from INRA (Animal Health Division, AAP 2012) and ENVT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian S, 2008, INFECT IMMUN, V76, P3116, DOI 10.1128/IAI.00173-08; Baranowski E, 2010, INFECT IMMUN, V78, P1542, DOI 10.1128/IAI.01195-09; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Bergonier D, 1997, REV SCI TECH OIE, V16, P848, DOI 10.20506/rst.16.3.1062; Buonavoglia D, 1999, MICROBIOLOGICA, V22, P27; Cacciotto C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057775; Chen HJ, 2011, MICROB PATHOGENESIS, V51, P285, DOI 10.1016/j.micpath.2011.03.012; Chopra-Dewasthaly R, 2005, INT J MED MICROBIOL, V294, P447, DOI 10.1016/j.ijmm.2004.09.010; Chopra-Dewasthaly R, 2008, MOL MICROBIOL, V67, P1196, DOI 10.1111/j.1365-2958.2007.06103.x; Chopra-Dewasthaly R, 2012, FEMS IMMUNOL MED MIC, V66, P307, DOI 10.1111/j.1574-695X.2012.01010.x; Citti C, 2010, FUTURE MICROBIOL, V5, P1073, DOI 10.2217/FMB.10.71; Corrales JC, 2007, SMALL RUMINANT RES, V68, P154, DOI 10.1016/j.smallrumres.2006.09.010; Dallo SF, 2002, MOL MICROBIOL, V46, P1041, DOI 10.1046/j.1365-2958.2002.03207.x; Dumke R, 2011, MICROBIOL-SGM, V157, P2328, DOI 10.1099/mic.0.048298-0; Fontecave M, 2005, J BIOL INORG CHEM, V10, P713, DOI 10.1007/s00775-005-0025-1; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Glew MD, 2000, INFECT IMMUN, V68, P6027, DOI 10.1128/IAI.68.10.6027-6033.2000; Halbedel S, 2007, INT J MED MICROBIOL, V297, P37, DOI 10.1016/j.ijmm.2006.11.001; Henderson B, 2011, INFECT IMMUN, V79, P3476, DOI 10.1128/IAI.00179-11; Hidese R, 2011, APPL MICROBIOL BIOT, V91, P47, DOI 10.1007/s00253-011-3336-x; Huet G, 2005, J BACTERIOL, V187, P6137, DOI 10.1128/JB.187.17.6137-6146.2005; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; MACOWAN KJ, 1984, J HYG-CAMBRIDGE, V93, P455, DOI 10.1017/S0022172400065050; Marenda MS, 2005, MICROBIOL-SGM, V151, P475, DOI 10.1099/mic.0.27590-0; Nicholas RAJ, 2011, VET REC, V168, P459, DOI 10.1136/vr.d2468; Nouvel LX, 2009, J BACTERIOL, V191, P4111, DOI 10.1128/JB.00251-09; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Razin S, 2010, BIOLOGICALS, V38, P183, DOI 10.1016/j.biologicals.2009.11.008; Runyen-Janecky L, 2008, INFECT IMMUN, V76, P1083, DOI 10.1128/IAI.01211-07; Sanchis R, 1998, SMALL RUMINANT RES, V27, P31, DOI 10.1016/S0921-4488(96)00996-0; Sanchis R, 2000, VET RES, V31, P329, DOI 10.1051/vetres:2000104; Sirand-Pugnet P, 2007, RES MICROBIOL, V158, P754, DOI 10.1016/j.resmic.2007.09.007; Sirand-Pugnet P, 2007, PLOS GENET, V3, P744, DOI 10.1371/journal.pgen.0030075; Skapski A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025291; Thomas C, 2013, MICROBIOL-SGM, V159, P352, DOI 10.1099/mic.0.061184-0; *WORLD ORG ANIM HL, 2012, OIE MAN DIAGN TESTS; Zimmerman CU, 2005, FEMS MICROBIOL LETT, V253, P315, DOI 10.1016/j.femsle.2005.09.054	39	17	17	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93970	10.1371/journal.pone.0093970	http://dx.doi.org/10.1371/journal.pone.0093970			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699671	Green Published, gold, Green Submitted			2022-12-25	WOS:000334105000129
J	de Goeij, MCM; Rotmans, JI; Eijgenraam, JW; Dekker, FW; Halbesma, N				de Goeij, Moniek C. M.; Rotmans, Joris I.; Eijgenraam, Jan-Willem; Dekker, Friedo W.; Halbesma, Nynke			Course of Symptoms and Health-Related Quality of Life during Specialized Pre-Dialysis Care	PLOS ONE			English	Article							STAGE RENAL-DISEASE; ILLNESS PERCEPTION QUESTIONNAIRE; CHRONIC KIDNEY-DISEASE; DIALYSIS INITIATION; START; HEMODIALYSIS; MORTALITY; SURVIVAL; REPRESENTATIONS; COMORBIDITY	Background:Concerns are present on the limited value of renal function alone in defining the optimal moment to start dialysis. Disease-related symptoms and health-related quality of life (HRQOL) may have additional clinical value in defining this moment, but little is known about how these parameters change during pre-dialysis care. The aims of our study were to describe the course of symptoms and HRQOL during pre-dialysis care and to investigate their association with poor health outcomes. Methods: In the prospective PREPARE-2 cohort, incident patients starting specialized pre-dialysis care were included when referred to one of the 25 participating Dutch outpatient clinics (2004-2011). In the present analysis, 436 patients with data available on symptoms and HRQOL were included. Clinical data, symptoms (revised illness perception questionnaire), and HRQOL (short form-36 questionnaire; physical and mental summary score) were collected every 6-month interval. A time-dependent Cox proportional hazard model was used to associate symptoms and HRQOL with the combined poor health outcome (i.e. starting dialysis, receiving a kidney transplant, and death). Results: All symptoms increased, especially fatigue and loss of strength, and both the physical and mental summary score decreased over time, with the most pronounced change during the last 6-12 months of follow-up. Furthermore, each additional symptom (adjusted HR 1.04 (95% CI, 1.00-1.09)) and each 3-point lower physical and mental summary score (adjusted HR 1.04 (1.02-1.06) and 1.04 (1.02-1.06) respectively) were associated with a higher risk of reaching the combined poor health outcome within the subsequent 6 months. Conclusions: The number of symptoms increased and both the physical and mental HRQOL score decreased during pre-dialysis care and these changes were associated with starting dialysis, receiving a kidney transplant, and death. These results may indicate that symptoms and HRQOL are good markers for the medical condition and disease stage of pre-dialysis patients.	[de Goeij, Moniek C. M.; Rotmans, Joris I.; Dekker, Friedo W.; Halbesma, Nynke] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Rotmans, Joris I.] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [Eijgenraam, Jan-Willem] Groene Hart Hosp, Dept Internal Med, Gouda, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	de Goeij, MCM (corresponding author), Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands.	M.C.M.de_Goeij@lumc.nl	Rotmans, Joris I./G-8866-2014; Dekker, Friedo W/B-6452-2011	Rotmans, Joris I./0000-0001-9682-6234; Dekker, Friedo W/0000-0002-2433-2494	Dutch Kidney Foundation [SB 110]; Amgen; Baxter	Dutch Kidney Foundation; Amgen(Amgen); Baxter	This study was supported by a grant from the Dutch Kidney Foundation (SB 110, www.nierstichting.nl), and unrestricted grants from Amgen (www.amgen.nl) and Baxter (www.baxter.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Abdel-Kader K, 2009, CLIN J AM SOC NEPHRO, V4, P1057, DOI 10.2215/CJN.00430109; [Anonymous], 2011, ERA EDTA REG ANN REP; Beddhu S, 2003, J AM SOC NEPHROL, V14, P2305, DOI 10.1097/01.ASN.0000080184.67406.11; Chilcot J, 2013, ANN BEHAV MED, V45, P78, DOI 10.1007/s12160-012-9410-5; Chilcot J, 2012, PSYCHOL HEALTH MED, V17, P578, DOI 10.1080/13548506.2011.647702; Chin HJ, 2008, NEPHROL DIAL TRANSPL, V23, P2810, DOI 10.1093/ndt/gfn132; Clark WF, 2011, CAN MED ASSOC J, V183, P47, DOI 10.1503/cmaj.100349; Cooper BA, 2010, NEW ENGL J MED, V363, P609, DOI 10.1056/NEJMoa1000552; Covic A, 2004, NEPHROL DIAL TRANSPL, V19, P2078, DOI 10.1093/ndt/gfh254; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; DUBOIS D, 1989, NUTRITION, V5, P303; Dutch Federation of Nephrology, 2011, MULT GUID PRED; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; European Best Practice Guidelines Expert Group on Hemodialysis European Renal Association, 2002, Nephrol Dial Transplant, V17 Suppl 7, P7; Hwang SJ, 2010, NEPHROL DIAL TRANSPL, V25, P2616, DOI 10.1093/ndt/gfq308; Jager KJ, 2012, NEPHROL DIAL TRANSPL, V27, P27, DOI 10.1093/ndt/gfs277; Kazmi WH, 2005, AM J KIDNEY DIS, V46, P887, DOI 10.1053/j.ajkd.2005.08.005; Kidney Disease: Improving Global Outcomes (KDIGO), 2011, CLIN PRACT GUID; Korevaar JC, 2001, LANCET, V358, P1046, DOI 10.1016/S0140-6736(01)06180-3; Krediet RT, 2010, NAT REV NEPHROL, V6, P563, DOI 10.1038/nrneph.2010.109; Kusek JW, 2002, AM J KIDNEY DIS, V39, P513, DOI 10.1053/ajkd.2002.31401; Lameire N, 2010, NEW ENGL J MED, V363, P678, DOI 10.1056/NEJMe1006669; Lassalle M, 2010, KIDNEY INT, V77, P700, DOI 10.1038/ki.2010.14; Leaf DE, 2009, KIDNEY INT, V75, P15, DOI 10.1038/ki.2008.414; Ledebo Ingrid, 2001, Nephrology Dialysis Transplantation, V16, P1132, DOI 10.1093/ndt/16.6.1132; Levey AS, 2000, J AM SOC NEPHROL, V11, p155A; Meyer TW, 2007, NEW ENGL J MED, V357, P1316, DOI 10.1056/NEJMra071313; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Pagels A, 2012, SCAND J CARING SCI, V26, P474, DOI 10.1111/j.1471-6712.2011.00952.x; Perlman RL, 2005, AM J KIDNEY DIS, V45, P658, DOI 10.1053/j.ajkd.2004.12.021; Rosansky SJ, 2011, ARCH INTERN MED, V171, P396, DOI 10.1001/archinternmed.2010.415; Rosansky SJ, 2009, KIDNEY INT, V76, P257, DOI 10.1038/ki.2009.161; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Stel VS, 2011, CAN MED ASSOC J, V183, P24, DOI 10.1503/cmaj.101636; Stel VS, 2010, NEPHROL DIAL TRANSPL, V25, P3315, DOI 10.1093/ndt/gfq209; Stel VS, 2009, NEPHROL DIAL TRANSPL, V24, P3175, DOI 10.1093/ndt/gfp264; Tattersall J, 2011, NEPHROL DIAL TRANSPL, V26, P2082, DOI 10.1093/ndt/gfr168; Termorshuizen F, 2003, NEPHROL DIAL TRANSPL, V18, P552, DOI 10.1093/ndt/18.3.552; Traynor JP, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000025294.40179.E8; Tsai YC, 2010, NEPHROL DIAL TRANSPL, V25, P1621, DOI 10.1093/ndt/gfp671; Van Biesen W, 2010, NEPHROL DIAL TRANSPL, V25, P2405, DOI 10.1093/ndt/gfq391; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; van Dijk S, 2009, NEPHROL DIAL TRANSPL, V24, P3183, DOI 10.1093/ndt/gfp184; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weinman J, 1996, PSYCHOL HEALTH, V11, P431, DOI 10.1080/08870449608400270; Weisbord SD, 2005, J AM SOC NEPHROL, V16, P2487, DOI 10.1681/ASN.2005020157; Wright S, 2010, CLIN J AM SOC NEPHRO, V5, P1828, DOI 10.2215/CJN.06230909	48	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93069	10.1371/journal.pone.0093069	http://dx.doi.org/10.1371/journal.pone.0093069			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LR	24699666	Green Published, Green Submitted, gold			2022-12-25	WOS:000334105000042
J	Sun, Y; Zhang, HX; Hu, RM; Sun, JY; Mao, X; Zhao, ZH; Chen, Q; Zhang, ZG				Sun, Yu; Zhang, Hongxia; Hu, Ruimin; Sun, Jianyong; Mao, Xing; Zhao, Zhonghua; Chen, Qi; Zhang, Zhigang			The Expression and Significance of Neuronal Iconic Proteins in Podocytes	PLOS ONE			English	Article							ACTIN-ASSOCIATED PROTEIN; TERMINAL HYDROLASE; NESTIN EXPRESSION; SYNAPTIC FUNCTION; SPINE APPARATUS; DENTATE GYRUS; RAT; ENOLASE; SYNAPTOPODIN; UCH-L1	Growing evidence suggests that there are many common cell biological features shared by neurons and podocytes; however, the mechanism of podocyte foot process formation remains unclear. Comparing the mechanisms of process formation between two cell types should provide useful guidance from the progress of neuron research. Studies have shown that some mature proteins of podocytes, such as podocin, nephrin, and synaptopodin, were also expressed in neurons. In this study, using cell biological experiments and immunohistochemical techniques, we showed that some neuronal iconic molecules, such as Neuron-specific enolase, nestin and Neuron-specific nuclear protein, were also expressed in podocytes. We further inhibited the expression of Neuron-specific enolase, nestin, synaptopodin and Ubiquitin carboxy terminal hydrolase-1 by Small interfering RNA in cultured mouse podocytes and observed the significant morphological changes in treated podocytes. When podocytes were treated with Adriamycin, the protein expression of Neuron-specific enolase, nestin, synaptopodin and Ubiquitin carboxy terminal hydrolase-1 decreased over time. Meanwhile, the morphological changes in the podocytes were consistent with results of the Small interfering RNA treatment of these proteins. The data demonstrated that neuronal iconic proteins play important roles in maintaining and regulating the formation and function of podocyte processes.	[Sun, Yu; Hu, Ruimin; Mao, Xing; Zhao, Zhonghua; Chen, Qi; Zhang, Zhigang] Fudan Univ, Sch Basic Med Sci, Shanghai Med Coll, Dept Pathol,Key Lab Mol Med,Chinese Minist Educ, Shanghai 200433, Peoples R China; [Zhang, Hongxia] Weifang Med Univ, Dept Pathol, Weifang, Shandong, Peoples R China; [Sun, Jianyong] Chinese Acad Sci, Inst Hlth Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China	Fudan University; Weifang Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhang, ZG (corresponding author), Fudan Univ, Sch Basic Med Sci, Shanghai Med Coll, Dept Pathol,Key Lab Mol Med,Chinese Minist Educ, Shanghai 200433, Peoples R China.	zzg@shmu.edu.cn			National Nature Science Foundation of China [NFSC: 81070566]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the National Nature Science Foundation of China (NFSC: 81070566). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Bertelli E, 2007, J HISTOCHEM CYTOCHEM, V55, P411, DOI 10.1369/jhc.6A7058.2007; BRADY ST, 1981, CELL, V23, P515, DOI 10.1016/0092-8674(81)90147-1; Cameron HA, 1998, NEUROSCIENCE, V82, P349; Cartier AE, 2009, J NEUROSCI, V29, P7857, DOI 10.1523/JNEUROSCI.1817-09.2009; Choi J, 2004, J BIOL CHEM, V279, P13256, DOI 10.1074/jbc.M314124200; Deller T, 2003, P NATL ACAD SCI USA, V100, P10494, DOI 10.1073/pnas.1832384100; Deller T, 2000, J COMP NEUROL, V418, P164, DOI 10.1002/(SICI)1096-9861(20000306)418:2<164::AID-CNE4>3.0.CO;2-0; Deller T, 2000, HIPPOCAMPUS, V10, P569, DOI 10.1002/1098-1063(2000)10:5<569::AID-HIPO7>3.3.CO;2-D; Duggal N, 1997, BRAIN RES, V768, P1, DOI 10.1016/S0006-8993(97)00588-X; George B, 2012, SEMIN NEPHROL, V32, P307, DOI 10.1016/j.semnephrol.2012.06.002; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Gould E, 1997, NEUROSCIENCE, V80, P427, DOI 10.1016/S0306-4522(97)00127-9; HARDEMARK HG, 1989, J NEUROSURG, V71, P727, DOI 10.3171/jns.1989.71.5.0727; Huber TB, 2006, J CLIN INVEST, V116, P1337, DOI 10.1172/JCI27400; Kang Yl, 2009, J APPL CLIN PEDIAT, V24, P383; Kobayashi N, 1998, CELL TISSUE RES, V291, P163, DOI 10.1007/s004410050988; Kobayashi Naoto, 2004, Anatomical Science International, V79, P1, DOI 10.1111/j.1447-073x.2004.00066.x; Kriz W, 2005, KIDNEY INT, V67, P404, DOI 10.1111/j.1523-1755.2005.67097.x; Krum JM, 1999, EXP NEUROL, V160, P348, DOI 10.1006/exnr.1999.7222; Lansbury PT, 2006, CELL, V126, P655, DOI 10.1016/j.cell.2006.08.011; [李俊岑 Li Juncen], 2010, [中国康复医学杂志, Chinese Journal of Rehabilitation Medicine], V25, P833; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Liu Y, 2009, J PATHOL, V217, P642, DOI 10.1002/path.2511; LOWE J, 1990, J PATHOL, V161, P153, DOI 10.1002/path.1711610210; Meyer-Schwesinger C, 2009, J PATHOL, V217, P452, DOI 10.1002/path.2446; Meyer-Schwesinger C, 2011, AM J PATHOL, V178, P2044, DOI 10.1016/j.ajpath.2011.01.017; Moeller MJ, 2000, J AM SOC NEPHROL, V11, P2306, DOI 10.1681/ASN.V11122306; MUNDEL P, 1991, J HISTOCHEM CYTOCHEM, V39, P1047, DOI 10.1177/39.8.1856454; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Parent JM, 1997, J NEUROSCI, V17, P3727; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Rao J, 2010, NEPHRON EXP NEPHROL, V115, pE38, DOI 10.1159/000313829; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; Saigoh K, 1999, NAT GENET, V23, P47, DOI 10.1038/12647; Sakurai M, 2006, J CELL SCI, V119, P162, DOI 10.1242/jcs.02716; Shirato I, 2000, J AM SOC NEPHROL, V11, P2381, DOI 10.1681/ASN.V11122381; Shirato I, 1996, AM J PATHOL, V148, P1283; Siu Brian, 2006, BMC Nephrol, V7, P6, DOI 10.1186/1471-2369-7-6; Susor A, 2007, REPRODUCTION, V134, P559, DOI 10.1530/REP-07-0079; Tan H, 2008, CHINESE J INTEGRATED, V09, P6; VINORES SA, 1984, J HISTOCHEM CYTOCHEM, V32, P1295, DOI 10.1177/32.12.6389693; VINORES SA, 1986, HISTOPATHOLOGY, V10, P891; Wang G, 2007, NEPHRON CLIN PRACT, V106, P169, DOI 10.1159/000104428; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Yang Q, 2004, J HISTOCHEMISTRY CYT, V39; Yq Wen, 2008, CHIN J OBS GYNE PEDI, V04	49	15	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93999	10.1371/journal.pone.0093999	http://dx.doi.org/10.1371/journal.pone.0093999			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699703	Green Published, gold, Green Submitted			2022-12-25	WOS:000334105000133
J	Christou, CM; Hadjisavvas, A; Kyratzi, M; Flouri, C; Neophytou, I; Anastasiadou, V; Loizidou, MA; Kyriacou, K				Christou, Charita M.; Hadjisavvas, Andreas; Kyratzi, Maria; Flouri, Christina; Neophytou, Ioanna; Anastasiadou, Violetta; Loizidou, Maria A.; Kyriacou, Kyriacos			The BRCA1 Variant p.Ser36Tyr Abrogates BRCA1 Protein Function and Potentially Confers a Moderate Risk of Breast Cancer	PLOS ONE			English	Article							DNA-SEQUENCE VARIANTS; UNKNOWN CLINICAL-SIGNIFICANCE; UBIQUITIN LIGASE ACTIVITY; NUCLEAR EXPORT SEQUENCE; MISSENSE VARIANTS; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSION; GENETIC-ANALYSIS; MUTATIONS; CLASSIFICATION	The identification of variants of unknown clinical significance (VUS) in the BRCA1 gene complicates genetic counselling and causes additional anxiety to carriers. In silico approaches currently used for VUS pathogenicity assessment are predictive and often produce conflicting data. Furthermore, functional assays are either domain or function specific, thus they do not examine the entire spectrum of BRCA1 functions and interpretation of individual assay results can be misleading. PolyPhen algorithm predicted that the BRCA1 p.Ser36Tyr VUS identified in the Cypriot population was damaging, whereas Align-GVGD predicted that it was possibly of no significance. In addition the BRCA1 p.Ser36Tyr variant was found to be associated with increased risk (OR=3.47, 95% CI 1.13-10.67, P=0.02) in a single case-control series of 1174 cases and 1109 controls. We describe a cellular system for examining the function of exogenous full-length BRCA1 and for classifying VUS. We achieved strong protein expression of full-length BRCA1 in transiently transfected HEK293T cells. The p.Ser36Tyr VUS exhibited low protein expression similar to the known pathogenic variant p.Cys61Gly. Co-precipitation analysis further demonstrated that it has a reduced ability to interact with BARD1. Further, co-precipitation analysis of nuclear and cytosolic extracts as well as immunofluorescence studies showed that a high proportion of the p.Ser36Tyr variant is withheld in the cytoplasm contrary to wild type protein. In addition the ability of p.Ser36Tyr to co-localize with conjugated ubiquitin foci in the nuclei of S-phase synchronized cells following genotoxic stress with hydroxyurea is impaired at more pronounced levels than that of the p.Cys61Gly pathogenic variant. The p.Ser36Tyr variant demonstrates abrogated function, and based on epidemiological, genetic, and clinical data we conclude that the p.Ser36Tyr variant is probably associated with a moderate breast cancer risk.	[Christou, Charita M.; Hadjisavvas, Andreas; Kyratzi, Maria; Flouri, Christina; Neophytou, Ioanna; Loizidou, Maria A.; Kyriacou, Kyriacos] Cyprus Inst Neurol & Genet, Dept Elect Microscopy Mol Pathol, Nicosia, Cyprus; [Kyratzi, Maria] Univ Cyprus, Dept Biol Sci, Nicosia, Cyprus; [Anastasiadou, Violetta] Cyprus Inst Neurol & Genet, Dept Clin Genet, Nicosia, Cyprus	University of Cyprus	Kyriacou, K (corresponding author), Cyprus Inst Neurol & Genet, Dept Elect Microscopy Mol Pathol, Nicosia, Cyprus.	kyriacos@cing.ac.cy	Loizidou, Maria A/C-6607-2009	Flouri, Christina/0000-0001-6341-6239	Cyprus Institute of Neurology and Genetics (TELETHON); Cyprus Research Promotion Foundation [YGEIA/1104/33, ERYEX/0308/14]; Cyprus Institute of Neurology and Genetics	Cyprus Institute of Neurology and Genetics (TELETHON); Cyprus Research Promotion Foundation; Cyprus Institute of Neurology and Genetics	This work was supported by grants from The Cyprus Institute of Neurology and Genetics (TELETHON 2009), the Cyprus Research Promotion Foundation (YGEIA/1104/33 and ERYEX/0308/14) and The Cyprus Institute of Neurology and Genetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Cyprus Institute of Neurology and Genetics URL: www.cing.ac.cy, Cyprus Research Promotion Foundation URL: http://www.research.org.cy.	Abkevich V, 2004, J MED GENET, V41, P492, DOI 10.1136/jmg.2003.015867; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Brzovic PS, 1998, J BIOL CHEM, V273, P7795, DOI 10.1074/jbc.273.14.7795; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Carvalho MA, 2007, CANCER RES, V67, P1494, DOI 10.1158/0008-5472.CAN-06-3297; Chang SW, 2009, J CLIN INVEST, V119, P3160, DOI 10.1172/JCI39836; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; Chen CF, 1996, J BIOL CHEM, V271, P32863, DOI 10.1074/jbc.271.51.32863; Chen SN, 2006, J CLIN ONCOL, V24, P863, DOI 10.1200/JCO.2005.03.6772; Chen YM, 1996, CANCER RES, V56, P3168; Chenevix-Trench G, 2006, CANCER RES, V66, P2019, DOI 10.1158/0008-5472.CAN-05-3546; Deffenbaugh AM, 2002, GENET TEST, V6, P119, DOI 10.1089/10906570260199375; Drost R, 2011, CANCER CELL, V20, P797, DOI 10.1016/j.ccr.2011.11.014; Easton DF, 2007, AM J HUM GENET, V81, P873, DOI 10.1086/521032; Evans DG, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-155; Fabbro M, 2002, J BIOL CHEM, V277, P21315, DOI 10.1074/jbc.M200769200; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Frank TS, 2002, J CLIN ONCOL, V20, P1480, DOI 10.1200/JCO.20.6.1480; Garcia EBG, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2223; Goldgar DE, 2008, HUM MUTAT, V29, P1265, DOI 10.1002/humu.20897; Goldgar DE, 2004, AM J HUM GENET, V75, P535, DOI 10.1086/424388; Gomez-Garcia EB, 2005, J CLIN ONCOL, V23, P2185, DOI 10.1200/JCO.2005.07.013; Hadjisavvas A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-447; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hofmann W, 2000, J CANCER RES CLIN, V126, P487, DOI 10.1007/s004320000140; Kurian AW, 2010, CURR OPIN OBSTET GYN, V22, P72, DOI 10.1097/GCO.0b013e328332dca3; Kuznetsov SG, 2008, NAT MED, V14, P875, DOI 10.1038/nm.1719; Lee MS, 2010, CANCER RES, V70, P4880, DOI 10.1158/0008-5472.CAN-09-4563; Lindor NM, 2011, HUM MUTAT; Mallery DL, 2002, EMBO J, V21, P6755, DOI 10.1093/emboj/cdf691; Meza JE, 1999, J BIOL CHEM, V274, P5659, DOI 10.1074/jbc.274.9.5659; Millot GA, 2012, HUM MUTAT, V33, P1526, DOI 10.1002/humu.22150; Mirkovic N, 2004, CANCER RES, V64, P3790, DOI 10.1158/0008-5472.CAN-03-3009; Monteiro ANA, 1996, P NATL ACAD SCI USA, V93, P13595, DOI 10.1073/pnas.93.24.13595; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Morris JR, 2006, HUM MOL GENET, V15, P599, DOI 10.1093/hmg/ddi476; Morris JR, 2004, HUM MOL GENET, V13, P807, DOI 10.1093/hmg/ddh095; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Osorio A, 2007, HUM MUTAT, V28, P477, DOI 10.1002/humu.20470; Osorio A, 2002, INT J CANCER, V99, P305, DOI 10.1002/ijc.10337; Phelan CM, 2005, J MED GENET, V42, P138, DOI 10.1136/jmg.2004.024711; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Ransburgh DJR, 2010, CANCER RES, V70, P988, DOI 10.1158/0008-5472.CAN-09-2850; Rodriguez JA, 2000, J BIOL CHEM, V275, P38589, DOI 10.1074/jbc.M003851200; Rodriguez JA, 2004, EXP CELL RES, V293, P14, DOI 10.1016/j.yexcr.2003.09.027; Ruffner H, 2001, P NATL ACAD SCI USA, V98, P5134, DOI 10.1073/pnas.081068398; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; Shakya R, 2011, SCIENCE, V334, P525, DOI 10.1126/science.1209909; Spearman AD, 2008, J CLIN ONCOL, V26, P5393, DOI 10.1200/JCO.2008.17.8228; Spurdle AB, 2008, J CLIN ONCOL, V26, P1657, DOI 10.1200/JCO.2007.13.2779; Spurdle AB, 2012, J MED GENET, V49, P525, DOI 10.1136/jmedgenet-2012-101037; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; Thompson D, 2003, AM J HUM GENET, V73, P652, DOI 10.1086/378100; Thompson ME, 2005, J BIOL CHEM, V280, P21854, DOI 10.1074/jbc.M502676200; Tomlinson GE, 1998, CANCER RES, V58, P3237; Vallon-Christersson J, 2001, HUM MOL GENET, V10, P353, DOI 10.1093/hmg/10.4.353; Vega A, 2001, Hum Mutat, V17, P520, DOI 10.1002/humu.1136; Williams RS, 2004, NAT STRUCT MOL BIOL, V11, P519, DOI 10.1038/nsmb776; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Xia Y, 2003, J BIOL CHEM, V278, P5255, DOI 10.1074/jbc.M204591200	63	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93400	10.1371/journal.pone.0093400	http://dx.doi.org/10.1371/journal.pone.0093400			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695549	gold, Green Submitted, Green Published			2022-12-25	WOS:000334103000067
J	Hudson, DM; Werther, R; Weis, M; Wu, JJ; Eyre, DR				Hudson, David M.; Werther, Rachel; Weis, MaryAnn; Wu, Jiann-Jiu; Eyre, David R.			Evolutionary Origins of C-Terminal (GPP) n 3-Hydroxyproline Formation in Vertebrate Tendon Collagen	PLOS ONE			English	Article							OSTEOGENESIS IMPERFECTA; POSTTRANSLATIONAL MODIFICATION; PROLYL 3-HYDROXYLATION; CONNECTIVE TISSUES; CROSS-LINKING; I COLLAGEN; MUTATIONS; EXPRESSION; ENZYMES; FAMILY	Approximately half the proline residues in fibrillar collagen are hydroxylated. The predominant form is 4-hydroxyproline, which helps fold and stabilize the triple helix. A minor form, 3-hydroxyproline, still has no clear function. Using peptide mass spectrometry, we recently revealed several previously unknown molecular sites of 3-hydroxyproline in fibrillar collagen chains. In fibril-forming A-clade collagen chains, four new partially occupied 3-hydroxyproline sites were found (A2, A3, A4 and (GPP)(n)) in addition to the fully occupied A1 site at Pro986. The C-terminal (GPP)(n) motif has five consecutive GPP triplets in alpha 1(I), four in alpha 2(I) and three in alpha 1(II), all subject to 3-hydroxylation. The evolutionary origins of this substrate sequence were investigated by surveying the pattern of its 3-hydroxyproline occupancy from early chordates through amphibians, birds and mammals. Different tissue sources of type I collagen (tendon, bone and skin) and type II collagen (cartilage and notochord) were examined by mass spectrometry. The (GPP)(n) domain was found to be a major substrate for 3-hydroxylation only in vertebrate fibrillar collagens. In higher vertebrates (mouse, bovine and human), up to five 3-hydroxyproline residues per (GPP)(n) motif were found in alpha 1(I) and four in alpha 2(I), with an average of two residues per chain. In vertebrate type I collagen the modification exhibited clear tissue specificity, with 3-hydroxyproline prominent only in tendon. The occupancy also showed developmental changes in Achilles tendon, with increasing 3-hydroxyproline levels with age. The biological significance is unclear but the level of 3-hydroxylation at the (GPP)(n) site appears to have increased as tendons evolved and shows both tendon type and developmental variations within a species.	[Hudson, David M.; Werther, Rachel; Weis, MaryAnn; Wu, Jiann-Jiu; Eyre, David R.] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Eyre, DR (corresponding author), Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA.	deyre@uw.edu			National Institutes of Health from National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR37694, AR37318]; Ernest M. Burgess Endowed Chair research program of the University of Washington; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR037318, R01AR036794, R01AR037318] Funding Source: NIH RePORTER	National Institutes of Health from National Institute of Arthritis and Musculoskeletal and Skin Diseases; Ernest M. Burgess Endowed Chair research program of the University of Washington; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health grants AR37694 and AR37318 from National Institute of Arthritis and Musculoskeletal and Skin Diseases. This work was also supported by funds from the Ernest M. Burgess Endowed Chair research program of the University of Washington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey AJ, 2001, MECH AGEING DEV, V122, P735, DOI 10.1016/S0047-6374(01)00225-1; Brondijk THC, 2012, P NATL ACAD SCI USA, V109, P5253, DOI 10.1073/pnas.1112388109; Byers PH, 2012, ANNU REV GENET, V46, P475, DOI 10.1146/annurev-genet-110711-155608; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Canty EG, 2004, J CELL BIOL, V165, P553, DOI 10.1083/jcb.200312071; Capellini TD, 2008, GENESIS, V46, P683, DOI 10.1002/dvg.20406; Cundy T, 2012, CALCIFIED TISSUE INT, V90, P439, DOI 10.1007/s00223-012-9588-3; Ehrlich H, 2010, NAT CHEM, V2, P1084, DOI 10.1038/NCHEM.899; Eyre DR, 2011, J BIOL CHEM, V286, P7732, DOI 10.1074/jbc.C110.195768; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; Fernandes RJ, 2011, J BIOL CHEM, V286, P30662, DOI 10.1074/jbc.M111.267906; Ha-Vinh R, 2004, AM J MED GENET A, V131A, P115, DOI 10.1002/ajmg.a.30231; Hudson DM, 2013, CONNECT TISSUE RES, V54, P245, DOI 10.3109/03008207.2013.800867; Hudson DM, 2012, BIOCHEMISTRY-US, V51, P2417, DOI 10.1021/bi2019139; Hudson DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019336; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; LIGHT ND, 1979, FEBS LETT, V97, P183, DOI 10.1016/0014-5793(79)80080-0; Meeuwig MH, 2005, T AM FISH SOC, V134, P19, DOI 10.1577/FT03-206.1; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; PARRY DAD, 1978, PROC R SOC SER B-BIO, V203, P305, DOI 10.1098/rspb.1978.0107; Pokidysheva E, 2013, J BIOL CHEM, V288, P24742, DOI 10.1074/jbc.M113.464156; Pyott SM, 2011, HUM MOL GENET, V20, P1595, DOI 10.1093/hmg/ddr037; Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978; Shadwick RE, 2002, COMP BIOCHEM PHYS A, V133, P1109, DOI 10.1016/S1095-6433(02)00215-5; SHADWICK RE, 1990, J APPL PHYSIOL, V68, P1033, DOI 10.1152/jappl.1990.68.3.1033; STEINMANN B, 1995, AM J HUM GENET, V57, P1505; Summers AP, 2002, COMP BIOCHEM PHYS A, V133, P1159, DOI 10.1016/S1095-6433(02)00241-6; Tiainen P, 2008, J BIOL CHEM, V283, P19432, DOI 10.1074/jbc.M802973200; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Vranka J, 2009, CELL STRUCT FUNCT, V34, P97, DOI 10.1247/csf.09002; Weis MA, 2010, J BIOL CHEM, V285, P2580, DOI 10.1074/jbc.M109.068726; Widmer C, 2012, P NATL ACAD SCI USA, V109, P13243, DOI 10.1073/pnas.1208072109; WU JJ, 1985, ANN NY ACAD SCI, V460, P520, DOI 10.1111/j.1749-6632.1985.tb51228.x	34	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93467	10.1371/journal.pone.0093467	http://dx.doi.org/10.1371/journal.pone.0093467			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695516	Green Published, gold, Green Submitted			2022-12-25	WOS:000334103000076
J	Mitchell, CL; Saul, MC; Lei, L; Wei, HR; Werner, T				Mitchell, Chelsea L.; Saul, Michael C.; Lei, Liang; Wei, Hairong; Werner, Thomas			The Mechanisms Underlying alpha-Amanitin Resistance in Drosophila melanogaster: A Microarray Analysis	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; VECTOR ANOPHELES-GAMBIAE; INSECTICIDE-RESISTANCE; CYTOCHROME-P450 GENES; DDT RESISTANCE; HETEROLOGOUS EXPRESSION; MYCOPHAGOUS DROSOPHILA; NATURAL-POPULATION; OVER-EXPRESSION; MUSCA-DOMESTICA	The rapid evolution of toxin resistance in animals has important consequences for the ecology of species and our economy. Pesticide resistance in insects has been a subject of intensive study; however, very little is known about how Drosophila species became resistant to natural toxins with ecological relevance, such as alpha-amanitin that is produced in deadly poisonous mushrooms. Here we performed a microarray study to elucidate the genes, chromosomal loci, molecular functions, biological processes, and cellular components that contribute to the alpha-amanitin resistance phenotype in Drosophila melanogaster. We suggest that toxin entry blockage through the cuticle, phase I and II detoxification, sequestration in lipid particles, and proteolytic cleavage of alpha-amanitin contribute in concert to this quantitative trait. We speculate that the resistance to mushroom toxins in D. melanogaster and perhaps in mycophagous Drosophila species has evolved as cross-resistance to pesticides, other xenobiotic substances, or environmental stress factors.	[Mitchell, Chelsea L.; Werner, Thomas] Michigan Technol Univ, Dept Biol Sci, Houghton, MI 49931 USA; [Saul, Michael C.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Lei, Liang; Wei, Hairong] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA	Michigan Technological University; University of Wisconsin System; University of Wisconsin Madison; Michigan Technological University	Werner, T (corresponding author), Michigan Technol Univ, Dept Biol Sci, Houghton, MI 49931 USA.	twerner@mtu.edu	wei, hairong/GNM-7061-2022; Saul, Michael C./N-9303-2019	wei, hairong/0000-0002-3551-4998; Saul, Michael C./0000-0002-4916-8619	Michigan Technological University	Michigan Technological University	This work was supported by a start-up fund and a seed grant from Michigan Technological University to TW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alias Z, 2007, PROTEOMICS, V7, P3618, DOI 10.1002/pmic.200700070; Amichot M, 2004, EUR J BIOCHEM, V271, P1250, DOI 10.1111/j.1432-1033.2004.04025.x; Baxter SW, 2011, GENETICS, V189, P675, DOI 10.1534/genetics.111.130971; Begun DJ, 2000, HEREDITY, V85, P184, DOI 10.1046/j.1365-2540.2000.00729.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bogwitz MR, 2005, P NATL ACAD SCI USA, V102, P12807, DOI 10.1073/pnas.0503709102; Brandt A, 2002, INSECT MOL BIOL, V11, P337, DOI 10.1046/j.1365-2583.2002.00344.x; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Bricelj VM, 2005, NATURE, V434, P763, DOI 10.1038/nature03415; Brun A, 1996, INSECT BIOCHEM MOLEC, V26, P697, DOI 10.1016/S0965-1748(96)00036-7; CHAMBERS TC, 1990, J BIOL CHEM, V265, P7679; Chung H, 2009, P NATL ACAD SCI USA, V106, P5731, DOI 10.1073/pnas.0812141106; CLARK AG, 1986, PESTIC BIOCHEM PHYS, V25, P169, DOI 10.1016/0048-3575(86)90044-1; CLARK AG, 1984, PESTIC BIOCHEM PHYS, V22, P249, DOI 10.1016/0048-3575(84)90018-X; Daborn P, 2001, MOL GENET GENOMICS, V266, P556, DOI 10.1007/s004380100531; Daborn PJ, 2007, INSECT BIOCHEM MOLEC, V37, P512, DOI 10.1016/j.ibmb.2007.02.008; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Despres L, 2007, TRENDS ECOL EVOL, V22, P298, DOI 10.1016/j.tree.2007.02.010; Dierick HA, 2006, NAT GENET, V38, P1023, DOI 10.1038/ng1864; Dunkov BC, 1997, DNA CELL BIOL, V16, P1345, DOI 10.1089/dna.1997.16.1345; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Feldman CR, 2012, P NATL ACAD SCI USA, V109, P4556, DOI 10.1073/pnas.1113468109; Festucci-Buselli RA, 2005, INSECT MOL BIOL, V14, P69, DOI 10.1111/j.1365-2583.2005.00532.x; Ffrench-Constant RH, 2013, GENETICS, V194, P807, DOI 10.1534/genetics.112.141895; FOURNIER D, 1992, J BIOL CHEM, V267, P1840; Giraudo M, 2010, PESTIC BIOCHEM PHYS, V97, P115, DOI 10.1016/j.pestbp.2009.06.009; Gunasekaran K, 2011, J MED ENTOMOL, V48, P561, DOI 10.1603/ME10194; Guzov VM, 1998, ARCH BIOCHEM BIOPHYS, V359, P231, DOI 10.1006/abbi.1998.0901; Hallen HE, 2007, P NATL ACAD SCI USA, V104, P19097, DOI 10.1073/pnas.0707340104; Hansen BH, 2008, GEN COMP ENDOCR, V158, P115, DOI 10.1016/j.ygcen.2008.05.013; Harrop TWR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084879; Howell B, 2008, J COLLOID INTERF SCI, V319, P81, DOI 10.1016/j.jcis.2007.11.018; Howell BA, 2010, MATERIALS, V3, P2483, DOI 10.3390/ma3042483; Huang QY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050383; JAENIKE J, 1985, EVOLUTION, V39, P1295, DOI [10.2307/2408786, 10.1111/j.1558-5646.1985.tb05695.x]; JAENIKE J, 1983, SCIENCE, V221, P165, DOI 10.1126/science.221.4606.165; Joussen N, 2008, PEST MANAG SCI, V64, P65, DOI 10.1002/ps.1472; Jumbo-Lucioni PP, 2013, DIS MODEL MECH, V6, P84, DOI 10.1242/dmm.010207; Kadota K, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-227; Kalajdzic P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040296; Kang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029800; King-Jones K, 2006, CELL METAB, V4, P37, DOI 10.1016/j.cmet.2006.06.006; Laing Emma, 2010, BMC Res Notes, V3, P221, DOI 10.1186/1756-0500-3-221; Le Goff G, 2003, INSECT BIOCHEM MOLEC, V33, P701, DOI 10.1016/S0965-1748(03)00064-X; LINDELL TJ, 1970, SCIENCE, V170, P447, DOI 10.1126/science.170.3956.447; Lumjuan N, 2005, INSECT BIOCHEM MOLEC, V35, P861, DOI 10.1016/j.ibmb.2005.03.008; Lumjuan N, 2011, INSECT BIOCHEM MOLEC, V41, P203, DOI 10.1016/j.ibmb.2010.12.005; Luque T, 2002, EUR J BIOCHEM, V269, P819, DOI 10.1046/j.0014-2956.2001.02723.x; Mansuy D, 1998, COMP BIOCHEM PHYS C, V121, P5, DOI 10.1016/S0742-8413(98)10026-9; McDonnell CM, 2012, J MOL EVOL, V74, P281, DOI 10.1007/s00239-012-9506-3; Misra JR, 2011, GENE DEV, V25, P1796, DOI 10.1101/gad.17280911; Moskalev A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086051; Mullner H, 2004, ACTA BIOCHIM POL, V51, P323; Neal SJ, 2006, PHYSIOL GENOMICS, V25, P493, DOI 10.1152/physiolgenomics.00195.2005; Ortelli F, 2003, BIOCHEM J, V373, P957, DOI 10.1042/BJ20030169; Pedra JHF, 2004, P NATL ACAD SCI USA, V101, P7034, DOI 10.1073/pnas.0400580101; Peiren N, 2008, TOXICON, V52, P72, DOI 10.1016/j.toxicon.2008.05.003; Penilla RP, 1998, MED VET ENTOMOL, V12, P217, DOI 10.1046/j.1365-2915.1998.00123.x; Perlman SJ, 2003, EVOLUTION, V57, P544, DOI 10.1111/j.0014-3820.2003.tb01546.x; Persson S, 2005, P NATL ACAD SCI USA, V102, P8633, DOI 10.1073/pnas.0503392102; PHILLIPS JP, 1982, CAN J GENET CYTOL, V24, P151, DOI 10.1139/g82-014; PIMENTEL D, 1992, BIOSCIENCE, V42, P750, DOI 10.2307/1311994; PRAPANTHADARA LA, 1993, PESTIC BIOCHEM PHYS, V47, P119, DOI 10.1006/pest.1993.1070; Prapanthadara LA, 1996, INSECT BIOCHEM MOLEC, V26, P277, DOI 10.1016/0965-1748(95)00090-9; Rahman MM, 2006, J INSECT PHYSIOL, V52, P754, DOI 10.1016/j.jinsphys.2006.04.003; Ranson H, 2005, METHOD ENZYMOL, V401, P226, DOI 10.1016/S0076-6879(05)01014-1; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Ranson H, 2001, BIOCHEM J, V359, P295, DOI 10.1042/0264-6021:3590295; Saul MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038128; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stump AD, 2011, ENVIRON ENTOMOL, V40, P1604, DOI 10.1603/EN11136; Sun LJ, 2011, PESTIC BIOCHEM PHYS, V100, P7, DOI 10.1016/j.pestbp.2011.01.009; Sun W, 2006, INSECT MOL BIOL, V15, P455, DOI 10.1111/j.1365-2583.2006.00662.x; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Thomas AM, 2013, G3-GENES GENOM GENET, V3, P91, DOI 10.1534/g3.112.003996; Tuno N, 2007, J CHEM ECOL, V33, P311, DOI 10.1007/s10886-006-9228-3; Wan H, 2013, PEST MANAG SCI; WANG JY, 1991, MOL GEN GENET, V227, P260, DOI 10.1007/BF00259679; Wang LM, 2008, P NATL ACAD SCI USA, V105, P5657, DOI 10.1073/pnas.0801327105; Wang SP, 2012, ARCH INSECT BIOCHEM, V79, P264, DOI 10.1002/arch.21021; Wei HR, 2006, PLANT PHYSIOL, V142, P762, DOI 10.1104/pp.106.080358; Wei HR, 2013, J PLANT RES, V126, P305, DOI 10.1007/s10265-012-0524-4; Wei SH, 2001, INSECT BIOCHEM MOLEC, V31, P1145, DOI 10.1016/S0965-1748(01)00059-5; Willoughby L, 2006, INSECT BIOCHEM MOLEC, V36, P934, DOI 10.1016/j.ibmb.2006.09.004; Yepiskoposyan H, 2006, NUCLEIC ACIDS RES, V34, P4866, DOI 10.1093/nar/gkl606; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	88	9	10	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93489	10.1371/journal.pone.0093489	http://dx.doi.org/10.1371/journal.pone.0093489			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695618	Green Published, gold			2022-12-25	WOS:000334103000080
J	Perez, NM; Ramakrishnan, G				Perez, Natalie Marie; Ramakrishnan, Girija			The Reduced Genome of the Francisella tularensis Live Vaccine Strain (LVS) Encodes Two Iron Acquisition Systems Essential for Optimal Growth and Virulence	PLOS ONE			English	Article							FERROUS IRON; MYCOBACTERIUM-TUBERCULOSIS; INTRACELLULAR BACTERIUM; SALMONELLA-ENTERICA; FULL VIRULENCE; MAJOR ROLE; FEOB; MACROPHAGES; SIDEROPHORE; TRANSPORTER	Bacterial pathogens require multiple iron-specific acquisition systems for survival within the iron-limiting environment of the host. Francisella tularensis is a virulent intracellular pathogen that can replicate in multiple cell-types. To study the interrelationship of iron acquisition capability and virulence potential of this organism, we generated single and double deletion mutants within the ferrous iron (feo) and ferric-siderophore (fsl) uptake systems of the live vaccine strain (LVS). The Feo system was disrupted by a partial deletion of the feoB gene (Delta feoB '), which led to a growth defect on iron-limited modified Muller Hinton agar plates. Fe-55 uptake assays verified that the Delta feoB ' mutant had lost the capacity for ferrous iron uptake but was still competent for Fe-55-siderophore-mediated ferric iron acquisition. Neither the Delta feoB ' nor the siderophore-deficient Delta fslA mutant was defective for replication within J774A.1 murine macrophage-like cells, thus demonstrating the ability of LVS to survive using either ferrous or ferric sources of intracellular iron. A LVS Delta fslA Delta feoB ' mutant defective for both ferrous iron uptake and siderophore production was isolated in the presence of exogenous F. tularensis siderophore. In contrast to the single deletion mutants, the Delta fslA Delta feoB ' mutant was unable to replicate within J774A.1 cells and was attenuated in virulence following intraperitoneal infection of C57BL/6 mice. These studies demonstrate that the siderophore and feoB-mediated ferrous uptake systems are the only significant iron acquisition systems in LVS and that they operate independently. While one system can compensate for loss of the other, both are required for optimal growth and virulence.	[Perez, Natalie Marie] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA USA; [Ramakrishnan, Girija] Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Ramakrishnan, G (corresponding author), Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22908 USA.	girija@virginia.edu			National Institutes of Health (NIH) [AI056227, Al067823]; University of Virginia School of Medicine; NIH pre-doctoral Training Grant [T32AI055432]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI056227, T32AI007046, T32AI055432] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Virginia School of Medicine; NIH pre-doctoral Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grants AI056227 and Al067823 (to G. R.) and by intramural funding from the University of Virginia School of Medicine. N.M.P was supported in part by the NIH pre-doctoral Training Grant T32AI055432. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyer E, 2002, INFECT IMMUN, V70, P6032, DOI 10.1128/IAI.70.11.6032-6042.2002; Cartron ML, 2006, BIOMETALS, V19, P143, DOI 10.1007/s10534-006-0003-2; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; Cendrowski S, 2004, MOL MICROBIOL, V51, P407, DOI 10.1046/j.1365-2958.2003.03861.x; CHAMBERL.RE, 1965, APPL MICROBIOL, V13, P232, DOI 10.1128/AEM.13.2.232-235.1965; Clemens DL, 2004, INFECT IMMUN, V72, P3204, DOI 10.1128/IAI.72.6.3204-3217.2004; De Voss JJ, 2000, P NATL ACAD SCI USA, V97, P1252, DOI 10.1073/pnas.97.3.1252; Deng K, 2006, INFECT IMMUN, V74, P4224, DOI 10.1128/IAI.01975-05; EBERL L, 1994, MOL MICROBIOL, V12, P131, DOI 10.1111/j.1365-2958.1994.tb01002.x; Elkins KL, 2003, MICROBES INFECT, V5, P135, DOI 10.1016/S1286-4579(02)00084-9; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Fetherston JD, 2012, INFECT IMMUN, V80, P3880, DOI 10.1128/IAI.00086-12; FORTIER AH, 1995, INFECT IMMUN, V63, P1478, DOI 10.1128/IAI.63.4.1478-1483.1995; FORTIER AH, 1991, INFECT IMMUN, V59, P2922, DOI 10.1128/IAI.59.9.2922-2928.1991; Golovliov I, 2003, INFECT IMMUN, V71, P5940, DOI 10.1128/IAI.71.10.5940-5950.2003; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Kakhlon O, 2002, FREE RADICAL BIO MED, V33, P1037, DOI 10.1016/S0891-5849(02)01006-7; KAMMLER M, 1993, J BACTERIOL, V175, P6212, DOI 10.1128/JB.175.19.6212-6219.1993; Kieffer TL, 2003, MICROBES INFECT, V5, P397, DOI 10.1016/S1286-4579(03)00052-2; Kim H, 2013, J BACTERIOL, V195, P3364, DOI 10.1128/JB.00343-13; Kim H, 2012, BIOCHEM BIOPH RES CO, V423, P733, DOI 10.1016/j.bbrc.2012.06.027; Kiss K, 2008, FEMS MICROBIOL LETT, V285, P270, DOI 10.1111/j.1574-6968.2008.01237.x; Larsson P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000472; Latunde-Dada GO, 2009, BIOESSAYS, V31, P1309, DOI 10.1002/bies.200900101; Lindgren H, 2009, INFECT IMMUN, V77, P4429, DOI 10.1128/IAI.00702-09; LITWIN CM, 1993, CLIN MICROBIOL REV, V6, P137, DOI 10.1128/CMR.6.2.137-149.1993; Marlovits TC, 2002, P NATL ACAD SCI USA, V99, P16243, DOI 10.1073/pnas.242338299; Naikare H, 2006, INFECT IMMUN, V74, P5433, DOI 10.1128/IAI.00052-06; Olakanmi O, 2010, ANTIMICROB AGENTS CH, V54, P244, DOI 10.1128/AAC.00655-09; Pan X, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-64; Pechous R, 2006, INFECT IMMUN, V74, P4452, DOI 10.1128/IAI.00666-06; Ramakrishnan G, 2008, J BACTERIOL, V190, P5353, DOI 10.1128/JB.00181-08; Ramakrishnan G, 2014, MICROBIOL-SGM, V160, P446, DOI 10.1099/mic.0.072835-0; Ramakrishnan G, 2012, J BIOL CHEM, V287, P25191, DOI 10.1074/jbc.M112.371856; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Reddy PV, 2013, J INFECT DIS, V208, P1255, DOI 10.1093/infdis/jit250; Robey M, 2002, INFECT IMMUN, V70, P5659, DOI 10.1128/IAI.70.10.5659-5669.2002; Rohmer L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r102; Rohmer L, 2006, INFECT IMMUN, V74, P6895, DOI 10.1128/IAI.01006-06; Runyen-Janecky LJ, 2003, INFECT IMMUN, V71, P1919, DOI 10.1128/IAI.71.4.1919-1928.2003; Salomonsson E, 2009, INFECT IMMUN, V77, P3424, DOI 10.1128/IAI.00196-09; Santiago AE, 2009, VACCINE, V27, P2426, DOI 10.1016/j.vaccine.2009.02.073; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Sen B, 2010, INFECT IMMUN, V78, P4276, DOI 10.1128/IAI.00503-10; SHENKER M, 1995, SOIL SCI SOC AM J, V59, P1612, DOI 10.2136/sssaj1995.03615995005900060015x; Sjodin A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-268; Su JL, 2007, INFECT IMMUN, V75, P3089, DOI 10.1128/IAI.01865-06; Sullivan JT, 2006, J BACTERIOL, V188, P3785, DOI 10.1128/JB.00027-06; Thomas-Charles CA, 2013, INFECT IMMUN, V81, P2828, DOI 10.1128/IAI.00170-13; Tsolis RM, 1996, INFECT IMMUN, V64, P4549, DOI 10.1128/IAI.64.11.4549-4556.1996; Velayudhan J, 2000, MOL MICROBIOL, V37, P274, DOI 10.1046/j.1365-2958.2000.01987.x; Weaver EA, 2013, J BACTERIOL, V195, P4826, DOI 10.1128/JB.00738-13; Wehrly TD, 2009, CELL MICROBIOL, V11, P1128, DOI 10.1111/j.1462-5822.2009.01316.x	54	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93558	10.1371/journal.pone.0093558	http://dx.doi.org/10.1371/journal.pone.0093558			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695402	Green Published, Green Submitted, gold			2022-12-25	WOS:000334103000090
J	van der Laan, S; Golfetto, E; Vanacker, JM; Maiorano, D				van der Laan, Siem; Golfetto, Eleonora; Vanacker, Jean-Marc; Maiorano, Domenico			Cell Cycle-Dependent Expression of Dub3, Nanog and the p160 Family of Nuclear Receptor Coactivators (NCoAs) in Mouse Embryonic Stem Cells	PLOS ONE			English	Article							ESTROGEN-RELATED RECEPTORS; ERR-ALPHA; THERAPEUTIC TARGET; PROSTATE-CANCER; ORPHAN; TRANSCRIPTION; PLURIPOTENCY; GROWTH; CDC25A; ESRRB	Pluripotency of embryonic stem cells (ESC) is tightly regulated by a network of transcription factors among which the estrogen-related receptor beta (Esrrb). Esrrb contributes to the relaxation of the G1 to S-phase (G1/S) checkpoint in mouse ESCs by transcriptional control of the deubiquitylase Dub3 gene, contributing to Cdc25A persistence after DNA damage. We show that in mESCs, Dub3 gene expression is cell cycle regulated and is maximal prior G1/S transition. In addition, following UV-induced DNA damage in G1, Dub3 expression markedly increases in S-phase also suggesting a role in checkpoint recovery. Unexpectedly, we also observed cell cycle-regulation of Nanog expression, and not Oct4, reaching high levels prior to G1/S transition, finely mirroring Cyclin E1 fluctuations. Curiously, while Esrrb showed only limited cell-cycle oscillations, transcript levels of the p160 family of nuclear receptor coactivators (NCoAs) displayed strong cell cycle-dependent fluctuations. Since NCoAs function in concert with Esrrb in transcriptional activation, we focussed on NCoA1 whose levels specifically increase prior onset of Dub3 transcription. Using a reporter assay, we show that NCoA1 potentiates Esrrb-mediated transcription of Dub3 and we present evidence of protein interaction between the SRC1 splice variant NCoA1 and Esrrb. Finally, we show a differential developmental regulation of all members of the p160 family during neural conversion of mESCs. These findings suggest that in mouse ESCs, changes in the relative concentration of a coactivator at a given cell cycle phase, may contribute to modulation of the transcriptional activity of the core transcription factors of the pluripotent network and be implicated in cell fate decisions upon onset of differentiation.	[van der Laan, Siem; Golfetto, Eleonora; Maiorano, Domenico] Inst Human Genet, CNRS, Dept Mol Bases Human Dis, Genome Surveillance & Stabil Lab,UPR1142, Montpellier, France; [Vanacker, Jean-Marc] Ecole Normale Super Lyon, Inst Genom Fonctionnelle Lyon, F-69364 Lyon, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Maiorano, D (corresponding author), Inst Human Genet, CNRS, Dept Mol Bases Human Dis, Genome Surveillance & Stabil Lab,UPR1142, Montpellier, France.	domenico.maiorano@igh.cnrs.fr	Maiorano, Domenico/N-5755-2017	Maiorano, Domenico/0000-0003-4229-5903; VAN DER LAAN, Siem/0000-0001-8169-1963	"Fondation ARC" pour la recherche sur le cancer [3156]; Fondation pour la Recherche Medicale; Ligue contre le Cancer; ERASMUS mobility grant from University of Padova (Italy)	"Fondation ARC" pour la recherche sur le cancer; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Ligue contre le Cancer(Ligue nationale contre le cancer); ERASMUS mobility grant from University of Padova (Italy)	Research in DM's laboratory was funded by grants from "Fondation ARC" pour la recherche sur le cancer (URL: http://www.arc-cancer.net/; grant No 3156 to DM and a personal fellowship to SVDL) and "Fondation pour la Recherche Medicale (URL: http://www.frm.org/; FRM Equipes). Work in J-MV's laboratory is funded by Ligue contre le Cancer (URL: http://www.ligue-cancer.net; comites Rhone and Drome). EG was supported by an ERASMUS mobility grant (URL: http://ec.europa.eu/programmes/erasmus-plus/index_en.htm) coming from the University of Padova (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianco S, 2009, J BIOL CHEM, V284, P23286, DOI 10.1074/jbc.M109.028191; Buschhorn BA, 2006, NAT CELL BIOL, V8, P209, DOI 10.1038/ncb0306-209; Busino L, 2004, ONCOGENE, V23, P2050, DOI 10.1038/sj.onc.1207394; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Deblois G, 2013, ONCOGENE, V32, P3483, DOI 10.1038/onc.2012.529; Deblois G, 2009, CANCER RES, V69, P6149, DOI 10.1158/0008-5472.CAN-09-1251; EDGAR BA, 1989, CELL, V57, P177, DOI 10.1016/0092-8674(89)90183-9; Feng Q, 2006, MOL CELL BIOL, V26, P7846, DOI 10.1128/MCB.00568-06; Frietze S, 2008, CANCER RES, V68, P301, DOI 10.1158/0008-5472.CAN-07-1983; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Horard B, 2003, J MOL ENDOCRINOL, V31, P349, DOI 10.1677/jme.0.0310349; Kalkhoven E, 1998, EMBO J, V17, P232, DOI 10.1093/emboj/17.1.232; Kuijk EW, 2012, DEVELOPMENT, V139, P871, DOI 10.1242/dev.071688; Lu DS, 2001, CANCER RES, V61, P6755; McFarlane C, 2010, CANCER RES, V70, P3329, DOI 10.1158/0008-5472.CAN-09-4152; Meijer OC, 2005, ENDOCRINOLOGY, V146, P1438, DOI 10.1210/en.2004-0411; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Naeem H, 2007, MOL CELL BIOL, V27, P120, DOI 10.1128/MCB.00815-06; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; NORBURY C, 1992, ANNU REV BIOCHEM, V61, P441, DOI 10.1146/annurev.bi.61.070192.002301; Papp B, 2012, EMBO J, V31, P4255, DOI 10.1038/emboj.2012.285; Pauklin S, 2013, CELL, V155, P135, DOI 10.1016/j.cell.2013.08.031; Percharde M, 2012, GENE DEV, V26, P2286, DOI 10.1101/gad.195545.112; Pereg Y, 2010, NAT CELL BIOL, V12, P400, DOI 10.1038/ncb2041; Roode M, 2012, DEV BIOL, V361, P358, DOI 10.1016/j.ydbio.2011.10.030; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Shibue T, 2003, GENE DEV, V17, P2233, DOI 10.1101/gad.1103603; Singh AM, 2013, STEM CELL REP, V1, P532, DOI 10.1016/j.stemcr.2013.10.009; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Tremblay Annie M, 2007, Nucl Recept Signal, V5, pe009, DOI 10.1621/nrs.05009; Uranishi K, 2013, MOL CELL BIOL, V33, P2056, DOI 10.1128/MCB.01520-12; van der Laan S, 2008, EUR J PHARMACOL, V585, P483, DOI 10.1016/j.ejphar.2008.01.060; van der Laan S, 2013, MOL CELL, V52, P366, DOI 10.1016/j.molcel.2013.10.003; Vanacker JM, 1999, MOL ENDOCRINOL, V13, P764, DOI 10.1210/me.13.5.764; Villena JA, 2008, TRENDS ENDOCRIN MET, V19, P269, DOI 10.1016/j.tem.2008.07.005; Xie W, 1999, MOL ENDOCRINOL, V13, P2151, DOI 10.1210/me.13.12.2151; Xu JM, 2003, MOL ENDOCRINOL, V17, P1681, DOI 10.1210/me.2003-0116; Yu S, 2008, ONCOGENE, V27, P3313, DOI 10.1038/sj.onc.1210986; Yu SA, 2007, CANCER RES, V67, P4904, DOI 10.1158/0008-5472.CAN-06-3855; Zhang X, 2009, J CELL BIOL, V184, P67, DOI 10.1083/jcb.200801009	40	15	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93663	10.1371/journal.pone.0093663	http://dx.doi.org/10.1371/journal.pone.0093663			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695638	Green Published, gold, Green Submitted			2022-12-25	WOS:000334103000100
J	Zimmermann, AS; Morrison, SD; Hu, MS; Li, SL; Nauta, A; Sorkin, M; Meyer, NP; Walmsley, GG; Maan, ZN; Chan, DA; Gurtner, GC; Giaccia, AJ; Longaker, MT				Zimmermann, Andrew S.; Morrison, Shane D.; Hu, Michael S.; Li, Shuli; Nauta, Allison; Sorkin, Michael; Meyer, Nathaniel P.; Walmsley, Graham G.; Maan, Zeshaan N.; Chan, Denise A.; Gurtner, Geoffrey C.; Giaccia, Amato J.; Longaker, Michael T.			Epidermal or Dermal Specific Knockout of PHD-2 Enhances Wound Healing and Minimizes Ischemic Injury	PLOS ONE			English	Article							DIABETIC FOOT; HYPOXIA; EXPRESSION; INDUCTION; GROWTH; ANGIOGENESIS; THERAPY; OXYGEN; CELLS	Introduction: Hypoxia-inducible factor (HIF)-1 alpha, part of the heterodimeric transcription factor that mediates the cellular response to hypoxia, is critical for the expression of multiple angiogenic growth factors, cell motility, and the recruitment of endothelial progenitor cells. Inhibition of the oxygen-dependent negative regulator of HIF-1 alpha, prolyl hydroxylase domain-2 (PHD-2), leads to increased HIF-1 alpha and mimics various cellular and physiological responses to hypoxia. The roles of PHD-2 in the epidermis and dermis have not been clearly defined in wound healing. Methods: Epidermal and dermal specific PHD-2 knockout (KO) mice were developed in a C57BL/6J (wild type) background by crossing homozygous floxed PHD-2 mice with heterozygous K14-Cre mice and heterozygous Col1A2-Cre-ER mice to get homozygous floxed PHD-2/heterozygous K14-Cre and homozygous floxed PHD-2/heterozygous floxed Col1A2-Cre-ER mice, respectively. Ten to twelve-week-old PHD-2 KO and wild type (WT) mice were subjected to wounding and ischemic pedicle flap model. The amount of healing was grossly quantified with ImageJ software. Western blot and qRT-PCR was run on protein and RNA from primary cells cultured in vitro. Results: qRT-PCR demonstrated a significant decrease of PHD-2 in keratinocytes and fibroblasts derived from tissue specific KO mice relative to control mice (*p < 0.05). Western blot analysis showed a significant increase in HIF-1 alpha and VEGF protein levels in PHD-2 KO mice relative to control mice (*p < 0.05). PHD-2 KO mice showed significantly accelerated wound closure relative to WT (*p < 0.05). When ischemia was analyzed at day nine post-surgery in a flap model, the PHD-2 tissue specific knockout mice showed significantly more viable flaps than WT (*p < 0.05). Conclusions: PHD-2 plays a significant role in the rates of wound healing and response to ischemic insult in mice. Further exploration shows PHD-2 KO increases cellular levels of HIF-1 alpha and this increase leads to the transcription of downstream angiogenic factors such as VEGF.	[Zimmermann, Andrew S.; Morrison, Shane D.; Hu, Michael S.; Li, Shuli; Nauta, Allison; Sorkin, Michael; Meyer, Nathaniel P.; Walmsley, Graham G.; Maan, Zeshaan N.; Gurtner, Geoffrey C.; Longaker, Michael T.] Stanford Univ, Sch Med, Div Plast & Reconstruct Surg, Hagey Lab Pediat Regenerat Med,Dept Surg, Stanford, CA 94305 USA; [Hu, Michael S.] Univ Hawaii, John A Burns Sch Med, Dept Surg, Honolulu, HI 96822 USA; [Walmsley, Graham G.; Longaker, Michael T.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Chan, Denise A.] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA USA; [Giaccia, Amato J.] Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA	Stanford University; University of Hawaii System; Stanford University; University of California System; University of California San Francisco; Stanford University	Longaker, MT (corresponding author), Stanford Univ, Sch Med, Div Plast & Reconstruct Surg, Hagey Lab Pediat Regenerat Med,Dept Surg, Stanford, CA 94305 USA.	longaker@stanford.edu		Morrison, Shane/0000-0003-3868-3532; Maan, Zeshaan/0000-0002-7683-1914	NIA NIH HHS [R00 AG049958] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Albina JE, 2001, AM J PHYSIOL-CELL PH, V281, pC1971, DOI 10.1152/ajpcell.2001.281.6.C1971; Catrina SB, 2004, DIABETES, V53, P3226, DOI 10.2337/diabetes.53.12.3226; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chan DA, 2005, MOL CELL BIOL, V25, P6415, DOI 10.1128/MCB.25.15.6415-6426.2005; Chan DA, 2009, CANCER CELL, V15, P527, DOI 10.1016/j.ccr.2009.04.010; Chang EI, 2007, CIRCULATION, V116, P2818, DOI 10.1161/CIRCULATIONAHA.107.715847; Covello KL, 2004, CURR TOP DEV BIOL, V62, P37; Cross KJ, 2003, SURG CLIN N AM, V83, P531, DOI 10.1016/S0039-6109(02)00202-5; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Driver VR, 2010, J VASC SURG, V52, p17S, DOI 10.1016/j.jvs.2010.06.003; Elson DA, 2000, CANCER RES, V60, P6189; Fonder MA, 2008, J AM ACAD DERMATOL, V58, P185, DOI 10.1016/j.jaad.2007.08.048; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Hirota K, 2005, BIOCHEM BIOPH RES CO, V338, P610, DOI 10.1016/j.bbrc.2005.08.193; Holscher M, 2011, J BIOL CHEM, V286, P11185, DOI 10.1074/jbc.M110.186809; Huang M, 2008, CIRCULATION, V118, pS226, DOI 10.1161/CIRCULATIONAHA.107.760785; Huang M, 2009, CIRCULATION, V120, pS230, DOI 10.1161/CIRCULATIONAHA.108.841155; Kelly BD, 2003, CIRC RES, V93, P1074, DOI 10.1161/01.RES.0000102937.50486.1B; Kirsner RS, 2010, ARCH DERMATOL, V146, P857, DOI 10.1001/archdermatol.2010.164; Ko SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027844; Kranke P, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004123.pub3, 10.1002/14651858.CD004123.pub4]; Li W, 2007, EMBO J, V26, P1221, DOI 10.1038/sj.emboj.7601579; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Loh SA, 2009, PLAST RECONSTR SURG, V123, p65S, DOI 10.1097/PRS.0b013e318191bdf4; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Tandara AA, 2004, WORLD J SURG, V28, P294, DOI 10.1007/s00268-003-7400-2; Thangarajah H, 2009, P NATL ACAD SCI USA, V106, P13505, DOI 10.1073/pnas.0906670106; Zheng B, 2002, AM J PATHOL, V160, P1609, DOI 10.1016/S0002-9440(10)61108-X	28	24	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93373	10.1371/journal.pone.0093373	http://dx.doi.org/10.1371/journal.pone.0093373			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695462	gold, Green Published, Green Submitted			2022-12-25	WOS:000334103000063
J	Arbyn, M; Fabri, V; Temmerman, M; Simoens, C				Arbyn, Marc; Fabri, Valerie; Temmerman, Marleen; Simoens, Cindy			Attendance at Cervical Cancer Screening and Use of Diagnostic and Therapeutic Procedures on the Uterine Cervix Assessed from Individual Health Insurance Data ( Belgium, 2002-2006)	PLOS ONE			English	Article							EUROPEAN GUIDELINES; QUALITY-ASSURANCE; MORTALITY; VALIDITY; OUTCOMES; ACCURACY; HISTORY; LESIONS	Objective: To assess the coverage for cervical cancer screening as well as the use of cervical cytology, colposcopy and other diagnostic and therapeutic interventions on the uterine cervix in Belgium, using individual health insurance data. Methods: The Intermutualistic Agency compiled a database containing 14 million records from reimbursement claims for Pap smears, colposcopies, cervical biopsies and surgery, performed between 2002 and 2006. Cervical cancer screening coverage was defined as the proportion of women aged 25-64 that had a Pap smear within the last 3 years. Results: Cervical cancer screening coverage was 61% at national level, for the target population of women between 25 and 64 years old, in the period 2004- 2006. Differences between the 3 regions were small, but varied more substantially between provinces. Coverage was 70% for 25-34 year old women, 67% for those aged 35-39 years, and decreased to 44% in the age group of 60-64 years. The median screening interval was 13 months. The screening coverage varied substantially by social category: 40% and 64%, in women categorised as beneficiary or not- beneficiary of increased reimbursement from social insurance, respectively. In the 3- year period 2004-2006, 3.2 million screen tests were done in the target group consisting of 2.8 million women. However, only 1.7 million women got one or more smears and 1.1 million women had no smears, corresponding to an average of 1.88 smears per woman in three years of time. Colposcopy was excessively used (number of Pap smears over colposcopies =3.2). The proportion of women with a history of conisation or hysterectomy, before the age of 65, was 7% and 19%, respectively. Conclusion: The screening coverage increased slightly from 59% in 2000 to 61% in 2006. The screening intensity remained at a high level, and the number of cytological examinations was theoretically sufficient to cover more than the whole target population.	[Arbyn, Marc; Simoens, Cindy] Sci Inst Publ Hlth, Canc Epidemiol Unit, Brussels, Belgium; [Fabri, Valerie] AIM, Intermutualist Agcy IMA, Brussels, Belgium; [Temmerman, Marleen] Univ Ghent, Dept Obstet & Gynaecol, B-9000 Ghent, Belgium; [Temmerman, Marleen] WHO, CH-1211 Geneva, Switzerland; [Simoens, Cindy] Univ Antwerp, Lab Cell Biol & Histol, B-2020 Antwerp, Belgium	Ghent University; World Health Organization; University of Antwerp	Arbyn, M (corresponding author), Sci Inst Publ Hlth, Canc Epidemiol Unit, Brussels, Belgium.	Marc.Arbyn@wiv-isp.be			Belgian Cancer Foundation (Brussels, Belgium); 7th Framework Programme of DG Research of the European Commission (CoheaHr Project) [603019]; FNRS (le Fonds National de la Recherche Scientific), through TELEVIE, Brussels, Belgium [7.4523.11.F]; Belgian Cancer Centre	Belgian Cancer Foundation (Brussels, Belgium); 7th Framework Programme of DG Research of the European Commission (CoheaHr Project); FNRS (le Fonds National de la Recherche Scientific), through TELEVIE, Brussels, Belgium(Fonds de la Recherche Scientifique - FNRS); Belgian Cancer Centre	Financial support was received from (1) the Belgian Cancer Foundation (Brussels, Belgium); (2) the 7th Framework Programme of DG Research of the European Commission (CoheaHr Project, coordinated by the Vrije Universiteit Amsterdam, the Netherlands, Grant number: 603019); (3) FNRS (le Fonds National de la Recherche Scientific), through TELEVIE, Brussels, Belgium (ref 7.4523.11.F); and (4) the Belgian Cancer Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, OFF J EUR UNION L, VL327, P34; ANTTILA A, 2008, EUROPEAN GUIDELINES, P11; Arbyn M, 1997, EUR J CANCER PREV, V6, P389, DOI 10.1097/00008469-199708000-00012; Arbyn M, 2000, EUR J CANCER, V36, P2191, DOI 10.1016/S0959-8049(00)00308-7; Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015; Arbyn M., 2002, Archives of Public Health, V60, P73; Arbyn M, 2002, INT J CANCER, V102, P649, DOI 10.1002/ijc.10761; Arbyn M, 2010, ANN ONCOL, V21, P448, DOI 10.1093/annonc/mdp471; Arbyn M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1284; Arbyn M, 2011, IPH EPI REPORTS; Arbyn M, 1999, EUR J HLTH LAW, V6, P401; Arbyn M, 2011, EUR J CANCER PREV, V20, P18, DOI 10.1097/CEJ.0b013e32833ecbc6; Arbyn M, 2009, EUR J CANCER, V45, P2640, DOI 10.1016/j.ejca.2009.07.018; Arbyn M, 2009, PREV MED, V48, P438, DOI 10.1016/j.ypmed.2009.02.021; Bowman JA, 1997, SOC SCI MED, V44, P969, DOI 10.1016/S0277-9536(96)00222-5; Caplan LS, 2003, CANCER EPIDEM BIOMAR, V12, P1182; Centre for Operational Research in Public Health, 2006, STAND PROC MORT AN V; COLEMAN D, 1993, EUR J CANCER, V29A, pS1; Demarest S, 2006, HLTH INTERVIEW SURVE, P1; Desai MM, 2001, AM J EPIDEMIOL, V153, P299, DOI 10.1093/aje/153.3.299; European Commission. Directorate-General for Health and Consumer Protection. & International Agency for Research on Cancer, 2008, EUROPEAN GUIDELINES; FRUCHTER RG, 1992, NEW YORK STATE J MED, V92, P421; Habbema D, 2012, MILBANK Q, V90, P5, DOI 10.1111/j.1468-0009.2011.00652.x; International Agency for Research on Cancer (IARC), 2005, IARC HDB CANC PREV, V10, P45; Jordan J, 2008, CYTOPATHOLOGY, V19, P342, DOI 10.1111/j.1365-2303.2008.00623.x; Kleinbaum DG, 1982, EPIDEMIOLOGIC RES PR; Klungsoyr O, 2009, J MED SCREEN, V16, P91, DOI 10.1258/jms.2009.008087; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; LAARA E, 1987, LANCET, V1, P1247; Miller AB, 2002, EUR J CANCER, V38, P321, DOI 10.1016/S0959-8049(01)00374-4; MONTANO DE, 1995, AM J PUBLIC HEALTH, V85, P795, DOI 10.2105/AJPH.85.6.795; Noehr B, 2009, OBSTET GYNECOL, V114, P1232, DOI 10.1097/AOG.0b013e3181bf1ef2; Nygard JF, 2002, J MED SCREEN, V9, P86, DOI 10.1136/jms.9.2.86; Onkelinx L, 2013, KONINKLIJK BESLUIT V, P11882; Peto J, 2004, LANCET, V364, P249, DOI 10.1016/S0140-6736(04)16674-9; Quinn M, 1999, BRIT MED J, V318, P904, DOI 10.1136/bmj.318.7188.904; Racey CS, 2013, CAN J PUBLIC HEALTH, V104, pE159, DOI 10.1007/BF03405681; Simoens C, 2012, BJOG-INT J OBSTET GY, V119, P1247, DOI 10.1111/j.1471-0528.2012.03429.x; Sirovich BE, 2004, JAMA-J AM MED ASSOC, V291, P2990, DOI 10.1001/jama.291.24.2990; Tjalma W, 2005, TIJDSCHR GENEESKUNDE, V61, P108; van der Aa MA, 2008, EUR J OBSTET GYN R B, V139, P204, DOI 10.1016/j.ejogrb.2007.10.017; Weyers S, 2005, TIJDSCHR GENEESKUNDE, V61, P129	42	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92615	10.1371/journal.pone.0092615	http://dx.doi.org/10.1371/journal.pone.0092615			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6KM	24690620	Green Published, Green Submitted, gold			2022-12-25	WOS:000334101100029
J	Doron, R; Lotan, D; Versano, Z; Benatav, L; Franko, M; Armoza, S; Kately, N; Rehavi, M				Doron, Ravid; Lotan, Dafna; Versano, Ziv; Benatav, Layla; Franko, Motty; Armoza, Shir; Kately, Nadav; Rehavi, Moshe			Escitalopram or Novel Herbal Mixture Treatments during or following Exposure to Stress Reduce Anxiety-Like Behavior through Corticosterone and BDNF Modifications	PLOS ONE			English	Article							NEUROTROPHIC FACTOR EXPRESSION; NEONATAL MATERNAL SEPARATION; LONG-LASTING CHANGES; MOOD DISORDERS; ANIMAL-MODELS; MILD STRESS; DEPRESSION; BRAIN; MICE; MOUSE	Anxiety disorders are a major public health concern worldwide. Studies indicate that repeated exposure to adverse experiences early in life can lead to anxiety disorders in adulthood. Current treatments for anxiety disorders are characterized by a low success rate and are associated with a wide variety of side effects. The aim of the present study was to evaluate the anxiolytic effects of a novel herbal treatment, in comparison to treatment with the selective serotonin reuptake inhibitor escitalopram. We recently demonstrated the anxiolytic effects of these treatments in BALB mice previously exposed to one week of stress. In the present study, ICR mice were exposed to post natal maternal separation and to 4 weeks of unpredictable chronic mild stress in adolescence, and treated during or following exposure to stress with the novel herbal treatment or with escitalopram. Anxiety-like behavior was evaluated in the elevated plus maze. Blood corticosterone levels were evaluated using radioimmunoassay. Brain derived neurotrophic factor levels in the hippocampus were evaluated using enzyme-linked immunosorbent assay. We found that (1) exposure to stress in childhood and adolescence increased anxiety-like behavior in adulthood; (2) the herbal treatment reduced anxiety-like behavior, both when treated during or following exposure to stress; (3) blood corticosterone levels were reduced following treatment with the herbal treatment or escitalopram, when treated during or following exposure to stress; (4) brain derived neurotrophic factor levels in the hippocampus of mice treated with the herbal treatment or escitalopram were increased, when treated either during or following exposure to stress. This study expands our previous findings and further points to the proposed herbal compound's potential to be highly efficacious in treating anxiety disorders in humans.	[Doron, Ravid; Versano, Ziv; Benatav, Layla; Franko, Motty; Armoza, Shir] Acad Coll Tel Aviv Yaffo, Sch Behav Sci, Tel Aviv, Israel; [Doron, Ravid; Lotan, Dafna] Open Univ Israel, Dept Educ & Psychol, Raanana, Israel; [Doron, Ravid] Hadassah Acad Coll, Sch Hlth & Life Sci, Jerusalem, Israel; [Lotan, Dafna] Sch Psychol Sci, Tel Aviv, Israel; [Lotan, Dafna] Sagol Sch Neurosci, Tel Aviv, Israel; [Kately, Nadav] Tel Aviv Univ, IL-69978 Tel Aviv, Israel; [Versano, Ziv; Armoza, Shir; Rehavi, Moshe] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Rehavi, Moshe] Tel Aviv Univ, Sackler Fac Med, Dr Miriam & Sheldon G Adelson Chair Biol Addict D, IL-69978 Tel Aviv, Israel	Open University Israel; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Doron, R (corresponding author), Acad Coll Tel Aviv Yaffo, Sch Behav Sci, Tel Aviv, Israel.	raviddor@mta.ac.il			Israel Science Foundation [ISF 738/11]; National Institute for Psychobiology in Israel [NIPI-7-2011-12]; Open University foundation	Israel Science Foundation(Israel Science Foundation); National Institute for Psychobiology in Israel; Open University foundation	This work was funded by the Israel Science Foundation (http://www.isf.org.il/english/ [ISF 738/11]), by the National Institute for Psychobiology in Israel (http://www.psychobiology.org.il/ [NIPI-7-2011-12]), and by the Open University foundation. No individuals employed or contracted by the funders (other than the named authors) played any role in: study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avital A, 2005, INT J NEUROPSYCHOPH, V8, P163, DOI 10.1017/S1461145704004808; Avitsur R, 2006, BRAIN BEHAV IMMUN, V20, P339, DOI 10.1016/j.bbi.2005.09.006; Baker-Herman TL, 2004, NAT NEUROSCI, V7, P48, DOI 10.1038/nn1166; Baldwin DS, 2011, INT J NEUROPSYCHOPH, V14, P697, DOI 10.1017/S1461145710001434; Barbui C, 2009, EVID-BASED MENT HEAL, V12, P79, DOI 10.1136/ebmh.12.3.79; Buhl ES, 2010, AM J PHYSIOL-ENDOC M, V298, pE920, DOI 10.1152/ajpendo.00606.2009; Carobrez AP, 2005, NEUROSCI BIOBEHAV R, V29, P1193, DOI 10.1016/j.neubiorev.2005.04.017; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; Culpepper L, 2002, J CLIN PSYCHIAT, V63, P35; De Bellis MD, 2005, CHILD ADOL PSYCH CL, V14, P745, DOI 10.1016/j.chc.2005.05.006; Dording Christina M, 2002, Ann Clin Psychiatry, V14, P143, DOI 10.1023/A:1021137118956; Doron R, 2014, LIFE SCI, V94, P151, DOI 10.1016/j.lfs.2013.10.025; Doron R, 2012, LIFE SCI, V90, P995, DOI 10.1016/j.lfs.2012.05.014; Ducottet C, 2004, PHYSIOL BEHAV, V81, P417, DOI 10.1016/j.physbeh.2004.01.013; Dulawa SC, 2004, NEUROPSYCHOPHARMACOL, V29, P1321, DOI 10.1038/sj.npp.1300433; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Dwivedi Y, 2006, NEUROSCIENCE, V139, P1017, DOI 10.1016/j.neuroscience.2005.12.058; File SE, 2001, BEHAV BRAIN RES, V125, P151, DOI 10.1016/S0166-4328(01)00292-3; Frielingsdorf H, 2010, ANN NY ACAD SCI, V1208, P150, DOI 10.1111/j.1749-6632.2010.05722.x; Hashimoto K, 2004, BRAIN RES REV, V45, P104, DOI 10.1016/j.brainresrev.2004.02.003; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; Heim C, 1997, ANN NY ACAD SCI, V821, P194, DOI 10.1111/j.1749-6632.1997.tb48279.x; Ihne JL, 2012, NEUROPHARMACOLOGY, V62, P464, DOI 10.1016/j.neuropharm.2011.08.045; Kalinichev M, 2002, PHARMACOL BIOCHEM BE, V73, P131, DOI 10.1016/S0091-3057(02)00781-5; Katzman MA, 2009, CNS DRUGS, V23, P103, DOI 10.2165/00023210-200923020-00002; Lang UE, 2005, PSYCHOPHARMACOLOGY, V180, P95, DOI 10.1007/s00213-004-2137-7; Larsen MH, 2010, J PSYCHIATR RES, V44, P808, DOI 10.1016/j.jpsychires.2010.01.005; Lee TTY, 2012, NEUROSCIENCE, V204, P17, DOI 10.1016/j.neuroscience.2011.10.006; Lenze EJ, 2011, AM J GERIAT PSYCHIAT, V19, P482, DOI 10.1097/JGP.0b013e3181ec806c; Linde K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000448.pub3; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Maayan R, 2006, EUR NEUROPSYCHOPHARM, V16, P329, DOI 10.1016/j.euroneuro.2005.10.002; Mantella RC, 2008, PSYCHONEUROENDOCRINO, V33, P773, DOI 10.1016/j.psyneuen.2008.03.002; Marco EM, 2012, NEUROPHARMACOLOGY; Middeldorp CM, 2010, GENES BRAIN BEHAV, V9, P808, DOI 10.1111/j.1601-183X.2010.00619.x; Millstein RA, 2007, NEUROSCI BIOBEHAV R, V31, P3, DOI 10.1016/j.neubiorev.2006.05.003; Muller WE, 1997, PHARMACOPSYCHIATRY, V30, P102, DOI 10.1055/s-2007-979528; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Panossian A, 1999, PHYTOMEDICINE, V6, P147, DOI 10.1016/S0944-7113(99)80002-6; Reinhold JA, 2011, EXPERT OPIN PHARMACO, V12, P2457, DOI 10.1517/14656566.2011.618496; Roceri M, 2004, BIOL PSYCHIAT, V55, P708, DOI 10.1016/j.biopsych.2003.12.011; Romeo RD, 2003, HORM BEHAV, V43, P561, DOI 10.1016/S0018-506X(03)00063-1; Sanchez C, 2003, PSYCHOPHARMACOLOGY, V167, P353, DOI 10.1007/s00213-002-1364-z; Sanchez MM, 2001, DEV PSYCHOPATHOL, V13, P419, DOI 10.1017/S0954579401003029; Sarris J, 2009, J ALTERN COMPLEM MED, V15, P827, DOI 10.1089/acm.2009.0066; Scheid Volker, 2009, CHINESE HERBAL MED F, V2nd; Schmidt MV, 2007, PSYCHONEUROENDOCRINO, V32, P417, DOI 10.1016/j.psyneuen.2007.02.011; Simmen U, 1999, J RECEPT SIGNAL TR R, V19, P59, DOI 10.3109/10799899909036637; Slotten HA, 2006, BRAIN RES, V1097, P123, DOI 10.1016/j.brainres.2006.04.066; Tamaji A, 2012, HUM PSYCHOPHARM CLIN, V27, P329, DOI 10.1002/hup.2220; Thase ME, 2006, EXPERT OPIN PHARMACO, V7, P429, DOI 10.1517/14656566.7.4.429; Tsoory M, 2007, EUR NEUROPSYCHOPHARM, V17, P245, DOI 10.1016/j.euroneuro.2006.06.007; Vermetten E, 2006, ANN NY ACAD SCI, V1071, P184, DOI 10.1196/annals.1364.014; Vreeburg SA, 2010, PSYCHOSOM MED, V72, P340, DOI 10.1097/PSY.0b013e3181d2f0c8; WILLNER P, 1992, NEUROSCI BIOBEHAV R, V16, P525, DOI 10.1016/S0149-7634(05)80194-0; Witte S, 2005, PHYTOTHER RES, V19, P183, DOI 10.1002/ptr.1609	56	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e91455	10.1371/journal.pone.0091455	http://dx.doi.org/10.1371/journal.pone.0091455			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690945	Green Submitted, Green Published, gold			2022-12-25	WOS:000334101100015
J	Hansen, DS; Ryg-Cornejo, V; Ioannidis, LJ; Chiu, CY; Ly, A; Nie, CQ; Scalzo, AA; Schofield, L				Hansen, Diana S.; Ryg-Cornejo, Victoria; Ioannidis, Lisa J.; Chiu, Chris Y.; Ly, Ann; Nie, Catherine Q.; Scalzo, Anthony A.; Schofield, Louis			The Contribution of Natural Killer Complex Loci to the Development of Experimental Cerebral Malaria	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; TUMOR-NECROSIS-FACTOR; ENHANCED VASCULAR-PERMEABILITY; NK CELL ACTIVATION; IFN-GAMMA; T-CELLS; GENE-COMPLEX; INFECTED ERYTHROCYTES; INTERFERON-GAMMA; DENDRITIC CELLS	Background: The Natural Killer Complex (NKC) is a genetic region of highly linked genes encoding several receptors involved in the control of NK cell function. The NKC is highly polymorphic and allelic variability of various NKC loci has been demonstrated in inbred mice, providing evidence for NKC haplotypes. Using BALB.B6-Cmv1(r) congenic mice, in which NKC genes from C57BL/6 mice were introduced into the BALB/c background, we have previously shown that the NKC is a genetic determinant of malarial pathogenesis. C57BL/6 alleles are associated with increased disease-susceptibility as BALB.B6-Cmv1(r) congenic mice had increased cerebral pathology and death rates during P. berghei ANKA infection than cerebral malaria-resistant BALB/c controls. Methods: To investigate which regions of the NKC are involved in susceptibility to experimental cerebral malaria (ECM), intra-NKC congenic mice generated by backcrossing recombinant F2 progeny from a (BALB/c x BALB.B6-Cmv1(r)) F1 intercross to BALB/c mice were infected with P. berghei ANKA. Results: Our results revealed that C57BL/6 alleles at two locations in the NKC contribute to the development of ECM. The increased severity to severe disease in intra-NKC congenic mice was not associated with higher parasite burdens but correlated with a significantly enhanced systemic IFN-gamma response to infection and an increased recruitment of CD8(+) T cells to the brain of infected animals. Conclusions: Polymorphisms within the NKC modulate malarial pathogenesis and acquired immune responses to infection.	[Hansen, Diana S.; Ryg-Cornejo, Victoria; Ioannidis, Lisa J.; Chiu, Chris Y.; Ly, Ann; Schofield, Louis] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Nie, Catherine Q.] Burnet Inst, Melbourne, Vic, Australia; [Ryg-Cornejo, Victoria; Chiu, Chris Y.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Scalzo, Anthony A.] Lions Eye Inst, Ctr Expt Immunol, Nedlands, WA, Australia; [Scalzo, Anthony A.] Univ Western Australia, Ctr Ophthalmol & Visual Sci, Nedlands, WA 6009, Australia; [Schofield, Louis] James Cook Univ, Australian Inst Trop Hlth & Med, Douglas, Qld, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; Burnet Institute; University of Melbourne; Lions Eye Institute; University of Western Australia; University of Western Australia; James Cook University	Hansen, DS (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	hansen@wehi.edu.au		Chiu, Yu Ho Chris/0000-0002-5380-1114	 [1031212]		This work was made possible through Victorian State Government Operational Infrastructure Support, Australian Government National Health and Medical Research Council IRIISS, and Project Grant 1031212. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amani V, 2000, EUR J IMMUNOL, V30, P1646, DOI 10.1002/1521-4141(200006)30:6&lt;1646::AID-IMMU1646&gt;3.0.CO;2-0; Arase H, 1996, J EXP MED, V183, P2391, DOI 10.1084/jem.183.5.2391; Armah HB, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-147; Artavanis-Tsakonas K, 2003, J IMMUNOL, V171, P5396, DOI 10.4049/jimmunol.171.10.5396; Artavanis-Tsakonas K, 2002, J IMMUNOL, V169, P2956, DOI 10.4049/jimmunol.169.6.2956; Baratin M, 2005, P NATL ACAD SCI USA, V102, P14747, DOI 10.1073/pnas.0507355102; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; Brown MG, 2001, IMMUNOGENETICS, V53, P584, DOI 10.1007/s002510100365; Campanella GSV, 2008, P NATL ACAD SCI USA, V105, P4814, DOI 10.1073/pnas.0801544105; D'Ombrain MC, 2007, EUR J IMMUNOL, V37, P1864, DOI 10.1002/eji.200636889; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; El-Assaad F, 2013, INFECT IMMUN, V81, P3984, DOI 10.1128/IAI.00428-13; Franke-Fayard B, 2005, P NATL ACAD SCI USA, V102, P11468, DOI 10.1073/pnas.0503386102; Grau GE, 2003, J INFECT DIS, V187, P461, DOI 10.1086/367960; GRAU GE, 1989, P NATL ACAD SCI USA, V86, P5572, DOI 10.1073/pnas.86.14.5572; GRAU GE, 1987, SCIENCE, V237, P1210, DOI 10.1126/science.3306918; Hansen DS, 2007, CURR OPIN IMMUNOL, V19, P416, DOI 10.1016/j.coi.2007.07.011; Hansen DS, 2007, J IMMUNOL, V178, P5779, DOI 10.4049/jimmunol.178.9.5779; Hansen DS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003045; Hansen DS, 2003, IMMUNITY, V18, P391, DOI 10.1016/S1074-7613(03)00052-9; Hansen DS, 2005, INFECT IMMUN, V73, P2288, DOI 10.1128/IAI.73.4.2288-2297.2005; Ho EL, 2002, J IMMUNOL, V169, P3667, DOI 10.4049/jimmunol.169.7.3667; HO M, 1995, J INFECT DIS, V172, P838, DOI 10.1093/infdis/172.3.838; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Ing R, 2009, INFECT IMMUN, V77, P770, DOI 10.1128/IAI.00994-08; Jain V, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-83; Karre K, 2002, SCAND J IMMUNOL, V55, P221, DOI 10.1046/j.1365-3083.2002.01053.x; Koch O, 2002, J INFECT DIS, V185, P1684, DOI 10.1086/340516; Lundie RJ, 2008, P NATL ACAD SCI USA, V105, P14509, DOI 10.1073/pnas.0806727105; Ma NL, 1996, AM J PATHOL, V149, P1745; Mason LH, 2000, J IMMUNOL, V164, P603, DOI 10.4049/jimmunol.164.2.603; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Miu J, 2008, J IMMUNOL, V180, P1217, DOI 10.4049/jimmunol.180.2.1217; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Nie CQ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000369; Nitcheu J, 2003, J IMMUNOL, V170, P2221, DOI 10.4049/jimmunol.170.4.2221; Ochiel DO, 2005, INFECT IMMUN, V73, P4190, DOI 10.1128/IAI.73.7.4190-4197.2005; PATNAIK JK, 1994, AM J TROP MED HYG, V51, P642, DOI 10.4269/ajtmh.1994.51.642; PORTA J, 1993, CLIN NEUROPATHOL, V12, P142; RINGWALD P, 1991, J CLIN MICROBIOL, V29, P2076, DOI 10.1128/JCM.29.9.2076-2078.1991; Ryg-Cornejo V, 2013, IMMUNOBIOLOGY, V218, P263, DOI 10.1016/j.imbio.2012.05.018; Scalzo AA, 1999, IMMUNOGENETICS, V49, P238, DOI 10.1007/s002510050486; SCALZO AA, 1995, GENOMICS, V27, P435, DOI 10.1006/geno.1995.1074; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; Trowsdale J, 2001, IMMUNITY, V15, P363, DOI 10.1016/S1074-7613(01)00197-2; WHITE NJ, 1992, ADV PARASIT, V31, P83, DOI 10.1016/S0065-308X(08)60021-4; Yanez DM, 1996, J IMMUNOL, V157, P1620; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055	49	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93268	10.1371/journal.pone.0093268	http://dx.doi.org/10.1371/journal.pone.0093268			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691125	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000334101100059
J	Wang, XL; Wang, YJ; Huang, H; Chen, BY; Chen, XJ; Hu, JD; Chang, T; Lin, RJ; Yee, JK				Wang, Xiaoling; Wang, Yingjia; Huang, He; Chen, Buyuan; Chen, Xinji; Hu, Jianda; Chang, Tammy; Lin, Ren-Jang; Yee, Jiing-Kuan			Precise Gene Modification Mediated by TALEN and Single-Stranded Oligodeoxynucleotides in Human Cells	PLOS ONE			English	Article							DNA-BINDING SPECIFICITY; EFFECTOR NUCLEASES; HUMAN HEPATOCYTES; STEM-CELLS; OLIGONUCLEOTIDES; REPAIR; DIFFERENTIATION; RECOMBINATION; RECOGNITION; DISRUPTION	The development of human embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) facilitates in vitro studies of human disease mechanisms, speeds up the process of drug screening, and raises the feasibility of using cell replacement therapy in clinics. However, the study of genotype-phenotype relationships in ESCs or iPSCs is hampered by the low efficiency of site-specific gene editing. Transcription activator-like effector nucleases (TALENs) spurred interest due to the ease of assembly, high efficiency and faithful gene targeting. In this study, we optimized the TALEN design to maximize its genomic cutting efficiency. We showed that using optimized TALENs in conjunction with single-strand oligodeoxynucleotide (ssODN) allowed efficient gene editing in human cells. Gene mutations and gene deletions for up to 7.8 kb can be accomplished at high efficiencies. We established human tumor cell lines and H9 ESC lines with homozygous deletion of the microRNA-21 (miR-21) gene and miR-9-2 gene. These cell lines provide a robust platform to dissect the roles these genes play during cell differentiation and tumorigenesis. We also observed that the endogenous homologous chromosome can serve as a donor template for gene editing. Overall, our studies demonstrate the versatility of using ssODN and TALEN to establish genetically modified cells for research and therapeutic application.	[Wang, Xiaoling; Wang, Yingjia; Chang, Tammy; Yee, Jiing-Kuan] Beckman Res Inst City Hope, Dept Virol, Duarte, CA 91010 USA; [Chen, Buyuan; Chen, Xinji; Lin, Ren-Jang] Beckman Res Inst City Hope, Dept Mol & Cellular Biol, Duarte, CA USA; [Wang, Yingjia; Huang, He] Zhejiang Univ, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Buyuan; Chen, Xinji; Hu, Jianda] Fujian Med Univ, Union Hosp, Dept Hematol, Fuzhou, Fujian, Peoples R China	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; Zhejiang University; Fujian Medical University	Yee, JK (corresponding author), Beckman Res Inst City Hope, Dept Virol, Duarte, CA 91010 USA.	JYee@coh.org	Lin, Ren-Jang/G-2052-2014	Lin, Ren-Jang/0000-0002-2738-2438	California Institute of Regenerative Medicine [RB3-02161]; Nesvig Foundation; Beckman Research Institute Excellence Award; National Natural Science Foundation of China; Zhejiang Provincial Natural Science Foundation of China; Zhejiang Provincial Major Science and Technology Project; China Scholarship Council; P.R.C. National and Fujian Provincial Key Clinical Specialty Discipline Construction Program	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Nesvig Foundation; Beckman Research Institute Excellence Award; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Major Science and Technology Project; China Scholarship Council(China Scholarship Council); P.R.C. National and Fujian Provincial Key Clinical Specialty Discipline Construction Program	This work is supported by grant RB3-02161 from California Institute of Regenerative Medicine to JKY, grants from Nesvig Foundation and Beckman Research Institute Excellence Award to RJL. YJW was supported by grants from National Natural Science Foundation of China, Zhejiang Provincial Natural Science Foundation of China, Zhejiang Provincial Major Science and Technology Project and China Scholarship Council. BC and XC were supported in part by the P.R.C. National and Fujian Provincial Key Clinical Specialty Discipline Construction Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts M, 2010, NUCLEIC ACIDS RES, V38, P6956, DOI 10.1093/nar/gkq589; Andrieu-Soler C, 2005, NUCLEIC ACIDS RES, V33, P3733, DOI 10.1093/nar/gki686; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bultmann S, 2012, NUCLEIC ACIDS RES, V40, P5368, DOI 10.1093/nar/gks199; CAMPBELL C R, 1989, New Biologist, V1, P223; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Chen SJ, 2013, NUCLEIC ACIDS RES, V41, P2769, DOI 10.1093/nar/gks1356; Cho S. W., 2013, GENOME RES; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Dajas-Bailador F, 2012, NAT NEUROSCI, V15, P697, DOI 10.1038/nn.3082; De Preter K, 2002, MODERN PATHOL, V15, P159, DOI 10.1038/modpathol.3880508; Delaloy C, 2010, CELL STEM CELL, V6, P323, DOI 10.1016/j.stem.2010.02.015; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Dvorak Z, 2003, MOL PHARMACOL, V64, P160, DOI 10.1124/mol.64.1.160; Fine E.J., 2013, NUCL ACIDS RES; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Gandhi M, 2012, P NATL ACAD SCI USA, V109, P9454, DOI 10.1073/pnas.1205759109; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Hu RZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063074; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Igoucheva O, 2006, OLIGONUCLEOTIDES, V16, P94, DOI 10.1089/oli.2006.16.94; Igoucheva O, 2008, OLIGONUCLEOTIDES, V18, P111, DOI 10.1089/oli.2008.0120; Laneve P, 2010, NUCLEIC ACIDS RES, V38, P6895, DOI 10.1093/nar/gkq604; Lee HJ, 2010, GENOME RES, V20, P81, DOI 10.1101/gr.099747.109; Lei Y, 2012, P NATL ACAD SCI USA, V109, P17484, DOI 10.1073/pnas.1215421109; Leucht C, 2008, NAT NEUROSCI, V11, P641, DOI 10.1038/nn.2115; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Osborn MJ, 2013, MOL THER, V21, P1151, DOI 10.1038/mt.2013.56; Papaioannou I, 2009, J GENE MED, V11, P267, DOI 10.1002/jgm.1296; Park J, 2013, NAT STRUCT MOL BIOL; Radecke S, 2006, J GENE MED, V8, P217, DOI 10.1002/jgm.828; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Richardson C, 1998, GENE DEV, V12, P3831, DOI 10.1101/gad.12.24.3831; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Shibata M, 2008, J NEUROSCI, V28, P10415, DOI 10.1523/JNEUROSCI.3219-08.2008; Shibata M, 2011, J NEUROSCI, V31, P3407, DOI 10.1523/JNEUROSCI.5085-10.2011; Streubel J, 2012, NAT BIOTECHNOL, V30, P593, DOI 10.1038/nbt.2304; Takada S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076004; Tong C, 2012, J GENET GENOMICS, V39, P275, DOI 10.1016/j.jgg.2012.04.004; Uchida N, 2010, CELL STEM CELL, V6, P294, DOI 10.1016/j.stem.2010.03.010; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wefers B, 2013, P NATL ACAD SCI USA, V110, P3782, DOI 10.1073/pnas.1218721110; Yuva-Aydemir Y, 2011, RNA BIOL, V8, P557, DOI 10.4161/rna.8.4.16019	62	52	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93575	10.1371/journal.pone.0093575	http://dx.doi.org/10.1371/journal.pone.0093575			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691488	gold, Green Published			2022-12-25	WOS:000334101100106
J	Wakabayashi, H; Monaghan, M; Fay, PJ				Wakabayashi, Hironao; Monaghan, Morgan; Fay, Philip J.			Cofactor Activity in Factor VIIIa of the Blood Clotting Pathway Is Stabilized by an Interdomain Bond between His281 and Ser524 Formed in Factor VIII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Blood Coagulation Factors; Factor VIII; Mutagenesis; Protein Stability; Protein Structure	THROMBIN-CATALYZED ACTIVATION; A2 DOMAIN INTERFACE; PROTEIN-C; CRYSTAL-STRUCTURE; CHARGED RESIDUES; CA2+ BINDING; FACTOR XASE; SUBUNIT; COAGULATION; GENERATION	Background: Intermediate resolution FVIII x-ray structures show His(281) (A1) and Ser(524) (A2) in close proximity. Ala mutations at these residues show functional defects. Results: Residue swap (H281S/S524H) or disulfide bridge (H281C/S524C) variants possess WT-like stability and function. Conclusion: Side chains of His(281) and Ser(524) form a bond in FVIII that is retained in FVIIIa. Significance: This bond stabilizes the FVIIIa A2 subunit from dissociation. The factor VIII (FVIII) crystal structure suggests a possible bonding interaction of His(281) (A1 domain) with Ser(524) (A2 domain), although the resolution of the structure (approximate to 4 ) does not firmly establish this bonding. To establish that side chains of these residues participate in an interdomain bond, we prepared and examined the functional properties of a residue swap variant (H281S/S524H) where His(281) and Ser(524) residues were exchanged with one another and a disulfide-bridged variant (H281C/S524C) where the two residues were replaced with Cys. The latter variant showed efficient disulfide bonding of the A1 and A2 domains. The swap variant showed WT-like FVIII and FVIIIa stability, which were markedly reduced for H281A and S524A variants in an earlier study. The disulfide-bridged variant showed approximate to 20% increased FVIII stability, and FVIIIa did not decay during the time course measured. This variant also yielded 35% increased thrombin peak values compared with WT in a plasma-based thrombin generation assay. Binding analyses of H281S-A1/A3C1C2 dimer with S524H-A2 subunit yielded a near WT-like affinity value, whereas combining the variant dimer or A2 subunit with the WT complement yielded approximate to 5- and approximate to 10-fold reductions, respectively, in affinity. Other functional properties including thrombin generation potential, FIXa binding affinity, K-m for FX of FXase complexes, thrombin activation efficiency, and down-regulation by activated protein C showed similar results for the two variants compared with WT FVIII. These results indicate that the side chains of His(281) and Ser(524) are in close proximity and contribute to a bonding interaction in FVIII that is retained in FVIIIa.	[Wakabayashi, Hironao; Monaghan, Morgan; Fay, Philip J.] Univ Rochester, Sch Med, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Fay, PJ (corresponding author), Dept Biochem & Biophys, POB 712,601 Elmwood Ave, Rochester, NY 14642 USA.	philip_fay@urmc.rochester.edu			National Institutes of Health [HL38199]; National Institutes of Health Predoctoral Trainee Grant from the Institutional Ruth L. Kirschstein National Research Award [GM068411]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM068411] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Predoctoral Trainee Grant from the Institutional Ruth L. Kirschstein National Research Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant HL38199 (to P. J. F.). This work was also supported by National Institutes of Health Predoctoral Trainee Grant GM068411 from the Institutional Ruth L. Kirschstein National Research Award (to M. M.).	Ansong C, 2006, BIOCHEMISTRY-US, V45, P13140, DOI 10.1021/bi061202w; Bajaj SP, 2001, J BIOL CHEM, V276, P16302, DOI 10.1074/jbc.M011680200; Doering CB, 2002, THROMB HAEMOSTASIS, V88, P450; ESMON CT, 1981, P NATL ACAD SCI-BIOL, V78, P2249, DOI 10.1073/pnas.78.4.2249; ESMON NL, 1982, J BIOL CHEM, V257, P859; Fay PJ, 1996, J BIOL CHEM, V271, P6027, DOI 10.1074/jbc.271.11.6027; Fay PJ, 2004, BLOOD REV, V18, P1, DOI 10.1016/S0268-960X(03)00025-0; Gale AJ, 2006, J THROMB HAEMOST, V4, P1315, DOI 10.1111/j.1538-7836.2006.01951.x; Griffiths AE, 2013, J BIOL CHEM, V288, P15057, DOI 10.1074/jbc.M113.456467; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Hockin MF, 2002, J BIOL CHEM, V277, P18322, DOI 10.1074/jbc.M201173200; Jagannathan I, 2009, J BIOL CHEM, V284, P32248, DOI 10.1074/jbc.M109.050781; LOLLAR P, 1993, METHOD ENZYMOL, V222, P128; LOLLAR P, 1992, J BIOL CHEM, V267, P23652; Machlus KR, 2009, THROMB HAEMOSTASIS, V102, P936, DOI 10.1160/TH09-03-0180; Ngo JCK, 2008, STRUCTURE, V16, P597, DOI 10.1016/j.str.2008.03.001; OVER J, 1984, SCAND J HAEMATOL, V33, P13; Pemberton S, 1997, BLOOD, V89, P2413, DOI 10.1182/blood.V89.7.2413; Radtke KP, 2007, J THROMB HAEMOST, V5, P102, DOI 10.1111/j.1538-7836.2006.02283.x; Schmidt B, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-49; Shen BW, 2008, BLOOD, V111, P1240, DOI 10.1182/blood-2007-08-109918; Varfaj F, 2007, J BIOL CHEM, V282, P20264, DOI 10.1074/jbc.M701327200; Wakabayashi H, 2005, BIOCHEMISTRY-US, V44, P10298, DOI 10.1021/bi050638t; Wakabayashi H, 2001, BIOCHEMISTRY-US, V40, P10293, DOI 10.1021/bi010353q; Wakabayashi H, 2004, J BIOL CHEM, V279, P12677, DOI 10.1074/jbc.M311042200; Wakabayashi H, 2002, BIOCHEMISTRY-US, V41, P8485, DOI 10.1021/bi025589o; Wakabayashi H, 2009, J THROMB HAEMOST, V7, P438, DOI 10.1111/j.1538-7836.2008.03256.x; Wakabayashi H, 2008, BLOOD, V112, P2761, DOI 10.1182/blood-2008-02-142158; Wakabayashi H, 2008, J BIOL CHEM, V283, P11645, DOI 10.1074/jbc.M710252200; Wakabayashi H, 2013, BIOCHEMISTRY-US, V52, P3921, DOI 10.1021/bi400295x; Wakabayashi H, 2013, BIOCHEM J, V452, P293, DOI 10.1042/BJ20130025; Wakabayashi H, 2011, J BIOL CHEM, V286, P25748, DOI 10.1074/jbc.M111.241109	32	5	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14020	14029		10.1074/jbc.M114.550566	http://dx.doi.org/10.1074/jbc.M114.550566			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24692542	Green Published, hybrid			2022-12-25	WOS:000335984600032
J	Walinda, E; Morimoto, D; Sugase, K; Konuma, T; Tochio, H; Shirakawa, M				Walinda, Erik; Morimoto, Daichi; Sugase, Kenji; Konuma, Tsuyoshi; Tochio, Hidehito; Shirakawa, Masahiro			Solution Structure of the Ubiquitin-associated ( UBA) Domain of Human Autophagy Receptor NBR1 and Its Interaction with Ubiquitin and Polyubiquitin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Nuclear Magnetic Resonance; Protein Degradation; Protein Structure; Ubiquitin	SELECTIVE AUTOPHAGY; NMR-SPECTROSCOPY; RECOGNITION; P62; BINDING; CHAINS; SOFTWARE; PROTEINS; MICE; DIMERIZATION	Background: The autophagic receptor NBR1 is commonly found in ubiquitin-positive inclusions in neurodegenerative diseases. Results: Molecular recognition of ubiquitin and polyubiquitin by NBR1 is described. Conclusion: The ubiquitin-associated domain of NBR1 shows unexpectedly high affinity for monoubiquitin but lacks polyubiquitin linkage specificity. Significance: NBR1 may be highly efficient at forming intracellular inclusions with ubiquitylated proteins via non-linkage-specific association with ubiquitin. NBR1 (neighbor of BRCA1 gene 1) is a protein commonly found in ubiquitin-positive inclusions in neurodegenerative diseases. Due to its high architectural similarity to the well studied autophagy receptor protein p62/SQSTM1, NBR1 has been thought to analogously bind to ubiquitin-marked autophagic substrates via its C-terminal ubiquitin-associated (UBA) domain and deliver them to autophagosomes for degradation. Unexpectedly, we find that NBR1 differs from p62 in its UBA structure and accordingly in its interaction with ubiquitin. Structural differences are observed on helix -3, which is tilted farther from helix -2 and extended by approximately one turn in NBR1. This results not only in inhibition of a p62-type self-dimerization of NBR1 UBA but also in a significantly higher affinity for monoubiquitin as compared with p62 UBA. Importantly, the NBR1 UBA-ubiquitin complex structure shows that the negative charge of the side chain in front of the conserved MGF motif in the UBA plays an integral role in the recognition of ubiquitin. In addition, NMR and isothermal titration calorimetry experiments show that NBR1 UBA binds to each monomeric unit of polyubiquitin with similar affinity and by the same surface used for binding to monoubiquitin. This indicates that NBR1 lacks polyubiquitin linkage-type specificity, in good agreement with the nonspecific linkages observed in intracellular ubiquitin-positive inclusions. Consequently, our results demonstrate that the structural differences between NBR1 UBA and p62 UBA result in a much higher affinity of NBR1 for ubiquitin, which in turn suggests that NBR1 may form intracellular inclusions with ubiquitylated autophagic substrates more efficiently than p62.	[Walinda, Erik; Morimoto, Daichi; Tochio, Hidehito; Shirakawa, Masahiro] Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Kyoto 6158510, Japan; [Sugase, Kenji; Konuma, Tsuyoshi] Suntory Fdn Life Sci, Bioorgan Res Inst, Osaka 6188503, Japan	Kyoto University; Suntory Holdings Ltd	Shirakawa, M (corresponding author), Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Nishikyo Ku, Kyoto 6158510, Japan.	shirakawa@moleng.kyoto-u.ac.jp	Sugase, Kenji/S-3132-2016; Tochio, Hidehito/GWV-0429-2022; Sugase, Kenji/AAF-4552-2021	Sugase, Kenji/0000-0001-8623-7743; Tochio, Hidehito/0000-0003-3843-3330; Sugase, Kenji/0000-0001-8623-7743; Konuma, Tsuyoshi/0000-0002-4412-2849; Morimoto, Daichi/0000-0002-7672-2136	Grants-in-Aid for Scientific Research [11J06373] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Castaneda CA, 2013, STRUCTURE, V21, P1168, DOI 10.1016/j.str.2013.04.029; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Clausen TH, 2010, AUTOPHAGY, V6, P330, DOI 10.4161/auto.6.3.11226; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hubbard S. J., 1993, NACCESS; Isogai S, 2011, J BIOL CHEM, V286, P31864, DOI 10.1074/jbc.M111.259630; Itakura E, 2011, J CELL BIOL, V192, P17, DOI 10.1083/jcb.201009067; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Jung YS, 2004, J BIOMOL NMR, V30, P11, DOI 10.1023/B:JNMR.0000042954.99056.ad; Kaiser SE, 2011, NAT METHODS, V8, P691, DOI [10.1038/NMETH.1649, 10.1038/nmeth.1649]; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kobayashi N, 2007, J BIOMOL NMR, V39, P31, DOI 10.1007/s10858-007-9175-5; Kobayashi N, 2012, J BIOMOL NMR, V53, P311, DOI 10.1007/s10858-012-9641-6; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Long J, 2008, J BIOL CHEM, V283, P5427, DOI 10.1074/jbc.M704973200; Long J, 2010, J MOL BIOL, V396, P178, DOI 10.1016/j.jmb.2009.11.032; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; Murphy JM, 2007, P NATL ACAD SCI USA, V104, P14336, DOI 10.1073/pnas.0703012104; Ohno A, 2005, STRUCTURE, V13, P521, DOI 10.1016/j.str.2005.01.011; Peschard P, 2007, MOL CELL, V27, P474, DOI 10.1016/j.molcel.2007.06.023; Press W H, 2007, NUMERICAL RECIPES AR, P807; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Riley BE, 2010, J CELL BIOL, V191, P537, DOI 10.1083/jcb.201005012; Ruschak AM, 2010, NATURE, V467, P868, DOI 10.1038/nature09444; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sims JJ, 2009, NAT STRUCT MOL BIOL, V16, P883, DOI 10.1038/nsmb.1637; Sugase K, 2013, J BIOMOL NMR, V56, P275, DOI 10.1007/s10858-013-9747-5; Tenno T, 2004, GENES CELLS, V9, P865, DOI 10.1111/j.1365-2443.2004.00780.x; Valafar H, 2004, J MAGN RESON, V167, P228, DOI 10.1016/j.jmr.2003.12.012; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang YX, 1998, J AM CHEM SOC, V120, P7385, DOI 10.1021/ja980862o; Zhang D, 2008, J MOL BIOL, V377, P162, DOI 10.1016/j.jmb.2007.12.029; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	43	44	44	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13890	13902		10.1074/jbc.M114.555441	http://dx.doi.org/10.1074/jbc.M114.555441			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24692539	Green Published, hybrid			2022-12-25	WOS:000335984600021
J	Rafacho, A; Goncalves-Neto, LM; Santos-Silva, JC; Alonso-Magdalena, P; Merino, B; Taboga, SR; Carneiro, EM; Boschero, AC; Nadal, A; Quesada, I				Rafacho, Alex; Goncalves-Neto, Luiz M.; Santos-Silva, Junia C.; Alonso-Magdalena, Paloma; Merino, Beatriz; Taboga, Sebastiao R.; Carneiro, Everardo M.; Boschero, Antonio C.; Nadal, Angel; Quesada, Ivan			Pancreatic Alpha-Cell Dysfunction Contributes to the Disruption of Glucose Homeostasis and Compensatory Insulin Hypersecretion in Glucocorticoid-Treated Rats	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; GLUCAGON-LIKE PEPTIDE-1; ISLET CELLS; SECRETION; RESISTANCE; RECEPTORS; MASS; PREDNISOLONE; MECHANISMS; RESPONSIVENESS	Glucocorticoid (GC)-based therapies can cause insulin resistance (IR), glucose intolerance, hyperglycemia and, occasionally, overt diabetes. Understanding the mechanisms behind these metabolic disorders could improve the management of glucose homeostasis in patients undergoing GC treatment. For this purpose, adult rats were treated with a daily injection of dexamethasone (1 mg/kg b.w., i.p.) (DEX) or saline as a control for 5 consecutive days. The DEX rats developed IR, augmented glycemia, hyperinsulinemia and hyperglucagonemia. Treatment of the DEX rats with a glucagon receptor antagonist normalized their blood glucose level. The characteristic inhibitory effect of glucose on glucagon secretion was impaired in the islets of the DEX rats, while no direct effects were found on alpha-cells in islets that were incubated with DEX in vitro. A higher proportion of docked secretory granules was found in the DEX alpha-cells as well as a trend towards increased alpha-cell mass. Additionally, insulin secretion in the presence of glucagon was augmented in the islets of the DEX rats, which was most likely due to their higher glucagon receptor content. We also found that the enzyme 11 beta HSD-1, which participates in GC metabolism, contributed to the insulin hypersecretion in the DEX rats under basal glucose conditions. Altogether, we showed that GC treatment induces hyperglucagonemia, which contributes to an imbalance in glucose homeostasis and compensatory beta-cell hypersecretion. This hyperglucagonemia may result from altered alpha-cell function and, likely, alpha-cell mass. Additionally, blockage of the glucagon receptor seems to be effective in preventing the elevation in blood glucose levels induced by GC administration.	[Rafacho, Alex; Goncalves-Neto, Luiz M.] Fed Univ Santa Catarina UFSC, Ctr Biol Sci, Dept Physiol Sci, Florianopolis, SC, Brazil; [Santos-Silva, Junia C.; Carneiro, Everardo M.; Boschero, Antonio C.] State Univ Campinas UNICAMP, Inst Biol, Dept Struct & Funct Biol, Campinas, SP, Brazil; [Santos-Silva, Junia C.; Carneiro, Everardo M.; Boschero, Antonio C.] State Univ Campinas UNICAMP, OCRC, Campinas, SP, Brazil; [Alonso-Magdalena, Paloma; Merino, Beatriz; Nadal, Angel; Quesada, Ivan] Miguel Hernandez Univ, Inst Bioengn, Elche, Spain; [Alonso-Magdalena, Paloma; Merino, Beatriz; Nadal, Angel; Quesada, Ivan] Miguel Hernandez Univ, Biomed Res Ctr Diabet & Associated Metab Disorder, Elche, Spain; [Taboga, Sebastiao R.] Sao Paulo State Univ UNESP, Dept Biol, Inst Biosci Humanities & Exact Sci, Sao Jose Do Rio Preto, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidad Miguel Hernandez de Elche; Universidad Miguel Hernandez de Elche; Universidade Estadual Paulista	Rafacho, A (corresponding author), Fed Univ Santa Catarina UFSC, Ctr Biol Sci, Dept Physiol Sci, Florianopolis, SC, Brazil.	alex.rafacho@ufsc.br; ivanq@umh.es	Alonso-Magdalena, Paloma/AAH-2076-2021; Ivan, Quesada/P-6541-2014; Carneiro, Everardo/D-4758-2012; Rafacho, Alex/O-8609-2016; Nadal, Angel/G-6721-2014; MERINO, BEATRIZ/V-4121-2017; Silva, Junia C Santos/E-5052-2015; Boschero, Antonio/O-7525-2014	Ivan, Quesada/0000-0002-9808-514X; Rafacho, Alex/0000-0002-8637-6097; Nadal, Angel/0000-0003-4178-2152; MERINO, BEATRIZ/0000-0002-4761-3977; Silva, Junia C Santos/0000-0002-8667-8140; Boschero, Antonio/0000-0003-3829-8570; ALONSO MAGDALENA, PALOMA/0000-0003-1065-5388; Taboga, Sebastiao/0000-0002-0970-4288	FAPESP; CNPq [471397/2011-3]; Instituto Nacional de Ciencia e Tecnologia: Obesidade e Diabetes; Ministerio de Ciencia e Innovacion [BFU2010-21773, BFU2011-28358]; Generalitat Valenciana [PROMETEO/2011/080, ACOMP/2013/022]; European Foundation for the Study of Diabetes	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia: Obesidade e Diabetes; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); European Foundation for the Study of Diabetes	GRANTS: This study was supported by grants from the Brazilian foundations FAPESP, CNPq (471397/2011-3), and the Instituto Nacional de Ciencia e Tecnologia: Obesidade e Diabetes, the Spanish foundations the Ministerio de Ciencia e Innovacion (BFU2010-21773; BFU2011-28358) and the Generalitat Valenciana (PROMETEO/2011/080; ACOMP/2013/022), and the European Foundation for the Study of Diabetes (EFSD/BI Basic Programme and the Albert Renold Travel Fellowships for Young Scientists). CIBERDEM is an initiative of the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaudry JL, 2013, ENDOCRINOLOGY, V154, P3197, DOI 10.1210/en.2012-2114; Cummings BP, 2013, J ENDOCRINOL, V216, P207, DOI 10.1530/JOE-12-0459; Diederich S, 2011, HORM METAB RES, V43, P66, DOI 10.1055/s-0030-1267170; Dirlewanger M, 2000, CLIN NUTR, V19, P29, DOI 10.1054/clnu.1999.0064; Gromada J, 1997, PFLUG ARCH EUR J PHY, V434, P515, DOI 10.1007/s004240050431; Henquin JC, 2011, DIABETOLOGIA, V54, P1720, DOI 10.1007/s00125-011-2118-4; Huypens P, 2000, DIABETOLOGIA, V43, P1012, DOI 10.1007/s001250051484; Jensen DH, 2012, DIABETOLOGIA, V55, P1406, DOI 10.1007/s00125-012-2459-7; Karlsson S, 2001, PANCREAS, V22, P148, DOI 10.1097/00006676-200103000-00007; MARCO J, 1976, DIABETOLOGIA, V12, P307, DOI 10.1007/BF00420973; Marroqui L, 2012, ENDOCRINOLOGY, V153, P1663, DOI 10.1210/en.2011-1623; Meier JJ, 2011, AM J PHYSIOL-ENDOC M, V300, pE717, DOI 10.1152/ajpendo.00315.2010; Moens K, 1996, DIABETES, V45, P257, DOI 10.2337/diabetes.45.2.257; Moens K, 1998, DIABETES, V47, P66, DOI 10.2337/diabetes.47.1.66; Montanya E, 2009, METHODS MOL BIOL, V560, P137, DOI 10.1007/978-1-59745-448-3_11; Mu J, 2011, DIABETOLOGIA, V54, P2381, DOI 10.1007/s00125-011-2217-2; Nicod N, 2003, OBES RES, V11, P625, DOI 10.1038/oby.2003.90; Nunes EA, 2013, APPL PHYSIOL NUTR ME, V38, P1137, DOI 10.1139/apnm-2012-0456; Ortsater H., 2012, STATE ART THERAPEUTI, V1st, P1; Pereira CD, 2012, DIABETES OBES METAB, V14, P869, DOI 10.1111/j.1463-1326.2012.01582.x; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Quesada I, 2008, J ENDOCRINOL, V199, P5, DOI 10.1677/JOE-08-0290; Rafacho A, 2011, HORM METAB RES, V43, P275, DOI 10.1055/s-0030-1269896; Rafacho A, 2010, ACTA PHYSIOL, V200, P223, DOI 10.1111/j.1748-1716.2010.02146.x; Rafacho A, 2010, ENDOCRINOLOGY, V151, P85, DOI 10.1210/en.2009-0704; Rafacho A, 2009, AM J PHYSIOL-ENDOC M, V296, pE681, DOI 10.1152/ajpendo.90931.2008; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Schneiter P, 1998, AM J PHYSIOL-ENDOC M, V275, pE806, DOI 10.1152/ajpendo.1998.275.5.E806; Soriano S, 2010, ENDOCRINOLOGY, V151, P3543, DOI 10.1210/en.2010-0008; Swali A, 2008, DIABETOLOGIA, V51, P2003, DOI 10.1007/s00125-008-1137-2; Turban S, 2012, DIABETES, V61, P642, DOI 10.2337/db11-1054; UNSON CG, 1989, PEPTIDES, V10, P1171, DOI 10.1016/0196-9781(89)90010-7; van Raalte DH, 2009, EUR J CLIN INVEST, V39, P81, DOI 10.1111/j.1365-2362.2008.02067.x; van Raalte DH, 2010, EUR J ENDOCRINOL, V162, P729, DOI 10.1530/EJE-09-1034; WAJNGOT A, 1992, P NATL ACAD SCI USA, V89, P6035, DOI 10.1073/pnas.89.13.6035; WISE JK, 1973, J CLIN INVEST, V52, P2774, DOI 10.1172/JCI107473	37	28	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93531	10.1371/journal.pone.0093531	http://dx.doi.org/10.1371/journal.pone.0093531			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705399	Green Published, Green Submitted, gold			2022-12-25	WOS:000334107500041
J	Cartellieri, M; Koristka, S; Arndt, C; Feldmann, A; Stamova, S; von Bonin, M; Topfer, K; Kruger, T; Geib, M; Michalk, I; Temme, A; Bornhauser, M; Lindemann, D; Ehninger, G; Bachmann, MP				Cartellieri, Marc; Koristka, Stefanie; Arndt, Claudia; Feldmann, Anja; Stamova, Slava; von Bonin, Malte; Toepfer, Katrin; Krueger, Thomas; Geib, Mathias; Michalk, Irene; Temme, Achim; Bornhaeser, Martin; Lindemann, Dirk; Ehninger, Gerhard; Bachmann, Michael P.			A Novel Ex Vivo Isolation and Expansion Procedure for Chimeric Antigen Receptor Engrafted Human T Cells	PLOS ONE			English	Article							CD28 COSTIMULATION; ADOPTIVE TRANSFER; TUMOR-CELLS; CD8(+); LYMPHOCYTES; CANCER; IMMUNOTHERAPY; CD4(+); PROLIFERATION; REDIRECTION	Genetically engineered T lymphocytes are a promising option for cancer therapy. Prior to adoptive transfer they have to be expanded in vitro to reach therapeutically sufficient numbers. So far, no universal method exists for selective in vitro expansion of engineered T lymphocytes. In order to overcome this problem and for proof of concept we incorporated a novel unique peptide sequence of ten amino acids as epitope (E-Tag) into the binding domains of two novel chimeric antigen receptors (ECARs) directed against either prostate stem cell antigen (PSCA) for the treatment of prostate cancer (PCa) or CD33 for the treatment of acute myeloide leukemia (AML). The epitope tag then was utilized for expanding ECAR engrafted T cells by triggering the modified T cells via a monoclonal antibody directed against the E-Tag (Emab). Moreover, the E-Tag served as an efficient selection epitope for immunomagnetic isolation of modified T cells to high purity. ECAR engrafted T cells were fully functional and mediated profound anti-tumor effects in the respective models of PCa or AML both in vitro and in vivo. The method can be integrated straightforward into clinical protocols to improve therapeutic efficiency of tumor treatment with CAR modified T lymphocytes.	[Cartellieri, Marc; Koristka, Stefanie; Arndt, Claudia; Feldmann, Anja; Stamova, Slava; Krueger, Thomas; Geib, Mathias; Michalk, Irene; Bachmann, Michael P.] Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Immunol, Dresden, Germany; [Cartellieri, Marc; Feldmann, Anja; Bachmann, Michael P.] Helmholtz Zentrum Dresden Rossendorf, Inst Radiopharmaceut Canc Res, Dept Radioimmunol, Dresden, Germany; [von Bonin, Malte; Bornhaeser, Martin; Ehninger, Gerhard] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Med Clin & Polyclin, Dresden, Germany; [Toepfer, Katrin; Temme, Achim] Tech Univ Dresden, Med Fac Carl Gustav Carus, Dept Neurosurg, Sect Expt Neurosurg & Tumor Immunol, Dresden, Germany; [Lindemann, Dirk] Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Virol, Dresden, Germany; [Bornhaeser, Martin; Lindemann, Dirk; Bachmann, Michael P.] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden	Bachmann, MP (corresponding author), Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Immunol, Dresden, Germany.	michael.bachman@tu-dresden.de	Lindemann, Dirk/H-5857-2013; Bachmann, Michael/AAA-5153-2020; Cartellieri, Marc/M-3281-2013; Feldmann, Anja/AAI-1809-2020; Arndt, Claudia/F-1648-2019; Cartellieri, Marc/AAL-8197-2020; Bachmann, Michael P/E-8850-2010	Lindemann, Dirk/0000-0002-0320-4223; Bachmann, Michael/0000-0002-8029-5755; Cartellieri, Marc/0000-0002-4672-3963; Feldmann, Anja/0000-0001-5099-2448; Arndt, Claudia/0000-0002-1285-5052; Bachmann, Michael P/0000-0002-8029-5755; Stamova, Slava/0000-0002-2543-1523; von Bonin, Malte/0000-0002-2995-3230	Medical faculty of the TU Dresden; Center for Regenerative Therapies Dresden (CRTD), TU Dresden, Dresden, Germany	Medical faculty of the TU Dresden; Center for Regenerative Therapies Dresden (CRTD), TU Dresden, Dresden, Germany	This study was supported by grants of the Medical faculty of the TU Dresden to Marc Cartellieri and seed grants given to Michael Bachmann by the Center for Regenerative Therapies Dresden (CRTD), TU Dresden, Dresden, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt C, 2014, LEUKEMIA, V28, P59, DOI 10.1038/leu.2013.243; Arndt C, 2013, LEUKEMIA, V27, P964, DOI 10.1038/leu.2013.18; Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; Brenner MK, 2010, CURR OPIN IMMUNOL, V22, P251, DOI 10.1016/j.coi.2010.01.020; Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Brentjens RJ, 2003, NAT MED, V9, P279, DOI 10.1038/nm827; Cartellieri M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/956304; Dannull J, 2000, CANCER RES, V60, P5522; Davila ML, 2012, ONCOIMMUNOLOGY, V1, P1577, DOI 10.4161/onci.22524; De Oliveira SN, 2013, HUM GENE THER, V24, P824, DOI 10.1089/hum.2012.202; Elinav E, 2008, GASTROENTEROLOGY, V134, P2014, DOI 10.1053/j.gastro.2008.02.060; Elinav E, 2009, GASTROENTEROLOGY, V136, P1721, DOI 10.1053/j.gastro.2009.01.049; Feldmann A, 2012, J IMMUNOL, V189, P3249, DOI 10.4049/jimmunol.1200341; Feldmann A, 2011, PROSTATE, V71, P998, DOI 10.1002/pros.21315; Finney HM, 2004, J IMMUNOL, V172, P104, DOI 10.4049/jimmunol.172.1.104; Finney HM, 1998, J IMMUNOL, V161, P2791; Grigorian A, 2009, IMMUNOL REV, V230, P232, DOI 10.1111/j.1600-065X.2009.00796.x; Ho YP, 2012, MOL THER, V20, P1167, DOI 10.1038/mt.2012.61; Hollyman D, 2009, J IMMUNOTHER, V32, P169, DOI 10.1097/CJI.0b013e318194a6e8; Hombach A, 2001, J IMMUNOL, V167, P6123, DOI 10.4049/jimmunol.167.11.6123; Hombach AA, 2013, CURR MOL MED, V13, P1079; Hombach AA, 2009, GENE THER, V16, P1088, DOI 10.1038/gt.2009.75; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kiessling A, 2008, EUR UROL, V53, P694, DOI 10.1016/j.eururo.2007.11.043; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Kloss CC, 2013, NAT BIOTECHNOL, V31, P71, DOI 10.1038/nbt.2459; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Koehler H, 2007, CANCER RES, V67, P2265, DOI 10.1158/0008-5472.CAN-06-2098; Koristka S, 2013, J AUTOIMMUN, V42, P105, DOI 10.1016/j.jaut.2013.01.002; Maher J, 2002, NAT BIOTECHNOL, V20, P70, DOI 10.1038/nbt0102-70; Maus MV, 2002, NAT BIOTECHNOL, V20, P143, DOI 10.1038/nbt0202-143; Milone MC, 2009, MOL THER, V17, P1453, DOI 10.1038/mt.2009.83; Mitsuyasu RT, 2000, BLOOD, V96, P785, DOI 10.1182/blood.V96.3.785.015k10_785_793; Morgenroth A, 2007, PROSTATE, V67, P1121, DOI 10.1002/pros.20608; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Rasmussen AM, 2010, J IMMUNOL METHODS, V355, P52, DOI 10.1016/j.jim.2010.02.004; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; ROBERTS MR, 1994, BLOOD, V84, P2878; Savoldo B, 2011, J CLIN INVEST, V121, P1822, DOI 10.1172/JCI46110; Stamova S, 2011, LEUKEMIA, V25, P1053, DOI 10.1038/leu.2011.42; Stamova S, 2011, MOL IMMUNOL, V49, P474, DOI 10.1016/j.molimm.2011.09.019; Stirnnagel K, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-45; Suerth JD, 2012, CURR OPIN IMMUNOL, V24, P598, DOI 10.1016/j.coi.2012.08.007; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Themeli M, 2013, NAT BIOTECHNOL, V31, P928, DOI 10.1038/nbt.2678; Topfer K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/918471; Turtle CJ, 2012, CURR OPIN IMMUNOL, V24, P633, DOI 10.1016/j.coi.2012.06.004; von Bonin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060680; Walter RB, 2012, BLOOD, V119, P6198, DOI 10.1182/blood-2011-11-325050; Wang XL, 2011, BLOOD, V118, P1255, DOI 10.1182/blood-2011-02-337360	50	33	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93745	10.1371/journal.pone.0093745	http://dx.doi.org/10.1371/journal.pone.0093745			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699869	Green Submitted, Green Published, gold			2022-12-25	WOS:000334105000098
J	Dietz, JA; Maes, ME; Huang, S; Yandell, BS; Schlamp, CL; Montgomery, AD; Allingham, RR; Hauser, MA; Nickells, RW				Dietz, Joel A.; Maes, Margaret E.; Huang, Shuang; Yandell, Brian S.; Schlamp, Cassandra L.; Montgomery, Angela D.; Allingham, R. Rand; Hauser, Michael A.; Nickells, Robert W.			Spink2 Modulates Apoptotic Susceptibility and Is a Candidate Gene in the Rgcs1 QTL That Affects Retinal Ganglion Cell Death after Optic Nerve Damage	PLOS ONE			English	Article							SERINE-PROTEASE INHIBITOR; OPEN-ANGLE GLAUCOMA; IRIS ATROPHY; DBA/2J MICE; EXPRESSION; OPTINEURIN; MUTATIONS; BAX; NEURODEGENERATION; INDUCTION	The Rgcs1 quantitative trait locus, on mouse chromosome 5, influences susceptibility of retinal ganglion cells to acute damage of the optic nerve. Normally resistant mice (DBA/2J) congenic for the susceptible allele from BALB/cByJ mice exhibit susceptibility to ganglion cells, not only in acute optic nerve crush, but also to chronic inherited glaucoma that is characteristic of the DBA/2J strain as they age. SNP mapping of this QTL has narrowed the region of interest to 1 Mb. In this region, a single gene (Spink2) is the most likely candidate for this effect. Spink2 is expressed in retinal ganglion cells and is increased after optic nerve damage. This gene is also polymorphic between resistant and susceptible strains, containing a single conserved amino acid change (threonine to serine) and a 220 bp deletion in intron 1 that may quantitatively alter endogenous expression levels between strains. Overexpression of the different variants of Spink2 in D407 tissue culture cells also increases their susceptibility to the apoptosis-inducing agent staurosporine in a manner consistent with the differential susceptibility between the DBA/2J and BALB/cByJ strains.	[Dietz, Joel A.; Maes, Margaret E.; Schlamp, Cassandra L.; Montgomery, Angela D.; Nickells, Robert W.] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI 53706 USA; [Huang, Shuang; Yandell, Brian S.] Univ Wisconsin, Dept Biostat, Madison, WI USA; [Allingham, R. Rand; Hauser, Michael A.] Duke Univ, Med Ctr, Dept Med, Ctr Human Genet, Durham, NC 27710 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Duke University	Nickells, RW (corresponding author), Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI 53706 USA.	nickells@wisc.edu		Maes, Margaret/0000-0001-9642-1085	National Eye Institute [R01EY018869, P30 EY016665]; Research to Prevent Blindness, Inc.; NATIONAL EYE INSTITUTE [P30EY016665, R01EY018869] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Eye Institute grants R01EY018869 (RWN) and vision core grant P30 EY016665, and an unrestricted grant to the Department of Ophthalmology and Visual Sciences at the University of Wisconsin from Research to Prevent Blindness, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agam A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012839; Alward WLM, 2003, AM J OPHTHALMOL, V136, P904, DOI 10.1016/S0002-9394(03)00577-4; Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; Burdon KP, 2011, NAT GENET, V43, P574, DOI 10.1038/ng.824; Burgoyne CF, 2011, EXP EYE RES, V93, P120, DOI 10.1016/j.exer.2010.09.005; Chang B, 1999, NAT GENET, V21, P405, DOI 10.1038/7741; Chang LK, 2002, BIOCHIMIE, V84, P223, DOI 10.1016/S0300-9084(02)01372-X; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; Chen T, 2009, PROTEINS, V77, P209, DOI 10.1002/prot.22432; Chera S, 2006, J CELL SCI, V119, P846, DOI 10.1242/jcs.02807; Chera S, 2009, BBA-MOL CELL RES, V1793, P1432, DOI 10.1016/j.bbamcr.2009.03.010; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; Dietz JA, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-74; Ding C, 2011, EXP EYE RES, V92, P512, DOI 10.1016/j.exer.2011.03.016; Fingert JH, 2011, EYE, V25, P587, DOI 10.1038/eye.2011.97; Fingert JH, 2011, HUM MOL GENET, V20, P2482, DOI 10.1093/hmg/ddr123; Howell GR, 2007, J CELL BIOL, V179, P1523, DOI 10.1083/jcb.200706181; John SWM, 1998, INVEST OPHTH VIS SCI, V39, P951; Johnson EC, 2007, INVEST OPHTH VIS SCI, V48, P3161, DOI 10.1167/iovs.06-1282; Kawase K, 2012, EXP EYE RES, V96, P178, DOI 10.1016/j.exer.2011.12.021; Korac J, 2013, J CELL SCI, V126, P580, DOI 10.1242/jcs.114926; LANDER ES, 1989, GENETICS, V121, P185; Lee B, 2011, J BIOL CHEM, V286, P29108, DOI 10.1074/jbc.M111.244905; Leung YF, 2003, INVEST OPHTH VIS SCI, V44, P3880, DOI 10.1167/iovs.02-0693; Li Y, 1999, INVEST OPHTH VIS SCI, V40, P1004; Li Y, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-19; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; Libby RT, 2005, PLOS GENET, V1, P17, DOI 10.1371/journal.pgen.0010004; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Nedelsky NB, 2008, BBA-MOL BASIS DIS, V1782, P691, DOI 10.1016/j.bbadis.2008.10.002; Nickells RW, 2012, ANNU REV NEUROSCI, V35, P153, DOI 10.1146/annurev.neuro.051508.135728; Ohmuraya M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00126; Ohmuraya M, 2011, EXP ANIM TOKYO, V60, P433; Ohta T, 2002, J CELL BIOL, V156, P87, DOI 10.1083/jcb.200108088; Pelzel HR, 2012, INVEST OPHTH VIS SCI, V53, P1428, DOI 10.1167/iovs.11-8872; Pelzel HR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-62; QUIGLEY HA, 1995, INVEST OPHTH VIS SCI, V36, P774; Ramdas WD, 2011, HUM MOL GENET, V20, P2464, DOI 10.1093/hmg/ddr120; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Rodriguez-Muela N, 2012, CELL DEATH DIFFER, V19, P162, DOI 10.1038/cdd.2011.88; Schlamp CL, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-66; Schlamp CL, 2013, MOL VIS, V19, P1387; Schlamp CT, 1996, J NEUROSCI, V16, P2164; Semaan SJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-554; Sternberg C, 2010, BRAZ J MED BIOL RES, V43, P950, DOI 10.1590/S0100-879X2010001000005; Weidberg H, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002355; Weishaupt JH, 2005, J MOL NEUROSCI, V26, P17, DOI 10.1385/JMN:26:1:017; Wiggs JL, 2007, ARCH OPHTHALMOL-CHIC, V125, P30, DOI 10.1001/archopht.125.1.30; Wiggs JL, 2012, PLOS GENET, V8, P413, DOI 10.1371/journal.pgen.1002654; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281	50	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93564	10.1371/journal.pone.0093564	http://dx.doi.org/10.1371/journal.pone.0093564			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699552	Green Published, Green Submitted, gold			2022-12-25	WOS:000334105000069
J	Iida, R; Welner, RS; Zhao, WK; Alberola-lla, J; Medina, KL; Zhao, ZZJ; Kincade, PW				Iida, Ryuji; Welner, Robert S.; Zhao, Wanke; Alberola-lla, Josee; Medina, Kay L.; Zhao, Zhizhuang Joe; Kincade, Paul W.			Stem and Progenitor Cell Subsets Are Affected by JAK2 Signaling and Can Be Monitored by Flow Cytometry	PLOS ONE			English	Article							VERA-LIKE DISEASE; HEMATOPOIETIC STEM; POLYCYTHEMIA-VERA; MYELOPROLIFERATIVE NEOPLASMS; SELF-RENEWAL; BONE-MARROW; IN-VIVO; ESSENTIAL THROMBOCYTHEMIA; JAK2(V617F) EXPRESSION; ADAPTER PROTEIN	Although extremely rare, hematopoietic stem cells (HSCs) are divisible into subsets that differ with respect to differentiation potential and cell surface marker expression. For example, we recently found that CD86(-) CD150(+) CD48(-) HSCs have limited potential for lymphocyte production. This could be an important new tool for studying hematological abnormalities. Here, we analyzed HSC subsets with a series of stem cell markers in JAK2V617F transgenic (Tg) mice, where the mutation is sufficient to cause myeloproliferative neoplasia with lymphocyte deficiency. Total numbers of HSC were elevated 3 to 20 fold in bone marrow of JAK2V617F mice. Careful analysis suggested the accumulation involved multiple HSC subsets, but particularly those characterized as CD150(HI) CD86(-) CD18(Lo)CD41(+) and excluding Hoechst dye. Real-Time PCR analysis of their HSC revealed that the erythropoiesis associated gene transcripts Gata1, Klf1 and Epor were particularly high. Flow cytometry analyses based on two differentiation schemes for multipotent progenitors (MPP) also suggested alteration by JAK2 signals. The low CD86 on HSC and multipotent progenitors paralleled the large reductions we found in lymphoid progenitors, but the few that were produced functioned normally when sorted and placed in culture. Either of two HSC subsets conferred disease when transplanted. Thus, flow cytometry can be used to observe the influence of abnormal JAK2 signaling on stem and progenitor subsets. Markers that similarly distinguish categories of human HSCs might be very valuable for monitoring such conditions. They could also serve as indicators of HSC fitness and suitability for transplantation.	[Iida, Ryuji; Alberola-lla, Josee; Kincade, Paul W.] Oklahoma Med Res Fdn, Immunobiol & Canc Program, Oklahoma City, OK 73104 USA; [Welner, Robert S.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Zhao, Wanke; Zhao, Zhizhuang Joe] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; [Medina, Kay L.] Mayo Clin, Dept Immunol, Rochester, MN USA	Oklahoma Medical Research Foundation; Harvard University; Beth Israel Deaconess Medical Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Mayo Clinic	Kincade, PW (corresponding author), Oklahoma Med Res Fdn, Immunobiol & Canc Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	kincade@omrf.org	Hofer, Benedikt/G-2183-2017	Hofer, Benedikt/0000-0002-4787-3373; alberola-ila, Jose/0000-0003-2439-553X	National Institutes of Health [AI020069, HL107138, R01 HL096108, HL079441]; Oklahoma Center for Adult Stem Cell Research [4340-04-09-0]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096108, R01HL107138, R01HL079441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020069, R01AI020069] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Center for Adult Stem Cell Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants AI020069, and HL107138 (PWK); R01 HL096108 (KLM); HL079441 (ZJZ) from the National Institutes of Health and 4340-04-09-0 from the Oklahoma Center for Adult Stem Cell Research. PWK holds the William H. and Rita Bell Endowed Chair in Biomedical Research and is Scientific Director, Oklahoma Center for Adult Stem Cell Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Akada H, 2010, BLOOD, V115, P3589, DOI 10.1182/blood-2009-04-215848; Baran-Marszak F, 2010, BLOOD, V116, P5961, DOI 10.1182/blood-2009-12-256768; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Benz C, 2012, CELL STEM CELL, V10, P273, DOI 10.1016/j.stem.2012.02.007; Bersenev A, 2010, J CLIN INVEST, V120, P2058, DOI 10.1172/JCI42032; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Chen E, 2012, IMMUNITY, V36, P529, DOI 10.1016/j.immuni.2012.03.017; Chen E, 2010, CANCER CELL, V18, P524, DOI 10.1016/j.ccr.2010.10.013; Copley MR, 2012, CELL STEM CELL, V10, P690, DOI 10.1016/j.stem.2012.05.006; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Esplin BL, 2011, J IMMUNOL, V186, P5367, DOI 10.4049/jimmunol.1003438; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Gekas C, 2013, BLOOD, V121, P4463, DOI 10.1182/blood-2012-09-457929; Gerrits A, 2010, BLOOD, V115, P2610, DOI 10.1182/blood-2009-06-229757; Gery S, 2009, J LEUKOCYTE BIOL, V85, P957, DOI 10.1189/jlb.0908575; Hasan S, 2013, BLOOD, V122, P1464, DOI 10.1182/blood-2013-04-498956; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Kent DG, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001576; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kimura S, 1998, P NATL ACAD SCI USA, V95, P1195, DOI 10.1073/pnas.95.3.1195; Lacout C, 2006, BLOOD, V108, P1652, DOI 10.1182/blood-2006-02-002030; Li J, 2011, DIS MODEL MECH, V4, P311, DOI 10.1242/dmm.006817; Li JA, 2010, BLOOD, V116, P1528, DOI 10.1182/blood-2009-12-259747; Liu F, 2011, CANCER CELL, V19, P283, DOI 10.1016/j.ccr.2010.12.020; Lu R, 2011, NAT BIOTECHNOL, V29, P928, DOI 10.1038/nbt.1977; Marty C, 2010, BLOOD, V116, P783, DOI 10.1182/blood-2009-12-257063; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Mullally A, 2013, BLOOD, V121, P3692, DOI 10.1182/blood-2012-05-432989; Mullally A, 2012, BLOOD, V120, P166, DOI 10.1182/blood-2012-01-402396; Mullally A, 2010, CANCER CELL, V17, P584, DOI 10.1016/j.ccr.2010.05.015; Muller-Sieburg CE, 2002, BLOOD, V100, P1302, DOI 10.1182/blood.V100.4.1302.h81602001302_1302_1309; Muller-Sieburg CE, 2012, BLOOD, V119, P3900, DOI 10.1182/blood-2011-12-376749; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; Pecquet C, 2012, BLOOD, V119, P4625, DOI 10.1182/blood-2011-08-372524; Quintas-Cardama A, 2013, BLOOD, V122, P893, DOI 10.1182/blood-2012-07-442012; Shide K, 2008, LEUKEMIA, V22, P87, DOI 10.1038/sj.leu.2405043; Shimazu T, 2012, BLOOD, V119, P4889, DOI 10.1182/blood-2011-10-388736; SPANGRUDE GJ, 1993, BLOOD, V82, P3327; Sugimura R, 2012, CELL, V150, P351, DOI 10.1016/j.cell.2012.05.041; Takaki S, 2002, J EXP MED, V195, P151, DOI 10.1084/jem.20011170; Tiedt R, 2008, BLOOD, V111, P3931, DOI 10.1182/blood-2007-08-107748; Tong W, 2005, BLOOD, V105, P4604, DOI 10.1182/blood-2004-10-4093; Vainchenker W, 2011, BLOOD, V118, P1723, DOI 10.1182/blood-2011-02-292102; Van Etten RA, 2011, HAEMATOL-HEMATOL J, V96, P590, DOI 10.3324/haematol.2010.035675; Velazquez L, 2002, J EXP MED, V195, P1599, DOI 10.1084/jem.20011883; Walz C, 2012, BLOOD, V119, P3550, DOI 10.1182/blood-2011-12-397554; Weksberg DC, 2008, BLOOD, V111, P2444, DOI 10.1182/blood-2007-09-115006; Wernig G, 2006, BLOOD, V107, P4274, DOI 10.1182/blood-2005-12-4824; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Xing S, 2008, BLOOD, V111, P5109, DOI 10.1182/blood-2007-05-091579; Yan DQ, 2012, BLOOD, V119, P3539, DOI 10.1182/blood-2011-03-345215; Zaleskas VM, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000018	55	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93643	10.1371/journal.pone.0093643	http://dx.doi.org/10.1371/journal.pone.0093643			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699465	Green Submitted, gold, Green Published			2022-12-25	WOS:000334105000085
J	Kellawan, JM; Tschakovsky, ME				Kellawan, J. Mikhail; Tschakovsky, Michael E.			The Single-Bout Forearm Critical Force Test: A New Method to Establish Forearm Aerobic Metabolic Exercise Intensity and Capacity	PLOS ONE			English	Article							MUSCLE BLOOD-FLOW; CRITICAL POWER; OXYGEN-UPTAKE; RESPONSES; RELIABILITY; PERFORMANCE; ACTIVATION; CONTRACTIONS; FATIGUE; PROFILE	No non-invasive test exists for forearm exercise that allows identification of power-time relationship parameters (W', critical power) and thereby identification of the heavy-severe exercise intensity boundary and scaling of aerobic metabolic exercise intensity. The aim of this study was to develop a maximal effort handgrip exercise test to estimate forearm critical force (fCF; force analog of power) and establish its repeatability and validity. Ten healthy males (20-43 years) completed two maximal effort rhythmic handgrip exercise tests (repeated maximal voluntary contractions (MVC); 1 s contraction-2 s relaxation for 600 s) on separate days. Exercise intensity was quantified via peak contraction force and contraction impulse. There was no systematic difference between test 1 and 2 for fCF(peak force) (p = 0.11) or fCF(impulse) (p = 0.76). Typical error was small for both fCF(peak force) (15.3 N, 5.5%) and fCF(impulse) (15.7 N.s, 6.8%), and test re-test correlations were strong (fCF(peak force), r = 0.91, ICC = 0.94, p<0.01; fCF(impulse), r = 0.92, ICC = 0.95, p<0.01). Seven of ten subjects also completed time-to-exhaustion tests (TTE) at target contraction force equal to 10%<fCF(peak force) and 10%. fCF(peak force). TTE predicted by W' showed good agreement with actual TTE during the TTE tests (r = 0.97, ICC = 0.97, P<0.01; typical error 0.98 min, 12%; regression fit slope = 0.99 and y intercept not different from 0, p = 0.31). MVC did not predict fCF(peak force) (p = 0.37), fCF(impulse) (p = 0.49) or W' (p = 0.15). In conclusion, the poor relationship between MVC and fCF or W' illustrates the serious limitation of MVC in identifying metabolism-based exercise intensity zones. The maximal effort handgrip exercise test provides repeatable and valid estimates of fCF and should be used to normalize forearm aerobic metabolic exercise intensity instead of MVC.	[Kellawan, J. Mikhail; Tschakovsky, Michael E.] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada	Queens University - Canada	Tschakovsky, ME (corresponding author), Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada.	mt29@queensu.ca	Kellawan, Jeremy Mikhail/J-3599-2019	Kellawan, Jeremy Mikhail/0000-0001-7889-8146	Natural Sciences and Engineering Council of Canada (NSERC) [250367-06]; Canada Foundation for Innovation; Ontario Innovation Trust Infrastructure Grants; Queen's University Chancellor's Research Award; Ontario Graduate Scholarship; Ontario Graduate Scholarship in Science and Technology; R.S. McLaughlin Fellowship	Natural Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Innovation Trust Infrastructure Grants; Queen's University Chancellor's Research Award; Ontario Graduate Scholarship(Ontario Graduate Scholarship); Ontario Graduate Scholarship in Science and Technology; R.S. McLaughlin Fellowship	M.E. Tschakovsky was funded by Natural Sciences and Engineering Council of Canada (NSERC) Discovery Grant 250367-06, Canada Foundation for Innovation and Ontario Innovation Trust Infrastructure Grants, Queen's University Chancellor's Research Award. J. Mikhail Kellawan was funded by the Ontario Graduate Scholarship, the Ontario Graduate Scholarship in Science and Technology, and the R.S. McLaughlin Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker T, 2006, EXP PHYSIOL, V91, P621, DOI 10.1113/expphysiol.2005.032789; Bland JM, 2010, INT J NURS STUD, V47, P931, DOI 10.1016/j.ijnurstu.2009.10.001; Burnley M, 2006, MED SCI SPORT EXER, V38, P1995, DOI 10.1249/01.mss.0000232024.06114.a6; Burnley M, 2009, J APPL PHYSIOL, V106, P975, DOI 10.1152/japplphysiol.91474.2008; Casey DP, 2011, J APPL PHYSIOL, V110, P687, DOI 10.1152/japplphysiol.00787.2010; Casey DP, 2009, J APPL PHYSIOL, V107, P429, DOI 10.1152/japplphysiol.00331.2009; Crecelius AR, 2011, J PHYSL, V589, P3871; Dekerle J, 2012, EUR J APPL PHYSIOL, V112, P327, DOI 10.1007/s00421-011-1979-z; DiMenna FJ, 2009, J EXERC SCI FIT, V7, P67, DOI 10.1016/S1728-869X(09)60009-5; Faisal A, 2010, J PHYSIOL-LONDON, V588, P3785, DOI 10.1113/jphysiol.2010.188698; Hamann JJ, 2005, J APPL PHYSIOL, V98, P2096, DOI 10.1152/japplphysiol.00400.2004; Herbert RD, 1996, J APPL PHYSIOL, V80, P1351, DOI 10.1152/jappl.1996.80.4.1351; Hogan MC, 1998, AM J PHYSIOL-ENDOC M, V274, pE397, DOI 10.1152/ajpendo.1998.274.3.E397; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hopkins WG, 2001, SPORTS MED, V31, P211, DOI 10.2165/00007256-200131030-00005; Jeukendrup A, 1996, MED SCI SPORT EXER, V28, P266, DOI 10.1097/00005768-199602000-00017; Jones AM, 2008, AM J PHYSIOL-REG I, V294, pR585, DOI 10.1152/ajpregu.00731.2007; Jones AM, 2010, MED SCI SPORT EXER, V42, P1876, DOI 10.1249/MSS.0b013e3181d9cf7f; KENTBRAUN JA, 1993, J APPL PHYSIOL, V75, P573, DOI 10.1152/jappl.1993.75.2.573; MCLELLAN TM, 1995, CAN J APPL PHYSIOL, V20, P39, DOI 10.1139/h95-003; POOLE DC, 1988, ERGONOMICS, V31, P1265, DOI 10.1080/00140138808966766; Saugen E, 1997, EXP PHYSIOL, V82, P213, DOI 10.1113/expphysiol.1997.sp004010; Saunders NR, 2004, J APPL PHYSIOL, V97, P1143, DOI 10.1152/japplphysiol.01284.2003; Schabort EJ, 1999, J SPORT SCI, V17, P627, DOI 10.1080/026404199365650; Taylor SA, 2002, EUR J APPL PHYSIOL, V87, P43, DOI 10.1007/s00421-002-0586-4; Todd G, 2003, J PHYSIOL-LONDON, V551, P661, DOI 10.1113/jphysiol.2003.044099; Vanhatalo A, 2008, EXP PHYSIOL, V93, P383, DOI 10.1113/expphysiol.2007.039883; Vanhatalo A, 2007, MED SCI SPORT EXER, V39, P548, DOI 10.1249/mss.0b013e31802dd3e6; Vanhatalo A, 2011, INT J SPORT PHYSIOL, V6, P128, DOI 10.1123/ijspp.6.1.128; Vanhatalo A, 2010, EXP PHYSIOL, V95, P528, DOI 10.1113/expphysiol.2009.050500; Wilson GJ, 1996, SPORTS MED, V22, P19, DOI 10.2165/00007256-199622010-00003	31	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93481	10.1371/journal.pone.0093481	http://dx.doi.org/10.1371/journal.pone.0093481			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699366	Green Published, gold, Green Submitted			2022-12-25	WOS:000334105000063
J	Martini, P; Sales, G; Brugiolo, M; Gandaglia, A; Naso, F; De Pitta, C; Spina, M; Gerosa, G; Chemello, F; Romualdi, C; Cagnin, S; Lanfranchi, G				Martini, Paolo; Sales, Gabriele; Brugiolo, Mattia; Gandaglia, Alessandro; Naso, Filippo; De Pitta, Cristiano; Spina, Michele; Gerosa, Gino; Chemello, Francesco; Romualdi, Chiara; Cagnin, Stefano; Lanfranchi, Gerolamo			Tissue-Specific Expression and Regulatory Networks of Pig MicroRNAome	PLOS ONE			English	Article							SKELETAL-MUSCLE; PORCINE MICRORNAS; IDENTIFICATION; MIRNA; TRANSCRIPTOME; PREDICTION; PROFILES; CLONING; GENES; XENOTRANSPLANTATION	Background: Despite the economic and medical importance of the pig, knowledge about its genome organization, gene expression regulation, and molecular mechanisms involved in physiological processes is far from that achieved for mouse and rat, the two most used model organisms in biomedical research. MicroRNAs (miRNAs) are a wide class of molecules that exert a recognized role in gene expression modulation, but only 280 miRNAs in pig have been characterized to date. Results: We applied a novel computational approach to predict species-specific and conserved miRNAs in the pig genome, which were then subjected to experimental validation. We experimentally identified candidate miRNAs sequences grouped in high-confidence (424) and medium-confidence (353) miRNAs according to RNA-seq results. A group of miRNAs was also validated by PCR experiments. We established the subtle variability in expression of isomiRs and miRNA-miRNA star couples supporting a biological function for these molecules. Finally, miRNA and mRNA expression profiles produced from the same sample of 20 different tissue of the animal were combined, using a correlation threshold to filter miRNA-target predictions, to identify tissue-specific regulatory networks. Conclusions: Our data represent a significant progress in the current understanding of miRNAome in pig. The identification of miRNAs, their target mRNAs, and the construction of regulatory circuits will provide new insights into the complex biological networks in several tissues of this important animal model.	[Martini, Paolo; Sales, Gabriele; Brugiolo, Mattia; De Pitta, Cristiano; Chemello, Francesco; Romualdi, Chiara; Cagnin, Stefano; Lanfranchi, Gerolamo] Univ Padua, Dept Biol, Padua, Italy; [Martini, Paolo; Brugiolo, Mattia; Cagnin, Stefano; Lanfranchi, Gerolamo] Univ Padua, CRIBI Biotechnol Ctr, Padua, Italy; [Gandaglia, Alessandro; Naso, Filippo; Gerosa, Gino] Univ Padua, Dept Cardiac Thorac & Vasc Sci, Padua, Italy; [Spina, Michele] Univ Padua, Dept Biomed Sci, Padua, Italy	University of Padua; University of Padua; University of Padua; University of Padua	Cagnin, S (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	stefano.cagnin@unipd.it; gerolamo.lanfranchi@unipd.it	Gerosa, Gino/M-8106-2014; cagnin, stefano/E-9095-2011; Romualdi, Chiara/K-1132-2016; Spina, Michele/ABE-6014-2020; Martini, Paolo/AAG-7398-2020; Chemello, Francesco/ABB-3801-2020; De Pitta, Cristiano/AAY-7302-2020; Sales, Gabriele/K-5065-2016	Gerosa, Gino/0000-0002-6261-699X; cagnin, stefano/0000-0001-7271-4625; Romualdi, Chiara/0000-0003-4792-9047; Spina, Michele/0000-0001-6576-8182; Martini, Paolo/0000-0002-0146-1031; De Pitta, Cristiano/0000-0001-8013-8162; Naso, Filippo/0000-0002-8198-8799; Sales, Gabriele/0000-0003-2078-5661; Chemello, Francesco/0000-0002-3877-527X; Gandaglia, Alessandro/0000-0002-0227-5257	Regione Veneto; Ricerca Sanitaria Finalizzata [RSF 286/08]; Fondazione della Cassa di Risparmio di Padova e Rovigo	Regione Veneto(Regione Veneto); Ricerca Sanitaria Finalizzata(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF)); Fondazione della Cassa di Risparmio di Padova e Rovigo	This work was supported by a grant from Regione Veneto, Ricerca Sanitaria Finalizzata (RSF 286/08) to GG and by a grant from the Fondazione della Cassa di Risparmio di Padova e Rovigo (Excellence project 2010-2011) to GL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058306; Alexiou P, 2009, BIOINFORMATICS, V25, P3049, DOI 10.1093/bioinformatics/btp565; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; [Anonymous], 2005, MCGRAW HILL CONCISE; Berezikov E, 2006, GENOME RES, V16, P1289, DOI 10.1101/gr.5159906; Biscontin A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-44; Bissels U, 2009, RNA, V15, P2375, DOI 10.1261/rna.1754109; Brattelid T, 2011, PHYSIOL GENOMICS, V43, P604, DOI 10.1152/physiolgenomics.00131.2010; Cagnin S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-13; Chen CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-448; Cox MB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012132; Curry E, 2011, THERIOGENOLOGY, V76, P1532, DOI 10.1016/j.theriogenology.2011.06.025; Dawson HD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-332; Dudley AM, 2002, P NATL ACAD SCI USA, V99, P7554, DOI 10.1073/pnas.112683499; Ekser B, 2009, TRANSPL IMMUNOL, V21, P87, DOI 10.1016/j.trim.2008.10.005; Fairbairn L, 2013, J IMMUNOL, V190, P6389, DOI 10.4049/jimmunol.1300365; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Fosse J, 2009, ZOONOSES PUBLIC HLTH, V56, P429, DOI 10.1111/j.1863-2378.2008.01185.x; Foucar K., 2010, BONE MARROW PATHOLOG, V3rd ed; Freeman TC, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-90; Granada JF, 2009, EUROINTERVENTION, V5, P140, DOI 10.4244/EIJV5I1A22; Guo L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011387; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Helvik SA, 2007, BIOINFORMATICS, V23, P142, DOI 10.1093/bioinformatics/btl570; Hofacker IL, 2004, BIOINFORMATICS, V20, P186, DOI 10.1093/bioinformatics/btg388; Huang PL, 2009, TRENDS ENDOCRIN MET, V20, P295, DOI 10.1016/j.tem.2009.03.005; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Hulst M, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-18; Kadner A, 2000, EUR J CARDIO-THORAC, V17, P474, DOI 10.1016/S1010-7940(00)00362-6; Kikuchi K, 2012, ANNU REV CELL DEV BI, V28, P719, DOI 10.1146/annurev-cellbio-101011-155739; Kim HJ, 2006, GENOME, V49, P1283, DOI 10.1139/G06-120; Kim J, 2008, MAMM GENOME, V19, P570, DOI 10.1007/s00335-008-9111-3; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kragh PM, 2009, TRANSGENIC RES, V18, P545, DOI 10.1007/s11248-009-9245-4; Kronick MN, 2004, EXPERT REV PROTEOMIC, V1, P19, DOI 10.1586/14789450.1.1.19; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052256; Li HY, 2012, ANIM GENET, V43, P704, DOI 10.1111/j.1365-2052.2012.02332.x; Li HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024883; Li MT, 2011, INT J INNOV COMPUT I, V7, P1055; Li MZ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1854; Li MZ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015168, 10.1371/journal.pone.0011541]; Lian CJ, 2012, FEBS J, V279, P964, DOI 10.1111/j.1742-4658.2012.08480.x; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Liu YK, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-7; Lu YJ, 2010, CIRCULATION, V122, P2378, DOI 10.1161/CIRCULATIONAHA.110.958967; Luo LF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011744; Ma YD, 2013, BIOCHEM PHARMACOL, V85, P223, DOI 10.1016/j.bcp.2012.10.025; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Martini P, 2013, INT J MOL SCI, V14, P23160, DOI 10.3390/ijms141123160; Maxmen A, 2012, NATURE, V486, P453, DOI 10.1038/486453a; Mayr JA, 2007, AM J HUM GENET, V80, P478, DOI 10.1086/511788; McDaneld TG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042039; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; McGregor CGA, 2011, J THORAC CARDIOV SUR, V141, P269, DOI 10.1016/j.jtcvs.2010.08.064; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Nelson PT, 2004, NAT METHODS, V1, P155, DOI 10.1038/NMETH717; Nielsen M, 2010, ANIM GENET, V41, P159, DOI 10.1111/j.1365-2052.2009.01981.x; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Podolska A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014494; Martins RP, 2013, DEV COMP IMMUNOL, V41, P100, DOI 10.1016/j.dci.2013.04.020; Rajani R, 2007, J HEART VALVE DIS, V16, P519; Reddy AM, 2008, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-65; Risso D, 2009, BIOINFORMATICS, V25, P2685, DOI 10.1093/bioinformatics/btp443; Ross JW, 2012, INVEST OPHTH VIS SCI, V53, P501, DOI 10.1167/iovs.11-8784; Sales G, 2010, NUCLEIC ACIDS RES, V38, pW352, DOI 10.1093/nar/gkq423; Sandrin MS, 2001, J CARDIAC SURG, V16, P448, DOI 10.1111/j.1540-8191.2001.tb00549.x; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharbati S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-275; Siengdee P, 2013, ANIM GENET, V44, P398, DOI 10.1111/age.12032; Stangl K, 2002, BIOCHEM BIOPH RES CO, V291, P542, DOI 10.1006/bbrc.2002.6476; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Suzuki Y, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/195483; Timoneda O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055402; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Valdes-Gonzalez RA, 2005, EUR J ENDOCRINOL, V153, P419, DOI 10.1530/eje.1.01982; WU CI, 1985, P NATL ACAD SCI USA, V82, P1741, DOI 10.1073/pnas.82.6.1741; Xie SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016235; Xu SY, 2009, FEBS J, V276, P175, DOI 10.1111/j.1742-4658.2008.06771.x; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310; Yada H, 2007, CIRC RES, V101, P69, DOI 10.1161/CIRCRESAHA.106.146399; Zhang QS, 2013, GUT MICROBES, V4, P193, DOI 10.4161/gmic.23867; Zhao JJ, 2010, BLOOD, V115, P2630, DOI 10.1182/blood-2009-09-243147; Zhou B, 2010, ANIM GENET, V41, P499, DOI 10.1111/j.1365-2052.2010.02026.x; Zhou Y, 2013, REPROD DOMEST ANIM, V48, P112, DOI 10.1111/j.1439-0531.2012.02040.x	91	17	17	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e89755	10.1371/journal.pone.0089755	http://dx.doi.org/10.1371/journal.pone.0089755			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699212	gold, Green Submitted, Green Published			2022-12-25	WOS:000334105000007
J	Martins-Melo, FR; Lima, MD; Ramos, AN; Alencar, CH; Heukelbach, J				Martins-Melo, Francisco Rogerlandio; Lima, Mauricelia da Silveira; Ramos, Alberto Novaes, Jr.; Alencar, Carlos Henrique; Heukelbach, Jorg			Mortality and Case Fatality Due to Visceral Leishmaniasis in Brazil: A Nationwide Analysis of Epidemiology, Trends and Spatial Patterns	PLOS ONE			English	Article							UNDERLYING-CAUSE; CHAGAS-DISEASE; AMERICA; SPREAD; DEATH; STATE	Background: Visceral leishmaniasis (VL) is a significant public health problem in Brazil and several regions of the world. This study investigated the magnitude, temporal trends and spatial distribution of mortality related to VL in Brazil. Methods: We performed a study based on secondary data obtained from the Brazilian Mortality Information System. We included all deaths in Brazil from 2000 to 2011, in which VL was recorded as cause of death. We present epidemiological characteristics, trend analysis of mortality and case fatality rates by joinpoint regression models, and spatial analysis using municipalities as geographical units of analysis. Results: In the study period, 12,491,280 deaths were recorded in Brazil. VL was mentioned in 3,322 (0.03%) deaths. Average annual age-adjusted mortality rate was 0.15 deaths per 100,000 inhabitants and case fatality rate 8.1%. Highest mortality rates were observed in males (0.19 deaths/100,000 inhabitants), <1 year-olds (1.03 deaths/100,000 inhabitants) and residents in Northeast region (0.30 deaths/100,000 inhabitants). Highest case fatality rates were observed in males (8.8%), >= 70 year-olds (43.8%) and residents in South region (17.7%). Mortality and case fatality rates showed a significant increase in Brazil over the period, with different patterns between regions: increasing mortality rates in the North (Annual Percent Change - APC: 9.4%; 95% confidence interval - CI: 5.3 to 13.6), and Southeast (APC: 8.1%; 95% CI: 2.6 to 13.9); and increasing case fatality rates in the Northeast (APC: 4.0%; 95% CI: 0.8 to 7.4). Spatial analysis identified a major cluster of high mortality encompassing a wide geographic range in North and Northeast Brazil. Conclusions: Despite ongoing control strategies, mortality related to VL in Brazil is increasing. Mortality and case fatality vary considerably between regions, and surveillance and control measures should be prioritized in high-risk clusters. Early diagnosis and treatment are fundamental strategies for reducing case fatality of VL in Brazil.	[Martins-Melo, Francisco Rogerlandio; Lima, Mauricelia da Silveira; Ramos, Alberto Novaes, Jr.; Alencar, Carlos Henrique; Heukelbach, Jorg] Univ Fed Ceara, Sch Med, Dept Community Hlth, Fortaleza, Ceara, Brazil; [Heukelbach, Jorg] James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Anton Breinl Ctr Publ Hlth & Trop Med, Townsville, Qld 4811, Australia	Universidade Federal do Ceara; James Cook University	Heukelbach, J (corresponding author), Univ Fed Ceara, Sch Med, Dept Community Hlth, Fortaleza, Ceara, Brazil.	heukelbach@web.de	Júnior, Alberto Novaes Ramos/A-4276-2013; Martins-Melo, Francisco Rogerlandio/I-4868-2012	Júnior, Alberto Novaes Ramos/0000-0001-7982-1757; Martins-Melo, Francisco Rogerlandio/0000-0003-3690-5023; Alencar, Carlos Henrique/0000-0003-2967-532X; Heukelbach, Jorg/0000-0002-7845-5510				Alencar CH, 2012, TROP MED INT HEALTH, V17, P518, DOI 10.1111/j.1365-3156.2011.02945.x; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; [Anonymous], 2010, 1 WHO; [Anonymous], 2006, MAN VIG CONTR LEISHM; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Borges BKA, 2008, CAD SAUDE PUBLICA, V24, P777, DOI 10.1590/S0102-311X2008000400007; Assuncao R M, 1998, Cad Saude Publica, V14, P713, DOI 10.1590/S0102-311X1998000400013; Belo VS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002182; Bern C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000313; Bhunia GS, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-64; Clegg LX, 2009, STAT MED, V28, P3670, DOI 10.1002/sim.3733; Cliff A. D., 1981, SPATIAL PROCESSES MO; Costa C H, 2001, Rev Soc Bras Med Trop, V34, P223; Cota GF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001153; Dantas-Torres Filipe, 2006, Rev. Inst. Med. trop. S. Paulo, V48, P151, DOI 10.1590/S0036-46652006000300007; Dantas-Torres F, 2006, REV SOC BRAS MED TRO, V39, P352, DOI 10.1590/S0037-86822006000400007; de Almeida AS, 2011, AM J TROP MED HYG, V84, P681, DOI 10.4269/ajtmh.2011.10-0325; de Sousa-Gomes ML, 2011, EPIDEMIOL SERV SAUDE, V20, P519, DOI 10.5123/S1679-49742011000400011; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Goldacre MJ, 2003, J PUBLIC HEALTH MED, V25, P249, DOI 10.1093/pubmed/fdg058; Gontijo Célia Maria Ferreira, 2004, Rev. bras. epidemiol., V7, P338; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001; Lindoso JAL, 2009, REV INST MED TROP SP, V51, P247, DOI 10.1590/S0036-46652009000500003; Madalosso G, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/281572; Maia-Elkhoury Ana Nilce Silveira, 2007, Rev. Saúde Pública, V41, P931, DOI 10.1590/S0034-89102007000600007; Maia-Elkhoury ANS, 2008, CAD SAUDE PUBLICA, V24, P2941, DOI 10.1590/S0102-311X2008001200024; Martins-Melo FR, 2014, T R SOC TRO IN PRESS; Martins-Melo FR, 2012, TROP MED INT HEALTH, V17, P1066, DOI 10.1111/j.1365-3156.2012.03043.x; Martins-Melo FR, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001508; de Araujo VEM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001511; Costa CHN, 2010, REV SOC BRAS MED TRO, V43, P386, DOI 10.1590/S0037-86822010000400010; Oliveira CDL, 2008, CAD SAUDE PUBLICA, V24, P2953, DOI 10.1590/S0102-311X2008001200026; Oliveira Janaina Michelle de, 2010, Rev. Soc. Bras. Med. Trop., V43, P188; Queiroz Márcia J. A., 2004, J. Pediatr. (Rio J.), V80, P141, DOI 10.1590/S0021-75572004000200012; Redelings MD, 2006, EPIDEMIOLOGY, V17, P100, DOI 10.1097/01.ede.0000187177.96138.c6; Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584; Santo AH, 2007, REV PANAM SALUD PUBL, V22, P178, DOI 10.1590/S1020-49892007000800004; Secretaria de Vigilancia em Saude, 2013, LEISHM VISC; Secretaria de Vigilancia em Saude, 2013, MAP ESTR LEISHM VISC; Secretaria de Vigilancia em Saude Ministerio da Saude, 2013, CAS CONF LEISHM VISC; Secretaria de Vigilancia em Saude Ministerio da Saude, 2011, LEISHM VISC REC CLIN; Werneck GL, 2002, EPIDEMIOLOGY, V13, P364, DOI 10.1097/00001648-200205000-00020; Werneck Guilherme L., 2002, Cad. Saúde Pública, V18, P633, DOI [10.1590/S0102-311X2002000300012, 10.1590/S0102-311X2002000300007]; Werneck Guilherme L., 2010, Cad. Saúde Pública, V26, P644, DOI 10.1590/S0102-311X2010000400001; Werneck GL, 2008, CAD SAUDE PUBLICA, V24, P2937, DOI 10.1590/S0102-311X2008001200023; WHO, 2010, CONTR LEISHM; Word Health Organization, 2007, STAT CLASS DIS REL H	48	76	79	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93770	10.1371/journal.pone.0093770	http://dx.doi.org/10.1371/journal.pone.0093770			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LR	24699517	Green Published, gold, Green Accepted			2022-12-25	WOS:000334105000105
J	Ruan, T; Lin, YJ; Hsu, TH; Lu, SH; Jow, GM; Kou, YR				Ruan, Ting; Lin, Yu-Jung; Hsu, Tien-Huan; Lu, Shing-Hwa; Jow, Guey-Mei; Kou, Yu Ru			Sensitization by Pulmonary Reactive Oxygen Species of Rat Vagal Lung C-Fibers: The Roles of the TRPV1, TRPA1, and P2X Receptors	PLOS ONE			English	Article							EXHALED BREATH CONDENSATE; AIRWAY SENSORY NERVES; INHALED WOOD SMOKE; ACID-PEPSIN INSULT; ANESTHETIZED RATS; OXIDATIVE STRESS; ION CHANNELS; AFFERENTS; CAPSAICIN; ASTHMA	Sensitization of vagal lung C-fibers (VLCFs) induced by mediators contributes to the pathogenesis of airway hypersensitivity, which is characterized by exaggerated sensory and reflex responses to stimulants. Reactive oxygen species (ROS) are mediators produced during airway inflammation. However, the role of ROS in VLCF-mediated airway hypersensitivity has remained elusive. Here, we report that inhalation of aerosolized 0.05% H2O2 for 90 s potentiated apneic responses to intravenous capsaicin (a TRPV1 receptor agonist), alpha,beta-methylene-ATP (a P2X receptor agonist), and phenylbiguanide (a 5HT(3) receptor agonist) in anesthetized rats. The apneic responses to these three stimulants were abolished by vagatomy or by perivagal capsaicin treatment, a procedure that blocks the neural conduction of VLCFs. The potentiating effect of H2O2 on the apneic responses to these VLCF stimulants was prevented by catalase (an enzyme that degrades H2O2) and by dimethylthiourea (a hydroxyl radical scavenger). The potentiating effect of H2O2 on the apneic responses to capsaicin was attenuated by HC-030031 (a TRPA1 receptor antagonist) and by iso-pyridoxalphosphate-6-azophenyl-2 ',5 '-disulphonate (a P2X receptor antagonist). The potentiating effect of H2O2 on the apneic responses to a, b-methylene-ATP was reduced by capsazepine (a TRPV1 receptor antagonist), and by HC-030031. The potentiating effect of H2O2 on the apneic responses to phenylbiguanide was totally abolished when all three antagonists were combined. Consistently, our electrophysiological studies revealed that airway delivery of aerosolized 0.05% H2O2 for 90 s potentiated the VLCF responses to intravenous capsaicin, alpha,beta-methylene-ATP, and phenylbiguanide. The potentiating effect of H2O2 on the VLCF responses to phenylbiguanide was totally prevented when all antagonists were combined. Inhalation of 0.05% H2O2 indeed increased the level of ROS in the lungs. These results suggest that 1) increased lung ROS sensitizes VLCFs, which leads to exaggerated reflex responses in rats and 2) the TRPV1, TRPA1, and P2X receptors are all involved in the development of this airway hypersensitivity.	[Ruan, Ting; Jow, Guey-Mei] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan; [Lin, Yu-Jung; Kou, Yu Ru] Natl Yang Ming Univ, Sch Med, Dept Physiol, Taipei 112, Taiwan; [Hsu, Tien-Huan] Natl Chung Hsing Univ, Dept Vet Med, Taichung 40227, Taiwan; [Lu, Shing-Hwa] Taipei City Hosp, Zhong Xiao Branch, Dept Urol, Taipei, Taiwan; [Ruan, Ting] Chung Shan Med Univ, Sch Med, Dept Physiol, Taichung, Taiwan	Fu Jen Catholic University; National Yang Ming Chiao Tung University; National Chung Hsing University; Taipei City Hospital; Chung Shan Medical University	Kou, YR (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Physiol, Taipei 112, Taiwan.	yrkou@ym.edu.tw	Lin, Yu-Jung/AAH-6195-2021	Kou, Yu Ru/0000-0002-4681-9009	National Science Council, Taiwan [NSC 101-2320-B-010-042-MY3, NSC 98-2628-B-030-001-MY3]; Taipei City Hospital [10201-62-063]; Ministry of Education, Aim for the Top University Plan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Taipei City Hospital; Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan)	This study was supported by the following grants, NSC 101-2320-B-010-042-MY3 and NSC 98-2628-B-030-001-MY3 from the National Science Council, Taiwan, a grant 10201-62-063 from Taipei City Hospital, and a grant from Ministry of Education, Aim for the Top University Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bessac BF, 2008, J CLIN INVEST, V118, P1899, DOI 10.1172/JCI34192; Caceres AI, 2009, P NATL ACAD SCI USA, V106, P9099, DOI 10.1073/pnas.0900591106; Chen MJ, 2001, TOXICOL APPL PHARM, V171, P165, DOI 10.1006/taap.2000.9117; Chuang HH, 2009, P NATL ACAD SCI USA, V106, P20097, DOI 10.1073/pnas.0902675106; Comhair SAA, 2002, AM J PHYSIOL-LUNG C, V283, pL246, DOI 10.1152/ajplung.00491.2001; Dai Y, 2004, PAIN, V108, P258, DOI 10.1016/j.pain.2003.12.034; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Doherty MJ, 2000, THORAX, V55, P643, DOI 10.1136/thorax.55.8.643; Dozor AJ, 2010, ANN NY ACAD SCI, V1203, P133, DOI 10.1111/j.1749-6632.2010.05562.x; Fox AJ, 1996, NAT MED, V2, P814, DOI 10.1038/nm0796-814; FOX RB, 1984, J CLIN INVEST, V74, P1456, DOI 10.1172/JCI111558; Gu QH, 2003, J APPL PHYSIOL, V95, P1315, DOI 10.1152/japplphysiol.00107.2003; Ho CY, 2001, RESP PHYSIOL, V127, P113, DOI 10.1016/S0034-5687(01)00241-9; Ho CY, 2000, AM J RESP CRIT CARE, V162, P528, DOI 10.1164/ajrccm.162.2.9910059; Hsu CC, 2013, AM J PHYSIOL-REG I, V305, pR769, DOI 10.1152/ajpregu.00202.2013; Keating C, 2011, J IMMUNOL, V187, P1467, DOI 10.4049/jimmunol.1100423; KOU YR, 1995, J APPL PHYSIOL, V78, P2070, DOI 10.1152/jappl.1995.78.6.2070; Kou YR, 2011, RESP PHYSIOL NEUROBI, V178, P395, DOI 10.1016/j.resp.2011.03.004; Kuo YL, 2008, J APPL PHYSIOL, V105, P611, DOI 10.1152/japplphysiol.01099.2007; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lai CJ, 2005, J APPL PHYSIOL, V98, P620, DOI 10.1152/japplphysiol.00539.2004; Lai CJ, 1998, J APPL PHYSIOL, V84, P30, DOI 10.1152/jappl.1998.84.1.30; LEE BP, 1992, J APPL PHYSIOL, V72, P1050, DOI 10.1152/jappl.1992.72.3.1050; Lee LY, 2010, J PHYSIOL-LONDON, V588, P747, DOI 10.1113/jphysiol.2010.187286; Lee LY, 2009, CURR OPIN PHARMACOL, V9, P243, DOI 10.1016/j.coph.2009.02.002; Lee LY, 2001, RESP PHYSIOL, V125, P47, DOI 10.1016/S0034-5687(00)00204-8; LEE LY, 1993, RESP PHYSIOL, V93, P83, DOI 10.1016/0034-5687(93)90070-Q; Li GL, 2010, NEUROCHEM INT, V56, P984, DOI 10.1016/j.neuint.2010.04.010; Lin YS, 2010, J APPL PHYSIOL, V108, P1293, DOI 10.1152/japplphysiol.01048.2009; Lin YS, 2009, J APPL PHYSIOL, V106, P1142, DOI 10.1152/japplphysiol.91229.2008; Lin YJ, 2013, RESP PHYSIOL NEUROBI, V189, P1, DOI 10.1016/j.resp.2013.06.021; Lin YJ, 2013, J APPL PHYSIOL, V114, P361, DOI 10.1152/japplphysiol.00977.2012; Masuda H, 2008, BJU INT, V101, P775, DOI 10.1111/j.1464-410X.2007.07310.x; Riedl MA, 2008, CURR OPIN ALLERGY CL, V8, P49, DOI 10.1097/ACI.0b013e3282f3d913; Ruan T, 2005, J PHYSIOL-LONDON, V565, P563, DOI 10.1113/jphysiol.2005.086181; Ruan T, 2005, J PHYSIOL-LONDON, V565, P295, DOI 10.1113/jphysiol.2005.084319; Ruan T, 2003, J APPL PHYSIOL, V94, P1987, DOI 10.1152/japplphysiol.01047.2002; Ruan T, 2006, J APPL PHYSIOL, V101, P644, DOI 10.1152/japplphysiol.00192.2006; Shen MY, 2012, AM J PHYSIOL-REG I, V303, pR1175, DOI 10.1152/ajpregu.00227.2012; Susankova K, 2006, MOL PHARMACOL, V70, P383, DOI 10.1124/mol.106.023069; Taylor-Clark T, 2006, J APPL PHYSIOL, V101, P950, DOI 10.1152/japplphysiol.00222.2006; Taylor-Clark TE, 2011, RESP PHYSIOL NEUROBI, V178, P406, DOI 10.1016/j.resp.2011.05.003; Taylor-Clark TE, 2010, J PHYSIOL-LONDON, V588, P423, DOI 10.1113/jphysiol.2009.183301; Teng Y, 2011, CHEST, V140, P108, DOI 10.1378/chest.10-2816; Tsai TL, 2006, J APPL PHYSIOL, V101, P328, DOI 10.1152/japplphysiol.00064.2006; Tsai TL, 2009, J APPL PHYSIOL, V106, P1584, DOI 10.1152/japplphysiol.91517.2008; Ueno T, 2008, RESPIROLOGY, V13, P654, DOI 10.1111/j.1440-1843.2008.01315.x; Widdicombe JG, 2003, PULM PHARMACOL THER, V16, P23, DOI 10.1016/S1094-5539(02)00178-5; Zhang GF, 2008, J APPL PHYSIOL, V105, P128, DOI 10.1152/japplphysiol.01367.2007	49	33	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e91763	10.1371/journal.pone.0091763	http://dx.doi.org/10.1371/journal.pone.0091763			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699274	Green Published, Green Submitted, gold			2022-12-25	WOS:000334105000016
J	Huang, MZ; Tang, SN; Upadhyay, G; Marsh, JL; Jackman, CP; Shankar, S; Srivastava, RK				Huang, Minzhao; Tang, Su-Ni; Upadhyay, Ghanshyam; Marsh, Justin L.; Jackman, Christopher P.; Shankar, Sharmila; Srivastava, Rakesh K.			Embelin Suppresses Growth of Human Pancreatic Cancer Xenografts, and Pancreatic Cancer Cells Isolated from Kras(G12D) Mice by Inhibiting Akt and Sonic Hedgehog Pathways	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; PROLIFERATION; METASTASIS; APOPTOSIS; FAMILY; DEATH; IL-8	Pancreatic cancer is a deadly disease, and therefore effective treatment and/or prevention strategies are urgently needed. The objectives of this study were to examine the molecular mechanisms by which embelin inhibited human pancreatic cancer cell growth in vitro, and xenografts in Balb C nude mice, and pancreatic cancer cell growth isolated from Kras(G12D) transgenic mice. XTT assays were performed to measure cell viability. AsPC-1 cells were injected subcutaneously into Balb c nude mice and treated with embelin. Cell proliferation and apoptosis were measured by Ki67 and TUNEL staining, respectively. The expression of Akt, and Sonic Hedgehog (Shh) and their target gene products were measured by the immunohistochemistry, and Western blot analysis. The effects of embelin on pancreatic cancer cells isolated from 10months old Kras(G12D) mice were also examined. Embelin inhibited cell viability in pancreatic cancer AsPC-1, PANC-1, MIA PaCa-2 and Hs 766T cell lines, and these inhibitory effects were blocked either by constitutively active Akt or Shh protein. Embelin-treated mice showed significant inhibition in tumor growth which was associated with reduced expression of markers of cell proliferation (Ki67, PCNA and Bcl-2) and cell cycle (cyclin D1, CDK2, and CDK6), and induction of apoptosis (activation of caspase-3 and cleavage of PARP, and increased expression of Bax). In addition, embelin inhibited the expression of markers of angiogenesis (COX-2, VEGF, VEGFR, and IL-8), and metastasis (MMP-2 and MMP-9) in tumor tissues. Antitumor activity of embelin was associated with inhibition of Akt and Shh pathways in xenografts, and pancreatic cancer cells isolated from Kras(G12D) mice. Furthermore, embelin also inhibited epithelial-to-mesenchymal transition (EMT) by upregulating E-cadherin and inhibiting the expression of Snail, Slug, and ZEB1. These data suggest that embelin can inhibit pancreatic cancer growth, angiogenesis and metastasis by suppressing Akt and Shh pathways, and can be developed for the treatment and/or prevention of pancreatic cancer.	[Huang, Minzhao; Tang, Su-Ni; Upadhyay, Ghanshyam; Srivastava, Rakesh K.] Univ Kansas, Med Ctr, Ctr Canc, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA; [Marsh, Justin L.; Jackman, Christopher P.] Univ Texas Hlth Ctr Tyler, Dept Biochem, Tyler, TX 75710 USA; [Shankar, Sharmila] Univ Kansas, Med Ctr, Ctr Canc, Dept Pathol & Lab Med, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center; University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of Kansas; University of Kansas Medical Center	Shankar, S (corresponding author), Univ Kansas, Med Ctr, Ctr Canc, Dept Pathol & Lab Med, Kansas City, KS 66103 USA.	sshankar@kumc.edu; rsrivastava@kumc.edu		Srivastava, Rakesh/0000-0002-0065-4069; Srivastava, Rakesh/0000-0003-3112-4252	NCI NIH HHS [R01 CA114469] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA114469] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Basanez G, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001399; Choy SW, 2012, VITAM HORM, V88, P1, DOI 10.1016/B978-0-12-394622-5.00001-8; Fernando RI, 2011, CANCER RES, V71, P5296, DOI 10.1158/0008-5472.CAN-11-0156; Folkman J, 2003, J THROMB HAEMOST, V1, P1681, DOI 10.1046/j.1538-7836.2003.00344.x; Fu JS, 2013, CANCER LETT, V330, P22, DOI 10.1016/j.canlet.2012.11.018; Gold E B, 1998, Surg Oncol Clin N Am, V7, P67; Hao K, 2013, ONCOL REP, V29, P1124, DOI 10.3892/or.2012.2210; Harada Hisashi, 2003, Rev Clin Exp Hematol, V7, P117; Harris MH, 2000, CELL DEATH DIFFER, V7, P1182, DOI 10.1038/sj.cdd.4400781; Heo JY, 2011, CANCER LETT, V308, P71, DOI 10.1016/j.canlet.2011.04.015; Hill R, 2012, MOL CANCER THER, V11, P2127, DOI 10.1158/1535-7163.MCT-12-0342; Hill R, 2010, CANCER RES, V70, P7114, DOI 10.1158/0008-5472.CAN-10-1649; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hu R, 2011, MED ONCOL, V28, P1584, DOI 10.1007/s12032-010-9601-5; Huang YX, 2012, BIOCONJUGATE CHEM, V23, P1443, DOI 10.1021/bc3000468; Jaffee EM, 2002, CANCER CELL, V2, P25, DOI 10.1016/S1535-6108(02)00093-4; Jenkins D, 2009, CELL SIGNAL, V21, P1023, DOI 10.1016/j.cellsig.2009.01.033; Kennedy Alyssa L, 2011, Small GTPases, V2, P264; Kim SW, 2013, PROSTATE, V73, P296, DOI 10.1002/pros.22574; KINZLER KW, 1988, NATURE, V332, P371, DOI 10.1038/332371a0; Li DH, 2001, CANCER J, V7, P259; Li J, 2010, AAPS J, V12, P223, DOI 10.1208/s12248-010-9181-5; Li SH, 2013, MOL CELL BIOCHEM, V373, P217, DOI 10.1007/s11010-012-1493-6; Magee CJ, 2002, BEST PRACT RES CL GA, V16, P435, DOI 10.1053/bega.2002.0317; Maitra A, 2005, CANCER CELL, V8, P171, DOI 10.1016/j.ccr.2005.08.007; Marsh JL, 2014, FRONT BIOSCI-LANDMRK, V19, P113, DOI 10.2741/4198; Nikolovska-Coleska Z, 2004, J MED CHEM, V47, P2430, DOI 10.1021/jm030420+; Palena C, 2012, FUTURE ONCOL, V8, P713, DOI [10.2217/FON.12.59, 10.2217/fon.12.59]; Pavelic SK, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-22; Segura PP, 2012, CLIN TRANSL ONCOL, V14, P553, DOI 10.1007/s12094-012-0840-0; Rodova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046083; Rohatgi R, 2007, NAT CELL BIOL, V9, P1005, DOI 10.1038/ncb435; Roy Sanjit K, 2010, J Mol Signal, V5, P10, DOI 10.1186/1750-2187-5-10; Saqui-Salces M, 2010, BBA-MOL CELL RES, V1803, P786, DOI 10.1016/j.bbamcr.2010.03.008; Shankar S, 2005, INT J MOL MED, V16, P1125; Shankar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016530; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Siegelin MD, 2009, NEUROCHEM INT, V55, P423, DOI 10.1016/j.neuint.2009.04.011; Singh BN, 2012, BIOCHEM PHARMACOL, V84, P1154, DOI 10.1016/j.bcp.2012.08.007; Singh BN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027306; Srivastava Rakesh K, 2011, Front Biosci (Elite Ed), V3, P515, DOI 10.2741/e266; Srivastava Rakesh K., 2000, Molecular Cell Biology Research Communications, V4, P67, DOI 10.1006/mcbr.2001.0265; Srivastava RK, 2001, NEOPLASIA, V3, P535, DOI 10.1038/sj.neo.7900203; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Tang SN, 2012, INT J CANCER, V131, P30, DOI 10.1002/ijc.26323; Tang Su-Ni, 2010, J Mol Signal, V5, P14, DOI 10.1186/1750-2187-5-14; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wang ZW, 2011, NAT REV GASTRO HEPAT, V8, P27, DOI 10.1038/nrgastro.2010.188; Xu MJ, 2005, PLANTA MED, V71, P944, DOI 10.1055/s-2005-871250; Zhao M, 2013, CANCER LETT, V337, P210, DOI 10.1016/j.canlet.2013.05.009	52	41	43	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e92161	10.1371/journal.pone.0092161	http://dx.doi.org/10.1371/journal.pone.0092161			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24694877	Green Submitted, gold, Green Published			2022-12-25	WOS:000334103000015
J	Brett, M; McPherson, J; Zang, ZJ; Lai, A; Tan, ES; Ng, I; Ong, LC; Cham, B; Tan, P; Rozen, S; Tan, EC				Brett, Maggie; McPherson, John; Zang, Zhi Jiang; Lai, Angeline; Tan, Ee-Shien; Ng, Ivy; Ong, Lai-Choo; Cham, Breana; Tan, Patrick; Rozen, Steve; Tan, Ene-Choo			Massively Parallel Sequencing of Patients with Intellectual Disability, Congenital Anomalies and/or Autism Spectrum Disorders with a Targeted Gene Panel	PLOS ONE			English	Article							DE-NOVO MUTATIONS; PERIVENTRICULAR NODULAR HETEROTOPIA; THALASSEMIA-MENTAL-RETARDATION; IDENTIFICATION; ENZYME; FOXP1; AHI1	Developmental delay and/or intellectual disability (DD/ID) affects 1-3% of all children. At least half of these are thought to have a genetic etiology. Recent studies have shown that massively parallel sequencing (MPS) using a targeted gene panel is particularly suited for diagnostic testing for genetically heterogeneous conditions. We report on our experiences with using massively parallel sequencing of a targeted gene panel of 355 genes for investigating the genetic etiology of eight patients with a wide range of phenotypes including DD/ID, congenital anomalies and/or autism spectrum disorder. Targeted sequence enrichment was performed using the Agilent SureSelect Target Enrichment Kit and sequenced on the Illumina HiSeq2000 using paired-end reads. For all eight patients, 81-84% of the targeted regions achieved read depths of at least 20x, with average read depths overlapping targets ranging from 322x to 798x. Causative variants were successfully identified in two of the eight patients: a nonsense mutation in the ATRX gene and a canonical splice site mutation in the L1CAM gene. In a third patient, a canonical splice site variant in the USP9X gene could likely explain all or some of her clinical phenotypes. These results confirm the value of targeted MPS for investigating DD/ID in children for diagnostic purposes. However, targeted gene MPS was less likely to provide a genetic diagnosis for children whose phenotype includes autism.	[Brett, Maggie; Tan, Ene-Choo] KK Womens & Childrens Hosp, KK Res Ctr, Singapore, Singapore; [McPherson, John; Tan, Patrick; Rozen, Steve] Duke NUS Grad Med Sch, Singapore, Singapore; [Zang, Zhi Jiang; Tan, Patrick] Natl Canc Ctr, Singapore, Singapore; [Lai, Angeline; Tan, Ee-Shien; Ng, Ivy; Cham, Breana] KK Womens & Childrens Hosp, Genet Serv, Singapore, Singapore; [Ong, Lai-Choo] Univ Malaya Med Ctr, Petaling Jaya, Malaysia	KK Women's & Children's Hospital; National University of Singapore; National Cancer Centre Singapore (NCCS); KK Women's & Children's Hospital; Universiti Malaya	Tan, EC (corresponding author), KK Womens & Childrens Hosp, KK Res Ctr, Singapore, Singapore.	tanec@bigfoot.com	Ong, Lai Choo/G-6439-2011; Tan, EC/W-6304-2019; McPherson, John D/D-2633-2017; Rozen, Steven G./J-5939-2013	Ong, Lai Choo/0000-0003-3903-9343; McPherson, John D/0000-0001-8049-9347; Rozen, Steven G./0000-0002-4288-0056	Agency for Science and Technology and Research [BMRC 06/1/50/19/485]; National Medical Research Council, Ministry of Health, Republic of Singapore [NMRC/PPG/KKH12010-Theme3]	Agency for Science and Technology and Research(Agency for Science Technology & Research (A*STAR)); National Medical Research Council, Ministry of Health, Republic of Singapore(Ministry of Health-SingaporeNational Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study is funded by Grant number BMRC 06/1/50/19/485 from the Agency for Science and Technology and Research; and NMRC/PPG/KKH12010-Theme3 from the National Medical Research Council, Ministry of Health, Republic of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Retuerto AI, 2008, HUM MOL GENET, V17, P3887, DOI 10.1093/hmg/ddn291; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Brownstein Z, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r89; Carter MT, 2013, CLIN GENET, V83, P399, DOI 10.1111/cge.12101; Chelly J, 2006, EUR J HUM GENET, V14, P701, DOI 10.1038/sj.ejhg.5201595; Coe BP, 2012, AM J MED GENET C, V160C, P118, DOI 10.1002/ajmg.c.31327; Devlin B, 2012, CURR OPIN GENET DEV, V22, P229, DOI 10.1016/j.gde.2012.03.002; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Finckh U, 2000, AM J MED GENET, V92, P40, DOI 10.1002/(SICI)1096-8628(20000501)92:1<40::AID-AJMG7>3.0.CO;2-R; Gibbons R, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-15; Gibbons RJ, 2008, HUM MUTAT, V29, P796, DOI 10.1002/humu.20734; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Hamdan FF, 2010, AM J HUM GENET, V87, P671, DOI 10.1016/j.ajhg.2010.09.017; Horn D, 2010, HUM MUTAT, V31, pE1851, DOI 10.1002/humu.21362; Jolly LA, 2009, MOL BIOL CELL, V20, P2015, DOI 10.1091/mbc.E08-06-0596; Jones MH, 1996, HUM MOL GENET, V5, P1695, DOI 10.1093/hmg/5.11.1695; Kakita A, 2002, ACTA NEUROPATHOL, V104, P649, DOI 10.1007/s00401-002-0594-9; Kalscheuer VM, 2007, HUM GENET, V121, P501, DOI 10.1007/s00439-006-0284-0; Kroes HY, 2008, EUR J MED GENET, V51, P24, DOI 10.1016/j.ejmg.2007.10.001; Kunishima S, 2010, J HUM GENET, V55, P844, DOI 10.1038/jhg.2010.114; Latiff ZA, 2013, J PEDIATR NEUROL, V11, P67, DOI 10.3233/JPN-120598; Leblond CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002521; Lemke JR, 2012, EPILEPSIA, V53, P1387, DOI 10.1111/j.1528-1167.2012.03516.x; Matsunami N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052239; Meder B, 2011, CIRC-CARDIOVASC GENE, V4, P110, DOI 10.1161/CIRCGENETICS.110.958322; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Neveling K, 2012, HUM MUTAT, V33, P963, DOI 10.1002/humu.22045; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; Pantaleon M, 2001, MECH DEVELOP, V109, P151, DOI 10.1016/S0925-4773(01)00551-2; Rehnberg M, 2011, AM J MED GENET A, V155A, P439, DOI 10.1002/ajmg.a.33803; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sultana R, 2002, GENOMICS, V80, P129, DOI 10.1006/geno.2002.6810; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367	34	29	29	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93409	10.1371/journal.pone.0093409	http://dx.doi.org/10.1371/journal.pone.0093409			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690944	Green Published, gold, Green Submitted			2022-12-25	WOS:000334101100076
J	Crimi, A; Commowick, O; Maarouf, A; Ferre, JC; Bannier, E; Tourbah, A; Berry, I; Ranjeva, JP; Edan, G; Barillot, C				Crimi, Alessandro; Commowick, Olivier; Maarouf, Adil; Ferre, Jean-Christophe; Bannier, Elise; Tourbah, Ayman; Berry, Isabelle; Ranjeva, Jean-Philippe; Edan, Gilles; Barillot, Christian			Predictive Value of Imaging Markers at Multiple Sclerosis Disease Onset Based on Gadolinium- and USPIO-Enhanced MRI and Machine Learning	PLOS ONE			English	Article							CLINICALLY ISOLATED SYNDROMES; SPIN-ECHO MRI; HYPOINTENSE LESIONS; IRON-OXIDE; DIAGNOSTIC-CRITERIA; AXONAL INJURY; DISABILITY; PROGRESSION; DEMYELINATION; PATHOLOGY	Objectives : A novel characterization of Clinically Isolated Syndrome (CIS) patients according to lesion patterns is proposed. More specifically, patients are classified according to the nature of inflammatory lesions patterns. It is expected that this characterization can infer new prospective figures from the earliest imaging signs of Multiple Sclerosis (MS), since it can provide a classification of different types of lesions across patients. Methods: The method is based on a two- tiered classification. Initially, the spatio- temporal lesion patterns are classified. The discovered lesion patterns are then used to characterize groups of patients. The patient groups are validated using statistical measures and by correlations at 24- month follow- up with hypointense lesion loads. Results: The methodology identified 3 statistically significantly different clusters of lesion patterns showing p- values smaller than 0.01. Moreover, these patterns defined at baseline correlated with chronic hypointense lesion volumes by follow-up with an R-2 score of 0.90. Conclusions: The proposed methodology is capable of identifying three major different lesion patterns that are heterogeneously present in patients, allowing a patient classification using only two MRI scans. This finding may lead to more accurate prognosis and thus to more suitable treatments at early stage of MS.	[Crimi, Alessandro; Commowick, Olivier; Barillot, Christian] INRIA Atlantique, Rennes, France; [Maarouf, Adil; Ranjeva, Jean-Philippe] Aix Marseille Univ, CNRS, CRMBM, Marseille, France; [Ferre, Jean-Christophe; Bannier, Elise; Edan, Gilles] CHU Rennes, Rennes, France; [Maarouf, Adil; Tourbah, Ayman] CHU Reims, Reims, France; [Berry, Isabelle] CHU Toulouse, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; CHU Rennes; CHU de Reims; CHU de Toulouse	Crimi, A (corresponding author), INRIA Atlantique, Campus Beaulieu, Rennes, France.	alecrimi@alice.it	Edan, Gilles/AAI-5944-2020; Crimi, Alessandro/Y-3535-2019	Crimi, Alessandro/0000-0001-5397-6363; Ferre, Jean-Christophe/0000-0003-3911-1800; Bannier, Elise/0000-0002-8942-7486; Ranjeva, Jean-Philippe/0000-0001-8073-102X; BERRY, Isabelle/0000-0002-0886-3252	ARSEP (Foundation pour l'Aide a la Recherche sur la Scelerose en Plaques); ERCIM (European Research Consortium for Informatics and Mathematics)	ARSEP (Foundation pour l'Aide a la Recherche sur la Scelerose en Plaques); ERCIM (European Research Consortium for Informatics and Mathematics)	The study was supported by ARSEP (Foundation pour l'Aide a la Recherche sur la Scelerose en Plaques). The scholarship of Dr. Crimi has been financed by ERCIM (European Research Consortium for Informatics and Mathematics). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboul-Enein F, 2006, ACTA NEUROPATHOL, V111, P539, DOI 10.1007/s00401-006-0047-y; Anderson VM, 2006, J MAGN RESON IMAGING, V23, P605, DOI 10.1002/jmri.20550; Barkhof F, 2001, BRAIN, V124, P1396, DOI 10.1093/brain/124.7.1396; BARTLETT MS, 1954, J ROY STAT SOC B, V16, P296; Bezdek JC, 1998, IEEE T SYST MAN CY B, V28, P301, DOI 10.1109/3477.678624; Bitsch A, 2000, BRAIN, V123, P1174, DOI 10.1093/brain/123.6.1174; Brex PA, 2002, NEW ENGL J MED, V346, P158, DOI 10.1056/NEJMoa011341; Brex PA, 2001, J NEUROL NEUROSUR PS, V70, P390, DOI 10.1136/jnnp.70.3.390; Calinski T., 1974, COMMUNICATIONS STAT, V3, P1, DOI [DOI 10.1080/03610927408827101, 10.1080/03610927408827101]; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Confavreux C, 2003, BRAIN, V126, P770, DOI 10.1093/brain/awg081; Dousset V, 2006, AM J NEURORADIOL, V27, P1000; Dousset V, 2002, ACAD RADIOL, V9, pS156, DOI 10.1016/S1076-6332(03)80426-9; Duda R.O., 2000, PATTERN CLASSIFICATI; Dunn J. C., 1973, Journal of Cybernetics, V3, P32, DOI 10.1080/01969727308546046; FILIPPI M, 1994, NEUROLOGY, V44, P635, DOI 10.1212/WNL.44.4.635; Fox E, 2006, NEUROLOGY, V28; Gokcay E, 2002, IEEE T PATTERN ANAL, V24, P158, DOI 10.1109/34.982897; Haermae V., 2010, PLOS ONE, V5, P245; INRIA, 2013, MED SOFTW PAG; Kornek B, 1999, BRAIN PATHOL, V9, P651; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lassmann H, 2010, EXP NEUROL, V225, P2, DOI 10.1016/j.expneurol.2009.10.009; Leray E, 2010, BRAIN, V133, P1900, DOI 10.1093/brain/awq076; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Marriott J, 2010, NEUROLOGY, V74; Maulik U, 2002, IEEE T PATTERN ANAL, V24, P1650, DOI 10.1109/TPAMI.2002.1114856; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Miller D, 2005, LANCET NEUROL, V4, P341, DOI 10.1016/S1474-4422(05)70095-8; Molyneux PD, 1998, ANN NEUROL, V43, P332, DOI 10.1002/ana.410430311; Ng A, 2001, NIPS, V14, P224; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Redford EJ, 1997, BRAIN, V120, P2149, DOI 10.1093/brain/120.12.2149; Reuter M, 2006, COMPUT AIDED DESIGN, V38, P342, DOI 10.1016/j.cad.2005.10.011; Scalfari A, 2010, BRAIN, V133, P1914, DOI 10.1093/brain/awq118; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Smith KJ, 2001, ANN NEUROL, V49, P470; SMITH ME, 1993, ANN NEUROL, V33, P480, DOI 10.1002/ana.410330511; Steel R, 1960, PRINCIPLES PROCEDURE, V70, P187; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Tourdias T, 2012, RADIOLOGY, V264, P225, DOI 10.1148/radiol.12111416; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Truyen L, 1996, NEUROLOGY, V47, P1469, DOI 10.1212/WNL.47.6.1469; van Walderveen M, 1995, NEUROLOGY, V454; van Walderveen MAA, 1998, NEUROLOGY, V50, P1282, DOI 10.1212/WNL.50.5.1282; Vellinga MM, 2008, BRAIN, V131, P800, DOI 10.1093/brain/awn009; Zelnik-Manor L, 2004, NIPS, V17	49	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93024	10.1371/journal.pone.0093024	http://dx.doi.org/10.1371/journal.pone.0093024			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691080	gold, Green Published, Green Submitted			2022-12-25	WOS:000334101100039
J	Gallardo-Escarate, C; Valenzuela-Munoz, V; Nunez-Acuna, G				Gallardo-Escarate, Cristian; Valenzuela-Munoz, Valentina; Nunez-Acuna, Gustavo			RNA-Seq Analysis Using De Novo Transcriptome Assembly as a Reference for the Salmon Louse Caligus rogercresseyi	PLOS ONE			English	Article							CALANUS-FINMARCHICUS CRUSTACEA; LEPEOPHTHEIRUS-SALMONIS; ATLANTIC SALMON; SALAR L.; EMAMECTIN BENZOATE; MOLECULAR CHARACTERIZATION; REDUCED SENSITIVITY; BRITISH-COLUMBIA; SNP DISCOVERY; LICE	Despite the economic and environmental impacts that sea lice infestations have on salmon farming worldwide, genomic data generated by high-throughput transcriptome sequencing for different developmental stages, sexes, and strains of sea lice is still limited or unknown. In this study, RNA-seq analysis was performed using de novo transcriptome assembly as a reference for evidenced transcriptional changes from six developmental stages of the salmon louse Caligus rogercresseyi. EST-datasets were generated from the nauplius I, nauplius II, copepodid and chalimus stages and from female and male adults using MiSeq Illumina sequencing. A total of 151,788,682 transcripts were yielded, which were assembled into 83,444 high quality contigs and subsequently annotated into roughly 24,000 genes based on known proteins. To identify differential transcription patterns among salmon louse stages, cluster analyses were performed using normalized gene expression values. Herein, four clusters were differentially expressed between nauplius I-II and copepodid stages (604 transcripts), five clusters between copepodid and chalimus stages (2,426 transcripts), and six clusters between female and male adults (2,478 transcripts). Gene ontology analysis revealed that the nauplius I-II, copepodid and chalimus stages are mainly annotated to aminoacid transfer/repair/breakdown, metabolism, molting cycle, and nervous system development. Additionally, genes showing differential transcription in female and male adults were highly related to cytoskeletal and contractile elements, reproduction, cell development, morphogenesis, and transcription-translation processes. The data presented in this study provides the most comprehensive transcriptome resource available for C. rogercresseyi, which should be used for future genomic studies linked to host-parasite interactions.	[Gallardo-Escarate, Cristian; Valenzuela-Munoz, Valentina; Nunez-Acuna, Gustavo] Univ Concepcion, Interdisciplinary Ctr Aquaculture Res INCAR, Lab Biotechnol & Aquat Genom, Concepcion, Chile	Universidad de Concepcion	Gallardo-Escarate, C (corresponding author), Univ Concepcion, Interdisciplinary Ctr Aquaculture Res INCAR, Lab Biotechnol & Aquat Genom, Concepcion, Chile.	crisgallardo@udec.cl	Gallardo-Escárate, Cristian/AAE-8980-2022	Gallardo-Escárate, Cristian/0000-0002-7094-6702; Nunez-Acuna, Gustavo/0000-0003-2568-0332; Valenzuela-Munoz, Valentina/0000-0002-9402-6695	FONDAP [15110027]; CONICYT-Chile	FONDAP; CONICYT-Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This study was supported by the FONDAP (15110027) project granted by CONICYT-Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarseth KA, 1999, MAR ECOL PROG SER, V186, P211, DOI 10.3354/meps186211; Belles X, 2005, INVERTEBR REPROD DEV, V47, P23, DOI 10.1080/07924259.2005.9652144; Bellin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-555; Bowers JM, 2000, J FISH DIS, V23, P165, DOI 10.1046/j.1365-2761.2000.00225.x; BRANDAL PO, 1976, NORW J ZOOL, V24, P341; Bravo S, 2010, AQUACULTURE, V303, P22, DOI 10.1016/j.aquaculture.2010.03.007; Bravo S, 2008, AQUACULTURE, V282, P7, DOI 10.1016/j.aquaculture.2008.06.011; Bravo S, 2013, AQUACULTURE, V404, P55, DOI 10.1016/j.aquaculture.2013.04.002; Bravo S, 2010, EXP PARASITOL, V125, P51, DOI 10.1016/j.exppara.2009.12.001; Brooks KM, 2005, REV FISH SCI, V13, P177, DOI 10.1080/10641260500207109; Carmichael SN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-408; Christie AE, 2008, GEN COMP ENDOCR, V155, P526, DOI 10.1016/j.ygcen.2007.09.002; Christie AE, 2013, COMP BIOCHEM PHYS D, V8, P165, DOI 10.1016/j.cbd.2013.04.002; Christie AE, 2013, GEN COMP ENDOCR, V187, P117, DOI 10.1016/j.ygcen.2013.03.018; Christie AE, 2013, COMP BIOCHEM PHYS D, V8, P45, DOI 10.1016/j.cbd.2012.11.002; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dalvin S, 2011, DIS AQUAT ORGAN, V94, P211, DOI 10.3354/dao02331; Duston J, 2002, AQUACULTURE, V207, P1, DOI 10.1016/S0044-8486(01)00734-7; Eichner C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-126; Everett MV, 2011, MOL ECOL RESOUR, V11, P93, DOI 10.1111/j.1755-0998.2010.02969.x; Fast MD, 2003, J PARASITOL, V89, P7, DOI 10.1645/0022-3395(2003)089[0007:ERFLSI]2.0.CO;2; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; Firth KJ, 2000, J PARASITOL, V86, P1199, DOI 10.1645/0022-3395(2000)086[1199:COPITS]2.0.CO;2; Gonzalez L, 2003, AQUACULTURE, V220, P101, DOI 10.1016/S0044-8486(02)00512-4; Hamre LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073539; He LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047195; Hergarden AC, 2012, P NATL ACAD SCI USA, V109, P3967, DOI 10.1073/pnas.1200778109; JONES MW, 1992, J FISH DIS, V15, P197, DOI 10.1111/j.1365-2761.1992.tb00654.x; Jones SRM, 2012, J EUKARYOT MICROBIOL, V59, P206, DOI 10.1111/j.1550-7408.2011.00614.x; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kristoffersen AB, 2013, PREV VET MED, V111, P165, DOI 10.1016/j.prevetmed.2013.03.015; Kvamme BO, 2005, GENE, V352, P63, DOI 10.1016/j.gene.2005.03.011; Kvamme BO, 2004, INT J PARASITOL, V34, P823, DOI 10.1016/j.ijpara.2004.02.004; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; Mordue AJ, 2009, J FISH DIS, V32, P3, DOI 10.1111/j.1365-2761.2008.01004.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Neira-Oviedo M, 2011, INSECT MOL BIOL, V20, P141, DOI 10.1111/j.1365-2583.2010.01053.x; Porter ML, 2007, MOL BIOL EVOL, V24, P253, DOI 10.1093/molbev/msl152; Ritdachyeng E, 2013, PHYSIOL ENTOMOL, V38, P183, DOI 10.1111/phen.12010; Rodriguez EM, 2007, COMP BIOCHEM PHYS A, V146, P661, DOI 10.1016/j.cbpa.2006.04.030; Roth M, 1996, AQUACULTURE, V140, P217, DOI 10.1016/0044-8486(95)01181-1; Sahasrabudhe PV, 1998, PROTEINS, V33, P558, DOI 10.1002/(SICI)1097-0134(19981201)33:4<558::AID-PROT8>3.3.CO;2-Q; Saksida SM, 2013, J FISH DIS, V36, P515, DOI 10.1111/jfd.12018; Sappington TW, 1998, INSECT BIOCHEM MOLEC, V28, P277, DOI 10.1016/S0965-1748(97)00110-0; Seeb JE, 2011, MOL ECOL RESOUR, V11, P1, DOI 10.1111/j.1755-0998.2010.02979.x; Sekhon BS, 2010, RES REP BIOL, V1, P1, DOI 10.2147/RRB.S12043; Sevatdal S, 2003, AQUACULTURE, V218, P21, DOI 10.1016/S0044-8486(02)00339-3; Skilbrei OT, 2013, J FISH DIS, V36, P249, DOI 10.1111/jfd.12052; Sutherland BJG, 2012, MOL ECOL, V21, P6000, DOI 10.1111/mec.12072; Tadiso TM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-141; Gonzalez MT, 2012, AQUAC RES, V43, P853, DOI 10.1111/j.1365-2109.2011.02900.x; Torrissen O, 2013, J FISH DIS, V36, P171, DOI 10.1111/jfd.12061; Tufail M, 2008, J INSECT PHYSIOL, V54, P1447, DOI 10.1016/j.jinsphys.2008.08.007; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Wilson CH, 2011, J COMP NEUROL, V519, P3259, DOI 10.1002/cne.22695; Wilstermann A, 2013, J PEST SCI, V86, P419, DOI 10.1007/s10340-013-0496-8; Yasuike M, 2012, MAR BIOTECHNOL, V14, P155, DOI 10.1007/s10126-011-9398-z	59	54	56	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92239	10.1371/journal.pone.0092239	http://dx.doi.org/10.1371/journal.pone.0092239			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691066	Green Published, Green Submitted, gold			2022-12-25	WOS:000334101100017
J	Matsunaga, M; Isowa, T; Yamakawa, K; Fukuyama, S; Shinoda, J; Yamada, J; Ohira, H				Matsunaga, Masahiro; Isowa, Tokiko; Yamakawa, Kaori; Fukuyama, Seisuke; Shinoda, Jun; Yamada, Jitsuhiro; Ohira, Hideki			Genetic Variations in the Human Cannabinoid Receptor Gene Are Associated with Happiness	PLOS ONE			English	Article							PREFRONTAL CORTEX; ENDOCANNABINOID SYSTEM; NUCLEUS-ACCUMBENS; REWARD SYSTEM; CNR1 GENE; LONG-TERM; ANANDAMIDE; BRAIN; VALIDATION; PATHWAYS	Happiness has been viewed as a temporary emotional state (e. g., pleasure) and a relatively stable state of being happy (subjective happiness level). As previous studies demonstrated that individuals with high subjective happiness level rated their current affective states more positively when they experience positive events, these two aspects of happiness are interrelated. According to a recent neuroimaging study, the cytosine to thymine single-nucleotide polymorphism of the human cannabinoid receptor 1 gene is associated with sensitivity to positive emotional stimuli. Thus, we hypothesized that our genetic traits, such as the human cannabinoid receptor 1 genotypes, are closely related to the two aspects of happiness. In Experiment 1, 198 healthy volunteers were used to compare the subjective happiness level between cytosine allele carriers and thymine-thymine carriers of the human cannabinoid receptor 1 gene. In Experiment 2, we used positron emission tomography with 20 healthy participants to compare the brain responses to positive emotional stimuli of cytosine allele carriers to that of thymine-thymine carriers. Compared to thymine-thymine carriers, cytosine allele carriers have a higher subjective happiness level. Regression analysis indicated that the cytosine allele is significantly associated with subjective happiness level. The positive mood after watching a positive film was significantly higher for the cytosine allele carriers compared to the thymine-thymine carriers. Positive emotion-related brain region such as the medial prefrontal cortex was significantly activated when the cytosine allele carriers watched the positive film compared to the thyminethymine carriers. Thus, the human cannabinoid receptor 1 genotypes are closely related to two aspects of happiness. Compared to thymine-thymine carriers, the cytosine allele carriers of the human cannabinoid receptor 1 gene, who are sensitive to positive emotional stimuli, exhibited greater magnitude positive emotions when they experienced positive events and had a higher subjective happiness level.	[Matsunaga, Masahiro] Aichi Med Univ, Sch Med, Dept Hlth & Psychosocial Med, Aichi, Japan; [Isowa, Tokiko] Mie Univ, Fac Med, Dept Gerontol Nursing, Tsu, Mie, Japan; [Yamakawa, Kaori; Ohira, Hideki] Nagoya Univ, Grad Sch Environm Studies, Dept Psychol, Aichi, Japan; [Fukuyama, Seisuke; Shinoda, Jun; Yamada, Jitsuhiro] Kizawa Mem Hosp, Chubu Med Ctr Prolonged Traumat Brain Dysfunct, Gifu, Japan	Aichi Medical University; Mie University; Nagoya University	Matsunaga, M (corresponding author), Aichi Med Univ, Sch Med, Dept Hlth & Psychosocial Med, Aichi, Japan.	matsunag@aichi-med-u.ac.jp	YAMAKAWA, Kaori/ABC-8782-2020		Japan Society for the Promotion of Science [25750354]; Grants-in-Aid for Scientific Research [25284003] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (25750354 to MM). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding was received for this study.	Berridge KC, 2011, PSYCHOL WELL-BEING, V1, DOI 10.1186/2211-1522-1-3; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Carlson JM, 2011, NEUROIMAGE, V57, P1608, DOI 10.1016/j.neuroimage.2011.05.037; Chakrabarti B, 2006, EUR J NEUROSCI, V23, P1944, DOI 10.1111/j.1460-9568.2006.04697.x; DEVANE WA, 1994, P NATL ACAD SCI USA, V91, P6698, DOI 10.1073/pnas.91.14.6698; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Hoffman AF, 2003, EUR J NEUROSCI, V18, P524, DOI 10.1046/j.1460-9568.2003.02773.x; Katona I, 2001, J NEUROSCI, V21, P9506, DOI 10.1523/JNEUROSCI.21-23-09506.2001; KOZMA A, 1983, J GERONTOL, V38, P626, DOI 10.1093/geronj/38.5.626; KOZMA A, 1990, SOC INDIC RES, V22, P119, DOI 10.1007/BF00354836; Krueger F, 2009, TRENDS COGN SCI, V13, P103, DOI 10.1016/j.tics.2008.12.005; Lyubomirsky S, 1999, SOC INDIC RES, V46, P137, DOI 10.1023/A:1006824100041; Mahler SV, 2007, NEUROPSYCHOPHARMACOL, V32, P2267, DOI 10.1038/sj.npp.1301376; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Matsunaga M, 2011, NAT SCI, V3, P723, DOI DOI 10.4236/NS.2011.38095; Matsunaga M, 2008, BRAIN BEHAV IMMUN, V22, P408, DOI 10.1016/j.bbi.2007.09.008; Matsunaga M, 2011, NEUROENDOCRINOL LETT, V32, P458; Mitjans M, 2013, PSYCHOPHARMACOLOGY, V227, P509, DOI 10.1007/s00213-013-2995-y; Moreira FA, 2008, ADDICT BIOL, V13, P196, DOI 10.1111/j.1369-1600.2008.00104.x; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Okamoto Y, 2007, CHEM BIODIVERS, V4, P1842, DOI 10.1002/cbdv.200790155; Otake Keiko, 2006, J Happiness Stud, V7, P361, DOI 10.1007/s10902-005-3650-z; Petrides M, 2007, J NEUROSCI, V27, P11573, DOI 10.1523/JNEUROSCI.2419-07.2007; Roy M, 2012, TRENDS COGN SCI, V16, P147, DOI 10.1016/j.tics.2012.01.005; Schimmack U., 2008, SCI SUBJECTIVE WELL, P97, DOI DOI 10.5860/CHOICE.45-5867; Seligman MEP, 2005, AM PSYCHOL, V60, P410, DOI 10.1037/0003-066X.60.5.410; Sharot T, 2007, NATURE, V450, P102, DOI 10.1038/nature06280; Shimai Satoshi, 2004, Nihon Koshu Eisei Zasshi, V51, P845; Sperlagh B, 2009, NEUROCHEM INT, V54, P452, DOI 10.1016/j.neuint.2009.01.017; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Stones MJ, 1995, SOC INDIC RES, V36, P129, DOI 10.1007/BF01079722; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Bos W, 2012, CEREB CORTEX, V22, P1247, DOI 10.1093/cercor/bhr198; van der Stelt M, 2003, EUR J PHARMACOL, V480, P133, DOI 10.1016/j.ejphar.2003.08.101; Waterman AS, 2008, J HAPPINESS STUD, V9, P41, DOI 10.1007/s10902-006-9020-7; Zhang PW, 2004, MOL PSYCHIATR, V9, P916, DOI 10.1038/sj.mp.4001560	38	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93771	10.1371/journal.pone.0093771	http://dx.doi.org/10.1371/journal.pone.0093771			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690898	Green Published, Green Submitted, gold			2022-12-25	WOS:000334101100133
J	Yamanaka, T; Hosoi, H; Murai, T; Kobayashi, T; Inada, Y; Nakamura, T				Yamanaka, Toshiaki; Hosoi, Hiroshi; Murai, Takayuki; Kobayashi, Takehiko; Inada, Yuji; Nakamura, Tatsuo			Regeneration of the Nerves in the Aerial Cavity with an Artificial Nerve Conduit -Reconstruction of Chorda Tympani Nerve Gaps-	PLOS ONE			English	Article							ACID-COLLAGEN TUBE; TASTE; ELECTROGUSTOMETRY; RELIABILITY; SURGERY; ANATOMY; INJURY; REPAIR	Objectives/Hypothesis: Due to its anatomical features, the chorda tympani nerve (CTN) is sometimes sacrificed during middle ear surgery, resulting in taste dysfunction. We examined the effect of placing an artificial nerve conduit, a polyglycolic acid (PGA)-collagen tube, across the gap in the section of the resected chorda tympani nerve (CTN) running through the tympanic cavity. Methods: The CTN was reconstructed with a PGA-collagen tube in three patients with taste disturbance who underwent CTN resection. To evaluate the effect of the reconstruction procedure on the patients' gustatory function, we measured the patients' electrogustometry (EGM) thresholds. The patients were followed-up for at least two years. Results: Gustatory function was completely restored in all of the patients after the reconstruction. The patients' EGM thresholds exhibited early improvements within one to two weeks and had returned to their normal ranges within three months. They subsequently remained stable throughout the two-year follow-up period. In a patient who underwent a second surgical procedure, it was found that the PGA-collagen tube used in the first surgical procedure had been absorbed and replaced by new CTN fibers with blood vessels on their surfaces. Conclusion: These results suggest that reconstruction of the CTN with an artificial nerve conduit, a PGA-collagen tube, allows functional and morphological regeneration of the nerve and facilitates the recovery of taste function. PGA-collagen tubes might be useful for repairing CTNs that are resected during middle ear surgery. Further research is required to confirm these preliminary results although this is the first report to describe the successful regeneration of a nerve running through an aerial space.	[Yamanaka, Toshiaki; Hosoi, Hiroshi; Murai, Takayuki; Kobayashi, Takehiko] Nara Med Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Nara, Japan; [Inada, Yuji] Inada Hosp, Dept Orthoped Surg, Nara, Japan; [Nakamura, Tatsuo] Kyoto Univ, Inst Frontier Med Sci, Dept Bioartificial Organs, Kyoto, Japan	Nara Medical University; Kyoto University	Yamanaka, T (corresponding author), Nara Med Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Nara, Japan.	toshya@naramed-u.ac.jp						ANSON BJ, 1972, ANN OTO RHINOL LARYN, V81, P616, DOI 10.1177/000348947208100502; Boyd KU, 2011, CLIN PLAST SURG, V38, P643, DOI 10.1016/j.cps.2011.07.008; Horie RT, 2010, LARYNGOSCOPE, V120, P377, DOI 10.1002/lary.20713; Ichihara S, 2008, INJURY, V39, pS29, DOI 10.1016/j.injury.2008.08.029; Inada Y, 2005, PAIN, V117, P251, DOI 10.1016/j.pain.2005.05.033; Inada Y, 2004, NEUROSURGERY, V55, P640, DOI 10.1227/01.NEU.0000134388.86603.11; Kannan RY, 2005, BIOTECHNOL APPL BIOC, V41, P193, DOI 10.1042/BA20040137; Kiverniti E, 2012, J LARYNGOL OTOL, V126, P34, DOI 10.1017/S0022215111002623; Kiyotani T, 1996, BRAIN RES, V740, P66, DOI 10.1016/S0006-8993(96)00848-7; KVETON JF, 1994, LARYNGOSCOPE, V104, P25; Leung RM, 2009, LARYNGOSCOPE, V119, P2061, DOI 10.1002/lary.20588; Lobb B, 2000, CLIN OTOLARYNGOL, V25, P531, DOI 10.1046/j.1365-2273.2000.00392.x; MACKINNON SE, 1990, PLAST RECONSTR SURG, V85, P419, DOI 10.1097/00006534-199003000-00015; Mahendran S, 2005, EUR ARCH OTO-RHINO-L, V262, P482, DOI 10.1007/s00405-004-0854-5; McManus LJ, 2012, J LARYNGOL OTOL, V126, P8, DOI 10.1017/S0022215111002039; McManus LJ, 2011, J LARYNGOL OTOL, V125, P1101, DOI 10.1017/S0022215111001873; MURPHY C, 1995, CHEM SENSES, V20, P499, DOI 10.1093/chemse/20.5.499; Nakamura T, 2004, BRAIN RES, V1027, P18, DOI 10.1016/j.brainres.2004.08.040; Nectow AR, 2012, TISSUE ENG PART B-RE, V18, P40, DOI [10.1089/ten.teb.2011.0240, 10.1089/ten.TEB.2011.0240]; Nin T, 2006, AURIS NASUS LARYNX, V33, P13, DOI 10.1016/j.anl.2005.07.015; Pfister Bryan J., 2011, Critical Reviews in Biomedical Engineering, V39, P81, DOI 10.1615/CritRevBiomedEng.v39.i2.20; Saito T, 2001, LARYNGOSCOPE, V111, P2064, DOI 10.1097/00005537-200111000-00037; Sakagami M, 2005, CHEM SENSES, V30, pI220, DOI 10.1093/chemse/bjh193; Seddon HJ, 1943, J PHYSIOL-LONDON, V102, P191, DOI 10.1113/jphysiol.1943.sp004027; Toba T, 2001, J BIOMED MATER RES, V58, P622, DOI 10.1002/jbm.1061	25	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92258	10.1371/journal.pone.0092258	http://dx.doi.org/10.1371/journal.pone.0092258			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691095	gold, Green Published, Green Submitted			2022-12-25	WOS:000334101100018
J	Zhang, JC; Pu, RL; Yuan, L; Wang, JH; Huang, WJ; Yang, GJ				Zhang, Jingcheng; Pu, Ruiliang; Yuan, Lin; Wang, Jihua; Huang, Wenjiang; Yang, Guijun			Monitoring Powdery Mildew of Winter Wheat by Using Moderate Resolution Multi- Temporal Satellite Imagery	PLOS ONE			English	Article							LEAST-SQUARES REGRESSION; YELLOW RUST; REFLECTANCE MEASUREMENTS; SPECTRAL REFLECTANCE; VEGETATION INDEXES; AREA INDEX; DISEASE; INFESTATION; PINE; SENSITIVITY	Powdery mildew is one of the most serious diseases that have a significant impact on the production of winter wheat. As an effective alternative to traditional sampling methods, remote sensing can be a useful tool in disease detection. This study attempted to use multi- temporal moderate resolution satellite- based data of surface reflectances in blue ( B), green ( G), red ( R) and near infrared (NIR) bands from HJ-CCD ( CCD sensor on Huanjing satellite) to monitor disease at a regional scale. In a suburban area in Beijing, China, an extensive field campaign for disease intensity survey was conducted at key growth stages of winter wheat in 2010. Meanwhile, corresponding time series of HJ- CCD images were acquired over the study area. In this study, a number of single- stage and multi- stage spectral features, which were sensitive to powdery mildew, were selected by using an independent t- test. With the selected spectral features, four advanced methods: mahalanobis distance, maximum likelihood classifier, partial least square regression and mixture tuned matched filtering were tested and evaluated for their performances in disease mapping. The experimental results showed that all four algorithms could generate disease maps with a generally correct distribution pattern of powdery mildew at the grain filling stage ( Zadoks 72). However, by comparing these disease maps with ground survey data ( validation samples), all of the four algorithms also produced a variable degree of error in estimating the disease occurrence and severity. Further, we found that the integration of MTMF and PLSR algorithms could result in a significant accuracy improvement of identifying and determining the disease intensity ( overall accuracy of 72% increased to 78% and kappa coefficient of 0.49 increased to 0.59). The experimental results also demonstrated that the multi- temporal satellite images have a great potential in crop diseases mapping at a regional scale.	[Zhang, Jingcheng; Yuan, Lin; Wang, Jihua; Huang, Wenjiang; Yang, Guijun] Beijing Acad Agr & Forestry Sci, Beijing Res Ctr Informat Technol Agr, Beijing, Peoples R China; [Zhang, Jingcheng; Pu, Ruiliang] Univ S Florida, Sch Geosci, Tampa, FL USA; [Zhang, Jingcheng; Yuan, Lin; Wang, Jihua] Zhejiang Univ, Inst Agr Remote Sensing & Informat Syst Applicat, Hangzhou 310003, Zhejiang, Peoples R China; [Huang, Wenjiang] Chinese Acad Sci, Ctr Earth Observat & Digital Earth, Beijing, Peoples R China	Beijing Academy of Agriculture & Forestry; State University System of Florida; University of South Florida; Zhejiang University; Chinese Academy of Sciences	Yang, GJ (corresponding author), Beijing Acad Agr & Forestry Sci, Beijing Res Ctr Informat Technol Agr, Beijing, Peoples R China.	yanggj@nercita.org.cn	huang, wenjiang/AAM-6844-2021	Yang, Guijun/0000-0002-6425-8321	National Natural Science Foundation of China [41301476, 41271412]; Beijing Natural Science Foundation [4132029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was subsidized by National Natural Science Foundation of China (41301476, 41271412), and Beijing Natural Science Foundation (4132029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew ME, 2008, REMOTE SENS ENVIRON, V112, P4301, DOI 10.1016/j.rse.2008.07.016; Bauriegel E, 2011, COMPUT ELECTRON AGR, V75, P304, DOI 10.1016/j.compag.2010.12.006; BOARDMAN JW, 1998, P 5 JPL GEOSC WORKSH; Cao XR, 2013, CROP PROT, V45, P124, DOI 10.1016/j.cropro.2012.12.002; Chen X, 2007, INT J REMOTE SENS, V28, P5183, DOI 10.1080/01431160701620683; Christou P, 2004, NUTR RES REV, V17, P23, DOI 10.1079/NRR200373; Cooke BM, 2006, EPIDEMIOLOGY PLANT D; Coops NC, 2006, REMOTE SENS ENVIRON, V105, P83, DOI 10.1016/j.rse.2006.06.007; Devadas R, 2009, PRECIS AGRIC, V10, P459, DOI 10.1007/s11119-008-9100-2; Eklundh L, 2009, REMOTE SENS ENVIRON, V113, P1566, DOI 10.1016/j.rse.2009.03.008; Faber NM, 2007, ANAL CHIM ACTA, V595, P98, DOI 10.1016/j.aca.2007.05.030; Franke J, 2007, PRECIS AGRIC, V8, P161, DOI 10.1007/s11119-007-9036-y; Gonsamo A, 2012, ISPRS J PHOTOGRAMM, V70, P15, DOI 10.1016/j.isprsjprs.2012.03.009; Goodwin NR, 2008, REMOTE SENS ENVIRON, V112, P3680, DOI 10.1016/j.rse.2008.05.005; Hahn F, 2009, ALGORITHMS, V2, P301, DOI 10.3390/a2010301; Huang W, 2007, PRECIS AGRIC, V8, P187, DOI 10.1007/s11119-007-9038-9; Jones CD, 2010, COMPUT ELECTRON AGR, V74, P329, DOI 10.1016/j.compag.2010.09.008; Kennedy RE, 2009, REMOTE SENS ENVIRON, V113, P1382, DOI 10.1016/j.rse.2008.07.018; Li BB, 2002, CHEMOMETR INTELL LAB, V64, P79, DOI 10.1016/S0169-7439(02)00051-5; Li G.B., 1989, INTEGRATED MANAGEMEN; Liang SL, 2001, IEEE T GEOSCI REMOTE, V39, P2490, DOI 10.1109/36.964986; Liu DS, 2006, REMOTE SENS ENVIRON, V101, P167, DOI 10.1016/j.rse.2005.12.012; LORENZEN B, 1989, REMOTE SENS ENVIRON, V27, P201, DOI 10.1016/0034-4257(89)90018-7; Lu D, 2004, INT J REMOTE SENS, V25, P2365, DOI 10.1080/0143116031000139863; Mitchell JJ, 2009, INT J REMOTE SENS, V30, P6099, DOI 10.1080/01431160902810620; Moshou D, 2004, COMPUT ELECTRON AGR, V44, P173, DOI 10.1016/j.compag.2004.04.003; Muhammed HH, 2005, BIOSYST ENG, V91, P9, DOI 10.1016/j.biosystemseng.2005.02.007; Naidu RA, 2009, COMPUT ELECTRON AGR, V66, P38, DOI 10.1016/j.compag.2008.11.007; NILSSON HE, 1995, CAN J PLANT PATHOL, V17, P154, DOI 10.1080/07060669509500707; Nofal MA, 2006, CROP PROT, V25, P480, DOI 10.1016/j.cropro.2005.08.003; Olsen M, 2003, CROP PROT, V22, P679, DOI 10.1016/S0261-2194(02)00245-4; Pu RL, 2012, REMOTE SENS ENVIRON, V124, P516, DOI 10.1016/j.rse.2012.06.011; Pu RL, 2012, GISCI REMOTE SENS, V49, P92, DOI 10.2747/1548-1603.49.1.92; Qin ZH, 2005, INT J APPL EARTH OBS, V7, P115, DOI 10.1016/j.jag.2005.03.004; RABBINGE R, 1985, NETH J PLANT PATHOL, V91, P235, DOI 10.1007/BF01997967; Remus-Borel W, 2005, PHYSIOL MOL PLANT P, V66, P108, DOI 10.1016/j.pmpp.2005.05.006; Richards J. A., 2006, REMOTE SENSING DIGIT, P267; Sankaran S, 2010, COMPUT ELECTRON AGR, V72, P1, DOI 10.1016/j.compag.2010.02.007; Sharma AK, 2004, CROP PROT, V23, P249, DOI 10.1016/j.cropro.2003.08.009; Sims DA, 2002, REMOTE SENS ENVIRON, V81, P337, DOI 10.1016/S0034-4257(02)00010-X; Skakun RS, 2003, REMOTE SENS ENVIRON, V86, P433, DOI 10.1016/S0034-4257(03)00112-3; Song SL, 2011, ISPRS J PHOTOGRAMM, V66, P672, DOI 10.1016/j.isprsjprs.2011.05.002; Stohlgren TJ, 2005, N AM WEED MANAGEMENT; Strange RN, 2005, ANNU REV PHYTOPATHOL, V43, P83, DOI 10.1146/annurev.phyto.43.113004.133839; Townshend JRG, 1992, IEEE T GEOSCI REMOTE, V30, P1056; Veraverbeke S, 2012, ISPRS J PHOTOGRAMM, V68, P28, DOI 10.1016/j.isprsjprs.2011.12.007; West JS, 2003, ANNU REV PHYTOPATHOL, V41, P593, DOI 10.1146/annurev.phyto.41.121702.103726; Yang CM, 2007, CROP SCI, V47, P329, DOI 10.2135/cropsci2006.05.0335; Zhang J., 2012, THESIS ZHEJIANG U; Zhang JC, 2012, COMPUT ELECTRON AGR, V85, P13, DOI 10.1016/j.compag.2012.03.006; Zhang JC, 2011, INTELL AUTOM SOFT CO, V17, P531; Zhang JC, 2011, PRECIS AGRIC, V12, P716, DOI 10.1007/s11119-010-9214-1; Zhang M., 2003, INT J APPL EARTH OBS, V4, P295, DOI 10.1016/S0303-2434(03)00008-4; Zhang Minghua, 2005, Precision Agriculture, V6, P489, DOI 10.1007/s11119-005-5640-x; Zhao CJ, 2004, INT GEOSCI REMOTE SE, P4318	55	23	30	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93107	10.1371/journal.pone.0093107	http://dx.doi.org/10.1371/journal.pone.0093107			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691435	Green Published, gold, Green Submitted			2022-12-25	WOS:000334101100045
J	Ma, Y; Kang, XN; Ding, WB; Yang, HZ; Wang, Y; Zhang, J; Huang, YR; Dai, HL				Ma, Yi; Kang, Xiao-Nan; Ding, Wen-Bin; Yang, Hao-Zheng; Wang, Ye; Zhang, Jin; Huang, Yi-Ran; Dai, Hui-Li			Renal Tissue Thawed for 30 Minutes Is Still Suitable for Gene Expression Analysis	PLOS ONE			English	Article							FRESH-FROZEN TISSUE; RNA INTEGRITY; WARM ISCHEMIA; IMPACT; TIME; QUALITY; DEGRADATION; MICROARRAYS; STABILITY	Some biosamples obtained from biobanks may go through thawing before processing. We aim to evaluate the effects of thawing at room temperature for different time periods on gene expression analysis. A time course study with four time points was conducted to investigate the expression profiling on 10 thawed normal mice renal tissue samples through Affymetrix GeneChip mouse gene 2.0 st array. Microarray results were validated by quantitative real time polymerase chain reactions (qPCR) on 6 candidate reference genes and 11 target genes. Additionally, we used geNorm plus and NormFinder to identify the most stably expressed reference genes over time. The results showed RNA degraded more after longer incubation at room temperature. However, microarray results showed only 240 genes (0.91%) altered significantly in response to thawing at room temperature. The signal of majority altered probe sets decreased with thawing time, and the crossing point (Cp) values of all candidate reference genes correlated positively with the thawing time (p < 0.05). The combination of B2M, ACTB and PPIA was identified as the best choice for qPCR normalization. We found most target genes were stable by using this normalization method. However, serious gene quantification errors were resulted from improper reference genes. In conclusion, thirty minutes of thawing at room temperature has a limited impact on microarray and qPCR analysis, gene expression variations due to RNA degradation in early period after thawing can be largely reduced by proper normalization.	[Ma, Yi; Kang, Xiao-Nan; Ding, Wen-Bin; Wang, Ye; Dai, Hui-Li] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Biobank, Shanghai 200030, Peoples R China; [Ma, Yi; Zhang, Jin; Huang, Yi-Ran] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Urol, Shanghai 200030, Peoples R China; [Yang, Hao-Zheng] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Cent Lab, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Huang, YR (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Urol, Shanghai 200030, Peoples R China.	dr_yrh@126.com; dr_dhl@126.com			Science and Technology Commission of Shanghai Municipality [124119a1300, 12DZ2295005]; Shanghai JiaoTong University School of Medicine [12XJ10014, YBKL2013004]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai JiaoTong University School of Medicine	This work was supported by Science and Technology Commission of Shanghai Municipality (124119a1300; 12DZ2295005) and Shanghai JiaoTong University School of Medicine (12XJ10014; YBKL2013004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah-Sayani A, 2006, NAT CLIN PRACT ONCOL, V3, P501, DOI 10.1038/ncponc0587; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Antonov J, 2005, LAB INVEST, V85, P1040, DOI 10.1038/labinvest.3700303; Auer H, 2003, NAT GENET, V35, P292, DOI 10.1038/ng1203-292; Barry WT, 2010, J CLIN ONCOL, V28, P2198, DOI 10.1200/JCO.2009.26.7245; Becker C, 2010, METHODS, V50, P237, DOI 10.1016/j.ymeth.2010.01.010; Blackhall FH, 2004, NEOPLASIA, V6, P761, DOI 10.1593/neo.04301; Botling J, 2009, DIAGN MOL PATHOL, V18, P44, DOI 10.1097/PDM.0b013e3181857e92; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Dash A, 2002, AM J PATHOL, V161, P1743, DOI 10.1016/S0002-9440(10)64451-3; De Cecco L, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-409; Elger BS, 2006, EMBO REP, V7, P661, DOI 10.1038/sj.embor.7400740; Ellis M, 2002, CLIN CANCER RES, V8, P1155; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Hatzis C, 2011, JNCI-J NATL CANCER I, V103, P1871, DOI 10.1093/jnci/djr438; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Ioannidis JPA, 2007, ONCOLOGIST, V12, P301, DOI 10.1634/theoncologist.12-3-301; Lin DW, 2006, J CLIN ONCOL, V24, P3763, DOI 10.1200/JCO.2005.05.1458; Ma Y, 2012, DIAGN MOL PATHOL, V21, P157, DOI 10.1097/PDM.0b013e31824d3435; Ma Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036050; Ma Y, 2012, ANAL BIOCHEM, V423, P229, DOI 10.1016/j.ab.2012.02.003; Mager SR, 2007, EUR J CANCER, V43, P828, DOI 10.1016/j.ejca.2007.01.002; Micke P, 2006, LAB INVEST, V86, P202, DOI 10.1038/labinvest.3700372; Mutter GL, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-88; Perez-Novo CA, 2005, BIOTECHNIQUES, V39, P52; Rudloff U, 2010, ANN SURG ONCOL, V17, P2229, DOI 10.1245/s10434-010-0959-6; Schlomm T, 2008, EUR UROL, V53, P333, DOI 10.1016/j.eururo.2007.03.075; Schoor O, 2003, BIOTECHNIQUES, V35, P1192, DOI 10.2144/03356rr01; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Thompson KL, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-57; Vermeulen J, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr065	31	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2014	9	3							e93175	10.1371/journal.pone.0093175	http://dx.doi.org/10.1371/journal.pone.0093175			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GP	24687048	gold, Green Submitted, Green Published			2022-12-25	WOS:000340842300005
J	Wang, RP; Cleary, RA; Wang, T; Li, J; Tang, DD				Wang, Ruping; Cleary, Rachel A.; Wang, Tao; Li, Jia; Tang, Dale D.			The Association of Cortactin with Profilin-1 Is Critical for Smooth Muscle Contraction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Cytoskeleton; Excitation-Contraction Coupling; Protein Phosphorylation; Smooth Muscle; Adapter Protein; Contraction	CRK-ASSOCIATED SUBSTRATE; ACTIN POLYMERIZATION; TYROSINE KINASE; AIRWAY HYPERRESPONSIVENESS; P21-ACTIVATED KINASE; TENSION DEVELOPMENT; CELL PROLIFERATION; FORCE DEVELOPMENT; VIMENTIN NETWORK; ABL	Background: Profilin-1 (Pfn-1) regulates actin dynamics and contraction in smooth muscle. Results: Contractile activation increases the association of cortactin with Pfn-1 via c-Abl, which controls actin dynamics and contraction. Conclusion: The coupling of cortactin with Pfn-1 regulated by c-Abl is critical for actin polymerization and contraction. Significance: The c-Abl-mediated cortactin/Pfn-1 interaction is a novel mechanism for the regulation of smooth muscle contraction. Profilin-1 (Pfn-1) is an actin-regulatory protein that has a role in modulating smooth muscle contraction. However, the mechanisms that regulate Pfn-1 in smooth muscle are not fully understood. Here, stimulation with acetylcholine induced an increase in the association of the adapter protein cortactin with Pfn-1 in smooth muscle cells/tissues. Furthermore, disruption of the protein/protein interaction by a cell-permeable peptide (CTTN-I peptide) attenuated actin polymerization and smooth muscle contraction without affecting myosin light chain phosphorylation at Ser-19. Knockdown of cortactin by lentivirus-mediated RNAi also diminished actin polymerization and smooth muscle force development. However, cortactin knockdown did not affect myosin activation. In addition, cortactin phosphorylation has been implicated in nonmuscle cell migration. In this study, acetylcholine stimulation induced cortactin phosphorylation at Tyr-421 in smooth muscle cells. Phenylalanine substitution at this position impaired cortactin/Pfn-1 interaction in response to contractile activation. c-Abl is a tyrosine kinase that is necessary for actin dynamics and contraction in smooth muscle. Here, c-Abl silencing inhibited the agonist-induced cortactin phosphorylation and the association of cortactin with Pfn-1. Finally, treatment with CTTN-I peptide reduced airway resistance and smooth muscle hyperreactivity in a murine model of asthma. These results suggest that the interaction of cortactin with Pfn-1 plays a pivotal role in regulating actin dynamics, smooth muscle contraction, and airway hyperresponsiveness in asthma. The association of cortactin with Pfn-1 is regulated by c-Abl-mediated cortactin phosphorylation.	[Wang, Ruping; Cleary, Rachel A.; Wang, Tao; Li, Jia; Tang, Dale D.] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA	Albany Medical College	Tang, DD (corresponding author), Albany Med Coll, Ctr Cardiovasc Sci, 47 New Scotland Ave,MC 8, Albany, NY 12208 USA.	tangd@mail.amc.edu		Tang, Dale/0000-0002-7339-9249; Wang, Ruping/0000-0003-4233-7755	National Institutes of Health [HL-110951, HL-113208]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110951, R01HL113208] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-110951 and HL-113208 (to D. D. T.).	Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Amrani Y, 2004, CURR OPIN PHARMACOL, V4, P230, DOI 10.1016/j.coph.2004.02.004; Anfinogenova Y, 2007, CIRC RES, V101, P420, DOI 10.1161/CIRCRESAHA.107.156463; BJORCK T, 1992, AM REV RESPIR DIS, V145, P1087; Boukhelifa M, 2006, FEBS J, V273, P26, DOI 10.1111/j.1742-4658.2005.05036.x; Boyle SN, 2007, CURR BIOL, V17, P445, DOI 10.1016/j.cub.2007.01.057; Brooks H, 2005, ADV DRUG DELIVER REV, V57, P559, DOI 10.1016/j.addr.2004.12.001; Chen S, 2009, AM J PHYSIOL-HEART C, V297, pH533, DOI 10.1152/ajpheart.00237.2009; Cleary RA, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-105; Cosen-Binker LI, 2006, PHYSIOLOGY, V21, P352, DOI 10.1152/physiol.00012.2006; Coulson FR, 2003, PHARMACOL THERAPEUT, V98, P59, DOI 10.1016/S0163-7258(03)00004-4; Deshpande DA, 2004, AM J RESP CELL MOL, V31, P36, DOI 10.1165/rcmb.2003-0313OC; Ding ZJ, 2006, J CELL SCI, V119, P4127, DOI 10.1242/jcs.03178; Fan Y, 2012, NAT CELL BIOL, V14, P1046, DOI 10.1038/ncb2580; Forsythe SM, 2002, AM J RESP CELL MOL, V26, P298, DOI 10.1165/ajrcmb.26.3.4564; Gerthoffer WT, 2001, J APPL PHYSIOL, V91, P963, DOI 10.1152/jappl.2001.91.2.963; Guedes AGP, 2006, AM J PHYSIOL-LUNG C, V291, pL1286, DOI 10.1152/ajplung.00187.2006; Gunst SJ, 2000, EUR RESPIR J, V15, P600, DOI 10.1034/j.1399-3003.2000.15.29.x; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; Herrera AM, 2004, AM J PHYSIOL-LUNG C, V286, pL1161, DOI 10.1152/ajplung.00298.2003; Hu HL, 2005, CURR BIOL, V15, P815, DOI 10.1016/j.cub.2005.03.049; Jia L, 2012, AM J PHYSIOL-CELL PH, V302, pC1026, DOI 10.1152/ajpcell.00373.2011; Jia L, 2010, AM J PHYSIOL-CELL PH, V299, pC630, DOI 10.1152/ajpcell.00095.2010; KAMM KE, 1989, ANNU REV PHYSIOL, V51, P299; Kim HR, 2008, AM J PHYSIOL-CELL PH, V295, pC768, DOI 10.1152/ajpcell.00174.2008; Lapetina S, 2009, J CELL BIOL, V185, P503, DOI 10.1083/jcb.200809085; Li QF, 2006, J BIOL CHEM, V281, P34716, DOI 10.1074/jbc.M607715200; Li QF, 2009, AM J PHYSIOL-CELL PH, V297, pC1424, DOI 10.1152/ajpcell.00324.2009; Li QF, 2009, AM J PHYSIOL-CELL PH, V297, pC299, DOI 10.1152/ajpcell.00037.2009; Ma XF, 2002, AM J PHYSIOL-LUNG C, V283, pL1181, DOI 10.1152/ajplung.00389.2001; Morgan KG, 2008, J CELL MOL MED, V12, P2157, DOI 10.1111/j.1582-4934.2008.00565.x; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Qiu ZZ, 2010, P NATL ACAD SCI USA, V107, P1136, DOI 10.1073/pnas.0913131107; Rembold CM, 2007, AM J PHYSIOL-CELL PH, V293, pC993, DOI 10.1152/ajpcell.00090.2007; Somlyo AV, 2004, PHILOS T R SOC B, V359, P1921, DOI 10.1098/rstb.2004.1562; Tang DD, 2008, J CARDIOVASC PHARM T, V13, P130, DOI 10.1177/1074248407313737; Tang DD, 2009, J CARDIOVASC PHARM T, V14, P89, DOI 10.1177/1074248409333490; Tang DD, 2005, J BIOL CHEM, V280, P23380, DOI 10.1074/jbc.M413390200; Tang DD, 2004, J BIOL CHEM, V279, P51722, DOI 10.1074/jbc.M408351200; Tang DD, 2003, HYPERTENSION, V42, P858, DOI 10.1161/01.HYP.0000085333.76141.33; Tang DD, 2003, AM J PHYSIOL-HEART C, V285, pH1528, DOI 10.1152/ajpheart.00188.2003; Tliba O, 2003, BRIT J PHARMACOL, V140, P1159, DOI 10.1038/sj.bjp.0705558; Wang JYJ, 2004, NAT CELL BIOL, V6, P3, DOI 10.1038/ncb0104-3; Wang RP, 2007, AM J PHYSIOL-LUNG C, V292, pL240, DOI 10.1152/ajplung.00199.2006; Wang RP, 2006, AM J PHYSIOL-CELL PH, V291, pC483, DOI 10.1152/ajpcell.00097.2006; Wang RP, 2013, AM J RESP CELL MOL, V48, P172, DOI 10.1165/rcmb.2012-0315OC; Wang T, 2013, J BIOL CHEM, V288, P20713, DOI 10.1074/jbc.M112.439877; Wegmann M, 2007, AM J RESP CELL MOL, V36, P61, DOI 10.1165/rcmb.2006-0188OC; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Yang CS, 2000, J CELL BIOL, V150, P1001, DOI 10.1083/jcb.150.5.1001	50	43	43	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14157	14169		10.1074/jbc.M114.548099	http://dx.doi.org/10.1074/jbc.M114.548099			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24700464	hybrid, Green Published			2022-12-25	WOS:000335984600043
J	Chan, BK; Wilson, T; Fischer, KF; Kriesel, JD				Chan, Benjamin K.; Wilson, Theodore; Fischer, Kael F.; Kriesel, John D.			Deep Sequencing to Identify the Causes of Viral Encephalitis	PLOS ONE			English	Article							SHORT DNA-SEQUENCES; HUMAN GENOME; VIRUS; MICROARRAY; ETIOLOGIES	Deep sequencing allows for a rapid, accurate characterization of microbial DNA and RNA sequences in many types of samples. Deep sequencing (also called next generation sequencing or NGS) is being developed to assist with the diagnosis of a wide variety of infectious diseases. In this study, seven frozen brain samples from deceased subjects with recent encephalitis were investigated. RNA from each sample was extracted, randomly reverse transcribed and sequenced. The sequence analysis was performed in a blinded fashion and confirmed with pathogen-specific PCR. This analysis successfully identified measles virus sequences in two brain samples and herpes simplex virus type-1 sequences in three brain samples. No pathogen was identified in the other two brain specimens. These results were concordant with pathogen-specific PCR and partially concordant with prior neuropathological examinations, demonstrating that deep sequencing can accurately identify viral infections in frozen brain	[Chan, Benjamin K.; Kriesel, John D.] Univ Utah, Sch Med, Dept Internal Med, Div Infect Dis, Salt Lake City, UT 84112 USA; [Wilson, Theodore; Fischer, Kael F.] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Kriesel, JD (corresponding author), Univ Utah, Sch Med, Dept Internal Med, Div Infect Dis, Salt Lake City, UT 84112 USA.	john.kriesel@hsc.utah.edu	Fischer, Kael/F-7756-2015	Fischer, Kael/0000-0002-7547-330X	National Institutes of Health NIH/NINDS [R21NS077023]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS077023] Funding Source: NIH RePORTER	National Institutes of Health NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health NIH/NINDS award # R21NS077023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chiu CY, 2007, J CLIN MICROBIOL, V45, P2340, DOI 10.1128/JCM.00364-07; Chiu CY, 2006, CLIN INFECT DIS, V43, pE71, DOI 10.1086/507896; De Boer J, 1991, CWI Q, V4, P283; Gea-Banacloche J, 2004, ANN INTERN MED, V140, P545, DOI 10.7326/0003-4819-140-7-200404060-00015; Glaser CA, 2006, CLIN INFECT DIS, V43, P1565, DOI 10.1086/509330; Glaser CA, 2003, CLIN INFECT DIS, V36, P731, DOI 10.1086/367841; Greninger AL, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-82; Jones E., 2001, SCIPY OPEN SOURCE SC; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kriesel JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031886; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lim ES, 2013, VIROLOGY, V436, P295, DOI 10.1016/j.virol.2012.12.005; Mailles A, 2009, CLIN INFECT DIS, V49, P1838, DOI 10.1086/648419; Patterson JB, 2001, VIROLOGY, V291, P215, DOI 10.1006/viro.2001.1182; PUCHHAMMERSTOCKL E, 1991, J CLIN MICROBIOL, V29, P1513; Relman DA, 2012, NATURE, V486, P194, DOI 10.1038/486194a; ROTA PA, 1995, J CLIN MICROBIOL, V33, P2485, DOI 10.1128/JCM.33.9.2485-2488.1995; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Steel CD, 2010, J NEUROIMMUNOL, V226, P81, DOI 10.1016/j.jneuroim.2010.05.034; Stevenson J, 2005, J CLIN MICROBIOL, V43, P2391, DOI 10.1128/JCM.43.5.2391-2398.2005; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	25	24	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93993	10.1371/journal.pone.0093993	http://dx.doi.org/10.1371/journal.pone.0093993			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699691	Green Submitted, Green Published, gold			2022-12-25	WOS:000334105000132
J	Giubellino, A; Shankavaram, U; Bullova, P; Schovanek, J; Zhang, YQ; Shen, M; Patel, N; Elkahloun, A; Lee, MJ; Trepel, J; Ferrer, M; Pacak, K				Giubellino, Alessio; Shankavaram, Uma; Bullova, Petra; Schovanek, Jan; Zhang, Yaqin; Shen, Min; Patel, Nikita; Elkahloun, Abdel; Lee, Min-Jung; Trepel, Jane; Ferrer, Marc; Pacak, Karel			High-Throughput Screening for the Identification of New Therapeutic Options for Metastatic Pheochromocytoma and Paraganglioma	PLOS ONE			English	Article							GENETICS; COMBINATION; MUTATIONS; UPDATE; MODELS; MAX; MYC	Drug repurposing or repositioning is an important part of drug discovery that has been growing in the last few years for the development of therapeutic options in oncology. We applied this paradigm in a screening of a library of about 3,800 compounds (including FDA-approved drugs and pharmacologically active compounds) employing a model of metastatic pheochromocytoma, the most common tumor of the adrenal medulla in children and adults. The collection of approved drugs was screened in quantitative mode, testing the compounds in compound-titration series (dose-response curves). Analysis of the dose-response screening data facilitated the selection of 50 molecules with potential bioactivity in pheochromocytoma cells. These drugs were classified based on molecular/cellular targets and signaling pathways affected, and selected drugs were further validated in a proliferation assay and by flow cytometric cell death analysis. Using meta-analysis information from molecular targets of the top drugs identified by our screening with gene expression data from human and murine microarrays, we identified potential drugs to be used as single drugs or in combination. An example of a combination with a synergistic effect is presented. Our study exemplifies a promising model to identify potential drugs from a group of clinically approved compounds that can more rapidly be implemented into clinical trials in patients with metastatic pheochromocytoma or paraganglioma.	[Giubellino, Alessio; Bullova, Petra; Schovanek, Jan; Patel, Nikita; Pacak, Karel] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD 20892 USA; [Zhang, Yaqin; Shen, Min; Ferrer, Marc] NIH, Natl Ctr Adv Translat Sci, Rockville, MD USA; [Elkahloun, Abdel] NHGRI, NIH, Bethesda, MD 20892 USA; [Lee, Min-Jung; Trepel, Jane] NCI, Med Oncol Branch, NIH, Bethesda, MD 20892 USA; [Shankavaram, Uma] NCI, Radiat Oncol Branch, NIH, Bethesda, MD 20892 USA; [Bullova, Petra] Slovak Acad Sci, Inst Virol, Dept Mol Med, Bratislava, Slovakia; [Schovanek, Jan] Univ Hosp Olomouc, Dept Internal Med Nephrol Rheumatol & Endocrinol, Olomouc, Czech Republic	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Slovak Academy of Sciences; University Hospital Olomouc	Giubellino, A (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD 20892 USA.	giubella@mail.nih.gov; karel@mail.nih.gov	Schovanek, Jan/AAP-9273-2021; Bullova, Petra/ABG-5262-2020; Giubellino, Alessio/H-3432-2019	Schovanek, Jan/0000-0002-5776-6766; Bullova, Petra/0000-0002-5411-2185; Giubellino, Alessio/0000-0002-5352-0662	Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008735] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZICSC006743] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZICHG200365] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the Intramural Research funding of the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjalle R, 2009, HORM METAB RES, V41, P687, DOI 10.1055/s-0029-1231025; Adler JT, 2008, ONCOLOGIST, V13, P779, DOI 10.1634/theoncologist.2008-0043; Ayala-Ramirez M, 2011, J CLIN ENDOCR METAB, V96, P717, DOI 10.1210/jc.2010-1946; Buffet A, 2012, HORM METAB RES, V44, P359, DOI 10.1055/s-0032-1304594; Burnichon N, 2012, HUM MOL GENET, V21, P5397, DOI 10.1093/hmg/dds374; Cascon A, 2012, CANCER RES, V72, P3119, DOI 10.1158/0008-5472.CAN-11-3891; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Collins FS, 2011, NAT REV DRUG DISCOV, V10, P397, DOI 10.1038/nrd3461; Comino-Mendez I, 2011, NAT GENET, V43, P663, DOI 10.1038/ng.861; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Duenas-Gonzalez A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-82; Fliedner SMJ, 2010, SEMIN ONCOL, V37, P627, DOI 10.1053/j.seminoncol.2010.10.017; Fliedner SMJ, 2010, CELL TISSUE RES, V340, P607, DOI 10.1007/s00441-010-0965-9; Gimenez-Roqueplo AP, 2012, HORM METAB RES, V44, P328, DOI 10.1055/s-0031-1301302; Giubellino A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056083; Gray J, 2012, CANCER BIOL THER, V13, P614, DOI 10.4161/cbt.19848; HOPEWELL R, 1995, MOL CELL BIOL, V15, P3470; Huang RL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001862; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jimenez C, 2013, CURR ONCOL REP; Karasek D, 2013, J HUM HYPERTENS, V27, P141, DOI 10.1038/jhh.2012.20; Killian JK, 2013, CANC DISCOV; King KS, 2011, J CLIN ONCOL, V29, P4137, DOI 10.1200/JCO.2011.34.6353; Martiniova L, 2011, ENDOCR-RELAT CANCER, V18, P143, DOI 10.1677/ERC-10-0090; Martiniova L, 2009, CLIN EXP METASTAS, V26, P239, DOI 10.1007/s10585-009-9236-0; Nakane M, 2003, ANN ONCOL, V14, P1449, DOI 10.1093/annonc/mdg358; Pacak K, 2012, INT J CANC; Powers JF, 2000, CELL TISSUE RES, V302, P309, DOI 10.1007/s004410000290; R Core Team, 2021, R LANG ENV STAT COMP; Sardana D, 2011, BRIEF BIOINFORM, V12, P346, DOI 10.1093/bib/bbr021; Schuetz CS, 2006, CANCER RES, V66, P5278, DOI 10.1158/0008-5472.CAN-05-4610; Shah U, 2012, MINERVA ENDOCRINOL, V37, P141; Shankavaram U, 2013, NEOPLASIA, V15, P435, DOI 10.1593/neo.122132; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tischler AS, 2004, HISTOL HISTOPATHOL, V19, P883, DOI 10.14670/HH-19.883; Vicha A, 2013, CURR OPIN ENDOCRINOL, V20, P186, DOI 10.1097/MED.0b013e32835fcc45; Wu GM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r53; Yang CZ, 2012, FASEB J, V26, P4506, DOI 10.1096/fj.12-210146	40	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e90458	10.1371/journal.pone.0090458	http://dx.doi.org/10.1371/journal.pone.0090458			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699253	Green Submitted, Green Published, gold			2022-12-25	WOS:000334105000010
J	Meyer, AF; Diepenbrock, JP; Happel, MFK; Ohl, FW; Anemuller, J				Meyer, Arne F.; Diepenbrock, Jan-Philipp; Happel, Max F. K.; Ohl, Frank W.; Anemueller, Joern			Discriminative Learning of Receptive Fields from Responses to Non-Gaussian Stimulus Ensembles	PLOS ONE			English	Article							PRIMARY AUDITORY-CORTEX; SUPPORT VECTOR MACHINES; INFERIOR COLLICULUS; NATURAL SOUNDS; CORTICAL-NEURONS; SPECTRAL MOTION; NEURAL MODEL; CLASSIFICATION; INFORMATION; SELECTIVITY	Analysis of sensory neurons' processing characteristics requires simultaneous measurement of presented stimuli and concurrent spike responses. The functional transformation from high-dimensional stimulus space to the binary space of spike and non-spike responses is commonly described with linear-nonlinear models, whose linear filter component describes the neuron's receptive field. From a machine learning perspective, this corresponds to the binary classification problem of discriminating spike-eliciting from non-spike-eliciting stimulus examples. The classification-based receptive field (CbRF) estimation method proposed here adapts a linear large-margin classifier to optimally predict experimental stimulus-response data and subsequently interprets learned classifier weights as the neuron's receptive field filter. Computational learning theory provides a theoretical framework for learning from data and guarantees optimality in the sense that the risk of erroneously assigning a spike-eliciting stimulus example to the non-spike class (and vice versa) is minimized. Efficacy of the CbRF method is validated with simulations and for auditory spectro-temporal receptive field (STRF) estimation from experimental recordings in the auditory midbrain of Mongolian gerbils. Acoustic stimulation is performed with frequency-modulated tone complexes that mimic properties of natural stimuli, specifically non-Gaussian amplitude distribution and higher-order correlations. Results demonstrate that the proposed approach successfully identifies correct underlying STRFs, even in cases where second-order methods based on the spike-triggered average (STA) do not. Applied to small data samples, the method is shown to converge on smaller amounts of experimental recordings and with lower estimation variance than the generalized linear model and recent information theoretic methods. Thus, CbRF estimation may prove useful for investigation of neuronal processes in response to natural stimuli and in settings where rapid adaptation is induced by experimental design.	[Meyer, Arne F.; Anemueller, Joern] Carl von Ossietzky Univ Oldenburg, Dept Med Phys & Acoust, D-26111 Oldenburg, Germany; [Meyer, Arne F.; Anemueller, Joern] Carl von Ossietzky Univ Oldenburg, Cluster Excellence Hearing4all, D-26111 Oldenburg, Germany; [Diepenbrock, Jan-Philipp; Happel, Max F. K.; Ohl, Frank W.] Leibniz Inst Neurobiol, Dept Syst Physiol Learning, Magdeburg, Germany; [Happel, Max F. K.; Ohl, Frank W.] Guericke Univ, Inst Biol, Dept Neuroprosthet, Magdeburg, Germany	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; Leibniz Institut fur Neurobiologie (LIN)	Meyer, AF (corresponding author), Carl von Ossietzky Univ Oldenburg, Dept Med Phys & Acoust, D-26111 Oldenburg, Germany.	arne.f.meyer@uni-oldenburg.de	Anemüller, Jörn/A-8090-2009	Happel, Max/0000-0002-9581-5856; Meyer, Arne/0000-0002-0468-3369	German Research Foundation (DFG) within the Collaborative Research Centre [SFB/TRR31]	German Research Foundation (DFG) within the Collaborative Research Centre(German Research Foundation (DFG))	This study was supported by the German Research Foundation (DFG) within the Collaborative Research Centre SFB/TRR31 "The Active Auditory System". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman TL, 2003, NEURON, V40, P823, DOI 10.1016/S0896-6273(03)00680-9; Andoni S, 2007, J NEUROSCI, V27, P4882, DOI 10.1523/JNEUROSCI.4342-06.2007; Andoni S, 2011, J NEUROSCI, V31, P16529, DOI 10.1523/JNEUROSCI.1306-11.2011; Atencio CA, 2012, J NEUROPHYSIOL, V107, P2594, DOI 10.1152/jn.01025.2011; Atencio CA, 2009, P NATL ACAD SCI USA, V106, P21894, DOI 10.1073/pnas.0908383106; Bartlett PL, 2006, J AM STAT ASSOC, V101, P138, DOI 10.1198/016214505000000907; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; BRUCKNER S, 1995, HEARING RES, V86, P1, DOI 10.1016/0378-5955(95)00048-9; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Calabrese A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016104; Cant NB, 2005, HEARING RES, V206, P12, DOI 10.1016/j.heares.2005.02.014; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Christianson GB, 2008, J NEUROSCI, V28, P446, DOI 10.1523/JNEUROSCI.1775-07.2007; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; David SV, 2007, NETWORK-COMP NEURAL, V18, P191, DOI 10.1080/09548980701609235; David SV, 2004, J NEUROSCI, V24, P6991, DOI 10.1523/JNEUROSCI.1422-04.2004; Dayan P., 2005, THEORETICAL NEUROSCI; DEBOER E, 1968, IEEE T BIO-MED ENG, VBM15, P169, DOI 10.1109/TBME.1968.4502561; deCharms RC, 1998, SCIENCE, V280, P1439, DOI 10.1126/science.280.5368.1439; Eliades SJ, 2008, J NEUROSCI METH, V172, P201, DOI 10.1016/j.jneumeth.2008.04.029; Escabi MA, 2002, J NEUROSCI, V22, P4114, DOI 10.1523/JNEUROSCI.22-10-04114.2002; Fishbach A, 2003, J NEUROPHYSIOL, V90, P3663, DOI 10.1152/jn.00654.2003; Fishbach A, 2001, J NEUROPHYSIOL, V85, P2303, DOI 10.1152/jn.2001.85.6.2303; Fitzgerald JD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002249; Fitzgerald JD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001111; Franc V., 2011, PROC INT C MACHINE L, P665; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Garofolo JS, 1993, TIMIT ACOUSTIC PHONE; Gill P, 2006, J COMPUT NEUROSCI, V21, P5, DOI 10.1007/s10872-006-7059-4; Happel MFK, 2010, J NEUROSCI, V30, P11114, DOI 10.1523/JNEUROSCI.0689-10.2010; Hsu A, 2004, J NEUROSCI, V24, P9201, DOI 10.1523/JNEUROSCI.2449-04.2004; Kouh M, 2009, NETWORK-COMP NEURAL, V20, P49, DOI 10.1080/09548980902950891; Lesica NA, 2008, J NEUROSCI, V28, P5412, DOI 10.1523/JNEUROSCI.0073-08.2008; Lesica NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003060; Lin CJ, 2008, J MACH LEARN RES, V9, P627; Lin Y, 2002, DATA MIN KNOWL DISC, V6, P259, DOI 10.1023/A:1015469627679; Lin Y, 2000, MACH LEARN, P191; Machens CK, 2004, J NEUROSCI, V24, P1089, DOI 10.1523/JNEUROSCI.4445-03.2004; MCCULLOCH WS, 1990, B MATH BIOL, V52, P99, DOI 10.1016/S0092-8240(05)80006-0; Meyer AF, 2013, P 6 INT IEEE EMBS C; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Nelken I, 2003, BIOL CYBERN, V89, P397, DOI 10.1007/s00422-003-0445-3; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Paninski L, 2004, NETWORK-COMP NEURAL, V15, P243, DOI 10.1088/0954-898X/15/4/002; Paninski L, 2003, NETWORK-COMP NEURAL, V14, P437, DOI 10.1088/0954-898X/14/3/304; Paninski L, 2003, NEURAL COMPUT, V15, P1191, DOI 10.1162/089976603321780272; Park IM, 2013, ADV NEURAL INFORM PR, V26, P2454; Park M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002219; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Pollak GD, 2011, HEARING RES, V274, P27, DOI 10.1016/j.heares.2010.05.010; Rabinowitz NC, 2011, NEURON, V70, P1178, DOI 10.1016/j.neuron.2011.04.030; Rieke F., 1997, SPIKES EXPLORING NEU; Schnupp JWH, 2001, NATURE, V414, P200, DOI 10.1038/35102568; Schwartz O, 2006, J VISION, V6, P484, DOI 10.1167/6.4.13; Sharpee T, 2004, NEURAL COMPUT, V16, P223, DOI 10.1162/089976604322742010; Sharpee TO, 2008, J NEUROPHYSIOL, V99, P2496, DOI 10.1152/jn.01397.2007; Sharpee TO, 2006, NATURE, V439, P936, DOI 10.1038/nature04519; Sharpee TO, 2011, CURRENT OPINION NEUR; Teeters JL, 2008, NEUROINFORMATICS, V6, P47, DOI 10.1007/s12021-008-9009-y; Theunissen FE, 2000, J NEUROSCI, V20, P2315; Touryan J, 2002, J NEUROSCI, V22, P10811; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Vapnik V., 1995, NATURE STAT LEARNING, V38, P409; Woolley SMN, 2005, NAT NEUROSCI, V8, P1371, DOI 10.1038/nn1536; Wu MCK, 2006, ANNU REV NEUROSCI, V29, P477, DOI 10.1146/annurev.neuro.29.051605.113024; Zhang T, 2004, ANN STAT, V32, P56	67	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93062	10.1371/journal.pone.0093062	http://dx.doi.org/10.1371/journal.pone.0093062			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699631	Green Published, Green Submitted, gold			2022-12-25	WOS:000334105000041
J	Purahong, W; Kapturska, D; Pecyna, MJ; Schulz, E; Schloter, M; Buscot, F; Hofrichter, M; Kruger, D				Purahong, Witoon; Kapturska, Danuta; Pecyna, Marek J.; Schulz, Elke; Schloter, Michael; Buscot, Francois; Hofrichter, Martin; Krueger, Dirk			Influence of Different Forest System Management Practices on Leaf Litter Decomposition Rates, Nutrient Dynamics and the Activity of Ligninolytic Enzymes: A Case Study from Central European Forests	PLOS ONE			English	Article							MANGANESE PEROXIDASE; WOOD; INTENSITY; FUNGI; DEGRADATION; COMMUNITIES; VARIABILITY; CONVERSION; OXIDATION; LACCASES	Leaf litter decomposition is the key ecological process that determines the sustainability of managed forest ecosystems, however very few studies hitherto have investigated this process with respect to silvicultural management practices. The aims of the present study were to investigate the effects of forest management practices on leaf litter decomposition rates, nutrient dynamics (C, N, Mg, K, Ca, P) and the activity of ligninolytic enzymes. We approached these questions using a 473 day long litterbag experiment. We found that age-class beech and spruce forests (high forest management intensity) had significantly higher decomposition rates and nutrient release (most nutrients) than unmanaged deciduous forest reserves (P < 0.05). The site with near-to-nature forest management (low forest management intensity) exhibited no significant differences in litter decomposition rate, C release, lignin decomposition, and C/N, lignin/N and ligninolytic enzyme patterns compared to the unmanaged deciduous forest reserves, but most nutrient dynamics examined in this study were significantly faster under such near-to-nature forest management practices. Analyzing the activities of ligninolytic enzymes provided evidence that different forest system management practices affect litter decomposition by changing microbial enzyme activities, at least over the investigated time frame of 473 days (laccase, P < 0.0001; manganese peroxidase (MnP), P=0.0260). Our results also indicate that lignin decomposition is the rate limiting step in leaf litter decomposition and that MnP is one of the key oxidative enzymes of litter degradation. We demonstrate here that forest system management practices can significantly affect important ecological processes and services such as decomposition and nutrient cycling.	[Purahong, Witoon; Kapturska, Danuta; Schulz, Elke; Buscot, Francois; Krueger, Dirk] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Saale, Germany; [Purahong, Witoon] Tech Univ Munich, Chair Soil Sci, Oberschleissheim, Germany; [Kapturska, Danuta; Pecyna, Marek J.; Hofrichter, Martin] Tech Univ Dresden, Int Inst Zittau, Dept Bio & Environm Sci, Zittau, Germany; [Schloter, Michael] Helmholtz Zentrum Munchen, Res Unit Environm Genom, Oberschleissheim, Germany; [Buscot, Francois] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Technical University of Munich; Technische Universitat Dresden; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Purahong, W (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Saale, Germany.	witoon.purahong@ufz.de	Purahong, Witoon/AAX-8455-2021; Buscot, Francois/A-4125-2016; Schloter, 1Michael/H-9151-2013; Krüger, Dirk/C-3316-2012	Purahong, Witoon/0000-0002-4113-6428; Buscot, Francois/0000-0002-2364-0006; Krüger, Dirk/0000-0002-7305-5104; Hofrichter, Martin/0000-0001-5174-7604	DFG [KR 3587/1-1, KR 3587/3-2, SCHL 446/13-2., HO 1961/4-1, HO 1961/5-2]; Helmholtz Impulse and Networking Fund via the Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE)	DFG(German Research Foundation (DFG)); Helmholtz Impulse and Networking Fund via the Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE)	This work was funded in part by DFG Priority Program 1374 on 'Infrastructure-Biodiversity-Exploratories' (KR 3587/1-1, KR 3587/3-2, SCHL 446/13-2, HO 1961/4-1, HO 1961/5-2). W. Purahong and D. Kapturska also were kindly supported by the Helmholtz Impulse and Networking Fund via the Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE). The funders DFG and HIGRADE had no input into the study design, the data collection and analysis, the decision to publish, or the preparation of the manuscript.	[Anonymous], 2010, GLOBAL FOREST RESOUR; Aubert M, 2010, FOREST ECOL MANAG, V259, P563, DOI 10.1016/j.foreco.2009.11.014; Ayres E, 2009, SOIL BIOL BIOCHEM, V41, P606, DOI 10.1016/j.soilbio.2008.12.022; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Bates JD, 2007, J ARID ENVIRON, V70, P222, DOI 10.1016/j.jaridenv.2006.12.015; Brumelis G, 2011, SILVA FENN, V45, P807, DOI 10.14214/sf.446; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; COUTEAUX MM, 1995, TRENDS ECOL EVOL, V10, P63, DOI 10.1016/S0169-5347(00)88978-8; EFFLAND MJ, 1977, TAPPI, V60, P143; FARHANGRAZI ZS, 1994, BIOCHEMISTRY-US, V33, P5647, DOI 10.1021/bi00184a038; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Graca MAS, 2014, OECOLOGIA, V174, P1021, DOI 10.1007/s00442-013-2825-2; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Heinzkill M, 1998, APPL ENVIRON MICROB, V64, P1601; Hessenmoller D., 2011, Forstarchiv, V82, P171; Hofrichter M, 2002, ENZYME MICROB TECH, V30, P454, DOI 10.1016/S0141-0229(01)00528-2; Hofrichter M, 2001, APPL ENVIRON MICROB, V67, P4588, DOI 10.1128/AEM.67.10.4588-4593.2001; IPCC, 2003, GOOD PRACT GUID LAND; Jacob M, 2010, OECOLOGIA, V164, P1083, DOI 10.1007/s00442-010-1699-9; Jacob M, 2009, SOIL BIOL BIOCHEM, V41, P2122, DOI 10.1016/j.soilbio.2009.07.024; Leonowicz A, 2001, J BASIC MICROB, V41, P185, DOI 10.1002/1521-4028(200107)41:3/4&lt;185::AID-JOBM185&gt;3.0.CO;2-T; Liers C, 2011, FEMS MICROBIOL ECOL, V78, P91, DOI 10.1111/j.1574-6941.2011.01144.x; Lonsdale D, 2008, EUR J FOREST RES, V127, P1, DOI 10.1007/s10342-007-0182-6; Lummer D, 2012, OIKOS, V121, P1649, DOI 10.1111/j.1600-0706.2011.20073.x; Lundell TK, 2010, J BASIC MICROB, V50, P5, DOI 10.1002/jobm.200900338; Luyssaert S, 2011, ECOL APPL, V21, P3272, DOI 10.1890/10-2395.1; Ma SY, 2010, FOREST ECOL MANAG, V259, P904, DOI 10.1016/j.foreco.2009.11.030; Manzoni S, 2010, ECOL MONOGR, V80, P89, DOI 10.1890/09-0179.1; Martin A, 1997, ANN SCI FOREST, V54, P191, DOI 10.1051/forest:19970206; Moretto AS, 2001, APPL SOIL ECOL, V18, P31, DOI 10.1016/S0929-1393(01)00151-2; Muller J, 2007, EUR J FOREST RES, V126, P513, DOI 10.1007/s10342-007-0173-7; Naether A, 2012, APPL ENVIRON MICROB, V78, P7398, DOI 10.1128/AEM.01325-12; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Prescott CE, 2005, FOREST ECOL MANAG, V220, P66, DOI 10.1016/j.foreco.2005.08.005; Purahong W, 2011, FUNGAL DIVERS, V47, P1, DOI 10.1007/s13225-010-0083-8; Raiskila S, 2007, SILVA FENN, V41, P351, DOI 10.14214/sf.301; Salazar S, 2011, ECOL ENG, V37, P1123, DOI 10.1016/j.ecoleng.2011.02.007; Santa-Regina I, 2001, FORESTRY, V74, P11, DOI 10.1093/forestry/74.1.11; SANTA-REGINA I, 1995, ARID SOIL RES REHAB, V9, P201, DOI 10.1080/15324989509385886; Schall P, 2013, EUR J FOREST RES, V132, P379, DOI 10.1007/s10342-013-0681-6; Schliemann SA, 2011, FOREST ECOL MANAG, V261, P1143, DOI 10.1016/j.foreco.2011.01.011; Schoning I, 2013, PLANT SOIL, V370, P625, DOI 10.1007/s11104-013-1654-8; Steffen KT, 2007, RES MICROBIOL, V158, P447, DOI 10.1016/j.resmic.2007.04.002; Steffen KT, 2000, APPL MICROBIOL BIOT, V54, P819, DOI 10.1007/s002530000473; Torras O, 2008, FOREST ECOL MANAG, V255, P3322, DOI 10.1016/j.foreco.2008.02.013; Trum F., 2010, Proceedings of the 19th World Congress of Soil Science: Soil solutions for a changing world, Brisbane, Australia, 1-6 August 2010. Working Group 3.2 Forest soil processes and change, P40; Unterseher M, 2013, FUNGAL DIVERS, V60, P43, DOI 10.1007/s13225-013-0222-0; Waldchen J, 2013, FOREST ECOL MANAG, V289, P243, DOI 10.1016/j.foreco.2012.10.014; Waldrop MP, 2003, SOIL SCI SOC AM J, V67, P1250, DOI 10.2136/sssaj2003.1250; WARIISHI H, 1992, J BIOL CHEM, V267, P23688; Wubet T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047500; Xuluc-Tolosa FJ, 2003, FOREST ECOL MANAG, V174, P401, DOI 10.1016/S0378-1127(02)00059-2; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433	53	49	51	1	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93700	10.1371/journal.pone.0093700	http://dx.doi.org/10.1371/journal.pone.0093700			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699676	Green Published, gold, Green Submitted			2022-12-25	WOS:000334105000091
J	Qiu, Q; Scott, A; Scheerer, H; Sapkota, N; Lee, DK; Ma, LM; Yu, CR				Qiu, Qiang; Scott, Aaron; Scheerer, Hayley; Sapkota, Nirjal; Lee, Daniel K.; Ma, Limei; Yu, C. Ron			Automated Analyses of Innate Olfactory Behaviors in Rodents	PLOS ONE			English	Article							PSYCHOMETRIC FUNCTION; STIMULUS-CONTROL; ODOR MEMORY; DISCRIMINATION; RAT; MICE; ACCURACY; SPEED; MOUSE; PERFORMANCE	Olfaction based behavioral experiments are important for the investigation of sensory coding, perception, decision making and memory formation. The predominant experimental paradigms employ forced choice operant assays, which require associative learning and reinforced training. Animal performance in these assays not only reflects odor perception but also the confidence in decision making and memory. In this study, we describe a versatile and automated setup, "Poking-Registered Olfactory Behavior Evaluation System" (PROBES), which can be adapted to perform multiple olfactory assays. In addition to forced choice assays, we employ this system to examine animal's innate ability for odor detection, discrimination and preference without elaborate training procedures. These assays provide quantitative measurements of odor discrimination and robust readouts of odor preference. Using PROBES, we find odor detection thresholds are at lower concentrations in naive animals than those determined by forced choice assays. PROBES-based automated assays provide an efficient way of analyzing innate odor-triggered behaviors.	[Qiu, Qiang; Scott, Aaron; Scheerer, Hayley; Sapkota, Nirjal; Lee, Daniel K.; Ma, Limei; Yu, C. Ron] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Yu, C. Ron] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Yu, CR (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	cry@stowers.org		Scott, Aaron/0000-0002-1210-3731	Stowers Institute	Stowers Institute	This work is supported by funding from the Stowers Institute to C.R.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; [Anonymous], HDB OLFACTION GUSTAT; Barnes DC, 2008, NAT NEUROSCI, V11, P1378, DOI 10.1038/nn.2217; Bodyak N, 1999, CHEM SENSES, V24, P637, DOI 10.1093/chemse/24.6.637; Cleland TA, 2002, BEHAV NEUROSCI, V116, P222, DOI 10.1037//0735-7044.116.2.222; Clevenger AC, 2006, CHEM SENSES, V31, P9, DOI 10.1093/chemse/bjj001; DARLING FMC, 1994, PHYSIOL BEHAV, V55, P817, DOI 10.1016/0031-9384(94)90065-5; Doty R. L., 2003, HDB OLFACTION GUSTAT, P203, DOI DOI 10.1201/9780203911457; DUNCAN HJ, 1992, PHYSIOL BEHAV, V52, P617, DOI 10.1016/0031-9384(92)90357-8; Eichenbaum H., 2003, HDB OLFACTION GUSTAT, P409; Grosmaitre X, 2007, NAT NEUROSCI, V10, P348, DOI 10.1038/nn1856; HASTINGS L, 1991, CHEM SENSES, V16, P43, DOI 10.1093/chemse/16.1.43; Hu J, 2007, SCIENCE, V317, P953, DOI 10.1126/science.1144233; Hubener F, 2001, PHYSIOL BEHAV, V72, P511, DOI 10.1016/S0031-9384(00)00447-9; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Klein SA, 2001, PERCEPT PSYCHOPHYS, V63, P1421, DOI 10.3758/BF03194552; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Linster C, 1999, PHYSIOL BEHAV, V66, P701, DOI 10.1016/S0031-9384(99)00007-4; Lorig TS, 1999, BEHAV RES METH INS C, V31, P370, DOI 10.3758/BF03207734; Ma LM, 2012, P NATL ACAD SCI USA, V109, P5481, DOI 10.1073/pnas.1117491109; Mihalick SM, 2000, J EXP ANAL BEHAV, V73, P305, DOI 10.1901/jeab.2000.73-305; Moulton DG, 1977, CHEM SIGNALS VERTEBR, P455; NIGROSH BJ, 1975, J COMP PHYSIOL PSYCH, V89, P285, DOI 10.1037/h0076821; PASSE DH, 1985, NEUROSCI BIOBEHAV R, V9, P431, DOI 10.1016/0149-7634(85)90021-1; PFAFFMANN C, 1958, SCIENCE, V128, P1007, DOI 10.1126/science.128.3330.1007; Rinberg D, 2006, NEURON, V51, P351, DOI 10.1016/j.neuron.2006.07.013; SLOTNICK BM, 1991, PHYSIOL BEHAV, V50, P555, DOI 10.1016/0031-9384(91)90545-Y; SLOTNICK BM, 1974, PERCEPT MOTOR SKILL, V39, P583, DOI 10.2466/pms.1974.39.1.583; THIESSEN DD, 1971, ANIM BEHAV, V19, P505, DOI 10.1016/S0003-3472(71)80105-7; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; VARLEY GC, 1953, NATURE, V171, P789, DOI 10.1038/172789a0; WALKER JC, 1986, CHEM SENSES, V11, P439, DOI 10.1093/chemse/11.4.439; Wesson DW, 2008, PLOS BIOL, V6, P717, DOI 10.1371/journal.pbio.0060082; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; [No title captured]	35	11	11	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93468	10.1371/journal.pone.0093468	http://dx.doi.org/10.1371/journal.pone.0093468			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699673	Green Published, Green Submitted, gold			2022-12-25	WOS:000334105000062
J	Vergara, M; Becerra, S; Berrios, J; Osses, N; Reyes, J; Rodriguez-Moya, M; Gonzalez, R; Altamirano, C				Vergara, Mauricio; Becerra, Silvana; Berrios, Julio; Osses, Nelson; Reyes, Juan; Rodriguez-Moya, Maria; Gonzalez, Ramon; Altamirano, Claudia			Differential Effect of Culture Temperature and Specific Growth Rate on CHO Cell Behavior in Chemostat Culture	PLOS ONE			English	Article							HAMSTER OVARY CELLS; RECOMBINANT PROTEIN PRODUCTIVITY; INTERFERON-GAMMA PRODUCTION; MAMMALIAN-CELLS; TRANSCRIPTION LEVEL; DILUTION RATE; EXPRESSION; ERYTHROPOIETIN; SUSPENSION; ANTIBODY	Mild hypothermia condition in mammalian cell culture technology has been one of the main focuses of research for the development of breeding strategies to maximize productivity of these production systems. Despite the large number of studies that show positive effects of mild hypothermia on specific productivity of r-proteins, no experimental approach has addressed the indirect effect of lower temperatures on specific cell growth rate, nor how this condition possibly affects less specific productivity of r-proteins. To separately analyze the effects of mild hypothermia and specific growth rate on CHO cell metabolism and recombinant human tissue plasminogen activator productivity as a model system, high dilution rate (0.017 h(-1)) and low dilution rate (0.012 h(-1)) at two cultivation temperatures (37 and 33 degrees C) were evaluated using chemostat culture. The results showed a positive effect on the specific productivity of r-protein with decreasing specific growth rate at 33 degrees C. Differential effect was achieved by mild hypothermia on the specific productivity of r-protein, contrary to the evidence reported in batch culture. Interestingly, reduction of metabolism could not be associated with a decrease in culture temperature, but rather with a decrease in specific growth rate.	[Vergara, Mauricio; Becerra, Silvana; Berrios, Julio; Altamirano, Claudia] Pontificia Univ Catolica Valparaiso, Sch Biochem Engn, Valparaiso, Chile; [Becerra, Silvana; Altamirano, Claudia] GORE Valparaiso, CREAS CONICYT REG, Valparaiso, Chile; [Osses, Nelson; Reyes, Juan] Pontificia Univ Catolica Valparaiso, Inst Chem, Valparaiso, Chile; [Rodriguez-Moya, Maria; Gonzalez, Ramon] Rice Univ, Dept Chem & Biomol Engn, Houston, TX USA; [Gonzalez, Ramon] Rice Univ, Dept Bioengn, Houston, TX USA	Pontificia Universidad Catolica de Valparaiso; Pontificia Universidad Catolica de Valparaiso; Rice University; Rice University	Altamirano, C (corresponding author), Pontificia Univ Catolica Valparaiso, Sch Biochem Engn, Valparaiso, Chile.	claudia.altamirano@ucv.cl	Osses, Nelson/V-9065-2019; Gonzalez, Ramon/B-1961-2010	Osses, Nelson/0000-0003-0974-1051; Becerra, Silvana/0000-0002-0604-398X; Berrios, Julio/0000-0002-6180-0023; Reyes, Juan G./0000-0001-5541-5172; Altamirano, Claudia/0000-0002-6389-086X	FONDECYT [1120667]; VRIEA-Pontificia Universidad Catolica de Valparaiso; CONICYT	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); VRIEA-Pontificia Universidad Catolica de Valparaiso; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by FONDECYT 1120667, VRIEA-Pontificia Universidad Catolica de Valparaiso, and by CONICYT Doctoral scholarship to MV and SB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Fageeh MB, 2006, BIOTECHNOL BIOENG, V93, P829, DOI 10.1002/bit.20789; Altamirano C, 2001, BIOTECHNOL PROGR, V17, P1032, DOI 10.1021/bp0100981; Baik JY, 2006, BIOTECHNOL BIOENG, V93, P361, DOI 10.1002/bit.20717; BAILEY JE, 1986, BIOCH ENG FUNDAMENTA, P373; Becerra S, 2012, BIOCHEM ENG J, V60, P1, DOI 10.1016/j.bej.2011.10.003; Berrios J, 2011, CHEM ENG SCI, V66, P2431, DOI 10.1016/j.ces.2011.03.011; Berrios J, 2009, BIOTECHNOL LETT, V31, P1493, DOI 10.1007/s10529-009-0050-1; Bi JX, 2004, BIOTECHNOL BIOENG, V85, P741, DOI 10.1002/bit.20025; Bollati-Fogolin M, 2005, BIOTECHNOL PROGR, V21, P17, DOI 10.1021/bp049825t; Burleigh SC, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-95; Carvalhal AV, 2003, BIOTECHNOL PROGR, V19, P69, DOI 10.1021/bp0255917; Diaz-Barrera A, 2012, J IND MICROBIOL BIOT, V39, P613, DOI 10.1007/s10295-011-1055-z; Fogolin MB, 2004, J BIOTECHNOL, V109, P179, DOI 10.1016/j.jbiotec.2003.10.035; Fox SR, 2004, BIOTECHNOL BIOENG, V85, P177, DOI 10.1002/bit.10861; Furukawa K, 1998, CYTOTECHNOLOGY, V26, P153, DOI 10.1023/A:1007934216507; HAYTER PM, 1993, BIOTECHNOL BIOENG, V42, P1077, DOI 10.1002/bit.260420909; Hendrick V, 2001, CYTOTECHNOLOGY, V36, P71, DOI 10.1023/A:1014088919546; Hoskisson PA, 2005, MICROBIOL-SGM, V151, P3153, DOI 10.1099/mic.0.27924-0; Kaufmann H, 1999, BIOTECHNOL BIOENG, V63, P573, DOI 10.1002/(SICI)1097-0290(19990605)63:5<573::AID-BIT7>3.0.CO;2-Y; Kim JY, 2012, APPL MICROBIOL BIOT, V93, P917, DOI 10.1007/s00253-011-3758-5; Kou TC, 2011, J BIOSCI BIOENG, V111, P365, DOI 10.1016/j.jbiosc.2010.11.016; Krampe B, 2011, BIOTECHNOL BIOENG, V108, P1603, DOI 10.1002/bit.23100; Lim Y, 2010, BIOTECHNOL APPL BIOC, V55, P175, DOI 10.1042/BA20090363; LINARDOS TI, 1992, BIOTECHNOL BIOENG, V40, P359, DOI 10.1002/bit.260400305; Marchant RJ, 2008, MOL BIOTECHNOL, V39, P69, DOI 10.1007/s12033-008-9032-0; Masterton RJ, 2010, BIOTECHNOL BIOENG, V105, P215, DOI 10.1002/bit.22533; MILLER WM, 1988, BIOTECHNOL BIOENG, V32, P947, DOI 10.1002/bit.260320803; Nam JH, 2008, BIOTECHNOL BIOENG, V100, P1178, DOI 10.1002/bit.21853; Nam JH, 2009, CYTOTECHNOLOGY, V59, P81, DOI 10.1007/s10616-009-9196-x; Oguchi S, 2006, CYTOTECHNOLOGY, V52, P199, DOI 10.1007/s10616-007-9059-2; Omasa T, 2010, BIOPROC BIOSYST ENG, V33, P117, DOI 10.1007/s00449-009-0351-8; RAY NG, 1989, BIOTECHNOL BIOENG, V33, P724, DOI 10.1002/bit.260330610; ROBINSON DK, 1991, BIOTECHNOL BIOENG, V38, P972, DOI 10.1002/bit.260380903; Schatz SM, 2003, BIOTECHNOL BIOENG, V84, P433, DOI 10.1002/bit.10793; Shi M, 2005, BIOTECHNOL LETT, V27, P1879, DOI 10.1007/s10529-005-3897-9; Sinclair R, 1974, In Vitro, V10, P295, DOI 10.1007/BF02615311; Smales CM, 2004, BIOTECHNOL BIOENG, V88, P474, DOI 10.1002/bit.20272; Sonna LA, 2002, J APPL PHYSIOL, V92, P1725, DOI 10.1152/japplphysiol.01143.2001; Trummer E, 2006, BIOTECHNOL BIOENG, V94, P1033, DOI 10.1002/bit.21013; Vergara M, 2012, ELECTRON J BIOTECHN, V15, DOI 10.2225/vol15-issue6-fulltext-2; Visiongain Biosimilars and Follow-On Biologics, 2012, GLOB MARK OUTL 2010, V142; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Yee JC, 2009, BIOTECHNOL BIOENG, V102, P246, DOI 10.1002/bit.22039; Yoon SK, 2005, BIOTECHNOL BIOENG, V89, P345, DOI 10.1002/bit.20353; Yoon SK, 2003, BIOTECHNOL BIOENG, V82, P289, DOI 10.1002/bit.10566; Yoon SK, 2003, BIOTECHNOL PROGR, V19, P1383, DOI 10.1021/bp034051m; Yoon SK, 2006, ENZYME MICROB TECH, V39, P362, DOI 10.1016/j.enzmictec.2005.11.029	47	43	45	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93865	10.1371/journal.pone.0093865	http://dx.doi.org/10.1371/journal.pone.0093865			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699760	Green Published, Green Submitted, gold			2022-12-25	WOS:000334105000115
J	Jaganathan, H; Mitra, S; Srinivasan, S; Dave, B; Godin, B				Jaganathan, Hamsa; Mitra, Sucharita; Srinivasan, Srimeenakshi; Dave, Bhuvanesh; Godin, Biana			Design and In Vitro Evaluation of Layer by Layer siRNA Nanovectors Targeting Breast Tumor Initiating Cells	PLOS ONE			English	Article							COATED GOLD NANOPARTICLES; CANCER CELLS; STEM-CELLS; DELIVERY; THERAPY; CHEMOTHERAPY; EXPRESSION; EFFICIENT; STAT3	Efficient therapeutics and early detection has helped to increase breast cancer survival rates over the years. However, the recurrence of breast cancer remains to be a problem and this may be due to the presence of a small population of cells, called tumor initiating cells (TICs). Breast TICs are resistant to drugs, difficult to detect, and exhibit high self-renewal capabilities. In this study, layer by layer (LBL) small interfering RNA (siRNA) nanovectors (SNVs) were designed to target breast TICs. SNVs were fabricated using alternating layers of poly-L-lysine and siRNA molecules on gold (Au) nanoparticle (NP) surfaces. The stability, cell uptake, and release profile for SNVs were examined. In addition, SNVs reduced TIC-related STAT3 expression levels, CD44(+)/CD24(-)/EpCAM(+) surface marker levels and the number of mammospheres formed compared to the standard transfection agent. The data from this study show, for the first time, that SNVs in LBL assembly effectively delivers STAT3 siRNA and inhibit the growth of breast TICs in vitro.	[Jaganathan, Hamsa; Srinivasan, Srimeenakshi; Godin, Biana] Houston Methodist Res Inst, Dept Nanomed, Houston, TX 77030 USA; [Mitra, Sucharita; Dave, Bhuvanesh] Houston Methodist Res Inst, Canc Ctr Excellence, Houston, TX USA	The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston	Godin, B (corresponding author), Houston Methodist Res Inst, Dept Nanomed, Houston, TX 77030 USA.	BGodin@houstonmethodist.org	Godin, Biana/AAB-3190-2020; Dave, Bhuvanesh/ABF-8334-2020	Dave, Bhuvanesh/0000-0001-6741-1363; Godin, Biana/0000-0001-6089-6695	Susan G. Komen Postdoctoral Fellowship [PDF12229449]; Houston Methodist Cancer Center of Excellence startup funds; NIH [U54CA143837]; DOD [W81XWH-11-02-0168];  [DODW81XWH-09-1-0212]; NATIONAL CANCER INSTITUTE [U54CA151668, U54CA143837] Funding Source: NIH RePORTER	Susan G. Komen Postdoctoral Fellowship(Susan G. Komen Breast Cancer Foundation); Houston Methodist Cancer Center of Excellence startup funds; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank Susan G. Komen Postdoctoral Fellowship (PDF12229449), Houston Methodist Cancer Center of Excellence startup funds, NIH U54CA143837 (CTO, PS-OC), DODW81XWH-09-1-0212 and DOD W81XWH-11-02-0168. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Zaid Siddiquee K, CELL RES, V18, P254; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Caruso F, 2001, ADV MATER, V13, P11, DOI 10.1002/1521-4095(200101)13:1<11::AID-ADMA11>3.0.CO;2-N; Choi SY, 2012, TOXICOL IN VITRO, V26, P229, DOI 10.1016/j.tiv.2011.11.016; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Daka A, 2012, ADV DRUG DELIVER REV, V64, P1508, DOI 10.1016/j.addr.2012.08.014; Dave B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030207; Dave B, 2009, J MAMMARY GLAND BIOL, V14, P79, DOI 10.1007/s10911-009-9117-9; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Dontu G, 2005, STEM CELL REV, V1, P207, DOI 10.1385/SCR:1:3:207; Elbakry A, 2009, NANO LETT, V9, P2059, DOI 10.1021/nl9003865; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Guo ST, 2010, ACS NANO, V4, P5505, DOI 10.1021/nn101638u; Han L, 2012, ACS NANO, V6, P7340, DOI 10.1021/nn3024688; Jeong JH, 2011, PHARM RES-DORDR, V28, P2072, DOI 10.1007/s11095-011-0412-y; Kong WH, 2012, PHARM RES-DORDR, V29, P362, DOI 10.1007/s11095-011-0554-y; Lee MY, 2011, ACS NANO, V5, P6138, DOI 10.1021/nn2017793; Lee SK, 2011, SMALL, V7, P364, DOI 10.1002/smll.201001314; Lee SH, 2008, INT J PHARMACEUT, V364, P94, DOI 10.1016/j.ijpharm.2008.07.027; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Lvov Y, 1997, LANGMUIR, V13, P6195, DOI 10.1021/la970517x; Malikova N, 2002, LANGMUIR, V18, P3694, DOI 10.1021/la025563y; Meyer M, 2008, J AM CHEM SOC, V130, P3272, DOI 10.1021/ja710344v; Moghimi SM, 2005, MOL THER, V11, P990, DOI 10.1016/j.ymthe.2005.02.010; Rodriguez-Pinilla SM, 2006, CLIN CANCER RES, V12, P1533, DOI 10.1158/1078-0432.CCR-05-2281; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Song H, 2004, ONCOGENE, V23, P8301, DOI 10.1038/sj.onc.1208026; Song WJ, 2010, SMALL, V6, P239, DOI 10.1002/smll.200901513; Tan SJ, 2011, SMALL, V7, P841, DOI 10.1002/smll.201001389; Tanaka T, 2010, CANCER RES, V70, P3687, DOI 10.1158/0008-5472.CAN-09-3931; Tang ZY, 2006, ADV MATER, V18, P3203, DOI 10.1002/adma.200600113; Valent P, 2012, NAT REV CANCER, V12, P767, DOI 10.1038/nrc3368; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wallgren A, 2003, J CLIN ONCOL, V21, P1205, DOI 10.1200/JCO.2003.03.130; Wang Y, 2008, CHEM MATER, V20, P848, DOI 10.1021/cm7024813; Ware M, 2014, CATIONIC POLYM REGEN; Yessine MA, 2003, BBA-BIOMEMBRANES, V1613, P28, DOI 10.1016/S0005-2736(03)00137-8; Zhang X, 2010, BIOMATERIALS, V31, P6013, DOI 10.1016/j.biomaterials.2010.04.024; Zhao EY, 2012, NANOSCALE, V4, P5102, DOI 10.1039/c2nr31290e	41	15	15	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e91986	10.1371/journal.pone.0091986	http://dx.doi.org/10.1371/journal.pone.0091986			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24694753	Green Submitted, Green Published, gold			2022-12-25	WOS:000334103000012
J	Knight, L; Muloiwa, R; Dlamini, S; Lehloenya, RJ				Knight, Lauren; Muloiwa, Rudzani; Dlamini, Sipho; Lehloenya, Rannakoe J.			Factors Associated with Increased Mortality in a Predominantly HIV-Infected Population with Stevens Johnson Syndrome and Toxic Epidermal Necrolysis	PLOS ONE			English	Article								Introduction: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening drug reactions with a higher incidence in HIV-infected persons. SJS/TEN are associated with skin and mucosal failure, predisposing to systemic bacterial infection (BSI), a major cause of death. There are limited data on risk factors associated with BSI and and mortality in HIV-infected people with SJS/TEN. Methods: We conducted a retrospective study of patients admitted to a university hospital with SJS/TEN over a 3 year period. We evaluated their underlying illnesses, eliciting drugs, predictive value of bacterial skin cultures and other factors associated with mortality and BSI in a predominantly HIV-infected population by comparing characteristics of the patients who demised and those who survived. Results: We admitted 86 cases during the study period and 67/86(78%) were HIV-infected. Tuberculosis was the commonest co-morbidity, diagnosed in 12/86(14%) cases. Skin cultures correlated with BSI by the same organism in 7/64(11%) cases and 6/7 were Gram-negative. Two of the 8 cases of Gram-negative BSI had an associated Gram-negative skin culture, although not always the same organism. All 8 fatalities had >30% epidermal detachment, 7 were HIV-infected, 6 died of BSI and 6 had tuberculosis. Conclusions: Having >30% epidermal detachment in SJS/TEN carries an increased risk of BSI and mortality. Tuberculosis and BSI are associated with higher risk of death in SJS/TEN. Our data suggests there may be an association between Gram-negative BSI and Gram-negative skin infection.	[Knight, Lauren] Groote Schuur Hosp, ZA-7925 Cape Town, South Africa; [Muloiwa, Rudzani] Univ Cape Town, Dept Paediat & Child Hlth, ZA-7925 Cape Town, South Africa; [Dlamini, Sipho] Univ Cape Town, Dept Med, Div Infect Dis & HIV Med, ZA-7925 Cape Town, South Africa; [Lehloenya, Rannakoe J.] Univ Cape Town, Dept Med, Div Dermatol, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town	Lehloenya, RJ (corresponding author), Univ Cape Town, Dept Med, Div Dermatol, ZA-7925 Cape Town, South Africa.	rannakoe.lehloenya@uct.ac.za	Muloiwa, Rudzani/AAY-7338-2020; Muloiwa, Rudzani/AAG-8139-2021; Lehloenya, Rannakoe J/C-5672-2012	Muloiwa, Rudzani/0000-0002-4527-0827; Lehloenya, Rannakoe J/0000-0002-1281-1789	Fogarty International Center [U2RTW007373]; Netcare through a Hamilton Naki Clinical Scholarship; Sanofi Pasteur; Discovery Foundation; Dermatological Society of South Africa; Carnergie Corporation Research Award	Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Netcare through a Hamilton Naki Clinical Scholarship; Sanofi Pasteur; Discovery Foundation; Dermatological Society of South Africa; Carnergie Corporation Research Award	L.K. was partially supported by grant number U2RTW007373 from the Fogarty International Center; R.M. is supported by Netcare through a Hamilton Naki Clinical Scholarship and Sanofi Pasteur; R.J.L. was supported by the Discovery Foundation, Dermatological Society of South Africa and received Carnergie Corporation Research Award. S.D. has no financial disclosures to make. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastuji-Garin S, 2000, J INVEST DERMATOL, V115, P149, DOI 10.1046/j.1523-1747.2000.00061.x; COOPMAN SA, 1993, NEW ENGL J MED, V328, P1670, DOI 10.1056/NEJM199306103282304; de Prost N, 2010, MEDICINE, V89, P28, DOI 10.1097/MD.0b013e3181ca4290; EDELL DS, 1992, PEDIATRICS, V89, P429; Fritsch P O, 2000, Am J Clin Dermatol, V1, P349, DOI 10.2165/00128071-200001060-00003; George SMC, 2008, CRIT CARE, V12, DOI 10.1186/cc6141; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Inamadar Arun C, 2005, Indian J Dermatol Venereol Leprol, V71, P379; McGee T, 1998, PLAST RECONSTR SURG, V102, P1018, DOI 10.1097/00006534-199809040-00014; Montefour K, 2008, CRIT CARE NURSE, V28, P15; Powell N, 2006, POSTGRAD MED J, V82, DOI 10.1136/pgmj.2005.042952; REVUZ J, 1987, ARCH DERMATOL, V123, P1160, DOI 10.1001/archderm.123.9.1160; Roujeau Jean-Claude, 1997, Journal of Dermatology (Tokyo), V24, P726; Statistics South Africa, 2011, MID POP EST; Struck MF, 2010, INTENS CARE MED, V36, P22, DOI 10.1007/s00134-009-1659-1	15	14	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93543	10.1371/journal.pone.0093543	http://dx.doi.org/10.1371/journal.pone.0093543			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695805	Green Published, gold, Green Submitted			2022-12-25	WOS:000334103000087
J	Pilling, D; Gomer, RH				Pilling, Darrell; Gomer, Richard H.			Persistent Lung Inflammation and Fibrosis in Serum Amyloid P Component (Apcs(-/-)) Knockout Mice	PLOS ONE			English	Article							INDUCED PULMONARY-FIBROSIS; ACUTE-PHASE REACTANTS; C-REACTIVE PROTEIN; PERIPHERAL-BLOOD FIBROCYTES; FC-GAMMA RECEPTORS; CIRCULATING FIBROCYTES; MACROPHAGE SUBPOPULATIONS; SPONTANEOUS AUTOIMMUNITY; APOPTOTIC CELLS; T-CELLS	Fibrosing diseases, such as pulmonary fibrosis, cardiac fibrosis, myelofibrosis, liver fibrosis, and renal fibrosis are chronic and debilitating conditions and are an increasing burden for the healthcare system. Fibrosis involves the accumulation and differentiation of many immune cells, including macrophages and fibroblast-like cells called fibrocytes. The plasma protein serum amyloid P component (SAP; also known as pentraxin-2, PTX2) inhibits fibrocyte differentiation in vitro, and injections of SAP inhibit fibrosis in vivo. SAP also promotes the formation of immuno-regulatory Mreg macrophages. To elucidate the endogenous function of SAP, we used bleomycin aspiration to induce pulmonary inflammation and fibrosis in mice lacking SAP. Compared to wildtype C57BL/6 mice, we find that in Apcs(-/-) "SAP knock-out'' mice, bleomycin induces a more persistent inflammatory response and increased fibrosis. In both C57BL/6 and Apcs(-/-) mice, injections of exogenous SAP reduce the accumulation of inflammatory macrophages and prevent fibrosis. The types of inflammatory cells present in the lungs following bleomycin-aspiration appear similar between C57BL/6 and Apcs(-/-) mice, suggesting that the initial immune response is normal in the Apcs(-/-) mice, and that a key endogenous function of SAP is to promote the resolution of inflammation and fibrosis.	[Pilling, Darrell; Gomer, Richard H.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Pilling, D (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	dpilling@bio.tamu.edu; rgomer@tamu.edu		Pilling, Darrell/0000-0002-7413-2773; Gomer, Richard/0000-0003-2361-4307	Texas AM University; National Institutes of Health [HL083029]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083029] Funding Source: NIH RePORTER	Texas AM University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Texas A&M University and National Institutes of Health grant HL083029. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; Bharadwaj D, 2001, J IMMUNOL, V166, P6735, DOI 10.4049/jimmunol.166.11.6735; Biburger M, 2011, IMMUNITY, V35, P932, DOI 10.1016/j.immuni.2011.11.009; Bickerstaff MCM, 1999, NAT MED, V5, P694, DOI 10.1038/9544; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Botto M, 1997, NAT MED, V3, P855, DOI 10.1038/nm0897-855; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Bygrave AE, 2004, PLOS BIOL, V2, P1081, DOI 10.1371/journal.pbio.0020243; Carlucci F, 2007, J IMMUNOL, V178, P2352, DOI 10.4049/jimmunol.178.4.2352; Castano AP, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000111; Chi M, 2002, J IMMUNOL, V168, P1413, DOI 10.4049/jimmunol.168.3.1413; Chung MP, 2003, AM J RESP CELL MOL, V29, P375, DOI 10.1165/rcmb.2003-0029OC; Cox N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045674; Crawford JR, 2012, J LEUKOCYTE BIOL, V92, P699, DOI 10.1189/jlb.0112033; Crawford JR, 2010, J IMMUNOL METHODS, V363, P9, DOI 10.1016/j.jim.2010.09.025; Daubeuf F, 2012, CURRENT PROTOCOLS MO, P167; Dillingh MR, 2013, PULM PHARMACOL THER, V26, P672, DOI 10.1016/j.pupt.2013.01.008; Ding JQ, 2011, J CLIN INVEST, V121, P1930, DOI 10.1172/JCI45260; Duan M, 2012, J IMMUNOL, V189, P946, DOI 10.4049/jimmunol.1200660; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Duffield JS, 2010, DRUG NEWS PERSPECT, V23, P305, DOI 10.1358/dnp.2010.23.5.1444206; Gibbons MA, 2011, AM J RESP CRIT CARE, V184, P569, DOI 10.1164/rccm.201010-1719OC; Gomer RH, 2013, CURRENT ALLERGY ASTH, P1; Gomer RH, 2009, WOUND REPAIR REGEN, V17, P397, DOI 10.1111/j.1524-475X.2009.00482.x; Grage-Griebenow E, 2001, J LEUKOCYTE BIOL, V69, P11; Hashimoto N, 2004, J CLIN INVEST, V113, P243, DOI 10.1172/JCI200418847; Haston CK, 2002, HUM MOL GENET, V11, P1855, DOI 10.1093/hmg/11.16.1855; Haston CK, 1996, CANCER RES, V56, P2596; Haudek SB, 2008, P NATL ACAD SCI USA, V105, P10179, DOI 10.1073/pnas.0804910105; Haudek SB, 2006, P NATL ACAD SCI USA, V103, P18284, DOI 10.1073/pnas.0608799103; Heidari Y, 2006, GENES IMMUN, V7, P592, DOI 10.1038/sj.gene.6364335; Herlihy SE, 2013, J IMMUNOL, V190, P6468, DOI 10.4049/jimmunol.1202583; Huebner RH, 2008, BIOTECHNIQUES, V44, P507, DOI 10.2144/000112729; Ji Z, 2012, IMMUNOL CELL BIOL, V90, P388, DOI 10.1038/icb.2011.51; Johnston LK, 2012, AM J RESP CELL MOL, V47, P417, DOI 10.1165/rcmb.2012-0090OC; Kebaier C, 2012, J INFECT DIS, V205, P807, DOI 10.1093/infdis/jir846; KELLER R, 1990, EUR J IMMUNOL, V20, P2137, DOI 10.1002/eji.1830200937; Kulkarni AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063798; Kumar RK, 2005, METH MOLEC MED, V117, P179; Kumar V, 2005, ACUTE CHRONIC INFLAM, V7th, P47; LE PT, 1982, J IMMUNOL, V129, P665; Lu JH, 2012, IMMUNOL REV, V250, P230, DOI 10.1111/j.1600-065X.2012.01162.x; Lu JH, 2008, NATURE, V456, P989, DOI 10.1038/nature07468; MacDonald SL, 2006, SCAND J IMMUNOL, V64, P48, DOI 10.1111/j.1365-3083.2006.01774.x; Maharjan AS, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-2; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mehrad B, 2007, BIOCHEM BIOPH RES CO, V353, P104, DOI 10.1016/j.bbrc.2006.11.149; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Mold C, 2002, J AUTOIMMUN, V19, P147, DOI 10.1006/jaut.2002.0615; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Moore BB, 2006, AM J RESP CELL MOL, V35, P175, DOI 10.1165/rcmb.2005-0239OC; Moreira AP, 2010, J ALLERGY CLIN IMMUN, V126, P712, DOI 10.1016/j.jaci.2010.06.010; MORTENSEN RF, 1983, J IMMUNOL, V130, P885; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mouratis MA, 2011, CURR OPIN PULM MED, V17, P355, DOI 10.1097/MCP.0b013e328349ac2b; Murray LA, 2011, INT J BIOCHEM CELL B, V43, P154, DOI 10.1016/j.biocel.2010.10.013; Murray LA, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-11; Murray LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009683; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Naik-Mathuria B, 2008, WOUND REPAIR REGEN, V16, P266, DOI 10.1111/j.1524-475X.2008.00366.x; Niedermeier M, 2009, P NATL ACAD SCI USA, V106, P17892, DOI 10.1073/pnas.0906070106; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Parker JC, 2004, AM J PHYSIOL-LUNG C, V286, pL231, DOI 10.1152/ajplung.00049.2003; PEPYS MB, 1979, NATURE, V278, P259, DOI 10.1038/278259a0; PEPYS MB, 1980, IMMUNOLOGY, V39, P249; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Pilling D, 1999, EUR J IMMUNOL, V29, P1041, DOI 10.1002/(SICI)1521-4141(199903)29:03<1041::AID-IMMU1041>3.0.CO;2-#; Pilling D, 2003, J IMMUNOL, V171, P5537, DOI 10.4049/jimmunol.171.10.5537; Pilling D, 2007, J IMMUNOL, V179, P4035, DOI 10.4049/jimmunol.179.6.4035; Pilling D, 2009, J IMMUNOL METHODS, V351, P62, DOI 10.1016/j.jim.2009.09.011; Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475; Pilling D, 2006, J LEUKOCYTE BIOL, V79, P1242, DOI 10.1189/jlb.0805456; Quan TE, 2004, INT J BIOCHEM CELL B, V36, P598, DOI 10.1016/j.biocel.2003.10.005; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; Reilkoff RA, 2011, NAT REV IMMUNOL, V11, P427, DOI 10.1038/nri2990; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Schmidt M, 2003, J IMMUNOL, V171, P380, DOI 10.4049/jimmunol.171.1.380; SCHRIER DJ, 1983, AM REV RESPIR DIS, V127, P63, DOI 10.1164/arrd.1983.127.1.63; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Shao DD, 2008, J LEUKOCYTE BIOL, V83, P1323, DOI 10.1189/jlb.1107782; Soma M, 2001, BIOCHEM BIOPH RES CO, V286, P200, DOI 10.1006/bbrc.2001.5364; STEEL DM, 1994, IMMUNOL TODAY, V15, P81, DOI 10.1016/0167-5699(94)90138-4; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Togashi S, 1997, LAB INVEST, V77, P525; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; Van Molle W, 2000, INFECT IMMUN, V68, P5026, DOI 10.1128/IAI.68.9.5026-5029.2000; Walters DM, 2008, MOUSE MODELS BLEOMYC; Wang DC, 2010, MOL THER, V18, P625, DOI 10.1038/mt.2009.317; Wynn Thomas A, 2011, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1422s93; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Yuste J, 2007, PLOS PATHOG, V3, P1208, DOI 10.1371/journal.ppat.0030120; Zhang WJ, 2011, J IMMUNOL, V187, P1764, DOI 10.4049/jimmunol.1002315	95	60	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93730	10.1371/journal.pone.0093730	http://dx.doi.org/10.1371/journal.pone.0093730			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695531	Green Published, gold, Green Submitted			2022-12-25	WOS:000334103000112
J	Song, ZL; Yang, GH; Liu, XF; Yan, ZY; Yuan, YX; Liao, YZ				Song, Zilin; Yang, Gaihe; Liu, Xiaofeng; Yan, Zhiying; Yuan, Yuexiang; Liao, Yinzhang			Comparison of Seven Chemical Pretreatments of Corn Straw for Improving Methane Yield by Anaerobic Digestion	PLOS ONE			English	Article							DILUTE-ACID PRETREATMENT; BIOGAS PRODUCTION; FERMENTATION; ETHANOL; STOVER; SACCHARIFICATION; BIOMASS	Agriculture straw is considered a renewable resource that has the potential to contribute greatly to bioenergy supplies. Chemical pretreatment prior to anaerobic digestion can increase the anaerobic digestibility of agriculture straw. The present study investigated the effects of seven chemical pretreatments on the composition and methane yield of corn straw to assess their effectiveness of digestibility. Four acid reagents (H2SO4, HCl, H2O2, and CH3COOH) at concentrations of 1%, 2%, 3%, and 4% (w/w) and three alkaline reagents (NaOH, Ca(OH)(2), and NH3 center dot H2O) at concentrations of 4%, 6%, 8%, and 10% (w/w) were used for the pretreatments. All pretreatments were effective in the biodegradation of the lignocellulosic straw structure. The straw, pretreated with 3% H2O2 and 8% Ca(OH)(2), acquired the highest methane yield of 216.7 and 206.6 mL CH4 g VS-1 in the acid and alkaline pretreatments, which are 115.4% and 105.3% greater than the untreated straw. H2O2 and Ca(OH)(2) can be considered as the most favorable pretreatment methods for improving the methane yield of straw because of their effectiveness and low cost.	[Song, Zilin; Liu, Xiaofeng; Yuan, Yuexiang; Liao, Yinzhang] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China; [Yang, Gaihe; Yan, Zhiying] Northwest A&F Univ, Res Ctr Recycle Agr Engn Technol Shaanxi Prov, Yangling, Shaanxi, Peoples R China	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Northwest A&F University - China	Liu, XF (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China.	lxf3636@163.com; zhiyingyan2010@yeah.net	Feng, Yongzhong/F-5090-2012	Feng, Yongzhong/0000-0002-5202-4368	National 973 of China [2013CB733502]; Applied Basic Research Program of Sichuan Province, China [2013JY0050]; Chinese Academy of Sciences [KGZD-EW-304-1]	National 973 of China(National Basic Research Program of China); Applied Basic Research Program of Sichuan Province, China; Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by the National 973 of China (No. 2013CB733502), Applied Basic Research Program of Sichuan Province, China (No. 2013JY0050) and Deployment Project of Chinese Academy of Sciences (No. KGZD-EW-304-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Public Health Association (APHA), 1998, AM PHYS ED REV, V20th; Amon T, 2007, BIORESOURCE TECHNOL, V98, P3204, DOI 10.1016/j.biortech.2006.07.007; Cao WX, 2012, BIORESOURCE TECHNOL, V111, P215, DOI 10.1016/j.biortech.2012.02.034; Cara C, 2008, BIORESOURCE TECHNOL, V99, P1869, DOI 10.1016/j.biortech.2007.03.037; Chandra R, 2012, ENERGY, V43, P273, DOI 10.1016/j.energy.2012.04.029; Chen Y, 2008, BIORESOURCE TECHNOL, V99, P4044, DOI 10.1016/j.biortech.2007.01.057; Chengdu Institute of Biology Chinese Academy of Sciences, 1984, SCI TECHNOLOGY; Estevez MM, 2012, BIORESOURCE TECHNOL, V104, P749, DOI 10.1016/j.biortech.2011.11.017; Fernandez-Cegri V, 2013, J CHEM TECHNOL BIOT, V88, P924, DOI 10.1002/jctb.3922; Ferreira LC, 2013, BIORESOURCE TECHNOL, V143, P251, DOI 10.1016/j.biortech.2013.05.065; Gomez-Tovar F, 2012, BIORESOURCE TECHNOL, V116, P372, DOI 10.1016/j.biortech.2012.03.109; Gonzalez G, 2005, J CHEM TECHNOL BIOT, V80, P151, DOI 10.1002/jctb.1165; Guo P, 2011, BIORESOURCE TECHNOL, V102, P7526, DOI 10.1016/j.biortech.2011.04.083; Hwang MH, 2004, J BIOTECHNOL, V111, P297, DOI 10.1016/j.jbiotec.2004.04.024; Cuetos MJ, 2011, BIOTECHNOL BIOPROC E, V16, P1044, DOI 10.1007/s12257-011-0117-4; Kang KE, 2012, BIOPROC BIOSYST ENG, V35, P77, DOI 10.1007/s00449-011-0606-z; Li CL, 2010, BIORESOURCE TECHNOL, V101, P4900, DOI 10.1016/j.biortech.2009.10.066; Li Q, 2012, BIORESOURCE TECHNOL, V125, P193, DOI 10.1016/j.biortech.2012.08.095; Li ZL, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-119; Lin YQ, 2009, J HAZARD MATER, V170, P366, DOI 10.1016/j.jhazmat.2009.04.086; Michalska K, 2012, BIORESOURCE TECHNOL, V119, P72, DOI 10.1016/j.biortech.2012.05.105; Monlau F, 2013, APPL ENERG, V102, P1105, DOI 10.1016/j.apenergy.2012.06.042; Murphy JD, 2009, BIOMASS BIOENERG, V33, P504, DOI 10.1016/j.biombioe.2008.08.018; National Bureau of Statistics of China, 2010, CHIN STAT YB 2009; Pakarinen OM, 2011, INT J HYDROGEN ENERG, V36, P14401, DOI 10.1016/j.ijhydene.2011.08.028; Pang YZ, 2008, ENERG FUEL, V22, P2761, DOI 10.1021/ef800001n; Rocha MVP, 2009, APPL BIOCHEM BIOTECH, V155, P407, DOI 10.1007/s12010-008-8432-8; Saha BC, 2005, PROCESS BIOCHEM, V40, P3693, DOI 10.1016/j.procbio.2005.04.006; Sapci Z, 2013, BIORESOURCE TECHNOL, V128, P487, DOI 10.1016/j.biortech.2012.09.094; Silverstein RA, 2007, BIORESOURCE TECHNOL, V98, P3000, DOI 10.1016/j.biortech.2006.10.022; Song ZL, 2012, BIORESOURCES, V7, P3223; Taherzadeh MJ, 2008, INT J MOL SCI, V9, P1621, DOI 10.3390/ijms9091621; Teghammar A, 2010, BIORESOURCE TECHNOL, V101, P1206, DOI 10.1016/j.biortech.2009.09.029; Us E, 2012, CHEM ENG J, V181, P120, DOI 10.1016/j.cej.2011.11.038; Wang Y.W., 1987, MICROBIOLOGY, V2, P81; Xiao B, 2001, POLYM DEGRAD STABIL, V74, P307, DOI 10.1016/S0141-3910(01)00163-X; Zhang QH, 2011, BIORESOURCE TECHNOL, V102, P3958, DOI 10.1016/j.biortech.2010.12.031; Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066845; Zheng MX, 2009, BIORESOURCE TECHNOL, V100, P5140, DOI 10.1016/j.biortech.2009.05.045; Zhong WZ, 2011, BIORESOURCE TECHNOL, V102, P11177, DOI 10.1016/j.biortech.2011.09.077; Zhou SX, 2012, ENERGY, V46, P644, DOI 10.1016/j.energy.2012.07.017; Zhu JY, 2010, BIORESOURCE TECHNOL, V101, P7523, DOI 10.1016/j.biortech.2010.04.060	42	73	78	8	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93801	10.1371/journal.pone.0093801	http://dx.doi.org/10.1371/journal.pone.0093801			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695485	Green Submitted, Green Published, gold			2022-12-25	WOS:000334103000125
J	Collares, RVA; Salgado, W; Tirapelli, DPD; dos Santos, JS				Collares, Renata Viesti A.; Salgado, Wilson, Jr.; da Cunha Tirapelli, Daniela Pretti; dos Santos, Jose Sebastiao			The Expression of LEP, LEPR, IGF1 and IL10 in Obesity and the Relationship with microRNAs	PLOS ONE			English	Article							METABOLIC SYNDROME; ADIPOSE-TISSUE; INSULIN-RESISTANCE; GENE-EXPRESSION; SERUM LEPTIN; INTERLEUKIN-10; FAT; ADIPOCYTOKINES; ASSOCIATION; ACTIVATION	Obesity is a multifactorial disease, with epigenetic alterations. Have been described modifications in the expression of some microRNAs, and some proteins related to obesity. The objective was to determine and correlate, in obese patients, the gene expression of LEP, LEPR, IGF1, IL10 and of miR-27a, miR-27b, miR-143 and miR-145. RNA was extracted from biopsies of subcutaneous fat, liver and visceral fat of 15 obese subjects submitted to bariatric surgery and of 15 non-obese subjects submitted to cholecystectomy for cDNA synthesis and for RT-PCR. The microRNAs were chosen using the TargetScan software. An increased expression of LEP and IGF1 was detected in the subcutaneous fat of the obese group compared to control, while the expression of IGF1 was higher in the control group than in the obese one. MiRNA-27a had a higher expression in the omentum of the obese patients and there was also a correlation in the expression of miRNA-145 and LEPR in the omentum of this group.	[Collares, Renata Viesti A.; Salgado, Wilson, Jr.; da Cunha Tirapelli, Daniela Pretti; dos Santos, Jose Sebastiao] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Surg & Anat, BR-14049 Ribeirao Preto, SP, Brazil; [da Cunha Tirapelli, Daniela Pretti] Mol Biol Lab, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo	Salgado, W (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Surg & Anat, BR-14049 Ribeirao Preto, SP, Brazil.	wsalgado@fmrp.usp.br	Salgado, Wilson/L-1470-2016; Santos, José Sebastião/A-2179-2008; Tirapelli, Daniela PC/F-9230-2012	Santos, José Sebastião/0000-0001-5118-0361; Tirapelli, Daniela PC/0000-0002-1886-4988	Fundacao Waldemar Barnsley Pessoa, Ribeirao Preto, SP, Brazil	Fundacao Waldemar Barnsley Pessoa, Ribeirao Preto, SP, Brazil	Research supported by Fundacao Waldemar Barnsley Pessoa, Ribeirao Preto, SP, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Bassols J, 2010, OBESITY, V18, P611, DOI 10.1038/oby.2009.313; Bruun JM, 2003, AM J PHYSIOL-ENDOC M, V285, pE527, DOI 10.1152/ajpendo.00110.2003; Buchwald H, 2004, OBES SURG, V14, P1157, DOI 10.1381/0960892042387057; Carmina E, 2008, FERTIL STERIL, V89, P642, DOI 10.1016/j.fertnstert.2007.03.085; Cleveland-Donovan K, 2010, ENDOCRINOLOGY, V151, P3752, DOI 10.1210/en.2010-0043; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Dusserre E, 2000, BBA-MOL BASIS DIS, V1500, P88, DOI 10.1016/S0925-4439(99)00091-5; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Esposito K, 2003, J CLIN ENDOCR METAB, V88, P1055, DOI 10.1210/jc.2002-021437; Esteghamati A, 2011, ARCH MED RES, V42, P244, DOI 10.1016/j.arcmed.2011.05.005; Fain JN, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/513948; Funahashi T, 1999, INTERNAL MED, V38, P202, DOI 10.2169/internalmedicine.38.202; Gautron L, 2011, J CLIN INVEST, V121, P2087, DOI 10.1172/JCI45888; Gnacinska M, 2009, ADV MED SCI-POLAND, V54, P150, DOI 10.2478/v10039-009-0035-2; Gomez JM, 2004, GROWTH HORM IGF RES, V14, P91, DOI 10.1016/j.ghir.2003.11.004; Heneghan HM, 2010, OBES REV, V11, P354, DOI 10.1111/j.1467-789X.2009.00659.x; Jackson Richard J, 2007, Sci STKE, V2007, pre1, DOI 10.1126/stke.3672007re1; Ji JL, 2009, FEBS LETT, V583, P759, DOI 10.1016/j.febslet.2009.01.034; Jordan SD, 2011, NAT CELL BIOL, V13, P434, DOI 10.1038/ncb2211; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kim SY, 2010, BIOCHEM BIOPH RES CO, V392, P323, DOI 10.1016/j.bbrc.2010.01.012; Kloting N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004699; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; La Rocca G, 2011, EXP CELL RES, V317, P488, DOI 10.1016/j.yexcr.2010.11.010; Lowery AJ, 2008, CLIN CANCER RES, V14, P360, DOI 10.1158/1078-0432.CCR-07-0992; Martins IS, 2003, REV SAUDE PUBL, V37, P760, DOI 10.1590/S0034-89102003000600011; Matsuzawa Y, 2002, J DIABETES COMPLICAT, V16, P17, DOI 10.1016/S1056-8727(01)00194-5; Mehta R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-39; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Moses AGW, 2001, BRIT J SURG, V88, P588, DOI 10.1046/j.1365-2168.2001.01743.x; Nam SY, 1997, INT J OBESITY, V21, P355, DOI 10.1038/sj.ijo.0800412; Nyomba BLG, 1999, METABOLISM, V48, P840, DOI 10.1016/S0026-0495(99)90215-9; Ortega FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009022; Owecki M, 2010, HORM METAB RES, V42, P585, DOI 10.1055/s-0030-1253422; Pardina E, 2010, OBES SURG, V20, P623, DOI 10.1007/s11695-010-0103-5; Ramis JM, 2005, J NUTR BIOCHEM, V16, P279, DOI 10.1016/j.jnutbio.2004.12.009; Romero Carla Eduarda Machado, 2006, Rev. Nutr., V19, P85, DOI 10.1590/S1415-52732006000100009; Russell CD, 2001, AM J PHYSIOL-ENDOC M, V280, pE399, DOI 10.1152/ajpendo.2001.280.3.E399; Scarpelli D, 2006, DIABETES, V55, P1529, DOI 10.2337/db06-0047; Schoof E, 2004, EUR J ENDOCRINOL, V150, P579, DOI 10.1530/eje.0.1500579; Seron K, 2006, BIOCHEM BIOPH RES CO, V348, P1232, DOI 10.1016/j.bbrc.2006.07.068; Siegmund B, 2004, J LEUKOCYTE BIOL, V76, P782, DOI 10.1189/jlb.0404239; Takanabe R, 2008, BIOCHEM BIOPH RES CO, V376, P728, DOI 10.1016/j.bbrc.2008.09.050; Tang XQ, 2009, RNA, V15, P287, DOI 10.1261/rna.1211209; van Exel E, 2002, DIABETES, V51, P1088, DOI 10.2337/diabetes.51.4.1088; Vettor R, 2005, ALIMENT PHARM THER, V22, P3, DOI 10.1111/j.1365-2036.2005.02587.x; Wajchenberg BL, 2000, ARQUIVOS BRASILEIROS, V44, P13; Yang Weining, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P140	50	29	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93512	10.1371/journal.pone.0093512	http://dx.doi.org/10.1371/journal.pone.0093512			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690978	Green Published, Green Submitted, gold			2022-12-25	WOS:000334101100095
J	Zhou, YB; Wang, QX; Liang, S; Gong, YH; Yang, MX; Nie, SJ; Nan, L; Yang, AH; Liao, Q; Yang, Y; Song, XX; Jiang, QW				Zhou, Yi-Biao; Wang, Qi-Xing; Liang, Song; Gong, Yu-Han; Yang, Mei-xia; Nie, Shi-Jiao; Nan, Lei; Yang, Ai-Hui; Liao, Qiang; Yang, Yang; Song, Xiu-Xia; Jiang, Qing-Wu			HIV-, HCV-, and Co- Infections and Associated Risk Factors among Drug Users in Southwestern China: A Township-Level Ecological Study Incorporating Spatial Regression	PLOS ONE			English	Article							HEPATITIS-C; SICHUAN PROVINCE; PREVALENCE; COINFECTION; METHADONE; VIRUS; SEX; EPIDEMIOLOGY; BEHAVIORS; COMMUNITY	Background: The human immunodeficiency virus (HIV) and hepatitis C virus (HCV) are major public health problems. Many studies have been performed to investigate the association between demographic and behavioral factors and HIV or HCV infection. However, some of the results of these studies have been in conflict. Methodology/Principal Findings: The data of all entrants in the 11 national methadone clinics in the Yi Autonomous Prefecture from March 2004 to December 2012 were collected from the national database. Several spatial regression models were used to analyze specific community characteristics associated with the prevalence of HIV and HCV infection at the township level. The study enrolled 6,417 adult patients. The prevalence of HIV infection, HCV infection and co-infection was 25.4%, 30.9%, and 11.0%, respectively. Prevalence exhibited stark geographical variations in the area studied. The four regression models showed Yi ethnicity to be associated with both the prevalence of HIV and of HIV/HCV co-infection. The male drug users in some northwestern counties had greater odds of being infected with HIV than female drug users, but the opposite was observed in some eastern counties. The 'being in drug rehabilitation variable was found to be positively associated with prevalence of HCV infection in some southern townships, however, it was found to be negatively associated with it in some northern townships. Conclusions/Significance: The spatial modeling creates better representations of data such that public health interventions must focus on areas with high frequency of HIV/HCV to prevent further transmission of both HIV and HCV.	[Zhou, Yi-Biao; Nie, Shi-Jiao; Yang, Ai-Hui; Song, Xiu-Xia; Jiang, Qing-Wu] Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai 200433, Peoples R China; [Zhou, Yi-Biao; Nie, Shi-Jiao; Yang, Ai-Hui; Song, Xiu-Xia; Jiang, Qing-Wu] Fudan Univ, Minist Educ, Key Lab Publ Hlth Safety, Shanghai 200433, Peoples R China; [Zhou, Yi-Biao; Nie, Shi-Jiao; Yang, Ai-Hui; Song, Xiu-Xia; Jiang, Qing-Wu] Fudan Univ, Trop Dis Res Ctr, Shanghai 200433, Peoples R China; [Wang, Qi-Xing; Gong, Yu-Han; Nan, Lei; Liao, Qiang] Ctr Dis Prevent & Control Liangshan Prefecture, Chengdu, Sichuan, Peoples R China; [Liang, Song; Yang, Yang] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL USA; [Liang, Song] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Yang, Mei-xia] Xuhui Ctr Dis Prevent & Control, Shanghai, Peoples R China; [Yang, Yang] Univ Florida, Dept Biostat, Gainesville, FL USA	Fudan University; Fudan University; Fudan University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Zhou, YB (corresponding author), Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai 200433, Peoples R China.	ybzhou@fudan.edu.cn; jiangqw@fudan.edu.cn		Jiang, Qingwu/0000-0001-8921-3317				Aceijas C, 2007, INT J DRUG POLICY, V18, P352, DOI 10.1016/j.drugpo.2007.04.004; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; Anselin LY, 2004, J GEOGRAPHICAL SYSTE, V6, P197, DOI DOI 10.1007/S10109-004-0132-5; Arraiz I, 2010, J REGIONAL SCI, V50, P592, DOI 10.1111/j.1467-9787.2009.00618.x; Bivand R, 2006, GEOGR ANAL, V38, P23, DOI 10.1111/j.0016-7363.2005.00672.x; Booth RE, 2011, AIDS BEHAV, V15, P30, DOI 10.1007/s10461-010-9751-7; Buse K, 2008, J ROY SOC MED, V101, P572, DOI 10.1258/jrsm.2008.08k036; Chen HT, 2013, AIDS EDUC PREV, V25, P336, DOI 10.1521/aeap.2013.25.4.336; Choi SYP, 2006, SOC SCI MED, V62, P1672, DOI 10.1016/j.socscimed.2005.08.046; Conley JF, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-20; Cuadros DF, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-28; Dai SY, 2012, J MED VIROL, V84, P1, DOI 10.1002/jmv.22214; Davies AG, 1996, AIDS CARE, V8, P517, DOI 10.1080/09540129650125489; De Cock KM, 2012, AIDS, V26, P1205, DOI 10.1097/QAD.0b013e328354622a; Du WJ, 2008, DRUG ALCOHOL DEPEN, V94, P158, DOI 10.1016/j.drugalcdep.2007.11.009; Fang YX, 2006, ACTA PHARMACOL SIN, V27, P140, DOI 10.1111/j.1745-7254.2006.00270.x; Gaskin, 2000, Int J Drug Policy, V11, P423, DOI 10.1016/S0955-3959(00)00069-4; Hu ZY, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-26; Karim SSA, 2009, INT J EPIDEMIOL, V38, P1016, DOI 10.1093/ije/dyp201; Kelejian HH, 2007, J ECONOMETRICS, V140, P131, DOI 10.1016/j.jeconom.2006.09.005; Kelejian HH, 1999, INT ECON REV, V40, P509, DOI 10.1111/1468-2354.00027; Kelejian HH, 1998, J REAL ESTATE FINANC, V17, P99, DOI 10.1023/A:1007707430416; Kim AY, 2013, J INFECT DIS, V207, pS1, DOI 10.1093/infdis/jis927; Koziel MJ, 2007, NEW ENGL J MED, V356, P1445, DOI 10.1056/NEJMra065142; Kretzschmar M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-108; Maier I, 2002, WORLD J GASTROENTERO, V8, P577, DOI 10.3748/wjg.v8.i4.577; Messina JP, 2010, SOC SCI MED, V71, P1428, DOI 10.1016/j.socscimed.2010.07.025; Pang L, AIDS S8, V21, pS103; Qian HZ, 2008, J SUBST ABUSE TREAT, V34, P391, DOI 10.1016/j.jsat.2007.07.002; Rey SJ, 2006, GEOGR ANAL, V38, P67, DOI 10.1111/j.0016-7363.2005.00675.x; Sherman KE, 2002, CLIN INFECT DIS, V34, P831, DOI 10.1086/339042; Strader DB, 2005, CLIN INFECT DIS, V41, pS7, DOI 10.1086/429489; Strathdee SA, 2001, ARCH INTERN MED, V161, P1281, DOI 10.1001/archinte.161.10.1281; SUSSER M, 1994, AM J PUBLIC HEALTH, V84, P825, DOI 10.2105/AJPH.84.5.825; Tan Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003608; Tanser F, 2009, INT J EPIDEMIOL, V38, P1008, DOI 10.1093/ije/dyp148; Weidmann C, 2012, VOX SANG, V102, P47, DOI 10.1111/j.1423-0410.2011.01501.x; Wilson D, 2008, LANCET, V372, P423, DOI 10.1016/S0140-6736(08)60883-1; Yang Y, 2012, ASIAN J ANDROL, V14, P758, DOI 10.1038/aja.2012.25; Yen YF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1066; Yin WY, 2010, INT J EPIDEMIOL, V39, pII29, DOI 10.1093/ije/dyq210; Zhuang X, 2012, DRUG ALCOHOL DEPEN, V126, P286, DOI 10.1016/j.drugalcdep.2012.05.028	42	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2014	9	3							e93157	10.1371/journal.pone.0093157	http://dx.doi.org/10.1371/journal.pone.0093157			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GP	24687006	Green Published, Green Submitted, gold			2022-12-25	WOS:000340842300004
J	Komori, T; Tanaka, M; Senba, E; Miyajima, A; Morikawa, Y				Komori, Tadasuke; Tanaka, Minoru; Senba, Emiko; Miyajima, Atsushi; Morikawa, Yoshihiro			Deficiency of OncostatinMReceptor beta (OSMR beta) Exacerbates High-fat Diet-induced Obesity and Related Metabolic Disorders in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipose Tissue; Cytokine; Inflammation; Insulin Resistance; Obesity; Hepatic Steatosis; High-fat Diet	ADIPOSE-TISSUE INFLAMMATION; INDUCED INSULIN-RESISTANCE; HEPATIC STEATOSIS; SKELETAL-MUSCLE; T-CELLS; LIVER; ACTIVATION; RECEPTOR; KINASE; EXPRESSION	Background: Obesity is associated with adipose tissue inflammation, insulin resistance, and hepatic steatosis. Results: OSM receptor (OSMR)-deficient mice fed a high-fat diet exhibited severe obesity, adipose tissue inflammation, insulin resistance, and hepatic steatosis. Conclusion: OSM signaling has suppressive effects on the deterioration of obesity-induced metabolic disorders. Significance: These results indicate that OSM signaling may be a promising therapeutic target of obesity-induced metabolic disorders. Oncostatin M (OSM) belongs to the IL-6 family of cytokines and has diverse biological effects, including the modulation of inflammatory responses. In the present study we analyzed the roles of OSM signaling in obesity and related metabolic disorders. Under a high-fat diet condition, OSM receptor subunit-deficient (OSMR-/-) mice exhibited increases in body weight and food intake compared with those observed in WT mice. In addition, adipose tissue inflammation, insulin resistance, and hepatic steatosis were more severe in OSMR-/- mice than in wild-type (WT) mice. These metabolic phenotypes did not improve when OSMR-/- mice were pair-fed with WT mice, suggesting that the effects of OSM signaling on these phenotypes are independent of the increases in the body weight and food intake. In the liver of OSMR-/- mice, the insulin-induced phosphorylation of p70 S6 kinase remained intact, whereas insulin-induced FOXO1 phosphorylation was impaired. In addition, OSMR-/- mice displayed a higher expression of genes related to de novo lipogenesis in the liver than WT mice. Furthermore, treatment of genetically obese ob/ob mice with OSM improved insulin resistance, adipose tissue inflammation, and hepatic steatosis. Intraportal administration of OSM into ob/ob mice activated STAT3 and increased the expression of long-chain acyl-CoA synthetase (ACSL) 3 and ACSL5 with decreased expression of fatty acid synthase in the liver, suggesting that OSM directly induces lipolysis and suppresses lipogenesis in the liver of obese mice. These findings suggest that defects in OSM signaling promote the deterioration of high-fat diet-induced obesity and related metabolic disorders.	[Komori, Tadasuke; Senba, Emiko; Morikawa, Yoshihiro] Wakayama Med Univ, Dept Anat & Neurobiol, Wakayama 6418509, Japan; [Tanaka, Minoru; Miyajima, Atsushi] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Cell Growth & Differentiat, Tokyo 1130032, Japan	Wakayama Medical University; University of Tokyo	Morikawa, Y (corresponding author), Wakayama Med Univ, Dept Anat & Neurobiol, 811-1 Kimiidera, Wakayama 6418509, Japan.	yoshim@wakayama-med.ac.jp			Wakayama Medical University	Wakayama Medical University	This work was supported in part by a Research Grant on Priority Areas from Wakayama Medical University.	Bae EJ, 2012, J BIOL CHEM, V287, P18769, DOI 10.1074/jbc.M112.365544; Beaven SW, 2013, CELL METAB, V18, P106, DOI 10.1016/j.cmet.2013.04.021; Benhamed F, 2012, J CLIN INVEST, V122, P2176, DOI 10.1172/JCI41636; Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013; Bornfeldt KE, 2011, CELL METAB, V14, P575, DOI 10.1016/j.cmet.2011.07.015; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Broxmeyer HE, 2002, IMMUNITY, V16, P815, DOI 10.1016/S1074-7613(02)00319-9; de Alvaro C, 2004, J BIOL CHEM, V279, P17070, DOI 10.1074/jbc.M312021200; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Gao MM, 2013, MOL THER, V21, P1852, DOI 10.1038/mt.2013.125; Goerdt S, 1999, IMMUNITY, V10, P137, DOI 10.1016/S1074-7613(00)80014-X; Grzelkowska-Kowalczyk K, 2010, CELL BIOL INT, V34, P117, DOI 10.1042/CBI20090135; Hong EG, 2009, DIABETES, V58, P2525, DOI 10.2337/db08-1261; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Kamiya A, 1999, EMBO J, V18, P2127, DOI 10.1093/emboj/18.8.2127; Komori T, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.461905; Komori T, 2012, J BIOL CHEM, V287, P19985, DOI 10.1074/jbc.M112.367854; Komori T, 2010, J BIOL CHEM, V285, P37884, DOI 10.1074/jbc.M110.148973; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183; Moreno-Aliaga MJ, 2011, CELL METAB, V14, P242, DOI 10.1016/j.cmet.2011.05.013; Morikawa Y, 2004, J NEUROSCI, V24, P1941, DOI 10.1523/JNEUROSCI.4975-03.2004; Mozaffarian A, 2008, J IMMUNOL, V181, P7243, DOI 10.4049/jimmunol.181.10.7243; Mukouyama YS, 1998, IMMUNITY, V8, P105, DOI 10.1016/S1074-7613(00)80463-X; Nguyen MTA, 2005, J BIOL CHEM, V280, P35361, DOI 10.1074/jbc.M504611200; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; O'Rourke RW, 2012, METABOLISM, V61, P1152, DOI 10.1016/j.metabol.2012.01.018; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Owen JL, 2012, P NATL ACAD SCI USA, V109, P16184, DOI 10.1073/pnas.1213343109; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Racioppi L, 2012, J BIOL CHEM, V287, P11579, DOI 10.1074/jbc.M111.336032; Repovic P, 2002, J NEUROSCI, V22, P5334; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Sun Z, 2013, TRENDS ENDOCRIN MET, V24, P4, DOI 10.1016/j.tem.2012.09.005; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Tamura S, 2002, DEV DYNAM, V225, P327, DOI 10.1002/dvdy.10156; Tanaka M, 1999, BLOOD, V93, P804, DOI 10.1182/blood.V93.3.804.403a16_804_815; Tanaka M, 2003, BLOOD, V102, P3154, DOI 10.1182/blood-2003-02-0367; Tilg H, 2008, TRENDS ENDOCRIN MET, V19, P371, DOI 10.1016/j.tem.2008.08.005; Wallace PM, 1999, J IMMUNOL, V162, P5547; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Watt MJ, 2006, NAT MED, V12, P541, DOI 10.1038/nm1383; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Zhou Y, 2007, ARTERIOSCL THROM VAS, V27, P2198, DOI 10.1161/ATVBAHA.107.148429	51	32	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13821	13837		10.1074/jbc.M113.542399	http://dx.doi.org/10.1074/jbc.M113.542399			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24695736	hybrid, Green Published			2022-12-25	WOS:000335984600016
J	Pokutta, S; Choi, HJ; Ahlsen, G; Hansen, SD; Weis, WI				Pokutta, Sabine; Choi, Hee-Jung; Ahlsen, Goran; Hansen, Scott D.; Weis, William I.			Structural and Thermodynamic Characterization of Cadherin center dot beta-Catenin center dot alpha-Catenin Complex Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Analytical Ultracentrifugation; Cadherins; Cell Adhesion; Isothermal Titration Calorimetry; X-ray Crystallography; -Catenin; -Catenin	CRYSTAL-STRUCTURE; VINCULIN ACTIVATION; CELL-ADHESION; F-ACTIN; BINDING; PROTEIN; PHOSPHORYLATION; CONTACTS; TENSION; SITES	Background: Cadherin cell adhesion molecules are linked to the actin cytoskeleton by the proteins - and -catenin. Results: The interactions of -catenins in the cadherin-catenin-catenin complex have been thermodynamically and structurally defined. Conclusion: The architecture of -catenin enables regulation of its interactions in the adhesive complex. Significance: The data provide molecular insights into the regulation of the cadherincatenin complex. The classical cadherin-catenin-catenin complex mediates homophilic cell-cell adhesion and mechanically couples the actin cytoskeletons of adjacent cells. Although -catenin binds to -catenin and to F-actin, -catenin significantly weakens the affinity of -catenin for F-actin. Moreover, -catenin self-associates into homodimers that block -catenin binding. We investigated quantitatively and structurally E- and N-catenin dimer formation, their interaction with -catenin and the cadherin-catenin complex, and the effect of the -catenin actin-binding domain on -catenin association. The two -catenin variants differ in their self-association properties: at physiological temperatures, E-catenin homodimerizes 10x more weakly than does N-catenin but is kinetically trapped in its oligomeric state. Both E- and N-catenin bind to -catenin with a K-d of 20 nm, and this affinity is increased by an order of magnitude when cadherin is bound to -catenin. We describe the crystal structure of a complex representing the full -cateninN-catenin interface. A three-dimensional model of the cadherin-catenin-catenin complex based on these new structural data suggests mechanisms for the enhanced stability of the ternary complex. The C-terminal actin-binding domain of -catenin has no influence on the interactions with -catenin, arguing against models in which -catenin weakens actin binding by stabilizing inhibitory intramolecular interactions between the actin-binding domain and the rest of -catenin.	[Pokutta, Sabine; Choi, Hee-Jung; Weis, William I.] Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA; [Pokutta, Sabine; Choi, Hee-Jung; Weis, William I.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Choi, Hee-Jung] Seoul Natl Univ, Sch Biol Sci, Seoul 151747, South Korea; [Ahlsen, Goran] Columbia Univ, Howard Hughes Med Inst, Dept Syst Biol, New York, NY 10032 USA; [Ahlsen, Goran] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Hansen, Scott D.] Univ Calif San Francisco, Sch Med, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	Stanford University; Stanford University; Seoul National University (SNU); Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weis, WI (corresponding author), Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA.	bill.weis@stanford.edu	Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150; Choi, Hee-Jung/0000-0002-1167-1526	United States Department of Energy; National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056169, U01GM094663] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [0918535] Funding Source: National Science Foundation	United States Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank Barry Honig and Larry Shapiro for access to AUC facilities at Columbia University and James Nelson for comments on the manuscript. Portions of this work were carried out at the Stanford Synchrotron Radiation Lightsource, which is supported by the United States Department of Energy and the National Institutes of Health.	Abe K, 2004, NAT NEUROSCI, V7, P357, DOI 10.1038/nn1212; Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Aberle H, 1996, J BIOL CHEM, V271, P1520, DOI 10.1074/jbc.271.3.1520; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; Benjamin JM, 2010, J CELL BIOL, V189, P339, DOI 10.1083/jcb.200910041; Borghi N, 2012, P NATL ACAD SCI USA, V109, P12568, DOI 10.1073/pnas.1204390109; Borgon RA, 2004, STRUCTURE, V12, P1189, DOI 10.1016/j.str.2004.05.009; Choi HJ, 2012, P NATL ACAD SCI USA, V109, P8576, DOI 10.1073/pnas.1203906109; Choi HJ, 2006, J BIOL CHEM, V281, P1027, DOI 10.1074/jbc.M511338200; de la Roche M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1680; Dickinson DJ, 2011, SCIENCE, V331, P1336, DOI 10.1126/science.1199633; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Giagtzoglou N, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003079; Giannotta M, 2013, DEV CELL, V26, P441, DOI 10.1016/j.devcel.2013.08.020; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Hansen SD, 2013, MOL BIOL CELL, V24, P3710, DOI 10.1091/mbc.E13-07-0388; Hazan RB, 1997, J BIOL CHEM, V272, P32448, DOI 10.1074/jbc.272.51.32448; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Hulpiau P, 2013, PROG MOL BIOL TRANSL, V116, P71, DOI 10.1016/B978-0-12-394311-8.00004-2; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Imamura Y, 1999, J CELL BIOL, V144, P1311, DOI 10.1083/jcb.144.6.1311; Ishiyama N, 2013, J BIOL CHEM, V288, P15913, DOI 10.1074/jbc.M113.453928; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Izard T, 2004, J BIOL CHEM, V279, P27667, DOI 10.1074/jbc.M403076200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Koslov ER, 1997, J BIOL CHEM, V272, P27301, DOI 10.1074/jbc.272.43.27301; Kwiatkowski AV, 2010, P NATL ACAD SCI USA, V107, P14591, DOI 10.1073/pnas.1007349107; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; Miller PW, 2013, J BIOL CHEM, V288, P22324, DOI 10.1074/jbc.M113.458406; Pai LM, 1996, J BIOL CHEM, V271, P32411, DOI 10.1074/jbc.271.50.32411; Papagrigoriou E, 2004, EMBO J, V23, P2942, DOI 10.1038/sj.emboj.7600285; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Piedra J, 2001, J BIOL CHEM, V276, P20436, DOI 10.1074/jbc.M100194200; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Pokutta S, 2007, ANNU REV CELL DEV BI, V23, P237, DOI 10.1146/annurev.cellbio.22.010305.104241; Rangarajan ES, 2013, NAT STRUCT MOL BIOL, V20, P188, DOI 10.1038/nsmb.2479; Rangarajan ES, 2012, J BIOL CHEM, V287, P18492, DOI 10.1074/jbc.M112.351023; Sampietro J, 2006, MOL CELL, V24, P293, DOI 10.1016/j.molcel.2006.09.001; Tachibana K, 2000, J CELL BIOL, V150, P1161, DOI 10.1083/jcb.150.5.1161; Taguchi K, 2011, J CELL BIOL, V194, P643, DOI 10.1083/jcb.201104124; Weiss EE, 1998, J CELL BIOL, V141, P755, DOI 10.1083/jcb.141.3.755; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yang J, 2001, EMBO J, V20, P3645, DOI 10.1093/emboj/20.14.3645; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055	48	43	44	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13589	13601		10.1074/jbc.M114.554709	http://dx.doi.org/10.1074/jbc.M114.554709			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24692547	Green Published, hybrid			2022-12-25	WOS:000335522800053
J	Ray, S; Bender, S; Kang, S; Lin, R; Glicksman, MA; Liu, M				Ray, Soumya; Bender, Samantha; Kang, Stephanie; Lin, Regina; Glicksman, Marcie A.; Liu, Min			The Parkinson Disease-linked LRRK2 Protein Mutation I2020T Stabilizes an Active State Conformation Leading to Increased Kinase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Inhibitors; Enzyme Kinetics; LRRK2; Molecular modeling; Parkinson Disease	STRUCTURAL MECHANISM; NEURONAL TOXICITY; GTP-BINDING; MUTANT; INHIBITORS; GENE; PHOSPHORYLATES; G2019S	Background: LRRK2 has emerged as one of the most relevant players in Parkinson disease pathogenesis. Results: Enzyme kinetic and modeling studies elucidate the effect of the LRRK2 I2020T mutant on kinase activity. Conclusion: The I2020T mutant stabilizes the active conformation and leads to increased kinase activity. As a result, it binds to type II inhibitors competitively. Significance: This study may contribute to the development of new classes of inhibitors of LRRK2. The effect of leucine-rich repeat kinase 2 (LRRK2) mutation I2020T on its kinase activity has been controversial, with both increased and decreased effects being reported. We conducted steady-state and pre-steady-state kinetic studies on LRRKtide and its analog LRRKtide(S). Their phosphorylation differs by the rate-limiting steps: product release is rate-limiting for LRRKtide and phosphoryl transfer is rate-limiting for LRRKtide(S). As a result, we observed that the I2020T mutant is more active than wild type (WT) LRRK2 for LRRKtide(S) phosphorylation, whereas it is less active than WT for LRRKtide phosphorylation. Our pre-steady-state kinetic data suggest that (i) the I2020T mutant accelerates the rates of phosphoryl transfer of both reactions by 3-7-fold; (ii) this increase is masked by a rate-limiting product release step for LRRKtide phosphorylation; and (iii) the observed lower activity of the mutant for LRRKtide phosphorylation is a consequence of its instability: the concentration of the active form of the mutant is 3-fold lower than WT. The I2020T mutant has a dramatically low K-ATP and therefore leads to resistance to ATP competitive inhibitors. Two well known DFG-out or type II inhibitors are also weaker toward the mutant because they inhibit the mutant in an unexpected ATP competitive mechanism. The I2020 residue lies next to the DYG motif of the activation loop of the LRRK2 kinase domain. Our modeling and metadynamic simulations suggest that the I2020T mutant stabilizes the DYG-in active conformation and creates an unusual allosteric pocket that can bind type II inhibitors but in an ATP competitive fashion.	[Bender, Samantha; Kang, Stephanie; Lin, Regina; Glicksman, Marcie A.; Liu, Min] Harvard Univ, Sch Med, Lab Drug Discovery Neurodegenerat, Harvard NeuroDiscovery Ctr, Cambridge, MA 02139 USA; [Ray, Soumya; Bender, Samantha; Kang, Stephanie; Lin, Regina; Glicksman, Marcie A.; Liu, Min] Harvard Univ, Sch Med, Brigham & Womens Hosp, Cambridge, MA 02139 USA	Harvard University; Harvard University; Brigham & Women's Hospital	Liu, M (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Cambridge, MA 02139 USA.	mliu@rics.bwh.harvard.edu		liu, min/0000-0003-0500-3246	National Institutes of Health [R21 NS 072519]; Harvard Milton fund foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS072519] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Milton fund foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R21 NS 072519 and the Harvard Milton fund foundation.	Anand VS, 2009, FEBS J, V276, P466, DOI 10.1111/j.1742-4658.2008.06789.x; Bailey RM, 2013, ACTA NEUROPATHOL, V126, P809, DOI 10.1007/s00401-013-1188-4; Barducci A, 2006, J AM CHEM SOC, V128, P2705, DOI 10.1021/ja057076l; Barducci A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.020603; Barducci A, 2010, BIOPHYS J, V98, pL44, DOI 10.1016/j.bpj.2010.01.033; Berg D, 2005, BRAIN, V128, P3000, DOI 10.1093/brain/awh666; Berteotti A, 2011, J AM CHEM SOC, V133, P17200, DOI 10.1021/ja202849a; Bonomi M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.190601; Bonomi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013208; Branduardi D, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2432340; Bussi G, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.090601; Choi HG, 2012, BIOORG MED CHEM LETT, V22, P5297, DOI 10.1016/j.bmcl.2012.06.036; COX S, 1994, CURR OPIN STRUC BIOL, V4, P893, DOI 10.1016/0959-440X(94)90272-0; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Garuti L, 2010, CURR MED CHEM, V17, P2804, DOI 10.2174/092986710791859333; Gilsbach BK, 2012, P NATL ACAD SCI USA, V109, P10322, DOI 10.1073/pnas.1203223109; Gloeckner CJ, 2009, J NEUROCHEM, V109, P959, DOI 10.1111/j.1471-4159.2009.06024.x; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Guo LX, 2007, EXP CELL RES, V313, P3658, DOI 10.1016/j.yexcr.2007.07.007; Ito G, 2007, BIOCHEMISTRY-US, V46, P1380, DOI 10.1021/bi061960m; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; John B, 2003, NUCLEIC ACIDS RES, V31, P3982, DOI 10.1093/nar/gkg460; Johnson DA, 2001, CHEM REV, V101, P2243, DOI 10.1021/cr000226k; Kawakami F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030834; Khan NL, 2005, BRAIN, V128, P2786, DOI 10.1093/brain/awh667; Leone V, 2010, CURR OPIN STRUC BIOL, V20, P148, DOI 10.1016/j.sbi.2010.01.011; Limongelli V, 2012, P NATL ACAD SCI USA, V109, P1467, DOI 10.1073/pnas.1112181108; Limongelli V, 2010, P NATL ACAD SCI USA, V107, P5411, DOI 10.1073/pnas.0913377107; Liu M, 2013, BIOCHEMISTRY-US, V52, P1725, DOI 10.1021/bi3012077; Liu M, 2011, BIOCHEMISTRY-US, V50, P9399, DOI 10.1021/bi201173d; Liu M, 2010, BIOCHEMISTRY-US, V49, P2008, DOI 10.1021/bi901851y; Mata IF, 2005, NEUROSCI LETT, V382, P309, DOI 10.1016/j.neulet.2005.03.033; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Nichols RJ, 2010, BIOCHEM J, V430, P393, DOI 10.1042/BJ20100483; Ohta E, 2009, BIOCHEM BIOPH RES CO, V390, P710, DOI 10.1016/j.bbrc.2009.10.034; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Ray S, 2012, FUTURE MED CHEM, V4, P1701, DOI [10.4155/fmc.12.110, 10.4155/FMC.12.110]; Reichling LJ, 2009, BIOCHEM BIOPH RES CO, V384, P255, DOI 10.1016/j.bbrc.2009.04.098; Sanchez R, 1997, PROTEINS, P50; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Segel I.H., 1975, ENZYME KINETICS; Sheng ZJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004485; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Xiong YL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000902; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhou TJ, 2011, CHEM BIOL DRUG DES, V77, P1, DOI 10.1111/j.1747-0285.2010.01054.x; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	54	32	32	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13042	13053		10.1074/jbc.M113.537811	http://dx.doi.org/10.1074/jbc.M113.537811			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24695735	Green Published, hybrid			2022-12-25	WOS:000335522800008
J	Bustos, FJ; Varela-Nallar, L; Campos, M; Henriquez, B; Phillips, M; Opazo, C; Aguayo, LG; Montecino, M; Constantine-Paton, M; Inestrosa, NC; van Zundert, B				Bustos, Fernando J.; Varela-Nallar, Lorena; Campos, Matias; Henriquez, Berta; Phillips, Marnie; Opazo, Carlos; Aguayo, Luis G.; Montecino, Martin; Constantine-Paton, Martha; Inestrosa, Nibaldo C.; van Zundert, Brigitte			PSD95 Suppresses Dendritic Arbor Development in Mature Hippocampal Neurons by Occluding the Clustering of NR2B-NMDA Receptors	PLOS ONE			English	Article							LONG-TERM POTENTIATION; MAGUK SCAFFOLDING PROTEINS; NMDA RECEPTOR; POSTSYNAPTIC DENSITY; SUBUNIT COMPOSITION; SYNAPSE STABILIZATION; DIFFERENTIAL ROLES; VISUAL-CORTEX; PSD-95; PLASTICITY	Considerable evidence indicates that the NMDA receptor (NMDAR) subunits NR2A and NR2B are critical mediators of synaptic plasticity and dendritogenesis; however, how they differentially regulate these processes is unclear. Here we investigate the roles of the NR2A and NR2B subunits, and of their scaffolding proteins PSD-95 and SAP102, in remodeling the dendritic architecture of developing hippocampal neurons (2-25 DIV). Analysis of the dendritic architecture and the temporal and spatial expression patterns of the NMDARs and anchoring proteins in immature cultures revealed a strong positive correlation between synaptic expression of the NR2B subunit and dendritogenesis. With maturation, the pruning of dendritic branches was paralleled by a strong reduction in overall and synaptic expression of NR2B, and a significant elevation in synaptic expression of NR2A and PSD95. Using constructs that alter the synaptic composition, we found that either over-expression of NR2B or knock-down of PSD95 by shRNA-PSD95 augmented dendritogenesis in immature neurons. Reactivation of dendritogenesis could also be achieved in mature cultured neurons, but required both manipulations simultaneously, and was accompanied by increased dendritic clustering of NR2B. Our results indicate that the developmental increase in synaptic expression of PSD95 obstructs the synaptic clustering of NR2B-NMDARs, and thereby restricts reactivation of dendritic branching. Experiments with shRNA-PSD95 and chimeric NR2A/NR2B constructs further revealed that C-terminus of the NR2B subunit (tail) was sufficient to induce robust dendritic branching in mature hippocampal neurons, and suggest that the NR2B tail is important in recruiting calcium-dependent signaling proteins and scaffolding proteins necessary for dendritogenesis.	[Bustos, Fernando J.; Varela-Nallar, Lorena; Campos, Matias; Henriquez, Berta; Montecino, Martin; van Zundert, Brigitte] Univ Andres Bello, Fac Biol Sci, Ctr Biomed Res, Santiago, Chile; [Bustos, Fernando J.; Varela-Nallar, Lorena; Campos, Matias; Henriquez, Berta; Montecino, Martin; van Zundert, Brigitte] Univ Andres Bello, Fac Med, Santiago, Chile; [Bustos, Fernando J.; Opazo, Carlos; Aguayo, Luis G.] Univ Concepcion, Fac Biol Sci, Concepcion, Chile; [Varela-Nallar, Lorena; Inestrosa, Nibaldo C.] Pontificia Univ Catolica Chile, Fac Biol Sci, Dept Mol & Cellular Biol, Santiago, Chile; [Phillips, Marnie; Constantine-Paton, Martha] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Bustos, Fernando J.; Montecino, Martin] FONDAP Ctr Genome Regulat, Santiago, Chile	Universidad Andres Bello; Universidad Andres Bello; Universidad de Concepcion; Pontificia Universidad Catolica de Chile; Massachusetts Institute of Technology (MIT)	van Zundert, B (corresponding author), Univ Andres Bello, Fac Biol Sci, Ctr Biomed Res, Santiago, Chile.	bvanzundert@unab.cl	Varela-Nallar, Lorena/AAV-3304-2021	Opazo, Carlos/0000-0003-3473-7548; Bustos, Fernando/0000-0002-0487-7032; Varela-Nallar, Lorena/0000-0003-2588-6437	Conicyt [24110099, PFB12/2007]; Fondecyt [11110012, 1100502, 1120156, 1101012]; FONDAP [15090007]; National Institutes of Health Grant [EY014074]; Anillo [ACT1114];  [3110138]; NATIONAL EYE INSTITUTE [R01EY014074] Funding Source: NIH RePORTER	Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONDAP; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Anillo(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/ANILLOS); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Conicyt 24110099 (FJB), Fondecyt 11110012 (LVN), 3110138 (BH), Fondecyt 1100502 (LGA), FONDAP 15090007 (MM), National Institutes of Health Grant EY014074 (to MCP), Fondecyt 1120156 and CONICYT PFB12/2007 (NCI) and Fondecyt 1101012 and Anillo ACT1114 (BvZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hallaq RA, 2007, J NEUROSCI, V27, P8334, DOI 10.1523/JNEUROSCI.2155-07.2007; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Beique JC, 2003, J PHYSIOL-LONDON, V546, P859, DOI 10.1113/jphysiol.2002.031369; Buerli T, 2007, NAT PROTOC, V2, P3090, DOI 10.1038/nprot.2007.445; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Charych EI, 2006, J NEUROSCI, V26, P10164, DOI 10.1523/JNEUROSCI.2379-06.2006; Chen BS, 2011, J NEUROSCI, V31, P89, DOI 10.1523/JNEUROSCI.1034-10.2011; Chen XB, 2008, P NATL ACAD SCI USA, V105, P4453, DOI 10.1073/pnas.0800897105; Chen XB, 2011, J NEUROSCI, V31, P6329, DOI 10.1523/JNEUROSCI.5968-10.2011; Cline H, 2008, J PHYSIOL-LONDON, V586, P1509, DOI 10.1113/jphysiol.2007.150029; Cousins SL, 2012, J BIOL CHEM, V287, P13465, DOI 10.1074/jbc.M111.292862; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; Elias GM, 2008, P NATL ACAD SCI USA, V105, P20953, DOI 10.1073/pnas.0811025106; Elias GM, 2007, TRENDS CELL BIOL, V17, P343, DOI 10.1016/j.tcb.2007.07.005; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Espinosa JS, 2009, NEURON, V62, P205, DOI 10.1016/j.neuron.2009.03.006; Fallini C, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-17; Foster KA, 2010, J NEUROSCI, V30, P2676, DOI 10.1523/JNEUROSCI.4022-09.2010; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Gambrill AC, 2011, P NATL ACAD SCI USA, V108, P5855, DOI 10.1073/pnas.1012676108; Henriquez B, 2013, MOL CELL NEUROSCI, V57, P130, DOI 10.1016/j.mcn.2013.07.012; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Keith D, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.004.2008; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Kulkarni VA, 2012, MOL CELL NEUROSCI, V50, P10, DOI 10.1016/j.mcn.2012.03.005; Lee WCA, 2006, PLOS BIOL, V4, P271, DOI 10.1371/journal.pbio.0040029; Lim IA, 2003, NEUROPHARMACOLOGY, V45, P738, DOI 10.1016/S0028-3908(03)00276-4; Luo JH, 2002, NEUROPHARMACOLOGY, V42, P306, DOI 10.1016/S0028-3908(01)00188-5; Murata Y, 2013, J NEUROSCI, V33, P5040, DOI 10.1523/JNEUROSCI.2896-12.2013; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; de Arce KP, 2010, J NEUROSCI, V30, P3728, DOI 10.1523/JNEUROSCI.2024-09.2010; Petralia RS, 2005, MOL CELL NEUROSCI, V29, P436, DOI 10.1016/j.mcn.2005.03.013; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Sepulveda FJ, 2010, J NEUROPHYSIOL, V103, P1758, DOI 10.1152/jn.00823.2009; Stein V, 2003, J NEUROSCI, V23, P5503; Steiner P, 2008, NEURON, V60, P788, DOI 10.1016/j.neuron.2008.10.014; Sweet ES, 2011, J NEUROSCI, V31, P1038, DOI 10.1523/JNEUROSCI.1205-10.2011; Tovar KR, 1999, J NEUROSCI, V19, P4180; Townsend M, 2003, P NATL ACAD SCI USA, V100, P1340, DOI 10.1073/pnas.0335786100; van Zundert B, 2004, TRENDS NEUROSCI, V27, P428, DOI 10.1016/j.tins.2004.05.010; Varela-Nallar L, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-41; Xu W, 2008, NEURON, V57, P248, DOI 10.1016/j.neuron.2007.11.027; Yoshii A, 2003, P NATL ACAD SCI USA, V100, P1334, DOI 10.1073/pnas.0335785100; Yoshii A, 2007, NAT NEUROSCI, V10, P702, DOI 10.1038/nn1903; Zhao JP, 2013, P NATL ACAD SCI USA, V110, P707, DOI 10.1073/pnas.1215854110; Zheng CY, 2010, J NEUROSCI, V30, P4757, DOI 10.1523/JNEUROSCI.6108-09.2010	51	47	53	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94037	10.1371/journal.pone.0094037	http://dx.doi.org/10.1371/journal.pone.0094037			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705401	Green Published, gold			2022-12-25	WOS:000334107500113
J	Huang, ZQ; Tan, N; Guo, WJ; Wang, LL; Li, HG; Zhang, TY; Liu, XJ; Xu, Q; Li, JS; Guo, ZM				Huang, Zhiquan; Tan, Ning; Guo, Weijie; Wang, Lili; Li, Haigang; Zhang, Tianyu; Liu, Xiaojia; Xu, Qin; Li, Jinsong; Guo, Zhongmin			Overexpression of EMMPRIN Isoform 2 Is Associated with Head and Neck Cancer Metastasis	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE INDUCER; PLASMINOGEN-ACTIVATOR SYSTEM; SQUAMOUS-CELL CARCINOMA; CATHEPSIN-B; IN-VITRO; BASIGIN; CD147; EXPRESSION; INVASION; MARKER	Extracellular matrix metalloproteinase inducer (EMMPRIN), a plasma membrane protein of the immunoglobulin (Ig) superfamily, has been reported to promote cancer cell invasion and metastasis in several human malignancies. However, the roles of the different EMMPRIN isoforms and their associated mechanisms in head and neck cancer progression remain unknown. Using quantitative real-time PCR, we found that EMMPRIN isoform 2 (EMMPRIN-2) was the only isoform that was overexpressed in both head and neck cancer tissues and cell lines and that it was associated with head and neck cancer metastasis. To determine the effects of EMMPRIN-2 on head and neck cancer progression, we transfected head and neck cancer cells with an EMMPRIN-2 expression vector and EMMPRIN-2 siRNA to exogenously modulate EMMPRIN-2 expression and examined the functional importance of EMMPRIN-2 in head and neck cancer invasion and metastasis. We found that EMMPRIN-2 promoted head and neck cancer cell invasion, migration, and adhesion in vitro and increased lung metastasis in vivo. Mechanistic studies revealed that EMMPRIN-2 overexpression promoted the secretion of extracellular signaling molecules, including matrix metalloproteinases-2(MMP-2), urokinase-type plasminogen activator(uPA) and Cathepsin B, in head and neck cancer cells. While MMP-2 and uPA have been demonstrated to be important mediators of EMMPRIN signaling, the role of Cathepsin B in EMMPRIN-mediated molecular cascades and tumorigenesis has not been established. We found that EMMPRIN-2 overexpression and Cathepsin B down-regulation significantly inhibited the invasion, migration and adhesion of Tca8133 cells, suggesting that Cathepsin B is required for EMMPRIN-2 enhanced cell migration and invasion in head and neck cancer. The results of our study demonstrate the important role of EMMPRIN-2 in head and neck cancer progression for the first time and reveal that increased extracellular secretion of Cathepsin B may be a novel mechanism underlying EMMPRIN-2 enhanced tumor progression in head and neck cancer.	[Huang, Zhiquan; Li, Jinsong] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Oral & Maxillofacial Surg, Guangzhou 510275, Guangdong, Peoples R China; [Tan, Ning; Xu, Qin] Guilin Med Coll, Guangxi Key Lab Mol Med Liver Injury & Repair, Guilin, Guangxi, Peoples R China; [Guo, Weijie] Fudan Univ, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Guo, Weijie] Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Renji Hosp, Shanghai 200030, Peoples R China; [Wang, Lili; Li, Haigang] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Tianyu] Guilin Med Coll, Dept Urinary Surg, Affiliated Hosp, Guilin, Guangxi, Peoples R China; [Liu, Xiaojia] Guilin Med Coll, Dept Pathol, Affiliated Hosp, Guilin, Guangxi, Peoples R China; [Guo, Zhongmin] Indiana Univ Sch Med, Med Sci Program, Bloomington, IN USA	Sun Yat Sen University; Guilin Medical University; Fudan University; Shanghai Jiao Tong University; Sun Yat Sen University; Guilin Medical University; Guilin Medical University; Indiana University System; Indiana University Bloomington	Li, JS (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Oral & Maxillofacial Surg, Guangzhou 510275, Guangdong, Peoples R China.	lijinsong1967@163.com; zguo@gopathlabs.com		Guo, Weijie/0000-0001-7167-9899	National Natural Science Foundation of China [81101592, 81272951]; Guangdong Province Natural Science Foundation [S2013010014794]; Flight Attendant Medical Research Institute [062545]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Flight Attendant Medical Research Institute	This work was supported by grants from the National Natural Science Foundation of China (#81101592, to Z. Huang) and Guangdong Province Natural Science Foundation (#S2013010014794, to Z. Huang), and by the awards from the Flight Attendant Medical Research Institute (#062545, to Z. Guo) and by grants from the National Natural Science Foundation of China (#81272951, to J.Li). The funders had no role in study design, data collection and analysis, decision topublish, or preparation of the manuscript.	Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Ass K, 2008, CANCER TREAT REV, V34, P122, DOI 10.1016/j.ctrv.2007.10.005; Beckham TH, 2012, INT J CANCER, V131, P2034, DOI 10.1002/ijc.27480; Belton RJ, 2008, J BIOL CHEM, V283, P17805, DOI 10.1074/jbc.M801876200; Berditchevski F, 1997, J BIOL CHEM, V272, P29174, DOI 10.1074/jbc.272.46.29174; Bougatef F, 2009, BLOOD, V114, P5547, DOI 10.1182/blood-2009-04-217380; Chen BS, 2012, MOL CANCER RES, V10, P305, DOI 10.1158/1541-7786.MCR-11-0300; Colevas AD, 2006, J CLIN ONCOL, V24, P2644, DOI 10.1200/JCO.2005.05.3348; Coste I, 2001, BLOOD, V97, P3984, DOI 10.1182/blood.V97.12.3984; Dang DM, 2008, ANTICANCER RES, V28, P2049; Davidson B, 2003, CLIN EXP METASTAS, V20, P161, DOI 10.1023/A:1022696012668; Denaro N, 2012, ONCOLOGY-BASEL, V83, P108, DOI 10.1159/000339542; Galanski M, 2006, RECENT PAT ANTI-CANC, V1, P285, DOI 10.2174/157489206777442287; Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975; Hanna S Melanie, 2003, BMC Biochem, V4, P17, DOI 10.1186/1471-2091-4-17; Herszenyi L, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-194; Huang ZQ, 2010, J CRANIOFAC SURG, V21, P1855, DOI 10.1097/SCS.0b013e3181f43f7e; Huang ZQ, 2009, J ORAL PATHOL MED, V38, P518, DOI 10.1111/j.1600-0714.2009.00775.x; Hunter KD, 2005, NAT REV CANCER, V5, P127, DOI 10.1038/nrc1549; Igakura T, 1996, BIOCHEM BIOPH RES CO, V224, P33, DOI 10.1006/bbrc.1996.0980; Kikkawa Y, 2007, J BIOL CHEM, V282, P14853, DOI 10.1074/jbc.M611706200; Kuno N, 1998, FEBS LETT, V425, P191, DOI 10.1016/S0014-5793(98)00213-0; Lescaille G, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-115; Liao CG, 2011, MOL CELL BIOL, V31, P2591, DOI 10.1128/MCB.05160-11; Lu YD, 2005, CANCER RES, V65, P6843, DOI 10.1158/0008-5472.CAN-04-3822; Matarrese P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-207; Nabeshima K, 2006, PATHOL INT, V56, P359, DOI 10.1111/j.1440-1827.2006.01972.x; Nouh MA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-1; Palermo C, 2008, TRENDS PHARMACOL SCI, V29, P22, DOI 10.1016/j.tips.2007.10.011; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Philp NJ, 2003, INVEST OPHTH VIS SCI, V44, P1305, DOI 10.1167/iovs.02-0552; Quemener C, 2007, CANCER RES, V67, P9, DOI 10.1158/0008-5472.CAN-06-2448; Rafn B, 2012, MOL CELL, V45, P764, DOI 10.1016/j.molcel.2012.01.029; Schlegel J, 2009, J MOL BIOL, V391, P518, DOI 10.1016/j.jmb.2009.05.080; Shang ZJ, 2006, INT J ORAL MAX SURG, V35, P539, DOI 10.1016/j.ijom.2006.01.004; Sier CFM, 2006, INT J CANCER, V118, P2991, DOI 10.1002/ijc.21778; Sumida T, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-141; Suzuki S, 2004, EXP CELL RES, V293, P259, DOI 10.1016/j.yexcr.2003.10.010; Tang Y, 2005, CANCER RES, V65, P3193, DOI 10.1158/0008-5472.CAN-04-3605; Toole BP, 2003, CURR TOP DEV BIOL, V54, P371, DOI 10.1016/S0070-2153(03)54015-7; Tsai WC, 2007, APMIS, V115, P929, DOI 10.1111/j.1600-0463.2007.apm_858.x; Vermorken JB, 2010, ANN ONCOL, V21, P252, DOI 10.1093/annonc/mdq453; Victor BC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3058; Yao J, 2010, HEPATOLOGY, V51, P846, DOI 10.1002/hep.23443; Yu ZW, 2010, ORAL ONCOL, V46, P317, DOI 10.1016/j.oraloncology.2010.02.002; Yurchenko V, 2006, IMMUNOLOGY, V117, P301, DOI 10.1111/j.1365-2567.2005.02316.x; Zucker S, 2001, AM J PATHOL, V158, P1921, DOI 10.1016/S0002-9440(10)64660-3	47	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e91596	10.1371/journal.pone.0091596	http://dx.doi.org/10.1371/journal.pone.0091596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705283	Green Published, gold, Green Submitted			2022-12-25	WOS:000334107500006
J	Jackson, AR; Nagarkatti, P; Nagarkatti, M				Jackson, Austin R.; Nagarkatti, Prakash; Nagarkatti, Mitzi			Anandamide Attenuates Th-17 Cell-Mediated DelayedType Hypersensitivity Response by Triggering IL-10 Production and Consequent microRNA Induction	PLOS ONE			English	Article							NF-KAPPA-B; ENDOCANNABINOID SYSTEM; T-CELL; CYTOKINE PRODUCTION; TH1 POLARIZATION; IN-VITRO; CANNABINOIDS; SUPPRESSION; ACTIVATION; EXPRESSION	Endogenous cannabinoids [endocannabinoids] are lipid signaling molecules that have been shown to modulate immune functions. However, their role in the regulation of Th17 cells has not been studied previously. In the current study, we used methylated Bovine Serum Albumin [mBSA]-induced delayed type hypersensitivity [DTH] response in C57BL/6 mice, mediated by Th17 cells, as a model to test the anti-inflammatory effects of endocannabinoids. Administration of anandamide [AEA], a member of the endocannabinoid family, into mice resulted in significant mitigation of mBSA- induced inflammation, including foot pad swelling, cell infiltration, and cell proliferation in the draining lymph nodes [LN]. AEA treatment significantly reduced IL-17 and IFN-gamma production, as well as decreased ROR gamma t expression while causing significant induction of IL-10 in the draining LNs. IL-10 was critical for the AEA-induced mitigation of DTH response inasmuch as neutralization of IL-10 reversed the effects of AEA. We next analyzed miRNA from the LN cells and found that 100 out of 609 miRNA species were differentially regulated in AEA-treated mice when compared to controls. Several of these miRNAs targeted proinflammatory mediators. Interestingly, many of these miRNA were also upregulated upon in vitro treatment of LN cells with IL-10. Together, the current study demonstrates that AEA may suppress Th-17 mediated DTH response by inducing IL-10 which in turn triggers miRNA that target proinflammatory pathways.	[Jackson, Austin R.; Nagarkatti, Prakash; Nagarkatti, Mitzi] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Nagarkatti, M (corresponding author), Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.	mnagark@uscmed.sc.edu		Nagarkatti, Mitzi/0000-0002-5977-5615; Nagarkatti, Prakash/0000-0003-2663-0759	NIH [P01AT003961, R01AT006888, R01ES019313, R01MH094755, P20RR032684]; VA Merit Award [BX001357]; National Center for Complementary & Integrative Health [R01AT006888, P01AT003961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094755] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award(US Department of Veterans Affairs); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funded by NIH grants P01AT003961, R01AT006888, R01ES019313, R01MH094755, P20RR032684 and VA Merit Award BX001357.	Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Berdyshev EV, 1997, EUR J PHARMACOL, V330, P231, DOI 10.1016/S0014-2999(97)01007-8; Cai BB, 2013, ONCOL REP, V29, P1769, DOI 10.3892/or.2013.2297; Callard RE, 2007, IMMUNOL CELL BIOL, V85, P300, DOI 10.1038/sj.icb.7100060; Cao L, 2012, INT J MOL MED, V30, P1095, DOI 10.3892/ijmm.2012.1092; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Correa F, 2011, BRAIN BEHAV IMMUN, V25, P736, DOI 10.1016/j.bbi.2011.01.020; Costola-de-Souza C, 2013, PLOS ONE, V8; De Petrocellis L, 2004, BRIT J PHARMACOL, V141, P765, DOI 10.1038/sj.bjp.0705666; Do Y, 2004, J IMMUNOL, V173, P2373, DOI 10.4049/jimmunol.173.4.2373; Echigo R, 2012, ONCOL REP, V28, P1176, DOI 10.3892/or.2012.1937; Egan PJ, 2008, ARTHRITIS RHEUM-US, V58, P3720, DOI 10.1002/art.24075; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Greineisen WE, 2010, INT IMMUNOPHARMACOL, V10, P547, DOI 10.1016/j.intimp.2010.02.012; Guan HB, 2013, EUR J IMMUNOL, V43, P104, DOI 10.1002/eji.201242702; Hegde VL, 2008, MOL PHARMACOL, V74, P20, DOI 10.1124/mol.108.047035; Hegde VL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018281; Hegde VL, 2010, EUR J IMMUNOL, V40, P3358, DOI 10.1002/eji.201040667; Horvath B, 2012, AM J PATHOL, V180, P432, DOI 10.1016/j.ajpath.2011.11.003; Karsak M, 2007, SCIENCE, V316, P1494, DOI 10.1126/science.1142265; Kosaka S, 2011, IMMUNOBIOLOGY, V216, P811, DOI 10.1016/j.imbio.2010.12.003; Kozela E, 2013, J NEUROIMMUNE PAHRM; Kozela E, 2011, BRIT J PHARMACOL, V163, P1507, DOI 10.1111/j.1476-5381.2011.01379.x; Lalor SJ, 2011, J IMMUNOL, V186, P5738, DOI 10.4049/jimmunol.1003597; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee WW, 2010, BLOOD, V115, P530, DOI 10.1182/blood-2009-08-236521; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu DZ, 2010, ACTA PHARMACOL SIN, V31, P1611, DOI 10.1038/aps.2010.155; Lu TX, 2011, J IMMUNOL, V187, P3362, DOI 10.4049/jimmunol.1101235; Maccarrone M, 2001, ARCH BIOCHEM BIOPHYS, V393, P321, DOI 10.1006/abbi.2001.2500; Mach CM, 2013, CANCER LETT, V335, P314, DOI 10.1016/j.canlet.2013.02.043; Mallat A, 2013, J HEPATOL, V59, P891, DOI 10.1016/j.jhep.2013.03.032; Marquez L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006893; Matias I, 2002, EUR J BIOCHEM, V269, P3771, DOI 10.1046/j.1432-1033.2002.03078.x; McKallip RJ, 2005, J IMMUNOL, V174, P3281, DOI 10.4049/jimmunol.174.6.3281; McKallip RJ, 2002, J PHARMACOL EXP THER, V302, P451, DOI 10.1124/jpet.102.033506; Mimeault M, 2003, PROSTATE, V56, P1, DOI 10.1002/pros.10190; Nagarkatti P, 2009, FUTURE MED CHEM, V1, P1333, DOI 10.4155/FMC.09.93; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Nambu A, 2006, INT IMMUNOL, V18, P701, DOI 10.1093/intimm/dxl007; Newton CA, 2004, J LEUKOCYTE BIOL, V76, P854, DOI 10.1189/jlb.0304184; Pandey R, 2011, J PHARMACOL EXP THER, V338, P819, DOI 10.1124/jpet.111.182717; Pandey R, 2009, PHARMACOL RES, V60, P85, DOI 10.1016/j.phrs.2009.03.019; Sakai M, 2009, J TOXICOL SCI, V34, P483, DOI 10.2131/jts.34.483; Sarnstrand B, 1999, J PHARMACOL EXP THER, V288, P1174; SCHWARZ H, 1994, J NEUROIMMUNOL, V55, P107, DOI 10.1016/0165-5728(94)90152-X; Solberg OD, 2012, AM J RESP CRIT CARE, V186, P965, DOI 10.1164/rccm.201201-0027OC; Sugamura K, 2009, CIRCULATION, V119, P28, DOI 10.1161/CIRCULATIONAHA.108.811992; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tajiri K, 2013, CARDIOVASC DRUG THER, V27, P413, DOI 10.1007/s10557-013-6464-y; Takahashi H, 2012, CELLS; Wang L, 2013, MOL CELL BIOL, V33, P1956, DOI 10.1128/MCB.01580-12; Wu ZW, 2012, FEBS LETT, V586, P2459, DOI 10.1016/j.febslet.2012.06.004; Yao R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046082	56	40	40	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93954	10.1371/journal.pone.0093954	http://dx.doi.org/10.1371/journal.pone.0093954			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699635	Green Published, gold, Green Submitted			2022-12-25	WOS:000334105000127
J	Schmidt, RS; Butikofer, P				Schmidt, Remo S.; Buetikofer, Peter			Autophagy in Trypanosoma brucei: Amino Acid Requirement and Regulation during Different Growth Phases	PLOS ONE			English	Article							AFRICAN TRYPANOSOMES; FLOW-CYTOMETRY; PROTEIN P67; PATHWAYS; FORMS; DEGRADATION; MECHANISMS; DEATH; YEAST; STATE	Autophagy in the protozoan parasite, Trypanosoma brucei, may be involved in differentiation between different life cycle forms and during growth in culture. We have generated multiple parasite cell lines stably expressing green fluorescent protein-or hemagglutinin-tagged forms of the autophagy marker proteins, TbAtg8.1 and TbAtg8.2, in T. brucei procyclic forms to establish a trypanosome system for quick and reliable determination of autophagy under different culture conditions using flow cytometry. We found that starvation-induced autophagy in T. brucei can be inhibited by addition of a single amino acid, histidine, to the incubation buffer. In addition, we show that autophagy is induced when parasites enter stationary growth phase in culture and that their capacity to undergo starvation-induced autophagy decreases with increasing cell density.	[Schmidt, Remo S.; Buetikofer, Peter] Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland; [Schmidt, Remo S.] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland	University of Bern; University of Bern	Butikofer, P (corresponding author), Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland.	peter.buetikofer@ibmm.unibe.ch		Schmidt, Remo S./0000-0002-6599-9201	COST action [BM0802]; Swiss National Science Foundation [31003A_130815]	COST action(European Cooperation in Science and Technology (COST)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funding came from COST action BM0802 http://www.cost.eu/, and Swiss National Science Foundation grant 31003A_130815, http://www.snf.ch/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DL, 2002, J CELL SCI, V115, P3253; Alvarez VE, 2008, AUTOPHAGY, V4, P361, DOI 10.4161/auto.5592; Alvarez VE, 2008, J BIOL CHEM, V283, P3454, DOI 10.1074/jbc.M708474200; Alvers AL, 2009, AGING CELL, V8, P353, DOI 10.1111/j.1474-9726.2009.00469.x; Brennand A, 2011, MOL BIOCHEM PARASIT, V177, P83, DOI 10.1016/j.molbiopara.2011.02.003; Bringaud F, 2006, MOL BIOCHEM PARASIT, V149, P1, DOI 10.1016/j.molbiopara.2006.03.017; BRUN R, 1979, ACTA TROP, V36, P289; Burkard G, 2007, MOL BIOCHEM PARASIT, V153, P220, DOI 10.1016/j.molbiopara.2007.02.008; Cavalier-Smith T, 2010, BIOL LETTERS, V6, P342, DOI 10.1098/rsbl.2009.0948; Duszenko M, 2006, TRENDS PARASITOL, V22, P536, DOI 10.1016/j.pt.2006.08.010; Furger A, 1997, MOL CELL BIOL, V17, P4372, DOI 10.1128/MCB.17.8.4372; Goldshmidt H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000731; Hanaoka H, 2002, PLANT PHYSIOL, V129, P1181, DOI 10.1104/pp.011024; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Herman M, 2006, AUTOPHAGY, V2, P107, DOI 10.4161/auto.2.2.2369; Hundeshagen P, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-38; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Klionsky DJ, 2006, AUTOPHAGY, V2, P63, DOI 10.4161/auto.2.2.2418; Kneen M, 1998, BIOPHYS J, V74, P1591, DOI 10.1016/S0006-3495(98)77870-1; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Li FJ, 2012, CELL MICROBIOL, V14, P1242, DOI 10.1111/j.1462-5822.2012.01795.x; McCann AK, 2008, MOL BIOCHEM PARASIT, V159, P146, DOI 10.1016/j.molbiopara.2008.02.003; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Merkel P, 2007, TOXICON, V50, P457, DOI 10.1016/j.toxicon.2007.04.022; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nair U, 2005, J BIOL CHEM, V280, P41785, DOI 10.1074/jbc.R500016200; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Peck RF, 2008, MOL MICROBIOL, V68, P933, DOI 10.1111/j.1365-2958.2008.06195.x; Picazarri K, 2008, INFECT IMMUN, V76, P278, DOI 10.1128/IAI.00636-07; Reggiori F, 2002, EUKARYOT CELL, V1, P11, DOI 10.1128/EC.01.1.11-21.2002; Roditi I, 2008, CURR OPIN MICROBIOL, V11, P345, DOI 10.1016/j.mib.2008.06.006; Sakai Y, 2006, BBA-MOL CELL RES, V1763, P1767, DOI 10.1016/j.bbamcr.2006.08.023; Shvets E, 2008, AUTOPHAGY, V4, P621, DOI 10.4161/auto.5939; Tolkovsky AM, 2009, BBA-MOL CELL RES, V1793, P1508, DOI 10.1016/j.bbamcr.2009.03.002; Uzcategui NL, 2007, AUTOPHAGY, V3, P626, DOI 10.4161/auto.4907; Vassella E, 2000, GENE DEV, V14, P615; Williams RA, 2006, MOL MICROBIOL, V61, P655, DOI 10.1111/j.1365-2958.2006.05274.x; Williams RAM, 2009, AUTOPHAGY, V5, P159, DOI 10.4161/auto.5.2.7328; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Yan XH, 2012, AUTOPHAGY, V8, P213, DOI 10.4161/auto.8.2.18563	45	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93875	10.1371/journal.pone.0093875	http://dx.doi.org/10.1371/journal.pone.0093875			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699810	Green Published, gold, Green Submitted			2022-12-25	WOS:000334105000116
J	De Cao, E; Melegaro, A; Klok, R; Postma, M				De Cao, Elisabetta; Melegaro, Alessia; Klok, Rogier; Postma, Maarten			Optimising Assessments of the Epidemiological Impact in the Netherlands of Paediatric Immunisation with 13-Valent Pneumococcal Conjugate Vaccine Using Dynamic Transmission Modelling	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; COST-EFFECTIVENESS; NASOPHARYNGEAL CARRIAGE; SEROTYPE REPLACEMENT; DISEASE; CHILDREN; INFANTS; PROGRAM; ENGLAND; TRENDS	This work is the first attempt to quantify the overall effects of a 13-valent pneumococcal conjugate vaccine (PCV13) vaccination programme in the Dutch population taking into account all the direct and indirect effects of the vaccine on invasive pneumococcal disease. Using available Dutch data, a dynamic transmission model for the spread of pneumococci and potential subsequent invasive pneumococcal disease has been adapted to the Dutch setting. Overall, invasive pneumococcal disease cases in the Netherlands are predicted to decrease from a pre-vaccination level of 2623 cases annually to 2475, 2289, 2185, 2179, and 2178 cases annually 5-, 10-, 20-, 30-, and 40- years, respectively, post-vaccination. Therefore, vaccination with PCV13 in the Netherlands is predicted to lower invasive pneumococcal disease cases per year by up to 445 cases in the medium- to long-term. The results are quite robust for the sensitivity analyses performed on the parameters that regulate herd immunity and competition between vaccine and non-vaccine types.	[De Cao, Elisabetta; Postma, Maarten] Univ Groningen, Dept Pharm, Groningen, Netherlands; [De Cao, Elisabetta] Univ Groningen, Dept Econ Econometr & Finance, Groningen, Netherlands; [Melegaro, Alessia] Bocconi Univ, Policy Anal & Publ Management Dept, Milan, Italy; [Melegaro, Alessia] Bocconi Univ, Dondena Ctr Res Social Dynam, Milan, Italy	University of Groningen; University of Groningen; Bocconi University; Bocconi University	Postma, M (corresponding author), Univ Groningen, Dept Pharm, Groningen, Netherlands.	m.j.postma@rug.nl		De Cao, Elisabetta/0000-0002-7769-486X; Melegaro, Alessia/0000-0003-2221-8898; Postma, Maarten/0000-0002-6306-3653	Pfizer Inc.	Pfizer Inc.(Pfizer)	This study was funded by Pfizer Inc. The role of Pfizer Inc included study design, decision to publish, and preparation of the manuscript. Pfizer Inc had no role in data collection and analysis.	Bingen E, 2008, EUR J CLIN MICROBIOL, V27, P191, DOI 10.1007/s10096-007-0417-y; Black S, 2004, PEDIATR INFECT DIS J, V23, P485, DOI 10.1097/01.inf.0000129685.04847.94; Cauchemez S, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-14; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; Choi YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026190; Cox CM, 2012, 1 NAT IMM C ONL MARC; Dagan R, 1996, J INFECT DIS, V174, P1271, DOI 10.1093/infdis/174.6.1271; de Vries R, 2008, VALUE HEALTH, V11, P272, DOI 10.1111/j.1524-4733.2007.00225.x; de Vries R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013392; Dery Mark Alain, 2007, Curr Infect Dis Rep, V9, P301, DOI 10.1007/s11908-007-0047-7; Farkouh RA, 2012, EXPERT REV VACCINES, V11, P1235, DOI [10.1586/erv.12.99, 10.1586/ERV.12.99]; Fedson DS, 1999, VACCINE, V17, pS11, DOI 10.1016/S0264-410X(99)00122-X; Givon-Lavi N, 2003, PEDIATR INFECT DIS J, V22, P524, DOI 10.1097/00006454-200306000-00008; Hammitt LL, 2012, 8 INT S PNEUM PNEUM; Hausdorff WP, 2005, LANCET INFECT DIS, V5, P83, DOI 10.1016/S1473-3099(05)01280-6; Klein JO, 2007, CLIN INFECT DIS, V45, P2, DOI 10.1086/520068; Klugman K P, 2001, Lancet Infect Dis, V1, P85, DOI 10.1016/S1473-3099(01)00063-9; Koshy E, 2010, THORAX, V65, P770, DOI 10.1136/thx.2010.137802; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Link-Gelles R, 2013, VACCINE, V31, P2572, DOI 10.1016/j.vaccine.2013.03.049; MACLEOD CM, 1945, J EXP MED, V82, P445, DOI 10.1084/jem.82.6.445; Mbelle N, 1999, J INFECT DIS, V180, P1171, DOI 10.1086/315009; Melegaro A, 2007, AM J EPIDEMIOL, V166, P228, DOI 10.1093/aje/kwm076; Melegaro A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-90; Miller E, 2011, VACCINE, V29, P9127, DOI 10.1016/j.vaccine.2011.09.112; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Moore M, 2012, IDWEEK 2012 OCT 17 2; Moore MR, 2004, J INFECT DIS, V190, P2031, DOI 10.1086/425422; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Obaro SK, 1996, LANCET, V348, P271, DOI 10.1016/S0140-6736(05)65585-7; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Prymula R, 2013, VACCINE, V31, P2080, DOI 10.1016/j.vaccine.2013.01.044; Prymula R, 2011, VACCINE, V29, P1959, DOI 10.1016/j.vaccine.2010.12.086; Prymula R, 2009, LANCET, V374, P1339, DOI 10.1016/S0140-6736(09)61208-3; Public Health England, PNEUM DIS; Roche PW, 2008, COMMUN DIS INTELL, V32, P18; Rozenbaum MH, 2012, VACCINE, V30, P7327, DOI 10.1016/j.vaccine.2012.06.026; Rozenbaum MH, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2509; Rozenbaum MH, 2010, VACCINE, V28, P2367, DOI 10.1016/j.vaccine.2010.01.005; Spijkerman J, 2011, EMERG INFECT DIS, V17, P584, DOI 10.3201/eid1704.101115; Talbot TR, 2004, PEDIATR INFECT DIS J, V23, P726, DOI 10.1097/01.inf.0000133046.60555.de; van Deursen AMM, 2012, EMERG INFECT DIS, V18, P1729, DOI 10.3201/eid1811.120329; van Gils EJM, 2009, JAMA-J AM MED ASSOC, V302, P159, DOI 10.1001/jama.2009.975; van Hoek AJ, 2012, VACCINE, V30, P7205, DOI 10.1016/j.vaccine.2012.10.017; van Lier EA, 2013, 150202001 RIVM; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	47	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e89415	10.1371/journal.pone.0089415	http://dx.doi.org/10.1371/journal.pone.0089415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24694656	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000334103000006
J	Elfes, CT; Longo, C; Halpern, BS; Hardy, D; Scarborough, C; Best, BD; Pinheiro, T; Dutra, GF				Elfes, Cristiane T.; Longo, Catherine; Halpern, Benjamin S.; Hardy, Darren; Scarborough, Courtney; Best, Benjamin D.; Pinheiro, Tiago; Dutra, Guilherme F.			A Regional-Scale Ocean Health Index for Brazil	PLOS ONE			English	Article								Brazil has one of the largest and fastest growing economies and one of the largest coastlines in the world, making human use and enjoyment of coastal and marine resources of fundamental importance to the country. Integrated assessments of ocean health are needed to understand the condition of a range of benefits that humans derive from marine systems and to evaluate where attention should be focused to improve the health of these systems. Here we describe the first such assessment for Brazil at both national and state levels. We applied the Ocean Health Index framework, which evaluates ten public goals for healthy oceans. Despite refinements of input data and model formulations, the national score of 60 (out of 100) was highly congruent with the previous global assessment for Brazil of 62. Variability in scores among coastal states was most striking for goals related to mariculture, protected areas, tourism, and clean waters. Extractive goals, including Food Provision, received low scores relative to habitat-related goals, such as Biodiversity. This study demonstrates the applicability of the Ocean Health Index at a regional scale, and its usefulness in highlighting existing data and knowledge gaps and identifying key policy and management recommendations. To improve Brazil's ocean health, this study suggests that future actions should focus on: enhancing fisheries management, expanding marine protected areas, and monitoring coastal habitats.	[Elfes, Cristiane T.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Longo, Catherine; Halpern, Benjamin S.; Hardy, Darren; Scarborough, Courtney; Best, Benjamin D.] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA USA; [Halpern, Benjamin S.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Halpern, Benjamin S.] Univ London Imperial Coll Sci Technol & Med, London, Berks, England; [Hardy, Darren] Stanford Univ, Stanford, CA 94305 USA; [Pinheiro, Tiago] Conservat Int Brazil, Atlantic Forest Program, Belo Horizonte, MG, Brazil; [Dutra, Guilherme F.] Conservat Int Brazil, Marine Program, Rio De Janeiro, RJ, Brazil	University of California System; University of California Santa Barbara; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; Imperial College London; Stanford University	Elfes, CT (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	cristiane.elfes@lifesci.ucsb.edu		Scarborough, Courtney/0000-0001-7270-9228	Thomas W. Haas Fund of the New Hampshire Charitable Foundation; Oak Foundation; Akiko Shiraki Dynner Fund for Ocean Exploration and Conservation; Darden Restaurants Inc.; Foundation, Conservation International, New England Aquarium, National Geographic; National Center for Ecological Analysis and Synthesis	Thomas W. Haas Fund of the New Hampshire Charitable Foundation; Oak Foundation; Akiko Shiraki Dynner Fund for Ocean Exploration and Conservation; Darden Restaurants Inc.; Foundation, Conservation International, New England Aquarium, National Geographic; National Center for Ecological Analysis and Synthesis	Beau and Heather Wrigley provided the founding grant for the original Ocean Health Index work and the Pacific Life Foundation is the Founding Presenting Sponsor. Additional financial and in-kind support was provided by the Thomas W. Haas Fund of the New Hampshire Charitable Foundation, the Oak Foundation, Akiko Shiraki Dynner Fund for Ocean Exploration and Conservation, Darden Restaurants Inc. Foundation, Conservation International, New England Aquarium, National Geographic, and the National Center for Ecological Analysis and Synthesis, which supported the Ecosystem Health Working Group as part of the Science of Ecosystem-Based Management project funded by the David and Lucile Packard Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035171; [Anonymous], 2010, COP OUT BIOD LOSS RI; Guimaraes AS, 2005, MONOGRAPH FEDERAL U; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2013, MAR POLICY, V42, P68, DOI 10.1016/j.marpol.2013.01.019; Halpern BS, 2012, NATURE, V488, P615, DOI 10.1038/nature11397; IMF (International Monetary Fund), 2013, REP SEL COUNTR SUBJ; Koslow JA, 2001, MAR ECOL PROG SER, V213, P111, DOI 10.3354/meps213111; Marone E, 2012, BIOMAS BRASILEIROS R; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; MMA, 2006, REL EX PROGR REVIZEE; Peres M.B., 2012, 6 WORLD FISH C 7 11, P21; PEREZ J. A. A., 2003, DINAMICA FROTAS PESQ, P117; Polette M, 2003, J COASTAL RES, P94; Rapport DJ, 1999, ECOSYST HEALTH, V5, P82, DOI 10.1046/j.1526-0992.1999.09913.x; Samhouri JF, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00366.1; Selig ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009278; TOBEY J, 1998, MAINTAINING BALANCE; Valenti, 2008, 2008 REV IUCN RED LI	19	41	46	5	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e92589	10.1371/journal.pone.0092589	http://dx.doi.org/10.1371/journal.pone.0092589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695103	Green Published, gold, Green Submitted			2022-12-25	WOS:000334103000023
J	Serckx, A; Huynen, MC; Bastin, JF; Hambuckers, A; Beudels-Jamar, RC; Vimond, M; Raynaud, E; Kuhl, HS				Serckx, Adeline; Huynen, Marie-Claude; Bastin, Jean-Francois; Hambuckers, Alain; Beudels-Jamar, Roseline C.; Vimond, Marie; Raynaud, Emilien; Kuehl, Hjalmar S.			Nest Grouping Patterns of Bonobos (Pan paniscus) in Relation to Fruit Availability in a Forest-Savannah Mosaic	PLOS ONE			English	Article							SALONGA NATIONAL-PARK; TROGLODYTES-SCHWEINFURTHII; ENVIRONMENTAL-INFLUENCES; DENSITY-ESTIMATION; LOWLAND GORILLAS; KALINZU FOREST; CHIMPANZEES; SIZE; BEHAVIOR; CENSUS	A topic of major interest in socio-ecology is the comparison of chimpanzees and bonobos' grouping patterns. Numerous studies have highlighted the impact of social and environmental factors on the different evolution in group cohesion seen in these sister species. We are still lacking, however, key information about bonobo social traits across their habitat range, in order to make accurate inter-species comparisons. In this study we investigated bonobo social cohesiveness at nesting sites depending on fruit availability in the forest-savannah mosaic of western Democratic Republic of Congo (DRC), a bonobo habitat which has received little attention from researchers and is characterized by high food resource variation within years. We collected data on two bonobo communities. Nest counts at nesting sites were used as a proxy for night grouping patterns and were analysed with regard to fruit availability. We also modelled bonobo population density at the site in order to investigate yearly variation. We found that one community density varied across the three years of surveys, suggesting that this bonobo community has significant variability in use of its home range. This finding highlights the importance of forest connectivity, a likely prerequisite for the ability of bonobos to adapt their ranging patterns to fruit availability changes. We found no influence of overall fruit availability on bonobo cohesiveness. Only fruit availability at the nesting sites showed a positive influence, indicating that bonobos favour food 'hot spots' as sleeping sites. Our findings have confirmed the results obtained from previous studies carried out in the dense tropical forests of DRC. Nevertheless, in order to clarify the impact of environmental variability on bonobo social cohesiveness, we will need to make direct observations of the apes in the forest-savannah mosaic as well as make comparisons across the entirety of the bonobos' range using systematic methodology.	[Serckx, Adeline; Huynen, Marie-Claude; Hambuckers, Alain; Vimond, Marie; Raynaud, Emilien] Univ Liege, Behav Biol Unit, Liege, Belgium; [Serckx, Adeline; Beudels-Jamar, Roseline C.] Royal Belgian Inst Nat Sci, Conservat Biol Unit, Brussels, Belgium; [Serckx, Adeline; Bastin, Jean-Francois] Univ Kinshasa, Ecole Reg Postuniv Amenagement & Gest Integres Fo, Kinshasa, DEM REP CONGO; [Serckx, Adeline; Kuehl, Hjalmar S.] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [Bastin, Jean-Francois] Univ Libre Bruxelles, Landscape Ecol & Vegetal Prod Syst Unit, Brussels, Belgium; [Bastin, Jean-Francois] Univ Liege, Gembloux AgroBiotech, Biodivers & Landscape Architecture Unit, Gembloux, Belgium; [Kuehl, Hjalmar S.] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	University of Liege; Royal Belgian Institute of Natural Sciences; Universite de Kinshasa; Max Planck Society; Universite Libre de Bruxelles; University of Liege	Serckx, A (corresponding author), Univ Liege, Behav Biol Unit, Liege, Belgium.	adelineserckx@gmail.com	, Hambuckers/H-9911-2014	, Hambuckers/0000-0003-2594-2064	National Fund for Scientific Research (FNRS, Belgium); Fonds Leopold III from the Royal Belgian Institute of Natural Sciences (Belgium); Ecole Regionale post-universitaire d'Amenagement et de gestion Integres des Forets et Territoires tropicaux (ERAIFT, Democratic Republic of Congo)	National Fund for Scientific Research (FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); Fonds Leopold III from the Royal Belgian Institute of Natural Sciences (Belgium); Ecole Regionale post-universitaire d'Amenagement et de gestion Integres des Forets et Territoires tropicaux (ERAIFT, Democratic Republic of Congo)	This project was funded by the National Fund for Scientific Research (FNRS, Belgium), the Fonds Leopold III from the Royal Belgian Institute of Natural Sciences (Belgium) and the Ecole Regionale post-universitaire d'Amenagement et de gestion Integres des Forets et Territoires tropicaux (ERAIFT, Democratic Republic of Congo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancrenaz M, 2004, INT J PRIMATOL, V25, P983, DOI 10.1023/B:IJOP.0000043347.84757.9a; Basabose AK, 2002, INT J PRIMATOL, V23, P263, DOI 10.1023/A:1013879427335; Beaune D, 2013, J TROP ECOL, V29, P367, DOI 10.1017/S0266467413000515; Boesch Christophe, 1996, P101, DOI 10.1017/CBO9780511752414.010; Brekus Catherine A., OXFORD HIST PROTESTA, V2, P190; Brugiere D, 2001, J ZOOL, V255, P251, DOI 10.1017/S0952836901001315; Brummett R., 2009, FORESTS CONGO BASIN, P141; Buckland S.T., 2001, pi; Burnham KP, 2002, MULTIMODEL INFERENCE; Chapman Colin A., 1994, P41; Devos C, 2011, LOCAL ASSESSMENT GOR; Devos C, 2008, AM J PRIMATOL, V70, P439, DOI 10.1002/ajp.20514; Djoufack SD, 2007, MANUEL IDENTIFICATIO; Dobson AJ., 2008, INTRO GEN LINEAR MOD, DOI 10.1201/9780367807849; Fox J., 2019, R COMPANION APPL REG, V3rd Edn; FRUTH B, 1993, ETHOLOGY, V94, P113; Fruth B, 1995, THESIS LUDWIG MAXIMI; Fruth Barbara, 1996, P225, DOI 10.1017/CBO9780511752414.019; Furuichi T, 2004, INT J PRIMATOL, V25, P755, DOI 10.1023/B:IJOP.0000029121.25284.7f; Furuichi T, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P156, DOI 10.1017/CBO9780511606397.016; Furuichi T, 1997, INT J PRIMATOL, V18, P855, DOI 10.1023/A:1026327627943; Furuichi T, 2001, INT J PRIMATOL, V22, P913, DOI 10.1023/A:1012057403512; Furuichi T, 2008, DEV PRIMATOL-PROG PR, P135, DOI 10.1007/978-0-387-74787-3_8; Furuichi T, 2009, PRIMATES, V50, P197, DOI 10.1007/s10329-009-0141-6; Grossmann F, 2008, DEV PRIMATOL-PROG PR, P189, DOI 10.1007/978-0-387-74787-3_11; HASHIMOTO C, 1995, PRIMATES, V36, P477, DOI 10.1007/BF02382870; Hernandez-Aguilar RA, 2013, AM J PRIMATOL, V75, P979, DOI 10.1002/ajp.22163; Hernandez-Aguilar RA, 2006, THESIS U SO CALIFORN; Hickey JR, 2013, BIODIVERS CONSERV, V22, P3085, DOI 10.1007/s10531-013-0572-7; Hohmann G, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P138, DOI 10.1017/CBO9780511606397.014; Hohmann Gottfried, 2006, P123; Idani G., 1990, African Study Monographs, V11, P153; Inogwabini BI, 2008, DEV PRIMATOL-PROG PR, P273, DOI 10.1007/978-0-387-74787-3_14; Inogwabini BI, 2007, ORYX, V41, P136; IUCN, 2013, IUCN RED LIST THREAT; IUCN & ICCN, 2012, BON PAN PAN CONS STR; Jackman S., 2012, PSCL CLASSES METHODS; Junker J, 2012, DIVERS DISTRIB, V18, P1077, DOI 10.1111/ddi.12005; Kano T., 1984, P233; Kano T., 1992, LAST APE PYGMY CHIMP; Kano T, 1992, LAST APE PYGMY CHIMP, P225; Kawamoto Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059660; Khl H., 2007, GORILLA J, V34, P20; Kideghesho JR, 2007, BIODIVERS CONSERV, V16, P2213, DOI 10.1007/s10531-006-9132-8; Koops K, 2011, THESIS U CAMBRIDGE; Koops K, 2012, INT J PRIMATOL, V33, P356, DOI 10.1007/s10764-012-9585-4; Kouakou CY, 2009, AM J PRIMATOL, V71, P447, DOI 10.1002/ajp.20673; Kuehl H.S., 2008, BEST PRACTICE GUIDEL; Lacambra Carmen, 2005, P83; Laing SE, 2003, J APPL ECOL, V40, P1102, DOI 10.1111/j.1365-2664.2003.00861.x; MALENKY RK, 1994, AM J PRIMATOL, V32, P1, DOI 10.1002/ajp.1350320102; Mathewson PD, 2008, ECOL APPL, V18, P208, DOI 10.1890/07-0385.1; Mohneke M, 2008, DEV PRIMATOL-PROG PR, P151, DOI 10.1007/978-0-387-74787-3_9; Mulavwa M, 2010, AM J PRIMATOL, V71, P1; Nyariki D. M., 2009, J SOC SCI, V19, P91, DOI DOI 10.1080/09718923.2009.11892696; PEN Prototype Questionnaire, 2008, PEN PROT QUEST; Plumptre AJ, 1996, INT J PRIMATOL, V17, P85, DOI 10.1007/BF02696160; Plumptre AJ, 1997, INT J PRIMATOL, V18, P475, DOI 10.1023/A:1026302920674; Pruetz JD, 2008, AM J PRIMATOL, V70, P393, DOI 10.1002/ajp.20508; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reinartz GE, 2006, INT J PRIMATOL, V27, P1229, DOI 10.1007/s10764-006-9053-0; Rothman JM, 2006, AM J PRIMATOL, V68, P361, DOI 10.1002/ajp.20230; Russon AE, 2007, ANIM COGN, V10, P189, DOI 10.1007/s10071-006-0058-z; Samson DR, 2013, PRIMATES, V54, P73, DOI 10.1007/s10329-012-0329-z; Samson DR, 2012, AM J PRIMATOL, V74, P811, DOI 10.1002/ajp.22031; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Shibia Mohamed G., 2010, Journal of Human Ecology, V30, P55; Stanford CB, 2008, AM J PRIMATOL, V70, P642, DOI 10.1002/ajp.20539; Stewart FA, 2011, THESIS U CAMBRIDGE; Stewart FA, 2007, AM J PRIMATOL, V69, P930, DOI 10.1002/ajp.20432; Sunderland-Groves JL, 2009, INT J PRIMATOL, V30, P253, DOI 10.1007/s10764-009-9340-7; Tailfer Y, 1989, FORET DENSE AFRIQUE; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Thompson JAM, 2001, DEV PRIMATOL, P75; TUTIN CEG, 1995, INT J PRIMATOL, V16, P53, DOI 10.1007/BF02700153; Van Krunkelsven E, 2001, BIOL CONSERV, V99, P387, DOI 10.1016/S0006-3207(00)00216-0; Vancutsem C, 2006, CARTE OCCUPATION REP; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Warnes GR, 2013, GTOOLS VARIOUS R PRO; White F. J., 2007, AM J PRIMATOL, V69, P1; WHITE FJ, 1988, BEHAVIOUR, V105, P148, DOI 10.1163/156853988X00494; Wilks C, 2000, ARBRES GUINEE EQUATO; Wrangham RW, 2000, PRIMATE MALES, P248; WRANGHAM RW, 1993, HUM NATURE-INT BIOS, V4, P47, DOI 10.1007/BF02734089; Zeileis A, 2007, RES REPORT SERIES DE, V53	85	25	25	0	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93742	10.1371/journal.pone.0093742	http://dx.doi.org/10.1371/journal.pone.0093742			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695637	gold, Green Published, Green Submitted			2022-12-25	WOS:000334103000117
J	Takeuchi, K; Noda, N; Someya, N				Takeuchi, Kasumi; Noda, Naomi; Someya, Nobutaka			Complete Genome Sequence of the Biocontrol Strain Pseudomonas protegens Cab57 Discovered in Japan Reveals Strain-Specific Diversity of This Species	PLOS ONE			English	Article							FLUORESCENS CHA0; BIOLOGICAL-CONTROL; 2,4-DIACETYLPHLOROGLUCINOL BIOSYNTHESIS; REGULATORY RNA; GENE CLUSTERS; BACTERIAL; AERUGINOSA; IDENTIFICATION; SPP.; PF-5	The biocontrol strain Pseudomonas sp. Cab57 was isolated from the rhizosphere of shepherd's purse growing in a field in Hokkaido by screening the antibiotic producers. The whole genome sequence of this strain was obtained by paired-end and whole-genome shotgun sequencing, and the gaps between the contigs were closed using gap-spanning PCR products. The P. sp. Cab57 genome is organized into a single circular chromosome with 6,827,892 bp, 63.3% G+C content, and 6,186 predicted protein-coding sequences. Based on 16S rRNA gene analysis and whole genome analysis, strain Cab57 was identified as P. protegens. As reported in P. protegens CHA0 and Pf-5, four gene clusters (phl, prn, plt, and hcn) encoding the typical antibiotic metabolites and the reported genes associated with Gac/Rsm signal transduction pathway of these strains are fully conserved in the Cab57 genome. Actually strain Cab57 exhibited typical Gac/Rsm activities and antibiotic production, and these activities were enhanced by knocking out the retS gene (for a sensor kinase acting as an antagonist of GacS). Two large segments (79 and 115 kb) lacking in the Cab57 genome, as compared with the Pf-5 genome, accounted for the majority of the difference (247 kb) between these genomes. One of these segments was the complete rhizoxin analog biosynthesis gene cluster (ca. 79 kb) and another one was the 115-kb mobile genomic island. A whole genome comparison of those relative strains revealed that each strain has unique gene clusters involved in metabolism such as nitrite/nitrate assimilation, which was identified in the Cab57 genome. These findings suggest that P. protegens is a ubiquitous bacterium that controls its biocontrol traits while building up strain-specific genomic repertoires for the biosynthesis of secondary metabolites and niche adaptation.	[Takeuchi, Kasumi; Noda, Naomi] Natl Inst Agrobiol Sci, Plant Microbe Interact Res Unit, Tsukuba, Ibaraki, Japan; [Someya, Nobutaka] Natl Agr & Food Res Org, Hokkaido Agr Res Ctr, Memuro, Hokkaido, Japan	National Institute of Agrobiological Sciences - Japan; National Agriculture & Food Research Organization - Japan	Takeuchi, K (corresponding author), Natl Inst Agrobiol Sci, Plant Microbe Interact Res Unit, Tsukuba, Ibaraki, Japan.	kasumit@affrc.go.jp		Takeuchi, Kasumi/0000-0002-6521-6748	Program for the Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN)	Program for the Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN)	This work was supported by the Program for the Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMES GFL, 1985, EMBO J, V4, P539, DOI 10.1002/j.1460-2075.1985.tb03662.x; Blumer C, 1999, P NATL ACAD SCI USA, V96, P14073, DOI 10.1073/pnas.96.24.14073; de Souza JT, 2003, FEMS MICROBIOL ECOL, V43, P21, DOI 10.1111/j.1574-6941.2003.tb01042.x; Duffy BK, 1999, APPL ENVIRON MICROB, V65, P2429; Goodman AL, 2009, GENE DEV, V23, P249, DOI 10.1101/gad.1739009; Gross H, 2007, CHEM BIOL, V14, P53, DOI 10.1016/j.chembiol.2006.11.007; Gross H, 2009, NAT PROD REP, V26, P1408, DOI 10.1039/b817075b; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Haas D, 2003, ANNU REV PHYTOPATHOL, V41, P117, DOI 10.1146/annurev.phyto.41.052002.095656; Heeb S, 2000, MOL PLANT MICROBE IN, V13, P232, DOI 10.1094/MPMI.2000.13.2.232; Heeb S, 2002, J BACTERIOL, V184, P1046, DOI 10.1128/jb.184.4.1046-1056.2002; HOWELL CR, 1979, PHYTOPATHOLOGY, V69, P480, DOI 10.1094/Phyto-69-480; Humair B, 2009, ISME J, V3, P955, DOI 10.1038/ismej.2009.42; IWASAKI S, 1984, J ANTIBIOT, V37, P354, DOI 10.7164/antibiotics.37.354; Kay E, 2005, P NATL ACAD SCI USA, V102, P17136, DOI 10.1073/pnas.0505673102; Kay E, 2006, J BACTERIOL, V188, P6026, DOI 10.1128/JB.00409-06; KEEL C, 1992, MOL PLANT MICROBE IN, V5, P4, DOI 10.1094/MPMI-5-004; Keel C, 1996, APPL ENVIRON MICROB, V62, P552, DOI 10.1128/AEM.62.2.552-563.1996; Kim YC, 2011, APPL ENVIRON MICROB, V77, P1548, DOI 10.1128/AEM.01867-10; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lackner G, 2011, J BACTERIOL, V193, P783, DOI 10.1128/JB.01318-10; Langille MGI, 2010, NAT REV MICROBIOL, V8, P372, DOI 10.1038/nrmicro2350; Lapouge K, 2008, MOL MICROBIOL, V67, P241, DOI 10.1111/j.1365-2958.2007.06042.x; Loper JE, 2008, APPL ENVIRON MICROB, V74, P3085, DOI 10.1128/AEM.02848-07; Loper JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002784; Maurhofer M, 1998, PHYTOPATHOLOGY, V88, P678, DOI 10.1094/PHYTO.1998.88.7.678; Mavrodi DV, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-8; Mavrodi OV, 2001, PHYTOPATHOLOGY, V91, P35, DOI 10.1094/PHYTO.2001.91.1.35; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Mulet M, 2010, ENVIRON MICROBIOL, V12, P1513, DOI 10.1111/j.1462-2920.2010.02181.x; Noriega C, 2005, CURR MICROBIOL, V51, P419, DOI 10.1007/s00284-005-0125-8; Partida-Martinez LP, 2007, CHEMBIOCHEM, V8, P41, DOI 10.1002/cbic.200600393; Partida-Martinez LP, 2005, NATURE, V437, P884, DOI 10.1038/nature03997; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; Pechy-Tarr M, 2008, ENVIRON MICROBIOL, V10, P2368, DOI 10.1111/j.1462-2920.2008.01662.x; Raaijmakers JM, 1997, APPL ENVIRON MICROB, V63, P881, DOI 10.1128/AEM.63.3.881-887.1997; Ramette A, 2011, SYST APPL MICROBIOL, V34, P180, DOI 10.1016/j.syapm.2010.10.005; Reimmann C, 2005, J BACTERIOL, V187, P276, DOI 10.1128/JB.187.1.276-285.2005; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Romeo A, 2012, MICROBIOL-SGM, V158, P1543, DOI 10.1099/mic.0.053850-0; Sambrook J, 2001, MOL CLONING LAB MANU; Schnider-Keel U, 2000, J BACTERIOL, V182, P1215, DOI 10.1128/JB.182.5.1215-1225.2000; Siddiqui IA, 2005, APPL ENVIRON MICROB, V71, P5646, DOI 10.1128/AEM.71.9.5646-5649.2005; Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51; Someya N, 2012, MICROBES ENVIRON, V27, P122, DOI 10.1264/jsme2.ME11237; Stockwell VO, 2007, PHYTOPATHOLOGY, V97, P244, DOI 10.1094/PHYTO-97-2-0244; STUTZ EW, 1986, PHYTOPATHOLOGY, V76, P181, DOI 10.1094/Phyto-76-181; Svercel M, 2007, J MICROBIOL METH, V70, P209, DOI 10.1016/j.mimet.2007.03.018; Takeuchi K, 2012, MOL PLANT MICROBE IN, V25, P1440, DOI 10.1094/MPMI-02-12-0034-R; Takeuchi K, 2009, J BIOL CHEM, V284, P34976, DOI 10.1074/jbc.M109.052571; Valverde C, 2003, MOL MICROBIOL, V50, P1361, DOI 10.1046/j.1365-2958.2003.03774.x; VOISARD C, 1994, MOLECULAR ECOLOGY OF RHIZOSPHERE MICROORGANISMS, P67, DOI 10.1002/9783527615810.ch6; VOISARD C, 1988, FEMS MICROBIOL LETT, V55, P9, DOI 10.1016/0378-1097(88)90143-7; Winsor GL, 2009, NUCLEIC ACIDS RES, V37, pD483, DOI 10.1093/nar/gkn861; Youard ZA, 2007, J BIOL CHEM, V282, P35546, DOI 10.1074/jbc.M707039200	57	32	34	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93683	10.1371/journal.pone.0093683	http://dx.doi.org/10.1371/journal.pone.0093683			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695768	Green Submitted, Green Published, gold			2022-12-25	WOS:000334103000103
J	Vidigal, PG; Musken, M; Becker, KA; Haussler, S; Wingender, J; Steinmann, E; Kehrmann, J; Gulbins, E; Buer, J; Rath, PM; Steinmann, J				Vidigal, Pedrina G.; Muesken, Mathias; Becker, Katrin A.; Haeussler, Susanne; Wingender, Jost; Steinmann, Eike; Kehrmann, Jan; Gulbins, Erich; Buer, Jan; Rath, Peter Michael; Steinmann, Joerg			Effects of Green Tea Compound Epigallocatechin-3-Gallate against Stenotrophomonas maltophilia Infection and Biofilm	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; POLYPHENOL (-)-EPIGALLOCATECHIN-3-GALLATE EGCG; PSEUDOMONAS-AERUGINOSA; CANDIDA-ALBICANS; GALLATE; PATHOGENS; CATECHIN; STAPHYLOCOCCI; TOBRAMYCIN; TOXICITY	We investigated the in vitro and in vivo activities of epigallocatechin- 3- gallate ( EGCg), a green tea component, against Stenotrophomonas maltophilia ( Sm) isolates from cystic fibrosis ( CF) patients. In vitro effects of EGCg and the antibiotic colistin ( COL) on growth inhibition, survival, and also against young and mature biofilms of S. maltophilia were determined. Qualitative and quantitative changes on the biofilms were assessed by confocal laser scanning microscopy ( CLSM). Further, in vivo effects of nebulized EGCg in C57BL/ 6 and Cftr mutant mice during acute Sm lung infection were evaluated. Subinhibitory concentrations of EGCg significantly reduced not only biofilm formation, but also the quantity of viable cells in young and mature biofilms. CLSM showed that EGCg- exposed biofilms exhibited either a change in total biofilm biovolume or an increase of the fraction of dead cells contained within the biofilm in a dose depended manner. Sm infected wild- type and Cftr mutant mice treated with 1,024 mg/ L EGCg by inhalation exhibited significantly lower bacterial counts than those undergoing no treatment or treated with COL. EGCg displayed promising inhibitory and anti- biofilm properties against CF Sm isolates in vitro and significantly reduced Sm bacterial counts in an acute infection model with wild type and CF mice. This natural compound may represent a novel therapeutic agent against Sm infection in CF.	[Vidigal, Pedrina G.; Kehrmann, Jan; Buer, Jan; Rath, Peter Michael; Steinmann, Joerg] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Microbiol, Essen, Germany; [Muesken, Mathias; Haeussler, Susanne] Ctr Expt & Clin Infect Res, TWINCORE, Inst Mol Bacteriol, Hannover, Germany; [Muesken, Mathias; Haeussler, Susanne] Helmholtz Ctr Infect Res, Dept Mol Bacteriol, Braunschweig, Germany; [Becker, Katrin A.; Gulbins, Erich] Univ Duisburg Essen, Inst Mol Biol, Essen, Germany; [Wingender, Jost] Univ Duisburg Essen, Fac Chem, Dept Aquat Microbiol, Biofilm Ctr, Essen, Germany; [Steinmann, Eike] Ctr Expt & Clin Infect Res, TWINCORE, Div Expt Virol, Hannover, Germany	University of Duisburg Essen; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; University of Duisburg Essen; University of Duisburg Essen; Helmholtz Association; Helmholtz-Center for Infection Research	Steinmann, J (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Med Microbiol, Essen, Germany.	Joerg.Steinmann@uk-essen.de	Gulbins, Erich/L-6989-2014; Pohl, Sarah/B-3102-2016; Häussler, Susanne/I-2605-2014	Gulbins, Erich/0000-0002-3117-1342; Pohl, Sarah/0000-0003-2655-7037; Häussler, Susanne/0000-0001-6141-9102; Musken, Mathias/0000-0002-5624-1378; Buer, Jan/0000-0002-7602-1698; Steinmann, Eike/0000-0002-3654-9965	Mercator Stiftung	Mercator Stiftung	Pedrina Goncalves Vidigal holds a scholarship from the Mercator Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa H, 2004, BIOL PHARM BULL, V27, P277, DOI 10.1248/bpb.27.277; Arciola CR, 2012, BIOMATERIALS, V33, P5967, DOI 10.1016/j.biomaterials.2012.05.031; Benelli R, 2002, BIOL CHEM, V383, P101, DOI 10.1515/BC.2002.010; Bjarnsholt T, 2013, TRENDS MICROBIOL, V21, P466, DOI 10.1016/j.tim.2013.06.002; Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11; Chernish RN, 2003, CURR OPIN PULM MED, V9, P509, DOI 10.1097/00063198-200311000-00011; Clinical and Laboratory Standards Institute, 2009, M07A8 CLSI; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cui Y, 2012, FOOD MICROBIOL, V29, P80, DOI 10.1016/j.fm.2011.08.019; de Vrankrijker AMM, 2010, PAEDIATR RESPIR REV, V11, P246, DOI 10.1016/j.prrv.2010.07.003; Di Bonaventura G, 2007, FOLIA MICROBIOL, V52, P86, DOI 10.1007/BF02932144; Di Bonaventura G, 2004, ANTIMICROB AGENTS CH, V48, P151, DOI 10.1128/AAC.48.1.151-160.2004; Evensen NA, 2009, CAN J MICROBIOL, V55, P1033, DOI [10.1139/W09-058, 10.1139/w09-058]; Gales AC, 2001, CLIN INFECT DIS, V32, pS104, DOI 10.1086/320183; Gordon NC, 2010, INT J ANTIMICROB AG, V36, P129, DOI 10.1016/j.ijantimicag.2010.03.025; Hauser AR, 2011, CLIN MICROBIOL REV, V24, P29, DOI 10.1128/CMR.00036-10; Herrmann G, 2010, J INFECT DIS, V202, P1585, DOI 10.1086/656788; Hirasawa M, 2004, J ANTIMICROB CHEMOTH, V53, P225, DOI 10.1093/jac/dkh046; Hoiby Niels, 2002, J Cyst Fibros, V1, P249, DOI 10.1016/S1569-1993(02)00104-2; Isbrucker RA, 2006, FOOD CHEM TOXICOL, V44, P636, DOI 10.1016/j.fct.2005.11.003; Isbrucker RA, 2006, FOOD CHEM TOXICOL, V44, P626, DOI 10.1016/j.fct.2005.07.005; Lechtzin N, 2006, RESPIRATION, V73, P27, DOI 10.1159/000087686; McCaughey G, 2012, J CYST FIBROS, V11, P163, DOI 10.1016/j.jcf.2011.11.003; Musken M, 2010, NAT PROTOC, V5, P1460, DOI 10.1038/nprot.2010.110; Navarro-Martinez MD, 2005, ANTIMICROB AGENTS CH, V49, P2914, DOI 10.1128/AAC.49.7.2914-2920.2005; O'Connell OJ, 2011, RESP CARE, V56, P771, DOI 10.4187/respcare.00866; Osterburg A, 2009, CLIN MICROBIOL INFEC, V15, P341, DOI 10.1111/j.1469-0691.2009.02710.x; Pompilio A, 2011, PEPTIDES, V32, P1807, DOI 10.1016/j.peptides.2011.08.002; Pompilio A, 2010, J MED MICROBIOL, V59, P76, DOI 10.1099/jmm.0.011981-0; Pompilio A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-159; Pompilio A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-102; Rayamajhi M., 2011, JOVE-J VIS EXP, V51, P2702; Roccaro AS, 2004, ANTIMICROB AGENTS CH, V48, P1968, DOI 10.1128/AAC.48.6.1968-1973.2004; Steinmann J, 2013, BRIT J PHARMACOL, V168, P1059, DOI 10.1111/bph.12009; Stepanovic S, 2007, APMIS, V115, P891, DOI 10.1111/j.1600-0463.2007.apm_630.x; UK Cystic Fibrosis Trust Antibiotic Working Group, 2009, ANT TREATM CYST FIBR; Waters V, 2013, J CYST FIBROS, V12, P482, DOI 10.1016/j.jcf.2012.12.006; Waters V, 2011, AM J RESP CRIT CARE, V183, P635, DOI 10.1164/rccm.201009-1392OC; Wolfensohn S., 1999, HUMANE ENDPOINTS ANI, P48; Wu F, 2012, TOXICOL APPL PHARM, V258, P166, DOI 10.1016/j.taap.2011.10.018; Xu X, 2011, ANTIMICROB AGENTS CH, V55, P1229, DOI 10.1128/AAC.01016-10; Yamada H, 2006, J AM MED DIR ASSOC, V7, P79, DOI 10.1016/j.jamda.2005.06.002; Yoda Yoshiyuki, 2004, Journal of Infection and Chemotherapy, V10, P55, DOI 10.1007/s10156-003-0284-0; Zaveri NT, 2006, LIFE SCI, V78, P2073, DOI 10.1016/j.lfs.2005.12.006	45	23	25	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92876	10.1371/journal.pone.0092876	http://dx.doi.org/10.1371/journal.pone.0092876			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690894	gold, Green Published			2022-12-25	WOS:000334101100033
J	Zhong, HJ; Liu, LJ; Chong, CM; Lu, LH; Wang, MD; Chan, DSH; Chan, PWH; Lee, SMY; Ma, DL; Leung, CH				Zhong, Hai-Jing; Liu, Li-Juan; Chong, Cheong-Meng; Lu, Lihua; Wang, Modi; Chan, Daniel Shiu-Hin; Chan, Philip Wai Hong; Lee, Simon Ming-Yuen; Ma, Dik-Lung; Leung, Chung-Hang			Discovery of a Natural Product-Like iNOS Inhibitor by Molecular Docking with Potential Neuroprotective Effects In Vivo	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; DRUG DISCOVERY; SELECTIVE INHIBITOR; PARKINSONS-DISEASE; MPTP; ZEBRAFISH; LIGAND; IDENTIFICATION; INFLAMMATION; SUPPRESSION	In this study, we applied structure- based virtual screening techniques to identify natural product or natural product- like inhibitors of iNOS. The iNOS inhibitory activity of the hit compounds was characterized using cellular assays and an in vivo zebrafish larvae model. The natural product- like compound 1 inhibited NO production in LPS- stimulated Raw264.7 macrophages, without exerting cytotoxic effects on the cells. Significantly, compound 1 was able to reverse MPTP-induced locomotion deficiency and neurotoxicity in an in vivo zebrafish larval model. Hence, compound 1 could be considered as a scaffold for the further development of iNOS inhibitors for potential anti- inflammatory or anti- neurodegenerative applications.	[Zhong, Hai-Jing; Liu, Li-Juan; Chong, Cheong-Meng; Lee, Simon Ming-Yuen; Leung, Chung-Hang] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macao, Peoples R China; [Lu, Lihua; Wang, Modi; Chan, Daniel Shiu-Hin; Ma, Dik-Lung] Hong Kong Baptist Univ, Dept Chem, Kowloon Tong, Hong Kong, Peoples R China; [Chan, Philip Wai Hong] Nanyang Technol Univ, Sch Phys & Math Sci, Div Chem & Biol Chem, Singapore 639798, Singapore	University of Macau; Hong Kong Baptist University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Ma, DL (corresponding author), Hong Kong Baptist Univ, Dept Chem, Kowloon Tong, Hong Kong, Peoples R China.	edmondma@hkbu.edu.hk; duncanleung@umac.mo	Wang, Modi/ABG-9659-2021	Zhong, Hai-Jing/0000-0002-1247-3150; Ma, Dik-Lung/0000-0002-9515-340X	Hong Kong Baptist University [FRG2/12-13/021]; Centre for Cancer and Inflammation Research, School of Chinese Medicine (CCIR-SCM, HKBU); Health and Medical Research Fund [HMRF/13121482]; Research Grants Council [HKBU/201811, HKBU/204612, HKBU/201913]; French National Research Agency/Research Grants Council Joint Research Scheme [A-HKBU201/12]; Science and Technology Development Fund, Macao SAR [001/2012/A, 103/2012/A3]; University of Macau [MYRG091(Y2-L2)-ICMS12-LCH, MYRG121(Y2-L2)-ICMS12-LCH, MRG023/LCH/2013/ICMS]	Hong Kong Baptist University; Centre for Cancer and Inflammation Research, School of Chinese Medicine (CCIR-SCM, HKBU); Health and Medical Research Fund; Research Grants Council(Hong Kong Research Grants Council); French National Research Agency/Research Grants Council Joint Research Scheme(French National Research Agency (ANR)); Science and Technology Development Fund, Macao SAR; University of Macau	This work is supported by Hong Kong Baptist University (FRG2/12-13/021), Centre for Cancer and Inflammation Research, School of Chinese Medicine (CCIR-SCM, HKBU), the Health and Medical Research Fund (HMRF/13121482), the Research Grants Council (HKBU/201811, HKBU/204612 and HKBU/201913), the French National Research Agency/Research Grants Council Joint Research Scheme (A-HKBU201/12), the Science and Technology Development Fund, Macao SAR (001/2012/A and 103/2012/A3) and the University of Macau (MYRG091(Y2-L2)-ICMS12-LCH, MYRG121(Y2-L2)-ICMS12-LCH and MRG023/LCH/2013/ICMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abagyan AR, 2009, ICM MANUAL 3 0; Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Ando K, 2008, PSYCHOPHARMACOLOGY, V195, P509, DOI 10.1007/s00213-007-0929-2; Anichtchik OV, 2004, J NEUROCHEM, V88, P443, DOI 10.1046/j.1471-4159.2003.02190.x; Arias-Salvatierra D, 2011, CELL SIGNAL, V23, P425, DOI 10.1016/j.cellsig.2010.10.017; Brown GC, 2001, BBA-BIOENERGETICS, V1504, P46, DOI 10.1016/S0005-2728(00)00238-3; Butler MS, 2004, J NAT PROD, V67, P2141, DOI 10.1021/np040106y; Chan DSH, 2010, ANGEW CHEM INT EDIT, V49, P2860, DOI 10.1002/anie.200907360; Cheshire DR, 2011, BIOORG MED CHEM LETT, V21, P2468, DOI 10.1016/j.bmcl.2011.02.061; Coleman JW, 2001, INT IMMUNOPHARMACOL, V1, P1397, DOI 10.1016/S1567-5769(01)00086-8; CONNOR JR, 1995, EUR J PHARMACOL, V273, P15, DOI 10.1016/0014-2999(94)00672-T; Davey DD, 2007, J MED CHEM, V50, P1146, DOI 10.1021/jm061319i; Dehmer T, 2000, J NEUROCHEM, V74, P2213, DOI 10.1046/j.1471-4159.2000.0742213.x; Forstermann U, 1998, FASEB J, V12, P773; Gasparotto J, 2013, CELL BIOL TOXICOL, V29, P175, DOI 10.1007/s10565-013-9245-2; Gradler U, 2011, BIOORG MED CHEM LETT, V21, P4228, DOI 10.1016/j.bmcl.2011.05.073; Hansel TT, 2003, FASEB J, V17, P1298, DOI 10.1096/fj.02-0633fje; Hemmens B, 2000, J BIOL CHEM, V275, P35786, DOI 10.1074/jbc.M005976200; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; JONES RSG, 1982, PROG NEUROBIOL, V19, P117, DOI 10.1016/0301-0082(82)90023-5; Lam CS, 2005, EUR J NEUROSCI, V21, P1758, DOI 10.1111/j.1460-9568.2005.03988.x; Lassiani L, 2009, BIOORGAN MED CHEM, V17, P2336, DOI 10.1016/j.bmc.2009.02.012; Lee HM, 2010, CHEM COMMUN, V46, P4680, DOI 10.1039/b926359d; Leung CH, 2011, CHEM COMMUN, V47, P2511, DOI 10.1039/c0cc04927a; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Liberatore GT, 1999, NAT MED, V5, P1403; Luiking YC, 2010, CURR OPIN CLIN NUTR, V13, P97, DOI 10.1097/MCO.0b013e328332f99d; Ma DL, 2011, CHEM SCI, V2, P1656, DOI 10.1039/c1sc00152c; McKinley ET, 2005, MOL BRAIN RES, V141, P128, DOI 10.1016/j.molbrainres.2005.08.014; McMillan K, 2000, P NATL ACAD SCI USA, V97, P1506, DOI 10.1073/pnas.97.4.1506; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; MOORE WM, 1994, J MED CHEM, V37, P3886, DOI 10.1021/jm00049a007; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Nosal R, 2010, NEUROENDOCRINOL LETT, V31, P69; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Rollinger Judith M., 2008, V65; Rosenfeld RJ, 2002, BIOCHEMISTRY-US, V41, P13915, DOI 10.1021/bi026313j; Schapira M, 1999, J MOL RECOGNIT, V12, P177, DOI 10.1002/(SICI)1099-1352(199905/06)12:3<177::AID-JMR451>3.0.CO;2-Z; Schuster D, 2010, CURR PHARM DESIGN, V16, P1666, DOI 10.2174/138161210791164072; Suaifan GARY, 2012, J MOL GRAPH MODEL, V37, P1, DOI 10.1016/j.jmgm.2012.04.001; Tanrikulu Y, 2013, DRUG DISCOV TODAY, V18, P358, DOI 10.1016/j.drudis.2013.01.007; Tinker AC, 2003, J MED CHEM, V46, P913, DOI 10.1021/jm0255926; Totrov M, 1997, PROTEINS, P215; Zhang ZJ, 2011, INT J MOL MED, V27, P195, DOI 10.3892/ijmm.2010.571; Zhong HJ, 2012, BIOCHIMIE, V94, P2457, DOI 10.1016/j.biochi.2012.06.004; Zhu YZ, 2012, CNS NEUROL DISORD-DR, V11, P350, DOI 10.2174/187152712800792901	48	29	29	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92905	10.1371/journal.pone.0092905	http://dx.doi.org/10.1371/journal.pone.0092905			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690920	gold, Green Published			2022-12-25	WOS:000334101100035
J	Ke, Y; Hunter, MJ; Ng, CA; Perry, MD; Vandenberg, JI				Ke, Ying; Hunter, Mark J.; Ng, Chai Ann; Perry, Matthew D.; Vandenberg, Jamie I.			Role of the Cytoplasmic N-terminal Cap and Per-Arnt-Sim ( PAS) Domain in Trafficking and Stabilization of Kv11.1 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hERG; Potassium Channels; Site-directed Mutagenesis; Trafficking; Western Blotting; PAS Domain; Subunit-Subunit Interaction	GENE POTASSIUM CHANNELS; LONG-QT SYNDROME; ENDOPLASMIC-RETICULUM; EAG DOMAIN; HERG; INACTIVATION; MUTATIONS; MECHANISM; IDENTIFICATION; ARRHYTHMIA	Background: A cytoplasmic PAS domain regulates Kv11.1 function, but its role in channel assembly is unclear. Results: PAS domain deletion does not alter assembly, but removal of the N-Cap that immediately precedes the PAS domain severely disrupts channel trafficking. Conclusion: The N-Cap is vital for PAS domain stability and channel trafficking. Significance: Kv11.1 channel assembly defects underlie the pathogenesis of long QT syndrome. The N-terminal cytoplasmic region of the Kv11.1a potassium channel contains a Per-Arnt-Sim (PAS) domain that is essential for the unique slow deactivation gating kinetics of the channel. The PAS domain has also been implicated in the assembly and stabilization of the assembled tetrameric channel, with many clinical mutants in the PAS domain resulting in reduced stability of the domain and reduced trafficking. Here, we use quantitative Western blotting to show that the PAS domain is not required for normal channel trafficking nor for subunit-subunit interactions, and it is not necessary for stabilizing assembled channels. However, when the PAS domain is present, the N-Cap amphipathic helix must also be present for channels to traffic to the cell membrane. Serine scan mutagenesis of the N-Cap amphipathic helix identified Leu-15, Ile-18, and Ile-19 as residues critical for the stabilization of full-length proteins when the PAS domain is present. Furthermore, mutant cycle analysis experiments support recent crystallography studies, indicating that the hydrophobic face of the N-Cap amphipathic helix interacts with a surface-exposed hydrophobic patch on the core of the PAS domain to stabilize the structure of this critical gating domain. Our data demonstrate that the N-Cap amphipathic helix is critical for channel stability and trafficking.	[Ke, Ying; Hunter, Mark J.; Ng, Chai Ann; Perry, Matthew D.; Vandenberg, Jamie I.] Victor Chang Cardiac Res Inst, Mark Cowley Lidwill Res Program Cardiac Electroph, Darlinghurst, NSW 2010, Australia; [Ke, Ying; Ng, Chai Ann; Perry, Matthew D.; Vandenberg, Jamie I.] Univ New S Wales, St Vincents Clin Sch, Darlinghurst, NSW 2010, Australia	Victor Chang Cardiac Research Institute; University of New South Wales Sydney	Vandenberg, JI (corresponding author), Victor Chang Cardiac Res Inst, Mark Cowley Lidwill Res Program Cardiac Electroph, 405 Liverpool St, Darlinghurst, NSW 2010, Australia.	j.vandenberg@victorchang.edu.au	Vandenberg, Jamie I/B-6608-2013	Vandenberg, Jamie I/0000-0002-3859-3716; Ng, Chai Ann/0000-0002-3120-5450	Health Foundation of Australia [G11S 5829]; National Health and Medical Research Council Senior Research Fellowship [1019693]	Health Foundation of Australia; National Health and Medical Research Council Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Grant-in-aid G11S 5829 from the Health Foundation of Australia and National Health and Medical Research Council Senior Research Fellowship 1019693 (to J.V.).	Adaixo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059265; Akhavan A, 2005, J CELL SCI, V118, P2803, DOI 10.1242/jcs.02423; Akhavan A, 2003, J BIOL CHEM, V278, P40105, DOI 10.1074/jbc.M307837200; Al-Owais M, 2009, EUR BIOPHYS J BIOPHY, V38, P569, DOI 10.1007/s00249-009-0408-2; Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Aydar E, 2001, J PHYSIOL-LONDON, V534, P1, DOI 10.1111/j.1469-7793.2001.t01-3-00001.x; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Delisle BP, 2004, CIRC RES, V94, P1418, DOI 10.1161/01.RES.0000128561.28701.ea; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fernandez-Trillo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024674; Gianulis EC, 2011, J BIOL CHEM, V286, P22160, DOI 10.1074/jbc.M110.205948; Gustina AS, 2012, CELL SIGNAL, V24, P1592, DOI 10.1016/j.cellsig.2012.04.004; Gustina AS, 2011, J GEN PHYSIOL, V137, P315, DOI 10.1085/jgp.201010582; Haitin Y, 2013, NATURE, V501, P444, DOI 10.1038/nature12487; Harley CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032654; Heide J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045624; Huffaker SJ, 2009, NAT MED, V15, P509, DOI 10.1038/nm.1962; Jones EMC, 2004, J BIOL CHEM, V279, P44690, DOI 10.1074/jbc.M408344200; Kaltman JR, 2011, CIRCULATION, V123, P1911, DOI 10.1161/CIRCULATIONAHA.110.017228; Ke Y, 2013, BIOCHEM J, V454, P69, DOI 10.1042/BJ20130328; Key J, 2007, BIOCHEMISTRY-US, V46, P3614, DOI 10.1021/bi0620407; Knollmann BC, 2008, NATURE, V451, P929, DOI 10.1038/nature06799; Li QX, 2010, BIOCHEM BIOPH RES CO, V403, P126, DOI 10.1016/j.bbrc.2010.10.132; Moss AJ, 2005, CIRCULATION, V111, P1199, DOI 10.1161/01.CIR.0000157069.91834.DA; Muskett FW, 2011, J BIOL CHEM, V286, P6184, DOI 10.1074/jbc.M110.199364; Ng CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016191; Perry MD, 2013, J BIOL CHEM, V288, P11482, DOI 10.1074/jbc.M113.461442; Phartiyal P, 2008, J BIOL CHEM, V283, P3702, DOI 10.1074/jbc.M708999200; Phartiyal P, 2007, J BIOL CHEM, V282, P9874, DOI 10.1074/jbc.M610875200; Schonherr R, 1996, J PHYSIOL-LONDON, V493, P635, DOI 10.1113/jphysiol.1996.sp021410; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; Viloria CG, 2000, BIOPHYS J, V79, P231, DOI 10.1016/S0006-3495(00)76286-2; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637; Zhao JT, 2009, J CARDIOVASC ELECTR, V20, P923, DOI 10.1111/j.1540-8167.2009.01468.x	35	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13782	13791		10.1074/jbc.M113.531277	http://dx.doi.org/10.1074/jbc.M113.531277			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24695734	Green Published, hybrid			2022-12-25	WOS:000335984600012
J	Qadota, H; Luo, YT; Matsunaga, Y; Park, AS; Gernert, KM; Benian, GM				Qadota, Hiroshi; Luo, Yating; Matsunaga, Yohei; Park, Angela S.; Gernert, Kim M.; Benian, Guy M.			Suppressor Mutations Suggest a Surface on PAT-4 ( Integrin-linked Kinase) That Interacts with UNC-112 ( Kindlin)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adhesion; C; elegans; Muscle; Protein Structure; Protein-Protein Interactions; Integrin-linked Kinase; Kindlin; Suppressor Genetics	CAENORHABDITIS-ELEGANS; ADHESION COMPLEXES; LOCALIZATION; PROTEINS; UNC-97/PINCH; COMPONENTS; GENE; ILK	Background: Interaction between PAT-4 (ILK) and UNC-112 (kindlin) is required for localization of each protein to integrin adhesions. Results: PAT-4 missense mutations were identified that restore binding of a mutant UNC-112 protein and its proper localization. Conclusion: Residues mutated in the suppressor mutants cluster in two regions on the surface of a homology model of PAT-4. Significance: An interaction surface between PAT-4 and UNC-112 is suggested. Caenorhabditis elegans striated muscle cells attach to basement membrane and transmit the force of muscle contraction through integrin adhesion complexes. The cytoplasmic tail of -integrin (PAT-3) is associated with a conserved four-protein complex that includes UNC-112 (kindlin), PAT-4 (integrin-linked kinase), PAT-6 (-parvin/actopaxin), and UNC-97 (PINCH). The proper localization of UNC-112 to muscle integrin adhesion sites requires PAT-4. A recent report (Qadota, H., Moerman, D. G., and Benian, G. M. (2012) A molecular mechanism for the requirement of PAT-4 (integrin-linked kinase (ILK)) for the localization of UNC-112 (kindlin) to integrin adhesion sites. J. Biol. Chem. 287, 28537-28551) suggests a possible molecular mechanism for this requirement: that UNC-112 exists in closed inactive and open active conformations, and conversion to the open active form is promoted by binding to PAT-4 (ILK). Previously, we also reported identification of a single missense mutation in UNC-112, D382V, which abolishes both binding to PAT-4 and normal localization to integrin adhesion sites in vivo. In this report, we describe isolation and characterization of PAT-4 missense mutations that permit binding with UNC-112 D382V and place nine affected residues on a homology model of PAT-4. These nine residues cluster in two regions on the surface of PAT-4, do not overlap the likely binding surface for PAT-6 (-parvin), and therefore may reside along the interaction surface of PAT-4 for UNC-112 (kindlin). We also show that one of these PAT-4 mutations restores the ability of UNC-112 D382V to localize to integrin adhesions and participate in complex formation.	[Qadota, Hiroshi; Luo, Yating; Matsunaga, Yohei; Park, Angela S.; Benian, Guy M.] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA; [Gernert, Kim M.] Emory Univ, Atlanta, GA 30322 USA	Emory University; Emory University	Benian, GM (corresponding author), Emory Univ, Dept Pathol, Whitehead Bldg 105E,615 Michael St, Atlanta, GA 30322 USA.	pathgb@emory.edu			American Heart Association [11GRNT7820000]	American Heart Association(American Heart Association)	This study was supported by American Heart Association Grant 11GRNT7820000.	BRENNER S, 1974, GENETICS, V77, P71; Brotherton DH, 1998, NATURE, V395, P244, DOI 10.1038/26164; Chiswell BP, 2008, P NATL ACAD SCI USA, V105, P20677, DOI 10.1073/pnas.0811415106; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; FRANCIS GR, 1985, J CELL BIOL, V101, P1532, DOI 10.1083/jcb.101.4.1532; Fukuda K, 2009, MOL CELL, V36, P819, DOI 10.1016/j.molcel.2009.11.028; Hobert O, 1999, J CELL BIOL, V144, P45, DOI 10.1083/jcb.144.1.45; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; James P, 1996, GENETICS, V144, P1425; Lin XY, 2003, CURR BIOL, V13, P922, DOI 10.1016/S0960-9822(03)00372-5; Lo SH, 2006, DEV BIOL, V294, P280, DOI 10.1016/j.ydbio.2006.03.029; Mackinnon AC, 2002, CURR BIOL, V12, P787, DOI 10.1016/S0960-9822(02)00810-2; Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339; Meves A, 2009, TRENDS CELL BIOL, V19, P504, DOI 10.1016/j.tcb.2009.07.006; Miller RK, 2006, J CELL BIOL, V175, P853, DOI 10.1083/jcb.200608043; MITANI S, 1995, DEV GROWTH DIFFER, V37, P551; Moerman D., 2006, WORMBOOK, DOI 10.1895/wormbook.1.81.1; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Norman KR, 2007, DEV BIOL, V309, P45, DOI 10.1016/j.ydbio.2007.06.014; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qadota H, 2007, MOL BIOL CELL, V18, P4317, DOI 10.1091/mbc.E07-03-0278; Qadota H, 2012, J BIOL CHEM, V287, P28537, DOI 10.1074/jbc.M112.354852; Qadota H, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/864749; Rogalski TM, 2000, J CELL BIOL, V150, P253, DOI 10.1083/jcb.150.1.253; Warner A, 2013, MOL BIOL CELL, V24, P601, DOI 10.1091/mbc.E12-06-0478; Warner A, 2011, MOL BIOL CELL, V22, P2551, DOI 10.1091/mbc.E10-12-0941; Waterston R., 1988, NEMATODE C ELEGANS, P281; WILLIAMS BD, 1994, J CELL BIOL, V124, P475, DOI 10.1083/jcb.124.4.475; Wilson KJ, 2012, METHODS MOL BIOL, V798, P171, DOI 10.1007/978-1-61779-343-1_10; Yochem J, 1998, GENETICS, V149, P1323; Zamir E, 2001, J CELL SCI, V114, P3583; Zamir E, 2001, J CELL SCI, V114, P3577	34	7	8	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14252	14262		10.1074/jbc.M114.556308	http://dx.doi.org/10.1074/jbc.M114.556308			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24692564	Green Published, hybrid			2022-12-25	WOS:000335984600050
J	Rabolli, V; Wallemme, L; Lo Re, S; Uwambayinema, F; Palmai-Pallag, M; Thomassen, L; Tyteca, D; Octave, JN; Marbaix, E; Lison, D; Devuyst, O; Huaux, F				Rabolli, Virginie; Wallemme, Laurent; Lo Re, Sandra; Uwambayinema, Francine; Palmai-Pallag, Mihaly; Thomassen, Leen; Tyteca, Donatienne; Octave, Jean-Noel; Marbaix, Etienne; Lison, Dominique; Devuyst, Olivier; Huaux, Francois			Critical Role of Aquaporins in Interleukin 1 beta( IL-1 beta)- induced Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aquaporin; Caspase; Inflammation; Interleukin; Water Channel; RVD; Cell Swelling; Inflammasome	NALP3 INFLAMMASOME; EXPRESSION; ACTIVATION; MICE; LUNG; SILICA; CELLS; MACROPHAGES; INFECTION; MIGRATION	Background: Aquaporins are channels permeable to water, and they are essential for immune cell migration. Results: We demonstrate that aquaporin-mediated water fluxes are necessary for the NLRP3 inflammasome-dependent release of mature IL-1 in vitro and in vivo. Conclusion: Aquaporins are implicated in the mechanisms of proinflammatory cytokine secretion during inflammation. Significance: The discovery of a new function for AQPs opens new diagnostic and therapeutic opportunities in inflammatory disorders. Rapid changes in cell volume characterize macrophage activation, but the role of water channels in inflammation remains unclear. We show here that, in vitro, aquaporin (AQP) blockade or deficiency results in reduced IL-1 release by macrophages activated with a variety of NLRP3 activators. Inhibition of AQP specifically during the regulatory volume decrease process is sufficient to limit IL-1 release by macrophages through the NLRP3 inflammasome axis. The immune-related activity of AQP was confirmed in vivo in a model of acute lung inflammation induced by crystals. AQP1 deficiency is associated with a marked reduction of both lung IL-1 release and neutrophilic inflammation. We conclude that AQP-mediated water transport in macrophages constitutes a general danger signal required for NLRP3-related inflammation. Our findings reveal a new function of AQP in the inflammatory process and suggest a novel therapeutic target for anti-inflammatory therapy.	[Rabolli, Virginie; Wallemme, Laurent; Lo Re, Sandra; Uwambayinema, Francine; Palmai-Pallag, Mihaly; Lison, Dominique; Huaux, Francois] Catholic Univ Louvain, Louvain Ctr Toxicol & Appl Pharmacol LTAP, B-1200 Brussels, Belgium; [Devuyst, Olivier] Catholic Univ Louvain, Div Nephrol, Inst Rech Expt & Clin IREC, B-1200 Brussels, Belgium; [Tyteca, Donatienne; Marbaix, Etienne] Catholic Univ Louvain, Cell Biol Unit, Duve Inst, B-1200 Brussels, Belgium; [Octave, Jean-Noel; Lison, Dominique] Catholic Univ Louvain, Inst NeuroSci IoNS, B-1200 Brussels, Belgium; [Thomassen, Leen] Katholieke Univ Leuven, Ctr Surface Chem & Catalysis, B-3001 Heverlee, Belgium; [Devuyst, Olivier] Univ Zurich, Inst Physiol, Zurich Ctr Integrat Human Physiol, CH-8006 Zurich, Switzerland	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; KU Leuven; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Huaux, F (corresponding author), Catholic Univ Louvain, Louvain Ctr Toxicol & Appl Pharmacol LTAP, Ave Mounier 53 Bte B1 52 12, B-1200 Brussels, Belgium.	francois.huaux@uclouvain.be	Lison, Dominique/A-8985-2010; Thomassen, Leen CJ/A-9186-2015	Thomassen, Leen CJ/0000-0002-4970-7475; Devuyst, Olivier/0000-0003-3744-4767; Lison, Dominique/0000-0001-6557-2518	Programme d'excellence Marshall Diane convention; Fonds de la Recherche Scientifique Medicale (FRSM); Actions de Recherche Concertees; Communaute Francaise de Belgique; Direction de la Recherche Scientifique [ARC 09/14-021]; Fondation Contre le Cancer; Fonds de la Recherche Scientifique (FNRS) [PDR T.0119.13 14633768]; European Commission [202047]; Agence Nationale de Securite Sanitaire de L'Alimentation, de l'Environnement, et du Travail (ANSES, France); Fondation Saint-Luc at Universite Catholique de Louvain; Baxter extramural grant; NCCR Kidney; CH program (Swiss National Science Foundation); Swiss National Science Foundation [310030-146490]	Programme d'excellence Marshall Diane convention; Fonds de la Recherche Scientifique Medicale (FRSM)(Fonds de la Recherche Scientifique - FNRS); Actions de Recherche Concertees(University of Liege); Communaute Francaise de Belgique(Australian Research Council); Direction de la Recherche Scientifique; Fondation Contre le Cancer; Fonds de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); European Commission(European CommissionEuropean Commission Joint Research Centre); Agence Nationale de Securite Sanitaire de L'Alimentation, de l'Environnement, et du Travail (ANSES, France); Fondation Saint-Luc at Universite Catholique de Louvain; Baxter extramural grant; NCCR Kidney; CH program (Swiss National Science Foundation)(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Programme d'excellence Marshall Diane convention, by the Fonds de la Recherche Scientifique Medicale (FRSM), by Actions de Recherche Concertees, Communaute Francaise de Belgique, Direction de la Recherche Scientifique grant ARC 09/14-021), by the Fondation Contre le Cancer, by Fonds de la Recherche Scientifique (FNRS) Project PDR T.0119.13 14633768, by the European Commission under FP7-HEALTH-F4-2008 contract no. 202047, and by Agence Nationale de Securite Sanitaire de L'Alimentation, de l'Environnement, et du Travail (ANSES, France). This work was also supported in part by the Fondation Saint-Luc at Universite Catholique de Louvain, by a Baxter extramural grant, by the Inter-University Attraction Pole (IUAP, Belgium Federal Government), by the NCCR Kidney. CH program (Swiss National Science Foundation), and by Swiss National Science Foundation grant 310030-146490 (to O.D.).	Adamzik M, 2011, ANESTHESIOLOGY, V114, P912, DOI 10.1097/ALN.0b013e31820ca911; AGRE P, 1993, AM J PHYSIOL, V265, pF461, DOI 10.1152/ajprenal.1993.265.3.F461; Auguste KI, 2007, FASEB J, V21, P108, DOI 10.1096/fj.06-6848com; Bonventre JV, 2003, J AM SOC NEPHROL, V14, P2199, DOI 10.1097/01.ASN.0000079785.13922.F6; Cai SS, 2012, J IMMUNOL, V188, P5623, DOI 10.4049/jimmunol.1200195; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Compan V, 2012, IMMUNITY, V37, P487, DOI 10.1016/j.immuni.2012.06.013; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; de Baey A, 2000, J EXP MED, V191, P743, DOI 10.1084/jem.191.4.743; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Gross O, 2012, IMMUNITY, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Hansel NN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014226; Hardin JA, 2004, CELL TISSUE RES, V318, P313, DOI 10.1007/s00441-004-0932-4; HERZYK DJ, 1992, J IMMUNOL METHODS, V148, P243, DOI 10.1016/0022-1759(92)90178-V; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hoshino T, 2009, AM J RESP CELL MOL, V41, P661, DOI 10.1165/rcmb.2008-0182OC; Huysseune S, 2009, FASEB J, V23, P4158, DOI 10.1096/fj.09-140012; Jablonski EM, 2004, AM J PHYSIOL-CELL PH, V286, pC975, DOI 10.1152/ajpcell.00180.2003; Jang AS, 2004, INTENS CARE MED, V30, P489, DOI 10.1007/s00134-003-2129-9; Ko SBH, 2009, J MED INVESTIG, V56, P318; Li LH, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-94; Liu XB, 2006, J BIOL CHEM, V281, P15485, DOI 10.1074/jbc.M600549200; Ma TH, 1998, J BIOL CHEM, V273, P4296, DOI 10.1074/jbc.273.8.4296; Mao KR, 2013, CELL RES, V23, P201, DOI 10.1038/cr.2013.6; Mobasheri A, 2010, ANN ANAT, V192, P116, DOI 10.1016/j.aanat.2010.01.001; Moftakhar P, 2010, J NEUROPATH EXP NEUR, V69, P1201, DOI 10.1097/NEN.0b013e3181fd252c; Moon C, 2004, AM J HEMATOL, V75, P128, DOI 10.1002/ajh.10476; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Nishino T, 2008, PFLUG ARCH EUR J PHY, V456, P721, DOI 10.1007/s00424-007-0402-4; Oliveira RP, 2002, CRIT CARE, V6, P418, DOI 10.1186/cc1541; Palomaki J, 2011, ACS NANO, V5, P6861, DOI 10.1021/nn200595c; PANKOW W, 1995, CANCER DETECT PREV, V19, P268; Papadopoulos MC, 2008, PFLUG ARCH EUR J PHY, V456, P693, DOI 10.1007/s00424-007-0357-5; Pelegrin P, 2009, EMBO J, V28, P2114, DOI 10.1038/emboj.2009.163; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Perregaux DG, 1996, J BIOL CHEM, V271, P29830, DOI 10.1074/jbc.271.47.29830; Rabolli V, 2011, TOXICOL LETT, V203, P127, DOI 10.1016/j.toxlet.2011.03.009; Savage DF, 2007, J MOL BIOL, V368, P607, DOI 10.1016/j.jmb.2007.02.070; Schorn C, 2011, J BIOL CHEM, V286, P35, DOI 10.1074/jbc.M110.139048; Shen Y, 2011, J CELL MOL MED, V15, P1355, DOI 10.1111/j.1582-4934.2010.01103.x; SOKOL RJ, 1987, J ANAT, V151, P27; SOLEZ K, 1993, KIDNEY INT, V44, P411, DOI 10.1038/ki.1993.259; Talwar S, 2006, PHYSIOL GENOMICS, V25, P203, DOI 10.1152/physiolgenomics.00192.2005; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Thomassen LCJ, 2010, LANGMUIR, V26, P328, DOI 10.1021/la902050k; Towne JE, 2000, AM J RESP CELL MOL, V22, P34, DOI 10.1165/ajrcmb.22.1.3818; Van Belle AB, 2012, J IMMUNOL, V188, P462, DOI 10.4049/jimmunol.1102224; Verkman AS, 2012, ANNU REV MED, V63, P303, DOI 10.1146/annurev-med-043010-193843; Xu P, 2013, J IMMUNOL, V190, P5247, DOI 10.4049/jimmunol.1203182; Zhu N, 2011, FASEB J, V25, P4233, DOI 10.1096/fj.11-182808	50	43	49	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13937	13947		10.1074/jbc.M113.534594	http://dx.doi.org/10.1074/jbc.M113.534594			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24700466	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000335984600025
J	Chai, RC; Kouspou, MM; Lang, BJ; Nguyen, CH; van der Kraan, AGJ; Vieusseux, JL; Lim, RC; Gillespie, MT; Benjamin, IJ; Quinn, JMW; Price, JT				Chai, Ryan C.; Kouspou, Michelle M.; Lang, Benjamin J.; Nguyen, Chau H.; van der Kraan, A. Gabrielle J.; Vieusseux, Jessica L.; Lim, Reece C.; Gillespie, Matthew T.; Benjamin, Ivor J.; Quinn, Julian M. W.; Price, John T.			Molecular Stress-inducing Compounds Increase Osteoclast Formation in a Heat Shock Factor 1 Protein-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone; Heat Shock Protein; HSP90; Osteoclast; Stress Response; HSF1; Cell Stress; Chemotherapy; HSP90 Inhibitors	MICROPHTHALMIA TRANSCRIPTION FACTOR; KAPPA-B ACTIVATION; BREAST-CANCER; HEAT-SHOCK-PROTEIN-90 HSP90; CARCINOMA-CELLS; CLINICAL-TRIAL; BONE LOSS; IN-VITRO; EXPRESSION; DIFFERENTIATION	Background: HSP90 inhibitors increase osteoclast formation and bone loss. Results: Altered Hsf1 activity impacts the ability of stress-inducing compounds to modulate osteoclast formation. Conclusion: Hsf1 plays an important role in stress-associated osteoclast formation, potentially via MITF. Significance: We identified a novel pathway whereby agents inducing stress can enhance osteoclast formation. Many anticancer therapeutic agents cause bone loss, which increases the risk of fractures that severely reduce quality of life. Thus, in drug development, it is critical to identify and understand such effects. Anticancer therapeutic and HSP90 inhibitor 17-(allylamino)-17-demethoxygeldanamycin (17-AAG) causes bone loss by increasing osteoclast formation, but the mechanism underlying this is not understood. 17-AAG activates heat shock factor 1 (Hsf1), the master transcriptional regulator of heat shock/cell stress responses, which may be involved in this negative action of 17-AAG upon bone. Using mouse bone marrow and RAW264.7 osteoclast differentiation models we found that HSP90 inhibitors that induced a heat shock response also enhanced osteoclast formation, whereas HSP90 inhibitors that did not (including coumermycin A1 and novobiocin) did not affect osteoclast formation. Pharmacological inhibition or shRNAmir knockdown of Hsf1 in RAW264.7 cells as well as the use of Hsf1 null mouse bone marrow cells demonstrated that 17-AAG-enhanced osteoclast formation was Hsf1-dependent. Moreover, ectopic overexpression of Hsf1 enhanced 17-AAG effects upon osteoclast formation. Consistent with these findings, protein levels of the essential osteoclast transcription factor microphthalmia-associated transcription factor were increased by 17-AAG in an Hsf1-dependent manner. In addition to HSP90 inhibitors, we also identified that other agents that induced cellular stress, such as ethanol, doxorubicin, and methotrexate, also directly increased osteoclast formation, potentially in an Hsf1-dependent manner. These results, therefore, indicate that cellular stress can enhance osteoclast differentiation via Hsf1-dependent mechanisms and may significantly contribute to pathological and therapeutic related bone loss.	[Chai, Ryan C.; Kouspou, Michelle M.; Lang, Benjamin J.; Nguyen, Chau H.; van der Kraan, A. Gabrielle J.; Vieusseux, Jessica L.; Lim, Reece C.; Gillespie, Matthew T.; Quinn, Julian M. W.; Price, John T.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [van der Kraan, A. Gabrielle J.; Gillespie, Matthew T.; Quinn, Julian M. W.] Prince Henrys Inst, Clayton, Vic 3168, Australia; [Benjamin, Ivor J.] Med Coll Wisconsin, Div Cardiovasc Med, Milwaukee, WI 53226 USA; [Price, John T.] Victoria Univ, Coll Hlth & Biomed, Melbourne, Vic 8001, Australia	Monash University; Prince Henry's Institute of Medical Research; Medical College of Wisconsin; Victoria University	Price, JT (corresponding author), Victoria Univ, Coll Hlth & Biomed, Melbourne, Vic 3801, Australia.	john.price@vu.edu.au	Lang, Benjamin/AAO-9976-2020	Lang, Benjamin/0000-0002-2205-8591; Price, John/0000-0002-8244-1023; Gillespie, Matthew/0000-0001-6543-8909	Australian National Health and Medical Research Council [606549, 1057706]; RD Wright Fellowship [395525]; Victorian Government Operational Infrastructure Support Program	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); RD Wright Fellowship; Victorian Government Operational Infrastructure Support Program	This work was supported by Australian National Health and Medical Research Council Project Grants 606549 and 1057706, by RD Wright Fellowship No. 395525 (to J.T.P.), and by the Victorian Government Operational Infrastructure Support Program.	Ali A, 1998, MOL CELL BIOL, V18, P4949, DOI 10.1128/MCB.18.9.4949; Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Arikoski P, 1999, J BONE MINER RES, V14, P2002, DOI 10.1359/jbmr.1999.14.12.2002; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; CIOCCA DR, 1992, CANCER RES, V52, P3648; Conde R, 2009, BIOCHEM CELL BIOL, V87, P845, DOI [10.1139/O09-049, 10.1139/o09-049]; Dai JL, 2000, J CLIN INVEST, V106, P887, DOI 10.1172/JCI10483; Davies JH, 2002, BONE, V31, P319, DOI 10.1016/S8756-3282(02)00822-0; Donnelly A, 2008, CURR MED CHEM, V15, P2702, DOI 10.2174/092986708786242895; Ferry DR, 1996, CLIN CANCER RES, V2, P659; Fox SW, 2008, BIOCHEM BIOPH RES CO, V366, P123, DOI 10.1016/j.bbrc.2007.11.120; FRIEDLAENDER GE, 1984, J BONE JOINT SURG AM, V66A, P602, DOI 10.2106/00004623-198466040-00016; Galvin RJS, 1999, BIOCHEM BIOPH RES CO, V265, P233, DOI 10.1006/bbrc.1999.1632; Guise T, 2010, SEMIN ONCOL, V37, pS2, DOI 10.1053/j.seminoncol.2010.10.007; Guise TA, 2006, ONCOLOGIST, V11, P1121, DOI 10.1634/theoncologist.11-10-1121; Guise Theresa A, 2005, Clin Breast Cancer, V5 Suppl, pS46, DOI 10.3816/CBC.2005.s.004; Hadji P, 2009, EUR J CANCER, V45, P3205, DOI 10.1016/j.ejca.2009.09.026; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Iitsuka N, 2012, INT J MOL MED, V30, P165, DOI [10.3892/ijmnn.2012.974, 10.3892/ijmm.2012.974]; Karsenty G, 2012, NATURE, V481, P314, DOI 10.1038/nature10763; Kim YS, 2009, CURR TOP MED CHEM, V9, P1479, DOI 10.2174/156802609789895728; King TJ, 2012, AM J PATHOL, V181, P121, DOI 10.1016/j.ajpath.2012.03.037; Lamoureux F, 2011, CLIN CANCER RES, V17, P2301, DOI 10.1158/1078-0432.CCR-10-3077; Lang BJ, 2012, CELL STRESS CHAPERON, V17, P765, DOI 10.1007/s12192-012-0349-z; Langer T, 2002, CELL BIOL INT, V26, P653, DOI 10.1006/cbir.2002.0882; Laramie JM, 2008, SHOCK, V29, P623, DOI 10.1097/SHK.0b013e318157f33c; LI GC, 1983, J CELL PHYSIOL, V115, P116, DOI 10.1002/jcp.1041150203; Lu SY, 2010, MOL BIOL CELL, V21, P1763, DOI 10.1091/mbc.E09-07-0584; Luchin A, 2000, J BONE MINER RES, V15, P451, DOI 10.1359/jbmr.2000.15.3.451; Mandrekar P, 2008, J LEUKOCYTE BIOL, V84, P1335, DOI 10.1189/jlb.0407256; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Meadows NA, 2007, J BIOL CHEM, V282, P1891, DOI 10.1074/jbc.M608572200; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; Motyckova G, 2001, P NATL ACAD SCI USA, V98, P5798, DOI 10.1073/pnas.091479298; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; NAGAI N, 1995, BIOCHEM BIOPH RES CO, V208, P1099, DOI 10.1006/bbrc.1995.1447; Naylor K, 2012, NAT REV RHEUMATOL, V8, P379, DOI 10.1038/nrrheum.2012.86; Nguyen CH, 2013, BIOCHEM J, V452, P321, DOI 10.1042/BJ20130098; Nguyen ND, 2007, J BONE MINER RES, V22, P781, DOI 10.1359/JBMR.070315; Nomura S, 2001, J BONE MINER METAB, V19, P183, DOI 10.1007/s007740170040; Okawa Y, 2009, BLOOD, V113, P846, DOI 10.1182/blood-2008-04-151928; Pfeilschifter J, 2000, J CLIN ONCOL, V18, P1570, DOI 10.1200/JCO.2000.18.7.1570; Pick E, 2007, CANCER RES, V67, P2932, DOI 10.1158/0008-5472.CAN-06-4511; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Powers MV, 2007, FEBS LETT, V581, P3758, DOI 10.1016/j.febslet.2007.05.040; Price JT, 2005, CANCER RES, V65, P4929, DOI 10.1158/0008-5472.CAN-04-4458; Quinn JMW, 1999, BONE, V25, P1, DOI 10.1016/S8756-3282(99)00094-0; Quinn JMW, 2002, BONE, V30, P164, DOI 10.1016/S8756-3282(01)00654-8; Radanyi C, 2008, BIOORG MED CHEM LETT, V18, P2495, DOI 10.1016/j.bmcl.2008.01.128; Rangan GK, 1999, AM J PHYSIOL-RENAL, V277, pF779, DOI 10.1152/ajprenal.1999.277.5.F779; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Roccisana JL, 2004, J BIOL CHEM, V279, P10500, DOI 10.1074/jbc.M303727200; Sharma SM, 2007, J BIOL CHEM, V282, P15921, DOI 10.1074/jbc.M609723200; STEINGRIMSSON E, 1994, NAT GENET, V8, P256, DOI 10.1038/ng1194-256; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; van der Kraan AGJ, 2013, BIOCHEM J, V451, P235, DOI 10.1042/BJ20121626; Vargas-Roig LM, 1998, INT J CANCER, V79, P468, DOI 10.1002/(SICI)1097-0215(19981023)79:5<468::AID-IJC4>3.0.CO;2-Z; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wu BY, 2000, J NEUROSCI RES, V62, P730, DOI 10.1002/1097-4547(20001201)62:5<730::AID-JNR13>3.3.CO;2-B; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Yano A, 2008, P NATL ACAD SCI USA, V105, P15541, DOI 10.1073/pnas.0805354105; YEUNG YG, 1987, P NATL ACAD SCI USA, V84, P1268, DOI 10.1073/pnas.84.5.1268; Yokota S, 2000, CANCER RES, V60, P2942; Zanini C, 2007, J NEUROCHEM, V103, P1344, DOI 10.1111/j.1471-4159.2007.04835.x; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	68	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13602	13614		10.1074/jbc.M113.530626	http://dx.doi.org/10.1074/jbc.M113.530626			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24692538	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000335522800054
J	Zhou, LC; Yang, H; Okoro, EU; Guo, ZM				Zhou, LiChun; Yang, Hong; Okoro, Emmanuel U.; Guo, Zhongmao			Up-regulation of Cholesterol Absorption Is a Mechanism for Cholecystokinin-induced Hypercholesterolemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cholesterol Metabolism; Hormone Receptors; Intestine; Signal Transduction; Transporters	DENSITY-LIPOPROTEIN RECEPTOR; PLASMA CHOLECYSTOKININ; EPITHELIAL-CELLS; MICE; NPC1L1; SECRETION; MULTIPLE; PATHWAYS; SURFACE; TRANSLOCATION	Background: Intravenous injection of cholecystokinin (CCK) elevated mouse plasma cholesterol level. Results: CCK enhances cholesterol absorption in mice and cultured cells. Inhibition of CCK receptors and their downstream signaling proteins diminishes CCK-induced cholesterol absorption. Conclusion: Activation of enterocyte CCK receptors accelerates cholesterol absorption and induces hypercholesterolemia. Significance: Inhibition of CCK receptors could be a therapeutic strategy for treatment of hypercholesterolemia. Excessive absorption of intestinal cholesterol is a risk factor for atherosclerosis. This report examines the effect of cholecystokinin (CCK) on plasma cholesterol level and intestinal cholesterol absorption using the in vivo models of C57BL/6 wild-type and low density lipoprotein receptor knock-out (LDLR-/-) mice. These data were supported by in vitro studies involving mouse primary intestinal epithelial cells and human Caco-2 cells; both express CCK receptor 1 and 2 (CCK1R and CCK2R). We found that intravenous injection of [Thr(28),Nle(31)]CCK increased plasma cholesterol levels and intestinal cholesterol absorption in both wild-type and LDLR-/- mice. Treatment of mouse primary intestinal epithelial cells with [Thr(28),Nle(31)]CCK increased cholesterol absorption, whereas selective inhibition of CCK1R and CCK2R with antagonists attenuated CCK-induced cholesterol absorption. In Caco-2 cells, CCK enhanced CCK1R/CCK2R heterodimerization. Knockdown of both CCK1R and CCK2 or either one of them diminished CCK-induced cholesterol absorption to the same extent. CCK also increased cell surface-associated NPC1L1 (Niemann-Pick C1-like 1) transporters but did not alter their total protein expression. Inhibition or knockdown of NPC1L1 attenuated CCK-induced cholesterol absorption. CCK enhanced phosphatidylinositide 3-kinase (PI3K) and Akt phosphorylation and augmented the interaction between NPC1L1 and Rab11a (Rab-GTPase-11a), whereas knockdown of CCK receptors or inhibition of G protein dimer (G) diminished CCK-induced PI3K and Akt phosphorylation. Inhibition of PI3K and Akt or knockdown of PI3K diminished CCK-induced NPC1L1-Rab11a interaction and cholesterol absorption. Knockdown of Rab11a suppressed CCK-induced NPC1L1 translocation and cholesterol absorption. These data imply that CCK enhances cholesterol absorption by activation of a pathway involving CCK1R/CCK2R, G, PI3K, Akt, Rab11a, and NPC1L.	[Zhou, LiChun; Yang, Hong; Okoro, Emmanuel U.; Guo, Zhongmao] Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA	Meharry Medical College	Guo, ZM (corresponding author), Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA.	zguo@mmc.edu			National Institutes of Health [R01HL089382, SC1HL101431]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [SC1HL101431, R01HL089382] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL089382 (to Z. G.) and SC1HL101431 (to H. Y.).	Berna MJ, 2007, CURR OPIN PHARMACOL, V7, P583, DOI 10.1016/j.coph.2007.09.011; Calandra S, 2011, J LIPID RES, V52, P1885, DOI 10.1194/jlr.R017855; Cawston EE, 2010, BRIT J PHARMACOL, V159, P1009, DOI 10.1111/j.1476-5381.2009.00489.x; Chen XP, 2012, J BIOL CHEM, V287, P3751, DOI 10.1074/jbc.M111.310888; Cheng ZJ, 2003, J BIOL CHEM, V278, P52972, DOI 10.1074/jbc.M310090200; Cheng ZJ, 2001, J BIOL CHEM, V276, P48040, DOI 10.1074/jbc.M105668200; Chu BB, 2009, J BIOL CHEM, V284, P22481, DOI 10.1074/jbc.M109.034355; Dietschy JM, 2002, J BIOL CHEM, V277, P3801, DOI 10.1074/jbc.R100057200; Dufresne M, 2006, PHYSIOL REV, V86, P805, DOI 10.1152/physrev.00014.2005; Flint A, 2002, NEUROPSYCHOPHARMACOL, V27, P663; Foster LJ, 2001, J BIOL CHEM, V276, P44212, DOI 10.1074/jbc.M102964200; GERTLER MM, 1950, CIRCULATION, V2, P517, DOI 10.1161/01.CIR.2.4.517; GOMEZ G, 1990, J CLIN INVEST, V86, P323, DOI 10.1172/JCI114703; Gukovsky I, 2004, GASTROENTEROLOGY, V126, P554, DOI 10.1053/j.gastro.2003.11.017; Havel RJ, 2004, ARTERIOSCL THROM VAS, V24, P213, DOI 10.1161/01.ATV.0000115382.53810.24; Iqbal J, 2005, J LIPID RES, V46, P1491, DOI 10.1194/jlr.M500023-JLR200; Iqbal J, 2003, J BIOL CHEM, V278, P31610, DOI 10.1074/jbc.M301177200; Iqbal J, 2009, AM J PHYSIOL-ENDOC M, V296, pE1183, DOI 10.1152/ajpendo.90899.2008; ISHIBASHI S, 1994, J CLIN INVEST, V93, P1885, DOI 10.1172/JCI117179; Jin Honglian, 2008, J Med Dent Sci, V55, P145; LEBIVIC A, 1990, J CELL BIOL, V111, P1351, DOI 10.1083/jcb.111.4.1351; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; LEVY E, 1995, FASEB J, V9, P626, DOI 10.1096/fasebj.9.8.7768354; Lin XH, 2013, J BIOL CHEM, V288, P14815, DOI 10.1074/jbc.M113.466565; MacIntosh CG, 1999, AM J CLIN NUTR, V69, P999; MASCLEE AAM, 1988, AGE, V11, P136, DOI 10.1007/BF02432293; NIEDERAU C, 1987, GUT, V28, P63, DOI 10.1136/gut.28.Suppl.63; Pasley J N, 1987, Prog Clin Biol Res, V227A, P371; Petersen NH, 2008, J LIPID RES, V49, P2023, DOI 10.1194/jlr.M800145-JLR200; Piiper A, 1997, AM J PHYSIOL-GASTR L, V272, pG135, DOI 10.1152/ajpgi.1997.272.1.G135; Rackley C E, 2000, Cardiol Rev, V8, P124, DOI 10.1097/00045415-200008020-00010; Ramsauer VP, 2003, J BIOL CHEM, V278, P30142, DOI 10.1074/jbc.M303220200; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Sane AT, 2006, J LIPID RES, V47, P2112, DOI 10.1194/jlr.M600174-JLR200; SCEMAMA JL, 1988, FEBS LETT, V242, P61, DOI 10.1016/0014-5793(88)80985-2; SOUDAH HC, 1992, AM J PHYSIOL, V263, pG102, DOI 10.1152/ajpgi.1992.263.1.G102; Wang DQH, 2002, J LIPID RES, V43, P1950, DOI 10.1194/jlr.M200078-JLR200; Wang ZF, 2009, FREE RADICAL BIO MED, V47, P1221, DOI 10.1016/j.freeradbiomed.2009.08.001; Welsh GI, 2007, J CELL SCI, V120, P4197, DOI 10.1242/jcs.007310; Wu DF, 2005, J LIPID RES, V46, P1380, DOI 10.1194/jlr.M400430-JLR200; Yu LQ, 2006, J BIOL CHEM, V281, P6616, DOI 10.1074/jbc.M511123200; Zhou LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051011	44	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					12989	12999		10.1074/jbc.M113.534388	http://dx.doi.org/10.1074/jbc.M113.534388			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24692543	Green Published, hybrid			2022-12-25	WOS:000335522800004
J	Feng, LY; Hu, LP; Fu, XT; Liao, H; Li, X; Zhan, AB; Zhang, LL; Wang, S; Huang, XT; Bao, ZM				Feng, Liying; Hu, Liping; Fu, Xiaoteng; Liao, Huan; Li, Xuan; Zhan, Aibin; Zhang, Lingling; Wang, Shi; Huang, Xiaoting; Bao, Zhenmin			An Integrated Genetic and Cytogenetic Map for Zhikong Scallop, Chlamys farreri, Based on Microsatellite Markers	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; CHROMOSOMAL LOCALIZATION; LINKAGE MAPS; PATINOPECTEN-YESSOENSIS; ARGOPECTEN-IRRADIANS; STAINING TECHNIQUES; RIBOSOMAL DNA; BIVALVIA; IDENTIFICATION; PRESTON	The reliability of genome analysis and proficiency of genetic manipulation requires knowledge of the correspondence between the genetic and cytogenetic maps. In the present study, we integrated cytogenetic and microsatellite-based linkage maps for Zhikong scallop, Chlamys farreri. Thirty-eight marker-anchored BAC clones standing for the 19 linkage groups were used to be FISH probes. Of 38 BAC clones, 30 were successfully located on single chromosome by FISH and used to integrate the genetic and cytogenetic map. Among the 19 linkage groups, 12 linkage groups were physically anchored by 2 markers, 6 linkage groups were anchored by 1 marker, and one linkage group was not anchored any makers by FISH. In addition, using two-color FISH, six linkage groups were distinguished by different chromosomal location; linkage groups LG6 and LG16 were placed on chromosome 10, LG8 and LG18 on chromosome 14. As a result, 18 of 19 linkage groups were localized to 17 pairs of chromosomes of C. farreri. We first integrated genetic and cytogenetic map for C. farreri. These 30 chromosome specific BAC clones in the cytogenetic map could be used to identify chromosomes of C. farreri. The integrated map will greatly facilitate molecular genetic studies that will be helpful for breeding applications in C. farreri and the upcoming genome projects of this species.	[Feng, Liying; Hu, Liping; Fu, Xiaoteng; Liao, Huan; Li, Xuan; Zhang, Lingling; Wang, Shi; Huang, Xiaoting; Bao, Zhenmin] Ocean Univ China, Coll Marine Life Sci, Minist Educ, Key Lab Marine Genet & Breeding MGB, Qingdao, Peoples R China; [Hu, Liping] Yantai Fisheries Res Inst, Yantai, Peoples R China; [Zhan, Aibin] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, Beijing, Peoples R China	Ocean University of China; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	Huang, XT (corresponding author), Ocean Univ China, Coll Marine Life Sci, Minist Educ, Key Lab Marine Genet & Breeding MGB, Qingdao, Peoples R China.	xthuang@ouc.edu.cn; zmbao@ouc.edu.cn	zhang, lingling/HDM-2189-2022; Zhan, Aibin/A-7240-2011	Li, Xuan/0000-0003-0066-2373	National Natural Science Foundation of China [31270027]; National Basic Research Program of China [2010CB126402]; National High Tech RD Program [2012AA10A410]; National Key Technology R&D Program of China [2011BAD45B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National High Tech RD Program(National High Technology Research and Development Program of China); National Key Technology R&D Program of China(National Key Technology R&D Program)	This research work was financially supported by National Natural Science Foundation of China (31270027), National Basic Research Program of China (2010CB126402), National High Tech R&D Program (2012AA10A410), and National Key Technology R&D Program of China (2011BAD45B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bureau of Fisheries, 2012, 2012 CHIN FISH STAT; Chen SP, 2005, ACTA OCEANOL SIN, V24, P107; Duke SE, 2007, CHROMOSOME RES, V15, P361, DOI 10.1007/s10577-007-1131-4; Guo XM, 1999, J SHELLFISH RES, V18, P19; Howell EC, 2002, GENETICS, V161, P1225; Hu LP, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/785831; Huan Pin, 2009, Marine Sciences (Beijing), V33, P10; Huan P, 2010, GENET MOL BIOL, V33, P36, DOI 10.1590/S1415-47572010005000015; Huan Pin, 2009, Yichuan, V31, P1241, DOI 10.3724/SP.J.1005.2009.01241; [黄超 Huang Chao], 2012, [海洋科学, Marine Sciences], V36, P1; Huang XT, 2007, J MOLLUS STUD, V73, P393, DOI 10.1093/mollus/eym036; Huang XT, 2007, GENES GENET SYST, V82, P257, DOI 10.1266/ggs.82.257; Huang XT, 2006, ACTA OCEANOL SIN, V25, P108; Huang YH, 2006, GENETICS, V173, P287, DOI 10.1534/genetics.105.053256; Hubert S, 2004, GENETICS, V168, P351, DOI 10.1534/genetics.104.027342; Insua A, 2006, GENETICA, V126, P291, DOI 10.1007/s10709-005-7408-7; Insua A, 1998, GENES GENET SYST, V73, P193, DOI 10.1266/ggs.73.193; Islam-Faridi MN, 2002, GENETICS, V161, P345; Kim JS, 2002, GENOME, V45, P402, DOI 10.1139/G01-141; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Li L, 2005, AQUACULTURE, V245, P63, DOI 10.1016/j.aquaculture.2004.12.015; Li Z, 2002, J OCEAN U QINGDAO, V32, P179; Lopez-Pinon MJ, 2005, J HERED, V96, P52, DOI 10.1093/jhered/esi001; Odierna G, 2006, GENETICA, V127, P341, DOI 10.1007/s10709-005-5366-8; Ren Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005795; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sandhu D, 2001, GENETICS, V157, P1735; Stratikopoulos EE, 2008, GENETICA, V133, P147, DOI 10.1007/s10709-007-9195-9; Waller T.R., 1991, Developments in Aquaculture and Fisheries Science, V21, P1; Wang LL, 2005, AQUAC RES, V36, P643, DOI 10.1111/j.1365-2109.2005.01268.x; Wang m., 1990, Journal of Ocean University of Qingdao, V20, P81; Wang S, 2004, J SHELLFISH RES, V23, P491; Wang YP, 2004, BIOL BULL-US, V207, P247, DOI 10.2307/1543213; Wang Yun-tao, 1999, Oceanologia et Limnologia Sinica, V30, P770; Xiao H, 2005, AQUACULTURE, V250, P602, DOI 10.1016/j.aquaculture.2005.05.002; Yoshido A, 2005, GENETICS, V170, P675, DOI 10.1534/genetics.104.040352; Zhan A, 2009, ANIM GENET, V40, P821, DOI 10.1111/j.1365-2052.2009.01920.x; Zhang FS, 1999, MAR SCI, V30, P38; Zhang LL, 2008, MAR BIOTECHNOL, V10, P151, DOI 10.1007/s10126-007-9045-x; Zhang LL, 2007, GENETICA, V130, P193, DOI 10.1007/s10709-006-9006-8; Zhao Bo-Song, 2013, Zhongguo Haiyang Daxue Xuebao, V43, P57; Zhao Y, 2002, J OCEAN U QINGDAO S, V32, P41	42	10	13	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e92567	10.1371/journal.pone.0092567	http://dx.doi.org/10.1371/journal.pone.0092567			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705086	Green Submitted, gold, Green Published			2022-12-25	WOS:000334107500019
J	Zhang, QW; Li, HH; Feng, XJ; Liu, BF; Liu, X				Zhang, Qiwei; Li, Henghui; Feng, Xiaojun; Liu, Bi-Feng; Liu, Xin			Purification of Derivatized Oligosaccharides by Solid Phase Extraction for Glycomic Analysis	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; PERMETHYLATED N-GLYCANS; MALDI-MS; SERUM; ELECTROPHORESIS; GLYCOPROTEINS; SENSITIVITY; PROFILES; STRATEGY	Profiling of glycans released from proteins is very complex and important. To enhance the detection sensitivity, chemical derivatization is required for the analysis of carbohydrates. Due to the interference of excess reagents, a simple and reliable purification method is usually necessary for the derivatized oligosaccharides. Various SPE based methods have been applied for the clean-up process. To demonstrate the differences among these methods, seven types of self-packed SPE cartridges were systematically compared in this study. The optimized conditions were determined for each type of cartridge and it was found that microcrystalline cellulose was the most appropriate SPE material for the purification of derivatized oligosaccharide. Normal phase HPLC analysis of the derivatized maltoheptaose was realized with a detection limit of 0.12 pmol (S N-1 = 3) and a recovery over 70%. With the optimized SPE method, relative quantification analysis of N-glycans from model glycoproteins were carried out accurately and over 40 N-glycans from human serum samples were determined regardless of the isomers. Due to the high stability and sensitivity, microcrystalline cellulose cartridge showed potential applications in glycomics analysis.	[Zhang, Qiwei; Li, Henghui; Feng, Xiaojun; Liu, Bi-Feng; Liu, Xin] Huazhong Univ Sci & Technol, Hubei Bioinformat & Mol Imaging Key Lab, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect,Dept Biomed Engn,Coll Li, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Feng, XJ (corresponding author), Huazhong Univ Sci & Technol, Hubei Bioinformat & Mol Imaging Key Lab, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect,Dept Biomed Engn,Coll Li, Wuhan 430074, Peoples R China.	xfeng@mail.hust.edu.cn; xliu@mail.hust.edu.cn	li, henghui/AAH-3203-2019		National Natural Science Foundation of China [20905027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors gratefully acknowledge the financial support from the National Natural Science Foundation of China (20905027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley WR, 2012, J PROTEOME RES, V11, P2282, DOI 10.1021/pr201070k; Alley WR, 2010, ANAL CHEM, V82, P5095, DOI 10.1021/ac100131e; Anumula KR, 1999, ANAL BIOCHEM, V275, P236, DOI 10.1006/abio.1999.4323; Anumula KR, 2006, ANAL BIOCHEM, V350, P1, DOI 10.1016/j.ab.2005.09.037; Anumula KR, 1998, GLYCOBIOLOGY, V8, P685, DOI 10.1093/glycob/8.7.685; Arnold JN, 2011, J PROTEOME RES, V10, P1755, DOI 10.1021/pr101034t; Bynum MA, 2009, ANAL CHEM, V81, P8818, DOI 10.1021/ac901326u; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Desantos-Garcia JL, 2011, ELECTROPHORESIS, V32, P3516, DOI 10.1002/elps.201100378; Gornik O, 2007, GLYCOBIOLOGY, V17, P1321, DOI 10.1093/glycob/cwm106; Gornik O, 2009, GLYCOBIOLOGY, V19, P1547, DOI 10.1093/glycob/cwp134; Guttman A, 1996, ELECTROPHORESIS, V17, P412, DOI 10.1002/elps.1150170221; Hu YL, 2012, ELECTROPHORESIS, V33, P1768, DOI 10.1002/elps.201100703; Kamoda S, 2006, J CHROMATOGR A, V1133, P332, DOI 10.1016/j.chroma.2006.08.028; Kang P, 2008, RAPID COMMUN MASS SP, V22, P721, DOI 10.1002/rcm.3395; Kita Y, 2007, MOL CELL PROTEOMICS, V6, P1437, DOI 10.1074/mcp.T600063-MCP200; Lattova E, 2013, MASS SPECTROM REV, V32, P366, DOI 10.1002/mas.21367; Liu X, 2008, PROTEOMICS, V8, P2849, DOI 10.1002/pmic.200701093; Liu X, 2010, ANAL CHEM, V82, P8300, DOI 10.1021/ac101831t; Mysling S, 2010, ANAL CHEM, V82, P5598, DOI 10.1021/ac100530w; Neville DCA, 2004, ANAL BIOCHEM, V331, P275, DOI 10.1016/j.ab.2004.03.051; Pabst M, 2009, ANAL BIOCHEM, V384, P263, DOI 10.1016/j.ab.2008.09.041; Prater BD, 2007, ANAL BIOCHEM, V369, P202, DOI 10.1016/j.ab.2007.07.011; Royle L, 2002, ANAL BIOCHEM, V304, P70, DOI 10.1006/abio.2002.5619; Royle L, 2008, ANAL BIOCHEM, V376, P1, DOI 10.1016/j.ab.2007.12.012; Ruhaak LR, 2010, ANAL BIOANAL CHEM, V397, P3457, DOI 10.1007/s00216-010-3532-z; Ruhaak LR, 2008, ANAL CHEM, V80, P6119, DOI 10.1021/ac800630x; Scott NE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M000031-MCP201; Selman MHJ, 2011, ANAL CHEM, V83, P2492, DOI 10.1021/ac1027116; Shental-Bechor D, 2009, CURR OPIN STRUC BIOL, V19, P524, DOI 10.1016/j.sbi.2009.07.002; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Volpi N, 2010, NAT PROTOC, V5, P993, DOI 10.1038/nprot.2010.48; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Yang HM, 2011, ANAL CHIM ACTA, V701, P45, DOI 10.1016/j.aca.2011.05.051; Yodoshi M, 2008, J CHROMATOGR A, V1203, P137, DOI 10.1016/j.chroma.2008.07.053	36	20	20	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94232	10.1371/journal.pone.0094232	http://dx.doi.org/10.1371/journal.pone.0094232			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705408	gold, Green Submitted, Green Published			2022-12-25	WOS:000334107500135
J	Chou, CP; Huang, NC; Jhuang, SJ; Pan, HB; Peng, NJ; Cheng, JT; Chen, CF; Chen, JJ; Chang, TH				Chou, Chen-Pin; Huang, Nan-Chieh; Jhuang, Shu-Jhen; Pan, Huay-Ben; Peng, Nan-Jing; Cheng, Jiin-Tsuey; Chen, Chian-Feng; Chen, Jih-Jung; Chang, Tsung-Hsien			Ubiquitin-Conjugating Enzyme UBE2C Is Highly Expressed in Breast Microcalcification Lesions	PLOS ONE			English	Article							UBCH10 EXPRESSION; CANCER; OVEREXPRESSION; RNA; PROGRESSION; CARCINOMAS; DIAGNOSIS; MARKERS; INHIBITION; GENE	Ubiquitin-conjugating enzyme 2C (UBE2C) contributes to ubiquitin-mediated proteasome degradation of cell cycle progression in breast cancer. Microcalcification (MC) is the most common mammographic feature of early breast cancer. In this study, we evaluated whether UBE2C could be a tumor marker of early breast cancer with MC found on screening mammography. UBE2C protein and mRNA expression were measured in breast core biopsy pairs of MC and adjacent non-MC breast tissue from each subject. Immunohistochemistry revealed UBE2C positivity in 69.4% of MC samples and 77.6% negativity in non-MC samples (p<0.0001). On RT-qPCR, 56.1% of malignant MC lesion samples showed high mRNA level of UBE2C and 80% of benign MC lesion samples showed a low level of UBE2C (p = 0.1766). We investigated the carcinogenic role of UBE2C in MCF-7 breast cancer cells with UBE2C knockdown; UBE2C knockdown downregulated cell proliferation and activated the cellular apoptosis pathway to inhibit cell colony formation. Furthermore, UBE2C expression was associated with that of carcinogenic genes human epidermal growth factor receptor type 2 (HER2), cellular c-Ki-ras2 proto-oncogene (KRAS), vascular endothelial growth factor (VEGF), CXC chemokine receptor 4 (CXCR4), C-C motif chemokine 5 (CCL5), neural precursor cell expressed, developmentally downregulated 9 (NEDD9) and Ras homolog family member C (RhoC). UBE2C may be a marker for diagnosis of nonpalpable breast lesions but not benign or malignant tumors in mammography core biopsies. Suppression of UBE2C may be a potential therapy target in breast cancer.	[Chou, Chen-Pin; Pan, Huay-Ben] Kaohsiung Vet Gen Hosp, Dept Radiol, Kaohsiung, Taiwan; [Chou, Chen-Pin; Pan, Huay-Ben] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Huang, Nan-Chieh] Kaohsiung Armed Forces Gen Hosp, Zuoying Branch, Dept Family Med, Kaohsiung, Taiwan; [Jhuang, Shu-Jhen] Kaohsiung Vet Gen Hosp, Dept Pathol & Lab Med, Kaohsiung, Taiwan; [Jhuang, Shu-Jhen; Chang, Tsung-Hsien] Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan; [Jhuang, Shu-Jhen; Cheng, Jiin-Tsuey] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan; [Pan, Huay-Ben] I Shou Univ, Dept Med Imaging & Radiol Sci, Kaohsiung, Taiwan; [Peng, Nan-Jing] Kaohsiung Vet Gen Hosp, Nucl Med Sect, Kaohsiung, Taiwan; [Chen, Chian-Feng] Natl Yang Ming Univ, VYM Genome Res Ctr, Taipei 112, Taiwan; [Chen, Jih-Jung; Chang, Tsung-Hsien] Tajen Univ, Grad Inst Pharmaceut Technol, Pingtung, Taiwan	Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; National Sun Yat Sen University; I Shou University; Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University	Chang, TH (corresponding author), Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan.	changth@vghks.gv.tw	Chang, Tsung-Hsien/AAG-9384-2019; chen, JJ/HGB-6029-2022	Chang, Tsung-Hsien/0000-0003-4806-7864; 	Kaohsiung Veterans General Hospital, Taiwan [VGHKS100-G02-4, VGHKS101-G02-3]; Zuoying Branch of Kaohsiung Armed Forces General Hospital, Taiwan [ZBH 103-10]	Kaohsiung Veterans General Hospital, Taiwan; Zuoying Branch of Kaohsiung Armed Forces General Hospital, Taiwan	This work was supported by grants of Kaohsiung Veterans General Hospital, Taiwan (VGHKS100-G02-4 and VGHKS101-G02-3, http://www.vghks.gov.tw/English/) and Zuoying Branch of Kaohsiung Armed Forces General Hospital, Taiwan (ZBH 103-10, http://806.mnd.gov.tw/english/index.php). The founders had no role in study design, data collection and analysis, preparation of the manuscript, decision to publish, or preparation of the manuscript.	Bavi P, 2011, AM J PATHOL, V178, P2109, DOI 10.1016/j.ajpath.2011.01.034; Berlingieri MT, 2007, EUR J CANCER, V43, P2729, DOI 10.1016/j.ejca.2007.09.003; Bernstein JR, 1996, SEMIN SURG ONCOL, V12, P290, DOI 10.1002/(SICI)1098-2388(199609/10)12:5<290::AID-SSU3>3.3.CO;2-2; Bureau of Health Promotion, 2009, ANN REP 2008 2009; Chen CC, 2006, ONCOLOGY-BASEL, V70, P438, DOI 10.1159/000098557; Cheng SH, 2000, BREAST CANCER RES TR, V63, P213, DOI 10.1023/A:1006468514396; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Chou CP, 2012, BREATS J, V18, P2; Donato G, 2008, CLIN NEUROPATHOL, V27, P219; Fujita T, 2008, CANC SCI; Fujita T, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-87; Giger ML, 2013, ANNU REV BIOMED ENG, V15, P327, DOI 10.1146/annurev-bioeng-071812-152416; Gondi CS, 2009, INT J ONCOL, V35, P851, DOI 10.3892/ijo_00000399; Guerriero E, 2010, CANCER CYTOPATHOL, V118, P157, DOI 10.1002/cncy.20046; Haka AS, 2002, CANCER RES, V62, P5375; Hofvind S, 2013, CANCER; Jancik S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/150960; Jiang L, 2010, J CANCER RES CLIN, V136, P211, DOI 10.1007/s00432-009-0651-z; Lakhani SR, 2002, J CLIN ONCOL, V20, P2310, DOI 10.1200/JCO.2002.09.023; Lambros MBK, 2007, HUM PATHOL, V38, P1105, DOI 10.1016/j.humpath.2007.04.011; Loussouarn D, 2009, BRIT J CANCER, V101, P166, DOI 10.1038/sj.bjc.6605122; Misek DE, 2011, J PROTEOMICS, V2011; Pallante P, 2005, BRIT J CANCER, V93, P464, DOI 10.1038/sj.bjc.6602721; Parris TZ, 2013, INT J CANC; Psyrri A, 2012, ANN ONCOL, V23, P1422, DOI 10.1093/annonc/mdr527; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Rawat A, 2013, CELL ONCOL DORDR; Richards MA, 1999, LANCET, V353, P1119, DOI 10.1016/S0140-6736(99)02143-1; Sabitha K, 2012, BIOINFORMATION, V8, P1047, DOI 10.6026/97320630081047; Shen ZH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-192; STOMPER PC, 1989, RADIOLOGY, V172, P235, DOI 10.1148/radiology.172.1.2544922; Summers MK, 2008, MOL CELL, V31, P544, DOI 10.1016/j.molcel.2008.07.014; Troncone G, 2009, HISTOPATHOLOGY, V54, P731, DOI 10.1111/j.1365-2559.2009.03296.x; van Ree JH, 2010, J CELL BIOL, V188, P83, DOI 10.1083/jcb.200906147; VOGELSTEIN B, 1994, CELL, V79, P1, DOI 10.1016/0092-8674(94)90393-X; Wagner KW, 2004, ONCOGENE, V23, P6621, DOI 10.1038/sj.onc.1207861; Wang HY, 2011, CANCER RES, V71, P4866, DOI 10.1158/0008-5472.CAN-10-4576; Wernicke AG, 2011, BREAST CANCER RES TR, V125, P893, DOI 10.1007/s10549-010-1167-6; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Yang G, 2004, J BIOL CHEM, V279, P4339, DOI 10.1074/jbc.M311153200	40	34	35	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93934	10.1371/journal.pone.0093934	http://dx.doi.org/10.1371/journal.pone.0093934			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699941	Green Published, gold, Green Submitted			2022-12-25	WOS:000334105000122
J	Huhn, C; Winter, C; Wolfsperger, T; Wuppenhorst, N; Smrdel, KS; Skuballa, J; Pfaffle, M; Petney, T; Silaghi, C; Dyachenko, V; Pantchev, N; Straubinger, RK; Schaarschmidt-Kiener, D; Ganter, M; Aardema, ML; von Loewenich, FD				Huhn, Christian; Winter, Christina; Wolfsperger, Timo; Wueppenhorst, Nicole; Smrdel, Katja Straek; Skuballa, Jasmin; Pfaefle, Miriam; Petney, Trevor; Silaghi, Cornelia; Dyachenko, Viktor; Pantchev, Nikola; Straubinger, Reinhard K.; Schaarschmidt-Kiener, Daniel; Ganter, Martin; Aardema, Matthew L.; von Loewenich, Friederike D.			Analysis of the Population Structure of Anaplasma phagocytophilum Using Multilocus Sequence Typing	PLOS ONE			English	Article							HUMAN GRANULOCYTIC EHRLICHIOSIS; HEDGEHOG ERINACEUS-EUROPAEUS; GENETIC-VARIANTS; INFECTION; IDENTIFICATION; DIVERSITY; STRAINS; AGENT; SHEEP; INFERENCE	Anaplasma phagocytophilum is a Gram-negative obligate intracellular bacterium that replicates in neutrophils. It is transmitted via tick-bite and causes febrile disease in humans and animals. Human granulocytic anaplasmosis is regarded as an emerging infectious disease in North America, Europe and Asia. However, although increasingly detected, it is still rare in Europe. Clinically apparent A. phagocytophilum infections in animals are mainly found in horses, dogs, cats, sheep and cattle. Evidence from cross-infection experiments that A. phagocytophilum isolates of distinct host origin are not uniformly infectious for heterologous hosts has led to several approaches of molecular strain characterization. Unfortunately, the results of these studies are not always easily comparable, because different gene regions and fragment lengths were investigated. Multilocus sequence typing is a widely accepted method for molecular characterization of bacteria. We here provide for the first time a universal typing method that is easily transferable between different laboratories. We validated our approach on an unprecedented large data set of almost 400 A. phagocytophilum strains from humans and animals mostly from Europe. The typability was 74% (284/383). One major clonal complex containing 177 strains was detected. However, 54% (49/90) of the sequence types were not part of a clonal complex indicating that the population structure of A. phagocytophilum is probably semiclonal. All strains from humans, dogs and horses from Europe belonged to the same clonal complex. As canine and equine granulocytic anaplasmosis occurs frequently in Europe, human granulocytic anaplasmosis is likely to be underdiagnosed in Europe. Further, wild boars and hedgehogs may serve as reservoir hosts of the disease in humans and domestic animals in Europe, because their strains belonged to the same clonal complex. In contrast, as they were only distantly related, roe deer, voles and shrews are unlikely to harbor A. phagocytophilum strains infectious for humans, domestic or farm animals.	[Huhn, Christian; Winter, Christina; Wolfsperger, Timo; Wueppenhorst, Nicole; von Loewenich, Friederike D.] Univ Freiburg, Inst Med Microbiol & Hyg, D-79106 Freiburg, Germany; [Smrdel, Katja Straek] Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia; [Skuballa, Jasmin; Pfaefle, Miriam; Petney, Trevor] Karlsruhe Inst Technol, Dept Ecol & Parasitol, D-76021 Karlsruhe, Germany; [Silaghi, Cornelia] Univ Munich, Munich, Germany; [Dyachenko, Viktor; Straubinger, Reinhard K.] Univ Munich, Inst Infect Dis & Zoonoses, Munich, Germany; [Pantchev, Nikola] IDEXX Vet Med Lab, Ludwigsburg, Germany; [Schaarschmidt-Kiener, Daniel] Lab Zugersee, Hunenberg, Switzerland; [Ganter, Martin] Univ Vet Med Hannover, Clin Swine & Small Ruminants, Hannover, Germany; [Aardema, Matthew L.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	University of Freiburg; University of Ljubljana; Helmholtz Association; Karlsruhe Institute of Technology; University of Munich; University of Munich; University of Veterinary Medicine Hannover, Foundation; Princeton University	von Loewenich, FD (corresponding author), Univ Freiburg, Inst Med Microbiol & Hyg, Hugstetter Str 55, D-79106 Freiburg, Germany.	friederike.loewenich@uniklinik-freiburg.de	Loewenich, Friederike/AAL-1587-2020; Straubinger, Reinhard K/D-1719-2010	Pfaffle, Miriam/0000-0001-6486-7701; Straubinger, Reinhard/0000-0001-8382-7182	German Research Foundation [LO1163/1-2]	German Research Foundation(German Research Foundation (DFG))	This study was supported by the German Research Foundation (http://www.dfg.de/), grant number LO1163/1-2. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Deborah A., 2012, Morbidity and Mortality Weekly Report, V59, P1; Barbet AF, 2013, PATHOGENS, V2, P544, DOI 10.3390/pathogens2030544; Blanco JR, 2002, CLIN MICROBIOL INFEC, V8, P763, DOI 10.1046/j.1469-0691.2002.00557.x; Bown KJ, 2007, J CLIN MICROBIOL, V45, P1771, DOI 10.1128/JCM.00365-07; Bown KJ, 2011, VECTOR-BORNE ZOONOT, V11, P947, DOI 10.1089/vbz.2010.0185; Bown KJ, 2009, EMERG INFECT DIS, V15, P1948, DOI 10.3201/eid1512.090178; Brown JR, 2001, SYST BIOL, V50, P497, DOI 10.1080/10635150117729; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Carlyon JA, 2005, CURR PROTOC MICROBIO, DOI [10.1002/9780471729259.mc03a02s00., DOI 10.1002/9780471729259.MC03A02S00]; Carrade DD, 2009, J VET INTERN MED, V23, P1129, DOI 10.1111/j.1939-1676.2009.0384.x; Carrico JA, 2006, J CLIN MICROBIOL, V44, P2524, DOI 10.1128/JCM.02536-05; Casey ANJ, 2004, MICROBIOL-SGM, V150, P727, DOI 10.1099/mic.0.26648-0; CHEN SM, 1994, J CLIN MICROBIOL, V32, P589, DOI 10.1128/JCM.32.3.589-595.1994; Cui F, 2013, AM J TROP MED HYG, V88, P510, DOI 10.4269/ajtmh.11-0760; Dumler JS, 2001, INT J SYST EVOL MICR, V51, P2145, DOI 10.1099/00207713-51-6-2145; Hotopp JCD, 2006, PLOS GENET, V2, P208, DOI 10.1371/journal.pgen.0020021; Dziegiel B, 2013, RES VET SCI, V95, P316, DOI 10.1016/j.rvsc.2013.05.010; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Feil EJ, 2004, NAT REV MICROBIOL, V2, P483, DOI 10.1038/nrmicro904; Feil EJ, 2001, ANNU REV MICROBIOL, V55, P561, DOI 10.1146/annurev.micro.55.1.561; Foley JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008265; Granquist EG, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-25; Hartelt K, 2008, PARASITOL RES, V103, pS109, DOI 10.1007/s00436-008-1059-4; Hartwig V, 2014, TICKS TICK BORNE DIS; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Henniger T, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-38; Herndon DR, 2013, INFECT IMMUN, V81, P1852, DOI 10.1128/IAI.00199-13; Ismail N, 2010, CLIN LAB MED, V30, P261, DOI 10.1016/j.cll.2009.10.004; Jakobsen IB, 1996, COMPUT APPL BIOSCI, V12, P291; Jin HT, 2012, VECTOR-BORNE ZOONOT, V12, P269, DOI 10.1089/vbz.2011.0753; Levin BR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000601; Li HY, 2011, INT J INFECT DIS, V15, pE859, DOI 10.1016/j.ijid.2011.09.008; Little SE, 2010, VET CLIN N AM-SMALL, V40, P1121, DOI 10.1016/j.cvsm.2010.07.004; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Majazki J, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-235; Massung RF, 1998, J CLIN MICROBIOL, V36, P1090, DOI 10.1128/JCM.36.4.1090-1095.1998; Michalik J, 2012, EMERG INFECT DIS, V18, P998, DOI 10.3201/eid1806.110997; NEI M, 1986, MOL BIOL EVOL, V3, P418; Ogden NH, 1998, MED VET ENTOMOL, V12, P423, DOI 10.1046/j.1365-2915.1998.00133.x; Pfaffle M, 2011, EXP APPL ACAROL, V54, P151, DOI 10.1007/s10493-011-9432-x; Poitout FM, 2005, J CLIN MICROBIOL, V43, P796, DOI 10.1128/JCM.43.2.796-801.2005; Pritchard JK, 2000, GENETICS, V155, P945; Rar V, 2011, INFECT GENET EVOL, V11, P1842, DOI 10.1016/j.meegid.2011.09.019; Rikihisa Y, 2010, CURR OPIN MICROBIOL, V13, P59, DOI 10.1016/j.mib.2009.12.008; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rymaszewska A, 2008, EUR J CLIN MICROBIOL, V27, P1025, DOI 10.1007/s10096-008-0539-x; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Scharf W, 2011, J CLIN MICROBIOL, V49, P790, DOI 10.1128/JCM.02051-10; Severiano A, 2011, J CLIN MICROBIOL, V49, P3997, DOI 10.1128/JCM.00624-11; Silaghi C, 2012, TICKS TICK-BORNE DIS, V3, P49, DOI 10.1016/j.ttbdis.2011.11.005; Skuballa J, 2010, VECTOR-BORNE ZOONOT, V10, P1055, DOI 10.1089/vbz.2009.0150; SMITH JM, 1992, J MOL EVOL, V34, P126; Smrdel KS, 2009, CLIN MICROBIOL INFEC, V15, P50, DOI 10.1111/j.1469-0691.2008.02174.x; Stafford KC, 1999, J CLIN MICROBIOL, V37, P2887, DOI 10.1128/JCM.37.9.2887-2892.1999; Strle F, 2004, INT J MED MICROBIOL, V293, P27, DOI 10.1016/S1433-1128(04)80006-8; Stuen S, 2008, VET REC, V163, P338, DOI 10.1136/vr.163.11.338; Stuen S, 2002, J CLIN MICROBIOL, V40, P3192, DOI 10.1128/JCM.40.9.3192-3197.2002; Stuen S, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00031; Stuen S, 2013, TICKS TICK-BORNE DIS, V4, P197, DOI 10.1016/j.ttbdis.2012.11.014; Stuen S, 2009, ACTA VET SCAND, V51, DOI 10.1186/1751-0147-51-41; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Telford SR, 1996, P NATL ACAD SCI USA, V93, P6209, DOI 10.1073/pnas.93.12.6209; Vichova B, 2013, INFECT GENET EVOL; von Loewenich FD, 2003, J CLIN MICROBIOL, V41, P5033, DOI 10.1128/JCM.41.11.5033-5040.2003; Woldehiwet Z, 2010, VET PARASITOL, V167, P108, DOI 10.1016/j.vetpar.2009.09.013; Xu BL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002369; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zeman P, 2008, INT J MED MICROBIOL, V298, P203, DOI 10.1016/j.ijmm.2008.03.003; Zhang LJ, 2008, JAMA-J AM MED ASSOC, V300, P2263, DOI 10.1001/jama.2008.626; Zhang LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057155	73	60	64	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93725	10.1371/journal.pone.0093725	http://dx.doi.org/10.1371/journal.pone.0093725			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699849	Green Submitted, Green Published, gold			2022-12-25	WOS:000334105000097
J	Santiago, P; Grinsztejn, B; Friedman, RK; Cunha, CB; Coelho, LE; Luz, PM; de Oliveira, AV; Moreira, RI; Cardoso, SW; Veloso, VG; Suassuna, JHR				Santiago, Patricia; Grinsztejn, Beatriz; Friedman, Ruth Khalili; Cunha, Cynthia B.; Coelho, Lara Esteves; Luz, Paula Mendes; de Oliveira, Albanita Viana; Moreira, Ronaldo Ismerio; Cardoso, Sandra W.; Veloso, Valdilea G.; Rocco Suassuna, Jose H.			Screening for Decreased Glomerular Filtration Rate and Associated Risk Factors in a Cohort of HIV-Infected Patients in a Middle-Income Country	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CHRONIC-RENAL-FAILURE; ANTIRETROVIRAL THERAPY; CARDIOVASCULAR MORTALITY; ESTIMATING EQUATIONS; ALL-CAUSE; PREVALENCE; PROGRESSION; POPULATION; ADULTS	With the introduction of combined active antiretroviral therapy and the improved survival of HIV-infected patients, degenerative diseases and drug toxicity have emerged as long-term concerns. We studied the prevalence of decreased glomerular filtration rate (GFR) and associated risk factors in a cohort of HIV-infected patients from a middle-income country. Our cross-sectional study included all adult patients who attended an urban outpatient clinic in 2008. GFR was estimated using the CKD-EPI equation. The prevalence ratio (PR) of decreased GFR (defined as < 60 mL/min/1.73 m(2)) was estimated using generalizing linear models assuming a Poisson distribution. We analyzed data from 1,970 patients, of which 82.9% had been exposed to ART. A total of 249 patients (12.6%) had a GFR between 60 and 89 mL/min/1.73 m(2), 3.1% had a GFR between 30 and 59, 0.3% had a GFR between 15 and 29, and 0.4% had a GFR < 15. Decreased GFR was found in only 74 patients (3.8%). In the multivariate regression model, the factors that were independently associated with a GFR below 60 mL/min/1.73 m(2) were as follows: age >= 50 years (PR=3.4; 95% CI: 1.7-6.8), diabetes (PR=2.0; 95% CI: 1.2-3.4), hypertension (PR=2.0; 95% CI: 1.3-3.2), current CD4+ cell count < 350 cells/mm3 (PR=2.1; 95% CI: 1.3-3.3), past exposure to tenofovir (PR=4.7; 95% CI: 2.3-9.4) and past exposure to indinavir (PR=1.7; 95% CI: 1.0-2.8). As in high-income countries, CKD was the predominant form of kidney involvement among HIV-infected individuals in our setting. The risk factors associated with decreased glomerular filtration were broad and included virus-related factors as well as degenerative and nephrotoxic factors. Despite the potential for nephrotoxicity associated with some antiretroviral drugs, in the short-term, advanced chronic renal disease remains very rare.	[Santiago, Patricia; Grinsztejn, Beatriz; Friedman, Ruth Khalili; Cunha, Cynthia B.; Coelho, Lara Esteves; Luz, Paula Mendes; Moreira, Ronaldo Ismerio; Cardoso, Sandra W.; Veloso, Valdilea G.] Fundaco Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, STD AIDS Clin Res Lab, Rio De Janeiro, Brazil; [Santiago, Patricia; Rocco Suassuna, Jose H.] Univ Estado Rio de Janeiro, Fac Ciencias Med, Hosp Univ Pedro Ernesto, Clin & Acad Unit Nephrol, BR-20550011 Rio De Janeiro, Brazil; [de Oliveira, Albanita Viana] Univ Estado Rio de Janeiro, Fac Ciencias Med, Dept Pathol, BR-20550011 Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro	Suassuna, JHR (corresponding author), Univ Estado Rio de Janeiro, Fac Ciencias Med, Hosp Univ Pedro Ernesto, Clin & Acad Unit Nephrol, BR-20550011 Rio De Janeiro, Brazil.	jsuassuna@alternex.com.br	Cardoso, Sandra W/D-7965-2015; Suassuna, José/N-5074-2014	Cardoso, Sandra W/0000-0001-5230-0003; Suassuna, José/0000-0002-4720-5391; Luz, Paula/0000-0001-9746-719X				Alves TP, 2010, CLIN J AM SOC NEPHRO, V5, P2269, DOI 10.2215/CJN.00520110; Astor BC, 2008, AM J EPIDEMIOL, V167, P1226, DOI 10.1093/aje/kwn033; Atta MG, 2006, NEPHROL DIAL TRANSPL, V21, P2809, DOI 10.1093/ndt/gfl337; Atta MG, 2008, SEMIN NEPHROL, V28, P563, DOI 10.1016/j.semnephrol.2008.08.009; Campbell LJ, 2009, HIV MED, V10, P329, DOI 10.1111/j.1468-1293.2008.00691.x; Choi AI, 2007, J AM SOC NEPHROL, V18, P2968, DOI 10.1681/ASN.2007040402; Colson AW, 2010, ACTA CLIN BELG, V65, P392, DOI 10.1179/acb.2010.65.6.004; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Crum-Cianflone N, 2010, AIDS PATIENT CARE ST, V24, P353, DOI 10.1089/apc.2009.0326; DAVIES DF, 1950, J CLIN INVEST, V29, P496, DOI 10.1172/JCI102286; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Deti EK, 2010, HIV MED, V11, P308, DOI 10.1111/j.1468-1293.2009.00780.x; Di Angelantonio E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4986; Earley A, 2012, ANN INTERN MED, V156, P785, DOI 10.7326/0003-4819-156-11-201203200-00391; Effros RB, 2008, CLIN INFECT DIS, V47, P542, DOI 10.1086/590150; Fernando SK, 2008, AM J MED SCI, V335, P89, DOI 10.1097/MAJ.0b013e31812e6b34; Flandre P, 2011, CLIN J AM SOC NEPHRO; Gardner LI, 2003, JAIDS-J ACQ IMM DEF, V32, P203, DOI 10.1097/00126334-200302010-00013; Giles PD, 2007, BMJ-BRIT MED J, V334, P1198, DOI 10.1136/bmj.39226.400694.80; Glassock RJ, 2008, CLIN J AM SOC NEPHRO, V3, P1563, DOI 10.2215/CJN.00960208; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Gupta SK, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-31; Gupta SK, 2005, CLIN INFECT DIS, V40, P1559, DOI 10.1086/430257; Hallan SI, 2006, BMJ-BRIT MED J, V333, P1047, DOI 10.1136/bmj.39001.657755.BE; Hasse B, 2011, CLIN INFECT DIS, V53, P1130, DOI 10.1093/cid/cir626; Holmberg SD, 2008, SCI ERRORS CONTROVER, P1; Ibrahim F, 2012, AM J KIDNEY DIS, V60, P539, DOI 10.1053/j.ajkd.2012.03.006; Inker LA, 2012, JAIDS-J ACQ IMM DEF, V61, P302, DOI 10.1097/QAI.0b013e31826a6c4f; Jaar BG, 2008, CLIN J AM SOC NEPHRO, V3, P601, DOI 10.2215/CJN.02540607; Kalyesubula R, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/562790; Lucas GM, 2008, J INFECT DIS, V197, P1548, DOI 10.1086/587994; Lucas GM, 2010, JAIDS-J ACQ IMM DEF, V55, P491, DOI 10.1097/QAI.0b013e3181e8d5a8; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Matsushita K, 2010, AM J KIDNEY DIS, V55, P648, DOI 10.1053/j.ajkd.2009.12.016; Medapalli RK, 2012, JAIDS-J ACQ IMM DEF, V60, P393, DOI 10.1097/QAI.0b013e31825b70d9; Mocroft A, 2007, AIDS, V21, P1119, DOI 10.1097/QAD.0b013e3280f774ee; Mocroft A, 2010, AIDS, V24, P1667, DOI 10.1097/QAD.0b013e328339fe53; Mulenga LB, 2008, AIDS, V22, P1821, DOI 10.1097/QAD.0b013e328307a051; Myers Jeffrey D, 2009, JAAPA, V22, P20; O'Hare AM, 2007, J AM SOC NEPHROL, V18, P2758, DOI 10.1681/ASN.2007040422; Overton ET, 2009, HIV MED, V10, P343, DOI 10.1111/j.1468-1293.2009.00693.x; Phair J, 2011, CURR OPIN HIV AIDS, V6, P285, DOI 10.1097/COH.0b013e3283476bc3; Ramos AN, 2011, AIDS PATIENT CARE ST, V25, P713, DOI 10.1089/apc.2011.0044; Reid A, 2008, CLIN INFECT DIS, V46, P1271, DOI 10.1086/533468; Roe J, 2008, CLIN INFECT DIS, V47, P242, DOI 10.1086/589296; Ryom L, 2013, J INFECT DIS, V207, P1359, DOI 10.1093/infdis/jit043; Scherzer R, 2012, AIDS, V26, P867, DOI 10.1097/QAD.0b013e328351f68f; Scialla JJ, 2007, AIDS, V21, P263, DOI 10.1097/QAD.0b013e3280119592; Sorli ML, 2008, J INT AIDS SOC, V11, pP130; Szczech LA, 2004, CLIN INFECT DIS, V39, P1199, DOI 10.1086/424013; US Renal Data System, 2011, USRDS 2011 ANN DAT R; Van Biesen W, 2007, EUR HEART J, V28, P478, DOI 10.1093/eurheartj/ehl455; Wever K, 2010, J ACQ IMMUN DEF SYND, V00, P1; White SL, 2010, AM J KIDNEY DIS, V55, P660, DOI 10.1053/j.ajkd.2009.12.011; WHO' UNAIDS and UNICEF Global HIV/AIDS response, WHO UNAIDS UNIEF GLO; Wyatt CM, 2007, AIDS, V21, P2101, DOI 10.1097/QAD.0b013e3282ef1bb4; Wyatt CM, 2006, AIDS, V20, P561, DOI 10.1097/01.aids.0000210610.52836.07; Yahalom G, 2013, EUROPEAN J PREVENTIV	59	21	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93748	10.1371/journal.pone.0093748	http://dx.doi.org/10.1371/journal.pone.0093748			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699873	Green Published, gold, Green Submitted			2022-12-25	WOS:000334105000099
J	Dygalo, NN; Shemenkova, TV; Kalinina, TS; Shishkina, GT				Dygalo, Nikolay N.; Shemenkova, Tatjana V.; Kalinina, Tatjana S.; Shishkina, Galina T.			A Critical Point of Male Gonad Development: Neuroendocrine Correlates of Accelerated Testicular Growth in Rats during Early Life	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; FOLLICLE-STIMULATING-HORMONE; INHIBIN-B LEVELS; POSTNATAL-DEVELOPMENT; LUTEINIZING-HORMONE; GENE-EXPRESSION; NEONATAL-RATS; GNRH NEURONS; SIGNALING PATHWAYS; SERTOLI-CELLS	Testis growth during early life is important for future male fertility and shows acceleration during the first months of life in humans. This acceleration coincides with the peak in gonadotropic hormones in the blood, while the role of hypothalamic factors remains vague. Using neonatal rats to assess this issue, we found that day 9 of life is likely critical for testis development in rats. Before this day, testicular growth was proportional to body weight gain, but after that the testes showed accelerated growth. Hypothalamic kisspeptin and its receptor mRNA levels begin to elevate 2 days later, at day 11. A significant increase in the mRNA levels for gonadotropin-releasing hormone ( GnRH) receptors in the hypothalamus between days 5 and 7 was followed by a 3-fold decrease in GnRH mRNA levels in this brain region during the next 2 days. Starting from day 9, hypothalamic GnRH mRNA levels increased significantly and positively correlated with accelerated testicular growth. Triptorelin, an agonist of GnRH, at a dose that had no effect on testicular growth during "proportional" period, increased testis weights during the period of accelerated growth. The insensitivity of testicular growth to GnRH during "proportional" period was supported by inability of a 2.5-fold siRNA knockdown of GnRH expression in the hypothalamus of the 7-day-old animals to produce any effect on their testis weights. GnRH receptor blockade with cetrorelix was also without effect on testis weights during "proportional" period but the same doses of this GnRH antagonist significantly inhibited "accelerated" testicular growth. GnRH receptor mRNA levels in the pituitary as well as plasma LH concentrations were higher during "accelerated" period of testicular growth than during "proportional" period. In general, our data defined two distinct periods in rat testicular development that are primarily characterized by different responses to GnRH signaling.	[Dygalo, Nikolay N.; Kalinina, Tatjana S.; Shishkina, Galina T.] Russian Acad Sci, Inst Cytol & Genet, Lab Funct Neurogen, Novosibirsk 630090, Russia; [Dygalo, Nikolay N.; Shemenkova, Tatjana V.; Kalinina, Tatjana S.] Novosibirsk State Univ, Dept Physiol, Novosibirsk 630090, Russia	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Novosibirsk State University	Dygalo, NN (corresponding author), Russian Acad Sci, Inst Cytol & Genet, Lab Funct Neurogen, Novosibirsk 630090, Russia.	dygalo@bionet.nsc.ru	Kalinina, Tatyana/R-8412-2016	Kalinina, Tatyana/0000-0002-2575-4621; Dygalo, Nikolay/0000-0002-0638-1794	Russian Foundation for Basic Research [N 11-04-00375]; RAS [MCB 6.20]; FCP [8060]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); RAS(Russian Academy of SciencesRegione Sardegna); FCP	This work was supported by Russian Foundation for Basic Research grant N 11-04-00375, RAS Program MCB 6.20, FCP No. 8060. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKLAND JF, 1991, BIOL REPROD, V45, P295, DOI 10.1095/biolreprod45.2.295; Andersson AM, 1998, J CLIN ENDOCR METAB, V83, P675, DOI 10.1210/jc.83.2.675; AUBERT ML, 1985, ENDOCRINOLOGY, V116, P1565, DOI 10.1210/endo-116-4-1565; Barakat B, 2008, REPRODUCTION, V136, P345, DOI 10.1530/REP-08-0140; Bhattacharya I, 2012, AM J PHYSIOL-ENDOC M, V303, pE886, DOI 10.1152/ajpendo.00293.2012; Buzzard JJ, 2004, ENDOCRINOLOGY, V145, P3532, DOI 10.1210/en.2003-1036; Campbell RE, 2009, P NATL ACAD SCI USA, V106, P10835, DOI 10.1073/pnas.0903463106; Castellano JM, 2006, MOL CELL ENDOCRINOL, V257-8, P75, DOI 10.1016/j.mce.2006.07.002; Chan YM, 2009, J NEUROENDOCRINOL, V21, P1015, DOI 10.1111/j.1365-2826.2009.01926.x; Chen PL, 2009, J NEUROSCI, V29, P9809, DOI 10.1523/JNEUROSCI.2509-09.2009; Ciechanowska M, 2010, REPROD BIOL, V10, P85, DOI 10.1016/S1642-431X(12)60054-0; Clarkson J, 2012, J NEUROENDOCRINOL, V24, P907, DOI 10.1111/j.1365-2826.2012.02294.x; Constantin S, 2009, ENDOCRINOLOGY, V150, P3221, DOI 10.1210/en.2008-1711; Cottrell EC, 2006, ENDOCRINOLOGY, V147, P3652, DOI 10.1210/en.2006-0296; Danneman PJ, 1997, LAB ANIM SCI, V47, P386; Dygalo NN, 2010, NEUROSCI LETT, V486, P224, DOI 10.1016/j.neulet.2010.09.058; Ehmcke J, 2006, HUM REPROD UPDATE, V12, P275, DOI 10.1093/humupd/dmk001; Glidewell-Kenney C, 2008, ENDOCRINOLOGY, V149, P4168, DOI 10.1210/en.2007-1807; Gore AC, 1999, ENDOCRINOLOGY, V140, P2280, DOI 10.1210/en.140.5.2280; Grigorova M, 2013, ANDROLOGY-US, V1, P293, DOI 10.1111/j.2047-2927.2012.00028.x; Grigorova M, 2011, J CLIN ENDOCR METAB, V96, pE1534, DOI 10.1210/jc.2011-0632; Grumbach MM, 2005, J CLIN ENDOCR METAB, V90, P3122, DOI 10.1210/jc.2004-2465; HABERT R, 1993, ACTA ENDOCRINOL-COP, V128, P268, DOI 10.1530/acta.0.1280268; Hadziselimovic F, 2005, J UROLOGY, V174, P1536, DOI 10.1097/01.ju.0000181506.97839.b0; Han SK, 2010, J NEUROENDOCRINOL, V22, P188, DOI 10.1111/j.1365-2826.2009.01950.x; KERR JB, 1988, DEVELOPMENT, V103, P535; KETELSLEGERS JM, 1978, ENDOCRINOLOGY, V103, P212, DOI 10.1210/endo-103-1-212; Kuijper EAM, 2008, HUM REPROD, V23, P792, DOI 10.1093/humrep/den021; Kuiri-Hanninen T, 2011, J CLIN ENDOCR METAB, V96, P98, DOI 10.1210/jc.2010-1359; LALAU JD, 1990, NEUROENDOCRINOLOGY, V51, P284, DOI 10.1159/000125351; LEE VWK, 1975, J REPROD FERTIL, V42, P121, DOI 10.1530/jrf.0.0420121; Lindzey J, 1998, ENDOCRINOLOGY, V139, P4092, DOI 10.1210/en.139.10.4092; MACLUSKY NJ, 1979, BRAIN RES, V178, P143, DOI 10.1016/0006-8993(79)90094-5; Main KM, 2006, J CLIN ENDOCR METAB, V91, P2732, DOI 10.1210/jc.2005-2443; Migrenne S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053257; Navarro VM, 2004, ENDOCRINOLOGY, V145, P4565, DOI 10.1210/en.2004-0413; NEMESKERI A, 1986, EXP CLIN ENDOCRINOL, V88, P275, DOI 10.1055/s-0029-1210607; Nowak FV, 1999, J NEUROENDOCRINOL, V11, P951; O'Shaughnessy PJ, 2009, MOL CELL ENDOCRINOL, V306, P2, DOI 10.1016/j.mce.2008.11.005; O'Shaughnessy PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035136; O'Shaughnessy PJ, 1998, ENDOCRINOLOGY, V139, P1141, DOI 10.1210/en.139.3.1141; PAKARINEN PA, 1992, ACTA ENDOCRINOL-COP, V127, P454, DOI 10.1530/acta.0.1270454; Petersen C, 2006, HORM RES, V66, P153, DOI 10.1159/000094142; Pinilla L, 2012, PHYSIOL REV, V92, P1235, DOI 10.1152/physrev.00037.2010; Poling MC, 2012, ENDOCRINOLOGY, V153, P782, DOI 10.1210/en.2011-1838; SALISBURY RL, 1982, NEUROENDOCRINOLOGY, V35, P265, DOI 10.1159/000123392; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; Shishkina GT, 2004, NEUROSCIENCE, V129, P521, DOI 10.1016/j.neuroscience.2004.08.015; SHISHKINA GT, 1994, EXPERIENTIA, V50, P721, DOI 10.1007/BF01919370; Stukenborg JB, 2010, SEX DEV, V4, P199, DOI 10.1159/000317090; Walker DM, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102798; Walker DM, 2009, ENDOCRINOLOGY, V150, P2308, DOI 10.1210/en.2008-1396; Wu XF, 2010, REPRODUCTION, V140, P113, DOI 10.1530/REP-09-0349; Xu C, 2004, ENDOCRINOLOGY, V145, P728, DOI 10.1210/en.2003-0562; Zapatero-Caballero H, 2003, BIOL REPROD, V68, P1764, DOI 10.1095/biolreprod.102.008821; Zhang FP, 2004, ENDOCRINOLOGY, V145, P1453, DOI 10.1210/en.2003-1049; ZHENGWEI Y, 1990, BIOL REPROD, V43, P629, DOI 10.1095/biolreprod43.4.629	57	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93007	10.1371/journal.pone.0093007	http://dx.doi.org/10.1371/journal.pone.0093007			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695464	Green Published, Green Submitted, gold			2022-12-25	WOS:000334103000033
J	Comish, PB; Drumond, AL; Kinnell, HL; Anderson, RA; Matin, A; Meistrich, ML; Shetty, G				Comish, Paul B.; Drumond, Ana Luiza; Kinnell, Hazel L.; Anderson, Richard A.; Matin, Angabin; Meistrich, Marvin L.; Shetty, Gunapala			Fetal Cyclophosphamide Exposure Induces Testicular Cancer and Reduced Spermatogenesis and Ovarian Follicle Numbers in Mice	PLOS ONE			English	Article							CELL TUMOR SUSCEPTIBILITY; ANTI-MULLERIAN HORMONE; PRIMORDIAL GERM-CELLS; DNA-DAMAGE; MOUSE; CHEMOTHERAPY; RADIOSENSITIVITY; MALIGNANCIES; MECHANISMS; PREGNANCY	Exposure to radiation during fetal development induces testicular germ cell tumors (TGCT) and reduces spermatogenesis in mice. However, whether DNA damaging chemotherapeutic agents elicit these effects in mice remains unclear. Among such agents, cyclophosphamide (CP) is currently used to treat breast cancer in pregnant women, and the effects of fetal exposure to this drug manifested in the offspring must be better understood to offer such patients suitable counseling. The present study was designed to determine whether fetal exposure to CP induces testicular cancer and/or gonadal toxicity in 129 and in 129.MOLF congenic (L1) mice. Exposure to CP on embryonic days 10.5 and 11.5 dramatically increased TGCT incidence to 28% in offspring of 129 mice (control value, 2%) and to 80% in the male offspring of L1 (control value 33%). These increases are similar to those observed in both lines of mice by radiation. In utero exposure to CP also significantly reduced testis weights at 4 weeks of age to similar to 70% of control and induced atrophic seminiferous tubules in similar to 30% of the testes. When the in utero CP-exposed 129 mice reached adulthood, there were significant reductions in testicular and epididymal sperm counts to 62% and 70%, respectively, of controls. In female offspring, CP caused the loss of 77% of primordial follicles and increased follicle growth activation. The results indicate that i) DNA damage is a common mechanism leading to induction of testicular cancer, ii) increased induction of testis cancer by external agents is proportional to the spontaneous incidence due to inherent genetic susceptibility, and iii) children exposed to radiation or DNA damaging chemotherapeutic agents in utero may have increased risks of developing testis cancer and having reduced spermatogenic potential or diminished reproductive lifespan.	[Comish, Paul B.; Drumond, Ana Luiza; Meistrich, Marvin L.; Shetty, Gunapala] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Matin, Angabin] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Kinnell, Hazel L.; Anderson, Richard A.] Univ Edinburgh, MRC, Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Edinburgh	Shetty, G (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA.	sgunapal@mdanderson.org	Drumond-Bock, Ana Luiza/A-2152-2019	Drumond-Bock, Ana Luiza/0000-0003-3555-7741; Shetty, Gunapala/0000-0001-5786-0667	Florence M. Thomas Professorship in Cancer Research; Cancer Center Support Grant from the National Institutes of Health and Medical Reasearch Council [G1100357]; MRC [G1100357, G1002033, G1002118] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; Medical Research Council [G1002033, G1002118, G1100357] Funding Source: researchfish	Florence M. Thomas Professorship in Cancer Research; Cancer Center Support Grant from the National Institutes of Health and Medical Reasearch Council; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Florence M. Thomas Professorship in Cancer Research to MLM, Cancer Center Support Grant P30CA016672 from the National Institutes of Health and Medical Reasearch Council grant G1100357 to RAA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Amant F, 2012, LANCET ONCOL, V13, P256, DOI 10.1016/S1470-2045(11)70363-1; Arora P, 2011, OBSTET GYNAECOL, V13, P67, DOI 10.1576/toag.13.2.67.27648; Aviles A, 2001, CLIN LYMPHOMA, V2, P173, DOI 10.3816/CLM.2001.n.023; BEAUMONT HM, 1960, INT J RADIAT BIOL RE, V2, P247, DOI 10.1080/09553006014550291; BEAUMONT HM, 1961, INT J RADIAT BIOL RE, V3, P59, DOI 10.1080/09553006114550071; BOFFETTA P, 1994, ACTA ONCOL, V33, P591, DOI 10.3109/02841869409121767; Brougham MFH, 2012, J CLIN ENDOCR METAB, V97, P2059, DOI 10.1210/jc.2011-3180; Cardonick E, 2010, AM J CLIN ONCOL-CANC, V33, P221, DOI 10.1097/COC.0b013e3181a44ca9; CARLSEN E, 1992, BRIT MED J, V305, P609, DOI 10.1136/bmj.305.6854.609; Chia VM, 2010, CANCER EPIDEM BIOMAR, V19, P1151, DOI 10.1158/1055-9965.EPI-10-0031; Chung CC, 2013, NAT GENET, V45, P680, DOI 10.1038/ng.2634; Da Silva-Buttkus P, 2009, P NATL ACAD SCI USA, V106, P456, DOI 10.1073/pnas.0810012106; Drumond AL, 2011, REPROD TOXICOL, V32, P395, DOI 10.1016/j.reprotox.2011.09.010; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; Hahn KME, 2006, CANCER, V107, P1219, DOI 10.1002/cncr.22081; Heaney JD, 2008, CANCER RES, V68, P5193, DOI 10.1158/0008-5472.CAN-08-0779; HEMSWORTH BN, 1963, J REPROD FERTIL, V6, P229; HIRSHFIELD AN, 1994, BIOL REPROD, V50, P421, DOI 10.1095/biolreprod50.2.421; Howlader N, 2013, SEER CANC STAT REV 1; Kanetsky PA, 2009, NAT GENET, V41, P811, DOI 10.1038/ng.393; Kerr JR, 2005, PHARMACOTHERAPY, V25, P438, DOI 10.1592/phco.25.3.438.59291; Krentz AD, 2009, P NATL ACAD SCI USA, V106, P22323, DOI 10.1073/pnas.0905431106; LU CC, 1979, CANCER RES, V39, P3575; McGlynn KA, 2009, CANCER RES, V69, P1901, DOI 10.1158/0008-5472.CAN-08-3935; Meistrich M.L., 1993, METHODS REPROD TOXIC, V3, P106; Mitchell RT, 2008, HUM REPROD, V23, P2755, DOI 10.1093/humrep/den295; Morgan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070117; PILLANS PI, 1989, CARCINOGENESIS, V10, P83, DOI 10.1093/carcin/10.1.83; PLOWCHALK DR, 1992, REPROD TOXICOL, V6, P411, DOI 10.1016/0890-6238(92)90004-D; Ray B, 2012, BRATISL MED J, V113, P637, DOI 10.4149/BLL_2012_144; Shah MN, 2007, INT J ANDROL, V30, P206, DOI 10.1111/j.1365-2605.2007.00795.x; Shetty G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032064; Siddik ZH, 2002, CANC HDB, P1295; Sievers S, 2005, GENE CHROMOSOME CANC, V44, P256, DOI 10.1002/gcc.20237; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; STEVENS LC, 1966, J NATL CANCER I, V37, P859; Surani MA, 2010, COLD SH Q B, V75, P211, DOI 10.1101/sqb.2010.75.010; Tang MS, 2011, MOL NUTR FOOD RES, V55, P1291, DOI 10.1002/mnfr.201100148; Turnbull C, 2010, NAT GENET, V42, P604, DOI 10.1038/ng.607; Ustaalioglu BBO, 2010, INT J GYNECOL CANCER, V20, P698, DOI 10.1111/IGC.0b013e3181daaf3e; Van Calsteren K, 2010, GYNECOL ONCOL, V119, P594, DOI 10.1016/j.ygyno.2010.08.019; Van der Zwan YG, 2013, INT J DEV BIOL, V57, P299, DOI 10.1387/ijdb.130017ll; VERGOUWEN RPFA, 1995, RADIAT RES, V141, P66, DOI 10.2307/3579091; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/S0079-6603(08)60611-X; WATSON AR, 1985, BRIT MED J, V291, P1457, DOI 10.1136/bmj.291.6507.1457; Zhu R, 2007, MAMM GENOME, V18, P584, DOI 10.1007/s00335-007-9036-2	47	27	27	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93311	10.1371/journal.pone.0093311	http://dx.doi.org/10.1371/journal.pone.0093311			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691397	Green Published, Green Submitted, gold			2022-12-25	WOS:000334101100064
J	Hamada, K; Osaka, M; Yoshida, M				Hamada, Katsuhiko; Osaka, Mizuko; Yoshida, Masayuki			Cell Density Impacts Epigenetic Regulation of Cytokine-Induced E-Selectin Gene Expression in Vascular Endothelium	PLOS ONE			English	Article							NF-KAPPA-B; ADHESION MOLECULES; NITRIC-OXIDE; ACTIVATION; CHROMATIN; ATHEROSCLEROSIS; TRANSCRIPTION; RESOLUTION; PROMOTER; REQUIRES	Growing evidence suggests that the phenotype of endothelial cells during angiogenesis differs from that of quiescent endothelial cells, although little is known regarding the difference in the susceptibility to inflammation between both the conditions. Here, we assessed the inflammatory response in sparse and confluent endothelial cell monolayers. To obtain sparse and confluent monolayers, human umbilical vein endothelial cells were seeded at a density of 7.3x10(3) cells/cm(2) and 29.2x10(3) cells/cm(2), respectively, followed by culturing for 36 h and stimulation with tumor necrosis factor alpha. The levels of tumor necrosis factor alpha-induced E-selectin protein and mRNA expression were higher in the confluent monolayer than in the sparse monolayer. The phosphorylation of c-jun N-terminal kinase and p38 mitogen-activated protein kinase or nuclear factor-kappa B activation was not involved in this phenomenon. A chromatin immunoprecipitation assay of the E-selectin promoter using an anti-acetyl-histone H3 antibody showed that the E-selectin promoter was highly and specifically acetylated in the confluent monolayer after tumor necrosis factor alpha activation. Furthermore, chromatin accessibility real-time PCR showed that the chromatin accessibility at the E-selectin promoter was higher in the confluent monolayer than in the sparse monolayer. Our data suggest that the inflammatory response may change during blood vessel maturation via epigenetic mechanisms that affect the accessibility of chromatin.	[Hamada, Katsuhiko; Osaka, Mizuko; Yoshida, Masayuki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Life Sci & Bioeth, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Yoshida, M (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Life Sci & Bioeth, Tokyo, Japan.	masa.vasc@tmd.ac.jp						Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Alberts AS, 1998, CELL, V92, P475, DOI 10.1016/S0092-8674(00)80941-1; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Calao M, 2008, TRENDS BIOCHEM SCI, V33, P339, DOI 10.1016/j.tibs.2008.04.015; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Cines DB, 1998, BLOOD, V91, P3527; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Edelstein LC, 2005, J BIOL CHEM, V280, P11192, DOI 10.1074/jbc.M412997200; Fish JE, 2010, J BIOL CHEM, V285, P810, DOI 10.1074/jbc.M109.067868; Fish JE, 2005, J BIOL CHEM, V280, P24824, DOI 10.1074/jbc.M502115200; Freire MO, 2013, PERIODONTOL 2000, V63, P149, DOI 10.1111/prd.12034; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; Gerszten RE, 1996, CIRC RES, V79, P1205, DOI 10.1161/01.RES.79.6.1205; Helfrich I, 2011, MOL ONCOL, V5, P137, DOI 10.1016/j.molonc.2011.01.003; KASZUBSKA W, 1993, MOL CELL BIOL, V13, P7180, DOI 10.1128/MCB.13.11.7180; Lampugnani MG, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; Liebner S, 2006, ARTERIOSCL THROM VAS, V26, P1431, DOI 10.1161/01.ATV.0000218510.04541.5e; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Matouk CC, 2008, CIRC RES, V102, P873, DOI 10.1161/CIRCRESAHA.107.171025; Mestas J, 2008, TRENDS CARDIOVAS MED, V18, P228, DOI 10.1016/j.tcm.2008.11.004; Mochizuki N, 2009, CIRC J, V73, P2183, DOI 10.1253/circj.CJ-09-0666; Napione L, 2012, BLOOD, V119, P5599, DOI 10.1182/blood-2011-11-390666; Orpana A, 1997, J CELL BIOCHEM, V64, P538; Pober JS, 2002, ARTHRITIS RES THER, V4, pS109, DOI 10.1186/ar576; Rao SH, 2001, J IMMUNOL, V167, P4494, DOI 10.4049/jimmunol.167.8.4494; Read MA, 1997, J BIOL CHEM, V272, P2753, DOI 10.1074/jbc.272.5.2753; Rothballer A, 2013, CHROMOSOMA, V122, P415, DOI 10.1007/s00412-013-0417-x; WHITLEY MZ, 1994, MOL CELL BIOL, V14, P6464, DOI 10.1128/MCB.14.10.6464; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706	31	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e90502	10.1371/journal.pone.0090502	http://dx.doi.org/10.1371/journal.pone.0090502			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690766	Green Published, Green Submitted, gold			2022-12-25	WOS:000334101100011
J	Lexa, KW; Dolghih, E; Jacobson, MP				Lexa, Katrina W.; Dolghih, Elena; Jacobson, Matthew P.			A Structure-Based Model for Predicting Serum Albumin Binding	PLOS ONE			English	Article							PLASMA-PROTEIN BINDING; DRUG DISCOVERY; ATOMIC-STRUCTURE; DOCKING; LIGAND; SITES; CONFORMATIONS; FLEXIBILITY; AFFINITIES; METABOLISM	One of the many factors involved in determining the distribution and metabolism of a compound is the strength of its binding to human serum albumin. While experimental and QSAR approaches for determining binding to albumin exist, various factors limit their ability to provide accurate binding affinity for novel compounds. Thus, to complement the existing tools, we have developed a structure-based model of serum albumin binding. Our approach for predicting binding incorporated the inherent flexibility and promiscuity known to exist for albumin. We found that a weighted combination of the predicted logP and docking score most accurately distinguished between binders and nonbinders. This model was successfully used to predict serum albumin binding in a large test set of therapeutics that had experimental binding data.	[Lexa, Katrina W.; Dolghih, Elena; Jacobson, Matthew P.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Lexa, KW (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	Katrina.lexa@ucsf.edu	Jacobson, Matthew/Y-5161-2018	Jacobson, Matthew/0000-0001-6262-655X	National Institutes of Health [AG021601, GM100619]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM100619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG021601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work has been supported by the National Institutes of Health (AG021601); www.nia.nih.gov. KWL also thanks the National Institutes of Health for funding (GM100619); www.nigms.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, QIKPROP VERS 3 3; [Anonymous], 2010, PRIMEX VERS 1 7; [Anonymous], 2010, PROT PREP WIZ; [Anonymous], 2010, LIGPREP VERS 2 4; [Anonymous], 2010, IND FIT; Ascenzi P, 2006, MINI-REV MED CHEM, V6, P483, DOI 10.2174/138955706776361448; Ascenzi P, 2010, BIOPHYS CHEM, V148, P16, DOI 10.1016/j.bpc.2010.03.001; Aureli L, 2005, J MED CHEM, V48, P2469, DOI 10.1021/jm049227l; Baur F, 2010, J MED CHEM, V53, P3675, DOI 10.1021/jm100068m; Beer J, 2009, AAPS J, V11, P1, DOI 10.1208/s12248-008-9072-1; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P38; Bhattacharya AA, 2000, J MOL BIOL, V303, P721, DOI 10.1006/jmbi.2000.4158; Bolli A, 2010, BIOCHEM BIOPH RES CO, V398, P444, DOI 10.1016/j.bbrc.2010.06.096; Bottegoni G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018845; Bottegoni G, 2009, J MED CHEM, V52, P397, DOI 10.1021/jm8009958; Brunton L., 2011, GOODMAN GILMANS PHAR; Campagna-Slater V, 2012, J CHEM INF MODEL, V52, P2471, DOI 10.1021/ci3003073; CARTER DC, 1990, SCIENCE, V249, P302, DOI 10.1126/science.2374930; Claussen H, 2001, J MOL BIOL, V308, P377, DOI 10.1006/jmbi.2001.4551; Colmenarejo G, 2001, J MED CHEM, V44, P4370, DOI 10.1021/jm010960b; CONN HL, 1961, J CLIN INVEST, V40, P509, DOI 10.1172/JCI104278; di Masi A, 2011, FEBS J, V278, P654, DOI 10.1111/j.1742-4658.2010.07986.x; Dunbar JB, 2013, J CHEM INF MODEL, V53, P1842, DOI [10.1021/ci400161J, 10.1021/ci4000486]; Durdagi S, 2011, J CHEM INF MODEL, V51, P463, DOI 10.1021/ci100409y; Ferreira RJ, 2012, J CHEM THEORY COMPUT, V8, P1853, DOI 10.1021/ct300083m; Fourches D, 2010, J CHEM INF MODEL, V50, P1189, DOI 10.1021/ci100176x; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Hall ML, 2013, J CHEM INF MODEL, V53, P907, DOI 10.1021/ci3006098; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; Hein KL, 2010, J STRUCT BIOL, V171, P353, DOI 10.1016/j.jsb.2010.03.014; Howard ML, 2010, COMB CHEM HIGH T SCR, V13, P170, DOI 10.2174/138620710790596745; Huang SY, 2007, PROTEINS, V66, P399, DOI 10.1002/prot.21214; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Kratochwil NA, 2002, BIOCHEM PHARMACOL, V64, P1355, DOI 10.1016/S0006-2952(02)01074-2; Kratz F, 2012, J CONTROL RELEASE, V161, P429, DOI 10.1016/j.jconrel.2011.11.028; Lexa KW, 2012, Q REV BIOPHYS, V45, P301, DOI 10.1017/S0033583512000066; Li HY, 2011, BIOPHARM DRUG DISPOS, V32, P333, DOI 10.1002/bdd.762; Li JN, 2011, J CHEM THEORY COMPUT, V7, P3829, DOI 10.1021/ct200462q; Liu XP, 2010, EUR J MED CHEM, V45, P4043, DOI 10.1016/j.ejmech.2010.05.063; Martin TM, 2012, J CHEM INF MODEL, V52, P2570, DOI 10.1021/ci300338w; Mitchell ML, 2010, BIOORG MED CHEM LETT, V20, P1589, DOI 10.1016/j.bmcl.2010.01.085; Mittal RR, 2009, J CHEM INF MODEL, V49, P1810, DOI 10.1021/ci900117m; Petitpas I, 2003, P NATL ACAD SCI USA, V100, P6440, DOI 10.1073/pnas.1137188100; Reichel A, 2009, CHEM BIODIVERS, V6, P2030, DOI 10.1002/cbdv.200900103; ROLAN PE, 1994, BRIT J CLIN PHARMACO, V37, P125, DOI 10.1111/j.1365-2125.1994.tb04251.x; Rueda M, 2010, J CHEM INF MODEL, V50, P186, DOI 10.1021/ci9003943; Ryan AJ, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-18; Schrodinger LLC, 2010, EP VERS 2 1; Simard JR, 2006, J MOL BIOL, V361, P336, DOI 10.1016/j.jmb.2006.06.028; Soskic M, 2007, BIOORGAN MED CHEM, V15, P4595, DOI 10.1016/j.bmc.2007.04.005; Totrov M, 2008, CURR OPIN STRUC BIOL, V18, P178, DOI 10.1016/j.sbi.2008.01.004; Triballeau N, 2005, J MED CHEM, V48, P2534, DOI 10.1021/jm049092j; Tropsha A, 2010, MOL INFORM, V29, P476, DOI 10.1002/minf.201000061; Tyzack JD, 2013, J CHEM INF MODEL, V53, P1294, DOI 10.1021/ci400058s; Valko K, 2003, J PHARM SCI-US, V92, P2236, DOI 10.1002/jps.10494; Votano JR, 2006, J MED CHEM, V49, P7169, DOI 10.1021/jm051245v; Wardell M, 2002, BIOCHEM BIOPH RES CO, V291, P813, DOI 10.1006/bbrc.2002.6540; Warren GL, 2012, DRUG DISCOV TODAY, V17, P1270, DOI 10.1016/j.drudis.2012.06.011; Weaver S, 2008, J MOL GRAPH MODEL, V26, P1315, DOI 10.1016/j.jmgm.2008.01.002; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Yamaguchi S, 2010, J AM CHEM SOC, V132, P824, DOI 10.1021/ja908878n; Zhang FL, 2012, DRUG DISCOV TODAY, V17, P475, DOI 10.1016/j.drudis.2011.12.018; Zhang QY, 2009, J CHEM INF MODEL, V49, P1857, DOI 10.1021/ci900080f; Zsila F, 2011, BIOINFORMATICS, V27, P1806, DOI 10.1093/bioinformatics/btr284	69	46	47	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93323	10.1371/journal.pone.0093323	http://dx.doi.org/10.1371/journal.pone.0093323			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691448	Green Published, gold, Green Submitted			2022-12-25	WOS:000334101100065
J	Li, BJ; Wang, L; Sun, ZH; Zhou, Y; Shao, DY; Zhao, J; Song, YN; Lv, JY; Dong, X; Liu, CH; Wang, P; Zhang, XY; Cui, RJ				Li, Bingjin; Wang, Liang; Sun, Zhihui; Zhou, Yang; Shao, Dongyuan; Zhao, Jing; Song, Yunong; Lv, Jiayin; Dong, Xue; Liu, Changhong; Wang, Pu; Zhang, Xingyi; Cui, Ranji			The Anticonvulsant Effects of SR 57227 on Pentylenetetrazole- Induced Seizure in Mice	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; C-FOS EXPRESSION; 5-HT3 RECEPTOR; RAT; ONDANSETRON; CITALOPRAM; SEROTONIN; MORPHINE	Recently, studies have shown that serotonin plays an important role in the control of seizure. However, the specific role of 5HT receptor subtypes is not yet well described, in particular that of the 5- HT3 receptor. The present study was aimed to investigate the role of 5 HT3 receptor on the pentylenetetrazole ( PTZ)- induced seizure in mice. Firstly, seizure latency was significantly prolonged by a 5 HT3 receptor agonist SR 57227 in a dose-dependent manner. Seizure score and mortality were also decreased by SR 57227 in PTZ- treated mice. Furthermore, these anticonvulsant effects of SR 57227 were inhibited by a 5- HT3 receptor antagonist ondansetron. However, ondansetron alone had no effect on seizure latency, seizure score or mortality at different doses. Immunohistochemical studies have also shown that c- Fos expression was significantly increased in hippocampus ( dentate gyrus, CA1, CA3 and CA4) of PTZ- treated mice. Furthermore, c- Fos expression was significantly inhibited by ondansetron in mice treated with PTZ and SR 57227. An ELISA study showed that SR 57227 attenuated the PTZinduced inhibitory effects of GABA levels in hippocampus and cortex, and the attenuated effects of SR 57227 were antagonized by ondansetron in hippocampus but not cortex. Our findings suggest that activation of 5-HT3 receptor by SR 57227, which plays an important role on the control of seizure induced by PTZ, may be related to GABA activity in hippocampus. Therefore, 5-HT3 receptor subtype is a potential target for the treatment of epilepsy.	[Li, Bingjin; Zhang, Xingyi; Cui, Ranji] Jilin Univ, Hosp 2, Changchun 130023, Peoples R China; [Li, Bingjin; Wang, Liang; Zhou, Yang; Shao, Dongyuan; Zhao, Jing; Song, Yunong; Dong, Xue; Liu, Changhong; Wang, Pu; Cui, Ranji] NE Normal Univ, Natl Engn Lab Druggable Gene & Prot Screening, Changchun, Peoples R China; [Sun, Zhihui] Jilin Univ, Hosp 1, Changchun 130023, Peoples R China; [Lv, Jiayin] China Japan Union Hosp, Changchun, Peoples R China	Jilin University; Northeast Normal University - China; Jilin University; Jilin University	Wang, L (corresponding author), Jilin Univ, Hosp 2, Changchun 130023, Peoples R China.	wangliangnenu@hotmail.com; xyzhang@jlu.edu.cn; cuiranji@hotmail.com	Wang, Liang/AAB-6335-2021; cui, ranji/AAV-6234-2021		Natural Science Foundation of China [31171123, 31300850, 81328011]; Program for New Century Excellent Talents in University [NCET-13-0715]; Jilin Provincial Department of Human Resources and Social Security Project [[2012]39]; Jilin Science and Technology Agency [20110726, 20140414039GH, 20130303095YY]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Jilin Provincial Department of Human Resources and Social Security Project; Jilin Science and Technology Agency	This work was supported by Natural Science Foundation of China (31171123; 31300850; 81328011). The project was supported by Program for New Century Excellent Talents in University (NCET-13-0715); Jilin Provincial Department of Human Resources and Social Security Project ([2012]39); and Jilin Science and Technology Agency funding (20110726; 20140414039GH; 20130303095YY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre V, 1998, EUR J NEUROSCI, V10, P2094, DOI 10.1046/j.1460-9568.1998.00223.x; BACHY A, 1993, EUR J PHARMACOL, V237, P299, DOI 10.1016/0014-2999(93)90282-M; Bagdy G, 2007, J NEUROCHEM, V100, P857, DOI 10.1111/j.1471-4159.2006.04277.x; Bahremand A, 2011, EPILEPSY BEHAV, V21, P122, DOI 10.1016/j.yebeh.2011.03.010; Chen CR, 2011, BRIT J PHARMACOL, V164, P1534, DOI 10.1111/j.1476-5381.2011.01456.x; Cui RJ, 2009, EUR J PHARMACOL, V609, P74, DOI 10.1016/j.ejphar.2008.12.051; Davis LL, 2000, J CLIN PSYCHOPHARM, V20, p1S, DOI 10.1097/00004714-200002001-00001; Erdtmann-Vourliotis M, 1998, BRAIN RES, V792, P299, DOI 10.1016/S0006-8993(98)00159-0; Fakhfouri G, 2012, DRUG DISCOV TODAY, V17, P741, DOI 10.1016/j.drudis.2012.02.009; Gholipour T, 2010, SEIZURE-EUR J EPILEP, V19, P17, DOI 10.1016/j.seizure.2009.10.006; Hirose S, 2000, EPILEPSY RES, V41, P191, DOI 10.1016/S0920-1211(00)00141-8; Jain S, 2012, HUM EXP TOXICOL, V31, P905, DOI 10.1177/0960327112436406; Li B, 2013, PROG NEUROPSYCHOPHAR, V48C, P199; Li BJ, 2013, J BIOCHEM MOL TOXIC, V27, P486, DOI 10.1002/jbt.21510; Li BJ, 2013, J PHARMACOL SCI, V123, P195, DOI 10.1254/jphs.13057SC; Li M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067060; Miraucourt LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029086; Morales M, 1997, J NEUROSCI, V17, P3157; Nichols RA, 1996, J NEUROCHEM, V67, P581; Payandemehr B, 2012, EPILEPSY RES, V101, P217, DOI 10.1016/j.eplepsyres.2012.04.004; PSARROPOULOU C, 1994, EPILEPSIA, V35, P12, DOI 10.1111/j.1528-1157.1994.tb02906.x; Puig MV, 2004, CEREB CORTEX, V14, P1365, DOI 10.1093/cercor/bhh097; Puthuran GJ, 2009, PHARMACOLOGYONLINE, V3, P463; Sharma A, 2001, ANN ONCOL, V12, P131, DOI 10.1023/A:1008394422101; Szyndler J, 2009, EPILEPSY BEHAV, V16, P216, DOI 10.1016/j.yebeh.2009.07.030; Walsh LA, 1999, J PHARMACOL EXP THER, V289, P1626; Watanabe K, 1998, EUR J PHARMACOL, V350, P181, DOI 10.1016/S0014-2999(98)00255-6; Watanabe Y, 2011, EPILEPSIA, V52, P140, DOI 10.1111/j.1528-1167.2010.02764.x; Ye JH, 1997, EUR J PHARMACOL, V337, P87, DOI 10.1016/S0014-2999(97)01279-X	29	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93158	10.1371/journal.pone.0093158	http://dx.doi.org/10.1371/journal.pone.0093158			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690630	Green Published, gold, Green Submitted			2022-12-25	WOS:000334101100049
J	Loison, E; Poirier-Beaudouin, B; Seffer, V; Paoletti, A; Abitbol, V; Tartour, E; Launay, O; Gougeon, ML				Loison, Emily; Poirier-Beaudouin, Beatrice; Seffer, Valerie; Paoletti, Audrey; Abitbol, Vered; Tartour, Eric; Launay, Odile; Gougeon, Marie-Lise			Suppression by Thimerosal of Ex- Vivo CD4(+) T Cell Response to Influenza Vaccine and Induction of Apoptosis in Primary Memory T Cells	PLOS ONE			English	Article							INTERFERON-GAMMA; FLOW-CYTOMETRY; CYTOCHROME-C; LIVING CELLS; EARLY EVENTS; ACTIVATION; PROTECTION; PATHWAYS; EXPOSURE; DEATH	Thimerosal is a preservative used widely in vaccine formulations to prevent bacterial and fungal contamination in multidose vials of vaccine. Thimerosal was included in the multidose non- adjuvanted pandemic 2009 H1N1 vaccine Panenza. In the context of the analysis of the ex-vivo T cell responses directed against influenza vaccine, we discovered the in vitro toxicity Panenza, due to its content in thimerosal. Because thimerosal may skew the immune response to vaccines, we investigated in detail the ex- vivo effects of thimerosal on the fate and functions of T cells in response to TCR ligation. We report that exvivo exposure of quiescent or TCR- activated primary human T cells to thimerosal induced a dose- dependent apoptotic cell death associated with depolarization of mitochondrial membrane, generation of reactive oxygen species, cytochrome c release from the mitochondria and caspase- 3 activation. Moreover, exposure to non- toxic concentrations of thimerosal induced cell cycle arrest in G0/G1 phase of TCR- activated T cells, and inhibition of the release of proinflammatory cytokines such as IFN gamma, IL- 1 beta, TNF alpha, IL- 2, as well as the chemokine MCP1. No shift towards Th2 or Th17 cells was detected. Overall these results underline the proapoptotic effect of thimerosal on primary human lymphocytes at concentrations 100 times less to those contained in the multidose vaccine, and they reveal the inhibitory effect of this preservative on T- cell proliferation and functions at nanomolar concentrations.	[Loison, Emily; Poirier-Beaudouin, Beatrice; Seffer, Valerie; Gougeon, Marie-Lise] Inst Pasteur, Antiviral Immun Biotherapy & Vaccine Unit, Paris, France; [Paoletti, Audrey] Inst Gustave Roussy, Inserm U1030, Villejuif, France; [Abitbol, Vered] Hop Cochin, AP HP, Dept Gastroenterol, F-75674 Paris, France; [Tartour, Eric] Univ Paris 05, PARCC, HEGP, Inserm U970, Paris, France; [Launay, Odile] Hop Cochin, AP HP, Ctr Invest Clin BT 505, F-75674 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Gougeon, ML (corresponding author), Inst Pasteur, Antiviral Immun Biotherapy & Vaccine Unit, Paris, France.	marie-lise.gougeon@pasteur.fr	tartour, eric/O-7957-2017	tartour, eric/0000-0002-7323-468X; paoletti, audrey/0000-0001-8979-385X	French Ministry of Health (Programme Hospitalier de Recherche Clinique (PHRC) National); ANRT (Agence Nationale de la Recherche et de la Technologie); Institut Pasteur; Crossject Company	French Ministry of Health (Programme Hospitalier de Recherche Clinique (PHRC) National); ANRT (Agence Nationale de la Recherche et de la Technologie)(French National Research Agency (ANR)); Institut Pasteur(European Commission); Crossject Company	This work was supported by grants from the French Ministry of Health (Programme Hospitalier de Recherche Clinique (PHRC) National), ANRT (Agence Nationale de la Recherche et de la Technologie) and Institut Pasteur. Crossject Company and ANRT provided the academic research/private research partnership to fund a CIFRE PhD fellowship to Emily Loison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2007, J LEUKOCYTE BIOL, V81, P474, DOI 10.1189/jlb.0706467; Ball LK, 2001, PEDIATRICS, V107, P1147, DOI 10.1542/peds.107.5.1147; Barile JP, 2012, J PEDIATR PSYCHOL, V37, P106, DOI 10.1093/jpepsy/jsr048; Baskin DS, 2003, TOXICOL SCI, V74, P361, DOI 10.1093/toxsci/kfg126; Cai JY, 1998, J BIOL CHEM, V273, P11401, DOI 10.1074/jbc.273.19.11401; Caserta TM, 2003, APOPTOSIS, V8, P345, DOI 10.1023/A:1024116916932; Chatterjee Archana, 2010, Expert Rev Vaccines, V9, P497, DOI 10.1586/erv.10.36; Chauvat A, 2012, J IMMUNOL METHODS, V378, P81, DOI 10.1016/j.jim.2012.02.008; CHEN LB, 1988, ANNU REV CELL BIOL, V4, P155, DOI 10.1146/annurev.cellbio.4.1.155; Cossarizza A, 2009, NAT PROTOC, V4, P1790, DOI 10.1038/nprot.2009.189; Dorea JG, 2013, J APPL TOXICOL, V33, P700, DOI 10.1002/jat.2855; Dussmann H, 2003, J BIOL CHEM, V278, P12645, DOI 10.1074/jbc.M210826200; Ferraro-Peyret C, 2002, J IMMUNOL, V169, P4805, DOI 10.4049/jimmunol.169.9.4805; Geier DA, 2007, J TOXICOL ENV HEAL B, V10, P575, DOI 10.1080/10937400701389875; Guzzi Gianpaolo, 2012, Interdiscip Toxicol, V5, P159, DOI 10.2478/v10102-012-0026-1; Humphrey ML, 2005, NEUROTOXICOLOGY, V26, P407, DOI 10.1016/j.neuro.2005.03.008; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Le Buanec H, 2011, P NATL ACAD SCI USA, V108, P18995, DOI 10.1073/pnas.1113301108; Lecoeur H, 1997, J IMMUNOL METHODS, V209, P111, DOI 10.1016/S0022-1759(97)00138-5; Lecoeur H, 2008, METHOD ENZYMOL, V442, P51, DOI 10.1016/S0076-6879(08)01403-1; Lee S, 2006, ENVIRON TOXICOL PHAR, V22, P194, DOI 10.1016/j.etap.2006.03.003; Li WX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049064; Liu SI, 2007, TOXICOL SCI, V100, P109, DOI 10.1093/toxsci/kfm205; Makani S, 2002, GENES IMMUN, V3, P270, DOI 10.1038/sj.gene.6363854; Masters SL, 2010, EMBO REP, V11, P640, DOI 10.1038/embor.2010.93; McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333; PETIT PX, 1995, J CELL BIOL, V130, P157, DOI 10.1083/jcb.130.1.157; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; ROTHE G, 1990, J LEUKOCYTE BIOL, V47, P440, DOI 10.1002/jlb.47.5.440; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Seror C, 2011, J EXP MED, V208, P1823, DOI 10.1084/jem.20101805; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; Tafani M, 2001, CANCER RES, V61, P2459; TORRESROCA JF, 1995, CELL DEATH DIFFER, V2, P309; Trompezinski S, 2008, TOXICOL APPL PHARM, V230, P397, DOI 10.1016/j.taap.2008.03.012; Wells AD, 1997, J CLIN INVEST, V100, P3173, DOI 10.1172/JCI119873; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Woo KJ, 2006, MOL CARCINOGEN, V45, P657, DOI 10.1002/mc.20202; Yel L, 2005, INT J MOL MED, V16, P971; Yole M, 2007, TOXICOLOGY, V231, P40, DOI 10.1016/j.tox.2006.11.062	40	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92705	10.1371/journal.pone.0092705	http://dx.doi.org/10.1371/journal.pone.0092705			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690681	gold, Green Published, Green Submitted			2022-12-25	WOS:000334101100030
J	Merk, B; Rohde, U; Glivici-Cotruta, V; Litskevich, D; Scholl, S				Merk, Bruno; Rohde, Ulrich; Glivici-Cotruta, Varvara; Litskevich, Dzianis; Scholl, Susanne			On the Use of a Molten Salt Fast Reactor to Apply an Idealized Transmutation Scenario for the Nuclear Phase Out	PLOS ONE			English	Article								In the view of transmutation of transuranium ( TRU) elements, molten salt fast reactors (MSFRs) offer certain advantages compared to solid fuelled reactor types like sodium cooled fast reactors (SFRs). In the first part these advantages are discussed in comparison with the SFR technology, and the research challenges are analyzed. In the second part cycle studies for the MSFR are given for different configurations - a core with U-238 fertile, a fertile free core, and a core with Th-232 as fertile material. For all cases, the transmutation potential is determined and efficient transmutation performance for the case with thorium as a fertile material as well as for the fertile free case is demonstrated and the individual advantages are discussed. The time evolution of different important isotopes is analyzed. In the third part a strategy for the optimization of the transmutation efficiency is developed. The final aim is dictated by the phase out decision of the German government, which requests to put the focus on the determination of the maximal transmutation efficiency and on an as much as possible reduced leftover of transuranium elements at the end of the reactor life. This minimal leftover is achieved by a two step procedure of a first transmuter operation phase followed by a second deep burning phase. There the U-233, which is bred in the blanket of the core consisting of thorium containing salt, is used as feed. It is demonstrated, that transmutation rates up to more than 90% can be achieved for all transuranium isotopes, while the production of undesired high elements like californium is very limited. Additionally, the adaptations needed for the simulation of a MSFR, and the used tool HELIOS 1.10 is described.	[Merk, Bruno; Rohde, Ulrich; Glivici-Cotruta, Varvara; Litskevich, Dzianis; Scholl, Susanne] Helmholtz Zentrum Dresden Rossendorf, Inst Resource Ecol, Dept Reactor Safety, Dresden, Germany	Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR)	Merk, B (corresponding author), Helmholtz Zentrum Dresden Rossendorf, Inst Resource Ecol, Dept Reactor Safety, Dresden, Germany.	b.merk@hzdr.de		Litskevich, Dzianis/0000-0002-3207-3058				[Anonymous], 2012, OV; [Anonymous], 2011, MOLTEN SALT FAST REA; [Anonymous], 2003, HELIOS METH; Buiron L, 2009, GLOB 2009 PAR FRANC; Capelli E, 2013, EVOL WP2 WORKSH EVOL; Gauche F, 2012, INT WORKSH PREV MIT; Generation IV International Forum, 2009, ANN REP GEN 4 INF FO; Ingatiev V, 2007, ICAPP 2007 NIC FRANC; Ingatiev V, 2012, ICAPP 12 CHIC US JUN; Languille A., 1995, PROC VERSAILLES; MACPHERSON HG, 1985, NUCL SCI ENG, V90, P374, DOI 10.13182/NSE90-374; Mathieu L, 2009, NUCL SCI ENG, V161, P78, DOI 10.13182/NSE07-49; Mathieu L, 2005, P GLOBAL 2005 TSUK J; Merk B, 2011, ICAPP 12 CHIC US JUN; Merk B, 2008, ATOMWIRTSCHAFT, V6, P404; Merk B, 2006, 9 INF EXCH M P T NIM; Merk B, 2013, PLOS ONE UNPUB; Merk B, 2014, ANN NUCL ENERGY, V64, P441, DOI 10.1016/j.anucene.2013.07.014; Merk B, 2013, SCI TECHNOL NUCL INS, V2013, DOI 10.1155/2013/217548; Merk B, 2013, SCI TECHNOL NUCL INS, V2013, DOI 10.1155/2013/172518; Merk B, 2012, NUCL SCI ENG, V171, P136, DOI 10.13182/NSE10-58; Merk B, 2011, ANN NUCL ENERGY, V38, P2374, DOI 10.1016/j.anucene.2011.07.005; Merk B, 2011, ANN NUCL ENERGY, V38, P921, DOI 10.1016/j.anucene.2011.01.024; Merle-Lucotte E., 2011, P ICAPP 2011 NIC FRA; Merle-Lucotte E, 2009, P GLOB 2009 PAR FRAN; Rachamin R, 2013, ANN NUCL ENERGY, V55, P194, DOI 10.1016/j.anucene.2012.11.030; Renault C, 2010, 4 INPRO GIF INT M VI; Renault C, 2005, MOST FINAL REPORT; Salvatore M, 2004, 8 IEM P T LAS VEG US; Sauvage J. F., 2009, PHENIX 35 YEARS HIST; Schwenk-Ferrero A, 2013, SCI TECHNOL NUCL INS, V2013, DOI 10.1155/2013/293792; VILLARINO EA, 1992, NUCL SCI ENG, V112, P16, DOI 10.13182/NSE112-16; Wiese HW, 1998, J ALLOY COMPD, V271, P522, DOI 10.1016/S0925-8388(98)00141-8	33	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92776	10.1371/journal.pone.0092776	http://dx.doi.org/10.1371/journal.pone.0092776			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690768	Green Published, gold, Green Submitted			2022-12-25	WOS:000334101100031
J	Fei, C; He, XL; Xie, SC; Miao, HF; Zhou, ZL; Li, L				Fei, Cong; He, Xiaoli; Xie, Sichun; Miao, Haofei; Zhou, Zhilei; Li, Lin			Smurf1-mediated Axin Ubiquitination Requires Smurf1 C2 Domain and Is Cell Cycle-dependent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Beta-catenin; Cell Cycle; Protein-Protein Interactions; Ubiquitination; Wnt Signaling	LIGASE SMURF1; CATENIN; PROMOTE; PATHWAY; CANCER; DEGRADATION; STABILITY; DISEASE; PROTEIN; TARGET	Background: Smurf1 ubiquitinates Axin via K29 poly-ubiquitin chains, and interferes with Wnt/-catenin signaling. Results: The C2 domain of Smurf1 is responsible for interacting with Axin, and Smurf1-mediated Axin ubiquitination attenuates in the G2/M phase of cell cycle. Conclusion: Smurf1-Axin interaction follows a non-canonical pattern and is under the control of cell cycle. Significance: Further clarification of the characteristic of Smurf1-mediated K29-linked poly-ubiquitination of Axin. Previously, Smad ubiquitination regulatory factor 1 (Smurf1)-mediated Lys29 (K29)-linked poly-ubiquitination of Axin has been identified as a novel regulatory process in Wnt/-catenin signaling. In this work, we discovered that the C2 domain of Smurf1 is critical for targeting Axin for ubiquitination. We found that the C2 domain-mediated plasma membrane localization of Smurf1 is required for Axin ubiquitination, and interfering with that disturbs the co-localization of Smurf1 and Axin around the plasma membrane. Moreover, the C2 domain of Smurf1, rather than its WW domains, is involved in Smurf1's interaction with Axin; and the putative PPXY motifs (PY motif) of Axin are not essential for such an interaction, indicating that Smurf1 binds to Axin in a non-canonical way independent of WW-PY interaction. Further, we found that Smurf1-Axin interaction and Axin ubiquitination are attenuated in the G2/M phase of cell cycle, contributing to an increased cell response to Wnt stimulation at that stage. Collectively, we uncovered a dual role of Smurf1 C2 domain, recruiting Smurf1 to membrane for accessing Axin and mediating its interaction with Axin, and that Smurf1-mediated Axin ubiquitination is subjected to the regulation of cell cycle.	[Fei, Cong; He, Xiaoli; Xie, Sichun; Miao, Haofei; Zhou, Zhilei; Li, Lin] Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Li, L (corresponding author), Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China.	lli@sibs.ac.cn	Li, Li/AEM-3636-2022; li, li/HII-4157-2022; zhou, zhou/HCH-1084-2022; LI, LI/GVS-5344-2022		Ministry of Science and Technology of China [2010CB912100]; National Natural Science Foundation of China [31230044, 30930052, 91213304]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Ministry of Science and Technology of China Grant 2010CB912100, and National Natural Science Foundation of China Grants 31230044, 30930052, and 91213304.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Chen YL, 2009, J BIOL CHEM, V284, P23481, DOI 10.1074/jbc.M109.007864; Chong PA, 2010, P NATL ACAD SCI USA, V107, P18404, DOI 10.1073/pnas.1003023107; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Davidson G, 2009, DEV CELL, V17, P788, DOI 10.1016/j.devcel.2009.11.006; Fei C, 2013, MOL CELL BIOL, V33, P4095, DOI 10.1128/MCB.00418-13; Hanson AJ, 2012, MOL CELL, V45, P619, DOI 10.1016/j.molcel.2011.12.032; Tran H, 2013, J BIOL CHEM, V288, P3753, DOI 10.1074/jbc.M112.415240; Kim S, 2010, J BIOL CHEM, V285, P36420, DOI 10.1074/jbc.M110.137471; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Li S, 2010, MOL CELL BIOCHEM, V338, P11, DOI 10.1007/s11010-009-0315-y; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu KF, 2011, J BIOL CHEM, V286, P16861, DOI 10.1074/jbc.M110.211979; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Sangadala S, 2007, J BIOMOL STRUCT DYN, V25, P11, DOI 10.1080/07391102.2007.10507151; Suzuki C, 2002, J BIOL CHEM, V277, P39919, DOI 10.1074/jbc.M201901200; Tian MY, 2011, FEBS LETT, V585, P2199, DOI 10.1016/j.febslet.2011.06.016; Wang JY, 2013, J BIOL CHEM, V288, P33667, DOI 10.1074/jbc.M113.503292; Wang W, 2011, CELL RES, V21, P730, DOI 10.1038/cr.2011.30; Wei W, 2012, MOL CELL BIOL, V32, P3903, DOI 10.1128/MCB.00251-12; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	23	12	15	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14170	14177		10.1074/jbc.M113.536714	http://dx.doi.org/10.1074/jbc.M113.536714			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24700460	Green Published, hybrid			2022-12-25	WOS:000335984600044
J	Koraishy, FM; Silva, C; Mason, S; Wu, DQ; Cantley, LG				Koraishy, Farrukh M.; Silva, Cynthia; Mason, Sherene; Wu, Dianqing; Cantley, Lloyd G.			Hepatocyte Growth Factor ( Hgf) Stimulates Low Density Lipoprotein Receptor-related Protein ( Lrp) 5/6 Phosphorylation and Promotes Canonical Wnt Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Beta-catenin; Glycogen synthase kinase 3; Hepatocyte growth factor; Kidney; Wnt signaling	GLYCOGEN-SYNTHASE KINASE-3; EPITHELIAL-CELLS; MET; KIDNEY; BETA; ACTIVATION; REPAIR; REGENERATION; INHIBITION; EXPRESSION	Background: The crosstalk between Hgf and Wnt signaling pathways is not well defined. Results: Hgf was found to stimulate Gsk3-dependent Lrp5/6 phosphorylation, increase nuclear -catenin and reduce apoptosis in an Lrp5/6-dependent fashion. Conclusion: Hgf transactivates canonical Wnt signaling. Significance: This pathway is involved in the survival of renal epithelial cells and is activated in vivo after renal ischemia. While Wnt and Hgf signaling pathways are known to regulate epithelial cell responses during injury and repair, whether they exhibit functional cross-talk is not well defined. Canonical Wnt signaling is initiated by the phosphorylation of the Lrp5/6 co-receptors. In the current study we demonstrate that Hgf stimulates Met and Gsk3-dependent and Wnt-independent phosphorylation of Lrp5/6 at three separate activation motifs in subconfluent, de-differentiated renal epithelial cells. Hgf treatment stimulates the selective association of active Gsk3 with Lrp5/6. In contrast, Akt-phosphorylated inactive Gsk3 is excluded from this association. Hgf stimulates -catenin stabilization and nuclear accumulation and protects against epithelial cell apoptosis in an Lrp5/6-dependent fashion. In vivo, the increase in Lrp5/6 phosphorylation and -catenin stabilization in the first 6-24 h after renal ischemic injury was significantly reduced in mice lacking Met receptor in the renal proximal tubule. Our results thus identify Hgf as an important transactivator of canonical Wnt signaling that is mediated by Met-stimulated, Gsk3-dependent Lrp5/6 phosphorylation.	[Koraishy, Farrukh M.; Cantley, Lloyd G.] Yale Univ, Sch Med, Nephrol Sect, Dept Internal Med, New Haven, CT 06510 USA; [Wu, Dianqing] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Silva, Cynthia; Mason, Sherene] Connecticut Childrens Med Ctr, Sect Pediat Nephrol, Hartford, CT 06106 USA	Yale University; Yale University; Connecticut Children's Medical Center	Koraishy, FM (corresponding author), Yale Univ, Sch Med, Nephrol Sect, Box 208029, New Haven, CT 06520 USA.	farrukh.koraishy@yale.edu	Koraishy, Farrukh/GLQ-8827-2022	Koraishy, Farrukh/0000-0001-6974-5674	NIDDK, National Institutes of Health [DK65109]; American Society of Nephrology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD068201] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA139395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065109, P30DK079310, T32DK007276] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112182] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Society of Nephrology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NIDDK, National Institutes of Health Grant DK65109 (to L. G. C.) and an American Society of Nephrology (Ben J. Lipps) Research Fellowship (to F. M. K.).	Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; CANTLEY LG, 1994, AM J PHYSIOL, V267, pF271, DOI 10.1152/ajprenal.1994.267.2.F271; Cervenka I, 2011, MOL CELL BIOL, V31, P179, DOI 10.1128/MCB.00550-10; Chen MY, 2009, J BIOL CHEM, V284, P35040, DOI 10.1074/jbc.M109.047456; Cho J, 2009, J BIOL CHEM, V284, P36647, DOI 10.1074/jbc.M109.019109; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Davidson G, 2009, DEV CELL, V17, P788, DOI 10.1016/j.devcel.2009.11.006; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Hader C, 2010, ONCOGENE, V29, P1031, DOI 10.1038/onc.2009.397; Hagen T, 2002, J BIOL CHEM, V277, P23330, DOI 10.1074/jbc.M201364200; Hartigan JA, 2001, BIOCHEM BIOPH RES CO, V284, P485, DOI 10.1006/bbrc.2001.4986; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; Ishibe S, 2008, CURR OPIN NEPHROL HY, V17, P379, DOI 10.1097/MNH.0b013e3283046507; Ishibe S, 2006, MOL CELL BIOL, V26, P9232, DOI 10.1128/MCB.01312-06; Ishibe S, 2009, DEVELOPMENT, V136, P337, DOI 10.1242/dev.024463; Kaidanovich-Beilin O, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00040; Krejci P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035826; Li QF, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-302; Lin SL, 2010, P NATL ACAD SCI USA, V107, P4194, DOI 10.1073/pnas.0912228107; Liu J, 2013, ACTA GEOL SIN-ENGL, V87, P1501, DOI 10.1111/1755-6724.12154; Lyu J, 2004, DEVELOPMENT, V131, P1813, DOI 10.1242/dev.01060; Ma H, 2009, KIDNEY INT, V76, P868, DOI 10.1038/ki.2009.304; MacDonald BT, 2008, J BIOL CHEM, V283, P16115, DOI 10.1074/jbc.M800327200; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Mason S, 2014, J AM SOC NEPHROL, V25, P329, DOI 10.1681/ASN.2013050473; Medina Miguel, 2011, Int J Alzheimers Dis, V2011, P479249, DOI 10.4061/2011/479249; Mi KH, 2006, J BIOL CHEM, V281, P4787, DOI 10.1074/jbc.M508657200; Niehrs C, 2010, CELL MOL LIFE SCI, V67, P2551, DOI 10.1007/s00018-010-0329-3; RAUCHMAN MI, 1993, AM J PHYSIOL, V265, pF416, DOI 10.1152/ajprenal.1993.265.3.F416; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shaw M, 1997, FEBS LETT, V416, P307, DOI 10.1016/S0014-5793(97)01235-0; Sinha D, 2003, AM J PHYSIOL-RENAL, V284, pF488, DOI 10.1152/ajprenal.00172.2002; Suzuki A, 2008, J CELL BIOCHEM, V104, P304, DOI 10.1002/jcb.21626; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Wan M, 2008, GENE DEV, V22, P2968, DOI 10.1101/gad.1702708; Wang ZY, 2009, J AM SOC NEPHROL, V20, P1919, DOI 10.1681/ASN.2009030253; Yi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036560; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhang T, 2001, CANCER RES, V61, P8664; Zhou D, 2013, KIDNEY INT, V84, P509, DOI 10.1038/ki.2013.102; Zhou D, 2012, KIDNEY INT, V82, P537, DOI 10.1038/ki.2012.173	46	17	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14341	14350		10.1074/jbc.M114.563213	http://dx.doi.org/10.1074/jbc.M114.563213			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24692544	Green Published, hybrid			2022-12-25	WOS:000335984600059
J	Yamazaki, Y; Nagata, T; Terakita, A; Kandori, H; Shichida, Y; Imamoto, Y				Yamazaki, Yoichi; Nagata, Tomoko; Terakita, Akihisa; Kandori, Hideki; Shichida, Yoshinori; Imamoto, Yasushi			Intramolecular Interactions That Induce Helical Rearrangement upon Rhodopsin Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fourier Transform IR (FTIR); G-protein-coupled Receptor (GPCR); Phototransduction; Protein Conformation; Rhodopsin; Vision	PROTEIN-COUPLED RECEPTOR; S-H BAND; METARHODOPSIN-II; CRYSTAL-STRUCTURE; BOVINE RHODOPSIN; TRANSMEMBRANE HELICES; VISUAL PIGMENTS; CONFORMATIONAL-CHANGES; MOLECULAR-PROPERTIES; SIDE-CHAINS	Background: Identification of the intramolecular interactions in metarhodopsin IIa is essential for understanding the activation mechanism of rhodopsin. Results: Environmental changes around the chromophore, Ala-164, His-211, and Phe-261 were observed by probing with cysteine S-H vibrations. Conclusion: The interactions involving these residues are altered before the helical rearrangements. Significance: The intramolecular interactions by which rhodopsin adopts the transducin-activating conformation are shown. Rhodopsin undergoes rearrangements of its transmembrane helices after photon absorption to transfer a light signal to the G-protein transducin. To investigate the mechanism by which rhodopsin adopts the transducin-activating conformation, the local environmental changes in the transmembrane region were probed using the cysteine S-H group, whose stretching frequency is well isolated from the other protein vibrational modes. The S-H stretching modes of cysteine residues introduced into Helix III, which contains several key residues for the helical movements, and of native cysteine residues were measured by Fourier transform infrared spectroscopy. This method was applied to metarhodopsin IIa, a precursor of the transducin-activating state in which the intramolecular interactions are likely to produce a state ready for helical movements. No environmental change was observed near the ionic lock between Arg-135 in Helix III and Glu-247 in Helix VI that maintains the inactive conformation. Rather, the cysteine residues that showed environmental changes were located around the chromophore, Ala-164, His-211, and Phe-261. These findings imply that the hydrogen bond between Helix III and Helix V involving Glu-122 and His-211 and the hydrophobic packing between Helix III and Helix VI involving Gly-121, Leu-125, Phe-261, and Trp-265 are altered before the helical rearrangement leading toward the active conformation.	[Yamazaki, Yoichi; Nagata, Tomoko; Terakita, Akihisa; Kandori, Hideki; Shichida, Yoshinori; Imamoto, Yasushi] Kyoto Univ, Dept Biophys, Grad Sch Sci, Kyoto 6068502, Japan; [Yamazaki, Yoichi] Nara Inst Sci & Technol, Grad Sch Mat Sci, Nara 6300192, Japan; [Terakita, Akihisa] Osaka City Univ, Dept Biol & Geosci, Grad Sch Sci, Osaka 5588585, Japan; [Kandori, Hideki] Nagoya Inst Technol, Dept Frontier Mat, Grad Sch Engn, Nagoya, Aichi 4668555, Japan	Kyoto University; Nara Institute of Science & Technology; Osaka Metropolitan University; Nagoya Institute of Technology	Imamoto, Y (corresponding author), Kyoto Univ, Dept Biophys, Grad Sch Sci, Kyoto 6068502, Japan.	imamoto@rh.biophys.kyoto-u.ac.jp		Terakita, Akihisa/0000-0002-8379-8913; Imamoto, Yasushi/0000-0002-0803-4163	Japanese Ministry of Education, Culture, Sports, Science, and Technology	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (to Y.Y., A. T., H. K., Y.S., and Y.I.).	ARNIS S, 1993, P NATL ACAD SCI USA, V90, P7849, DOI 10.1073/pnas.90.16.7849; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Deupi X, 2011, CURR OPIN STRUC BIOL, V21, P541, DOI 10.1016/j.sbi.2011.06.002; Dunham TD, 1999, J BIOL CHEM, V274, P1683, DOI 10.1074/jbc.274.3.1683; FAHMY K, 1993, P NATL ACAD SCI USA, V90, P10206, DOI 10.1073/pnas.90.21.10206; FAHMY K, 1993, BIOCHEMISTRY-US, V32, P7229, DOI 10.1021/bi00079a020; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Han M, 1996, J BIOL CHEM, V271, P32330, DOI 10.1074/jbc.271.50.32330; Han M, 1996, J BIOL CHEM, V271, P32337, DOI 10.1074/jbc.271.50.32337; Hwa J, 1997, P NATL ACAD SCI USA, V94, P10571, DOI 10.1073/pnas.94.20.10571; IMAI H, 1994, BIOCHEMISTRY-US, V33, P14351, DOI 10.1021/bi00251a049; Imai H, 1997, P NATL ACAD SCI USA, V94, P2322, DOI 10.1073/pnas.94.6.2322; Imai H, 2007, J BIOL CHEM, V282, P6677, DOI 10.1074/jbc.M610086200; Imamoto Y, 2000, BIOCHEMISTRY-US, V39, P15225, DOI 10.1021/bi0018685; Imamoto Y, 2013, BIOCHEMISTRY-US, V52, P3010, DOI 10.1021/bi3015967; JAGER F, 1994, BIOCHEMISTRY-US, V33, P10878; Kandori H, 1998, J AM CHEM SOC, V120, P5828, DOI 10.1021/ja980837i; Knierim B, 2007, P NATL ACAD SCI USA, V104, P20290, DOI 10.1073/pnas.0710393104; LI HM, 1991, J AM CHEM SOC, V113, P456, DOI 10.1021/ja00002a012; Mahalingam M, 2008, P NATL ACAD SCI USA, V105, P17795, DOI 10.1073/pnas.0804541105; MATTHEWS RG, 1963, J GEN PHYSIOL, V47, P215, DOI 10.1085/jgp.47.2.215; Nagata T, 1998, BIOCHEMISTRY-US, V37, P17216, DOI 10.1021/bi9810149; NAKAYAMA TA, 1991, J BIOL CHEM, V266, P4269; NATHANS J, 1989, VISION RES, V29, P907, DOI 10.1016/0042-6989(89)90105-3; NATHANS J, 1990, BIOCHEMISTRY-US, V29, P9746, DOI 10.1021/bi00493a034; Nishimura S, 1995, BIOCHEMISTRY-US, V34, P16758, DOI 10.1021/bi00051a025; OHKITA YJ, 1995, BIOPHYS CHEM, V56, P71, DOI 10.1016/0301-4622(95)00017-R; Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; PARKES JH, 1984, BIOCHEMISTRY-US, V23, P5054, DOI 10.1021/bi00316a035; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; RATH P, 1994, BIOPHYS J, V66, P2085, DOI 10.1016/S0006-3495(94)81003-3; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Sato K, 2010, BIOCHEMISTRY-US, V49, P736, DOI 10.1021/bi9018412; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Vogel R, 2003, BIOPOLYMERS, V72, P133, DOI 10.1002/bip.10407; Vogel R, 2008, J MOL BIOL, V380, P648, DOI 10.1016/j.jmb.2008.05.022; WEITZ CJ, 1992, NEURON, V8, P465, DOI 10.1016/0896-6273(92)90274-H; Yamazaki Yoichi, 2014, Biophysics (Nagoya-shi), V10, P1, DOI 10.2142/biophysics.10.1; Ye SX, 2010, NATURE, V464, P1386, DOI 10.1038/nature08948; Zaitseva E, 2010, J AM CHEM SOC, V132, P4815, DOI 10.1021/ja910317a; ZHUKOVSKY EA, 1989, SCIENCE, V246, P928, DOI 10.1126/science.2573154	47	9	8	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13792	13800		10.1074/jbc.M113.527606	http://dx.doi.org/10.1074/jbc.M113.527606			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24692562	hybrid, Green Published			2022-12-25	WOS:000335984600013
J	Casini, M; Rouyer, T; Bartolino, V; Larson, N; Grygiel, W				Casini, Michele; Rouyer, Tristan; Bartolino, Valerio; Larson, Niklas; Grygiel, Wlodzimierz			Density-Dependence in Space and Time: Opposite Synchronous Variations in Population Distribution and Body Condition in the Baltic Sea Sprat (Sprattus sprattus) over Three Decades	PLOS ONE			English	Article							HERRING CLUPEA-HARENGUS; HABITAT SELECTION; GROWTH; DYNAMICS; AUTOCORRELATION; TEMPERATURE; ECOSYSTEM; ECOLOGY; CLIMATE; COASTAL	Spatio-temporal density-dependent processes are crucial regulatory factors for natural populations. However, there is a lack of studies addressing spatial density-dependence in fish growth. A previous investigation has suggested spatio-temporal density-dependence in body condition of Baltic sprat. Here, we used different techniques, such as centre of gravity, distance, and homogeneity indices, to better characterize the spatial and temporal variations in sprat density and body condition in the Baltic Proper. Our results evidenced a negative spatio-temporal co-variation between the centres of gravity of density and maximum condition. In the 1980s-early 1990s both centres were located in the middle of the Baltic Proper. From the mid 1990s the centres progressively separated in space, as the sprat population moved towards the north-eastern Baltic Proper, and the centre of maximum condition towards the south-western areas. Moreover, at low abundances, sprat density and condition were homogeneously distributed in space, whereas at high abundances both density and condition showed pronounced geographical gradients. The ecological processes potentially explaining the observed patterns were discussed in the light of the Ideal Free Distribution theory. We provide evidence that the shift in the spatial distribution of cod, the main predator of sprat, has been the main factor triggering the overall spatial changes in sprat density, and thus condition, during the past thirty years. The spatial indices shown here, synthesizing the spatio-temporal patterns of fish distribution, can support the implementation of the EU Marine Strategy Framework Directive.	[Casini, Michele; Bartolino, Valerio; Larson, Niklas] Swedish Univ Agr Sci, Inst Marine Res, Dept Aquat Resources, Lysekil, Sweden; [Rouyer, Tristan] Univ Oslo, Dept Biol, CEES, Oslo, Norway; [Rouyer, Tristan] IFREMER, UMR EME 212, Sete, France; [Bartolino, Valerio] Univ Gothenburg, Dept Earth Sci, Gothenburg, Sweden; [Grygiel, Wlodzimierz] Natl Marine Fisheries Res Inst NMFRI, Dept Fisheries Resources, Gdynia, Poland	Swedish University of Agricultural Sciences; University of Oslo; Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Gothenburg; National Marine Fisheries Research Institute	Casini, M (corresponding author), Swedish Univ Agr Sci, Inst Marine Res, Dept Aquat Resources, Lysekil, Sweden.	michele.casini@slu.se		Casini, Michele/0000-0003-4910-5236; Bartolino, Valerio/0000-0002-4506-4329; Grygiel, Wlodzimierz/0000-0002-4897-5216	Swedish PLAN FISH project; Swedish Environmental Protection Agency; Swedish Agency for Marine and Water Management; Norwegian Research Council through the ARCWARM Project [178239]	Swedish PLAN FISH project; Swedish Environmental Protection Agency; Swedish Agency for Marine and Water Management; Norwegian Research Council through the ARCWARM Project	MC was partially funded by the Swedish PLAN FISH project financed by the "Swedish Environmental Protection Agency" and the "Swedish Agency for Marine and Water Management." Funding for TR was provided by the Norwegian Research Council through the ARCWARM Project (#178239). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolino V, 2011, ECOLOGY, V92, P189, DOI 10.1890/09-1129.1; BERTNESS MD, 1985, OECOLOGIA, V67, P192, DOI 10.1007/BF00384283; Bez N, 2001, FISH RES, V50, P41, DOI 10.1016/S0165-7836(00)00241-1; Bez N, 2000, ICES J MAR SCI, V57, P383, DOI 10.1006/jmsc.2000.0644; Bjornstad ON, 1999, ECOLOGY, V80, P1278; BRANCH GM, 1975, J ANIM ECOL, V44, P263, DOI 10.2307/3862; Burgess MD, 2011, P R SOC B, V275, P1209; Cardinale M, 2002, AQUAT LIVING RESOUR, V15, P273, DOI 10.1016/S0990-7440(02)01188-9; Cardinale M, 2009, MAR ECOL PROG SER, V386, P197, DOI 10.3354/meps08076; Casini M, 2006, OIKOS, V112, P638, DOI 10.1111/j.0030-1299.2006.13860.x; Casini M, 2008, P ROY SOC B-BIOL SCI, V275, P1793, DOI 10.1098/rspb.2007.1752; Casini M, 2011, POPUL ECOL, V53, P511, DOI 10.1007/s10144-011-0269-2; EC, 2010, 2010477EU EC; European Commission (EC), 2012, SCI TECHN RES SER, DOI [10.2788/25697.69pp, DOI 10.2788/25697.69]; Fauchald P, 2006, ECOLOGY, V87, P2915, DOI 10.1890/0012-9658(2006)87[2915:DMWITM]2.0.CO;2; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Grygiel W., 2003, B SEA FISH I, V2, P1; HAILS RS, 1992, J ANIM ECOL, V61, P567, DOI 10.2307/5612; HOLT RD, 2001, DISPERSAL; Hsieh CH, 2008, CAN J FISH AQUAT SCI, V65, P947, DOI 10.1139/F08-017; Hsieh CH, 2010, AQUAT SCI, V72, P165, DOI 10.1007/s00027-009-0122-2; Husebo A, 2007, ICES J MAR SCI, V64, P1161, DOI 10.1093/icesjms/fsm081; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; ICES, 2012, 2012ACOM43 ICES CM; ICES, 2013, 2013SSGRSP11 ICES; ICES, 2012, 2012SSGESST02 ICES C; ICES, 2012, 2012ACIN10 ICES CM W; Kondratjeva N., 1993, ICES CM, VJ25, P1; Kritzer JP, 2004, FISH FISH, V5, P131, DOI 10.1111/j.1467-2979.2004.00131.x; MacKenzie BR, 2004, ECOLOGY, V85, P784, DOI 10.1890/02-0780; Mollmann C, 2005, ICES J MAR SCI, V62, P1270, DOI 10.1016/j.icesjms.2005.04.021; MORRIS DW, 1989, EVOL ECOL, V3, P80, DOI 10.1007/BF02147934; Ojaveer E, 2010, REV FISH BIOL FISHER, V20, P203, DOI 10.1007/s11160-009-9130-5; Overmars KP, 2003, ECOL MODEL, V164, P257, DOI 10.1016/S0304-3800(03)00070-X; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pyper BJ, 1998, CAN J FISH AQUAT SCI, V55, P2127; RAJASILTA M, 1992, CAN J FISH AQUAT SCI, V49, P644, DOI 10.1139/f92-073; Shepherd TD, 2004, FISH FISH, V5, P141, DOI 10.1111/j.1467-2979.2004.00143.x; Uuemaa E, 2008, ECOL INDIC, V8, P783, DOI 10.1016/j.ecolind.2006.12.002; Van Leeuwen A, 2008, J SEA RES, V60, P89, DOI 10.1016/j.seares.2008.02.008; WINTERS GH, 1994, CAN J FISH AQUAT SCI, V51, P1169, DOI 10.1139/f94-116	41	22	22	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e92278	10.1371/journal.pone.0092278	http://dx.doi.org/10.1371/journal.pone.0092278			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699501	gold, Green Published			2022-12-25	WOS:000334105000021
J	Rubinstein, A; Gutierrez, L; Beratarrechea, A; Irazola, VE				Rubinstein, Adolfo; Gutierrez, Laura; Beratarrechea, Andrea; Irazola, Vilma E.			Increased Prevalence of Diabetes in Argentina Is Due to Easier Health Care Access Rather than to an Actual Increase in Prevalence	PLOS ONE			English	Article							RISK-FACTORS; RELIABILITY; OBESITY; DISEASE; STROKE; WOMEN	Introduction: According to the Argentine National Risk Factor Survey (ANRFS), between 2005 and 2009, self-reported Diabetes increased in Argentina from 8.4% to 9.6%, accompanied by a raise in the prevalence of obesity and low physical activity. In the same period, it also increased blood sugar checks from 69.3% to 75.7%. Since surveillance data in Argentina rely on self-reports, the estimated prevalence of diabetes may be affected by an increase in the proportion of subjects with access to preventive services. We evaluated the independent effect of a recent blood sugar check, on the increase in self-reported diagnoses of diabetes between 2005 and 2009. Materials and Methods: A secondary analysis of data from the 2005 and 2009 ANRFS was performed. Diabetes was defined as having been diagnosed Diabetes or high blood sugar by a health professional, obesity was calculated as BMI >= 30 kg/m(2), based on self-reported height and weight and physical activity was measured using the International Physical Activity Questionnaire. We used logistic regression models to explore the relationship between prevalence of self-reported diabetes and recent blood sugar check as the main predictor. Results: The prevalence of diabetes rose from 8.4% to 9.6%; obesity from 14.5% to 18% and low physical activity from 46.2% to 55%, between 2005 and 2009. Among those who recently checked their blood sugar no differences were found in the prevalence of diabetes: 13% in 2005 vs. 13.2% in 2009. Findings of the multivariable analysis showed that obesity and low physical activity were significantly associated with self reported diabetes in the adjusted model (OR = 1.80 for obesity, and OR = 1.12 for low physical activity but the strongest predictor was recent blood sugar check (OR = 4.75). Discussion: An increased prevalence of self-reported diabetes between 2005 and 2009 might indicate an improvement in the access to preventive services rather than a positive increase in the prevalence of diabetes.	[Rubinstein, Adolfo; Gutierrez, Laura; Beratarrechea, Andrea; Irazola, Vilma E.] Inst Clin Effectiveness & Hlth Policy IECS, Ctr Excellence, South Amer Ctr Cardiovasc Hlth SACECH, Buenos Aires, DF, Argentina		Rubinstein, A (corresponding author), Inst Clin Effectiveness & Hlth Policy IECS, Ctr Excellence, South Amer Ctr Cardiovasc Hlth SACECH, Buenos Aires, DF, Argentina.	arubinstein@iecs.org.ar						Agrawal S, 2012, PUBLIC HEALTH NUTR, V15, P1065, DOI 10.1017/S1368980011002813; Brancati FL, 1999, ARCH INTERN MED, V159, P957, DOI 10.1001/archinte.159.9.957; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Danaei G, 2006, LANCET, V368, P1651, DOI 10.1016/S0140-6736(06)69700-6; Danaei Goodarz, 2009, Popul Health Metr, V7, P16, DOI 10.1186/1478-7954-7-16; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Ferrante D, 2011, REV ARGENTINA SALUD, V2, P34; Ferrante D, 2011, REV ARGENT SALUD PUB, V2, P34; Ferrante Daniel, 2007, Rev. argent. cardiol., V75, P20; Fleischer NL, 2011, AM J PUBLIC HEALTH, V101, P294, DOI 10.2105/AJPH.2009.190165; Folsom AR, 2000, ARCH INTERN MED, V160, P2117, DOI 10.1001/archinte.160.14.2117; Gasparini L, 2001, CUADERNOS EC, V38, P49; Hennekens C. H., 1987, EPIDEMIOLOGY MED LIT; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Jahangir E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045053; Javier E, 1995, ARGENTINAS POOR PROF; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; RIMM EB, 1995, BRIT MED J, V310, P555, DOI 10.1136/bmj.310.6979.555; Roux AVD, 2002, J EPIDEMIOL COMMUN H, V56, P588, DOI 10.1136/jech.56.8.588; Saydah SH, 2004, ANN EPIDEMIOL, V14, P507, DOI 10.1016/j.annepidem.2003.09.016; Schneider ALC, 2012, AM J EPIDEMIOL, V176, P738, DOI 10.1093/aje/kws156; SELDEN C., 2000, HLTH LIT	22	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e92245	10.1371/journal.pone.0092245	http://dx.doi.org/10.1371/journal.pone.0092245			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699429	Green Published, Green Submitted, gold			2022-12-25	WOS:000334105000020
J	Doi, T; Doi, S; Nakashima, A; Ueno, T; Yokoyama, Y; Kohno, N; Masaki, T				Doi, Toshiki; Doi, Shigehiro; Nakashima, Ayumu; Ueno, Toshinori; Yokoyama, Yukio; Kohno, Nobuoki; Masaki, Takao			Mizoribine Ameliorates Renal Injury and Hypertension along with the Attenuation of Renal Caspase-1 Expression in Aldosterone-Salt-Treated Rats	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; EXPERIMENTAL PERITONEAL FIBROSIS; IL-1-BETA-CONVERTING ENZYME; MYOCARDIAL-INFARCTION; PODOCYTE INJURY; DIABETIC-RATS; INFLAMMATION; MICE; EPLERENONE; BLOCKER	Aldosterone-salt treatment induces not only hypertension but also extensive inflammation that contributes to fibrosis in the rat kidney. However, the mechanism underlying aldosterone-salt-induced renal inflammation remains unclear. Pyroptosis has recently been identified as a new type of cell death that is accompanied by the activation of inflammatory cytokines. We hypothesized that aldosterone-salt treatment could induce inflammation through pyroptosis and that mizoribine, an effective immunosuppressant, would ameliorate the renal inflammation that would otherwise cause renal fibrosis. Ten days after recovery from left uninephrectomy, rats were given drinking water with 1% sodium chloride. The animals were divided into three groups (n=7 per group): (1) vehicle infusion group, (2) aldosterone infusion group, or (3) aldosterone infusion plus oral mizoribine group. Aldosterone-salt treatment increased the expression of the nucleotide-binding oligomerization domain, leucine-rich repeat and pyrin domain containing 3 and caspase-1, and also increased the number of terminal deoxynucleotidyl transferase dUTP nick end labeling-positive cells. However, the oral administration of mizoribine attenuated these alterations. Furthermore, mizoribine inhibited hypertension and renal fibrosis, and also attenuated the aldosterone-induced expression of serum/glucocorticoid-regulated kinase and a epithelial sodium channel. These results suggest that caspase-1 activation plays an important role in the development of inflammation induced by aldosterone-salt treatment and that it functions as an anti-inflammatory strategy that protects against renal injury and hypertension.	[Doi, Toshiki; Doi, Shigehiro; Nakashima, Ayumu; Ueno, Toshinori; Yokoyama, Yukio; Masaki, Takao] Hiroshima Univ Hosp, Dept Nephrol, Hiroshima, Japan; [Kohno, Nobuoki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol & Internal Med, Hiroshima, Japan	Hiroshima University; Hiroshima University	Masaki, T (corresponding author), Hiroshima Univ Hosp, Dept Nephrol, Hiroshima, Japan.	masakit@hiroshima-u.ac.jp	Hiyama, Eiso/A-2013-2019; Nakashima, Ayumu/CAF-0274-2022; Nakashima, Ayumu/N-9158-2017; Doi, Shigehiro/AAQ-2655-2020	Hiyama, Eiso/0000-0001-9179-5037; Nakashima, Ayumu/0000-0002-7838-1494; Nakashima, Ayumu/0000-0002-7838-1494; DOI, TOSHIKI/0000-0001-8870-5790	Tsuchiya Memorial Medical Foundation Grant	Tsuchiya Memorial Medical Foundation Grant	This work was supported by the Tsuchiya Memorial Medical Foundation Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders HJ, 2011, J AM SOC NEPHROL, V22, P1007, DOI 10.1681/ASN.2010080798; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Booth RE, 2002, ADV PHYSIOL EDUC, V26, P8, DOI 10.1152/advan.00051.2001; Brown NJ, 2013, NAT REV NEPHROL, V9, P459, DOI 10.1038/nrneph.2013.110; Brown NJ, 2000, KIDNEY INT, V58, P1219, DOI 10.1046/j.1523-1755.2000.00277.x; CAVAILLON JM, 1994, BIOMED PHARMACOTHER, V48, P445, DOI 10.1016/0753-3322(94)90005-1; Cheng JZ, 2010, KIDNEY INT, V78, P668, DOI 10.1038/ki.2010.214; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; de las Hera N, 2007, J HYPERTENS, V25, P629, DOI 10.1097/HJH.0b013e3280112ce5; Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037; Elmarakby AA, 2008, AM J PHYSIOL-REG I, V294, pR76, DOI 10.1152/ajpregu.00466.2007; Elmarakby AA, 2007, HYPERTENSION, V50, P1069, DOI 10.1161/HYPERTENSIONAHA.107.098806; Epstein M, 2006, CLIN J AM SOC NEPHRO, V1, P940, DOI 10.2215/CJN.00240106; Feria I, 2003, KIDNEY INT, V63, P43, DOI 10.1046/j.1523-1755.2003.00707.x; Frantz S, 2003, J MOL CELL CARDIOL, V35, P685, DOI 10.1016/S0022-2828(03)00113-5; Furuichi K, 2003, J AM SOC NEPHROL, V14, P2503, DOI 10.1097/01.ASN.0000089563.63641.A8; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; HEPTINSTALL RH, 1967, LAB INVEST, V16, P751; Hill GS, 2008, CURR OPIN NEPHROL HY, V17, P266, DOI 10.1097/MNH.0b013e3282f88a1f; Ikeda H, 2009, KIDNEY INT, V75, P147, DOI 10.1038/ki.2008.507; Kanamori H, 2007, BIOCHEM BIOPH RES CO, V360, P772, DOI 10.1016/j.bbrc.2007.06.148; Kawasaki Y, 2009, CLIN DEV IMMUNOL, DOI 10.1155/2009/681482; Kikuchi Y, 2005, NEPHROL DIAL TRANSPL, V20, P1573, DOI 10.1093/ndt/gfh888; Kitagawa K, 2004, AM J PATHOL, V165, P237, DOI 10.1016/S0002-9440(10)63292-0; Lee SB, 2010, KIDNEY INT, V78, pS22, DOI 10.1038/ki.2010.418; Leroy V, 2009, J AM SOC NEPHROL, V20, P131, DOI 10.1681/ASN.2008020232; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Nagase M, 2006, HYPERTENSION, V47, P1084, DOI 10.1161/01.HYP.0000222003.28517.99; Nishiyama A, 2010, J PHARMACOL EXP THER, V332, P1072, DOI 10.1124/jpet.109.158113; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Rodriguez-Iturbe B, 2012, CLIN EXP PHARMACOL P, V39, P96, DOI 10.1111/j.1440-1681.2011.05482.x; Sakai T, 1997, J UROLOGY, V158, P2316, DOI 10.1016/S0022-5347(01)68242-9; Schielke GP, 1998, J CEREBR BLOOD F MET, V18, P180, DOI 10.1097/00004647-199802000-00009; Schrier RW, 2010, NAT REV NEPHROL, V6, P61, DOI 10.1038/nrneph.2009.228; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Shimizu M, 1998, NEPHRON, V79, P67, DOI 10.1159/000044994; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Soundararajan R, 2010, J BIOL CHEM, V285, P30363, DOI 10.1074/jbc.R110.155341; Takahashi S, 2009, NEPHRON EXP NEPHROL, V112, pE59, DOI 10.1159/000213896; Terada Y, 2012, CLIN EXP NEPHROL, V16, P81, DOI 10.1007/s10157-011-0498-x; Ueno T, 2013, KIDNEY INT, V84, P297, DOI 10.1038/ki.2013.81; White WB, 2003, HYPERTENSION, V41, P1021, DOI 10.1161/01.HYP.0000067463.13172.EA; Williams GH, 2004, AM J CARDIOL, V93, P990, DOI 10.1016/j.amjcard.2004.01.007; Zhang AH, 2007, AM J PHYSIOL-RENAL, V293, pF723, DOI 10.1152/ajprenal.00480.2006; Zhang AH, 2011, KIDNEY INT, V80, P51, DOI 10.1038/ki.2011.29	46	22	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93513	10.1371/journal.pone.0093513	http://dx.doi.org/10.1371/journal.pone.0093513			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695748	Green Submitted, Green Published, gold			2022-12-25	WOS:000334103000083
J	Thiebaut, F; Grativol, C; Tanurdzic, M; Carnavale-Bottino, M; Vieira, T; Motta, MR; Rojas, C; Vincentini, R; Chabregas, SM; Hemerly, AS; Martienssen, RA; Ferreira, PCG				Thiebaut, Flavia; Grativol, Clicia; Tanurdzic, Milos; Carnavale-Bottino, Mariana; Vieira, Tauan; Motta, Mariana Romeiro; Rojas, Cristian; Vincentini, Renato; Chabregas, Sabrina Moutinho; Hemerly, Adriana Silva; Martienssen, Robert A.; Gomes Ferreira, Paulo Cavalcanti			Differential sRNA Regulation in Leaves and Roots of Sugarcane under Water Depletion	PLOS ONE			English	Article							DROUGHT-RESPONSIVE MICRORNAS; PLANT SMALL RNAS; SIRNA BIOGENESIS; DNA METHYLATION; MEDICAGO-TRUNCATULA; STRESS RESPONSES; PRI-MIRNA; RT-PCR; ARABIDOPSIS; GENOME	Plants have developed multiple regulatory mechanisms to respond and adapt to stress. Drought stress is one of the major constraints to agricultural productivity worldwide and recent reports have highlighted the importance of plant sRNA in the response and adaptation to water availability. In order to increase our understanding of the roles of sRNA in response to water depletion, cultivars of sugarcane were submitted to treatment of ceasing drip irrigation for 24 hours. Deep sequencing analysis was carried out to identify the sRNA regulated in leaves and roots of sugarcane cultivars with different drought sensitivities. The pool of sRNA selected allowed the analysis of different sRNA classes ( miRNA and siRNA). Twenty-eight and 36 families of conserved miRNA were identified in leaf and root libraries, respectively. Dynamic regulation of miRNA was observed and the expression profiles of eight miRNA were verified in leaf samples from three biological replicates by stem-loop qRT-PCR assay using the cultivars: SP90-1638-sensitive cultivar- and; SP83-2847 and SP83-5073 tolerant cultivars. Altered miRNA regulation was correlated with changes in mRNA levels of specific targets. Two leaf libraries from individual sugarcane cultivars with contrasting drought-tolerance properties were also analyzed. An enrichment of 22-nt sRNA species was observed in leaf libraries. 22-nt miRNA triggered siRNA production by cleavage of their targets in response to water depletion. A number of genes of the sRNA biogenesis pathway were down-regulated in tolerant genotypes and up-regulated in sensitive in response to water depletion treatment. Our analysis contributes to increase the knowledge on the roles of sRNA in sugarcane submitted to water depletion.	[Thiebaut, Flavia; Grativol, Clicia; Carnavale-Bottino, Mariana; Vieira, Tauan; Motta, Mariana Romeiro; Hemerly, Adriana Silva; Gomes Ferreira, Paulo Cavalcanti] Univ Fed Rio de Janeiro, Inst Bioquim Med, Lab Biol Mol Plantas, Rio De Janeiro, Brazil; [Tanurdzic, Milos] Univ Queensland, Sch Biol Sci, Brisbane St Lucia, Qld, Australia; [Rojas, Cristian] Univ Fed INTEGRACAO Latino Amer, Foz Do Iguacu, Parana, Brazil; [Vincentini, Renato] Univ Estadual Campinas, Ctr Biol Mol Engn Genet, Campinas, SP, Brazil; [Chabregas, Sabrina Moutinho] Fazenda St Antonio Lab Biol Mol, Ctr Tecnol Canavieira, Sao Paulo, Brazil; [Martienssen, Robert A.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Martienssen, Robert A.] Cold Spring Harbor Lab, Gordon & Betty Moore Fdn, Cold Spring Harbor, NY 11724 USA	Universidade Federal do Rio de Janeiro; University of Queensland; Universidade Federal da Integracao Latino-Americana; Universidade Estadual de Campinas; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Cold Spring Harbor Laboratory	Ferreira, PCG (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Lab Biol Mol Plantas, Rio De Janeiro, Brazil.	paulof@bioqmed.ufrj.br	Thiebaut, Flavia/AAU-5318-2021; Ferreira, Paulo C G/I-2836-2015; Thiebaut, Flavia/B-3867-2018; Tanurdzic, Milos/A-5712-2012; Rojas, Cristian/X-1027-2018	Ferreira, Paulo C G/0000-0002-5510-999X; Thiebaut, Flavia/0000-0002-8833-1722; Tanurdzic, Milos/0000-0002-7564-0868; Rojas, Cristian/0000-0002-9085-6261; Grativol, Clicia/0000-0002-8873-701X; Romeiro Motta, Mariana/0000-0002-9163-0619	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Instituto Nacional de Ciencia e Tecnologia em Fixacao Biologica de Nitrogenio (INCT); Financiadora de Estudos e Projetos (FINEP); Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067014] Funding Source: NIH RePORTER	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia em Fixacao Biologica de Nitrogenio (INCT); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research by the group is supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Instituto Nacional de Ciencia e Tecnologia em Fixacao Biologica de Nitrogenio (INCT), Financiadora de Estudos e Projetos (FINEP), Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Allen E, 2010, SEMIN CELL DEV BIOL, V21, P798, DOI 10.1016/j.semcdb.2010.03.008; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bottino MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059423; Breakfield NW, 2012, GENOME RES, V22, P163, DOI 10.1101/gr.123547.111; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Cantu D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-408; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Chen S, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048747, 10.1371/journal.pone.0046703, 10.1371/journal.pone.0029579, 10.1371/journal.pone.0050850]; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Cho SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000314; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; Dong Z, 2008, P NATL ACAD SCI USA, V105, P9970, DOI 10.1073/pnas.0803356105; Fu J, 2012, J BOT, V2012, P1, DOI DOI 10.1155/2012/835836; Golldack D, 2011, PLANT CELL REP, V30, P1383, DOI 10.1007/s00299-011-1068-0; Grativol C, 2012, BBA-GENE REGUL MECH, V1819, P176, DOI 10.1016/j.bbagrm.2011.08.010; Grivet L, 2002, CURR OPIN PLANT BIOL, V5, P122, DOI 10.1016/S1369-5266(02)00234-0; Guleria Praveen, 2011, Genomics Proteomics & Bioinformatics, V9, P183, DOI 10.1016/S1672-0229(11)60022-3; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Havecker ER, 2010, PLANT CELL, V22, P321, DOI 10.1105/tpc.109.072199; He GM, 2010, PLANT CELL, V22, P17, DOI 10.1105/tpc.109.072041; Hsieh LC, 2009, PLANT PHYSIOL, V151, P2120, DOI 10.1104/pp.109.147280; Jagadeeswaran G, 2009, PLANTA, V229, P1009, DOI 10.1007/s00425-009-0889-3; Jamalkandi SA, 2009, FUNCT INTEGR GENOMIC, V9, P419, DOI 10.1007/s10142-009-0141-z; Jeong DH, 2010, METHODS MOL BIOL, V592, P203, DOI 10.1007/978-1-60327-005-2_14; Khraiwesh Basel, 2012, Biochim Biophys Acta, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Khraiwesh B, 2010, CELL, V140, P111, DOI 10.1016/j.cell.2009.12.023; Kidner CA, 2005, CURR OPIN PLANT BIOL, V8, P38, DOI 10.1016/j.pbi.2004.11.008; Kong Y. Q. M., 2010, American Journal of Plant Sciences, V1, P69, DOI 10.4236/ajps.2010.12009; Krasnikova MS, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/952304; Kurihara Y, 2006, RNA, V12, P206, DOI 10.1261/rna.2146906; Li BS, 2011, J EXP BOT, V62, P3765, DOI 10.1093/jxb/err051; Liu QP, 2009, FUNCT INTEGR GENOMIC, V9, P277, DOI 10.1007/s10142-009-0111-5; Lv DK, 2010, GENE, V459, P39, DOI 10.1016/j.gene.2010.03.011; Madlung A, 2004, ANN BOT-LONDON, V94, P481, DOI 10.1093/aob/mch172; Martinez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019523; Mica E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-109; Mirouze M, 2011, CURR OPIN PLANT BIOL, V14, P267, DOI 10.1016/j.pbi.2011.03.004; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Moxon S, 2008, BIOINFORMATICS, V24, P2252, DOI 10.1093/bioinformatics/btn428; Nobuta K, 2008, P NATL ACAD SCI USA, V105, P14958, DOI 10.1073/pnas.0808066105; OMALLEY DM, 1993, PLANT J, V4, P751, DOI 10.1046/j.1365-313X.1993.04050751.x; Park MY, 2005, P NATL ACAD SCI USA, V102, P3691, DOI 10.1073/pnas.0405570102; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Reddy AR, 2004, J PLANT PHYSIOL, V161, P1189, DOI 10.1016/j.jplph.2004.01.013; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; Silva M, 1997, J PLANT PHYSL, V19, P193; Simon SA, 2011, CURR OPIN PLANT BIOL, V14, P148, DOI 10.1016/j.pbi.2010.11.007; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-37; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Thiebaut F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-290; Thiebaut F, 2012, PLANT CELL ENVIRON, V35, P502, DOI 10.1111/j.1365-3040.2011.02430.x; Turck F, 2007, PLOS GENET, V3, P855, DOI 10.1371/journal.pgen.0030086; Vargas L, 2012, PLANT SOIL, V356, P127, DOI 10.1007/s11104-012-1274-8; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Vazquez F, 2010, TRENDS PLANT SCI, V15, P337, DOI 10.1016/j.tplants.2010.04.001; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Wang W., 2010, DROUGHT INDUCED SITE, P1, DOI [10.1093/jxb/erq391, DOI 10.1093/JXB/ERQ391]; Wei LQ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r53; Willmann Matthew R, 2011, Arabidopsis Book, V9, pe0146, DOI 10.1199/tab.0146; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Xia R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r47; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yang TW, 2007, PLANT SCI, V172, P423, DOI 10.1016/j.plantsci.2006.10.009; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Zanca AS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-260; Zhai JX, 2011, GENE DEV, V25, P2540, DOI 10.1101/gad.177527.111; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang XM, 2011, MOL CELL, V42, P356, DOI 10.1016/j.molcel.2011.04.010; Zhang X, 2007, NAT STRUCT MOL BIOL, V14, P869, DOI 10.1038/nsmb1283; Zheng XW, 2007, EMBO J, V26, P1691, DOI 10.1038/sj.emboj.7601603; Zheng XN, 2009, BIOCHEM BIOPH RES CO, V379, P985, DOI 10.1016/j.bbrc.2008.12.163; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695; Zilberman D, 2004, CURR BIOL, V14, P1214, DOI 10.1016/j.cub.2004.06.055	85	19	19	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93822	10.1371/journal.pone.0093822	http://dx.doi.org/10.1371/journal.pone.0093822			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695493	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000334103000126
J	Burt, SA; Ojo-Fakunle, VTA; Woertman, J; Veldhuizen, EJA				Burt, Sara A.; Ojo-Fakunle, Victoria T. A.; Woertman, Jenifer; Veldhuizen, Edwin J. A.			The Natural Antimicrobial Carvacrol Inhibits Quorum Sensing in Chromobacterium violaceum and Reduces Bacterial Biofilm Formation at Sub-Lethal Concentrations	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; SUBINHIBITORY CONCENTRATIONS; LISTERIA-MONOCYTOGENES; STAINLESS-STEEL; ESSENTIAL OILS; TYPHIMURIUM; INACTIVATION; ANTIBIOTICS; POLYSTYRENE	The formation of biofilm by bacteria confers resistance to biocides and presents problems in medical and veterinary clinical settings. Here we report the effect of carvacrol, one of the major antimicrobial components of oregano oil, on the formation of biofilms and its activity on existing biofilms. Assays were carried out in polystyrene microplates to observe (a) the effect of 0-0.8 mM carvacrol on the formation of biofilms by selected bacterial pathogens over 24 h and (b) the effect of 0-8 mM carvacrol on the stability of pre-formed biofilms. Carvacrol was able to inhibit the formation of biofilms of Chromobacterium violaceum ATCC 12472, Salmonella enterica subsp. Typhimurium DT104, and Staphylococcus aureus 0074, while it showed no effect on formation of Pseudomonas aeruginosa (field isolate) biofilms. This inhibitory effect of carvacrol was observed at sub-lethal concentrations (<0.5 mM) where no effect was seen on total bacterial numbers, indicating that carvacrol's bactericidal effect was not causing the observed inhibition of biofilm formation. In contrast, carvacrol had (up to 8 mM) very little or no activity against existing biofilms of the bacteria described, showing that formation of the biofilm also confers protection against this compound. Since quorum sensing is an essential part of biofilm formation, the effect of carvacrol on quorum sensing of C. violaceum was also studied. Sub-MIC concentrations of carvacrol reduced expression of cviI (a gene coding for the N-acyl-L-homoserine lactone synthase), production of violacein (pigmentation) and chitinase activity (both regulated by quorum sensing) at concentrations coinciding with carvacrol's inhibiting effect on biofilm formation. These results indicate that carvacrol's activity in inhibition of biofilm formation may be related to the disruption of quorum sensing.	[Burt, Sara A.; Ojo-Fakunle, Victoria T. A.; Woertman, Jenifer] Univ Utrecht, Fac Vet Med, Vet Publ Hlth Div, Inst Risk Assessment Sci, Utrecht, Netherlands; [Veldhuizen, Edwin J. A.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands	Utrecht University; Utrecht University	Burt, SA (corresponding author), Univ Utrecht, Fac Vet Med, Vet Publ Hlth Div, Inst Risk Assessment Sci, Utrecht, Netherlands.	s.a.burt@uu.nl			Utrecht University, the Netherlands	Utrecht University, the Netherlands(Netherlands Government)	This study was funded by Utrecht University, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borges A, 2014, BIOFOULING, V30, P183, DOI 10.1080/08927014.2013.852542; Chernin LS, 1998, J BACTERIOL, V180, P4435, DOI 10.1128/JB.180.17.4435-4441.1998; Desai MA, 2012, J FOOD PROTECT, V75, P1332, DOI 10.4315/0362-028X.JFP-11-517; Gray KM, 2001, MICROBIOL-SGM, V147, P2379, DOI 10.1099/00221287-147-8-2379; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Inamuco J, 2012, VET MICROBIOL, V157, P200, DOI 10.1016/j.vetmic.2011.12.021; Knowles JR, 2005, APPL ENVIRON MICROB, V71, P797, DOI 10.1128/AEM.71.2.797-803.2005; Langeveld WT, 2014, CRIT REV MICROBIOL, V40, P76, DOI 10.3109/1040841X.2013.763219; Liu ZJ, 2013, FEMS MICROBIOL LETT, V341, P37, DOI 10.1111/1574-6968.12086; Molhoek EM, 2011, INT J ANTIMICROB AG, V37, P476, DOI 10.1016/j.ijantimicag.2010.12.020; Niu C, 2006, LETT APPL MICROBIOL, V43, P489, DOI 10.1111/j.1472-765X.2006.02001.x; Nostro A, 2007, J MED MICROBIOL, V56, P519, DOI 10.1099/jmm.0.46804-0; Nostro A, 2009, J MED MICROBIOL, V58, P791, DOI 10.1099/jmm.0.009274-0; Perez-Conesa D, 2006, J FOOD PROTECT, V69, P2947, DOI 10.4315/0362-028X-69.12.2947; Rasko DA, 2008, SCIENCE, V321, P1078, DOI 10.1126/science.1160354; Shapira R, 2007, MICROB DRUG RESIST, V13, P157, DOI 10.1089/mdr.2007.731; Singh BN, 2009, FOOD CHEM TOXICOL, V47, P778, DOI 10.1016/j.fct.2009.01.009; Soni KA, 2013, J FOOD PROTECT, V76, P205, DOI 10.4315/0362-028X.JFP-12-196; Sperandio V, 2002, MOL MICROBIOL, V43, P809, DOI 10.1046/j.1365-2958.2002.02803.x; Stauff DL, 2011, J BACTERIOL, V193, P3871, DOI 10.1128/JB.05125-11; van Alphen LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045343; Veldhuizen EJA, 2006, J AGR FOOD CHEM, V54, P1874, DOI 10.1021/jf052564y; Xue T, 2013, INT J ANTIMICROB AG, V41, P85, DOI 10.1016/j.ijantimicag.2012.08.016	23	155	165	2	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93414	10.1371/journal.pone.0093414	http://dx.doi.org/10.1371/journal.pone.0093414			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691035	Green Published, gold			2022-12-25	WOS:000334101100078
J	Johansson, HM; Newman, DR; Sannes, PL				Johansson, Helena Morales; Newman, Donna R.; Sannes, Philip L.			Whole-Genome Analysis of Temporal Gene Expression during Early Transdifferentiation of Human Lung Alveolar Epithelial Type 2 Cells In Vitro	PLOS ONE			English	Article							KERATINOCYTE GROWTH-FACTOR; HUMAN PROTEIN ATLAS; II CELLS; EXTRACELLULAR-MATRIX; RAT LUNG; DIFFERENTIATION INVITRO; PULMONARY SURFACTANT; IMPROVED MAINTENANCE; BASEMENT-MEMBRANE; SODIUM-CHANNELS	It is generally accepted that the surfactant-producing pulmonary alveolar epithelial type II (AT2) cell acts as the progenitor of the type I (AT1) cell, but the regulatory mechanisms involved in this relationship remain the subject of active investigation. While previous studies have established a number of specific markers that are expressed during transdifferentiation from AT2 to AT1 cells, we hypothesized that additional, previously unrecognized, signaling pathways and relevant cellular functions are transcriptionally regulated at early stages of AT2 transition. In this study, a discovery-based gene expression profile analysis was undertaken of freshly isolated human AT2 (hAT2) cells grown on extracellular matrix (ECM) substrata known to either support (type I collagen) or retard (Matrigel) the early transdifferentiation process into hAT1-like cells over the first three days. Cell type-specific expression patterns analyzed by Illumina Human HT-12 BeadChip yielded over 300 genes that were up- or down-regulated. Candidate genes significantly induced or down-regulated during hAT2 transition to hAT1-like cells compared to non-transitioning hAT2 cells were identified. Major functional groups were also recognized, including those of signaling and cytoskeletal proteins as well as genes of unknown function. Expression of established signatures of hAT2 and hAT1 cells, such as surfactant proteins, caveolin-1, and channels and transporters, was confirmed. Selected novel genes further validated by qRT-PCR, protein expression analysis, and/or cellular localization included SPOCK2, PLEKHO1, SPRED1, RAB11FIP1, PTRF/CAVIN-1 and RAP1GAP. These results further demonstrate the utility of genome-wide analysis to identify relevant, novel cell type-specific signatures of early ECM-regulated alveolar epithelial transdifferentiation processes in vitro.	[Johansson, Helena Morales; Newman, Donna R.; Sannes, Philip L.] N Carolina State Univ, Coll Vet Med, Ctr Comparat Med & Translat Res, Dept Mol Biomed Sci, Raleigh, NC 27607 USA	University of North Carolina; North Carolina State University	Sannes, PL (corresponding author), N Carolina State Univ, Coll Vet Med, Ctr Comparat Med & Translat Res, Dept Mol Biomed Sci, Raleigh, NC 27607 USA.	plsannes@ncsu.edu			PHS [HL44497, HL95411, DK065988]; State of North Carolina; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044497, R03HL095411, R56HL044497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK065988] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); State of North Carolina; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by: PHS grants HL44497, HL95411, DK065988 and the State of North Carolina. http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboulaich N, 2006, BIOCHEM BIOPH RES CO, V350, P657, DOI 10.1016/j.bbrc.2006.09.094; Aboulaich N, 2011, DIABETES, V60, P757, DOI 10.2337/db10-0744; ADAMSON IYR, 1975, LAB INVEST, V32, P736; ADAMSON IYR, 1992, ANAT EMBRYOL, V185, P275, DOI 10.1007/BF00211826; Adamson IYR, 1996, AM J PHYSIOL-LUNG C, V270, pL1017, DOI 10.1152/ajplung.1996.270.6.L1017; Ballard PL, 2010, AM J PHYSIOL-LUNG C, V299, pL36, DOI 10.1152/ajplung.00427.2009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Borok Z, 1998, AM J RESP CELL MOL, V18, P554, DOI 10.1165/ajrcmb.18.4.2838; Borok Z, 1998, AM J PHYSIOL-LUNG C, V275, pL155, DOI 10.1152/ajplung.1998.275.1.L155; Buckley S, 1997, AM J PHYSIOL-LUNG C, V273, pL572, DOI 10.1152/ajplung.1997.273.3.L572; Campbell L, 1999, BIOCHEM BIOPH RES CO, V262, P744, DOI 10.1006/bbrc.1999.1280; Chen ZM, 2004, BIOCHEM BIOPH RES CO, V319, P774, DOI 10.1016/j.bbrc.2004.05.048; Comellas AP, 2010, J CELL SCI, V123, P1343, DOI 10.1242/jcs.066464; CRAPO JD, 1982, AM REV RESPIR DIS, V126, P332; Deng W, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-29; Deterding RR, 1996, AM J PHYSIOL-LUNG C, V271, pL495, DOI 10.1152/ajplung.1996.271.4.L495; DETERDING RR, 1995, J CLIN INVEST, V95, P2963, DOI 10.1172/JCI118004; Dietl P, 1995, AM J PHYSIOL-LUNG C, V269, pL873, DOI 10.1152/ajplung.1995.269.6.L873; Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003; Dobbs LG, 1997, AM J PHYSIOL-LUNG C, V273, pL347, DOI 10.1152/ajplung.1997.273.2.L347; Eaton DC, 2009, ANNU REV PHYSIOL, V71, P403, DOI 10.1146/annurev.physiol.010908.163250; EVANS MJ, 1975, EXP MOL PATHOL, V22, P142, DOI 10.1016/0014-4800(75)90059-3; Fujino N, 2012, AM J RESP CELL MOL, V46, P422, DOI 10.1165/rcmb.2011-0172OC; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Gonzalez R, 2005, AM J PHYSIOL-LUNG C, V288, pL179, DOI 10.1152/ajplung.00272.2004; Grau V, 2006, INT J BIOCHEM CELL B, V38, P279, DOI 10.1016/j.biocel.2005.09.010; Hadchouel A, 2011, AM J RESP CRIT CARE, V184, P1164, DOI 10.1164/rccm.201103-0548OC; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; Herzog Erica L, 2008, Proc Am Thorac Soc, V5, P778, DOI 10.1513/pats.200803-028HR; Johnson MD, 2006, P NATL ACAD SCI USA, V103, P4964, DOI 10.1073/pnas.0600855103; Kajstura J, 2011, NEW ENGL J MED, V364, P1795, DOI 10.1056/NEJMoa1101324; Kasper M, 1996, HISTOCHEM CELL BIOL, V106, P419; KASPER M, 1993, HISTOCHEMISTRY, V100, P65, DOI 10.1007/BF00268879; KAWADA H, 1988, BIOCHIM BIOPHYS ACTA, V972, P152, DOI 10.1016/0167-4889(88)90114-0; KAWADA H, 1990, AM J RESP CELL MOL, V3, P33, DOI 10.1165/ajrcmb/3.1.33; Kho AT, 2009, AM J RESP CELL MOL, V40, P47, DOI 10.1165/rcmb.2008-0048OC; KIKKAWA Y, 1983, LAB INVEST, V49, P122; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Lee IH, 2009, J BIOL CHEM, V284, P12663, DOI 10.1074/jbc.M809737200; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; MCCRAY PB, 1992, J CLIN INVEST, V90, P619, DOI 10.1172/JCI115901; McElroy MC, 2004, EUR RESPIR J, V24, P664, DOI 10.1183/09031936.04.00096003; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; MOORE KJ, 1992, GENOMICS, V12, P388, DOI 10.1016/0888-7543(92)90389-A; Nguyen NM, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-28; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; Qiao R, 2008, AM J RESP CELL MOL, V38, P239, DOI 10.1165/rcmb.2007-0172OC; Ramirez MI, 2002, J HISTOCHEM CYTOCHEM, V50, P33, DOI 10.1177/002215540205000104; Rawlins EL, 2008, AM J PHYSIOL-LUNG C, V295, pL231, DOI 10.1152/ajplung.90209.2008; Rice WR, 2002, AM J PHYSIOL-LUNG C, V283, pL256, DOI 10.1152/ajplung.00302.2001; Richter M, 2007, J NEUROSCI, V27, P14205, DOI 10.1523/JNEUROSCI.2746-07.2007; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; SANNES PL, 1984, J HISTOCHEM CYTOCHEM, V32, P827, DOI 10.1177/32.8.6747274; Schnepp A, 2005, J BIOL CHEM, V280, P11274, DOI 10.1074/jbc.M414276200; Schultess J, 2005, BLOOD, V105, P3185, DOI 10.1182/blood-2004-09-3605; Taipale J, 1997, FASEB J, V11, P51, DOI 10.1096/fasebj.11.1.9034166; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Wang JR, 2007, AM J RESP CELL MOL, V36, P661, DOI 10.1165/rcmb.2006-0410OC; Wang YL, 2010, AM J PHYSIOL-LUNG C, V298, pL775, DOI 10.1152/ajplung.00327.2009; WOODCOCKMITCHELL J, 1989, AM REV RESPIR DIS, V139, P343, DOI 10.1164/ajrccm/139.2.343; Yu W, 2007, MOL BIOL CELL, V18, P1693, DOI 10.1091/mbc.E06-11-1052; Zhang HY, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-69	66	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93413	10.1371/journal.pone.0093413	http://dx.doi.org/10.1371/journal.pone.0093413			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690998	Green Published, Green Submitted, gold			2022-12-25	WOS:000334101100077
J	Sakane, H; Horii, Y; Nogami, S; Kawano, Y; Kaneko-Kawano, T; Shirataki, H				Sakane, Hiroshi; Horii, Yukimi; Nogami, Satoru; Kawano, Yoji; Kaneko-Kawano, Takako; Shirataki, Hiromichi			alpha-Taxilin Interacts with Sorting Nexin 4 and Participates in the Recycling Pathway of Transferrin Receptor	PLOS ONE			English	Article							MEMBRANE-FUSION; EXPRESSION; PROTEIN; IDENTIFICATION; DEGRADATION; ENDOSOME; ENDOCYTOSIS; INTEGRINS; MUSCLES; COMPLEX	Membrane traffic plays a crucial role in delivering proteins and lipids to their intracellular destinations. We previously identified alpha-taxilin as a binding partner of the syntaxin family, which is involved in intracellular vesicle traffic. alpha-Taxilin is overexpressed in tumor tissues and interacts with polymerized tubulin, but the precise function of alpha-taxilin remains unclear. Receptor proteins on the plasma membrane are internalized, delivered to early endosomes and then either sorted to the lysosome for degradation or recycled back to the plasma membrane. In this study, we found that knockdown of alpha-taxilin induced the lysosomal degradation of transferrin receptor (TfnR), a well-known receptor which is generally recycled back to the plasma membrane after internalization, and impeded the recycling of transferrin. alpha-Taxilin was immunoprecipitated with sorting nexin 4 (SNX4), which is involved in the recycling of TfnR. Furthermore, knockdown of alpha-taxilin decreased the number and length of SNX4-positive tubular structures. We report for the first time that alpha-taxilin interacts with SNX4 and plays a role in the recycling pathway of TfnR.	[Sakane, Hiroshi; Horii, Yukimi; Nogami, Satoru; Kawano, Yoji; Kaneko-Kawano, Takako; Shirataki, Hiromichi] Dokkyo Med Univ, Grad Sch Med, Dept Mol & Cell Biol, Mibu, Tochigi, Japan	Dokkyo Medical University	Shirataki, H (corresponding author), Dokkyo Med Univ, Grad Sch Med, Dept Mol & Cell Biol, Mibu, Tochigi, Japan.	hiro-sh@dokkyomed.ac.jp	Nogami, Satoru/G-6061-2014; Kawano, Yoji/C-7484-2011	Nogami, Satoru/0000-0002-4517-0180; Kawano, Yoji/0000-0003-0687-2777	JSPS KAKENHI [23659403, 24790280]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI grant number 23659403 to H. Shirataki and grant number 24790280 to H. Sakane. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bottcher RT, 2012, NAT CELL BIOL, V14, P584, DOI 10.1038/ncb2501; Carlton J, 2005, TRAFFIC, V6, P75, DOI 10.1111/j.1600-0854.2005.00260.x; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Fujimori KE, 2002, FEBS LETT, V529, P303, DOI 10.1016/S0014-5793(02)03386-0; Haft CR, 1998, MOL CELL BIOL, V18, P7278, DOI 10.1128/MCB.18.12.7278; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Horii Y, 2014, HISTOCHEM CELL BIOL, V141, P165, DOI 10.1007/s00418-013-1147-0; Horii Y, 2012, CELL STRUCT FUNCT, V37, P111, DOI 10.1247/csf.12002; Hunt SD, 2013, J CELL SCI, V126, P2493, DOI 10.1242/jcs.122317; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kikuchi A, 2009, TRENDS CELL BIOL, V19, P119, DOI 10.1016/j.tcb.2009.01.003; Kurten RC, 1996, SCIENCE, V272, P1008, DOI 10.1126/science.272.5264.1008; Leprince C, 2003, J CELL SCI, V116, P1937, DOI 10.1242/jcs.00403; Mashidori T, 2011, BIOMED RES-TOKYO, V32, P103, DOI 10.2220/biomedres.32.103; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Nogami S, 2004, BIOCHEM BIOPH RES CO, V319, P936, DOI 10.1016/j.bbrc.2004.05.073; Nogami S, 2003, GENES CELLS, V8, P17, DOI 10.1046/j.1365-2443.2003.00612.x; Oba-Shinjo SM, 2005, MOL BRAIN RES, V140, P25, DOI 10.1016/j.molbrainres.2005.06.015; Ohtomo N, 2010, INT J ONCOL, V37, P1417, DOI 10.3892/ijo_00000793; Skanland SS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005935; Steinberg F, 2012, J CELL BIOL, V197, P219, DOI 10.1083/jcb.201111121; Traer CJ, 2007, NAT CELL BIOL, V9, P1370, DOI 10.1038/ncb1656; Uyeda A, 2000, BIOCHEM BIOPH RES CO, V269, P564, DOI 10.1006/bbrc.2000.2330; van Kerkhof P, 2005, EMBO J, V24, P2851, DOI 10.1038/sj.emboj.7600756; van Weering JRT, 2012, TRAFFIC, V13, P94, DOI 10.1111/j.1600-0854.2011.01297.x; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Worby CA, 2002, NAT REV MOL CELL BIO, V3, P919, DOI 10.1038/nrm974; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Yoshida K, 2005, GENES CELLS, V10, P465, DOI 10.1111/j.1365-2443.2005.00848.x	32	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93509	10.1371/journal.pone.0093509	http://dx.doi.org/10.1371/journal.pone.0093509			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690921	Green Published, gold, Green Submitted			2022-12-25	WOS:000334101100094
J	Yu, HG; Wang, QY; Wang, ZW; Sahinkaya, E; Li, YL; Ma, JX; Wu, ZC				Yu, Hongguang; Wang, Qiaoying; Wang, Zhiwei; Sahinkaya, Erkan; Li, Yongli; Ma, Jinxing; Wu, Zhichao			Start-Up of an Anaerobic Dynamic Membrane Digester for Waste Activated Sludge Digestion: Temporal Variations in Microbial Communities	PLOS ONE			English	Article							METHANOGENIC ACTIVITY; BIOREACTOR; BACTERIAL; DIVERSITY; ARCHAEAL	An anaerobic dynamic membrane digester (ADMD) was developed to digest waste sludge, and pyrosequencing was used to analyze the variations of the bacterial and archaeal communities during the start-up. Results showed that bacterial community richness decreased and then increased over time, while bacterial diversity remained almost the same during the start-up. Proteobacteria and Bacteroidetes were the major phyla. At the class level, Betaproteobacteria was the most abundant at the end of start-up, followed by Sphingobacteria. In the archaeal community, richness and diversity peaked at the end of the start-up stage. Principle component and cluster analyses demonstrated that archaeal consortia experienced a distinct shift and became stable after day 38. Methanomicrobiales and Methanosarcinales were the two predominant orders. Further investigations indicated that Methanolinea and Methanosaeta were responsible for methane production in the ADMD system. Hydrogenotrophic pathways might prevail over acetoclastic means for methanogenesis during the start-up, supported by specific methanogenic activity tests.	[Yu, Hongguang; Wang, Qiaoying; Wang, Zhiwei; Ma, Jinxing; Wu, Zhichao] Tongji Univ, Sch Environm Sci & Engn, State Key Lab Pollut Control & Resource Reuse, Shanghai 200092, Peoples R China; [Sahinkaya, Erkan] Istanbul Medeniyet Univ, Dept Bioengn, Istanbul, Turkey; [Li, Yongli] Univ Rouen, CNRS INSA, Lab Polymeres Biopolymeres & Surfaces, UMR 6270, Mont St Aignan, France	Tongji University; Istanbul Medeniyet University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Rouen Normandie	Wang, QY (corresponding author), Tongji Univ, Sch Environm Sci & Engn, State Key Lab Pollut Control & Resource Reuse, Shanghai 200092, Peoples R China.	qywang@tongji.edu.cn; zwwang@tongji.edu.cn	Wang, Zhiwei/F-5666-2012; Ma, Jinxing/D-9981-2013; Sahinkaya, Erkan/A-5227-2018; Wang, Qiaoying/AAN-6945-2020	Wang, Zhiwei/0000-0001-6729-2237; Ma, Jinxing/0000-0002-5087-3972; SAHINKAYA, ERKAN/0000-0002-9898-9173	Key Special Program on the S&T for the Pollution Control and Treatment of Water Bodies [2011ZX07303-001]; Science and Technology Commission of Shanghai Municipality [12230707000]	Key Special Program on the S&T for the Pollution Control and Treatment of Water Bodies; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work is partially supported by the Key Special Program on the S&T for the Pollution Control and Treatment of Water Bodies (2011ZX07303-001) and by the Science and Technology Commission of Shanghai Municipality research project (12230707000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Public Health Association, 2012, HIDROL ME, V22nd; An Y, 2009, CHEM ENG J, V155, P709, DOI 10.1016/j.cej.2009.09.003; Appels L, 2008, PROG ENERG COMBUST, V34, P755, DOI 10.1016/j.pecs.2008.06.002; Ariesyady HD, 2007, WATER RES, V41, P1554, DOI 10.1016/j.watres.2006.12.036; Chouari R, 2005, ENVIRON MICROBIOL, V7, P1104, DOI 10.1111/j.1462-2920.2005.00795.x; Coates JD, 1996, J MICROBIOL METH, V26, P237, DOI 10.1016/0167-7012(96)00915-3; Connaughton S, 2006, WATER RES, V40, P1009, DOI 10.1016/j.watres.2005.12.026; Dagnew M, 2010, WATER SCI TECHNOL, V61, P1451, DOI 10.2166/wst.2010.028; DONLON BA, 1995, APPL ENVIRON MICROB, V61, P3889, DOI 10.1128/AEM.61.11.3889-3893.1995; Fan B, 2002, ENVIRON SCI TECHNOL, V36, P5245, DOI 10.1021/es025789n; Gao WJ, 2012, J MEMBRANE SCI, V421, P131, DOI 10.1016/j.memsci.2012.07.003; Garcia JL, 2000, ANAEROBE, V6, P205, DOI 10.1006/anae.2000.0345; Hatziconstantinou GJ, 1996, WATER SCI TECHNOL, V34, P417, DOI 10.1016/0273-1223(96)00545-8; Kapdan IK, 2006, ENZYME MICROB TECH, V38, P569, DOI 10.1016/j.enzmictec.2005.09.015; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Krause L, 2008, J BIOTECHNOL, V136, P91, DOI 10.1016/j.jbiotec.2008.06.003; Krober M, 2009, J BIOTECHNOL, V142, P38, DOI 10.1016/j.jbiotec.2009.02.010; Liao BQ, 2006, CRIT REV ENV SCI TEC, V36, P489, DOI 10.1080/10643380600678146; Ma JX, 2013, PROCESS BIOCHEM, V48, P510, DOI 10.1016/j.procbio.2013.02.003; Ma JX, 2013, WATER RES, V47, P859, DOI 10.1016/j.watres.2012.11.013; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Nelson MC, 2011, BIORESOURCE TECHNOL, V102, P3730, DOI 10.1016/j.biortech.2010.11.119; Padmasiri SI, 2007, WATER RES, V41, P134, DOI 10.1016/j.watres.2006.09.021; Riviere D, 2009, ISME J, V3, P700, DOI 10.1038/ismej.2009.2; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Wang ZW, 2013, BIOTECHNOL ADV, V31, P1187, DOI 10.1016/j.biotechadv.2013.02.004; Xu ML, 2011, BIORESOURCE TECHNOL, V102, P5617, DOI 10.1016/j.biortech.2011.02.038; Yu HG, 2013, CHEM ENG J, V231, P206, DOI 10.1016/j.cej.2013.07.012; Yukselen MA, 1997, J ENVIRON SCI HEAL A, V32, P2069; Zhang T, 2012, ISME J, V6, P1137, DOI 10.1038/ismej.2011.188; Zhang XY, 2010, CHEM ENG J, V165, P175, DOI 10.1016/j.cej.2010.09.013; Zheng D, 2000, MICROBIAL ECOL, V39, P246	34	53	53	3	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93710	10.1371/journal.pone.0093710	http://dx.doi.org/10.1371/journal.pone.0093710			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695488	Green Submitted, Green Published, gold			2022-12-25	WOS:000334103000109
J	Kim, MC; Lee, SW; Ryu, DY; Cui, FJ; Bhak, J; Kim, Y				Kim, Myung-Chul; Lee, Seung-Woo; Ryu, Doug-Young; Cui, Feng-Ji; Bhak, Jong; Kim, Yongbaek			Identification and Characterization of MicroRNAs in Normal Equine Tissues by Next Generation Sequencing	PLOS ONE			English	Article							ADIPOSE-TISSUE; EXPRESSION; HORSE; RNA; PRINCIPLES; DISORDERS; MIR-17-92; CARTILAGE; GENOMICS; PLANT	The role of microRNAs (miRNAs) as a post-transcriptional gene regulator has been elucidated in a broad range of organisms including domestic animals. Characterization of miRNAs in normal tissues is an important step to investigate the functions of miRNAs in various physiological and pathological conditions. Using Illumina Next Generation Sequencing (NGS) technology, we identified a total of 292 known and 329 novel miRNAs in normal horse tissues including skeletal muscle, colon and liver. Distinct sets of miRNAs were differentially expressed in a tissue-specific manner. The miRNA genes were distributed across all the chromosomes except chromosomes 29 and 31 in the horse reference genome. In some chromosomes, multiple miRNAs were clustered and considered to be polycistronic transcript. A base composition analysis showed that equine miRNAs had a higher frequency of A+U than G+C. Furthermore, U tended to be more frequent at the 59 end of miRNA sequences. This is the first experimental study that identifies and characterizes the global miRNA expression profile in normal horse tissues. The present study enriches the horse miRNA database and provides useful information for further research dissecting biological functions of miRNAs in horse.	[Kim, Myung-Chul; Cui, Feng-Ji; Kim, Yongbaek] Seoul Natl Univ, Coll Vet Med, Clin Pathol Lab, Seoul, South Korea; [Lee, Seung-Woo; Ryu, Doug-Young] Seoul Natl Univ, Coll Vet Med, Lab Environm Hlth, Seoul, South Korea; [Ryu, Doug-Young; Kim, Yongbaek] Seoul Natl Univ, Coll Vet Med, Res Inst Vet Sci, Seoul, South Korea; [Bhak, Jong] Theragen Bio Inst, Suwon, Gyeonggi Do, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, Y (corresponding author), Seoul Natl Univ, Coll Vet Med, Clin Pathol Lab, Seoul, South Korea.	yongbaek@snu.ac.kr			Bio-industry Technology Development Program of iPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries), Ministry of Agriculture, Food and Rural Affairs, Republic of Korea [1111594]; Brain Korea 21 Plus Program for Creative Veterinary Science Research, College of Veterinary Medicine, Seoul National University	Bio-industry Technology Development Program of iPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries), Ministry of Agriculture, Food and Rural Affairs, Republic of Korea; Brain Korea 21 Plus Program for Creative Veterinary Science Research, College of Veterinary Medicine, Seoul National University	This study was supported by Bio-industry Technology Development Program (Grant no. 1111594) of iPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries), Ministry of Agriculture, Food and Rural Affairs, Republic of Korea. Myung-Chul Kim and Seung-Woo Lee were additionally supported by the Brain Korea 21 Plus Program for Creative Veterinary Science Research, College of Veterinary Medicine, Seoul National University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai L, 2012, PARASITOL RES, V110, P2373, DOI 10.1007/s00436-011-2773-x; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Barrey E, 2010, EQUINE VET J, V42, P561, DOI 10.1111/j.2042-3306.2010.00267.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Boggs RM, 2008, MAMM GENOME, V19, P561, DOI 10.1007/s00335-008-9128-7; Boggs RM, 2007, GENE, V404, P25, DOI 10.1016/j.gene.2007.08.015; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chi XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027530; Chowdhary BP, 2008, ANIM REPROD SCI, V107, P208, DOI 10.1016/j.anireprosci.2008.04.010; Creighton CJ, 2009, BRIEF BIOINFORM, V10, P490, DOI 10.1093/bib/bbp019; Das PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056535; Dunn W, 2009, ARTHRITIS RHEUM-US, V60, P2333, DOI 10.1002/art.24678; Engels BM, 2006, ONCOGENE, V25, P6163, DOI 10.1038/sj.onc.1209909; Fleischhacker SN, 2013, VET J, V197, P688, DOI 10.1016/j.tvjl.2013.03.027; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; FREESTONE JF, 1991, EQUINE VET J, V23, P86, DOI 10.1111/j.2042-3306.1991.tb02726.x; GALUPPO LD, 1995, AM J VET RES, V56, P518; Gu ZL, 2007, FEBS LETT, V581, P981, DOI 10.1016/j.febslet.2007.01.081; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Ji ZB, 2012, MOL BIOL REP, V39, P9361, DOI 10.1007/s11033-012-1779-5; Jin WW, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-90; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lacourt M, 2012, OSTEOARTHR CARTILAGE, V20, P572, DOI 10.1016/j.joca.2012.02.004; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Li GX, 2011, J CELL BIOCHEM, V112, P1318, DOI 10.1002/jcb.23045; Li HL, 2012, MOL MED REP, V5, P1457, DOI 10.3892/mmr.2012.831; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Mair T., 2002, MANUAL EQUINE GASTRO; Mair TS, 2005, EQUINE VET J, V37, P296, DOI 10.2746/0425164054529409; McKenzie E, 2011, EQUINE VET J, V43, P637, DOI 10.1111/j.2042-3306.2011.00468.x; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Nicholas FW, 2003, NUCLEIC ACIDS RES, V31, P275, DOI 10.1093/nar/gkg074; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Song GS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007829; Thatcher EJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-253; Vila C, 2001, SCIENCE, V291, P474, DOI 10.1126/science.291.5503.474; Voelkerding KV, 2009, CLIN CHEM, V55, P641, DOI 10.1373/clinchem.2008.112789; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Wang LW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-154; Wei LQ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r53; West HJ, 1996, EQUINE VET J, V28, P146, DOI 10.1111/j.2042-3306.1996.tb01607.x; Yang Hong, 2010, Yichuan, V32, P211, DOI 10.3724/SP.J.1005.2010.00211; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhou M, 2009, GENOMICS, V94, P125, DOI 10.1016/j.ygeno.2009.04.006	48	28	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93662	10.1371/journal.pone.0093662	http://dx.doi.org/10.1371/journal.pone.0093662			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24988450	Green Published, Green Submitted, gold			2022-12-25	WOS:000334103000099
J	Zhang, YG; Qiu, L; Li, SJ; Xiang, YC; Chen, JY; Ren, YG				Zhang, Yiguo; Qiu, Lu; Li, Shaojun; Xiang, Yuancai; Chen, Jiayu; Ren, Yonggang			The C-Terminal Domain of Nrf1 Negatively Regulates the Full-Length CNC-bZIP Factor and Its Shorter Isoform LCR-F1/Nrf1 beta; Both Are Also Inhibited by the Small Dominant-Negative Nrf1 gamma/delta Isoforms that Down-Regulate ARE-Battery Gene Expression	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NRF1; TNF-ALPHA PROMOTER; OXIDATIVE STRESS; PROTEASOMAL DEGRADATION; ENDOPLASMIC-RETICULUM; TARGETED DISRUPTION; EMBRYONIC LETHALITY; BINDING DOMAIN; BETA-TRCP; KEAP1	The C-terminal domain (CTD, aa 686-741) of nuclear factor-erythroid 2 p45-related factor 1 (Nrf1) shares 53% amino acid sequence identity with the equivalent Neh3 domain of Nrf2, a homologous transcription factor. The Neh3 positively regulates Nrf2, but whether the Neh3-like (Neh3L) CTD of Nrf1 has a similar role in regulating Nrf1-target gene expression is unknown. Herein, we report that CTD negatively regulates the full-length Nrf1 (i.e. 120-kDa glycoprotein and 95-kDa deglycoprotein) and its shorter isoform LCR-F1/Nrf1 beta (55-kDa). Attachment of its CTD-adjoining 112-aa to the C-terminus of Nrf2 yields the chimaeric Nrf2-C112(Nrf1) factor with a markedly decreased activity. Live-cell imaging of GFP-CTD reveals that the extra-nuclear portion of the fusion protein is allowed to associate with the endoplasmic reticulum (ER) membrane through the amphipathic Neh3L region of Nrf1 and its basic c-tail. Thus removal of either the entire CTD or the essential Neh3L portion within CTD from Nrf1, LCR-F1/Nrf1 beta and Nrf2-C112(Nrf1), results in an increase in their transcriptional ability to regulate antioxidant response element (ARE)-driven reporter genes. Further examinations unravel that two smaller isoforms, 36-kDa Nrf1 gamma and 25-kDa Nrf1 delta, act as dominant-negative inhibitors to compete against Nrf1, LCR-F1/Nrf1 beta and Nrf2. Relative to Nrf1, LCR-F1/Nrf1 beta is a weak activator, that is positively regulated by its Asn/Ser/Thr-rich (NST) domain and acidic domain 2 (AD2). Like AD1 of Nrf1, both AD2 and NST domain of LCR-F1/Nrf1 beta fused within two different chimaeric contexts to yield Gal4D:Nrf1 beta(607) and Nrf1 beta:C270(Nrf2), positively regulate their transactivation activity of cognate Gal4- and Nrf2-target reporter genes. More importantly, differential expression of endogenous ARE-battery genes is attributable to up-regulation by Nrf1 and LCR-F1/Nrf1 beta and down-regulation by Nrf1 gamma and Nrf1 delta.	[Zhang, Yiguo] Chongqing Univ, Coll Med Bioengn, Lab Cell Biochem & Gene Regulat, Chongqing 630044, Peoples R China; Chongqing Univ, Fac Life Sci, Chongqing 630044, Peoples R China	Chongqing University; Chongqing University	Zhang, YG (corresponding author), Chongqing Univ, Coll Med Bioengn, Lab Cell Biochem & Gene Regulat, Chongqing 630044, Peoples R China.	yiguozhang@cqu.edu.cn		Jia, Jianping/0000-0003-4624-0336; Zhang, Yujuan/0000-0002-3243-1644; Zhang, Yiguo/0000-0003-3910-2779; Hayes, John/0000-0002-2927-5548	National Natural Science Foundation of China [91129703, 31270879]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (key program 91129703 and project 31270879) awarded to Prof. Yiguo Zhang (University of Chongqing, China). The authors state that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2012, ONCOGENE, V31, P3051, DOI 10.1038/onc.2011.484; Bean TL, 1997, NUCLEIC ACIDS RES, V25, P2509, DOI 10.1093/nar/25.12.2509; CATERINA JJ, 1994, NUCLEIC ACIDS RES, V22, P2383, DOI 10.1093/nar/22.12.2383; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11371, DOI 10.1073/pnas.90.23.11371; Chan JY, 1998, EMBO J, V17, P1779, DOI 10.1093/emboj/17.6.1779; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Chen LY, 2003, MOL CELL BIOL, V23, P4673, DOI 10.1128/MCB.23.13.4673-4686.2003; Chepelev NL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029167; Chowdhry S, 2013, ONCOGENE, V32, P3765, DOI 10.1038/onc.2012.388; Farmer SC, 1997, GENE DEV, V11, P786, DOI 10.1101/gad.11.6.786; Grimberg KB, 2011, MOL CELL BIOL, V31, P897, DOI 10.1128/MCB.00799-10; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; Higgins LG, 2009, TOXICOL APPL PHARM, V237, P267, DOI 10.1016/j.taap.2009.03.005; Hirotsu Y, 2012, MOL CELL BIOL, V32, P2760, DOI 10.1128/MCB.06706-11; Huang CF, 2000, J BIOL CHEM, V275, P12313, DOI 10.1074/jbc.275.16.12313; Husberg C, 2001, J BIOL CHEM, V276, P17641, DOI 10.1074/jbc.M007951200; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Johnsen O, 1996, NUCLEIC ACIDS RES, V24, P4289, DOI 10.1093/nar/24.21.4289; Johnsen O, 1998, NUCLEIC ACIDS RES, V26, P512, DOI 10.1093/nar/26.2.512; Katoh Y, 2001, GENES CELLS, V6, P857, DOI 10.1046/j.1365-2443.2001.00469.x; Kim J, 2010, PHYSIOL GENOMICS, V40, P100, DOI 10.1152/physiolgenomics.00105.2009; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi A, 2011, GENES CELLS, V16, P692, DOI 10.1111/j.1365-2443.2011.01522.x; Koch A, 2011, CELL CYCLE, V10, P1200, DOI 10.4161/cc.10.8.15327; Kusunoki H, 2002, NAT STRUCT BIOL, V9, P252, DOI 10.1038/nsb771; Kwak MK, 2010, TOXICOL APPL PHARM, V244, P66, DOI 10.1016/j.taap.2009.08.028; Kwong EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048404; Kwong M, 1999, J BIOL CHEM, V274, P37491, DOI 10.1074/jbc.274.52.37491; Lee CS, 2011, P NATL ACAD SCI USA, V108, P8408, DOI 10.1073/pnas.1019209108; Leung L, 2003, J BIOL CHEM, V278, P48021, DOI 10.1074/jbc.M308439200; Li X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002119; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; LUNA L, 1994, GENOMICS, V22, P553, DOI 10.1006/geno.1994.1428; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; McMahon M, 2004, J BIOL CHEM, V279, P31556, DOI 10.1074/jbc.M403061200; McMahon M, 2006, J BIOL CHEM, V281, P24756, DOI 10.1074/jbc.M601119200; Nioi P, 2005, MOL CELL BIOL, V25, P10895, DOI 10.1128/MCB.25.24.10895-10906.2005; Novotny V, 1998, NUCLEIC ACIDS RES, V26, P5480, DOI 10.1093/nar/26.23.5480; Ogura T, 2010, P NATL ACAD SCI USA, V107, P2842, DOI 10.1073/pnas.0914036107; Ohtsuji M, 2008, J BIOL CHEM, V283, P33554, DOI 10.1074/jbc.M804597200; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Prieschl EE, 1998, NUCLEIC ACIDS RES, V26, P2291, DOI 10.1093/nar/26.10.2291; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Rupert PB, 1998, NAT STRUCT BIOL, V5, P484, DOI 10.1038/nsb0698-484; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; SAKURAI A, 1990, MOL ENDOCRINOL, V4, P1988, DOI 10.1210/mend-4-12-1988; Schultz MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087204; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Tong KI, 2006, BIOL CHEM, V387, P1311, DOI 10.1515/BC.2006.164; Tsuchiya Y, 2013, MOL CELL BIOL, V33, P3461, DOI 10.1128/MCB.01271-12; Tsuchiya Y, 2011, MOL CELL BIOL, V31, P4500, DOI 10.1128/MCB.05663-11; Wang HY, 2013, CANCER RES, V73, P3097, DOI 10.1158/0008-5472.CAN-12-3386; Wang WP, 2007, J BIOL CHEM, V282, P24670, DOI 10.1074/jbc.M700159200; Wang WP, 2006, J BIOL CHEM, V281, P19676, DOI 10.1074/jbc.M602802200; Wu JL, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-9; Xiao H, 2013, CURR CHEM BIOL, V7, P151, DOI [DOI 10.2174/2212796811307020008, 10.2174/2212796811307020008]; Xu CJ, 2006, CANCER RES, V66, P8293, DOI 10.1158/0008-5472.CAN-06-0300; Xu ZR, 2005, P NATL ACAD SCI USA, V102, P4120, DOI 10.1073/pnas.0500660102; Yang HP, 2005, MOL CELL BIOL, V25, P5933, DOI 10.1128/MCB.25.14.5933-5946.2005; Zhang J, 2007, BIOCHEM J, V404, P459, DOI 10.1042/BJ20061611; Zhang Y, 2014, MS1305858; Zhang YG, 2001, J BIOL CHEM, V276, P11775, DOI 10.1074/jbc.M006000200; Zhang Y, 2007, BIOCHEM J, V408, P161, DOI 10.1042/BJ20070761; Zhang YG, 2006, BIOCHEM J, V399, P373, DOI 10.1042/BJ20060725; Zhang YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093458; Zhang YG, 2013, SCI REP-UK, V3, DOI 10.1038/srep02006; Zhang YG, 2009, BIOCHEM J, V418, P293, DOI 10.1042/BJ20081575; Zhang Y, 2009, J BIOL CHEM, V284, P3195, DOI 10.1074/jbc.M805337200; [张玉台 Zhang Yutai], 2009, [管理世界, Management World], P1; Zhong YW, 2012, J BIOL CHEM, V287, P28057, DOI 10.1074/jbc.M112.381798	71	446	470	16	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109159	10.1371/journal.pone.0109159	http://dx.doi.org/10.1371/journal.pone.0109159			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290918	Green Published, gold, Green Submitted			2022-12-25	WOS:000342798000041
J	Zhang, YJ; Wang, DM; Yang, LN; Zhou, D; Zhang, JF				Zhang, Yujuan; Wang, Dongmei; Yang, Lina; Zhou, Dan; Zhang, Jingfang			Purification and Characterization of Flavonoids from the Leaves of Zanthoxylum bungeanum and Correlation between Their Structure and Antioxidant Activity	PLOS ONE			English	Article							ALDOSE REDUCTASE; DNA-DAMAGE; EXTRACTS; ALKYLAMIDES; PROTECTION; PERICARPS; QUERCETIN; CHROMATOGRAPHY; CONSTITUENTS; INHIBITION	Nine flavonoids were isolated and characterized from the leaves of Zanthoxylum bungeanum. Their structures were elucidated by spectroscopic techniques as quercetin (1), afzelin (2), quercitrin (3), trifolin (4), quercetin-3-O-beta-D-glucoside (5), isorhamnetin 3-O-alpha-L-rhamnoside (6), hyperoside (7), vitexin (8) and rutin (9). All compounds were isolated from the leaves of Z. bungeanum for the first time. Five compounds (2, 4, 5, 6 and 8) were found for the first time in the genus Zanthoxylum. To learn the mechanisms underlying its health benefits, in vitro (DPPH, ABTS, FRAP and lipid peroxidation inhibition assays) and in vivo (protective effect on Escherichia coli under peroxide stress) antioxidant activities of the nine flavonoids were measured. Quercetin and quercetin glycosides (compounds 1, 3, 5, 7, 9) showed the highest antioxidant activity. Structure-activity relationships indicated that the -OH in 49 position on the B ring and the -OH in 7 position on the A ring possessed high antioxidant activity; B ring and/or A ring with adjacent -OH groups could greatly increase their antioxidant ability. Also, due to the different structures of various flavonoids, they will certainly exhibit different antioxidant capacity when the reactions occur in solution or in oil-in-water emulsion. These findings suggest that Z. bungeanum leaves may have health benefits when consumed. It could become a useful supplement for pharmaceutical products and functional food ingredients in both nutraceutical and food industries as a potential source of natural antioxidants.	[Zhang, Yujuan; Wang, Dongmei; Yang, Lina; Zhou, Dan; Zhang, Jingfang] Northwest A&F Univ, Coll Forestry, Yangling, Peoples R China	Northwest A&F University - China	Wang, DM (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling, Peoples R China.	dmwli@163.com		Jia, Jianping/0000-0003-4624-0336; Zhang, Yujuan/0000-0002-3243-1644; Zhang, Yiguo/0000-0003-3910-2779; Hayes, John/0000-0002-2927-5548	Special Fund for Forestry Scientific Research in the Public Interest of China [201304811]; Fundamental Research Funds for the Central Universities [ZD2013010]	Special Fund for Forestry Scientific Research in the Public Interest of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The authors are grateful to the research fund from the Special Fund for Forestry Scientific Research in the Public Interest of China (201304811) and the Fundamental Research Funds for the Central Universities (ZD2013010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aherne SA, 2000, FREE RADICAL BIO MED, V29, P507, DOI 10.1016/S0891-5849(00)00360-9; Azimova SS, 2013, PHYSICOCHEMCIAL PHAR; Bauer R, 2011, CURR CLIN UROL, P191, DOI 10.1007/978-1-60327-420-3_10; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Bourassa P, 2013, J PHOTOCH PHOTOBIO B, V128, P43, DOI 10.1016/j.jphotobiol.2013.07.021; Chang ZQ, 1981, ACTA PHARM SINICA, V16, P394; Costantino L, 1997, EXPERT OPIN THER PAT, V7, P843, DOI 10.1517/13543776.7.8.843; de Freitas V, 2001, J AGR FOOD CHEM, V49, P940, DOI 10.1021/jf000981z; Decker EA, 2005, J AGR FOOD CHEM, V53, P4303, DOI 10.1021/jf058012x; [邓振义 Deng Zhenyi], 2005, [西北林学院学报, Journal of Northwest Forestry College], V20, P179; Dhar P, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-259; Dorman H. J. D., 1995, Journal of Essential Oil Research, V7, P645; Dubeau S, 2010, FOOD CHEM, V122, P539, DOI 10.1016/j.foodchem.2010.03.005; Duke J. A., 1985, MED PLANTS CHINA, P705; Ferrali M, 1997, FEBS LETT, V416, P123, DOI 10.1016/S0014-5793(97)01182-4; GALVEZ J, 1993, J PHARM PHARMACOL, V45, P157, DOI 10.1111/j.2042-7158.1993.tb03706.x; Gouveia S, 2012, PHYTOCHEM ANALYSIS, V23, P72, DOI 10.1002/pca.1326; Harwood M, 2007, FOOD CHEM TOXICOL, V45, P2179, DOI 10.1016/j.fct.2007.05.015; HUANG XL, 1993, PHYTOTHER RES, V7, P41, DOI 10.1002/ptr.2650070111; Ibrahim LF, 2002, MOLECULES, V7, P245; Jung HA, 2011, FOOD CHEM TOXICOL, V49, P376, DOI 10.1016/j.fct.2010.11.012; KIMUYA Y, 1981, CHEM PHARM BULL, V29, P2610; Lee KW, 2003, J AGR FOOD CHEM, V51, P6516, DOI 10.1021/jf034475w; Li H, 2012, FOOD CHEM, V135, P2942, DOI 10.1016/j.foodchem.2012.07.048; Li Y, 2001, Zhong Yao Cai, V24, P572; Ma XF, 2005, J CHROMATOGR A, V1070, P211, DOI 10.1016/j.chroma.2005.02.052; Matsuda H, 2002, CHEM PHARM BULL, V50, P788, DOI 10.1248/cpb.50.788; Melidou M, 2005, FREE RADICAL BIO MED, V39, P1591, DOI 10.1016/j.freeradbiomed.2005.08.009; Miguel G, 2004, FOOD CHEM, V86, P183, DOI 10.1016/j.foodchem.2003.08.031; MIZUTANI K, 1988, CHEM PHARM BULL, V36, P2362, DOI 10.1248/cpb.36.2362; Nassar M. I., 2010, Revista Latinoamericana de Quimica, V38, P103; Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418; OSHIMA R, 1982, CARBOHYD RES, V107, P169, DOI 10.1016/S0008-6215(00)80536-4; Rastelli G, 2000, BIOORGAN MED CHEM, V8, P1151, DOI 10.1016/S0968-0896(00)00052-3; Ren L, 1981, XAOXUE XUEBAO, V16, P672; RiceEvans CA, 1997, TRENDS PLANT SCI, V2, P152, DOI 10.1016/S1360-1385(97)01018-2; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Rodriguez P, 2010, FITOTERAPIA, V81, P1220, DOI 10.1016/j.fitote.2010.08.007; Smirnova GV, 2010, WORLD J MICROB BIOT, V26, P2269, DOI 10.1007/s11274-010-0417-4; Smirnova GV, 2009, FREE RADICAL BIO MED, V46, P759, DOI 10.1016/j.freeradbiomed.2008.11.017; Tachakittirungrod S, 2007, FOOD CHEM, V103, P381, DOI 10.1016/j.foodchem.2006.07.034; Tirillini B., 1994, Journal of Essential Oil Research, V6, P249; TK Lim, 2012, ZANTHOXYLUM SIMULANS, P904; Urzhumtsev A, 1997, STRUCTURE, V5, P601, DOI 10.1016/S0969-2126(97)00216-5; Wang DM, 2013, ALLELOPATHY J, V32, P67; Wang S, 2011, J LIQ CHROMATOGR R T, V34, P2640, DOI 10.1080/10826076.2011.593219; Watjen W, 2005, J NUTR, V135, P525, DOI 10.1093/jn/135.3.525; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; XIONG QB, 1995, PHYTOCHEMISTRY, V39, P723, DOI 10.1016/0031-9422(94)00965-V; Xiong QB, 1997, PHYTOCHEMISTRY, V46, P1123, DOI 10.1016/S0031-9422(97)84398-1; Xu HR, 2010, TEXTBOOK OF PERINATAL EPIDEMIOLOGY, P111; Yang LC, 2013, J AGR FOOD CHEM, V61, P1772, DOI 10.1021/jf3042825; Yang XG, 2008, J AGR FOOD CHEM, V56, P1689, DOI 10.1021/jf0728101; YEN GC, 1995, J AGR FOOD CHEM, V43, P27, DOI 10.1021/jf00049a007; Yeung H., 1985, HDB CHINESE HERBS FO, VVolume 1; Zhou X, 2005, J CHROMATOGR A, V1092, P216, DOI 10.1016/j.chroma.2005.07.064	56	446	470	16	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105725	10.1371/journal.pone.0105725	http://dx.doi.org/10.1371/journal.pone.0105725			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25290918	Green Submitted, Green Published, gold			2022-12-25	WOS:000341303200055
